author_id,created_at,entities_cashtags,entities_hashtags,entities_urls,tweet_id,possibly_sensitive,public_metrics_like_count,public_metrics_quote_count,public_metrics_reply_count,public_metrics_retweet_count,source,text,entities_mentions,in_reply_to_user_id,created_at_user,location,name,profile_image_url,public_metrics_followers_count,public_metrics_following_count,public_metrics_listed_count,public_metrics_tweet_count,username,media_type
121193853,2021-09-30 17:59:02,,,"dlvr.it/S8h97Q, ",1443696916668182547,False,0,0,0,0,dlvr.it,"New job posting:  Research Scientist, Antibody Pharmacology (6-12 Month Work Contract) - Incyte Corporation - Wilmington, DE https://t.co/83u9ha8LrH",,,2010-03-08 13:38:25,"Alexandria, VA",ASCPT Alexandria,https://pbs.twimg.com/profile_images/887708754527088640/WMcvsw3m_normal.jpg,1524,328,20,8323,ASCPT_ClinPharm,
55654926,2021-09-30 17:49:18,,"cholangiocarcinoma, ","cholangiocarcinoma.org/pdf/CCA_Intera‚Ä¶, pic.twitter.com/vqSzOPlsTK, ",1443694469593935873,False,12,1,0,4,Twitter Web App,"Most #cholangiocarcinoma patients experience an average of 14 symptoms that impact their daily lives. To help address the needs of the patient community, CCF and @Incyte are sharing insights from a 2019 survey. Discover more: https://t.co/eS48WorN6R. https://t.co/vqSzOPlsTK","Incyte, ",,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,video
898725111615823873,2021-09-30 15:55:45,,"COVID, ","pic.twitter.com/lH1SY70LC2, pic.twitter.com/lH1SY70LC2, ",1443665893293101076,False,9,0,1,3,Twitter for iPhone,"Looking for a #COVID test? Incyte Diagnostics is another place offering it. You do need a doctor‚Äôs referral for a test. 

Incyte Diagnostics also processes tests for clinics and other places in our community. They‚Äôre feeling the impacts of the current covid surge, too. @kxly4news https://t.co/lH1SY70LC2","kxly4news, ",,2017-08-18 21:55:38,"Spokane, WA",Elenee Dao KXLY,https://pbs.twimg.com/profile_images/1164680718334586881/L2Oi10O9_normal.jpg,1077,542,43,4150,Elenee_Dao,photo
478901594,2021-09-30 15:32:20,,,"square1radio.com, pic.twitter.com/OfiY72IDji, ",1443659998207352835,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Streaming On https://t.co/XL7Q5eebYQ https://t.co/OfiY72IDji,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
627695874,2021-09-30 15:01:01,"LLY, INCY, ",,"investorsobserver.com/news/stock-upd‚Ä¶, ",1443652117844070402,False,1,0,0,0,Twitter Web App,"Eli Lilly and Company $LLY and Incyte $INCY Announce Positive OLUMIANT Hair Regrowth Results from Alopecia Areata Trials

https://t.co/KRgfF2qoJW",,,2012-07-05 14:32:58,,InvestorsObserver,https://pbs.twimg.com/profile_images/1389624586346631184/oPmFX5sq_normal.jpg,2110,48,47,13548,IOInvestors,
55654926,2021-09-30 14:00:49,,"cholangiocarcinoma, ","cholangiocarcinoma.org/newly-diagnose‚Ä¶, ",1443636968647270401,False,5,0,0,1,Meltwater Social,"Today is Rare Cancer Day!

A 2019 survey of people living with #cholangiocarcinoma revealed some of the challenges they face every day. Learn more: https://t.co/lVIDqEvydi. @Incyte","Incyte, ",,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,
18026170,2021-09-30 13:16:32,,"JAK, baricitinib, AlopeciaAreata, EADVCongress, ClinicalTrials, HairLoss, dermatology, ","investor.lilly.com/news-releases/‚Ä¶, pic.twitter.com/r3n2UCVps6, ",1443625825350426627,False,1,0,0,0,Twitter Web App,".@LillyPad &amp; @Incyte to share efficacy of #JAK inhibitor #baricitinib in severe #AlopeciaAreata at #EADVCongress

In 2 Ph3 #ClinicalTrials, see significant hair regrowth as early as 16 wks for 1 in 5 subjects (1 in 3 at 36 wks)

https://t.co/XpxxqjU0B7
#HairLoss #dermatology https://t.co/r3n2UCVps6","LillyPad, Incyte, ",,2008-12-10 13:29:19,"Midland, ON",DDNews Online,https://pbs.twimg.com/profile_images/1286709262287278080/SHRMveT5_normal.jpg,3372,439,86,13763,DDNewsOnline,photo
2252961132,2021-09-30 12:03:20,,"derminnovation, dermatology, ","finance.yahoo.com/news/incyte-an‚Ä¶, ",1443607403421962245,False,1,0,0,0,Agorapulse app,"Last week @Incyte announced that Opzelura‚Ñ¢ (ruxolitinib) Cream has become FDA approved. Opzelura is the first and only topical Janus kinase (JAK) inhibitor approved in the United States. 

Read more here: https://t.co/6OAclpUwPb

 #derminnovation #dermatology","Incyte, ",,2013-12-18 23:24:40,,Dermatology Advances,https://pbs.twimg.com/profile_images/651049705607069696/h65GwGxn_normal.jpg,1368,1257,59,774,AdvancingDerm,
25406480,2021-09-30 09:17:43,,,"awesomecapital.blogspot.com/2021/09/lilly-‚Ä¶, ",1443565723561955331,False,0,0,0,1,Twitter Web App,"AwesomeCapital: Lilly, Incyte : Olumiant Superior to Placebo in Sc... https://t.co/KRTDAWC6XY",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
72928001,2021-09-30 08:10:48,"INCY, ",,"bit.ly/3kWnSVO, ",1443548885289340932,False,0,0,0,0,BriefingInPlayLimited,"$INCY: Incyte and Eli Lilly (LLY) reports two pivotal Phase 3 trials, which found once-daily OLUMIANT 4-mg was... https://t.co/D6uXQBQ6cA",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
15296897,2021-09-30 07:00:59,"LLY, INCY, ",,"seekingalpha.com/news/3746463-l‚Ä¶, ",1443531315781857281,False,0,0,0,1,SANewsTwitter,"$LLY $INCY - Lilly, Incyte's Olumiant significantly improved hair regrowth in Phase 3 studies for alopecia areata https://t.co/RWpxhk5qSm",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1269758829690052610,2021-09-30 06:04:03,"LLY, INCY, ",,,1443516984935788546,False,0,0,0,0,Zapier.com,"Eli Lilly, Incyte present detailed BRAVE-AA1 and BRAVE-AA2 trial results at EADV
$LLY $INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
812004702594486272,2021-09-30 06:01:14,,"FDA, Jakafi, GVHD, ","checkrare.com/fda-approves-r‚Ä¶, ",1443516277490917378,False,2,0,0,0,Hootsuite Inc.,"The U.S. Food and Drug Administration #FDA approved ruxolitinib #Jakafi  to treat chronic graft-versus-host disease #GVHD after failure of one or two lines of systemic therapy in patients 12 years and older. @US_FDA US FDA News FDA @Incyte Incyte Incyte 
https://t.co/NN9yKbRYOk","US_FDA, Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1297934794588737542,2021-09-30 05:59:56,"INCY, ","Biotech, General, News, ",,1443515951979196418,False,0,0,0,0,Twitter,"$INCY - Eli Lilly and Company And Incyte Announce OLUMIANT Significantly Improved Hair Regrowth To At Least 80% Scalp Coverage As Early As 24 Weeks Across First Completed Phase 3 Studies For Alopecia Areata

#Biotech #General #News",,,2020-08-24 12:32:36,"Johnson City, VA",REAL-TIME STOCK NEWS ALERT,https://pbs.twimg.com/profile_images/1442405465187487750/P_pMmnxE_normal.jpg,212,39,2,7388,FactCheckBot5,
374729426,2021-09-30 00:41:23,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/3061890, pic.twitter.com/440vWNww7j, ",1443435783969337347,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on September 22, 2021. View odds for this and other indicators: https://t.co/wPoAxqFUir #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/440vWNww7j",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
20067285,2021-09-29 21:00:43,,,"ow.ly/Bm5U50GfuGj, ",1443380252969943045,False,0,0,0,0,Hootsuite Inc.,The Food and Drug Administration has approved Incyte‚Äôs Opzelura (ruxolitinib) cream for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised patients. https://t.co/RgVxeZdztz,,,2009-02-04 11:40:09,"New York, NY",Drug Store News,https://pbs.twimg.com/profile_images/1449075795281031169/WZevJXO6_normal.jpg,11961,897,327,31332,DrugStoreNews,
1321134820894846976,2021-09-29 18:57:07,"INCY, ",,"endpts.com/inctyes-ruxoli‚Ä¶, ",1443349146132533249,False,0,0,0,0,Twitter Web App,"$INCY Incyte's ruxolitinib scores its second approval in two days, this time in chronic graft-versus-host disease - https://t.co/OgFk3Qjlt4",,,2020-10-27 13:01:17,"Atlanta, GA",Venture Investment Partners,https://pbs.twimg.com/profile_images/1363833220983357440/aJTCMLF__normal.jpg,3253,3773,26,59540,GeorgeB14941177,
726470882,2021-09-29 16:53:45,,"PrixGalien, ","pic.twitter.com/QCgThtNPxR, ",1443318101311959052,False,0,0,0,0,Twitter Web App,".@Incyte is a #PrixGalien nominee for Pemazyre¬Æ (pemigatinib), a small molecule inhibitor of FGFR 1, 2 and 3 kinases that blocks FGFR phosphorylation and signaling and decreases the viability of cells expressing FGFR gene alterations in preclinical models. https://t.co/QCgThtNPxR","Incyte, ",,2012-07-30 13:19:05,"New York, New York",The Galien Foundation,https://pbs.twimg.com/profile_images/910249286796967936/us4E5IPb_normal.jpg,2080,2464,97,4409,GalienFdn,photo
2656754371,2021-09-29 16:00:59,,"monoclonalantibody, clinicalresearch, collaboration, Partnerships, GvHD, ","Pharm2Market.app, fiercebiotech.com/biotech/syndax‚Ä¶, ",1443304820824236032,False,0,0,0,0,SocialPilot.co,"Syndax and Incyte, both reeling from cancer drug setbacks, pen chronic graft-versus-host disease collab - More stories like this at https://t.co/Ch0OzV8Nyh | @Incyte @Syndax #monoclonalantibody #clinicalresearch #collaboration #Partnerships #GvHD https://t.co/JQlmhP7z4w","Incyte, Syndax, ",,2014-07-18 09:20:39,San Diego,Aspen Biosciences,https://pbs.twimg.com/profile_images/1006725217568186368/B34yK1F1_normal.jpg,316,725,33,6079,aspenbio,
1029128656650555393,2021-09-29 16:00:59,,"monoclonalantibody, clinicalresearch, collaboration, Partnerships, GvHD, ","Pharm2Market.app, j.mp/39F76V3, ",1443304820761403394,False,0,0,0,0,SocialPilot.co,"Syndax and Incyte, both reeling from cancer drug setbacks, pen chronic graft-versus-host disease collab - More stories like this at https://t.co/7hAuMonHwn | @Incyte @Syndax #monoclonalantibody #clinicalresearch #collaboration #Partnerships #GvHD https://t.co/HjOhvIpBjo","Incyte, Syndax, ",,2018-08-13 18:12:46,,Pharm2Market,https://pbs.twimg.com/profile_images/1041479880368484353/xr9ZBpXF_normal.jpg,190,849,2,2538,pharm2market,
1286635807,2021-09-29 15:50:42,"INCY, ","corpgov, ","bit.ly/2Wnchpp, ",1443302232540205070,False,0,0,0,0,Twitter Web App,"Incyte adds Otis W. Brawley (Fmr Chief Medical and Scientific Officer, American Cancer Society) to Board $INCY #corpgov https://t.co/bQhTvosShV",,,2013-03-21 14:20:50,Chicago,JamesDruryPartners,https://pbs.twimg.com/profile_images/948933059935657984/4zARxdMk_normal.jpg,200,34,10,11520,JDruryPartners,
3911174913,2021-09-29 14:05:44,,"EADVCongress, atopicdermatitis, eczema, ","bit.ly/39MltGT, pic.twitter.com/gU2vZJJHWN, ",1443275820190076930,False,19,0,0,2,Twitter Web App,"Tomorrow at the #EADVCongress, we are presenting data from our Phase 3 TRuE-AD program in patients with #atopicdermatitis (#eczema). Learn more.¬†https://t.co/INrXosjJvC https://t.co/gU2vZJJHWN",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
889321711966998528,2021-09-29 13:17:43,,"stemcell, transplant, Immunotherapy, GeneOnline, ","geneonline.com/syndax-incyte-‚Ä¶, ",1443263734701568001,False,2,0,0,0,Twitter Web App,".@Syndax Pharmaceuticals and @Incyte announce collaboration to develop and commercialize the former‚Äôs anti-CSF-1R monoclonal antibody for cGVHD

#stemcell #transplant #Immunotherapy #GeneOnline

https://t.co/8je3EdqyJG","Syndax, Incyte, ",,2017-07-23 23:09:53,"Santa Clara, CA",GeneOnline,https://pbs.twimg.com/profile_images/1290669170913312769/KyH5AwCK_normal.jpg,4796,4702,12,3813,GeneOnlineNews,
33360563,2021-09-29 13:00:02,,,"aishealth.com/datapoint/data‚Ä¶, ",1443259283013922818,False,0,0,0,0,TweetDeck,"Datapoint: FDA approved @Incyte's JAK inhibitor Jakafi for treatment of chronic GVHD in patients that have not responded to 1 or 2 other lines of systemic therapy. Jakafi, approved for acute GVHD, holds covered or better status for 70% of insured lives.
https://t.co/vz3vEVeubf","Incyte, ",,2009-04-19 21:00:03,"Washington, D.C.",AIS Health,https://pbs.twimg.com/profile_images/1392526145581555714/q1iVOtaD_normal.jpg,2984,1202,155,9861,AISHealth,
280747092,2021-09-29 11:09:52,,,"businesswire.com/news/home/2021‚Ä¶, ",1443231558052294659,False,0,0,0,0,GetCurata,Incyte Names New Member to Its Board of Directors https://t.co/cZyqMjPtNZ,,,2011-04-11 19:23:47,Boston,BoardProspects,https://pbs.twimg.com/profile_images/508236277636816896/vI0RH0Lw_normal.png,2728,2031,78,20335,BoardProspects,
478901594,2021-09-29 10:22:31,,,"square1radio.com, pic.twitter.com/4mAun4NKKC, ",1443219644358307842,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5eebYQ https://t.co/4mAun4NKKC,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
3911174913,2021-09-29 10:06:35,,"dermatology, EADVCongress, ","bit.ly/3zPnpJn, pic.twitter.com/34pT38zwf8, ",1443215635887140864,False,14,0,1,3,Twitter Web App,We are presenting key data from our #dermatology portfolio at the #EADVCongress. Learn more about our accepted posters. https://t.co/Pm63unfaul https://t.co/34pT38zwf8,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1943734777,2021-09-29 08:24:03,,,"dlvr.it/S8ZcNd, ",1443189832415539204,False,0,0,0,0,dlvr.it,Syndax and Incyte to develop axatilimab for fibrotic diseases https://t.co/NegRxfKmnH,,,2013-10-07 06:37:25,Grimsby,Pharma Business Int,https://pbs.twimg.com/profile_images/1184014435368742913/DxTdM0oY_normal.jpg,290,42,9,4775,PBIForum,
633824212,2021-09-29 05:14:10,,,"ift.tt/3F52GFw, Theflyonthewall.com, ",1443142045388972033,False,0,0,0,0,IFTTT,"Incyte management to meet virtually with Oppenheimer https://t.co/bKRL5ZGBfK See the rest of the story here.

https://t.co/tnMXlCjEqv provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps indivi‚Ä¶",,,2012-07-12 11:31:45,NYC,flylemurs,https://pbs.twimg.com/profile_images/2393843079/wc5oiacqodhfzivmyvmh_normal.jpeg,37,32,4,129630,flylemurs,
633824212,2021-09-29 05:13:57,,,"ift.tt/3kQ3UMq, Theflyonthewall.com, ",1443141989554339847,False,0,0,0,0,IFTTT,"Incyte management to meet virtually with Oppenheimer https://t.co/OsDJNwXBMN See the rest of the story here.

https://t.co/tnMXlCjEqv provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps indivi‚Ä¶",,,2012-07-12 11:31:45,NYC,flylemurs,https://pbs.twimg.com/profile_images/2393843079/wc5oiacqodhfzivmyvmh_normal.jpeg,37,32,4,129630,flylemurs,
166539231,2021-09-29 04:33:19,,,"tinyurl.com/ydksguof, ",1443131763665129474,False,0,0,0,0,PressReleasePoint.Com,https://t.co/Dqs2ZdkrHD Incyte Names New Member to Its Board of Directors,,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
1207759186131652608,2021-09-29 01:09:00,,"FDA, Incyte, Ruxolitinib, AtopicDermatitis, Eczema, Opzelura, Dermatology, Cardiovascular, ","drugdiscoverytrends.com/incyte-wins-fd‚Ä¶, ",1443080347051233281,False,0,0,0,0,Sprout Social,"The #FDA has approved #Incyte‚Äôs #Ruxolitinib, a cream for short-term &amp; non-continuous chronic treatment of mild-to-moderate #AtopicDermatitis (#Eczema). 

https://t.co/9ErbNJr05x

#Opzelura #Dermatology #Cardiovascular @JonathanMd @ClevelandClinic @GW_OVPR @GWSMHS @Incyte","JonathanMd, ClevelandClinic, GW_OVPR, GWSMHS, Incyte, ",,2019-12-19 15:26:52,United States,Drug Discovery & Development,https://pbs.twimg.com/profile_images/1214216496043323393/Dk0NlVB__normal.jpg,462,96,2,791,DrugDiscoverDev,
1370731105674956800,2021-09-29 01:01:59,,,"postxnews.com/incyte-buys-in‚Ä¶, ",1443078580771037187,False,0,0,0,0,WordPress.com,Incyte buys into monoclonal antibody collab for $152M ‚Äì¬†DBT https://t.co/Oy5KXs9qOo,,,2021-03-13 08:39:11,"California, USA",PostX News,https://pbs.twimg.com/profile_images/1417120237774725122/_nsC30G7_normal.jpg,33,4,1,102590,xpostnews,
1315434407692509184,2021-09-29 00:37:05,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/yglHS9yg6P, ",1443072313365352449,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3045 out of 5597 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/yglHS9yg6P",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1134049078424162304,2021-09-28 18:35:56,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1442981430460489736,False,0,0,0,0,Newsfilter.io,Incyte adds Otis Brawley to its board of directors $INCY https://t.co/uzkuRGQ9IM,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1043127646828355584,2021-09-28 17:50:13,,,"bit.ly/2Yhc47P, pic.twitter.com/fPuaUlhYcp, ",1442969923903528960,False,1,0,0,0,Twitter Web App,"Join Atopic Dermatitis expert, Jonathan I. Silverberg, MD, PhD, MPH, virtually on October 7, 8:00 PM-9:30 PM (EST) for Atopic Dermatitis: The Burden of Disease, the JAK-STAT Pathway, and Recent Developments. The program is sponsored by Incyte Dermatology. https://t.co/LfG9x6gE4T https://t.co/fPuaUlhYcp",,,2018-09-21 09:19:46,Virtual Conference,Revolutionizing AD,https://pbs.twimg.com/profile_images/1044231557936963585/_NEg06uK_normal.jpg,151,37,2,326,RevAtopicDerm,photo
1281758467036811264,2021-09-28 17:42:12,,,"dataemia.com/?p=617949, pic.twitter.com/ciRXr8jg5E, ",1442967905285541909,False,0,0,0,0,MasMaz,Incyte Names New Member to Its Board of Directors - https://t.co/4Xp5jRoYF2 https://t.co/ciRXr8jg5E,,,2020-07-10 21:13:35,United States ,MasMaz,https://pbs.twimg.com/profile_images/1297036654163582981/IWV5OJ_7_normal.jpg,62,0,1,83701,MasMazCom,photo
360220091,2021-09-28 17:42:10,,,"dataemia.com/?p=617949, pic.twitter.com/En1LAombde, ",1442967898595627020,False,0,0,0,0,Newsemia,Incyte Names New Member to Its Board of Directors - https://t.co/0HO28ZHpZZ https://t.co/En1LAombde,,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,photo
1281661503947468801,2021-09-28 17:38:45,"INCY, ",,"fda.report/applications/2‚Ä¶, ",1442967036007641111,False,0,0,0,0,Twitter,FDA New Drug Application NDA215309 INCYTE CORP https://t.co/QT2yaYtrnM $INCY,,,2020-07-10 14:48:12,,FDA.report,https://pbs.twimg.com/profile_images/1281661789193646082/Yus3LqeB_normal.jpg,301,2,5,1473,fda_report,
4058194633,2021-09-28 17:35:55,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1442966324418793475,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Names New Member to Its Board of Directors | Business Wire https://t.co/A9K88xmjma,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
270492072,2021-09-28 17:22:17,,"news, SeekingAlpha, ","seekingalpha.com/news/3745541-i‚Ä¶, ",1442962894279217153,False,0,0,0,0,Microsoft Power Platform,Incyte adds Otis Brawley to its board of directors https://t.co/0C7EIrP8xx via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
963495628545327104,2021-09-28 17:17:43,"INCY, INCY, ",,"stck.pro/news/INCY/1592‚Ä¶, stck.pro/news/INCY, pic.twitter.com/axnqK5ZXUq, ",1442961744192622593,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Names New Member to Its Board of Directors https://t.co/jhTubGAGcT Get all the latest $INCY related news here : https://t.co/MBjnAUYXBx https://t.co/axnqK5ZXUq,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
472650465,2021-09-28 17:10:19,"INCY, ",,"otcdynamics.com/incy-incyte-na‚Ä¶, ",1442959884236910596,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Names New Member to Its Board of Directors https://t.co/p5NPKqbN0m,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
950010035396136962,2021-09-28 17:07:14,,"INCY, ",,1442959105975480321,False,0,0,0,0,Cresus AI,"Incyte Corporation (#INCY) closed at 68.68, score +379, credit rating B",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
976297820532518914,2021-09-28 17:07:09,,,"dlvr.it/S8XQY8, pic.twitter.com/8tDZIQ6Qri, ",1442959085561806849,False,0,0,0,0,dlvr.it,Incyte Names New Member to Its Board of Directors https://t.co/5G8Uu1J47C https://t.co/8tDZIQ6Qri,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1345717047456624643,2021-09-28 17:03:47,"INCY, ",,"investor.incyte.com/press-releases‚Ä¶, ",1442958239063175168,False,0,0,0,0,Twitter,$INCY Incyte Names New Member to Its Board of Directors https://t.co/oWnuIvNb0T,,,2021-01-03 08:03:02,,Phase Five,https://pbs.twimg.com/profile_images/1380078545557422084/S_k9w_Eq_normal.png,57,1,1,4349,phasefivebot,
1355194932445786112,2021-09-28 17:01:02,"INCY, ",,"tinyurl.com/yjbv53dw, ",1442957544511586304,False,0,0,0,0,Twitter,"$INCY Five9 Wins Best Application of AI Award at Enterprise Connect
https://t.co/AuGy3LDToY",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
3318510966,2021-09-28 17:00:56,,,"crweworld.com/article/news-p‚Ä¶, ",1442957521166082048,False,0,0,0,0,CRWE World,Incyte Names New Member to Its Board of Directors https://t.co/9k4pQxFPun,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1134049078424162304,2021-09-28 17:00:56,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1442957520599805955,False,0,0,0,0,Newsfilter.io,Incyte Names New Member to Its Board of Directors $INCY https://t.co/iCG4gCV8NA,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1254035253104181256,2021-09-28 17:00:16,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1442957352689278978,False,0,0,0,0,stocktitan,"$INCY Incyte Names New Member to Its Board of Directors
https://t.co/tPMuwUU7ec",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1393303407801294850,2021-09-28 17:00:04,"INCY, ",,"webchronicletoday.com/incyte-names-n‚Ä¶, ",1442957304136024064,False,0,0,0,0,Twitter,"$INCY Incyte Names New Member to Its Board of Directors
 
https://t.co/mwpdQiB6lP",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
1407357174423207941,2021-09-28 16:54:26,"INCY, ",,"ledge.bedrock-ai.com/dashboard?comp‚Ä¶, ",1442955884649320448,False,0,0,0,0,Twitter,"$INCY - There is no arrangement or understanding between Dr.¬†Brawley and any other person pursuant to which he was selected as a director of the Company, and there is no family relationship between...
https://t.co/NSL5WwHw2k",,,2021-06-22 11:18:52,Toronto,LedgeBot,https://pbs.twimg.com/profile_images/1407360068006428682/Yexr2CIF_normal.jpg,48,4,2,1930,BotLedge,
1171873456276889600,2021-09-28 16:48:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1442954477368012801,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (28 Sep, 4:48pm)

üì∞ Departure of Directors or Certain Officers; Election of Directors

https://t.co/bt2xYYcLDL

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1072907304767512581,2021-09-28 15:06:03,,"Medicine, ","briefly.co/anchor/Medicin‚Ä¶, ",1442928609509789699,False,0,0,0,0,MedicinePlow,"Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate (Entrepreneur)

This story originally appeared on ZacksIncyte recently entered into an exclusive worldwide c...

Add your highlights:
https://t.co/BmEZjXdERO
 #Medicine",,,2018-12-12 12:33:29,internet,Medicine Briefly,https://pbs.twimg.com/profile_images/1263257882319106048/v1sr7xnk_normal.jpg,1869,4829,6,5763,MedicineNews_b,
4635975621,2021-09-28 14:08:37,,"MERIWEATHERASSOC, ","dlvr.it/S8WxgP, pic.twitter.com/G4sd6zpcdy, ",1442914155262922754,False,0,0,0,0,dlvr.it,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/bRHOprGDJ7 #MERIWEATHERASSOC https://t.co/G4sd6zpcdy,,,2015-12-28 15:58:17,"Indianapolis, IN",WBMN Groovin' 24/7,https://pbs.twimg.com/profile_images/1301616281511243777/7dxBDcxe_normal.png,801,1749,40,315242,RadioBlackOn,photo
3297799818,2021-09-28 14:08:35,,,"dlvr.it/S8Wxfp, ",1442914148350763008,False,0,0,0,0,dlvr.it,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/mT3GMjS6Gz,,,2015-07-27 10:32:13,"Indiana, USA",Gregory Meriweather,https://pbs.twimg.com/profile_images/1373688720289849346/YKmJP4Ob_normal.jpg,60,172,1,31368,MastermindGM,
283746639,2021-09-28 14:08:35,,"Business, Startup, Success, ","dlvr.it/S8Wxdr, pic.twitter.com/d6GVNkwuUD, ",1442914147876802562,False,0,0,0,0,dlvr.it,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/4WtuRAZeCe #Business #Startup #Success https://t.co/d6GVNkwuUD,,,2011-04-17 19:17:14,,"Doug Brown, DBA",https://pbs.twimg.com/profile_images/691051165757394944/41WIkZaK_normal.jpg,989,1669,467,125949,dougbrownDBA,photo
40721566,2021-09-28 14:08:35,,,"dlvr.it/S8Wxdm, pic.twitter.com/83F76wiVPd, ",1442914147595739139,False,0,0,0,0,dlvr.it,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/8chwAjKqMu https://t.co/83F76wiVPd,,,2009-05-17 15:40:14,Canada,Ron,https://pbs.twimg.com/profile_images/1396716069373480960/TQqANv_h_normal.jpg,18837,20726,176,323935,ronmc1,photo
1107300023786786816,2021-09-28 14:08:35,,,"dlvr.it/S8Wxdy, pic.twitter.com/ebwxTpDlPx, ",1442914147490951171,False,0,0,0,0,dlvr.it,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/PKnGuVP3uj https://t.co/ebwxTpDlPx,,,2019-03-17 11:17:53,19006,Valley Green Web Design,https://pbs.twimg.com/profile_images/1140413216469737472/VWRgOWmw_normal.png,69,39,0,54393,valley_design,photo
3315909714,2021-09-28 14:08:35,,,"dlvr.it/S8Wxdh, pic.twitter.com/86C0Pm2OF2, ",1442914147289624588,False,0,0,0,0,dlvr.it,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/Z1ZRQmq9fy https://t.co/86C0Pm2OF2,,,2015-08-15 09:01:56,India,FoundersGyan,https://pbs.twimg.com/profile_images/691882374309765120/YKuqdr8Z_normal.jpg,10155,10582,412,177241,FoundersGyan,photo
920471194540953601,2021-09-28 14:08:35,,,"dlvr.it/S8Wxdk, pic.twitter.com/4QGXxUiynB, ",1442914147016970240,False,0,0,0,0,dlvr.it,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/Va4daKE2OW https://t.co/4QGXxUiynB,,,2017-10-17 22:06:49,"New Jersey, USA",Dragon Advantage,https://pbs.twimg.com/profile_images/975114197548777472/U2GBRaRQ_normal.jpg,70,0,2,116005,dragonadvantage,photo
931673612838244352,2021-09-28 14:08:35,,,"entrepreneur.com/article/388202‚Ä¶, pic.twitter.com/desPdI82SI, ",1442914146886979588,False,0,0,0,0,dlvr.it,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/DmavdO2MLd https://t.co/desPdI82SI,,,2017-11-17 19:01:13,"Henderson, NV",Business Solutions,https://pbs.twimg.com/profile_images/931674803219689474/HlcVmvhd_normal.jpg,46,8,1,50128,bizsolutionsvcs,photo
848712517467746306,2021-09-28 14:08:34,,,"dlvr.it/S8Wxcx, ",1442914144051630083,False,0,0,0,0,dlvr.it,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/Ti7ffSBV7r,,,2017-04-02 21:43:27,"Tuscaloosa, AL",VandalsSmile,https://pbs.twimg.com/profile_images/848713415430242304/1lcgEMxK_normal.jpg,218,1381,10,23065,VandalsSmile,
1368242615540416516,2021-09-28 14:08:34,,"Stocks, ","dlvr.it/S8Wxcr, ",1442914143699288074,False,0,0,0,1,dlvr.it,#Stocks Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/QSy1wNVEc4,,,2021-03-06 11:51:14,"Cairo, Egypt",WeFixIt Egypt,https://pbs.twimg.com/profile_images/1368242834495705088/hL00VftN_normal.jpg,11,0,1,13075,WefixitE,
1233104313771184129,2021-09-28 14:08:34,,"FaithDrivenVentureCapital, FaithDrivenInvestors, FaithDrivenEntrepreneurs, ","entrepreneur.com/article/388202‚Ä¶, ",1442914143422451713,False,0,0,0,1,dlvr.it,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/QkvZWw44To #FaithDrivenVentureCapital #FaithDrivenInvestors #FaithDrivenEntrepreneurs,,,2020-02-27 13:59:33,Vancouver & Worldwide,Faith Driven Venture Capital‚Ñ¢ üèî,https://pbs.twimg.com/profile_images/1275268107766923265/a-gmY-FT_normal.jpg,236,25,6,78576,FaithDrivenVC,
3657871,2021-09-28 14:08:31,,,"ift.tt/3kNs76c, ",1442914132143972354,False,0,0,0,0,IFTTT,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/XwSvhQm9Mn,,,2007-04-06 17:38:51,Madrid,Octavio Rojas,https://pbs.twimg.com/profile_images/682492412481122304/ZRUHXF2s_normal.jpg,7340,3326,657,107253,octaviorojas,
721209165243379712,2021-09-28 14:06:38,,,"ift.tt/1qEhOCr, ",1442913658271531009,False,0,0,0,0,IFTTT,Incyte (INCY) Collaborates With Syndax for Chronic GVHD Candidate https://t.co/zuuGKDcCbF,,,2016-04-16 01:30:39,"Summit, NJ","Matthew Abenante, IRC",https://pbs.twimg.com/profile_images/968532571847045120/RwTs6Jf9_normal.jpg,232,1173,2,35155,matt_ir_guru,
1315434407692509184,2021-09-28 12:35:07,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/o8y8VoB27I, ",1442890626933137418,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3045 out of 5598 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/o8y8VoB27I",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
55591433,2021-09-28 12:23:35,,"FDA, ","buff.ly/3zOaGqt, ",1442887722318778370,False,0,0,0,0,Buffer,"Pfizer receives an EUA for its COVID-19 booster, a biosimilar of Lucentis to treat macular degeneration is approved, Incyte receives two approvals for JAK inhibitors, one for atopic dermatitis and another for GVHD, and more #FDA news. 
https://t.co/MLQtRPv705",,,2009-07-10 11:37:25,,Managed Healthcare,https://pbs.twimg.com/profile_images/555038727743881216/Gx4WLgKf_normal.png,3550,460,247,13351,MHExecutive,
15974185,2021-09-28 12:04:34,,,"dlvr.it/S8WY0F, ",1442882939457400832,False,0,0,0,0,dlvr.it,Incyte and Syndax to jointly develop and commercialize axatilimab https://t.co/N1LU1ORy5Q,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
41352815,2021-09-28 11:10:31,"INCY, ",,"statnews.com/pharmalot/2021‚Ä¶, ",1442869334519418886,False,0,0,0,0,Twitter Web App,"This is a @statnews @edsilverman from Aug., but I have to say -- getting charged with insider trading to make $107,066 in ""illicit profits"" from an illegal stock trade on $INCY is not worth it. LESSON: DON'T DO INSIDER TRADING. 
https://t.co/mI8u5wepsE","statnews, edsilverman, ",,2009-05-20 08:58:52,New York,Kimberly Ha,https://pbs.twimg.com/profile_images/513184922342027264/_iqO3igB_normal.jpeg,1620,1567,136,10770,pharmaprodigy,
4058194633,2021-09-28 10:35:01,"INCY, SNDX, ",,"delawarebusinesstimes.com/news/incyte-sy‚Ä¶, ",1442860402744836111,False,0,0,0,0,Twitter for iPhone,$INCY $SNDX Incyte Buys Into Monoclonal Antibody Collaboration For $152M https://t.co/7dLSme1WgV,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
3147921735,2021-09-28 10:33:03,,,"buff.ly/3ofQGLi, pic.twitter.com/BdoRAS1oGD, ",1442859908458635265,False,1,0,0,0,Buffer,"Syndax and Incyte will develop axatilimab, an investigational therapy for idiopathic pulmonary fibrosis and other fibrotic diseases. https://t.co/gttAJUKkf7 https://t.co/BdoRAS1oGD",,,2015-04-08 09:48:04,"Pensacola, FL",Pulmonary Fibrosis News,https://pbs.twimg.com/profile_images/1267865203221430272/zT-EAwu3_normal.jpg,1788,275,21,6242,pulmonaryfibros,photo
3911174913,2021-09-28 09:42:54,,"Soaring76, ","bit.ly/3kKCUOq, pic.twitter.com/Jgf3nSQTws, ",1442847286908891143,False,17,0,0,4,Twitter Web App,Incyte has been recognized again by @PHLBizJournal as one of the fastest-growing companies in Philadelphia. #Soaring76 https://t.co/mUFXgVNqRF https://t.co/Jgf3nSQTws,"PHLBizJournal, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
32492934,2021-09-28 09:39:28,,,"bioworld.com/articles/51179‚Ä¶, ",1442846421057630211,False,1,0,0,0,TweetDeck,Syndax enters deal worth up to $602M with Incyte https://t.co/ME8tMWnVYp,,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
2384219072,2021-09-28 08:22:01,,"DEBIO, IWSTEM2021, ICYMI, Incyte, ","loom.ly/_hl2TMI, pic.twitter.com/5SmJxkT5Ku, ",1442826932438056960,False,0,0,0,0,Loomly,"Thank you #DEBIO member @Incyte for your Gold Sponsorship of #IWSTEM2021 on Oct. 14th! #ICYMI Dana Shuey, Ph.D. of #Incyte will be hosting a Mentors of the Day session!  Check it out: https://t.co/44gBlcWZyQ https://t.co/5SmJxkT5Ku","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
812004702594486272,2021-09-28 06:01:23,,"FDA, Jakafi, GVHD, ","checkrare.com/fda-approves-r‚Ä¶, ",1442791540192055302,False,1,0,0,0,Hootsuite Inc.,"The U.S. Food and Drug Administration #FDA approved ruxolitinib #Jakafi  to treat chronic graft-versus-host disease #GVHD after failure of one or two lines of systemic therapy in patients 12 years and older. @US_FDA US FDA News FDA @Incyte Incyte Incyte 
https://t.co/NN9yKbRYOk","US_FDA, Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
454898193,2021-09-28 05:35:36,,,"finance.yahoo.com/news/syndax-ph‚Ä¶, ",1442785051205410821,False,1,0,0,0,Twitter for Android,Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases https://t.co/8TTkIhupBa,,,2012-01-04 09:20:27,Buffalo,Philip McCarthy,https://pbs.twimg.com/profile_images/466351626219823104/K2IQ5P6I_normal.jpeg,3700,1013,89,7500,PLMcCarthyMD,
1325115160353103872,2021-09-28 05:20:33,"INCY, ",,"quantisnow.com/insight/181428‚Ä¶, ",1442781263505465347,False,0,0,0,0,Twitter,"$INCY ‚öïÔ∏è FDA Approval for JAKAFI issued to INCYTE CORP

https://t.co/YXLUUKBADS

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1889492676,2021-09-28 04:25:43,"SNDX, INCY, ","SyndaxPharmaceuticals, Incyte, Axatilimab, ","1stoncology.com/blog/syndax-ph‚Ä¶, ",1442767464035536896,False,0,0,0,0,Troi URL Plug-in,#SyndaxPharmaceuticals and #Incyte Announce Global Collaboration to Develop and Commercialize #Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases $SNDX $INCY https://t.co/lfmGE9Lr2Z,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
21079030,2021-09-28 04:02:24,,"PharmaScrip, ","bit.ly/3kMkc9l, ",1442761594992267267,False,0,0,0,0,Sprinklr,"Incyte, Syndax Team Up On Chronic GVHD, But Some Uncertainties Remain
https://t.co/wuYz1FtdVq #PharmaScrip",,,2009-02-17 05:33:29,Global,Scrip,https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg,21541,1629,654,35335,PharmaScrip,
1979190776,2021-09-28 02:33:24,"INCY, ",,"tickerreport.com/?p=7924785, ",1442739199979970564,False,0,0,0,0,Zapier.com,William Blair Equities Analysts Reduce Earnings Estimates for Incyte Co. $INCY https://t.co/FEfecZdIQe,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2280068370,2021-09-28 01:14:54,,,"bioworld.com/articles/51179‚Ä¶, ",1442719442203410436,False,0,0,0,0,Twitter Web App,Syndax enters deal worth up to $602M with Incyte https://t.co/qA9FSY0BIq,,,2014-01-07 00:14:17,Bangalore,Pushpita Deb,https://pbs.twimg.com/profile_images/873455113112666112/PBJskz-z_normal.jpg,33,114,61,1202,Pushpita_deb,
1134049078424162304,2021-09-28 01:10:52,"SNDX, INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1442718430763831297,False,0,0,0,0,Newsfilter.io,Incyte and Syndax in pact for xatilimab targeting immune-related conditions $SNDX $INCY https://t.co/OmtONzXCRS,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
478901594,2021-09-28 00:19:20,,,"square1radio.com, pic.twitter.com/VMmxiUm4QP, ",1442705461791297536,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Streaming On https://t.co/XL7Q5eebYQ https://t.co/VMmxiUm4QP,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1399103920522334219,2021-09-27 22:14:04,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/GNThqtHySD, ",1442673934428688386,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3045 out of 5598 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/GNThqtHySD",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
1134049078424162304,2021-09-27 21:51:53,"SNDX, INCY, ",,"newsfilter.io/articles/synda‚Ä¶, ",1442668351252312070,False,0,0,0,0,Newsfilter.io,"Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate $SNDX $INCY https://t.co/Xth8cEANBR",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
3426014292,2021-09-27 21:32:47,"SNDX, ",,,1442663544504438787,False,4,0,0,1,Twitter for iPhone,Baird/l $SNDX New Collaboration with Incyte on Axatilimab Is Positive; PT to $32 (+$1),,,2015-09-02 09:10:37,,dough,https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_normal.jpg,32805,529,852,59439,semodough,
46297868,2021-09-27 19:24:34,,,"dlvr.it/S8St6r, ",1442631281263607811,True,0,0,0,0,dlvr.it,"UPDATED: Incyte nabs approval of topical ruxolitinib in atopic dermatitis, but gets slapped with JAK warning https://t.co/P6OUmwnzfW",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
4893474783,2021-09-27 19:19:44,,,"via.news/markets/incyte‚Ä¶, pic.twitter.com/BtO2lC4561, ",1442630063720124418,False,0,0,0,0,World time zone,"Incyte Corporation Stock Went Down By Over 8% Today
https://t.co/Ze3r5rRJqi
(VIANEWS) - Shares of Incyte Corporation (NASDAQ Composite: INCY) dropped 8.51% to $69.59 at 19:18 EST on Monday, following the last session's downward tr... https://t.co/BtO2lC4561",,,2016-02-09 19:06:07,,Via News,https://pbs.twimg.com/profile_images/1102363201587634181/TJeRzWNR_normal.png,2462,4822,43,59142,ViaNewsAgency,photo
32492934,2021-09-27 18:07:32,,,"bioworld.com/articles/51179‚Ä¶, ",1442611893093507087,False,1,0,0,0,TweetDeck,Syndax enters deal worth up to $602M with Incyte https://t.co/ME8tMWFxmZ,,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
2274838086,2021-09-27 17:56:20,,,"twitter.com/BioCentury/sta‚Ä¶, ",1442609074193854467,False,2,0,0,3,Twitter Web App,Why @Syndax's anti-CSF1R mAb made sense for @Incyte: https://t.co/v5udPoPdLW,"Syndax, Incyte, ",,2014-01-03 12:39:31,,Paul Bonanos,https://pbs.twimg.com/profile_images/438472546187345920/0GrOUC2f_normal.jpeg,538,232,23,1004,BioBonanos,
227778014,2021-09-27 17:00:25,"INCY, SNDX, ",,"buff.ly/3uf6W01, ",1442595003658813441,False,0,1,0,0,Buffer,"Incyte's deal for Syndax's axatilimab gives the company a therapy with a second mechanism beyond JAK inhibitor Jakafi for chronic graft-versus-host disease, potentially setting it up for wholly-owned combinations $INCY $SNDX https://t.co/zuPS1B2YBY",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
23330343,2021-09-27 15:00:52,,,"cancerletter.com/drugs-and-targ‚Ä¶, pic.twitter.com/HETcuNJ0dh, ",1442564917534478337,False,0,0,0,0,Hootsuite Inc.,"Jakafi (@Incyte) receives @FDAOncology approval for treatment of chronic GVHD.
https://t.co/ZxqwIEbdq9 https://t.co/HETcuNJ0dh","Incyte, FDAOncology, ",,2009-03-08 13:32:44,"Washington, D.C.",The Cancer Letter,https://pbs.twimg.com/profile_images/813803520969310208/nsbPr5gH_normal.jpg,22312,1559,505,5654,TheCancerLetter,photo
1269758829690052610,2021-09-27 14:53:22,"INCY, SNDX, ",,,1442563029623664647,False,0,0,0,0,Zapier.com,"Incyte's in-licensing of axatilimab 'a strategically sound move,' says Stifel
$INCY $SNDX",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
4058194633,2021-09-27 13:40:57,"INCY, SNDX, KDMN, SNY, ",,"evaluate.com/vantage/articl‚Ä¶, ",1442544805305675782,False,1,0,0,0,Twitter for iPhone,$INCY $SNDX $KDMN $SNY Incyte turns to in-licensing https://t.co/Yl1Hsth8Jh,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4876582225,2021-09-27 13:39:03,"INCY, ",,"ideas.quantcha.com/2021/09/27/52-‚Ä¶, ",1442544325502455809,False,0,0,0,0,WordPress.com,52-Week Low Alert: Trading today‚Äôs movement in INCYTE¬†$INCY https://t.co/1EIaxLeu0a,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
25406480,2021-09-27 13:09:41,,,"awesomecapital.blogspot.com/2021/09/incyte‚Ä¶, ",1442536935260524547,False,0,0,0,1,Twitter Web App,AwesomeCapital: Incyte turns to in-licensing https://t.co/F2VHudhxbR,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
627695874,2021-09-27 12:43:31,"SNDX, INCY, ",,"investorsobserver.com/news/stock-upd‚Ä¶, ",1442530352027865092,False,1,0,0,1,Twitter Web App,"Syndax Pharmaceuticals $SNDX and Incyte $INCY Enter into Agreement to Develop Syndax's Axatilimab Monoclonal Antibody

https://t.co/lE3TjaSkRt",,,2012-07-05 14:32:58,,InvestorsObserver,https://pbs.twimg.com/profile_images/1389624586346631184/oPmFX5sq_normal.jpg,2110,48,47,13548,IOInvestors,
1065838258528104448,2021-09-27 12:37:08,"SNDX, ","smallcapsdaily, smallcaps, microcap, stocks, trading, profits, ","finance.yahoo.com/news/syndax-ph‚Ä¶, ",1442528745114509320,False,0,0,0,0,Twitter,$SNDX Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases PR Newswire https://t.co/KLORxg15ri #smallcapsdaily #smallcaps #microcap #stocks #trading #profits,,,2018-11-23 00:23:37,"New York, NY",SmallCapsDaily,https://pbs.twimg.com/profile_images/1237502128110759936/r5CB3eME_normal.jpg,1067,13,18,30984,SmallCapsDaily,
32450040,2021-09-27 11:35:15,"INCY, SNDX, SNY, ","Incyte, axatilimab, GVHD, ","evaluate.com/vantage/articl‚Ä¶, pic.twitter.com/1nnXu5rmwV, ",1442513171768557578,False,3,0,0,1,Twitter Web App,"#Incyte turns to in-licensing (Via @ByLizC) 
#axatilimab $INCY $SNDX #GVHD $SNY https://t.co/E3ZZj0giBF https://t.co/1nnXu5rmwV","ByLizC, ",,2009-04-17 11:37:01,"London, UK",Evaluate Vantage,https://pbs.twimg.com/profile_images/1246341890452193282/YN-iBs1e_normal.jpg,6999,481,186,6859,evaluatevantage,photo
61561912,2021-09-27 11:00:05,,"HealthCarePHL, ","chamberphl.com/2021/09/member‚Ä¶, pic.twitter.com/fOs1jyUm9m, ",1442504321086726145,False,1,0,0,0,Buffer,"Liz Croft Richards, M.D. of @Incyte shares the pivots biopharmaceutical companies have made to their clinical trials during the pandemic and the changes in research as a result. To read more: https://t.co/SykZmGZuMy #HealthCarePHL https://t.co/fOs1jyUm9m","Incyte, ",,2009-07-30 14:34:55,"Philadelphia, PA",The Chamber of Commerce for Greater Philadelphia,https://pbs.twimg.com/profile_images/1145779124281237507/PmWRs2Wh_normal.png,10742,821,337,15317,ChamberPHL,photo
4058194633,2021-09-27 10:56:36,"INCY, ",,"google.com/amp/s/m.invest‚Ä¶, ",1442503447257911299,False,0,0,0,0,Twitter for iPhone,"$INCY Mizuho Maintains Hold Rating On Incyte, $95 PT https://t.co/LHgCirLwpV",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-09-27 10:55:39,"SNDX, INCY, ",,"fiercebiotech.com/biotech/syndax‚Ä¶, ",1442503204470616070,False,0,0,0,0,Twitter for iPhone,"$SNDX $INCY Syndax and Incyte, both reeling from cancer drug setbacks, pen chronic graft-versus-host disease collab https://t.co/0HmQVTEnJk",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
959818250816237568,2021-09-27 10:19:09,,,"dlvr.it/S8RJN1, pic.twitter.com/WawAwRJggC, ",1442494019418791936,False,0,0,0,0,dlvr.it,"Syndax and Incyte, both reeling from cancer drug setbacks, pen chronic graft-versus-host disease collab https://t.co/zmM50Aa009 https://t.co/WawAwRJggC",,,2018-02-03 10:57:58,LATAM,Flare Consultants & Partners,https://pbs.twimg.com/profile_images/959849303496835072/Cv7XP4k4_normal.jpg,12,127,1,4939,FlareCP,photo
16697257,2021-09-27 10:07:09,,,"pink.pharmaintelligence.informa.com/articles/2021/‚Ä¶, ",1442491000941957121,False,0,0,0,0,Twitter Web App,"Also this...Keeping Track: US FDA Is Approving JAK Inhibitors Again, Starting With Incyte‚Äôs Opzelura; Seagen‚Äôs Tivdak Cleared https://t.co/IWPVq43Jh5",,,2008-10-11 12:03:28,Maryland,Derrick,https://pbs.twimg.com/profile_images/108491643/0323091904_normal.jpg,1169,748,94,16595,dgingery,
478901594,2021-09-27 09:52:29,,,"square1radio.com, pic.twitter.com/qlvd6RvDHT, ",1442487309199454210,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Tune In @ https://t.co/XL7Q5eebYQ https://t.co/qlvd6RvDHT,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
4058194633,2021-09-27 09:39:20,"INCY, SNDX, INCY, SNDX, ",,"benzinga.com/z/23109662#.YV‚Ä¶, ",1442483999364947972,False,0,0,0,0,Twitter for iPhone,"$INCY $SNDX Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate $INCY $SNDX https://t.co/Bgt72e8WAj # via @benzinga","Benzinga, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
963495628545327104,2021-09-27 09:37:03,"INCY, SNDX, INCY, ",,"stck.pro/news/INCY/1589‚Ä¶, stck.pro/news/INCY, pic.twitter.com/jPupdEUOco, ",1442483427496787971,False,0,0,0,0,STCK.PR0,"$INCY $SNDX NEW ARTICLE : Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate https://t.co/vaHlVI0b1d Get all the latest $INCY related news here : https://t.co/MBjnAUYXBx https://t.co/jPupdEUOco",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1403008149020459013,2021-09-27 09:31:26,,,"ift.tt/2Y2yjPa, ",1442482013588557826,False,0,0,0,0,IFTTT,"Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate https://t.co/LYHcRFAIJE",,,2021-06-10 11:17:38,,Stock Market News,https://pbs.twimg.com/profile_images/1403010687564136462/3Z237JI4_normal.jpg,101,96,2,16360,AglowStockNews,
108617488,2021-09-27 08:55:02,,,"invst.ly/w547s, ",1442472852213714945,False,2,0,0,1,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/zK5Z59IVMU,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
4058194633,2021-09-27 08:47:35,"SNDX, INCY, ",,"marketwatch.com/story/syndax-p‚Ä¶, ",1442470975967137792,False,0,0,0,0,Twitter for iPhone,"$SNDX $INCY  Syndax Pharmaceuticals, Incyte Set Global Axatilimab Collaboration &gt;SNDX INCY https://t.co/6c0R0OjODW",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
35789155,2021-09-27 08:31:22,"INCY, SNDX, ",,"new.firstwordpharma.com/story/5406917, ",1442466896662646787,False,0,0,0,0,TweetDeck,Incyte inks deal with Syndax to develop axatilimab in GvHD $INCY $SNDX https://t.co/qzjvBJFERA,,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
15296897,2021-09-27 08:10:05,"SNDX, INCY, ",,"seekingalpha.com/news/3744798-i‚Ä¶, ",1442461538816708613,False,0,0,0,0,SANewsTwitter,$SNDX $INCY - Incyte and Syndax in pact for xatilimab targeting immune-related conditions https://t.co/1L6uAVOleL,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
72928001,2021-09-27 08:05:26,"SNDX, ",,"bit.ly/3oiTYgy, ",1442460370958909446,False,0,0,0,0,BriefingInPlayLimited,$SNDX: Syndax Pharmaceuticals and Incyte (INCY) to collaborate to develop Axatilimab; Syndax to receive $ 152... https://t.co/8xwHuuCr7j,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1400541360512405504,2021-09-27 08:04:05,,"boston, biotech, ","tinyurl.com/yzsrtzn3, ",1442460031211933700,False,0,0,0,0,FeedBlitz,"BCBN Feed: Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases: WALTHAM, Mass. and ... #boston #biotech https://t.co/bqbQQTSVs7",,,2021-06-03 15:55:28,,Boston Cambridge Biotech Networks,https://pbs.twimg.com/profile_images/1400551055453089794/fM3Vd_w5_normal.jpg,284,3062,1,1533,BCBionetwork,
2334614718,2021-09-27 07:55:49,"SNDX, INCY, ",,"ooc.bz/l/83709, ",1442457949155307520,False,1,0,0,0,Open Outcrier,"$SNDX (+6.3% pre) Syndax Pharmaceuticals and Incyte $INCY Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases - PRN

https://t.co/9ht1pH9MpR",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
455963890,2021-09-27 07:51:59,"SNDX, INCY, ",,"ir.syndax.com/news-releases/‚Ä¶, ",1442456986654814210,False,1,0,0,0,Twitter for iPhone,Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases | $SNDX $INCY https://t.co/DIo8Oc6CJ2,,,2012-01-05 13:28:51,"Tampa, FL",Manny,https://pbs.twimg.com/profile_images/1283220048463659011/4kygRjJE_normal.jpg,503,3364,14,2340,Apollo_Charts,
325676237,2021-09-27 07:45:00,"SNDX, ","patients, GVHD, IPF, ",,1442455227098189826,False,11,1,287,2,Twitter for Advertisers.,We‚Äôre thrilled to announce a worldwide agreement with @Incyte for the development and commercialization of our investigational anti-CSF1-R antibody. We look forward to working together to bring potential new options to #patients with chronic diseases like #GVHD and #IPF. $SNDX,"Incyte, ",,2011-06-28 13:51:11,"Waltham, MA",Syndax,https://pbs.twimg.com/profile_images/714455011200262144/VtCOwN6f_normal.jpg,322,164,11,233,Syndax,
875382419251019776,2021-09-27 07:30:04,,,"bit.ly/39GfL9F, pic.twitter.com/Ja39HEXQVD, ",1442451469307842563,False,0,0,0,0,dlvr.it,"Syndax and Incyte, both reeling from cancer drug setbacks, pen chronic graft-versus-host disease collab https://t.co/lEXSmMNkrJ https://t.co/Ja39HEXQVD",,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
3911174913,2021-09-27 07:19:01,,"News, GVHD, ","bit.ly/3COU2J1, ",1442448690162151426,False,5,0,1,1,Twitter for Advertisers,#News: We‚Äôve announced a global collaboration and license agreement with Syndax to develop a potential treatment for patients living with chronic graft-versus-host disease (#GVHD) and other fibrotic diseases. https://t.co/AnVteLPdD4,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
472650465,2021-09-27 06:35:49,"INCY, ",,"otcdynamics.com/incy-syndax-ph‚Ä¶, ",1442437818878410753,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases https://t.co/MoFC1pMVqF,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
284054290,2021-09-27 06:18:08,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/comme‚Ä¶, ",1442433366834368521,False,0,0,0,0,BLOX CMS for DEV,"WALTHAM, Mass. and WILMINGTON, Del., Sept. 27, 2021 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) and Incyte (Nasdaq: INCY) announced today that they have entered into an exclusive worldwide collaboration and license agreement to devel‚Ä¶ https://t.co/3NOq23yjVj",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
3142088601,2021-09-27 06:16:02,"KDMN, SAN, SNY, SNDX, INCY, ",,"prn.to/3m6M0Vr, ",1442432840159858692,False,9,1,1,4,Twitter Web App,"New deal for cGvHD after $KDMN buyout by $SAN $SNY earlier this month

$SNDX &amp; $INCY Announce Global Collab to Develop &amp; Commercialize Axatilimab for cGvHD+Other Fibrotic Dzz

117m$ u/f+35m$ equity+450m$ milestones+50/50 profit share US/double-digit ex-US

https://t.co/LuSNYuULzn",,,2015-04-06 18:27:23,"Lyon, France",Bertrand Delsuc,https://pbs.twimg.com/profile_images/1118239110018273280/DDy8QJv8_normal.png,8047,263,283,59416,BertrandBio,
1134049078424162304,2021-09-27 06:15:51,"INCY, SNDX, ",,"newsfilter.io/articles/synda‚Ä¶, ",1442432793284382723,False,0,1,0,0,Newsfilter.io,Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Hos.. $INCY $SNDX https://t.co/KN8CwBusvy,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1069693680066420736,2021-09-27 06:08:02,"SNDX, ",,"s.flashalert.me/5onhaw, ",1442430826814316549,False,0,0,0,0,flashalerts,"$SNDX [15s. delayed]: Issued Press Release on September 27, 06:00:00: Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases https://t.co/6VbHRVHiYl",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842260,FlashAlert_me,
1269758829690052610,2021-09-27 06:06:56,"SNDX, INCY, ",,,1442430547679059969,False,0,0,0,0,Zapier.com,"Syndax, Incyte enter collaboration and license agreement for axatilimab
$SNDX $INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
1345717047456624643,2021-09-27 06:02:38,"SNDX, ",,"ir.syndax.com/news-releases/‚Ä¶, ",1442429467520028679,False,0,1,0,0,Twitter,$SNDX Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases https://t.co/pcqoQyLe2j,,,2021-01-03 08:03:02,,Phase Five,https://pbs.twimg.com/profile_images/1380078545557422084/S_k9w_Eq_normal.png,57,1,1,4349,phasefivebot,
1261713765063700481,2021-09-27 06:02:18,"INCY, ","Contracts, News, ",,1442429380731424775,False,0,0,0,0,Divest Twitter Bot,"$INCY - Syndax Pharmaceuticals And Incyte Announce Global Collaboration To Develop And Commercialize Axatilimab For Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases

#Contracts #News",,,2020-05-16 13:43:41,"Arcata, CA",Successful Trading News,https://pbs.twimg.com/profile_images/1442405402621087744/HG0_f8yJ_normal.jpg,198,279,0,8603,FreePalestBot,
1355194932445786112,2021-09-27 06:01:26,"SNDX, INCY, ",,"tinyurl.com/yhev4oj5, ",1442429162690473989,False,0,0,0,0,Twitter,"$SNDX $INCY Luminex Announces Anglo American Pegasus Joint Venture Update
https://t.co/Ow5wBadvA5",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1355194932445786112,2021-09-27 06:01:26,"HITI, ",,"tinyurl.com/yfubqbmv, ",1442429162677948434,False,1,0,0,0,Twitter,"$HITI Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases
https://t.co/9kauYGYVYr",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
53097729,2021-09-27 06:00:56,"INCY, SNDX, ",,,1442429039898251266,False,4,0,0,0,Twitter Web App,$INCY $SNDX Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases,,,2009-07-02 11:44:23,"Toronto, Ontario",Stockwits‚Ñ¢ Ó®Ä,https://pbs.twimg.com/profile_images/1408587167111303171/Qrn1abyM_normal.jpg,26206,983,189,29344,mikalche,
1254035253104181256,2021-09-27 06:00:40,"SNDX, INCY, ",,"stocktitan.net/news/SNDX/synd‚Ä¶, ",1442428970843217920,False,0,0,0,0,stocktitan,"$SNDX $INCY Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases
https://t.co/BL44UUjSfp",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1325115160353103872,2021-09-27 06:00:39,"INCY, SNDX, ",,"quantisnow.com/insight/180989‚Ä¶, ",1442428967898652677,False,0,0,0,0,Twitter,"$INCY $SNDX üì∞ Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases

https://t.co/tQaaKu6NLQ

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
3318510966,2021-09-27 06:00:38,,,"crweworld.com/article/news-p‚Ä¶, ",1442428964140568580,False,0,0,0,0,CRWE World,Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic  https://t.co/bPIRCakFVo,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1393303407801294850,2021-09-27 06:00:11,"SNDX, ",,"webchronicletoday.com/syndax-pharmac‚Ä¶, ",1442428848398749696,False,0,0,0,0,Twitter,"$SNDX Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases
 
https://t.co/JLRhcW13aw",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
1306028311311654912,2021-09-27 03:48:27,,"ùëªùíâùíÇùíçùíÇùíîùíîùíÜùíéùíäùíÇ, market, pharma, ","bit.ly/3APRM3K, ",1442395700147277827,False,1,0,0,0,Twitter Web App,"#ùëªùíâùíÇùíçùíÇùíîùíîùíÜùíéùíäùíÇ #market ùë∞ùíî ùë∑ùíìùíÜùíÖùíäùíÑùíïùíÜùíÖ ùëªùíê ùëÆùíìùíêùíò ùë®ùíï ùë™ùë®ùëÆùëπ ùë∂ùíá 10.8% ùë∞ùíè ùë≠ùíêùíìùíÜùíÑùíÇùíîùíï ùë∑ùíÜùíìùíäùíêùíÖ #pharma 

Access full rsearch report @ https://t.co/klZZYAxMZl

Key players@AcceleronPharma @CelgeneDK @Incyte @GamidaCellTx @KiadisP @ionispharma","CelgeneDK, Incyte, GamidaCellTx, KiadisP, ionispharma, ",,2020-09-15 20:33:34,Pune,Jyoti Waghmare,https://pbs.twimg.com/profile_images/1306028528325087232/8EeDNNfl_normal.jpg,3,44,0,668,JyotiWa58903971,
732361939490312192,2021-09-27 01:49:05,"INCY, ","markets, ","americanbankingnews.com/?p=22214480, ",1442365659166306305,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Forecasted to Post FY2022 Earnings of $3.53 Per Share https://t.co/SAwHbn6GEb #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-09-27 01:49:04,"INCY, ","stocks, ","americanbankingnews.com/?p=22214480, ",1442365656033382401,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Forecasted to Post FY2022 Earnings of $3.53 Per Share https://t.co/hIdlXdM4Rz #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2021-09-27 01:17:20,"INCY, ","markets, ","americanbankingnews.com/?p=22214265, ",1442357666664239107,False,0,0,0,0,Zapier.com,"Incyte Co. to Post Q3 2021 Earnings of $0.64 Per Share, Oppenheimer Forecasts $INCY https://t.co/Gngqczbdld #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-09-27 01:17:19,"INCY, ","stocks, ","americanbankingnews.com/?p=22214265, ",1442357663514304518,False,0,0,0,0,Zapier.com,"Incyte Co. to Post Q3 2021 Earnings of $0.64 Per Share, Oppenheimer Forecasts $INCY https://t.co/BjvB7bjBuz #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2021-09-27 01:17:07,"INCY, ",,"tickerreport.com/?p=7921581, ",1442357614059401217,False,0,0,0,0,Zapier.com,"Incyte Co. to Post Q3 2021 Earnings of $0.64 Per Share, Oppenheimer Forecasts $INCY https://t.co/ARvoMFGh19",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1280938376099741697,2021-09-27 00:19:32,,"iexStock, ","iexcloud.io, pic.twitter.com/J6KpuwMhnl, ",1442343122239885312,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Pfizer Inc.
-Dollar Tree Inc
-Incyte Corp.
-Caterpillar Inc.
-Unitedhealth Group Inc

Data provided by https://t.co/oXreiEXTgd https://t.co/J6KpuwMhnl",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2021-09-26 16:34:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/3053780, pic.twitter.com/xoy88Wriaa, ",1442226187976118272,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/TwBND1rnO6 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xoy88Wriaa,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
4893474783,2021-09-26 15:33:54,,,"via.news/markets/incyte‚Ä¶, pic.twitter.com/bUTMdVf934, ",1442210843127582729,False,0,0,0,0,World time zone,"Incyte Corporation Stock Over 8% Down As Session Comes To An End Today
https://t.co/MNpAo1aYDj
(VIANEWS) - Shares of Incyte Corporation (NASDAQ Composite: INCY) dropped 8.51% to $69.59 at 15:32 EST on Sunday,... https://t.co/bUTMdVf934",,,2016-02-09 19:06:07,,Via News,https://pbs.twimg.com/profile_images/1102363201587634181/TJeRzWNR_normal.png,2462,4822,43,59142,ViaNewsAgency,photo
1281758467036811264,2021-09-26 13:41:41,,,"dataemia.com/?p=614241, pic.twitter.com/flipVCD1xD, ",1442182600899104769,False,0,0,0,0,MasMaz,"Better late than never? Eczema drug now approved, Incyte says warning unwarranted - https://t.co/SmSEbHl5ZA https://t.co/flipVCD1xD",,,2020-07-10 21:13:35,United States ,MasMaz,https://pbs.twimg.com/profile_images/1297036654163582981/IWV5OJ_7_normal.jpg,62,0,1,83701,MasMazCom,photo
360220091,2021-09-26 13:41:40,,,"dataemia.com/?p=614241, pic.twitter.com/DhW4LS4S8s, ",1442182597275119622,False,0,0,0,0,Newsemia,"Better late than never? Eczema drug now approved, Incyte says warning unwarranted - https://t.co/RiDXAGbG0c https://t.co/DhW4LS4S8s",,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,photo
630844235,2021-09-26 12:51:32,,"jakafi, chronicGVHD, ","pic.twitter.com/4klHMWlvZA, ",1442169982733852677,False,0,0,0,0,Twitter for iPhone,Lunch time! Thank you @Incyte for sponsoring today‚Äôs non-CME lunch #jakafi #chronicGVHD https://t.co/4klHMWlvZA,"Incyte, ",,2012-07-09 02:21:55,"Altamonte Springs, FL",APAO,https://pbs.twimg.com/profile_images/1445748643605057539/tEfJXr4m_normal.jpg,233,334,5,351,APAOnc,photo
478901594,2021-09-26 09:33:29,,,"square1radio.com, pic.twitter.com/Jbq4rJkt6U, ",1442120142771474433,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Streaming On https://t.co/XL7Q5evMQo https://t.co/Jbq4rJkt6U,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
849417718642159616,2021-09-26 04:12:48,"INCY, ",,"zpr.io/pH6nYKVZrGQr, ",1442039439505690625,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $80.00 https://t.co/vyAhOrsqLb,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
478901594,2021-09-25 17:10:35,,,"square1radio.com, pic.twitter.com/QhcH3durDy, ",1441872784125140993,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5evMQo https://t.co/QhcH3durDy,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
4893474783,2021-09-25 08:17:45,,,"via.news/markets/incyte‚Ä¶, pic.twitter.com/yQpHokIWCo, ",1441738695103684608,False,0,0,0,0,World time zone,"Incyte Corporation Stock Is 8% Down Today
https://t.co/cogEeMKdS1
(VIANEWS) - Shares of Incyte Corporation (NASDAQ Composite: INCY) slid 8.51% to $69.59 at 08:16 EST on Saturday, after five successive sessions in a row of losses. NASDA... https://t.co/yQpHokIWCo",,,2016-02-09 19:06:07,,Via News,https://pbs.twimg.com/profile_images/1102363201587634181/TJeRzWNR_normal.png,2462,4822,43,59142,ViaNewsAgency,photo
1889492676,2021-09-25 06:51:02,"GUD, ","KnightTherapeutics, Incyte, Tafasitamab, Pemigatinib, ","1stoncology.com/blog/knight-th‚Ä¶, ",1441716871003140102,False,0,0,0,0,Troi URL Plug-in,#KnightTherapeutics Enters into Exclusive Supply and Distribution Agreement with #Incyte for #Tafasitamab and #Pemigatinib in Latin America $GUD https://t.co/e6emCSr7dg,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
140618811,2021-09-25 05:43:30,,"Calculus, BERT, EdgeComputing, DistributedCloud, LSTMs, AIoT, Neuromorphic, ComputerVision, MetaLearning, PyTorch, Javascript, CyberSecurity, DitributedLedger, ","news.google.com/./articles/CBM‚Ä¶, ",1441699875461107718,False,2,0,0,6,shem0304,"Incyte (INCY) Jakafi Wins FDA Approval for Chronic GVHD
2021-09-23T13:15:00Z

#Calculus #BERT #EdgeComputing #DistributedCloud #LSTMs #AIoT #Neuromorphic #ComputerVision #MetaLearning #PyTorch #Javascript #CyberSecurity #DitributedLedger 

https://t.co/lCWpylgqGt",,,2010-05-05 20:20:48,,"Richard Kim, PhD",https://pbs.twimg.com/profile_images/1342402165189439488/d9vYyh3z_normal.jpg,3169,4946,199,48402,richardkimphd,
849417718642159616,2021-09-25 05:12:51,"INCY, ",,"zpr.io/6L8ccnVwBER8, ",1441692162316324867,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $86.00 https://t.co/SDydnQFINl,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2416188264,2021-09-25 02:18:52,"INCY, ","markets, ","thestockobserver.com/?p=4774779, ",1441648378375544833,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 1-Year Low on Analyst Downgrade  https://t.co/3ed85lL15R #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2021-09-24 22:37:18,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/3049547, pic.twitter.com/ZV4Yeu32nw, ",1441592617620303873,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on September 22, 2021. View odds for this and other indicators: https://t.co/ZeTfU6hN4k #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZV4Yeu32nw",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1269612893529444354,2021-09-24 20:25:21,,,"usa366.com/lab-notes-incy‚Ä¶, ",1441559414440271875,False,0,0,0,0,WordPress.com,"Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and¬†more https://t.co/5qS1GlBtpL",,,2020-06-07 08:51:30,United States,News Bht,https://pbs.twimg.com/profile_images/1422621967971061761/FfpuzkLS_normal.jpg,852,4942,8,436800,newsbht1,
1283765688616628233,2021-09-24 18:12:19,,,"besthinditech.com/lab-notes-incy‚Ä¶, ",1441525935463878661,False,0,0,0,0,WordPress.com,"Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and¬†more https://t.co/DuF7OqTZrV",,,2020-07-16 10:09:41,United States,Galla Go,https://pbs.twimg.com/profile_images/1283766896551026689/nYTccLJe_normal.jpg,260,2723,1,214899,galla_go,
1413847110718423046,2021-09-24 18:12:19,,,"besthinditech.com/lab-notes-incy‚Ä¶, ",1441525931777089537,False,0,0,0,0,WordPress.com,"Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and¬†more https://t.co/ID9Gdb8Vy8",,,2021-07-10 09:06:45,India,Best Hindi Tech,https://pbs.twimg.com/profile_images/1413847234035150848/HA1H9j-l_normal.jpg,110,1565,0,73011,BestHindiTech1,
25560065,2021-09-24 17:00:33,,"lifesciences, PHLInno, ","bizjournals.com/philadelphia/i‚Ä¶, ",1441507874006577153,False,4,0,0,4,True Anthem,"Local #lifesciences industry news this week includes developments for @Incyte, @CarismaTher, @VirpaxPharma and  @Coriell_Science. #PHLInno https://t.co/KyWBJ27HPu","Incyte, CarismaTher, VirpaxPharma, Coriell_Science, ",,2009-03-20 15:31:03,Philadelphia,PHL Business Journal,https://pbs.twimg.com/profile_images/378800000077412316/8b22fbb8c4be97c69f048ff47fe712b6_normal.jpeg,35028,8899,1065,77326,PHLBizJournal,
19249427,2021-09-24 12:31:21,,,"investor.incyte.com/press-releases‚Ä¶, pic.twitter.com/g1ZY8Dlqmx, ",1441440126731706369,False,0,0,0,0,Twitter Web App,Congratulations to our friends at @Incyte ! Read more about their latest approval: https://t.co/0pHe2YaJxL https://t.co/g1ZY8Dlqmx,"Incyte, ",,2009-01-20 13:36:32,"Charlotte, North Carolina",Addison Whitney,https://pbs.twimg.com/profile_images/1402986746413916174/1oHahnTu_normal.jpg,895,661,222,5465,AddisonWhitney,photo
3686628867,2021-09-24 09:02:11,,,"ResearchAndMarkets.com, pharmaceuticaldaily.com/purinergic-rec‚Ä¶, ",1441387489424392205,False,0,0,0,0,WordPress.com,"Purinergic Receptor Antagonists Market Insights 2021 ‚Äì Players Include Incyte, Arcus Biosciences and Corvus Pharmaceuticals Among Others ‚Äì https://t.co/8vPVgQDr8R https://t.co/rTpDtQGok3",,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
732361939490312192,2021-09-24 08:13:25,"INCY, ","markets, ","americanbankingnews.com/?p=22177219, ",1441375217503203336,False,0,0,0,0,Zapier.com,FY2021 Earnings Forecast for Incyte Co. $INCY Issued By Oppenheimer https://t.co/ikXmLeR30c #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-09-24 08:13:25,"INCY, ","stocks, ","americanbankingnews.com/?p=22177219, ",1441375213749301251,False,0,0,0,0,Zapier.com,FY2021 Earnings Forecast for Incyte Co. $INCY Issued By Oppenheimer https://t.co/Ki4D0s2Pms #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
812004702594486272,2021-09-24 07:34:52,,"FDA, Jakafi, GVHD, ","checkrare.com/fda-approves-r‚Ä¶, ",1441365515268591624,False,3,0,0,0,Hootsuite Inc.,"The U.S. Food and Drug Administration #FDA approved ruxolitinib #Jakafi  to treat chronic graft-versus-host disease #GVHD after failure of one or two lines of systemic therapy in patients 12 years and older. @US_FDA US FDA News FDA @Incyte Incyte Incyte 
https://t.co/NN9yKc9zFS","US_FDA, Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
976297820532518914,2021-09-24 06:54:07,,,"ResearchAndMarkets.com, dlvr.it/S8D3L9, pic.twitter.com/7QKHS8VEpG, ",1441355259553533964,False,0,0,0,0,dlvr.it,"Purinergic Receptor Antagonists Market Insights 2021 - Players Include Incyte, Arcus Biosciences and Corvus Pharmaceuticals Among Others - https://t.co/guyiBzPH8C https://t.co/weqK25fvWA https://t.co/7QKHS8VEpG",,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
15974185,2021-09-24 06:35:03,,,"dlvr.it/S8Cz5Z, ",1441350460036632578,False,0,0,0,0,dlvr.it,Incyte on a Roll with Two FDA Wins in Two Days https://t.co/jLnbJyfI1w,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
20780650,2021-09-24 04:20:13,,,"biedexmarkets.com/incyte-corpora‚Ä¶, pic.twitter.com/A2KFelWuW2, ",1441316529446944772,False,0,0,0,0,Twitter,"Incyte Corporation (NASDAQ:INCY) - Incyte, Knight Therapeutics Ink Distribution Pact For Two Cancer Drugs In Latin America

       https://t.co/37kQSqhYnk https://t.co/A2KFelWuW2",,,2009-02-13 11:02:18,"London, England",Biedex Markets,https://pbs.twimg.com/profile_images/1288488731654201349/MSrdzFac_normal.jpg,4018,4862,120,362261,biedexmarkets,photo
1134049078424162304,2021-09-24 03:58:42,"INCY, ",,"newsfilter.io/articles/knigh‚Ä¶, ",1441311112197140492,False,0,0,0,0,Newsfilter.io,Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America $INCY https://t.co/4dI0VehPsM,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
2495689267,2021-09-24 00:56:57,,,"lnkd.in/eRKdipgq, ",1441265376159932424,False,0,0,0,0,LinkedIn,"US FDA approves Incyte‚Äôs Opzelura cream to treat moderate atopic dermatitis
Link: https://t.co/JUY99TgicX",,,2014-05-15 00:52:27,Delhi,Catalyst Clinical ,https://pbs.twimg.com/profile_images/1303646253696204801/-3RQC0UF_normal.jpg,494,1913,12,374,CatalystClinica,
1134049078424162304,2021-09-23 20:40:41,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1441200884231311360,False,0,0,0,0,Newsfilter.io,"Incyte, Knight Therapeutics Ink Distribution Pact For Two Cancer Drugs In Latin America $INCY https://t.co/MdOi22I8JJ",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
889321711966998528,2021-09-23 20:09:07,,"JAKInhibitor, fdaapproved, Cancer, cGVHD, GeneOnline, ","geneonline.com/fda-approves-i‚Ä¶, ",1441192937849819137,False,0,0,0,0,Twitter Web App,".@Incyte's JAK Inhibitor bags @US_FDA approval for fourth indication, this time for the treatment of chronic graft-versus-host disease.

#JAKInhibitor #fdaapproved #Cancer #cGVHD #GeneOnline

https://t.co/aM9TVLS2Ia","Incyte, US_FDA, ",,2017-07-23 23:09:53,"Santa Clara, CA",GeneOnline,https://pbs.twimg.com/profile_images/1290669170913312769/KyH5AwCK_normal.jpg,4796,4702,12,3813,GeneOnlineNews,
4058194633,2021-09-23 19:13:39,"INCY, ",,"fiercepharma.com/pharma/a-jak-r‚Ä¶, ",1441178979499593736,False,1,0,0,0,Twitter for iPhone,"$INCY On a JAK roll, Incyte wins FDA green light to expand Jakafi in chronic graft-versus-host disease https://t.co/ruf8v1s0bw",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
2416364454,2021-09-23 17:37:27,,,"canva.com/design/DAEkYDQ‚Ä¶, ",1441154772526981121,False,0,0,0,0,Twitter Web App,"We are excited to share with you our September ""Sponsor Spotlight"": @Incyte 

Thank you for being supporters of CHOP!

https://t.co/YgWuvGvEY2","Incyte, ",,2014-03-28 15:33:41,,CHOP,https://pbs.twimg.com/profile_images/1453051378822176785/JIKOcAim_normal.jpg,150,136,2,365,CHOPractices,
1128239740329705472,2021-09-23 16:00:01,"INCY, ","GVHD, biotech, ","endpts.com/inctyes-ruxoli‚Ä¶, ",1441130249375387651,False,0,0,0,0,TweetDeck,"The FDA has approved @Incyte's Jakafi (ruxolitinib) for treatment of chronic graft-versus-host-disease (GVHD). This is the fourth FDA-approved indication for Jakafi after its 2019 approval for steroid refractory acute #GVHD. #biotech $INCY

Read more here: https://t.co/bBJEpYD1VN","Incyte, ",,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
14442889,2021-09-23 14:45:16,,,"dlvr.it/S88Pqz, pic.twitter.com/xfLtBHER3g, ",1441111439490486275,False,0,0,0,0,dlvr.it,Incyte on a Roll with Two FDA Wins in Two Days https://t.co/f5R6r1fI4v https://t.co/xfLtBHER3g,,,2008-04-19 08:47:12,,Pharmaceutical,https://pbs.twimg.com/profile_images/1249577991/Pill_with_transparent_background_normal.png,26095,1507,434,54180,Pharmaceutical,photo
3911174913,2021-09-23 14:09:34,,,"pic.twitter.com/2t9Cz3FMAy, ",1441102454897070090,False,9,1,0,0,Twitter Web App,"Herv√© Hoppenot, CEO of Incyte shares his perspective on this week's monumental milestone for our recently launched Incyte Dermatology franchise. https://t.co/2t9Cz3FMAy",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
18294275,2021-09-23 13:35:00,,,"fiercepharma.com/pharma/a-jak-r‚Ä¶, ",1441093755923156996,False,0,0,0,0,TweetDeck,"On a JAK roll, Incyte wins FDA green light to expand Jakafi in chronic graft-versus-host disease https://t.co/0T8P4z4EgO",,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
172288755,2021-09-23 13:12:41,,,"fiercepharma.com/pharma/a-jak-r‚Ä¶, ",1441088139792027655,False,0,0,0,0,Twitter for Android,"On a JAK roll, Incyte wins FDA green light to expand Jakafi in chronic graft-versus-host disease https://t.co/rQ6zLaK1pb",,,2010-07-29 06:10:36,"Yong-In city, Korea",Kyung Seok Lee,https://pbs.twimg.com/profile_images/922433020748898305/cjOW-D4X_normal.jpg,17,60,0,646,ksloveis,
722701984160182272,2021-09-23 13:02:30,,,"endpts.com/inctyes-ruxoli‚Ä¶, ",1441085578787786756,False,0,0,0,0,Twitter for iPad,"Incyte's ruxolitinib scores its second approval in two days, this time in chronic graft-versus-host disease ‚Äì Endpoints News https://t.co/iIUs7oDCGd",,,2016-04-20 04:22:34,,Dr Anthony Martin,https://pbs.twimg.com/profile_images/722704898178093056/U4usuS0x_normal.jpg,595,1524,10,144132,AMAinsight,
875382419251019776,2021-09-23 12:53:19,,,"bit.ly/3lVDZ5m, pic.twitter.com/YIVz4shs5Z, ",1441083268233760778,False,0,0,0,0,dlvr.it,Incyte on a Roll with Two FDA Wins in Two Days https://t.co/bAqvGnWO5F https://t.co/YIVz4shs5Z,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
325135887,2021-09-23 12:45:00,"INCY, ","dermatology, ","bit.ly/3EKLmVM, ",1441081172700901381,False,1,0,0,0,Twitter Web App,"Incyte's Jakafi sister med clears FDA for atopic dermatitis, but safety warning a heavy cross to bear! A relatively clean label for the drug despite increased FDA scrutiny on the entire JAK inhibitor class, was previously expected! $INCY #dermatology 
https://t.co/H9S2KGOSBl",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
32492934,2021-09-23 11:27:00,,,"bioworld.com/articles/51164‚Ä¶, ",1441061543592923143,False,0,0,0,0,TweetDeck,"Incyte wins FDA approval for ruxolitinib cream in AD, with class-related boxed warnings https://t.co/VfkfVgIqU5",,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
4058194633,2021-09-23 11:21:38,"INCY, ",,"news.bloomberglaw.com/pharma-and-lif‚Ä¶, ",1441060194646048773,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Sinks After Skin Cream Wins Approval With a Warning (1) https://t.co/MMTcHURsjS,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-09-23 11:20:55,"INCY, ",,"marketscreener.com/quote/stock/IN‚Ä¶, ",1441060011820552194,False,0,0,0,0,Twitter for iPhone,"$INCY Stifel Adjusts Incyte's Price Target to $85 from $93, Keeps Hold Rating | MarketScreener https://t.co/IgGiM6sMNe",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-09-23 11:19:37,"INCY, ",,"finance.yahoo.com/news/knight-th‚Ä¶, ",1441059686212521992,False,0,0,0,0,Twitter for iPhone,$INCY Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America https://t.co/ZQzpun2H9S,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-09-23 11:19:02,"INCY, ",,"fiercepharma.com/pharma/a-jak-r‚Ä¶, ",1441059537998413832,False,0,0,0,0,Twitter for iPhone,"$INCY On a JAK roll, Incyte wins FDA green light to expand Jakafi in chronic graft-versus-host disease https://t.co/ruf8v1s0bw",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1382837477128470532,2021-09-23 11:11:45,"INCY, ",,"sparknewswire.com/newsfeed/incyt‚Ä¶, ",1441057705083342858,False,0,0,0,0,Twitter Web App,"$INCY Incyte, Knight Therapeutics Ink Distribution Pact For Two Cancer Drugs In Latin America https://t.co/ZgolH6euCF",,,2021-04-15 19:25:31,,Spark Newswire,https://pbs.twimg.com/profile_images/1425277325994721282/7PFtMClk_normal.jpg,205,788,5,1412,SparkNewswire,
3643934180,2021-09-23 11:11:26,,,"twitter.com/PharmaDJEditor‚Ä¶, ",1441057628541440005,False,0,0,0,0,Twitter Web App,"Pemigatinib is a FGFR1/2/3 inhibitor, which the Suzhou company licensed from Incyte in 2018 to develop and commercialize it in hematology and oncology in mainland China, Hong Kong, Macau and Taiwan. https://t.co/UXlKGpwIRM",,,2015-09-21 22:13:10,,Minhua Chu,https://pbs.twimg.com/profile_images/1342068871285460995/b5YJAnAP_normal.jpg,33,38,0,150,chuminhua432,
732361939490312192,2021-09-23 11:05:29,"INCY, ","markets, ","americanbankingnews.com/?p=22164158, ",1441056131233636355,False,0,0,0,0,Zapier.com,Morgan Stanley Cuts Incyte $INCY Price Target to $80.00 https://t.co/t7Ci4FvEP3 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-09-23 11:05:28,"INCY, ","stocks, ","americanbankingnews.com/?p=22164158, ",1441056127374938126,False,0,0,0,0,Zapier.com,Morgan Stanley Cuts Incyte $INCY Price Target to $80.00 https://t.co/XbRZRG9d4m #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
4058194633,2021-09-23 10:52:49,"INCY, ",,"marketbeat.com/ratings/upgrad‚Ä¶, ",1441052942740570112,False,0,0,0,0,Twitter for iPhone,"$INCY Morgan Stanley Reduces Incyte PT To $80 From $85, Equal Weight Rating; Royal Bank of Canada Cuts PT To $86 From $91; Leerink Cuts PT To $66 From $67, Downgrades To Market Perform From Outperform https://t.co/3UKOjR6L3S",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
409241995,2021-09-23 10:36:28,,,"twitter.com/choosedelaware‚Ä¶, ",1441048826060574725,False,0,0,0,1,Twitter for iPad,"Congratulations to the entire team @Incyte and to @IloveIncyte in particular, personally! https://t.co/YnbV1qIf4N","Incyte, IloveIncyte, ",,2011-11-10 08:27:16,United States,Michael Marquardt,https://pbs.twimg.com/profile_images/885564840844169218/97wDd1qt_normal.jpg,12939,494,159,10283,MarquardtGlobal,
46297868,2021-09-23 10:29:04,,,"dlvr.it/S87bxy, ",1441046963277815813,True,0,0,0,0,dlvr.it,"On a JAK roll, Incyte wins FDA green light to expand Jakafi in chronic graft-versus-host disease https://t.co/bIeMFQRWax",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
1269758829690052610,2021-09-23 10:09:34,"INCY, ALXN, AZN, ",,,1441042059746553863,False,0,0,0,0,Zapier.com,"Gordon Haskett compares Incyte to Alexion before Astra buyout
$INCY $ALXN $AZN",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
1273844033861844993,2021-09-23 10:00:20,"INCY, ",,"pic.twitter.com/dBxnVa6Pek, ",1441039732121559040,False,0,0,0,0,StockTwits Web,"$INCY [Incyte]: Morgan Stanley Maintains Equal-Weight Lowers Price Target $85 --&gt; 80 
charts: courtesy of finviz https://t.co/dBxnVa6Pek",,,2020-06-19 01:04:32,United States,Jarvis-Alerts,https://pbs.twimg.com/profile_images/1374794584513986568/eWDm8YFI_normal.jpg,4169,102,79,63687,Jarvis_Alerts,photo
221961207,2021-09-23 09:43:28,,,,1441035491562991622,False,0,0,0,0,IFTTT,Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America - Yahoo Finance,,,2010-12-01 21:38:35,Switzerland,LGT Capital,https://pbs.twimg.com/profile_images/433244425427226624/Q5tCy83y_normal.jpeg,403,450,23,55072,lgtcaptial,
732361939490312192,2021-09-23 09:39:47,"INCY, ","markets, ","americanbankingnews.com/?p=22162079, ",1441034561505435650,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $86.00 https://t.co/uqhUpx2VGh #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-09-23 09:39:46,"INCY, ","stocks, ","americanbankingnews.com/?p=22162079, ",1441034557621342210,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $86.00 https://t.co/LJMXEewhJQ #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2021-09-23 09:03:42,"INCY, ","markets, ","americanbankingnews.com/?p=22161508, ",1441025482326171648,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Market Perform at SVB Leerink https://t.co/BQxECZE8eC #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-09-23 09:03:41,"INCY, ","stocks, ","americanbankingnews.com/?p=22161508, ",1441025479251738624,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Market Perform at SVB Leerink https://t.co/av5LpwgI5F #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
3911174913,2021-09-23 09:00:15,,"dermatology, ","pic.twitter.com/8DYSLhmz92, ",1441024614092705796,True,6,0,0,0,Twitter Web App,"Incyte has recently announced the launch of its dedicated #dermatology franchise. Today, Incyte Dermatology marks its first approval milestone as we continue to Solve On. in our commitment to the relentless research of science to improve the lives of patients. https://t.co/8DYSLhmz92",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1269758829690052610,2021-09-23 08:57:45,"INCY, ",,,1441023984565325825,False,0,0,0,0,Zapier.com,"Incyte price target lowered to $86 from $91 at RBC Capital
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
1158849693696217089,2021-09-23 08:48:30,"GuD.TO, ",,"gudknight.irpass.com/Knight-Therape‚Ä¶, ",1441021657607376896,False,0,0,0,0,Twitter for iPhone,$GuD.TO Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America https://t.co/szidCwzlll,,,2019-08-06 17:17:52,"Coquitlam, British Columbia",Microcapconnection,https://pbs.twimg.com/profile_images/1187400118237941760/tKRvVx_0_normal.jpg,486,254,13,2865,Microcapconnec1,
1325115160353103872,2021-09-23 08:42:55,"INCY, ",,"quantisnow.com/insight/180266‚Ä¶, ",1441020252939177986,False,0,0,0,0,Twitter,"$INCY üì° Morgan Stanley reiterated coverage on Incyte with a new price target

https://t.co/MPmr7yHvSQ

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1134049078424162304,2021-09-23 08:42:48,"INCY, ",,,1441020221133819904,False,0,0,0,0,Newsfilter.io,$INCY Morgan Stanley analyst Vikram Purohit maintains Incyte with a Equal-Weight and lowers the price target from $85 to $80.,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
2570920968,2021-09-23 08:30:00,"INCY, ","dermatology, ","bit.ly/3EKLmVM, ",1441017000130748422,False,2,0,0,0,Twitter Web App,"Incyte's Jakafi sister med clears FDA for atopic dermatitis, but safety warning a heavy cross to bear! A relatively clean label for the drug despite increased FDA scrutiny on the entire JAK inhibitor class, was previously expected! $INCY #dermatology 
https://t.co/tAFKi6WMCk",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
1154064859929014272,2021-09-23 08:28:47,,"FDA, Opzelura, dermatitis, AD, Bluestar, insulin, ","pic.twitter.com/j4eQ825Zvc, ",1441016695901106177,False,1,0,0,0,Twitter Web App,"More Clearance &amp; Approvals

~@moleculight #FDA clearance for the wound detection device

~FDA approves @Incyte #Opzelura - cream for atopic #dermatitis #AD

~@Welldoc's #Bluestar lands FDA clearance for expanded #insulin dosing support https://t.co/j4eQ825Zvc","moleculight, Incyte, Welldoc, ",,2019-07-24 12:24:38,,MedTechNow,https://pbs.twimg.com/profile_images/1359909439399026689/l_fe8Tje_normal.jpg,603,801,3,2053,MedTechNow_,photo
75337774,2021-09-23 08:26:10,,,"medcitynews.com/2021/09/better‚Ä¶, ",1441016036594233348,False,0,0,0,0,Twitter for Android,"Better late than never? Eczema drug now approved, Incyte says warning unwarranted https://t.co/PwsbhZRbtm",,,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
4862224559,2021-09-23 08:10:29,,"netde, ","investor.incyte.com/press-releases‚Ä¶, ",1441012087480750094,False,2,0,0,1,Twitter Web App,Congrats to Delaware innovator @Incyte for receiving @US_FDA approval for the first treatment of its kind for atopic dermatitisüëèüèæüëèüèæüëèüèæ #netde https://t.co/fx4zrzDLEC,"Incyte, US_FDA, ",,2016-01-29 20:24:48,"Delaware, USA",Del Biz Roundtable,https://pbs.twimg.com/profile_images/693248970559229952/_U6MVbv__normal.jpg,791,293,18,1294,DelawareBRT,
2469392952,2021-09-23 08:01:22,"GUD, ",,"gudknight.irpass.com/Knight-Therape‚Ä¶, ",1441009796124233736,False,18,0,0,2,Twitter Web App,"New deal for Knight Therapeutics $GUD: New distribution of Tafasitamab and Pemigatinib in Latin America.

- Knight will seek regulatory approvals
- Another deal that improves its distribution scale (Oncology)
- Seed projects always thinking long term

https://t.co/zHUbxm24SK",,,2014-04-29 10:58:44,Oslo & Madrid,Rodri V.R.,https://pbs.twimg.com/profile_images/1451510011436404746/xDd9aH0V_normal.jpg,9203,1010,170,8207,HolyFinance,
1273844033861844993,2021-09-23 08:00:31,"INCY, ",,"pic.twitter.com/J9yKyeXh4p, ",1441009582567002116,False,0,0,0,0,StockTwits Web,"$INCY [Incyte]: SVB Leerink Upgrades Underperform --&gt; Market Perform Lowers Price Target $67 --&gt; 66 
charts: courtesy of finviz https://t.co/J9yKyeXh4p",,,2020-06-19 01:04:32,United States,Jarvis-Alerts,https://pbs.twimg.com/profile_images/1374794584513986568/eWDm8YFI_normal.jpg,4169,102,79,63687,Jarvis_Alerts,photo
1273844033861844993,2021-09-23 08:00:27,"INCY, ",,"pic.twitter.com/HpIPjElbm2, ",1441009564980334592,False,0,0,0,0,StockTwits Web,"$INCY [Incyte]: RBC Capital Maintains Sector Perform Lowers Price Target $91 --&gt; 86 
charts: courtesy of finviz https://t.co/HpIPjElbm2",,,2020-06-19 01:04:32,United States,Jarvis-Alerts,https://pbs.twimg.com/profile_images/1374794584513986568/eWDm8YFI_normal.jpg,4169,102,79,63687,Jarvis_Alerts,photo
1134049078424162304,2021-09-23 07:52:40,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1441007606378770438,False,1,0,0,0,Newsfilter.io,Incyte and Knight Therapeutics ink exclusive supply and distribution agreement $INCY https://t.co/CeO3KS4Yj4,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
15296897,2021-09-23 07:49:46,"INCY, KHTRF, ",,"seekingalpha.com/news/3743383-i‚Ä¶, ",1441006876322254849,False,1,1,0,0,SANewsTwitter,$INCY $KHTRF - Incyte and Knight Therapeutics ink exclusive supply and distribution agreement https://t.co/hmDDAOhmiA,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3222334541,2021-09-23 07:45:48,,,"investor.lilly.com/news-releases/‚Ä¶, pic.twitter.com/2wNjZGnDjQ, pic.twitter.com/2wNjZGnDjQ, pic.twitter.com/2wNjZGnDjQ, pic.twitter.com/2wNjZGnDjQ, ",1441005878547664900,False,0,0,0,0,Twitter for Android,"06:42, Real Solutions for you, @SenThomTillis, as I work my way back into the Light? -&gt; https://t.co/S34vILylVt If you choose to accept? Go @DukeU ROTC! https://t.co/2wNjZGnDjQ","SenThomTillis, DukeU, ",,2015-04-29 17:39:15,"Clear Lake Shores, TX",Mike Holland,https://pbs.twimg.com/profile_images/1184409251940372480/bFd6OuNr_normal.jpg,188,632,21,32402,MHolland_VA,photo
3460109487,2021-09-23 07:45:44,,,"endpts.com/inctyes-ruxoli‚Ä¶, ",1441005860562604032,False,0,0,0,0,TweetDeck,"A day after approving a topical formulation of Incyte‚Äôs cash cow ruxolitinib for atopic dermatitis, regulators are back with more good news for the company‚Äôs favorite JAK inhibitor.

https://t.co/pCKPy3XJNb",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
1269758829690052610,2021-09-23 07:37:43,"KHTRF, INCY, ",,,1441003845107306500,False,1,0,0,0,Zapier.com,"Knight Therapeutics enters supply, distribution agreement with Incyte 
$KHTRF $INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
2334614718,2021-09-23 07:36:12,"INCY, ",,"ooc.bz/l/83496, ",1441003462427299844,False,1,0,0,0,Open Outcrier,"$INCY (+0.6% pre) Incyte (INCY) Enters Exclusive Supply and Distribution Agreement with Knight Therapeutics for Tafasitamab and Pemigatinib in Latin America - SI

https://t.co/sOozRagNDq",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
2348878033,2021-09-23 07:36:06,,"Comunicados, ","dlvr.it/S872cv, ",1441003438230228995,False,0,0,0,5,dlvr.it,Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America https://t.co/AbZ41N16A3 #Comunicados,,,2014-02-17 13:15:24,Per√∫,Noticias Per√∫ üáµüá™,https://pbs.twimg.com/profile_images/1420723717672521730/QMZYxITD_normal.jpg,54365,12437,259,1529764,peruenlanoticia,
3318510966,2021-09-23 07:35:19,,,"crweworld.com/article/news-p‚Ä¶, ",1441003239923650565,False,0,0,0,0,CRWE World,Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigati https://t.co/K116GNs5Lm,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1069693680066420736,2021-09-23 07:32:13,"INCY, ",,"s.flashalert.me/lcI8u, ",1441002457958686720,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on September 23, 07:30:00: Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America https://t.co/QLxAaN7iA7",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842260,FlashAlert_me,
1325115160353103872,2021-09-23 07:30:32,"INCY, ",,"quantisnow.com/insight/180191‚Ä¶, ",1441002035755642890,False,0,0,0,0,Twitter,"$INCY üì∞ Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America

https://t.co/Vo5qQFlPte

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1325115160353103872,2021-09-23 07:27:59,"INCY, ",,"quantisnow.com/insight/180188‚Ä¶, ",1441001393179873281,False,0,0,0,0,Twitter,"$INCY üì° RBC Capital reiterated coverage on Incyte with a new price target

https://t.co/qS9mC70nzD

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1134049078424162304,2021-09-23 07:27:34,"INCY, ",,,1441001289962463232,False,0,0,0,0,Newsfilter.io,$INCY RBC Capital analyst Brian Abrahams maintains Incyte with a Sector Perform and lowers the price target from $91 to $86.,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1269758829690052610,2021-09-23 07:13:03,"INCY, ",,,1440997634324451329,False,0,0,0,0,Zapier.com,"Incyte's higher price for Opzelura makes up for black box, says Benchmark
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
1254906887490936845,2021-09-23 06:45:31,"INCY, ",,"quantdata.us/news/23067233, ",1440990704935837698,False,0,0,0,0,Quant Data (Production),"SVB Leerink Upgrades Incyte to Market Perform, Lowers Price Target to $66

Related Tickers: $INCY
Read more at: https://t.co/B6wrbC6stl",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
1269758829690052610,2021-09-23 06:33:49,"INCY, ",,,1440987760807006208,False,0,0,0,0,Zapier.com,"Incyte downgraded to Market Perform from Outperform at SVB Leerink
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
1325115160353103872,2021-09-23 06:30:59,"INCY, ",,"quantisnow.com/insight/180158‚Ä¶, ",1440987048500858881,False,0,0,0,0,Twitter,"$INCY üì° Incyte upgraded by SVB Leerink with a new price target

https://t.co/rTcmBNJw8Q

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1134049078424162304,2021-09-23 06:30:31,"INCY, ",,,1440986930162831361,False,0,0,0,0,Newsfilter.io,$INCY SVB Leerink analyst Andrew Berens upgrades Incyte from Underperform to Market Perform and lowers the price target from $67 to $66.,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1022473214457348096,2021-09-23 06:22:42,,,"pharmashots.com/64739/incytes-‚Ä¶, pic.twitter.com/6Dd7cWb8Hd, ",1440984965244604416,False,1,0,0,0,Twitter Web App,"Incyte‚Äôs Jakafi (ruxolitinib) Receives the US FDA‚Äôs Approval for the Treatment of Chronic Graft-Versus-Host Disease @Pharmashot @Incyte 
https://t.co/3Of8XnxlX5 https://t.co/6Dd7cWb8Hd","Pharmashot, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,photo
65630688,2021-09-23 06:15:00,,"vitiligo, ESDR2021, ","esdrmeeting.org/scientific-pro‚Ä¶, ",1440983025957801990,False,1,0,0,0,Twitter Web App,"Join a symposium today sponsored by @Incyte where innovative research on signal transduction pathways involved in the pathogenesis of #vitiligo will be presented. Tune in at 13:15, September 23.  #ESDR2021  
https://t.co/7KplqRl9SL","Incyte, ",,2009-08-14 09:10:20,"Geneva, Switzerland",ESDR,https://pbs.twimg.com/profile_images/1255849793177387011/XWNNooSs_normal.jpg,3057,480,38,3241,ESDRorg,
1414718797546676229,2021-09-23 05:59:14,,,,1440979061086511112,False,0,0,1,0,Twitter for iPhone,"Something to potentially watch moving forward ‚Äî Incyte‚Äôs Opzelura was just approved with a BBW for blood clots and serious CV-related events despite being a topical formulation

Although these are class-wide concerns with JAK inhibitors, Opzelura was given the BBW theoretically..",,,2021-07-12 18:50:31,,"Preston Skersick, PharmD",https://pbs.twimg.com/profile_images/1414718987020218380/M5DqpIIF_normal.jpg,31,106,0,160,P_SkersickRx,
14442889,2021-09-23 05:44:33,,,"dlvr.it/S86hs3, pic.twitter.com/v9240U6WaP, ",1440975365174808578,False,1,0,0,0,dlvr.it,New Atopic Dermatitis Option Available as FDA Approves Incyte's Opzelura https://t.co/dEyeYVXA78 https://t.co/v9240U6WaP,,,2008-04-19 08:47:12,,Pharmaceutical,https://pbs.twimg.com/profile_images/1249577991/Pill_with_transparent_background_normal.png,26095,1507,434,54180,Pharmaceutical,photo
1325115160353103872,2021-09-23 05:12:26,"INCY, ",,"quantisnow.com/insight/180130‚Ä¶, ",1440967281920528385,False,0,0,0,0,Twitter,"$INCY ‚öïÔ∏è FDA Approval for JAKAFI issued to INCYTE CORP

https://t.co/x8PXxdqhby

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1883393875,2021-09-23 04:57:02,,,"dlvr.it/S86ZRN, ",1440963406383566849,False,0,0,0,0,dlvr.it,Incyte Announces FDA Approval of Jakafi https://t.co/JFLsO4BbpF,,,2013-09-19 10:40:31,Amsterdam,Pharma Market News,https://pbs.twimg.com/profile_images/378800000501255643/53b0cadf7327b09ab8610040b07fcb10_normal.jpeg,1499,1215,21,7595,pharmamarketnws,
454898193,2021-09-23 04:52:17,,,"finance.yahoo.com/news/back-back‚Ä¶, ",1440962210478624770,False,1,0,0,0,Twitter for Android,Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD https://t.co/5vTbCLNPhs,,,2012-01-04 09:20:27,Buffalo,Philip McCarthy,https://pbs.twimg.com/profile_images/466351626219823104/K2IQ5P6I_normal.jpeg,3700,1013,89,7500,PLMcCarthyMD,
1134049078424162304,2021-09-23 04:49:56,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1440961617357852674,False,0,0,0,0,Newsfilter.io,Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis $INCY https://t.co/k8nnyOa0BR,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
14442905,2021-09-23 04:47:02,,,"dlvr.it/S86YFm, pic.twitter.com/lRCjOXtBvO, ",1440960889641848841,False,1,0,0,2,dlvr.it,New Atopic Dermatitis Option Available as FDA Approves Incyte's Opzelura https://t.co/hjJqPuPZsQ https://t.co/lRCjOXtBvO,,,2008-04-19 08:48:59,,Biotechnology,https://pbs.twimg.com/profile_images/1235765602/horizon1202906805-double_helix_500x500_normal.png,57151,3269,1002,53397,Biotechnology,photo
631661989,2021-09-23 02:00:00,,"Delaware, biopharmaceutical, choosedelaware, globalde, ","hubs.ly/H0XWSV-0, pic.twitter.com/D8qtX195os, ",1440918854612422656,False,3,0,0,0,HubSpot,"#Delaware-based #biopharmaceutical innovator @Incyte ‚Äì one of the most innovative companies in the United States ‚Äì has received @US_FDA  approval for the first and only treatment of its kind for atopic dermatitis. 
https://t.co/TGhoGu5M1j 
#choosedelaware #globalde https://t.co/D8qtX195os","Incyte, US_FDA, ",,2012-07-09 23:54:36,"Wilmington, Delaware",Global Delaware,https://pbs.twimg.com/profile_images/1059868013459992577/IjSZsC14_normal.jpg,5389,1817,222,6107,DelawareGlobal,photo
76385834,2021-09-23 01:54:03,,,"dlvr.it/S866Bw, pic.twitter.com/RNsULvAV1D, ",1440917356251738113,False,0,0,0,0,dlvr.it,New Atopic Dermatitis Option Available as FDA Approves Incyte's Opzelura https://t.co/iJGPPFwoaC https://t.co/RNsULvAV1D,,,2009-09-22 13:03:55,,Corixis,https://pbs.twimg.com/profile_images/1234473809/favicon_normal.PNG,92,111,17,43317,Corixis,photo
875382419251019776,2021-09-23 01:52:33,,,"bit.ly/2XVuGKG, pic.twitter.com/6cWSnnbjtD, ",1440916978743451651,False,0,0,0,0,dlvr.it,New Atopic Dermatitis Option Available as FDA Approves Incyte's Opzelura https://t.co/DVEoM7UWjD https://t.co/6cWSnnbjtD,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
1134049078424162304,2021-09-23 01:13:55,"RWLK, ENSC, CRVS, BKYI, VRDN, ",,"newsfilter.io/articles/fedex‚Ä¶, ",1440907258939027457,False,0,0,0,0,Newsfilter.io,"FedEx, Incyte, Leap Therapeutics among major healthcare premarket losers' pack $RWLK $ENSC $CRVS $BKYI $VRDN https://t.co/jpkPT26dl2",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
803764650668126208,2021-09-22 20:42:11,,,"enwp.org/Incyte, ",1440838873832050691,False,0,0,0,0,Wikipedia Random Walk,"https://t.co/9H84POZ2Ze Corp is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware and Morges, Switzerland.",,,2016-11-29 19:56:40,,Wikipedia Random Walk,https://pbs.twimg.com/profile_images/1134974653431189504/MxKcAZC8_normal.png,57,0,1,27563,WikiRandomWalk,
172288755,2021-09-22 20:23:49,,,"fiercepharma.com/pharma/incyte-‚Ä¶, ",1440834249444130820,False,0,0,0,0,Twitter for Android,"Incyte's Jakafi sister med clears FDA for atopic dermatitis, but safety warning a heavy cross to bear https://t.co/f6G5X2CqbG",,,2010-07-29 06:10:36,"Yong-In city, Korea",Kyung Seok Lee,https://pbs.twimg.com/profile_images/922433020748898305/cjOW-D4X_normal.jpg,17,60,0,646,ksloveis,
2278450285,2021-09-22 18:39:02,,,"businesswire.com/news/home/2021‚Ä¶, ",1440807880429486082,False,0,0,0,0,Twitter for iPhone,Incyte Announces FDA Approval of Jakafi¬Æ (ruxolitinib) for Treatment of Chronic Graft-Versus-Host Disease (GVHD) | Business Wire https://t.co/tTgsv94n1R,,,2014-01-05 22:37:04,"Houston, TX",Alison Gulbis üò∑üíâ‚úåüèº,https://pbs.twimg.com/profile_images/1379596379274813444/5KHr1qpL_normal.jpg,72,127,0,173,AlisonGulbis,
1280938376099741697,2021-09-22 17:32:13,,"iexStock, ","iexcloud.io, pic.twitter.com/80uOomZhDC, ",1440791064562962432,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-JPMorgan Chase &amp; Co.
-Idexx Laboratories, Inc.
-Qualcomm, Inc.
-Ulta Beauty Inc
-Incyte Corp.

Data provided by https://t.co/oXreiEGhRD https://t.co/80uOomZhDC",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1250830691824283648,2021-09-22 17:18:02,"FDX, INCY, TIXT, LCID, PTON, FB, WMG, DOCS, EXAS, ADBE, UPS, DAR, ",,,1440787495638102021,False,11,0,4,4,Twitter Web App,"Worst performing large cap stocks from today

FedEx $FDX -9.1%
Incyte $INCY -8.5%
Telus $TIXT -8%
Lucid $LCID +6.9%
Peloton $PTON -6.3%
Facebook $FB -4%
Warner Music $WMG -4%
Doximity $DOCS -3.2%
Exact Science $EXAS -3.2%
Adobe $ADBE -3.1%
$UPS -2.3%
Darling $DAR -2.3%",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
4058194633,2021-09-22 16:47:53,"INCY, INCY, ",,"benzinga.com/z/23057229#.YU‚Ä¶, ",1440779910662873088,False,0,0,0,0,Twitter for iPhone,$INCY Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD $INCY https://t.co/UK1VY6YK6P # via @benzinga,"Benzinga, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1564125781,2021-09-22 16:45:00,"INCY, ",,"biopharmadive.com/news/incyte-fd‚Ä¶, ",1440779182921818113,False,0,0,0,0,TweetDeck,"Incyte eczema drug wins FDA OK, but with safety warning  https://t.co/hX1Hih9cFZ by Kristin Jensen $INCY",,,2013-07-02 17:00:07,"Washington, D.C.",BioPharma Dive,https://pbs.twimg.com/profile_images/1247897788702052354/8g5XsbZF_normal.jpg,11666,334,333,14463,BioPharmaDive,
478786305,2021-09-22 16:11:55,,"GVHD, ","bit.ly/3ECfZgl, ",1440770859640115205,False,0,0,0,0,SocialPilot.co,üëç FDA approves new indication for Jakafi @Incyte for chronic graft-versus-host disease https://t.co/660kzKsUfO #GVHD,"Incyte, ",,2012-01-30 12:23:35,"Thorofare, NJ",Healio,https://pbs.twimg.com/profile_images/1136693496306458625/-IoG0_TG_normal.png,5258,1161,271,41580,GoHealio,
211220879,2021-09-22 15:57:39,,"ruxolitinib, atopicdermatitis, Opzelura, eczema, ","medcitynews.com/2021/09/better‚Ä¶, ",1440767266270769159,False,2,0,1,2,Twitter Web App,".@Incyte finally got @US_FDA approval for #ruxolitinib in #atopicdermatitis. The entire class of JAK inhibitors is under greater FDA scrutiny for safety, and $INCY‚Äôs drug, which will be marketed as #Opzelura, carries a black box warning https://t.co/4NVx4bAeYe #eczema","Incyte, US_FDA, ",,2010-11-02 13:20:59,North Carolina,Frank Vinluan,https://pbs.twimg.com/profile_images/1503948370/billy_3_normal.jpg,1579,716,105,5339,frankvinluan,
279184000,2021-09-22 15:42:36,,,"bit.ly/3tZGw2c, ",1440763479304990731,False,4,0,0,2,Buffer,"FDA approves Jakafi for chronic GVHD. Ruxolitinib (Jakafi, Incyte), an oral Janus kinase 1/2 inhibitor, previously received approval for treatment of patients aged 12 years or older with steroid-refractory acute GVHD.  https://t.co/isItDebNZ8",,,2011-04-08 15:16:02,"Dallas, TX",Dr. John Cush,https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3_normal.jpg,12140,432,178,16241,RheumNow,
1269758829690052610,2021-09-22 15:41:06,"INCY, ",,,1440763103629639685,False,0,0,0,0,Zapier.com,"Incyte management to meet virtually with Oppenheimer
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
1250156125053423619,2021-09-22 15:23:37,,,"fool.com/investing/2021‚Ä¶, ",1440758701443346432,False,0,0,0,0,PyMarketWatch,"Facebook, Incyte Fall Despite the Nasdaq's Strong Wednesday Start - The Motley Fool https://t.co/5QCPCbPIS8",,,2020-04-14 16:17:09,,PyMarketWatch,https://pbs.twimg.com/profile_images/1251051867263598592/hU5UXcPw_normal.jpg,377,0,4,34632,PyMarketWatch,
780839403501432832,2021-09-22 15:18:27,,"deeplearning, intoAInews, ","neurons.ai/blog/news-stor‚Ä¶, ",1440757402425454594,False,1,0,0,1,Neurons.AI,Recon: FDA approves Incyte‚Äôs eczema cream with boxed warnings; Biden pledges 500M ‚Ä¶ - ... https://t.co/rKfmJ6Mshg #deeplearning #intoAInews,,,2016-09-27 14:39:55,Global,Neurons.AI #intoAI #Neurons #AI,https://pbs.twimg.com/profile_images/891699350346379264/g_g4WsrR_normal.jpg,3102,3683,112,30437,Neurons_AI,
2427427951,2021-09-22 15:18:24,,,"medcitynews.com/2021/09/better‚Ä¶, ",1440757391528632322,False,0,0,0,0,Twitter Web App,"Better late than never? Eczema drug now approved, Incyte says warning unwarranted https://t.co/TW0ZD9Tuat",,,2014-04-04 11:04:23,Sunderland - Tyne &Wear - UK,FibroFlutters,https://pbs.twimg.com/profile_images/1437439192376692739/ilYZhuFa_normal.jpg,3634,4540,106,39289,FibroFlutters,
27645777,2021-09-22 15:14:48,,"GVHD, ","bit.ly/3ECfZgl, ",1440756483973517314,False,0,0,0,2,SocialPilot.co,üëç FDA approves new indication for Jakafi @Incyte for chronic graft-versus-host disease https://t.co/pi3093NhpW #GVHD,"Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,
1109103166757527553,2021-09-22 15:06:48,,,"ift.tt/2XKk3dU, ",1440754471227691009,False,0,0,0,0,IFTTT,"Better late than never? Eczema drug now approved, Incyte says warning unwarranted https://t.co/A55fxBsh39",,,2019-03-22 10:42:55,"Melbourne, Victoria",Luke Lazarus,https://pbs.twimg.com/profile_images/1109161690527158273/J-xz4dNF_normal.png,444,26,1,9667,LukeLazarusAU,
1006334607946649600,2021-09-22 15:05:10,,"StockMarket, Stocks, ","dlvr.it/S84n6w, pic.twitter.com/TAKzApSB8e, ",1440754058457845763,False,0,0,0,0,dlvr.it,Back To Back FDA Approval For Incyte ‚Äì This Time For Jakafi In GVHD https://t.co/bpLatvuH95 #StockMarket #Stocks https://t.co/TAKzApSB8e,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
836298809605046278,2021-09-22 14:54:23,,,"bit.ly/3u4qXGD, ",1440751345317801984,False,6,1,0,5,Sprout Social,"FDA approved ruxolitinib (Jakafi, Incyte Corp.) for chronic graft-versus-host disease (cGVHD) after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older.
https://t.co/EClORPg5pc",,,2017-02-27 14:35:48,"Silver Spring, MD",FDA Oncology,https://pbs.twimg.com/profile_images/836300624199364609/6UHslRrT_normal.jpg,28020,325,325,5167,FDAOncology,
20780650,2021-09-22 14:51:40,,,"biedexmarkets.com/incyte-corpora‚Ä¶, pic.twitter.com/c3dfVETgXc, ",1440750661235195913,False,0,0,0,0,Twitter,"Incyte Corporation (NASDAQ:INCY) - Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD

       https://t.co/1D302sVOVr https://t.co/c3dfVETgXc",,,2009-02-13 11:02:18,"London, England",Biedex Markets,https://pbs.twimg.com/profile_images/1288488731654201349/MSrdzFac_normal.jpg,4018,4862,120,362261,biedexmarkets,photo
1407780158,2021-09-22 14:50:38,,,"businesswire.com/news/home/2021‚Ä¶, ",1440750401477775365,False,48,0,0,13,Twitter for iPad,Another option for patients with chronic GVHD. Great news for our patients with 3 drugs approved in recent years. ‚Å¶@Incyte‚Å© Announces FDA Approval of Jakafi¬Æ (ruxolitinib) for Chronic GVHD- COI I have participated in Incyte trials &amp; served as advisor https://t.co/OqwKwKu12C,"Incyte, ",,2013-05-06 09:41:58,"New York, NY",Miguel Perales M.D.,https://pbs.twimg.com/profile_images/1250512673470590981/ldD-7z-v_normal.jpg,15352,2299,358,33645,DrMiguelPerales,
2809497047,2021-09-22 14:49:24,,"BMT, GVHD, ","nejm.org/doi/full/10.10‚Ä¶, twitter.com/Mohty_EBMT/sta‚Ä¶, ",1440750093267705861,False,31,0,0,4,Twitter for iPhone,"This is üëç news for our #BMT patients with refractory chronic #GVHD; REACH3 RCT showed ‚¨ÜÔ∏è response, failure free survival, and symptom control in Ruxolitinib arm https://t.co/n2pPTYIqSH 

(PS: I do have $ COI w/@Incyte) https://t.co/Ey4Gqma7fl","Incyte, ",,2014-10-05 23:06:52,"Nashville, TN","Navneet Majhail, MD, MS",https://pbs.twimg.com/profile_images/1447967367594643470/9jzMSdvz_normal.jpg,16662,890,0,39555,BldCancerDoc,
407212567,2021-09-22 14:43:38,,"eHealth, ","ift.tt/2XKk3dU, ",1440748639035355140,False,0,0,0,1,IFTTT,"Mi seguimiento üì° sobre #eHealth Better late than never? Eczema drug now approved, Incyte says warning unwarranted: https://t.co/bsgrzVF2Mg",,,2011-11-07 14:56:05,Espa√±a,Eugenio Ghirardi,https://pbs.twimg.com/profile_images/378800000532943977/0f99af81bf68382f40a90e89c7ca525c_normal.png,341,485,32,19973,GhirardiEugenio,
25406480,2021-09-22 14:42:33,,,"awesomecapital.blogspot.com/2021/09/incyte‚Ä¶, ",1440748368007864332,False,0,0,0,1,Twitter Web App,AwesomeCapital: Incyte Jakafi sister med clears FDA for atopic der... https://t.co/VG98nW1L6E,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
3911174913,2021-09-22 14:30:08,,"GVHD, ","pic.twitter.com/Ux2Nq4z5VL, ",1440745243381436416,False,7,0,0,1,Twitter Web App,"Peg Squier, Group VP, U.S. Medical Affairs, Incyte, shares her perspective on the significance of our FDA approval for the treatment for chronic graft-verse-host disease (#GVHD) after failure of one or two lines of systemic therapy in adult &amp; pediatric patients 12 years &amp; older. https://t.co/Ux2Nq4z5VL",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
140599113,2021-09-22 14:27:31,,,"winway.me/health-care/be‚Ä¶, ",1440744586591150081,False,0,0,0,0,WordPress.com,"Better late than never? Eczema drug now approved, Incyte says warning¬†unwarranted https://t.co/lYSvwPl4GB",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
3901351277,2021-09-22 14:20:09,,"healthnews, ","bit.ly/3u4hnUb, ",1440742732394164227,False,0,0,0,0,IFTTT,"Better late than never? Eczema drug now approved, Incyte says warning unwarranted : https://t.co/WP13XxMveJ #healthnews",,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
1134049078424162304,2021-09-22 14:12:37,"INCY, ",,"newsfilter.io/articles/back-‚Ä¶, ",1440740833729286150,False,0,0,0,0,Newsfilter.io,Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD $INCY https://t.co/8gkv3ZK3YN,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
21793154,2021-09-22 14:09:00,,"biotech, medicalnews, ","hubs.li/H0XWdYj0, ",1440739924081217551,False,1,0,0,0,HubSpot,"New atopic dermatitis option available as @US_FDA approves @Incyte's Opzelura 
#biotech #medicalnews
https://t.co/jucVVg48XR","US_FDA, Incyte, ",,2009-02-24 15:27:40,"Des Moines, IA",BioSpace,https://pbs.twimg.com/profile_images/1042117112020389888/8MCBEVkx_normal.jpg,21738,2830,509,25196,biospace,
1270220114340851712,2021-09-22 14:08:05,,"PharmaTwitter, MedTwitter, MedEd, ","medpub.io, medcitynews.com/2021/09/better‚Ä¶, ",1440739694338187273,False,0,0,0,0,Automate.io,"Better late than never? Eczema drug now approved, Incyte says warning unwarranted

More medical news at https://t.co/WN5LVURb3L
#PharmaTwitter #MedTwitter #MedEd
https://t.co/c6C8tudZ03",,,2020-06-09 01:04:18,Look here üëâ,MedPub Pharmaceutical,https://pbs.twimg.com/profile_images/1443232668716515331/xzljON0s_normal.jpg,2,69,0,3346,PharmaPublisher,
963495628545327104,2021-09-22 14:07:08,"INCY, INCY, ",,"stck.pro/news/INCY/1579‚Ä¶, stck.pro/news/INCY, pic.twitter.com/0B72aVUgAq, ",1440739453501280262,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD https://t.co/3IKO2jTM3v Get all the latest $INCY related news here : https://t.co/MBjnAUYXBx https://t.co/0B72aVUgAq,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
18834912,2021-09-22 14:05:17,,,"trib.al/nshgBd5, ",1440738991133769728,False,0,0,0,0,SocialFlow,"Better late than never? Eczema drug now approved, Incyte says warning unwarranted https://t.co/Rp7Hl3cXxV",,,2009-01-10 09:09:33,"MedCity, USA",MedCity News,https://pbs.twimg.com/profile_images/598875829976834048/MLQosVo1_normal.png,32781,7502,1628,37912,medcitynews,
21079030,2021-09-22 14:02:26,,"PharmaScrip, ","bit.ly/3hTuHFS, ",1440738273362472972,False,0,1,0,0,Sprinklr,"Incyte Plays Down Ruxolitinib Cream Label Worries Following Atopic Dermatitis Approval
https://t.co/PBZGnP1Q7C #PharmaScrip",,,2009-02-17 05:33:29,Global,Scrip,https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg,21541,1629,654,35335,PharmaScrip,
2851552811,2021-09-22 13:52:10,"INCY, ","GVHD, BMT, ","businesswire.com/news/home/2021‚Ä¶, ",1440735690426241025,False,40,1,0,3,Twitter for Android,"3 drugs approved in chronic #GVHD with the approval of Ruxolitinib. Congratulations to all at $INCY. Big day for our #BMT patients
https://t.co/Zl8zWNx8m5",,,2014-10-30 11:39:14,"Boston, MA",Corey Cutler,https://pbs.twimg.com/profile_images/1351947730352893952/U4D7Y6Ke_normal.jpg,1971,213,44,763,DrCCutler,
437085904,2021-09-22 13:51:07,,,"dlvr.it/S84Z6B, pic.twitter.com/1pxZ58cbUG, ",1440735425421721602,False,0,0,0,1,dlvr.it,"Better late than never? Eczema drug now approved, Incyte says warning unwarranted https://t.co/35RA6aSItn https://t.co/1pxZ58cbUG",,,2011-12-14 19:20:30,"Hudson Valley, New York",Bruce Judson Telemed,https://pbs.twimg.com/profile_images/904040523580661760/7sz5Ry6z_normal.jpg,5677,1562,245,82548,JudsonTelemed,photo
1004375641171603458,2021-09-22 13:36:03,,"Delaware, biopharmaceutical, choosedelaware, netde, ","hubs.ly/H0XWRQN0, pic.twitter.com/AXtlqrRe49, ",1440731632575545353,False,2,1,0,1,HubSpot,"#Delaware-based #biopharmaceutical innovator @Incyte ‚Äì one of the most innovative companies in the U.S. ‚Äì has received @US_FDA  approval for the first and only treatment of its kind for atopic dermatitis. 
https://t.co/ifxtByTt40 
#choosedelaware #netde https://t.co/AXtlqrRe49","Incyte, US_FDA, ",,2018-06-06 10:53:08,,Delaware Prosperity Partnership @choosedelaware,https://pbs.twimg.com/profile_images/1059872509540134913/PX_tVV7O_normal.jpg,4337,1030,21,2792,choosedelaware,photo
1416435855338606592,2021-09-22 13:09:05,,,"nowyoureadme.com/facebook-incyt‚Ä¶, ",1440724847496105990,False,0,0,0,0,WordPress.com,"Facebook, Incyte Fall Despite the Nasdaq‚Äôs Strong Wednesday¬†Start https://t.co/hPqa5e5STy",,,2021-07-17 12:33:45,,Now You Read Me,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,2,0,0,35448,NowYouReadMe1,
963495628545327104,2021-09-22 12:52:29,"INCY, INCY, ",,"stck.pro/news/INCY/1579‚Ä¶, stck.pro/news/INCY, ",1440720669260402691,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : FDA approves Incyte's Jakafi in chronic graft-versus-host disease indication https://t.co/u370oBfdz2 Get all the latest $INCY related news here : https://t.co/MBjnAUYXBx,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
4876582225,2021-09-22 12:48:28,"INCY, ",,"ideas.quantcha.com/2021/09/22/sto‚Ä¶, ",1440719658298974212,False,0,0,0,0,WordPress.com,StockTwits Trending Alert: Trading recent interest in INCYTE¬†$INCY https://t.co/WFG8dsyo26,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
176597920,2021-09-22 12:46:25,"INCY, ",,"investor.incyte.com/press-releases‚Ä¶, ",1440719143066488839,False,0,0,0,1,Twitter Web App,$INCY https://t.co/9bH4PSObCd,,,2010-08-09 19:33:23,"Ghent, Belgium",Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,https://pbs.twimg.com/profile_images/957256474018934784/1n7evwD2_normal.jpg,943,137,17,37474,kevinjaybe,
963495628545327104,2021-09-22 12:45:03,"INCY, INCY, ",,"stck.pro/news/INCY/1579‚Ä¶, stck.pro/news/INCY, pic.twitter.com/aPA8LIiWNs, ",1440718799091634183,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Announces FDA Approval of Jakafi¬Æ (ruxolitinib) for Treatment of Chronic Graft-Versus-Host Disease (GVHD) https://t.co/ykqCGnuyaI Get all the latest $INCY related news here : https://t.co/MBjnAUYXBx https://t.co/aPA8LIiWNs,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1269758829690052610,2021-09-22 12:40:58,"INCY, ",,,1440717770832834561,False,1,0,0,1,Zapier.com,"Incyte says FDA approves Jakafi for treatment of chronic GVHD
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
1069693680066420736,2021-09-22 12:40:43,"INCY, ",,"s.flashalert.me/7EPQl, ",1440717709679812628,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on September 22, 12:38:00: Incyte Announces FDA Approval of Jakafi¬Æ (ruxolitinib) for Treatment of Chronic Graft-Versus-Host Disease (GVHD) https://t.co/gjSS2Zeuhx",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842260,FlashAlert_me,
4382570173,2021-09-22 12:39:21,"INCY, ",,"benzinga.grsm.io/truetrader, ",1440717362383110156,False,2,0,0,1,Twitter Web App,$INCY Incyte Announces FDA Of Jakafi For Treatment Of Chronic Graft-Versus-Host Diseases https://t.co/Ne4UHbylKd,,,2015-11-27 18:52:09,Trade Smart. Trade Safe.,True Trader,https://pbs.twimg.com/profile_images/1345464980972457985/LPfaCBUN_normal.jpg,3288,1676,36,4962,TrueTraderNet,
1395522293040828418,2021-09-22 12:39:10,"INCY, ",,,1440717319232110599,False,0,0,0,0,Twitter Web App,Incyte Announces FDA Of Jakafi For Treatment Of Chronic Graft-Versus-Host Diseases $INCY,,,2021-05-20 19:31:59,,Potter Stocks,https://pbs.twimg.com/profile_images/1447531194653069317/RgJzueoF_normal.jpg,2098,172,4,2870,potter_stocks,
1134049078424162304,2021-09-22 12:38:38,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1440717181692432394,False,0,0,0,0,Newsfilter.io,Incyte Announces FDA Approval of Jakafi¬Æ for Treatment of Chronic Graft-Versus-Host Disease $INCY https://t.co/AWgycTiXde,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1325115160353103872,2021-09-22 12:38:31,"INCY, ",,"quantisnow.com/insight/179928‚Ä¶, ",1440717154286899207,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces FDA Approval of Jakafi¬Æ (ruxolitinib) for Treatment of Chronic Graft-Versus-Host Disease (GVHD)

https://t.co/g8knULUByh

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
505056659,2021-09-22 12:37:32,,,"dlvr.it/S84LyY, ",1440716906449620998,False,0,0,0,0,dlvr.it,"Facebook, Incyte Fall Despite the Nasdaqs Strong Wednesday Start (newsfeedback@fool.com (Dan Caplinger)/Fool.com Headlines) https://t.co/Nqitpj2QAk",,,2012-02-26 16:56:35,San Francisco,TIN-Facebook News,https://pbs.twimg.com/profile_images/1907875735/TINFavicon2012-FINAL_normal.png,86,0,28,63211,TINFacebookNews,
3435682714,2021-09-22 12:25:46,"HOTH, INCY, LPTX, ",,"pic.twitter.com/5Td8D2lDyu, ",1440713945896001540,False,1,0,0,0,Twitter for iPhone,"Tiny biotech company $HOTH developed Biolexa lotion Non-corticosteroid treatment targeted for treatment of both pediatric and adult mild to moderate AD populations. Market potential $8B-18B, so far no effective treatment exist @Incyte $INCY should acquire the company 

$LPTX https://t.co/5Td8D2lDyu","Incyte, ",,2015-08-22 12:15:30,"New York, USA",Biotech,https://pbs.twimg.com/profile_images/1336863494373859328/lSWUKPa5_normal.jpg,688,16,16,7065,ej23ny,photo
1085936440855416832,2021-09-22 12:15:32,"INCY, FB, ","ACFMarketWrap, Incyte, Facebook, ACFView, ","twitter.com/ACFER01/status‚Ä¶, ",1440711371612516355,False,0,0,0,0,Twitter Web App,"#ACFMarketWrap #Incyte  (US biotech) $INCY 6% fall on the back of qualified FDA approval for Opzelura is an e.g. of the uncertainty effect. #Facebook $FB on the other hand is embroiled in another conflict of interest problem - oddly, that feels more 'predictable'. #ACFView https://t.co/c6P0MjvR9W",,,2019-01-17 11:26:38,London,ACFER5 - Head of Research,https://pbs.twimg.com/profile_images/1085937284531277825/P6x3w98O_normal.jpg,54,93,0,1183,ACFER5,
4876582225,2021-09-22 12:05:44,"INCY, ",,"ideas.quantcha.com/2021/09/22/52-‚Ä¶, ",1440708905777070085,False,0,0,0,0,WordPress.com,52-Week Low Alert: Trading today‚Äôs movement in INCYTE¬†$INCY https://t.co/jMZjEFQQjO,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
963495628545327104,2021-09-22 11:41:12,"FB, INCY, FB, ",,"stck.pro/news/FB/157914‚Ä¶, stck.pro/news/FB, pic.twitter.com/OPSDgoR3Ck, ",1440702730633236491,False,0,0,0,0,STCK.PR0,"$FB $INCY NEW ARTICLE : Facebook, Incyte Fall Despite the Nasdaq's Strong Wednesday Start https://t.co/P1qBAju1vf Get all the latest $FB related news here : https://t.co/GV0TK8W5mx https://t.co/OPSDgoR3Ck",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
15974185,2021-09-22 11:30:05,,,"dlvr.it/S847kP, ",1440699931988164610,False,0,0,0,0,dlvr.it,"Incyte nabs approval of topical ruxolitinib in atopic dermatitis, but gets slapped with JAK warning https://t.co/WSMmPn6cZC",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
32450040,2021-09-22 11:28:48,"INCY, SGEN, ","Incyte, Seagen, Opzelura, Tivdak, FDA, Genmab, ","evaluate.com/vantage/articl‚Ä¶, ",1440699608108179459,False,1,0,0,0,Twitter Web App,#Incyte and #Seagen face tricky launches (Via @ByLizC) $INCY $SGEN https://t.co/GlhHFsyqJq #Opzelura #Tivdak #FDA #Genmab,"ByLizC, ",,2009-04-17 11:37:01,"London, UK",Evaluate Vantage,https://pbs.twimg.com/profile_images/1246341890452193282/YN-iBs1e_normal.jpg,6999,481,186,6859,evaluatevantage,
4876582225,2021-09-22 11:19:13,"INCY, ",,"ideas.quantcha.com/2021/09/22/big‚Ä¶, ",1440697196437905417,False,0,0,0,0,WordPress.com,Big Loser Alert: Trading today‚Äôs -7.1% move in INCYTE¬†$INCY https://t.co/2lGoi5VcL5,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
1325115160353103872,2021-09-22 11:16:53,"INCY, ",,"quantisnow.com/insight/179884‚Ä¶, ",1440696611907063811,False,1,0,0,0,Twitter,"$INCY ‚öïÔ∏è FDA Approval for OPZELURA issued to INCYTE CORP

https://t.co/grBhb8jJNU

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
4058194633,2021-09-22 11:14:09,"INCY, SGEN, GMAB, MRK, ",,"evaluate.com/vantage/articl‚Ä¶, ",1440695921419841538,False,1,0,0,1,Twitter for iPhone,$INCY $SGEN $GMAB $MRK Incyte and Seagen face tricky launches https://t.co/GuPWNSuuqz,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
166597717,2021-09-22 11:01:02,"INCY, PFE, LLY, ABBV, ",,"bit.ly/3Czv54i, ",1440692621370744838,False,2,0,1,1,TweetDeck,Incyte sinks after eczema cream approval comes with boxed warnings $INCY $PFE $LLY $ABBV https://t.co/MWEixxjY2B,,,2010-07-14 11:10:34,Greater New York City Area,The Fly,https://pbs.twimg.com/profile_images/885896700472287233/NunLvfQW_normal.jpg,27381,167,0,106350,theflynews,
1269758829690052610,2021-09-22 10:57:29,"INCY, PFE, LLY, ABBV, ",,,1440691727770140689,False,0,0,0,0,Zapier.com,"Incyte sinks after eczema cream approval comes with boxed warnings
$INCY $PFE $LLY $ABBV",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
4893474783,2021-09-22 10:44:55,,,"via.news/markets/incyte‚Ä¶, pic.twitter.com/Rc7pXC0jwN, ",1440688563989843969,False,0,0,0,0,World time zone,"Incyte Corporation Stock Bearish Momentum With A 6% Fall At Session Start Today
https://t.co/QgdGtth6xa
(VIANEWS) - Shares of Incyte Corporation (NASDAQ Composite: INCY) fell 6.44% to $71.16 at 10:43 EST ... https://t.co/Rc7pXC0jwN",,,2016-02-09 19:06:07,,Via News,https://pbs.twimg.com/profile_images/1102363201587634181/TJeRzWNR_normal.png,2462,4822,43,59142,ViaNewsAgency,photo
3911174913,2021-09-22 10:44:14,,"WCMLDay21, CML, ","bit.ly/3u0bTcM, pic.twitter.com/WFTYIdwnNF, ",1440688395269775373,False,4,0,1,1,Twitter Web App,"This #WCMLDay21, we are supporting @cmlnet in bringing the chronic myeloid leukemia (#CML) global community together to raise awareness of the challenges patients are facing and show our commitment to improving patient care. Learn more. https://t.co/E1RLDo6kcg https://t.co/WFTYIdwnNF","cmlnet, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
2398845223,2021-09-22 09:48:31,,,"ow.ly/ECbP102XFzR, ",1440674371022962689,False,0,0,0,0,Hootsuite Inc.,"Incyte's Jakafi sister med clears FDA for atopic dermatitis, but safety warning a heavy cross to bear https://t.co/f02P3fkzXk",,,2014-03-19 23:11:51,Maryland,Continental Clinical,https://pbs.twimg.com/profile_images/673876383358062593/qyzjJcMn_normal.jpg,669,521,13,5348,Conti_Clinical,
1250830691824283648,2021-09-22 09:46:58,"FDX, WMG, TIXT, UPS, ADBE, INCY, PATH, NMR, GRFS, FB, PTON, BIIB, SNAP, TWTR, EDR, UNH, ",,,1440673982076710918,False,15,0,1,3,Twitter Web App,"Worst performing large cap stocks at today's open

FedEx $FDX
Warner Music $WMG
Telus $TIXT
United Parcel $UPS
Adobe $ADBE
Incyte $INCY
UiPath $PATH
Nomura $NMR
Grifols $GRFS
Facebook $FB
Peloton $PTON
Biogen $BIIB
Snapchat $SNAP
Twitter $TWTR
Endeavor $EDR
UnitedHealth $UNH",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
46297868,2021-09-22 09:46:32,,,"dlvr.it/S83nvw, ",1440673872508977168,True,0,0,0,0,dlvr.it,"Incyte's Jakafi sister med clears FDA for atopic dermatitis, but safety warning a heavy cross to bear https://t.co/g3kuJHdyb8",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
624413,2021-09-22 09:33:42,,,"on.mktw.net/3hWm1OY, ",1440670645201747971,False,15,0,2,0,SocialFlow,Incyte gets FDA approval for atopic dermatitis drug https://t.co/eDOEfAHFMu,,,2007-01-11 00:15:48,"New York, NY",MarketWatch,https://pbs.twimg.com/profile_images/705601245596090368/Z6xUOnRg_normal.jpg,4125163,200,28863,354060,MarketWatch,
1432410102565330946,2021-09-22 09:29:45,,,"automationinvestors.com/9715964/incyte‚Ä¶, pic.twitter.com/6rYXpLBdMU, ",1440669647829827594,False,0,0,0,0,newsy.co,Incyte gets FDA approval for atopic dermatitis drug - https://t.co/gFhjUxZXzj https://t.co/6rYXpLBdMU,,,2021-08-30 14:29:28,,News Aggregator,https://pbs.twimg.com/profile_images/1432410614291435529/W9NdDSk7_normal.jpg,0,12,0,1020,PopularNewsBot,photo
23939188,2021-09-22 09:24:19,,"AtopicDermatitis, ","twitter.com/Incyte/status/‚Ä¶, ",1440668282411884547,False,1,0,0,0,Twitter Web App,"Exciting news for patients with mild to moderate #AtopicDermatitis
- Opzelura is the first and only topical Janus kinase (JAK) inhibitor approved in the U.S.
- In Phase 3 studies, Opzelura reduced the skin inflammation and itch associated with AD
Click the link to learn more! https://t.co/mftwYEGkyH",,,2009-03-12 08:34:25,"Vienna, VA",Allergy & Asthma Network,https://pbs.twimg.com/profile_images/512619339749404672/_5fuaToo_normal.jpeg,8739,3870,136,10595,AllergyAsthmaHQ,
270492072,2021-09-22 09:21:50,,"news, mktw, wsj, ","feeds.marketwatch.com/~r/marketwatch‚Ä¶, ",1440667655371821062,False,0,0,0,0,Microsoft Power Platform,Incyte gets FDA approval for atopic dermatitis drug https://t.co/DRjWOCATLl via MarketWatch #news #mktw #wsj,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
3316713321,2021-09-22 09:20:09,,,"marketwatch.com/news/story/inc‚Ä¶, ",1440667233751945232,False,0,0,0,0,WordPress.com,Incyte gets FDA approval for atopic dermatitis¬†drug https://t.co/KpHv45zNkL,,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
4058194633,2021-09-22 09:03:22,"INCY, ",,"reuters.com/business/healt‚Ä¶, ",1440663009165148164,False,0,1,0,0,Twitter for iPhone,$INCY FDA approves Incyte's eczema cream with boxed warnings https://t.co/A8VIsVBdLH,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
13557562,2021-09-22 08:41:02,,,"reuters.com/business/healt‚Ä¶, ",1440657391452758031,False,0,0,0,0,Twitter Web App,FDA approves Incyte's eczema cream with boxed warnings https://t.co/f46r4azCVQ,,,2008-02-16 11:58:12,"iPhone: 35.121323,-89.830750","Michael Blaiss, MD",https://pbs.twimg.com/profile_images/1397602816345186304/FFET4jcx_normal.jpg,3944,811,177,14618,wheezemd,
15296897,2021-09-22 08:30:05,,,"seekingalpha.com/news/3742189-f‚Ä¶, ",1440654635027419152,False,0,0,0,1,SANewsTwitter,"FedEx, Incyte, Leap Therapeutics among major healthcare premarket losers' pack https://t.co/zn4C2iHNz0",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
2334614718,2021-09-22 08:14:09,"INCY, ",,"ooc.bz/l/83395, ",1440650624111038470,False,2,0,0,2,Open Outcrier,"$INCY (-4.0% pre) FDA approves Incyte's eczema cream with boxed warnings - Reuters

https://t.co/c8YPITd5gY",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
727519600787750913,2021-09-22 08:10:04,"INCY, ","Incyte, ","marketchameleon.com/Overview/INCY/‚Ä¶, pic.twitter.com/AjxbIY01so, ",1440649595512442895,False,0,0,0,0,MarketChameleon.com,$INCY #Incyte declines in premarket trading. See the latest news. https://t.co/xvU1P9uF2A https://t.co/AjxbIY01so,,,2016-05-03 11:26:04,"Philadelphia, PA",Chameleon ü¶é,https://pbs.twimg.com/profile_images/1141429857613680640/UQDYIDcD_normal.png,10088,29,265,124065,MarketChmln,photo
980467278385958912,2021-09-22 07:47:10,"INCY, ",,"billionaireclubcollc.com/incyte-corpora‚Ä¶, ",1440643833788715012,False,0,0,0,0,Twitter Web App,Incyte Corporation (NASDAQ: $INCY) ‚Äì Incyte‚Äôs Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis https://t.co/ra8oeOIINO,,,2018-04-01 11:29:50,"New York, USA",Billionaireclubcollc.com,https://pbs.twimg.com/profile_images/1420395068754628612/Zr8OoRN9_normal.jpg,6959,225,78,125759,LlcBillionaire,
386042607,2021-09-22 07:44:45,,"dermtwitter, ","hubs.ly/H0XV7QB0, ",1440643224670851076,False,1,0,0,1,HubSpot,Opzelura (ruxolitinib) cream from @Incyte is now @US_FDA approved for short-term &amp; non-continuous chronic treatment of mild-to-moderate atopic dermatitis in non-immunocompromised patients 12 &amp; older https://t.co/zy3WwPpnuQ #dermtwitter,"Incyte, US_FDA, ",,2011-10-06 11:34:39,,Practical Derm,https://pbs.twimg.com/profile_images/1172186203099189249/6ZV9TJxF_normal.jpg,2800,888,49,4503,Practical_Derm,
1399103920522334219,2021-09-22 07:38:06,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/UYSFXJByfQ, ",1440641551361662977,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3039 out of 5580 companies in our database. 

üëâ https://t.co/xYpt7r0Abp $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/UYSFXJByfQ",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
133504478,2021-09-22 07:32:08,,"strategy, competitiveintelligence, marketing, pharmaceutical, productmarketing, healthcare, pharma, biotech, ","dlvr.it/S83LMT, pic.twitter.com/9zjtQbJPme, ",1440640050627104768,False,0,0,0,1,dlvr.it,"Incyte nabs approval of topical ruxolitinib in atopic dermatitis, but gets slapped with JAK warning https://t.co/TNHvZH1WnC #strategy #competitiveintelligence #marketing #pharmaceutical #productmarketing #healthcare #pharma #biotech https://t.co/9zjtQbJPme",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
270492072,2021-09-22 07:18:51,,"news, SeekingAlpha, ","seekingalpha.com/news/3742134-i‚Ä¶, ",1440636706705723395,False,0,0,0,0,Microsoft Power Platform,Incyte trades lower on safety warning in FDA approval for Opzelura https://t.co/Wi48a62htp via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
3460109487,2021-09-22 07:18:27,,,"endpts.com/incyte-nabs-ap‚Ä¶, ",1440636606457671682,False,2,0,0,2,TweetDeck,"The FDA approved a topical formulation of the JAK inhibitor ruxolitinib for mild-to-moderate atopic dermatitis, Incyte announced Tuesday afternoon.

https://t.co/1yq24NTRcE",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
65630688,2021-09-22 07:15:00,,"vitiligo, ESDR2021, ","esdrmeeting.org/scientific-pro‚Ä¶, ",1440635737582538752,False,2,0,0,1,Twitter Web App,"Join a symposium tomorrow sponsored by @Incyte where innovative research on signal transduction pathways involved in the pathogenesis of #vitiligo will be presented. Tune in at 13:15, September 23.  #ESDR2021  
https://t.co/7KplqR3z1d","Incyte, ",,2009-08-14 09:10:20,"Geneva, Switzerland",ESDR,https://pbs.twimg.com/profile_images/1255849793177387011/XWNNooSs_normal.jpg,3057,480,38,3241,ESDRorg,
1134049078424162304,2021-09-22 07:14:37,"INCY, ABBV, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1440635643760025600,False,0,0,0,0,Newsfilter.io,Incyte trades lower on safety warning in FDA approval for Opzelura $INCY $ABBV https://t.co/eO6r9bydf7,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
963495628545327104,2021-09-22 07:13:08,"INCY, INCY, ",,"stck.pro/news/INCY/1578‚Ä¶, stck.pro/news/INCY, pic.twitter.com/saAAcODC8z, ",1440635269451894795,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis https://t.co/uN8c5wSq48 Get all the latest $INCY related news here : https://t.co/MBjnAUYXBx https://t.co/saAAcODC8z,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
46297868,2021-09-22 07:05:33,,,"dlvr.it/S83G3Y, ",1440633361941164040,True,0,0,0,0,dlvr.it,"Incyte nabs approval of topical ruxolitinib in atopic dermatitis, pushing blockbuster JAK to new frontier https://t.co/SuOf2qLBcB",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
23184067,2021-09-22 06:59:18,,,"buff.ly/3AxREWw, ",1440631786443141120,False,2,0,0,4,Buffer,"FDA approves Incyte's eczema cream with boxed warnings. The ruxolitinib cream is the first topical JAK inhibitor, a class of treatments that work by blocking inflammation-causing enzymes Janus kinases, to be approved in the US. https://t.co/DctDtlXG9G",,,2009-03-07 05:56:51,Buenos Aires,Juan C Ivancevich MD,https://pbs.twimg.com/profile_images/1427600321505857539/-m2-zdWi_normal.jpg,6820,603,249,84875,Aller_MD,
27254739,2021-09-22 05:48:51,,"Pharma, ","pharmaphorum.com/news/incyte-le‚Ä¶, ",1440614056696573956,False,0,0,0,0,Sprout Social,"#Pharma company @Incyte beats its oral JAK inhibitor rivals to the US atopic dermatitis market with its topical Opzelura cream, but can't escape the FDA's class-wide safety warnings https://t.co/cYzDCha0eC","Incyte, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
773485929969414148,2021-09-22 05:47:10,,,"pharmaphorum.com/news/incyte-le‚Ä¶, ",1440613634372108296,False,0,0,0,0,Publer.io,"Incyte leads JAK push into eczema as FDA clears Opzelura
cream

 The FDA has approved Incyte‚Äôs Opzelura cream for atopic dermatitis, commonly called eczema, becoming the first and only topical JAK inhibitor registered in the US. Opzelura (ruxolitinib) ‚Äì  https://t.co/u4R8wy97Em",,,2016-09-07 07:39:51,"Hyderabad, India",Sarang Pokhare,https://pbs.twimg.com/profile_images/1453364968737296391/M0Xff8ch_normal.jpg,584,1756,17,152669,sarang143u,
773485929969414148,2021-09-22 05:46:03,,,"pharmashots.com/64691/incytes-‚Ä¶, ",1440613355228524550,False,0,0,0,0,Publer.io,"Incyte‚Äôs Opzelura (ruxolitinib) Receives the US FDA‚Äôs
Approval for the Treatment of Atopic Dermatitis

 Shots: The approval is based on the TRuE-AD clinical trial program which consists of two P-III studies i.e., TRuE-AD1 &amp; 2 evaluating the safety and ef https://t.co/jHLZyDbdHN",,,2016-09-07 07:39:51,"Hyderabad, India",Sarang Pokhare,https://pbs.twimg.com/profile_images/1453364968737296391/M0Xff8ch_normal.jpg,584,1756,17,152669,sarang143u,
1883393875,2021-09-22 05:39:03,,,"dlvr.it/S830k3, ",1440611592895287304,False,0,0,0,0,dlvr.it,Incyte Announces US FDA Approval of Opzelura https://t.co/5V4Dg5UBQd,,,2013-09-19 10:40:31,Amsterdam,Pharma Market News,https://pbs.twimg.com/profile_images/378800000501255643/53b0cadf7327b09ab8610040b07fcb10_normal.jpeg,1499,1215,21,7595,pharmamarketnws,
786038665625554944,2021-09-22 04:13:24,"INCY, ","FreeTip, ",,1440590036974456840,False,0,0,0,0,SFE Robot1,Don't be a human chump. Instead just hold on to Incyte $INCY #FreeTip,,,2016-10-11 22:59:56,The Markets,Stock Advicebot 2000,https://pbs.twimg.com/profile_images/786041984376983553/Zkm6Ab6h_normal.jpg,1797,69,38,43757,StockTipRobot,
1022473214457348096,2021-09-22 04:10:52,,,"pharmashots.com/64691/incytes-‚Ä¶, pic.twitter.com/5ijujpsT9k, ",1440589400476295171,False,1,0,0,0,Twitter Web App,"Incyte‚Äôs Opzelura (ruxolitinib) Receives the US FDA‚Äôs Approval for the Treatment of Atopic Dermatitis
@Pharmashot @Incyte 
https://t.co/IZ6r5L6tmk https://t.co/5ijujpsT9k","Pharmashot, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,photo
1041754187283935234,2021-09-22 03:31:03,,"wednesdaythought, UNGA, hartaberfair, ŸÉŸÑŸÜÿß_ÿ≠ŸÖÿØÿßŸÑŸÑŸá, ","reuters.com/business/healt‚Ä¶, ",1440579377960394759,False,0,0,0,0,Twitter for Android,"FDA approves Incyte's eczema cream for dermatitis for adults with boxed warnings

#wednesdaythought
#UNGA #hartaberfair #ŸÉŸÑŸÜÿß_ÿ≠ŸÖÿØÿßŸÑŸÑŸá
https://t.co/zFHlDLu9TX",,,2018-09-17 14:22:07,"Maharashtra, India",R.M.Hanfi.,https://pbs.twimg.com/profile_images/1300715894268592129/z8c9eZq1_normal.jpg,245,912,0,17190,RiyazHanfi,
1140381086553378816,2021-09-22 02:28:36,,,"twitter.com/Incyte/status/‚Ä¶, ",1440563663220330505,False,14,0,1,3,Twitter for iPhone,"A new first in class drug for atopic dermatitis and a lovely example of translational medicine led by @itchdoctor 

Looking forward to seeing what this drug does for our patients in the clinic

COI: none https://t.co/qndO0r7YZZ","itchdoctor, ",,2019-06-16 18:10:13,"Dublin City, Ireland",Alan Irvine,https://pbs.twimg.com/profile_images/1304183818270670850/UHAkwp9c_normal.jpg,1697,252,9,2742,irvinederm,
909347503,2021-09-22 01:55:32,,,"reuters.com/business/healt‚Ä¶, ",1440555342203523076,False,2,0,0,0,Twitter Web App,FDA approves Incyte's eczema cream with boxed warnings https://t.co/rdrJ2PFGyg,,,2012-10-27 22:18:19,"Kigali, Rwanda",Mali John II,https://pbs.twimg.com/profile_images/1423060776416268289/uu_exq5O_normal.jpg,799,937,5,73384,FouSurLaColline,
1350261925133889541,2021-09-22 01:37:50,,,"twitter.com/DeItaone/statu‚Ä¶, ",1440550886338547721,False,1,0,0,0,IFTTT,DeItaone: Incyte: Opzelura Is First and Only Topical Janus Kinase (JAK) Inhibitor Approved in U.S. https://t.co/Q5wfX2jWge,,,2021-01-15 21:01:51,,SPCAPITAL NEWS,https://pbs.twimg.com/profile_images/1350262145091571715/kWumz5CS_normal.jpg,63,0,2,5642,SpcapitalN,
25562183,2021-09-22 01:15:04,,,"reuters.com/business/healt‚Ä¶, ",1440545159830114310,False,1,0,0,0,True Anthem,"The U.S. Food and Drug Administration on Tuesday approved Incyte Corp's cream Opzelura for treating inflammatory skin condition atopic dermatitis, commonly called eczema, in adolescents and adults with boxed warnings. https://t.co/KGLR5hffMq",,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
15108530,2021-09-22 00:40:05,,,"reut.rs/3EIPyp5, pic.twitter.com/7BOol9TLw4, ",1440536353163210755,False,0,0,0,1,True Anthem,FDA approves Incyte's eczema cream with boxed warnings https://t.co/LnSTJEStBJ https://t.co/7BOol9TLw4,,,2008-06-13 11:54:21,,Reuters U.S. News,https://pbs.twimg.com/profile_images/877263299439493121/4Otn8oxB_normal.jpg,117962,318,3927,208882,ReutersUS,photo
1652541,2021-09-22 00:40:05,,,"reut.rs/3EFOoKZ, pic.twitter.com/JlHv9lUygZ, ",1440536353108676626,False,39,0,6,17,True Anthem,FDA approves Incyte's eczema cream with boxed warnings https://t.co/bxtAFeUMvI https://t.co/JlHv9lUygZ,,,2007-03-20 13:46:05,Around the world,Reuters,https://pbs.twimg.com/profile_images/1194751949821939712/3VBu4_Sa_normal.jpg,23931761,1176,129609,766905,Reuters,photo
108617488,2021-09-21 22:25:01,,,"invst.ly/w3cxj, ",1440502365593817092,False,0,0,0,0,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/EtVduTbQ8I,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
227778014,2021-09-21 22:00:05,"INCY, MIRM, STOK, JNJ, ","FDA, ","buff.ly/3nZijYK, ",1440496089044381699,False,1,0,0,0,Buffer,"BioCentury's latest round up of Quick Takes: #FDA nod for Incyte‚Äôs topical JAK; plus Mirum‚Äôs partner in Japan, a Boehringer deal in tumor antigens, an early readout for Stoke and more $INCY $MIRM $STOK $JNJ https://t.co/DRt2gTNsAd",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
374729426,2021-09-21 21:47:23,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/3042166, pic.twitter.com/xI0T9YgjRW, ",1440492892183674882,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators: https://t.co/XZa99v4REd #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xI0T9YgjRW,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
2365066716,2021-09-21 21:36:04,,,"reuters.com/business/healt‚Ä¶, ",1440490044645523460,False,2,0,0,1,Twitter for Android,FDA approves Incyte's eczema cream with boxed warnings https://t.co/3hJPJ00PaP,,,2014-02-27 23:38:16,,Abrazos üëë #EasyGain,https://pbs.twimg.com/profile_images/873300506101260288/pgF5DuLq_normal.jpg,37757,37939,70,101160,Abrazos4u,
1652541,2021-09-21 21:35:12,,,"reut.rs/39xvaJ7, pic.twitter.com/IEhOuj8A9k, ",1440489826235543558,False,32,1,5,18,True Anthem,FDA approves Incyte's eczema cream with boxed warnings https://t.co/QU32rr0091 https://t.co/IEhOuj8A9k,,,2007-03-20 13:46:05,Around the world,Reuters,https://pbs.twimg.com/profile_images/1194751949821939712/3VBu4_Sa_normal.jpg,23931761,1176,129609,766905,Reuters,photo
25562183,2021-09-21 21:00:30,,,"reuters.com/business/healt‚Ä¶, ",1440481093740757000,False,1,0,0,1,True Anthem,"The U.S. Food and Drug Administration on Tuesday approved Incyte Corp's cream Opzelura for treating inflammatory skin condition atopic dermatitis, commonly called eczema, in adolescents and adults with boxed warnings. https://t.co/7cquVF5ZVV",,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
1134049078424162304,2021-09-21 19:56:32,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1440464997952356360,False,0,0,0,0,Newsfilter.io,Incyte Announces U.S. FDA Approval of Opzelura‚Ñ¢ Cream for the Treatment of Atopic Dermatitis $INCY https://t.co/mUvPzM9ah4,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
287327290,2021-09-21 19:36:11,,,"reuters.com/business/healt‚Ä¶, ",1440459876392570880,False,0,0,0,0,Twitter Web App,FDA approves Incyte's eczema cream with boxed warnings https://t.co/mjkRTG0fox,,,2011-04-24 15:35:29,"Reno, NV","Jason Bellak, MD, FAAAAI, FACAAI, FACP",https://pbs.twimg.com/profile_images/892453281074528256/YPavkhL4_normal.jpg,2599,2925,132,4600,JasonBellakMD,
3064967368,2021-09-21 19:24:30,,"clinicaltrial, eczema, atopicdermatitis, itch, ","twitter.com/Incyte/status/‚Ä¶, ",1440456935807979523,False,97,3,6,3,Twitter for iPhone,So excited to see what started off as a draft protocol I wrote from @Starbucks on Clayton Road turn into a pivotal phase 2 #clinicaltrial by @Incyte with publication in @jacionline in 2020 and now a first in class new drug for #eczema #atopicdermatitis #itch approved by @US_FDA!! https://t.co/BohA1AJRFW,"Starbucks, Incyte, jacionline, US_FDA, ",,2015-02-28 14:04:33,"St. Louis, MO","Brian S. Kim, MD, MTR",https://pbs.twimg.com/profile_images/1390351360303026176/LaQoWrfp_normal.jpg,2104,371,16,1490,itchdoctor,
14453501,2021-09-21 19:15:54,,,"delawarebusinessnow.com/2021/09/incyte‚Ä¶, ",1440454772943822854,True,0,0,0,0,WordPress.com,Incyte cream medication gets FDA OK for atopic dermatitis skin¬†disease https://t.co/MSW9dbQM7P,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
1134049078424162304,2021-09-21 19:14:32,"INCY, ROLL, PFE, ABBV, ",,"newsfilter.io/articles/updat‚Ä¶, ",1440454428574638090,False,0,0,0,0,Newsfilter.io,UPDATE 2-FDA approves Incyte's eczema cream with boxed warnings $INCY $ROLL $PFE $ABBV https://t.co/ABNyrwaT9S,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1435638352204554245,2021-09-21 19:07:57,,,"reportwire.org/2021/09/21/fda‚Ä¶, ",1440452768573968391,False,0,0,0,0,WordPress.com,FDA approves Incyte‚Äôs eczema cream with boxed warnings By¬†Reuters https://t.co/MGrHRywFW2,,,2021-09-08 12:17:22,,ReportWire,https://pbs.twimg.com/profile_images/1435638759752560643/D25h3dbK_normal.jpg,19,82,0,25090,reportwire_,
1318190289941491713,2021-09-21 19:07:55,,,"reportwire.org/2021/09/21/fda‚Ä¶, ",1440452764270694402,False,0,0,0,0,WordPress.com,FDA approves Incyte‚Äôs eczema cream with boxed warnings By¬†Reuters https://t.co/r3DRL3HkyI,,,2020-10-19 10:00:42,,Lithium Promotions,https://pbs.twimg.com/profile_images/1318236371614457856/cNkBz4pg_normal.png,12,1,0,46358,LithiumPromos,
1370906497,2021-09-21 18:56:05,"INCY, INCY, ",,,1440449784175685635,False,0,0,0,0,Twitter Web App,"$INCY Incyte Announces U.S. FDA Approval of Opzelura‚Ñ¢ (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD)

$INCY After Hours 72.77  -3.29 (-4.33%)",,,2013-04-21 20:38:27,U.S.A,MAISA,https://pbs.twimg.com/profile_images/3557296223/a73cb8bb8effbfd1f90590ab48523b10_normal.jpeg,2858,7,76,70211,MaisaCorp,
252697395,2021-09-21 18:53:45,,"Opzelura, ruxolitinib, atopicdermatitis, ","go.nationaleczema.org/blog-opzelura-‚Ä¶, ",1440449197136748549,False,18,3,2,5,Twitter Web App,"Today the eczema community is a step closer to having a new treatment option. @US_FDA approved #Opzelura‚Ñ¢ (#ruxolitinib) cream from @Incyte, for treatment of #atopicdermatitis in patients 12+.
Learn more: https://t.co/eakCtqZuGu","US_FDA, Incyte, ",,2011-02-15 13:37:34,"Novato, CA",National Eczema,https://pbs.twimg.com/profile_images/1323285049479884800/WLAnVjaM_normal.jpg,5948,305,53,5929,nationaleczema,
1134049078424162304,2021-09-21 18:29:34,"INCY, PFE, ABBV, ",,"newsfilter.io/articles/updat‚Ä¶, ",1440443109486129159,False,0,0,0,0,Newsfilter.io,UPDATE 1-FDA approves Incyte's eczema cream $INCY $PFE $ABBV https://t.co/csrcl2jsEA,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
72928001,2021-09-21 18:22:17,"INCY, ",,"bit.ly/3zFvssp, ",1440441277024112649,False,1,0,0,2,BriefingInPlayLimited,$INCY: Incyte: FDA approves Opzelura cream for mild to moderate atopic dermatitis (halted) https://t.co/musZjgX5y4,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
3911174913,2021-09-21 17:38:42,,"AtopicDermatitis, ","pic.twitter.com/RKe4BIPCqx, ",1440430308864585733,False,21,0,0,1,Twitter Web App,The FDA approval of Incyte's new innovative therapy  provides an important new treatment option for certain patients with mild to moderate #AtopicDermatitis. https://t.co/RKe4BIPCqx,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1002595171270307840,2021-09-21 17:36:08,,,"twitter.com/DermTimesNow/s‚Ä¶, ",1440429664070111236,False,0,0,0,0,Twitter for iPhone,"Ruxolitinib¬†is the first and only topical JAK inhibitor approved in the U.S., according to @Incyte. https://t.co/yCQigBKzAu","Incyte, ",,2018-06-01 12:58:10,"Lakewood, OH",Morgan Petronelli,https://pbs.twimg.com/profile_images/1145848174323613698/15nPWxp1_normal.jpg,440,816,1,609,PetronelliMedia,
55642575,2021-09-21 17:32:16,,"ruxolitinib, atopicdermatitis, ","buff.ly/39sCCWe, pic.twitter.com/ZHQ36Wz4iB, ",1440428690148499456,False,5,2,0,3,Buffer,Incyte announced the FDA has approved its topical selective Janus kinase (JAK)1/JAK2 inhibitor #ruxolitinib (Opzelura) for the treatment of mild to moderate #atopicdermatitis. https://t.co/T07TIRiGj9 https://t.co/ZHQ36Wz4iB,,,2009-07-10 15:27:01,"North Olmsted, Ohio",Dermatology Times,https://pbs.twimg.com/profile_images/1402733466987470848/i_Bjwcxa_normal.jpg,26818,622,341,15262,DermTimesNow,photo
1269758829690052610,2021-09-21 17:29:13,"INCY, ",,,1440427921735180288,False,0,0,0,0,Zapier.com,"Incyte trading resumes
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
19255955,2021-09-21 17:16:47,,,"hcplive.com/view/fda-appro‚Ä¶, ",1440424793275133953,False,0,0,0,2,Twitter Web App,"Ruxolitinib from @Incyte becomes the first FDA-approved JAK inhibitor cream therapy, for atopic dermatitis: https://t.co/2W0ve6eXvy","Incyte, ",,2009-01-20 15:39:44,United States,HCPLive,https://pbs.twimg.com/profile_images/1223302172969971712/NqGicATM_normal.png,7153,930,392,44710,MDMagazine,
1307732487146217472,2021-09-21 17:13:04,"INCY, ","stockmarket, tradingresume, ",,1440423859824463880,False,0,0,0,0,Twitter,Trading Will Resume for $INCY  Incyte Corporation | at 17:25:00 ET on NASDAQ | 2021-09-21 #stockmarket #tradingresume,,,2020-09-20 13:25:11,"Bedford, TX",LiquidityNews,https://pbs.twimg.com/profile_images/1307752385482293249/9AidwM6K_normal.png,3978,10,53,21081,LiquidityNews,
799069924450766848,2021-09-21 17:12:48,"INCY, ","daytrading, daytrader, INCY, ","apps.apple.com/us/app/apple-s‚Ä¶, ",1440423790656192519,False,0,0,0,0,InsiderForms,"$INCY Trading to resume for Incyte Corporation (INCY). Halt Reason: NEWS DISSEMINATED. Resume Time: 09/21/2021 17:25:00
#daytrading #daytrader #INCY 
Get realtime notifications at https://t.co/xHvR7YAaeK",,,2016-11-16 21:01:30,United States,Insider Forms,https://pbs.twimg.com/profile_images/1448375542013628418/Dbx6hCfO_normal.jpg,2877,0,67,46526,InsiderForms,
799069924450766848,2021-09-21 17:09:35,"INCY, ","daytrading, daytrader, INCY, ","apps.apple.com/us/app/apple-s‚Ä¶, ",1440422984766812163,False,0,0,0,0,InsiderForms,"$INCY Trading Halted for Incyte Corporation (INCY). Halt Reason: NEWS RELEASED.
#daytrading #daytrader #INCY 
Get realtime notifications at https://t.co/xHvR7YAaeK",,,2016-11-16 21:01:30,United States,Insider Forms,https://pbs.twimg.com/profile_images/1448375542013628418/Dbx6hCfO_normal.jpg,2877,0,67,46526,InsiderForms,
32492934,2021-09-21 17:02:47,"INCY, ",,"bioworld.com/articles/51164‚Ä¶, ",1440421270982586374,False,1,0,0,0,TweetDeck,"Breaking News: Incyte wins FDA approval for ruxolitinib cream in AD, with class-related boxed warnings $INCY https://t.co/VfkfVgIqU5",,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
25562183,2021-09-21 16:45:07,,,"reuters.com/business/healt‚Ä¶, ",1440416823724240897,False,1,0,0,2,True Anthem,"The U.S. Food and Drug Administration on Tuesday approved Incyte Corp's cream Opzelura for treating inflammatory skin condition atopic dermatitis, commonly called eczema, in adolescents and adults. https://t.co/tJQ7gMUFtZ",,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
1254906887490936845,2021-09-21 16:28:42,"INCY, ",,"quantdata.us/news/23040677, ",1440412694473965575,False,0,0,0,0,Quant Data (Production),"Incyte Reports FDA Approval Of Opzelura Cream For Treatment Of Atopic Dermatitis

Related Tickers: $INCY
Read more at: https://t.co/RgS2XLvaXL",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
1269758829690052610,2021-09-21 16:20:04,"INCY, ",,,1440410520394240000,False,0,0,0,0,Zapier.com,"Incyte gets FDA approval of Opzelura cream in Atopic Dermatitis treatment
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
1349429572266323979,2021-09-21 16:16:18,"INCY, ",,,1440409575245500421,False,1,0,0,0,Twitter Web App,$INCY Incyte Reports FDA Approval Of Opzelura Cream For Treatment Of Atopic Dermatitis,,,2021-01-13 13:54:28,"Porto Alegre, Brasil",Luckinvest,https://pbs.twimg.com/profile_images/1349431657816875009/jGDe7UJi_normal.jpg,608,359,12,5696,Luckinvest17,
1069693680066420736,2021-09-21 16:15:39,"INCY, ",,"s.flashalert.me/fXurf, ",1440409410019336196,False,1,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on September 21, 16:13:00: Incyte Announces U.S. FDA Approval of Opzelura‚Ñ¢ (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD) https://t.co/2UjW6FV56J",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842260,FlashAlert_me,
84402174,2021-09-21 16:15:25,"INCY, ",,"streetinsider.com/Corporate+News‚Ä¶, pic.twitter.com/RrhMLf4L6c, ",1440409351261351940,False,3,1,0,1,StockTwits Web,"Incyte $INCY Announces U.S. FDA Approval of Opzelura Cream, Topical JAK Inhibitor for Treatment of Atopic Dermatitis https://t.co/Ut8VXAqJjB https://t.co/RrhMLf4L6c",,,2009-10-22 15:27:37,United States,Streetinsider.com,https://pbs.twimg.com/profile_images/504446210/small_icon_blue_on_blue_normal.jpg,72542,928,2180,46972,Street_Insider,photo
2704294333,2021-09-21 16:14:35,,,"twitter.com/DeItaone/statu‚Ä¶, ",1440409142070427650,False,21,1,0,4,TweetDeck,Incyte: Opzelura Is First and Only Topical Janus Kinase (JAK) Inhibitor Approved in U.S. https://t.co/xlqXSvKRPq,,,2014-08-03 10:34:52,Switzerland,*Walter Bloomberg,https://pbs.twimg.com/profile_images/1282648991348527104/A8HCjqZk_normal.jpg,392435,34,6566,104545,DeItaone,
1320913537959682054,2021-09-21 16:14:27,"INCY, ",,,1440409106955714569,False,1,0,0,1,Twitter Web App,$INCY Incyte Reports FDA Approval Of Opzelura Cream For Treatment Of Atopic Dermatitis,,,2020-10-26 22:21:55,United States ,SUNG,https://pbs.twimg.com/profile_images/1453456728310362120/sj9mqMo7_normal.jpg,4511,236,31,4358,meetsung,
4382570173,2021-09-21 16:14:19,"INCY, ",,"benzinga.grsm.io/truetrader, ",1440409074865094657,False,0,0,0,0,Twitter Web App,$INCY Incyte Reports FDA Approval Of Opzelura Cream For Treatment Of Atopic Dermatitis https://t.co/Ne4UHbylKd,,,2015-11-27 18:52:09,Trade Smart. Trade Safe.,True Trader,https://pbs.twimg.com/profile_images/1345464980972457985/LPfaCBUN_normal.jpg,3288,1676,36,4962,TrueTraderNet,
2704294333,2021-09-21 16:13:50,"INCY, ",,,1440408954530500616,False,16,0,1,3,TweetDeck,"*Incyte Gets FDA Approval of Opzelura Cream for Atopic Dermatitis 
$INCY",,,2014-08-03 10:34:52,Switzerland,*Walter Bloomberg,https://pbs.twimg.com/profile_images/1282648991348527104/A8HCjqZk_normal.jpg,392435,34,6566,104545,DeItaone,
1325115160353103872,2021-09-21 16:13:31,"INCY, ",,"quantisnow.com/insight/179504‚Ä¶, quantisnow.com/feed, ",1440408872494141453,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces U.S. FDA Approval of Opzelura‚Ñ¢ (ruxolitinib) Cream, a Topical JAK Inhibitor, for the Treatment of Atopic Dermatitis (AD)

https://t.co/qiESRfxtnG

This and other insights appear 30 seconds early at üí™ https://t.co/TvhaBDQJ0C üí™",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1043127646828355584,2021-09-21 15:17:21,,,"bit.ly/2Yhc47P, pic.twitter.com/iCfzExqhP7, ",1440394737706356742,False,3,0,0,1,Twitter Web App,"Please join us October 7, 8:00 PM-9:30 PM (EST) for Atopic Dermatitis: The Burden of Disease, the JAK-STAT Pathway, and Recent Developments. The program will be presented by Jonathan I. Silverberg, MD, PhD, MPH and sponsored by Incyte Dermatology. https://t.co/LfG9x5Z2Gj https://t.co/iCfzExqhP7",,,2018-09-21 09:19:46,Virtual Conference,Revolutionizing AD,https://pbs.twimg.com/profile_images/1044231557936963585/_NEg06uK_normal.jpg,151,37,2,326,RevAtopicDerm,photo
1307732487146217472,2021-09-21 15:13:04,"INCY, ","stockmarket, tradinghalt, ",,1440393661309587472,False,0,0,0,0,Twitter,Trading Halted for $INCY  Incyte Corporation | at 15:07:01 ET on NASDAQ | Halt - News Pending | 2021-09-21 #stockmarket #tradinghalt,,,2020-09-20 13:25:11,"Bedford, TX",LiquidityNews,https://pbs.twimg.com/profile_images/1307752385482293249/9AidwM6K_normal.png,3978,10,53,21081,LiquidityNews,
1435758021485993987,2021-09-21 15:11:32,"INCY, ",,"biospace.com/article/fda-ac‚Ä¶, ",1440393275525853187,False,1,0,0,0,TweetDeck,"$INCY halted - ""has a target action date of September 21, 2021, for its New Drug Application (NDA) for ruxolitinib cream for atopic dermatitis (AD)."" https://t.co/Fhn7mfAkZI
Just waiting to see what their IR has to say! Hopefully good news for them!",,,2021-09-08 20:13:21,Nobody's Business,CrowdTraitors,https://pbs.twimg.com/profile_images/1437511733879390215/mEQ4_Qji_normal.jpg,1254,26,19,642,CrowdTraitors,
799069924450766848,2021-09-21 15:10:05,"INCY, ","daytrading, daytrader, INCY, ","apps.apple.com/us/app/apple-s‚Ä¶, ",1440392908411047937,False,0,0,0,0,InsiderForms,"$INCY Trading Halted for Incyte Corporation (INCY). Halt Reason: NEWS PENDING.
#daytrading #daytrader #INCY 
Get realtime notifications at https://t.co/xHvR7YAaeK",,,2016-11-16 21:01:30,United States,Insider Forms,https://pbs.twimg.com/profile_images/1448375542013628418/Dbx6hCfO_normal.jpg,2877,0,67,46526,InsiderForms,
1269758829690052610,2021-09-21 15:09:53,"INCY, ",,,1440392860725960710,False,0,0,0,0,Zapier.com,"Incyte trading halted, news pending
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
1250830691824283648,2021-09-21 15:08:52,"INCY, ",,,1440392603241881610,False,3,0,0,1,Twitter Web App,"Trading in Incyte $INCY is currently halted due to ""News Pending""",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
1313517451817050113,2021-09-21 14:12:46,"INCY, ",,,1440378486590349319,False,0,0,0,0,Twitter Web App,$INCY --Susquehanna Fundamental Investments LLC Has $5.44 Million Stake in Incyte Co. ‚ù§Ô∏è,,,2020-10-06 12:32:30,,IsitArt,https://pbs.twimg.com/profile_images/1313517774153502720/RY_EXjlp_normal.jpg,244,6,8,3818,art_isit,
30005320,2021-09-21 13:55:43,,"jobs, pharma, hiringnow, pharmiweb, ","pharmiweb.jobs/job/1228585/in‚Ä¶, ",1440374194080944141,False,0,0,0,0,Madgex Twitter Tweeter,INcyte Clinical Trial Manager Eastern Countries - Budapest - IQVIA #jobs #pharma #hiringnow #pharmiweb https://t.co/BEQjm6hIP4,,,2009-04-09 11:33:38,UK,PharmiWeb Jobs,https://pbs.twimg.com/profile_images/595963733047975936/aa7m_k97_normal.png,1554,250,76,165145,PharmiWebJobs,
960403142197248000,2021-09-21 04:02:37,,,"pressrelease.cc/2021/09/20/lip‚Ä¶, ",1440224936405049351,False,0,0,0,0,WordPress.com,"Liposarcoma Therapeutics Market to Escalate During the Forecast Period | Key Companies includes ‚Äì Sanofi, Janssen, Eisai, Rain Therapeutics, Karyopharm, GlaxoSmithKline, Novartis, Incyte and¬†Others https://t.co/PWi6UqyfQv",,,2018-02-05 01:42:07,"Dallas, TX",PressRelease.cc,https://pbs.twimg.com/profile_images/1120211264360337408/hhR28Cwc_normal.png,1081,1362,10,255874,PressRelease_cc,
4035355935,2021-09-21 02:32:13,,,,1440202187360014336,False,0,0,0,0,WPTS Playlist,Incyte - Numbers,,,2015-10-24 21:01:50,"Pittsburgh, PA",WPTS Playlist,https://pbs.twimg.com/profile_images/658129792408023041/8nflCFL-_normal.jpg,478,5,38,638221,WPTSPlaylist,
20780650,2021-09-21 01:36:59,,,"biedexmarkets.com/incyte-corpora‚Ä¶, pic.twitter.com/Ahp274q4Zi, ",1440188286715121668,False,1,0,0,0,Twitter,"Incyte Corporation (NASDAQ:INCY) - Incyte's Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada

               https://t.co/RBFALOEroQ https://t.co/Ahp274q4Zi",,,2009-02-13 11:02:18,"London, England",Biedex Markets,https://pbs.twimg.com/profile_images/1288488731654201349/MSrdzFac_normal.jpg,4018,4862,120,362261,biedexmarkets,photo
916335048,2021-09-21 00:23:20,,"Europe, HealthMedicine, PharmaceuticalsBiotech, UK, US, ","dlvr.it/S7yX8x, pic.twitter.com/laPFVimE9U, ",1440169751561465867,False,0,0,0,0,dlvr.it,"Liposarcoma Therapeutics Market to Escalate During the Forecast Period | Key Companies includes ‚Äì Sanofi, Janssen, Eisai, Rain Therapeutics, Karyopharm, GlaxoSmithKline, Novartis, Incyte and Others https://t.co/usiTY5AVAB #Europe #HealthMedicine #PharmaceuticalsBiotech #UK #US https://t.co/laPFVimE9U",,,2012-10-31 03:27:23,,ABNewswire,https://pbs.twimg.com/profile_images/3568218059/4649a03b94d5a22697cd7f8bfd4a284c_normal.png,1052,132,139,368959,ABNewswire,photo
4058194633,2021-09-20 17:29:56,"INCY, INCY, ",,"benzinga.com/z/23014837#.YU‚Ä¶, ",1440065715101331456,False,0,0,0,0,Twitter for iPhone,$INCY Incyte‚Äôs Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada $INCY https://t.co/F8EEcS6aUE # via @benzinga,"Benzinga, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
285835021,2021-09-20 16:09:55,,,"bit.ly/3haGZt6, pic.twitter.com/SBUpwFf3U4, ",1440045580512759818,False,0,0,0,0,Meltwater Social,"Reminder to join GBI this Weds for a 60-min webinar introducing Green Globes for EB 21 and ft. a presentation from Jessica Kavanagh and Lauren Harris of @L2P_Arch showcasing the Incyte Administrative Headquarters, the first to certify under EB 21. More at https://t.co/4W2JUAGXsN https://t.co/SBUpwFf3U4","L2P_Arch, ",,2011-04-21 17:41:20,"Portland, Oregon",Green Building Initiative,https://pbs.twimg.com/profile_images/1088845506539704320/j4W6SbSF_normal.jpg,774,332,30,292,TheGBIorg,photo
2384219072,2021-09-20 15:22:23,,"DEBIO, IWSTEM2021, ICYMI, Incyte, ","loom.ly/_hl2TMI, pic.twitter.com/31uAqiZ8xM, ",1440033617523011587,False,0,0,0,0,Loomly,Thank you #DEBIO member @Incyte for your Gold Sponsorship of #IWSTEM2021 on Oct. 14th! #ICYMI Ann O'Brien of #Incyte will be hosting the Mindful Morning Movement session!  Check it out: https://t.co/44gBlcFoag https://t.co/31uAqiZ8xM,"Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
1250830691824283648,2021-09-20 14:24:16,"AAL, INCY, CNP, ARE, AWK, D, ED, IVZ, NUE, DVN, APA, FCX, LNC, ALB, ",,,1440018990944948233,False,5,0,0,0,Twitter Web App,"Best and worst performing S&amp;P 500 stocks so far today

Best:
1 American $AAL
2 Incyte $INCY
3 Centerpoint $CNP
4 Alexandria $ARE
5 American Water $AWK
6 Dominion $D
7 Edison $ED

Worst:
1 Invesco $IVZ
2 Nucor $NUE
3 Devon $DVN
4 $APA
5 Freeport $FCX
6 Lincoln $LNC
7 $ALB",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
1134049078424162304,2021-09-20 13:56:28,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1440011994959163397,False,1,0,0,0,Newsfilter.io,Incyte's Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada $INCY https://t.co/kXCivDhbym,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1382837477128470532,2021-09-20 13:48:25,"INCY, ",,"sparknewswire.com/newsfeed/incyt‚Ä¶, ",1440009970368466946,False,0,0,0,0,Twitter for iPhone,$INCY Incyte‚Äôs Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada https://t.co/xWhPSWOzXf,,,2021-04-15 19:25:31,,Spark Newswire,https://pbs.twimg.com/profile_images/1425277325994721282/7PFtMClk_normal.jpg,205,788,5,1412,SparkNewswire,
95497135,2021-09-20 12:35:04,,"PM360TrailblazerAwards, ","bit.ly/3DGFhJH, pic.twitter.com/LbaQzKgpAa, ",1439991512322953221,False,1,0,0,0,Buffer,"Give it up for the #PM360TrailblazerAwards Hematology/Oncology Brand Champion Melanie Nicholson, Executive Director, Immunoncology Global Product Strategy, Global Strategy and Corporate Development, @Incyte. Celebrate all of the Brand Champs on Sept 23: https://t.co/vhYd3qnDLD https://t.co/LbaQzKgpAa","Incyte, ",,2009-12-08 15:35:35,New York City,PM360,https://pbs.twimg.com/profile_images/565473900/BEST_pm360_logo_bird_normal.jpg,4352,2025,202,4104,PM360online,photo
3911174913,2021-09-20 11:04:09,,"CCA, ","bit.ly/3nVsIox, pic.twitter.com/rnwxGVQD6K, ",1439968629295038465,False,17,0,0,2,Twitter Web App,"Check out this blog post written by Peter Langmuir, Group Vice President, Oncology Targeted Therapeutics, that highlights the key challenges of diagnosing and managing cholangiocarcinoma (#CCA) with an expert panel from our partnership with @GoHealio. https://t.co/9hr2Nrtqqq https://t.co/rnwxGVQD6K","GoHealio, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
277009994,2021-09-20 08:26:23,"AGTC, APRE, BMY, ",,"benzinga.com/z/23002535#.YU‚Ä¶, ",1439928927456137223,False,0,0,0,0,Twitter for Android,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight $AGTC $APRE $BMY https://t.co/hniMBKT9MK @benzinga ÎãòÏù¥ ÏîÄ","Benzinga, ",,2011-04-04 10:32:44,,Ï∂ïÎ≥µ„ÜçÏãúÎ∞©ÊôÇÊñπ,https://pbs.twimg.com/profile_images/1272295878594719746/s_wvHufa_normal.jpg,997,231,12,112990,here_and_now_be,
478901594,2021-09-20 08:16:27,,,"square1radio.com, pic.twitter.com/116kuIiFtI, ",1439926429135908867,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Streaming On https://t.co/XL7Q5eebYQ https://t.co/116kuIiFtI,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1315434407692509184,2021-09-20 02:15:07,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/1zopxBMrHY, ",1439835494859386888,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3040 out of 5581 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/1zopxBMrHY",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1412621552860811268,2021-09-19 22:58:36,,,"trendadvisor.net/go/news/230025‚Ä¶, ",1439786040152113158,False,1,0,0,0,Twitter Web App,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight https://t.co/hhC0B3l4dA",,,2021-07-06 23:56:49,,David Frye,https://pbs.twimg.com/profile_images/1419774881021915150/UZsLuETK_normal.jpg,56,386,3,466,DavidFr42443679,
478901594,2021-09-19 18:07:26,,,"square1radio.com, pic.twitter.com/mpkAiN9x2A, ",1439712765652914176,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5eebYQ https://t.co/mpkAiN9x2A,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1304774550014615554,2021-09-19 14:29:01,,"ESMO21, Incyte, PrecisionMedicine, cholangiocarcinoma, CCA, JuanValle, DavidMalka, LorenzaRimassa, ","pic.twitter.com/p2ubTjxhfw, ",1439657797688471552,False,13,0,2,1,Twitter Web App,"A pleasure to have been invited to present at #ESMO21 #Incyte symposium on #PrecisionMedicine for patients with #cholangiocarcinoma #CCA, &amp; to be part of such a great Q&amp;A panel. Thank you to #JuanValle #DavidMalka #LorenzaRimassa 
@myESMO @HUNIMED @HumanitasMilano @CharityAMMF https://t.co/p2ubTjxhfw","myESMO, HUNIMED, HumanitasMilano, CharityAMMF, ",,2020-09-12 09:32:06,UK,Helen Morement,https://pbs.twimg.com/profile_images/1304775126232293377/dwFksdw9_normal.jpg,182,299,0,268,HelenMorement,photo
3402544414,2021-09-19 14:12:01,,"ESMO21, PrecisionMedicine, cholangiocarcinoma, CCA, JuanValle, DavidMalka, ","pic.twitter.com/EkUCw36JPD, pic.twitter.com/EkUCw36JPD, pic.twitter.com/EkUCw36JPD, pic.twitter.com/EkUCw36JPD, ",1439653519116668935,False,6,0,0,0,Twitter for iPhone,Amazing presentations and discussion at #ESMO21 Incyte symposium on #PrecisionMedicine for patients with #cholangiocarcinoma #CCA. @CharityAMMF @HelenMorement #JuanValle #DavidMalka @myESMO @HUNIMED @HumanitasMilano https://t.co/EkUCw36JPD,"CharityAMMF, HelenMorement, myESMO, HUNIMED, HumanitasMilano, ",,2015-08-04 05:57:47,"Milan, Italy ",Lorenza Rimassa,https://pbs.twimg.com/profile_images/1140987670417629184/CCejApO8_normal.jpg,955,1163,6,2433,LorenzaRimassa,photo
3402544414,2021-09-19 14:06:55,,"ESMO21, PrecisionMedicine, cholangiocarcinoma, CCA, JuanValle, DavidMalka, ","pic.twitter.com/bVKRH61IqX, ",1439652236695592961,False,18,0,0,1,Twitter for iPhone,"Amazing presentations and discussion at #ESMO21 Incyte symposium on #PrecisionMedicine for patients with #cholangiocarcinoma #CCA. Patient advocacy, academia and industry @CharityAMMF @HelenMorement #JuanValle #DavidMalka @myESMO @HUNIMED @HumanitasMilano https://t.co/bVKRH61IqX","CharityAMMF, HelenMorement, myESMO, HUNIMED, HumanitasMilano, ",,2015-08-04 05:57:47,"Milan, Italy ",Lorenza Rimassa,https://pbs.twimg.com/profile_images/1140987670417629184/CCejApO8_normal.jpg,955,1163,6,2433,LorenzaRimassa,photo
1006334607946649600,2021-09-19 10:56:06,,"StockMarket, Stocks, ","dlvr.it/S7sWYZ, pic.twitter.com/VBDaDk837D, ",1439604215404400649,False,0,0,0,0,dlvr.it,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight https://t.co/BxFmuMi8Lx #StockMarket #Stocks https://t.co/VBDaDk837D",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
1361259743550046208,2021-09-19 10:53:47,,,"zpr.io/XSFEijEgGEXP, ",1439603632081719307,False,0,0,0,0,Zapier.com,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA

Decisions And Conference Presentations In The Spotlight | Source: https://t.co/v3gg04RPao",,,2021-02-15 05:23:17,https://discord.io/trndtrading,Thomas aka Doc Holliday,https://pbs.twimg.com/profile_images/1430439348357451778/0pOShr7y_normal.jpg,1545,657,11,31811,trndtrader,
972364208108163074,2021-09-19 10:28:16,"IBB, ZLAB, MRTX, ",,"benzinga.com/z/23002535#.YU‚Ä¶, ",1439597212590280704,False,0,0,0,0,Twitter Web App,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight $IBB $ZLAB $MRTX https://t.co/BtSJtDklyK via @benzinga","Benzinga, ",,2018-03-10 01:51:07,South Africa & Europe,thegreenisback,https://pbs.twimg.com/profile_images/972367018946191361/ywzowTW8_normal.jpg,141,5,6,22777,thegreenisback,
20780650,2021-09-19 10:27:10,,,"pic.twitter.com/korCJ5IhBC, ",1439596934612799499,False,0,0,0,0,Twitter,"iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Applied Genetic (NASDAQ:AGTC) - The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
          Biotech stocks declined for the week ending¬†Sept. 17, extending ... https://t.co/korCJ5IhBC",,,2009-02-13 11:02:18,"London, England",Biedex Markets,https://pbs.twimg.com/profile_images/1288488731654201349/MSrdzFac_normal.jpg,4018,4862,120,362261,biedexmarkets,photo
980467278385958912,2021-09-19 10:25:24,"IBB, AGTC, ",,"billionaireclubcollc.com/ishares-nasdaq‚Ä¶, ",1439596492084453376,False,0,0,0,0,Twitter Web App,"iShares NASDAQ Biotechnology Index Fund (NASDAQ: $IBB), Applied Genetic (NASDAQ: $AGTC) ‚Äì The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight https://t.co/xO9OZTJw05",,,2018-04-01 11:29:50,"New York, USA",Billionaireclubcollc.com,https://pbs.twimg.com/profile_images/1420395068754628612/Zr8OoRN9_normal.jpg,6959,225,78,125759,LlcBillionaire,
1166772455417024512,2021-09-19 10:19:32,,"AGTC, APRE, ","dlvr.it/S7sS1j, pic.twitter.com/TT4PhgKRkS, ",1439595015890628608,False,0,0,0,0,dlvr.it,"#AGTC #APRE The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight https://t.co/VJMnfpgQ8d https://t.co/TT4PhgKRkS",,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
1089978712685273090,2021-09-19 10:15:05,"INTC, ","biotech, Incyte, StockMarket, ","dlvr.it/S7sRZf, pic.twitter.com/mBU5ofzDap, ",1439593895390683136,False,0,0,0,0,dlvr.it,"The Week Ahead In #biotech (Sept. 19-25): #Incyte $INTC, Verrica FDA Decisions And Conference Presentations In The Spotlight https://t.co/ie0MFIU8Ox #StockMarket https://t.co/mBU5ofzDap",,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,photo
1134049078424162304,2021-09-19 10:06:24,"PFE, BNTX, TAK, CALT, INCY, ",,"newsfilter.io/articles/the-w‚Ä¶, ",1439591711181873159,False,0,0,0,0,Newsfilter.io,"The Week Ahead In Biotech: Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight $PFE $BNTX $TAK $CALT $INCY https://t.co/k9Q6Iq6njp",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
780474320799666177,2021-09-19 10:02:13,"INCY, VRCA, MRTX, TGTX, AGTC, ",,"benzinga.com/general/biotec‚Ä¶, ",1439590657438322691,False,9,0,1,3,Twitter Web App,"$INCY $VRCA $MRTX $TGTX $AGTC and more

your go-to-guide for week's biotech investing..

https://t.co/6dDmp02PK6",,,2016-09-26 14:29:13,"Chennai, India",Shanthi Rexaline,https://pbs.twimg.com/profile_images/1187404925958930433/LWeq_NZ-_normal.jpg,1065,78,27,1419,shanthirex,
1403008149020459013,2021-09-19 09:51:26,,,"ift.tt/3Cuekr1, ",1439587942897434642,False,0,0,0,0,IFTTT,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight https://t.co/P8mJspEwuf",,,2021-06-10 11:17:38,,Stock Market News,https://pbs.twimg.com/profile_images/1403010687564136462/3Z237JI4_normal.jpg,101,96,2,16360,AglowStockNews,
1199800417821048834,2021-09-19 09:51:03,,"AGTC, APRE, Biotech, BMY, BNTX, ","dlvr.it/S7sP0l, bit.ly/3euPGwc, pic.twitter.com/1Qnc3Lwmxq, ",1439587845472079881,False,0,0,0,0,dlvr.it,"#AGTC #APRE #Biotech #BMY #BNTX The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight https://t.co/I5fWgnaTuq https://t.co/HhkKr6EmNW https://t.co/1Qnc3Lwmxq",,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,photo
2920726547,2021-09-19 09:40:29,"INCY, ","FDA, ","pic.twitter.com/6E1pDXglxa, ",1439585187231371265,False,1,0,1,0,Twitter Web App,Wed 9/22: It is the #FDA action date on Incyte Corporation's $INCY Ruxolitinib. Shares of INCY have rallied in the past on days that Ruxolitinib news broke. https://t.co/6E1pDXglxa,,,2014-12-13 21:09:47,"New Jersey, USA",Greg5thTrad,https://pbs.twimg.com/profile_images/859574367877050368/A-VNdeTh_normal.jpg,1116,107,57,30433,Greg5thTrad,photo
3402544414,2021-09-19 03:54:50,,"ESMO21, PrecisionMedicine, cholangiocarcinoma, CCA, JuanValle, DavidMalka, ","pic.twitter.com/bjZDImsTog, ",1439498202072469504,False,13,0,0,3,Twitter for iPhone,Join us today at the #ESMO21 Incyte Symposium on #PrecisionMedicine for patients with #cholangiocarcinoma #CCA! With @HelenMorement #JuanValle #DavidMalka @myESMO @HUNIMED @HumanitasMilano https://t.co/bjZDImsTog,"HelenMorement, myESMO, HUNIMED, HumanitasMilano, ",,2015-08-04 05:57:47,"Milan, Italy ",Lorenza Rimassa,https://pbs.twimg.com/profile_images/1140987670417629184/CCejApO8_normal.jpg,955,1163,6,2433,LorenzaRimassa,photo
3402544414,2021-09-19 03:49:50,,"ESMO21, PrecisionMedicine, CCA, JuanValle, DavidMalka, ","twitter.com/CharityAMMF/st‚Ä¶, ",1439496942468358147,False,5,0,1,1,Twitter for iPhone,Happy to participate in the #ESMO21 Incyte Symposium on #PrecisionMedicine for patients with #CCA with @HelenMorement #JuanValle #DavidMalka @myESMO @HUNIMED @HumanitasMilano https://t.co/uqgXilWc3D,"HelenMorement, myESMO, HUNIMED, HumanitasMilano, ",,2015-08-04 05:57:47,"Milan, Italy ",Lorenza Rimassa,https://pbs.twimg.com/profile_images/1140987670417629184/CCejApO8_normal.jpg,955,1163,6,2433,LorenzaRimassa,
1138312924269862916,2021-09-18 17:37:24,,,"finance.yahoo.com/news/incyte-an‚Ä¶, ",1439342821140541440,False,10,0,1,1,Twitter Web App,"Congrats Incyte!!!!!üéâüéâüéâüéâIncyte Announces Health Canada Conditional Approval of Pemazyre¬Æ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma https://t.co/o11LaR4v8d",,,2019-06-11 01:12:04,,Cholangio Warrior,https://pbs.twimg.com/profile_images/1446242650462556162/3Ol_Cu_a_normal.jpg,185,436,0,1065,Cholangiocarci2,
374729426,2021-09-18 16:26:47,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/3034600, pic.twitter.com/Gr6bzAQDsK, ",1439325048393719809,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on September 9, 2021. View odds for this and other indicators: https://t.co/ax3aDXcnUJ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Gr6bzAQDsK",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
4058194633,2021-09-18 11:04:31,"INCY, ",,"finance.yahoo.com/news/incyte-an‚Ä¶, ",1439243945624494094,False,0,0,0,0,Twitter for iPhone,"$INCY Incyte Announces Health Canada Conditional Approval of Pemazyre¬Æ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma https://t.co/Kwv5kWiXxc",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
478901594,2021-09-18 08:20:31,,,"square1radio.com, pic.twitter.com/QG6iBtEAVD, ",1439202673455243265,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Tune In @ https://t.co/XL7Q5eebYQ https://t.co/QG6iBtEAVD,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1315434407692509184,2021-09-18 06:39:05,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/j5QMhv8GCa, ",1439177147671797761,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3113 out of 5574 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/j5QMhv8GCa",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
928837919103582208,2021-09-17 22:45:46,,"NewNOCAlert, HCApproves, ",,1439058036526620674,False,0,0,0,0,NOC Bot,New drug approved for PEMAZYRE by INCYTE CORPORATION #NewNOCAlert #HCApproves,,,2017-11-09 23:13:11,,Health Canada NOC,https://pbs.twimg.com/profile_images/1353940025659035648/ZWlFlmca_normal.jpg,103,0,0,759,HealthCanadaNOC,
1134049078424162304,2021-09-17 16:58:50,"INCY, ",,"newsfilter.io/articles/healt‚Ä¶, ",1438970724870459401,False,0,0,0,0,Newsfilter.io,Health Canada grants conditional approval to Incyte's Pemazyre cancer treatment $INCY https://t.co/mvcNcnFVFE,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
3318510966,2021-09-17 16:42:44,,,"crweworld.com/article/news-p‚Ä¶, ",1438966674389016581,False,0,0,0,0,CRWE World,Incyte Announces Health Canada Conditional Approval of Pemazyre¬Æ (pemigatinib) as First Targeted Treatment for Adul https://t.co/kxNjCq5z9U,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
284054290,2021-09-17 16:18:03,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/medic‚Ä¶, ",1438960462570401793,False,0,0,0,0,BLOX CMS for DEV,"MONTREAL, Sept. 17, 2021 /CNW/ - Incyte (NASDAQ: INCY) today announced that Health Canada has granted a Notice of Compliance with conditions for Pemazyre¬Æ (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatme‚Ä¶ https://t.co/9Mv9OG35Ro",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
270492072,2021-09-17 16:16:38,,"news, SeekingAlpha, ","seekingalpha.com/news/3740958-h‚Ä¶, ",1438960104607412224,False,0,0,0,0,Microsoft Power Platform,Health Canada grants conditional approval to Incyte's Pemazyre cancer treatment https://t.co/z1TL9c5mFB via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
472650465,2021-09-17 16:08:22,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1438958025814024194,False,0,0,0,0,OTC Dynamics Twitter Login,"$INCY Incyte Announces Health Canada Conditional Approval of Pemazyre¬Æ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarc https://t.co/46UMkGB9hA",,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
15296897,2021-09-17 16:07:18,"INCY, ",,"seekingalpha.com/news/3740958-h‚Ä¶, ",1438957756539617283,False,0,0,0,0,SANewsTwitter,$INCY - Health Canada grants conditional approval to Incyte's Pemazyre cancer treatment https://t.co/hcLbuEHm7Q,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1269758829690052610,2021-09-17 16:05:33,"INCY, ",,,1438957317215641603,False,0,0,0,0,Zapier.com,"Incyte says Health Canada grants conditional approval of Pemazyre
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
1325115160353103872,2021-09-17 16:00:39,"INCY, ",,"quantisnow.com/insight/178481‚Ä¶, ",1438956083754668034,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces Health Canada Conditional Approval of Pemazyre¬Æ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma

https://t.co/qBOFdqsrhW

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1366091384151760896,2021-09-17 02:28:50,,,"fiercepharma.com/marketing/big-‚Ä¶, ",1438751783011196931,False,0,0,0,0,Twitter Web App,"Three smaller pharma companies landed in the top five‚ÄîRegeneron, Seagen and Incyte‚Äîand two had never before cracked the top 30. Two other smaller companies made the top 30 list for the first time: Moderna at No. 20 and BeiGene at No. 27.

https://t.co/MtoPivlCXN",,,2021-02-28 13:22:57,,Bergeron News 2.0,https://pbs.twimg.com/profile_images/1433308801193713664/XF-_T3y1_normal.jpg,112,501,2,14659,bergeron_brent,
801519503146385408,2021-09-16 17:54:26,"CALA, ",,"twitter.com/EdgarInsider/s‚Ä¶, ",1438622330830442504,False,1,0,5,0,Twitter for iPhone,$CALA what‚Äôs the amount paid by Incyte ?? There‚Äôs no mention in the PR ‚Ä¶ https://t.co/Egh2Z9QzbE,,,2016-11-23 15:15:15,Roma,EM,https://pbs.twimg.com/profile_images/854648867127734272/HSnP1OoY_normal.jpg,512,71,19,4548,8thKingofRome,
4832529395,2021-09-16 12:02:01,,"sensorics, biotech, materials, sustainable, ","pic.twitter.com/Cd96nxFp9x, pic.twitter.com/Cd96nxFp9x, pic.twitter.com/Cd96nxFp9x, pic.twitter.com/Cd96nxFp9x, ",1438533642926665736,False,9,0,2,1,Twitter Web App,"""Green light"" for our interdisciplinary nanotech center INCYTE. We are deeply grateful to the government of Northrhine-Westfalia for the final ""go"". 5200m2 high-tech for #sensorics #biotech and #materials research and innovation at the service of #sustainable future @UniSiegen ! https://t.co/Cd96nxFp9x","UniSiegen, ",,2016-01-21 06:31:08,"Olpe, Nordrhein-Westfalen",Peter Haring Bol√≠var,https://pbs.twimg.com/profile_images/1221741824601219072/L-D0bGAd_normal.jpg,39,36,0,42,PHBmex,photo
2752355256,2021-09-16 10:30:17,,"antibody, Minjuvi, ","loom.ly/4GNTsCo, pic.twitter.com/vNVf1nSts1, ",1438510557867352065,False,0,0,0,0,Loomly,"The EU has approved the #antibody drug #Minjuvi, developed by @Incyte and @MorphoSys, for the treatment of a type of advanced blood cancer called diffuse large B-cell lymphoma. This follows the @FDA approval for the same drug in July last year. More news: https://t.co/G0Tfldt8mB https://t.co/vNVf1nSts1","Incyte, MorphoSys, FDA, ",,2014-08-21 11:35:19,"Berlin, Germany",Labiotech.eu,https://pbs.twimg.com/profile_images/923844013412769792/UYCJUiSN_normal.jpg,31061,1043,630,26328,Labiotech_eu,photo
3302806273,2021-09-16 10:20:21,,"ONSBridge, ","pic.twitter.com/XwSqzGRmES, ",1438508057349144582,False,1,0,0,0,Twitter for iPhone,"Thank you for supporting 
@oncologynursing #ONSBridge! @Amgen @Incyte @Regeneron @genentech @pfizer @NovartisCancer @Merck @abbvie @AstraZeneca @ScienceAtBMS @JanssenGlobal @G1Therapeutics @AstellasUS @GSK @Sandoz_Global @SanofiUS https://t.co/XwSqzGRmES","oncologynursing, Amgen, Incyte, Regeneron, genentech, pfizer, NovartisCancer, Merck, abbvie, AstraZeneca, ScienceAtBMS, JanssenGlobal, G1Therapeutics, AstellasUS, GSK, Sandoz_Global, SanofiUS, ",,2015-07-31 17:06:44,Delaware,"Darcy Burbage, DNP, RN, AOCN",https://pbs.twimg.com/profile_images/628694973605642241/geA1-2o9_normal.jpg,3742,4999,91,19855,DarcyBurbage,photo
374729426,2021-09-16 04:21:32,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/3029038, pic.twitter.com/9HEUrKcBpC, ",1438417757423341569,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/Ikz6z7k9LB #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/9HEUrKcBpC,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
478901594,2021-09-16 00:15:25,,,"square1radio.com, pic.twitter.com/btgh25rGeJ, ",1438355819192627202,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5eebYQ https://t.co/btgh25rGeJ,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
979532017967575040,2021-09-15 22:10:02,,,"fb.watch/82ofQWMKQe/, ",1438324267775508484,False,0,0,0,0,Twitter Web App,Visit the Site https://t.co/m5tEzkBkif via @FacebookWatch,"FacebookWatch, ",,2018-03-29 21:33:26,,David Karl Myers,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,6,54,0,6267,ImdkmbKarl,
478901594,2021-09-15 06:20:31,,,"square1radio.com, pic.twitter.com/tr5JmNFNi3, ",1438085313126096898,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Tune In @ https://t.co/XL7Q5eebYQ https://t.co/tr5JmNFNi3,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1134049078424162304,2021-09-14 23:43:32,"INCY, ",,"newsfilter.io/articles/nimbl‚Ä¶, ",1437985409368215552,False,1,0,0,0,Newsfilter.io,Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics $INCY https://t.co/4gyiocJKXs,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1134049078424162304,2021-09-14 22:49:32,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1437971820624416770,False,0,0,0,0,Newsfilter.io,"Incyte, Nimble Therapeutics expand research partnership for peptide drugs $INCY https://t.co/sCdQggH3WR",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1134049078424162304,2021-09-14 21:37:00,"INCY, ",,"newsfilter.io/articles/price‚Ä¶, ",1437953563251068928,False,0,0,0,0,Newsfilter.io,Price Over Earnings Overview: Incyte $INCY https://t.co/hpaWbOenZ5,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
3686628867,2021-09-14 18:02:08,,,"pharmaceuticaldaily.com/nimble-therape‚Ä¶, ",1437899491747713033,False,0,0,0,0,WordPress.com,Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide¬†Therapeutics https://t.co/uzXG0fiHt9,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
104862477,2021-09-14 17:30:44,,"NMSDC, ","pic.twitter.com/UpP6HYFm1O, ",1437891591113412616,False,9,0,1,3,Twitter for iPhone,"Our partners make the difference!¬†#NMSDC¬†welcomes our newest corporate members: Groom Construction Company, @Incyte, Insight Sourcing Group, @InvescoUS, @Kforce, Knight Foundation, @LaytonConstruct, Masco Corporation, Merakey, @MyMetaBank, Miller Electric Company, and @Navient!üôå https://t.co/UpP6HYFm1O","Incyte, InvescoUS, Kforce, LaytonConstruct, MyMetaBank, Navient, ",,2010-01-14 11:45:44,"New York, New York",NMSDC,https://pbs.twimg.com/profile_images/469566899622117376/ysYB5uWx_normal.jpeg,6975,1243,156,15777,NMSDCHQ,photo
4058194633,2021-09-14 16:23:53,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1437874766518448130,False,0,0,0,0,Twitter for iPhone,$INCY Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics | Business Wire https://t.co/lDkvJuh77W,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
72928001,2021-09-14 11:03:15,"INCY, ",,"bit.ly/3hyhlPk, ",1437794075500064778,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte expands strategic research collaboration with Nimble Therapeutics https://t.co/KNDKHYWzL5,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1199800417821048834,2021-09-14 10:53:13,,"BZI_PE, Earnings, INCY, News, Intraday_Update, ","dlvr.it/S7YHMD, bit.ly/3euPGwc, pic.twitter.com/afb5HVsHUI, ",1437791550013120519,False,0,0,0,0,dlvr.it,#BZI_PE #Earnings #INCY #News #Intraday_Update Price Over Earnings Overview: Incyte https://t.co/gEMVPLsWmB https://t.co/HhkKr6VYcw https://t.co/afb5HVsHUI,,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,photo
1166772455417024512,2021-09-14 10:37:09,,"BZIPE, Earnings, ","dlvr.it/S7YDnK, pic.twitter.com/Y0DwTPsVsH, ",1437787507698147336,False,0,0,0,0,dlvr.it,#BZIPE #Earnings Price Over Earnings Overview: Incyte https://t.co/Sts7BSrc7h https://t.co/Y0DwTPsVsH,,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
31720614,2021-09-14 10:12:09,,"PharmaNews, ClinicalResearchNews, BiotechNews, LifeSciencesNews, MedicalNews, HealthcareNews, PharmiwebNews, ","zpr.io/dcmfC5bLyS4S, pic.twitter.com/tntzXigWzB, ",1437781215730409479,False,0,0,0,0,Zapier.com,"Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics
https://t.co/SWrGxnXT5D
#PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/tntzXigWzB",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,photo
166539231,2021-09-14 09:57:10,,,"tinyurl.com/yh8xhcq2, ",1437777446271602697,False,0,0,0,0,PressReleasePoint.Com,https://t.co/oJA980mAJL Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress,,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
1262114478986010632,2021-09-14 09:16:29,"INCY, ",,,1437767206524305410,False,0,0,0,0,Twitter Web App,"$INCY Incyte, Nimble Therapeutics expand research partnership for peptide drugs @Biotech_SD is this a good thing .....","Biotech_SD, ",,2020-05-17 16:15:42,,GapUpüß©,https://pbs.twimg.com/profile_images/1262126091671670784/fUEaPN8a_normal.jpg,161,649,5,6750,GapUp4,
15296897,2021-09-14 09:14:35,"INCY, ",,"seekingalpha.com/news/3739499-i‚Ä¶, ",1437766728751091712,False,0,0,0,0,SANewsTwitter,"$INCY - Incyte, Nimble Therapeutics expand research partnership for peptide drugs https://t.co/a4JiRtzmaD",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
976297820532518914,2021-09-14 09:10:13,,,"dlvr.it/S7Xy5H, pic.twitter.com/gsJabIPLNS, ",1437765630032105483,False,0,0,0,0,dlvr.it,Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics https://t.co/YZHijB9Abz https://t.co/gsJabIPLNS,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1355194932445786112,2021-09-14 09:01:07,"SCHW, SWTXX, ",,"tinyurl.com/ygfs2ul2, ",1437763342911905793,False,0,0,0,0,Twitter,"$SCHW $SWTXX Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics
https://t.co/dkE9UfmzVK",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1355194932445786112,2021-09-14 09:01:07,"INCY, ",,,1437763342886658051,False,0,0,0,0,Twitter,"$INCY Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics
Something went wrong",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1262114478986010632,2021-09-14 09:00:33,"INCY, ",,,1437763197029781506,False,0,0,0,0,Twitter Web App,$INCY Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics,,,2020-05-17 16:15:42,,GapUpüß©,https://pbs.twimg.com/profile_images/1262126091671670784/fUEaPN8a_normal.jpg,161,649,5,6750,GapUp4,
1254035253104181256,2021-09-14 09:00:22,"INCY, ",,"stocktitan.net/news/INCY/nimb‚Ä¶, ",1437763151802642440,False,0,0,0,0,stocktitan,"$INCY Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics
https://t.co/PoNZRJnvVr",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
4058194633,2021-09-13 22:01:57,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1437597454862458885,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress | Business Wire https://t.co/owNYVU7UQP,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1281758467036811264,2021-09-13 19:41:47,,,"dataemia.com/?p=593535, pic.twitter.com/Fc8ilmTu8R, ",1437562181999120384,False,0,0,0,0,MasMaz,Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress - https://t.co/liGcoRuODd https://t.co/Fc8ilmTu8R,,,2020-07-10 21:13:35,United States ,MasMaz,https://pbs.twimg.com/profile_images/1297036654163582981/IWV5OJ_7_normal.jpg,62,0,1,83701,MasMazCom,photo
360220091,2021-09-13 19:41:46,,,"dataemia.com/?p=593535, pic.twitter.com/pjGKJHJKN6, ",1437562176907141120,False,0,0,0,0,Newsemia,Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress - https://t.co/twwMYWyhQR https://t.co/pjGKJHJKN6,,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,photo
950010035396136962,2021-09-13 17:01:53,,"INCY, ",,1437521942928666632,False,0,0,0,0,Cresus AI,"Incyte Corporation (#INCY) closed at 72.45, score +364, credit rating B",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
472650465,2021-09-13 16:47:26,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1437518307318505472,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress https://t.co/ktYUqFw4sT,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
976297820532518914,2021-09-13 16:36:06,,,"dlvr.it/S7VfhB, pic.twitter.com/Pi0USinImR, ",1437515452398194688,False,0,0,0,0,dlvr.it,Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress https://t.co/0MeEdRBrWr https://t.co/Pi0USinImR,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3911174913,2021-09-13 16:35:25,,"News, vitiligo, atopicdermatitis, eczema, EADVCongress, EADV2021, ","bit.ly/3k5cG9a, pic.twitter.com/oAytz0jhWM, ",1437515281753116672,False,7,0,0,1,Twitter Web App,#News: Data from our dermatology portfolio on #vitiligo and #atopicdermatitis (#eczema) will be presented at the #EADVCongress. Learn more. #EADV2021 https://t.co/eeKPaF6L1Q https://t.co/oAytz0jhWM,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1069693680066420736,2021-09-13 16:34:22,"INCY, ",,"s.flashalert.me/mWC5Ii, ",1437515015569952777,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on September 13, 16:30:00: Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress https://t.co/b8bgo29NXv",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842260,FlashAlert_me,
1134049078424162304,2021-09-13 16:32:34,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1437514565605023744,False,0,0,0,0,Newsfilter.io,Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology Virtual Congress $INCY https://t.co/7v81QKluIk,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1355194932445786112,2021-09-13 16:31:03,"INCY, ",,"tinyurl.com/yhekovx8, ",1437514180794503169,False,0,0,0,0,Twitter,"$INCY Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress
https://t.co/0KWnt4qE6w",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1325115160353103872,2021-09-13 16:30:31,"INCY, ",,"quantisnow.com/insight/176599‚Ä¶, ",1437514047432183809,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress

https://t.co/dSJEtF750X

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1254035253104181256,2021-09-13 16:30:17,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1437513990788325380,False,0,0,0,0,stocktitan,"$INCY Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress
https://t.co/YqYA4Pxiit",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1393303407801294850,2021-09-13 16:30:04,"INCY, ",,"webchronicletoday.com/incyte-announc‚Ä¶, ",1437513935108800512,False,0,0,0,0,Twitter,"$INCY Incyte Announces Ruxolitinib Cream Data Accepted for Presentation at the 2021 European Academy of Dermatology and Venereology (EADV) Virtual Congress
 
https://t.co/SC9ShxjnEq",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
55654926,2021-09-13 16:27:15,,,"cholangiocarcinoma.org/new-cancer-pro‚Ä¶, ",1437513227722706948,False,7,0,0,2,Twitter Web App,"CCF is proud to announce the launch of its Newly Diagnosed program to support patients and caregivers following a CCA diagnosis. 

Thank you Zymeworks, Incyte, QED Therapeutics, Servier and Taiho Oncology for helping to make this program possible. 

https://t.co/nzZCv8ZRTy",,,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,
4876582225,2021-09-13 12:15:04,"INCY, ",,"ideas.quantcha.com/2021/09/13/52-‚Ä¶, ",1437449764271009802,False,0,0,0,0,WordPress.com,52-Week Low Alert: Trading today‚Äôs movement in INCYTE¬†$INCY https://t.co/iQGgYMSeu9,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
4876582225,2021-09-13 12:12:40,"INCY, ",,"ideas.quantcha.com/2021/09/13/52-‚Ä¶, ",1437449159783718912,False,0,0,0,0,WordPress.com,52-Week Low Alert: Trading today‚Äôs movement in INCYTE¬†$INCY https://t.co/1jl99x4pQr,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
374729426,2021-09-12 02:32:11,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/3019172, pic.twitter.com/wr3gbA5LVJ, ",1436940688323579905,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/l9Y9VmHPJ4 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wr3gbA5LVJ,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1280938376099741697,2021-09-11 18:23:39,,"iexStock, ","iexcloud.io, pic.twitter.com/osdrMCL3f1, ",1436817742326374402,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-United Airlines Holdings Inc
-Incyte Corp.
-T-Mobile US Inc
-Salesforce.Com Inc
-Expedia Group Inc

Data provided by https://t.co/oXreiEXTgd https://t.co/osdrMCL3f1",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
980467278385958912,2021-09-11 13:49:58,"INCY, ",,"billionaireclubcollc.com/incyte-enters-‚Ä¶, ",1436748868356648971,False,0,0,0,0,StockTwits Web,$INCY https://t.co/HCsEIzFhQZ,,,2018-04-01 11:29:50,"New York, USA",Billionaireclubcollc.com,https://pbs.twimg.com/profile_images/1420395068754628612/Zr8OoRN9_normal.jpg,6959,225,78,125759,LlcBillionaire,
1416768592276717571,2021-09-11 08:29:13,,,"newsinsure.in/incyte-enters-‚Ä¶, ",1436668148032413697,False,0,0,0,0,WordPress.com,Incyte Enters Oversold Territory¬†(INCY) https://t.co/hbgJws7LTC,,,2021-07-18 10:35:46,,News Insure,https://pbs.twimg.com/profile_images/1418833299795976192/0DCG_IKi_normal.jpg,23,144,0,15155,NewsInsure,
4893474783,2021-09-11 06:23:17,,,"via.news/markets/alamo-‚Ä¶, pic.twitter.com/vLk3mDz3Ft, ",1436636458475999238,False,0,0,0,0,World time zone,"Alamo Group  And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity
https://t.co/waSFs01ryD
(VIANEWS) - Alamo Group (ALG), Incyte Corporation (INCY), Catalyst Pharmaceuticals (CPRX) a... https://t.co/vLk3mDz3Ft",,,2016-02-09 19:06:07,,Via News,https://pbs.twimg.com/profile_images/1102363201587634181/TJeRzWNR_normal.png,2462,4822,43,59142,ViaNewsAgency,photo
30005320,2021-09-11 02:55:21,,,"pharmiweb.jobs/job/1221078/in‚Ä¶, ",1436584129290723332,False,0,0,0,0,Madgex Twitter Tweeter,"In-house Clinical Research Associate - Incyte - Rome, IT;Homeworking - Advanced Clinical https://t.co/Q3eSodPAGW",,,2009-04-09 11:33:38,UK,PharmiWeb Jobs,https://pbs.twimg.com/profile_images/595963733047975936/aa7m_k97_normal.png,1554,250,76,165145,PharmiWebJobs,
30005320,2021-09-11 02:55:21,,,"pharmiweb.jobs/job/1221076/in‚Ä¶, ",1436584128309252099,False,0,0,0,0,Madgex Twitter Tweeter,"In-house Clinical Research Associate - Incyte - Remote-Japan, JP;Homeworking - Advanced Clinical https://t.co/2UU9qwgl4O",,,2009-04-09 11:33:38,UK,PharmiWeb Jobs,https://pbs.twimg.com/profile_images/595963733047975936/aa7m_k97_normal.png,1554,250,76,165145,PharmiWebJobs,
183294525,2021-09-11 02:05:03,,,"nasdaq.com/articles/incyt‚Ä¶, ",1436571469245390855,False,0,0,0,0,dlvr.it,"Incyte Enters Oversold Territory (INCY): Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical‚Ä¶ https://t.co/Qzk1Vzof1W NASDAQ",,,2010-08-26 13:08:22,,FinanzLinksUSA,https://pbs.twimg.com/profile_images/2666249900/ee5dd09921b66c73422c34bebb9cb9d2_normal.png,1008,106,289,519447,FinanzLinksCom,
1280938376099741697,2021-09-10 23:53:56,,"iexStock, ","iexcloud.io, pic.twitter.com/YHm0Z8tFDg, ",1436538473217994754,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Paychex Inc.
-Take-Two Interactive Software, Inc.
-Adobe Inc
-Incyte Corp.
-Microsoft Corporation

Data provided by https://t.co/oXreiEXTgd https://t.co/YHm0Z8tFDg",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
3068641671,2021-09-10 23:34:13,"INCY, ","Incyte, equity, stocks, ","dlvr.it/S7Lr6G, pic.twitter.com/bZqbssV3uG, ",1436533512287391750,False,0,0,0,0,dlvr.it,"$INCY #Incyte Corp. INCY - Embedded Expectations Analysis - 2021 09 10: Incyte Corporation (INCY:USA) currently trades well below corporate averages relative to UAFRS-based (Uniform) earnings, with a 7.6x Uniform P/E. At these levels, the‚Ä¶ https://t.co/kGcRsvL4LF #equity #stocks https://t.co/bZqbssV3uG",,,2015-03-03 17:15:05,"Paris, France",ResearchPool,https://pbs.twimg.com/profile_images/932829644558016512/Godn_LkX_normal.jpg,8971,4234,0,405156,ResearchPool,photo
1280938376099741697,2021-09-10 21:40:13,,"iexStock, ","iexcloud.io, pic.twitter.com/wU2utXmWMW, ",1436504823088783361,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-PayPal Holdings Inc
-Intuit Inc
-Wynn Resorts Ltd.
-Incyte Corp.
-Mesoblast Ltd - ADR

Data provided by https://t.co/oXreiEXTgd https://t.co/wU2utXmWMW",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
782954815739527168,2021-09-10 21:26:02,,,"dlvr.it/S7LfCZ, ",1436501255568773121,False,0,0,0,0,dlvr.it,"Director to Sr. Director, Clinical Research Scientist - Incyte Corporation - Wilmington, DE https://t.co/rvh1yXOvlZ",,,2016-10-03 10:45:49,"Washington, DC",Clinical Research Forum,https://pbs.twimg.com/profile_images/793945936200351744/foN7mcbj_normal.jpg,345,452,1,1449,CRForumUS,
2416188264,2021-09-10 11:51:23,"INCY, ","markets, ","thestockobserver.com/?p=4724998, ",1436356636877144085,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 52-Week Low at $71.26  https://t.co/5VME7Ufwyg #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2021-09-10 07:39:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/3014850, pic.twitter.com/NKp4cBctDF, ",1436293361657212933,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/XrWZCoj7kZ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/NKp4cBctDF,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1139042834550407168,2021-09-09 16:15:40,,,"cfc.umt.edu/research/bioge‚Ä¶, ",1436060760233349122,False,10,0,0,4,Twitter for Android,"Great postdoc position to help develop and lead a NSF funded project titled, INCyTE: Investigating Nutrient Cycling in Terrestrial Ecosystems: Integrating Observations, Experiments, and Models w/ Cory.Cleveland@umontana.edu
https://t.co/q366UKHnfx",,,2019-06-13 01:32:28,"Nebraska, USA",Arshdeep Singh,https://pbs.twimg.com/profile_images/1372798441164734468/s_Swqdi1_normal.jpg,146,114,0,228,SinghArshdeep_,
998915197061488645,2021-09-09 15:26:38,,"biogeochemistry, ","cfc.umt.edu/research/bioge‚Ä¶, ",1436048421257826316,False,20,1,0,29,Twitter Web App,"Please spread the word! INCyTE is recruiting a postdoc! Please reach out for more info. https://t.co/ZzeFg7fYg4
#biogeochemistry",,,2018-05-22 09:15:16,,INCyTE RCN,https://pbs.twimg.com/profile_images/1063085319887695873/d_uRHryG_normal.jpg,221,32,1,46,IncyteRcn,
18396070,2021-09-09 13:19:23,,"MPNs, MPNAwarenessDay, IncytePartner, Ad, youhavetogotoknow, ","bit.ly/3jwxGVZ, pic.twitter.com/Djr2naFCZZ, ",1436016395192516611,False,478,2,6,42,Twitter for iPad,It's as clear as the sky is blue: if you have a myeloproliferative neoplasm (#MPNs) you need to put your health first. I‚Äôm excited to partner with Incyte this #MPNAwarenessDay. Watch this video to learn more! #IncytePartner #Ad #youhavetogotoknow https://t.co/vr2A64DqYM https://t.co/Djr2naFCZZ,,,2008-12-26 16:51:53,This Now Moment,LeVar Burton,https://pbs.twimg.com/profile_images/1423665531308036111/ejc7NcWz_normal.jpg,2151861,1052,18298,17903,levarburton,video
1397557769553723398,2021-09-09 12:24:42,,,"twitter.com/lindeymarie/st‚Ä¶, ",1436002634842968066,False,1,0,1,0,Twitter Web App,"+ Experienced and highly respected management team
+ Expanded into prostate cancer, melanoma, and lung cancer (filling up pipeline)
+ Still small microcap with room to run
+ Collaborations with giant bio firms like Merck and Incyte
+ Everything that Lindey stated below. https://t.co/PH8ROoSOYA",,,2021-05-26 10:18:42,,TheLastJewmurai,https://pbs.twimg.com/profile_images/1397559628121190402/yZgsQbTB_normal.jpg,38,73,0,391,jewmurai,
1269758829690052610,2021-09-09 07:24:25,"INCY, SNY, KDMN, ",,,1435927064901783555,False,0,0,0,0,Zapier.com,"Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
$INCY $SNY $KDMN",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
478901594,2021-09-08 13:20:29,,,"square1radio.com, pic.twitter.com/ee0mzcA86y, ",1435654286634070018,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Tune In @ https://t.co/XL7Q5eebYQ https://t.co/ee0mzcA86y,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1029128656650555393,2021-09-08 11:30:12,,"jakinhibitors, DrugDevelopment, AtopicDermatitis, autoimmune, ","j.mp/3kZlMDD, ",1435626530596704260,False,1,0,0,0,SocialPilot.co,Pharmas with up-and-coming JAK inhibitors face 'shrinking' potential after FDA crackdow -More like this https://Pharm2Market.appn | @Pfizer @GileadSciences @Incyte @Roche @TheravanceBio @JNJNews #jakinhibitors #DrugDevelopment #AtopicDermatitis #autoimmune https://t.co/Ieq0yhJNHJ,"pfizer, GileadSciences, Incyte, Roche, TheravanceBio, JNJNews, ",,2018-08-13 18:12:46,,Pharm2Market,https://pbs.twimg.com/profile_images/1041479880368484353/xr9ZBpXF_normal.jpg,190,849,2,2538,pharm2market,
2656754371,2021-09-08 11:30:12,,"jakinhibitors, DrugDevelopment, AtopicDermatitis, autoimmune, ","fiercebiotech.com/biotech/after-‚Ä¶, ",1435626530596655115,False,1,0,0,0,SocialPilot.co,Pharmas with up-and-coming JAK inhibitors face 'shrinking' potential after FDA crackdow -More like this https://Pharm2Market.appn | @Pfizer @GileadSciences @Incyte @Roche @TheravanceBio @JNJNews #jakinhibitors #DrugDevelopment #AtopicDermatitis #autoimmune https://t.co/c2M7cZZOVn,"pfizer, GileadSciences, Incyte, Roche, TheravanceBio, JNJNews, ",,2014-07-18 09:20:39,San Diego,Aspen Biosciences,https://pbs.twimg.com/profile_images/1006725217568186368/B34yK1F1_normal.jpg,316,725,33,6079,aspenbio,
1315434407692509184,2021-09-07 17:03:05,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/PNBr6mln0q, ",1435347915439026184,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3040 out of 5574 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/PNBr6mln0q",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
478901594,2021-09-07 13:05:25,,,"square1radio.com, pic.twitter.com/01782uz4cy, ",1435288104005369856,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5evMQo https://t.co/01782uz4cy,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1280938376099741697,2021-09-06 23:38:31,,"iexStock, ","iexcloud.io, pic.twitter.com/EIpXRVOOII, ",1435085042523516933,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Ulta Beauty Inc
-Caterpillar Inc.
-Incyte Corp.
-Lonza Group AG - ADR
-Monster Beverage Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/EIpXRVOOII",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
478901594,2021-09-06 21:28:27,,,"square1radio.com, pic.twitter.com/h8RblzMWRK, ",1435052310321934338,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5eebYQ https://t.co/h8RblzMWRK,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1294417095149662209,2021-09-06 19:43:14,,"resist, resisters, ","twitter.com/Incyte/status/‚Ä¶, ",1435025830175023106,False,0,0,0,0,Twitter for iPhone,"I‚Äôll #resist for as long as I‚Äôm able. It‚Äôs my kid‚Äôs and grandchildren‚Äôs future at stake. 

Equal access to quality healthcare  is a National imperative. Please retweet #resisters. https://t.co/bo04N16Hp1",,,2020-08-14 19:34:32,,Exit Strategy: A CRO‚Äôs Race against Cancer,https://pbs.twimg.com/profile_images/1294432887639547905/P549kZ7i_normal.jpg,308,420,0,4989,bryan_jersey,
4496252499,2021-09-06 15:33:32,"AGEN, AGEN, ",,"pic.twitter.com/KfmZdGsWzY, pic.twitter.com/KfmZdGsWzY, pic.twitter.com/KfmZdGsWzY, pic.twitter.com/KfmZdGsWzY, ",1434962991565484037,False,9,0,0,0,Twitter for iPhone,"$AGEN

A trawl through $AGEN 10Q is always interesting‚Ä¶

- CEO stock-based compensation 

- Incyte, Merck, Gilead ‚Äî the company has never been wanting for assets 

- Subsidiary, MiNK confidential IPO process still apparently underway‚Ä¶
                                     . https://t.co/KfmZdGsWzY",,,2015-12-15 17:04:48,,Persimmon Tree Investments,https://pbs.twimg.com/profile_images/1011759509394591745/lx982XoB_normal.jpg,5026,67,116,6290,PersimmonTI,photo
478901594,2021-09-06 10:28:28,,,"square1radio.com, pic.twitter.com/HbLNTanXkw, ",1434886221088624642,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Tune In @ https://t.co/XL7Q5eebYQ https://t.co/HbLNTanXkw,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
325135887,2021-09-06 09:05:00,,"BloodCancerAwarenessMonth, Cancers, ","twitter.com/Incyte/status/‚Ä¶, ",1434865214894133256,False,0,0,0,0,Twitter Web App,Great commitment! Thanks for sharing! @Incyte #BloodCancerAwarenessMonth #Cancers https://t.co/CpCwKl2oQc,"Incyte, ",,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
966006214818697218,2021-09-06 06:01:10,"INCY, ",,"theenterpriseleader.com/?p=5250218, ",1434818951092051968,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $29,763.48 in Stock  https://t.co/FG3gAbIUmn",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
374729426,2021-09-05 14:13:45,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/3003447, pic.twitter.com/opdMfmnQrG, ",1434580526933831680,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/j8SlnSckHx #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/opdMfmnQrG,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
166539231,2021-09-04 21:34:50,,,"tinyurl.com/yh2ezsy2, ",1434329139503321092,False,0,0,0,0,PressReleasePoint.Com,https://t.co/YMIGWLtXI1 Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference,,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
166539231,2021-09-04 21:34:44,,,"tinyurl.com/yjjk2tl4, ",1434329117646901249,False,0,0,0,0,PressReleasePoint.Com,https://t.co/RXRL847R9O Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC),,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
166539231,2021-09-04 21:34:29,,,"tinyurl.com/yzvoa3bh, ",1434329052018524165,False,0,0,0,0,PressReleasePoint.Com,https://t.co/bXIW9HHjnT Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi) in Chronic Graft-Versus-Host Disease (GVHD),,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
166539231,2021-09-04 21:34:17,,,"tinyurl.com/ygrsbe2g, ",1434329002815131651,False,0,0,0,0,PressReleasePoint.Com,https://t.co/WUs4btWXYp Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC),,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
166539231,2021-09-04 21:34:03,,,"tinyurl.com/yevyqqyf, ",1434328946003283970,False,0,0,0,0,PressReleasePoint.Com,https://t.co/jyNN5hJI3u Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo,,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
166539231,2021-09-04 21:33:38,,,"tinyurl.com/ydrgpp44, ",1434328840176869376,False,0,0,0,0,PressReleasePoint.Com,https://t.co/JQUS6AmVwr Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis,,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
166539231,2021-09-04 21:33:28,,,"tinyurl.com/yk3dfk74, ",1434328796656701442,False,0,0,0,0,PressReleasePoint.Com,https://t.co/skLCuBwlyV Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC),,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
166539231,2021-09-04 21:33:07,,,"tinyurl.com/yhwojbwb, ",1434328709448806400,False,0,0,0,0,PressReleasePoint.Com,https://t.co/XTAa8A2IZX Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021,,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
975765540257128448,2021-09-04 20:51:30,,,"twitter.com/Incyte/status/‚Ä¶, ",1434318236502331398,False,1,0,0,0,Twitter for iPhone,Remembering my dad always &amp; forever. https://t.co/QaICBcLt2j,,,2018-03-19 12:06:48,"Pennsylvania, USA",JPro,https://pbs.twimg.com/profile_images/1439612187996266506/jaSKW6zM_normal.jpg,82,601,1,1889,AllPro1717,
1399103920522334219,2021-09-04 05:54:03,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/5lhWznLjEu, ",1434092384674062337,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3117 out of 5573 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/5lhWznLjEu",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
1134049078424162304,2021-09-04 03:03:58,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1434049584276426757,False,0,0,0,0,Newsfilter.io,"$29,763.48 of shares sold by Dhanak Dashyant (EVP &amp; Chief Scientific Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/hqRJmu2osS",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1429509934534864898,2021-09-04 02:53:32,,,"barrons.com/articles/abbvi‚Ä¶, ",1434046957484445698,False,0,0,0,0,Twitter Web App,"The FDA said that it wouldn‚Äôt require warnings for two other approved JAK inhibitors, made by Incyte (INCY) and Bristol Myers Squibb (BMY), because they are used to treat blood disorders rather than inflammatory conditions.https://t.co/RODkphpOAe",,,2021-08-22 14:25:36,,QcLiLi,https://pbs.twimg.com/profile_images/1429510440745324556/L6EOpqBC_normal.jpg,114,564,0,3752,LiLiQuebec,
478901594,2021-09-04 00:04:24,,,"square1radio.com, pic.twitter.com/IUutdoiGN3, ",1434004394673156098,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Tune In @ https://t.co/XL7Q5eebYQ https://t.co/IUutdoiGN3,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1262915121103491074,2021-09-03 23:11:25,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1433991059516784640,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 388 shares on 2021-09-01. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1386711127116103682,2021-09-03 10:17:46,,"BUY, INCY, MidTerm, HighRisk, ","stockthor.com/stocksignals/, ",1433796362458574853,False,1,0,0,0,Twitter Web App,"üí∞#BUY Incyte #INCY $76.05
üéØ Target Price: $83 (üöÄüöÄüöÄ9.1% Upside)
üõë StopLoss: $71.7
üçï 4% of Portfolio ""MidTerm""
‚è∞ Investment horizon: 1-3 month
#MidTerm, #HighRisk
https://t.co/QMElQ4mnEC",,,2021-04-26 11:58:30,United States,StockThor.com,https://pbs.twimg.com/profile_images/1432718298882486276/PdvojJzr_normal.jpg,7,8,0,77,Stock_Thor,
2763660607,2021-09-03 04:30:02,,,"buff.ly/3ByPS7G, pic.twitter.com/DzYy0Pf7q8, ",1433708853774929936,False,0,0,0,0,Buffer,"Incyte (INCY), MorphoSys Win EC Approval for Lymphoma Drug https://t.co/1ayfOxepq9 https://t.co/DzYy0Pf7q8",,,2014-08-24 15:18:55,"Chicago, IL",Hedge of Hedgies,https://pbs.twimg.com/profile_images/744970960483323905/0K6ZBWc8_normal.jpg,3257,3156,76,24553,hedgeofhedgies,photo
374729426,2021-09-02 17:34:19,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2996693, pic.twitter.com/ff8DDSKtrb, ",1433543839222951939,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/XnoXfjy8t4 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ff8DDSKtrb,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1067819244279214080,2021-09-02 12:44:34,,,"aacr.org/professionals/‚Ä¶, ",1433470920283283462,False,17,1,0,3,Twitter Web App,"Congratulations to 2019 @AACR-@Incyte Immuno-oncology Fellow Dr. Won Jin Ho, with the mentorship of past AACR President Dr. Liz Jaffee for their recent paper on targeting PTPN22: https://t.co/OF45drqW67 @wonjinho1 @DrLizJaffee @hopkinskimmel","AACR, Incyte, wonjinho1, DrLizJaffee, hopkinskimmel, ",,2018-11-28 11:35:21,,Christina Leah Kline,https://pbs.twimg.com/profile_images/1189580299488899073/yNFavGqj_normal.jpg,41,10,0,239,ChristinaLeahK1,
1255127435080679424,2021-09-02 00:25:52,,,"biopharminternational.com/view/incyte-an‚Ä¶, ",1433285020341321730,False,0,0,0,0,Twitter Web App,"Incyte and MorphoSys Receive EC Approval for Minjuvi in Combination Therapy for Lymphoma
https://t.co/gsgIKTwUNw",,,2020-04-28 09:31:26,United Kingdom,ophthalmology research,https://pbs.twimg.com/profile_images/1255127555750850562/50j8zDaz_normal.jpg,476,729,2,923,ophthalmologyr9,
3363332327,2021-09-01 23:50:03,,,"buff.ly/3ByPS7G, pic.twitter.com/3sppUGYzYh, ",1433276004093419520,False,0,0,0,0,Buffer,"Incyte (INCY), MorphoSys Win EC Approval for Lymphoma Drug https://t.co/H6O6UP12TP https://t.co/3sppUGYzYh",,,2015-07-06 20:15:16,"Stockholm, Sweden",Swedish Biotech,https://pbs.twimg.com/profile_images/825044879411650560/BVzozrPt_normal.jpg,2794,2365,25,25407,BiotechSweden,photo
189364778,2021-09-01 20:11:39,,"chemjobs, ","incyte.hrmdirect.com/employment/vie‚Ä¶, ",1433221044031033352,False,1,0,0,0,Twitter Web App,"Incyte (Wilmington, DE) is looking for a BS/MS organic chemist (0-5 years): https://t.co/ptdjwP45iK #chemjobs",,,2010-09-10 22:05:38,United States of America,Chemjobber,https://pbs.twimg.com/profile_images/1348511242625847300/TrC1Lyrj_normal.jpg,34183,6008,411,159792,Chemjobber,
3372415895,2021-09-01 19:38:21,,,"twitter.com/Incyte/status/‚Ä¶, ",1433212662398205953,False,0,0,0,0,Twitter for Android,"As a Hodgkin's Lymphoma survivor , to actually help us, please donate to reputable companies like American Cancer Society (@AmericanCancer ) or the Leukemia and Lymphoma Society (@LLSAdvocacy ). Shirts and shaving heads while great in spirit don't actually accomplish anything. https://t.co/btEFORphA3","AmericanCancer, LLSAdvocacy, ",,2015-07-12 11:12:31,venmo @vstetler,"Vi Stasiya, MPH üè≥Ô∏è‚Äçüåà‚ôø üíó‚ô•Ô∏èüß°üíúüíö",https://pbs.twimg.com/profile_images/1452714908269875205/-eFPHV3n_normal.jpg,513,2028,6,8862,ViStasiya,
4876644330,2021-09-01 19:38:03,,,"buff.ly/3ByPS7G, pic.twitter.com/NyC4OXvOrf, ",1433212587219501058,False,0,0,0,0,Buffer,"Incyte (INCY), MorphoSys Win EC Approval for Lymphoma Drug https://t.co/QWoGUOJWob https://t.co/NyC4OXvOrf",,,2016-02-07 22:20:58,"Chicago, IL",Zack Capp,https://pbs.twimg.com/profile_images/696539389556625408/ZMgC9WNY_normal.jpg,4297,3987,141,31618,zackcapp,photo
478901594,2021-09-01 17:57:21,,,"square1radio.com, pic.twitter.com/WJXZW6qtxO, ",1433187246648270848,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5eebYQ https://t.co/WJXZW6qtxO,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
4058194633,2021-09-01 17:04:06,"INCY, ",,"google.com/amp/s/m.invest‚Ä¶, ",1433173844974575616,False,0,0,0,0,Twitter for iPhone,"$INCY Mizuho Maintains Hold Rating On Incyte, $95 PT https://t.co/IsLLlKnMXj",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
620487016,2021-09-01 16:26:02,,,"dlvr.it/S6m5Nk, ",1433164264768827393,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Receive EC Approval for Minjuvi in Combination Therapy for Lymphoma - BioPharm International https://t.co/iGwXYKltAo,,,2012-06-27 20:41:16,"USA, Alaska",Stem cell Watch,https://pbs.twimg.com/profile_images/2974988642/252972fe389b7bcf03c80859a4650e4c_normal.jpeg,3374,2235,73,21743,StemcellWatch,
1269758829690052610,2021-09-01 14:19:22,"INCY, ",,,1433132387626536968,False,0,0,0,0,Zapier.com,"Odds of Incyte drug exclusion from class warning 'largely unchanged,' says Cowen
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
121158213,2021-09-01 13:36:04,"INCY, ",,"AlertTrade.us, ",1433121491600625668,False,0,0,0,0,dlvr.it,VOLUME RADAR: $INCY Incyte Corporation üì≥ TradeIdeas via ‚ü∂ https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161360,152443,2585,2462625,AlertTrade,
4058194633,2021-09-01 13:08:54,"ABBV, ",,"news.bloomberglaw.com/health-law-and‚Ä¶, ",1433114654872506368,False,0,0,0,0,Twitter for iPhone,$ABBV AbbVie Drops After FDA Seeks New Rinvoq Warning; Incyte Gains https://t.co/EjMrBSd5kL,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
108617488,2021-09-01 12:55:02,,,"invst.ly/vxh0o, ",1433111165761200129,False,0,0,0,0,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/ZWcrgxaJ9D,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
121158213,2021-09-01 12:14:34,"INCY, ",,"AlertTrade.us, ",1433100982653632514,False,0,0,0,0,dlvr.it,DYNAMOgapDOWN $INCY - Incyte Corporation üì≥ TradeIdeas via  ‚ü∂ https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161360,152443,2585,2462625,AlertTrade,
869657570,2021-09-01 12:08:41,,,"news.bloomberglaw.com/health-law-and‚Ä¶, ",1433099502051725315,False,0,0,0,0,Twitter Web App,"AbbVie Drops After FDA Seeks New Rinvoq Warning; Incyte Gains
https://t.co/YLGQjozO23",,,2012-10-09 06:49:35,Êù±‰∫¨,Âõ£Âú∞Ê£≤„ÅøVTuberÂÜçÁÑ°ËÅ∑FE‰∫∫ÁîüË©∞„ÅøÂ§™ÈÉéÔº†(„Åµ¬¥Ôπè`„Å°)Ôæâ,https://pbs.twimg.com/profile_images/1161229868421582848/hMvD986R_normal.png,164,1825,7,220736,Fuchi_JPN,
1304209340195201024,2021-09-01 11:40:11,,,"news.bloomberglaw.com/health-law-and‚Ä¶, ",1433092329624117249,False,0,0,0,0,Twitter Web App,AbbVie Drops After FDA Seeks New Rinvoq Warning; Incyte Gains https://t.co/79tWfqYkK9,,,2020-09-10 20:05:37,,tokyo_investment,https://pbs.twimg.com/profile_images/1437077251401547778/K61ehZ4Y_normal.png,66,121,2,8653,InvestmentTokyo,
3911174913,2021-09-01 10:10:10,,"BloodCancerAwarenessMonth, ","pic.twitter.com/L8zSVttxRz, ",1433069675244576777,False,161,5,4,42,Twitter Web App,This #BloodCancerAwarenessMonth we reaffirm our commitment to Solve On. Join us in raising awareness for those affected by blood cancers worldwide. https://t.co/L8zSVttxRz,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
963495628545327104,2021-09-01 10:08:03,"INCY, INCY, ",,"stck.pro/news/INCY/1530‚Ä¶, stck.pro/news/INCY, pic.twitter.com/i9wqmq7LK2, ",1433069143755010054,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Should You Buy Incyte Stock Around $75 Levels? https://t.co/3YH57AOHMd Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/i9wqmq7LK2,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
3767896936,2021-09-01 10:06:33,,,"forbes.com/sites/greatspe‚Ä¶, ",1433068765428678663,False,0,0,0,0,dlvr.it,"Should You Buy Incyte Stock Around $75 Levels?: We believe that the stock price of Incyte, a global biopharmaceutical company, is undervalued at current levels of $75. INCY stock is down 21% over the last-twelve months period, despite revenue increasing‚Ä¶ https://t.co/rHwo2BZPHJ",,,2015-09-25 01:33:29,Sagittarius,King Tri-Zi üëë,https://pbs.twimg.com/profile_images/1453018315438247942/snp2M145_normal.jpg,583,230,4,49950,KingTriZi,
358197053,2021-09-01 09:55:26,,,"CVSoci.al/fEVARSA8, ",1433065966460710916,False,0,0,0,0,"Clearview Social, Inc.","The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration https://t.co/FWSOJQ4b04",,,2011-08-19 10:53:18,"Brooklyn, New York",Michael Siem,https://pbs.twimg.com/profile_images/1445501764606717957/Rl0LwKAn_normal.jpg,2149,3585,0,12397,michael_siem,
374729426,2021-09-01 07:13:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2993171, pic.twitter.com/zaqVRGDrJV, ",1433025257514827784,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/tYXM9r94Uf #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/zaqVRGDrJV,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1280938376099741697,2021-09-01 00:54:18,,"iexStock, ","iexcloud.io, pic.twitter.com/A2UfPFta42, ",1432929786108817410,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Western Digital Corp.
-Xcel Energy, Inc.
-Dow Inc
-Walmart Inc

Data provided by https://t.co/oXreiEXTgd https://t.co/A2UfPFta42",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
4058194633,2021-08-31 19:20:31,"INCY, INCY, ",,"bit.ly/2WBkeYq, ",1432845789730983939,False,0,0,0,0,Twitter for iPhone,$INCY Should You Buy Incyte Stock Around $75 Levels? https://t.co/exdz9o0k1G via @trefis $INCY,"Trefis, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
716327654,2021-08-30 19:04:22,,,"statnews.com/pharmalot/2021‚Ä¶, ",1432479335944949765,True,0,0,0,0,Twitter Web App,Former Medivation exec charged with insider trading after buying stock 'within minutes' of learning of a deal - STAT https://t.co/gprHzlOIUV,,,2012-07-25 12:09:55,"YOUNGSTOWN,OHIO","Andrew J.Bennett,Jr",https://pbs.twimg.com/profile_images/522892735754153984/rYlxZZsf_normal.jpeg,597,5004,25,63278,crossboy56jr,
478901594,2021-08-30 07:16:26,,,"square1radio.com, pic.twitter.com/tj5nl4q8Ea, ",1432301177606230018,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5eebYQ https://t.co/tj5nl4q8Ea,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
3545684907,2021-08-29 16:26:00,,"cartcr, tcell, cart, ","buff.ly/3kw9ZMY, ",1432077094423498753,False,7,1,0,1,Buffer,"Incyte, MorphoSys' CAR-T rival tafasitamab approved in EU - https://t.co/X4GUGBcmda #cartcr #tcell #cart",,,2015-09-04 10:54:01,"London, England",CAR-TCR,https://pbs.twimg.com/profile_images/1181914638365200394/ZaqiZpm5_normal.jpg,3169,1454,31,1706,CAR_TCell,
776377795815571456,2021-08-29 07:24:02,,"pathology, pancreaspath, ","twitter.com/Incyte/status/‚Ä¶, ",1431940704968888326,False,1,0,0,0,Twitter Web App,"Advanced cholangiocarcinoma had its first treatment antiFGFR2 Pemazyre, and now has Second Anti-IDH1 (ivosidenib ),  months or longer survival depends on mutational status. #pathology #pancreaspath https://t.co/2T0EHZpoQ6",,,2016-09-15 07:11:05,"My views, not my employer",IO,https://pbs.twimg.com/profile_images/796761601630228485/AsdqOY44_normal.jpg,471,255,6,1639,DraSabin,
478901594,2021-08-28 23:11:21,,,"square1radio.com, pic.twitter.com/4PwxxkBFjr, ",1431816716514992129,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Streaming On https://t.co/XL7Q5eebYQ https://t.co/4PwxxkBFjr,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1280938376099741697,2021-08-28 01:36:44,,"iexStock, ","iexcloud.io, pic.twitter.com/XQIOZ1d1pd, ",1431490916494319619,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-ASML Holding NV - New York Shares
-Incyte Corp.
-Roche Holding AG - ADR
-JD.com Inc - ADR
-Microsoft Corporation

Data provided by https://t.co/oXreiEXTgd https://t.co/XQIOZ1d1pd",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1134049078424162304,2021-08-28 01:10:54,"BMY, INCY, RGEN, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1431484411711791108,False,0,0,0,0,Newsfilter.io,"Incyte, MorphoSys Win EC Approval for Lymphoma Drug $BMY $INCY $RGEN $MOR https://t.co/ROiJbrLfA3",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
15193667,2021-08-27 23:28:37,,,"morphosys.com/media-investor‚Ä¶, morphosys.com/media-investor‚Ä¶, ",1431458671641305089,False,0,0,1,0,Twitter for iPad,(2021/08/26) MorphoSys and Incyte Announce the European Commission Approval of Minjuvi¬ÆÔ∏é (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory DLBCL | MorphoSys AG https://t.co/VQyvV9Tvrr https://t.co/VQyvV9Tvrr,,,2008-06-21 20:09:52,Êñ∞ÊΩüÁúå‰ΩêÊ∏°Â∏Ç,matiere*,https://pbs.twimg.com/profile_images/1187122868/maru_1_normal.jpg,2490,4998,0,1410326,matiere,
478901594,2021-08-27 19:08:24,,,"square1radio.com, pic.twitter.com/zpQ6d1SmxK, ",1431393188414111746,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5eebYQ https://t.co/zpQ6d1SmxK,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
627695874,2021-08-27 15:19:05,"MOR, INCY, ",,"investorsobserver.com/news/stock-upd‚Ä¶, ",1431335476452110340,False,1,0,0,0,Twitter Web App,"MorphoSys $MOR and Incyte $INCY Receive European Commission Approval for Minjuvi(R) Combined with Lenalidomide for Treating Large B-Cell Lymphoma

https://t.co/tw4lUyQQcZ",,,2012-07-05 14:32:58,,InvestorsObserver,https://pbs.twimg.com/profile_images/1389624586346631184/oPmFX5sq_normal.jpg,2110,48,47,13548,IOInvestors,
374729426,2021-08-27 14:49:12,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2981910, pic.twitter.com/YxkEvG6LI2, ",1431327955729346562,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/NR11UIeDts #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/YxkEvG6LI2,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1315434407692509184,2021-08-27 13:47:03,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/bN5ShjngFL, ",1431312315945791489,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3007 out of 5562 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/bN5ShjngFL",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1399103920522334219,2021-08-27 10:34:03,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/7rtNafOfXl, ",1431263745494429703,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3007 out of 5562 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/7rtNafOfXl",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
208053736,2021-08-27 09:22:12,,,"chineselgz.com/2021/08/27/inc‚Ä¶, ",1431245666731319297,False,0,0,0,0,theglobe,(Incyte and MorphoSys Announce the European Commission Approval of Minjuvi¬Æ (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma  ...) has been published on  - https://t.co/rEEd4yQCYz,,,2010-10-26 10:57:19,Zieglerville PA,Wellcome-home,https://pbs.twimg.com/profile_images/1269342722/Becky_mug__428x640__normal.jpg,127,10,2,348028,Wellcome_Home,
4058194633,2021-08-27 09:13:49,"IMMP, NVS, MOR, INCY, BMY, XNCR, BOLT, NLTX, JNJ, AGEN, ALKS, ALZN, ",,"benzinga.com/z/22691787#.YS‚Ä¶, ",1431243554794344457,False,1,0,0,0,Twitter for iPhone,"$IMMP $NVS $MOR $INCY $BMY $XNCR $BOLT $NLTX $JNJ The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration $AGEN $ALKS $ALZN https://t.co/1U5tGrNq55 # via @benzinga","Benzinga, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
82832569,2021-08-27 09:00:27,"IBB, CTLT, BLFS, ",,"benzinga.com/z/22691787#.YS‚Ä¶, ",1431240190627037191,False,0,0,0,0,Twitter Web App,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration $IBB $CTLT $BLFS https://t.co/234hTo6Wem via @benzinga","Benzinga, ",,2009-10-16 04:35:46,,bill eijgenberger,https://pbs.twimg.com/profile_images/561184975697895425/oEUJ3Hjt_normal.jpeg,163,12,8,52777,weijgenberger,
2334614718,2021-08-27 08:27:15,"MOR, INCY, ",,"ooc.bz/l/81743, ",1431231838408826885,False,0,0,0,0,Open Outcrier,"$MOR (+1.5% pre) Incyte $INCY and MorphoSys AG (MOR) Announces European Approval of Minjuvi¬Æ in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

https://t.co/JqzI1OIWIZ",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
1176027461588574208,2021-08-27 08:07:07,"IBB, CTLT, BLFS, ",,"benzinga.com/z/22691787#.YS‚Ä¶, ",1431226769286303744,False,1,0,0,1,Twitter Web App,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration $IBB $CTLT $BLFS https://t.co/uHxBx3pCHM via @benzinga","Benzinga, ",,2019-09-23 02:56:21,"Pretoria, South Africa",Boikanyogroup,https://pbs.twimg.com/profile_images/1176028682651086848/uRVZXE0V_normal.jpg,70,0,0,3669,boikanyogroup,
780474320799666177,2021-08-27 08:03:25,"IMMP, INCY, MOR, BOLT, NLTX, ",,"benzinga.com/general/biotec‚Ä¶, ",1431225840692457480,False,2,0,1,1,Twitter Web App,"$IMMP $INCY $MOR $BOLT $NLTX and more

biotech stocks on the move....

https://t.co/wbYnDQAkZ7",,,2016-09-26 14:29:13,"Chennai, India",Shanthi Rexaline,https://pbs.twimg.com/profile_images/1187404925958930433/LWeq_NZ-_normal.jpg,1065,78,27,1419,shanthirex,
27254739,2021-08-27 08:00:20,,"DLBCL, pharma, ","pharmaphorum.com/news/incyte-mo‚Ä¶, ",1431225062384934919,False,0,0,0,0,Sprout Social,"European Commission clears @Incyte and @MorphoSys CD19-targeting tafasitamab as Minjuvi for B-cell lymphoma #DLBCL, providing an alternative to current therapies including CAR-Ts #pharma  https://t.co/RnkcEk5Tft","Incyte, MorphoSys, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
1134049078424162304,2021-08-27 07:53:40,"AGEN, ALKS, BYSI, BLFS, CLDX, ",,"newsfilter.io/articles/the-d‚Ä¶, ",1431223386055876608,False,0,0,0,0,Newsfilter.io,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bol.. $AGEN $ALKS $BYSI $BLFS $CLDX https://t.co/0VmijCskwF",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
133504478,2021-08-27 07:53:06,,"strategy, competitiveintelligence, marketing, competitivemarketing, biotech, pharmaceutical, pharma, healthcare, ","dlvr.it/S6R4mf, pic.twitter.com/GS8etZ2OsE, ",1431223242149154817,False,1,0,1,1,dlvr.it,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology‚Ä¶ https://t.co/EqYrlC8ari #strategy #competitiveintelligence #marketing #competitivemarketing #biotech #pharmaceutical #pharma #healthcare https://t.co/GS8etZ2OsE",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1166772455417024512,2021-08-27 07:46:33,,"AGEN, ALKS, ","dlvr.it/S6R3t7, pic.twitter.com/JHsj9vYl1f, ",1431221594567811074,False,0,0,0,0,dlvr.it,"#AGEN #ALKS The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration https://t.co/PVmiY8kwth https://t.co/JHsj9vYl1f",,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
1403008149020459013,2021-08-27 07:46:18,,,"ift.tt/38fzPPq, ",1431221532253167616,False,0,0,0,0,IFTTT,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration https://t.co/hVr1k6VjCa",,,2021-06-10 11:17:38,,Stock Market News,https://pbs.twimg.com/profile_images/1403010687564136462/3Z237JI4_normal.jpg,101,96,2,16360,AglowStockNews,
20780650,2021-08-27 07:04:35,,,"biedexmarkets.com/incyte-corpora‚Ä¶, pic.twitter.com/sAfGzL56g9, ",1431211032077287434,False,0,0,0,0,Twitter,"Incyte Corporation (NASDAQ:INCY), (MOR) - Incyte - MorphoSys's Diffuse Large B-Cell Lymphoma Drug Wins European Approval

               https://t.co/yb3CL24GlF https://t.co/sAfGzL56g9",,,2009-02-13 11:02:18,"London, England",Biedex Markets,https://pbs.twimg.com/profile_images/1288488731654201349/MSrdzFac_normal.jpg,4018,4862,120,362261,biedexmarkets,photo
27254739,2021-08-27 07:00:11,,"DLBCL, pharma, ","pharmaphorum.com/news/incyte-mo‚Ä¶, ",1431209927582887943,False,0,0,0,0,Sprout Social,"European Commission clears @Incyte and @MorphoSys CD19-targeting tafasitamab as Minjuvi for B-cell lymphoma #DLBCL, providing an alternative to current therapies including CAR-Ts #pharma https://t.co/RnkcEk5Tft","Incyte, MorphoSys, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
1134049078424162304,2021-08-27 06:40:50,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1431205054443364357,False,0,0,0,0,Newsfilter.io,Incyte - MorphoSys's Diffuse Large B-Cell Lymphoma Drug Wins European Approval $INCY $MOR https://t.co/GOxjlSpVhP,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
963495628545327104,2021-08-27 06:27:03,"INCY, MOR, INCY, ",,"stck.pro/news/INCY/1519‚Ä¶, stck.pro/news/INCY, ",1431201587096064003,False,0,0,0,0,STCK.PR0,$INCY $MOR NEW ARTICLE : Incyte - MorphoSys's Diffuse Large B-Cell Lymphoma Drug Wins European Approval https://t.co/EADnzil4gN Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
1403008149020459013,2021-08-27 06:26:48,,,"ift.tt/3ktsMs4, ",1431201526295502848,False,0,0,0,0,IFTTT,Incyte - MorphoSys's Diffuse Large B-Cell Lymphoma Drug Wins European Approval https://t.co/HsVaJHYpn6,,,2021-06-10 11:17:38,,Stock Market News,https://pbs.twimg.com/profile_images/1403010687564136462/3Z237JI4_normal.jpg,101,96,2,16360,AglowStockNews,
1171873456276889600,2021-08-27 06:15:50,"MOR, ","MOR, 6K, Morphosys, News, ","docoh.com/filing/1340243‚Ä¶, ",1431198763561930754,False,0,0,0,0,Investor Feed,"$MOR  6-K  Morphosys   (27 Aug, 6:15am)

üì∞ MorphoSys and Incyte Announce the European Commission

https://t.co/mXCPG8XwNK

#MOR #6K #Morphosys #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1883393875,2021-08-27 06:11:08,,,"dlvr.it/S6Qn0j, ",1431197581292425220,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Announce the EC Approval of Minjuvi https://t.co/bStImJwolD,,,2013-09-19 10:40:31,Amsterdam,Pharma Market News,https://pbs.twimg.com/profile_images/378800000501255643/53b0cadf7327b09ab8610040b07fcb10_normal.jpeg,1499,1215,21,7595,pharmamarketnws,
1889492676,2021-08-27 05:03:15,"INCY, MOR, ","Incyte, MorphoSys, Minjuvi, Tafasitamab, Lenalidomide, Relapsed, Refractory, DiffuseLargeBCellLymphoma, ","1stoncology.com/blog/incytemor‚Ä¶, ",1431180499792191491,False,0,0,0,0,Troi URL Plug-in,#Incyte and #MorphoSys Announce the European Commission Approval of #Minjuvi (#Tafasitamab) in Combination With #Lenalidomide for the Treatment of Adults With #Relapsed or #Refractory #DiffuseLargeBCellLymphoma $INCY $MOR https://t.co/s1YT0sfBqN,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
95165334,2021-08-27 04:39:41,,"Approval, Lymphoma, ","bit.ly/2Wonndw, ",1431174566777339904,False,1,0,0,0,Twitter Web App,".@MorphoSys and @Incyte Announce the European Commission #Approval of Minjuvi¬Æ (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell #Lymphoma
https://t.co/V05rGpbFy4","MorphoSys, Incyte, ",,2009-12-07 03:53:59,Munich/Dusseldorf,MC Services AG,https://pbs.twimg.com/profile_images/510095774332383232/zJw8hAE1_normal.jpeg,459,1057,0,3699,MCServicesAG,
1022473214457348096,2021-08-27 03:21:14,,,"pharmashots.com/63849/morphosy‚Ä¶, ",1431154823362080769,False,0,0,0,0,Twitter Web App,"MorphoSys and Incyte‚Äôs Minjuvi (tafasitamab) + Lenalidomide Receive EC‚Äôs Approval for the Treatment of R/R DLBCL @Pharmashot @MorphoSys @Incyte 
https://t.co/x7eTA60hcq","Pharmashot, MorphoSys, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
1134049078424162304,2021-08-26 20:25:09,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1431050113007378437,False,0,0,0,0,Newsfilter.io,Incyte and MorphoSys Announce the European Commission Approval of Minjuvi¬Æ in Combination With Lenalidomide for the Treatment of Adults With Re.. $INCY $MOR https://t.co/VoY7GgJwdK,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1134049078424162304,2021-08-26 19:17:09,"INCY, MOR, ",,"newsfilter.io/articles/europ‚Ä¶, ",1431033000041582596,False,0,0,0,0,Newsfilter.io,European Commission grants conditional approval to Incyte and MorphoSys' Minjuvi combo $INCY $MOR https://t.co/AM7l0z6Kmk,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
72928001,2021-08-26 18:07:51,"MOR, ",,"bit.ly/3BdprEk, ",1431015560305790981,False,0,0,0,0,BriefingInPlayLimited,$MOR: MorphoSys and Incyte (INCY) announce European Commission approval of Minjuvi in combination with lenalidomide... https://t.co/9inZqsHf0q,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
478901594,2021-08-26 17:36:28,,,"square1radio.com, pic.twitter.com/TUsZF85m42, ",1431007662427213824,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Tune In @ https://t.co/XL7Q5eebYQ https://t.co/TUsZF85m42,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
3686628867,2021-08-26 17:22:10,,,"pharmaceuticaldaily.com/incyte-and-mor‚Ä¶, ",1431004065618702336,False,0,0,0,0,WordPress.com,Incyte and MorphoSys Announce the European Commission Approval of Minjuvi¬Æ (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell¬†Lymphoma https://t.co/pVSuTyWWFR,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1345093906527100929,2021-08-26 17:08:08,"MOR, ",,,1431000535000309761,False,0,0,0,0,StockTwits Web,$MOR - MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,,,2021-01-01 14:46:01,Click the link below to join :,TheStockTraderHub,https://pbs.twimg.com/profile_images/1345094114451316736/Q8t-dmph_normal.jpg,6195,33,49,5974,StockTraderHub,
261473143,2021-08-26 16:57:51,,,"morphosys.com/media-investor‚Ä¶, life-sciences-europe.com/news/vlfm-iito‚Ä¶, pic.twitter.com/AW3rARXXIY, ",1430997944312938506,False,0,0,0,0,Twitter Web App,MorphoSys/Incyte: EU Approval for Minjuvi (tafasitamab) in Combi with Lenalidomide for Rel/Ref DLBCL https://t.co/5rFmGw9mBp @MorphoSys @Incyte More European life science business news at [LSE] at https://t.co/df6Gi5dTPT https://t.co/AW3rARXXIY,"MorphoSys, Incyte, ",,2011-03-05 20:26:19,"Bremen, Germany",[iito] Life Science,https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_normal.jpeg,2596,238,89,29254,iitoLifeScience,photo
4058194633,2021-08-26 16:48:55,"INCY, MOR, XNCR, ",,"businesswire.com/news/home/2021‚Ä¶, ",1430995696971239425,False,1,0,0,0,Twitter for iPhone,$INCY $MOR $XNCR Incyte and MorphoSys Announce the European Commission Approval of Minjuvi¬Æ (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Business Wire https://t.co/txkeGmLWJR,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
2236261122,2021-08-26 16:37:26,"XNCR, ",,"morphosys.com/media-investor‚Ä¶, ",1430992807871848455,False,1,0,0,0,Twitter Web App,"EU Approval of Minjuvi (tafasitamab) + LEN for the Treatment of r/r DLBCL -&gt; this should trigger a milestone payment to $XNCR in the tens of millions of dollars

https://t.co/bidaRf0gqk",,,2013-12-08 11:23:17,Germany,German Biotech,https://pbs.twimg.com/profile_images/1184938278224646145/CdvTZ-M6_normal.jpg,1199,78,32,1941,GermanBiotech,
208053736,2021-08-26 16:30:18,,,"chineselgz.com/2021/08/26/inc‚Ä¶, ",1430991012646825991,False,0,0,0,0,theglobe,(Incyte and MorphoSys Announce the European Commission Approval of Minjuvi¬Æ (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma ‚Äì Business Wire) has been published on ch ... - https://t.co/bJXZrAdySo,,,2010-10-26 10:57:19,Zieglerville PA,Wellcome-home,https://pbs.twimg.com/profile_images/1269342722/Becky_mug__428x640__normal.jpg,127,10,2,348028,Wellcome_Home,
1428803612650532868,2021-08-26 16:14:37,"MOR, ",,"finance.yahoo.com/news/morphosys‚Ä¶, ",1430987065618018305,False,0,0,0,0,Twitter,"$MOR 
Sentiments: title 0.4767 | summary -0.1027
Aft-Price: 15.5 | Bid: 14.13 | Ask: 14.16
Volume: 28,488
https://t.co/c2uplnbvyM",,,2021-08-20 15:39:06,,PennyStockNews,https://pbs.twimg.com/profile_images/1428804163052335105/iqj6tj8N_normal.jpg,2,0,0,499,PennyStockNews5,
620487016,2021-08-26 16:13:04,,,"dlvr.it/S6Nz9B, ",1430986673400074242,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Announce the European Commission Approval of Minjuvi¬Æ (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Business Wire https://t.co/6xdokM6OpP,,,2012-06-27 20:41:16,"USA, Alaska",Stem cell Watch,https://pbs.twimg.com/profile_images/2974988642/252972fe389b7bcf03c80859a4650e4c_normal.jpeg,3374,2235,73,21743,StemcellWatch,
3318510966,2021-08-26 16:09:32,,,"crweworld.com/article/news-p‚Ä¶, ",1430985784572530690,False,0,0,0,0,CRWE World,MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenal https://t.co/4k5nklQqis,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3318510966,2021-08-26 16:08:50,,,"crweworld.com/article/news-p‚Ä¶, ",1430985611624599552,False,0,0,0,0,CRWE World,Incyte and MorphoSys Announce the European Commission Approval of Minjuvi¬Æ (tafasitamab) in Combination With Lenali https://t.co/1T3JVMQ4K0,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1428803612650532868,2021-08-26 16:08:25,"MOR, ",,"finance.yahoo.com/news/incyte-mo‚Ä¶, ",1430985506838491140,False,0,0,0,0,Twitter,"$MOR 
Sentiments: title 0.4767 | summary 0.4767
Aft-Price: 15.5 | Bid: 14.14 | Ask: 14.18
Volume: 28,488
https://t.co/t0XycbbVY1",,,2021-08-20 15:39:06,,PennyStockNews,https://pbs.twimg.com/profile_images/1428804163052335105/iqj6tj8N_normal.jpg,2,0,0,499,PennyStockNews5,
1269758829690052610,2021-08-26 16:06:58,"INCY, ",,,1430985142017961987,False,0,0,0,0,Zapier.com,"Incyte, Morphosys get European Commission approval of Minjuvi in DLBCL
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
976297820532518914,2021-08-26 16:04:11,,,"dlvr.it/S6Nxjf, pic.twitter.com/BO6qQmPuL5, ",1430984439673147394,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Announce the European Commission Approval of Minjuvi¬Æ (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma https://t.co/1gl8sPNhnR https://t.co/BO6qQmPuL5,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
33467057,2021-08-26 16:03:46,,"lymphoma, DLBCL, ","morphosys.com, pic.twitter.com/RU098N4aeD, ",1430984334236917760,False,10,0,0,5,Twitter Web App,BREAKING NEWS: Our antibody is now approved in the EU as a new treatment option for eligible adults with relapsed or refractory diffuse large B-cell #lymphoma #DLBCL. The novel therapy will be marketed by our partner @Incyte. More info: https://t.co/rckRFz6OPY https://t.co/RU098N4aeD,"Incyte, ",,2009-04-20 05:13:43,"Planegg, Germany",MorphoSys,https://pbs.twimg.com/profile_images/1414967751538511873/dOJDE_2G_normal.jpg,1563,205,37,315,MorphoSys,photo
1355194932445786112,2021-08-26 16:03:12,"MOR, ",,"stocktitan.net/news/MOR/morph‚Ä¶, ",1430984191039188997,False,0,0,0,0,Twitter,"$MOR MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell...
https://t.co/kbZFisBYUY",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1355194932445786112,2021-08-26 16:03:03,"INCY, MOR, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1430984153319759885,False,0,0,0,0,Twitter,"$INCY $MOR Incyte and MorphoSys Announce the European Commission Approval of Minjuvi¬Æ (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell L...
https://t.co/v2O32Ze1YA",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
42410755,2021-08-26 16:02:24,,,"dgap.de/dgap/News/corp‚Ä¶, ",1430983989502922758,False,0,1,0,0,DGAP_News_Int,MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combin... https://t.co/LPMfV8ffBw,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
1325115160353103872,2021-08-26 16:01:43,"MOR, ",,"quantisnow.com/insight/171305‚Ä¶, ",1430983820191223810,False,0,0,0,0,Twitter,"$MOR üì∞ MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

https://t.co/TJ63AjArsT

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1254035253104181256,2021-08-26 16:01:26,"MOR, ",,"stocktitan.net/news/MOR/morph‚Ä¶, ",1430983747009196034,False,0,0,0,0,stocktitan,"$MOR MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
https://t.co/TVDU0deUhh",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1254035253104181256,2021-08-26 16:01:18,"INCY, MOR, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1430983713349832711,False,0,0,0,0,stocktitan,"$INCY $MOR Incyte and MorphoSys Announce the European Commission Approval of Minjuvi¬Æ (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
https://t.co/jAkiPQDNtY",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
266143766,2021-08-26 16:01:11,"MOR, ",,"accesswire.com/661575/MorphoS‚Ä¶, ",1430983682983137286,False,0,0,0,0,Accesswire,$MOR MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with ... https://t.co/itQBdPFvR0,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
121193853,2021-08-26 10:59:32,,,"dlvr.it/S6N3jj, ",1430907771537420291,False,0,0,0,0,dlvr.it,"New job posting:  New job posting:  Sr. Research Scientist, Antibody Pharmacology (Contract) - Incyte Corporation - Wilmington, DE https://t.co/waPX9uVvaX",,,2010-03-08 13:38:25,"Alexandria, VA",ASCPT Alexandria,https://pbs.twimg.com/profile_images/887708754527088640/WMcvsw3m_normal.jpg,1524,328,20,8323,ASCPT_ClinPharm,
478901594,2021-08-26 03:53:19,,,"square1radio.com, pic.twitter.com/EFVR443Nds, ",1430800509561098241,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5eebYQ https://t.co/EFVR443Nds,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
631661989,2021-08-26 02:00:01,,"ChooseDelaware, GlobalDE, ","hubs.ly/H0VR26s0, pic.twitter.com/P7ZUt8IsXW, ",1430771996418318337,False,2,0,0,1,HubSpot,".@Incyte signs a more than US$100M deal with a Chinese biopharmaceutical company for the rights to develop and commercialize tafasitamab, allowing both companies to continue research and development of the monoclonal antibody. 
https://t.co/okpZtuOP8K 
#ChooseDelaware #GlobalDE https://t.co/P7ZUt8IsXW","Incyte, ",,2012-07-09 23:54:36,"Wilmington, Delaware",Global Delaware,https://pbs.twimg.com/profile_images/1059868013459992577/IjSZsC14_normal.jpg,5389,1817,222,6107,DelawareGlobal,photo
1408531432071319554,2021-08-26 01:15:21,"INCY, ",,"stockmacro.com/incyte-corpora‚Ä¶, ",1430760759294898180,False,0,0,0,0,StockTwits Web,"$INCY: Experts Long Term Analysis of Incyte Corporation 08 25 2021
https://t.co/v7opLE4LRZ",,,2021-06-25 17:04:33,,StockMacro,https://pbs.twimg.com/profile_images/1408531759529005057/mRCfj6CK_normal.png,45,0,0,11222,StockMacroDaily,
374729426,2021-08-25 21:00:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2977623, pic.twitter.com/kfWgE1Wkt5, ",1430696658363289602,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/wQCLhB0aIz #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kfWgE1Wkt5,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1299115385330053126,2021-08-25 18:54:34,,,"pluto.bio/blog/research-‚Ä¶, ",1430664929154043907,False,3,0,0,2,Twitter Web App,"This week's Research Spotlight was written by MacKenzie Demmel, bioinformatics intern at Pluto! She highlights a collaboration by researchers at @MerusNV, @Incyte and @Penn on a novel human CD137xPD-L1 bispecific antibody with promising anti-tumor activity https://t.co/Ng3gg7tdQr","MerusNV, Incyte, Penn, ",,2020-08-27 18:44:20,Join us on Pluto!,Pluto,https://pbs.twimg.com/profile_images/1423443801138470914/QG0LK8Dv_normal.png,42,39,0,16,tryplutobio,
478901594,2021-08-25 12:43:22,,,"square1radio.com, pic.twitter.com/oMQ0j5VFnZ, ",1430571515137888262,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5eebYQ https://t.co/oMQ0j5VFnZ,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1004375641171603458,2021-08-25 09:00:11,,"ChooseDelaware, NetDE, ","hubs.ly/H0VR6jN0, pic.twitter.com/7VUQxHAS2P, ",1430515349611597825,False,0,0,0,1,HubSpot,".@Incyte signs a more than $100M deal with a Chinese biopharmaceutical company for the rights to develop and commercialize tafasitamab, allowing both companies to continue research and development of the monoclonal antibody. 
https://t.co/uoAjF8RqoY 
#ChooseDelaware #NetDE https://t.co/7VUQxHAS2P","Incyte, ",,2018-06-06 10:53:08,,Delaware Prosperity Partnership @choosedelaware,https://pbs.twimg.com/profile_images/1059872509540134913/PX_tVV7O_normal.jpg,4337,1030,21,2792,choosedelaware,photo
19606233,2021-08-25 08:01:27,,,"pic.twitter.com/oqYO6x2TXc, ",1430500568187953165,False,2,0,0,1,Hootsuite Inc.,"Congratulations to @Accenture, @AtriumHealth, @FAANews and ESC Media Solutions, @GarantiBBVA, @Incyte and @NXLSolutions, @Nordea and @InfoproLearning, @pfizer and @themosaicco, @sanofi and @innovativeLG, and @Swisscom for winning a Silver in Best Advance in Compliance Training! https://t.co/oqYO6x2TXc","Accenture, AtriumHealth, FAANews, GarantiBBVA, Incyte, NXLSolutions, Nordea, InfoproLearning, pfizer, themosaicco, sanofi, innovativeLG, Swisscom, ",,2009-01-27 13:21:24,"Boca Raton, Florida",Brandon Hall Group,https://pbs.twimg.com/profile_images/556950060152270848/BmY2jmo3_normal.png,7752,2269,504,10877,BrandonHallGrp,photo
108617488,2021-08-25 05:15:18,,,"invst.ly/vuuo8, ",1430458756605820935,False,1,0,0,0,FP News Publisher - COM,JMP Securities Stick to Their Buy Rating for Incyte Corp - https://t.co/iBEEfFylGP,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
1315434407692509184,2021-08-25 03:31:05,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/AqFdXdQRe7, ",1430432526422642690,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3007 out of 5563 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/AqFdXdQRe7",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1280938376099741697,2021-08-24 21:53:10,,"iexStock, ","iexcloud.io, pic.twitter.com/v2MNG2cHzu, ",1430347486602924033,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-BioNTech SE - ADR
-AMGEN Inc.
-Roche Holding AG - ADR
-Caterpillar Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/v2MNG2cHzu",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
4058194633,2021-08-24 18:55:02,"INCY, MOR, ",,"finance.yahoo.com/news/incyte-an‚Ä¶, ",1430302658556878848,False,0,0,0,0,Twitter for iPhone,$INCY $MOR Incyte Announces Health Canada Approval of Minjuvi¬Æ (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma https://t.co/4FahGTvk88,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1408531432071319554,2021-08-24 18:13:44,"INCY, ",,"stockmacro.com/incyte-corpora‚Ä¶, ",1430292266409676802,False,0,0,0,0,StockTwits Web,"$INCY: Experts Analyzing and Forecasting Incyte Corporation 08 24 2021
https://t.co/v7opLE4LRZ",,,2021-06-25 17:04:33,,StockMacro,https://pbs.twimg.com/profile_images/1408531759529005057/mRCfj6CK_normal.png,45,0,0,11222,StockMacroDaily,
72928001,2021-08-24 10:41:21,"INCY, ",,"bit.ly/3yd3svl, ",1430178420877664275,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte announces Health Canada approval of Minjuvi (tafasitamab) in combination with lenalidomide for the... https://t.co/79qth1FDT6,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
284054290,2021-08-24 08:34:11,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/medic‚Ä¶, ",1430146418744954881,False,0,0,0,0,BLOX CMS for DEV,"- Minjuvi is an important new therapeutic option for eligible patients with DLBCL in Canada, addressing an urgent unmet medical need https://t.co/vB5ezk0RFq",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
3318510966,2021-08-24 08:31:26,,,"crweworld.com/article/news-p‚Ä¶, ",1430145724453326852,False,0,0,0,0,CRWE World,Incyte Announces Health Canada Approval of Minjuvi¬Æ (tafasitamab) in Combination with Lenalidomide for the Treatmen https://t.co/scOenBCldH,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1325115160353103872,2021-08-24 08:30:40,"INCY, ",,"quantisnow.com/insight/170121‚Ä¶, ",1430145533079822340,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces Health Canada Approval of Minjuvi¬Æ (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

https://t.co/5eL7y2Sk9L

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
852592522165710848,2021-08-23 12:05:35,,,"lnkd.in/dMRNvzVY, ",1429837231468974093,False,5,0,0,3,Twitter Web App,"Nominations are open now for @cure_magazine's 2021 MPN Heroes Recognition Program!

This program is in partnership with @Incyte and aims to honor those that have dedicated themselves to improving the lives of those with MPN.

For more: https://t.co/RGEp2HKNw6","cure_magazine, Incyte, ",,2017-04-13 14:41:12,"Cranbury, NJ",MJH Life Sciences,https://pbs.twimg.com/profile_images/1156907434289586181/DeRSnQDU_normal.jpg,959,2752,9,2155,MJHLifeSciences,
1263523805785276416,2021-08-23 09:30:14,"INCY, CRON, CTXS, ",,"heliumtrades.com/stock_predicti‚Ä¶, ",1429798135916810241,False,1,0,0,1,IFTTT,"Daily Stock Pick: $INCY (Incyte)

https://t.co/miR5Ha22iK

Last week's pick: $CRON down 2.51%
Last month's pick: $CTXS down 10.23%",,,2020-05-21 13:35:34,,Helium Trades,https://pbs.twimg.com/profile_images/1344088732169728000/Px6MjaOg_normal.jpg,105,15,0,145,HeliumTrades,
1408531432071319554,2021-08-23 07:53:24,"INCY, ",,"stockmacro.com/incyte-corpora‚Ä¶, ",1429773767509688326,False,0,0,0,0,StockTwits Web,"Long-Term Forecasting for Investors Incyte Corporation $INCY August 2021
https://t.co/v7opLE4LRZ",,,2021-06-25 17:04:33,,StockMacro,https://pbs.twimg.com/profile_images/1408531759529005057/mRCfj6CK_normal.png,45,0,0,11222,StockMacroDaily,
478901594,2021-08-21 23:03:20,,,"square1radio.com, pic.twitter.com/66kcQIBRNQ, ",1429277982309425153,False,0,0,0,0,Twitter,Now On Channel 412 - Numbers by Incyte - Tune In @ https://t.co/XL7Q5eebYQ https://t.co/66kcQIBRNQ,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
147056387,2021-08-21 22:01:21,,,"bit.ly/3zaJ8vP, ",1429262382774300678,False,1,0,1,1,Sprout Social,"Here are our latest jobs postings: Oncology Clinical Nurse Educator-Gulf Coast - Incyte Corporation - , NA https://t.co/I7hu27uvoR",,,2010-05-22 23:08:53,"Jacksonville, FL",HBCU Lifestyle,https://pbs.twimg.com/profile_images/493577044274327552/6k-HhSKz_normal.jpeg,18870,2211,0,78897,HBCU_Lifestyle,
1280938376099741697,2021-08-21 18:30:02,,"iexStock, ","iexcloud.io, pic.twitter.com/atL3xJ8XHB, ",1429209205936988161,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Roche Holding AG - ADR
-JPMorgan Chase &amp; Co.
-Laboratory Corp. Of America Holdings
-Incyte Corp.
-Adobe Inc

Data provided by https://t.co/oXreiEXTgd https://t.co/atL3xJ8XHB",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
478901594,2021-08-21 12:58:24,,,"square1radio.com, pic.twitter.com/ounoNsOQSo, ",1429125747239759880,False,0,0,0,0,Twitter,Now On Channel. 412 - Numbers by Incyte - Listen Live @ https://t.co/XL7Q5eebYQ https://t.co/ounoNsOQSo,,,2012-01-30 14:56:45,Pittsburgh,Square1Radio,https://pbs.twimg.com/profile_images/1792831781/IMG_0491_normal.JPG,344,148,2,30144,Square1Nation,photo
1408531432071319554,2021-08-21 11:43:33,"INCY, ",,"stockmacro.com/incyte-corpora‚Ä¶, ",1429106911941742593,False,0,0,0,0,StockTwits Web,"Long Term Investment Analysis of Incyte Corporation $INCY August 2021
https://t.co/hSC1CGKUlx",,,2021-06-25 17:04:33,,StockMacro,https://pbs.twimg.com/profile_images/1408531759529005057/mRCfj6CK_normal.png,45,0,0,11222,StockMacroDaily,
374729426,2021-08-21 05:52:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2966443, pic.twitter.com/4CM8YOn9OC, ",1429018680466173956,False,0,0,0,1,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/KvkYpuhX06 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/4CM8YOn9OC,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1315434407692509184,2021-08-21 04:43:43,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/Sd5kmC9Zaq, ",1429001254735425545,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3086 out of 5562 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/Sd5kmC9Zaq",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1399103920522334219,2021-08-21 04:42:53,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/rfkjAUsBLj, ",1429001046693646336,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 3086 out of 5562 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/rfkjAUsBLj",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
1134049078424162304,2021-08-20 22:03:57,"INCY, ",,"newsfilter.io/articles/8-k-f‚Ä¶, ",1428900649345892359,False,0,0,0,0,Newsfilter.io,"Form 8-K: Entry Into a Material Definitive Agreement. On August 18, 2021, Incyte and its subsidiary, Incyte Holdings , e.. $INCY https://t.co/wQuhKmj99E",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1068561714055012352,2021-08-20 16:14:14,"INCY, ",,"sec.report/Document/00011‚Ä¶, ",1428812641678491651,False,0,0,0,0,Edgar Filings,A Form 8-K [Press/News Current Report] filing has been made with the SEC:  $INCY INCYTE CORP  https://t.co/RAQy4cpxVM,,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
1325115160353103872,2021-08-20 16:06:23,"INCY, ",,"quantisnow.com/insight/169398‚Ä¶, ",1428810666035474434,False,0,0,0,0,Twitter,"$INCY üìú Incyte Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

https://t.co/NW7bhZwy2Z

30 seconds delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1171873456276889600,2021-08-20 16:03:51,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1428810030120325123,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (20 Aug, 4:02pm)

üì∞ Entry into a Material Definitive Agreement

https://t.co/X66wA8kAMg

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
55700354,2021-08-20 14:41:12,,,"linkedin.com/feed/update/ur‚Ä¶, ",1428789230059364354,False,1,0,1,0,Twitter Web App,"Incyte Studios is hiring

Feel free to DM if interested!

https://t.co/CPG0LfmmKm",,,2009-07-10 19:45:10,Saint Petersburg FL,Michael L. Benin,https://pbs.twimg.com/profile_images/506791553491144705/nfWqtVpW_normal.jpeg,599,1988,90,8984,michaelbenin,
20780650,2021-08-20 04:46:00,,,"biedexmarkets.com/incyte-corpora‚Ä¶, pic.twitter.com/zNt5A76Uen, ",1428639441837506563,False,0,0,0,0,Twitter,"Incyte Corporation (NASDAQ:INCY), (BCTX) - BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial

               https://t.co/b3GQDO5DP8 https://t.co/zNt5A76Uen",,,2009-02-13 11:02:18,"London, England",Biedex Markets,https://pbs.twimg.com/profile_images/1288488731654201349/MSrdzFac_normal.jpg,4018,4862,120,362261,biedexmarkets,photo
1280938376099741697,2021-08-20 00:53:34,,"iexStock, ","iexcloud.io, pic.twitter.com/A4BCc8qWE5, ",1428580950196297731,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Salesforce.Com Inc
-Monster Beverage Corp.
-Walgreens Boots Alliance Inc
-Incyte Corp.
-Lilly(Eli) &amp; Co

Data provided by https://t.co/oXreiEXTgd https://t.co/A4BCc8qWE5",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1370731105674956800,2021-08-19 17:46:36,,,"postxnews.com/incyte-signs-1‚Ä¶, ",1428473497915887619,False,0,0,0,0,WordPress.com,Incyte signs $100M+ Chinese licensing¬†deal https://t.co/0VuLs3XQtu,,,2021-03-13 08:39:11,"California, USA",PostX News,https://pbs.twimg.com/profile_images/1417120237774725122/_nsC30G7_normal.jpg,33,4,1,102590,xpostnews,
1194733791316774914,2021-08-19 16:36:00,"INCY, ",,"yhoo.it/36KcBAh, pic.twitter.com/qtlEtUjINs, ",1428455730387034117,False,7,0,0,3,Twitter Web App,"$INCY recently reported above-consensus revenue and earnings for 2Q21. @ArgusResearch reiterates their 2021 earnings forecast of $3.20 per share, helped by the FDA emergency use authorization of Incyte's baricitinib for for the treatment of COVID-19. https://t.co/dZ61TqW4Uu https://t.co/qtlEtUjINs","ArgusResearch, ",,2019-11-13 16:48:40,,Yahoo Finance Plus,https://pbs.twimg.com/profile_images/1374422006926508041/-WSwm_t__normal.png,2145,52,35,540,yfinanceplus,photo
60098087,2021-08-19 15:58:50,,,,1428446378603200517,False,0,0,0,0,Twitter for iPhone,It is crazy how much things change in just a few years. @Incyte ‚Äòs campus is massive now. I remember when they first leased the Wanamaker Building on Augustine Cutoff in Wilmington.,"Incyte, ",,2009-07-25 12:58:14,"Atlanta, GA,",Gregory Desgrosseilliers,https://pbs.twimg.com/profile_images/1400571841765384195/dR-rfRti_normal.jpg,211,1113,5,3369,GREGALDES,
19560636,2021-08-19 07:00:12,"PFE, PFE, INCY, ",,"bizjournals.com/sanfrancisco/n‚Ä¶, ",1428310825127878667,False,0,0,0,0,True Anthem,"$PFE's big Medivation buyout in 2016 leads to ""shadow trading"" civil charge by SEC against former Medivation exec $PFE $INCY  https://t.co/A1DkrOonr3",,,2009-01-26 16:53:18,San Francisco,San Francisco Business Times,https://pbs.twimg.com/profile_images/456849053133725697/U_NFM6pS_normal.png,41158,1760,2648,175608,SFBusinessTimes,
21079030,2021-08-19 03:02:16,,"PharmaScrip, ","bit.ly/3gdb5vq, ",1428250950825877512,False,0,0,0,0,Sprinklr,"Asia Deal Watch: Incyte Inks Chinese Marketing Partnership With InnoCare For Monjuvi
https://t.co/P8kXUbhiNg #PharmaScrip",,,2009-02-17 05:33:29,Global,Scrip,https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg,21541,1629,654,35335,PharmaScrip,
1889492676,2021-08-19 01:23:54,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1428226195296907271,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/AsOus6UJDq,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2021-08-19 01:19:28,"MOR, ","MorphoSys, Incyte, InnoCare, Tafasitamab, ","1stoncology.com/blog/morphosys‚Ä¶, ",1428225076420177925,False,0,0,0,0,Troi URL Plug-in,#MorphoSys' Partner #Incyte Announced Development and Commercialization Agreement with #InnoCare for #Tafasitamab  in Greater China $MOR https://t.co/nZ8hS4dHOw,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1280938376099741697,2021-08-19 01:17:51,,"iexStock, ","iexcloud.io, pic.twitter.com/XCDi63ePki, ",1428224671464542213,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Wynn Resorts Ltd.
-NanoViricides Inc
-Incyte Corp.
-Intuit Inc
-Fiserv, Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/XCDi63ePki",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
918515449,2021-08-18 19:20:30,,"pharma, ","scrip.pharmaintelligence.informa.com/articles/2021/‚Ä¶, ",1428134740410867713,False,1,0,0,0,Twitter Web App,"Chinese firms and deal-making active, check out @PharmaScrip's latest roundup. #pharma 

Asia Deal Watch: Incyte Inks Chinese Marketing Partnership With InnoCare For Monjuvi https://t.co/IrTLrLlznD","PharmaScrip, ",,2012-11-01 04:09:15,Tokyo,Ian Haydock,https://pbs.twimg.com/profile_images/1390109301709033481/PE3utarM_normal.jpg,924,55,84,7355,ScripIanHaydock,
194343133,2021-08-18 18:14:36,,,"bizjournals.com/sanfrancisco/n‚Ä¶, ",1428118155914727424,False,1,0,0,0,Twitter Web App,Alleged 'shadow trading' leads SEC to sue Bay Area biotech exec five years later https://t.co/NzMzhmlkBr via @SFBusinessTimes,"SFBusinessTimes, ",,2010-09-23 18:19:15,San Francisco,Ron Leuty,https://pbs.twimg.com/profile_images/1282470797164990465/hLCS-eo6_normal.jpg,10810,1332,526,25964,rleuty_biotech,
19560636,2021-08-18 18:00:05,"PFE, PFE, INCY, ",,"bizjournals.com/sanfrancisco/n‚Ä¶, ",1428114504425017346,False,0,0,0,0,True Anthem,"$PFE's big Medivation buyout in 2016 leads to ""shadow trading"" charge by SEC against former Medivation exec $PFE $INCY  https://t.co/MEFtkAiYyJ",,,2009-01-26 16:53:18,San Francisco,San Francisco Business Times,https://pbs.twimg.com/profile_images/456849053133725697/U_NFM6pS_normal.png,41158,1760,2648,175608,SFBusinessTimes,
32492934,2021-08-18 10:23:00,,,"bioworld.com/articles/51052‚Ä¶, ",1427999474303987718,False,0,0,0,0,TweetDeck,Innocare licenses Monjuvi rights from Incyte in $118M heme/onc deal https://t.co/6XgxAxUX56,,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
889321711966998528,2021-08-18 08:03:37,,"antibody, ","geneonline.com/innocare-incyt‚Ä¶, ",1427964399759728640,False,2,0,0,0,Twitter for iPhone,"Chinese-based InnoCare and Incyte announced that Incyte and a subsidiaryCAR of InnoCare have entered a collaboration and license agreement for Incyte‚Äôs monoclonal antibody tafasitamab.
#antibody 
https://t.co/efq3LvAYbD",,,2017-07-23 23:09:53,"Santa Clara, CA",GeneOnline,https://pbs.twimg.com/profile_images/1290669170913312769/KyH5AwCK_normal.jpg,4796,4702,12,3813,GeneOnlineNews,
75337774,2021-08-18 07:16:43,,,"statnews.com/pharmalot/2021‚Ä¶, ",1427952594589306883,False,0,0,0,0,Twitter for Android,Former Medivation exec charged with insider trading after buying stock ‚Äòwithin minutes‚Äô of... https://t.co/UFZ5HrBEbZ via @statnews,"statnews, ",,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
27254739,2021-08-18 07:00:16,,"biotech, ","pharmaphorum.com/news/years-aft‚Ä¶, ",1427948455171960838,False,1,0,0,1,Sprout Social,"Five years after @Pfizer's $14bn takeover of Medivation, a former executive at the #biotech has been accused of insider trading involving Incyte, another mid-cap cancer specialist https://t.co/qHiYHnfUFq","pfizer, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
746441781588426752,2021-08-18 06:07:02,,,"endpts.com/innocare-bags-‚Ä¶, ",1427935057730097152,False,1,0,0,0,Twitter Web App,"from yesterday ‚Äî by @Jasonmmast 

InnoCare bags Chinese rights to Incyte CAR-T rival Monjuvi in bid to expand in-house pipeline - https://t.co/xakRN2dnb5","Jasonmmast, ",,2016-06-24 16:36:03,Hong Kong,Amber Tong,https://pbs.twimg.com/profile_images/884631339940687872/t2YNNjMA_normal.jpg,2186,733,44,3674,AmberTongPW,
1134049078424162304,2021-08-18 02:09:17,"INCY, MOR, XNCR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1427875226193387521,False,0,0,0,0,Newsfilter.io,Incyte Out Licenses Lymphoma Drug To InnoCare In Greater China $INCY $MOR $XNCR https://t.co/5cAQPClHg0,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
3290364847,2021-08-18 00:48:23,,,"buff.ly/2W87Bn6, ",1427854866307768323,False,3,2,0,2,Buffer,The former head of business development at Medivation has been charged with insider trading by the U.S. Securities and Exchange Commission. https://t.co/R6OS6iWDX3,,,2015-07-24 12:09:35,,STAT,https://pbs.twimg.com/profile_images/1220049678420643841/00Z3yA4z_normal.png,160026,5239,4324,52578,statnews,
374729426,2021-08-18 00:18:46,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2958920, pic.twitter.com/0Ay2kQvqGq, ",1427847414069665797,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/7JoK8RrlqI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0Ay2kQvqGq,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
2280068370,2021-08-18 00:08:55,,,"bioworld.com/articles/51052‚Ä¶, ",1427844935944859652,False,0,0,0,0,Twitter Web App,Innocare licenses Monjuvi rights from Incyte in $118M heme/onc deal https://t.co/2QVSADoql3,,,2014-01-07 00:14:17,Bangalore,Pushpita Deb,https://pbs.twimg.com/profile_images/873455113112666112/PBJskz-z_normal.jpg,33,114,61,1202,Pushpita_deb,
1134049078424162304,2021-08-17 22:52:16,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1427825645963386883,False,0,0,0,0,Newsfilter.io,Incyte to Present at Upcoming Investor Conference $INCY https://t.co/05s5SfPkCJ,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
227778014,2021-08-17 21:30:00,"INCY, BGNE, AGIO, ANAB, GRTS, ",,"buff.ly/3CXa04D, ",1427804945324122119,False,1,0,1,0,Buffer,"BioCentury‚Äôs latest biopharma Quick Takes: InnoCare gains China rights to Incyte‚Äôs Monjuvi. Plus: Neuroblastoma approval for BeiGene, priority review for Agios‚Äô mitapivat, Arctic Vision, Vectura, AnaptysBio and more. $INCY $BGNE $AGIO $ANAB $GRTS https://t.co/U1OnShmKzO",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
3460109487,2021-08-17 19:30:00,,,"endpts.com/sec-charges-fo‚Ä¶, ",1427774745324318723,False,1,0,0,1,TweetDeck,"Within minutes of receiving highly confidential news that Medivation would be acquired by Pfizer for $14 billion, Medivation exec Matthew Panuwat bought stock options in another mid-cap cancer drug developer, Incyte, whose value he thought would explode.

https://t.co/XaiCCMROEu",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
1408531432071319554,2021-08-17 19:15:20,"INCY, ",,"stockmacro.com/long-term-fore‚Ä¶, ",1427771051501555716,False,0,0,0,0,StockTwits Web,"Long-Term Forecasting of INCYTE CORPORATION $INCY August 2021
https://t.co/0reGr2BJk3",,,2021-06-25 17:04:33,,StockMacro,https://pbs.twimg.com/profile_images/1408531759529005057/mRCfj6CK_normal.png,45,0,0,11222,StockMacroDaily,
32492934,2021-08-17 18:15:00,,,"bioworld.com/articles/51052‚Ä¶, ",1427755868876001281,False,0,0,0,0,TweetDeck,Innocare licenses Monjuvi rights from Incyte in $118M heme/onc deal https://t.co/6XgxAxUX56,,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
75337774,2021-08-17 17:04:50,,,"statnews.com/pharmalot/2021‚Ä¶, ",1427738213582528514,False,0,0,0,0,Twitter for Android,Former Medivation exec charged with insider trading after buying stock ‚Äòwithin minutes‚Äô of... https://t.co/UFZ5HrBEbZ via @statnews,"statnews, ",,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
1280938376099741697,2021-08-17 16:59:04,,"iexStock, ","iexcloud.io, pic.twitter.com/fJtMiUhPAp, ",1427736759589384192,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-International Business Machines Corp.
-Dow Inc
-Biomarin Pharmaceutical Inc. - Registere
-Incyte Corp.
-Advanced Micro Devices Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/fJtMiUhPAp",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
3460109487,2021-08-17 15:30:00,,,"endpts.com/innocare-bags-‚Ä¶, ",1427714345719500800,False,0,0,0,0,TweetDeck,"InnoCare expanded their pipeline on Tuesday, striking a deal with Incyte for the Boston biotech‚Äôs newly US-approved CD-19 antibody Monjuvi.

https://t.co/QilwpZyAwQ",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
121158213,2021-08-17 15:08:34,"INCY, ",,"AlertTrade.us, ",1427708951777345537,False,0,0,0,0,dlvr.it,REVERSALtoUP: $INCY Incyte Corporation üì≥ TradeIdeas via ‚ü∂ https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161360,152443,2585,2462625,AlertTrade,
3290364847,2021-08-17 14:00:49,,,"buff.ly/37NYzyb, ",1427691904708263944,False,2,0,0,1,Buffer,The SEC alleges the former executive used confidential information acquired at Medivation to purchase stock options in Incyte. https://t.co/QtPB1dZ4IH,,,2015-07-24 12:09:35,,STAT,https://pbs.twimg.com/profile_images/1220049678420643841/00Z3yA4z_normal.png,160026,5239,4324,52578,statnews,
877728723579088897,2021-08-17 12:51:44,,,"endpts.com/innocare-bags-‚Ä¶, ",1427674518592569350,False,0,0,0,0,Twitter Web App,InnoCare to license in @Incyte anti-CD19 antibody Monjuvi for $35 million upfront payment and $82.5 million in milestone payment. https://t.co/f1F9iWwoUx,"Incyte, ",,2017-06-21 23:23:29,,Chinese Antibody Society,https://pbs.twimg.com/profile_images/1099878582229389318/oq-1DWvx_normal.png,186,216,3,733,ChineseAntibody,
1270220114340851712,2021-08-17 12:24:22,,"PharmaTwitter, MedTwitter, MedEd, ","bit.ly/More-Medical-H‚Ä¶, statnews.com/pharmalot/2021‚Ä¶, ",1427667628924022787,False,0,0,0,0,Automate.io,"Former Medivation exec charged with insider trading after buying stock 'within minutes' of learning of a deal

More medical news at https://t.co/0Knf9q4SKS
#PharmaTwitter #MedTwitter #MedEd
https://t.co/56mwR6ZD1z",,,2020-06-09 01:04:18,Look here üëâ,MedPub Pharmaceutical,https://pbs.twimg.com/profile_images/1443232668716515331/xzljON0s_normal.jpg,2,69,0,3346,PharmaPublisher,
4058194633,2021-08-17 12:21:07,"MOR, INCY, ","jobs, ","biospace.com/article/releas‚Ä¶, ",1427666813756661763,False,0,0,0,1,Twitter for iPhone,$MOR $INCY MorphoSys ' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China | BioSpace https://t.co/GJNqGX2QKI #jobs,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-08-17 12:13:21,"INCY, ",,"endpts.com/innocare-bags-‚Ä¶, ",1427664858867113988,False,0,0,0,0,Twitter for iPhone,$INCY Innocare bags Chinese rights to Incyte CAR-T rival Monjuvi in bid to expand in-house pipeline - https://t.co/DMtDhfP68Y,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-08-17 12:12:39,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1427664679753506821,False,0,0,0,0,Twitter for iPhone,$INCY Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China | Business Wire https://t.co/UIWMISuGI9,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-08-17 12:12:01,"INCY, ",,"joplinglobe.com/region/nationa‚Ä¶, ",1427664523763228683,False,0,0,0,0,Twitter for iPhone,https://t.co/de0E1Fxn5I | $INCY Incyte to Present at Upcoming Investor Conference,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
13171622,2021-08-17 12:10:32,"PFE, INCY, ","pharma, biotech, insidertrading, SECGOV, ","statnews.com/pharmalot/2021‚Ä¶, ",1427664149962690565,False,2,0,0,0,Twitter Web App,Former Medivation exec charged with insider trading after buying stock ‚Äòwithin minutes‚Äô of learning of a deal.. https://t.co/sEVyo3ADvv #pharma #biotech #insidertrading $PFE $INCY #SECGOV,,,2008-02-06 13:52:16,New Jersey & New York,pharmalot,https://pbs.twimg.com/profile_images/692789281404907520/zwDNx-Jn_normal.jpg,61528,1252,1851,15521,pharmalot,
3460109487,2021-08-17 12:10:09,,,"endpts.com/sec-charges-fo‚Ä¶, ",1427664051480498182,False,1,0,0,0,TweetDeck,"Within minutes of receiving highly confidential news that Medivation would be acquired by Pfizer for $14 billion, Medivation exec Matthew Panuwat bought stock options in another mid-cap cancer drug developer, Incyte, whose value he thought would explode.

https://t.co/XaiCCMAdMW",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
25560065,2021-08-17 11:00:07,,,"bizjournals.com/philadelphia/n‚Ä¶, ",1427646426482413568,False,0,0,0,0,True Anthem,A Wilmington biotech firm could collect more than $110 million from a new collaboration and license deal with a Chinese biopharm firm.  https://t.co/6tyOwlRAHZ,,,2009-03-20 15:31:03,Philadelphia,PHL Business Journal,https://pbs.twimg.com/profile_images/378800000077412316/8b22fbb8c4be97c69f048ff47fe712b6_normal.jpeg,35028,8899,1065,77326,PHLBizJournal,
1883393875,2021-08-17 10:02:06,,,"dlvr.it/S5pgQK, ",1427631827620073486,False,0,0,0,0,dlvr.it,Incyte and Innocare Announce Collaboration and License Agreement for Tafasitamab https://t.co/ChMY8Sp1Xc,,,2013-09-19 10:40:31,Amsterdam,Pharma Market News,https://pbs.twimg.com/profile_images/378800000501255643/53b0cadf7327b09ab8610040b07fcb10_normal.jpeg,1499,1215,21,7595,pharmamarketnws,
35789155,2021-08-17 09:39:09,"INCY, MOR, ",,"new.firstwordpharma.com/story/5376693, ",1427626052029984777,False,1,0,1,0,Twitter Web App,Incyte grants InnoCare rights for CD19-directed antibody tafasitamab in China $INCY $MOR https://t.co/84yxovtqpT,,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
3460109487,2021-08-17 08:12:14,,,"endpts.com/innocare-bags-‚Ä¶, ",1427604180848594964,False,0,0,0,0,TweetDeck,"InnoCare expanded their pipeline on Tuesday, striking a deal with Incyte for the Boston biotech‚Äôs newly US-approved CD-19 antibody Monjuvi. 

https://t.co/QilwpZyAwQ",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
976297820532518914,2021-08-17 08:07:08,,,"dlvr.it/S5pKn8, pic.twitter.com/mpgmBMq1C1, ",1427602897039024131,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conference https://t.co/1jznRcdRiD https://t.co/mpgmBMq1C1,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2021-08-17 08:04:03,,,"crweworld.com/article/news-p‚Ä¶, ",1427602118874079236,False,0,0,0,0,CRWE World,Incyte to Present at Upcoming Investor Conference https://t.co/kkw1uzCi2M,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1355194932445786112,2021-08-17 08:03:57,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1427602092613685275,False,0,0,0,0,Twitter,"$INCY Incyte to Present at Upcoming Investor Conference
https://t.co/hTGjrdcSy7",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1069693680066420736,2021-08-17 08:02:53,"INCY, ",,"s.flashalert.me/ivzHB, ",1427601824287186945,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on August 17, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/0wT7YNxGL7",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842260,FlashAlert_me,
1254035253104181256,2021-08-17 08:02:12,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1427601652236828674,False,0,0,0,0,stocktitan,"$INCY Incyte to Present at Upcoming Investor Conference
https://t.co/iPF7i596V9",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1325115160353103872,2021-08-17 08:00:37,"INCY, ",,"quantisnow.com/insight/167668‚Ä¶, ",1427601253920436228,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte to Present at Upcoming Investor Conference

https://t.co/fuqHl2miHk

30s delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1393303407801294850,2021-08-17 08:00:06,"INCY, ",,"webchronicletoday.com/incyte-to-pres‚Ä¶, ",1427601125365198849,False,0,0,0,0,Twitter,"$INCY Incyte to Present at Upcoming Investor Conference
 
https://t.co/5BvciR3fTY",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
1006334607946649600,2021-08-17 07:36:05,,"StockMarket, Stocks, ","dlvr.it/S5pDf1, pic.twitter.com/TaQW84SBZD, ",1427595081410760710,False,0,0,0,0,dlvr.it,Incyte Out Licenses Lymphoma Drug To InnoCare In Greater China https://t.co/pL2Il6ZXsf #StockMarket #Stocks https://t.co/TaQW84SBZD,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
133504478,2021-08-17 07:33:33,,"lucidquest, genetherapy, celltherapy, ","dlvr.it/S5pDDj, pic.twitter.com/U6u3m9GvUL, ",1427594444010782720,False,0,0,0,3,dlvr.it,Gene&amp;Cell Therapy &gt;&gt; InnoCare bags Chinese rights to Incyte CAR-T rival Monjuvi in bid to expand in-house pipeline: Merck veteran Jasmine Cui has turned Beijing-based InnoCare into a $4 billion company largely on the‚Ä¶ https://t.co/4vQGtTpe1m #lucidquest #genetherapy #celltherapy https://t.co/U6u3m9GvUL,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
46297868,2021-08-17 07:25:04,,,"dlvr.it/S5pBtK, ",1427592310229848064,True,0,0,0,0,dlvr.it,InnoCare bags Chinese rights to Incyte CAR-T rival Monjuvi in bid to expand in-house pipeline https://t.co/rHcPGYb9rh,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
72928001,2021-08-17 07:20:27,"INCY, ",,"bit.ly/3xNNFms, ",1427591148160241671,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte to collaborate with InnoCare for Tafasitamab in Greater China https://t.co/6cEf5wxlUu,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1171873456276889600,2021-08-17 07:05:50,"MOR, ","MOR, 6K, Morphosys, News, ","docoh.com/filing/1340243‚Ä¶, ",1427587467037876229,False,0,0,0,0,Investor Feed,"$MOR  6-K  Morphosys   (17 Aug, 7:04am)

üì∞ MorphoSys‚Äô Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China

https://t.co/b3vWkrEn3s

#MOR #6K #Morphosys #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
963495628545327104,2021-08-17 06:47:03,"INCY, INCY, ",,"stck.pro/news/INCY/1497‚Ä¶, stck.pro/news/INCY, pic.twitter.com/C35mqqIvyT, ",1427582742074638340,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Out Licenses Lymphoma Drug To InnoCare In Greater China https://t.co/mlV74txFW6 Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/C35mqqIvyT,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
98736295,2021-08-17 06:45:03,"INCY, INCY, ",,"tinyurl.com/ygfz6jk4, ",1427582239148281858,False,0,0,0,0,Benzinga.com,"$INCY, $INCY Incyte Out Licenses Lymphoma Drug To InnoCare In Greater China - https://t.co/yFsPuPHxTH",,,2009-12-22 17:40:36,,BenzingaWire,https://pbs.twimg.com/profile_images/1599159142/bztwitter_normal.png,4970,126,260,340311,BenzingaMedia,
1403008149020459013,2021-08-17 06:41:47,,,"ift.tt/3k5g16X, ",1427581416267821057,False,0,0,0,0,IFTTT,Incyte Out Licenses Lymphoma Drug To InnoCare In Greater China https://t.co/9wiFpOY4ip,,,2021-06-10 11:17:38,,Stock Market News,https://pbs.twimg.com/profile_images/1403010687564136462/3Z237JI4_normal.jpg,101,96,2,16360,AglowStockNews,
1136923823146721281,2021-08-17 06:09:32,"INCY, ",,,1427573300230868995,False,0,0,0,0,Twitter for iPhone,"Incyte and InnoCare have entered into a collaboration and license agreement for the development and commercialization of tafasitamab, a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, in Greater China. $INCY",,,2019-06-07 05:12:17,Stock-land ,MO$E,https://pbs.twimg.com/profile_images/1430500750195630088/Jk_vFf5N_normal.jpg,153,448,3,3854,tradingwithmose,
803682476350697472,2021-08-17 06:03:03,,,"healthtechnologynet.com/2021/08/17/mor‚Ä¶, pic.twitter.com/G6DzblRga0, ",1427571667388092418,False,0,0,0,0,HealthTechnologyNet,"MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China - https://t.co/btU8tznhlD and MUNICH, GERMANY / ACCESSWIRE / August 17, 2021 / MorphoSys AG (FSE:MOR; NASDAQ:MOR) announced today that Incyte, its dev... https://t.co/G6DzblRga0",,,2016-11-29 14:30:08,"Ohio, USA",Lou Wallace,https://pbs.twimg.com/profile_images/814921452986269696/3-dX3nNP_normal.jpg,187,216,0,70477,Dw40031913,photo
261473143,2021-08-17 05:24:16,,"InnoCare, ","morphosys.com/media-investor‚Ä¶, life-sciences-asia.com/news/vlfm-iito‚Ä¶, pic.twitter.com/q51VP5cdH6, ",1427561908190732294,False,0,0,0,0,Twitter Web App,MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China https://t.co/byzA1zBEOg @MorphoSys @Incyte #InnoCare More Asian life science business news at [LSA] at https://t.co/BOlw85yA1L https://t.co/q51VP5cdH6,"MorphoSys, Incyte, ",,2011-03-05 20:26:19,"Bremen, Germany",[iito] Life Science,https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_normal.jpeg,2596,238,89,29254,iitoLifeScience,photo
1889492676,2021-08-17 04:56:33,"INCY, ","Incyte, InnoCare, Tafasitamab, ","1stoncology.com/blog/incyteinn‚Ä¶, ",1427554935348948997,False,0,0,0,0,Troi URL Plug-in,#Incyte and #InnoCare Announce Collaboration and License Agreement for #Tafasitamab in Greater China $INCY https://t.co/NLua3wDtew,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1022473214457348096,2021-08-17 04:03:41,,,"pharmashots.com/63506/incyte-s‚Ä¶, ",1427541631268384772,False,0,0,0,0,Twitter Web App,"Incyte Signs a License Agreement with InnoCare to Develop and Commercialize Tafasitamab in Greater China @Pharmashot 
https://t.co/r6aKGnMF8a","Pharmashot, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
347315451,2021-08-17 03:46:38,,,"morphosys.com/media-investor‚Ä¶, ",1427537336464723968,False,2,0,0,1,Twitter Web App,"MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China
https://t.co/Y6N3TnF4Oo",,,2011-08-02 12:17:10,Berlin,BIO Deutschland,https://pbs.twimg.com/profile_images/801026554834878465/TZRcLWOl_normal.jpg,4612,2717,178,29124,BIODeutschland,
1006334607946649600,2021-08-17 03:34:06,,,"dlvr.it/S5nYvC, pic.twitter.com/JtpCw9T9c8, ",1427534183853821961,False,0,0,0,0,dlvr.it,MorphoSys‚Äô Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China https://t.co/giwutn5TST https://t.co/JtpCw9T9c8,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
1089978712685273090,2021-08-17 02:57:37,"INTC, ","Incyte, StockMarket, ","dlvr.it/S5nTRS, pic.twitter.com/d6kNoDcXP3, ",1427525004510470145,False,0,0,0,0,dlvr.it,MorphoSys‚Äô Partner #Incyte $INTC Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China https://t.co/2E7flRmElm #StockMarket https://t.co/d6kNoDcXP3,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,photo
1400873276243591170,2021-08-17 02:50:00,,,"newsfallout.com/morphosys-part‚Ä¶, ",1427523088103747598,False,0,0,0,0,WordPress.com,MorphoSys‚Äô Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China ‚Äì Stocks News¬†Feed https://t.co/eea30Yun5l,,,2021-06-04 13:53:19,,News Fall Out,https://pbs.twimg.com/profile_images/1400873499732975621/nLAwpfIQ_normal.jpg,198,553,1,46849,NewsFallOut1,
963495628545327104,2021-08-17 02:33:03,"MOR, MOR, ",,"stck.pro/news/MOR/14969‚Ä¶, stck.pro/news/MOR, pic.twitter.com/q0ycKNK7xd, ",1427518820307152908,False,0,0,0,0,STCK.PR0,$MOR NEW ARTICLE : MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China https://t.co/GZWAg9P3vG Get all the latest $MOR related news here : https://t.co/8LQdYyvKJN https://t.co/q0ycKNK7xd,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1355194932445786112,2021-08-17 02:32:32,"MOR, ",,"stocktitan.net/news/MOR/morph‚Ä¶, ",1427518689340010498,False,0,0,0,0,Twitter,"$MOR MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China
https://t.co/uCF5jIcBhf",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
3318510966,2021-08-17 02:31:53,,,"crweworld.com/article/news-p‚Ä¶, ",1427518528395964421,False,0,0,0,0,CRWE World,MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Gre https://t.co/paztGzM1Jl,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1325115160353103872,2021-08-17 02:31:04,"MOR, ",,"quantisnow.com/insight/167558‚Ä¶, ",1427518321738485764,False,0,0,0,0,Twitter,"$MOR üì∞ MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China

https://t.co/xqYJEFZHIs

30s delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1254035253104181256,2021-08-17 02:30:46,"MOR, ",,"stocktitan.net/news/MOR/morph‚Ä¶, ",1427518245632978951,False,0,0,0,0,stocktitan,"$MOR MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China
https://t.co/iiioCd2Uwy",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
2368733657,2021-08-17 02:30:34,"MOR, ",,,1427518195964031014,False,0,0,1,0,Twitter,First out// $MOR: MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater,,,2014-02-27 05:32:16,US markets üëâ,Marketbit.pro,https://pbs.twimg.com/profile_images/1368821546454835202/14UYpgh2_normal.png,1393,587,55,28252,bthefirsttoknow,
266143766,2021-08-17 02:30:31,"MOR, ",,"accesswire.com/660084/MorphoS‚Ä¶, ",1427518182198325262,False,0,0,0,0,Accesswire,$MOR MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab ... https://t.co/bF66sPWrKg,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
31720614,2021-08-17 02:28:25,,"PharmaNews, ClinicalResearchNews, BiotechNews, LifeSciencesNews, MedicalNews, HealthcareNews, PharmiwebNews, ","zpr.io/ACGibrPgRYaQ, pic.twitter.com/wJHCT2KLfx, ",1427517655561515021,False,0,0,0,0,Zapier.com,"MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China
https://t.co/yPtv9JuIIc
#PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/wJHCT2KLfx",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,photo
270492072,2021-08-17 02:24:53,,"news, SeekingAlpha, ","seekingalpha.com/news/3731224-i‚Ä¶, ",1427516765077008387,False,0,0,0,0,Microsoft Power Platform,Incyte inks tafasitamab licensing deal with InnoCare in Greater China https://t.co/syq5ZaMsRO via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
31372539,2021-08-17 02:15:33,,,"dlvr.it/S5nPLs, pic.twitter.com/fIWPaggoUU, ",1427514415939604484,False,0,0,0,0,dlvr.it,Incyte inks tafasitamab licensing deal with InnoCare in Greater China https://t.co/nPRvuNhs73 https://t.co/fIWPaggoUU,,,2009-04-15 05:08:17,Amsterdam,Stocks tweets,https://pbs.twimg.com/profile_images/138834360/stocks1-avatar_normal.jpg,4407,3020,91,70157,stocks_tweets,photo
1184025479084331008,2021-08-17 02:13:26,"INCY, ",,"pic.twitter.com/Gg9zXyRu28, ",1427513883900751908,False,0,0,0,0,pythonmehabe,$INCY @ 73.99 - Incyte inks tafasitamab licensing deal with InnoCare in Greater China https://t.co/Gg9zXyRu28,,,2019-10-15 04:37:33,Germany,Jeremy,https://pbs.twimg.com/profile_images/1242903623446626304/g1A5BLr2_normal.jpg,2523,2,61,191178,mehabecapital,photo
42410755,2021-08-17 02:08:29,,,"dgap.de/dgap/News/corp‚Ä¶, ",1427512639035519004,False,0,1,0,0,DGAP_News_Int,MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Ta... https://t.co/fiimgMd6dX,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
1270010326600126464,2021-08-17 02:07:44,"INCY, ",,"newsfilter.io/a/605a32da9fe7‚Ä¶, ",1427512448303738903,False,1,0,0,0,StockTwits Web,"$INCY 
Incyte inks tafasitamab licensing deal with InnoCare in Greater China

https://t.co/uerNxXsxwU",,,2020-06-08 11:10:55,iTRaDe Anything That Makes üí∞,üòàFearLessTRaDeR.2.0‚ôªÔ∏è,https://pbs.twimg.com/profile_images/1452038311007031302/ZE--wsKU_normal.jpg,1935,222,34,9034,FearLessTraDeRx,
1315434407692509184,2021-08-17 02:07:04,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/hSX6b00n77, ",1427512281953447939,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 2.60% ranked 2969 out of 5575 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/hSX6b00n77",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1134049078424162304,2021-08-17 02:04:07,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1427511540803153925,False,0,0,0,0,Newsfilter.io,Incyte inks tafasitamab licensing deal with InnoCare in Greater China $INCY https://t.co/kZ5bpsuwbg,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
15296897,2021-08-17 02:03:21,"INCY, ",,"seekingalpha.com/news/3731224-i‚Ä¶, ",1427511348032786436,False,0,0,0,0,SANewsTwitter,$INCY - Incyte inks tafasitamab licensing deal with InnoCare in Greater China https://t.co/suc5YwepXW,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
2848493747,2021-08-16 20:44:36,,,"twitter.com/BioBonanos/sta‚Ä¶, ",1427431131142516755,False,2,0,0,0,Twitter Web App,"InnoCare will pay Incyte $35 million up front, and Incyte is eligible to receive up to an additional $82.5 million https://t.co/GktBY8BhCx",,,2014-10-28 13:19:58,"San Carlos, Calif.",Jeff Cranmer,https://pbs.twimg.com/profile_images/1009677183877447680/76chZHUe_normal.jpg,1807,1102,57,3932,jeff_cranmer,
963495628545327104,2021-08-16 20:42:16,"INCY, INCY, ",,"stck.pro/news/INCY/1496‚Ä¶, stck.pro/news/INCY, pic.twitter.com/XNONHGhxka, ",1427430543835205633,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China https://t.co/XNdXRzdpdx Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/XNONHGhxka,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
2274838086,2021-08-16 20:14:39,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1427423593357586433,False,3,1,0,0,Twitter Web App,Greater China deal for Incyte's tafasitamab (CD19); InnoCare pays $35m up front $INCY https://t.co/xukcdFs11C,,,2014-01-03 12:39:31,,Paul Bonanos,https://pbs.twimg.com/profile_images/438472546187345920/0GrOUC2f_normal.jpeg,538,232,23,1004,BioBonanos,
3686628867,2021-08-16 20:12:09,,,"pharmaceuticaldaily.com/incyte-and-inn‚Ä¶, ",1427422963951824923,False,0,0,0,0,WordPress.com,Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater¬†China https://t.co/uheMQgFaMt,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1006334607946649600,2021-08-16 19:49:43,,"StockMarket, Stocks, ","dlvr.it/S5mkyH, ",1427417316615090186,False,0,0,0,0,dlvr.it,Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China https://t.co/gUkXgEpPJH #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1281758467036811264,2021-08-16 19:41:13,,,"dataemia.com/?p=548639, pic.twitter.com/WBm40Za4Jr, ",1427415181328519173,False,0,0,0,0,MasMaz,Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China - https://t.co/kmmJN6UA2F https://t.co/WBm40Za4Jr,,,2020-07-10 21:13:35,United States ,MasMaz,https://pbs.twimg.com/profile_images/1297036654163582981/IWV5OJ_7_normal.jpg,62,0,1,83701,MasMazCom,photo
360220091,2021-08-16 19:41:13,,,"dataemia.com/?p=548639, pic.twitter.com/llPTjbI86P, ",1427415178963005447,False,0,0,0,0,Newsemia,Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China - https://t.co/F4SOGYhmUM https://t.co/llPTjbI86P,,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,photo
2520259915,2021-08-16 19:40:41,,,"headlinesoftoday.com/topic/press-re‚Ä¶, ",1427415045974208515,False,0,0,0,0,WordPress.com,Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater¬†China https://t.co/BJgUoThlks,,,2014-05-24 07:25:13,world news,The Headlines of Today,https://pbs.twimg.com/profile_images/1357683014445248515/4WmoFCSh_normal.jpg,289,1542,6,21393,HeadlinesOT,
3318510966,2021-08-16 19:11:35,,,"crweworld.com/article/news-p‚Ä¶, ",1427407720332750848,False,0,0,0,0,CRWE World,Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China https://t.co/L3hWt6gi58,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1269758829690052610,2021-08-16 19:07:57,"INCY, ",,,1427406809334231040,False,0,0,0,0,Zapier.com,"Incyte, InnoCare announces license agreement for tafasitamab in Greater China
$INCY",,,2020-06-07 18:31:22,"Manhattan, NY",63 Hyacinth,https://pbs.twimg.com/profile_images/1426268301055991816/PYXXE_KD_normal.jpg,1567,0,17,32978,63_hyacinth,
472650465,2021-08-16 19:07:24,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1427406668288122884,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China https://t.co/SHkJPLMG7m,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
976297820532518914,2021-08-16 19:03:10,,,"dlvr.it/S5mdnr, pic.twitter.com/fXwsCermzr, ",1427405601848455168,False,0,0,0,0,dlvr.it,Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China https://t.co/NPjxujfW1J https://t.co/fXwsCermzr,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2021-08-16 19:02:53,"INCY, ",,"s.flashalert.me/Fk3NkB, ",1427405530969018369,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on August 16, 19:00:00: Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China https://t.co/tqU9bR9TlD",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842260,FlashAlert_me,
1355194932445786112,2021-08-16 19:02:42,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1427405487256084481,False,0,0,0,0,Twitter,"$INCY Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China
https://t.co/6enTAaWuuV",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1134049078424162304,2021-08-16 19:01:07,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1427405089703145478,False,0,0,0,0,Newsfilter.io,Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China $INCY https://t.co/JrJVh4wB3e,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
1254035253104181256,2021-08-16 19:00:57,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1427405046384406532,False,0,0,0,0,stocktitan,"$INCY Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China
https://t.co/rwbS29TrQN",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1393303407801294850,2021-08-16 19:00:04,"INCY, ",,"webchronicletoday.com/incyte-and-inn‚Ä¶, ",1427404824367280132,False,0,0,0,0,Twitter,"$INCY Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China
 
https://t.co/VjbOG6lnHu",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
374729426,2021-08-16 11:49:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2955268, pic.twitter.com/ZyoldMSrSU, ",1427296545154605057,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on August 3, 2021. View odds for this and other indicators: https://t.co/VlSQS2HGVE #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZyoldMSrSU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
963495628545327104,2021-08-15 16:11:02,"BMY, BMYMP, INCY, BMY, ",,"stck.pro/news/BMY/14945‚Ä¶, stck.pro/news/BMY, ",1426999897115533314,False,0,0,1,0,STCK.PR0,$BMY $BMYMP $INCY NEW ARTICLE : Incyte: Undervalued And Expecting FDA Feedback In H2 2021 https://t.co/QnxT9WCc0Q Get all the latest $BMY related news here : https://t.co/D2ueQdp2M0,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
1134049078424162304,2021-08-15 16:09:02,"BMY, BMYMP, INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1426999395623579655,False,0,0,3,0,Newsfilter.io,Incyte: Undervalued And Expecting FDA Feedback In H2 2021 $BMY $BMYMP $INCY https://t.co/2gxH8GvWEy,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880676,newsfilterio,
23059499,2021-08-15 16:08:41,"INCY, ","finance, markets, stockmarket, ","seekingalpha.com/article/444957‚Ä¶, ",1426999306418982912,False,1,0,1,0,SAArticlesTwitter,$INCY - Incyte: Undervalued And Expecting FDA Feedback In H2 2021. https://t.co/6tWyWRwvax #finance #markets #stockmarket,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
23059499,2021-08-14 10:01:30,"INCY, ","finance, stocks, economy, ","seekingalpha.com/article/444949‚Ä¶, ",1426544513112186883,False,1,0,0,0,SAArticlesTwitter,"$INCY - Incyte: Not Exciting Yet, But Perhaps To Come. https://t.co/APmuxu0PEY #finance #stocks #economy",,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1408531432071319554,2021-08-12 16:30:25,"INCY, ",,"stockmacro.com/long-term-fore‚Ä¶, ",1425917610923790344,False,0,0,0,0,StockTwits Web,"Long-Term Forecasting of INCYTE CORPORATION $INCY August 2021
https://t.co/0reGr2BJk3",,,2021-06-25 17:04:33,,StockMacro,https://pbs.twimg.com/profile_images/1408531759529005057/mRCfj6CK_normal.png,45,0,0,11222,StockMacroDaily,
374729426,2021-08-12 01:48:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2947289, pic.twitter.com/VRCTzrOdi0, ",1425695660582395907,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/Qnz2EFuZBS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/VRCTzrOdi0,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1264979150676295680,2021-08-11 15:48:42,"INCY, ","Incyte, ","pic.twitter.com/bIfu2mzdc2, ",1425544724602032141,False,0,0,0,0,Twitter Web App,"$INCY  weekly
#Incyte Corp https://t.co/bIfu2mzdc2",,,2020-05-25 13:58:56,Trade What's Happening.......,Fillona De Gap,https://pbs.twimg.com/profile_images/1420449707575455751/-YE5U3JP_normal.jpg,257,2539,2,701,FillonaDeGap,photo
285835021,2021-08-11 15:28:25,,,"bit.ly/3CG2Lhl, pic.twitter.com/pfnFaeMFQh, ",1425539619899203584,False,1,0,0,0,Meltwater Social,"The 1st Green Globes for EB 2021 certification was awarded to @Incyte, earning Three Green Globes. Taylor McCracken, facilities lead, valued the collaborative nature of the process which helps teams back sustainability goals with meaningful action. More at https://t.co/bgYgWfiBH8 https://t.co/pfnFaeMFQh","Incyte, ",,2011-04-21 17:41:20,"Portland, Oregon",Green Building Initiative,https://pbs.twimg.com/profile_images/1088845506539704320/j4W6SbSF_normal.jpg,774,332,30,292,TheGBIorg,photo
30005320,2021-08-11 14:55:39,,,"pharmiweb.jobs/job/1193662/in‚Ä¶, ",1425531374270926850,False,0,0,0,0,Madgex Twitter Tweeter,"In-house Clinical Research Associate - Incyte - Remote-Belgium, BE;Homeworking - Advanced Clinical https://t.co/udTZw3XW3N",,,2009-04-09 11:33:38,UK,PharmiWeb Jobs,https://pbs.twimg.com/profile_images/595963733047975936/aa7m_k97_normal.png,1554,250,76,165145,PharmiWebJobs,
30005320,2021-08-11 14:55:38,,,"pharmiweb.jobs/job/1193660/in‚Ä¶, ",1425531372341444612,False,0,0,0,0,Madgex Twitter Tweeter,"In-house Clinical Research Associate - Incyte - London, UK;Homeworking - Advanced Clinical https://t.co/XqcwNeLd5n",,,2009-04-09 11:33:38,UK,PharmiWeb Jobs,https://pbs.twimg.com/profile_images/595963733047975936/aa7m_k97_normal.png,1554,250,76,165145,PharmiWebJobs,
56791082,2021-08-11 03:55:43,,,"pharmiweb.jobs/job/1193662/in‚Ä¶, ",1425365298706882562,False,0,0,0,0,Madgex Twitter Tweeter,"In-house Clinical Research Associate - Incyte - Remote-Belgium, BE;Homeworking - Advanced Clinical https://t.co/4aBQtcEcSC",,,2009-07-14 15:34:33,"Belgium, UK",Pharma Jobs in Belgium on PharmiWeb,https://pbs.twimg.com/profile_images/1189917628082597893/-NZDLFC9_normal.jpg,85,0,9,19134,PW_BE,
1280938376099741697,2021-08-11 01:13:45,,"iexStock, ","iexcloud.io, pic.twitter.com/CXiJx9miee, ",1425324538900975617,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Chevron Corp.
-Apple Inc
-Lam Research Corp.
-Synopsys, Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/CXiJx9miee",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
782954815739527168,2021-08-10 22:54:06,,,"dlvr.it/S5QHWd, ",1425289392202022916,False,0,0,0,0,dlvr.it,"Director to Sr. Director, Clinical Research Scientist - Incyte Corporation - Wilmington, DE https://t.co/DUiUu4co7Y",,,2016-10-03 10:45:49,"Washington, DC",Clinical Research Forum,https://pbs.twimg.com/profile_images/793945936200351744/foN7mcbj_normal.jpg,345,452,1,1449,CRForumUS,
1298516232140972038,2021-08-10 15:00:03,"INCY, ",,"tobaia.com/app/instrument‚Ä¶, ",1425170095127638017,False,0,0,0,0,Twitter,New Short opportunity for Incyte Corporation $INCY at 74.75$. More information of the event and live risk management at https://t.co/9nSmY4jwmV,,,2020-08-26 03:03:39,Global,Tobaia,https://pbs.twimg.com/profile_images/1298517759895252992/GrTPQaSE_normal.jpg,58,36,0,2601,Tobaia_com,
1156133747852374016,2021-08-10 10:16:29,,"FDA, Retifanlimab, Keytruda, Lenvima, EndometrialCancer, ",,1425098732060692491,False,1,0,1,0,Twitter Web App,"Recent Pharma News and Updates:
#FDA Issues a Complete Response Letter (CRL) to @Incyte's #Retifanlimab for Locally Advanced or Metastatic Squamous Cell Carcinoma of the Anal Canal Subgroup.

#Keytruda/#Lenvima Combo Dazzles with Regular Approval in #EndometrialCancer. (1/2)","Incyte, ",,2019-07-30 05:25:40,New Delhi,DelveInsight,https://pbs.twimg.com/profile_images/1222806973487255552/pWZKXuZ9_normal.jpg,122,1363,1,2930,delve_insight,
374729426,2021-08-10 07:22:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2942975, pic.twitter.com/xBNB28pQ0F, ",1425054982143832072,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/Zf0X3bgfCB #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xBNB28pQ0F,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
812004702594486272,2021-08-10 05:00:55,,,"checkrare.com/interim-data-g‚Ä¶, ",1425019316337053697,False,0,0,0,0,Hootsuite Inc.,"Peter Langmuir, MD, Group Vice President, Oncology Targeted Therapeutics at Incyte, discusses interim data of a phase 2 study assessing the combination of ruxolitinib and parsaclisib in patients with myelofibrosis. 
@Incyte 
https://t.co/S1bQKb0jFy","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1979190776,2021-08-10 03:12:59,"INCY, ",,"tickerreport.com/?p=7750687, ",1424992154041081874,False,0,0,0,0,Zapier.com,FY2021 Earnings Estimate for Incyte Co. $INCY Issued By Cantor Fitzgerald https://t.co/eNj994FUDR,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
4035355935,2021-08-10 00:52:24,,,,1424956776953171977,False,0,0,0,0,WPTS Playlist,Incyte - The Slide,,,2015-10-24 21:01:50,"Pittsburgh, PA",WPTS Playlist,https://pbs.twimg.com/profile_images/658129792408023041/8nflCFL-_normal.jpg,478,5,38,638221,WPTSPlaylist,
1423706911162122249,2021-08-09 17:07:09,,"news, stocks, ","dlvr.it/S5L8xP, ",1424839693863055375,False,0,0,0,0,dlvr.it,Oversold Conditions For Incyte (INCY) https://t.co/SU0VEoexck #news #stocks,,,2021-08-06 14:06:01,,StocksDatabase,https://pbs.twimg.com/profile_images/1423735858751057920/_mywTOLQ_normal.jpg,5,98,1,3003,StocksDatabase,
1298516232140972038,2021-08-09 12:40:02,"INCY, ",,"tobaia.com/app/instrument‚Ä¶, ",1424772469030850567,False,0,0,0,0,Twitter,New Short opportunity for Incyte Corporation $INCY at 75.74$. More information of the event and live risk management at https://t.co/9nSmY4jwmV,,,2020-08-26 03:03:39,Global,Tobaia,https://pbs.twimg.com/profile_images/1298517759895252992/GrTPQaSE_normal.jpg,58,36,0,2601,Tobaia_com,
585864688,2021-08-09 11:10:28,,"MPN, ","pic.twitter.com/7gAedYIkP6, ",1424749927889088516,False,31,0,0,3,Twitter for iPad,"More powerful stories from the myeloproliferative neoplasm (#MPN) community. Kathryn is an avid hiker who doesn‚Äôt let her polycythemia vera (PV) stop her from hitting the trails. To learn more @VoicesofMPN Rare Reflections Virtual Gallery, created in partnership with @Incyte. https://t.co/7gAedYIkP6","VoicesofMPN, Incyte, ",,2012-05-20 14:03:10,Philadelphia,JG Bones,https://pbs.twimg.com/profile_images/1444676776534364162/y8PGfv32_normal.jpg,3534,1073,56,4086,JG_JONESfanpage,photo
505056659,2021-08-09 08:40:04,,,"dlvr.it/S5Jl69, ",1424712078422544385,False,0,0,0,0,dlvr.it,"Gs Investments, Inc. Buys Facebook Inc, Incyte Corp, Alphabet Inc, Sells ATT Inc (GuruFocus) https://t.co/EZr2Cx9qSr",,,2012-02-26 16:56:35,San Francisco,TIN-Facebook News,https://pbs.twimg.com/profile_images/1907875735/TINFavicon2012-FINAL_normal.png,86,0,28,63211,TINFacebookNews,
172288755,2021-08-08 20:48:35,,,"fiercepharma.com/pharma/despite‚Ä¶, ",1424533029779763202,False,0,0,0,1,Twitter Web App,"Despite FDA holdups, Incyte's still counting on timely Jakafi, ruxolitinib cream verdicts https://t.co/5gvFljfMD8",,,2010-07-29 06:10:36,"Yong-In city, Korea",Kyung Seok Lee,https://pbs.twimg.com/profile_images/922433020748898305/cjOW-D4X_normal.jpg,17,60,0,646,ksloveis,
782954815739527168,2021-08-07 22:39:04,,,"dlvr.it/S5F0Q0, ",1424198444663468036,False,0,0,0,0,dlvr.it,"Director, Clinical Research Scientist - Incyte Corporation - Wilmington, DE https://t.co/16Ud3ScJ1w",,,2016-10-03 10:45:49,"Washington, DC",Clinical Research Forum,https://pbs.twimg.com/profile_images/793945936200351744/foN7mcbj_normal.jpg,345,452,1,1449,CRForumUS,
1322959497611063299,2021-08-07 12:03:07,,,"pic.twitter.com/KsY5mvOwo0, ",1424038404585631745,False,0,0,0,0,LaterMedia,"We are motivated knowing that our researchers aren‚Äôt the only ones looking for answers. No matter how difficult the challenge is, at Incyte, we use sound science to seek the right potential solutions. We exist to Solve On. https://t.co/KsY5mvOwo0",,,2020-11-01 12:52:07,,Biotech Planet,https://pbs.twimg.com/profile_images/1449376776463998979/u5LtKQFy_normal.jpg,4,8,0,49,biotech_planet,video
963495628545327104,2021-08-07 08:11:03,"INCY, INCY, ",,"stck.pro/news/INCY/1480‚Ä¶, stck.pro/news/INCY, pic.twitter.com/vXvWR9Gx2z, ",1423980001305706497,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Is the PD-(L)1 Party Over After Incyte's FDA Rejection? https://t.co/0Cbs1SOboY Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/vXvWR9Gx2z,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
94794805,2021-08-06 17:29:08,,,"hospimedica.com/covid-19/artic‚Ä¶, pic.twitter.com/9bJDAlSzlp, ",1423758059906686985,False,0,0,0,0,Globetech twi-connect,Eli Lilly and Incyte‚Äôs Baricitinib Reduces Deaths among COVID-19 Patients Receiving Invasive Mechanical... https://t.co/wfPnTYAIFS https://t.co/9bJDAlSzlp,,,2009-12-05 08:48:51,,HospiMedica.com,https://pbs.twimg.com/profile_images/843924355079979009/StpNpJz7_normal.jpg,901,0,14,6177,HospiMedica,photo
61023114,2021-08-06 16:25:59,,"CIFBiopharma, ","pic.twitter.com/XvyKB6sAH6, ",1423742167680487424,False,1,0,0,1,Twitter Web App,"Over the past few weeks, we have been sharing clips from our #CIFBiopharma event in June. Today we culminate the series by sharing some advice for in-house research from @IloveIncyte, CEO of @Incyte. Why is in-house research fundamental? Why is it good for business? Find out üëáüèº https://t.co/XvyKB6sAH6","IloveIncyte, Incyte, ",,2009-07-28 17:24:06,"New York, NY",CECP,https://pbs.twimg.com/profile_images/1443296993779101701/oJqtOdc-_normal.jpg,7728,3053,388,14477,CECPtweets,video
121193853,2021-08-06 13:45:02,,,"dlvr.it/S59NyX, ",1423701663156609024,False,0,0,0,0,dlvr.it,"New job posting:  New job posting:  Research Scientist, In Vitro Pharmacology (Contract) - Incyte Corporation - Wilmington, DE https://t.co/jZMWhkFX0I",,,2010-03-08 13:38:25,"Alexandria, VA",ASCPT Alexandria,https://pbs.twimg.com/profile_images/887708754527088640/WMcvsw3m_normal.jpg,1524,328,20,8323,ASCPT_ClinPharm,
2891146588,2021-08-06 10:04:31,,,"bit.ly/3iwPqAh, ",1423646167364157443,False,11,1,2,4,Twitter Web App,Sponsors of new cancer therapies made clinical trial enrollment easier during Covid. BriaCell is currently employing these strategies for its Phase I/II clinical trial of Bria-IMT‚Ñ¢ combination study with Incyte‚Äôs drugs. https://t.co/z0ZQNcjwqn,,,2014-11-24 13:16:48,"New York, NY",BriaCell,https://pbs.twimg.com/profile_images/1433876026656952323/yM_H4sLw_normal.jpg,1215,551,9,477,BriaCell,
766772674504826880,2021-08-06 08:00:39,"INCY, ","INCY, Healthcarestocks, stockstowatch, StocksToTrade, ","ow.ly/UgAZ50FJ2DO, pic.twitter.com/o5jmTheHX6, ",1423614998270595077,False,0,0,0,0,Hootsuite Inc.,"Incyte Stocks Make It on Today‚Äôs Healthcare Watchlist

These 7 stocks are on our Healthcare Stock Watchlist for today.  They are showing Bullish Investor Sentiment and generating media buzz.

https://t.co/MHY5HcnxSL

$INCY #INCY #Healthcarestocks #stockstowatch #StocksToTrade https://t.co/o5jmTheHX6",,,2016-08-19 19:03:46,,Editor Politics,https://pbs.twimg.com/profile_images/1388118346491645953/GMRpNc85_normal.jpg,16,68,0,1564,editorpamp,photo
374729426,2021-08-05 15:52:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2932491, pic.twitter.com/MxxHD5dzH2, ",1423371378229538817,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on July 2, 2021. View odds for this and other indicators: https://t.co/tyRqZBVmFv #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MxxHD5dzH2",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
325135887,2021-08-05 12:25:00,"INCY, ","dermatology, eczema, FDA, ","bit.ly/3yoIBGj, ",1423319134369103874,False,1,0,0,0,Twitter Web App,"Despite FDA holdups, Incyte's still counting on timely Jakafi, ruxolitinib cream verdicts! While the execs have voiced optimism, there's still reason to question whether the approvals will come in September! $INCY #dermatology #eczema #FDA 
https://t.co/7e32DNasbt",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
2570920968,2021-08-05 12:25:00,"INCY, ","dermatology, eczema, FDA, ","bit.ly/3yoIBGj, ",1423319134197018630,False,2,0,0,0,Twitter Web App,"Despite FDA holdups, Incyte's still counting on timely Jakafi, ruxolitinib cream verdicts! While the execs have voiced optimism, there's still reason to question whether the approvals will come in September! $INCY #dermatology #eczema #FDA 
https://t.co/UoTVxYg6b4",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
2570920968,2021-08-05 09:30:00,"INCY, ","dermatology, eczema, FDA, ","bit.ly/3yoIBGj, ",1423275095913639941,False,3,0,0,0,Twitter Web App,"Despite FDA holdups, Incyte's still counting on timely Jakafi, ruxolitinib cream verdicts! While the execs have voiced optimism, there's still reason to question whether the approvals will come in September! $INCY #dermatology #eczema #FDA 
https://t.co/UoTVxYxHzE",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
1883393875,2021-08-05 06:01:05,,,"dlvr.it/S54XsD, ",1423222518140178434,False,0,0,0,0,dlvr.it,Lilly and Incyte's baricitinib reduced deaths among COVID-19 patients https://t.co/tKVSH4hKwv,,,2013-09-19 10:40:31,Amsterdam,Pharma Market News,https://pbs.twimg.com/profile_images/378800000501255643/53b0cadf7327b09ab8610040b07fcb10_normal.jpeg,1499,1215,21,7595,pharmamarketnws,
2181281054,2021-08-05 03:39:29,"INCY, ","markets, ","wkrb13.com/?p=3421053, ",1423186882758909952,False,0,0,0,0,Zapier.com,Incyte Target of Unusually High Options Trading $INCY https://t.co/x5CuYeldH2 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1889492676,2021-08-05 03:24:38,,"Incyte, TABRECTA, ","1stoncology.com/blog/incyte-re‚Ä¶, ",1423183148301516803,False,0,0,0,0,Troi URL Plug-in,#Incyte World-Wide Sales for #TABRECTA was 2.48m USD in Q2 2021 (Up 251%) https://t.co/sxGIzKvbuT,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2021-08-05 03:15:08,,"Incyte, PEMAZYRE, ","1stoncology.com/blog/incyte-re‚Ä¶, ",1423180754805084160,False,0,0,0,0,Troi URL Plug-in,#Incyte World-Wide Sales for #PEMAZYRE was 17.91m USD in Q2 2021 (Up 373%) https://t.co/sxGIzKvbuT,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1399103920522334219,2021-08-04 14:20:08,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/mFdYpYUI33, ",1422985721040736259,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2338 out of 5568 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/mFdYpYUI33",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
4058194633,2021-08-04 12:59:07,"INCY, ",,"fiercepharma.com/pharma/despite‚Ä¶, ",1422965334055653378,False,0,0,0,0,Twitter for iPhone,"$INCY Despite FDA holdups, Incyte's still counting on timely Jakafi, ruxolitinib cream verdicts https://t.co/t5ISo206Xh",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1298516232140972038,2021-08-04 12:00:02,"INCY, ",,"tobaia.com/app/instrument‚Ä¶, ",1422950463901773827,False,0,0,0,0,Twitter,New Short opportunity for Incyte Corporation $INCY at 77.79$. More information of the event and live risk management at https://t.co/8ONpcT82t8,,,2020-08-26 03:03:39,Global,Tobaia,https://pbs.twimg.com/profile_images/1298517759895252992/GrTPQaSE_normal.jpg,58,36,0,2601,Tobaia_com,
25406480,2021-08-04 11:47:00,,,"awesomecapital.blogspot.com/2021/08/incyte‚Ä¶, ",1422947186296377346,False,0,0,0,1,Twitter Web App,"AwesomeCapital: Incyte's still counting on timely Jakafi, ruxoliti... https://t.co/NPHW40Kv3z",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
46297868,2021-08-04 11:19:05,,,"dlvr.it/S52057, ",1422940158798618624,True,0,0,0,0,dlvr.it,"Despite FDA holdups, Incyte's still counting on timely Jakafi, ruxolitinib cream verdicts https://t.co/LHZcR9J0no",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
121158213,2021-08-04 10:07:10,"INCY, ",,"dlvr.it/S51mCH, AlertTrade.us, ",1422922060519542798,False,0,0,0,0,dlvr.it,REVERSALtoUP: $INCY Incyte Corporation Common Stock https://t.co/x5T1J7UFl4 üì≥ TradeIdeas via ‚ü∂ https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
59310742,2021-08-04 10:04:34,,,"dlvr.it/S51lfS, pic.twitter.com/NO48vGQyQZ, ",1422921404182241281,False,0,0,0,0,dlvr.it,Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation https://t.co/eOQhC1igsF https://t.co/NO48vGQyQZ,,,2009-07-22 20:57:49,ANZ,David Ledger,https://pbs.twimg.com/profile_images/621209163566182400/AWY0hAql_normal.jpg,826,1827,26,25935,Vedere_Group,photo
108617488,2021-08-04 08:30:07,,,"invst.ly/vn008, ",1422897636454117378,False,0,0,0,0,FP News Publisher - COM,Leerink Partners Stick to Their Sell Rating for Incyte Corp - https://t.co/6ZExop2Y4k,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
1273844033861844993,2021-08-04 06:00:15,"INCY, ",,"pic.twitter.com/PHM4D74Z7j, ",1422859923009032193,False,0,0,0,0,StockTwits Web,"$INCY [Incyte]: SVB Leerink Maintains Underperform Lowers Price Target $70 --&gt; 67 
charts: courtesy of finviz https://t.co/PHM4D74Z7j",,,2020-06-19 01:04:32,United States,Jarvis-Alerts,https://pbs.twimg.com/profile_images/1374794584513986568/eWDm8YFI_normal.jpg,4169,102,79,63687,Jarvis_Alerts,photo
1325115160353103872,2021-08-04 04:47:58,"INCY, ",,"quantisnow.com/insight/161340‚Ä¶, ",1422841729984602113,False,0,0,0,0,Twitter,"$INCY üì° SVB Leerink reiterated coverage on Incyte with a new price target

https://t.co/GF4J7AWjdN

30s delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1134049078424162304,2021-08-04 04:47:47,"INCY, ",,,1422841687055945736,False,0,0,0,0,Newsfilter.io,$INCY SVB Leerink analyst Andrew Berens maintains Incyte with a Underperform and lowers the price target from $70 to $67.,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
2298709746,2021-08-04 04:40:47,"INCY, ",,"zpr.io/9vtEYiNPmUnt, ",1422839923015626753,False,0,0,0,0,Zapier.com,"Vijay K. Iyengar Sells 4,911 Shares of Incyte Co. $INCY Stock https://t.co/p90F8oxJlL",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
252546993,2021-08-04 04:09:55,,,"pharmaceutical-technology.com/news/lilly-inc‚Ä¶, ",1422832156636745730,False,1,0,0,0,Twitter Web App,"Eli Lilly and Incyte have reported new data from Phase III COV-BARRIER sub-study, where baricitinib lowered mortality risk in Covid-19 patients receiving mechanical ventilation or extracorporeal membrane oxygenation https://t.co/uHlK0EQ09s",,,2011-02-15 07:21:36,,Pharma Tech Focus,https://pbs.twimg.com/profile_images/1263845495425896448/HWH1Fkn6_normal.jpg,4160,2099,95,5874,PharmaTechFocus,
1889492676,2021-08-04 03:40:35,,"Incyte, JAKAFI, ","1stoncology.com/blog/incyte-re‚Ä¶, ",1422824773634072577,False,0,0,0,0,Troi URL Plug-in,#Incyte World-Wide Sales for #JAKAFI was 529.06m USD in Q2 2021 https://t.co/sxGIzKvbuT,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2021-08-04 03:03:19,,"Incyte, ICLUSIG, ","1stoncology.com/blog/incyte-re‚Ä¶, ",1422815396390789123,False,0,0,0,0,Troi URL Plug-in,#Incyte World-Wide Sales for #ICLUSIG was 28.19m USD in Q2 2021 (Up 24%) https://t.co/sxGIzKvbuT,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
43886423,2021-08-03 18:41:03,,,"dlvr.it/S4zf9W, pic.twitter.com/Smp6S7inhr, ",1422688994911875072,False,0,0,0,0,dlvr.it,Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation https://t.co/wqT6441Aef https://t.co/Smp6S7inhr,,,2009-06-01 09:48:34,,World Pharma News,https://pbs.twimg.com/profile_images/1058470025592561664/4EgXGRAY_normal.jpg,78652,4,338,5444,WorldPharmaNews,photo
1397584726068711431,2021-08-03 18:27:52,,,"worldpharmanews.com/lilly/5762-lil‚Ä¶, ",1422685679679574020,False,0,0,0,0,Twitter for iPhone,"""Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation""  https://t.co/F4UpNqPNgH",,,2021-05-26 12:05:54,Univers,QI 181,https://pbs.twimg.com/profile_images/1397590736741208068/bKNu8zGO_normal.jpg,224,219,5,18438,a__1_0_2,
464076395,2021-08-03 18:22:38,,,"fav-store.info/lilly-and-incy‚Ä¶, ",1422684360948469764,True,0,0,0,0,WordPress.com,Lilly and Incyte‚Äôs baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical¬†ventilation https://t.co/slB1OPS9VU,,,2012-01-14 15:25:49,U.S.,Fav-store,https://pbs.twimg.com/profile_images/2736537432/5ad439730f436aa66692640d58d99ea2_normal.jpeg,794,1772,16,19174,Store_Herbs,
1099039801397964802,2021-08-03 16:45:22,"INCY, ",,,1422659884148039683,False,0,0,1,0,EarningsAlley,Incyte Corporation $INCY held an earnings call on 8/3/2021. Here are the highlights:,,,2019-02-22 15:14:42,,Earnings Alley,https://pbs.twimg.com/profile_images/1113489113435508737/ulSmYR9O_normal.png,1802,1,33,87697,EarningsAlley,
25562183,2021-08-03 16:15:04,,,"reuters.com/business/healt‚Ä¶, ",1422652255703023618,False,5,1,1,3,True Anthem,Eli Lilly and Co (LLY.N) and partner Incyte Corp (INCY.O) said on Tuesday additional results from a late-stage study showed their COVID-19 drug baricitinib reduced the risk of death in patients on mechanical ventilation. https://t.co/ylstBUPznL,,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
1068561714055012352,2021-08-03 16:08:48,"INCY, ",,"sec.report/Document/00015‚Ä¶, ",1422650682046259201,False,0,0,0,0,Edgar Filings,"Filing Alert, FORM 10-Q [Quarterly Report] available.  $INCY INCYTE CORP  https://t.co/nzSK7PdNwo",,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
1171873456276889600,2021-08-03 16:05:51,"INCY, ","INCY, 10Q, Incyte, Earnings, ","docoh.com/filing/879169/‚Ä¶, ",1422649939100905476,False,0,0,0,0,Investor Feed,"$INCY  10-Q  Incyte   (3 Aug, 4:03pm)

üìä 2020 Q2 Earnings

https://t.co/En3s0Xxlt1

#INCY #10Q #Incyte #Earnings",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
4312114277,2021-08-03 16:05:17,"INCY, ",,"fintel.io/sf/us/incy?utm‚Ä¶, ",1422649797513723915,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 10-Q https://t.co/Oc4NyYycjO,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
838428908336734208,2021-08-03 14:54:29,,,,1422631978814296067,False,6,0,1,0,Twitter Web App,"My close friend and long-time colleague, Wenqing Yao, PhD, announced today he is stepping down as EVP &amp; Head of Chemistry @Incyte after 20 years. Some reflections‚Ä¶","Incyte, ",,2017-03-05 11:40:03,"Boston, MA",Reid Huber,https://pbs.twimg.com/profile_images/1450546865947099140/yJtYSl44_normal.jpg,182,164,3,134,ReidHuber,
773578537764851712,2021-08-03 14:10:03,"INCY, ",,"sitefocus.com/cif/ei/CM_incy‚Ä¶, ",1422620795352752129,False,0,0,0,0,CIF-QBA,"$INCY Earnings Intelligence Analysis of recent earnings identified Incyte Corp.  (NASDAQ: INCY ) business focus on (nda,ruxolitinib), (fda,nda,ruxolitinib), (ruxolitinib,vitiligo)

https://t.co/CDee3Q7nWD",,,2016-09-07 13:47:50,"Cupertino, CA",SiteFocus,https://pbs.twimg.com/profile_images/908465036598820864/6ZQsC4KD_normal.jpg,195,35,8,57439,SiteFocusHQ,
23059499,2021-08-03 13:29:10,"INCY, ","trading, finance, business, ","seekingalpha.com/article/444441‚Ä¶, ",1422610507714887684,False,1,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation's (INCY) CEO Herv√© Hoppenot on Q2 2021 Results - Earnings Call Transcript. https://t.co/9al5tJs2wz #trading #finance #business,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
4058194633,2021-08-03 13:10:42,"INCY, ",,"MarketBeat.com, marketbeat.com/instant-alerts‚Ä¶, ",1422605862238101504,False,0,0,0,0,Twitter for iPhone,$INCY Traders Purchase Large Volume of Incyte Call Options | https://t.co/NKb5pS3e1Y https://t.co/cQvMK3FWgg,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-08-03 13:09:59,"INCY, ",,"google.com/amp/s/m.invest‚Ä¶, ",1422605679953539076,False,0,0,0,0,Twitter for iPhone,"$INCY Mizuho Maintains Hold Rating On Incyte, $95 PT https://t.co/ivVIq0gHyT",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-08-03 13:09:01,"LLY, INCY, ",,"finance.yahoo.com/news/lilly-inc‚Ä¶, ",1422605437451399174,False,0,0,0,0,Twitter for iPhone,$LLY $INCY Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation https://t.co/Uej1pmAUVM,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-08-03 13:08:29,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1422605303657287682,False,1,0,0,0,Twitter for iPhone,$INCY Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs | Business Wire https://t.co/Q0zW4x5fht,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1298516232140972038,2021-08-03 12:40:03,"INCY, ",,"tobaia.com/app/instrument‚Ä¶, ",1422598147126214658,False,0,0,0,0,Twitter,New Short opportunity for Incyte Corporation $INCY at 76.34$. More information of the event and live risk management at https://t.co/wWNIQqk06Q,,,2020-08-26 03:03:39,Global,Tobaia,https://pbs.twimg.com/profile_images/1298517759895252992/GrTPQaSE_normal.jpg,58,36,0,2601,Tobaia_com,
254162198,2021-08-03 12:08:38,,,"bit.ly/3lsmriE, pic.twitter.com/HFOTsD2kQ9, ",1422590242113167365,False,1,0,0,0,HubSpot,"In this paper by @Incyte, ruxolitinib, a selective Jak1/2 inhibitor, ameliorated graft-versus-host disease severity in PBMC-engrafted immunodeficient hIL-15 NOG mice from Taconic Biosciences, supporting ongoing ruxolitinib clinical trials. Read more here: https://t.co/3uDJXeMqEX https://t.co/HFOTsD2kQ9","Incyte, ",,2011-02-18 13:47:38,"Rensselaer, NY",Taconic Biosciences,https://pbs.twimg.com/profile_images/1126928558654402561/HKDUGYCg_normal.png,1042,564,0,4541,Taconic,photo
25562183,2021-08-03 12:00:12,,,"reuters.com/business/healt‚Ä¶, ",1422588119136747527,False,3,0,0,1,True Anthem,Eli Lilly and Co (LLY.N) and partner Incyte Corp (INCY.O) said on Tuesday additional results from a late-stage study showed their COVID-19 drug baricitinib reduced the risk of death in patients on mechanical ventilation. https://t.co/FOJKZgiJHj,,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
18026170,2021-08-03 10:41:48,,"baricitinib, COVID19, ventilation, ECMO, ClinicalTrials, InfectiousDiseases, SARSCoV2, ","clinicaltrials.gov/ct2/show/NCT04‚Ä¶, ",1422568390217158657,False,1,0,0,0,Twitter Web App,".@LillyPad &amp; @Incyte tout JAK inhibitor #baricitinib atop SoC in #COVID19 patients on mechanical #ventilation or #ECMO

#ClinicalTrials sub-group 46% less likely to die than on SoC alone at Day 28. Effects similar to Day 60

https://t.co/lVdGNOd68r
#InfectiousDiseases #SARSCoV2","LillyPad, Incyte, ",,2008-12-10 13:29:19,"Midland, ON",DDNews Online,https://pbs.twimg.com/profile_images/1286709262287278080/SHRMveT5_normal.jpg,3372,439,86,13763,DDNewsOnline,
1394788264612188160,2021-08-03 09:21:02,"INCY, ",,"app.fincredible.ai/company/INCY/e‚Ä¶, ",1422548063038607361,False,0,0,0,0,Hootsuite Inc.,Missed the Incyte Corp Q2 earnings call on August 03? Easily spot key metrics or important updates from for the interactive transcript $INCY https://t.co/AxM1rb61fT,,,2021-05-18 18:53:37,,Fincredible Bites,https://pbs.twimg.com/profile_images/1409888298445770752/7GqL-4Tt_normal.jpg,75,33,2,11805,FincrediBites,
345555340,2021-08-03 09:07:48,,,"shar.es/aWpN7w, ",1422544733839241217,False,0,0,0,0,Twitter Web App,News for Medical Independent Sales Representatives and Medical Distributors: Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation https://t.co/u0SPx2Z67F,,,2011-07-30 15:56:45,USA,HSMN,https://pbs.twimg.com/profile_images/1469889801/globelayer_sm_normal.png,667,1802,92,6275,HSMN_com,
72928001,2021-08-03 09:03:43,"INCY, ",,"bit.ly/3A4CirJ, ",1422543705207042050,False,0,0,0,0,BriefingInPlayLimited,"$INCY: Incyte beats by $0.06, beats on revs https://t.co/x1oaCq3Leo",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
23059499,2021-08-03 08:41:14,"INCY, ","trading, business, finance, ","seekingalpha.com/article/444425‚Ä¶, ",1422538045438316548,False,1,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation 2021 Q2 - Results - Earnings Call Presentation. https://t.co/1JEflmRx38 #trading #business #finance,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1022473214457348096,2021-08-03 08:38:00,,,"pharmashots.com/63027/lilly-an‚Ä¶, ",1422537232934572045,False,0,0,0,0,Twitter Web App,"Lilly and Incyte Report Results of Baricitinib in P-III COV-BARRIER Study for Patients with COVID-19 Receiving Invasive Mechanical Ventilation @Pharmashot @LillyPad @Incyte 
https://t.co/GgoTNfFOVa","Pharmashot, LillyPad, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
108617488,2021-08-03 08:25:03,,,"invst.ly/vmkfk, ",1422533972697956363,False,0,0,0,0,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/HF5mFMnOFp,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
72928001,2021-08-03 08:03:43,"LLY, ",,"bit.ly/2Vcx2no, ",1422528603648978945,False,0,0,0,0,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) announced today results from an additional cohort of 101 adult patients from the... https://t.co/CbfmbRjN1d,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
15296897,2021-08-03 07:58:44,"INCY, ",,"seekingalpha.com/news/3723766-i‚Ä¶, ",1422527351972265987,False,0,0,0,0,SANewsTwitter,$INCY - Incyte tops Q1 forecast; Jakafi revenue outlook lowered https://t.co/kILKz0fggh,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
25406480,2021-08-03 07:50:09,,,"awesomecapital.blogspot.com/2021/08/lilly-‚Ä¶, ",1422525191310151682,False,0,0,0,1,Twitter Web App,"AwesomeCapital: Lilly, Incyte: Baricitinib Reduced Deaths In COVID... https://t.co/zkvlIyi3NG",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
25562183,2021-08-03 07:45:08,,,"reuters.com/business/healt‚Ä¶, ",1422523930485661710,False,7,1,0,4,True Anthem,Eli Lilly and Co (LLY.N) and partner Incyte Corp (INCY.O) said on Tuesday additional results from a late-stage study showed their COVID-19 drug baricitinib reduced the risk of death in patients on mechanical ventilation. https://t.co/75j9z4PX08,,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
1184025479084331008,2021-08-03 07:25:27,"INCY, ",,"pic.twitter.com/75aSPOPr5w, ",1422518973569114113,False,0,0,0,0,pythonmehabe,"(Earnings) Incyte ( $INCY ) Actual.EPS=0.8 vs Est.EPS=0.575, Actual.Rev=705.7M vs Est.Rev=687.96M, Last Quote: $78.47 https://t.co/75aSPOPr5w",,,2019-10-15 04:37:33,Germany,Jeremy,https://pbs.twimg.com/profile_images/1242903623446626304/g1A5BLr2_normal.jpg,2523,2,61,191178,mehabecapital,photo
3316713321,2021-08-03 07:21:30,,,"ca.investing.com/news/stock-mar‚Ä¶, ",1422517980852785153,False,0,0,0,0,WordPress.com,"Incyte Earnings, Revenue beat in¬†Q2 https://t.co/ToOlXD0eZv",,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
1254906887490936845,2021-08-03 07:21:20,"INCY, ",,"quantdata.us/news/22294290, ",1422517938867871750,False,0,0,0,0,Quant Data (Production),"Incyte Q2 Adj. EPS $0.80 Beats $0.75 Estimate, Sales $696.00M Beat $686.98M Estimate

Related Tickers: $INCY
Read more at: https://t.co/UIpiQDXQzt",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
17673635,2021-08-03 07:21:10,,,"livemint.com/news/india/lil‚Ä¶, ",1422517896178065409,False,2,0,0,0,Twitter Web App,Eli Lilly and Co and partner Incyte Corp on Tuesday said additional results from a late-stage study showed that their COVID-19 drug baricitinib reduced the risk of death in patients on mechanical ventilation.https://t.co/sSrw6vAkAe,,,2008-11-27 04:07:38,India,Mint,https://pbs.twimg.com/profile_images/1303221636745760768/jhoXTzaw_normal.jpg,1995294,69,3827,373856,livemint,
1068561714055012352,2021-08-03 07:19:10,"INCY, ",,"sec.report/Document/00015‚Ä¶, ",1422517394849746949,False,0,0,0,0,Edgar Filings,Filing for 8-K [Press/News Current Report] has been made with the SEC:  $INCY INCYTE CORP  https://t.co/OiX7nRVStP,,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
1402056489842274306,2021-08-03 07:15:44,"INCY, ",,"marketnewswire.live/index.php/2021‚Ä¶, ",1422516528117784581,False,0,0,0,0,Twitter,"$INCY SEC Filing: 8-K Earnings - INCYTE CORP (0000879169) August 03
 
https://t.co/alEIEdK3CO",,,2021-06-07 20:17:15,,Market Newswire,https://pbs.twimg.com/profile_images/1402059365117399048/4SdeRlrL_normal.jpg,6,0,0,9801,Market_Newswire,
108617488,2021-08-03 07:15:12,,,"invst.ly/vmj4a, ",1422516395036844036,False,1,0,0,0,FP News Publisher - COM,"Incyte Earnings, Revenue Beat in Q2 - https://t.co/xKGaSjDtev",,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
2812632288,2021-08-03 07:12:49,,,"invst.ly/vmj4a, ",1422515795133931528,False,0,0,0,0,ForexPros News & Analysis,"Incyte Earnings, Revenue Beat in Q2 - https://t.co/zXWHpxGbxR",,,2014-09-16 03:56:03,Worldwide,Investing.com Stocks,https://pbs.twimg.com/profile_images/1108338732019695616/CAvg-ixc_normal.png,20430,38,256,339289,InvestingStockz,
1136923823146721281,2021-08-03 07:10:32,"LLY, INCY, ",,,1422515221655134220,False,0,0,0,0,Twitter Web App,Eli Lilly and Incyte announce results from an additional cohort of 101 adult patients from the COV-BARRIER trial. $LLY $INCY,,,2019-06-07 05:12:17,Stock-land ,MO$E,https://pbs.twimg.com/profile_images/1430500750195630088/Jk_vFf5N_normal.jpg,153,448,3,3854,tradingwithmose,
963495628545327104,2021-08-03 07:09:02,"INCY, INCY, ",,"stck.pro/news/INCY/1472‚Ä¶, stck.pro/news/INCY, ",1422514844662702084,False,0,0,0,0,STCK.PR0,"$INCY NEW ARTICLE : Incyte EPS beats by $0.06, beats on revenue https://t.co/DoiwWDJXiY Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
976297820532518914,2021-08-03 07:06:49,,,"dlvr.it/S4xjmN, pic.twitter.com/hyQRV5csbp, ",1422514284026753028,False,0,0,0,0,dlvr.it,Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/XQavBRcgEB https://t.co/hyQRV5csbp,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2021-08-03 07:06:31,,,"crweworld.com/article/news-p‚Ä¶, ",1422514208894189572,False,0,0,0,0,CRWE World,Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/e8zGE13uRc,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1355194932445786112,2021-08-03 07:03:45,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1422513515282276361,False,0,0,0,0,Twitter,"$INCY Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
https://t.co/ej6NMTmQNN",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1069693680066420736,2021-08-03 07:03:12,"INCY, ",,"s.flashalert.me/PYLVd, ",1422513374525628416,False,0,0,0,0,flashalerts,"$INCY [15s. delayed, acc.~90%, always check] Earnings Release August 03, 07:00:00: Q2: Non-GAAP EPS of $0.80, GAAP EPS of $0.67, Revenue $705.70M. https://t.co/0f3W0vrrDv",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1069693680066420736,2021-08-03 07:03:09,"INCY, ",,"s.flashalert.me/fgxXU, ",1422513363381329921,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on August 03, 07:00:00: Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/LWBMOPGxyn",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1254035253104181256,2021-08-03 07:01:59,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1422513071650709524,False,0,0,0,0,stocktitan,"$INCY Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
https://t.co/ryvrYdIFnx",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1325115160353103872,2021-08-03 07:00:45,"INCY, ",,"quantisnow.com/insight/159264‚Ä¶, ",1422512758235439106,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

https://t.co/9YFBczBiuA

30s delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1393303407801294850,2021-08-03 07:00:06,"INCY, ",,"webchronicletoday.com/incyte-reports‚Ä¶, ",1422512594305355779,False,0,0,0,0,Twitter,"$INCY Incyte Reports 2021 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
 
https://t.co/cnLpAGlULP",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
15296897,2021-08-03 06:55:48,"LLY, INCY, ",,"seekingalpha.com/news/3723668-l‚Ä¶, ",1422511514716573702,False,0,0,0,0,SANewsTwitter,"$LLY $INCY - Lilly, Incyte's baricitinib reduces deaths among COVID-19 patients on mechanical ventilation https://t.co/qoZzcYdJmi",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
472650465,2021-08-03 06:45:42,"INCY, ",,"otcdynamics.com/incy-lilly-and‚Ä¶, ",1422508970800029697,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Lilly and Incyte‚Äôs baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation https://t.co/UKGVFFe63r,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1315434407692509184,2021-08-03 06:41:03,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/tQIqT1OCzX, ",1422507802480857091,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2338 out of 5568 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/tQIqT1OCzX",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1069693680066420736,2021-08-03 06:32:35,"INCY, ",,"s.flashalert.me/7McOFS, ",1422505671837224971,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on August 03, 06:00:00: Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation https://t.co/HcF1ylmAvq",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
284054290,2021-08-03 06:20:20,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/medic‚Ä¶, ",1422502588688314368,False,0,0,0,0,BLOX CMS for DEV,"INDIANAPOLIS, Aug. 3, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today results from an additional cohort of 101 adult patients from the COV-BARRIER trial. In this sub-study, patients with COVID-19 on me‚Ä¶ https://t.co/hXd1uofdiT",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
1355194932445786112,2021-08-03 06:02:47,"LLY, INCY, ",,"stocktitan.net/news/LLY/lilly‚Ä¶, ",1422498171708641304,False,0,0,0,0,Twitter,"$LLY $INCY Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
https://t.co/Q6WHxk5Dyg",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
3318510966,2021-08-03 06:01:30,,,"crweworld.com/article/news-p‚Ä¶, ",1422497849112109061,False,0,0,0,0,CRWE World,Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation https://t.co/YfbxSjbZAh,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2021-08-03 06:01:02,"LLY, INCY, ","covid19, ","stocktitan.net/news/LLY/lilly‚Ä¶, ",1422497731126435841,False,0,0,0,0,stocktitan,"$LLY $INCY Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
https://t.co/zZ8J7ReJSH

#covid19",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1325115160353103872,2021-08-03 06:01:01,"INCY, LLY, ",,"quantisnow.com/insight/159099‚Ä¶, ",1422497725795295241,False,0,0,0,0,Twitter,"$INCY $LLY üì∞ Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation

https://t.co/N7LZMKHYJX

30s delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1393303407801294850,2021-08-03 06:00:32,"LLY, ",,"webchronicletoday.com/lilly-and-incy‚Ä¶, ",1422497606190649344,False,0,0,0,0,Twitter,"$LLY Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation
 
https://t.co/zY56UJtl8i",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
1394788264612188160,2021-08-03 04:13:02,"INCY, ",,"app.fincredible.ai/company/INCY/e‚Ä¶, ",1422470552497893387,False,0,0,0,0,Hootsuite Inc.,$INCY Incyte Corp is holding their Q2 2021 earnings call today at 08:00 EDT . Click here to livestream the call!  https://t.co/Y3WbDBM0Zh,,,2021-05-18 18:53:37,,Fincredible Bites,https://pbs.twimg.com/profile_images/1409888298445770752/7GqL-4Tt_normal.jpg,75,33,2,11805,FincrediBites,
1979190776,2021-08-03 01:11:26,"INCY, ",,"tickerreport.com/?p=7720053, ",1422424851374120961,False,0,0,0,0,Zapier.com,Q2 2021 EPS Estimates for Incyte Co. Lowered by Oppenheimer $INCY https://t.co/vcqjSBfIax,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
4028839455,2021-08-02 14:15:03,,,"stocktrot.com/company/incyte‚Ä¶, ",1422259666583703560,False,0,0,0,0,StockTrot1,"7,337 shares: largest acquisition of Incyte Corp shares for Stamoulis Christiana in 5 months. https://t.co/Glm3Ox59RC",,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
15296897,2021-08-02 13:44:10,"INCY, ",,"seekingalpha.com/news/3723283-i‚Ä¶, ",1422251892906758145,False,0,0,0,0,SANewsTwitter,$INCY - Incyte Q2 2021 Earnings Preview https://t.co/VmpijTL7Ss,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
778267752679235585,2021-08-02 11:48:16,,,"stockmarketdaily.co/2021/08/02/inc‚Ä¶, pic.twitter.com/3IPaeGn9aF, ",1422222728195710978,False,0,0,0,0,StockMarketDaily,Factors Likely to Have Influenced Earnings Results Incyte (NASDAQ:INCY) - https://t.co/YqZ1jXjypa https://t.co/3IPaeGn9aF,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
45426794,2021-08-02 10:44:08,,,"amzn.to/2Vcmkgo, ",1422206588228669441,False,2,0,0,0,EveryoneSocial,"üìò
 New Case Study: Incyte Diagnostics worked with @druvainc &amp; AWS for the ultimate clinical data protection &amp; backup in the cloud era.  https://t.co/V974UUju14","druvainc, ",,2009-06-07 17:23:52,"Nashville, TN",‚òÅÔ∏è Donna Cheek LaGasse ‚òÅÔ∏è,https://pbs.twimg.com/profile_images/1358618566917054467/Kfh8VjT6_normal.jpg,1706,2351,202,8306,DonnaCheekNC,
374729426,2021-08-02 07:56:03,"INCY, ","Incyte, stockmarket, stock, earnings, money, trading, investing, daytrading, news, today, ","srnk.us/go/2924419, pic.twitter.com/h2Oe5RGiZS, ",1422164288651681797,False,0,0,0,0,Tickeron,"Incyte Corp. to report earnings on August 03, 2021. Earnings per share (EPS) estimate: $0.57 $INCY #Incyte #stockmarket #stock #earnings #money #trading #investing #daytrading #news #today https://t.co/k10CxuwX6a https://t.co/h2Oe5RGiZS",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
732361939490312192,2021-08-02 01:20:59,"INCY, ","markets, ","americanbankingnews.com/?p=21318017, ",1422064866676953089,False,0,0,0,0,Zapier.com,Oppenheimer Comments on Incyte Co.‚Äôs Q2 2021 Earnings $INCY https://t.co/hHrtyp4wzR #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-08-02 01:20:58,"INCY, ","stocks, ","americanbankingnews.com/?p=21318017, ",1422064863258595329,False,0,0,0,0,Zapier.com,Oppenheimer Comments on Incyte Co.‚Äôs Q2 2021 Earnings $INCY https://t.co/ilFbYEmFDD #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2462269507,2021-08-01 21:00:00,,,"newyorker.com/magazine/2021/‚Ä¶, ",1421999189035208708,False,0,0,0,0,Twitter Web App,"""Trump‚Äôs Club Med
Among the experimental drugs tried out on the President in the COVID ward: MyPill (placebo available in twin, full, and California king), Faucialis (weekends only), Lympho-incyte (causes white blood cells to storm the..."" https://t.co/yMq0XzLitk",,,2014-04-24 17:37:22,,Meme-Link,https://pbs.twimg.com/profile_images/1444692502020243465/RYKRUd1K_normal.jpg,6563,6955,20,46918,BreslerAlex,
16178342,2021-08-01 11:03:02,,"biotech, stocks, fintech, ","macroaxis.com/stock/INCY/Inc‚Ä¶, ",1421848955420254210,False,1,0,0,0,dlvr.it,Incyte Corp ($INCY) current valuation is FAIRLY VALUED. The real value is almost 78 per share https://t.co/tIA0RMeVyD #biotech #stocks #fintech,,,2008-09-07 22:35:32,San Francisco,Macroaxis,https://pbs.twimg.com/profile_images/378800000273197267/8e5af5ad945489e06413368ae6579304_normal.png,9327,5047,138,36975,macroaxis,
1979190776,2021-08-01 01:45:20,"INCY, ",,"tickerreport.com/?p=7712095, ",1421708606387412992,False,0,0,0,0,Zapier.com,Q3 2021 EPS Estimates for Incyte Co. Boosted by Analyst $INCY https://t.co/bZ4ztxFoGh,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
43051682,2021-08-01 01:00:10,,"oncology, ","ow.ly/xLoY50FERRs, ",1421697238338842625,False,0,0,0,0,Hootsuite Inc.,The @US_FDA issued a complete response letter to Incyte Corporation stating that it cannot approve the BLA for retifanlimab for use in patients w/ locally advanced or metastatic SCAC who are intolerant of platinum-based chemotherapy #oncology https://t.co/hX8WKtif6d,"US_FDA, ",,2009-05-28 01:04:27,"New Jersey, USA",OncLive.com,https://pbs.twimg.com/profile_images/1207309207004950533/hnCTQqRs_normal.jpg,30243,1496,560,78456,OncLive,
374729426,2021-07-31 16:57:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2920507, pic.twitter.com/Sgtta0AktX, ",1421575797920342018,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on July 12, 2021. View odds for this and other indicators: https://t.co/wCoz5TGapB #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Sgtta0AktX",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1134049078424162304,2021-07-31 04:18:58,"INCY, LLY, ",,"newsfilter.io/articles/fda-b‚Ä¶, ",1421384881876217856,False,0,0,0,1,Newsfilter.io,FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen $INCY $LLY https://t.co/PRh5MK2jve,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1315434407692509184,2021-07-30 19:01:19,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/pMVVtrNtrK, ",1421244545111666693,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2239 out of 5554 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/pMVVtrNtrK",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
54713716,2021-07-30 18:01:10,"INCY, ","NASDAQ, Incyte, algorithmic, daVinci, daytrading, ","pic.twitter.com/Nkm93WqBnS, ",1421229405830094853,False,0,0,0,0,Twitter Web App,"#NASDAQ | #Incyte, $INCY, #algorithmic trading, 3 for 3, scalped +$960.00 today with #daVinci, our 100% auto-ex #daytrading strategy for all liquid markets. Trade with confidence, trade our algorithms! End-user licenses available for @MultiCharts, @NinjaTrader or @TradeStation... https://t.co/Nkm93WqBnS","multicharts, NinjaTrader, TradeStation, ",,2009-07-07 19:07:52,"Miami, Florida  USA ",The Clockwork Group,https://pbs.twimg.com/profile_images/1180213543351803905/rLlPm7h__normal.jpg,1052,844,46,8572,ClockworkAlerts,photo
732361939490312192,2021-07-30 07:43:43,"INCY, ","markets, ","americanbankingnews.com/?p=21275699, ",1421074022792667138,False,0,0,0,0,Zapier.com,Oppenheimer Analysts Increase Earnings Estimates for Incyte Co. $INCY https://t.co/DQkxXTWuHc #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-07-30 07:43:43,"INCY, ","stocks, ","americanbankingnews.com/?p=21275699, ",1421074019785318402,False,0,0,0,0,Zapier.com,Oppenheimer Analysts Increase Earnings Estimates for Incyte Co. $INCY https://t.co/fgYmLoZmrK #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
94794805,2021-07-30 07:37:14,,,"hospimedica.com/covid-19/artic‚Ä¶, pic.twitter.com/aQ3YQBGJKU, ",1421072390948278276,False,0,0,0,0,Globetech twi-connect,Eli Lilly and Incyte‚Äôs Baricitinib Receives FDA EUA for Use as Monotherapy in Hospitalized COVID-19 Patients... https://t.co/W9QMofdEbe https://t.co/aQ3YQBGJKU,,,2009-12-05 08:48:51,,HospiMedica.com,https://pbs.twimg.com/profile_images/843924355079979009/StpNpJz7_normal.jpg,901,0,14,6177,HospiMedica,photo
252546993,2021-07-30 04:50:52,,,"pharmaceutical-technology.com/news/eualilly-‚Ä¶, ",1421030522600501251,False,0,0,0,0,Twitter Web App,"The US Food and Drug Administration has expanded the Emergency Use Authorization for Eli Lilly and Incyte‚Äôs drug, baricitinib, for Covid-19 treatment with or without remdesivir https://t.co/4VfpoViF5m",,,2011-02-15 07:21:36,,Pharma Tech Focus,https://pbs.twimg.com/profile_images/1263845495425896448/HWH1Fkn6_normal.jpg,4160,2099,95,5874,PharmaTechFocus,
1122964261981118467,2021-07-30 02:04:11,,,"dlvr.it/S4j0Rz, ",1420988573013012483,False,0,0,0,0,dlvr.it,"Marginal Zone Lymphoma Treatment Market Size, Key Opportunities, Strategic Assessment, Strong ... https://t.co/HUw7lrIEt7",,,2019-04-29 16:41:58,,Opportunity Zone Wealth,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,66,0,13053,zone_wealth,
1399103920522334219,2021-07-30 01:48:06,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/8Z4sR6uCBa, ",1420984527489490944,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2239 out of 5554 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/8Z4sR6uCBa",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
1335275589247197187,2021-07-29 17:46:37,,,"medicaltrend.org/2021/07/29/cov‚Ä¶, ",1420863356114665473,False,0,0,0,0,Twitter Web App,"https://t.co/oNfLO6ncBd 

COVID-19: FDA expands Incyte/Eli Lilly JAK inhibitor Olumiant (Barictinib) emergency use authorization (EUA)!  

Compared with placebo + standard care, Olumiant + standard care reduced the risk of death by 39%‚Ä¶.",,,2020-12-05 12:31:51,,medicalnews,https://pbs.twimg.com/profile_images/1335358397475037184/hd6xamVu_normal.png,60,109,1,3949,medicalnews20,
38197752,2021-07-29 14:28:32,,,"dlvr.it/S4gXBR, pic.twitter.com/OwRf6KPpGF, ",1420813509940547585,False,1,0,0,1,dlvr.it,"FDA rejects Incyte cancer drug, asking for more data to show clinical benefit https://t.co/pIvEULlNiu https://t.co/OwRf6KPpGF",,,2009-05-06 11:14:22,"Dubai, United Arab Emirates",Dr. Osama Ahmed,https://pbs.twimg.com/profile_images/1351682680111423493/wUfRGAIf_normal.jpg,1854,3669,106,9628,DrOsamaAhmed,photo
1134049078424162304,2021-07-29 13:53:54,"LLY, INCY, GILD, ",,"newsfilter.io/articles/eli-l‚Ä¶, ",1420804794713845766,False,0,0,0,0,Newsfilter.io,Eli Lilly-Incyte's Rheumatoid Arthritis Drug Gets OK From FDA For Solo Use In Hospitalized COVID-19 Patients $LLY $INCY $GILD https://t.co/BlklVHmZfo,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1254906887490936845,2021-07-29 13:52:47,"INCY, GILD, LLY, ",,"quantdata.us/news/22226384, ",1420804511770320903,False,0,0,0,0,Quant Data (Production),"Eli Lilly-Incyte's Rheumatoid Arthritis Drug Gets OK From FDA For Solo Use In Hospitalized COVID-19 Patients

Related Tickers: $INCY $GILD $LLY
Read more at: https://t.co/aVCeMdUdHI",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
4058194633,2021-07-29 12:30:39,"INCY, LLY, ",,"finance.yahoo.com/news/fda-broad‚Ä¶, ",1420783842416201730,False,0,0,0,0,Twitter for iPhone,$INCY $LLY FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen https://t.co/iMH9zoJZmh,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
17815045,2021-07-29 11:40:00,"INCY, ",,"pro.benzinga.com, ",1420771095939063809,False,0,0,0,0,Twitter Web App,"FDA Late Wednesday Approved Eli Lilly And Incyte Arthritis Drug Baricitinib, In Combination With Remdesivir, To Treat COVID-19 $INCY https://t.co/lfF9w9Oyls @benzinga","Benzinga, ",,2008-12-02 13:58:09,"41.284941,-73.172508",Gerald,https://pbs.twimg.com/profile_images/1483012274/IMG_0188_normal.JPG,1195,3767,14,8651,gerr102,
72928001,2021-07-29 11:29:44,"LLY, ",,"bit.ly/3BTBmZ6, ",1420768510314123266,False,2,0,0,1,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) announce that the U.S. Food and Drug Administration has broadened the Emergency... https://t.co/2P0EMtel0n,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
15296897,2021-07-29 09:59:39,"GILD, INCY, LLY, ",,"seekingalpha.com/news/3721602-f‚Ä¶, ",1420745842881753093,False,0,0,0,0,SANewsTwitter,"$GILD $INCY $LLY - FDA broadens EUA for Lilly, Incyte's baricitinib for COVID-19 https://t.co/OJPxjS78Xx",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
284054290,2021-07-29 09:31:13,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/medic‚Ä¶, ",1420738688301113347,False,0,0,0,0,BLOX CMS for DEV,"INDIANAPOLIS, July 29, 2021 /PRNewswire/ --¬†Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today the U.S. Food and Drug Administration (FDA) has broadened the Emergency Use Authorization (EUA) for baricitinib to allow¬†for treat‚Ä¶ https://t.co/9hZCT2VGYU",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
472650465,2021-07-29 09:30:46,"INCY, ",,"otcdynamics.com/incy-fda-broad‚Ä¶, ",1420738574048239616,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY FDA broadens existing emergency use of Lilly and Incyte‚Äôs baricitinib in patients hospitalized with COVID-19 requiring oxygen https://t.co/JxZsR9LtFZ,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
831019099325132801,2021-07-29 09:28:40,"LLY, INCY, ",,,1420738042629959680,False,0,0,0,0,Twitter for iPhone,FDA has broadened its existing emergency use authorisation of Eli-Lilly's ( $LLY ) and Incyte's ( $INCY ) baricitinib for patients hospitalised with COVID-19,,,2017-02-13 00:56:07,/r/WallStreetBets,WallStreetBets & Co.,https://pbs.twimg.com/profile_images/1073223467468840962/lWY3Dc10_normal.jpg,50487,1535,455,15714,WSBConsensus,
1254035253104181256,2021-07-29 09:26:46,"LLY, ","covid19, ","stocktitan.net/news/LLY/fda-b‚Ä¶, ",1420737565724925952,False,0,0,0,0,stocktitan,"$LLY FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen
https://t.co/LHQIiXXRMk

#covid19",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1393303407801294850,2021-07-29 09:26:13,"LLY, ",,"webchronicletoday.com/fda-broadens-e‚Ä¶, ",1420737429267419140,False,0,0,0,0,Twitter,"$LLY FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen
 
https://t.co/VKyPe3abcC",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
2368733657,2021-07-29 09:26:12,"INCY, ",,,1420737424611708929,False,0,0,1,0,Twitter,$INCY: FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring,,,2014-02-27 05:32:16,US markets üëâ,Marketbit.pro,https://pbs.twimg.com/profile_images/1368821546454835202/14UYpgh2_normal.png,1393,587,55,28252,bthefirsttoknow,
1315434407692509184,2021-07-28 23:49:06,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/0tR2iM3zU5, ",1420592193119694854,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2239 out of 5551 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/0tR2iM3zU5",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
374729426,2021-07-28 23:06:49,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2913794, pic.twitter.com/YL1FOacPeC, ",1420581551436296195,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on July 2, 2021. View odds for this and other indicators: https://t.co/YVMKOHp2sw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/YL1FOacPeC",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
3460109487,2021-07-28 18:00:00,"INCY, ",,"endpts.com/fda-unsurprisi‚Ä¶, ",1420504339609645059,False,1,0,0,0,TweetDeck,"Incyte $INCY revealed late Friday the FDA has slammed its PD-1 retifanlimab with a complete response letter, demanding ‚Äúadditional data‚Äù to show clinical benefit.

https://t.co/Z6Kc0wKugG",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
75337774,2021-07-28 17:26:07,,,"medcitynews.com/2021/07/fda-re‚Ä¶, ",1420495810094055425,False,0,0,0,0,Twitter for Android,"FDA rejects Incyte cancer drug, asking for more data to show clinical benefit https://t.co/rXqdd4JpN7",,,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
4058194633,2021-07-28 15:27:46,"INCY, ",,"finance.yahoo.com/news/incyte-in‚Ä¶, ",1420466028719476736,False,0,0,0,0,Twitter for iPhone,$INCY Incyte to Post Q2 Earnings: Will Jakafi Sales Disappoint? https://t.co/Zw4Q8BH0v9,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
325135887,2021-07-28 13:25:00,"INCY, ","eczema, dermatology, ","bit.ly/3BJoVin, ",1420435130699689987,False,2,0,0,0,Twitter Web App,"Despite JAK anxiety, ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis! The class-wide safety saga for JAK drugs kicked off early this year! $INCY #eczema #dermatology 
https://t.co/ktjWk8nAlr",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
509089629,2021-07-28 11:11:02,,,"go.aws/3zHHwd1, pic.twitter.com/9nnKwCz40y, ",1420401416041082883,False,3,0,0,7,Sprinklr,üìò New Case Study: Incyte Diagnostics worked with @druvainc &amp; AWS for the ultimate clinical data protection &amp; backup in the cloud era. https://t.co/stMT4MpsJ3 https://t.co/9nnKwCz40y,"druvainc, ",,2012-02-29 13:24:55,"Seattle, WA",AWS Partner Network,https://pbs.twimg.com/profile_images/1150890148604895234/0CXJdBbh_normal.png,75967,2130,793,9538,AWS_Partners,photo
941548405490200576,2021-07-28 08:49:46,,,"scq.io/vmOMJB9, alliedacademies.org/journal-geneti‚Ä¶, ",1420365867578101761,False,0,0,0,0,Twitter Web App,Recon: Shape Therapeutics' $112M gene therapy play; Incyte's cancer drug flops at FDA https://t.co/bJWl1taCoS  to know more visit:https://t.co/bIJsup69Vm,,,2017-12-15 01:00:07,,Journal of Genetics and Molecular Biology,https://pbs.twimg.com/profile_images/1017370796703010816/NhonEIR3_normal.jpg,66,208,2,460,AAGMBJ,
2570920968,2021-07-28 08:30:00,"INCY, ","eczema, dermatology, ","bit.ly/3BJoVin, ",1420360892802236420,False,3,0,0,0,Twitter Web App,"Despite JAK anxiety, ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis! The class-wide safety saga for JAK drugs kicked off early this year! $INCY #eczema #dermatology 
https://t.co/dBHYLfd5RZ",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
158350630,2021-07-28 05:17:12,,"RareDiseaseAdvisor, cholangiocarcinoma, liverfluke, NORD, immunotherapy, WorldCCADay, ","bit.ly/3765B0E, ",1420312372636528642,False,11,1,0,6,Twitter Web App,"My feature story in today's #RareDiseaseAdvisor on #cholangiocarcinoma, or #liverfluke. @RareDiseases #NORD @GlobalLiver @RareDisease_Adv @NCI_CCR_SB #immunotherapy @curecc @melinda_bachini @AgiosPharma #WorldCCADay @incyte @AHPBA    https://t.co/77EbVhX2QC","RareDiseases, GlobalLiver, RareDisease_Adv, NCI_CCR_SB, curecc, melinda_bachini, AgiosPharma, Incyte, AHPBA, ",,2010-06-22 08:13:50,Tel Aviv,Larry Luxner,https://pbs.twimg.com/profile_images/1203317491465957378/m_MUflcg_normal.jpg,843,329,22,940,LLuxner,
1280938376099741697,2021-07-28 01:57:06,,"iexStock, ","iexcloud.io, pic.twitter.com/V3VGExqaX5, ",1420262016267210758,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Intuit Inc
-International Business Machines Corp.
-Baidu Inc - ADR
-Incyte Corp.
-Monster Beverage Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/V3VGExqaX5",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1277426946373124096,2021-07-28 01:52:05,,"MondayMotivation, AWS, DataProtection, ","druva.info/3iYEI4a, pic.twitter.com/cknlU9WssK, ",1420260751923625988,False,0,0,0,0,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/g7Bz93Baev

#AWS #DataProtection @druvainc https://t.co/cknlU9WssK","druvainc, ",,2020-06-28 22:21:43,,JayJ,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1,0,0,2558,JayJ03982258,photo
32492934,2021-07-27 14:44:00,,,"bioworld.com/articles/50972‚Ä¶, ",1420092623960875014,False,1,0,0,1,TweetDeck,"FDA issues expected CRLs for Iterum, Incyte https://t.co/XVpFGT6jYz",,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
75337774,2021-07-27 09:22:49,,,"medcitynews.com/2021/07/fda-re‚Ä¶, ",1420011795704696837,False,0,0,0,0,Twitter for Android,"FDA rejects Incyte cancer drug, asking for more data to show clinical benefit https://t.co/rXqdd4JpN7",,,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
1321134820894846976,2021-07-27 08:14:14,"INCY, ",,"endpts.com/fda-unsurprisi‚Ä¶, ",1419994535074177025,False,0,0,0,0,Twitter Web App,FDA unsurprisingly brings down the hammer on $INCY Incyte's PD-1 ‚Äî drawing a line for future accelerated approvals - https://t.co/vlCqwCVe5r,,,2020-10-27 13:01:17,"Atlanta, GA",Venture Investment Partners,https://pbs.twimg.com/profile_images/1363833220983357440/aJTCMLF__normal.jpg,3253,3773,26,59540,GeorgeB14941177,
133504478,2021-07-27 06:58:40,,"strategy, competitiveintelligence, marketing, biotech, pharma, competitivemarketing, pharmaceutical, healthcare, ","dlvr.it/S4Vy8T, ",1419975520633069574,False,0,0,0,1,dlvr.it,Recon: Shape Therapeutics' $112M gene therapy play; Incyte's cancer drug flops at FDA - Regulatory Focus https://t.co/w8bcaaxIW7 #strategy #competitiveintelligence #marketing #biotech #pharma #competitivemarketing #pharmaceutical #healthcare,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
812004702594486272,2021-07-27 05:00:56,,,"checkrare.com/interim-data-g‚Ä¶, ",1419945891029524482,False,2,0,0,0,Hootsuite Inc.,"Peter Langmuir, MD, Group Vice President, Oncology Targeted Therapeutics at Incyte, discusses interim data of a phase 2 study assessing the combination of ruxolitinib and parsaclisib in patients with myelofibrosis. 
@Incyte 
https://t.co/S1bQKb0jFy","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1041133416287272960,2021-07-27 03:26:46,,,"bit.ly/3zHmQ4W, ",1419922194054979612,False,2,0,0,0,IFTTT,Recon: Shape Therapeutics' $112M gene therapy play; Incyte's cancer drug flops at FDA - Regulatory Focus https://t.co/UW8TLd57c5,,,2018-09-15 21:15:24,http://Veterans-SS.carrd.co,ZEN FORCE üí™üèæüß†‚òØÔ∏è,https://pbs.twimg.com/profile_images/1177694650083299328/rj7WHUKG_normal.jpg,559,632,7,70457,ZenForceVets,
1357848951525945345,2021-07-26 20:58:13,,,"ift.tt/2Veg3jW, ",1419824413722259456,False,0,0,0,0,IFTTT,"FDA Rejects Incyte‚Äôs PD-1 For Anal Most cancers ‚Äì PharmaLive
https://t.co/lqcVsT2Xxq",,,2021-02-05 19:30:50,"New York, USA",CAM Cancer Hub,https://pbs.twimg.com/profile_images/1357850308832067587/RAPm_8ku_normal.jpg,0,5,0,3288,CAMCancerHub,
172288755,2021-07-26 19:55:06,,,"fiercepharma.com/pharma/icer-bl‚Ä¶, ",1419808527304986624,False,0,0,0,0,Twitter Web App,"Despite JAK 'anxiety,' ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis https://t.co/4kLiMyl7hw",,,2010-07-29 06:10:36,"Yong-In city, Korea",Kyung Seok Lee,https://pbs.twimg.com/profile_images/922433020748898305/cjOW-D4X_normal.jpg,17,60,0,646,ksloveis,
374729426,2021-07-26 19:28:01,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2908485, pic.twitter.com/sm3Oi7vp44, ",1419801710692765803,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on July 12, 2021. View odds for this and other indicators: https://t.co/ttZwpzwai4 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/sm3Oi7vp44",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1280938376099741697,2021-07-26 18:35:47,,"iexStock, ","iexcloud.io, pic.twitter.com/wAkm4JjAVB, ",1419788567484772356,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Walt Disney Co (The)
-Dollar Tree Inc
-PayPal Holdings Inc
-BEST Inc - ADR
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/wAkm4JjAVB",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
32492934,2021-07-26 18:35:00,,,"bioworld.com/articles/50972‚Ä¶, ",1419788369253392385,False,0,0,0,0,TweetDeck,"FDA issues expected CRLs for Iterum, Incyte‚Ä¶ https://t.co/XVpFGSOIzZ",,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
133504478,2021-07-26 16:41:06,,"strategy, competitiveintelligence, marketing, healthcare, pharmaceutical, productmarketing, pharma, biotech, ","dlvr.it/S4T58Q, pic.twitter.com/V091jOH1OY, ",1419759708324302848,False,0,0,0,1,dlvr.it,"Despite JAK 'anxiety,' ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis https://t.co/w3URmLldRW #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #productmarketing #pharma #biotech https://t.co/V091jOH1OY",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
3460109487,2021-07-26 16:00:00,"INCY, ",,"endpts.com/fda-unsurprisi‚Ä¶, ",1419749363849469952,False,0,0,0,0,TweetDeck,"Incyte $INCY revealed late Friday the FDA has slammed its PD-1 retifanlimab ‚Äî which was under priority review for locally advanced or metastatic squamous cell carcinoma of the anal canal ‚Äî with a complete response letter.

https://t.co/Z6Kc0wKugG",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
102754598,2021-07-26 15:21:49,"INCY, ",,"endpts.com/fda-unsurprisi‚Ä¶, ",1419739755953152000,False,2,0,0,1,TweetDeck,"#3 You were thinking, what?
FDA unsurprisingly brings down the hammer on Incyte's PD-1 ‚Äî drawing a line for future accelerated approvals
By @AmberTongPW $INCY
https://t.co/YEoWOuWQZH","AmberTongPW, ",,2010-01-07 13:33:18,VT and TX (yes),John Carroll,https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_normal.jpeg,61485,280,1456,48410,JohnCendpts,
1272884973691899908,2021-07-26 15:11:02,,"jobs, ","biospace.com/article/fda-gi‚Ä¶, ",1419737042225872896,False,0,0,0,0,Twitter for iPhone,"FDA  Rejects Incyte's PD-1 For Anal Cancer, Requires More Proof of Benefit | BioSpace https://t.co/Xni2e360SS #jobs",,,2020-06-16 09:33:41,"Manhattan, NY",lifeisgood,https://pbs.twimg.com/profile_images/1305706291113975811/_kTroyBs_normal.jpg,0,22,0,92,ayuriver2,
140599113,2021-07-26 15:03:17,,,"winway.me/health-remedie‚Ä¶, ",1419735089928450049,False,0,0,0,0,WordPress.com,"Despite JAK ‚Äòanxiety,‚Äô ICER experts overwhelmingly back Incyte‚Äôs ruxolitinib cream in atopic¬†dermatitis https://t.co/ugstgbUK46",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
18294275,2021-07-26 15:00:02,,,"fiercepharma.com/pharma/icer-bl‚Ä¶, ",1419734271690887169,False,3,0,0,0,TweetDeck,"Despite JAK 'anxiety,' ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis https://t.co/luhuGjLmLm",,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
2398845223,2021-07-26 14:53:32,,,"ow.ly/sMJ9102R0mU, ",1419732635635617797,False,0,0,0,0,Hootsuite Inc.,"Despite JAK 'anxiety,' ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis https://t.co/vCzklIdTYy",,,2014-03-19 23:11:51,Maryland,Continental Clinical,https://pbs.twimg.com/profile_images/673876383358062593/qyzjJcMn_normal.jpg,669,521,13,5348,Conti_Clinical,
4058194633,2021-07-26 14:49:32,"INCY, ",,"fiercepharma.com/pharma/icer-bl‚Ä¶, ",1419731629711380507,False,0,0,0,0,Twitter for iPhone,"$INCY Despite JAK 'anxiety,' ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis https://t.co/g5qKVNweYF",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-07-26 14:49:07,"INCY, ",,"medcitynews.com/2021/07/fda-re‚Ä¶, ",1419731526598676482,False,0,0,0,0,Twitter for iPhone,"$INCY FDA rejects Incyte cancer drug, asking for more data to show clinical benefit https://t.co/pAbUDablCd",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-07-26 14:48:33,"INCY, ",,"fiercebiotech.com/biotech/fda-de‚Ä¶, ",1419731380561334272,False,1,0,0,0,Twitter for iPhone,$INCY FDA deals blow to Incyte's PD-1 retifanlimab after battering advisory panel meeting https://t.co/32G7BiInlk,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
760484491555139584,2021-07-26 13:41:04,,,"dlvr.it/S4ScNN, pic.twitter.com/8tdK799UCh, ",1419714399716012035,False,0,0,0,0,dlvr.it,"Despite JAK 'anxiety,' ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis https://t.co/xkyBp8C52H https://t.co/8tdK799UCh",,,2016-08-02 10:36:46,,analyst land news,https://pbs.twimg.com/profile_images/1075066740835606534/NpZYEW5E_normal.jpg,10,0,1,5551,analystlandnews,photo
1348353903306305543,2021-07-26 13:39:16,,,"nowandthennews.com/2021/07/26/fda‚Ä¶, ",1419713947259883525,False,0,0,0,0,WordPress.com,"FDA rejects Incyte cancer drug, asking for more data to show clinical¬†benefit https://t.co/loyZbLogLk",,,2021-01-10 14:40:04,,Now and Then News,https://pbs.twimg.com/profile_images/1353151251429486592/ojUsAClZ_normal.jpg,11,0,0,31712,NowandThenNews1,
1250830691824283648,2021-07-26 13:38:16,"HAS, AON, FTI, PKI, TSLA, DVN, BKR, WLTW, TWTR, LMT, CTLT, LVS, INCY, MRNA, ",,,1419713694246838272,False,9,0,2,2,Twitter Web App,"Best and worst performing S&amp;P 500 stocks so far today

Best:
1 Hasbro $HAS
2 $AON
3 TechnipFMC $FTI
4 Perkin $PKI
5 Tesla $TSLA
6 Devon $DVN
7 Baker $BKR

Worst:
1 Willis $WLTW
2 Twitter $TWTR
3 Lockheed $LMT
4 Catalent $CTLT
5 Las Vegas Sands $LVS
6 Incyte $INCY
7 Moderna $MRNA",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
1417309944,2021-07-26 13:13:44,,,"fiercebiotech.com/biotech/fda-de‚Ä¶, pic.twitter.com/aoGEPlEzyV, ",1419707520860442626,False,0,0,0,0,SocialPilot.co,FDA demands for data from Incyte as it rejects PD-1 retifanlimab for approval https://t.co/VGiMEUO07Z lifescience zone medical device https://t.co/aoGEPlEzyV,,,2013-05-10 02:24:22,Miami,ThinKeen Global,https://pbs.twimg.com/profile_images/923330811025350657/HmQMs2JY_normal.jpg,36,12,0,2244,thinkeenglobal,photo
875382419251019776,2021-07-26 12:54:22,,,"bit.ly/3BKhZ4L, pic.twitter.com/EHflH9NGDb, ",1419702648844918800,False,0,0,0,0,dlvr.it,"FDA Rejects Incyte's PD-1 For Anal Cancer, Requires More Proof of Benefit https://t.co/h3mnKVbvpl https://t.co/EHflH9NGDb",,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
750646032258793472,2021-07-26 12:24:31,,,"endpts.com/fda-unsurprisi‚Ä¶, ",1419695136225775618,False,0,0,0,0,Twitter Web App,FDA unsurprisingly brings down the hammer on Incyte's PD-1 ‚Äî drawing a line for future accelerated approvals - https://t.co/ULim0Emmcv,,,2016-07-06 07:02:15,"Paris, France",Mazars,https://pbs.twimg.com/profile_images/1238543616617963521/RBlZCFrU_normal.jpg,114,616,22,8618,CrMazars,
18834912,2021-07-26 12:02:00,"INCY, ","retifanlimab, cancer, biotech, ","medcitynews.com/2021/07/fda-re‚Ä¶, ",1419689467900792834,False,0,0,0,0,TweetDeck,"FDA rejected @Incyte drug #retifanlimab for a rare type of anal #cancer. It still has a shot at approval, but the regulator wants more clinical data from a larger study; that Phase 3 study is already underway, @frankvinluan reports https://t.co/3DO3VszIAo $INCY #biotech","Incyte, frankvinluan, ",,2009-01-10 09:09:33,"MedCity, USA",MedCity News,https://pbs.twimg.com/profile_images/598875829976834048/MLQosVo1_normal.png,32781,7502,1628,37912,medcitynews,
1129062072862437377,2021-07-26 11:57:03,,"Biotech, Biotechnology, IPO, ","dlvr.it/S4SJkX, ",1419688221961691140,False,0,0,0,0,dlvr.it,"FDA Rejects Incyte's PD-1 For Anal Cancer, Requires More Proof of Benefit https://t.co/AtRI5kxMQW #Biotech #Biotechnology #IPO",,,2019-05-16 12:32:29,"Aliso Viejo, CA",GenBioInc,https://pbs.twimg.com/profile_images/1242888651534524416/Zh9L6zLx_normal.jpg,914,1789,3,3824,GenBioUSA,
140599113,2021-07-26 11:56:36,,,"winway.me/health-care/fd‚Ä¶, ",1419688110221369353,False,0,0,0,0,WordPress.com,"FDA rejects Incyte cancer drug, asking for more data to show clinical¬†benefit https://t.co/XlDg9wGvet",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
46297868,2021-07-26 11:55:05,,,"dlvr.it/S4SJRt, ",1419687726966730756,True,0,0,0,0,dlvr.it,"Despite JAK 'anxiety,' ICER experts overwhelmingly back Incyte's ruxolitinib cream in atopic dermatitis https://t.co/P0hj2jJoQ2",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
792112490,2021-07-26 11:48:15,,,"medcitynews.com/2021/07/fda-re‚Ä¶, tweetedtimes.com/v/374?s=tnp, ",1419686006907936775,False,0,0,0,0,The Tweeted Times,"FDA rejects Incyte cancer drug, asking for more data to show clinical benefit - MedCity News https://t.co/ABkQkVrAEK, see more https://t.co/qOkEQgM3g4",,,2012-08-30 14:10:55,Cologne,Health Tech Watcher,https://pbs.twimg.com/profile_images/2559842323/doc_normal.jpg,193,16,57,13041,_HealthWatcher,
1326957342957694976,2021-07-26 11:20:25,,,"getworldnews.online/2021/07/26/fda‚Ä¶, ",1419679002890063879,False,0,0,0,0,WordPress.com,"FDA rejects Incyte cancer drug, asking for more data to show clinical¬†benefit https://t.co/gLArJohaJY",,,2020-11-12 13:37:51,,Get World News,https://pbs.twimg.com/profile_images/1327256480525926404/O0AiOlQ1_normal.jpg,90,90,0,71153,GetWorldNews2,
3901351277,2021-07-26 11:20:25,,"healthnews, ","bit.ly/3zCO8sZ, ",1419679002634170371,False,0,0,0,0,IFTTT,"FDA rejects Incyte cancer drug, asking for more data to show clinical benefit : https://t.co/sxMAgbFqRx #healthnews",,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
1109103166757527553,2021-07-26 11:06:13,,,"ift.tt/2VhbGoA, ",1419675431637332003,False,0,0,0,0,IFTTT,"FDA rejects Incyte cancer drug, asking for more data to show clinical benefit https://t.co/L0lN6njiDH",,,2019-03-22 10:42:55,"Melbourne, Victoria",Luke Lazarus,https://pbs.twimg.com/profile_images/1109161690527158273/J-xz4dNF_normal.png,444,26,1,9667,LukeLazarusAU,
372879078,2021-07-26 10:51:33,,,"dlvr.it/S4S6Tn, pic.twitter.com/l7sKZFD8Ol, ",1419671737113858048,False,0,0,0,0,dlvr.it,"FDA rejects Incyte cancer drug, asking for more data to show clinical benefit https://t.co/KfjWJjOIco - @MedCityNews https://t.co/l7sKZFD8Ol","medcitynews, ",,2011-09-13 11:51:51,"Montgomery County, MD",AE Eckert,https://pbs.twimg.com/profile_images/1381608105021165568/io8VhV9J_normal.jpg,558,355,50,50180,AndrewEEckert,photo
726304448,2021-07-26 10:51:02,,,"targetedonc.com/view/fda-denie‚Ä¶, ",1419671607447101443,False,0,0,0,0,Twitter Web App,"Breaking: The FDA issued a complete response letter to Incyte Corporation in response to the Biologics License Application for retifanlimab for the treatment of adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal. 
https://t.co/eZHrykNnUt",,,2012-07-30 11:43:54,Greater New York Area,Targeted Oncology,https://pbs.twimg.com/profile_images/1220813179909038081/ZUCe2srb_normal.jpg,15980,3107,283,32745,TargetedOnc,
407212567,2021-07-26 10:43:32,,"eHealth, ","ift.tt/2VhbGoA, ",1419669723734814720,False,0,0,0,1,IFTTT,"Mi seguimiento üì° sobre #eHealth FDA rejects Incyte cancer drug, asking for more data to show clinical benefit: https://t.co/5y4ozO0iFl",,,2011-11-07 14:56:05,Espa√±a,Eugenio Ghirardi,https://pbs.twimg.com/profile_images/378800000532943977/0f99af81bf68382f40a90e89c7ca525c_normal.png,341,485,32,19973,GhirardiEugenio,
4058194633,2021-07-26 10:40:55,"INCY, ITRM, ARDX, ","jobs, ","biospace.com/article/fda-ac‚Ä¶, ",1419669062469128195,False,0,0,1,0,Twitter for iPhone,"$INCY $ITRM $ARDX FDA Action Alert: Incyte, Iterum and Ardelyx | BioSpace https://t.co/7hb4wWOxuR #jobs",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
211220879,2021-07-26 10:33:14,"INCY, ","retifanlimab, cancer, ","medcitynews.com/2021/07/fda-re‚Ä¶, ",1419667130551840773,False,1,0,0,1,Twitter Web App,"FDA rejected @Incyte drug #retifanlimab for a rare type of anal #cancer, asking for more data showing patient benefit. An FDA advisory committee last month recommended deferring a decision until there‚Äôs more data. Larger Phase 3 study is underway https://t.co/oouKOjraxa $INCY","Incyte, ",,2010-11-02 13:20:59,North Carolina,Frank Vinluan,https://pbs.twimg.com/profile_images/1503948370/billy_3_normal.jpg,1579,716,105,5339,frankvinluan,
18834912,2021-07-26 10:27:20,,,"trib.al/2u4DAR7, ",1419665644920967169,False,0,0,0,0,SocialFlow,"FDA rejects Incyte cancer drug, asking for more data to show clinical benefit https://t.co/I0uCEE9Mep",,,2009-01-10 09:09:33,"MedCity, USA",MedCity News,https://pbs.twimg.com/profile_images/598875829976834048/MLQosVo1_normal.png,32781,7502,1628,37912,medcitynews,
15974185,2021-07-26 10:17:05,,,"dlvr.it/S4S18y, ",1419663064622788611,False,0,0,0,0,dlvr.it,FDA unsurprisingly brings down the hammer on Incyte's PD-1 ‚Äî drawing a line for future accelerated approvals https://t.co/idaMJmtpoe,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
437085904,2021-07-26 10:09:06,,,"dlvr.it/S4Rzcx, pic.twitter.com/YtyqoDy0fy, ",1419661056180297732,False,0,0,0,1,dlvr.it,"FDA rejects Incyte cancer drug, asking for more data to show clinical benefit https://t.co/hsOBi2AZOV https://t.co/YtyqoDy0fy",,,2011-12-14 19:20:30,"Hudson Valley, New York",Bruce Judson Telemed,https://pbs.twimg.com/profile_images/904040523580661760/7sz5Ry6z_normal.jpg,5677,1562,245,82548,JudsonTelemed,photo
1242082182748872705,2021-07-26 10:02:22,,"Epidemiology, MedTwitter, MedEd, ","bit.ly/More-Medical-H‚Ä¶, medcitynews.com/2021/07/fda-re‚Ä¶, ",1419659362520404007,False,0,0,0,0,Automate.io,"FDA rejects Incyte cancer drug, asking for more data to show clinical benefit

More medical news at https://t.co/HFclW5krA3
#Epidemiology #MedTwitter #MedEd
https://t.co/QJ13lScIkO",,,2020-03-23 09:34:16,Look here üëâ,MedPub Epidemiology,https://pbs.twimg.com/profile_images/1443234620619821060/fMOZ64Zb_normal.jpg,545,222,1,9397,EpidPublisher,
751020252247519232,2021-07-26 08:49:32,,,"dlvr.it/S4Rkn0, pic.twitter.com/yPAel8uP9r, ",1419641032531091463,False,1,0,0,0,dlvr.it,FDA demands for data from Incyte as it rejects PD-1 retifanlimab for approval - FierceBiotech: FDA demands for data from Incyte as it rejects PD-1 retifanlimab for approval¬†¬†FierceBiotech https://t.co/pyA9CidFuJ https://t.co/yPAel8uP9r,,,2016-07-07 07:49:16,,Oncology Board,https://pbs.twimg.com/profile_images/751020873184935936/zNVXlTcR_normal.jpg,857,0,266,40234,mb_Oncology,photo
3460109487,2021-07-26 08:32:22,"INCY, ",,"endpts.com/fda-unsurprisi‚Ä¶, ",1419636713928986627,False,0,0,0,0,TweetDeck,"Incyte $INCY revealed late Friday the FDA has slammed its PD-1 retifanlimab ‚Äî which was under priority review for locally advanced or metastatic squamous cell carcinoma of the anal canal ‚Äî with a complete response letter.

https://t.co/Z6Kc0x25Fg",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
133504478,2021-07-26 07:39:03,,"strategy, competitiveintelligence, marketing, productmarketing, biotech, pharmaceutical, healthcare, pharma, ","dlvr.it/S4RXD7, pic.twitter.com/mul0IFvjm2, ",1419623295146618888,False,0,0,0,1,dlvr.it,FDA unsurprisingly brings down the hammer on Incyte's PD-1 ‚Äî drawing a line for future accelerated approvals https://t.co/ZaX4aDSuIt #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharmaceutical #healthcare #pharma https://t.co/mul0IFvjm2,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1154064859929014272,2021-07-26 07:10:21,,"ClinicalData, AAIC21, toxicology, AlzheimerDisease, ","pic.twitter.com/CaHLFBc1QM, ",1419616073914142721,False,0,0,0,0,Twitter Web App,"#ClinicalData &amp; Results 

@Incyte gives update on the status of BLA for a treatment for certain adults with SCAC 

QYNAPSE  to present at the @alzassociation the #AAIC21 2021 

@AlzamendNeuro - positive results #toxicology study for #AlzheimerDisease https://t.co/CaHLFBc1QM","Incyte, alzassociation, AlzamendNeuro, ",,2019-07-24 12:24:38,,MedTechNow,https://pbs.twimg.com/profile_images/1359909439399026689/l_fe8Tje_normal.jpg,603,801,3,2053,MedTechNow_,photo
46297868,2021-07-26 06:45:06,,,"dlvr.it/S4RN59, ",1419609717991636993,True,0,0,0,0,dlvr.it,FDA unsurprisingly brings down the hammer on Incyte's PD-1 ‚Äî drawing a line for future accelerated approvals https://t.co/aCB13ueGfs,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
1022473214457348096,2021-07-26 06:38:00,,,"pharmashots.com/62706/the-us-f‚Ä¶, pic.twitter.com/0INCQPOf5T, ",1419607930760880131,False,0,0,0,0,Twitter Web App,"The US FDA Declines to Approve Incyte‚Äôs Retifanlimab to Treat Patients with Squamous Cell Carcinoma of the Anal Canal @Pharmashot @Incyte 
https://t.co/TSLxnG6iWz https://t.co/0INCQPOf5T","Pharmashot, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,photo
1166772455417024512,2021-07-26 06:37:33,,"AnalCancer, Biotech, ","dlvr.it/S4RLx4, pic.twitter.com/HCJSiDT0YL, ",1419607817523138562,False,0,0,0,0,dlvr.it,#AnalCancer #Biotech FDA Strikes Off Incyte's Retifanlimab Application In Anal Cancer https://t.co/1VpAtpyYfM https://t.co/HCJSiDT0YL,,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
963495628545327104,2021-07-26 06:37:03,"INCY, INCY, ",,"stck.pro/news/INCY/1456‚Ä¶, stck.pro/news/INCY, pic.twitter.com/p8tD8BoxgE, ",1419607692012888064,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : FDA Strikes Off Incyte's Retifanlimab Application In Anal Cancer https://t.co/9TYSGOC0K2 Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/p8tD8BoxgE,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
18294197,2021-07-26 06:20:44,,,"fiercebiotech.com/biotech/fda-de‚Ä¶, ",1419603586460307457,False,0,0,0,2,Twitter Web App,"Specifically that letter, which is not published by the FDA but comes via Incyte, says that it needs ‚Äúadditional data‚Äù in order to prove the clinical benefit of retifanlimab https://t.co/hjMUrrkW3x",,,2008-12-21 17:21:58,"Washington, DC",FierceBiotech,https://pbs.twimg.com/profile_images/1270578068701224962/2YHKa3mX_normal.jpg,92204,663,2073,25532,FierceBiotech,
1883393875,2021-07-26 04:13:03,,,"dlvr.it/S4QyVW, ",1419571451762397186,False,0,0,0,0,dlvr.it,Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with SCAC https://t.co/q6pHov7oZM,,,2013-09-19 10:40:31,Amsterdam,Pharma Market News,https://pbs.twimg.com/profile_images/378800000501255643/53b0cadf7327b09ab8610040b07fcb10_normal.jpeg,1499,1215,21,7595,pharmamarketnws,
1262114478986010632,2021-07-25 17:43:06,"INCY, ",,,1419412923311591425,False,0,0,1,0,Twitter Web App,$INCY FDA declines to approve Incyte's squamous cell carcinoma treatment retifanlimab,,,2020-05-17 16:15:42,,GapUpüß©,https://pbs.twimg.com/profile_images/1262126091671670784/fUEaPN8a_normal.jpg,161,649,5,6750,GapUp4,
4028839455,2021-07-25 12:15:03,,,"stocktrot.com/company/incyte‚Ä¶, ",1419330365441953793,False,0,0,0,0,StockTrot1,"Bullish Clancy Paul J acquires $23,808.79 of Incyte Corp shares. Largest in 2 months. https://t.co/Glm3Ox59RC",,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
1277426946373124096,2021-07-24 14:38:02,,"DataProtection, VMware, ","druva.info/3eTrnsL, ",1419003960812261452,False,0,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/lVDH4TrUmv

@druvainc","druvainc, ",,2020-06-28 22:21:43,,JayJ,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1,0,0,2558,JayJ03982258,
1194670770082996226,2021-07-24 13:00:35,,,"medicalupdateonline.com/2021/07/lilly-‚Ä¶, pic.twitter.com/sPlkAFTvYd, ",1418979437559877635,False,1,0,0,0,Hootsuite Inc.,Lilly and Incyte provide update on supplemental NDA for baricitinib for the treatment of moderate to severe atopic dermatitis https://t.co/CfX6ZaiqVe https://t.co/sPlkAFTvYd,,,2019-11-13 12:38:33,,MedicalUpdateOnline,https://pbs.twimg.com/profile_images/1194697408829165570/4y6Vt-3g_normal.jpg,782,605,7,1206,MedUpdateOn1ine,photo
1325115160353103872,2021-07-24 11:00:49,"INCY, ",,"quantisnow.com/insight/148225‚Ä¶, ",1418949293495537675,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)

https://t.co/6hre0mkm8M",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
25406480,2021-07-24 10:20:37,,,"awesomecapital.blogspot.com/2021/07/incyte‚Ä¶, ",1418939178033819650,False,0,0,0,1,Twitter Web App,AwesomeCapital: Incyte gets Complete Response Letter in carcinoma ... https://t.co/egtR05RqwB,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
1889492676,2021-07-24 05:42:05,"INCY, ","Incyte, Retifanlimab, SquamousCellCarcinomaoftheAnalCanal, SCAC, ","1stoncology.com/blog/incyte-pr‚Ä¶, ",1418869082452025348,False,0,0,0,0,Troi URL Plug-in,#Incyte Provides Regulatory Update on #Retifanlimab for the Treatment of Certain Patients with #SquamousCellCarcinomaoftheAnalCanal (#SCAC) $INCY https://t.co/bGyUcCuPdz,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
15232532,2021-07-24 05:34:36,,,"dlvr.it/S4Kyjh, ",1418867200971231242,False,0,0,0,0,dlvr.it,Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/9gyVQVVADB,,,2008-06-25 11:32:12,"Cape Cod, MA",DennisPartners,https://pbs.twimg.com/profile_images/777939023461511168/Lqtz-Jal_normal.jpg,415,425,13,7177,DennisPartners,
227778014,2021-07-23 22:30:01,"INCY, ",,"buff.ly/3iKI6Q6, ",1418760348941836289,False,1,0,0,0,Buffer,"BioCentury's latest roundup of regulatory &amp; policy news: FDA wants more data from Incyte on¬†retifanlimab; plus approvals for Dalvance,¬†Bydureon, a new PDUFA date for inclisiran and an upcoming adcomm on gene therapies¬†  $INCY https://t.co/rBpKl3ReUt",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
18396070,2021-07-23 22:07:35,,"Sponsored, YouHaveToGoToKnow, IncytePartner, ","pic.twitter.com/hzWAC4wZRa, ",1418754703253327874,False,2905,12,30,311,Twitter for iPhone,"Hey y‚Äôall‚Ä¶ I‚Äôm excited to announce that I‚Äôve partnered with Incyte to raise awareness for those living with a group of rare, chronic blood cancers known as myeloproliferative neoplasms. ¬†#Sponsored #YouHaveToGoToKnow #IncytePartner https://t.co/hzWAC4wZRa",,,2008-12-26 16:51:53,This Now Moment,LeVar Burton,https://pbs.twimg.com/profile_images/1423665531308036111/ejc7NcWz_normal.jpg,2151861,1052,18298,17903,levarburton,video
1315434407692509184,2021-07-23 22:03:06,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/vTCj3mVQ2s, ",1418753577368104960,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2216 out of 5557 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/vTCj3mVQ2s",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
4058194633,2021-07-23 19:12:45,"INCY, ZLAB, MGNX, ",,"new.firstwordpharma.com/story/5357769, ",1418710707760074756,False,0,0,0,0,Twitter for iPhone,$INCY $ZLAB $MGNX FDA declines to approve Incyte's retifanlimab for advanced anal cancer https://t.co/EIkixkGQZG via @fwpharma,"fwpharma, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-07-23 19:10:32,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1418710148843937797,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) | Business Wire https://t.co/AMDqjUzVHQ,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
56121651,2021-07-23 18:35:51,"TNXP, INCY, XBIO, ACOR, ADVM, LVTX, ABBV, AZN, IONS, PTIX, UBX, ",,"biopharmcatalyst.com/news/2021/toni‚Ä¶, ",1418701419926888454,False,6,1,1,5,TweetDeck,"BioPharmCatalyst updates 07/23/21:

$TNXP fibromyalgia fail -40% AH
$INCY CRL

$XBIO +35%; $ACOR +24%
$ADVM -23%; $LVTX -15%

Pipeline updates $ABBV $AZN $IONS $PTIX $UBX 

https://t.co/AuQCcqj0kw",,,2009-07-12 11:59:54,,BioPharmCatalyst,https://pbs.twimg.com/profile_images/1425820382091636746/Xx33Y7hR_normal.jpg,25993,182,548,6628,BPharmCatalyst,
72928001,2021-07-23 18:35:02,"INCY, ",,"bit.ly/3wZ7R4w, ",1418701216457003012,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte: US FDA cannot approve co's application for its retifanlimab drug in its present form https://t.co/AvzN9HAtkD,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1227080867832565760,2021-07-23 18:14:13,"INCY, ",,,1418695975326167042,False,0,0,0,0,Twitter Web App,$INCY: Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC),,,2020-02-10 23:04:40,"San Diego, CA",oryo,https://pbs.twimg.com/profile_images/1284688749180354560/4QESe1aF_normal.jpg,552,2695,12,17490,OryoJohn,
1006334607946649600,2021-07-23 18:14:10,,"StockMarket, Stocks, ","dlvr.it/S4Jq96, ",1418695964848582661,False,0,0,0,0,dlvr.it,Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/8W1G88iriM #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
35789155,2021-07-23 17:46:44,"INCY, ",,"new.firstwordpharma.com/story/5357769, ",1418689057853476864,False,1,0,0,0,Twitter Web App,FDA declines to approve Incyte's retifanlimab for advanced anal cancer $INCY https://t.co/EunfyBXo5g,,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
1087808573185449984,2021-07-23 17:24:19,,,"pic.twitter.com/v2L5NsgCTB, ",1418683420008407042,False,14,0,0,1,Twitter Web App,Congratulations to Dr. Ming Xiang for a successful thesis defense last week: Enantioselective Iridium- and Ruthenium-Catalyzed Carbonyl Reductive Coupling via Hydrogen Transfer. Ming will start his new position @Incyte next month! https://t.co/v2L5NsgCTB,"Incyte, ",,2019-01-22 15:25:49,"Austin, TX",Krische Lab,https://pbs.twimg.com/profile_images/1087812040515760128/elM2y5VZ_normal.jpg,1718,125,13,95,KrischeLab,photo
963495628545327104,2021-07-23 16:57:35,"INCY, INCY, ",,"stck.pro/news/INCY/1451‚Ä¶, stck.pro/news/INCY, ",1418676689601712128,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : FDA declines to approve Incyte's squamous cell carcinoma treatment retifanlimab https://t.co/PwdY25Nx7A Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
270492072,2021-07-23 16:57:22,,"news, SeekingAlpha, ","seekingalpha.com/news/3718775-f‚Ä¶, ",1418676636203970569,False,0,0,0,0,Microsoft Power Platform,FDA declines to approve Incyte's squamous cell carcinoma treatment retifanlimab https://t.co/JKUvdqvRqr via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
1134049078424162304,2021-07-23 16:56:33,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1418676432184750088,False,0,0,0,0,Newsfilter.io,Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal $INCY https://t.co/WDI8cL8h0A,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1058344962285289472,2021-07-23 16:43:42,"INCY, ",,,1418673198254723073,False,1,0,0,0,TweetDeck,"$INCY - Incyte Corp announces that the FDA has issued a Complete Response Letter (CRL) regarding pplication for retifanlimab, an intravenous PD-1 inhibitor to certain carcinoma (SCAC)

The CRL states that the FDA cannot approve the application in its present form.",,,2018-11-02 09:07:56,For a free 2-week trial click,Hammerstone Markets,https://pbs.twimg.com/profile_images/1058346560604430336/kDXZ5dlQ_normal.jpg,3555,378,127,11186,HammerstoneMar3,
1134049078424162304,2021-07-23 16:38:34,"INCY, ",,"newsfilter.io/articles/fda-d‚Ä¶, ",1418671905658359810,False,0,0,0,0,Newsfilter.io,FDA declines to approve Incyte's squamous cell carcinoma treatment retifanlimab $INCY https://t.co/q8yHZCtf8l,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
472650465,2021-07-23 16:38:13,"INCY, ",,"otcdynamics.com/incy-incyte-pr‚Ä¶, ",1418671815883382793,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/JtKwpNCUiC,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
360220091,2021-07-23 16:35:34,,,"dataemia.com/?p=530500, ",1418671148284448769,False,0,0,0,0,Newsemia,(Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)) https://t.co/PsoWwMTOoi,,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,
3318510966,2021-07-23 16:33:08,,,"crweworld.com/article/news-p‚Ä¶, ",1418670536339558402,False,0,0,0,0,CRWE World,Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma https://t.co/C11quZ5dkV,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1069693680066420736,2021-07-23 16:32:35,"INCY, ",,"s.flashalert.me/qGG5N, ",1418670399315972096,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on July 23, 16:30:00: Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/N9xRZMVeqs",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1355194932445786112,2021-07-23 16:32:31,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1418670382278656005,False,0,0,0,0,Twitter,"$INCY Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)
https://t.co/WnbgxkY9g3",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
976297820532518914,2021-07-23 16:32:11,,,"dlvr.it/S4JZtt, pic.twitter.com/8TdswLcUX8, ",1418670300393205761,False,0,0,0,0,dlvr.it,Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/YHYB5vyy9E https://t.co/8TdswLcUX8,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1254035253104181256,2021-07-23 16:30:46,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1418669940618432516,False,0,0,0,0,stocktitan,"$INCY Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)
https://t.co/23Dq2HLPZJ",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1325115160353103872,2021-07-23 16:30:33,"INCY, ",,"quantisnow.com/insight/148117‚Ä¶, ",1418669886209884164,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)

https://t.co/bOfcrclE63",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1393303407801294850,2021-07-23 16:30:05,"INCY, ",,"webchronicletoday.com/incyte-provide‚Ä¶, ",1418669769214021634,False,0,0,0,0,Twitter,"$INCY Incyte Provides Regulatory Update on Retifanlimab for the Treatment of Certain Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)
 
https://t.co/ozky67yb5X",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
374729426,2021-07-23 15:46:18,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2900697, pic.twitter.com/3UayKEnlBV, ",1418658752136318984,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on July 2, 2021. View odds for this and other indicators: https://t.co/xbRIUu26Rs #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/3UayKEnlBV",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
21213649,2021-07-23 06:42:41,,,"bit.ly/3iI1PQq, pic.twitter.com/Nf22NyoVCX, ",1418521947667935237,False,0,0,0,0,Twitter Web App,"NICE approves treatment for rare form of bile duct cancer

Read it here: https://t.co/XycjXygyWj 

@NICEComms @Incyte https://t.co/Nf22NyoVCX","NICEComms, Incyte, ",,2009-02-18 11:48:34,Cheshire,EPM Magazine,https://pbs.twimg.com/profile_images/1387429560820584448/aK4MTobV_normal.png,4072,1552,187,13699,EPM_Magazine,photo
1979190776,2021-07-23 01:19:21,"INCY, ",,"tickerreport.com/?p=7674571, ",1418440575666343940,False,0,0,0,0,Zapier.com,William Blair Equities Analysts Lower Earnings Estimates for Incyte Co. $INCY https://t.co/OGSyxQgNC4,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1207759186131652608,2021-07-22 17:50:03,,"EliLilly, OLUMIANT, Baricitinib, RheumatoidArthritis, AntagonistTherapies, Tumor, Pharma, Incyte, ","drugdiscoverytrends.com/olumiant-offer‚Ä¶, ",1418327506713776128,False,0,0,0,0,Sprout Social,"FDA has indicated #EliLilly‚Äôs #OLUMIANT (#Baricitinib) to treat adult patients with moderately to severely active #RheumatoidArthritis. 

MORE ON THE STORY HERE: https://t.co/LrT9a6stiw

#AntagonistTherapies #Tumor #Pharma @LillyPad @Incyte #Incyte","LillyPad, Incyte, ",,2019-12-19 15:26:52,United States,Drug Discovery & Development,https://pbs.twimg.com/profile_images/1214216496043323393/Dk0NlVB__normal.jpg,462,96,2,791,DrugDiscoverDev,
59310742,2021-07-22 15:00:33,,,"dlvr.it/S4Dt7W, pic.twitter.com/mDL0m5tRrc, ",1418284852458057731,False,0,0,0,0,dlvr.it,NICE recommends Incyte‚Äôs Pemazyre for rare bile duct cancer https://t.co/C3CcytbhNP https://t.co/mDL0m5tRrc,,,2009-07-22 20:57:49,ANZ,David Ledger,https://pbs.twimg.com/profile_images/621209163566182400/AWY0hAql_normal.jpg,826,1827,26,25935,Vedere_Group,photo
2570983608,2021-07-22 14:43:10,,,"pharmatimes.com/news/nice_reco‚Ä¶, ",1418280477157384193,False,0,0,0,0,Twitter Web App,NICE recommends Incyte‚Äôs Pemazyre for rare bile duct cancer https://t.co/fGgGhmfcS3,,,2014-06-16 10:03:47,United Kingdom,Oncology Forum UK,https://pbs.twimg.com/profile_images/1279035879500193792/Uk8VJf8F_normal.jpg,4636,1885,0,76916,OncologyForum,
19393686,2021-07-22 10:45:31,,,"lnkd.in/efQwbKy, lnkd.in/eqFcGjp, ",1418220670123606024,False,0,0,0,0,LinkedIn,"AMMF, the UK‚Äôs first and only cholangiocarcinoma charity is excited by an announcement made by Incyte Biosciences UK that a potentially life-extending oral treatment for some people with the rare and devastating liver cancer, chola‚Ä¶https://t.co/ldGvewq6R3 https://t.co/WFYmvR73AP",,,2009-01-23 08:27:30,"London, England",3CommPR,https://pbs.twimg.com/profile_images/891991201838231552/diFzf6Tk_normal.jpg,1385,2682,0,1132,3commpr,
4058194633,2021-07-22 10:13:22,"INCY, ",,"pharmaphorum.com/?p=82365, ",1418212578552029187,False,0,0,0,0,Twitter for iPhone,$INCY NICE changes its mind on rare bile duct cancer drug from Incyte https://t.co/k6EemKNWNo via @pharmaphorum,"pharmaphorum, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-07-22 10:12:14,"INCY, ",,"pharmatimes.com/news/nice_reco‚Ä¶, ",1418212292315869187,False,0,0,0,0,Twitter for iPhone,$INCY NICE recommends Incyte‚Äôs Pemazyre for rare bile duct cancer https://t.co/vwOdVaaDyi,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1097819621619630080,2021-07-22 08:10:03,,,"dlvr.it/S4CdWb, pic.twitter.com/ijKnfM4LzU, ",1418181546637361156,False,0,0,0,0,dlvr.it,NICE recommends Incyte‚Äôs Pemazyre for rare bile duct cancer https://t.co/zvk14i8xHh https://t.co/ijKnfM4LzU,,,2019-02-19 06:26:09,"London, England",PharmaCrowd,https://pbs.twimg.com/profile_images/1123311799561068545/UnJBMgbE_normal.png,29,22,0,2226,PharmaCrowd,photo
732361939490312192,2021-07-22 08:05:29,"INCY, ","markets, ","americanbankingnews.com/?p=21126536, ",1418180397280731141,False,0,0,0,0,Zapier.com,Q2 2021 EPS Estimates for Incyte Co. Lowered by William Blair $INCY https://t.co/7ZW2dmoYPm #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-07-22 08:05:29,"INCY, ","stocks, ","americanbankingnews.com/?p=21126536, ",1418180393837150212,False,0,0,0,0,Zapier.com,Q2 2021 EPS Estimates for Incyte Co. Lowered by William Blair $INCY https://t.co/RVvTCEpsb0 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1098710533,2021-07-22 07:42:31,,"cholangiocarcinoma, ","bit.ly/36SMxmx, ",1418174616531574787,False,12,0,0,5,HubSpot,"NICE has released final draft guidance recommending pemigatinib (Pemazyre) for FGFR2 #cholangiocarcinoma. Read up on this positive news from @Incyte and all the trial data on @OncologyCentral, as well as the recent drug evaluation on @FutureOncol_FSG https://t.co/VxvuMlg9ij","Incyte, OncologyCentral, FutureOncol_FSG, ",,2013-01-17 11:56:39,,Oncology Central,https://pbs.twimg.com/profile_images/1422197020547325956/KO3ba8zJ_normal.jpg,4667,3751,126,7967,OncologyCentral,
374341080,2021-07-22 07:21:02,,,"dlvr.it/S4CVDl, ",1418169209008267267,False,0,0,0,0,dlvr.it,NICE recommends Incyte‚Äôs Pemazyre for rare bile duct cancer https://t.co/tjYSmAPx4D,,,2011-09-16 00:35:32,,Pharma Trader,https://pbs.twimg.com/profile_images/1544984545/medicinenet_normal.jpg,85,29,1,11673,pharmatraders,
76768831,2021-07-22 07:21:02,,,"dlvr.it/S4CVDw, ",1418169208320397312,False,0,0,0,0,dlvr.it,NICE recommends Incyte‚Äôs Pemazyre for rare bile duct cancer https://t.co/UMdd6qBUtr,,,2009-09-23 17:56:06,"London, England",Iceberg Vision,https://pbs.twimg.com/profile_images/922924826712567808/RsSXYuFe_normal.jpg,67,116,5,1221,icebergvision,
2704905116,2021-07-22 07:21:02,,,"dlvr.it/S4CVFM, ",1418169208282566658,False,0,0,0,0,dlvr.it,NICE recommends Incyte‚Äôs Pemazyre for rare bile duct cancer https://t.co/OoYdI0yIN0,,,2014-08-03 17:01:43,Worldwide,Everything Pharma,https://pbs.twimg.com/profile_images/496040907154534400/7fJoRr4p_normal.jpeg,11,9,0,7417,EveryPharma,
50405984,2021-07-22 07:15:02,,"cholangiocarcinoma, ","ammf.org.uk/2021/07/22/nic‚Ä¶, pic.twitter.com/1ySWDnstNn, ",1418167701084778499,False,7,0,0,2,Hootsuite Inc.,"Dame Zandra Rhodes DBE, RDI, who was diagnosed with #cholangiocarcinoma during lockdown, is delighted to hear NICE have approved re pemigatinib today. For her comment in full see, https://t.co/VkcbFO6LAL
@CharityAMMF @Incyte @CcaEns @CCA_Alliance https://t.co/1ySWDnstNn","CharityAMMF, Incyte, CcaEns, CCA_Alliance, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
52354784,2021-07-22 07:10:18,,"pharmanews, pharma, ","feedproxy.google.com/~r/Pharmatimes‚Ä¶, ",1418166507826204673,False,0,0,0,0,SocialPilot.co,NICE recommends Incyte‚Äôs Pemazyre for rare bile duct cancer https://t.co/ONI94Nm168 #pharmanews #pharma,,,2009-06-30 05:46:48,"Surrey, UK",PharmaTimes,https://pbs.twimg.com/profile_images/533273520885616640/vb4_MuJ1_normal.png,53067,1318,1008,19444,PharmaTimes,
2181281054,2021-07-22 06:41:01,"INCY, ","markets, ","wkrb13.com/?p=3363333, ",1418159138803228675,False,0,0,0,0,Zapier.com,Stock Traders Buy Large Volume of Incyte Put Options $INCY https://t.co/DOwW5trnYd #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
50405984,2021-07-22 06:31:38,,"cholangiocarcinoma, ","pharmafile.com/news/583430/ni‚Ä¶, pic.twitter.com/Dtl40IIJAJ, ",1418156777229672452,False,17,0,0,7,Hootsuite Inc.,"IN THE NEWS:  The announcement of NICE approval today of @Incyte‚Äôs targeted therapy, pemigatinib, for those with #cholangiocarcinoma and the FGFR2 fusion, is reaching the press!
https://t.co/aIwBOPDk1x https://t.co/Dtl40IIJAJ","Incyte, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
527545839,2021-07-22 05:56:12,,,"justice.gov/opa/pr/incyte-‚Ä¶, ",1418147860965584898,False,0,0,0,0,Twitter for iPhone,Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks https://t.co/1Z2WIPVh5B,,,2012-03-17 11:11:19,"Denver, CO",Michelle Lee Kosik,https://pbs.twimg.com/profile_images/2159780283/image_normal.jpg,178,334,5,61178,michellekosik_,
27254739,2021-07-22 05:49:14,,"cholangiocarcinoma, heor, ","bit.ly/3kIMLEV, ",1418146106089803782,False,7,0,0,3,Sprout Social,.@Incyte's Pemazyre has become the first targeted therapy available for NHS patients with FGFR2-mutated #cholangiocarcinoma or bile duct cancer https://t.co/ktmW2qL3EQ #heor,"Incyte, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
1304774550014615554,2021-07-22 05:40:20,,"NICE, pemigatinib, cholangiocarcinoma, ","pharmafile.com/news/583430/ni‚Ä¶, ",1418143865752653828,False,22,0,0,9,Twitter Web App,"#NICE announcement is getting good press coverage today.  Approval of #pemigatinib opens the door to the possibility of molecular profiling for all diagnosed with #cholangiocarcinoma - a major step forward.      https://t.co/sewdQ1ehMJ
@Incyte @CharityAMMF @CcaEns @CCA_Alliance","Incyte, CharityAMMF, CcaEns, CCA_Alliance, ",,2020-09-12 09:32:06,UK,Helen Morement,https://pbs.twimg.com/profile_images/1304775126232293377/dwFksdw9_normal.jpg,182,299,0,268,HelenMorement,
50405984,2021-07-22 04:00:17,,"pemigatinib, cholangiocarcinoma, AMMF, ","ammf.org.uk/2021/07/22/nic‚Ä¶, pic.twitter.com/mUGEE76lMX, ",1418118688549580805,False,11,3,0,3,Hootsuite Inc.,"Today, 22 July 2021, NICE has approved #pemigatinib for those with #cholangiocarcinoma who have an FGFR2 genetic rearrangement. #AMMF believes this marks a major milestone in the fight against CCA &amp; brings new hope for the future. https://t.co/VkcbFO6LAL 
@Incyte https://t.co/mUGEE76lMX","Incyte, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
1304774550014615554,2021-07-22 03:16:55,,"cholangiocarcinoma, NICE, pemigatinib, ","ammf.org.uk/2021/07/22/nic‚Ä¶, ",1418107775310311424,False,48,2,2,16,Twitter Web App,A MILESTONE DAY TODAY for #cholangiocarcinoma patients in England &amp; Wales as #NICE announce approval of #pemigatinib for those with an FGFR2 fusion.  Looking forward to a day of press interviews to share the news! https://t.co/uNinWQ6ecp @Incyte @charityammf @CcaEns @CCA_Alliance,"Incyte, CharityAMMF, CcaEns, CCA_Alliance, ",,2020-09-12 09:32:06,UK,Helen Morement,https://pbs.twimg.com/profile_images/1304775126232293377/dwFksdw9_normal.jpg,182,299,0,268,HelenMorement,
1390980477998223361,2021-07-21 13:51:31,,"cholangiocarcinoma, bileductcancer, Awareness, hope, ",,1417905088484548614,False,19,1,1,1,Twitter for Android,"Holy shhhhmoke! 3 radio interviews and 1 TV interview tomorrow for me and my 20 strands of hair.
Really excited to help raise awareness of #cholangiocarcinoma and the importance of genomic testing üôå alongside @Incyte
and @CharityAMMF 

#bileductcancer #Awareness #hope","Incyte, CharityAMMF, ",,2021-05-08 06:43:07,Yorkshire,Beating Bile Duct Cancer - Megan üíö,https://pbs.twimg.com/profile_images/1422865480797282305/bT2yU81V_normal.jpg,142,364,0,232,RubyRedcurrant,
374729426,2021-07-21 11:02:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2895302, pic.twitter.com/1v36DXpO8z, ",1417862589233569792,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on July 2, 2021. View odds for this and other indicators: https://t.co/D7wklAl3cZ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1v36DXpO8z",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1207759186131652608,2021-07-21 10:57:01,,"JanusKinase, Rinvoq, Upadacitinib, AbbVie, Incyte, RheumatoidArthritis, Immunosuppressant, Methotrexate, ","drugdiscoverytrends.com/abbvies-and-in‚Ä¶, ",1417861174524321799,False,0,0,0,0,Sprout Social,"The #JanusKinase inhibitor #Rinvoq (#Upadacitinib) from #AbbVie &amp; #Incyte has a current indication for moderate - severe active #RheumatoidArthritis for patients with an inadequate response or intolerance to the #Immunosuppressant #Methotrexate

MORE HERE: https://t.co/uebZ5SJKFq",,,2019-12-19 15:26:52,United States,Drug Discovery & Development,https://pbs.twimg.com/profile_images/1214216496043323393/Dk0NlVB__normal.jpg,462,96,2,791,DrugDiscoverDev,
831801503694336000,2021-07-20 23:22:50,"INCY, ",,,1417686478138843137,False,0,0,0,0,StockTwits Web,$INCY Incyte (INCY) upgraded to Buy from Hold at The Benchmark Company; tgt $89,,,2017-02-15 04:45:07,,itsallaboutheoptions,https://pbs.twimg.com/profile_images/831802655752253441/cZDxLbiD_normal.jpg,9072,4,172,38317,aboutheoptions,
963495628545327104,2021-07-20 15:45:27,"INCY, INCY, ",,"stck.pro/news/INCY/1444‚Ä¶, stck.pro/news/INCY, pic.twitter.com/DwkDaV5t1c, ",1417571374470684672,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Benchmark Upgrades Incyte After Stock Selloff https://t.co/9ykoP9xVam Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/DwkDaV5t1c,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1416252425808326661,2021-07-20 15:40:02,"INCY, ","notification, investing, story, stockmarket, article, ","stockninja.io/stocks/incy/?u‚Ä¶, benzinga.com/analyst-rating‚Ä¶, ",1417570011313414145,False,0,0,0,0,Twitter,"Benchmark Upgrades Incyte After Stock Selloff - https://t.co/mqYCAdFjXR

https://t.co/ZjiwEHJQ1l

$INCY #notification #investing #story #stockmarket #article",,,2021-07-17 00:24:30,,Breaking Stock News,https://pbs.twimg.com/profile_images/1416252534881128448/oXTU2Qzv_normal.jpg,11,1,1,441,stockninja_news,
1272652048748535808,2021-07-20 14:26:04,,"MondayMotivation, AWS, DataProtection, ","druva.info/3xW1XCe, pic.twitter.com/X3IFl4Pcv2, ",1417551398217134080,False,0,0,0,0,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/fTk0IaZlQN

#AWS #DataProtection @druvainc https://t.co/X3IFl4Pcv2","druvainc, ",,2020-06-15 18:08:05,India,Aditya Shah,https://pbs.twimg.com/profile_images/1272652240608563200/bv36x8Un_normal.jpg,13,71,0,526,AdityaS62983764,photo
158350630,2021-07-20 14:15:41,,"RareDiseaseAdvisor, NORD, ","bit.ly/3wUqSoH, ",1417548784192610311,False,3,1,0,1,Twitter Web App,My story in #RareDiseaseAdvisor on #NORD's 2021 Rare Impact Awards. @RareDiseases @Incyte @CureDuchenne @RareDisease_Adv @DTRFoundation @ncats_nih_gov @Alnylam @AstraZeneca @BlueprintMeds @HorizonNews @loxooncology @Regeneron @PattyMurray @HannahEKaneMA https://t.co/cLEgTfikqu,"RareDiseases, Incyte, CureDuchenne, RareDisease_Adv, DTRFoundation, ncats_nih_gov, Alnylam, AstraZeneca, BlueprintMeds, HorizonNews, loxooncology, Regeneron, PattyMurray, HannahEKaneMA, ",,2010-06-22 08:13:50,Tel Aviv,Larry Luxner,https://pbs.twimg.com/profile_images/1203317491465957378/m_MUflcg_normal.jpg,843,329,22,940,LLuxner,
33360563,2021-07-20 13:04:00,,,"aishealth.com/datapoint/data‚Ä¶, ",1417530743396343811,False,0,0,0,0,TweetDeck,"Datapoint: Among the most advantaged therapies for graft-versus-host disease are J&amp;J and AbbVie‚Äôs Imbruvica, which holds covered or better status for 73% of all insured lives under the pharmacy benefit, Incyte‚Äôs Jakafi (72%) and Amgen‚Äôs Enbrel (70%)
https://t.co/xgqUjobZfq",,,2009-04-19 21:00:03,"Washington, D.C.",AIS Health,https://pbs.twimg.com/profile_images/1392526145581555714/q1iVOtaD_normal.jpg,2984,1202,155,9861,AISHealth,
491383486,2021-07-20 10:05:06,,"Incyte, mentoring, Biotech, SMDPBiotech, BiotechCareers, ConsumerHealth, ","pic.twitter.com/g3SW4ACnSv, ",1417485720902676486,False,1,0,0,0,Buffer,"We are pleased to announce Khary Adams, MBA, Senior Director for Laboratory Animal Resources at #Incyte Corporation is #mentoring a 2021 SMDP #Biotech Scholar.

#SMDPBiotech #BiotechCareers #ConsumerHealth https://t.co/g3SW4ACnSv",,,2012-02-13 10:39:22,United States of America,SMDP Scholars,https://pbs.twimg.com/profile_images/1288394914523492353/ynuAF9es_normal.jpg,4813,953,36,1743,smdpscholars,photo
4058194633,2021-07-20 09:53:45,"INCY, ",,"briefing.com/calendars/updo‚Ä¶, ",1417482866699784199,False,0,0,0,0,Twitter for iPhone,"$INCY Benchmark Upgrades Incyte From Hold To Buy, $89 PT https://t.co/0as1obImti",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1399103920522334219,2021-07-20 09:24:06,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/CQ0uE3mQOe, ",1417475406102421512,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2216 out of 5544 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/CQ0uE3mQOe",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
1273844033861844993,2021-07-20 09:00:50,"INCY, ",,"pic.twitter.com/2d0FATKJY2, ",1417469550082330624,False,0,0,0,1,StockTwits Web,"$INCY [Incyte]: Benchmark Upgrades Hold --&gt; Buy Announces Price Target $89 
charts: courtesy of finviz https://t.co/2d0FATKJY2",,,2020-06-19 01:04:32,United States,Jarvis-Alerts,https://pbs.twimg.com/profile_images/1374794584513986568/eWDm8YFI_normal.jpg,4169,102,79,63687,Jarvis_Alerts,photo
1261065948011864064,2021-07-20 08:59:59,"INCY, ",,,1417469336198041604,False,0,0,0,0,StockTwits Web,"Incyte (INCY) raised to buy at Benchmark; PT $89
$INCY",,,2020-05-14 18:50:34,"Dallas, TX",Print Trading,https://pbs.twimg.com/profile_images/1270530766913572864/362fWEDo_normal.jpg,1346,0,41,14970,print_trading,
2373909360,2021-07-20 08:49:13,,"benchmarkthis, incyte, ","upstract.com/p/8fma6ykn?ref‚Ä¶, ",1417466627646492674,False,0,0,0,0,News Users,Incyte upgraded to buy from hold at Benchmark #benchmarkthis #incyte https://t.co/t8n4naHDoF,,,2014-03-05 10:12:33,,Upstract News,https://pbs.twimg.com/profile_images/1318142188287627265/4u0Sc4gy_normal.jpg,1690,1,35,174392,upstractcom,
732361939490312192,2021-07-20 08:27:34,"INCY, ","markets, ","americanbankingnews.com/?p=21087837, ",1417461176708046849,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by Benchmark to ‚ÄúBuy‚Äù https://t.co/6Ag0aTeuBf #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-07-20 08:27:33,"INCY, ","stocks, ","americanbankingnews.com/?p=21087837, ",1417461174514356226,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by Benchmark to ‚ÄúBuy‚Äù https://t.co/vWM5MXHVjY #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2612788123,2021-07-20 08:13:18,"INCY, KRYS, ZION, IBM, SPG, ","Stocks, Upgrades, ",,1417457585620402182,False,1,0,0,0,TweetDeck,"#Stocks #Upgrades
$INCY Benchmark Upgrades Incyte toBuy from Hold, PT $88
$KRYS Goldman Neutral to Buy, Raises PT to $90
$ZION Baird Underperform to Neutral, PT $49
$IBM Soci√©t√© General Sell to Hold, Raises PT to $140 from $121
$SPG Stifel Hold to Buy, Raises PT to $132 from $125",,,2014-07-08 22:13:20,,MStang,https://pbs.twimg.com/profile_images/486698998728642560/jI7DiDYR_normal.jpeg,212,573,7,8251,StockJock22,
1254906887490936845,2021-07-20 07:57:24,"INCY, ",,"quantdata.us/news/22057780, ",1417453583642075139,False,0,0,0,0,Quant Data (Production),"Benchmark Upgrades Incyte to Buy, Announces $89 Price Target

Related Tickers: $INCY
Read more at: https://t.co/z1chr1mnI9",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
1325115160353103872,2021-07-20 07:42:46,"INCY, ",,"quantisnow.com/insight/142620‚Ä¶, ",1417449901433114634,False,0,0,0,0,Twitter,"$INCY üì° Incyte upgraded by Benchmark with a new price target

https://t.co/FJXRg1IrHp",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1134049078424162304,2021-07-20 07:42:23,"INCY, ",,,1417449807770230801,False,0,0,0,0,Newsfilter.io,$INCY Benchmark analyst Aydin Huseynov upgrades Incyte from Hold to Buy and announces $89 price target.,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
849417718642159616,2021-07-20 07:26:55,"INCY, ",,"zpr.io/gb3JsRvbYaC6, ",1417445913602240515,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Increased to Buy at Benchmark https://t.co/lB6jz2QJfj,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1325115160353103872,2021-07-20 07:25:40,"INCY, ",,"quantisnow.com/insight/142593‚Ä¶, ",1417445598622490625,False,0,0,0,0,Twitter,"$INCY üìã Incyte upgraded by The Benchmark Company with a new price target

https://t.co/lc9w7YjR4O",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1244266306485932034,2021-07-19 22:39:19,"KVSA, BLDE, QSI, INCY, CND, OPEN, NTDOY, BEKE, SCHW, ABBV, PSTG, ","ArkFunds, ",,1417313137611534336,False,6,0,0,2,Twitter Web App,"Ark Funds buy Khosla Ventures Acquisition Corp, Blade Air, QUANTUM-SI, Incyte, Concord Acquisition corp, 
and sell Opendoor Technologies, NINTENDO, KE Holdings, Charles Schwab, AbbVie, PURE STORAGE.
$KVSA $BLDE $QSI $INCY $CND $OPEN $NTDOY $BEKE $SCHW $ABBV $PSTG
#ArkFunds",,,2020-03-29 10:13:08,Shanghai HongKong,CN Wire,https://pbs.twimg.com/profile_images/1328240753353523200/XYefJVjh_normal.jpg,18912,661,462,15021,Sino_Market,
289846342,2021-07-19 14:21:55,,,"youtube.com/watch?v=W3Z0iz‚Ä¶, ",1417187964157931528,False,1,0,0,0,Twitter Web App,"I made a video about Incyte Corporation (INCY stock)
Check it on YouTube: https://t.co/jSlBuvSv01",,,2011-04-29 05:34:12,Moscow,Stelmak Denis,https://pbs.twimg.com/profile_images/511764951732457473/89ZcF0fa_normal.jpeg,5168,104,2,20382,IStelmak,
1298516232140972038,2021-07-19 13:20:02,"INCY, ",,"tobaia.com/app/instrument‚Ä¶, ",1417172389247528961,False,0,0,0,0,Twitter,New Short opportunity for Incyte Corporation $INCY at 77.70$. More information of the event and live risk management at https://t.co/8ONpcT82t8,,,2020-08-26 03:03:39,Global,Tobaia,https://pbs.twimg.com/profile_images/1298517759895252992/GrTPQaSE_normal.jpg,58,36,0,2601,Tobaia_com,
121158213,2021-07-19 09:52:06,"INCY, ",,"dlvr.it/S41VfC, AlertTrade.us, ",1417120061995700233,False,0,0,0,0,dlvr.it,SOCIAL ACTIVITY: $INCY - Incyte Corporation - Common Stock https://t.co/tMaNRcMqG7 üì≥ TradeIdeas via  ‚ü∂ https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
1883393875,2021-07-19 05:59:34,,,"dlvr.it/S40nZx, ",1417061544806944768,False,1,0,0,0,dlvr.it,Lilly and Incyte provide update on supplemental New Drug Application for baricitinib https://t.co/7MuZOYKIjT,,,2013-09-19 10:40:31,Amsterdam,Pharma Market News,https://pbs.twimg.com/profile_images/378800000501255643/53b0cadf7327b09ab8610040b07fcb10_normal.jpeg,1499,1215,21,7595,pharmamarketnws,
1315434407692509184,2021-07-18 10:11:03,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/Ywnx5hhM1m, ",1416762442919600150,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2216 out of 5542 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/Ywnx5hhM1m",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
374729426,2021-07-17 17:13:26,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2886098, pic.twitter.com/BwdB1FZ0Sb, ",1416506353267343360,False,0,0,0,1,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on July 2, 2021. View odds for this and other indicators: https://t.co/zJlqyrGsy1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BwdB1FZ0Sb",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1372429929409880067,2021-07-16 23:42:33,,,"wallstreetfacts.com/2021/07/16/her‚Ä¶, ",1416241889733451777,False,0,0,0,0,WordPress.com,Here is the latest forecast and market data for Incyte Corporation($INCY) https://t.co/iz5Hd0EbBq,,,2021-03-18 02:09:39,,The Wall Street Facts,https://pbs.twimg.com/profile_images/1372430092710912000/oEEQx4u9_normal.jpg,33,0,0,11736,WallStreetFact,
25406480,2021-07-16 12:46:35,,,"awesomecapital.blogspot.com/2021/07/lilly-‚Ä¶, ",1416076809842593797,False,0,0,0,1,Twitter Web App,"AwesomeCapital: Lilly, Incyte: FDA will not meet PDUFA date for de... https://t.co/SQNAMvxkQc",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
1196662654011674624,2021-07-16 12:40:17,,,"ift.tt/3xPhoMD, pic.twitter.com/MU3rTXJxdR, ",1416075223435255811,False,0,0,0,0,IFTTT,Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis https://t.co/XCK6oRUA1m https://t.co/MU3rTXJxdR,,,2019-11-19 00:33:28,Nashville,pressdaily,https://pbs.twimg.com/profile_images/1196686119087362049/6xdJq3Wj_normal.jpg,32,250,1,6135,pressdailynews,photo
72928001,2021-07-16 12:02:31,"LLY, ",,"bit.ly/3kpNAlP, ",1416065721012932615,False,0,0,0,0,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) announce that the FDA will not meet the PDUFA date for baricitinib sNDA https://t.co/8eExakKDfY,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
4058194633,2021-07-16 12:02:21,"INCY, LLY, ",,"prnewswire.com/news-releases/‚Ä¶, ",1416065679871016960,False,0,0,0,0,Twitter for iPhone,$INCY $LLY Incyte &amp; Lilly Provide Update On Supplemental NDA For Baricitinib For Moderate To Severe Atopic Dermatitis  https://t.co/YxJXkRNmPU,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
166597717,2021-07-16 11:30:00,"LLY, INCY, ",,"bit.ly/36HeWvO, ",1416057537904922624,False,1,0,0,1,TweetDeck,"Eli Lilly, Incyte: FDA will not meet PDUFA action date for SNDA for baricitinib $LLY $INCY https://t.co/dcZEQsuXV1",,,2010-07-14 11:10:34,Greater New York City Area,The Fly,https://pbs.twimg.com/profile_images/885896700472287233/NunLvfQW_normal.jpg,27381,167,0,106350,theflynews,
270492072,2021-07-16 10:22:11,,"news, SeekingAlpha, ","seekingalpha.com/news/3715993-l‚Ä¶, ",1416040471365779462,False,0,0,0,0,Microsoft Power Platform,Lilly and Incyte provide update on FDA regulatory timeline for baricitinib https://t.co/8qcfWPe9fR via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
284054290,2021-07-16 10:17:44,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/medic‚Ä¶, ",1416039349624393728,False,0,0,0,0,BLOX CMS for DEV,"INDIANAPOLIS, July 16, 2021 /PRNewswire/ --¬†Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) will not meet the Prescription Drug User Fee Act (PDUFA) action date for the supp‚Ä¶ https://t.co/qE0ER7b6yB",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
284054290,2021-07-16 10:16:53,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/incyte-logo-pr‚Ä¶, ",1416039134406266882,False,0,0,0,0,BLOX CMS for DEV,Incyte logo. (PRNewsFoto/Eli Lilly and Company) (PRNewsfoto/Eli Lilly and Company) https://t.co/DYjhhVr846,,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
1184025479084331008,2021-07-16 10:14:03,"INCY, ",,"pic.twitter.com/6xB9Pqj6x3, ",1416038425346646016,False,0,0,0,0,pythonmehabe,$INCY @ 9 - Lilly and Incyte provide update on FDA regulatory timeline for baricitinib https://t.co/6xB9Pqj6x3,,,2019-10-15 04:37:33,Germany,Jeremy,https://pbs.twimg.com/profile_images/1242903623446626304/g1A5BLr2_normal.jpg,2523,2,61,191178,mehabecapital,photo
1134049078424162304,2021-07-16 10:11:38,"INCY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1416037814559510530,False,0,0,0,0,Newsfilter.io,Lilly and Incyte provide update on FDA regulatory timeline for baricitinib $INCY https://t.co/XruEBEDVZW,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2021-07-16 10:09:28,"INCY, LLY, LLY, ",,"seekingalpha.com/news/3715993-l‚Ä¶, ",1416037270017110016,False,0,0,0,0,SANewsTwitter,$INCY $LLY $LLY - Lilly and Incyte provide update on FDA regulatory timeline for baricitinib https://t.co/LALnRbVdLB,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
472650465,2021-07-16 10:06:30,"INCY, ",,"otcdynamics.com/incy-lilly-and‚Ä¶, ",1416036523284258819,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis https://t.co/xnzIvPmD7q,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1069693680066420736,2021-07-16 10:06:05,"INCY, ",,"s.flashalert.me/cRjbYZ, ",1416036419680735243,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on July 16, 10:00:00: Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis https://t.co/R65Z8tnpaf",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1227080867832565760,2021-07-16 10:05:55,"LLY, INCY, ",,,1416036378190749703,False,0,0,0,0,Twitter Web App,$LLY $INCY: Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis,,,2020-02-10 23:04:40,"San Diego, CA",oryo,https://pbs.twimg.com/profile_images/1284688749180354560/4QESe1aF_normal.jpg,552,2695,12,17490,OryoJohn,
213137160,2021-07-16 10:04:08,,,"dlvr.it/S3rvJz, pic.twitter.com/fsqwH6iFmR, ",1416035928515117057,False,0,0,0,0,dlvr.it,Eli Lilly and¬†: Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis https://t.co/BpWtzaAHAR https://t.co/fsqwH6iFmR,,,2010-11-07 21:12:11,"San Diego, CA",Sniff Out Stocks,https://pbs.twimg.com/profile_images/1162213671/big_dog_nose_normal.jpg,3611,3936,82,49949,SniffOutStocks,photo
1355194932445786112,2021-07-16 10:02:24,"LLY, ",,"stocktitan.net/news/LLY/lilly‚Ä¶, ",1416035492496281607,False,0,0,0,0,Twitter,"$LLY Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
https://t.co/Wgoj8yDvat",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1261065948011864064,2021-07-16 10:02:11,"LLY, INCY, ",,,1416035435407712261,False,0,0,0,0,StockTwits Web,"*LILLY,INCYTE: U.S. FDA WILL NOT MEET PDUFA DATE FOR BARICITINIB $LLY $INCY",,,2020-05-14 18:50:34,"Dallas, TX",Print Trading,https://pbs.twimg.com/profile_images/1270530766913572864/362fWEDo_normal.jpg,1346,0,41,14970,print_trading,
3318510966,2021-07-16 10:01:35,,,"crweworld.com/article/news-p‚Ä¶, ",1416035284232245249,False,0,0,0,0,CRWE World,Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate t https://t.co/ZnswWQ5SWp,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2021-07-16 10:00:40,"LLY, ",,"stocktitan.net/news/LLY/lilly‚Ä¶, ",1416035054501998597,False,0,0,0,0,stocktitan,"$LLY Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
https://t.co/NyibQ5O7YG",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1134049078424162304,2021-07-16 10:00:39,"INCY, LLY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1416035050622181377,False,0,0,0,0,Newsfilter.io,Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to .. $INCY $LLY https://t.co/MIdja8onPu,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1393303407801294850,2021-07-16 10:00:08,"LLY, ",,"webchronicletoday.com/lilly-and-incy‚Ä¶, ",1416034921055883265,False,0,0,0,0,Twitter,"$LLY Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
 
https://t.co/sdqBChXIFm",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
2368733657,2021-07-16 10:00:07,"INCY, ",,,1416034917700587521,False,0,0,1,0,Twitter,$INCY: Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic,,,2014-02-27 05:32:16,US markets üëâ,Marketbit.pro,https://pbs.twimg.com/profile_images/1368821546454835202/14UYpgh2_normal.png,1393,587,55,28252,bthefirsttoknow,
1134049078424162304,2021-07-16 06:33:37,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1415982950932525057,False,0,0,0,0,Newsfilter.io,Incyte to Report Second Quarter Financial Results $INCY https://t.co/W3MDiJalQJ,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
374729426,2021-07-15 19:28:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2881397, pic.twitter.com/DMdINUYHHJ, ",1415815593832312833,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/QXBrPtgJCw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/DMdINUYHHJ,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
960403142197248000,2021-07-15 19:03:08,,,"pressrelease.cc/2021/07/15/int‚Ä¶, ",1415809183857926144,False,0,0,0,0,WordPress.com,"Intrahepatic Cholangiocarcinoma Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Incyte Corporation, Roche, Delcath Systems, Basilea¬†Pharmaceutica https://t.co/xwAdBrLsSi",,,2018-02-05 01:42:07,"Dallas, TX",PressRelease.cc,https://pbs.twimg.com/profile_images/1120211264360337408/hhR28Cwc_normal.png,1081,1362,10,255874,PressRelease_cc,
916335048,2021-07-15 19:01:32,,"Business, HealthMedicine, MarketingSales, PharmaceuticalsBiotech, ","dlvr.it/S3plTF, ",1415808780659421185,False,0,0,0,0,dlvr.it,"Intrahepatic Cholangiocarcinoma Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Incyte Corporation, Roche, Delcath Systems, Basilea‚Ä¶ https://t.co/MeHhCJoZGL #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech",,,2012-10-31 03:27:23,,ABNewswire,https://pbs.twimg.com/profile_images/3568218059/4649a03b94d5a22697cd7f8bfd4a284c_normal.png,1052,132,139,368959,ABNewswire,
154613745,2021-07-15 10:45:07,,"ClinicalTrial, BreastCancer, ","bit.ly/3hAc0Hv, pic.twitter.com/I0TMGukJi9, ",1415683855604875272,False,0,0,0,0,Sprout Social,"Industry news: üì∞ @BriaCell Therapeutics announced the enrollment of their #ClinicalTrial with @Incyte, designed to evaluate Bria-IMT‚Ñ¢, with Incyte's retifanlimab and epacadostat, for the treatment of advanced #BreastCancer. ü©∫

PR: https://t.co/SbCRn6AEf9 https://t.co/I0TMGukJi9","BriaCell, Incyte, ",,2010-06-11 14:41:34,,Mammary Cell News,https://pbs.twimg.com/profile_images/1280899133557993474/O8zIF8pJ_normal.jpg,1235,245,51,10556,MammaryCell,photo
3911174913,2021-07-15 10:08:34,,"CCA, ","bit.ly/3emTBvU, pic.twitter.com/qSrDTk51x0, ",1415674653654208512,False,145,0,5,23,Twitter Ads,Check out key presentations on cholangiocarcinoma (#CCA) at the @GoHealio virtual panel discussion focusing on the current landscape of genomic alterations and biomarker testing. https://t.co/6y9e4veQSy https://t.co/qSrDTk51x0,"GoHealio, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
890138669998276608,2021-07-15 09:39:36,,"thalassemia, ","bit.ly/3xJxuHJ, pic.twitter.com/D2c8rEIqZU, ",1415667366071967749,False,0,0,0,0,Twitter Web App,"#thalassemia Market Everything You Need to Know

Read More : https://t.co/3Ol5kKbohN

@Bluebird @AcceleronPharma @GlaxoBRK @Incyte  \@ionispharma @KiadisPharma @Sangamo https://t.co/D2c8rEIqZU","bluebird, AcceleronPharma, GlaxoBRK, Incyte, ionispharma, Sangamo, ",,2017-07-26 05:16:11,"Pune, India",karishma mulani,https://pbs.twimg.com/profile_images/1000943818332487681/Ivek9ywO_normal.jpg,15,65,0,5592,karishmamulani5,photo
472650465,2021-07-15 08:14:46,"INCY, ",,"otcdynamics.com/incy-incyte-to‚Ä¶, ",1415646018251669504,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte to Report Second Quarter Financial Results https://t.co/GidKlp76z1,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
3318510966,2021-07-15 08:06:46,,,"crweworld.com/article/news-p‚Ä¶, ",1415644005098954752,False,0,0,0,0,CRWE World,Incyte to Report Second Quarter Financial Results https://t.co/1fXHXl6CZY,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1355194932445786112,2021-07-15 08:04:28,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1415643425127518210,False,0,0,0,0,Twitter,"$INCY Incyte to Report Second Quarter Financial Results
https://t.co/0BAhoI322y",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
976297820532518914,2021-07-15 08:04:22,,,"dlvr.it/S3mpls, pic.twitter.com/x5VA3BWguN, ",1415643397944008704,False,0,0,0,0,dlvr.it,Incyte to Report Second Quarter Financial Results https://t.co/WixFCnFfHO https://t.co/x5VA3BWguN,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1254035253104181256,2021-07-15 08:02:43,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1415642984851386378,False,0,0,0,0,stocktitan,"$INCY Incyte to Report Second Quarter Financial Results
https://t.co/QwiPe5wzAr",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1069693680066420736,2021-07-15 08:01:43,"INCY, ",,"s.flashalert.me/sy78wy, ",1415642732618555392,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on July 15, 08:00:00: Incyte to Report Second Quarter Financial Results https://t.co/ByjDocYzyC",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1325115160353103872,2021-07-15 08:00:23,"INCY, ",,"quantisnow.com/insight/137470‚Ä¶, ",1415642396025495554,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte to Report Second Quarter Financial Results

https://t.co/nsggKAIxAM",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1393303407801294850,2021-07-15 08:00:06,"INCY, ",,"webchronicletoday.com/incyte-to-repo‚Ä¶, ",1415642326622511107,False,0,0,0,0,Twitter,"$INCY Incyte to Report Second Quarter Financial Results
 
https://t.co/BdZ1WSShMd",,,2021-05-14 16:34:04,,Web Chronicle Today,https://pbs.twimg.com/profile_images/1395347950260432902/Y0SK-4wc_normal.jpg,33,0,0,20835,WebChronicleTo1,
1134049078424162304,2021-07-15 07:18:33,"INCY, NVS, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1415631869303984130,False,0,0,0,0,Newsfilter.io,Incyte's Ruxolitinib Shows Better Outcomes Regardless Of Organs Affected In GvHD Patients $INCY $NVS https://t.co/KXPomuUmc7,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1166772455417024512,2021-07-15 07:16:36,,"Biotech, Briefs, ","dlvr.it/S3mgfj, pic.twitter.com/0JNA8nzLD1, ",1415631376888385541,False,0,0,0,0,dlvr.it,#Biotech #Briefs Incyte's Ruxolitinib Shows Better Outcomes Regardless Of Organs Affected In GvHD Patients https://t.co/h3v3CBq0gy https://t.co/0JNA8nzLD1,,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
1889492676,2021-07-15 06:23:20,"INCY, ","Incyte, REACH3, Ruxolitinib, Jakafi, ChronicGraftVersusHostDisease, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1415617972484251653,False,0,0,0,0,Troi URL Plug-in,#Incyte Announces Positive Phase 3 #REACH3 Study Data Published in NEJM for #Ruxolitinib (#Jakafi¬Æ) in #ChronicGraftVersusHostDisease $INCY https://t.co/j2ktfpyP8y,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1399103920522334219,2021-07-14 22:10:06,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/yim3bv1lXp, ",1415493849376595978,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2204 out of 5532 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/yim3bv1lXp",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
963495628545327104,2021-07-14 17:20:39,"INCY, INCY, ",,"stck.pro/news/INCY/1430‚Ä¶, stck.pro/news/INCY, pic.twitter.com/BqttK5Ht5y, ",1415421003702968321,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Announces Positive Phase 3 REACH3 Study Data Published in NEJM for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Host Disease https://t.co/30fOvdGmZ8 Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/BqttK5Ht5y,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
3911174913,2021-07-14 17:11:27,,"News, cGVHD, ",,1415418689650823168,False,5,0,0,1,Twitter for Advertisers,#News: Data from the REACH3 trial published in @NEJM show an Incyte therapy significantly improved outcomes in patients with steroid-refractory or steroid-dependent chronic graft-versus-host disease (#cGVHD).,"NEJM, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
1069693680066420736,2021-07-14 17:04:40,"INCY, ",,"s.flashalert.me/wQvFD, ",1415416982460043265,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on July 14, 17:00:00: Incyte Announces Positive Phase 3 REACH3 Study Data Published in NEJM for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Host Disease https://t.co/vEphtRjs8y",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
43945539,2021-07-14 10:13:25,"BCTX, ","Cancer, CancerResearch, StocksToWatch, ","yhoo.it/3i212JK, pic.twitter.com/2IQJEYYqP2, ",1415313486792560647,False,7,0,0,3,Sendible,"""The BriaCell and Incyte clinical program is a non-exclusive clinical trial collaboration to evaluate the effects of combinations of novel clinical candidates.""

Huge news for $BCTX! Full details on the trial:
https://t.co/cylAozgYCr

#Cancer #CancerResearch #StocksToWatch https://t.co/2IQJEYYqP2",,,2009-06-01 14:59:39,,SmallCapVoice,https://pbs.twimg.com/profile_images/448839839912169472/Iw-fB9U5_normal.jpeg,1848,1501,102,7025,smallcapvoice,photo
1397557769553723398,2021-07-14 08:58:09,"BCTX, INCY, BCTX, BCTX, BCTX, ",,"twitter.com/BriaCell/statu‚Ä¶, ",1415294548486545418,False,1,0,0,0,Twitter Web App,"$BCTX - Big. $INCY (17b mkt cap) is partnering w $BCTX ($100m micro-cap) for a combo study.  Also, note that $BCTX has some leverage here, as without the private placement (raised funds), $BCTX would have had needed Incyte to cover the full cost of study and would have 0 leverage https://t.co/9azReRQx3d",,,2021-05-26 10:18:42,,TheLastJewmurai,https://pbs.twimg.com/profile_images/1397559628121190402/yZgsQbTB_normal.jpg,38,73,0,391,jewmurai,
840615811,2021-07-14 08:56:07,"BCTX, ",,"seekingalpha.com/news/3715023-b‚Ä¶, ",1415294035162501129,False,1,0,0,0,Twitter for Android,$BCTX News - BriaCell/Incyte opens enrollment for Phase I/IIa combo study in breast cancer https://t.co/xQkxw9WEes,,,2012-09-22 19:17:46,,Julien Bonnepart,https://pbs.twimg.com/profile_images/1413905857990045696/NYBqxCv5_normal.jpg,1236,472,12,1646,SuperTradesTM,
1134049078424162304,2021-07-14 07:37:29,"BCTX, INCY, ",,"newsfilter.io/articles/briac‚Ä¶, ",1415274246473912322,False,2,0,0,1,Newsfilter.io,BriaCell/Incyte opens enrollment for Phase I/IIa combo study in breast cancer $BCTX $INCY https://t.co/s3ZS5kwXCs,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1280938376099741697,2021-07-13 21:12:14,,"iexStock, ","iexcloud.io, pic.twitter.com/cZCJVsSwIl, ",1415116896635170816,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-First Abu Dhabi Bank PJSC
-Advanced Micro Devices Inc.
-Hasbro, Inc.
-Incyte Corp.
-Sharjah Islamic Bank

Data provided by https://t.co/oXreiEXTgd https://t.co/cZCJVsSwIl",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1373655821717024777,2021-07-13 11:54:19,,,"linkedin.com/jobs/view/2646‚Ä¶, ",1414976493831303171,False,0,0,0,0,Twitter Web App,"Great Opportunity @Incyte Biochemistry
https://t.co/RTnA19zVo0","Incyte, ",,2021-03-21 11:21:15,,"Kanishk Kapilashrami, PhD",https://pbs.twimg.com/profile_images/1373656446651531271/5Yhofb7z_normal.jpg,18,97,0,17,KKapilashrami,
812004702594486272,2021-07-13 05:01:00,,,"checkrare.com/interim-data-g‚Ä¶, ",1414872476186816541,False,1,0,0,0,Hootsuite Inc.,"Peter Langmuir, MD, Group Vice President, Oncology Targeted Therapeutics at Incyte, discusses interim data of a phase 2 study assessing the combination of ruxolitinib and parsaclisib in patients with myelofibrosis. 
@Incyte Incyte 
https://t.co/S1bQKb0jFy","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
895929863521095680,2021-07-12 23:15:40,"INCY, ","Incyte, stocks, trading, finance, market, ","bit.ly/3yRKLy8, pic.twitter.com/YWjoLA6GmA, ",1414785570669223936,False,0,0,0,0,TradeFlags,"TD BUY $INCY at 81.18, Supp 81.18 Resis 86.83 R7  HiLo 16% T1Y 106 buy 2.2 PE 37.2 DIV N/A #Incyte Cor #stocks #trading #finance #market https://t.co/JNCRG7ZlHE https://t.co/YWjoLA6GmA",,,2017-08-11 04:48:19,1130,TradeFlags,https://pbs.twimg.com/profile_images/1444247772769792002/Hc_nWhvE_normal.jpg,636,206,11,58994,TradeFlags,photo
1399103920522334219,2021-07-12 21:22:06,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/r5xTm6G7ll, ",1414756992485412870,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2206 out of 5528 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/r5xTm6G7ll",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
374729426,2021-07-12 20:35:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2874101, pic.twitter.com/JoZCmdeza3, ",1414745169132277760,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/1hOoW3jzvo #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/JoZCmdeza3,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1280938376099741697,2021-07-12 18:52:39,,"iexStock, ","iexcloud.io, pic.twitter.com/lfMmRjID7q, ",1414719380374556672,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Al Dar Properties
-Intuit Inc
-Reem Investment PSC
-CSX Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/lfMmRjID7q",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
591393998,2021-07-12 18:30:04,,,,1414713697088512001,False,6,0,0,0,Twitter for iPhone,"After almost a decade at @JeffersonUniv doing cancer research under the guidance of phenomenal mentors @JonBrodyPhD and @AmerCancerCEO, today was a wholesome first day at @Incyte as Sr. Research Investigator. Cheers to new beginnings!","JeffersonUniv, JonBrodyPhD, AmerCancerCEO, Incyte, ",,2012-05-26 21:09:20,Philadelphia,"Saswati Chand, PhD",https://pbs.twimg.com/profile_images/1206665104646955008/-hFk_N2f_normal.jpg,72,292,1,5,SaswatiChand,
854068224299642880,2021-07-12 17:09:17,"EQ, ",,"twitter.com/EquilliumBio/s‚Ä¶, ",1414693370836905984,False,6,0,0,0,Twitter Web App,"$EQ will have a busy Q4 2021. Starting a pivotal trial in first-line aGvHD, plus Phase 2 readouts in Lupus Nephritis and Uncontrolled Asthma. Well financed. I'm happy to see it drift lower to add more. CR rate in aGvHD very impressive, gives them a better chance than Incyte had. https://t.co/qDeAOJ4YzE",,,2017-04-17 16:25:07,"Scottsdale, AZ",Matt,https://pbs.twimg.com/profile_images/1429627368193232897/cn0wjdS7_normal.jpg,2705,811,55,4932,MattBiotech,
108617488,2021-07-11 21:55:10,,,"invst.ly/vea5p, ",1414402923900153865,False,0,0,0,0,FP News Publisher - COM,RBC Capital Stick to Their Hold Rating for Incyte Corp - https://t.co/ycVK6fQK4g,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
172288755,2021-07-11 20:09:30,,,"fiercepharma.com/drug-delivery/‚Ä¶, ",1414376332620824576,False,0,0,0,0,Twitter Web App,What heart safety concern? Doctors like Incyte's eczema cream despite potential JAK warning: analyst https://t.co/MZviM88SaQ,,,2010-07-29 06:10:36,"Yong-In city, Korea",Kyung Seok Lee,https://pbs.twimg.com/profile_images/922433020748898305/cjOW-D4X_normal.jpg,17,60,0,646,ksloveis,
1315434407692509184,2021-07-11 13:35:06,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/QVxofb792U, ",1414277081266012160,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2205 out of 5526 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/QVxofb792U",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1280938376099741697,2021-07-11 00:35:58,,"iexStock, ","iexcloud.io, pic.twitter.com/3wfCjlS5Ec, ",1414081003195338753,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-AMGEN Inc.
-United Arab Bank
-Alphabet Inc - Class A
-Alexion Pharmaceuticals Inc.
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/3wfCjlS5Ec",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2570920968,2021-07-10 14:25:00,"INCY, ","eczema, dermatology, ","bit.ly/36oz71d, ",1413927248558661633,False,2,0,0,0,Twitter Web App,"What heart safety concern? Doctors like Incyte's eczema cream despite potential JAK warning: analyst! $INCY #eczema #dermatology 
https://t.co/pIrEivzwdw",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
325135887,2021-07-10 12:25:00,"INCY, ","eczema, dermatology, ","bit.ly/36oz71d, ",1413897049624436739,False,2,0,0,0,Twitter Web App,"What heart safety concern? Doctors like Incyte's eczema cream despite potential JAK warning: analyst! $INCY #eczema #dermatology 
https://t.co/iGOGYG7H9W",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
374729426,2021-07-10 05:13:34,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2867622, pic.twitter.com/YrDk9snpKS, ",1413788475078287361,False,1,0,0,2,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/EBLBlHRhcN #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/YrDk9snpKS,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
4058194633,2021-07-09 22:38:24,"IVBIY, INCY, ",,"google.com/amp/s/finance.‚Ä¶, ",1413689030164631553,False,0,0,0,0,Twitter for iPhone,$IVBIY $INCY Innovent Biologics‚Äô &amp; Incyte‚Äôs Pemigatinib Application Under Review In China For Bile Duct Cancer https://t.co/TGb7qxhJf9,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-07-09 22:34:10,"INCY, ",,"fiercepharma.com/drug-delivery/‚Ä¶, ",1413687966073987073,False,0,0,0,0,Twitter for iPhone,$INCY What heart safety concern? Doctors like Incyte's eczema cream despite potential JAK warning: analyst https://t.co/5CynqWwrOb,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
133504478,2021-07-09 14:52:45,,"strategy, competitiveintelligence, marketing, pharmaceutical, pharma, healthcare, productmarketing, biotech, ","dlvr.it/S3Pxx5, pic.twitter.com/C1PBEQpijS, ",1413571843349389317,False,0,0,0,1,dlvr.it,What heart safety concern? Doctors like Incyte's eczema cream despite potential JAK warning: analyst https://t.co/2jLb8k219o #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #healthcare #productmarketing #biotech https://t.co/C1PBEQpijS,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
18294275,2021-07-09 14:20:00,,,"fiercepharma.com/drug-delivery/‚Ä¶, ",1413563602590633985,False,3,0,0,2,TweetDeck,What heart safety concern? Doctors like Incyte's eczema cream despite potential JAK warning: analyst https://t.co/uF0VvAVEkj,,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
140599113,2021-07-09 13:21:49,,,"winway.me/health-remedie‚Ä¶, ",1413548961290407941,False,0,0,0,0,WordPress.com,What heart safety concern? Doctors like Incyte‚Äôs eczema cream despite potential JAK warning:¬†analyst https://t.co/jefhenbFHd,,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
46297868,2021-07-09 11:48:03,,,"dlvr.it/S3PP8J, ",1413525364211523593,True,0,0,0,0,dlvr.it,What heart safety concern? Doctors like Incyte's eczema cream despite potential JAK warning: analyst https://t.co/Bpr69W6p08,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
1134049078424162304,2021-07-09 10:41:37,"INCY, ",,"newsfilter.io/articles/innov‚Ä¶, ",1413508647104049168,False,0,0,0,0,Newsfilter.io,Innovent Biologics - Incyte's Pemigatinib Application Under Review In China For Bile Duct Cancer $INCY https://t.co/yZWPqZyJwU,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1166772455417024512,2021-07-09 09:56:06,,"BileDuctCancer, Biotech, ","dlvr.it/S3P0rz, pic.twitter.com/Xz9tcZgEAk, ",1413497190907973638,False,0,0,0,0,dlvr.it,#BileDuctCancer #Biotech Innovent Biologics - Incyte's Pemigatinib Application Under Review In China For Bile Duct Cancer https://t.co/hD4HwDmCxs https://t.co/Xz9tcZgEAk,,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
108617488,2021-07-08 17:30:05,,,"invst.ly/vdhlx, ",1413249049814253569,False,0,0,0,0,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/cMBHwenYxK,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
249556551,2021-07-08 14:48:04,,"BioPharma, BioTech, ",,1413208278079664134,False,5,0,2,1,Twitter Web App,"Global #BioPharma + #BioTech Stocks Watchlist : 
1. Beigene Ltd (BGNE)
2. Incyte Corporation (INCY)
3. Kodiak Sciences Inc (KOD)
4. ACADIA Pharmaceuticals Inc (ACAD)
5. Pandion Therapeutics Holdco (PAND) 
6. Vor Biopharma Inc (VOR)
7. Instil Bio Inc (TIL)",,,2011-02-09 03:51:08,Venus,Surabhi,https://pbs.twimg.com/profile_images/1438800033541869579/5dQ3LmCZ_normal.jpg,12587,4924,100,10523,WonderWoman991,
1390980477998223361,2021-07-08 12:08:55,,"cholangiocarcinoma, pemigatinib, grateful, oncologist, ","youtu.be/MYgiYkUngfo, ",1413168229376315393,False,11,0,2,3,Twitter for Android,"I had a wonderful chat with Rachel from Incyte today, discussing my diagnosis of #cholangiocarcinoma and how #pemigatinib is working for me. So far, I've had brilliant results, so I'm #grateful that my #oncologist organised molecular profiling for me. üß¨ https://t.co/oGO8GzPHHX",,,2021-05-08 06:43:07,Yorkshire,Beating Bile Duct Cancer - Megan üíö,https://pbs.twimg.com/profile_images/1422865480797282305/bT2yU81V_normal.jpg,142,364,0,232,RubyRedcurrant,
2344420430,2021-07-08 01:58:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1413014591941058560,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Principal Accounting Officer

PAUL TROWER:

https://t.co/FJ5UnyIGEo",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-07-08 01:26:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1413006535555432448,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Discovery Chem

YAO WENQING:

https://t.co/AAhB95jDoC",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-07-07 19:45:29,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1412920739729223682,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Human Resources

PAULA J SWAIN:

https://t.co/VxWeimF3gE",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1136762823030104064,2021-07-07 17:16:46,,,"bit.ly/3r0i6UH, ",1412883313753300996,False,0,0,0,0,Sprout Social,Recon: Pfizer to start large pediatric trial of COVID-19 vaccine; FDA pushes back decision on Incyte‚Äôs Jakafi https://t.co/YZjevG2fmf,,,2019-06-06 18:32:31,"San Francisco, CA",RAC Medical Consulting,https://pbs.twimg.com/profile_images/1137472123973226496/9km6CQps_normal.jpg,80,398,0,4496,RAC_Medical,
772471873539977217,2021-07-07 16:46:57,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1412875809388470272,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/u546eV5Qyw,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
58541330,2021-07-07 15:22:52,,"Incyte, ","pic.twitter.com/tkfIDal2Si, ",1412854649376362497,False,3,0,0,1,HubSpot,(1/2) Jennifer Romanski &amp; Alicia Whittlesey hosted a webinar highlighting current trends in enforcements from the recently amended #Incyte complaint. 1 takeaway: Compliance programs must be fluid &amp; should be continually assessed to remain current with the evolving landscape. https://t.co/tkfIDal2Si,,,2009-07-20 14:00:36,"Morristown, NJ",Porzio Life Sciences,https://pbs.twimg.com/profile_images/1376579848785825800/9en1pdCE_normal.png,530,498,26,2663,PorzioLS,photo
374729426,2021-07-07 14:34:00,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2861236, pic.twitter.com/PZ076ssr11, ",1412842349621780480,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/klNB7TyVEe #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/PZ076ssr11,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
41613603,2021-07-06 11:26:53,,"ClinicalTrial, SolidTumors, TrialTuesday, ","ow.ly/R7Bx50Fq3rr, pic.twitter.com/TRDQk5tzf9, ",1412432873479606275,False,3,0,0,2,Hootsuite Inc.,"In a new phase I #ClinicalTrial led at SKCC by @DrDrJen1, researchers are exploring INCB086550 as a potential treatment option for patients with advanced #SolidTumors who have failed prior treatments: https://t.co/PC7rgz0xhY @SarahCannonDocs @Incyte #TrialTuesday https://t.co/TRDQk5tzf9","DrDrJen1, SarahCannonDocs, Incyte, ",,2009-05-21 11:59:22,"Philadelphia, PA",Sidney Kimmel Cancer Center ‚Äì Jefferson Health,https://pbs.twimg.com/profile_images/454339109553577986/n1UJ-8c1_normal.jpeg,9963,1853,191,6137,KimmelCancerCtr,photo
1399103920522334219,2021-07-06 02:40:08,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/pgoXYyOSDw, ",1412300311172206593,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2177 out of 5518 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/pgoXYyOSDw",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
60224553,2021-07-06 01:01:08,,,"dlvr.it/S37hCM, pic.twitter.com/ecxnY2pn5O, ",1412275399728406528,False,0,0,0,0,dlvr.it,Hedge Funds Are Selling Incyte Corporation (INCY) - Yahoo Finance https://t.co/mBWLgUwJWz https://t.co/ecxnY2pn5O,,,2009-07-25 23:46:54,"NYC, NY, USA",Peter Went,https://pbs.twimg.com/profile_images/1216976432825540608/1d7laUNR_normal.jpg,9226,81,306,124562,HedgeFundRisk,photo
374729426,2021-07-05 17:56:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2856778, pic.twitter.com/KPmtTYsmsz, ",1412168542288433175,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on July 2, 2021. View odds for this and other indicators: https://t.co/rBrmqWEMkf #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/KPmtTYsmsz",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1399103920522334219,2021-07-04 23:20:07,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/KCYwNEcqu5, ",1411887587699171332,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2177 out of 5518 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/KCYwNEcqu5",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
1399103920522334219,2021-07-04 20:30:07,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/4pCn7PLVZx, ",1411844805819240451,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2177 out of 5518 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/4pCn7PLVZx",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
1399103920522334219,2021-07-04 12:44:08,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/5tt6WEhTu8, ",1411727536783044616,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2177 out of 5518 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/5tt6WEhTu8",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
1134049078424162304,2021-07-03 07:14:50,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1411282279499022341,False,0,0,0,0,Newsfilter.io,"$23,808.79 of shares acquired by Clancy Paul J (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/ZncKOAG2V0",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-07-03 07:11:51,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1411281528886267907,False,0,0,0,0,Newsfilter.io,"Statement of changes in beneficial ownership of securities filed with the SEC a day ago, reported in a new form 4 filed with the SEC  $INCY https://t.co/Vi6RT4o7wC",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-07-03 07:09:49,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1411281018728890371,False,0,0,0,0,Newsfilter.io,"Statement of changes in beneficial ownership of securities filed with the SEC a day ago, reported in a new form 4 filed wi.. $INCY https://t.co/dLpst3Lv2L",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-07-03 06:53:49,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1411276991941287936,False,0,0,0,0,Newsfilter.io,"Statement of changes in beneficial ownership of securities filed with the SEC a day ago, reported in a new form 4 filed with the SEC  $INCY https://t.co/AEXqK6EM9T",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-07-03 03:30:49,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1411225906073509892,False,0,0,0,0,Newsfilter.io,"Baker Bros. Advisors Lp (Director) acquired new securities, reported in a new form 4 filed with the SEC  $INCY https://t.co/OeDqHK9yp6",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1262915121103491074,2021-07-02 23:09:19,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1411160094549549058,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 396 shares on 2021-07-01. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1134049078424162304,2021-07-02 21:01:52,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1411128022766346240,False,0,0,0,0,Newsfilter.io,"Statement of changes in beneficial ownership of securities filed with the SEC 2 hours ago, reported in a new form 4 filed with the SEC  $INCY https://t.co/BlNbx3RtuV",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
374729426,2021-07-02 14:54:27,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2849267, pic.twitter.com/5GDah6CaEG, ",1411035560215412736,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/rQ8KR7s0Jm #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5GDah6CaEG,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1272652048748535808,2021-07-02 13:50:01,,"DataProtection, VMware, ","druva.info/3jz98fz, ",1411019344952373250,False,1,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/XgSOkwhsTw

@druvainc","druvainc, ",,2020-06-15 18:08:05,India,Aditya Shah,https://pbs.twimg.com/profile_images/1272652240608563200/bv36x8Un_normal.jpg,13,71,0,526,AdityaS62983764,
34324846,2021-07-02 12:55:18,,"ScienceJobs, ","jobs.sciencecareers.org/job/553567/van‚Ä¶, ",1411005572019851269,False,0,0,0,0,Madgex Twitter Tweeter,"Vanderbilt-Incyte Research Scholars Program  - Nashville, Tennessee - Vanderbilt-Ingram Cancer Center #ScienceJobs https://t.co/ZY3sTKYwNG",,,2009-04-22 12:51:07,"Washington, DC",Science Careers,https://pbs.twimg.com/profile_images/1298289631188922368/ta9Sb-p3_normal.jpg,47975,243,591,72316,ScienceCareers,
108617488,2021-07-02 05:15:28,,,"invst.ly/vb92v, ",1410889850971209728,False,0,0,1,0,FP News Publisher - COM,Leerink Partners Stick to Their Sell Rating for Incyte Corp - https://t.co/28ZuDk0q4N,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
23330343,2021-07-01 08:01:05,,,"cancerletter.com/the-cancer-let‚Ä¶, ",1410569141279416322,False,0,0,0,0,Hootsuite Inc.,"At the June 24 ODAC, @Incyte was seeking an accelerated approval ‚Äúfor the treatment of patients with locally advanced or metastatic squamous carcinoma of the anal canal who have progressed on or are intolerant of platinum-based chemotherapy.‚Äù
https://t.co/uQBonJmLGu","Incyte, ",,2009-03-08 13:32:44,"Washington, D.C.",The Cancer Letter,https://pbs.twimg.com/profile_images/813803520969310208/nsbPr5gH_normal.jpg,22312,1559,505,5654,TheCancerLetter,
2298709746,2021-07-01 07:43:01,"INCY, ",,"zpr.io/HRzpKTbAx3uD, ",1410564598038683648,False,0,0,0,0,Zapier.com,"Yao Wenqing Sells 27,194 Shares of Incyte Co. $INCY Stock https://t.co/rS7cNuepnJ",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1390011337066139655,2021-07-01 07:33:27,"INCY, ","followthemoney, investing, StocksToWatch, insiders, trading, ","tradinghints.app/company/INCY, pic.twitter.com/ew1QFCg2sF, ",1410562188125876224,False,0,0,0,1,Twitter,"Sell
Date: 2021-06-30
Name: WENQING YAO
Company: INCYTE CORP
Title: EVP Head of Discovery Chem
Value: $2,321,552
Shares: 27,194

https://t.co/u7Y2vZEvGE

$INCY #followthemoney #investing #StocksToWatch #insiders #trading https://t.co/ew1QFCg2sF",,,2021-05-05 14:31:53,,TradingHints,https://pbs.twimg.com/profile_images/1390011943696715777/rRucsPPL_normal.jpg,57,26,0,2876,TradingHints,photo
14133281,2021-07-01 07:05:16,,,,1410555096467869700,False,4,0,0,5,Twitter Web App,"The EC has selected Incyte and Eli Lilly repurposed rheumatoid arthritis drug Olumiant and four new antibody drugs developed by Celltrion, Regeneron, Eli Lilly, and an alliance of GlaxoSmithKline and Vir Biotechnology for its initial portfolio of preferred COVID-19 therapies",,,2008-03-12 12:33:01,Hyderabad,Dr.  Amit Dang,https://pbs.twimg.com/profile_images/1244646825627250691/jmIyfbBm_normal.jpg,453,237,9,923,dramitdang,
374729426,2021-06-30 21:09:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2845011, pic.twitter.com/7sneUxUcWT, ",1410405156575875073,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on June 9, 2021. View odds for this and other indicators: https://t.co/nPiPfmzJ3T #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/7sneUxUcWT",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1280938376099741697,2021-06-30 20:12:54,,"iexStock, ","iexcloud.io, pic.twitter.com/kqtRpyL3dl, ",1410390922274148355,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-NetEase Inc - ADR
-Incyte Corp.
-Marriott International, Inc. - Class A
-Al Dar Properties
-Mylan N.V.

Data provided by https://t.co/oXreiEXTgd https://t.co/kqtRpyL3dl",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
3911174913,2021-06-30 18:07:30,,,"pic.twitter.com/azvQx15oX8, ",1410359363621908482,False,5,1,0,1,Twitter for Advertisers,Rigorous science is at the core of everything we do. Thank you @PhilaPACT for acknowledging our commitment to innovation and finding solutions for patients. https://t.co/azvQx15oX8,"PhilaPACT, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
2344420430,2021-06-30 16:44:31,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1410338480815808523,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Discovery Chem

YAO WENQING:

https://t.co/oE3YzsGlSB",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1371371521621508097,2021-06-30 16:13:25,"INCY, ","Insider, stock, Sale, ",,1410330655184101377,False,0,0,0,0,Twitter,"INCY (INCYTE CORP) üö® #Insider #stock alert! üí∞ #Sale on 2021-06-28 - $INCY üá∫üá∏: Wenqing Yao (EVP, Head of Discovery Chem), total amount $2.321.551. Float 186.00M shares",,,2021-03-15 04:04:13,,day-trading.de,https://pbs.twimg.com/profile_images/1371372937593389059/uMPvUZK9_normal.jpg,560,30,6,6342,day_trading_de,
22195223,2021-06-30 13:15:13,,,"cancernetwork.com/view/decision-‚Ä¶, ",1410285808729403396,False,0,0,0,0,Hootsuite Inc.,"The Oncologic Drugs Advisory Committee has decided to wait until more results from a clinical trial of retifanlimab are available to make a final decision about approval in squamous cell carcinoma of the anal canal. | @Incyte 
https://t.co/65SKHDcrhA","Incyte, ",,2009-02-27 16:48:14,"Cranbury, NJ","CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",https://pbs.twimg.com/profile_images/1196832187376685056/BU2C0XFo_normal.jpg,23603,452,498,13559,CancerNetwrk,
1403682849614671874,2021-06-30 03:30:30,,,"rarediseasesnews.com/7272206/lilly-‚Ä¶, pic.twitter.com/VH8NTYT6YC, ",1410138659320471564,False,0,0,0,0,newsy.co,"Lilly, Incyte Report Positive New Data For Baricitinib In Adult Patients With Alopecia Areata - https://t.co/D0ecs9PapX https://t.co/VH8NTYT6YC",,,2021-06-12 07:57:34,,rarediseasesnews.com,https://pbs.twimg.com/profile_images/1403682962768596992/4t5epMAq_normal.jpg,4,0,0,2011,rarediseasesne1,photo
1399103920522334219,2021-06-29 21:34:04,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/IbMWPZHxJZ, ",1410048960178311173,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2178 out of 5480 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/IbMWPZHxJZ",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
702999329821188096,2021-06-29 17:28:16,,"WorldVitiligoDay, vitiligo, ","bit.ly/3w4hj5Z, pic.twitter.com/vSC6cJQNka, ",1409987101890953219,False,7,1,0,3,Twitter Web App,"Thanks to all who made this year‚Äôs Virtual #WorldVitiligoDay USA such a BIG success: Host Sharon King @LittyLigo, invited speakers, participants + 2021 sponsors: @AvitaMedical, @Incyte Dermatology + @Pfizer. Amazing #vitiligo community! Watch recording: https://t.co/m8MPq6XToH https://t.co/vSC6cJQNka","LittyLigo, AvitaMedical, Incyte, pfizer, ",,2016-02-25 18:31:16,"Chicago, IL",Global Vitiligo Foundation,https://pbs.twimg.com/profile_images/1235405131098869760/frWX3dp6_normal.jpg,1604,266,10,448,StepUp4Vitiligo,photo
1481092788,2021-06-29 13:49:24,,,"reuters.com/business/healt‚Ä¶, ",1409932024605937667,False,0,0,0,0,Twitter Web App,"No Ivermectin? which isn‚Äôt dangerous to people because of side effects, it‚Äôs dangerous to big pharma because it‚Äôs cheap and therefore the focus of their relentless smear campaign. https://t.co/K7ivLHbmjE",,,2013-06-03 22:06:20,,Antar üáÆüá™ üáµüá∏ üá®üá∫ üáæüá™,https://pbs.twimg.com/profile_images/1323495657089327104/DOiMvOoj_normal.jpg,737,1038,1,19382,MarkGolden16,
4058194633,2021-06-29 13:05:46,"INCY, BMY, ",,"finance.yahoo.com/news/incytes-i‚Ä¶, ",1409921045604179972,False,0,0,0,0,Twitter Web App,$INCY $BMY Incyte's (INCY) Lymphoma Drug Obtains Positive CHMP Opinion https://t.co/6rUTapRIxg,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
17960461,2021-06-29 12:38:00,,"PharmaNews, CHMP, ","bit.ly/361zQVX, pic.twitter.com/PFCVs9wGyi, ",1409914054693384203,False,0,0,0,0,TweetDeck,CHMP issue positive opinion for Incyte and MorphoSys‚Äô tafasitamab https://t.co/zMMYWe86QV #PharmaNews #CHMP https://t.co/PFCVs9wGyi,,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
1134049078424162304,2021-06-29 12:12:24,"LLY, INCY, REGN, GSK, VIR, ",,"newsfilter.io/articles/ec-se‚Ä¶, ",1409907611303034886,False,0,0,0,0,Newsfilter.io,"EC selects drugs from Lilly, Incyte, Regeneron, GSK, and Vir as preferred COVID treatments $LLY $INCY $REGN $GSK $VIR https://t.co/cxpy36o9vG",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
270492072,2021-06-29 12:11:13,,"news, SeekingAlpha, ","seekingalpha.com/news/3711043-e‚Ä¶, ",1409907314283335681,False,0,0,0,0,Microsoft Power Platform,"EC selects drugs from Lilly, Incyte, Regeneron, GSK, and Vir as preferred COVID treatments https://t.co/5jxloTFdrN via SeekingAlpha #news #SeekingAlpha",,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
15296897,2021-06-29 12:03:59,"REGN, LLY, GSK, ",,"seekingalpha.com/news/3711043-e‚Ä¶, ",1409905493665931268,False,0,0,0,0,SANewsTwitter,"$REGN $LLY $GSK - EC selects drugs from Lilly, Incyte, Regeneron, GSK, and Vir as preferred COVID treatments https://t.co/5lQy9d9cve",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
23330343,2021-06-29 10:01:12,,,"cancerletter.com/the-cancer-let‚Ä¶, ",1409874594559926273,False,0,0,0,0,Hootsuite Inc.,".@Incyte, was seeking an accelerated approval for retifanlimab based on an ongoing, open-label, single-arm trial that accrued 94 patients with locally advanced or metastatic SCAC.
https://t.co/uQBonJmLGu","Incyte, ",,2009-03-08 13:32:44,"Washington, D.C.",The Cancer Letter,https://pbs.twimg.com/profile_images/813803520969310208/nsbPr5gH_normal.jpg,22312,1559,505,5654,TheCancerLetter,
1076344425188597760,2021-06-29 09:20:05,,,"theguardian.com/p/txb73/stw, ",1409864246997946378,False,3,0,0,3,Twitter Web App,"‚ÄúThe commission‚Äôs pick of most promising treatments comprises Eli Lilly and Incyte‚Äôs Olumiant for hospitalised Covid-19 patients on oxygen, as well as new antibody drugs for early-stage disease developed by Regeneron, Eli Lilly , Celltrion and an https://t.co/nSgPqO0NHT",,,2018-12-22 00:11:23,Israel as soon as possible,TheWatcher,https://pbs.twimg.com/profile_images/1452197777623109641/2ra68mGv_normal.jpg,58,83,0,48472,Divideandattack,
17960461,2021-06-29 05:37:54,,"PharmaNews, CHMP, ","bit.ly/361zQVX, pic.twitter.com/ajVJKNvgso, ",1409808332932718592,False,1,0,0,0,TweetDeck,CHMP issue positive opinion for Incyte and MorphoSys‚Äô tafasitamab https://t.co/zMMYWepIfv #PharmaNews #CHMP https://t.co/ajVJKNvgso,,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
3901351277,2021-06-29 05:26:06,,"pharmaceutical, ","bit.ly/2UPKgWz, ",1409805363776569348,False,0,0,0,0,IFTTT,CHMP issue positive opinion for Incyte and MorphoSys‚Äô tafasitamab : https://t.co/kqnD8QEiyI #pharmaceutical,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
1883393875,2021-06-29 05:10:02,,,"dlvr.it/S2gtv1, ",1409801323017424901,False,1,0,0,0,dlvr.it,Incyte Announces Outcome of FDA ODAC Meeting https://t.co/1ULEYa5uSa,,,2013-09-19 10:40:31,Amsterdam,Pharma Market News,https://pbs.twimg.com/profile_images/378800000501255643/53b0cadf7327b09ab8610040b07fcb10_normal.jpeg,1499,1215,21,7595,pharmamarketnws,
812004702594486272,2021-06-29 05:00:53,,,"checkrare.com/interim-data-g‚Ä¶, ",1409799020298518532,False,0,0,0,0,Hootsuite Inc.,"Peter Langmuir, MD, Group Vice President, Oncology Targeted Therapeutics at Incyte, discusses interim data of a phase 2 study assessing the combination of ruxolitinib and parsaclisib in patients with myelofibrosis. 
@Incyte Incyte 
https://t.co/S1bQKb0jFy","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
750646032258793472,2021-06-29 04:28:37,,,"endpts.com/odac-echoes-fd‚Ä¶, ",1409790897852764160,False,0,0,0,0,Twitter Web App,"ODAC echoes FDA concern over Incyte PD-1, as Pazdur signals broader shift for accelerated approval - https://t.co/lRzyeEjIZo",,,2016-07-06 07:02:15,"Paris, France",Mazars,https://pbs.twimg.com/profile_images/1238543616617963521/RBlZCFrU_normal.jpg,114,616,22,8618,CrMazars,
849417718642159616,2021-06-29 02:01:00,"INCY, ",,"zpr.io/RJwUL, ",1409753749799804932,False,0,0,0,0,Zapier.com,Royal Bank of Canada Cuts Incyte $INCY Price Target to $88.00 https://t.co/DrSQNMnlYH,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1138312924269862916,2021-06-28 20:34:27,,,"facebook.com/JJMMeyer/posts‚Ä¶, ",1409671569752821762,False,2,0,0,0,Twitter Web App,"Excited to share...that tonight I had the distinct honor to present Incyte with an Industry Innovation Award from NORD.  So thankful to Dr. Jarnagin and Dr. Shcherba- my incredible medical team at MSKCC
https://t.co/3vJD7c2MIG",,,2019-06-11 01:12:04,,Cholangio Warrior,https://pbs.twimg.com/profile_images/1446242650462556162/3Ol_Cu_a_normal.jpg,185,436,0,1065,Cholangiocarci2,
16240525,2021-06-28 15:25:34,,"ASBMBCareers, ","dlvr.it/S2f0gv, ",1409593835726917638,False,0,1,0,0,dlvr.it,"New job posting:  Associate Director, Bioinformatics - Incyte Corporation - Wilmington, DE https://t.co/FkDppSGyUT #ASBMBCareers",,,2008-09-11 10:05:13,"Rockville, Maryland",ASBMB,https://pbs.twimg.com/profile_images/1410675263839649797/yUS4O9A9_normal.png,22501,3748,351,35463,ASBMB,
166539231,2021-06-28 12:49:32,,,"tinyurl.com/yzdfsxuk, ",1409554570091679746,False,0,0,0,0,PressReleasePoint.Com,https://t.co/av4FnBlzbp Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks,,,2010-07-14 08:02:43,,PressReleasePoint,https://pbs.twimg.com/profile_images/1432162498/zen_logo_normal.jpg,1715,1,270,1010780,prpnews,
3911174913,2021-06-28 11:31:16,,"raredisease, RareImpact, cholangiocarcinoma, ",,1409534874567036930,False,6,0,3,1,Twitter for Advertisers.,We are dedicated to making a difference for those living with a #raredisease. Thank you @RareDiseases for naming Incyte as one of the #RareImpact honorees for our approved therapy for patients with #cholangiocarcinoma.,"RareDiseases, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
14183663,2021-06-28 09:34:44,,,,1409505547922161668,False,21,0,1,1,Twitter Web App,"Today I'm speaking to @Incyte, a medical company. One thing they developed was so helpful for cancer patients that a group of patients got together &amp; put up a billboard next to the company headquarters to thank them. It's so fun that I get to encourage people who save lives!","Incyte, ",,2008-03-20 08:20:36,"Nashville, TN",Jon Acuff,https://pbs.twimg.com/profile_images/1313235007134208005/v5xU4LXa_normal.jpg,278758,69978,5044,56192,JonAcuff,
325135887,2021-06-28 09:25:00,"INCY, ","pharma, cancer, ","bit.ly/3hdgK4A, ",1409503096921726976,False,1,0,0,0,Twitter Web App,"Is that all? FDA committee reviewing Incyte's anal cancer drug flags bevy of trial concerns from deaths to diversity! $INCY #pharma #cancer 
https://t.co/PoFukfRjKs",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
3214830845,2021-06-28 08:20:36,,,"biopharmadive.com/news/incyte-fd‚Ä¶, ",1409486892811358213,False,0,0,0,0,Twitter Web App,"FDA advisers vote down Incyte cancer drug as agency takes tougher line 

https://t.co/X5xPTWN4mF",,,2015-04-27 19:27:31,Virtual and Live Meetings,The Medical Ed Cons.,https://pbs.twimg.com/profile_images/1105890002339356674/pAWsOuZl_normal.jpg,466,651,17,8563,medical_cons,
236854797,2021-06-28 07:34:37,,,"fdanews.com/articles/20333‚Ä¶, ",1409475321016033281,False,0,0,0,0,Twitter for iPhone,FDA Panel Says Incyte Should Conduct New Trial for Its Anal Cancer Drug  https://t.co/2fIqr8p9pT,,,2011-01-11 09:36:49,"Charlotte, NC",Pharmacy Now!,https://pbs.twimg.com/profile_images/1212826814/HaroldCohen_normal.jpg,186,106,13,14288,nyrxman,
2570920968,2021-06-28 07:30:00,"INCY, ","pharma, cancer, ","bit.ly/3hdgK4A, ",1409474156945608706,False,2,0,0,0,Twitter Web App,"Is that all? FDA committee reviewing Incyte's anal cancer drug flags bevy of trial concerns from deaths to diversity! $INCY #pharma #cancer 
https://t.co/qqhts0Ruds",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
1022006086872821762,2021-06-27 21:03:10,"INCY, INCY, ",,,1409316409839083523,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was UP ‚¨Ü on Fri Jun 25
Closed at 86.83 USD for a 0.81% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
374729426,2021-06-27 18:17:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2837466, pic.twitter.com/kNGzfky8IL, ",1409274755685883907,False,0,0,0,1,Tickeron,"$INCY's price moved above its 50-day Moving Average on June 16, 2021. View odds for this and other indicators: https://t.co/J2IDVLb9qp #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kNGzfky8IL",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
3460109487,2021-06-27 16:00:00,,,"endpts.com/odac-echoes-fd‚Ä¶, ",1409240116686512128,False,2,0,1,0,TweetDeck,"After the FDA lambasted their PD-1 ahead of an adcomm earlier this week, Incyte ran into new trouble Thursday as ODAC panelists voted against an accelerated OK by a wide margin.

https://t.co/7sefxayf8T",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
1280938376099741697,2021-06-26 19:20:35,,"iexStock, ","iexcloud.io, pic.twitter.com/uTp2spZl8E, ",1408928203683532802,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Emirates Telecommunication Group Company
-Kraft Heinz Co
-Xilinx, Inc.
-Incyte Corp.
-Sharjah Islamic Bank

Data provided by https://t.co/oXreiEXTgd https://t.co/uTp2spZl8E",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1134049078424162304,2021-06-26 16:54:40,"INCY, ",,"newsfilter.io/articles/rbc-c‚Ä¶, ",1408891483277643787,False,0,0,0,0,Newsfilter.io,$INCY RBC Capital analyst Brian Abrahams maintains Incyte with a Sector Perform and lowers the price target from $92 to $88.https://t.co/XCGzOsKNTo,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-06-26 16:29:40,"INCY, MOR, MPSYF, ",,"newsfilter.io/articles/morph‚Ä¶, ",1408885191301554186,False,0,0,0,0,Newsfilter.io,MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the .. $INCY $MOR $MPSYF https://t.co/fNBVGtbmz5,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3460109487,2021-06-26 10:00:01,,,"endpts.com/odac-echoes-fd‚Ä¶, ",1408787133679161344,False,1,0,0,0,TweetDeck,"After the FDA lambasted their PD-1 ahead of an adcomm earlier this week, Incyte ran into new trouble Thursday as ODAC panelists voted against an accelerated OK by a wide margin.

https://t.co/7sefxaPQxt",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
478786305,2021-06-26 09:02:56,,,"bit.ly/3gZbu4c, ",1408772768368410631,False,0,0,0,0,SocialPilot.co,14% overall response rate cited as reason why advisory panel recommends FDA defer decision on retifanlimab @Incyte for anal cancer subset https://t.co/8l9eq3wu7j @PamelaKunzMD @YaleCancer,"Incyte, PamelaKunzMD, YaleCancer, ",,2012-01-30 12:23:35,"Thorofare, NJ",Healio,https://pbs.twimg.com/profile_images/1136693496306458625/-IoG0_TG_normal.png,5258,1161,271,41580,GoHealio,
27645777,2021-06-26 08:01:05,,,"bit.ly/3gZbu4c, ",1408757205554405382,False,0,0,0,0,SocialPilot.co,14% overall response rate cited as reason why advisory panel recommends FDA defer decision on retifanlimab @Incyte for anal cancer subset https://t.co/bmW34XHfTS @PamelaKunzMD @YaleCancer,"Incyte, PamelaKunzMD, YaleCancer, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,
1889492676,2021-06-26 05:09:02,"MOR, INCY, ","MorphoSys, Incyte, CHMP, Tafasitamab, Lenalidomide, Relapsed, Refractory, DiffuseLargeBCellLymphoma, ","1stoncology.com/blog/morphosys‚Ä¶, ",1408713904927039490,False,0,0,0,0,Troi URL Plug-in,#MorphoSys and #Incyte Announce Positive #CHMP Opinion for #Tafasitamab in Combination with #Lenalidomide for the Treatment of Adults with #Relapsed or #Refractory #DiffuseLargeBCellLymphoma $MOR $INCY https://t.co/8PJqmXEPee,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
374729426,2021-06-26 04:19:10,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2833642, pic.twitter.com/FUoulpo9VS, ",1408701355418537988,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on June 16, 2021. View odds for this and other indicators: https://t.co/JGrRf0MtWl #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/FUoulpo9VS",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
1280938376099741697,2021-06-25 19:05:35,,"iexStock, ","iexcloud.io, pic.twitter.com/raUgzOd7nd, ",1408562041363828745,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Texas Instruments Inc.
-AXA Green Crescent Insurance Co. PJSC
-Activision Blizzard Inc
-Cognizant Technology Solutions Corp. - C
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/raUgzOd7nd",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2021-06-25 17:33:50,,"iexStock, ","iexcloud.io, pic.twitter.com/C79T2ry73W, ",1408538954354368516,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-National Corporation for Tourism &amp; Hotel
-Applied Materials Inc.
-Booking Holdings Inc
-Methaq Takaful Insurance Co

Data provided by https://t.co/oXreiEXTgd https://t.co/C79T2ry73W",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
21793154,2021-06-25 16:29:59,,"biopharma, fdaapproval, ","hubs.li/H0R2CMV0, ",1408522884725805058,False,3,0,0,1,HubSpot,"ODAC votes to defer decision on @Incyte's PD-1 inhibitor for squamous cell carcinoma 
#biopharma #fdaapproval
https://t.co/ilLFave6XW","Incyte, ",,2009-02-24 15:27:40,"Des Moines, IA",BioSpace,https://pbs.twimg.com/profile_images/1042117112020389888/8MCBEVkx_normal.jpg,21738,2830,509,25196,biospace,
185789961,2021-06-25 16:07:36,,,"dlvr.it/S2SzyN, ",1408517250143850496,False,0,0,0,1,dlvr.it,"Fighting stigma ‚Äî  Is that all? FDA committee reviewing Incyte's anal cancer drug flags bevy of trial concerns from ...: ... case with Biogen's Alzheimer's disease drug Aduhelm earlier this month. In the case of retifanlimab, ODAC determined that data‚Ä¶ https://t.co/nxLQc5iPrp",,,2010-09-01 17:06:16,Worldwide,STIGMABASE | EDU,https://pbs.twimg.com/profile_images/983490900927098880/W4EweR5t_normal.jpg,922,694,71,788289,stigmabase,
3460109487,2021-06-25 16:00:01,,,"endpts.com/odac-echoes-fd‚Ä¶, ",1408515342947655681,False,0,0,0,0,TweetDeck,"After the FDA lambasted their PD-1 ahead of an adcomm earlier this week, Incyte ran into new trouble Thursday as ODAC panelists voted against an accelerated OK by a wide margin.

https://t.co/7sefxayf8T",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
1564125781,2021-06-25 15:30:00,"INCY, ",,"biopharmadive.com/news/incyte-fd‚Ä¶, ",1408507790163951644,False,0,0,0,0,TweetDeck,FDA advisers vote down Incyte cancer drug as agency takes tougher line https://t.co/xPtkEAFta1 by @NedPagliarulo $INCY,"NedPagliarulo, ",,2013-07-02 17:00:07,"Washington, D.C.",BioPharma Dive,https://pbs.twimg.com/profile_images/1247897788702052354/8g5XsbZF_normal.jpg,11666,334,333,14463,BioPharmaDive,
4058194633,2021-06-25 15:23:12,"INCY, ","jobs, ","biospace.com/article/incyte‚Ä¶, ",1408506076601864193,False,0,0,0,0,Twitter Web App,$INCY ODAC Votes to Defer Decision on Incyte's PD-1 Inhibitor for Squamous Cell Carcinoma  | BioSpace https://t.co/Bxt35e4h6j #jobs,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-06-25 15:22:46,"INCY, MOR, ",,"finance.yahoo.com/news/incyte-mo‚Ä¶, ",1408505967663214594,False,0,0,0,0,Twitter Web App,$INCY $MOR Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma https://t.co/Gl3pwUzrXP,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-06-25 15:22:18,"INCY, ",,"finance.yahoo.com/news/incyte-an‚Ä¶, ",1408505853854982147,False,0,0,0,0,Twitter Web App,$INCY Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/nIV3o1s5JS,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-06-25 15:21:54,"INCY, MOR, ",,"marketwatch.com/story/incyte-m‚Ä¶, ",1408505752738693120,False,0,0,0,0,Twitter Web App,"$INCY $MOR Incyte, MorphoSys Get Positive Opinion in Europe for Lymphoma Treatment https://t.co/hk9fm7jUJA",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
865420178846236672,2021-06-25 12:47:47,,,"twitter.com/Incyte/status/‚Ä¶, ",1408466967795843074,False,0,0,0,0,Twitter for iPad,RP for my daughter and maternal grandmother who have/had it https://t.co/GtzuJrjLON,,,2017-05-19 00:13:44,"Oklahoma, USA",Just Birdie,https://pbs.twimg.com/profile_images/1354815091091230725/qGo9tV1l_normal.jpg,750,754,1,8541,SeeBeverly,
25406480,2021-06-25 12:22:08,,,"awesomecapital.blogspot.com/2021/06/morpho‚Ä¶, ",1408460513084940288,False,0,0,0,1,Twitter Web App,"AwesomeCapital: MorphoSys, Incyte: Positive CHMP Opinion for Tafas... https://t.co/Vvr0wibjFR",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
119537327,2021-06-25 12:12:09,,,"endpts.com/odac-echoes-fd‚Ä¶, ",1408457999266443269,False,1,0,0,0,Twitter Web App,"For anyone in oncology drug development this was a 8.0 earthquake on the regulatory Richter scale.

ODAC echoes FDA concern over Incyte PD-1, as Pazdur signals broader shift for accelerated approval - https://t.co/GvrvpE6F6f",,,2010-03-03 18:23:06,"San Francisco Bay area, CA",david lilienfeld,https://pbs.twimg.com/profile_images/874463681723211776/6eguF-jX_normal.jpg,2895,424,56,11603,lilienfeld1,
1313517451817050113,2021-06-25 12:11:37,"INCY, ",,,1408457862808956932,False,0,0,0,0,Twitter Web App,$INCY --FDA AdCom In Favor Of Delaying Incyte's Retifanlimab Approval In Anal Cancer!‚ù§Ô∏è,,,2020-10-06 12:32:30,,IsitArt,https://pbs.twimg.com/profile_images/1313517774153502720/RY_EXjlp_normal.jpg,244,6,8,3818,art_isit,
803682476350697472,2021-06-25 12:03:03,,,"healthtechnologynet.com/2021/06/25/mor‚Ä¶, pic.twitter.com/Y8fKOXbQQt, ",1408455708304052232,False,0,0,0,0,HealthTechnologyNet,"MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - https://t.co/92vZ7j5XA5 approved, tafasitamab in combination with lenalidomide would rep... https://t.co/Y8fKOXbQQt",,,2016-11-29 14:30:08,"Ohio, USA",Lou Wallace,https://pbs.twimg.com/profile_images/814921452986269696/3-dX3nNP_normal.jpg,187,216,0,70477,Dw40031913,photo
1134049078424162304,2021-06-25 12:01:30,"INCY, ",,"newsfilter.io/articles/fda-a‚Ä¶, ",1408455320142295043,False,0,0,0,0,Newsfilter.io,FDA AdCom In Favor Of Delaying Incyte's Retifanlimab Approval In Anal Cancer $INCY https://t.co/dqzuKADXL4,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1270220114340851712,2021-06-25 11:23:14,,"PharmaTwitter, MedTwitter, MedEd, ","bit.ly/More-Medical-H‚Ä¶, biopharmadive.com/news/incyte-fd‚Ä¶, ",1408445688082571273,False,0,0,0,0,Automate.io,"FDA advisers vote down Incyte cancer drug as agency takes tougher line

More medical news at https://t.co/0Knf9q4SKS
#PharmaTwitter #MedTwitter #MedEd
https://t.co/JbtqMQ48Pa",,,2020-06-09 01:04:18,Look here üëâ,MedPub Pharmaceutical,https://pbs.twimg.com/profile_images/1443232668716515331/xzljON0s_normal.jpg,2,69,0,3346,PharmaPublisher,
15974185,2021-06-25 11:16:05,,,"dlvr.it/S2S7cs, ",1408443887698333700,False,0,0,0,0,dlvr.it,No fast way to eighth place for Incyte https://t.co/YBqXUG9CfM,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1330055544,2021-06-25 11:07:25,"INCY, ","cancer, ","biopharmadive.com/news/incyte-fd‚Ä¶, ",1408441707373502465,False,0,1,1,1,Twitter Web App,FDA advisers vote down Incyte #cancer drug as agency takes tougher line https://t.co/OrXhpSHZ6L by @NedPagliarulo $INCY,"NedPagliarulo, ",,2013-04-05 16:58:03,Virginia,Ben Fidler,https://pbs.twimg.com/profile_images/1370960622293225472/D0Zpicim_normal.jpg,6730,425,300,5195,BentheFidler,
873399943,2021-06-25 10:56:36,"INCY, MGNX, ",,"evaluate.com/vantage/articl‚Ä¶, pic.twitter.com/RZaKlGPaQs, ",1408438984271974411,False,19,2,1,13,Twitter Web App,"What could now steal $INCY $MGNX retifanlimab's 8th-place prize? @evaluatevantage analysis shows 4 PD(L)1 rivals in US registration, plus 4 in late clinical https://t.co/SHZ9t0FBsJ https://t.co/RZaKlGPaQs","evaluatevantage, ",,2012-10-11 06:45:00,"London, UK",Jacob Plieth,https://pbs.twimg.com/profile_images/453547761401462784/a2Lp0d3m_normal.jpeg,17753,328,0,20982,JacobPlieth,photo
3686628867,2021-06-25 10:42:03,,,"pharmaceuticaldaily.com/incyte-and-mor‚Ä¶, ",1408435325073080324,False,0,0,0,0,WordPress.com,Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell¬†Lymphoma https://t.co/r9B5je3TXH,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1227080867832565760,2021-06-25 10:29:56,"INCY, ",,,1408432276996755456,False,0,0,0,0,Twitter Web App,$INCY: Incyte and MorphoSys receive Positive CHMP Opinion for Tafasitamab in combination with Lenalidomid,,,2020-02-10 23:04:40,"San Diego, CA",oryo,https://pbs.twimg.com/profile_images/1284688749180354560/4QESe1aF_normal.jpg,552,2695,12,17490,OryoJohn,
3911174913,2021-06-25 10:15:34,,"WorldVitiligoDay, vitiligo, ","pic.twitter.com/Yc0wklyZEF, ",1408428660789592065,False,5,0,0,0,Twitter Ads,"This #WorldVitiligoDay, hear from Barbara on what it‚Äôs like to live with #vitiligo and why it‚Äôs critical to advance science for people living with this immune-mediated condition. https://t.co/Yc0wklyZEF",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
185653786,2021-06-25 10:13:53,,,"endpts.com/odac-echoes-fd‚Ä¶, ",1408428235159912454,False,4,0,0,1,Twitter Web App,"Worth a read as more and more folks begin to realize the bargain being made with accelerated approval - products reach the market sooner, but with less certain evidence, and concerns about how long PMRs take to get done https://t.co/MJng2dkLj6",,,2010-09-01 10:25:45,,Joseph Ross,https://pbs.twimg.com/profile_images/1225492578/ross_MSSM_photo_normal.jpg,5338,1306,132,10047,jsross119,
72928001,2021-06-25 09:45:31,"INCY, ",,"bit.ly/3h1Ky48, ",1408421096051777543,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte and MorphoSys receive Positive CHMP Opinion for Tafasitamab in combination with Lenalidomide https://t.co/RBrIJ6cupw,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1262114478986010632,2021-06-25 09:28:41,"INCY, ",,,1408416860878540802,False,0,0,0,0,Twitter Web App,$INCY FDA AdCom In Favor Of Delaying Incyte's Retifanlimab Approval In Anal Cancer,,,2020-05-17 16:15:42,,GapUpüß©,https://pbs.twimg.com/profile_images/1262126091671670784/fUEaPN8a_normal.jpg,161,649,5,6750,GapUp4,
963495628545327104,2021-06-25 09:22:07,"INCY, INCY, ",,"stck.pro/news/INCY/1385‚Ä¶, stck.pro/news/INCY, pic.twitter.com/qsClOK6QYS, ",1408415210394750988,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : FDA AdCom In Favor Of Delaying Incyte's Retifanlimab Approval In Anal Cancer https://t.co/eLybckvTkw Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/qsClOK6QYS,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1166772455417024512,2021-06-25 09:17:34,,"AnalCancer, Biotech, ","dlvr.it/S2Rks3, pic.twitter.com/8gFniqJaqY, ",1408414065370697728,False,0,0,0,0,dlvr.it,#AnalCancer #Biotech FDA AdCom In Favor Of Delaying Incyte's Retifanlimab Approval In Anal Cancer https://t.co/0kriAgF3no https://t.co/8gFniqJaqY,,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
1006334607946649600,2021-06-25 09:14:35,,,"dlvr.it/S2RkS8, pic.twitter.com/KRE9StJG6T, ",1408413313961062401,False,0,0,0,0,dlvr.it,MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma https://t.co/FesgfmbLf1 https://t.co/KRE9StJG6T,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
1390214894729973760,2021-06-25 09:01:41,,,"e.endpointsnews.com/t/t-7887DC1FDF‚Ä¶, ",1408410066433232901,False,0,0,0,0,Twitter Web App,Richard Pazdur signals FDA shift as ODAC votes down Incyte's PD-1; House plan for FDA's budget falls short of Biden's request https://t.co/s9aYu4MbJZ,,,2021-05-06 04:01:00,"Trier, Germany",Arno Reh,https://pbs.twimg.com/profile_images/1390215167250767876/HPgSdSSr_normal.jpg,0,21,0,19,ArnoReh,
732361939490312192,2021-06-25 09:00:10,"INCY, ","markets, ","americanbankingnews.com/?p=20636725, ",1408409685439488005,False,0,0,0,0,Zapier.com,Royal Bank of Canada Lowers Incyte $INCY Price Target to $88.00 https://t.co/pkU0P0yR1U #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-06-25 09:00:10,"INCY, ","stocks, ","americanbankingnews.com/?p=20636725, ",1408409683048665092,False,0,0,0,0,Zapier.com,Royal Bank of Canada Lowers Incyte $INCY Price Target to $88.00 https://t.co/BsWYNdLDoQ #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
108617488,2021-06-25 08:30:08,,,"invst.ly/v8u60, ",1408402124875108361,False,0,0,0,0,FP News Publisher - COM,RBC Capital Stick to Their Hold Rating for Incyte Corp - https://t.co/AtOFqZi7B0,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
3460109487,2021-06-25 08:28:17,,,"endpts.com/odac-echoes-fd‚Ä¶, ",1408401659403907074,False,6,0,0,1,TweetDeck,"After the FDA lambasted their PD-1 ahead of an adcomm earlier this week, Incyte ran into new trouble Thursday as ODAC panelists voted against an accelerated OK by a wide margin.

https://t.co/7sefxaPQxt",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
4893474783,2021-06-25 08:24:23,,,"via.news/markets/camden‚Ä¶, pic.twitter.com/DfTq552IkU, ",1408400679971004418,False,0,0,0,0,World time zone,"Camden Property Trust  And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity
https://t.co/ZFMlZI1dUE
Incyte Corporation (INCY), Investar Holding Corporation... https://t.co/DfTq552IkU",,,2016-02-09 19:06:07,,Via News,https://pbs.twimg.com/profile_images/1102363201587634181/TJeRzWNR_normal.png,2462,4822,43,59142,ViaNewsAgency,photo
3318510966,2021-06-25 08:20:04,,,"crweworld.com/article/news-p‚Ä¶, ",1408399593331511300,False,0,0,0,0,CRWE World,MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatme https://t.co/TItIcXIRuH,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1355194932445786112,2021-06-25 08:13:52,"MOR, ",,"stocktitan.net/news/MOR/morph‚Ä¶, ",1408398032635367425,False,0,0,0,0,Twitter,"$MOR MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
https://t.co/ZKIyoupyrH",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1325115160353103872,2021-06-25 08:12:12,"INCY, MOR, ",,"quantisnow.com/insight/114677‚Ä¶, ",1408397612949016579,False,0,0,0,0,Twitter,"$INCY $MOR üì∞ MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

https://t.co/di9OtBriIt

15s delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1254035253104181256,2021-06-25 08:12:06,"MOR, ",,"stocktitan.net/news/MOR/morph‚Ä¶, ",1408397589960081408,False,0,0,0,0,stocktitan,"$MOR MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
https://t.co/bmsl6ZnDlu",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
266143766,2021-06-25 08:11:51,"MOR, ",,"accesswire.com/653099/MorphoS‚Ä¶, ",1408397526848376834,False,0,0,0,0,Accesswire,$MOR MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the ... https://t.co/5yMDldXyJT,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
1273844033861844993,2021-06-25 08:00:31,"INCY, ",,"pic.twitter.com/mEqWR6rATU, ",1408394672251314176,False,0,0,0,0,StockTwits Web,$INCY [Incyte]: RBC Capital Maintains Sector Perform Lowers Price Target $92 --&gt; 88 https://t.co/mEqWR6rATU,,,2020-06-19 01:04:32,United States,Jarvis-Alerts,https://pbs.twimg.com/profile_images/1374794584513986568/eWDm8YFI_normal.jpg,4169,102,79,63687,Jarvis_Alerts,photo
1262114478986010632,2021-06-25 07:59:58,"INCY, MOR, ",,,1408394534317432834,False,0,0,0,0,Twitter Web App,$INCY $MOR Incyte/Morphosys' tafasitamab gets CHMP opinion to treat certain patients with lymphoma,,,2020-05-17 16:15:42,,GapUpüß©,https://pbs.twimg.com/profile_images/1262126091671670784/fUEaPN8a_normal.jpg,161,649,5,6750,GapUp4,
1134049078424162304,2021-06-25 07:55:30,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1408393410067714048,False,0,0,0,0,Newsfilter.io,Incyte/Morphosys' tafasitamab gets CHMP opinion to treat certain patients with lymphoma $INCY $MOR https://t.co/VUI2A01kgb,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3318510966,2021-06-25 07:53:59,,,"crweworld.com/article/news-p‚Ä¶, ",1408393028826374149,False,0,0,0,0,CRWE World,Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatme https://t.co/NN0HXKxeL3,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
261473143,2021-06-25 07:53:38,,,"morphosys.com/media-investor‚Ä¶, Life-Sciences-Germany.com, pic.twitter.com/7gXBhYZOr4, ",1408392939949236232,False,0,0,0,0,Twitter Web App,MorphoSys &amp; Incyte: Positive CHMP Opinion for Tafasitamab in Combi with Lenalidomide in Rel/Ref Diffuse Large B-Cell Lymphoma https://t.co/rCSeGgP9Lc @MorphoSys @Incyte  More German news at https://t.co/xpUrFrLuQi https://t.co/7gXBhYZOr4,"MorphoSys, Incyte, ",,2011-03-05 20:26:19,"Bremen, Germany",[iito] Life Science,https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_normal.jpeg,2596,238,89,29254,iitoLifeScience,photo
33467057,2021-06-25 07:49:21,,"CHMP, DLBCL, ","bit.ly/2SrdbiJ, pic.twitter.com/QIZfzj4H6Q, ",1408391864772968451,False,6,0,1,4,Twitter Web App,"BREAKING NEWS: #CHMP has granted a positive opinion recommending approval of MorphoSys‚Äô and @Incyte's CD19-directed antibody in the EU, for the treatment of eligible adults with relapsed or refractory diffuse large B-cell lymphoma #DLBCL. Learn more: https://t.co/sIwKWgCuvY https://t.co/QIZfzj4H6Q","Incyte, ",,2009-04-20 05:13:43,"Planegg, Germany",MorphoSys,https://pbs.twimg.com/profile_images/1414967751538511873/dOJDE_2G_normal.jpg,1563,205,37,315,MorphoSys,photo
976297820532518914,2021-06-25 07:47:07,,,"dlvr.it/S2RRvN, pic.twitter.com/18NuT4kEE0, ",1408391301507076104,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma https://t.co/NCA6ASKIKF https://t.co/18NuT4kEE0,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2021-06-25 07:45:46,"INCY, ",,"s.flashalert.me/Mm5tG, ",1408390962972397570,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on June 25, 07:42:00: Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma https://t.co/vlAgHfG020",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
42410755,2021-06-25 07:45:23,,,"dgap.de/dgap/News/corp‚Ä¶, ",1408390865127624711,False,0,1,0,0,DGAP_News_Int,MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide... https://t.co/F50QLPBbBw,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
1355194932445786112,2021-06-25 07:44:19,"INCY, MOR, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1408390597719830528,False,0,0,0,1,Twitter,"$INCY $MOR Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
https://t.co/mgK3aAbH3s",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1058344962285289472,2021-06-25 07:44:05,"INCY, MOR, ",,"hammerstonemarkets.com, ",1408390536608862209,False,0,0,0,1,TweetDeck,"$INCY $MOR  Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

https://t.co/IjO24spcLS",,,2018-11-02 09:07:56,For a free 2-week trial click,Hammerstone Markets,https://pbs.twimg.com/profile_images/1058346560604430336/kDXZ5dlQ_normal.jpg,3555,378,127,11186,HammerstoneMar3,
111029613,2021-06-25 07:43:02,,,"endpts.com/odac-echoes-fd‚Ä¶, ",1408390273919422471,False,0,0,0,0,Twitter for iPhone,"ODAC echoes FDA concern over Incyte PD-1, as Pazdur signals broader shift for accelerated approval - https://t.co/SdbbYMtzLT",,,2010-02-03 10:34:58,,Peter Suzman,https://pbs.twimg.com/profile_images/694697889017241600/OcPh_cw0_normal.jpg,7250,1980,212,17917,Biomaven,
2334614718,2021-06-25 07:42:35,"MOR, INCY, ",,"ooc.bz/l/77760, ",1408390159675138048,False,1,0,0,0,Open Outcrier,"$MOR (+2.8% pre) Incyte $INCY and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - SI

https://t.co/YvZMjPZCp7",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
1254035253104181256,2021-06-25 07:42:34,"INCY, MOR, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1408390155447246853,False,0,0,0,0,stocktitan,"$INCY $MOR Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
https://t.co/84U0H3XIH2",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1134049078424162304,2021-06-25 07:42:29,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1408390136031817728,False,0,0,0,0,Newsfilter.io,Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large.. $INCY $MOR https://t.co/Aa2cokjQst,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1325115160353103872,2021-06-25 07:42:17,"INCY, MOR, ",,"quantisnow.com/insight/114639‚Ä¶, ",1408390084324298763,False,0,0,0,0,Twitter,"$INCY $MOR üì∞ Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

https://t.co/qxgYj6gnDh

15s delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1134049078424162304,2021-06-25 07:21:29,"INCY, ",,,1408384850197991424,False,0,0,0,0,Newsfilter.io,$INCY RBC Capital analyst Brian Abrahams maintains Incyte with a Sector Perform and lowers the price target from $92 to $88.,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1325115160353103872,2021-06-25 07:21:22,"INCY, ",,"quantisnow.com/insight/114620‚Ä¶, ",1408384821814915077,False,0,0,0,0,Twitter,"$INCY üì° RBC Capital reiterated coverage on Incyte with a new price target

https://t.co/LHhCFycCOW

15s delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1020244080,2021-06-25 07:02:24,,"PinkSheet, ","bit.ly/3xRN5Vk, ",1408380046709039106,False,0,0,1,0,Sprinklr,"Incyte‚Äôs Retifanlimab Tests US FDA‚Äôs Tolerance For Low Response Rates In Accelerated Approval
https://t.co/Udc5wBmZHe #PinkSheet",,,2012-12-18 12:22:53,Global,Pink Sheet,https://pbs.twimg.com/profile_images/1131186135294709760/JT6A0aKq_normal.png,5802,366,204,12938,PharmaPinkSheet,
1889492676,2021-06-25 05:32:19,"INCY, ","Incyte, FDA, ODAC, Retifanlimab, SquamousCellCarcinomaoftheAnalCanal, SCAC, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1408357378890756097,False,0,0,0,0,Troi URL Plug-in,#Incyte Announces Outcome of #FDA Oncologic Drugs Advisory Committee (#ODAC) Meeting Reviewing #Retifanlimab as a Treatment for Patients with #SquamousCellCarcinomaoftheAnalCanal (#SCAC) $INCY https://t.co/gg8Rnzj3ZB,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1227080867832565760,2021-06-24 20:03:54,"INCY, ",,,1408214329040773121,False,0,0,0,0,Twitter Web App,"$INCY:  Incyte announces the outcome of a meeting of the Oncologic Drugs Advisory Committee of FDA, which retifanlimab  (85.65 +0.52)
Retifanlimab.... regulatory decision on retifanlimab for the treatment of advanced or metastatic SCAC should be deferred",,,2020-02-10 23:04:40,"San Diego, CA",oryo,https://pbs.twimg.com/profile_images/1284688749180354560/4QESe1aF_normal.jpg,552,2695,12,17490,OryoJohn,
1406263672926871552,2021-06-24 18:56:45,"INCY, ","SwingTrade, Catalyst, Stocks, StocksInFocus, StocksToWatch, FDA, StockMarketNews, Trading, ","finance.yahoo.com/news/incyte-an‚Ä¶, ",1408197431028768771,False,0,0,0,0,Twitter for Android,"$INCY minor set back with today's news. There are still no treatment options for SCAC and Incyte will continue to work closely with FDA to overcome their concerns.

#SwingTrade #Catalyst #Stocks #StocksInFocus #StocksToWatch #FDA #StockMarketNews #Trading

https://t.co/uDQ1i00Ntr",,,2021-06-19 10:53:02,,BioTrader13,https://pbs.twimg.com/profile_images/1406265186672054275/AZ-uZPsf_normal.jpg,622,87,4,69,Bio_Trader13,
1276528931890515968,2021-06-24 18:54:48,,,"lnkd.in/gEbF6MW, ",1408196939993149441,False,0,0,0,0,LinkedIn,"Stephen Kaufhold, Incyte 
""the biggest achievement was when I started at Allergan, the company had about $850m of debt on the books. After we've gone through all these transformational transactions we peaked at about $44b of debt. Over that period we neve‚Ä¶https://t.co/BWuz22juSR",,,2020-06-26 10:53:22,,@treasurytalent,https://pbs.twimg.com/profile_images/1276529149964886022/NLBvljcE_normal.png,21,47,0,758,treasurytalent,
72928001,2021-06-24 17:34:23,"INCY, ",,"bit.ly/3wUo4ZB, ",1408176701788463105,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte announces the outcome of a meeting of the Oncologic Drugs Advisory Committee of the U.S. Food and Drug... https://t.co/Hnvo8jYiwT,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1262114478986010632,2021-06-24 17:29:52,"INCY, ",,,1408175565840990208,False,0,0,0,0,Twitter Web App,$INCY FDA panel recommends deferring Incyte's retifanlimab BLA decision. Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC),,,2020-05-17 16:15:42,,GapUpüß©,https://pbs.twimg.com/profile_images/1262126091671670784/fUEaPN8a_normal.jpg,161,649,5,6750,GapUp4,
133504478,2021-06-24 16:34:34,,"strategy, competitiveintelligence, marketing, pharma, healthcare, productmarketing, biotech, pharmaceutical, ","dlvr.it/S2PN90, pic.twitter.com/5Ng7O7Oslb, ",1408161649354178563,False,1,0,0,1,dlvr.it,"ODAC echoes FDA concern over Incyte PD-1, as Pazdur signals broader shift for accelerated approval https://t.co/r9JdcYVAMu #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #biotech #pharmaceutical https://t.co/5Ng7O7Oslb",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
3686628867,2021-06-24 16:32:01,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1408161009894924295,False,0,0,0,0,WordPress.com,Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal¬†(SCAC) https://t.co/aq7joksapf,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
25406480,2021-06-24 16:30:01,,,"awesomecapital.blogspot.com/2021/06/incyte‚Ä¶, ",1408160504472801291,False,0,0,0,1,Twitter Web App,AwesomeCapital: Incyte: FDA Defers Decision on Retifanlimab to Tre... https://t.co/qLEZFs0c87,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
1006334607946649600,2021-06-24 16:26:10,,"StockMarket, Stocks, ","dlvr.it/S2PLxN, ",1408159535634599936,False,0,0,0,0,dlvr.it,Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/6uQJ45x1i3 #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
3460109487,2021-06-24 16:05:15,,,"endpts.com/odac-echoes-fd‚Ä¶, ",1408154273733619712,False,2,1,0,0,TweetDeck,"After the FDA lambasted their PD-1 ahead of an adcomm earlier this week, Incyte ran into new trouble Thursday as ODAC panelists voted against an accelerated OK by a wide margin.

https://t.co/7sefxaPQxt",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
308763219,2021-06-24 16:02:30,,,"endpts.com/odac-echoes-fd‚Ä¶, ",1408153579773386756,False,4,2,1,0,TweetDeck,"ODAC recommended against approving Incyte's PD-1 in a mostly cut and dry adcomm, but the bigger development came as Richard Pazdur signaled a broader shift over how the FDA considers accelerated approvals for the checkpoint inhibitor class.
https://t.co/aeGEhIm0x1",,,2011-05-31 19:38:20,,Max Gelman,https://pbs.twimg.com/profile_images/988507805605875713/o3fvosku_normal.jpg,1433,467,36,11935,MaxGelman,
1089978712685273090,2021-06-24 15:55:05,"INTC, ","Incyte, StockMarket, ","dlvr.it/S2PFg6, ",1408151715476504577,False,0,0,0,0,dlvr.it,#Incyte $INTC Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/oZpVnE1kwi #StockMarket,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
963495628545327104,2021-06-24 15:54:31,"INCY, INCY, ",,"stck.pro/news/INCY/1383‚Ä¶, stck.pro/news/INCY, ",1408151571268001796,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : FDA panel recommends deferring Incyte's retifanlimab BLA decision https://t.co/DYaK7sBxAc Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
46297868,2021-06-24 15:44:04,,,"dlvr.it/S2PCjc, ",1408148939673456646,True,0,0,0,0,dlvr.it,"ODAC echoes FDA concern over Incyte PD-1, as Pazdur signals broader shift for accelerated approval https://t.co/V2PHFZE3Mb",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
976297820532518914,2021-06-24 15:37:38,,,"dlvr.it/S2PBxT, pic.twitter.com/7P5LoCUoqd, ",1408147322454773760,False,0,0,0,0,dlvr.it,Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/O3OQWyhi8h https://t.co/7P5LoCUoqd,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
53097729,2021-06-24 15:36:34,"INCY, ",,,1408147052618469376,False,2,0,3,0,Twitter Web App,$INCY Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC),,,2009-07-02 11:44:23,"Toronto, Ontario",Stockwits‚Ñ¢ Ó®Ä,https://pbs.twimg.com/profile_images/1408587167111303171/Qrn1abyM_normal.jpg,26206,983,189,29344,mikalche,
472650465,2021-06-24 15:36:19,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1408146990916149254,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/5RP0ycXaIh,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1069693680066420736,2021-06-24 15:35:45,"INCY, ",,"s.flashalert.me/WETHLb, ",1408146848150327300,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on June 24, 15:30:00: Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/ugZlDkRSBi",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
3318510966,2021-06-24 15:34:04,,,"crweworld.com/article/news-p‚Ä¶, ",1408146424936636417,False,0,0,0,0,CRWE World,Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatm https://t.co/PKQKaJrdTD,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1355194932445786112,2021-06-24 15:32:27,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1408146018714140681,False,0,0,0,0,Twitter,"$INCY Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)
https://t.co/IGbrboWjlF",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1134049078424162304,2021-06-24 15:31:23,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1408145749674766336,False,0,0,0,0,Newsfilter.io,Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Ca.. $INCY https://t.co/yU30JWR7Cx,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1254035253104181256,2021-06-24 15:30:42,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1408145577032945665,False,0,0,0,0,stocktitan,"$INCY Incyte Announces Outcome of FDA Oncologic Drugs Advisory Committee (ODAC) Meeting Reviewing Retifanlimab as a Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)
https://t.co/kU2iDcN29O",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
2377573750,2021-06-24 14:33:02,,"DataProtection, VMware, ","druva.info/35Qa3jK, ",1408131065252810752,False,1,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/VYlXFfqcTG

@druvainc","druvainc, ",,2014-03-02 19:28:28,,Dave Kunkel,https://pbs.twimg.com/profile_images/440282712734461952/ND0d9rhT_normal.jpeg,3,30,0,98,dtkunkel,
2306879202,2021-06-24 12:30:10,,,"pic.twitter.com/NT46vecT9r, ",1408100146345283586,False,0,0,0,0,Hootsuite Inc.,"Thank you sponsors of our 2021 ABC 7 Gibbons Virtual 5K Run and 3K Walk! @ABC7Chicago @abbvie @adctherapeutics 
Bristol Myers Squibb Incyte  Pfizer  Karyopharm Therapeutics  and Hallmark and Johnson! https://t.co/NT46vecT9r","ABC7Chicago, abbvie, adctherapeutics, ",,2014-01-23 11:35:36,Anywhere in the US!,ABC 7 Gibbons 5K Run,https://pbs.twimg.com/profile_images/976142279969779712/sMi4GaE8_normal.jpg,515,1866,0,1186,Gibbons5k,video
133504478,2021-06-24 11:19:03,,"strategy, competitiveintelligence, marketing, biotech, pharmaceutical, pharma, healthcare, competitivemarketing, ","dlvr.it/S2NNXb, pic.twitter.com/ytsE1M4co3, ",1408082250147631104,False,0,0,0,1,dlvr.it,"FDA slams Incyte's PD-1 over single-arm study, low response and trial deaths - Endpoints News https://t.co/krOEUPa2xb #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #healthcare #competitivemarketing https://t.co/ytsE1M4co3",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1407780158,2021-06-24 10:38:24,,"GVHD, sponsored, ","bit.ly/2uvja9K, ",1408072017153245184,False,9,0,0,0,Twitter Web App,It‚Äôs your last chance to apply for the @Incyte Ingenuity Award program before the June 30 deadline. This program will award funding to two novel initiatives that address challenges faced by the #GVHD community. Find program details here: https://t.co/2lFytJ4Xd8. #sponsored,"Incyte, ",,2013-05-06 09:41:58,"New York, NY",Miguel Perales M.D.,https://pbs.twimg.com/profile_images/1250512673470590981/ldD-7z-v_normal.jpg,15352,2299,358,33645,DrMiguelPerales,
728894570,2021-06-24 10:15:54,,,"iweller.com/all-health-fit‚Ä¶, pic.twitter.com/jXrnetgwpG, ",1408066357589991433,False,0,0,0,0,iweller.com,"Patients report AD symptom improvement with oral abrocitinib monotherapy - as a consultant for AbbVie, Anacor, AnaptysBio, Arena Pharmaceuticals, Dermira, Dermavant, Eli Lilly, Galderma, GSK, Glenmark, Incyte,... - https://t.co/x6WZfq9CBq https://t.co/jXrnetgwpG",,,2012-07-31 13:55:29,,iWeller.com,https://pbs.twimg.com/profile_images/1244249406477455360/tl4H1tq0_normal.jpg,121,141,0,264390,iWeller_health,photo
3308093475,2021-06-24 10:02:30,,"Pharmaceutical, innovation, invention, pharma, healthcare, ","pic.twitter.com/n4YgZdQooA, pic.twitter.com/n4YgZdQooA, ",1408062981854818319,False,1,0,0,0,Twitter Web App,"Index 2021 Top #Pharmaceutical companies: 
1. @LillyPad 
2. @Roche 
3. @Regeneron 
4. @SeagenGlobal 
5. @Incyte 
6. @GSK / @GSKUS 
7. @sanofi / @sanofipasteur / @SanofiUS 
8. @AstraZeneca 
9. @pfizer 
10. @GileadSciences 
11. @Novartis 

#innovation #invention #pharma #healthcare https://t.co/n4YgZdQooA","LillyPad, Roche, Regeneron, SeagenGlobal, Incyte, GSK, GSKUS, sanofi, sanofipasteur, SanofiUS, AstraZeneca, pfizer, GileadSciences, Novartis, ",,2015-06-04 08:33:03,"Lisbon, Portugal",Claude Waddington,https://pbs.twimg.com/profile_images/1435688032678682633/Z0ex7zyN_normal.jpg,828,1913,141,11615,Mr_C_Wadd,photo
891441550349275137,2021-06-24 08:40:43,,"ipo, invest, stocks, money, investment, finance, trading, ","ift.tt/3wSQ8MP, ",1408042400375783428,False,1,0,0,0,IFTTT,"üì∞ ""The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO"" #ipo #invest #stocks #money #investment #finance #trading https://t.co/6sN1FS8Dj1",,,2017-07-29 19:33:22,"Tampa, FL",ùïÑùï£. ‚Ñ§ùï†,https://pbs.twimg.com/profile_images/959946990334464000/rMN1-KOz_normal.jpg,138,549,0,7778,mrzoriley,
750646032258793472,2021-06-24 03:57:04,,,"endpts.com/fda-slams-incy‚Ä¶, ",1407971019399340034,False,0,0,0,0,Twitter Web App,"FDA slams Incyte's PD-1 over single-arm study, low response and trial deaths - https://t.co/SOy57uuwEc",,,2016-07-06 07:02:15,"Paris, France",Mazars,https://pbs.twimg.com/profile_images/1238543616617963521/RBlZCFrU_normal.jpg,114,616,22,8618,CrMazars,
1399103920522334219,2021-06-24 02:18:05,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/4YprUjt9xK, ",1407946110082113537,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2164 out of 5476 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/4YprUjt9xK",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
1280938376099741697,2021-06-23 22:19:30,,"iexStock, ","iexcloud.io, pic.twitter.com/KNBA8LbdVZ, ",1407886066707804162,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Starbucks Corp.
-Fiserv, Inc.
-National Corporation for Tourism &amp; Hotel
-KLA Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/KNBA8LbdVZ",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
14562968,2021-06-23 17:51:20,,,"endpts.com/fda-slams-incy‚Ä¶, ",1407818580847124481,False,1,0,0,0,Twitter Web App,"FDA slams Incyte's PD-1 over single-arm study, low response and trial deaths https://t.co/vpMQI6GTbY",,,2008-04-27 19:44:29,Pennsylvania,"Wafik S. El-Deiry, MD, PhD, FACP",https://pbs.twimg.com/profile_images/1423352521800699905/QAB54p61_normal.jpg,8804,6116,347,41415,weldeiry,
3460109487,2021-06-23 15:15:00,,,"endpts.com/fda-slams-incy‚Ä¶, ",1407779237944336387,False,0,0,0,0,TweetDeck,"The ever-growing PD-1 landscape could see a new entrant as an Incyte program is slated for an FDA decision next month. But first, the biotech will have to get through an adcomm Thursday.

https://t.co/Z0Lec2Rp9k",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
47819333,2021-06-23 13:42:03,,"DataProtection, VMware, ","druva.info/3d4KYFK, ",1407755845337763845,False,0,0,0,1,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/91NLRS8uwp

@druvainc","druvainc, ",,2009-06-16 22:14:22,"Raleigh, NC",Donnie Furcillo,https://pbs.twimg.com/profile_images/2922968436/4c0af1cd94ec22c050280525b6a4f773_normal.jpeg,318,766,8,1367,donnie_dedupe,
15974185,2021-06-23 12:05:05,,,"dlvr.it/S2JhQG, ",1407731444852551682,False,0,0,0,0,dlvr.it,"FDA slams Incyte's PD-1 over single-arm study, low response and trial deaths https://t.co/dEYnqANee6",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
133504478,2021-06-23 12:00:33,,"strategy, competitiveintelligence, marketing, pharmaceutical, biotech, productmarketing, pharma, healthcare, ","dlvr.it/S2JglZ, pic.twitter.com/28UhDgOGhw, ",1407730306010943492,False,0,0,0,1,dlvr.it,"FDA slams Incyte's PD-1 over single-arm study, low response and trial deaths https://t.co/sBd8if8DKN #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #productmarketing #pharma #healthcare https://t.co/28UhDgOGhw",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
46297868,2021-06-23 10:49:04,,,"dlvr.it/S2JRT5, ",1407712315126861824,True,0,0,0,0,dlvr.it,"FDA slams Incyte's PD-1 over single-arm study, low response and trial deaths https://t.co/h1cAz9o7ns",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
16697257,2021-06-23 08:06:53,,,"pink.pharmaintelligence.informa.com/articles/2021/‚Ä¶, ",1407671501067894785,False,1,0,0,0,Twitter Web App,There's another @US_FDA adcom tomorrow...Oncology Accelerated Approval In Spotlight (Again) With US FDA AdComm Review Of Incyte Retifanlimab For Anal Cancer https://t.co/X2oBAQKqpj,"US_FDA, ",,2008-10-11 12:03:28,Maryland,Derrick,https://pbs.twimg.com/profile_images/108491643/0323091904_normal.jpg,1169,748,94,16595,dgingery,
1134049078424162304,2021-06-23 05:35:14,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1407633334583316482,False,0,0,0,0,Newsfilter.io,Incyte-partnered anti-PD-1 therapy wins FDA‚Äôs orphan drug designation for liver cancer $INCY https://t.co/7jGYwZzsGN,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
19391292,2021-06-23 05:17:29,,"oxygenconcentrators, Government, hospitals, iahvcovidcare, COVID19, ","pic.twitter.com/HvZgn71a15, pic.twitter.com/HvZgn71a15, pic.twitter.com/HvZgn71a15, pic.twitter.com/HvZgn71a15, ",1407628868597387269,False,46,0,0,24,Twitter Web App,"17 #oxygenconcentrators was received by 4 #Government #hospitals
In Cities (Lauriya, Dhule, Hooghly, Giddalur), 
Across States (Bihar, Maharashtra, West Bengal, Andhra Pradesh)
With the support of our partners‚Äì @Incyte, @AtlasCopcoGroup, @InCredFin

#iahvcovidcare #COVID19 https://t.co/HvZgn71a15","Incyte, AtlasCopcoGroup, InCredFin, ",,2009-01-23 07:00:45,Worldwide,IAHV,https://pbs.twimg.com/profile_images/528406740040036352/DGsFEeH5_normal.jpeg,4487,218,34,1992,iahv,photo
1020244080,2021-06-23 05:02:14,,"PinkSheet, ","bit.ly/3qnHQu2, ",1407625032763912194,False,0,0,0,0,Sprinklr,"Oncology Accelerated Approval In Spotlight (Again) With US FDA AdComm Review Of Incyte Retifanlimab For Anal Cancer
https://t.co/94rWjUnL5i #PinkSheet",,,2012-12-18 12:22:53,Global,Pink Sheet,https://pbs.twimg.com/profile_images/1131186135294709760/JT6A0aKq_normal.png,5802,366,204,12938,PharmaPinkSheet,
1280938376099741697,2021-06-23 00:53:34,,"iexStock, ","iexcloud.io, pic.twitter.com/fAhvjJThx5, ",1407562453509099523,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Umm Al-Qaiwain General Investments Co. P
-Emirates Driving Company
-Incyte Corp.
-Costco Wholesale Corp
-Skyworks Solutions, Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/fAhvjJThx5",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2344420430,2021-06-23 00:45:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1407560398119788547,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/tB9A7xYdd8",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
4893474783,2021-06-22 20:23:19,,,"via.news/markets/abbott‚Ä¶, pic.twitter.com/GJ4FZwmXlS, ",1407494443352178688,False,0,0,0,0,World time zone,"Abbott Laboratories  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity
https://t.co/H6kvuhET65
Medpace Holdings (MEDP), Incyte Corporation (INCY), Barne... https://t.co/GJ4FZwmXlS",,,2016-02-09 19:06:07,,Via News,https://pbs.twimg.com/profile_images/1102363201587634181/TJeRzWNR_normal.png,2462,4822,43,59142,ViaNewsAgency,photo
1280938376099741697,2021-06-22 20:14:26,,"iexStock, ","iexcloud.io, pic.twitter.com/KzltzQYd41, ",1407492203958751234,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-National Bank of Umm Al-Qaiwain
-Incyte Corp.
-AMGEN Inc.
-Texas Instruments Inc.
-NXP Semiconductors NV

Data provided by https://t.co/oXreiEXTgd https://t.co/KzltzQYd41",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2021-06-22 17:26:25,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2825555, pic.twitter.com/2GxhtoF6eJ, ",1407449921695801345,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/gkHwgfbMJ4 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/2GxhtoF6eJ,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
772471873539977217,2021-06-22 16:06:18,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1407429760129581058,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/7CjgbgZ6EI,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
1324435125644464130,2021-06-22 15:13:59,,,"drugs.com/nda/ruxolitini‚Ä¶, ",1407416593227960323,False,1,0,0,0,Twitter Web App,Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis https://t.co/vk7P1dn5aq,,,2020-11-05 14:36:01,,Fernando Alberto Hidalgo Figuerola,https://pbs.twimg.com/profile_images/1324435743993978880/Hw-gIwt__normal.jpg,31,396,0,1902,FahfSCP150,
771805451281309698,2021-06-22 13:43:01,,"DataProtection, VMware, ","druva.info/3d5YYit, ",1407393701920378886,False,0,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/4sPYpLxazs

@druvainc","druvainc, ",,2016-09-02 16:22:13,,Trevor Marino,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,11,149,0,796,trevor_marino,
108617488,2021-06-22 12:55:02,,,"invst.ly/v7p4a, ",1407381627593019396,False,0,0,0,1,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/JK4e1vp6nV,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
121158213,2021-06-22 11:19:03,"INCY, ",,"dlvr.it/S2DjzW, AlertTrade.us, ",1407357472679993345,False,0,0,0,0,dlvr.it,UPSIDE MOMO: $INCY Incyte Corporation Common Stock https://t.co/HVabwI9xr6 üì≥ TradeIdeas via ‚ü∂ https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
836298809605046278,2021-06-22 10:56:26,,"FDAODAC, ","bit.ly/3d0XeH7, ",1407351782070759427,False,9,1,0,2,Sprout Social,"Briefing information has been posted for the Oncologic Drugs Advisory Committee #FDAODAC meeting June 24, on BLA 761209 retifanlimab injection, Incyte Corp, proposed for treatment of locally advanced or metastatic squamous carcinoma of the anal canal. üëá 
https://t.co/SbCg4I6FMK",,,2017-02-27 14:35:48,"Silver Spring, MD",FDA Oncology,https://pbs.twimg.com/profile_images/836300624199364609/6UHslRrT_normal.jpg,28020,325,325,5167,FDAOncology,
2334614718,2021-06-22 10:32:12,"INCY, ",,,1407345684165111816,False,0,0,0,0,Open Outcrier,$INCY Incyte/Macrogenics FDA Advisors to vote on deferring drug decision for more data - BBG,,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
406883738,2021-06-22 09:58:02,,"DataProtection, VMware, ","druva.info/3xFRJW5, ",1407337084474564616,False,0,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/qy3BgWbvnb

@druvainc","druvainc, ",,2011-11-07 05:09:39,"South East, England",Martin Edwards,https://pbs.twimg.com/profile_images/1162360933047504899/pL1n6nk__normal.jpg,143,89,16,1706,MEdwardsDruva,
1278287856474050563,2021-06-22 06:00:44,,"LungCancer, RenalCancer, BloodCancer, Bladdercancer, Melanoma, ","bit.ly/3vGYXIc, pic.twitter.com/QyOWJvm6sZ, ",1407277366968152069,False,0,0,0,1,Twitter Web App,"The major players in the checkpoint inhibitors market are, AstraZeneca PLC, Bristol-Myers Squibb Company, Merck &amp; Co., Inc., Roche Holding AG, Pfizer, Incyte Corporation, Novartis AG... @ @ https://t.co/6gGiH9a9zP

#LungCancer #RenalCancer #BloodCancer #Bladdercancer #Melanoma https://t.co/QyOWJvm6sZ",,,2020-07-01 07:22:41,Hyderabad,ramacharitbrc,https://pbs.twimg.com/profile_images/1278990388481544192/zTlZyWbh_normal.jpg,14,49,1,2910,ramacharitbrc,photo
25406480,2021-06-21 19:45:04,,,"awesomecapital.blogspot.com/2021/06/fda-ac‚Ä¶, ",1407122429139374081,False,0,0,0,1,Twitter Web App,AwesomeCapital: FDA Action Alert: Incyte and Ascendis https://t.co/wGKzOuvkwh,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
1216834108577312770,2021-06-21 17:42:01,,"DataProtection, VMware, ","druva.info/3wRnoUE, ",1407091461523443717,False,0,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/9gLiI4O64T

@druvainc","druvainc, ",,2020-01-13 16:27:45,,PupulEarl,https://pbs.twimg.com/profile_images/1216835198823723018/Vqp-6ng8_normal.jpg,4,55,0,695,EarlPupul,
374729426,2021-06-21 16:33:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2823048, pic.twitter.com/6grb2nC7lv, ",1407074251769729032,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/f7HGaQwZ22 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/6grb2nC7lv,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
836298809605046278,2021-06-21 13:12:06,,"FDAODAC, ","bit.ly/3d0XeH7, ",1407023533079908354,False,7,0,0,2,Sprout Social,"The Oncologic Drugs Advisory Committee #FDAODAC meets June 24, 10:30am-2:30pm Eastern to discuss BLA 761209, retifanlimab injection, Incyte Corp, proposed for treatment of locally advanced or metastatic squamous carcinoma of the anal canal. Meeting infoüëá 
https://t.co/SbCg4I6FMK",,,2017-02-27 14:35:48,"Silver Spring, MD",FDA Oncology,https://pbs.twimg.com/profile_images/836300624199364609/6UHslRrT_normal.jpg,28020,325,325,5167,FDAOncology,
340582241,2021-06-21 09:40:23,"INCY, ASND, ",,"biospace.com/article/fda-ac‚Ä¶, ",1406970253498847233,False,0,0,0,0,Twitter Web App,"$INCY and $ASND update to timeline for FDA review period for their drugs. 

https://t.co/DGx1vEqVHm",,,2011-07-22 18:59:28,"Kansas, USA",Rob - The Science SHIB üë®‚Äçüî¨ üìà,https://pbs.twimg.com/profile_images/1418749518183546887/43S9DjTa_normal.jpg,2955,4339,36,30786,r_bsal,
741745921,2021-06-21 09:33:19,"INCY, CFLT, BBBY, PLUG, ",,,1406968476254806017,False,1,0,0,0,Twitter Web App,"Incyte $INCY - The FDA is scheduled to rule on the company's New Drug Application  Monday.
Confluent $CFLT- An IPO scheduled for Thursday. 
Bed Bath &amp; Beyond $BBBY - CNBC's Jim Cramer, 
Plug Power $PLUG - Will report Q1 earnings before market open on Tuesday.",,,2012-08-06 20:15:46,New York City,A_Setup_Calls,https://pbs.twimg.com/profile_images/1417868484550221829/XI_MEnS7_normal.jpg,584,166,8,1199,A_Setup_Calls,
1022006086872821762,2021-06-21 05:02:54,"INCY, INCY, ",,,1406900421667459075,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was UP ‚¨Ü on Fri Jun 18
Closed at 83.96 USD for a 1.00% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
1391658191469961220,2021-06-21 02:12:23,,"novel, therapies, companies, GvHD, GvHD, ","bit.ly/3xD6t8c, pic.twitter.com/CMt42cUvHz, ",1406857511106318338,False,0,0,0,0,Twitter Web App,"The introduction of emerging #novel #therapies by key #companies such as @elsalys_biotech, @Incyte, @Syndax and others are expected to give the #GvHD market a significant boost.
To learn more about #GvHD, visit: https://t.co/bYuSS5F6Xg https://t.co/CMt42cUvHz","elsalys_biotech, Incyte, Syndax, ",,2021-05-10 03:36:22,USA,Charles Andrews,https://pbs.twimg.com/profile_images/1397523596205957124/Xa4Nvi4d_normal.png,7,8,0,146,Charles40121097,photo
1280938376099741697,2021-06-20 19:48:39,,"iexStock, ","iexcloud.io, pic.twitter.com/9hRRmO2KS5, ",1406760940574478338,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Gulf Pharmaceutical Industries
-Biogen Inc
-National Marine Dredging
-Texas Instruments Inc.
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/9hRRmO2KS5",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
4058194633,2021-06-20 16:45:32,"INCY, ASND, ABBV, IPHA, ALNY, VIR, ASMB, IVA, AKRO, ABUS, DRRX, CAPR, RDUS, FULC, RGLS, NTLA, MIRO, UNCY, ACXP, RGC, DAWN, CNTA, OMIC, ",,"benzinga.com/z/21630014#.YM‚Ä¶, ",1406714860663021568,False,2,0,0,0,Twitter for iPhone,"$INCY $ASND $ABBV $IPHA $ALNY $VIR $ASMB $IVA $AKRO $ABUS $DRRX $CAPR $RDUS $FULC $RGLS $NTLA $MIRO $UNCY $ACXP $RGC $DAWN $CNTA $OMIC The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs https://t.co/swpxEJHEtZ # via @benzinga","Benzinga, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1300746444819881987,2021-06-20 14:51:33,,,"dlvr.it/S26C0T, ",1406686173217517569,False,0,0,0,0,dlvr.it,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs https://t.co/aRULfq5TfP",,,2020-09-01 06:45:07,,Biznessman,https://pbs.twimg.com/profile_images/1376929048081825793/h8JpD-dq_normal.jpg,20,15,0,1437,biznessman77,
796393415189499904,2021-06-20 14:42:03,,,"dlvr.it/S269yC, pic.twitter.com/RDpHp0QfH6, ",1406683785186332676,False,0,0,0,0,dlvr.it,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs https://t.co/1exB719Zjv https://t.co/RDpHp0QfH6",,,2016-11-09 11:46:01,"Florida, USA",SimamsProperties,https://pbs.twimg.com/profile_images/796395756588560384/8NIyGcRk_normal.jpg,45,4,10,29345,SimamsProperty,photo
133504478,2021-06-20 13:52:33,,"strategy, competitiveintelligence, marketing, pharmaceutical, competitivemarketing, pharma, biotech, healthcare, ","dlvr.it/S264GW, pic.twitter.com/0FRIL67vNo, ",1406671326912282624,False,0,0,0,1,dlvr.it,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs - Benzinga https://t.co/fcRAdJdLFd #strategy #competitiveintelligence #marketing #pharmaceutical #competitivemarketing #pharma #biotech #healthcare https://t.co/0FRIL67vNo",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1217293817210200064,2021-06-20 12:27:40,,,"liverhealthonline.com/ishares-nasdaq‚Ä¶, ",1406649962751012869,False,0,0,0,0,WordPress.com,"iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABBV) ‚Äì The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4¬†IPOs https://t.co/s47ctE36P6",,,2020-01-14 22:54:23,"England, United Kingdom",NwokeAgulu,https://pbs.twimg.com/profile_images/1229419489227395074/9pmocdHX_normal.jpg,281,166,3,277755,AguluNwoke,
335201510,2021-06-20 12:00:32,,,"s.einnews.com/-fDVv2rLDx, ",1406643137536221188,False,0,0,0,0,EIN Presswire,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs https://t.co/brg6lHDlIB",,,2011-07-14 05:30:56,"Washington, D.C.",EIN Presswire: IPO Newswire,https://pbs.twimg.com/profile_images/1288514149396484096/EfOHHAyy_normal.jpg,1406,1777,56,40681,EINIPONews,
4759239404,2021-06-20 11:37:05,,,"fundswift.com/2021/06/20/ish‚Ä¶, pic.twitter.com/aH9JZqkwAy, ",1406637235445768198,False,0,0,0,0,App for FundSwift,"New post (iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ABBV) - The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs) has been published on FUNDSWIFT - https://t.co/Y6iaJbkf3j https://t.co/aH9JZqkwAy",,,2016-01-14 13:18:11,,FundSwift,https://pbs.twimg.com/profile_images/1051584741151891456/6NhcqNAx_normal.jpg,99,0,2,45528,fundswift,photo
185789961,2021-06-20 11:20:32,,,"dlvr.it/S25nTn, ",1406633070044741638,False,0,0,0,1,dlvr.it,"Fighting stigma ‚Äî  The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 ...: (NASDAQ: BIIB) faced multiple clinical trial disappointments, including a failed gene therapy study in choroideremia and stalling of an‚Ä¶ https://t.co/r1kvjIF8Co",,,2010-09-01 17:06:16,Worldwide,STIGMABASE | EDU,https://pbs.twimg.com/profile_images/983490900927098880/W4EweR5t_normal.jpg,922,694,71,788289,stigmabase,
1001192245,2021-06-20 11:19:52,"ALNY, DRRX, NVAX, ABBV, RGLS, RDUS, CAPR, NTLA, ABUS, ASND, ASMB, AKRO, FULC, VIR, DAWN, OMIC, CNTA, IVA, IPHA, ",,"talkmarkets.com/content/stocks‚Ä¶, ",1406632900452302851,False,3,0,0,0,TalkMarketsApp,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs $ALNY $DRRX $NVAX $ABBV $RGLS $RDUS $CAPR $NTLA $ABUS $ASND $ASMB $AKRO $FULC $VIR $DAWN $OMIC $CNTA $IVA $IPHA https://t.co/9fI99fj14f",,,2012-12-10 02:55:31,,TalkMarkets,https://pbs.twimg.com/profile_images/876851529990512641/zRRSWFBW_normal.jpg,4911,1136,597,292822,TalkMarkets,
1006334607946649600,2021-06-20 11:06:08,,"StockMarket, Stocks, ","dlvr.it/S25lr0, pic.twitter.com/8n5bv5SMay, ",1406629447051055112,False,0,0,0,0,dlvr.it,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs https://t.co/wgpRDpjhGf #StockMarket #Stocks https://t.co/8n5bv5SMay",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
1089978712685273090,2021-06-20 10:47:05,"INTC, ","biotech, Incyte, StockMarket, ","dlvr.it/S25jkP, pic.twitter.com/ptAlGW9VK9, ",1406624650843492364,False,0,0,0,0,dlvr.it,"The Week Ahead In #biotech: #Incyte $INTC, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs https://t.co/zSvjliJ2pz #StockMarket https://t.co/ptAlGW9VK9",,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,photo
891441550349275137,2021-06-20 10:40:40,,"ipo, invest, stocks, money, investment, finance, trading, ","ift.tt/3wKsylo, ",1406623036497870852,False,0,0,0,0,IFTTT,"üì∞ ""The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs"" #ipo #invest #stocks #money #investment #finance #trading https://t.co/X31Pc9FqhE",,,2017-07-29 19:33:22,"Tampa, FL",ùïÑùï£. ‚Ñ§ùï†,https://pbs.twimg.com/profile_images/959946990334464000/rMN1-KOz_normal.jpg,138,549,0,7778,mrzoriley,
86720236,2021-06-20 10:38:06,,"weekaheadinbiotech, fda, ascendis, iposbiotech, incyte, usfederalreserve, ","biztoc.com/p/3cnb3i2w?ref‚Ä¶, ",1406622389690003464,False,0,0,0,0,Twitter,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs #weekaheadinbiotech #fda #ascendis #iposbiotech #incyte #usfederalreserve https://t.co/e3vtoLecZq",,,2009-11-01 08:19:56,,BizToc News,https://pbs.twimg.com/profile_images/1452627311631736835/OCyl8AdS_normal.jpg,38,2,2,19577,biztocnews,
1166772455417024512,2021-06-20 10:36:06,,"ABBV, ABUS, ","dlvr.it/S25hY1, pic.twitter.com/VLhBKCLlBM, ",1406621888550367237,False,0,0,0,0,dlvr.it,"#ABBV #ABUS The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs https://t.co/kutQ2alQ4t https://t.co/VLhBKCLlBM",,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
44060322,2021-06-20 10:21:04,"BIIB, ORPH, NVAX, ETON, BPMC, TAK, CVAC, INCY, ASND, ABBV, ","biotech, ","benzinga.com/general/biotec‚Ä¶, ",1406618103744696322,False,5,0,0,5,Twitter Web App,"Want to know what's going on with biotech this week? Ck. out this article by @shanthirex.  $BIIB $ORPH $NVAX $ETON $BPMC $TAK $CVAC $INCY $ASND $ABBV #biotech
https://t.co/NCTEY0HoFx","shanthirex, ",,2009-06-02 00:43:10,"Downtown Detroit, MI & NYC",Benzinga,https://pbs.twimg.com/profile_images/1453004877068750855/6TIA_Ek-_normal.jpg,203880,1600,4450,170437,Benzinga,
1134049078424162304,2021-06-20 10:19:16,"BIIB, ORPH, ETON, BPMC, TAK, ",,"newsfilter.io/articles/the-w‚Ä¶, ",1406617652274024458,False,3,0,0,0,Newsfilter.io,"Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that preva.. $BIIB $ORPH $ETON $BPMC $TAK https://t.co/bKAOeP5lzv",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-06-20 10:17:16,"BIIB, ORPH, ETON, BPMC, TAK, ",,"newsfilter.io/articles/the-w‚Ä¶, ",1406617147422412802,False,1,0,0,0,Newsfilter.io,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs $BIIB $ORPH $ETON $BPMC $TAK https://t.co/bKAOeP5lzv",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
898363992,2021-06-20 09:18:02,,"DataProtection, VMware, ","druva.info/3gQaRd8, ",1406602243483258885,False,0,0,0,2,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/bHQd8RIij6

@druvainc","druvainc, ",,2012-10-22 16:40:14,Glasgow,glush,https://pbs.twimg.com/profile_images/1121377498472820737/0yv5sx_c_normal.jpg,123,269,4,832,garethjalush,
1052651211244138496,2021-06-20 08:08:48,,"financialfreedom, stockmarket, daytrader, investor, trading, finance, daytrading, invest, wallstreet, motivation, bitcoin, forex, investment, forextrader, crypto, investing, forextrading, stocks, ","techunveiled.com/is-incyte-comc‚Ä¶, ",1406584820361314305,False,0,0,2,0,Twitter Web App,"Is Incyte Comcast Stock A Good Delight? https://t.co/xe6lIEJj7h via @techunveiled 
#financialfreedom #stockmarket #daytrader #investor #trading #finance #daytrading #invest #wallstreet #motivation #bitcoin #forex #investment #forextrader #crypto #investing #forextrading #stocks","techunveiled, ",,2018-10-17 16:03:00,Pakistan ,Tech Unveiled,https://pbs.twimg.com/profile_images/1255058488486699008/HyvdT96__normal.jpg,11,85,0,252,techunveiled,
1315434407692509184,2021-06-20 06:16:09,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/5DOSQmCWfz, ",1406556471312138245,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2165 out of 5480 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/5DOSQmCWfz",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
406883738,2021-06-19 09:12:02,,"MondayMotivation, AWS, DataProtection, ","druva.info/3wImN7B, pic.twitter.com/0sKqaryhuE, ",1406238345471070213,False,1,0,0,1,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/KDQRKwJ1oq

#AWS #DataProtection @druvainc https://t.co/0sKqaryhuE","druvainc, ",,2011-11-07 05:09:39,"South East, England",Martin Edwards,https://pbs.twimg.com/profile_images/1162360933047504899/pL1n6nk__normal.jpg,143,89,16,1706,MEdwardsDruva,photo
826911692487548930,2021-06-18 20:22:26,,"autonomousCar, selfDrivingCar, ","bit.ly/2UjL3ib, ",1406044667813273600,False,0,0,0,0,SelfDrivingFeedfromAlerts,Incyte Corp. stock outperforms market on strong trading day - MarketWatch https://t.co/uQAdcU9bPf #autonomousCar #selfDrivingCar,,,2017-02-01 16:54:45,,Self Driving Cars,https://pbs.twimg.com/profile_images/826934547258306560/ozbuAIzM_normal.jpg,1921,607,99,87820,SelfDrivingFEED,
4058194633,2021-06-18 13:37:48,"INCY, ",,"MarketBeat.com, marketbeat.com/instant-alerts‚Ä¶, ",1405942839448543233,False,0,0,0,0,Twitter for iPhone,$INCY  Incyte Expected to Announce Earnings of $0.74 Per Share | https://t.co/NKb5pRLCDo https://t.co/JIRJf9jOur,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
3911174913,2021-06-18 10:30:27,,,"pic.twitter.com/LTDc9UHH4J, ",1405895690883112966,False,0,0,0,0,Twitter Web App,"As a company committed to the relentless pursuit of science that can make a difference in healthcare, we are honored to have been named as one of the 2021 Healthiest Employers by @PHLBizJournal. https://t.co/LTDc9UHH4J","PHLBizJournal, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
1315434407692509184,2021-06-18 06:26:39,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/0YIVyGUJaN, ",1405834334498656262,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2128 out of 5485 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/0YIVyGUJaN",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
849417718642159616,2021-06-18 03:59:13,"INCY, ",,"zpr.io/RL88L, ",1405797234956980226,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by SVB Leerink https://t.co/bhPKhsMUWl,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1315434407692509184,2021-06-17 23:08:53,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/CSZSHcHDTx, ",1405724167253729284,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2129 out of 5487 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/CSZSHcHDTx",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
374729426,2021-06-17 19:53:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2813835, pic.twitter.com/7wXJcdwATH, ",1405675103988240387,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator is sitting in oversold zone for 1 day. View odds for this and other indicators: https://t.co/LhRVK7upDl #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/7wXJcdwATH,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
4028839455,2021-06-17 16:15:02,,"insiderbuying, stocktrot, ","stocktrot.com/company/incyte‚Ä¶, ",1405620020076503042,False,0,0,0,0,StockTrot1,"Incyte Corp execs acquire $758,800.00. Biggest month in 3 months. https://t.co/Glm3Ox59RC #insiderbuying #stocktrot",,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
3911174913,2021-06-17 10:04:37,,"vitiligo, VitiligoAwarenessMonth, ","pic.twitter.com/LqCvsPRY5d, ",1405526800306896900,False,21,1,1,3,Twitter Ads,Did you know that #vitiligo affects 1.5-3 million people in the U.S.? This #VitiligoAwarenessMonth we are joining with the community to spread awareness of this immune-mediated condition. https://t.co/LqCvsPRY5d,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
963326388609736704,2021-06-17 05:55:51,,"EuroLeuk2021, Leukemia, StemCell, Immunotherapy, Bioevents, virtualconference, HaematoOncology, AML, Hematology, ","euroleuk2021.com, pic.twitter.com/hoY2LAnmqh, ",1405464198541414404,False,1,0,0,0,Twitter Web App,"We are delighted to welcome @Incyte as a Sponsor to #EuroLeuk2021 
#Leukemia #StemCell #Immunotherapy #Bioevents #virtualconference #HaematoOncology #AML #Hematology
To register for the Conference: https://t.co/Eon6BlCJPP https://t.co/hoY2LAnmqh","Incyte, ",,2018-02-13 03:18:03,United Kingdom,Bioevents - Sharing Biomed Knowledge,https://pbs.twimg.com/profile_images/963326900486721536/yQQ4nHYK_normal.jpg,239,255,1,1133,BiomedSharing,photo
19391292,2021-06-17 05:12:55,,"OxygenConcentrators, iahvcovidcare, ","pic.twitter.com/3UEbZB5kta, pic.twitter.com/3UEbZB5kta, pic.twitter.com/3UEbZB5kta, pic.twitter.com/3UEbZB5kta, ",1405453391921238019,False,45,0,2,17,Twitter Web App,"Distribution of 19 #OxygenConcentrators to 5 Government Hospitals in various cities (Charaideo, Jaisalmer, Kannur, Nagercoil, Bareilly) across states (Assam, Rajasthan, Kerala, Tamil Nadu, Uttar Pradesh).
Supported by‚Äì@Incyte, @iahvUK, @FromU2them &amp; @VMware 

#iahvcovidcare https://t.co/3UEbZB5kta","Incyte, iahvUK, FromU2them, VMware, ",,2009-01-23 07:00:45,Worldwide,IAHV,https://pbs.twimg.com/profile_images/528406740040036352/DGsFEeH5_normal.jpeg,4487,218,34,1992,iahv,photo
49364751,2021-06-17 01:26:01,,"DataProtection, VMware, ","druva.info/3gV67Dt, ",1405396291753029632,False,0,0,0,2,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/1kLa08iFeR

@druvainc","druvainc, ",,2009-06-21 13:06:31,"Pune, Maharashtra",Arindam Roy,https://pbs.twimg.com/profile_images/378800000501431118/4feff6961b09c3b5c3ecdbf62ea4397a_normal.jpeg,170,586,8,1330,arindamworld,
1099489411,2021-06-17 01:00:14,,"DataProtection, VMware, ","druva.info/3zxh1Ye, ",1405389802497875969,True,0,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/v8GC7g4CrS

@druvainc","druvainc, ",,2013-01-17 17:59:20,,Mark Vara,https://pbs.twimg.com/profile_images/3122435883/f3660d955bfec5489d38a6348ba5350e_normal.jpeg,65,312,0,2066,MarkVaraski,
374729426,2021-06-16 20:40:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2811783, pic.twitter.com/hjACuJOEsp, ",1405324333950537730,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/A9ZVc1LBPU #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/hjACuJOEsp,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390857,Tickeron,photo
127793556,2021-06-16 20:34:02,,"DataProtection, VMware, ","druva.info/3wzJc6X, ",1405322812903014404,False,1,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/FqjGoIYkRp

@druvainc","druvainc, ",,2010-03-30 03:26:26,Mumbai,DeepakAgrawal,https://pbs.twimg.com/profile_images/549534330741993472/tb5BFeL6_normal.jpeg,407,511,1,5084,deep_gem1,
1163724201192067072,2021-06-16 15:38:04,,"DataProtection, VMware, ","druva.info/3gwf9aJ, ",1405248330175815683,False,0,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/das8fRN0gq

@druvainc","druvainc, ",,2019-08-20 04:07:42,,Varun Gaikwad,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,0,5,0,645,VarunGa15479492,
62567174,2021-06-16 15:07:03,,"DataProtection, VMware, ","druva.info/3gul1Bf, ",1405240521912684544,False,0,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/6AGbWvj6Df

@druvainc","druvainc, ",,2009-08-03 13:22:13,Pune,Chandrajeet Panda,https://pbs.twimg.com/profile_images/467587972351528961/QpgZCCdZ_normal.jpeg,203,436,11,1700,jeetpanda,
1310910394253193216,2021-06-16 14:55:04,,"DataProtection, VMware, ","druva.info/3gUduen, ",1405237508519116806,False,0,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/1RkmC5NAhv

@druvainc","druvainc, ",,2020-09-29 07:52:59,,Bhavik @ CloudDataProtection,https://pbs.twimg.com/profile_images/1310911832194838529/1Hn0UT0p_normal.jpg,14,71,0,539,CloudDataBackup,
1280272972859584512,2021-06-16 14:10:02,,"DataProtection, VMware, ","druva.info/3q2EZWV, ",1405226174461235206,False,0,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/cxkZqNOblJ

@druvainc","druvainc, ",,2020-07-06 18:50:48,,sameeragashe,https://pbs.twimg.com/profile_images/1280273854204534785/jcEdoPqL_normal.jpg,10,152,0,2019,sameeragashe1,
58541330,2021-06-16 11:37:38,,"enforcement, compliance, ","hubs.li/H0QnFLW0, pic.twitter.com/ZwoJokYmZi, ",1405187822210977812,False,0,0,0,0,HubSpot,"(2/2) Next, register to join our deep dive into the current #enforcement trends the government is focusing on and the potential impact they may have on your company‚Äôs #compliance program. 

Info Here: https://t.co/MqnZzAh42P https://t.co/ZwoJokYmZi",,,2009-07-20 14:00:36,"Morristown, NJ",Porzio Life Sciences,https://pbs.twimg.com/profile_images/1376579848785825800/9en1pdCE_normal.png,530,498,26,2663,PorzioLS,photo
245932669,2021-06-16 11:21:01,,"DataProtection, VMware, ","bit.ly/2SHFiKy, ",1405183640481501188,False,0,0,0,0,Oktopost,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our Microsoft SQL and #VMware servers is now a very simple process."" ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics https://t.co/lbfeb9Sl46",,,2011-02-01 14:36:55,"Sunnyvale, CA",Druva Inc,https://pbs.twimg.com/profile_images/1412471783609946113/y5Zssf-x_normal.png,21162,3274,340,9899,druvainc,
163565297,2021-06-16 08:02:09,,"CSCDE, Incyte, ","cancersupportdelaware.org/resources/incy‚Ä¶, pic.twitter.com/Wt8CkjuzBS, ",1405133594985746437,False,0,0,0,0,Agorapulse app,"#CSCDE and our partner, #Incyte, find it critical to support our Delaware cancer patients and help maintain their financial health. The Incyte Cancer Care Assistance Fund helps cover costs, such as rent, mortgage, co-pays, and utilities. Learn more at https://t.co/aM35RQ6Zhg. https://t.co/Wt8CkjuzBS",,,2010-07-06 14:57:24,"Delaware, USA",Cancer Support DE,https://pbs.twimg.com/profile_images/667430529340473346/FSfER-Bd_normal.jpg,543,542,30,3173,CancerSupportDE,photo
19391292,2021-06-16 05:06:08,,"oxygenconcentrators, iahvcovidcare, CovidRelief, ","pic.twitter.com/PXnz05gaJd, pic.twitter.com/PXnz05gaJd, pic.twitter.com/PXnz05gaJd, pic.twitter.com/PXnz05gaJd, ",1405089296307032064,False,36,0,0,20,Twitter Web App,"Distributed 18 #oxygenconcentrators to 8 Government Hospitals across Maharashtra, Tamil Nadu, Bihar, Madhya Pradesh.
With the support of our Partners‚Äì @Incyte, @VMware, @InCredFin.
#iahvcovidcare #CovidRelief https://t.co/PXnz05gaJd","Incyte, VMware, InCredFin, ",,2009-01-23 07:00:45,Worldwide,IAHV,https://pbs.twimg.com/profile_images/528406740040036352/DGsFEeH5_normal.jpeg,4487,218,34,1992,iahv,photo
47819333,2021-06-15 14:57:04,,"MondayMotivation, AWS, DataProtection, ","okt.to/ztgsa7, pic.twitter.com/o0emb24RMX, ",1404875624762822660,False,0,0,0,0,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/fsWZQv8MbE

#AWS #DataProtection @druvainc https://t.co/o0emb24RMX","druvainc, ",,2009-06-16 22:14:22,"Raleigh, NC",Donnie Furcillo,https://pbs.twimg.com/profile_images/2922968436/4c0af1cd94ec22c050280525b6a4f773_normal.jpeg,318,766,8,1367,donnie_dedupe,photo
1399103920522334219,2021-06-15 14:14:49,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/egvrT1CbvJ, ",1404864988632735749,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2131 out of 5485 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/egvrT1CbvJ",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
2377573750,2021-06-15 13:11:03,,"MondayMotivation, AWS, DataProtection, ","okt.to/VwApER, pic.twitter.com/g208rhiL2I, ",1404848943717040131,False,0,0,0,1,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/PuwqIsMpkM

#AWS #DataProtection @druvainc https://t.co/g208rhiL2I","druvainc, ",,2014-03-02 19:28:28,,Dave Kunkel,https://pbs.twimg.com/profile_images/440282712734461952/ND0d9rhT_normal.jpeg,3,30,0,98,dtkunkel,photo
4058194633,2021-06-15 12:41:47,"INCY, ",,"MarketBeat.com, marketbeat.com/instant-alerts‚Ä¶, ",1404841579685183488,False,0,0,0,0,Twitter for iPhone,"$INCY Incyte ""Outperform"" Rating Reiterated at William Blair | https://t.co/NKb5pRLCDo https://t.co/NCmgUFKut0",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
812004702594486272,2021-06-15 05:00:53,,,"checkrare.com/interim-data-g‚Ä¶, ",1404725588238217217,False,0,0,0,0,Hootsuite Inc.,"Peter Langmuir, MD, Group Vice President, Oncology Targeted Therapeutics at Incyte, discusses interim data of a phase 2 study assessing the combination of ruxolitinib and parsaclisib in patients with myelofibrosis. 
@Incyte Incyte 
https://t.co/S1bQKb0jFy","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1280938376099741697,2021-06-15 00:10:50,,"iexStock, ","iexcloud.io, pic.twitter.com/kLUhg5P6V2, ",1404652594803453952,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Idexx Laboratories, Inc.
-NetFlix Inc
-Commercial Bank International
-Adobe Inc
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/kLUhg5P6V2",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2344420430,2021-06-14 20:20:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1404594574325161998,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/5jOWWChNLk",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1262915121103491074,2021-06-14 16:29:02,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1404536379132956673,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 3,845 shares on 2021-06-10. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1119687694291021824,2021-06-14 16:10:10,"EXPD, INCY, ","phiDaily, NASDAQ, NASDAQ, Expeditors, International, Incyte, Genomics, ","phi.eco/$10000, phi.eco/$EXPD, phi.eco/$INCY, pic.twitter.com/QeeTFngT5D, ",1404531633278050305,False,0,0,0,0,new-stocks,"#phiDaily extremes
s&amp;p 500 index
run : https://t.co/B88y3MdRM4

#NASDAQ : $EXPD
15.7% ‚¨Ü
https://t.co/ct0rf5JlSp

#NASDAQ : $INCY
-6.1% Ô∏è‚¨á
https://t.co/vcenhqs2Sj

#Expeditors #International #Incyte #Genomics https://t.co/QeeTFngT5D",,,2019-04-20 15:42:03,"New York, NY",phi,https://pbs.twimg.com/profile_images/1392376352876158976/avyNiWcK_normal.jpg,422,253,10,9150,FitchData,photo
50405984,2021-06-14 13:01:43,,"AMMF, ","ow.ly/rimr50ETTUy, pic.twitter.com/zI7F2W76W7, ",1404484208228286468,False,3,0,0,0,Hootsuite Inc.,"Miss the world premiere of ‚ÄòCholangiocarcinoma and the Importance of Molecular Profiling‚Äô at the #AMMF Conference this year? All made possible by the joint collaboration of  @Incyte, @CharityAMMF and expert Prof John Bridgewater, watch now at https://t.co/hOnXTVP2OF https://t.co/zI7F2W76W7","Incyte, CharityAMMF, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
247585711,2021-06-14 11:29:04,,"MSL, medicalaffairs, atopicdermatitis, dermatology, FDA, ","buff.ly/3vg7Sju, pic.twitter.com/QvT1X4xJVO, ",1404460891228278784,False,1,0,0,0,Buffer,"FDA has put off its decision for ruxolitinib cream in atopic dermatitis by three months, making the drug's new decision date September 21.
#MSL #medicalaffairs #atopicdermatitis #dermatology #FDA  https://t.co/qZL1dabP3s https://t.co/QvT1X4xJVO",,,2011-02-04 22:28:55,"Houston, TX",Dr. Melody Davis,https://pbs.twimg.com/profile_images/977758698163630080/votWl1oP_normal.jpg,1310,4968,211,37021,mrdphd,photo
391492257,2021-06-14 09:00:11,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, fdatracker.com/fda-calendar/, ",1404423422722002947,False,0,0,0,0,FDA Tracker,$INCY New PDUFA Date 2021-09-21 INCYTE CORPORATION Link:https://t.co/mAcfJFfwRx Calendar:https://t.co/sCt1qKoMdr,,,2011-10-15 13:01:13,San Francisco,FDA Tracker,https://pbs.twimg.com/profile_images/1667207308/square_logo_normal.png,4992,14,113,4060,fda_tracker,
49364751,2021-06-14 03:25:02,,"MondayMotivation, AWS, DataProtection, ","okt.to/G4JHjl, pic.twitter.com/6zvOxrKePm, ",1404339080763162624,False,1,0,0,1,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/w8JPmg4BEj

#AWS #DataProtection @druvainc https://t.co/6zvOxrKePm","druvainc, ",,2009-06-21 13:06:31,"Pune, Maharashtra",Arindam Roy,https://pbs.twimg.com/profile_images/378800000501431118/4feff6961b09c3b5c3ecdbf62ea4397a_normal.jpeg,170,586,8,1330,arindamworld,photo
172288755,2021-06-13 20:40:39,,,"fiercepharma.com/pharma/incyte-‚Ä¶, ",1404237312884502537,False,0,0,0,0,Twitter Web App,"Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib¬†cream https://t.co/C6PB1IYUkp",,,2010-07-29 06:10:36,"Yong-In city, Korea",Kyung Seok Lee,https://pbs.twimg.com/profile_images/922433020748898305/cjOW-D4X_normal.jpg,17,60,0,646,ksloveis,
55654926,2021-06-13 14:30:03,,"isawdave, ccfturns15, ","pic.twitter.com/rbGyet5mSm, ",1404144048252805130,False,6,1,0,1,Meltwater Social,"The 15,000 Mile Journey of Hope is made possible with the generous support of our sponsors. üöóüó∫Ô∏èüíö

We would like to thank QED Therapeutics, Incyte, Taiho, Zymeworks, EMD Serono, Servier, Dave Fleischer, Ken Garff Honda Orem, and Promotion In Motion. #isawdave #ccfturns15 https://t.co/rbGyet5mSm",,,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,photo
342124520,2021-06-13 12:07:35,,,"floridalatamworldofbusiness.com/2021/06/13/inc‚Ä¶, ",1404108194964725763,False,0,0,0,0,WordPress.com,Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual¬†Conference https://t.co/TwoQoobU9J,,,2011-07-25 10:38:20,Santo Domingo / Miami,ELMUNDOdelosNEGOCIOS,https://pbs.twimg.com/profile_images/469918932782960640/tPjIEg38_normal.jpeg,2135,1984,35,53267,EMdelosNEGOCIOS,
15974185,2021-06-13 05:47:32,,,"dlvr.it/S1dDh9, ",1404012551671664645,False,0,0,0,0,dlvr.it,"Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib cream https://t.co/rBHQG9SQ91",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
719463497755533312,2021-06-13 03:43:07,,"TargetedCancerDrugs, MarketAnalysis, ","innovationmarketresearch.com/market-reports‚Ä¶, ",1403981244199706633,False,0,0,0,0,Twitter Web App,"#TargetedCancerDrugs #MarketAnalysis 2016-2020.

Request A Sample  - https://t.co/ESHDAb6pgs

Major Players - @pfizer @Incyte @Novartis @EliLillyItalia  @GileadSciences @SanofiUS @galapagossip @abbvieuk @VertexPharma @tevapharmeurope @AstellasPharma @CelgeneDK","pfizer, Incyte, Novartis, EliLillyItalia, GileadSciences, SanofiUS, galapagossip, abbvieuk, VertexPharma, tevapharmeurope, AstellasPharma, CelgeneDK, ",,2016-04-11 05:53:59,India,"Innovation Market Research, Inc",https://pbs.twimg.com/profile_images/1157720358817976321/zmR7a_Bi_normal.jpg,26,51,0,156,InnovationImr,
601863431,2021-06-13 03:02:08,,"p, ","ift.tt/3cFT3Au, ift.tt/31iQLRO, ",1403970926333599745,False,0,0,0,0,IFTTT,Incyte Announces Updated Data For Ruxolitinib Cream Accepted For Presentation At The 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference https://t.co/VoaGJS6A46 Great source of personal finance ideas news tips! let me know what you think? #p‚Ä¶ https://t.co/d8xuCjHrpn,,,2012-06-07 09:18:29,,Bob Kennedy,https://pbs.twimg.com/profile_images/1445356413526675458/N5-vY3xe_normal.jpg,781,818,177,127128,Kennedy1Robert,
1280938376099741697,2021-06-12 22:45:05,,"iexStock, ","iexcloud.io, pic.twitter.com/N1AXUpuVZ7, ",1403906239051010052,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Umm Al-Qaiwain General Investments Co. P
-Mylan N.V.
-Foodco Holding
-Kraft Heinz Co
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/N1AXUpuVZ7",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2021-06-12 20:31:13,,"iexStock, ","iexcloud.io, pic.twitter.com/9D6iDigmQ8, ",1403872550715863041,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Ras Al Khaima Properties Co.
-United Arab Bank
-Synopsys, Inc.
-NXP Semiconductors NV

Data provided by https://t.co/oXreiEXTgd https://t.co/9D6iDigmQ8",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1006334607946649600,2021-06-12 17:50:34,,"StockMarket, Stocks, ","dlvr.it/S1c8JF, ",1403832120284377091,False,0,0,0,0,dlvr.it,Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference https://t.co/abWXUhJkXo #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1089978712685273090,2021-06-12 17:40:03,"INTC, ","Incyte, StockMarket, ","dlvr.it/S1c7NL, ",1403829475675049985,False,0,0,0,0,dlvr.it,#Incyte $INTC Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference https://t.co/GwlLgfL5r9 #StockMarket,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
360220091,2021-06-12 17:28:07,,,"dataemia.com/?p=520814, ",1403826471429459976,False,0,0,0,0,Newsemia,(Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference) https://t.co/gGhu4muTIh,,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,
3318510966,2021-06-12 17:18:01,,,"crweworld.com/article/news-p‚Ä¶, ",1403823932205985795,False,0,0,0,0,CRWE World,Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Der https://t.co/oAsFiaEWTe,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
963495628545327104,2021-06-12 17:11:03,"INCY, INCY, ",,"stck.pro/news/INCY/1356‚Ä¶, stck.pro/news/INCY, pic.twitter.com/mEnEVvYSwU, ",1403822177917538308,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference https://t.co/50BzfPqcLK Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/mEnEVvYSwU,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
3238213074,2021-06-12 17:10:58,,,"lifecarenews.in/incyte-announc‚Ä¶, ",1403822156866281476,False,0,0,0,0,WordPress.com,Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual¬†Conference https://t.co/ms0QdhIYl7,,,2015-06-06 18:50:37,"Rajkot, India",lifecarenews,https://pbs.twimg.com/profile_images/783273733397950464/4FcSGflU_normal.jpg,63,46,1,17495,lifecarenews247,
472650465,2021-06-12 17:09:05,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1403821680850526208,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference https://t.co/0xyCho9UM6,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1069693680066420736,2021-06-12 17:05:23,"INCY, ",,"s.flashalert.me/DxoS9c, ",1403820751367639043,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on June 12, 17:01:00: Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference https://t.co/fe1F2PnGkQ",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2021-06-12 17:05:06,,,"dlvr.it/S1c44K, pic.twitter.com/K08jRzvcZF, ",1403820678428577795,False,0,0,0,0,dlvr.it,Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference https://t.co/GQPazensqj https://t.co/K08jRzvcZF,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
213137160,2021-06-12 17:05:06,,,"dlvr.it/S1c44k, pic.twitter.com/rByEBnAVwX, ",1403820678038519808,False,0,0,0,0,dlvr.it,Incyte¬†: Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference https://t.co/F27QoOEKRl https://t.co/rByEBnAVwX,,,2010-11-07 21:12:11,"San Diego, CA",Sniff Out Stocks,https://pbs.twimg.com/profile_images/1162213671/big_dog_nose_normal.jpg,3611,3936,82,49949,SniffOutStocks,photo
1355194932445786112,2021-06-12 17:04:02,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1403820413461925890,False,0,0,0,0,Twitter,"$INCY Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference
https://t.co/bZFuCnczTt",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1134049078424162304,2021-06-12 17:03:02,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1403820161585516545,False,0,0,0,0,Newsfilter.io,Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis Virtual Co.. $INCY https://t.co/7K0HDd9zLh,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1254035253104181256,2021-06-12 17:02:18,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1403819973563256840,False,0,0,0,0,stocktitan,"$INCY Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference
https://t.co/Vaq1Xj36ba",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1325115160353103872,2021-06-12 17:01:16,"INCY, ",,"quantisnow.com/insight/992962‚Ä¶, ",1403819714678190088,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference

https://t.co/YwxOW8RAdj

15s delayed.",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1402056489842274306,2021-06-12 17:01:04,"INCY, ",,"mktn.ws/44760, ",1403819665877393411,False,0,0,0,0,Twitter,"$INCY Incyte Announces Updated Data for Ruxolitinib Cream Accepted for Presentation at the 2021 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference
 
https://t.co/ITpMm1Xflh",,,2021-06-07 20:17:15,,Market Newswire,https://pbs.twimg.com/profile_images/1402059365117399048/4SdeRlrL_normal.jpg,6,0,0,9801,Market_Newswire,
4058194633,2021-06-12 11:08:41,"INCY, ",,"thestreet.com/investing/incy‚Ä¶, ",1403730983669551109,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Sees Delay in FDA Review of Eczema Cream https://t.co/ljxvfDAIWw,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
223598435,2021-06-12 10:36:48,,,"businesswire.com/news/home/2021‚Ä¶, ",1403722962851803138,False,0,0,0,0,Twitter Web App,"FDA regulators are concerned that Jakafi, a new steroid-refractory chronic graft-versus-host disease (GVHD) drug, may carry cardiovascular and cancer risks similar to the rheumatoid arthritis drug Xeljanz.
https://t.co/2cf1IZkNES",,,2010-12-06 15:44:40,,Faith Anderson,https://pbs.twimg.com/profile_images/1185776313/red_cross_normal.png,263,903,6,1137,MedAlertBlogger,
374729426,2021-06-12 08:15:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2800844, pic.twitter.com/EQu9QM89tt, ",1403687298072338435,False,0,0,0,1,Tickeron,"$INCY's price moved below its 50-day Moving Average on June 11, 2021. View odds for this and other indicators: https://t.co/Ino9FQIBR1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/EQu9QM89tt",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1134049078424162304,2021-06-12 00:37:59,"INCY, ",,"newsfilter.io/articles/s-8-f‚Ä¶, ",1403572264730308613,False,0,0,0,0,Newsfilter.io,Form S-8 (securities to be offered to employees in employee benefit plans) filed with the SEC $INCY https://t.co/NGOJ4GXZpR,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
4035355935,2021-06-12 00:22:27,,,,1403568355626217478,False,0,0,0,0,WPTS Playlist,Incyte - Numbers,,,2015-10-24 21:01:50,"Pittsburgh, PA",WPTS Playlist,https://pbs.twimg.com/profile_images/658129792408023041/8nflCFL-_normal.jpg,478,5,38,638221,WPTSPlaylist,
374729426,2021-06-11 20:33:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2799678, pic.twitter.com/NHA3FcjdpE, ",1403510731157299201,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on June 3, 2021. View odds for this and other indicators: https://t.co/yBhqcXiqPI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/NHA3FcjdpE",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
4312114277,2021-06-11 16:57:37,"INCY, ",,"fintel.io/sf/us/incy?utm‚Ä¶, ",1403456410793435139,False,0,0,0,0,Fintel.io,$INCY / Incyte files S-8 registration statement (stock option plan) https://t.co/Oc4NyYycjO,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
18294275,2021-06-11 15:31:24,,,"fiercepharma.com/pharma/incyte-‚Ä¶, ",1403434712367079424,False,0,0,0,1,TweetDeck,"Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib cream https://t.co/hp6LCB3HAw",,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
15281391,2021-06-11 15:05:07,"INCY, ",,"thestreet.com/investing/incy‚Ä¶, ",1403428096750112770,False,3,0,0,0,Buffer,"Incyte¬†( $INCY ) fell after the FDA extended the review period for its ruxolitinib cream to treat eczema.
https://t.co/kWKoxvOnqp",,,2008-06-30 15:12:38,"New York, NY",TheStreet,https://pbs.twimg.com/profile_images/1438558308164644866/JLxN88qJ_normal.jpg,804746,1161,7179,215649,TheStreet,
1313110513904234498,2021-06-11 14:53:03,,"MondayMotivation, AWS, DataProtection, ","okt.to/JaTIAk, pic.twitter.com/87nFc3Tgv3, ",1403425058752806914,False,0,0,0,0,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/JNOFmPPKJ5

#AWS #DataProtection @druvainc https://t.co/87nFc3Tgv3","druvainc, ",,2020-10-05 09:35:32,,sedansereau,https://pbs.twimg.com/profile_images/1313900108224901120/lyFt2XDr_normal.jpg,1,105,0,120,sedansereau1,photo
133504478,2021-06-11 14:29:38,,"strategy, competitiveintelligence, marketing, biotech, pharma, pharmaceutical, productmarketing, healthcare, ","dlvr.it/S1XnxV, ",1403419169731743746,False,1,0,0,1,dlvr.it,"Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib¬†cream https://t.co/HKyexPuHYT #strategy #competitiveintelligence #marketing #biotech #pharma #pharmaceutical #productmarketing #healthcare",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
1250830691824283648,2021-06-11 14:26:26,"VFC, PVH, TPR, GPS, NVDA, NDAQ, WRK, VRTX, INCY, LLY, BIIB, CCI, PRGO, ADM, ",,,1403418360319201282,False,5,0,1,1,Twitter Web App,"Best and worst performing S&amp;P 500 stocks so far today

Best:
1 VF Corp $VFC
2 $PVH
3 Tapestry $TPR
4 Gap $GPS
5 Nvidia $NVDA
6 Nasdaq $NDAQ
7 WestRock $WRK

Worst:
1 Vertex $VRTX
2 Incyte $INCY
3 Eli Lilly $LLY
4 Biogen $BIIB
5 Crown Castle $CCI
6 Perrigo $PRGO
7 Archer $ADM",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
140599113,2021-06-11 14:20:26,,,"winway.me/health-remedie‚Ä¶, ",1403416853901418502,False,0,0,0,0,WordPress.com,"Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib¬†cream https://t.co/wqZDi4DhWt",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
780775431309963264,2021-06-11 14:08:09,,"Incyte, FDA, Ruxolitinib, AtopicDermatitis, FDA, NDA, TopicalTherapy, ","drugdeliverybusiness.com/fda-extends-nd‚Ä¶, ",1403413759335583750,False,1,0,0,0,Sprout Social,"#Incyte announced today that the #FDA extended the review period for the new drug application for its #Ruxolitinib cream.

MORE ON THE STORY HERE: https://t.co/Qz1HV82gps

#AtopicDermatitis #FDA #NDA #TopicalTherapy @Incyte","Incyte, ",,2016-09-27 10:25:43,"Cleveland, OH",Drug Delivery Business News,https://pbs.twimg.com/profile_images/783451516891897856/t4s29ZQh_normal.jpg,1775,531,22,3529,DrugDeliveryNow,
627695874,2021-06-11 13:55:41,"INCY, ",,"investorsobserver.com/news/stock-upd‚Ä¶, ",1403410624172941313,False,1,0,0,0,Twitter Web App,"Incyte $INCY Gets FDA Extension For New Drug Application Review Period for Atopic Dermatitis Cream

https://t.co/E74s3CGSPh",,,2012-07-05 14:32:58,,InvestorsObserver,https://pbs.twimg.com/profile_images/1389624586346631184/oPmFX5sq_normal.jpg,2110,48,47,13548,IOInvestors,
4058194633,2021-06-11 13:07:38,"INCY, ",,"finance.yahoo.com/news/incyte-an‚Ä¶, ",1403398531461783554,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis https://t.co/CFmzi5hSnh,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-06-11 13:07:16,"INCY, ",,"fiercepharma.com/pharma/incyte-‚Ä¶, ",1403398437748445184,False,0,0,0,0,Twitter for iPhone,"$INCY Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib¬†cream https://t.co/77Q6Kqylne",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
46297868,2021-06-11 11:45:06,,,"dlvr.it/S1XJm0, ",1403377759653564416,True,0,0,0,0,dlvr.it,"Incyte hits 2nd FDA delay in span of days, this time for atopic dermatitis hopeful ruxolitinib¬†cream https://t.co/uecAqQc26T",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
58541330,2021-06-11 11:28:55,,"Incyte, compliance, ","pic.twitter.com/DzB8NK1tNf, ",1403373688796463105,False,0,0,1,0,HubSpot,Join PLS' Jennifer Romanski &amp; Alicia Whittlesey on June 30th for a live webinar. This deep dive into the amended #Incyte complaint will cover current enforcement trends that the government focuses on and the potential impact they may have on your company‚Äôs #compliance program. https://t.co/DzB8NK1tNf,,,2009-07-20 14:00:36,"Morristown, NJ",Porzio Life Sciences,https://pbs.twimg.com/profile_images/1376579848785825800/9en1pdCE_normal.png,530,498,26,2663,PorzioLS,photo
2416188264,2021-06-11 10:47:00,"INCY, ","markets, ","thestockobserver.com/?p=4377800, ",1403363140885225479,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Gap Down to $87.53  https://t.co/xyntUnKpZ8 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1156133747852374016,2021-06-11 09:48:25,,"drug, Vitiligo, treatment, ","pic.twitter.com/IVxRvzkvU8, ",1403348398221119492,False,0,0,1,0,Twitter Web App,"Prominent companies such as @dermavant @Incyte, @Aclaris @Amgen @pfizer @ArcutisBio @AnaptysBio @BionizT, and others are developing potential #drug candidates to boost the #Vitiligo #treatment scenario. (1/2) https://t.co/IVxRvzkvU8","dermavant, Incyte, aclaris, Amgen, pfizer, ArcutisBio, AnaptysBio, BionizT, ",,2019-07-30 05:25:40,New Delhi,DelveInsight,https://pbs.twimg.com/profile_images/1222806973487255552/pWZKXuZ9_normal.jpg,122,1363,1,2930,delve_insight,photo
1250830691824283648,2021-06-11 09:48:16,"VRTX, CVAC, ORAN, SNOW, INCY, EBR, LLY, LOGI, UPST, NCLH, CHWY, PATH, MRNA, RCL, ZLAB, DAR, ",,,1403348359402987525,False,6,0,0,1,Twitter Web App,"Worst performing large cap stocks at today's open

Vertex $VRTX
CureVac $CVAC
Orange $ORAN
Snowflake $SNOW
Incyte $INCY
Centrais $EBR
Eli Lilly $LLY
Logitech $LOGI
UpStart $UPST
Norwegian $NCLH
Chewy $CHWY
UiPath $PATH
Moderna $MRNA
Royal Caribbean $RCL
Zai Lab $ZLAB
Darling $DAR",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
72928001,2021-06-11 09:32:02,"INCY, ",,"bit.ly/3gpnKLk, ",1403344273198620680,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte announces that the U.S. Food and Drug Administration has extended the review period for the New Drug... https://t.co/tYrlYfFKAN,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
4058194633,2021-06-11 09:28:58,"INCY, ",,"google.com/amp/s/m.invest‚Ä¶, ",1403343501169860614,False,0,0,0,0,Twitter for iPhone,"$INCY Mizuho Maintains Buy Rating On Incyte, $95 PT https://t.co/7E4ZR6aQ5h",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-06-11 09:28:02,"INCY, ",,"marketwatch.com/story/incyte-f‚Ä¶, ",1403343265596801034,False,0,0,0,0,Twitter for iPhone,$INCY Incyte: FDA Extends Review Period for New Drug Application for Ruxolitinib Cream in Atopic Dermatitis https://t.co/vVBlmfa6y7,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
898363992,2021-06-11 09:18:04,,"MondayMotivation, AWS, DataProtection, ","okt.to/3mG4Se, pic.twitter.com/nXRxvbjoEB, ",1403340760230109191,False,1,0,0,2,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/FsobaXDZdm

#AWS #DataProtection @druvainc https://t.co/nXRxvbjoEB","druvainc, ",,2012-10-22 16:40:14,Glasgow,glush,https://pbs.twimg.com/profile_images/1121377498472820737/0yv5sx_c_normal.jpg,123,269,4,832,garethjalush,photo
1262114478986010632,2021-06-11 08:50:00,"INCY, ",,,1403333695029891075,False,0,0,0,0,Twitter Web App,$INCY Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis,,,2020-05-17 16:15:42,,GapUpüß©,https://pbs.twimg.com/profile_images/1262126091671670784/fUEaPN8a_normal.jpg,161,649,5,6750,GapUp4,
1313517451817050113,2021-06-11 08:46:13,"INCY, ",,,1403332745997086723,False,0,0,0,0,Twitter Web App,$INCY --Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis!üôÇ,,,2020-10-06 12:32:30,,IsitArt,https://pbs.twimg.com/profile_images/1313517774153502720/RY_EXjlp_normal.jpg,244,6,8,3818,art_isit,
108617488,2021-06-11 08:40:04,,,"invst.ly/v3wut, ",1403331196348780547,False,0,0,0,0,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/ewj1Uofu8r,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
472650465,2021-06-11 08:06:38,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1403322783157915653,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis https://t.co/SSnS5jGpBk,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
2334614718,2021-06-11 07:51:39,"INCY, ",,"ooc.bz/l/76887, ",1403319011434242050,False,1,0,0,0,Open Outcrier,"$INCY (-2.9% pre) Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis - BW

https://t.co/oRnPkJgzax",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
1134049078424162304,2021-06-11 07:40:43,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1403316259199016961,False,0,0,0,0,Newsfilter.io,Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic De.. $INCY https://t.co/DtfbDLdHR9,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
963495628545327104,2021-06-11 07:39:07,"INCY, INCY, ",,"stck.pro/news/INCY/1353‚Ä¶, stck.pro/news/INCY, pic.twitter.com/86xcfWnOcg, ",1403315855967068164,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis https://t.co/6lOznts8m7 Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/86xcfWnOcg,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
3318510966,2021-06-11 07:36:34,,,"crweworld.com/article/news-p‚Ä¶, ",1403315218113986560,False,0,0,0,0,CRWE World,Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatmen https://t.co/b1ZiMroI3u,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
842579741697703936,2021-06-11 07:33:57,"INCY, ",,,1403314559113318406,False,0,0,0,0,Twitter Web App,$INCY - Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis,,,2017-03-16 23:33:59,"Alexandria, Virginia",Akram Siddique,https://pbs.twimg.com/profile_images/1380335543205068801/pYf-iKUl_normal.jpg,127,266,4,2787,AkramMSiddique,
1328777031299960833,2021-06-11 07:33:54,"INCY, ",,,1403314544634601473,False,1,0,0,0,Twitter Web App,$INCY - Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis,,,2020-11-17 14:08:58,"Alexandria, Virginia",Team of Stock Traders,https://pbs.twimg.com/profile_images/1328777820743450629/0_Yn-EGb_normal.jpg,933,185,12,8168,TeamofStockTra,
976297820532518914,2021-06-11 07:33:42,,,"dlvr.it/S1WWtM, pic.twitter.com/zUkLefEAQV, ",1403314492943994890,False,0,0,0,0,dlvr.it,Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis https://t.co/GEudsz48wy https://t.co/zUkLefEAQV,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1355194932445786112,2021-06-11 07:33:17,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1403314388292050944,False,0,0,0,0,Twitter,"$INCY Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis
https://t.co/OSWrsm7bhq",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1254035253104181256,2021-06-11 07:31:32,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1403313948540248068,False,0,0,0,1,stocktitan,"$INCY Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis
https://t.co/4aoakgzBbx",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1069693680066420736,2021-06-11 07:31:23,"INCY, ",,"s.flashalert.me/n4Ae1, ",1403313909780647943,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on June 11, 07:30:00: Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis https://t.co/84jMCgBDc6",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1325115160353103872,2021-06-11 07:30:46,"INCY, ",,"quantisnow.com/insight/983895‚Ä¶, ",1403313755400806409,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis

https://t.co/yTnXS6UE8T",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1402056489842274306,2021-06-11 07:30:03,"INCY, ",,"mktn.ws/44027, ",1403313577717420037,False,0,0,0,0,Twitter,"$INCY Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis
 
https://t.co/395bXwNbF7",,,2021-06-07 20:17:15,,Market Newswire,https://pbs.twimg.com/profile_images/1402059365117399048/4SdeRlrL_normal.jpg,6,0,0,9801,Market_Newswire,
1216834108577312770,2021-06-10 16:43:06,,"MondayMotivation, AWS, DataProtection, ","okt.to/cVSQvx, pic.twitter.com/wdVsQKiMS8, ",1403090366111391745,False,0,0,0,1,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/IGAR1DGBfh

#AWS #DataProtection @druvainc https://t.co/wdVsQKiMS8","druvainc, ",,2020-01-13 16:27:45,,PupulEarl,https://pbs.twimg.com/profile_images/1216835198823723018/Vqp-6ng8_normal.jpg,4,55,0,695,EarlPupul,photo
1134049078424162304,2021-06-10 08:25:31,"CNCE, INCY, ",,"newsfilter.io/articles/conce‚Ä¶, ",1402965146222346246,False,0,0,0,0,Newsfilter.io,"Concert Pharmaceuticals vs Incyte - AIA Trial, Denied $CNCE $INCY https://t.co/vScULB37f4",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1262114478986010632,2021-06-09 14:24:51,"ACRS, ",,,1402693189564256264,False,0,0,0,0,Twitter Web App,$ACRS Aclaris to meet competition from Incyte in atopic dermatitis,,,2020-05-17 16:15:42,,GapUpüß©,https://pbs.twimg.com/profile_images/1262126091671670784/fUEaPN8a_normal.jpg,161,649,5,6750,GapUp4,
963495628545327104,2021-06-09 14:00:40,"ACRS, ACRS, ",,"stck.pro/news/ACRS/1348‚Ä¶, stck.pro/news/ACRS, ",1402687101888602112,False,0,0,0,0,STCK.PR0,$ACRS NEW ARTICLE : Aclaris to meet competition from Incyte in atopic dermatitis https://t.co/AEIjCgkxYH Get all the latest $ACRS related news here : https://t.co/qywRXZNWHe,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
31372539,2021-06-09 13:58:09,,,"dlvr.it/S1PGCp, pic.twitter.com/vfYi8jpBhZ, ",1402686468166873092,False,0,0,0,0,dlvr.it,Aclaris to meet competition from Incyte in atopic dermatitis https://t.co/dvdHx1X0FZ https://t.co/vfYi8jpBhZ,,,2009-04-15 05:08:17,Amsterdam,Stocks tweets,https://pbs.twimg.com/profile_images/138834360/stocks1-avatar_normal.jpg,4407,3020,91,70157,stocks_tweets,photo
1134049078424162304,2021-06-09 13:48:20,"ACRS, ",,"newsfilter.io/articles/aclar‚Ä¶, ",1402683999961731074,False,0,0,0,0,Newsfilter.io,Aclaris to meet competition from Incyte in atopic dermatitis $ACRS https://t.co/5mze6KTaK5,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2021-06-09 13:46:15,"ACRS, ",,"seekingalpha.com/news/3704710-a‚Ä¶, ",1402683475619061761,False,0,0,0,1,SANewsTwitter,$ACRS - Aclaris to meet competition from Incyte in atopic dermatitis https://t.co/V87NS1zKVs,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
16256615,2021-06-09 12:00:10,,"DataProtection, ","bit.ly/3islN3l, pic.twitter.com/Gyad5p7Agz, ",1402656778245001221,False,1,0,0,1,Salesforce - Social Studio,"""We can now do data backups more frequently, helping us increase compliance with #DataProtection regulations. Restoring our @Microsoft SQL and @VMware servers is now a very simple process.‚Äù ‚Äì Lead Infrastructure Engineer, Incyte Diagnostics | @druvainc https://t.co/wJjHyDhMo0 https://t.co/Gyad5p7Agz","Microsoft, VMware, druvainc, ",,2008-09-12 09:58:27,,VMware Partner Connect,https://pbs.twimg.com/profile_images/1241050014400622593/QjHBz77z_normal.jpg,38576,1572,812,8282,VMware_Partners,photo
4058194633,2021-06-09 10:51:50,"INCY, PFE, ",,"fiercepharma.com/marketing/incy‚Ä¶, ",1402639580650565632,False,0,0,0,0,Twitter for iPhone,$INCY $PFE Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD https://t.co/mlSpqKX5Pl,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
325135887,2021-06-09 10:25:00,"INCY, ","pharma, atopicdermatitis, FDA, ","bit.ly/3x9T8Eq, ",1402632826952896518,False,2,0,0,0,Twitter Web App,"Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD! $INCY #pharma #atopicdermatitis #FDA 
https://t.co/dFxNfoUeiG",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
1289196501516812289,2021-06-09 10:11:01,,"pharmatopnews, ","fiercepharma.com/marketing/incy‚Ä¶, ",1402629309316145153,False,1,0,0,1,Twitter for iPhone,Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD | FiercePharma #pharmatopnews  https://t.co/yWPwgnfws0,,,2020-07-31 09:49:56,,Pharma Top News,https://pbs.twimg.com/profile_images/1289222230552072195/Fb5XMFYC_normal.jpg,16,0,0,2134,PharmaTopNews1,
391492257,2021-06-09 09:00:01,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, fdatracker.com/fda-calendar/, ",1402611443279613956,False,0,0,0,0,FDA Tracker,$INCY New PDUFA Date 2021-09-22 INCYTE Link:https://t.co/vNkIugYoSG Calendar:https://t.co/sCt1qKoMdr,,,2011-10-15 13:01:13,San Francisco,FDA Tracker,https://pbs.twimg.com/profile_images/1667207308/square_logo_normal.png,4992,14,113,4060,fda_tracker,
2570920968,2021-06-09 08:30:01,"INCY, ","pharma, atopicdermatitis, FDA, ","bit.ly/3x9T8Eq, ",1402603889761959936,False,2,0,0,0,Twitter Web App,"Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD! $INCY #pharma #atopicdermatitis #FDA 
https://t.co/6mcPlNU5Y1",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
25406480,2021-06-09 06:19:14,,,"awesomecapital.blogspot.com/2021/06/incyte‚Ä¶, ",1402570976773222404,False,0,0,0,1,Twitter Web App,AwesomeCapital: Incyte the latest to fall victim to JAK scrutiny a... https://t.co/uvQG2pfomZ,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
1134049078424162304,2021-06-09 04:49:18,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1402548344648515584,False,0,0,0,0,Newsfilter.io,Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib in Chronic Graft-Versus-Host Disease $INCY https://t.co/7uce5WXIYt,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3068641671,2021-06-09 02:43:06,"MOR, ","MorphoSys, equity, stocks, ","dlvr.it/S1MDqx, pic.twitter.com/t2pto9DF3T, ",1402516588067274752,False,0,0,0,0,dlvr.it,$MOR #MorphoSys AG MORPHOSYS: MOR‚Äôs full focus on hemato-oncology makes it an ideal target for Incyte | BUY vs. NEUTRAL | EUR112 VS. EUR115 (+65%): MORPHOSYS - BUY vs. NEUTRAL | EUR112 VS. EUR115 (+65%) MOR‚Äôs full focus on hemato-oncology‚Ä¶ https://t.co/ovnz709jqK #equity #stocks https://t.co/t2pto9DF3T,,,2015-03-03 17:15:05,"Paris, France",ResearchPool,https://pbs.twimg.com/profile_images/932829644558016512/Godn_LkX_normal.jpg,8971,4234,0,405156,ResearchPool,photo
15974185,2021-06-08 21:53:34,,,"dlvr.it/S1LjJF, ",1402443723582054402,False,1,0,0,0,dlvr.it,Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD https://t.co/MmIttgxs5t,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
2604756709,2021-06-08 21:03:43,,,"infiniti-cs-news.com/2021/06/08/inc‚Ä¶, ",1402431176896352267,False,0,0,0,0,WordPress.com,Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in¬†GVHD https://t.co/b0YsxPyT4h,,,2014-07-05 00:16:29,"Watford, England",Infiniti Cloud,https://pbs.twimg.com/profile_images/485277951814938624/4HiGmXE7_normal.png,391,816,2,15842,infiniticloud,
227778014,2021-06-08 20:30:01,"BAYN, ACRS, INCY, PFE, ",,"buff.ly/3wip216, ",1402422696248594432,False,0,0,0,0,Buffer,"BioCentury's latest Quick Takes: FDA approves Prevnar 20, plus Bayer subsidiary BlueRock, Innovent-IASO, Strateos, Aclaris, Incyte and Faro $BAYN $ACRS $INCY $PFE https://t.co/wB6KOJ1D3I",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
172288755,2021-06-08 20:07:22,,,"fiercepharma.com/marketing/incy‚Ä¶, ",1402416997418246147,False,0,0,0,0,Twitter Web App,Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD https://t.co/rAaXXN6CQb,,,2010-07-29 06:10:36,"Yong-In city, Korea",Kyung Seok Lee,https://pbs.twimg.com/profile_images/922433020748898305/cjOW-D4X_normal.jpg,17,60,0,646,ksloveis,
1280938376099741697,2021-06-08 19:44:55,,"iexStock, ","iexcloud.io, pic.twitter.com/F0JTG72h2m, ",1402411347942555649,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Al Ain Ahlia Insurance Co
-Al Buhaira National Insuranc
-United Arab Bank
-Incyte Corp.
-Abu Dhabi National Co. for Building Mate

Data provided by https://t.co/oXreiEXTgd https://t.co/F0JTG72h2m",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
18294275,2021-06-08 14:45:00,,,"fiercepharma.com/marketing/incy‚Ä¶, ",1402335870418518019,False,0,0,0,1,TweetDeck,Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD https://t.co/dmXpoVMIJX,,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
1333678078443335680,2021-06-08 14:32:37,,"Jakafi, PDUFA, GvHD, FDA, ","purepharmanews.com/ruxolitinib-gv‚Ä¶, ",1402332753119657986,False,0,0,0,0,Twitter Web App,"Incyte's #Jakafi sNDA review gets delayed. New #PDUFA target action date assigned. #GvHD #FDA

https://t.co/RDHjPAb4dK",,,2020-12-01 02:43:37,United Kingdom,Pure Pharma News,https://pbs.twimg.com/profile_images/1333678248337747969/GfdO3iuS_normal.jpg,11,79,0,329,pharma_pure,
2398845223,2021-06-08 13:59:10,,,"ow.ly/ct8C102LJUY, ",1402324334924992514,False,0,0,0,0,Hootsuite Inc.,Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD https://t.co/EeaOuQfbup,,,2014-03-19 23:11:51,Maryland,Continental Clinical,https://pbs.twimg.com/profile_images/673876383358062593/qyzjJcMn_normal.jpg,669,521,13,5348,Conti_Clinical,
133504478,2021-06-08 13:27:34,,"lucidquest, genetherapy, celltherapy, ","dlvr.it/S1KQk1, pic.twitter.com/vAzP6maTZZ, ",1402316386316128257,False,1,0,0,3,dlvr.it,Gene&amp;Cell Therapy &gt;&gt; Incyte faces delay on FDA's Jakafi decision for cGVHD; Bayer's Parkinson's cell therapy enters the clinic: Just 10 months after Incyte posted an upbeat assessment for Jakafi in a Phase III for‚Ä¶ https://t.co/kR2UGfB4yX #lucidquest #genetherapy #celltherapy https://t.co/vAzP6maTZZ,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
771805451281309698,2021-06-08 13:07:02,,"MondayMotivation, AWS, DataProtection, ","okt.to/em9iaI, pic.twitter.com/hb9c557saU, ",1402311218333892614,False,1,0,0,2,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/91W4FyG6FM

#AWS #DataProtection @druvainc https://t.co/hb9c557saU","druvainc, ",,2016-09-02 16:22:13,,Trevor Marino,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,11,149,0,796,trevor_marino,photo
133504478,2021-06-08 12:54:48,,"strategy, competitiveintelligence, marketing, biotech, pharma, healthcare, pharmaceutical, productmarketing, ","dlvr.it/S1KKVN, pic.twitter.com/apmzL9Tb0w, ",1402308137558761474,False,0,0,0,1,dlvr.it,Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD https://t.co/ztMbkzoLnn #strategy #competitiveintelligence #marketing #biotech #pharma #healthcare #pharmaceutical #productmarketing https://t.co/apmzL9Tb0w,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
4058194633,2021-06-08 12:46:38,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1402306084832825345,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Host Disease (GVHD) | Business Wire https://t.co/i00WxpZ7zz,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-06-08 12:45:11,"INCY, BAYRY, ",,"endpts.com/incyte-faces-d‚Ä¶, ",1402305719806808079,False,0,0,0,0,Twitter for iPhone,$INCY $BAYRY Incyte faces delay on FDA's Jakafi decision for cGVHD; Bayer's Parkinson's cell therapy enters the clinic - https://t.co/fjeKmrSM3D,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-06-08 12:44:39,"INCY, ",,"marketwatch.com/story/incyte-s‚Ä¶, ",1402305584410497024,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Says FDA Extends sNDA Review Period for Ruxolitinib in Chronic Graft-Versus-Host Disease https://t.co/kpAPJXPIXg,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
15232532,2021-06-08 12:09:06,,,"dlvr.it/S1KB6r, pic.twitter.com/Nmp02IEYIA, ",1402296638970892290,False,0,0,0,0,dlvr.it,Incyte faces delay on FDA's Jakafi decision for cGVHD; Bayer's Parkinson's cell therapy enters the clinic https://t.co/UdlurMlHBF https://t.co/Nmp02IEYIA,,,2008-06-25 11:32:12,"Cape Cod, MA",DennisPartners,https://pbs.twimg.com/profile_images/777939023461511168/Lqtz-Jal_normal.jpg,415,425,13,7177,DennisPartners,photo
140599113,2021-06-08 12:03:22,,,"winway.me/health-remedie‚Ä¶, ",1402295193924083721,False,0,0,0,0,WordPress.com,Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in¬†GVHD https://t.co/jOOmmK2kVA,,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
1270220114340851712,2021-06-08 11:52:36,,"PharmaTwitter, MedTwitter, MedEd, ","bit.ly/More-Medical-H‚Ä¶, fiercepharma.com/marketing/incy‚Ä¶, ",1402292486341550085,False,0,0,0,0,Automate.io,"Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD

More medical news at https://t.co/0Knf9q4SKS
#PharmaTwitter #MedTwitter #MedEd
https://t.co/F2264Yc499",,,2020-06-09 01:04:18,Look here üëâ,MedPub Pharmaceutical,https://pbs.twimg.com/profile_images/1443232668716515331/xzljON0s_normal.jpg,2,69,0,3346,PharmaPublisher,
46297868,2021-06-08 11:43:05,,,"dlvr.it/S1K652, ",1402290088554291203,True,0,0,0,0,dlvr.it,Incyte the latest to fall victim to JAK scrutiny as FDA pushes back Jakafi review in GVHD https://t.co/c6iaHPZzVA,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
3460109487,2021-06-08 11:35:09,,,"endpts.com/incyte-faces-d‚Ä¶, ",1402288093361803283,False,0,0,0,0,TweetDeck,"In today's News Briefing: Just 10 months after Incyte posted an upbeat assessment for Jakafi in a Phase III for chronic graft-versus-host disease, the FDA has opted to push back the sNDA to later in the year.

https://t.co/ZjYAgf4rwu",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
46297868,2021-06-08 11:24:06,,,"dlvr.it/S1K2yK, ",1402285312122839052,True,0,0,0,0,dlvr.it,Incyte faces delay on FDA's Jakafi decision for cGVHD; Bayer's Parkinson's cell therapy enters the clinic https://t.co/y5CnFCAIoI,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
72928001,2021-06-08 09:37:24,"INCY, ",,"bit.ly/2SlaGhZ, ",1402258461392400384,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte receives notice the FDA has extended the sNDA review period for Ruxolitinib https://t.co/14yd8OrzVI,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
53097729,2021-06-08 07:36:15,"INCY, ",,,1402227974225776641,False,2,0,0,0,Twitter Web App,$INCY Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Host Disease (GVHD),,,2009-07-02 11:44:23,"Toronto, Ontario",Stockwits‚Ñ¢ Ó®Ä,https://pbs.twimg.com/profile_images/1408587167111303171/Qrn1abyM_normal.jpg,26206,983,189,29344,mikalche,
1262114478986010632,2021-06-08 07:35:30,"INCY, ",,,1402227783275778051,False,0,0,0,0,Twitter Web App,$INCY Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Host Disease (GVHD),,,2020-05-17 16:15:42,,GapUpüß©,https://pbs.twimg.com/profile_images/1262126091671670784/fUEaPN8a_normal.jpg,161,649,5,6750,GapUp4,
1069693680066420736,2021-06-08 07:35:18,"INCY, ",,"s.flashalert.me/dAXZO, ",1402227732046663684,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on June 08, 07:30:00: Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Host Disease (GVHD) https://t.co/kxHdjYFUqD",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1355194932445786112,2021-06-08 07:34:02,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1402227414093152258,False,0,0,0,0,Twitter,"$INCY Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Host Disease (GVHD)
https://t.co/19CeANpnWl",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
976297820532518914,2021-06-08 07:32:20,,,"dlvr.it/S1JHQD, pic.twitter.com/3mS5PnaLlg, ",1402226988543143936,False,0,0,0,0,dlvr.it,Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Host Disease (GVHD) https://t.co/Yo3YkcJFuU https://t.co/3mS5PnaLlg,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2021-06-08 07:32:16,,,"crweworld.com/article/news-p‚Ä¶, ",1402226971413684228,False,0,0,0,0,CRWE World,Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Hos https://t.co/Uj1teEU2ay,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1325115160353103872,2021-06-08 07:31:46,"INCY, ",,"quantisnow.com/insight/969977‚Ä¶, ",1402226845005750272,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Host Disease (GVHD)

https://t.co/2TdNjfWC0e",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1254035253104181256,2021-06-08 07:31:37,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1402226806195986436,False,0,1,0,0,stocktitan,"$INCY Incyte Announces U.S. FDA Has Extended the sNDA Review Period for Ruxolitinib (Jakafi¬Æ) in Chronic Graft-Versus-Host Disease (GVHD)
https://t.co/Hgw809Zd44",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1163724201192067072,2021-06-08 01:14:03,,"MondayMotivation, AWS, DataProtection, ","okt.to/IqgDHJ, pic.twitter.com/b5KiVc0pfE, ",1402131787686584320,False,0,0,0,4,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/7NtGVk9Rba

#AWS #DataProtection @druvainc https://t.co/b5KiVc0pfE","druvainc, ",,2019-08-20 04:07:42,,Varun Gaikwad,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,0,5,0,645,VarunGa15479492,photo
1099489411,2021-06-08 00:32:02,,"MondayMotivation, AWS, DataProtection, ","okt.to/GuU41n, pic.twitter.com/mk19kjRdJR, ",1402121216371089408,True,0,0,0,0,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/4zTwAc3N69

#AWS #DataProtection @druvainc https://t.co/mk19kjRdJR","druvainc, ",,2013-01-17 17:59:20,,Mark Vara,https://pbs.twimg.com/profile_images/3122435883/f3660d955bfec5489d38a6348ba5350e_normal.jpeg,65,312,0,2066,MarkVaraski,photo
1280272972859584512,2021-06-07 22:36:03,,"MondayMotivation, AWS, DataProtection, ","okt.to/QZE8mP, pic.twitter.com/vmmczsKokz, ",1402092025399422976,False,0,0,0,1,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/fbWAWTCBaX

#AWS #DataProtection @druvainc https://t.co/vmmczsKokz","druvainc, ",,2020-07-06 18:50:48,,sameeragashe,https://pbs.twimg.com/profile_images/1280273854204534785/jcEdoPqL_normal.jpg,10,152,0,2019,sameeragashe1,photo
127793556,2021-06-07 21:36:02,,"MondayMotivation, AWS, DataProtection, ","okt.to/1d58fl, pic.twitter.com/p3n2oB2IWv, ",1402076924952854536,False,2,0,0,5,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/zn3hlwr5ar

#AWS #DataProtection @druvainc https://t.co/p3n2oB2IWv","druvainc, ",,2010-03-30 03:26:26,Mumbai,DeepakAgrawal,https://pbs.twimg.com/profile_images/549534330741993472/tb5BFeL6_normal.jpeg,407,511,1,5084,deep_gem1,photo
1310910394253193216,2021-06-07 20:48:04,,"MondayMotivation, AWS, DataProtection, ","okt.to/E5LTWo, pic.twitter.com/yedJRMdQT0, ",1402064850373779460,False,1,0,0,2,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/pPKEsoozoV

#AWS #DataProtection @druvainc https://t.co/yedJRMdQT0","druvainc, ",,2020-09-29 07:52:59,,Bhavik @ CloudDataProtection,https://pbs.twimg.com/profile_images/1310911832194838529/1Hn0UT0p_normal.jpg,14,71,0,539,CloudDataBackup,photo
374729426,2021-06-07 17:45:15,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2789712, pic.twitter.com/w8xSs25drS, ",1402018843204100097,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on May 4, 2021. View odds for this and other indicators: https://t.co/bsOZYiGICi #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/w8xSs25drS",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
62567174,2021-06-07 16:25:03,,"MondayMotivation, AWS, DataProtection, ","okt.to/FblT4S, pic.twitter.com/IMu7tFkQE8, ",1401998663862394882,False,0,0,0,0,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/yWtsoj0QlG

#AWS #DataProtection @druvainc https://t.co/IMu7tFkQE8","druvainc, ",,2009-08-03 13:22:13,Pune,Chandrajeet Panda,https://pbs.twimg.com/profile_images/467587972351528961/QpgZCCdZ_normal.jpeg,203,436,11,1700,jeetpanda,photo
245932669,2021-06-07 15:29:03,,"MondayMotivation, AWS, DataProtection, ","okt.to/vxhRat, pic.twitter.com/W6beeFGAwl, ",1401984566923907073,False,0,0,0,0,Oktopost,"#MondayMotivation üéâAfter moving to cloud, Incyte Diagnostics protects and backs up clinical data 95% faster, enabling more efficient company effort and time. https://t.co/7CuYTq6Xfu

#AWS #DataProtection https://t.co/W6beeFGAwl",,,2011-02-01 14:36:55,"Sunnyvale, CA",Druva Inc,https://pbs.twimg.com/profile_images/1412471783609946113/y5Zssf-x_normal.png,21162,3274,340,9899,druvainc,photo
2417648948,2021-06-07 09:35:39,"RGBP, RGBPP, ","CancerResearch, cancersurvivor, ","neighborwebsj.com/uncategorized/‚Ä¶, ",1401895631455666177,False,7,0,0,1,Twitter for iPad,"$RGBP $RGBPP In the NEWS Again! June 7th! #CancerResearch #cancersurvivor 
https://t.co/8cAFonpbod",,,2014-03-29 12:20:23,fort myers beach,zman/ rick zdany,https://pbs.twimg.com/profile_images/1217666151616040961/iVLobLgh_normal.jpg,1296,2234,13,25831,rickzdany,
781258003190321152,2021-06-07 09:32:17,"rgbp, ",,"neighborwebsj.com/uncategorized/‚Ä¶, ",1401894787129696265,False,16,0,0,4,Twitter for iPad,$rgbp mentioned again. https://t.co/F8AtcJuX7J,,,2016-09-28 18:23:17,Right here,¬•~Will Invest~aka ~Extreme~¬•,https://pbs.twimg.com/profile_images/1448608826605834241/-KfMr635_normal.jpg,2430,157,20,5222,ExtremeStock,
918773782122201088,2021-06-07 09:24:31,"RGBP, ",,"neighborwebsj.com/uncategorized/‚Ä¶, pic.twitter.com/HfFTEC1vjT, ",1401892830616821761,False,5,0,0,0,Twitter for Android,"$RGBP

F. Hoffmann-La Roche 
Bristol-Myers Squibb Company 
Ensemble Therapeutics Corp 
Netherlands Translational Research Center BV 
Globavir Biosciences Inc 
Genentech
Kyowa Hakko Kirin 
NewLink Genetics C
Regen BioPharma Inc 
Pfizer Inc 
Redx Pharma Plc
https://t.co/9axbKaNaSb https://t.co/HfFTEC1vjT",,,2017-10-13 05:41:54, Andromeda Galaxy,Takuri,https://pbs.twimg.com/profile_images/1077132948573470720/VfuqNMht_normal.jpg,1324,1531,2,2366,Takuri333,animated_gif
31358286,2021-06-07 08:50:04,,"CIFbiopharma, ","cecp.me/3fDWgCd, bit.ly/2Rn68XN, pic.twitter.com/xznB4Qop9T, ",1401884160021590020,False,1,0,0,1,dlvr.it,Watch along as biopharma CEOs share Long-Term Plans with investors @Moderna_tx @pfizer_news @CatalentPharma @Merck @Incyte @SanofiUS @ucb_news @GSK @TakedaPharma at @CECPTweets #CIFbiopharma https://t.co/1XkJdRrpax https://t.co/ZDgwf1t2qN https://t.co/xznB4Qop9T,"moderna_tx, pfizer_news, CatalentPharma, Merck, Incyte, SanofiUS, ucb_news, GSK, TakedaPharma, CECPtweets, ",,2009-04-15 02:44:35,"Northampton, MA",3BL Media News,https://pbs.twimg.com/profile_images/1179146447272448000/KG1FF7Vp_normal.jpg,24123,9503,1817,83702,3BLNews,photo
347315451,2021-06-07 03:29:53,,,"morphosys.com/media-investor‚Ä¶, ",1401803584015044609,False,1,0,0,1,Twitter Web App,MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL https://t.co/fA8zJ0TFMO,,,2011-08-02 12:17:10,Berlin,BIO Deutschland,https://pbs.twimg.com/profile_images/801026554834878465/TZRcLWOl_normal.jpg,4612,2717,178,29124,BIODeutschland,
477131488,2021-06-06 20:31:58,,"breastcancer, TNBC, IMpassion130, PDL1, ASCO21, ","pic.twitter.com/Xu21wMTjDQ, pic.twitter.com/Xu21wMTjDQ, pic.twitter.com/Xu21wMTjDQ, pic.twitter.com/Xu21wMTjDQ, ",1401698414371299329,False,9,0,0,4,Twitter for iPhone,Prof @EmensLeisha #breastcancer Guru @UPMCHillmanCC /Great breakdown of complexity of TME and its impact on response in women with #TNBC tx on #IMpassion130 #PDL1 #ASCO21 /Need more immune cells in these tumors/Vaccine combos could help? @Roche  @BMS_ImmunOnc_US @UbiVac @Incyte https://t.co/Xu21wMTjDQ,"EmensLeisha, UPMCHillmanCC, Roche, BMS_ImmunOnc_US, UbiVac, Incyte, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
3911174913,2021-06-06 14:00:01,,"sustainability, CIFBiopharma, ","pic.twitter.com/X9bIWnZf4q, ",1401599774738972674,False,1,0,0,1,Twitter for Advertisers,"Incyte CEO Herv√© Hoppenot will be presenting at the Biopharma CEO Investor Forum tomorrow, June 7. We look forward to being a part of the long-term #sustainability conversation! #CIFBiopharma @CECPTweets https://t.co/X9bIWnZf4q","CECPtweets, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
374729426,2021-06-06 08:50:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2786423, pic.twitter.com/A5dqtwyZM3, ",1401521876325654533,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 4, 2021. View odds for this and other indicators: https://t.co/iXLLTNr9pp #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/A5dqtwyZM3",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
166558126,2021-06-06 08:00:36,,,"s.einnews.com/PpUwOx-4QO, ",1401509324753620995,False,0,0,0,0,EIN Presswire,"Tyrosine Kinase JAK Inhibitors Market Size 2021 with CAGR of 61‚Ä§5%, Top Growth Companies: Pfizer, Incyte, Novartis, and, End-User, SWOT Analysis in Industry 2026 https://t.co/ODdx7Rhsgn",,,2010-07-14 09:13:23,"Washington, D.C.",EIN Presswire: Pharmaceutical Newswire,https://pbs.twimg.com/profile_images/1288519645650132994/GM15d2k-_normal.jpg,8267,1715,125,44783,EINPharmaNews,
1399103920522334219,2021-06-06 00:50:53,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/NN3iDSBR7v, ",1401401183445700609,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2161 out of 5473 companies in our database. 

üëâ https://t.co/xYpt7ribzZ $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/NN3iDSBR7v",,,2021-05-30 16:42:36,,Fundamentals Analysis Bot,https://pbs.twimg.com/profile_images/1399104992141844481/ILsIsJjg_normal.jpg,659,0,13,51351,earningsflyhq,photo
4058194633,2021-06-05 16:20:29,"INCY, MOR, ",,"businesswire.com/news/home/2021‚Ä¶, ",1401272735943192577,False,0,0,0,0,Twitter for iPhone,$INCY $MOR Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL | Business Wire https://t.co/7GaiuqPW4A,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1134049078424162304,2021-06-05 09:56:44,"INCY, MOR, MPSYF, ",,"newsfilter.io/articles/morph‚Ä¶, ",1401176164715184138,False,0,0,0,0,Newsfilter.io,MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Tre.. $INCY $MOR $MPSYF https://t.co/TbEBQlMfAV,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1889492676,2021-06-05 05:53:43,"INCY, MOR, ","MorphoSys, Incyte, LMIND, Tafasitamab, Lenalidomide, Relapsed, Refractory, DLBCL, ","1stoncology.com/blog/morphosys‚Ä¶, ",1401115004816920578,False,0,0,0,0,Troi URL Plug-in,#MorphoSys and #Incyte Announce Three-Year Results from Phase 2 #LMIND Study of #Tafasitamab in Combination with #Lenalidomide for the Treatment of #Relapsed or #Refractory #DLBCL $INCY $MOR https://t.co/oTr31V2fuS,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
360220091,2021-06-05 04:37:48,,,"dataemia.com/?p=518906, ",1401095899246383104,False,0,0,0,0,Newsemia,(Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL) https://t.co/hzO5leOI3d,,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,
1652354034,2021-06-05 02:15:03,,,"finanztreff.de/news/press-rel‚Ä¶, ",1401059975443750915,False,0,0,0,0,Buzztalk,PRESS RELEASE: MorphoSys and Incyte Announce -2- https://t.co/NhTqWsTeHx,,,2013-08-07 04:11:04,Netherlands & Germany,CBNG,https://pbs.twimg.com/profile_images/378800000254275678/983163ab8116ab67ca8ec22976afed3a_normal.jpeg,17,3,20,16089,CBNGx,
4058194633,2021-06-04 20:57:23,"KALA, ",,"google.com/amp/s/www.smar‚Ä¶, ",1400980032986619906,False,7,0,0,1,Twitter for iPhone,"$KALA Oppenheimer Maintains Buy Rating On Kala Pharmaceuticals, $22 PT https://t.co/7wGP4gGAWn",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-06-04 20:56:31,"INCY, ",,"google.com/amp/s/www.smar‚Ä¶, ",1400979813087649792,False,0,0,0,0,Twitter for iPhone,"$INCY Mizuho Securities Maintains Buy Rating On Incyte, $95 PT  https://t.co/7wGP4gGAWn",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
728894570,2021-06-04 19:17:58,,,"iweller.com/all-health-fit‚Ä¶, ",1400955014445625344,False,1,0,0,1,iweller.com,"Gene-edited T-cell therapy shows ‚Äòpromising efficacy‚Äô for rare sarcomas - D‚ÄôAngelo reports consultant/advisory roles with Adaptimmune, Amgen, EMD Serono, GlaxoSmithKline, Incyte, Immune Design, Immunocore, M... - https://t.co/2a0kafxkAm",,,2012-07-31 13:55:29,,iWeller.com,https://pbs.twimg.com/profile_images/1244249406477455360/tl4H1tq0_normal.jpg,121,141,0,264390,iWeller_health,
3318510966,2021-06-04 17:39:16,,,"crweworld.com/article/news-p‚Ä¶, ",1400930174510665728,False,0,0,0,0,CRWE World,MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenali https://t.co/rX2LQZ4tqp,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3318510966,2021-06-04 17:35:58,,,"crweworld.com/article/news-p‚Ä¶, ",1400929346055938048,False,0,0,0,0,CRWE World,Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenali https://t.co/5q1DlypxgS,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
25406480,2021-06-04 16:59:55,,,"awesomecapital.blogspot.com/2021/06/incyte‚Ä¶, ",1400920273218641920,False,0,0,0,1,Twitter Web App,"AwesomeCapital: Incyte, MorphoSys 3-Year Results from Phase 2 Stud... https://t.co/jdnnaazh04",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
72928001,2021-06-04 15:48:37,"INCY, ",,"bit.ly/3iexZod, ",1400902330048942087,False,0,0,0,1,BriefingInPlayLimited,"$INCY: Incyte and MorphoSys US Inc., a fully owned subsidiary of MorphoSys AG (MOR), announce new three-year... https://t.co/OjjMvuHxsW",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
3686628867,2021-06-04 15:41:58,,,"pharmaceuticaldaily.com/incyte-and-mor‚Ä¶, ",1400900655825489932,False,0,0,0,0,WordPress.com,Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory¬†DLBCL https://t.co/UAAaiwAr0q,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
270492072,2021-06-04 15:22:26,,"news, SeekingAlpha, ","seekingalpha.com/news/3703435-i‚Ä¶, ",1400895739836854272,False,0,0,0,0,Microsoft Power Platform,Incyte and MorphoSys present new three-year data for blood cancer therapy https://t.co/YQFalbOWiy via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
3524211082,2021-06-04 15:09:05,,,"dlvr.it/S153qW, ",1400892378852978688,False,0,0,0,0,dlvr.it,Incyte and MorphoSys present new three-year data for blood cancer therapy https://t.co/gVoGoIwxL8,,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
1006334607946649600,2021-06-04 14:53:12,,,"dlvr.it/S14zyP, pic.twitter.com/EM4UZyBTBs, ",1400888381404422152,False,0,0,0,0,dlvr.it,MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL https://t.co/fw7lodv9QP https://t.co/EM4UZyBTBs,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
1134049078424162304,2021-06-04 14:51:40,"MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1400887999563546626,False,0,0,0,0,Newsfilter.io,Incyte and MorphoSys presents new three-year data for blood cancer therapy $MOR https://t.co/nRpFTjngRS,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1006334607946649600,2021-06-04 14:20:07,,"StockMarket, Stocks, ","dlvr.it/S14swK, ",1400880056814096386,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL https://t.co/5A3fCCTMky #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1355194932445786112,2021-06-04 14:03:10,"MOR, INCY, ",,"stocktitan.net/news/MOR/morph‚Ä¶, ",1400875793815846912,False,0,0,0,0,Twitter,"$MOR $INCY MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL
https://t.co/FYqa83SY86",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1089978712685273090,2021-06-04 14:01:32,"INTC, ","Incyte, StockMarket, ","dlvr.it/S14nsF, ",1400875379028500481,False,0,0,0,0,dlvr.it,#Incyte $INTC and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL https://t.co/3WtSFCYcZ7 #StockMarket,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
1254035253104181256,2021-06-04 14:00:46,"MOR, INCY, ",,"stocktitan.net/news/MOR/morph‚Ä¶, ",1400875186702925828,False,0,0,0,0,stocktitan,"$MOR $INCY MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL
https://t.co/be1j1EephV",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
266143766,2021-06-04 14:00:30,"MOR, ",,"accesswire.com/650491/MorphoS‚Ä¶, ",1400875121057873932,False,0,0,0,0,Accesswire,$MOR MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with ... https://t.co/G8eXnbX4XI,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
1325115160353103872,2021-06-04 14:00:24,"INCY, ","healthcare, ","quantisnow.com/insight/962404‚Ä¶, ",1400875096823058433,False,0,0,0,0,Twitter,"$INCY üóûÔ∏è MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL

https://t.co/zgpPfAFoam

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
976297820532518914,2021-06-04 13:53:06,,,"dlvr.it/S14mmc, pic.twitter.com/MSQ2Ah2MKE, ",1400873258983911429,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL https://t.co/5GMmgrtEQ2 https://t.co/MSQ2Ah2MKE,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2021-06-04 13:50:34,"INCY, ",,"s.flashalert.me/QPpMHI, ",1400872619231125513,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on June 04, 13:45:00: Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL https://t.co/KyFHhYSnMY",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1355194932445786112,2021-06-04 13:47:54,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1400871948444483586,False,0,0,0,0,Twitter,"$INCY Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL
https://t.co/kmyv9sOizU",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1134049078424162304,2021-06-04 13:45:40,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1400871387418578953,False,0,0,0,0,Newsfilter.io,Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomid.. $INCY $MOR https://t.co/qa45gE1k1j,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1325115160353103872,2021-06-04 13:45:39,"INCY, ","healthcare, ","quantisnow.com/insight/962371‚Ä¶, ",1400871383614169089,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL

https://t.co/uu9URuZPpB

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1254035253104181256,2021-06-04 13:45:28,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1400871337112096775,False,0,1,0,0,stocktitan,"$INCY Incyte and MorphoSys Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL
https://t.co/00xY96SMj9",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
42410755,2021-06-04 13:33:22,,,"dgap.de/dgap/News/corp‚Ä¶, ",1400868291053244424,False,0,1,0,0,DGAP_News_Int,MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combina... https://t.co/BZC4rrxY8b,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
1315434407692509184,2021-06-04 12:50:11,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/zO154oAkCN, ",1400857423976542212,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2025 out of 5472 companies in our database. 

üëâ https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/zO154oAkCN",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
121158213,2021-06-04 10:29:03,"INCY, ",,"dlvr.it/S148vR, AlertTrade.us, ",1400821905976741904,False,0,0,0,0,dlvr.it,REVERSALtoUP: $INCY Incyte Corporation Common Stock https://t.co/uYMtfN7RQK üì≥ TradeIdeas via ‚ü∂ https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
975337043944407040,2021-06-03 17:41:01,"INCY, ","Incyte, INCY, ","finscreener.com/title/analysts‚Ä¶, ",1400568228032700419,False,0,0,0,0,StockTwits Web,Analyst summary of #Incyte #INCY $INCY https://t.co/3EC5vrA9z6,,,2018-03-18 07:44:06,,Finscreener,https://pbs.twimg.com/profile_images/976083323347984384/71mUunXo_normal.jpg,652,202,12,15317,Finscreener_com,
1362749334,2021-06-03 17:18:32,"INCY, CORE, ",,"pic.twitter.com/AXVeDnyGUT, twitter.com/nolastevedore/‚Ä¶, ",1400562569807491072,False,1,0,1,0,Twitter Web App,Long $INCY into @ASCO @Incyte; Vitiligo + RA + Oncology assets this is a $CORE holding! https://t.co/AXVeDnyGUT https://t.co/fmPaoWfGLy,"ASCO, Incyte, ",,2013-04-18 15:48:59,"smokeland, ca",compoundstarüåü,https://pbs.twimg.com/profile_images/1439281384544030720/p4sZYf5B_normal.jpg,102,644,1,1566,riceforthought,photo
1262915121103491074,2021-06-03 16:43:22,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1400553721247899655,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 395 shares on 2021-06-01. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
50405984,2021-06-03 13:01:32,,"AMMF, ","ow.ly/rimr50ETTUy, pic.twitter.com/6xcPiF8KUz, ",1400497892406738944,False,4,0,0,1,Hootsuite Inc.,"Miss the world premiere of ‚ÄòCholangiocarcinoma and the Importance of Molecular Profiling‚Äô at the #AMMF Conference this year? All made possible by the joint collaboration of  @Incyte, @CharityAMMF and expert Prof John Bridgewater, watch now at https://t.co/hOnXTVP2OF https://t.co/6xcPiF8KUz","Incyte, CharityAMMF, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
1265297174,2021-06-03 11:32:21,"BCTX, ",,,1400475448572841992,False,2,0,0,0,Twitter Web App,"$BCTX  Incyte was the private placement buyer.  Yeah, the one they are collaborating with.  That was a no brainer.

GLTA!",,,2013-03-13 15:48:33,"Naples, FL",TYMERZ,https://pbs.twimg.com/profile_images/1135000642773278721/TAkNn8dQ_normal.png,1724,191,27,4163,tymerzofficial,
374729426,2021-06-03 03:05:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2779071, pic.twitter.com/3OGG0B814l, ",1400348019862564868,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on May 20, 2021. View odds for this and other indicators: https://t.co/PgtnCD1ix4 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/3OGG0B814l",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1149086992828964865,2021-06-02 15:06:35,,,"pic.twitter.com/sGQufgFsLz, ",1400166974030757893,False,1,0,0,0,Twitter for iPad,Dave‚Äôs Journey of Hope @curecc @Incyte @TaihoOncology @ZymeworksInc https://t.co/sGQufgFsLz,"curecc, Incyte, TaihoOncology, ZymeworksInc, ",,2019-07-10 18:44:22,,Craine‚Äôs Cholangiocarcinoma Crew,https://pbs.twimg.com/profile_images/1149089425902751745/tN7eQV54_normal.jpg,141,145,1,136,CrainesCrew,photo
1149086992828964865,2021-06-02 15:06:03,,,"pic.twitter.com/4HDOMvMGIH, ",1400166840052207621,False,4,0,0,2,Twitter for iPad,Dave‚Äôs Journey of Hope @curecc @Incyte @TaihoOncology @ZymeworksInc https://t.co/4HDOMvMGIH,"curecc, Incyte, TaihoOncology, ZymeworksInc, ",,2019-07-10 18:44:22,,Craine‚Äôs Cholangiocarcinoma Crew,https://pbs.twimg.com/profile_images/1149089425902751745/tN7eQV54_normal.jpg,141,145,1,136,CrainesCrew,photo
1149086992828964865,2021-06-02 15:05:21,,,"pic.twitter.com/fPJg8moKuH, ",1400166663497134083,False,6,0,0,3,Twitter for iPad,Dave‚Äôs Journey of Hope @curecc @Incyte @TaihoOncology @ZymeworksInc https://t.co/fPJg8moKuH,"curecc, Incyte, TaihoOncology, ZymeworksInc, ",,2019-07-10 18:44:22,,Craine‚Äôs Cholangiocarcinoma Crew,https://pbs.twimg.com/profile_images/1149089425902751745/tN7eQV54_normal.jpg,141,145,1,136,CrainesCrew,photo
1904813486,2021-06-02 15:03:16,,,"pic.twitter.com/inYHWycZTy, ",1400166140798722049,False,4,0,0,2,Twitter for iPad,Dave‚Äôs Journey of Hope @curecc @Incyte @TaihoOncology @ZymeworksInc https://t.co/inYHWycZTy,"curecc, Incyte, TaihoOncology, ZymeworksInc, ",,2013-09-25 12:54:39,,Lisa Craine,https://pbs.twimg.com/profile_images/1406123490638548995/8vWHNS_E_normal.jpg,110,221,0,137,lisamariecraine,photo
1904813486,2021-06-02 15:02:22,,,"pic.twitter.com/37iwJMLJRN, ",1400165912670617606,False,3,0,0,0,Twitter for iPad,Dave‚Äôs Journey of Hope @curecc @ZymeworksInc @Incyte @TaihoOncology https://t.co/37iwJMLJRN,"curecc, ZymeworksInc, Incyte, TaihoOncology, ",,2013-09-25 12:54:39,,Lisa Craine,https://pbs.twimg.com/profile_images/1406123490638548995/8vWHNS_E_normal.jpg,110,221,0,137,lisamariecraine,photo
1904813486,2021-06-02 15:01:06,,,"pic.twitter.com/i8wd6n95AB, ",1400165597799911434,False,4,0,2,1,Twitter for iPad,Dave‚Äôs Journey of Hope @curecc @Incyte @ZymeworksInc @TaihoOncology https://t.co/i8wd6n95AB,"curecc, Incyte, ZymeworksInc, TaihoOncology, ",,2013-09-25 12:54:39,,Lisa Craine,https://pbs.twimg.com/profile_images/1406123490638548995/8vWHNS_E_normal.jpg,110,221,0,137,lisamariecraine,photo
22576342,2021-06-02 14:22:33,"INCY, ",,,1400155895980462080,False,0,0,0,0,TweetDeck,$INCY Incyte value play biotech with CEO buying $1 million in February is my top ASCO mover. Many more small cap biotechs in this very beaten down sector this year are coming.,,,2009-03-02 22:09:33,"Park City, UT",The Insiders Report,https://pbs.twimg.com/profile_images/1407239489202786315/17vEK27m_normal.jpg,925,281,8,2900,theinsidersfund,
707270913448919041,2021-06-02 12:55:41,,"MPN, ",,1400134032520847361,False,4,1,0,0,Twitter for Advertisers,Ask your myeloproliferative neoplasm #MPN questions live! Join a live event where you can watch an educational talk and then ask questions to Oncology Clinical Nurse Educators (OCNEs) from Incyte.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2021-06-02 12:53:48,,"MPN, ",,1400133560745476098,False,4,0,0,0,Twitter for Advertisers,Don‚Äôt miss the new events coming from Voices of MPN. You will have the opportunity to ask Oncology Clinical Nurse Educators (OCNEs) from Incyte questions about myeloproliferative neoplasms #MPN. See the calendar for more!,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
2334614718,2021-06-02 07:46:01,"LLY, INCY, ",,"ooc.bz/l/76203, ",1400056102125981697,False,1,0,0,0,Open Outcrier,"$LLY (+0.0% pre) Lilly (LLY), Incyte $INCY Announce OLUMIANT Improved Pain, Physical Function and Morning Joint Stiffness in Rheumatoid Arthritis in Phase 3 Post-Hoc Analyses - SI

https://t.co/skJ7MyoObp",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
72928001,2021-06-02 06:58:08,"INCY, ",,"bit.ly/3g0wW8J, ",1400044051693404161,False,0,0,0,1,BriefingInPlayLimited,"$INCY: Incyte and Eli Lilly (LLY) report OLUMIANT improved pain, physical function and morning joint stiffness in... https://t.co/ZCNXvPBX1O",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
270492072,2021-06-02 02:20:37,,"news, SeekingAlpha, ","seekingalpha.com/news/3702166-l‚Ä¶, ",1399974211829993472,False,0,0,0,0,Microsoft Power Platform,Lilly/Incyte's Olumiant reduces pain and duration of morning joint stiffness in rheumatoid arthritis https://t.co/USyda8dWKP via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
1134049078424162304,2021-06-02 02:15:41,"LLY, INCY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1399972971930869760,False,0,0,0,0,Newsfilter.io,Lilly/Incyte's Olumiant reduces pain and duration of morning joint stiffness in rheumatoid arthritis $LLY $INCY https://t.co/91q7V7ZGwz,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2021-06-02 02:13:57,"LLY, INCY, ",,"seekingalpha.com/news/3702166-l‚Ä¶, ",1399972534670356481,False,0,0,0,1,SANewsTwitter,$LLY $INCY - Lilly/Incyte's Olumiant reduces pain and duration of morning joint stiffness in rheumatoid arthritis https://t.co/hCdkctb57f,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
284054290,2021-06-01 19:46:14,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/medic‚Ä¶, ",1399874963897786371,False,0,0,0,0,BLOX CMS for DEV,"INDIANAPOLIS, June 1, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY)¬†will present data from post-hoc analyses that suggested OLUMIANT¬Æ (baricitinib) 4 mg tablet reduced pain and duration of morning joint stiffness, ‚Ä¶ https://t.co/noBEg8XLkC",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
374729426,2021-06-01 19:32:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2776159, pic.twitter.com/2EHlKlCseC, ",1399871620211085315,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 4, 2021. View odds for this and other indicators: https://t.co/NUTlGTyVxa #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/2EHlKlCseC",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
4058194633,2021-06-01 11:53:15,"INCY, ",,"MarketBeat.com, marketbeat.com/instant-alerts‚Ä¶, ",1399755935686414336,False,0,0,0,0,Twitter for iPhone,$INCY $691.93 Million in Sales Expected for Incyte Co. (NASDAQ:INCY) This Quarter | https://t.co/NKb5pRLCDo https://t.co/ix5Sqrv4aC,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1397174705686208518,2021-06-01 11:00:00,,,,1399742531898855433,False,0,0,0,0,TweetDeck,"""Monitoring of pupils‚Äô mental health and well-being has been significantly strengthened by the use of Steer's tool AS Tracking"" - Incyte International",,,2021-05-25 08:57:23,UK,STEER Education,https://pbs.twimg.com/profile_images/1397499703613345794/CXqZJvUt_normal.jpg,47,338,0,106,SteerEducation,
1134049078424162304,2021-05-31 17:28:38,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1399477947392745473,False,0,0,0,0,Newsfilter.io,Incyte-partnered anti-PD-1 therapy wins FDA‚Äôs orphan drug designation for liver cancer $INCY https://t.co/7jGYwZzsGN,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
981921691805904896,2021-05-31 03:50:16,,"ASCO, CommercialStrategy, Megatrends, CI, CompetitiveSimulation, Innovation, Leadership, TeamDevelopment, Success, HealthCare, Biotech, Pharma, Medtech, ","inspiredmove.ch/en/Consulting.‚Ä¶, biospace.com/article/asco-2‚Ä¶, ",1399271998241525761,False,1,0,0,0,Twitter Web App,"#ASCO 2021 Preview - Part 2 Watch for‚Ä¶

Get support:  https://t.co/szPWHnJPaj  for your #CommercialStrategy, #Megatrends #CI, #CompetitiveSimulation, #Innovation, #Leadership, #TeamDevelopment, and #Success in #HealthCare #Biotech #Pharma #Medtech

https://t.co/cITR5K5oF0",,,2018-04-05 11:49:09,"Z√ºrich, Schweiz",Annette Freund,https://pbs.twimg.com/profile_images/1045314568728301569/_pindGy1_normal.jpg,210,267,2,548,annettefreundIM,
1280938376099741697,2021-05-30 22:27:38,,"iexStock, ","iexcloud.io, pic.twitter.com/KC7D2Ymw9F, ",1399190807652012037,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Abu Dhabi National Energy Company PJSC
-Regeneron Pharmaceuticals, Inc.
-Alphabet Inc - Class C
-Incyte Corp.
-Eshraq Investments PJSC

Data provided by https://t.co/oXreiEXTgd https://t.co/KC7D2Ymw9F",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2676698935,2021-05-29 14:04:52,"BCTX, ",,,1398701890892873732,False,26,0,1,7,Twitter for iPhone,"$BCTX

Analyst Rating In Works ‚úÖ
Zoom for Retail in Works ‚úÖ
Corporate Presentations Ongoing ‚úÖ
Brand Upgrade ‚úÖ
New IR Team from Manhattan ‚úÖ
World Class Data ‚úÖ
$28m Cash - Runway till 2023‚úÖ
$20m Market Cap‚úÖ
7.6m Float ‚úÖ
Collab with $18bn Incyte ‚úÖ
Tutes + Insiders 60% ‚úÖ",,,2014-07-24 08:24:06,"Manchester, England",Fazza,https://pbs.twimg.com/profile_images/1407263248949329923/v_9Gf8fz_normal.jpg,500,74,6,2201,PatientWinner87,
1134049078424162304,2021-05-29 10:34:27,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1398648941349117957,False,0,0,0,0,Newsfilter.io,"Statement of changes in beneficial ownership of securities filed with the SEC a day ago, reported in a new form 4 filed with the .. $INCY https://t.co/e0mlrUEkBt",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-05-29 10:27:28,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1398647180420915205,False,0,0,0,0,Newsfilter.io,"1,923 shares acquired by Clancy Paul J (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/uaKPFx2C1d",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-05-29 10:26:27,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1398646926535450624,False,0,0,0,0,Newsfilter.io,"1,923 shares acquired by Dixon Wendy L (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/aH3UnNUAeb",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-05-29 10:25:28,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1398646679394566150,False,0,0,0,0,Newsfilter.io,"1,923 shares acquired by Fouse Jacqualyn A (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/LiU6J4V8ip",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-05-29 10:24:28,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1398646425228042240,False,0,0,0,0,Newsfilter.io,"Statement of changes in beneficial ownership of securities filed with the SEC a day ago, reported in a new form 4 filed with the SEC  $INCY https://t.co/IlAhE87Lgx",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-05-29 10:21:27,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1398645668898615298,False,0,0,0,0,Newsfilter.io,"Statement of changes in beneficial ownership of securities filed with the SEC a day ago, reported in a new form 4 filed with the SE.. $INCY https://t.co/oA8GgaMy2k",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-05-29 04:59:26,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1398564631497613316,False,0,0,0,0,Newsfilter.io,"Statement of changes in beneficial ownership of securities filed with the SEC 13 hours ago, reported in a new form 4 filed with the SEC  $INCY https://t.co/MHHX6TRg5k",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
374729426,2021-05-29 04:26:08,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2769194, pic.twitter.com/1x8sEmnuoZ, ",1398556248904134658,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on May 20, 2021. View odds for this and other indicators: https://t.co/dmHHYM7Kmz #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1x8sEmnuoZ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1325115160353103872,2021-05-28 07:12:20,"INCY, ","healthcare, ","quantisnow.com/insight/889305‚Ä¶, ",1398235686440824834,False,0,0,0,0,Twitter,"$INCY üìú SEC Form 4 filed by Incyte Corporation

https://t.co/NY4smpzHYa

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1315434407692509184,2021-05-27 17:58:15,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/EmlOHq5aaA, ",1398035850131382276,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2041 out of 5460 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/EmlOHq5aaA",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1174733097616543744,2021-05-27 16:38:43,,"incyte, qed, servier, taiho, zymeworks, ccf, curecc, ","pic.twitter.com/4gJx8Pbqv9, ",1398015835902386178,False,4,0,0,2,Twitter Web App,"I'm attending a webinar with CCF's industry partners and WOW, what an incredible group of companies.  #incyte #qed #servier #taiho #zymeworks #ccf #curecc https://t.co/4gJx8Pbqv9",,,2019-09-19 13:12:58,"Stansbury Park, Utah",Rick Pollock,https://pbs.twimg.com/profile_images/1174735787524382720/nROUIzLJ_normal.jpg,44,65,0,119,rick_pollock,photo
1171873456276889600,2021-05-27 16:10:11,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1398008655128190976,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (27 May, 4:06pm)

üì∞ Departure of Directors or Certain Officers; Election of Directors

https://t.co/TRbkctbYy4

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1068561714055012352,2021-05-27 16:08:17,"INCY, ",,"sec.report/Document/00011‚Ä¶, ",1398008175853400064,False,0,0,0,0,Edgar Filings,SEC Form 8-K [Press/News Current Report] filed by  $INCY INCYTE CORP  https://t.co/BqEyKHZUgh,,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
255637814,2021-05-27 13:14:10,,,"bit.ly/3ib6ZWP, ",1397964356105744386,False,0,0,0,0,CoSchedule,Incyte Corporation to pay $12.6 million. https://t.co/Uf6V0MUkjW,,,2011-02-21 14:32:31,www.racmonitor.com,RACmonitor,https://pbs.twimg.com/profile_images/839503779993092096/sZ5AXCRc_normal.jpg,1192,543,28,3168,RACmonitor,
50405984,2021-05-27 13:01:12,,"AMMF, ","ow.ly/rimr50ETTUy, pic.twitter.com/wrwCbRL4i4, ",1397961093528625153,False,10,0,0,3,Hootsuite Inc.,"Miss the world premiere of ‚ÄòCholangiocarcinoma and the Importance of Molecular Profiling‚Äô at the #AMMF Conference this year? All made possible by the joint collaboration of  @Incyte, @CharityAMMF and expert Prof John Bridgewater, watch now at https://t.co/hOnXTVP2OF https://t.co/wrwCbRL4i4","Incyte, CharityAMMF, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
374729426,2021-05-27 07:58:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2765503, pic.twitter.com/jnDUfbHpmr, ",1397884942206394377,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on May 4, 2021. View odds for this and other indicators: https://t.co/JO92ad2gqb #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/jnDUfbHpmr",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1218480193725091840,2021-05-27 07:29:09,,,"businesswire.com/news/home/2021‚Ä¶, ",1397877531970183169,False,0,0,0,0,Twitter Web App,"‚ÄúI am extremely encouraged by the findings from the TRuE-V program and the ruxolitinib cream as a topical treatment option for vitiligo patients, who have limited therapies available that effectively and safely address repigmentation.‚Äù said Dermatologist

https://t.co/6ffwFyWaSg",,,2020-01-18 05:28:28,,Mellalta Meets,https://pbs.twimg.com/profile_images/1239854909308039168/ZiS9Gw38_normal.jpg,63,346,0,1580,mellaltameets,
976297820532518914,2021-05-27 07:16:39,,,"ResearchAndMarkets.com, dlvr.it/S0WkPc, pic.twitter.com/EjVelB0fal, ",1397874386791583748,False,0,0,0,0,dlvr.it,"Global Cholangiocarcinoma Market (2021 to 2028) - Featuring Incyte, QED Therapeutics and RenovoRx Among Others - https://t.co/guyiBzPH8C https://t.co/U09udUkwTc https://t.co/EjVelB0fal",,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
4876582225,2021-05-27 04:42:52,"INCY, ",,"ideas.quantcha.com/2021/05/27/sto‚Ä¶, ",1397835686204506112,False,0,0,0,0,WordPress.com,StockTwits Trending Alert: Trading recent interest in INCYTE¬†$INCY https://t.co/BV7QN6Njq4,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
1183884634100289537,2021-05-26 05:07:02,,"lifesciences, biotechnology, science, biology, biotech, molecularbiology, healthcare, biochemistry, pharma, research, lifescience, genetics, technology, knowledge, COVID19, zoology, bioinformatics, immunology, medicine, scicomm, ","lifescivoice.com/incyte-agrees-‚Ä¶, pic.twitter.com/nc7tnd7QsB, ",1397479380650168320,False,1,0,0,1,Twitter for Android,"Follow the link: https://t.co/s9wheWDL5v
.
.
.
#lifesciences #biotechnology #science #biology  #biotech #molecularbiology #healthcare #biochemistry #pharma #research #lifescience #genetics #technology #knowledge #COVID19 #zoology #bioinformatics #immunology #medicine #scicomm https://t.co/nc7tnd7QsB",,,2019-10-14 19:17:58,,Life Sciences Voice,https://pbs.twimg.com/profile_images/1441342051824537607/yKgMSH8T_normal.jpg,401,0,0,221,LifeSciVoice,photo
1005254801066807297,2021-05-25 22:31:09,,"polycythemia_vera_drug, BlueWeave, ","bit.ly/34hOg3x, pic.twitter.com/KjHdhOj9Et, ",1397379751388409859,False,1,0,0,0,Twitter Web App,"#polycythemia_vera_drug sales market is growing at an impressive rate across the globe &amp; is expected to witness significant progress in foreseeable future. https://t.co/8VLGTlPqfj
#BlueWeave @ANPTechnologies @bmsnews @GileadSciences @italfarmacoes @Novartis @ZydusUniverse @Incyte https://t.co/KjHdhOj9Et","ANPTechnologies, bmsnews, GileadSciences, italfarmacoes, Novartis, ZydusUniverse, Incyte, ",,2018-06-08 21:06:36,"Noida, India",BlueWeave Consulting,https://pbs.twimg.com/profile_images/1026685722386989056/1PeBOMS-_normal.jpg,84,746,1,1177,BlueweaveC,photo
1280938376099741697,2021-05-25 21:52:52,,"iexStock, ","iexcloud.io, pic.twitter.com/Tboud84R8r, ",1397370115830726666,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-NXP Semiconductors NV
-JD.com Inc - ADR
-Incyte Corp.
-NortonLifeLock Inc
-Fiserv, Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/Tboud84R8r",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1022163061174673415,2021-05-25 10:02:09,,,"abcnews.go.com/Health/wireSto‚Ä¶, ",1397191259647795200,False,0,0,0,0,Hootsuite Inc.,Department of Justice officials said in a news release Tuesday that the settlement resolves allegations that Incyte Corp. improperly used an independent foundation to cover the copays of certain people taking the company‚Äôs cancer drug. https://t.co/xG2ruFlFHC,,,2018-07-25 12:53:59,"Baltimore, MD","Peter Angelos, P.C.",https://pbs.twimg.com/profile_images/1148618117012176897/HTXJT-T5_normal.jpg,21,34,0,245,LOPGAOfficial,
374729426,2021-05-24 19:39:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2759501, pic.twitter.com/x9tWnaU19t, ",1396974261374316546,False,0,0,1,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/2mWzcUHOIe #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/x9tWnaU19t,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
702999329821188096,2021-05-24 15:19:30,,"vitiligo, research, Ruxolitinib, ","bit.ly/3oL5kby, ",1396908736023728128,False,3,1,0,1,Twitter Web App,Read about latest #vitiligo #research news from @Incyte --Positive results from Phase 3 True-V Program Evaluating #Ruxolitinib Cream in Patients with Vitiligo: https://t.co/Qe19EWzAlv,"Incyte, ",,2016-02-25 18:31:16,"Chicago, IL",Global Vitiligo Foundation,https://pbs.twimg.com/profile_images/1235405131098869760/frWX3dp6_normal.jpg,1604,266,10,448,StepUp4Vitiligo,
1161722849788399616,2021-05-24 14:39:26,,,,1396898653579710470,False,2,0,0,1,Twitter for iPhone,"Hey @Incyte you fat, greedy fucks. Thanks for making Jakafi over $150,000 a year to take. Hope those stock prices are lovely over broke people‚Äôs bodies....assholes.","Incyte, ",,2019-08-14 15:34:45,,Bumblebee Jones,https://pbs.twimg.com/profile_images/1270702172406235137/uj1wA3Gw_normal.jpg,6,35,0,119,BumblebeeJones1,
4058194633,2021-05-24 14:29:17,"INCY, ",,"clinicaltrialsarena.com/comment/loa-up‚Ä¶, ",1396896096446685187,False,0,0,0,0,Twitter for iPhone,$INCY LoA Update: Incyte‚Äôs topical ruxolitinib has 15-point hike in approval likelihood in vitiligo after Phase III data reveal https://t.co/yDwuu9tman via @Clinical Trials Arena,"clinical, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
963495628545327104,2021-05-24 13:21:02,"INCY, INCY, ",,"stck.pro/news/INCY/1313‚Ä¶, stck.pro/news/INCY, ",1396878921296187393,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte: Slowly Moving Along https://t.co/v5rsAprsMK Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
23059499,2021-05-24 13:17:03,"INCY, ","economy, business, finance, ","seekingalpha.com/article/443091‚Ä¶, ",1396877919432036353,False,1,0,0,0,SAArticlesTwitter,$INCY - Incyte: Slowly Moving Along. https://t.co/IRFXigF7DL #economy #business #finance,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1188909056272019456,2021-05-23 16:00:00,,"EliLilly, Incyte, baricitinib, alopecia, areata, ","ow.ly/3vrd50ESDAO, pic.twitter.com/bFWYS7wqaB, ",1396556539029229571,False,0,0,0,0,Twitter Web App,"#EliLilly and #Incyte announce results from its phase 3 study evaluating #baricitinib 2 mg and 4 mg for the treatment of #alopecia #areata, making it the first phase 3 study with top-line results in patients with the hair disorder.
https://t.co/CA1gsguhYb https://t.co/bFWYS7wqaB",,,2019-10-28 16:03:11,"Cleveland, OH / Cranbury, NJ",Aesthetic Authority,https://pbs.twimg.com/profile_images/1402736618298122240/996IOFpP_normal.jpg,873,98,4,973,AestheticAuth,photo
374729426,2021-05-23 08:43:18,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2756036, pic.twitter.com/CeGLLHtnav, ",1396446640454606852,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/Eho9JKAGri #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/CeGLLHtnav,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
4876582225,2021-05-23 00:46:10,"INCY, ",,"ideas.quantcha.com/2021/05/22/sto‚Ä¶, ",1396326567899406339,False,0,0,0,0,WordPress.com,StockTwits Trending Alert: Trading recent interest in INCYTE¬†$INCY https://t.co/6LfZxvlDRk,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
1002361483169226752,2021-05-21 17:00:22,,"Dermatology, Immunology, Positive, Results, ","trialsitenews.com/incyte-announc‚Ä¶, pic.twitter.com/n5g7DvAHmm, ",1395846954274410496,False,1,0,0,0,Hootsuite Inc.,"Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo

https://t.co/X4W1c8tBd0

#Dermatology #Immunology #Positive #Results https://t.co/n5g7DvAHmm",,,2018-05-31 21:29:35,"Salt Lake City, Utah",TrialSite News,https://pbs.twimg.com/profile_images/1002368873918689280/0KP3xUVe_normal.jpg,7886,3205,76,11177,TrialsiteN,photo
88803949,2021-05-21 11:50:19,,"drugdiscovery, ","instagram.com/p/CPI-S_WCVx3/, pic.twitter.com/VLCw1VqSkU, ",1395768928010375170,False,1,0,0,1,Twitter Web App,"Vitiligo is a skin condition in which patches of skin loses color. Unfortunately, there is no cure, and it is usually a lifelong condition. Incyte‚Äôs ruxolitinib cream hits goal in vitiligo phase 3 trials. 
More:https://t.co/EoYgHy91rJ
#drugdiscovery https://t.co/VLCw1VqSkU",,,2009-11-09 19:18:06,"San Diego, CA",ChemDiv,https://pbs.twimg.com/profile_images/1181305235966349317/rxSrjOO2_normal.jpg,176,286,8,2910,ChemDiv,photo
1289196501516812289,2021-05-21 09:29:16,,"pharmatopnews, jobs, ","biospace.com/article/asco-2‚Ä¶, ",1395733433595408385,False,0,0,0,0,Twitter for iPhone,"ASCO 2021: Watch for Sanofi/Sloan Kettering, Incyte, Exelixis and AstraZeneca | BioSpace #pharmatopnews  https://t.co/k65j9lIkMM #jobs",,,2020-07-31 09:49:56,,Pharma Top News,https://pbs.twimg.com/profile_images/1289222230552072195/Fb5XMFYC_normal.jpg,16,0,0,2134,PharmaTopNews1,
1889492676,2021-05-21 06:04:08,"INCY, ","Incyte, InvestorConferences, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1395681810667905027,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConferences $INCY https://t.co/rusz9DyHpw,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1315434407692509184,2021-05-21 04:39:13,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/tNGuShwsWS, ",1395660438881329154,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 6.40% ranked 2006 out of 5449 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/tNGuShwsWS",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1249194189759406080,2021-05-21 04:30:08,,,"hebergementwebs.com/earnings/incyt‚Ä¶, pic.twitter.com/TtEUJ4HwuO, ",1395658152025235457,False,0,0,0,0,H France News,Incyte corp incy transcript of first quarter 2021 earnings call https://t.co/a8D7E4dOkT https://t.co/TtEUJ4HwuO,,,2020-04-12 00:34:47,USA,Hebergementwebs.com,https://pbs.twimg.com/profile_images/1383098813561384967/BWhKrTE6_normal.jpg,225,509,5,229317,Hebergementwebs,animated_gif
54287500,2021-05-21 04:02:54,,,"zpr.io/RD8V5, ",1395651299660738562,False,0,0,0,0,Zapier.com,"Tyrosine Kinase Inhibitor Market Business Strategy and Forecast to 2028 - Top Companies Incyte, Glaxo SmithKline, Celera Genomics Group, Onyx Pharmaceuticals, Chugai Pharmaceutical
https://t.co/K6wLLVqE4r",,,2009-07-06 14:24:37,UK,Industry Today,https://pbs.twimg.com/profile_images/696643138119716865/a0sG-bdg_normal.jpg,6259,3079,225,147863,IndustryToday,
1134049078424162304,2021-05-21 03:31:03,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1395643282659631111,False,0,0,0,0,Newsfilter.io,Incyte to Present at Upcoming Investor Conferences $INCY https://t.co/Xgb3GmkHmL,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
21793154,2021-05-20 15:04:59,,"biotechnology, pharmaceutical, ","hubs.li/H0NMDXv0, ",1395455531133902853,False,2,0,0,1,HubSpot,"ASCO 2021: Watch for @sanofi/@sloan_kettering, @Incyte, @ExelixisInc, and @AstraZenecaUS

#biotechnology #pharmaceutical

https://t.co/DhfGFAvUFn","sanofi, sloan_kettering, Incyte, ExelixisInc, AstraZenecaUS, ",,2009-02-24 15:27:40,"Des Moines, IA",BioSpace,https://pbs.twimg.com/profile_images/1042117112020389888/8MCBEVkx_normal.jpg,21738,2830,509,25196,biospace,
374729426,2021-05-20 14:22:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2749745, pic.twitter.com/E41io5TbnU, ",1395444947994570752,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on May 18, 2021. View odds for this and other indicators: https://t.co/VtxJwGpUEo #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/E41io5TbnU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
15974185,2021-05-20 13:17:35,,,"dlvr.it/S03sKh, ",1395428500794875904,False,0,0,0,0,dlvr.it,"ASCO 2021: Watch for Sanofi/Sloan Kettering, Incyte, Exelixis and AstraZeneca https://t.co/TjlXlvhQUq",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
31358286,2021-05-20 11:53:34,,,"cecp.me/3uZxcuO, pic.twitter.com/nqJu1Q1rof, ",1395407357161578497,False,0,0,0,1,dlvr.it,CEOs of biopharma companies @moderna_tx @pfizer @CatalentPharma @Merck @Incyte @sanofi @GSK @TakedaPharma @UCBUSA share Long-Term Business Plans with institutional investors June 7-8 @cecptweets Biopharma Sustainability Roundtable https://t.co/RSrq913bPR https://t.co/nqJu1Q1rof,"moderna_tx, pfizer, CatalentPharma, Merck, Incyte, sanofi, GSK, TakedaPharma, UCBUSA, CECPtweets, ",,2009-04-15 02:44:35,"Northampton, MA",3BL Media News,https://pbs.twimg.com/profile_images/1179146447272448000/KG1FF7Vp_normal.jpg,24123,9503,1817,83702,3BLNews,photo
875382419251019776,2021-05-20 11:20:12,,,"bit.ly/3f6cJz7, pic.twitter.com/s5btxXZ691, ",1395398963503583233,False,0,0,0,0,dlvr.it,"ASCO 2021: Watch for Sanofi/Sloan Kettering, Incyte, Exelixis and AstraZeneca https://t.co/NeiJ5h519u https://t.co/s5btxXZ691",,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
4058194633,2021-05-20 10:59:20,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1395393710209204228,False,0,0,0,0,Twitter for iPhone,$INCY Incyte to Present at Upcoming Investor Conferences | Business Wire https://t.co/gCObDcMqMv,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
72928001,2021-05-20 08:08:28,"INCY, ",,"bit.ly/3fvATSp, ",1395350711827800068,False,0,0,0,1,BriefingInPlayLimited,"$INCY: Incyte to present ""positive"" primary analysis from the Phase 2 OPTIC study of Ponatinib (Iclusig) in chronic... https://t.co/oHPGrkf3gA",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
976297820532518914,2021-05-20 08:08:24,,,"dlvr.it/S02s3R, pic.twitter.com/eHgplYiamL, ",1395350692156481537,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conferences https://t.co/LeSIonRkAt https://t.co/eHgplYiamL,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2021-05-20 08:04:39,"INCY, ",,"s.flashalert.me/AztQ3f, ",1395349749474238465,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on May 20, 08:00:00: Incyte to Present at Upcoming Investor Conferences https://t.co/Xe79yRNTo3",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1355194932445786112,2021-05-20 08:04:18,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1395349662668886023,False,0,0,0,0,Twitter,"$INCY Incyte to Present at Upcoming Investor Conferences
https://t.co/HtLQDNjRF9",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1889492676,2021-05-20 08:02:54,"INCY, ","Incyte, Oncology, ASCO21, ","1stoncology.com/blog/data-from‚Ä¶, ",1395349309772603393,False,0,0,0,0,Troi URL Plug-in,Data from #Incyte‚Äôs #Oncology Portfolio Accepted for Presentation at the #ASCO21 $INCY https://t.co/7TwtzKvZwe,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
3318510966,2021-05-20 08:01:15,,,"crweworld.com/article/news-p‚Ä¶, ",1395348894326747137,False,0,0,0,0,CRWE World,Incyte to Present at Upcoming Investor Conferences https://t.co/CsL9Cjiim1,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2021-05-20 08:00:33,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1395348718321381376,False,0,0,0,0,stocktitan,"$INCY Incyte to Present at Upcoming Investor Conferences
https://t.co/Og1GccsRDn",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1325115160353103872,2021-05-20 08:00:04,"INCY, ","healthcare, ","quantisnow.com/insight/781038‚Ä¶, ",1395348597789450242,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte to Present at Upcoming Investor Conferences

https://t.co/Ce2QqMvSLE

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
47519668,2021-05-20 06:08:15,"INCY, ",,"tradethenews.com/?twtId=22840, ",1395320457021247492,False,2,0,0,0,Updates Poster,"$INCY Positive Primary Analysis from the Phase 2 OPTIC Study of Ponatinib (Iclusig¬Æ) in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) to be Presented at the 2021 ASCO Annual Meeting (Incyte Corporation)
(More at https://t.co/1b4CInjE2w)",,,2009-06-15 22:37:04,Global,TradeTheNews.com,https://pbs.twimg.com/profile_images/916119563191889920/ylR4h5y0_normal.jpg,21141,1222,761,53590,Trade_The_News,
1006334607946649600,2021-05-19 18:09:03,,"StockMarket, Stocks, ","dlvr.it/S00nz8, ",1395139465576730624,False,0,0,0,0,dlvr.it,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 ASCO Annual Meeting https://t.co/6OLAlXWIqE #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1134049078424162304,2021-05-19 17:52:54,"INCY, ",,"newsfilter.io/articles/data-‚Ä¶, ",1395135399958360067,False,0,0,0,0,Newsfilter.io,Data from Incyte's Oncology Portfolio Accepted for Presentation at the 2021 ASCO Annual Meeting $INCY https://t.co/pTLxgHSTlm,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3318510966,2021-05-19 17:31:24,,,"crweworld.com/article/news-p‚Ä¶, ",1395129989322862592,False,0,0,0,0,CRWE World,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 ASCO Annual Meeting https://t.co/XfEZtqp2Q8,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
4058194633,2021-05-19 17:27:46,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1395129075077844994,False,0,0,0,0,Twitter for iPhone,$INCY  Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 ASCO Annual Meeting | Business Wire https://t.co/i7F6WUHpXY,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
472650465,2021-05-19 17:26:05,"INCY, ",,"otcdynamics.com/incy-data-from‚Ä¶, ",1395128650169823238,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 ASCO Annual Meeting https://t.co/ocroYBFcZ7,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1355194932445786112,2021-05-19 17:18:16,"INCY, ",,"stocktitan.net/news/INCY/data‚Ä¶, ",1395126686593736705,False,0,0,0,0,Twitter,"$INCY Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 ASCO Annual Meeting
https://t.co/aaMdjYvSYP",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1254035253104181256,2021-05-19 17:14:31,"INCY, ",,"stocktitan.net/news/INCY/data‚Ä¶, ",1395125740207755265,False,0,0,0,0,stocktitan,"$INCY Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 ASCO Annual Meeting
https://t.co/yeGfyK2FuV",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1306597845953318912,2021-05-19 17:09:02,"MRK, ",,"a.aiera.com/cZxN, ",1395124361774911494,False,0,0,0,0,Twitter,"‚úÖ $MRK: ""Merck"" mentioned during XOMA ""XOMA Corp Annual Shareholders Meeting"" event https://t.co/3TZ4yMLKtp",,,2020-09-17 10:16:50,"New York, NY",Aiera Alerts,https://pbs.twimg.com/profile_images/1306649352744636417/MBPPUWOT_normal.jpg,160,204,0,11447,AieraAlerts,
289923339,2021-05-19 15:17:46,,"vitiligo, ","dermatologyadvisor.com/home/meetings/‚Ä¶, ",1395096358806335500,False,12,0,0,2,Twitter Web App,"Good news from the US following the results from Phase 3 trials of Incyte‚Äôs ruxolitinib cream with #vitiligo patients.

Read the full article below: https://t.co/iHtvLH2qZw",,,2011-04-29 09:07:09,London,Vitiligo Society,https://pbs.twimg.com/profile_images/1166392540439941121/JYHF7f6V_normal.jpg,3724,659,16,1834,vitiligosociety,
279184000,2021-05-19 14:33:58,,,"bit.ly/3yobwum, ",1395085338931081225,False,12,1,0,3,Buffer,JAK inhibitor helping vitiligo? Results from phase 3 TRuE-V trial ruxolitinib cream in adolescent/adult vitiligo pts -  showed significantly more RUX pts with 75% improvement in facial vitiligo area scoring index (F-VASI75) compared to control at Week 24 https://t.co/q98CBjfdQi,,,2011-04-08 15:16:02,"Dallas, TX",Dr. John Cush,https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3_normal.jpg,12140,432,178,16241,RheumNow,
1302293239861522432,2021-05-19 12:07:41,,"vitiligo, clinicaltrial, clinicaltrials, ","thinktrial.com/new-vitiligo-t‚Ä¶, ",1395048522341306368,False,1,0,0,0,Twitter Web App,"Clinical Trial: New cream helps to return skin colour and tone in vitiligo | Think Trial https://t.co/xaRaGvgINF #vitiligo #clinicaltrial #clinicaltrials @Incyte @vitiligosociety @VitiligoUK 
This is such great innovation in a difficult area of medicine","Incyte, vitiligosociety, VitiligoUK, ",,2020-09-05 13:11:32,,Think Trial,https://pbs.twimg.com/profile_images/1394654294083768323/DvOFlfRa_normal.jpg,0,57,0,25,think_trial,
782954815739527168,2021-05-18 23:15:36,,,"dlvr.it/RzxQlh, ",1394854221191819269,False,0,0,0,0,dlvr.it,"Clinical/Senior Clinical Research Associate, Northeast - Incyte Corporation - , NA https://t.co/9vzhWvE3o3",,,2016-10-03 10:45:49,"Washington, DC",Clinical Research Forum,https://pbs.twimg.com/profile_images/793945936200351744/foN7mcbj_normal.jpg,345,452,1,1449,CRForumUS,
374729426,2021-05-18 17:24:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2746485, pic.twitter.com/vvUqtBUdIb, ",1394765980069339136,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators: https://t.co/Yg7PAEHTIw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/vvUqtBUdIb,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
772471873539977217,2021-05-18 16:45:05,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1394755946107260929,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form SC 13D/A https://t.co/EQvPlnOWoM,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
1366976710051328001,2021-05-18 15:48:00,"TLIS, ",,"twitter.com/fintel_io/stat‚Ä¶, ",1394741580083441674,False,1,0,0,0,Twitter for iPhone,"Randy Scott $TLIS insider buying. Cofounder of Genomic Health, Invitae, Incyte. https://t.co/O4LwH6B8B1",,,2021-03-03 00:00:37,,JoeBio,https://pbs.twimg.com/profile_images/1366977007029018625/OUNTP7BE_normal.jpg,107,33,7,930,BiotechJoe21,
4058194633,2021-05-18 11:51:18,"INCY, ",,"clinicaltrialsarena.com/news/incyte-ru‚Ä¶, ",1394682014754693126,False,0,0,0,0,Twitter for iPhone,$INCY Incyte‚Äôs ruxolitinib meets endpoints in Phase III trials for vitiligo https://t.co/n8LZm8hpCo via @Clinical Trials Arena,"clinical, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
728894570,2021-05-18 10:03:24,,"All_Health_Fitness_Tips, ","iweller.com/all-health-fit‚Ä¶, ",1394654859618447360,False,0,0,0,0,iweller.com,"Ruxolitinib cream improves facial vitiligo in phase 3 trials - #All_Health_Fitness_Tips - Ruxolitinib cream improved facial vitiligo and showed positive patient-reported outcomes in a phase 3 clinical trial program, Incyte... - https://t.co/zAL1pW8tJw",,,2012-07-31 13:55:29,,iWeller.com,https://pbs.twimg.com/profile_images/1244249406477455360/tl4H1tq0_normal.jpg,121,141,0,264390,iWeller_health,
1302293239861522432,2021-05-18 09:56:02,,"alopeciaareata, alopecia, autoimmune, trialbite, ","thinktrial.com/hair-regrowth-‚Ä¶, ",1394653004826038275,False,0,0,0,0,Twitter Web App,"Hair re-growth hope in alopecia areata | Think Trial https://t.co/Grpt81JdKd 
@LillyPad @Incyte @NAAF_org #alopeciaareata #alopecia #autoimmune #trialbite","LillyPad, Incyte, NAAF_org, ",,2020-09-05 13:11:32,,Think Trial,https://pbs.twimg.com/profile_images/1394654294083768323/DvOFlfRa_normal.jpg,0,57,0,25,think_trial,
27254739,2021-05-18 06:28:36,,"vitiligo, dermatology, ","bit.ly/346Bhlj, ",1394600803290259458,False,0,0,0,0,Sprout Social,".@Incyte has made further progress with its ruxolitinib cream, notching up a phase 3 trial showing it can re-pigment skin in #vitiligo ahead of a key FDA decision in atopic dermatitis https://t.co/cWympsAwzT #dermatology","Incyte, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
15974185,2021-05-18 06:25:34,,,"dlvr.it/RztWf4, ",1394600038286827520,False,0,0,0,0,dlvr.it,"Incyte‚Äôs Ruxolitinib Cream Shows Promise for Vitiligo in Phase III Trials Published: May 17, 2021 By Brandon May https://t.co/BitD1SFYuW",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1196304745603817472,2021-05-18 02:30:45,"INCY, ",,,1394540946507718656,False,0,0,1,0,Twitter for iPhone,"Incyte's flagship drug, ruxolitinib, is currently approved to treat myelofibrosis, a rare type of blood cancer.

And currently, $INCY is looking to expand the drug‚Äôs use in atopic dermatitis, a disease that produces a long-lasting itchy rash that periodically flares up.",,,2019-11-18 00:51:09,Blog üëâ,Dissecting the Markets | See pinned tweet,https://pbs.twimg.com/profile_images/1316148879423725568/uyA-ocsf_normal.jpg,1217,293,20,33934,dissectmarkets,
172288755,2021-05-17 22:42:23,,,"fiercebiotech.com/biotech/incyte‚Ä¶, ",1394483475864952833,False,0,0,0,0,Twitter Web App,"Incyte's ruxolitinib cream hits goal in vitiligo phase 3 trials, teeing up regulatory submissions https://t.co/DibrdM3MRS",,,2010-07-29 06:10:36,"Yong-In city, Korea",Kyung Seok Lee,https://pbs.twimg.com/profile_images/922433020748898305/cjOW-D4X_normal.jpg,17,60,0,646,ksloveis,
3686628867,2021-05-17 22:11:59,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1394475826754867202,False,0,0,0,0,WordPress.com,Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with¬†Vitiligo https://t.co/fgeEtdn2pG,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1280938376099741697,2021-05-17 20:10:40,,"iexStock, ","iexcloud.io, pic.twitter.com/0tSiUTtd8H, ",1394445295619035139,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Insurance House P.S.C
-Microsoft Corporation
-Alphabet Inc - Class A
-Ross Stores, Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/0tSiUTtd8H",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
108617488,2021-05-17 19:55:01,,,"invst.ly/uue76, ",1394441357888983052,False,0,0,0,0,FP News Publisher - COM,Oppenheimer Stick to Their Buy Rating for Incyte Corp - https://t.co/gbJFjpzaUj,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
2817332702,2021-05-17 14:30:20,,,"fiercebiotech.com/biotech/incyte‚Ä¶, ",1394359648409509894,False,147,1,23,26,Twitter Web App,"Great news today for vitiligo patients - Incyte's ruxolitinib cream hits goal in vitiligo phase 3 trials, teeing up regulatory submissions https://t.co/f899A4NduD",,,2014-09-18 12:50:29,UMass Medical School,"John E. Harris, MD, PhD",https://pbs.twimg.com/profile_images/716619871493210112/t88Vh-d3_normal.jpg,3705,476,19,2802,HarrisVitiligo,
133504478,2021-05-17 13:51:43,,"strategy, competitiveintelligence, marketing, pharma, healthcare, biotech, pharmaceutical, productmarketing, ","dlvr.it/RzqyvK, pic.twitter.com/f3BXDYrNYp, ",1394349927283642368,False,0,0,0,1,dlvr.it,"Incyte keeps rolling on topical cream for JAK inhibitor, passing two PhIII tests in vitiligo https://t.co/ro906DWScN #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #pharmaceutical #productmarketing https://t.co/f3BXDYrNYp",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1134049078424162304,2021-05-17 12:49:59,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1394334391556579335,False,0,0,0,0,Newsfilter.io,"Incyte's Ruxolitinib Cream Aces Late-Stage Vitiligo Trials, Teeing Up Regulatory Submissions $INCY https://t.co/clsHJLs3AJ",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
4058194633,2021-05-17 12:35:15,"INCY, ",,"endpts.com/incyte-keeps-r‚Ä¶, ",1394330687604334593,False,1,0,0,0,Twitter for iPhone,"$INCY Incyte keeps rolling on topical cream for JAK inhibitor, passing two PhIII tests in vitiligo - https://t.co/CFTx1YSxGg",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
381078043,2021-05-17 12:22:00,,"ruxolitnib, vitligo, phase3trials, ","fiercebiotech.com/biotech/incyte‚Ä¶, ",1394327350721011715,False,1,0,0,0,Twitter for iPhone,"This is big. #ruxolitnib #vitligo #phase3trials
Incyte's ruxolitinib cream hits goal in vitiligo phase 3 trials, teeing up regulatory submissions https://t.co/QHvimACtAk",,,2011-09-27 14:15:47,"Manhattan, NY",Fairuz Zein,https://pbs.twimg.com/profile_images/1297284304012218369/K80HQfqB_normal.jpg,41,278,1,329,Fairuz_Zein,
1100450877792370688,2021-05-17 12:05:17,"INCY, ",,"blueequity.io/r/216468/de-in‚Ä¶, ",1394323143146176514,False,0,0,0,0,Blue Equity,$INCY Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo https://t.co/HNCPDeo8QP,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
3048530250,2021-05-17 11:00:02,,,"bit.ly/3hwPEa9, ",1394306725050728454,False,0,0,0,0,Amplifr,"Regeneron (REGN) Upgrade Lifts Range-Bound Biotech Stocks

Biotech stocks gained after a Regeneron (REGN) upgrade. Trade the stock and industry heavyweight Incyte (INCY) with these tactical ideas. https://t.co/2lQNESwrWV",,,2015-02-27 23:17:28,"Salt Lake City, UT",Tiffany Thomas,https://pbs.twimg.com/profile_images/1298693838937051136/ebgO15_r_normal.jpg,363,293,6,25676,wealthytiffany,
3460109487,2021-05-17 10:55:49,,,"endpts.com/incyte-keeps-r‚Ä¶, ",1394305661224300551,False,3,0,0,1,TweetDeck,"As Incyte prepares to potentially hit the market with a topical formulation of its cash cow ruxolitinib in atopic dermatitis, the Wilmington, DE-based company is beefing up its data package for another indication: vitiligo.

https://t.co/Nj1w59m3ij",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
46297868,2021-05-17 10:33:34,,,"dlvr.it/RzqKhv, ",1394300061106905100,True,0,0,0,0,dlvr.it,"Incyte keeps rolling on topical cream for JAK inhibitor, passing two PhIII tests in vitiligo https://t.co/p7LMUKt5OD",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
4058194633,2021-05-17 10:14:22,"INCY, ",,"nasdaq.com/articles/incyt‚Ä¶, ",1394295232162766849,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Says Phase 3 TRuE-V Trial Met Primary And Key Secondary Endpoints - Quick Facts  | NASDAQ https://t.co/WDIht7azME,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
72928001,2021-05-17 09:33:51,"INCY, ",,"bit.ly/3fnDtKi, ",1394285035297992704,False,0,0,0,0,BriefingInPlayLimited,"$INCY: Incyte announces ""positive"" topline results from its pivotal Phase 3 TRuE-V clinical trial program evaluating... https://t.co/9g684P7Gzx",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
918883922489905152,2021-05-17 09:24:26,,,"investor.incyte.com/press-releases‚Ä¶, ",1394282666002771968,False,1,0,0,0,Twitter for iPhone,Still trying to absorb this information... there‚Äôs a topical formulation for Jakafi??!!   https://t.co/rwYhaDzzbW,,,2017-10-13 12:59:33,"Los Angeles, CA",Gino K In USC Norris,https://pbs.twimg.com/profile_images/919064521695567872/VuuIkxS-_normal.jpg,258,300,2,432,Gino_K_In_USC,
875382419251019776,2021-05-17 09:13:35,,,"bit.ly/3bv6geG, pic.twitter.com/qWNhbKZvSE, ",1394279933971599369,False,0,0,0,0,dlvr.it,"Incyte's ruxolitinib cream hits goal in vitiligo phase 3 trials, teeing up regulatory submissions https://t.co/dOc1h626N9 https://t.co/qWNhbKZvSE",,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
1297176535175176193,2021-05-17 09:12:34,,,"investing.com/news/stock-mar‚Ä¶, ",1394279677162934273,False,0,0,0,0,Tweepsmap,"Incyte Earnings Beat, Revenue Misses In Q1 https://t.co/w4T2kwqDZA",,,2020-08-22 10:19:38,,SmartTraderChick,https://pbs.twimg.com/profile_images/1297183142558806016/TLSO3aYu_normal.jpg,625,40,1,4819,AndreaRude3,
391492257,2021-05-17 09:00:11,"INCY, ",,"fda.gov/advisory-commi‚Ä¶, fdatracker.com/fda-calendar/, ",1394276562657185793,False,0,0,0,0,FDA Tracker,$INCY New FDA AdCom 2021-06-24 Incyte Corporation Link:https://t.co/lNYhHxsqJs Calendar:https://t.co/sCt1qKoMdr,,,2011-10-15 13:01:13,San Francisco,FDA Tracker,https://pbs.twimg.com/profile_images/1667207308/square_logo_normal.png,4992,14,113,4060,fda_tracker,
108617488,2021-05-17 08:30:03,,,"invst.ly/uu5ww, ",1394268980806922246,False,1,0,0,0,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/wSX9NcpvAL,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
25406480,2021-05-17 08:24:32,,,"awesomecapital.blogspot.com/2021/05/incyte‚Ä¶, ",1394267590470557697,False,0,0,0,1,Twitter Web App,AwesomeCapital: Incyte: Positive Results in Phase 3 Vitiligo Trial https://t.co/60WZGxoqQ7,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
30394712,2021-05-17 08:10:03,,,"newsbreakapp.com/n/0ZbslBYL?sha‚Ä¶, ",1394263946778005508,False,0,0,0,0,Twitter for Android,Incyte to pay $12.6 million to resolve drug charity kickback claims https://t.co/xpyhzT6DZW,,,2009-04-11 00:10:29,philadelphia,kevin Colbert,https://pbs.twimg.com/profile_images/537982903/image_normal.jpg,119,1378,3,7795,40ozhomie,
472650465,2021-05-17 08:07:35,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1394263324192382976,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo https://t.co/j4Hlep3TfX,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1262114478986010632,2021-05-17 07:51:36,"INCY, ",,,1394259303897477125,False,0,0,0,0,Twitter Web App,$INCY Incyte's vitiligo treatment meets late-stage trial main goal,,,2020-05-17 16:15:42,,GapUpüß©,https://pbs.twimg.com/profile_images/1262126091671670784/fUEaPN8a_normal.jpg,161,649,5,6750,GapUp4,
1254906887490936845,2021-05-17 07:47:31,"INCY, ",,"quantdata.us/news/21148858, ",1394258274610987009,False,0,0,0,0,Quant Data (Production),"Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo; Co. Reports 'Primary and key secondary endpoints met in both TRuE-V1 and TRuE-V2 studies'

Related Tickers: $INCY
Read more at: https://t.co/YNLTJHm4X9",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
15296897,2021-05-17 07:38:11,"INCY, ",,"seekingalpha.com/news/3696975-i‚Ä¶, ",1394255926056472576,False,0,0,0,1,SANewsTwitter,$INCY - Incyte's vitiligo treatment meets late-stage trial main goal https://t.co/Av2u2lrGTj,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
976297820532518914,2021-05-17 07:36:43,,,"dlvr.it/Rzpm6x, pic.twitter.com/lYePiDN4bl, ",1394255558589382656,False,0,0,0,0,dlvr.it,Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo https://t.co/n7SeyoDVBO https://t.co/lYePiDN4bl,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1355194932445786112,2021-05-17 07:34:40,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1394255039351427074,False,0,0,0,0,Twitter,"$INCY Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo 
https://t.co/vqnXrDijIh",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
3318510966,2021-05-17 07:33:56,,,"crweworld.com/article/news-p‚Ä¶, ",1394254857918324736,False,0,0,0,0,CRWE World,Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo https://t.co/SOyW4f5R9V,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1069693680066420736,2021-05-17 07:32:35,"INCY, ",,"s.flashalert.me/TOv3iA, ",1394254518125268995,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on May 17, 07:30:00: Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo https://t.co/gfUGRltttm",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1254035253104181256,2021-05-17 07:30:54,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1394254094446088196,False,0,0,0,1,stocktitan,"$INCY Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo 
https://t.co/QYEOo4VFR8",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1325115160353103872,2021-05-17 07:30:03,"INCY, ","healthcare, ","quantisnow.com/insight/747754‚Ä¶, ",1394253879999569924,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces Positive Results from Phase 3 TRuE-V Program Evaluating Ruxolitinib Cream in Patients with Vitiligo

https://t.co/GavZLKMwpN

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1304774550014615554,2021-05-17 04:59:40,,"AMMF, Cholangiocarcinoma, QEDTherapeutics, AMMF2021, ","pic.twitter.com/7tGZXluFVs, ",1394216033158901761,False,7,0,0,0,Twitter Web App,"Thank you to all our amazing sponsors who made possible  #AMMF's Virtual European #Cholangiocarcinoma Conference 13-14 May 202. Collaboration is key! @Incyte, #QEDTherapeutics, @HelsinnGroup
@TaihoOncology, @AstraZeneca
@MerckHealthcare,@NuCana_news
@ZymeworksInc  
#AMMF2021 https://t.co/7tGZXluFVs","Incyte, HelsinnGroup, TaihoOncology, AstraZeneca, MerckHealthcare, NuCana_news, ZymeworksInc, ",,2020-09-12 09:32:06,UK,Helen Morement,https://pbs.twimg.com/profile_images/1304775126232293377/dwFksdw9_normal.jpg,182,299,0,268,HelenMorement,photo
750646032258793472,2021-05-17 03:52:03,,,"endpts.com/incytes-pd-l1-‚Ä¶, ",1394199017492471809,False,1,0,0,0,Twitter Web App,Incyte‚Äôs PD-(L)1 inhibitor headed for an ODAC showdown next month - https://t.co/CiehkbfJLR,,,2016-07-06 07:02:15,"Paris, France",Mazars,https://pbs.twimg.com/profile_images/1238543616617963521/RBlZCFrU_normal.jpg,114,616,22,8618,CrMazars,
49666871,2021-05-16 20:19:04,,,"dlvr.it/RznDyF, ",1394085018880790532,False,2,0,0,2,dlvr.it,"New job posting: Sr. Research Scientist/Research Expert, Pharmacology - Incyte Corporation - Wilmington, DE https://t.co/KkFNjW3oUC",,,2009-06-22 11:46:47,,MAA,https://pbs.twimg.com/profile_images/807397869/maalogo_normal.jpg,91664,3772,1532,19525,maanow,
1925199355,2021-05-16 13:00:01,,"healthcare, ","bit.ly/2SGga6P, ",1393974529886670848,False,0,0,0,0,eClincher,Incyte pays $12.6 million to resolve charity kickback claims https://t.co/da7sdC7aiv via @statnews #healthcare,"statnews, ",,2013-10-01 21:01:01,Colorado,MailMyStatements üõ°üì¨,https://pbs.twimg.com/profile_images/1410554445453090817/xv9zzBf__normal.jpg,6003,4877,126,109024,MailMyStatement,
2656754371,2021-05-16 11:30:54,,"metastatic, orphandrugdesignation, Biotech, PaloAlto, California, Delaware, ","Pharm2Market.app, endpts.com/incytes-pd-l1-‚Ä¶, ",1393952104881008641,False,0,0,0,0,SocialPilot.co,Incyte‚Äôs PD-(L)1 inhibitor headed for an ODAC showdown next month - Find more stories like this at https://t.co/Ch0OzV8Nyh | @FDAOncology @US_FDA  @Incyte #metastatic #orphandrugdesignation #Biotech #PaloAlto #California #Delaware https://t.co/9atIQwvZjV,"FDAOncology, US_FDA, Incyte, ",,2014-07-18 09:20:39,San Diego,Aspen Biosciences,https://pbs.twimg.com/profile_images/1006725217568186368/B34yK1F1_normal.jpg,316,725,33,6079,aspenbio,
325135887,2021-05-16 11:05:00,,"DLBCL, ","bit.ly/3htnBZj, pic.twitter.com/W2esp5TTiN, twitter.com/Incyte/status/‚Ä¶, ",1393945585158221828,False,4,0,1,0,Twitter Web App,"Excellent news! Keep up the good work! @Incyte @MorphoSys #DLBCL 
https://t.co/t4SsaqT9vM https://t.co/W2esp5TTiN https://t.co/mzWEfoX2oP","Incyte, MorphoSys, ",,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,photo
4539949514,2021-05-15 17:08:00,,"healthcare, ","bit.ly/2SGga6P, ",1393674549850423296,False,0,0,0,0,eClincher,Incyte pays $12.6 million to resolve charity kickback claims https://t.co/Ry0dEo7RrY via @statnews #healthcare,"statnews, ",,2015-12-12 13:01:33,"Colorado, USA",Hugh Sullivan,https://pbs.twimg.com/profile_images/958446178235908096/kOpCRKkd_normal.jpg,2883,2412,29,17895,hughdsullivan,
374729426,2021-05-15 16:06:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2739398, pic.twitter.com/rrjaKkAP0S, ",1393658985727750144,False,0,0,1,0,Tickeron,$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators: https://t.co/IlBhdKw6Mp #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/rrjaKkAP0S,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1134049078424162304,2021-05-15 12:36:55,"INCY, ",,"newsfilter.io/articles/defa1‚Ä¶, ",1393606329479188481,False,0,0,0,0,Newsfilter.io,Form DEFA14A (additional definitive proxy soliciting materials and rule 14(a)(12) material) filed with the SEC $INCY https://t.co/f4rqj2UJH5,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
759387610640818176,2021-05-15 11:11:11,,,"kck.st/3vJ7o6i, ",1393584755740971010,False,0,0,2,1,Twitter for iPhone,"Help us get 1 of the 1st ever documentaries about Vitiligo off the ground! Please share and donate!!
 https://t.co/0RU6mhxMIU
@VanicreamSkin @Incyte @winnieharlow @MyVitiligoTeam @TheEllenShow @TDermatology @CrutchfieldDerm @ClarusDerm @HarrisVitiligo @StepUp4Vitiligo @joerogan","VanicreamSkin, Incyte, winnieharlow, MyVitiligoTeam, TheEllenShow, TDermatology, CrutchfieldDerm, ClarusDerm, HarrisVitiligo, StepUp4Vitiligo, joerogan, ",,2016-07-30 09:58:09,"Minnesota, USA",MinnesotaVITFriends,https://pbs.twimg.com/profile_images/1057364440977432580/szTsDB7e_normal.jpg,328,279,6,1210,MN_vitawareness,
1103013448659566592,2021-05-15 10:45:00,,"healthcare, ","bit.ly/2SGga6P, ",1393578165130436610,False,0,0,0,0,eClincher,Incyte pays $12.6 million to resolve charity kickback claims https://t.co/GJny8vQ2TT via @statnews #healthcare,"statnews, ",,2019-03-05 14:24:33,"Utah, USA",Derek Griffin,https://pbs.twimg.com/profile_images/1103013582130753541/b9SNUb_H_normal.jpg,2275,1934,14,8424,Derek_Griffin1,
84675341,2021-05-15 09:55:02,,"AONNMid2021, BranchingOutTogether, ",,1393565589470433284,False,0,0,0,0,Sprout Social,Join us for the industry session presentation sponsored by Incyte this morning at 10:00 am ET! #AONNMid2021 #BranchingOutTogether,,,2009-10-23 16:03:50,"Cranbury, NJ",AONN+,https://pbs.twimg.com/profile_images/825021507873161217/z_VlUvhe_normal.jpg,1571,893,31,3743,OncNav,
1925199355,2021-05-14 21:00:01,,"healthcare, ","bit.ly/2SGga6P, ",1393370548596527106,False,0,0,0,0,eClincher,Incyte pays $12.6 million to resolve charity kickback claims https://t.co/da7sdC7aiv via @statnews #healthcare,"statnews, ",,2013-10-01 21:01:01,Colorado,MailMyStatements üõ°üì¨,https://pbs.twimg.com/profile_images/1410554445453090817/xv9zzBf__normal.jpg,6003,4877,126,109024,MailMyStatement,
759387610640818176,2021-05-14 19:09:48,,,"kck.st/3vJ7o6i, ",1393342814814183428,False,1,0,2,2,Twitter for iPhone,"More than Our Skin documentary is currently in process for the story of vitiligo.  We need your help to get this going.  https://t.co/0RU6mhxMIU
@joerogan @winnieharlow @Incyte @MyHealthTeams @MyVitiligoTeam @VanicreamSkin @TheEllenShow","joerogan, winnieharlow, Incyte, MyHealthTeams, MyVitiligoTeam, VanicreamSkin, TheEllenShow, ",,2016-07-30 09:58:09,"Minnesota, USA",MinnesotaVITFriends,https://pbs.twimg.com/profile_images/1057364440977432580/szTsDB7e_normal.jpg,328,279,6,1210,MN_vitawareness,
374729426,2021-05-14 18:05:01,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2737279, pic.twitter.com/foUR3wdAmw, ",1393326512070225922,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 4, 2021. View odds for this and other indicators: https://t.co/PUzT1MNwbC #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/foUR3wdAmw",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
50405984,2021-05-14 07:00:33,,"AMMF, QEDTherapeutics, Cholangiocarcinoma, AMMF2021, ","pic.twitter.com/JbUPQcpycX, ",1393159291016781829,False,5,0,0,1,Hootsuite Inc.,"THANK YOU! #AMMF thanks @Incyte 
#QEDTherapeutics @HelsinnGroup @TaihoOncology @AstraZeneca @MerckHealthcare @NuCana_news   @ZymeworksInc for their generous support for this year‚Äôs AMMF Virtual #Cholangiocarcinoma Conference on the 13-14 May 2021 #AMMF2021 https://t.co/JbUPQcpycX","Incyte, HelsinnGroup, TaihoOncology, AstraZeneca, MerckHealthcare, NuCana_news, ZymeworksInc, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
227778014,2021-05-13 22:30:00,,,"buff.ly/3fkPMqL, ",1393030809490235399,False,1,0,0,0,Buffer,"BioCentury's latest round up of deals and product development news: NEA-backed Allay launches to deliver long-lasting non-opioid pain relief; plus updates from Heron,¬†Strongbridge,¬†Incyte https://t.co/CaEgvDSzyh",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
374729426,2021-05-13 17:11:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2734945, pic.twitter.com/3wV0tMistN, ",1392950737764642817,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 4, 2021. View odds for this and other indicators: https://t.co/EWWS1A4awz #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/3wV0tMistN",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3407278745,2021-05-13 16:50:13,,"TeamBoron, ","pic.twitter.com/8yvi2xTVpz, ",1392945297857269761,False,35,2,2,0,Twitter Web App,Congratulations to @mzliang for a great PhD defense! Michael worked on a variety of new C-C bond forming methods with #TeamBoron during his tenure. We'll miss you and good luck at Incyte! https://t.co/8yvi2xTVpz,"mzliang, ",,2015-08-07 10:30:27,"Chapel Hill, NC",Meek Lab,https://pbs.twimg.com/profile_images/1204964068848783361/eRZGwWIA_normal.jpg,1326,522,9,168,MeekLab,photo
4058194633,2021-05-13 15:36:21,"INCY, MGNX, ZLAB, ",,"endpts.com/incytes-pd-l1-‚Ä¶, ",1392926707959484416,False,0,0,0,0,Twitter for iPhone,$INCY $MGNX $ZLAB Incyte‚Äôs PD-(L)1 inhibitor headed for an ODAC showdown next month - https://t.co/7e67xwaTKB,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1289196501516812289,2021-05-13 13:10:24,,"pharmatopnews, oncology, immunooncology, checkpointinhibitors, ","endpts.com/incytes-pd-l1-‚Ä¶, ",1392889979337072644,False,1,0,0,1,Twitter for iPhone,Incyte‚Äôs PD-(L)1 inhibitor headed for an ODAC showdown next month ‚Äì Endpoints News #pharmatopnews #oncology #immunooncology #checkpointinhibitors https://t.co/thB7pK0A25,,,2020-07-31 09:49:56,,Pharma Top News,https://pbs.twimg.com/profile_images/1289222230552072195/Fb5XMFYC_normal.jpg,16,0,0,2134,PharmaTopNews1,
15974185,2021-05-13 12:21:34,,,"dlvr.it/RzZN1V, ",1392877690873548801,False,0,0,0,0,dlvr.it,Incyte‚Äôs PD-(L)1 inhibitor headed for an ODAC showdown next month https://t.co/F0TvwDtIss,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
3460109487,2021-05-13 11:29:10,,,"endpts.com/incytes-pd-l1-‚Ä¶, ",1392864503008833542,False,0,0,0,1,TweetDeck,"The FDA‚Äôs Oncologic Drugs Advisory Committee will spend a half day on June 24 reviewing Incyte‚Äôs PD-(L)1 inhibitor retifanlimab as a treatment for locally advanced or metastatic squamous carcinoma of the anal canal. 

https://t.co/7KM4hAu1xT",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
1407780158,2021-05-13 10:46:46,,"GVHD, sponsored, ","bit.ly/2uvja9K, ",1392853834331049986,False,13,0,0,1,Twitter Web App,Excited to partner with @Incyte on the Ingenuity Award program to support innovative ideas addressing the specific needs of the graft-versus-host disease (#GVHD) community. Learn more and submit your application by June 30: https://t.co/2lFytJ4Xd8. #sponsored,"Incyte, ",,2013-05-06 09:41:58,"New York, NY",Miguel Perales M.D.,https://pbs.twimg.com/profile_images/1250512673470590981/ldD-7z-v_normal.jpg,15352,2299,358,33645,DrMiguelPerales,
1925199355,2021-05-13 10:30:01,,"healthcare, ","bit.ly/2SGga6P, ",1392849616056487937,False,0,0,0,0,eClincher,Incyte pays $12.6 million to resolve charity kickback claims https://t.co/da7sdC7aiv via @statnews #healthcare,"statnews, ",,2013-10-01 21:01:01,Colorado,MailMyStatements üõ°üì¨,https://pbs.twimg.com/profile_images/1410554445453090817/xv9zzBf__normal.jpg,6003,4877,126,109024,MailMyStatement,
46297868,2021-05-13 10:14:04,,,"dlvr.it/RzZ2Pw, ",1392845604322111489,True,0,0,0,0,dlvr.it,Incyte‚Äôs PD-(L)1 inhibitor headed for an ODAC showdown next month https://t.co/peAx5m9gA1,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
1704701516,2021-05-13 08:49:11,"INCY, ","retifanlimab, ","public-inspection.federalregister.gov/2021-10181.pdf, pic.twitter.com/vLtKJFkvzT, ",1392824243222716417,False,0,2,1,2,Twitter Web App,FDA schedules Jun 24 advisory committee meeting for Incyte's #retifanlimab $INCY https://t.co/ZDj4qHfWwB https://t.co/vLtKJFkvzT,,,2013-08-27 09:27:52,Washington DC,SAC Tracker,https://pbs.twimg.com/profile_images/1022480906630488065/eD8QkMZS_normal.jpg,7742,439,212,14737,FDAadcomm,photo
50405984,2021-05-13 07:30:06,,"Cholangiocarcinoma, AMMF2021, ","ammf.org.uk/ammf-conferenc‚Ä¶, pic.twitter.com/IDAsSsmSNT, ",1392804339564044301,False,7,1,1,4,Hootsuite Inc.,"Coming up the world premiere of ‚Äú#Cholangiocarcinoma and the importance of molecular profiling‚Äù. Developed by @Incyte  @CharityAMMF , CCA expert Professor John Bridgewater,  @ucl  explaining the importance of molecular testing. Register at https://t.co/9tFucXu7Sx #AMMF2021 https://t.co/IDAsSsmSNT","Incyte, CharityAMMF, ucl, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
1889492676,2021-05-13 06:40:04,"INCY, ","Incyte, Oncology, EHA21, ","1stoncology.com/blog/data-from‚Ä¶, ",1392791748007530496,False,0,0,0,0,Troi URL Plug-in,Data From #Incyte‚Äôs #Oncology Portfolio Accepted for Presentation at the #EHA21 Virtual Congress $INCY https://t.co/5UcCdLSRx1,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1134049078424162304,2021-05-12 21:46:46,"INCY, ",,"newsfilter.io/articles/data-‚Ä¶, ",1392657541298106369,False,0,0,0,0,Newsfilter.io,Data From Incyte's Oncology Portfolio Accepted for Presentation at the 2021 EHA Virtual Congress $INCY https://t.co/us7MSlEDhp,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3686628867,2021-05-12 20:52:06,,,"pharmaceuticaldaily.com/data-from-incy‚Ä¶, ",1392643782760443907,False,0,0,0,0,WordPress.com,Data From Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 EHA Virtual¬†Congress https://t.co/UpPmAJhWbq,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
3318510966,2021-05-12 16:48:10,,,"crweworld.com/article/news-p‚Ä¶, ",1392582395790958594,False,0,0,0,0,CRWE World,Data From Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 EHA Virtual Congress https://t.co/DSxIW6faRH,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
4058194633,2021-05-12 16:38:00,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1392579837651349508,False,1,0,0,1,Twitter for iPhone,$INCY Data From Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 EHA Virtual Congress | Business Wire https://t.co/vNOyaOoFqc,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
976297820532518914,2021-05-12 16:23:08,,,"dlvr.it/RzWZk4, pic.twitter.com/nEELavmLWo, ",1392576095593979907,False,0,0,0,0,dlvr.it,Data From Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 EHA Virtual Congress https://t.co/1E0bIybquG https://t.co/nEELavmLWo,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1355194932445786112,2021-05-12 16:22:50,"INCY, ",,"stocktitan.net/news/INCY/data‚Ä¶, ",1392576017408172032,False,0,0,0,0,Twitter,"$INCY Data From Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 EHA Virtual Congress
https://t.co/BqbvVBBkal",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
472650465,2021-05-12 16:20:33,"INCY, ",,"otcdynamics.com/incy-data-from‚Ä¶, ",1392575443371544577,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Data From Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 EHA Virtual Congress https://t.co/J4MxEPQQTA,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1254035253104181256,2021-05-12 16:19:04,"INCY, ",,"stocktitan.net/news/INCY/data‚Ä¶, ",1392575070980149251,False,0,0,0,0,stocktitan,"$INCY Data From Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 2021 EHA Virtual Congress
https://t.co/XBHHlIaqeh",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
869617806,2021-05-12 12:02:03,,"CPD, ","ow.ly/RtB850EEhaP, pic.twitter.com/ryoWuFXiaq, ",1392510392572780544,False,1,0,0,0,Hootsuite Inc.,"Registration for the latest @Incyte webinar - Cracking the Code in CCA: Reshaping what‚Äôs possible in cholangiocarcinoma is open. 

The webinar is on 26 May 2021 16:00 ‚Äì 17:30 and has been approved for 1 #CPD credit.

Register now https://t.co/iY072jpZjP https://t.co/ryoWuFXiaq","Incyte, ",,2012-10-09 06:24:50,London ,RC of Pathologists,https://pbs.twimg.com/profile_images/1061901238906826753/x9lTDoI-_normal.jpg,12001,752,125,7066,RCPath,photo
1171873456276889600,2021-05-12 06:20:50,"MOR, ","MOR, 6K, Morphosys, News, ","docoh.com/filing/1340243‚Ä¶, ",1392424519659311105,False,0,0,0,0,Investor Feed,"$MOR  6-K  Morphosys   (12 May, 6:19am)

üì∞ MorphoSys and Incyte Announce First Patient Dosed in Phase 3

https://t.co/rJV7I6uefn

#MOR #6K #Morphosys #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1022473214457348096,2021-05-12 04:37:14,,,"pharmashots.com/59889/incyte-a‚Ä¶, ",1392398449409101826,False,0,0,0,0,Twitter Web App,"Incyte and MorphoSys Report First Patient Dosing in P-III frontMIND Study of Tafasitamab + Lenalidomide as a 1L Treatment for DLBCL @Pharmashot @Incyte  
https://t.co/zXMlebxsFZ","Pharmashot, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
1889492676,2021-05-12 02:45:42,"INCY, ","Incyte, MorphoSys, Tafasitamab, DiffuseLargeBCellLymphoma, ","1stoncology.com/blog/incytemor‚Ä¶, ",1392370382607290369,False,0,0,0,0,Troi URL Plug-in,#Incyte and #MorphoSys Announce First Patient Dosed in Phase 3 f#rontMIND Study Evaluating #Tafasitamab Combination as a First-Line Treatment for #DiffuseLargeBCellLymphoma $INCY https://t.co/pHWH7SXwO4,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
3686628867,2021-05-12 02:32:06,,,"pharmaceuticaldaily.com/incyte-and-mor‚Ä¶, ",1392366957110960132,False,0,0,0,0,WordPress.com,Incyte and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-Line Treatment for Diffuse Large B-Cell¬†Lymphoma https://t.co/B4fooY7y0m,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
347315451,2021-05-12 01:24:29,,,"morphosys.com/media-investor‚Ä¶, ",1392349943474659336,False,0,0,0,0,Twitter Web App,"MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma
https://t.co/HVYsYwn2VD",,,2011-08-02 12:17:10,Berlin,BIO Deutschland,https://pbs.twimg.com/profile_images/801026554834878465/TZRcLWOl_normal.jpg,4612,2717,178,29124,BIODeutschland,
1134049078424162304,2021-05-12 00:12:27,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1392331815365615616,False,0,0,0,0,Newsfilter.io,Incyte and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-Line Treatment for Diffuse Large B-Cell Lymphoma $INCY $MOR https://t.co/LF6Wx04Arr,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-05-11 22:35:27,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1392307403417440259,False,0,0,0,0,Newsfilter.io,Incyte and Morphosys dose first patient in late-stage lymphoma study $INCY $MOR https://t.co/hFG9oZgpHC,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1925199355,2021-05-11 18:30:01,,"healthcare, ","bit.ly/2SGga6P, ",1392245636301529090,False,0,0,0,0,eClincher,Incyte pays $12.6 million to resolve charity kickback claims https://t.co/da7sdC7aiv via @statnews #healthcare,"statnews, ",,2013-10-01 21:01:01,Colorado,MailMyStatements üõ°üì¨,https://pbs.twimg.com/profile_images/1410554445453090817/xv9zzBf__normal.jpg,6003,4877,126,109024,MailMyStatement,
72928001,2021-05-11 18:06:05,"INCY, ",,"bit.ly/3wcbrs7, ",1392239615210258433,False,1,0,0,1,BriefingInPlayLimited,$INCY: Incyte and MorphoSys (MOR) dose first patient in Phase 3 frontMIND study https://t.co/sVCrlHVNEN,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
36540001,2021-05-11 16:56:30,"mor, ",,"seekingalpha.com/news/3694803-i‚Ä¶, ",1392222105966546945,False,0,0,0,0,Twitter for iPad,$mor Incyte and Morphosys dose first patient in late-stage lymphoma study https://t.co/0qHlRwNABl,,,2009-04-29 20:45:15,Melbourne,Wolfgang Kissel,https://pbs.twimg.com/profile_images/1231018862843330560/mwUwyBvV_normal.jpg,317,385,14,3285,wkissel,
4058194633,2021-05-11 16:15:00,"INCY, MOR, ",,"businesswire.com/news/home/2021‚Ä¶, ",1392211659406680069,False,1,0,0,1,Twitter for iPhone,$INCY $MOR Incyte and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-Line Treatment for Diffuse Large B-Cell Lymphoma | Business Wire https://t.co/7jb0LMu9pj,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
3318510966,2021-05-11 16:11:19,,,"crweworld.com/article/news-p‚Ä¶, ",1392210731878158336,False,0,0,0,0,CRWE World,Incyte and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a https://t.co/6cWN7Y9gxI,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
15296897,2021-05-11 16:07:54,"INCY, MOR, ",,"seekingalpha.com/news/3694803-i‚Ä¶, ",1392209871819313154,False,0,0,0,1,SANewsTwitter,$INCY $MOR - Incyte and Morphosys dose first patient in late-stage lymphoma study https://t.co/qyZ8nZEVJH,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1355194932445786112,2021-05-11 16:06:07,"INCY, MOR, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1392209423146303491,False,0,0,0,0,Twitter,"$INCY $MOR Incyte and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-Line Treatment for Diffuse Large B-Cell Lymphoma
https://t.co/qYbrbTAkXE",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1069693680066420736,2021-05-11 16:06:00,"INCY, ",,"s.flashalert.me/zKKkLk, ",1392209394155331595,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on May 11, 16:01:00: Incyte and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-Line Treatment for Diffuse Large B-Cell Lymphoma https://t.co/GSzvfWzeV1",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1349429572266323979,2021-05-11 16:05:51,"INCY, ",,,1392209355668348929,False,0,0,0,0,Twitter for Mac,"$INCY Incyte, MorphoSys Report First Patient Dosed In Phase 3 frontMIND Study Evaluating Tafasitamab Combo As Treatment For Diffuse Large B-Cell Lymphoma",,,2021-01-13 13:54:28,"Porto Alegre, Brasil",Luckinvest,https://pbs.twimg.com/profile_images/1349431657816875009/jGDe7UJi_normal.jpg,608,359,12,5696,Luckinvest17,
33467057,2021-05-11 16:05:31,,"clinicaltrial, DLBCL, ","bit.ly/3vYwxdk, pic.twitter.com/uVlca6wo2i, ",1392209272038117382,False,4,0,0,1,Twitter Web App,Proud to announce the start of the pivotal Phase 3 frontMIND #clinicaltrial evaluating our CD19-directed antibody as a potential first-line treatment for previously untreated high-intermediate and high-risk patients with #DLBCL Learn more: https://t.co/ZwdwuWYxpp https://t.co/uVlca6wo2i,,,2009-04-20 05:13:43,"Planegg, Germany",MorphoSys,https://pbs.twimg.com/profile_images/1414967751538511873/dOJDE_2G_normal.jpg,1563,205,37,315,MorphoSys,photo
3318510966,2021-05-11 16:02:28,,,"crweworld.com/article/news-p‚Ä¶, ",1392208507403862016,False,0,0,0,0,CRWE World,MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a https://t.co/OhFJFLjI0r,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
42410755,2021-05-11 16:02:25,,,"dgap.de/dgap/News/corp‚Ä¶, ",1392208491796914184,False,0,0,0,0,DGAP_News_Int,MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab ... https://t.co/H9OcPHNRMc,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
53097729,2021-05-11 16:02:24,"INCY, MOR, ",,,1392208487711707140,False,1,0,0,0,Twitter Web App,$INCY $MOR MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma,,,2009-07-02 11:44:23,"Toronto, Ontario",Stockwits‚Ñ¢ Ó®Ä,https://pbs.twimg.com/profile_images/1408587167111303171/Qrn1abyM_normal.jpg,26206,983,189,29344,mikalche,
1254035253104181256,2021-05-11 16:02:22,"INCY, MOR, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1392208478932979713,False,0,0,0,0,stocktitan,"$INCY $MOR Incyte and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-Line Treatment for Diffuse Large B-Cell Lymphoma
https://t.co/cXfukN864v",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1117802764086779904,2021-05-11 16:01:50,"INCY, MOR, ",,"businesswire.com/news/home/2021‚Ä¶, ",1392208346103652370,False,0,0,0,0,Twitter Web App,Incyte $INCY and MorphoSys $MOR Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-Line Treatment for Diffuse Large B-Cell Lymphoma https://t.co/GwCVVMwJIb,,,2019-04-15 10:52:01,"Lyon, France",biotechradar.eu,https://pbs.twimg.com/profile_images/1118071131532079104/p9ON7wNG_normal.png,1535,122,25,8486,biotechradar_eu,
1325115160353103872,2021-05-11 16:01:30,"INCY, MOR, ","healthcare, majorpharmaceuticals, ","quantisnow.com/insight/731186‚Ä¶, ",1392208261978329088,False,0,0,0,0,Twitter,"$INCY $MOR üì∞ MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma

https://t.co/N3iiHAt7T6

#healthcare #majorpharmaceuticals",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
266143766,2021-05-11 16:01:27,"MOR, ",,"accesswire.com/646526/MorphoS‚Ä¶, ",1392208252205678594,False,0,0,0,0,Accesswire,$MOR MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination ... https://t.co/8EJ7uweULy,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
1325115160353103872,2021-05-11 16:01:05,"INCY, MOR, ","healthcare, majorpharmaceuticals, ","quantisnow.com/insight/731171‚Ä¶, ",1392208156881604613,False,0,0,0,0,Twitter,"$INCY $MOR üì∞ Incyte and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-Line Treatment for Diffuse Large B-Cell Lymphoma

https://t.co/LOFY2e84mX

#healthcare #majorpharmaceuticals",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
325135887,2021-05-11 13:05:00,,"oncology, NCRM21, ","twitter.com/Incyte/status/‚Ä¶, ",1392163844554772480,False,4,0,0,0,Twitter Web App,Thanks for sharing! Keep up the good work! @Incyte #oncology #NCRM21 https://t.co/IyUCE8pD5C,"Incyte, ",,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
1304774550014615554,2021-05-11 11:30:32,,"Cholangiocarcinoma, AMMF2021, ","ow.ly/qyfQ50EGXuc, pic.twitter.com/uDLD60E1jN, ",1392140071692812296,False,15,0,0,9,Twitter Web App,"Join us for AMMF‚Äôs Virtual European CCA Conference &amp; be at the 13 May premiere of ‚Äú#Cholangiocarcinoma &amp; the importance of molecular profiling‚Äù, an animation film by @Incyte, @CharityAMMF &amp; Prof John Bridgewater @ucl To register NOW, go to: https://t.co/W1rxsjFr58
#AMMF2021 https://t.co/uDLD60E1jN","Incyte, CharityAMMF, ucl, ",,2020-09-12 09:32:06,UK,Helen Morement,https://pbs.twimg.com/profile_images/1304775126232293377/dwFksdw9_normal.jpg,182,299,0,268,HelenMorement,photo
75337774,2021-05-11 11:11:41,,,"statnews.com/pharmalot/2021‚Ä¶, ",1392135326500544515,False,0,0,0,0,Twitter for Android,Incyte pays $12.6 million to resolve claims it paid drug kickbacks through charity https://t.co/s8D4eUXZQ7 via @statnews,"statnews, ",,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
732361939490312192,2021-05-11 10:17:45,"INCY, ","markets, ","americanbankingnews.com/?p=19876384, ",1392121754814926848,False,0,0,0,0,Zapier.com,Morgan Stanley Trims Incyte $INCY Target Price to $85.00 https://t.co/0gwCaUVOK0 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-05-11 10:17:44,"INCY, ","stocks, ","americanbankingnews.com/?p=19876384, ",1392121752923279362,False,0,0,0,0,Zapier.com,Morgan Stanley Trims Incyte $INCY Target Price to $85.00 https://t.co/iuvoFTK5UP #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
50405984,2021-05-11 10:02:05,,"AMMF2021, ","ammf.org.uk/ammf-conferenc‚Ä¶, pic.twitter.com/EVz6BDibBB, ",1392117811430965249,False,5,0,0,1,Hootsuite Inc.,"Huge thanks to our supporters, @Incyte QED, @HelsinnGroup, @TaihoOncology, @AstraZeneca, @Merck, @NuCana_news and @ZymeworksInc for making the  #AMMF2021 conference possible. Collaboration is key!
https://t.co/9tFucXu7Sx https://t.co/EVz6BDibBB","Incyte, HelsinnGroup, TaihoOncology, AstraZeneca, Merck, NuCana_news, ZymeworksInc, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
37829268,2021-05-11 09:43:11,,"Incyte, DOJ, OIG, AKS, FCA, CMP, ","lnkd.in/gcuqSwc, ",1392113057375997953,False,0,0,0,0,LinkedIn,"As evidenced by the¬†#Incyte¬†settlement¬†#DOJ¬†&amp;¬†#OIG¬†continue to heavily scrutinize charity foundations. If you are running one of these it should be audited for¬†#AKS,¬†#FCA, and¬†#CMP¬†compliance. https://t.co/QhJvn9vQMg",,,2009-05-04 22:06:36,"Minneapolis, Minnesota","Mark Gardner, MBA JD",https://pbs.twimg.com/profile_images/756118490289811456/k_crQhu8_normal.jpg,260,81,13,587,markegardner,
849417718642159616,2021-05-11 09:31:04,"INCY, ",,"zpr.io/RbXqN, ",1392110005252468738,False,0,0,0,0,Zapier.com,Morgan Stanley Trims Incyte $INCY Target Price to $85.00 https://t.co/ikaw1wbSGp,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
374729426,2021-05-11 00:11:24,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2728706, pic.twitter.com/5nH6YH1Zvz, ",1391969162109493249,False,0,0,0,1,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on May 4, 2021. View odds for this and other indicators: https://t.co/436BJVQdA7 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5nH6YH1Zvz",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
43855487,2021-05-10 23:45:00,,"US, EliLilly, PharmaCompanies, Pharma, ","mybs.in/2ZeLjXx, ",1391962517522436096,False,13,0,1,3,TweetDeck,"Olumiant, or Baricitinib, is an oral drug developed by #US biopharmaceutical major, Incyte Corporation, and licensed to #EliLilly

@sohinidastweets reports

#PharmaCompanies #Pharma
https://t.co/6qdg03go1h","sohinidastweets, ",,2009-06-01 04:52:08,India,Business Standard,https://pbs.twimg.com/profile_images/1194080296821559296/4GUNRuCM_normal.jpg,2146844,441,3548,364794,bsindia,
1304774550014615554,2021-05-10 15:34:02,,"AMMF2021, cholangiocarcinoma, QED, ","ammf.org.uk/ammf-conferenc, pic.twitter.com/P0NgxTfcUd, ",1391838960805163009,False,14,0,0,3,Twitter Web App,"Collaboration is key! Thank you to our generous sponsors who have made the #AMMF2021 #cholangiocarcinoma conference possible: @Incyte, #QED, @HelsinnGroup, @TaihoOncology, @AstraZeneca, @Merck, @NuCana_news and @ZymeworksInc. 

https://t.co/I6TRyXhT8S https://t.co/P0NgxTfcUd","Incyte, HelsinnGroup, TaihoOncology, AstraZeneca, Merck, NuCana_news, ZymeworksInc, ",,2020-09-12 09:32:06,UK,Helen Morement,https://pbs.twimg.com/profile_images/1304775126232293377/dwFksdw9_normal.jpg,182,299,0,268,HelenMorement,photo
42660725,2021-05-10 15:23:33,,,"policymed.com/2021/05/doj-an‚Ä¶, ",1391836326320824321,False,0,0,0,0,Twitter Web App,DOJ Announces $12.6 Million Settlement with Incyte Corporation https://t.co/sB2C7wyQKU,,,2009-05-26 12:34:32,United States,"Patricia Farrell, Ph.D.",https://pbs.twimg.com/profile_images/1193120866508460037/t81e5U_H_normal.jpg,9547,10344,460,549239,drpatfarrell,
826445551294115840,2021-05-10 15:15:00,,,"statnews.com/pharmalot/2021‚Ä¶, ",1391834171723689987,False,5,0,0,4,Twitter Web App,Incyte pays $12.6 million to resolve claims it paid drug kickbacks through charity https://t.co/dMK1HMXRNn via @statnews,"statnews, ",,2017-01-31 10:02:28,"Austin, TX",David Balat,https://pbs.twimg.com/profile_images/1331695336042139653/-JIgEGAP_normal.jpg,5361,3437,62,8057,DavidBalatHC,
50405984,2021-05-10 10:02:40,,"AMMF2021, ","ammf.org.uk/ammf-conferenc‚Ä¶, pic.twitter.com/uJCn7R2zxu, ",1391755572291244034,False,6,0,0,0,Hootsuite Inc.,"Huge thanks to our supporters, @Incyte QED, @HelsinnGroup, @TaihoOncology, @AstraZeneca, @Merck, @NuCana_news and @ZymeworksInc for making the  #AMMF2021 conference possible. Collaboration is key!
https://t.co/9tFucXu7Sx https://t.co/uJCn7R2zxu","Incyte, HelsinnGroup, TaihoOncology, AstraZeneca, Merck, NuCana_news, ZymeworksInc, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
1001180189752115200,2021-05-10 09:45:20,,,"ntla.curatasite.com/channel/31/art‚Ä¶, ",1391751207723671556,False,1,0,0,0,GetCurata,The U.S. DOJ Announced a $12.6 Million Settlement with Incyte Corporation Over False Claim Act Violations https://t.co/Gi5cfejJFO,,,2018-05-28 15:15:33,,NewsDotLaw,https://pbs.twimg.com/profile_images/1110893758948757504/3sZeQIBW_normal.png,648,1783,5,8061,NewsDotLaw1,
978711592060760065,2021-05-10 09:20:11,,,"ntla.curatasite.com/channel/23/art‚Ä¶, ",1391744880943247366,False,0,0,0,0,GetCurata,The U.S. DOJ Announced a $12.6 Million Settlement with Incyte Corporation Over False Claim Act Violations https://t.co/zHxqiYYkb5,,,2018-03-27 15:13:21,"Dothan, AL",The Trial Lawyer magazine,https://pbs.twimg.com/profile_images/978711900707020802/Vig7jvGJ_normal.jpg,934,585,3,7132,lawyer_trial,
236854797,2021-05-10 08:18:42,,,"fdanews.com/articles/20268‚Ä¶, ",1391729409510580226,False,0,0,0,0,Twitter for iPhone,Incyte Settles with DOJ Over Alleged Kickbacks  https://t.co/pgTwSHjuJw,,,2011-01-11 09:36:49,"Charlotte, NC",Pharmacy Now!,https://pbs.twimg.com/profile_images/1212826814/HaroldCohen_normal.jpg,186,106,13,14288,nyrxman,
37907016,2021-05-10 04:58:18,,,"policymed.com/?p=14346, ",1391678975328489475,False,1,0,0,2,Policy ,"New post: DOJ Announces $12.6 Million Settlement with Incyte Corporation On May 4, 2021, the United Sta https://t.co/4jlikKjMd5",,,2009-05-05 07:49:11,"Washington, DC",Policy and Medicine,https://pbs.twimg.com/profile_images/997531105333932032/IfQ18hVO_normal.jpg,824,71,37,4420,policymed,
261473143,2021-05-10 03:54:43,,,"crescendobiologics.com/wp-content/upl‚Ä¶, life-sciences-uk.com/news/vlfm-iito‚Ä¶, pic.twitter.com/Cldtgx0eDG, ",1391662972091748352,False,0,0,0,0,Twitter Web App,Crescendo Biologics Appoints Michael Booth as CFO; Joins from Incyte https://t.co/cCb9gNWViL @HUMABODY More British &amp; Irish life science business news at [LSUK] at https://t.co/sUJN0OxebE https://t.co/Cldtgx0eDG,"HUMABODY, ",,2011-03-05 20:26:19,"Bremen, Germany",[iito] Life Science,https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_normal.jpeg,2596,238,89,29254,iitoLifeScience,photo
374729426,2021-05-09 21:29:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2726105, pic.twitter.com/UznAUFXqFC, ",1391566116376309764,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on May 4, 2021. View odds for this and other indicators: https://t.co/qPU3L1gW3s #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/UznAUFXqFC",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3290364847,2021-05-09 20:00:31,,,"buff.ly/3vSMHon, ",1391543638367289346,False,3,1,0,3,Buffer,"Incyte agreed to pay $12.6 million to settle allegations that donations amounted to kickbacks paid to Medicare patients as a way to cover their out-of-pocket costs, the latest in a growing list of drug makers to reach such a deal with the U.S. government. https://t.co/0gJev0tPQi",,,2015-07-24 12:09:35,,STAT,https://pbs.twimg.com/profile_images/1220049678420643841/00Z3yA4z_normal.png,160026,5239,4324,52578,statnews,
1022006086872821762,2021-05-09 12:01:44,"INCY, INCY, ",,,1391423148193636353,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was UP ‚¨Ü on Fri May 07
Closed at 82.74 USD for a 0.52% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
108617488,2021-05-09 06:15:22,,,"invst.ly/uqk6c, ",1391335981480034306,False,1,0,0,0,FP News Publisher - COM,Leerink Partners Stick to Their Sell Rating for Incyte Corp - https://t.co/5HsESODtPz,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
1280938376099741697,2021-05-08 17:02:21,,"iexStock, ","iexcloud.io, pic.twitter.com/daH7IqvJnK, ",1391136411735183368,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Abu Dhabi National Co. for Building Mate
-Fastenal Co.
-Incyte Corp.
-National Bank of Ras Al Khaimah
-Vertex Pharmaceuticals, Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/daH7IqvJnK",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2151411816,2021-05-08 09:10:07,,"donations, drug, profits, ","ow.ly/SxJ050EHE3z, ",1391017569197465600,False,1,0,1,1,Hootsuite Inc.,"Catch of the Week: @Incyte makes ""charitable #donations"" to increase #drug #profits.
https://t.co/D5p0RA4JmA","Incyte, ",,2013-10-23 13:44:43,"NYC, DC, San Francisco, London",Constantine Cannon Whistleblower Team,https://pbs.twimg.com/profile_images/1164569576677478401/CEzzktRL_normal.jpg,3163,583,68,9204,CCWhistleblower,
728894570,2021-05-08 08:28:17,,"All_Health_Fitness_Tips, ","iweller.com/all-health-fit‚Ä¶, ",1391007043893358600,False,0,0,0,0,iweller.com,"Dabrafenib-trametinib combination active in BRAF V600E-mutant glioma - #All_Health_Fitness_Tips - Subbiah reports financial relationships with AbbVie, Amgen, Bayer, Blueprint Medicines, Eli Lilly, Exelixis, Incyte, Loxo Oncology,... - https://t.co/nFCgQKMwh2",,,2012-07-31 13:55:29,,iWeller.com,https://pbs.twimg.com/profile_images/1244249406477455360/tl4H1tq0_normal.jpg,121,141,0,264390,iWeller_health,
1889492676,2021-05-08 07:49:12,,"incyte, TABRECTA, ","1stoncology.com/blog/10-q-quar‚Ä¶, ",1390997207948533764,False,0,0,0,0,Troi URL Plug-in,#incyte World-Wide Sales for #TABRECTA was 2.05m USD in Q1 2021 https://t.co/bJsSEG3bpm,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2021-05-08 07:44:01,,"incyte, JAKAFI, ","1stoncology.com/blog/10-q-quar‚Ä¶, ",1390995902815301634,False,0,0,0,0,Troi URL Plug-in,#incyte World-Wide Sales for #JAKAFI was 465.71m USD in Q1 2021 (Up 1%) https://t.co/bJsSEG3bpm,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2021-05-08 07:29:40,,"incyte, ICLUSIG, ","1stoncology.com/blog/10-q-quar‚Ä¶, ",1390992290953371649,False,0,0,0,0,Troi URL Plug-in,#incyte World-Wide Sales for #ICLUSIG was 25.65m USD in Q1 2021 (Down 6%) https://t.co/bJsSEG3bpm,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2021-05-08 06:55:15,,"Incyte, PEMAZYRE, ","1stoncology.com/blog/10-q-quar‚Ä¶, ",1390983630118264833,False,0,0,0,0,Troi URL Plug-in,#Incyte World-Wide Sales for #PEMAZYRE was 13.46m USD in Q1 2021 https://t.co/bJsSEG3bpm,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
374729426,2021-05-08 05:22:15,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2722320, pic.twitter.com/TrlZrTTp5I, ",1390960227646730240,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 4, 2021. View odds for this and other indicators: https://t.co/34WbuTcbp8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/TrlZrTTp5I",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
176742975,2021-05-08 03:58:00,,,"ideapharma.com/pii/, twitter.com/Incyte/status/‚Ä¶, ",1390939024991346688,False,0,0,0,0,Twitter for iPhone,"For anyone who wants to know about @Incyte‚Äôs performance, the white paper is here: https://t.co/LddFzpCLWG https://t.co/ERmvlfBs3q","Incyte, ",,2010-08-10 05:30:06,,"Mike Rea, IDEA Pharma",https://pbs.twimg.com/profile_images/1332348150674317314/8xoaZYuI_normal.jpg,5514,1180,183,19924,ideapharma,
2393779669,2021-05-08 00:59:16,,"veterans, military, criminal, fraud, theft, justice, ","veterans-for-change.org/news/225-crimi‚Ä¶, pic.twitter.com/zIdjYfmC3m, ",1390894044901908483,False,0,0,0,0,Twitter Web App,"Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks
https://t.co/tkzXurBsIJ
#veterans #military #criminal #fraud #theft #justice https://t.co/zIdjYfmC3m",,,2014-03-17 00:41:19,"CA,WA,GA,NC",Vets-4-Change,https://pbs.twimg.com/profile_images/445627373359075328/pEJjsKUC_normal.jpeg,54,0,0,9772,Veterans4Change,photo
3290364847,2021-05-07 22:00:02,,,"buff.ly/3xXwZKH, ",1390848941349081095,False,1,0,0,0,Buffer,"Incyte agreed to pay $12.6 million to settle allegations that donations amounted to kickbacks paid to Medicare patients as a way to cover their out-of-pocket costs, the latest in a growing list of drug makers to reach such a deal with the U.S. government. https://t.co/SG0om8pO6R",,,2015-07-24 12:09:35,,STAT,https://pbs.twimg.com/profile_images/1220049678420643841/00Z3yA4z_normal.png,160026,5239,4324,52578,statnews,
133504478,2021-05-07 18:56:14,,"strategy, competitiveintelligence, marketing, productmarketing, pharma, biotech, pharmaceutical, healthcare, ","dlvr.it/RzHlT8, pic.twitter.com/ehmvzHoSLK, ",1390802683120869376,False,1,0,0,1,dlvr.it,Incyte ponies up $12M to settle charity foundation kickback claims; US exercises option for more doses of monkeypox vaccine https://t.co/H3dXqEgfXi #strategy #competitiveintelligence #marketing #productmarketing #pharma #biotech #pharmaceutical #healthcare https://t.co/ehmvzHoSLK,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
50405984,2021-05-07 13:00:41,,"Cholangiocarcinoma, AMMF2021, ","ow.ly/qyfQ50EGXuc, pic.twitter.com/PdcoP1sz6P, ",1390713207967387648,False,5,0,0,1,Hootsuite Inc.,"Be at the premiere! ‚Äú#Cholangiocarcinoma &amp; the importance of molecular profiling‚Äù, a short animation developed by @Incyte, @CharityAMMF &amp; Prof John Bridgewater, @ucl . Showing for the first time on 13 May at #AMMF2021 Conference.
To register now, go to: https://t.co/2TqHW70ypB https://t.co/PdcoP1sz6P","Incyte, CharityAMMF, ucl, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
15754281,2021-05-07 12:57:00,,,,1390712279251947520,False,1,0,0,0,Twitter for Advertisers,"While the physical symptoms of MPNs can be difficult to track and manage, the emotional impact can be just as hard. Story from @Incyte","Incyte, ",,2008-08-06 15:55:31,"USA TODAY HQ, McLean, Va.",USA TODAY,https://pbs.twimg.com/profile_images/924991591642796032/v90LrlR__normal.jpg,4467171,901,36311,360932,USATODAY,
39318996,2021-05-07 12:38:39,,,"medscape.com/viewarticle/95‚Ä¶, ",1390707661243551746,False,0,0,0,0,Twitter Web App,Pharma Company [Incyte Corp] to Pay $12.6M to Settle Kickback Allegations https://t.co/8LLdpxKkht,,,2009-05-11 15:21:06,,Roy Poses et al.,https://pbs.twimg.com/profile_images/942161700719034369/udaz4mHl_normal.jpg,1869,449,81,37911,HealthCareRenew,
1340024026366930951,2021-05-07 12:36:52,,"whistleblowers, pharmafraud, FCA, fraud, ","justice.gov/opa/pr/incyte-‚Ä¶, ",1390707213715574784,False,0,0,0,0,Twitter Web App,"To keep pharma prices high, yet another company paid  co-pays of Medicare beneficiaries. DOJ determined those were illegal kickbacks. Incyte paid taxpayers $12.6 million to settle. Not our case and details at link
#whistleblowers #pharmafraud #FCA #fraud

https://t.co/GnZslR4ji4",,,2020-12-18 15:00:52,Ohio,Erin M Campbell,https://pbs.twimg.com/profile_images/1352716583056142337/VI_Pbm5C_normal.jpg,2,33,0,15,ErinMCampbell1,
15974185,2021-05-07 12:03:07,,,"dlvr.it/RzGbHf, ",1390698718727262210,False,1,0,0,1,dlvr.it,Incyte to pay $12.6 million to resolve drug charity kickback claims https://t.co/zmn6hGzADr,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1158025866703589376,2021-05-07 11:43:44,,,"justice.gov/opa/pr/incyte-‚Ä¶, ",1390693841913536517,False,0,0,0,0,Twitter Web App,Incyte Corporation purportedly used an independent foundation as a conduit to pay the copays of certain federal beneficiaries taking Incyte‚Äôs drug Jakafi https://t.co/TgVMtsoiZB,,,2019-08-04 10:44:16,"Loudoun County, VA",Mark Newsom,https://pbs.twimg.com/profile_images/1446216079618056193/0y0Uc_Jn_normal.jpg,1459,3957,19,6899,NewsomHCP,
3460109487,2021-05-07 10:56:19,,,"endpts.com/incyte-ponies-‚Ä¶, ",1390681910628831232,False,0,0,0,0,TweetDeck,"In today's News Briefing: Incyte will shell out $12.6 million to settle claims it funneled funds through a charity foundation to cover federal copays for patients taking its JAK inhibitor Jakafi.

https://t.co/O0FKdXx9Fv",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
46297868,2021-05-07 10:45:34,,,"dlvr.it/RzGKD2, ",1390679203696111620,True,0,0,0,0,dlvr.it,Incyte ponies up $12M to settle charity foundation kickback claims; US exercises option for more doses of monkeypox vaccine https://t.co/0lJvhahWqU,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
50405984,2021-05-07 08:00:33,,"Cholangiocarcinoma, AMMF2021, ","ow.ly/qyfQ50EGXuc, pic.twitter.com/LgZViLGk31, ",1390637677163253760,False,4,0,0,0,Hootsuite Inc.,"Be at the premiere! ‚Äú#Cholangiocarcinoma &amp; the importance of molecular profiling‚Äù, a short animation developed by @Incyte, @CharityAMMF &amp; Prof John Bridgewater, @ucl . Showing for the first time on 13 May at #AMMF2021 Conference.
To register now, go to: https://t.co/2TqHW70ypB https://t.co/LgZViLGk31","Incyte, CharityAMMF, ucl, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
21649697,2021-05-07 08:00:30,,,"reuters.com/business/legal‚Ä¶, ",1390637663154286593,False,3,0,0,0,Twitter Web App,"So important that we understand how these things work... and that there's no such thing as a free lunch... 
https://t.co/8O8AJxsSuv",,,2009-02-23 07:44:53,Stanford MedX ePatient Scholar,ALS Advocacy,https://pbs.twimg.com/profile_images/81737939/alsadvocacytwitter_normal.jpg,10017,1994,312,97141,alsadvocacy,
14505105,2021-05-07 07:55:48,,"ValueInvesting, News, INCY, ","valueinvestingnews.com/5845211/incyte‚Ä¶, pic.twitter.com/DSbRNvCeb3, ",1390636479752327173,False,0,0,0,0,newsy.co,Incyte First Quarter Results - https://t.co/XMZzlawqOS #ValueInvesting #News #INCY https://t.co/DSbRNvCeb3,,,2008-04-23 22:16:14,,Value Investing News,https://pbs.twimg.com/profile_images/1396245200687833089/cp58oIA4_normal.jpg,10714,63,260,20297,valueinvesting,photo
143474683,2021-05-07 07:47:14,,,"reuters.com/business/legal‚Ä¶, ",1390634323284566016,False,0,0,0,0,Twitter Web App,Incyte to pay $12.6 million to resolve drug charity kickback claims https://t.co/dFy3Bq6LNN,,,2010-05-13 11:25:19,"Tampa Bay, Florida",Mark Hobraczk,https://pbs.twimg.com/profile_images/786922712455405568/JwpuVxlh_normal.jpg,1007,5000,21,9088,MHobraczk,
33318919,2021-05-07 01:01:26,,,"statnews.com/pharmalot/2021‚Ä¶, ",1390532201469648897,False,27,0,2,15,Twitter Web App,Its illegal to kickback money to patients to help w/ their medicine costs. But NOT illegal to kickback money to PBM to help them w/ their BOTTOM LINE. Also why so surprised that more assistance is given for expensive meds than cheap generics. https://t.co/vhWrg5lnJO via @statnews,"statnews, ",,2009-04-19 17:39:02,New Orleans,Madelaine Feldman,https://pbs.twimg.com/profile_images/1400280113514790915/0DzaivkR_normal.jpg,2122,1868,23,3664,MattieRheumMD,
14453501,2021-05-07 00:09:05,,,"delawarebusinessnow.com/2021/05/pharma‚Ä¶, ",1390519027685076993,True,0,0,0,0,WordPress.com,Pharma company Incyte reports higher earnings in first¬†quarter https://t.co/qKDunxR6l3,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
360220091,2021-05-06 22:46:24,,,"dataemia.com/?p=509252, pic.twitter.com/9sN8opaYCN, ",1390498218467864578,False,0,0,0,0,Newsemia,(STAT+: Incyte pays $12.6 million to resolve claims it paid drug kickbacks through charity) https://t.co/a8s9QTpfLI https://t.co/9sN8opaYCN,,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,photo
1237364454406447104,2021-05-06 22:31:03,,,"statnews.com/pharmalot/2021‚Ä¶, ",1390494355736170497,False,0,0,0,0,Twitter Web App,Incyte pays $12.6 million to resolve claims it paid drug kickbacks through charity https://t.co/11yLzJSqaM via @statnews,"statnews, ",,2020-03-10 09:07:52,,Abdulsatar Bochnak,https://pbs.twimg.com/profile_images/1330111530059386885/oOb-o5Ib_normal.jpg,126,4977,0,78113,AbdulsatarBoch1,
917480497000755200,2021-05-06 20:46:23,,,"reuters.com/business/legal‚Ä¶, ",1390468018442936320,False,0,0,0,0,Twitter Web App,"Biopharmaceutical company Incyte Corp will pay $12.6 million to resolve allegations that it used a charity as a conduit to pay Medicare and Tricare patients kickbacks to use its cancer drug Jakafi, the U.S. Justice Department said on Tuesday.
https://t.co/drC0NygGUc",,,2017-10-09 16:02:51,"Khanna, Punjab, India",Manu Kanchan,https://pbs.twimg.com/profile_images/918021211296227328/0Pc3WA9r_normal.jpg,98,103,2,2800,kanchan_manu,
3426758369,2021-05-06 19:50:54,,,"twitter.com/BaptistHealthS‚Ä¶, ",1390454052895526912,False,15,0,0,0,Twitter for iPhone,Diversity in clinical trials &amp; minority enrollment is one of the most important and critical challenge for drug development in oncology! @DrWinkfield @ASCO @ASCOPres @jrgralow @BaptistHealthSF @pfizer @bmsnews @Merck @AstraZeneca @Incyte @genentech @abbvie @FDAOncology https://t.co/WQjczjtgT1,"DrWinkfield, ASCO, ASCOPres, jrgralow, BaptistHealthSF, pfizer, bmsnews, Merck, AstraZeneca, Incyte, genentech, abbvie, FDAOncology, ",,2015-08-16 17:28:18,"Miami, FL","Manmeet Ahluwalia, MD, MBA",https://pbs.twimg.com/profile_images/1155308635431538689/bij0HSmX_normal.jpg,1715,821,0,1792,BrainTumorDoc,
75337774,2021-05-06 18:13:50,,,"statnews.com/pharmalot/2021‚Ä¶, ",1390429628091748354,False,0,0,0,0,Twitter for Android,Incyte pays $12.6 million to resolve claims it paid drug kickbacks through charity https://t.co/s8D4eUXZQ7 via @statnews,"statnews, ",,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
852931863547084801,2021-05-06 15:13:11,"INCY, ",,"zpr.io/RuqU4, ",1390384166064250882,False,0,0,0,0,Zapier.com,"Incyte $INCY Releases Quarterly Earnings Results, Beats Expectations By $0.25 EPS https://t.co/A9ttVQUa43",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
852931863547084801,2021-05-06 14:41:16,"INCY, ",,"zpr.io/RuGDA, ",1390376132210565125,False,0,0,0,0,Zapier.com,"Incyte $INCY Announces Earnings Results, Beats Expectations By $0.25 EPS https://t.co/ccLpDMPfx1",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
16900943,2021-05-06 12:45:36,,,"twitter.com/Reuters/status‚Ä¶, ",1390347024428638208,False,1,0,0,0,Twitter Web App,"The original complaint also claimed that Incyte ran a ""speakers program"" described as a pretext ""for paying thousands of dollars in sham speaking fees"" to oncologists. It said one Arizona doctor asked for his speech to take place at a preferred vacation spot. https://t.co/Xqf9EJe9Ev",,,2008-10-22 01:15:15,DEL/SEA/NYC/DF/AK,Karl Baker,https://pbs.twimg.com/profile_images/964205250025582593/SS1-jyIf_normal.jpg,1246,1508,70,1986,kbaker6,
248832938,2021-05-06 12:00:21,,,"bit.ly/3h6lpXl, ",1390335637535043585,False,0,0,0,0,Sendible,"Settlement Alert-Incyte Corporation To Pay $12.6M To Settle False Claims Act Allegations

https://t.co/DzKjwRQ98F",,,2011-02-07 15:34:24,,The McCalmon Group,https://pbs.twimg.com/profile_images/892130819225133060/TZoqe3fB_normal.jpg,75,10,2,12578,McCalmonGroup,
4058194633,2021-05-06 10:04:25,"SRPT, ",,"google.com/amp/s/www.smar‚Ä¶, ",1390306461494906891,False,0,0,0,0,Twitter for iPhone,"$SRPT Robert W Baird Maintains Buy Rating On Sarepta Therapeutics, $110 PT https://t.co/kkw8DQnIB8",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-05-06 10:03:14,"REGN, ",,"google.com/amp/s/www.smar‚Ä¶, ",1390306161983823886,False,0,0,0,0,Twitter for iPhone,"$REGN Evercore Maintains Buy Rating On Regeneron, $685 PT  https://t.co/kkw8DQnIB8",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-05-06 10:02:25,"INCY, ",,"google.com/amp/s/www.smar‚Ä¶, ",1390305956798496768,False,0,0,0,0,Twitter for iPhone,"$INCY Evercore Maintains Buy Rating On Incyte, $115 PT https://t.co/kkw8DQnIB8",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
3290364847,2021-05-06 10:00:52,,,"buff.ly/3b6vMa0, ",1390305568628281344,False,4,0,0,2,Buffer,Incyte will pay $12.6 million to settle allegations that donations amounted to kickbacks paid to Medicare patients as a way to cover their out-of-pocket costs. https://t.co/jZbJ6fPM1Z,,,2015-07-24 12:09:35,,STAT,https://pbs.twimg.com/profile_images/1220049678420643841/00Z3yA4z_normal.png,160026,5239,4324,52578,statnews,
1270220114340851712,2021-05-06 08:56:08,,"PharmaTwitter, MedTwitter, MedEd, ","bit.ly/More-Medical-H‚Ä¶, statnews.com/pharmalot/2021‚Ä¶, ",1390289275481214978,False,0,0,0,0,Automate.io,"Incyte pays $12.6 million to resolve charity kickback claims

More medical news at https://t.co/0Knf9q4SKS
#PharmaTwitter #MedTwitter #MedEd
https://t.co/wLaKHNHp0K",,,2020-06-09 01:04:18,Look here üëâ,MedPub Pharmaceutical,https://pbs.twimg.com/profile_images/1443232668716515331/xzljON0s_normal.jpg,2,69,0,3346,PharmaPublisher,
1273844033861844993,2021-05-06 08:01:53,"INCY, ",,"pic.twitter.com/9DjGO6tIcC, ",1390275624347086854,False,0,0,0,0,StockTwits Web,$INCY [Incyte]: Morgan Stanley Maintains Equal-Weight Lowers Price Target $86 --&gt; 85 https://t.co/9DjGO6tIcC,,,2020-06-19 01:04:32,United States,Jarvis-Alerts,https://pbs.twimg.com/profile_images/1374794584513986568/eWDm8YFI_normal.jpg,4169,102,79,63687,Jarvis_Alerts,photo
1104114055,2021-05-06 06:39:39,,,"justice.gov/opa/pr/incyte-‚Ä¶, ",1390254928766148613,False,0,0,0,0,Twitter for iPhone,Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks | OPA | Department of Justice https://t.co/jES85Tfjgd,,,2013-01-19 11:37:30,,JUICE,https://pbs.twimg.com/profile_images/1354130582289182722/MuScAlQO_normal.jpg,183,247,5,10552,JUICSAY,
374729426,2021-05-06 05:25:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2717646, pic.twitter.com/TaqV95ep2h, ",1390236271126007809,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 4, 2021. View odds for this and other indicators: https://t.co/OiIbacROiZ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/TaqV95ep2h",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
29897850,2021-05-05 21:36:00,,"myleofibrosis, ","justice.gov/opa/pr/incyte-‚Ä¶, ",1390118113539067905,False,0,0,0,0,Twitter for iPhone,"""...Incyte used the fund to pay the copays of federal beneficiaries taking Jakafi who were ineligible for assistance from the fund because they did not have #myleofibrosis "" https://t.co/PgNNxahFLm",,,2009-04-08 22:32:30,,sic,https://pbs.twimg.com/profile_images/900901038814887938/-pZjQTHp_normal.jpg,2786,4990,1772,737448,kimvie,
29897850,2021-05-05 21:34:52,,"Incyte, Kickbacks, ","justice.gov/opa/pr/incyte-‚Ä¶, ",1390117832176799745,False,0,0,0,0,Twitter for iPhone,""" #Incyte Corp. to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying #Kickbacks "" https://t.co/PgNNxahFLm",,,2009-04-08 22:32:30,,sic,https://pbs.twimg.com/profile_images/900901038814887938/-pZjQTHp_normal.jpg,2786,4990,1772,737448,kimvie,
23091897,2021-05-05 18:01:46,,,"ift.tt/2QXY9jF, ",1390064201499033600,False,0,0,0,0,IFTTT,Incyte to Pay $12.6M to Settle False Claim and Kickback Allegations https://t.co/EESEAc9mrp,,,2009-03-06 12:31:09,"Philadelphia, Pennsylvania",Legal Intelligencer,https://pbs.twimg.com/profile_images/1182752444662591489/VraMv91E_normal.png,36544,507,962,35012,thelegalintel,
1301569482800992256,2021-05-05 17:00:28,,"DOJ, pharmaceutical, FCA, whistleblower, ","whistleblowersblog.org/2021/05/articl‚Ä¶, ",1390048776539320332,False,5,0,0,2,Hootsuite Inc.,"On May 4, the U.S. Department of Justice (#DOJ) announced that #pharmaceutical company Incyte Corporation has agreed to pay $12.6 million to resolve #FCA allegations. The #whistleblower in the case will receive $3.59 million for his qui tam lawsuit. https://t.co/edjtK2ta5X",,,2020-09-03 13:15:30,,Whistleblower Network News,https://pbs.twimg.com/profile_images/1319758540899110914/hDR8U-ew_normal.jpg,1161,54,15,1206,WhistleblowerNN,
14307764,2021-05-05 16:30:00,,,"delawareonline.com/story/money/bu‚Ä¶, ",1390041108730761218,False,0,0,0,1,SocialNewsDesk,"Incyte has agreed to pay $12.6 million to settle allegations it used an independent foundation to induce Medicare and Tricare patients to purchase the company's drugs.

 https://t.co/8zlaskiljK",,,2008-04-04 21:46:58,"Wilmington, Delaware",Delaware Online,https://pbs.twimg.com/profile_images/988846473625272320/jrStiVpj_normal.jpg,120412,361,782,102172,delawareonline,
1262915121103491074,2021-05-05 16:09:56,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1390036056121110531,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 396 shares on 2021-05-03. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
142382474,2021-05-05 15:34:55,,,"bit.ly/3up5vez, ",1390027244228206603,False,1,0,0,0,Twitter Web App,Ross Feller Casey Federal Whistleblower Case Leads To $12.6M Settlement With Pharmaceutical Co. Incyte https://t.co/9Jr0M2esFA,,,2010-05-10 14:53:13,Philadelphia,Ross Feller Casey,https://pbs.twimg.com/profile_images/1202656891148623873/uTtePidU_normal.jpg,393,446,6,2783,RossFellerCasey,
2967416450,2021-05-05 14:54:15,,"Whistleblower, Norway, PonziScheme, Florida, MoneyLaundering, ","hbsslaw.com/blog/whistlebl‚Ä¶, pic.twitter.com/wEwAAuEimU, ",1390017010482876417,False,1,0,0,1,Twitter Web App,"#Whistleblower News:

Incyte to Pay $12M+ for False Claims Act Allegations, Paying Kickbacks

#Norway‚Äôs DNB fined $48.1M for AML violations

Actor indicted in $227M #PonziScheme

#Florida Men Charged in $46M Health Care Fraud &amp; #MoneyLaundering

more ¬ª https://t.co/Lmf4W2gvxq https://t.co/wEwAAuEimU",,,2015-01-08 17:46:37,National,Whistleblower Law,https://pbs.twimg.com/profile_images/726101262710628352/gRS4lgyT_normal.jpg,1257,130,41,4272,WhistleblowerHB,photo
4058194633,2021-05-05 13:13:59,"INCY, ",,"google.com/amp/s/www.smar‚Ä¶, ",1389991777164095492,False,0,0,0,0,Twitter for iPhone,"$INCY Oppenheimer Maintains Buy Rating On Incyte, $110 PT https://t.co/pCID8Wfkoo",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1335407219861565442,2021-05-05 13:06:06,,,"pic.twitter.com/Xre8idqjKv, ",1389989794810368002,False,0,0,0,0,Twitter Web App,"‚Ä¢5/04/21 Eli Lilly donates 400,000 tablets of baricitinib to India.
‚Ä¢5/04/21 Incyte Corporation $12.6 million settlement for paying kickbacks. 
‚Ä¢DEC 2009: Lilly+Incyte: Baricitinib-exclusive worldwide license and collaboration agreement.
‚Ä¢Side effects=ENDLESS DISEASE? https://t.co/Xre8idqjKv",,,2020-12-05 21:14:45,,Lynn Clevenger,https://pbs.twimg.com/profile_images/1420199730936750083/T9RIMddv_normal.jpg,85,277,0,1144,LTClev,photo
25560065,2021-05-05 12:56:18,,,"bizjournals.com/philadelphia/n‚Ä¶, ",1389987327104192516,False,1,0,0,1,True Anthem,Here's why this Wilmington biotechnology firm agreed to pay the federal government $12.6 million.‚Äã  https://t.co/VvAQiL2xBd,,,2009-03-20 15:31:03,Philadelphia,PHL Business Journal,https://pbs.twimg.com/profile_images/378800000077412316/8b22fbb8c4be97c69f048ff47fe712b6_normal.jpeg,35028,8899,1065,77326,PHLBizJournal,
34740650,2021-05-05 12:30:32,,,"courthousenews.com/pharmaceutical‚Ä¶, ",1389980843754524675,False,1,0,0,3,Hootsuite Inc.,Incyte will pay $12.6 million in a settlement to resolve allegations it violated the False Claims Act. The company was accused of using an independent foundation to pay copays of certain people taking its drug Jakafi. https://t.co/qlbvGkbN0L,,,2009-04-23 17:44:30,United States,Courthouse News,https://pbs.twimg.com/profile_images/984242217404456960/Y4dwmHqy_normal.jpg,60483,759,797,75134,CourthouseNews,
1359077910,2021-05-05 12:30:12,,,"europharmajobs.com/job_display/19‚Ä¶, ",1389980760829014017,False,0,0,0,0,EPJ Jobs Post,"Medical Director/Senior Medical Director, Early Clinical Development, Incyte, Morges, Switzerland

https://t.co/kSsINNBagM",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
3312412588,2021-05-05 12:14:50,,,"justice.gov/opa/pr/incyte-‚Ä¶, ",1389976891432574981,False,0,0,0,0,Twitter Web App,Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks https://t.co/NU91oFbR2P,,,2015-06-07 16:39:47,"Hutchinson, KS",Meghan C. Long,https://pbs.twimg.com/profile_images/607649009902186496/u1PS24bi_normal.jpg,57,132,1,5714,AlexM8806,
3911174913,2021-05-05 10:00:02,,"oncology, NCRM21, ","pic.twitter.com/ssAPo9gqCM, ",1389942968925114371,False,46,1,0,11,Twitter Ads,"At Incyte, we are committed to advancing our diverse #oncology portfolio as we seek to improve the lives of patients. Learn more about our portfolio this #NCRM21. https://t.co/ssAPo9gqCM",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1239968605787193344,2021-05-05 09:44:57,,,"lnkd.in/enM5FsX, lnkd.in/epAR7jR, ",1389939171704381443,False,0,0,0,0,LinkedIn,"The False Claims Act may be the most versatile tool in government prosecutors‚Äô toolbox.¬†The False Claims Act‚Äôs versatility is enhanced by the qui tam, or whistleblower, provisions of the Act.¬†The qui tam provisions provide anyone w‚Ä¶https://t.co/BqCl0PhQFN https://t.co/T02Q97LaGP",,,2020-03-17 13:35:46,"Knoxville, Tennessee",Ivan Boatner,https://pbs.twimg.com/profile_images/1239974565243015171/X1mZmY9p_normal.jpg,10,109,0,34,IvanBoatner,
732361939490312192,2021-05-05 09:43:11,"INCY, ","markets, ","americanbankingnews.com/?p=19771764, ",1389938730081964038,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $85.00 at Morgan Stanley https://t.co/QMuTBgxHrM #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-05-05 09:43:11,"INCY, ","stocks, ","americanbankingnews.com/?p=19771764, ",1389938727917654016,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $85.00 at Morgan Stanley https://t.co/pJxajBEz73 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
4383539753,2021-05-05 08:47:03,,,"justice.gov/opa/pr/incyte-‚Ä¶, ",1389924601053040642,False,0,0,0,0,Twitter for iPhone,Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks | OPA | Department of Justice https://t.co/rdG2UimBPi,,,2015-12-05 08:48:46,"Virginia, USA",Helen Ann,https://pbs.twimg.com/profile_images/676828297460772864/vd20A5h0_normal.jpg,1392,2066,6,187901,HelenAnn16,
185663478,2021-05-05 08:30:28,"INCY, ",,,1389920429880586240,False,0,0,0,0,Twitter for iPhone,"$INCY Morgan Stanley Maintains Equal-Weight on Incyte, Lowers Price Target to $85",,,2010-09-01 10:52:28,"Chicago, IL",CHItraders,https://pbs.twimg.com/profile_images/623935252357058560/AaeCRlHB_normal.jpg,1253,501,63,45319,CHItraders,
1134049078424162304,2021-05-05 08:28:40,"INCY, ",,,1389919976933445633,False,0,0,0,0,Newsfilter.io,$INCY Morgan Stanley maintains Incyte with a Equal-Weight and lowers the price target from $86 to $85.,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
27518005,2021-05-05 07:03:12,,,"morelaw.com/verdicts/case.‚Ä¶, ",1389898468546781185,False,0,0,0,0,Twitter Web App,"Philadelphia, PA: Incyte Corporation agreed to pay $12.6 million to settle False Claims Act violations relating to paying kickbacks to certain ederal beneficiaries taking Incyte‚Äôs drug Jakafi,

https://t.co/QQ8uR9jDWk",,,2009-03-29 18:17:19,Tulsa,Kent Morlan,https://pbs.twimg.com/profile_images/593374953744928768/-v-M_J32_normal.jpg,218,498,0,18927,AKMorlan,
334944709,2021-05-05 06:50:00,,,"reut.rs/3nKMAZi, pic.twitter.com/rcPndpr1dl, ",1389895145223376896,False,1,0,0,1,TweetDeck,"Biopharmaceutical company Incyte Corp will pay $12.6 million to resolve allegations that it used a charity as a conduit to pay Medicare and Tricare patients kickbacks to use its cancer drug Jakafi, the U.S. Justice Department said. @nateraymond https://t.co/rXCQigBKKv ($) https://t.co/rcPndpr1dl","nateraymond, ",,2011-07-13 18:28:32,New York,Reuters Legal,https://pbs.twimg.com/profile_images/877491866706395139/QnLtTu2w_normal.jpg,79678,556,1877,89501,ReutersLegal,photo
920073477897572352,2021-05-05 05:20:25,,,"justice.gov/opa/pr/incyte-‚Ä¶, ",1389872603083558914,False,0,0,0,0,Twitter Web App,Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks https://t.co/UjHKJl1Rk1,,,2017-10-16 19:46:26,USA,J. B NonCompliant,https://pbs.twimg.com/profile_images/1263994088182996992/7CibmUbh_normal.jpg,1537,1500,1,89469,firtreemanor,
1215712585,2021-05-04 23:43:34,,,"reut.rs/3nOUQYn, ",1389787831355297793,False,0,0,0,0,Twitter Web App,Incyte to pay $12.6 million to resolve drug charity kickback claims | Reuters - https://t.co/CWE7LyF4bv @Reuters,"Reuters, ",,2013-02-24 09:52:33,"Ankara, Turkey",Pƒ±nar Akart√ºrk,https://pbs.twimg.com/profile_images/1407943412863614976/YpSEmEoJ_normal.jpg,14085,240,133,331011,PinarAkarturk,
832957875290984449,2021-05-04 23:05:26,,,"justice.gov/opa/pr/incyte-‚Ä¶, ",1389778233340555265,False,1,0,0,0,Twitter Web App,"Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks

https://t.co/T0GAZ8O1kA",,,2017-02-18 09:20:07,,GETTR: @HoneeDesigner,https://pbs.twimg.com/profile_images/1368773840277368839/_QdMs0tJ_normal.jpg,3355,845,15,48592,HoneeDesigner,
1652541,2021-05-04 23:00:19,,,"reut.rs/2QL3NG1, pic.twitter.com/MTWxnrFEyq, ",1389776946242928641,False,33,3,6,14,True Anthem,Incyte to pay $12.6 million to resolve drug charity kickback claims https://t.co/mckVBpQBba https://t.co/MTWxnrFEyq,,,2007-03-20 13:46:05,Around the world,Reuters,https://pbs.twimg.com/profile_images/1194751949821939712/3VBu4_Sa_normal.jpg,23931761,1176,129609,766905,Reuters,photo
1197999879471026177,2021-05-04 20:08:35,,,"justice.gov/opa/pr/incyte-‚Ä¶, ",1389733728960671747,False,1,0,0,0,Twitter Web App,"Incyte Corp to Pay $12.6M to Resolve False Claims Act Allegations for Paying Kickbacks. The civil settlement whistleblower provisions of the False Claims Act by former Incyte compliance exec Justin Dillon, awards him $3.59 million of the recovery.
https://t.co/3JK72H5Vmy",,,2019-11-22 17:12:11,PNW ,InfoToadAlamode,https://pbs.twimg.com/profile_images/1198013934072057856/cOSHPSUs_normal.jpg,1002,1311,5,89061,ToadInfo,
17574329,2021-05-04 19:21:34,,,"reut.rs/2PPMnaL, ",1389721895268925444,False,0,0,0,0,Twitter for iPhone,Incyte to pay $12.6 million to resolve drug charity kickback claims ‚Å¶@ReutersLegal‚Å©  https://t.co/FXB78099P6,"ReutersLegal, ",,2008-11-23 11:12:12,"Boston, MA",Nate Raymond,https://pbs.twimg.com/profile_images/1284617800364036096/rq6kgPnF_normal.jpg,6691,2032,302,44165,nateraymond,
2227292650,2021-05-04 19:14:41,,,"justice.gov/usao-edpa/pr/p‚Ä¶, ",1389720163658907650,False,0,0,0,0,Twitter Web App,"The qui tam case is captioned U.S. ex rel. Dillon v. Incyte Corp., No. 2:18 -cv-2642 (E.D. Pa.) and was filed by Brian McCormick of @RossFellerCasey LLP in Philadelphia, PA.

https://t.co/hMHzOlTF1l","RossFellerCasey, ",,2013-12-15 11:17:41,"Philadelphia, PA","Kevin Harden, Jr.",https://pbs.twimg.com/profile_images/1327034787509530625/BsQumpwo_normal.jpg,3805,3071,47,15220,KHJ_Esq,
14453501,2021-05-04 19:11:23,,,"delawarebusinessnow.com/2021/05/incyte‚Ä¶, ",1389719332167553024,True,0,0,0,0,WordPress.com,Incyte agrees to pay $12.6 million to settle kickback¬†allegations https://t.co/xmfwi3fSkG,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
334944709,2021-05-04 19:10:00,,,"reut.rs/3eip6aR, pic.twitter.com/sWQTMRdptx, ",1389718984522485760,False,0,0,0,1,TweetDeck,Incyte to pay $12.6 million to resolve drug charity kickback claims https://t.co/nJcziBwZkL @nateraymond ($) https://t.co/sWQTMRdptx,"nateraymond, ",,2011-07-13 18:28:32,New York,Reuters Legal,https://pbs.twimg.com/profile_images/877491866706395139/QnLtTu2w_normal.jpg,79678,556,1877,89501,ReutersLegal,photo
1138312924269862916,2021-05-04 17:28:39,,"incytecaresaboutcholangiocarcinomapatients, wepartnerwiththebest, ","bit.ly/QuackOut, pic.twitter.com/9BOpSCUNxt, ",1389693479551332353,False,0,0,0,0,Twitter Web App,Our big cancer Quacker at the Quack Out Cholangio to CRUSH Bile Duct Cancer is INCYTE who once again were extremely generous in their sponsorship of our event. #incytecaresaboutcholangiocarcinomapatients #wepartnerwiththebest  Sign up today! https://t.co/2hlAbY5bQr https://t.co/9BOpSCUNxt,,,2019-06-11 01:12:04,,Cholangio Warrior,https://pbs.twimg.com/profile_images/1446242650462556162/3Ol_Cu_a_normal.jpg,185,436,0,1065,Cholangiocarci2,photo
27921459,2021-05-04 17:23:07,,"fraud, AKS, copayfoundation, ","lnkd.in/euqKUVh, ",1389692087801630721,False,0,0,0,0,LinkedIn,"Another foundation settlement, Incyte.  Interesting note is relator was a member of the compliance team #fraud #AKS #copayfoundation https://t.co/rK4rSSN4u9",,,2009-03-31 13:47:20,"Oklahoma City, OK",Tim Ayers,https://pbs.twimg.com/profile_images/2942145609/d5f5a329cb2f4b53aa77e87cd03cb64b_normal.jpeg,438,1381,7,1364,tsayers77,
3227359728,2021-05-04 17:04:30,,,"justice.gov/opa/pr/incyte-‚Ä¶, ",1389687402604675078,False,0,0,0,0,Twitter for iPhone,Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks | OPA | Department of Justice https://t.co/kkNJ2a97NS,,,2015-05-26 14:22:32,"Chicago, IL",Massah D,https://pbs.twimg.com/profile_images/860996580975030273/eAdwRLIN_normal.jpg,2189,2274,38,320637,klonokid,
2940557482,2021-05-04 16:37:34,,,"dlvr.it/Rz3Ghm, ",1389680622491213825,False,0,0,0,0,dlvr.it,Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks https://t.co/gcKEFxTg1G,,,2014-12-25 04:25:35,"Chicago, IL",360MediaX,https://pbs.twimg.com/profile_images/1305809898924630022/c6jDJknR_normal.jpg,105,56,5,119345,360mediaX,
4194426687,2021-05-04 16:18:38,"SGEN, INCY, BGEN, ","potstocks, ",,1389675859708104708,False,1,0,0,1,Twitter Web App,#potstocks sucked today so I looked elsewhere and created a little basket of Baker Bros. Advisors' biotechs by picking up some Seagen $SGEN and Incyte $INCY to go with my Beigene $BGEN.,,,2015-11-15 09:22:01,"Toronto, Ontario",Fred Roth @üè†,https://pbs.twimg.com/profile_images/665899352561348609/WQIs7Vv2_normal.jpg,844,732,15,9375,FredinToronto,
73181712,2021-05-04 16:15:14,,,"justice.gov/opa/pr/incyte-‚Ä¶, ",1389675002610466818,False,89,3,15,41,Hootsuite Inc.,"Incyte Corporation to Pay $12.6 Million to Resolve False Claims Act Allegations for Paying Kickbacks

https://t.co/uwzEDRRaIc",,,2009-09-10 14:16:25,United States of America,Justice Department,https://pbs.twimg.com/profile_images/445550654/twitter_logo_normal.png,2002451,182,10763,14594,TheJusticeDept,
1068561714055012352,2021-05-04 16:13:20,"INCY, ",,"sec.report/Document/00015‚Ä¶, ",1389674527731249153,False,0,0,0,0,Edgar Filings,New Form 10-Q [Quarterly Report] entry filed by  $INCY INCYTE CORP  https://t.co/ijDtXo0Agu,,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
4312114277,2021-05-04 16:13:15,"INCY, ",,"fintel.io/sf/us/incy?utm‚Ä¶, ",1389674506470543365,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 10-Q https://t.co/Oc4NyYycjO,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
1171873456276889600,2021-05-04 16:12:51,"INCY, ","INCY, 10Q, Incyte, Earnings, ","docoh.com/filing/879169/‚Ä¶, ",1389674404435697668,False,0,0,0,0,Investor Feed,"$INCY  10-Q  Incyte   (4 May, 4:10pm)

üìä 2021 Q1 Earnings

https://t.co/1DHzhNkb0W

#INCY #10Q #Incyte #Earnings",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
121158213,2021-05-04 14:58:07,"INCY, ",,"dlvr.it/Rz30DM, AlertTrade.us, ",1389655598178783233,False,1,0,0,0,dlvr.it,DOWNwithEARNINGS: $INCY Incyte Corporation Common Stock https://t.co/PDXLLWRMEb üì≥ TradeIdeas via ‚ü∂ https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
773578537764851712,2021-05-04 14:55:03,"INCY, ",,"sitefocus.com/cif/ei/CM_incy‚Ä¶, ",1389654826795954184,False,0,0,0,0,CIF-QBA,"$INCY Earnings Intelligence Analysis of recent earnings identified Incyte Corp.  (NASDAQ: INCY ) business focus on (lesions,ruxolitinib,vitiligo), (ruxolitinib,therapies), (lesions,vitiligo)

https://t.co/stMg9ofRb7",,,2016-09-07 13:47:50,"Cupertino, CA",SiteFocus,https://pbs.twimg.com/profile_images/908465036598820864/6ZQsC4KD_normal.jpg,195,35,8,57439,SiteFocusHQ,
23059499,2021-05-04 14:41:11,"INCY, ","stocks, finance, trading, ","seekingalpha.com/article/442417‚Ä¶, ",1389651334274584578,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation's (INCY) CEO Herv√© Hoppenot on Q1 2021 Results - Earnings Call Transcript. https://t.co/muWHpZH1Vq #stocks #finance #trading,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1134049078424162304,2021-05-04 14:08:49,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1389643190811123714,False,0,0,0,0,Newsfilter.io,Incyte's Q1 Jakafi Sales Hit By Pandemic; Reaffirms 2021 Guidance $INCY https://t.co/PqlGxuKzA0,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1100450877792370688,2021-05-04 13:39:52,"INCY, ",,"blueequity.io/r/208765/de-in‚Ä¶, ",1389635904084451330,False,0,0,0,0,Blue Equity,$INCY Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/wYsmIyWwlG,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
1099039801397964802,2021-05-04 12:45:15,"INCY, ",,,1389622160969318403,False,0,0,1,0,EarningsAlley,Incyte Corporation $INCY held an earnings call on 5/4/2021. Here are the highlights:,,,2019-02-22 15:14:42,,Earnings Alley,https://pbs.twimg.com/profile_images/1113489113435508737/ulSmYR9O_normal.png,1802,1,33,87697,EarningsAlley,
1056278376628056064,2021-05-04 12:40:48,,"trademoneta, forex, stock, ","tny.app/jscOBMFg, pic.twitter.com/g6yOvRh433, ",1389621039164968961,False,0,0,0,0,Integromat,Incyte Corp (INCY) Q1 2021 Earnings Call Transcript https://t.co/SxsjiV4gTu #trademoneta #forex #stock https://t.co/g6yOvRh433,,,2018-10-27 16:16:04,"London, England",Trade Moneta,https://pbs.twimg.com/profile_images/1381619299274665996/tfXGyJKa_normal.jpg,124,242,1,31094,TradeMoneta,photo
963495628545327104,2021-05-04 12:24:07,"INCY, INCY, ",,"stck.pro/news/INCY/1273‚Ä¶, stck.pro/news/INCY, pic.twitter.com/rBLmY817PN, ",1389616839886581770,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's Q1 Jakafi Sales Hit By Pandemic; Reaffirms 2021 Guidance https://t.co/PibwrHNU7G Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/rBLmY817PN,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1325446129325142016,2021-05-04 11:31:19,"INCY, ",,"seekingalpha.com/news/3689978-i‚Ä¶, ",1389603555254968328,False,0,0,0,0,Integromat,"$INCY - Incyte EPS beats by $0.03, misses on revenue; reaffirms guidance https://t.co/1e8zZLQ9T3",,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
23059499,2021-05-04 11:01:23,"INCY, ","stockmarket, finance, markets, ","seekingalpha.com/article/442400‚Ä¶, ",1389596020879753222,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation 2021 Q1 - Results - Earnings Call Presentation. https://t.co/3XKMPuWnId #stockmarket #finance #markets,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
4058194633,2021-05-04 10:47:39,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1389592565305921542,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs | Business Wire https://t.co/KB4yiKIviF,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
72928001,2021-05-04 09:09:37,"INCY, ",,"bit.ly/2SrYV99, ",1389567892950159364,False,0,0,0,0,BriefingInPlayLimited,"$INCY: Incyte beats by $0.04, misses on revs; reaffirms FY21 guidance https://t.co/PraYbpAA4R",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
15296897,2021-05-04 08:07:36,"INCY, ",,"seekingalpha.com/news/3690068-i‚Ä¶, ",1389552286339190785,False,1,0,0,1,SANewsTwitter,"$INCY - Incyte posts mixed Q1 results, reaffirms guidance https://t.co/1n6Z8AoCTV",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1199800417821048834,2021-05-04 07:47:39,,"BZI_Recaps, Earnings, INCY, News, INCY, ","dlvr.it/Rz1Wn1, bit.ly/3euPGwc, pic.twitter.com/XlotRjVPSm, ",1389547265916870662,False,0,0,0,0,dlvr.it,#BZI_Recaps #Earnings #INCY #News #INCY Recap: Incyte Q1 Earnings https://t.co/AODyFp6wIU https://t.co/HhkKr6VYcw https://t.co/XlotRjVPSm,,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,photo
756169655178235908,2021-05-04 07:45:00,"INCY, ",,"news.alphastreet.com/earnings/incy-‚Ä¶, ",1389546601102913542,False,0,0,0,0,Twitter Web App,$INCY Incyte Corp Q1 2021 Earnings Call https://t.co/GQPVciSy8i,,,2016-07-21 12:51:09,,Earnings Concalls,https://pbs.twimg.com/profile_images/1325761625173880832/-Bdm9yBq_normal.jpg,730,1978,5,9202,earningsinfo,
3142088601,2021-05-04 07:24:02,"INCY, MOR, ",,"pic.twitter.com/wFbmkwkXid, ",1389541324806832131,False,5,0,2,0,Twitter Web App,"$INCY no specific figure for $MOR tafasitamab/Monjuvi, just ""good uptake by both academic and community physicians"" from Incyte's CEO.

tafasitamab/Monjuvi milestones https://t.co/wFbmkwkXid",,,2015-04-06 18:27:23,"Lyon, France",Bertrand Delsuc,https://pbs.twimg.com/profile_images/1118239110018273280/DDy8QJv8_normal.png,8047,263,283,59416,BertrandBio,photo
772471873539977217,2021-05-04 07:22:48,"INCY, ",,"sec.gov/ix?doc=/Archiv‚Ä¶, ",1389541012146692096,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 8-K https://t.co/sNcnosdBM0,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
3316713321,2021-05-04 07:21:40,,,"ca.investing.com/news/stock-mar‚Ä¶, ",1389540726552375296,False,0,0,0,0,WordPress.com,"Incyte Earnings beat, Revenue misses In¬†Q1 https://t.co/JxybyXEuS6",,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
836549573048848384,2021-05-04 07:16:11,,"Sipgrab, UnitingPeopleWithThePossibilities, ","dlvr.it/Rz1PjM, ",1389539347024650242,False,0,0,0,0,dlvr.it,"Incyte Earnings Beat, Revenue Misses In Q1 https://t.co/1EykVAs8TO #Sipgrab #UnitingPeopleWithThePossibilities",,,2017-02-28 07:12:15,"Bengaluru, India",SipGrab,https://pbs.twimg.com/profile_images/1370274434217512968/MI4ydIHv_normal.jpg,266,94,2,43308,sipgrab,
1363799331766231040,2021-05-04 07:16:08,,,"dlvr.it/Rz1Pg6, pic.twitter.com/4RcmaGuT1U, ",1389539334324297733,False,0,0,0,0,dlvr.it,"Incyte Earnings Beat, Revenue Misses In Q1 https://t.co/EGGzUhGxth https://t.co/4RcmaGuT1U",,,2021-02-22 05:34:42,Cork,Financely Group,https://pbs.twimg.com/profile_images/1383938722660372480/m9rwOb_F_normal.jpg,614,4999,12,70483,financelygroup,photo
177662431,2021-05-04 07:16:05,,,"dlvr.it/Rz1PYp, pic.twitter.com/nveLJL9gG4, ",1389539322337050628,False,0,0,0,0,dlvr.it,"Incyte Earnings Beat, Revenue Misses In Q1 https://t.co/IRptPmrgVO https://t.co/nveLJL9gG4",,,2010-08-12 15:00:41,"San Marcos, CA",Carolyn C,https://pbs.twimg.com/profile_images/1024752575063633920/KtfNppmk_normal.jpg,134,23,0,46857,Carolyn6800,photo
789582770955702272,2021-05-04 07:16:05,,,"dlvr.it/Rz1PYr, pic.twitter.com/sl1Q8CMIZd, ",1389539321447858183,False,0,0,0,0,dlvr.it,"Incyte Earnings Beat, Revenue Misses In Q1 https://t.co/5jYJP7kPB7 https://t.co/sl1Q8CMIZd",,,2016-10-21 17:42:57,"Michigan, USA",Jesse,https://pbs.twimg.com/profile_images/1318988385202196482/bK4S5NLu_normal.jpg,1965,2937,9,77548,jlwoods0241,photo
108617488,2021-05-04 07:15:05,,,"invst.ly/uoglb, ",1389539070943059969,False,0,0,0,0,FP News Publisher - COM,"Incyte Earnings Beat, Revenue Misses In Q1 - https://t.co/IDHVBQ85sU",,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
1068561714055012352,2021-05-04 07:10:35,"INCY, ",,"sec.report/Document/00011‚Ä¶, ",1389537940334792706,False,0,0,0,0,Edgar Filings,A Form 8-K [Press/News Current Report] filing has been made with the SEC:  $INCY INCYTE CORP  https://t.co/acXcIV0uVF,,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
1355194932445786112,2021-05-04 07:10:29,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1389537912279216128,False,0,0,0,0,Twitter,"$INCY Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs
https://t.co/AiUF6kLO9K",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1171873456276889600,2021-05-04 07:09:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1389537748177072128,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (4 May, 7:08am)

üì∞ Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs

https://t.co/wOQv3xutQZ

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
4312114277,2021-05-04 07:09:24,"INCY, ",,"fintel.io/sf/us/incy?utm‚Ä¶, ",1389537641746550789,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 8-K - Results of Operations and Financial Condition -  FORM 8-K https://t.co/Oc4NyYycjO,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
976297820532518914,2021-05-04 07:09:18,,,"dlvr.it/Rz1NDz, pic.twitter.com/5twGVdTZCK, ",1389537616983322627,False,0,0,0,0,dlvr.it,Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/Wzy0DKJScl https://t.co/5twGVdTZCK,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
2812632288,2021-05-04 07:07:50,,,"invst.ly/uoglb, ",1389537247716941826,False,0,0,0,0,ForexPros News & Analysis,"Incyte Earnings Beat, Revenue Misses In Q1 - https://t.co/5DD2ufnvG1",,,2014-09-16 03:56:03,Worldwide,Investing.com Stocks,https://pbs.twimg.com/profile_images/1108338732019695616/CAvg-ixc_normal.png,20430,38,256,339289,InvestingStockz,
3318510966,2021-05-04 07:07:31,,,"crweworld.com/article/news-p‚Ä¶, ",1389537165231607812,False,0,0,0,0,CRWE World,Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/vWW86iPLZI,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2021-05-04 07:06:29,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1389536906699022338,False,0,0,0,0,stocktitan,"$INCY Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs
https://t.co/ac4b0gIrae",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1069693680066420736,2021-05-04 07:05:41,"INCY, ",,"s.flashalert.me/hxJhHW, ",1389536704965578752,False,0,0,0,0,flashalerts,"$INCY [15s. delayed, acc.~90%, always check] Earnings Release May 04, 07:00:00: Q1: Non-GAAP EPS of $0.67, GAAP EPS of $0.24, Revenue $604.71M. https://t.co/o54objUd3Q",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1069693680066420736,2021-05-04 07:05:39,"INCY, ",,"s.flashalert.me/ziK8Y, ",1389536698472796161,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on May 04, 07:00:00: Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/vhm7t3w6CN",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
15296897,2021-05-04 07:03:12,"INCY, ",,"seekingalpha.com/news/3689978-i‚Ä¶, ",1389536079439556608,False,0,0,0,1,SANewsTwitter,"$INCY - Incyte EPS beats by $0.03, misses on revenue; reaffirms guidance https://t.co/LOjzcReFb9",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1325115160353103872,2021-05-04 06:15:24,"INCY, ","healthcare, ","quantisnow.com/insight/689218‚Ä¶, ",1389524052331569157,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Corp. to Host Earnings Call

https://t.co/6Q9v9wivCg

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
266143766,2021-05-04 06:15:21,"INCY, ",,"accesswire.com/643918/Incyte-‚Ä¶, ",1389524036384923649,False,0,0,0,0,Accesswire,$INCY Incyte Corp. to Host Earnings Call https://t.co/79M650T6B3,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
1015383484439957510,2021-05-04 05:20:13,,,,1389510161769840643,False,0,0,0,0,Twitter Web App,"Congrats! Sarah diFrancesca was appointed as Executive Director of Compliance, Dermatolgy Lead at Incyte",,,2018-07-06 19:54:22,,clo,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,21,0,0,22596,clo31741753,
1129758268253884416,2021-05-04 02:33:46,,"Kidney_Cancer_Market, ","bit.ly/3xFvHUx, pic.twitter.com/AaW5D6acI9, ",1389468273020850185,False,0,0,0,0,Twitter Web App,"#Kidney_Cancer_Market Size, Share, Trends &amp; Analysis 2021-2027| Request a free sample copy @ https://t.co/SIjmnMCRf2

key players: @Merck @Novartis @AstraZeneca @bmsnews @pfizer @Roche @Amgen , Argos Therapeutics @AVEOoncology @BayerPharma @ExelixisInc @Incyte @AGN_Foundation https://t.co/AaW5D6acI9","Merck, Novartis, AstraZeneca, bmsnews, pfizer, Roche, Amgen, AVEOoncology, BayerPharma, ExelixisInc, Incyte, AGN_Foundation, ",,2019-05-18 10:38:55,"Mumbai, India",Eternity Insights,https://pbs.twimg.com/profile_images/1330164573631090689/zAYkPZty_normal.jpg,28,265,0,496,Eternity_MI,photo
1280938376099741697,2021-05-03 21:35:42,,"iexStock, ","iexcloud.io, pic.twitter.com/TDYDI9e3zF, ",1389393263942115328,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-National Corporation for Tourism &amp; Hotel
-Ras Al Khaima for White Cement Co
-Manazel Real Estate PJSC
-Apple Inc
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/TDYDI9e3zF",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2021-05-03 19:57:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2712737, pic.twitter.com/ckGzb9qTW9, ",1389368657906593794,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on April 20, 2021. View odds for this and other indicators: https://t.co/HhJqw2CJSS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ckGzb9qTW9",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280938376099741697,2021-05-03 18:34:47,,"iexStock, ","iexcloud.io, pic.twitter.com/h5ggxBjAvz, ",1389347735472689154,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Apple Inc
-KLA Corp.
-Illumina Inc
-Incyte Corp.
-Sharjah Group

Data provided by https://t.co/oXreiEXTgd https://t.co/h5ggxBjAvz",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1100450877792370688,2021-05-03 17:25:22,"INCY, ",,"blueequity.io/r/207965/de-in‚Ä¶, ",1389330266657673216,False,0,0,0,0,Blue Equity,$INCY Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021 https://t.co/f4XXYAqe7U,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
963495628545327104,2021-05-03 15:42:21,"INCY, INCY, ",,"stck.pro/news/INCY/1271‚Ä¶, stck.pro/news/INCY, ",1389304339764764674,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Q1 2021 Earnings Preview https://t.co/EgKklJCyb7 Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
15296897,2021-05-03 14:33:18,"INCY, ",,"seekingalpha.com/news/3689523-i‚Ä¶, ",1389286965111971840,False,0,0,0,1,SANewsTwitter,$INCY - Incyte Q1 2021 Earnings Preview https://t.co/HYFTZismyL,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
778267752679235585,2021-05-03 12:05:04,,,"stockmarketdaily.co/2021/05/03/inc‚Ä¶, pic.twitter.com/rebncxF6dN, ",1389249660548694017,False,0,0,0,0,StockMarketDaily,Earnings Scorecard &amp; Analyst Reports for Incyte (NASDAQ:INCY) - https://t.co/hVm984qVeu https://t.co/rebncxF6dN,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
4058194633,2021-05-03 10:47:37,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1389230168791683079,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021 | Business Wire https://t.co/N2w0YyQH0Z,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
325135887,2021-05-03 10:05:00,,"vitiligo, AADVMX2021, ","twitter.com/Incyte/status/‚Ä¶, ",1389219443276873732,False,3,0,0,0,Twitter Web App,"Interesting! Thanks for sharing! @Incyte #vitiligo 
#AADVMX2021 
https://t.co/7pwvcl98h8","Incyte, ",,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
3911174913,2021-05-03 10:00:00,,"atopicdermatitis, eczema, SID2021, ","pic.twitter.com/1NuYlRq73v, ",1389218186214612992,False,4,0,0,0,Twitter Ads,"Data presentations highlighting an investigational therapy for patients with #atopicdermatitis, a type of #eczema, being presented at the 2021 Society for Investigative Dermatology virtual meeting. #SID2021 https://t.co/1NuYlRq73v",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1022473214457348096,2021-05-03 09:26:41,,,"pharmashots.com/59562/eli-lill‚Ä¶, ",1389209802870386690,False,0,0,0,0,Twitter Web App,"Eli Lilly and Incyte Present New Data of Olumiant (baricitinib) in P-III BREEZE-AD5 Trial Moderate to Severe Atopic Dermatitis at AAD2021 @Pharmashot @LillyPad 
https://t.co/jWrMZEhIef","Pharmashot, LillyPad, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
472650465,2021-05-03 08:10:48,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1389190703222304772,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021 https://t.co/KQM7YVfzOg,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
4493706195,2021-05-03 08:10:06,,,"ow.ly/C0UL30rGjZw, ",1389190528877711361,False,0,0,0,0,Hootsuite Inc.,"EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use | Reuters https://t.co/ftfR5Uzgc7",,,2015-12-15 11:28:14,"Ontario, Canada",Mr. Brian Uberig,https://pbs.twimg.com/profile_images/1047073926990450690/NXLPvzrD_normal.jpg,476,905,20,54169,Brian_Uberig,
976297820532518914,2021-05-03 08:08:35,,,"dlvr.it/Ryxf9K, pic.twitter.com/GDW4ntvMgw, ",1389190146990305283,False,0,0,0,0,dlvr.it,Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021 https://t.co/lCRCohCFwI https://t.co/GDW4ntvMgw,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1355194932445786112,2021-05-03 08:07:44,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1389189931214442498,False,0,0,0,0,Twitter,"$INCY Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021
https://t.co/eaIROsqicb",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1254035253104181256,2021-05-03 08:03:44,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1389188924073984000,False,0,0,0,0,stocktitan,"$INCY Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021
https://t.co/cT0zX1Gtdq",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1069693680066420736,2021-05-03 08:02:58,"INCY, ",,"s.flashalert.me/YSCYe, ",1389188734541774849,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on May 03, 08:00:00: Incyte Announces Data on Ruxolitinib Cream in Atopic Dermatitis Accepted for Presentation at the Society for Investigative Dermatology (SID) Virtual Meeting 2021 https://t.co/W0JUbqHOWp",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
2361204445,2021-05-02 19:37:00,,"BioProcess, CHOSOURCE, ","bit.ly/3aLC2DL, pic.twitter.com/KPjV84kHKu, ",1389001002813214722,False,0,0,0,0,Semrush Social Media Tool,Did you miss #BioProcess International US West 2021 last month? Learn from Jay Sinha at Incyte Corp as he presents development of an antibody expression platform using Horizon‚Äôs CHO-K1 GS knockout cell line. Click here to watch on demand. https://t.co/2wReguLMUi #CHOSOURCE https://t.co/KPjV84kHKu,,,2014-02-25 09:46:42,"Cambridge, UK",Horizon Discovery,https://pbs.twimg.com/profile_images/1225093651044302849/QtHP95re_normal.jpg,9934,397,57,2776,HZDiscovery,photo
1270666821776089090,2021-05-02 18:04:33,,"bt80, Cookstown, ","reuters.com/business/healt‚Ä¶, ",1388977738850217984,False,0,0,0,0,Twitter Web App,"EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use https://t.co/VohBFH9mzS #bt80 #Cookstown",,,2020-06-10 06:39:34,,John,https://pbs.twimg.com/profile_images/1380179536617349130/LKeqLTkY_normal.jpg,102,75,0,15885,John55139,
1319406971968106496,2021-05-02 13:16:37,"INCY, ",,"earningscalendar.io, ",1388905276556861443,False,0,0,0,0,OneUp App,Upcoming Earnings Report: $INCY Incyte Reporting on 05/04/2021 at 7:00 AMüì© Get Free Daily ER Calendar Sent To Your Email  https://t.co/VGwS8deCNq üì©,,,2020-10-22 18:35:14,,Earnings Calendar IO,https://pbs.twimg.com/profile_images/1320124248417988609/0uGLUR7e_normal.jpg,142,163,1,28749,ERCalendar,
374729426,2021-05-01 23:13:10,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2708432, pic.twitter.com/miXAqzuYhd, ",1388693017268146176,False,0,0,0,1,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on April 20, 2021. View odds for this and other indicators: https://t.co/VpoiP0RO0m #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/miXAqzuYhd",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280938376099741697,2021-05-01 19:04:50,,"iexStock, ","iexcloud.io, pic.twitter.com/E53VTCsrSg, ",1388630520532291585,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Ras Al Khaima National Insurance Co
-Incyte Corp.
-Oman &amp; Emirates Investment Holding Co. S
-United Airlines Holdings Inc
-Synopsys, Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/E53VTCsrSg",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2926418704,2021-04-30 21:34:44,,,"news.yahoo.com/ema-quickly-re‚Ä¶, ",1388305857302179843,False,0,0,0,0,Twitter Web App,"EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use https://t.co/Cm2Knec4pv via @Yahoo","Yahoo, ",,2014-12-16 23:53:36,,Kevin Paul Oge,https://pbs.twimg.com/profile_images/545080446191562752/sd7k8cIO_normal.jpeg,39,782,0,28248,DE3x2ydy_dx,
374729426,2021-04-30 20:37:21,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2705832, pic.twitter.com/Upd2zEZIKc, ",1388291416044969985,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on April 20, 2021. View odds for this and other indicators: https://t.co/CBRlPi6QtC #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Upd2zEZIKc",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
4508351114,2021-04-30 15:12:34,,,"dlvr.it/RynfCz, pic.twitter.com/kYm4X3S1R2, ",1388209682435637250,False,0,0,0,0,dlvr.it,"EMA to Quickly Review Lilly, Incyte Arthritis Drug for COVID Use https://t.co/aey7zIIcWa https://t.co/kYm4X3S1R2",,,2015-12-09 09:56:53,"Polanco, Miguel Hidalgo.",Dr. Isaac Kalach,https://pbs.twimg.com/profile_images/832969869347811329/me4I-2IE_normal.jpg,429,1736,5,4404,OrtoKalach,photo
45764586,2021-04-30 13:36:35,,"InfectiousDiseases, News, ","dlvr.it/RynNBl, pic.twitter.com/Tvd4RBEA6n, ",1388185524892930051,False,0,0,0,0,dlvr.it,"#InfectiousDiseases #News EMA to Quickly Review Lilly, Incyte Arthritis Drug for COVID Use https://t.co/Td09JHTS52 https://t.co/Tvd4RBEA6n",,,2009-06-09 00:32:31,"San Francisco Bay Area, CA",Parvez Fatteh,https://pbs.twimg.com/profile_images/1335679382740877312/IXK44YmV_normal.jpg,364,868,7,13207,uptoParMD,photo
4058194633,2021-04-30 10:17:15,"INCY, ",,"delawarebusinessnow.com/2021/04/incyte‚Ä¶, ",1388135364661956613,False,0,0,0,0,Twitter for iPhone,$INCY Incyte cream continues to show promise in treating common skin disease https://t.co/rzt57aBZND via @Delaware Business Now,"Delaware, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-04-30 10:16:17,"INCY, LLY, ",,"kfgo.com/2021/04/29/ema‚Ä¶, ",1388135117697159169,False,0,0,0,0,Twitter for iPhone,"$INCY $LLY EMA To Quickly Review Eli Lilly, Incyte Arthritis Drug For COVID19 Use https://t.co/EV5yfbAGm6",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
25562183,2021-04-29 23:00:09,,,"reuters.com/business/healt‚Ä¶, ",1387964966473453568,False,2,0,0,2,True Anthem,"EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use‚Äã https://t.co/vqwsdmYs3r",,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
25562183,2021-04-29 18:00:17,,,"reuters.com/business/healt‚Ä¶, ",1387889502325256194,False,5,0,0,1,True Anthem,"EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use‚Äã https://t.co/lj4zygWcxW",,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
60017224,2021-04-29 17:00:01,,"EliLilly, Covid19, ","thepeninsulaqatar.com/article/29/04/‚Ä¶, ",1387874334803378179,False,1,0,0,0,TweetDeck,"EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use

#EliLilly #Covid19 

https://t.co/AQYjyNgmB5",,,2009-07-25 04:41:05,Qatar,The Peninsula Qatar,https://pbs.twimg.com/profile_images/1447948444753088513/FB637GUs_normal.jpg,59570,234,996,234014,PeninsulaQatar,
790019230389248000,2021-04-29 16:53:36,,,"hedgeaccordingly.com/eu-drug-regula‚Ä¶, ",1387872720541523972,False,0,0,0,0,WordPress.com,EU drug regulator to review Eli Lilly and Incyte arthritis drug for use in Covid-19 patients on¬†oxygen https://t.co/KgTM2f11iM,,,2016-10-22 22:37:17,Everywhere,PHedge,https://pbs.twimg.com/profile_images/1453462892787875842/Rl2u2_9e_normal.jpg,74213,63066,191,1049610,politicalHEDGE,
166558126,2021-04-29 16:00:38,,,"s.einnews.com/tU97LcnKuP, ",1387859388724125698,False,0,0,0,0,EIN Presswire,"EMA to quickly review Eli Lilly, Incyte arthritis‚Ä§‚Ä§‚Ä§ https://t.co/w77RFhf0EK",,,2010-07-14 09:13:23,"Washington, D.C.",EIN Presswire: Pharmaceutical Newswire,https://pbs.twimg.com/profile_images/1288519645650132994/GM15d2k-_normal.jpg,8267,1715,125,44783,EINPharmaNews,
39453212,2021-04-29 15:15:00,,,"gmanetwork.com/news/scitech/s‚Ä¶, ",1387847905273257984,False,4,0,0,2,TweetDeck,"EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use

https://t.co/TUJnHvzvXU",,,2009-05-12 03:14:09,Philippines,GMA News,https://pbs.twimg.com/profile_images/1131064290998231041/3by86sfl_normal.png,5987542,656,8729,750613,gmanews,
1134049078424162304,2021-04-29 14:32:41,"INCY, GILD, NVS, ",,"newsfilter.io/articles/ema-t‚Ä¶, ",1387837257529413637,False,0,0,0,0,Newsfilter.io,"EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use $INCY $GILD $NVS https://t.co/OfgglxjmzQ",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
282302066,2021-04-29 14:26:59,,,"ift.tt/2QF9PaU, pic.twitter.com/OW4c0H4gsi, ",1387835821928165382,False,0,0,0,0,IFTTT,EU drug regulator to review Eli Lilly and Incyte arthritis drug for use in Covid-19 patients on oxygen https://t.co/eIX22CrZKQ https://t.co/OW4c0H4gsi,,,2011-04-14 19:28:45,,World News !,https://pbs.twimg.com/profile_images/1102358655960317953/TLPVwfty_normal.png,92,257,0,15487,World00News,photo
53097729,2021-04-29 14:08:24,"INCY, ",,"linktr.ee/Stockwits, ",1387831146436861952,False,1,0,0,1,Twitter Web App,$INCY Incyte-partnered anti-PD-1 therapy wins FDA‚Äôs orphan drug designation for liver cancer https://t.co/3UtuY8atC2,,,2009-07-02 11:44:23,"Toronto, Ontario",Stockwits‚Ñ¢ Ó®Ä,https://pbs.twimg.com/profile_images/1408587167111303171/Qrn1abyM_normal.jpg,26206,983,189,29344,mikalche,
31372539,2021-04-29 14:07:04,,,"dlvr.it/RyjZxZ, ",1387830810363928576,False,0,0,0,0,dlvr.it,Incyte-partnered anti-PD-1 therapy wins FDA‚Äôs orphan drug designation for liver cancer https://t.co/vMV9QlkPuc,,,2009-04-15 05:08:17,Amsterdam,Stocks tweets,https://pbs.twimg.com/profile_images/138834360/stocks1-avatar_normal.jpg,4407,3020,91,70157,stocks_tweets,
1237406911819141120,2021-04-29 14:05:45,,,"survivalnomicsnow.com/eu-drug-regula‚Ä¶, ",1387830480704311300,False,0,0,0,0,WordPress.com,EU drug regulator to review Eli Lilly and Incyte arthritis drug for use in Covid-19 patients on¬†oxygen https://t.co/CSqCwqyHV9,,,2020-03-10 11:56:34,,Survivalnomics,https://pbs.twimg.com/profile_images/1423940649502576641/IXXtun7b_normal.jpg,19,10,1,28441,survivalnomics,
1134049078424162304,2021-04-29 14:04:42,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1387830213237673985,False,0,0,0,0,Newsfilter.io,Incyte-partnered anti-PD-1 therapy wins FDA‚Äôs orphan drug designation for liver cancer $INCY https://t.co/7jGYwZzsGN,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2021-04-29 14:01:45,"INCY, ",,"seekingalpha.com/news/3688093-i‚Ä¶, ",1387829470325710849,False,0,0,0,1,SANewsTwitter,$INCY - Incyte-partnered anti-PD-1 therapy wins FDA‚Äôs orphan drug designation for liver cancer https://t.co/CHXchEad6H,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
14453501,2021-04-29 13:53:20,,,"delawarebusinessnow.com/2021/04/incyte‚Ä¶, ",1387827354395938817,True,0,0,0,0,WordPress.com,Incyte cream continues to show promise in treating common skin¬†disease https://t.co/gOQ1hOTOV4,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
1239894835655348230,2021-04-29 13:39:05,,"WorldNews, BreakingNews, TopStories, Headlines, LatestNews, BREAKING, NEWS, WorldNewsApp, ","worldnewsapp.online/2021/04/eu-dru‚Ä¶, bit.ly/us_newsapp, ",1387823769184579590,False,0,0,0,0,IFTTT,"EU drug regulator to review Eli Lilly and Incyte arthritis drug for use in Covid-19 patients on oxygen
https://t.co/LwQMUpuOzf

Use our app: https://t.co/Dh5SYJDpDT

#WorldNews #BreakingNews #TopStories #Headlines #LatestNews #BREAKING #NEWS #WorldNewsApp",,,2020-03-17 08:42:27,United States,World News,https://pbs.twimg.com/profile_images/1239895031101571074/XkNxJhuE_normal.jpg,39,63,2,8644,WorldNewsApp1,
1343154914420125697,2021-04-29 13:16:46,,,"atdux.com/eu-drug-regula‚Ä¶, ",1387818150582960130,False,0,0,0,0,WordPress.com,EU drug regulator to review Eli Lilly and Incyte arthritis drug for use in Covid-19 patients on¬†oxygen https://t.co/gilI6dt3DR,,,2020-12-27 06:21:15,India,ATDUX.COM,https://pbs.twimg.com/profile_images/1352144136598646784/7gNwEhDJ_normal.jpg,1421,4539,0,47660,ATDUX_COM,
25562183,2021-04-29 13:00:20,,,"reuters.com/business/healt‚Ä¶, ",1387814014491705353,False,0,0,0,1,True Anthem,"EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use‚Äã https://t.co/rBZPklDDc4",,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
305271088,2021-04-29 12:19:57,,,"reut.rs/2SdPGt7, ",1387803855547686917,False,0,0,0,0,Twitter for iPhone,"Feel the need for speed: EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use https://t.co/i7igCxBxnI",,,2011-05-25 18:55:22,Zurich,John Miller,https://pbs.twimg.com/profile_images/1333342092525965313/Ih30-Ad6_normal.jpg,670,64,28,2137,JPMillerSwitz,
25406480,2021-04-29 12:14:06,,,"awesomecapital.blogspot.com/2021/04/ema-to‚Ä¶, ",1387802380578738176,False,0,0,0,1,Twitter Web App,"AwesomeCapital: EMA to quickly review Eli Lilly, Incyte arthritis ... https://t.co/ILLob5Uuo4",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
937962626222497793,2021-04-29 11:41:14,,,"devdiscourse.com/article/busine‚Ä¶, ",1387794111458074626,False,0,0,0,0,Devdiscourse News Desk,"EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use https://t.co/JQTJKVqInV",,,2017-12-05 03:31:31,National Capital Region,Devdiscourse,https://pbs.twimg.com/profile_images/994485257327046656/8DSy51HP_normal.jpg,110918,605,78,718652,dev_discourse,
374729426,2021-04-28 22:33:13,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2701469, pic.twitter.com/S26kEDt9WC, ",1387595799513604098,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on April 20, 2021. View odds for this and other indicators: https://t.co/jZzAMf6ecl #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/S26kEDt9WC",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
832836577508327424,2021-04-28 15:42:36,,"oncologyprogram, NCODAForum21, ","pic.twitter.com/Zuwr8KgrMj, ",1387492465373028360,False,1,0,0,0,Twitter Web App,"NCODA students, our Spring Forum Student Track is about to begin! Joe Cordaro, PharmD, MBA, Vice President, Market Access, Distribution and Patient Access Services, Incyte will present on Pharmaceutical Excellence in Leadership for Students.  #oncologyprogram #NCODAForum21 https://t.co/Zuwr8KgrMj",,,2017-02-18 01:18:08,100+ Member Organizations,NCODA,https://pbs.twimg.com/profile_images/1388172021033488392/HW_ZFiMR_normal.jpg,906,2860,8,673,NCODAorg,photo
203104266,2021-04-28 10:26:53,,"PCC2021, ","bit.ly/3u0yh4V, ",1387413012697518086,False,0,0,0,0,Twitter Web App,"Don't miss the Creative Compliance Training tabletop session at #PCC2021 today with Dan O'Connor of PharmaCertify, Jen Anderson of Vertex and Jackie Parris of Incyte! https://t.co/Vm904rYHu6",,,2010-10-15 10:59:30,"Lambertville, NJ",PharmaCertify,https://pbs.twimg.com/profile_images/1006932266923143168/IsVce4sI_normal.jpg,182,89,14,1859,PharmaCertify,
1889492676,2021-04-28 07:46:53,"INCY, ","Incyte, BankofAmericaSecuritiesVirtual2021HealthcareConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1387372746598875143,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming Investor Conference #BankofAmericaSecuritiesVirtual2021HealthcareConference $INCY https://t.co/eVU141xgUK,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1100450877792370688,2021-04-27 22:15:34,"INCY, ",,"blueequity.io/r/204383/de-in‚Ä¶, ",1387228969867485185,False,0,0,0,0,Blue Equity,$INCY Incyte to Present at Upcoming Investor Conference https://t.co/75J6iM85g5,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
55642575,2021-04-27 15:30:09,,"vitiligo, AADVMX2021, ","buff.ly/3aGL8Sg, pic.twitter.com/8P1UUZwK5r, ",1387126943728824320,False,6,1,0,4,Buffer,"Incyte's Phase 2 study evaluating ruxolitinib cream for #vitiligo meets primary endpoint, shows improvement in body and facial repigmentation compared to placebo. https://t.co/5MYiq70Cto #AADVMX2021 https://t.co/8P1UUZwK5r",,,2009-07-10 15:27:01,"North Olmsted, Ohio",Dermatology Times,https://pbs.twimg.com/profile_images/1402733466987470848/i_Bjwcxa_normal.jpg,26818,622,341,15262,DermTimesNow,photo
50405984,2021-04-27 13:30:07,,"AMMF2021, ","ammf.org.uk/ammf-conferenc‚Ä¶, pic.twitter.com/zbBkIH02Uf, ",1387096736624037891,False,5,0,0,1,Hootsuite Inc.,"Huge thanks to our supporters, @Incyte QED, @HelsinnGroup, @TaihoOncology, @AstraZeneca, @Merck, @NuCana_news and @ZymeworksInc for making the  #AMMF2021 conference possible. Collaboration is key!
https://t.co/9tFucXLIK5 https://t.co/zbBkIH02Uf","Incyte, HelsinnGroup, TaihoOncology, AstraZeneca, Merck, NuCana_news, ZymeworksInc, ",,2009-06-24 15:25:30,UK,AMMF,https://pbs.twimg.com/profile_images/3640580064/bb3d0498f8a9f03b4ebf339816b911ef_normal.jpeg,1788,1356,44,7655,CharityAMMF,photo
44381112,2021-04-27 11:17:30,,"pharma, innovation, pharmarookies, Regeneron, Seagen, Incyte, Top30, ","ow.ly/Lp6t50EyTSx, pic.twitter.com/nLbjs2IKHQ, ",1387063363142832128,False,0,1,0,0,Hootsuite Inc.,"Big Innovation Shift to Small Pharma. Rookies Grab Leading Spots. Pharmaceutical Innovation Index 2021
Three small pharma companies ‚ÄîRegeneron, Seagen and Incyte ‚Äî land in the top five. 
https://t.co/qCd0xv3x1h  #pharma #innovation #pharmarookies #Regeneron #Seagen #Incyte #Top30 https://t.co/nLbjs2IKHQ",,,2009-06-03 11:28:24,"Philadelphia, PA",Ashton Tweed,https://pbs.twimg.com/profile_images/463035692965064705/MTuVtkEq_normal.jpeg,433,566,20,5133,AshtonTweedLtd,photo
1254035253104181256,2021-04-27 08:08:30,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1387015797021843461,False,0,0,0,0,stocktitan,"$INCY Incyte to Present at Upcoming Investor Conference
https://t.co/0qDGlSCLNu",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1069693680066420736,2021-04-27 08:05:19,"INCY, ",,"s.flashalert.me/kAPQmA, ",1387014996455010305,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on April 27, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/X86LDfebcq",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2021-04-27 08:03:18,,,"dlvr.it/RyXRxb, pic.twitter.com/1jaswjvNx2, ",1387014488247791628,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conference https://t.co/vNRxG1HSIL https://t.co/1jaswjvNx2,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
2266388972,2021-04-27 05:39:44,"INCY, ","stocks, ","dailypolitical.com/?p=5457145, ",1386978358030962691,False,0,0,0,0,Zapier.com,Incyte $INCY Set to Announce Earnings on Tuesday https://t.co/iBVF8wPmTB #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2021-04-27 05:39:43,"INCY, ",,"dailypolitical.com/?p=5457145, ",1386978355996680192,False,0,0,0,0,Zapier.com,Incyte $INCY Set to Announce Earnings on Tuesday https://t.co/oi0wiEiP59,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1876846903,2021-04-26 18:38:58,,,"sphase.info/inc7992, ",1386812071795363840,False,0,0,0,0,Twitter Web App,"The PSW ""Lunch &amp; Learn"" series continues tomorrow! Click the link below to register.

Treatment Considerations in Polycythemia Vera and Myelofibrosis: Real-World Patient Case Discussion

Hosted by Incyte
https://t.co/hEyHKuWCc9",,,2013-09-17 16:31:22,"Madison, WI",PSW,https://pbs.twimg.com/profile_images/378800000470577771/876099b02d1fffe7e290d6cef7cb6e93_normal.jpeg,1576,152,31,1169,PSWpharmacists,
122820109,2021-04-26 15:54:05,,,"pharmaceutical-technology.com/news/lilly-inc‚Ä¶, ",1386770577340436483,False,0,0,0,0,Twitter for iPhone,Lilly and Incyte‚Äôs baricitinib misses primary endpoint in Covid-19 trial https://t.co/AT5fWhgNmB @PharmaTechFocus„Çà„Çä,"PharmaTechFocus, ",,2010-03-13 20:31:36,"Êù±‰∫¨ÈÉΩ  Tokyo,JAPAN FROM NORA",TOMO_YS,https://pbs.twimg.com/profile_images/1433676437744062465/hejONhp7_normal.jpg,1163,1133,0,71514,kutatomomin,
374729426,2021-04-26 13:57:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2696121, pic.twitter.com/JOUdid8jWy, ",1386741230986428417,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on April 14, 2021. View odds for this and other indicators: https://t.co/KLJXf9OXf6 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/JOUdid8jWy",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1188416386172903424,2021-04-26 06:00:02,,,"pic.twitter.com/NyZR83h2Zm, ",1386621079079227406,False,0,0,0,0,Twitter Web App,"Incyte Corporation

Incyte Corp actual stock price üî•üìàüôå

Follow us for more updates.
@fedholdinggroup

Your trusted management fund - FED HOLDING GROUP üìäüè¢ https://t.co/NyZR83h2Zm","fedholdinggroup, ",,2019-10-27 07:25:34,,FED Holding Group,https://pbs.twimg.com/profile_images/1281694942109278209/2pULSiQg_normal.jpg,9,0,0,236,fedholdinggroup,photo
386042607,2021-04-25 16:50:59,,"AADVMX2021, ","hubs.ly/H0LV-qw0, ",1386422511508758528,False,0,0,0,0,HubSpot,"Presented at the #AADVMX2021, new findings from TRuE-AD1 and TRuE-AD2 show that subjects receiving @Incyte's ruxolitinib cream 0.75% twice daily and ruxolitinib cream 1.5% BID both demonstrated greater improvement compared to vehicle https://t.co/F2u6cg1gJ1","Incyte, ",,2011-10-06 11:34:39,,Practical Derm,https://pbs.twimg.com/profile_images/1172186203099189249/6ZV9TJxF_normal.jpg,2800,888,49,4503,Practical_Derm,
374729426,2021-04-25 16:38:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2694031, pic.twitter.com/WIJjOrUsSC, ",1386419445275402241,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on April 14, 2021. View odds for this and other indicators: https://t.co/bJnkrq39mL #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/WIJjOrUsSC",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3911174913,2021-04-25 12:00:01,,"vitiligo, ","pic.twitter.com/reeku8OoVp, ",1386349286158479363,False,7,0,0,2,Twitter for Advertisers,We are committed to advancing science to help meet patient needs. Hear Barbara discuss her journey with #vitiligo and share perspective on what it‚Äôs like to live with this dermatologic condition. https://t.co/reeku8OoVp,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1311447591394193409,2021-04-25 03:58:03,,,"dlvr.it/RyNz42, ",1386227993396203525,False,0,0,0,0,dlvr.it,"Immune Checkpoint Inhibitors Market 2021 Industry Size, Share, Growth and Top Companies ... https://t.co/XNYp992dh8",,,2020-09-30 19:27:36,,Urologic Oncology Updates,https://pbs.twimg.com/profile_images/1311448182078013441/ZIlGm-Ka_normal.jpg,334,313,0,1202,UroOncologyOk,
1280938376099741697,2021-04-25 02:45:07,,"iexStock, ","iexcloud.io, pic.twitter.com/EYdRXgPRBO, ",1386209639675662338,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Lam Research Corp.
-Sharjah Islamic Bank
-EBay Inc.
-Incyte Corp.
-Texas Instruments Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/EYdRXgPRBO",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1274588409982382080,2021-04-25 02:33:42,,"partokmkcp, ","pic.twitter.com/hyUlM9ZAg4, ",1386206768804499456,False,1,0,0,0,Twitter for Android,"KMKCP Alumni Success Stories üôåüèªüåü Part-44
A health outcomes  expert, a guitarist and an oenologist‚Ä¶‚Ä¶‚Ä¶‚Ä¶.in short a rockstar !
Dr. Vijay Joish
Senior Director, US Health Economics &amp; Outcomes Research (HEOR), Incyte Corporation, USA.
Written by- Dr. Vandana Panda.

#partokmkcp https://t.co/hyUlM9ZAg4",,,2020-06-21 02:24:01,"Mumbai, India",KMKCP,https://pbs.twimg.com/profile_images/1274623896889614336/iNtJ7Hvz_normal.jpg,57,0,0,322,Kmkcp_official,photo
3911174913,2021-04-24 12:00:02,,"atopicdermatitis, eczema, ","pic.twitter.com/4NJAWjXbyT, ",1385986902302498819,False,3,0,0,1,Twitter Ads,"Hear Brittany‚Äôs perspective on the impact #atopicdermatitis, a type of #eczema, can have on daily life and the importance of progressing science for people living with this dermatologic condition. https://t.co/4NJAWjXbyT",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
360220091,2021-04-24 04:59:38,,,"dataemia.com/?p=505383, ",1385881105266532353,False,0,0,0,0,Newsemia,(Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis) https://t.co/Oa4RFSBRyZ,,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,
360220091,2021-04-24 04:19:37,,,"dataemia.com/?p=505378, ",1385871033593470980,False,0,0,0,0,Newsemia,(Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo) https://t.co/ZNqcsdWTRs,,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,
1325446129325142016,2021-04-24 00:30:11,"INCY, LLY, ",,"seekingalpha.com/news/3685158-i‚Ä¶, ",1385813296197087233,False,0,0,0,0,Integromat,$INCY $LLY - Incyte presents more data from positive late-stage studies for ruxolitinib in atopic dermatitis https://t.co/iz5uda02Aj,,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
1378726856254427138,2021-04-23 20:26:52,"INCY, ",,"tinyurl.com/yhqp7cmv, ",1385752064907694081,False,0,0,0,0,Twitter Web App,"$INCY
https://t.co/iGCwjxw8vN",,,2021-04-04 11:11:22,,üåê InvestingCraze üåê,https://pbs.twimg.com/profile_images/1386563165073383424/vIqVdAbk_normal.jpg,243,1651,4,4773,CrazeInvesting,
1043127646828355584,2021-04-23 17:41:58,,"atopicdermatitis, ","revolutionizingad.com, pic.twitter.com/P7RPHomjy6, ",1385710562756026374,False,2,0,0,0,Twitter Web App,"Thank you to our Platinum Sponsors of the Revolutionizing Atopic Dermatitis Virtual Conference that is scheduled to take place on Sun, June 13, 9AM-5PM (EST). Learn more and register: https://t.co/Z88HpqjM2G @abbvie @Incyte @EliLillyCo @pfizer @Regeneron @sanofi #atopicdermatitis https://t.co/P7RPHomjy6","abbvie, Incyte, EliLillyCo, pfizer, Regeneron, sanofi, ",,2018-09-21 09:19:46,Virtual Conference,Revolutionizing AD,https://pbs.twimg.com/profile_images/1044231557936963585/_NEg06uK_normal.jpg,151,37,2,326,RevAtopicDerm,photo
374729426,2021-04-23 17:24:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2689423, pic.twitter.com/kRlYWNueuM, ",1385706246418755586,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on April 14, 2021. View odds for this and other indicators: https://t.co/sgQQPJu348 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kRlYWNueuM",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1100450877792370688,2021-04-23 16:45:44,"INCY, ",,"blueequity.io/r/203049/de-in‚Ä¶, ",1385696414513070080,False,0,0,0,0,Blue Equity,$INCY Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo https://t.co/Ddw8XPu0rg,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
1100450877792370688,2021-04-23 16:35:40,"INCY, ",,"blueequity.io/r/203047/de-in‚Ä¶, ",1385693878561378307,False,0,0,0,0,Blue Equity,$INCY Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis https://t.co/fGQTckt0aH,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
3686628867,2021-04-23 15:32:01,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1385677861906837507,False,0,0,0,0,WordPress.com,Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic¬†Dermatitis https://t.co/cBmfDnhIqL,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1134049078424162304,2021-04-23 13:54:45,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1385653383739158528,False,0,0,0,0,Newsfilter.io,Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis $INCY https://t.co/FZOwxAX9f7,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-04-23 13:49:45,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1385652127150837761,False,0,0,0,0,Newsfilter.io,Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo $INCY https://t.co/HpasWOIDyE,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
963495628545327104,2021-04-23 13:35:07,"INCY, INCY, ",,"stck.pro/news/INCY/1250‚Ä¶, stck.pro/news/INCY, pic.twitter.com/EH3Ay5H7yP, ",1385648440915398664,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Announces New Ruxolitinib Data From Atopic Dermatitis and Vitiligo Studies https://t.co/YrMbnMXr48 Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/EH3Ay5H7yP,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1134049078424162304,2021-04-23 12:14:44,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1385628215461486592,False,0,0,0,0,Newsfilter.io,Incyte presents more data from positive late-stage studies for ruxolitinib in atopic dermatitis $INCY https://t.co/pPnZDh7gOy,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
72928001,2021-04-23 12:11:10,"LLY, ",,"bit.ly/3dMwfjv, ",1385627317624393729,False,0,0,0,0,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte's (INCY) OLUMIANT 2-mg tablet taken once daily showed improvement in key measured... https://t.co/s5V0gGk3yw,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
15296897,2021-04-23 11:53:02,"INCY, LLY, ",,"seekingalpha.com/news/3685158-i‚Ä¶, ",1385622753944883202,False,1,0,0,1,SANewsTwitter,$INCY $LLY - Incyte presents more data from positive late-stage studies for ruxolitinib in atopic dermatitis https://t.co/MBLwn8oRZi,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3911174913,2021-04-23 11:31:17,,"vitiligo, AADVMX2021, ","pic.twitter.com/DH4ymqTcbR, ",1385617281112330242,False,6,0,0,0,Twitter Ads,"David Rosmarin, M.D., Vice President of Research and Education, Dermatology Department at @TuftsMedicalCtr, explains the impact #vitiligo can have on patients and speaks to the importance of the data being presented at #AADVMX2021. Learn more. https://t.co/DH4ymqTcbR","TuftsMedicalCtr, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
166597717,2021-04-23 11:30:01,"INCY, LLY, ",,"bit.ly/3gzEAZx, ",1385616958343811077,False,0,0,0,0,TweetDeck,"Incyte, Lilly announce new analyses of BREEZE-AD5 Phase 3 clinical trial data $INCY $LLY https://t.co/Oa21BHXKme",,,2010-07-14 11:10:34,Greater New York City Area,The Fly,https://pbs.twimg.com/profile_images/885896700472287233/NunLvfQW_normal.jpg,27381,167,0,106350,theflynews,
3318510966,2021-04-23 11:10:01,,,"crweworld.com/article/news-p‚Ä¶, ",1385611927326322693,False,0,0,0,0,CRWE World,Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Pa https://t.co/cT1thXJxzJ,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3318510966,2021-04-23 11:09:57,,,"crweworld.com/article/news-p‚Ä¶, ",1385611911597756421,False,0,0,0,0,CRWE World,Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo https://t.co/qnGD7Q0Lfx,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
4058194633,2021-04-23 10:52:06,"INCY, ",,"tullahomanews.com/news/business/‚Ä¶, ",1385607416339828743,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo https://t.co/FZerYduCIA via @tullahomanews,"TullahomaNews, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1006334607946649600,2021-04-23 10:35:05,,"StockMarket, Stocks, ","dlvr.it/RyHpvX, ",1385603135188586501,False,0,0,0,0,dlvr.it,Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis https://t.co/Q2TcdbXTf5 #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1006334607946649600,2021-04-23 10:35:04,,"StockMarket, Stocks, ","dlvr.it/RyHpsp, ",1385603132718084099,False,0,0,0,0,dlvr.it,Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo https://t.co/VBbcMQHaYR #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1354134370362281985,2021-04-23 10:10:36,,,"dlvr.it/RyHkQv, ",1385596973495980037,False,0,0,0,0,dlvr.it,Incyte Announces New Findings From Pooled Analyses Of The Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream In Patients With Atopic Dermatitis https://t.co/wmx6EPyX1F,,,2021-01-26 13:29:41,"Fort Lauderdale, FL, US, 33301",NATIONAL TAX PREPARERS OF AMERICA,https://pbs.twimg.com/profile_images/1354134508879179776/Mpl17xJM_normal.jpg,11,12,0,14633,tax_preparers,
963495628545327104,2021-04-23 10:06:19,"INCY, INCY, ",,"stck.pro/news/INCY/1250‚Ä¶, stck.pro/news/INCY, pic.twitter.com/AxbMBk4o6l, ",1385595894825988097,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis https://t.co/SBBJ64z3DK Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/AxbMBk4o6l,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
963495628545327104,2021-04-23 10:06:11,"INCY, INCY, ",,"stck.pro/news/INCY/1250‚Ä¶, stck.pro/news/INCY, pic.twitter.com/taz5R7FZ5U, ",1385595861334478852,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo https://t.co/v7qMWnEs21 Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/taz5R7FZ5U,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1069693680066420736,2021-04-23 10:05:56,"INCY, ",,"s.flashalert.me/0CRIEC, ",1385595798071676931,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on April 23, 10:00:00: Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis https://t.co/8euCFTVC3F",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
59310742,2021-04-23 10:04:36,,,"dlvr.it/RyHjCP, pic.twitter.com/ggnbagutpr, ",1385595462925766659,False,0,0,0,0,dlvr.it,"Lilly, Incyte report positive results for baricitinib in alopecia areata https://t.co/zvkTOJsX5g https://t.co/ggnbagutpr",,,2009-07-22 20:57:49,ANZ,David Ledger,https://pbs.twimg.com/profile_images/621209163566182400/AWY0hAql_normal.jpg,826,1827,26,25935,Vedere_Group,photo
472650465,2021-04-23 10:03:43,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1385595240422199297,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis https://t.co/I8mM0NYVAf,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
472650465,2021-04-23 10:03:25,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1385595165759483904,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo https://t.co/HgUHb0JfEt,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
976297820532518914,2021-04-23 10:03:11,,,"dlvr.it/RyHhg3, pic.twitter.com/gyw8orTfPb, ",1385595107873738752,False,0,0,0,0,dlvr.it,Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis https://t.co/cZ1D13PcR5 https://t.co/gyw8orTfPb,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
976297820532518914,2021-04-23 10:03:09,,,"dlvr.it/RyHhfb, pic.twitter.com/5vjbhu8h6D, ",1385595101578072069,False,0,0,0,0,dlvr.it,Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo https://t.co/QpA142zYQG https://t.co/5vjbhu8h6D,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2021-04-23 10:02:38,"INCY, ",,"s.flashalert.me/JQ5GRM, ",1385594969394716674,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on April 23, 10:00:00: Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo https://t.co/aB0hxXRDrc",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1254035253104181256,2021-04-23 10:01:30,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1385594682433056768,False,0,0,0,0,stocktitan,"$INCY Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo
https://t.co/p9JWX3W2E7",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1254035253104181256,2021-04-23 10:00:29,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1385594426446290946,False,0,0,0,0,stocktitan,"$INCY Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis
https://t.co/p5hvCdcfMQ",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1325115160353103872,2021-04-23 10:00:06,"INCY, ","healthcare, ","quantisnow.com/insight/647690‚Ä¶, ",1385594331147292677,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo

https://t.co/jDKHaFzqgT

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1325115160353103872,2021-04-23 10:00:05,"INCY, ","healthcare, ","quantisnow.com/insight/647688‚Ä¶, ",1385594328890757123,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis

https://t.co/FQac0hZT6D

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
88803949,2021-04-23 08:56:38,,,"chemdiv.com/lilly-incyte-r‚Ä¶, pic.twitter.com/5ivUd4guPA, ",1385578359770558464,False,1,0,0,0,Twitter Web App,"Eli Lilly and Incyte have reported positive results from two Phase III trials evaluating their oral JAK inhibitor baricitinib in alopecia areata. It is an autoimmune condition that causes hair to fall out in small patches. 
More: https://t.co/k9bGw0BKIW https://t.co/5ivUd4guPA",,,2009-11-09 19:18:06,"San Diego, CA",ChemDiv,https://pbs.twimg.com/profile_images/1181305235966349317/rxSrjOO2_normal.jpg,176,286,8,2910,ChemDiv,photo
732361939490312192,2021-04-23 08:20:59,"INCY, ","markets, ","americanbankingnews.com/?p=19566842, ",1385569388485648384,False,0,0,0,0,Zapier.com,FY2021 Earnings Forecast for Incyte Co. $INCY Issued By Truist Securiti https://t.co/QXS5j5p6Ua #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-04-23 08:20:58,"INCY, ","stocks, ","americanbankingnews.com/?p=19566842, ",1385569386090610692,False,0,0,0,0,Zapier.com,FY2021 Earnings Forecast for Incyte Co. $INCY Issued By Truist Securiti https://t.co/VGNJm9BhDC #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2021-04-23 07:13:04,"INCY, ",,"tickerreport.com/?p=7322056, ",1385552295904137222,False,0,0,0,0,Zapier.com,Oppenheimer Equities Analysts Increase Earnings Estimates for Incyte Co. $INCY https://t.co/HEIotp0Zi1,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2021-04-23 07:13:01,"INCY, ","markets, ","americanbankingnews.com/?p=19565710, ",1385552282494939138,False,0,0,0,0,Zapier.com,Oppenheimer Equities Analysts Increase Earnings Estimates for Incyte Co. $INCY https://t.co/gp423imyyY #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-04-23 07:13:00,"INCY, ","stocks, ","americanbankingnews.com/?p=19565710, ",1385552279185526788,False,0,0,0,0,Zapier.com,Oppenheimer Equities Analysts Increase Earnings Estimates for Incyte Co. $INCY https://t.co/30ZyUwvqQ0 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
3664556061,2021-04-22 18:22:12,,,"pic.twitter.com/urM8HncPlt, ",1385358302914170881,False,0,0,0,0,Twitter for Android,"FLASCO hosts the Living With Myeloproliferative Neoplasms (MPN) Patient Advocacy Program, led by Dr. Andrew Kuykendall. 

We extend our sincere appreciation to our partner Incyte for their support and sponsorship of this program. https://t.co/urM8HncPlt",,,2015-09-15 10:10:46,Florida,FLASCO,https://pbs.twimg.com/profile_images/643789553975865344/l5WwzXik_normal.png,506,280,11,1013,FLASCO_ORG,photo
1290769296847667202,2021-04-22 16:48:49,,,"pic.twitter.com/fGHxdcLQin, pic.twitter.com/fGHxdcLQin, ",1385334801541042181,False,40,2,0,2,Twitter for iPhone,Congratulations to @charcole_chem for successfully defending his PhD thesis! Dr. Charles Cole made significant contributions in both method development and total synthesis in his years @UChiChemistry . Good luck for your future at Incyte in Delaware! https://t.co/fGHxdcLQin,"charcole_chem, UChiChemistry, ",,2020-08-04 17:59:53,"Chicago, IL",Snyder Lab,https://pbs.twimg.com/profile_images/1290774199817121792/1h5JED4L_normal.jpg,1123,138,3,36,SASnyderLab,photo
3911174913,2021-04-22 14:00:01,,"dermatology, vitiligo, AADVMX2021, ","pic.twitter.com/6s9F6O3LXi, ",1385292323035095041,False,5,0,0,0,Twitter Ads,"Our research in #dermatology is focused on addressing the needs of people with immune-mediated dermatologic conditions, including #vitiligo, a chronic autoimmune disease. Learn about the prevalence of vitiligo and when symptoms typically appear. #AADVMX2021 https://t.co/6s9F6O3LXi",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
325135887,2021-04-22 13:05:00,,"Atopicdermatitis, eczema, AADVMX2021, ","twitter.com/Incyte/status/‚Ä¶, ",1385278475079229445,False,3,0,0,0,Twitter Web App,"Great update! Thanks for sharing! @Incyte
#Atopicdermatitis #eczema #AADVMX2021 https://t.co/yPmlph6KqL","Incyte, ",,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
3911174913,2021-04-22 13:00:00,,"dermatology, AADVMX2021, ","pic.twitter.com/zkMjaZ46WT, ",1385277218880847875,False,13,0,0,0,Twitter Ads,"Steven Stein, M.D., Chief Medical Officer, speaks to how our discovery expertise in immunology forms the basis of our company, enabling Incyte‚Äôs work in dermatology. Learn about the research from our #dermatology portfolio that will be shared this weekend at #AADVMX2021. https://t.co/zkMjaZ46WT",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
2340177692,2021-04-22 11:42:09,,,"scrip.pharmaintelligence.informa.com/articles/2021/‚Ä¶, ",1385257627681280000,False,5,0,1,2,Twitter Web App,"Interesting results from latest Innovation &amp; Invention Index from @ideapharma . Lilly No.1 thanks to trial, drug launch metrics, with Seagen and Incyte also breaking into top 5. https://t.co/RnOLFpYkmt","ideapharma, ",,2014-02-12 06:23:48,Europe,Andrew McConaghie,https://pbs.twimg.com/profile_images/1283106639181156353/vzV0_pAG_normal.jpg,1704,4062,96,3900,awmcconaghie,
4058194633,2021-04-22 11:09:56,"INCY, ",,"google.com/amp/s/m.invest‚Ä¶, ",1385249518422167554,False,0,0,0,0,Twitter for iPhone,"$INCY Oppenheimer Maintains Buy Rating On Incyte, $110 PT https://t.co/7RqltgcERf",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
3911174913,2021-04-22 10:13:51,,"AADVMX2021, dermatology, vitiligo, ","pic.twitter.com/wsCoYySm69, ",1385235402806775817,False,25,0,1,1,Twitter Ads,"#AADVMX2021 will feature data from our #dermatology portfolio, including research on #vitiligo. Learn more about this dermatologic condition. https://t.co/wsCoYySm69",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
52354784,2021-04-22 06:10:09,,"pharma, pharmanews, ","feedproxy.google.com/~r/Pharmatimes‚Ä¶, ",1385174075748851712,False,1,0,0,0,SocialPilot.co,"Lilly, Incyte report positive results for baricitinib in alopecia areata https://t.co/FKvTqzCC6K #pharma #pharmanews",,,2009-06-30 05:46:48,"Surrey, UK",PharmaTimes,https://pbs.twimg.com/profile_images/533273520885616640/vb4_MuJ1_normal.png,53067,1318,1008,19444,PharmaTimes,
1280288213102292993,2021-04-22 05:44:29,,,"pharmabox.in/lilly-incyte-r‚Ä¶, ",1385167614079639553,False,0,0,0,0,Hootsuite Inc.,"Lilly, Incyte report positive results for baricitinib in alopecia areata https://t.co/ibYFiyPK3s",,,2020-07-06 19:51:21,,WWW.PHARMABOX.IN,https://pbs.twimg.com/profile_images/1284027505058381827/7o7Mcyq1_normal.jpg,856,450,0,5397,pharmabox_in,
1270220114340851712,2021-04-22 04:57:49,,"PharmaTwitter, MedTwitter, MedEd, ","bit.ly/More-Medical-H‚Ä¶, pharmatimes.com/news/lilly,_in‚Ä¶, ",1385155873656483844,False,0,0,0,0,Automate.io,"Lilly, Incyte report positive results for baricitinib in alopecia areata

More medical news at https://t.co/0Knf9q4SKS
#PharmaTwitter #MedTwitter #MedEd
https://t.co/yQuPQAlCQk",,,2020-06-09 01:04:18,Look here üëâ,MedPub Pharmaceutical,https://pbs.twimg.com/profile_images/1443232668716515331/xzljON0s_normal.jpg,2,69,0,3346,PharmaPublisher,
108617488,2021-04-21 22:55:01,,,"invst.ly/ujqdc, ",1385064571866656778,False,1,0,0,0,FP News Publisher - COM,Oppenheimer Stick to Their Buy Rating for Incyte Corp - https://t.co/ABntx6I8f9,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
1280938376099741697,2021-04-21 20:39:55,,"iexStock, ","iexcloud.io, pic.twitter.com/0ZgSBCG3XL, ",1385030570967769088,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Qualcomm, Inc.
-First Abu Dhabi Bank PJSC
-Abu Dhabi National Insurance
-Ras Al-Khaimah Ceramics

Data provided by https://t.co/oXreiEXTgd https://t.co/0ZgSBCG3XL",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2021-04-21 17:02:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2684784, pic.twitter.com/ET5RAepshV, ",1384975849594650625,False,0,0,0,0,Tickeron,"$INCY in +3.16% Uptrend, advancing for three consecutive days on April 15, 2021. View odds for this and other indicators: https://t.co/9vxRuj80Qe #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ET5RAepshV",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3911174913,2021-04-21 10:00:02,,"Atopicdermatitis, eczema, AADVMX2021, ","pic.twitter.com/fI5LG5KzU4, ",1384869538777423873,False,5,1,1,3,Twitter Ads,#Atopicdermatitis (#eczema) affects more than 30 million individuals in the U.S. Follow along at #AADVMX2021 to learn more about data being shared to address the needs of people with this disease. https://t.co/fI5LG5KzU4,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
337794567,2021-04-21 09:39:50,,"pharma, ","ideapharma.com/pii/, ",1384864456677724160,False,1,0,0,1,Twitter Web App,"We celebrate #pharma innovation! The 2021 Pharmaceutical Innovation and Invention Index.
Congratulations to:
1 @LillyPad
2 @Roche
3 @Regeneron
4 @SeagenGlobal
5 @Incyte
6 @GSK
7 @sanofi
8 @AstraZeneca and @pfizer
10 @GileadSciences and @Novartis
 
https://t.co/Zk4XxrwwQ6","LillyPad, Roche, Regeneron, SeagenGlobal, Incyte, GSK, sanofi, AstraZeneca, pfizer, GileadSciences, Novartis, ",,2011-07-18 11:56:12,The Netherlands,Jacqui üë©üèª‚ÄçüöÄüöÄ,https://pbs.twimg.com/profile_images/1133442410640551936/ewu_r6MR_normal.jpg,388,836,15,681,JacqBarendregt,
1199578004634165248,2021-04-21 07:01:04,,"COVID19, technologies, chemical, ","primefeed.in/news/3843714/c‚Ä¶, ",1384824501649645568,False,1,0,0,0,Twitter Web App,"The report comprises of detailed profiles of #COVID19 therapeutic products with key coverage of developmental activities including licensing &amp; collaboration deals, patents issued, #technologies and #chemical information @ https://t.co/XmxkTmjTkV",,,2019-11-27 01:37:48,india,Market Research,https://pbs.twimg.com/profile_images/1199581004240809984/t8nPviiS_normal.jpg,205,42,0,4192,PrimaryResearc2,
176742975,2021-04-21 07:00:22,,,"ideapharma.com/pii/?utm_sourc‚Ä¶, pic.twitter.com/j4vt0jxcBS, pic.twitter.com/j4vt0jxcBS, ",1384824324369027073,False,40,1,1,16,Twitter for Mac,"The 2021 Pharmaceutical Innovation and Invention Index, White Paper now available
Congratulations to:
1 @LillyPad 
2 @Roche 
3 @Regeneron 
4 @SeagenGlobal 
5 @Incyte 
6 @GSK 
7 @sanofi 
8 @AstraZeneca and @pfizer 
10 @GileadSciences and @Novartis 
https://t.co/aQMLDl9fns https://t.co/j4vt0jxcBS","LillyPad, Roche, Regeneron, SeagenGlobal, Incyte, GSK, sanofi, AstraZeneca, pfizer, GileadSciences, Novartis, ",,2010-08-10 05:30:06,,"Mike Rea, IDEA Pharma",https://pbs.twimg.com/profile_images/1332348150674317314/8xoaZYuI_normal.jpg,5514,1180,183,19924,ideapharma,photo
374729426,2021-04-20 18:03:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2682534, pic.twitter.com/tdSCxwNQY0, ",1384628715607318528,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on April 1, 2021. View odds for this and other indicators: https://t.co/ZWCeg9yOmN #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/tdSCxwNQY0",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
538402387,2021-04-20 17:01:04,,,"pic.twitter.com/xdnHiw3dLw, ",1384613109529124869,False,2,0,0,0,Hootsuite Inc.,"Congratulations to Suhani Bhatt, @newark_charter, a 2021 Catalyzing Change STEM Talent Conference Prize Winners. 
@DuPont_News 
@Incyte 
@airliquide_de 
@WSFS 
@FMCCorp 
@drone_workforce 
@choosedelaware 
@NERDiTNOW 
@FAME_Delaware https://t.co/xdnHiw3dLw","newark_charter, DuPont_News, Incyte, airliquide_de, WSFS, FMCCorp, drone_workforce, choosedelaware, NERDiTNOW, FAME_Delaware, ",,2012-03-27 14:58:09,"Newark, Delaware, USA",DESCA,https://pbs.twimg.com/profile_images/1387774824504823812/S66uJ_x0_normal.jpg,278,179,27,1864,DescaDelaware,photo
1100450877792370688,2021-04-20 16:28:38,"INCY, ",,"blueequity.io/r/200268/de-in‚Ä¶, ",1384604944796291073,False,0,0,0,0,Blue Equity,$INCY Multiple Abstracts from Incyte‚Äôs Dermatology Portfolio Accepted for Presentation at the AAD Virtual Meeting Experience https://t.co/AgjPwEx5Kj,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
3911174913,2021-04-20 11:27:34,,"dermatology, AADVMX2021, ","pic.twitter.com/mWHwEsWSHo, ",1384529178846957570,False,7,0,2,2,Twitter Web App,"Jim Lee, M.D., Ph.D., Group Vice President, Inflammation &amp; AutoImmunity, shares his perspective on our research and development work in #dermatology. Follow along to learn more about our efforts and data being presented at the upcoming #AADVMX2021 congress. (1/5) https://t.co/mWHwEsWSHo",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
4058194633,2021-04-20 09:15:20,"LLY, INCY, ","jobs, ","biospace.com/article/releas‚Ä¶, ",1384495901738082304,False,0,0,0,0,Twitter for iPhone,$LLY  $INCY  Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study | BioSpace https://t.co/0r3bZ6H8xB #jobs,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-04-20 09:13:33,"INCY, MOR, ",,"businesswire.com/news/home/2021‚Ä¶, ",1384495455145390082,False,0,0,0,0,Twitter for iPhone,$INCY $MOR Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory Follicular or Marginal Zone Lymphoma | Business Wire https://t.co/slJeTC93x8,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-04-20 09:12:17,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1384495136579543046,False,0,0,0,0,Twitter for iPhone,$INCY Multiple Abstracts from Incyte‚Äôs Dermatology Portfolio Accepted for Presentation at the AAD Virtual Meeting Experience | Business Wire https://t.co/fCq6c6gbC1,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
345555340,2021-04-20 09:05:02,,,"shar.es/aoRcVX, ",1384493311784886273,False,0,0,0,0,Twitter Web App,News for Medical Independent Sales Representatives and Medical Distributors: Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study https://t.co/EEPqeWJn1w,,,2011-07-30 15:56:45,USA,HSMN,https://pbs.twimg.com/profile_images/1469889801/globelayer_sm_normal.png,667,1802,92,6275,HSMN_com,
72928001,2021-04-20 08:52:33,"LLY, ",,"bit.ly/2QhjTa2, ",1384490167193399301,False,0,0,0,1,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) announce results from second Phase 3 trial evaluating efficacy and safety of... https://t.co/BkbP1C6GFf,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1022473214457348096,2021-04-20 08:41:26,,,"pharmashots.com/58706/lilly-an‚Ä¶, ",1384487373094875141,False,0,0,0,0,Twitter Web App,"Lilly and Incyte Report Results of Baricitinib in P-III BRAVE-AA1 Study for Severe Alopecia Areata @Pharmashot @LillyPad 
https://t.co/Jld4R3Rjo5","Pharmashot, LillyPad, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
3686628867,2021-04-20 08:31:59,,,"pharmaceuticaldaily.com/multiple-abstr‚Ä¶, ",1384484991501955082,False,0,0,0,0,WordPress.com,Multiple Abstracts from Incyte‚Äôs Dermatology Portfolio Accepted for Presentation at the AAD Virtual Meeting¬†Experience https://t.co/CGTMJRkUVr,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
3318510966,2021-04-20 08:11:32,,,"crweworld.com/article/news-p‚Ä¶, ",1384479848710606855,False,0,0,0,0,CRWE World,Multiple Abstracts from Incyte‚Äôs Dermatology Portfolio Accepted for Presentation at the AAD Virtual Meeting Experi https://t.co/uzpfdfqbRs,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2021-04-20 08:08:23,"INCY, ",,"stocktitan.net/news/INCY/mult‚Ä¶, ",1384479054942855169,False,0,0,0,0,stocktitan,"$INCY Multiple Abstracts from Incyte‚Äôs Dermatology Portfolio Accepted for Presentation at the AAD Virtual Meeting Experience
https://t.co/VfDdot17nH",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1069693680066420736,2021-04-20 08:05:47,"INCY, ",,"s.flashalert.me/Zg9p4J, ",1384478399306027011,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on April 20, 08:00:00: Multiple Abstracts from Incyte‚Äôs Dermatology Portfolio Accepted for Presentation at the AAD Virtual Meeting Experience https://t.co/tcodwEJQak",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1325115160353103872,2021-04-20 08:00:23,"INCY, ","healthcare, ","quantisnow.com/insight/632843‚Ä¶, ",1384477040502468615,False,0,0,0,0,Twitter,"$INCY üì∞ Multiple Abstracts from Incyte's Dermatology Portfolio Accepted for Presentation at the AAD Virtual Meeting Experience

https://t.co/qBp0Nep4zM

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
35789155,2021-04-20 07:56:14,"LLY, INCY, ",,"beta.firstwordpharma.com/story/5278091, ",1384475997865537538,False,1,0,0,1,TweetDeck,"Second positive read-out tees up regulatory filings for Lilly, Incyte's baricitinib in alopecia $LLY $INCY https://t.co/ANjOyzAREa",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
1006334607946649600,2021-04-20 07:13:11,,"StockMarket, Stocks, ","dlvr.it/Ry37Jc, ",1384465162573271047,False,0,0,0,0,dlvr.it,Lilly and Incyte‚Äôs Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study https://t.co/8JfVh7U1jZ #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1134049078424162304,2021-04-20 07:12:58,"LLY, INCY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1384465105845358592,False,0,0,0,0,Newsfilter.io,"Lilly, Incyte's second baricitinib study shows improvement in hair regrowth in alopecia areata patients $LLY $INCY https://t.co/jy06SXzRu0",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2021-04-20 07:11:48,"LLY, INCY, ",,"seekingalpha.com/news/3683289-l‚Ä¶, ",1384464813661687811,False,0,0,0,1,SANewsTwitter,"$LLY $INCY - Lilly, Incyte's second baricitinib study shows improvement in hair regrowth in alopecia areata patients https://t.co/aPkRwzS8Dg",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1069693680066420736,2021-04-20 07:00:53,"LLY, ",,"s.flashalert.me/7Qt12, ",1384462065885188097,False,0,0,0,0,flashalerts,"$LLY [15s. delayed]: Issued Press Release on April 20, 06:45:00: Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study https://t.co/ymCyO3rwkY",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
472650465,2021-04-20 06:59:36,"INCY, ",,"otcdynamics.com/incy-lilly-and‚Ä¶, ",1384461743846477829,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Lilly and Incyte‚Äôs Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study https://t.co/nnWSHDpHLO,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
842579741697703936,2021-04-20 06:58:21,"LLY, ",,,1384461428409585667,False,0,0,0,0,Twitter Web App,$LLY - Eli Lilly And Incyte Announce Baricitinib Improved Hair Regrowth For Alopecia Areata Patients In Second Phase 3 Study,,,2017-03-16 23:33:59,"Alexandria, Virginia",Akram Siddique,https://pbs.twimg.com/profile_images/1380335543205068801/pYf-iKUl_normal.jpg,127,266,4,2787,AkramMSiddique,
1328777031299960833,2021-04-20 06:57:59,"LLY, ",,,1384461336973742087,False,0,0,0,0,Twitter Web App,$LLY - Eli Lilly And Incyte Announce Baricitinib Improved Hair Regrowth For Alopecia Areata Patients In Second Phase 3 Study,,,2020-11-17 14:08:58,"Alexandria, Virginia",Team of Stock Traders,https://pbs.twimg.com/profile_images/1328777820743450629/0_Yn-EGb_normal.jpg,933,185,12,8168,TeamofStockTra,
2356524462,2021-04-20 06:48:47,"LLY, ",,,1384459023894958080,False,0,0,0,0,Stock News Alerts,"$LLY Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Stu
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
47519668,2021-04-20 06:48:19,"LLY, INCY, ",,"tradethenews.com/?twtId=22069, ",1384458904684351489,False,4,0,0,1,Updates Poster,"$LLY Lilly and Incyte's $INCY Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study (Eli Lilly and Co)
(More at https://t.co/slFxPA4r9Z)",,,2009-06-15 22:37:04,Global,TradeTheNews.com,https://pbs.twimg.com/profile_images/916119563191889920/ylR4h5y0_normal.jpg,21141,1222,761,53590,Trade_The_News,
284054290,2021-04-20 06:47:14,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/medic‚Ä¶, ",1384458631958212608,False,0,0,0,0,BLOX CMS for DEV,"INDIANAPOLIS, April 20, 2021 /PRNewswire/ --¬†Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today results from a second Phase 3 trial (BRAVE-AA1) evaluating the efficacy and safety of once-daily baricitinib 2-mg and 4-mg in ad‚Ä¶ https://t.co/ZiX3K4LOmo",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
3318510966,2021-04-20 06:46:35,,,"crweworld.com/article/news-p‚Ä¶, ",1384458466509557768,False,0,0,0,0,CRWE World,Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study https://t.co/j8PCOAK4Bd,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2021-04-20 06:45:23,"INCY, LLY, ",,"stocktitan.net/news/INCY/lill‚Ä¶, ",1384458168168747008,False,0,0,0,0,stocktitan,"$INCY $LLY Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
https://t.co/ouhja2EGqT",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1325115160353103872,2021-04-20 06:45:09,"INCY, LLY, ","healthcare, majorpharmaceuticals, ","quantisnow.com/insight/632255‚Ä¶, ",1384458107728797696,False,0,0,0,0,Twitter,"$INCY $LLY üì∞ Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study

https://t.co/Ud3EVZM3zi

#healthcare #majorpharmaceuticals",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1889492676,2021-04-20 06:00:32,"INCY, MOR, ","Incyte, MorphoSys, nMIND, Tafasitamab, Lenalidomide, Rituximab, Relapsed, Refractory, Follicular, MarginalZoneLymphoma, ","1stoncology.com/blog/incytemor‚Ä¶, ",1384446877974728704,False,0,0,1,0,Troi URL Plug-in,#Incyte and #MorphoSys Announce First Patient Dosed in Phase 3 #nMIND Study Evaluating the Addition of #Tafasitamab to #Lenalidomide and #Rituximab in #Relapsed or #Refractory #Follicular or #MarginalZoneLymphoma $INCY $MOR https://t.co/V9cUQf3r1F,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
347315451,2021-04-20 03:09:01,,,"eqs-cockpit.com/cgi-bin/fncls.‚Ä¶, ",1384403713792659456,False,3,0,1,0,Twitter Web App,"MorphoSys and Incyte Announce First Patient Dosed in Phase 3 in MIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory FL or MZL
https://t.co/QUVXUgPltG",,,2011-08-02 12:17:10,Berlin,BIO Deutschland,https://pbs.twimg.com/profile_images/801026554834878465/TZRcLWOl_normal.jpg,4612,2717,178,29124,BIODeutschland,
1022473214457348096,2021-04-20 02:32:18,,,"pharmashots.com/58670/incyte-a‚Ä¶, ",1384394475229696008,False,0,0,0,0,Twitter Web App,"Incyte and MorphoSys Report First Patient Dosing in P-III inMIND Study for Relapsed or Refractory Follicular or Marginal Zone Lymphoma @Pharmashot @Incyte 
https://t.co/C42xKXJrEs","Pharmashot, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
1134049078424162304,2021-04-19 21:18:54,"INCY, MOR, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1384315605562667011,False,1,0,0,0,Newsfilter.io,Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Rel.. $INCY $MOR $MOR https://t.co/ZVIVNRH3A0,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3686628867,2021-04-19 20:31:54,,,"pharmaceuticaldaily.com/incyte-and-mor‚Ä¶, ",1384303779978170368,False,1,0,0,0,WordPress.com,Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory Follicular or Marginal Zone¬†Lymphoma https://t.co/PuExVXJYdw,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1134049078424162304,2021-04-19 20:16:54,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1384300001723969544,False,0,0,0,0,Newsfilter.io,Incyte and Morphosys dose first patient in late-stage lymphoma study $INCY $MOR https://t.co/4IdM9PQlnY,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
916335048,2021-04-19 19:27:51,,"Business, HealthMedicine, MarketingSales, PharmaceuticalsBiotech, ","dlvr.it/Ry1QvV, pic.twitter.com/di7nHbbWvj, ",1384287661049868293,False,0,0,0,0,dlvr.it,"Bile Duct Neoplasms Market: Industry trends, Drugs, Companies and Analysis | Agios Pharmaceuticals, Incyte Corporation, Delcath Systems, QED Therapeutics, Nucana and Others https://t.co/nbLxRko6ho #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech https://t.co/di7nHbbWvj",,,2012-10-31 03:27:23,,ABNewswire,https://pbs.twimg.com/profile_images/3568218059/4649a03b94d5a22697cd7f8bfd4a284c_normal.png,1052,132,139,368959,ABNewswire,photo
960403142197248000,2021-04-19 19:10:09,,,"pressrelease.cc/2021/04/19/bil‚Ä¶, ",1384283203758813184,False,0,0,0,0,WordPress.com,"Bile Duct Neoplasms Market: Industry trends, Drugs, Companies and Analysis | Agios Pharmaceuticals, Incyte Corporation, Delcath Systems, QED Therapeutics, Nucana and¬†Others https://t.co/ChtpR2qJTt",,,2018-02-05 01:42:07,"Dallas, TX",PressRelease.cc,https://pbs.twimg.com/profile_images/1120211264360337408/hhR28Cwc_normal.png,1081,1362,10,255874,PressRelease_cc,
72928001,2021-04-19 18:19:25,"INCY, ",,"bit.ly/3xa4Gbd, ",1384270439195713537,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte and MorphoSys AG (MOR) announce that the first patient has been dosed in the placebo-controlled Phase... https://t.co/eZ8E6GOZwq,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1006334607946649600,2021-04-19 18:07:33,,,"dlvr.it/Ry1F7x, ",1384267452507250694,False,0,0,0,0,dlvr.it,MorphoSys and Incyte Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory Follicular or Marginal Zone Lymphoma https://t.co/ZfotOLWkf3,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
33467057,2021-04-19 17:39:14,,"clinicaltrial, lymphoma, ","bit.ly/3ejFqXu, pic.twitter.com/h1HSo7wue0, ",1384260327068499975,False,6,0,2,0,Twitter Web App,"Today, we announced in partnership with @Incyte the initiation of the Phase 3 inMIND #clinicaltrial for our CD19 antibody in patients with relapsed/refractory follicular #lymphoma or marginal zone lymphoma. https://t.co/LXjtamC5jv https://t.co/h1HSo7wue0","Incyte, ",,2009-04-20 05:13:43,"Planegg, Germany",MorphoSys,https://pbs.twimg.com/profile_images/1414967751538511873/dOJDE_2G_normal.jpg,1563,205,37,315,MorphoSys,photo
3318510966,2021-04-19 17:00:31,,,"crweworld.com/article/news-p‚Ä¶, ",1384250580349034508,False,0,0,0,0,CRWE World,MorphoSys and Incyte Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to  https://t.co/0SSaD93DCj,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1355145938793361411,2021-04-19 16:37:39,"INCY, ","Stocks, Trading, TradingNews, StockMarketNews, PQNews, ","pqn.li/ze3, ",1384244827429105664,False,0,0,0,0,Twitter,"$INCY

First patient dosed in late-stage lymphoma study
https://t.co/sW8oNb5UWs

#Stocks #Trading #TradingNews #StockMarketNews #PQNews",,,2021-01-29 08:29:08,,PorqueNo Trade,https://pbs.twimg.com/profile_images/1355146131760685057/mPy7D_os_normal.jpg,25,224,0,1886,PorqueNoTrade,
472650465,2021-04-19 16:23:48,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1384241341979258885,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory Follicular or Marginal Zone Lym https://t.co/ZUJHkni5Gh,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
4058194633,2021-04-19 16:22:56,"INCY, MOR, ",,"finance.yahoo.com/news/incyte-mo‚Ä¶, ",1384241124496138247,False,0,0,1,0,Twitter for iPhone,$INCY $MOR Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory Follicular or Marginal Zone Lymphoma https://t.co/UyJQS4AAyI,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1325115160353103872,2021-04-19 16:16:46,"INCY, MOR, ","healthcare, majorpharmaceuticals, ","quantisnow.com/insight/630112‚Ä¶, ",1384239571941019652,False,0,0,0,0,Twitter,"$INCY $MOR üì∞ MorphoSys and Incyte Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory Follicular or Marginal Zone Lymphoma

https://t.co/mWtVu0WMkS

#healthcare #majorpharmaceuticals",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1325115160353103872,2021-04-19 16:15:06,"INCY, MOR, ","healthcare, majorpharmaceuticals, ","quantisnow.com/insight/629991‚Ä¶, ",1384239152682586116,False,0,0,0,0,Twitter,"$INCY $MOR üì∞ Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory Follicular or Marginal Zone Lymphoma

https://t.co/deyjGEiYJs

#healthcare #majorpharmaceuticals",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
3318510966,2021-04-19 16:10:56,,,"crweworld.com/article/news-p‚Ä¶, ",1384238104937041931,False,0,0,0,0,CRWE World,Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to  https://t.co/FQIJsvvF4F,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1117802764086779904,2021-04-19 16:04:09,"INCY, MOR, ",,"businesswire.com/news/home/2021‚Ä¶, ",1384236396970319884,False,0,0,0,0,Twitter Web App,Incyte $INCY and MorphoSys $MOR Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory Follicular or Marginal Zone Lymphoma https://t.co/yG6Fi0zmTP,,,2019-04-15 10:52:01,"Lyon, France",biotechradar.eu,https://pbs.twimg.com/profile_images/1118071131532079104/p9ON7wNG_normal.png,1535,122,25,8486,biotechradar_eu,
213137160,2021-04-19 16:03:10,,,"dlvr.it/Ry0xvf, pic.twitter.com/un4s34jT8z, ",1384236148810141698,False,0,0,0,0,dlvr.it,PRESS RELEASE: MorphoSys and Incyte Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory FL or MZL https://t.co/FjNsQvQQ35 https://t.co/un4s34jT8z,,,2010-11-07 21:12:11,"San Diego, CA",Sniff Out Stocks,https://pbs.twimg.com/profile_images/1162213671/big_dog_nose_normal.jpg,3611,3936,82,49949,SniffOutStocks,photo
213137160,2021-04-19 16:03:07,,,"dlvr.it/Ry0xv0, pic.twitter.com/e2yz2jlUad, ",1384236135757467655,False,0,0,0,0,dlvr.it,PRESS RELEASE: MorphoSys and Incyte Announce -2- https://t.co/e34h2Wo5jT https://t.co/e2yz2jlUad,,,2010-11-07 21:12:11,"San Diego, CA",Sniff Out Stocks,https://pbs.twimg.com/profile_images/1162213671/big_dog_nose_normal.jpg,3611,3936,82,49949,SniffOutStocks,photo
213137160,2021-04-19 16:03:05,,,"dlvr.it/Ry0xpk, pic.twitter.com/a4fxHC09v7, ",1384236126643179523,False,0,0,0,0,dlvr.it,MorphoSys¬†: and Incyte Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory FL or MZL https://t.co/fj0oUubrWK https://t.co/a4fxHC09v7,,,2010-11-07 21:12:11,"San Diego, CA",Sniff Out Stocks,https://pbs.twimg.com/profile_images/1162213671/big_dog_nose_normal.jpg,3611,3936,82,49949,SniffOutStocks,photo
42410755,2021-04-19 16:02:22,,,"dgap.de/dgap/News/corp‚Ä¶, ",1384235948536332302,False,0,0,0,0,DGAP_News_Int,MorphoSys and Incyte Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of... https://t.co/Ji9xfez76Y,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
1254035253104181256,2021-04-19 16:01:43,"INCY, MOR, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1384235784488714249,False,0,0,0,0,stocktitan,"$INCY $MOR Incyte and MorphoSys Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory Follicular or Marginal Zone Lymphoma
https://t.co/B6SxiRknCv",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
980998848,2021-04-19 13:00:51,,"EarthDay, sustainability, ","pic.twitter.com/abDyrKK2aN, ",1384190265678655494,False,2,0,0,0,Hootsuite Inc.,"This week leading up to #EarthDay, we have an increased awareness of the environment as well as our health. Let's spotlight Green Globes certifications we've done over the last year for @chemours @mainlinehealth and @Incyte on their #sustainability achievements. https://t.co/abDyrKK2aN","chemours, mainlinehealth, Incyte, ",,2012-11-30 13:45:12,"West Chester, PA",JL Architects,https://pbs.twimg.com/profile_images/458986516841127938/EryLDgD1_normal.jpeg,138,407,0,1002,JLArchitects,photo
4058194633,2021-04-19 10:29:07,"INCY, ",,"trefis.com/data/companies‚Ä¶, ",1384152082165293061,False,0,0,0,0,Twitter for iPhone,$INCY Buy or Fear Incyte‚Äôs Stock: INCY‚Äôs 17% Decline In A Year Despite Revenues Increasing 17% YoY Over The Last 4 Quarters Looks Like A Buying Opportunity https://t.co/mCjYb2a6Z3,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
725577499,2021-04-19 07:25:32,"LLY, ",,"tipranks.com/news/eli-lilly‚Ä¶, ",1384105881986420742,False,1,0,0,0,Twitter Web App,"Eli Lilly And Incyte‚Äôs Baricitinib Fails To Meet Endpoint In Phase 3 COVID-19 Trial
https://t.co/CxDsvewwC0
$LLY",,,2012-07-30 03:57:38,,TipRanks,https://pbs.twimg.com/profile_images/1445275766195884032/dO0joyh1_normal.jpg,25516,1242,436,23612,TipRanks,
1056278376628056064,2021-04-19 07:18:08,,"trademoneta, stockmarket, ","tny.app/1ctsCPoA, pic.twitter.com/favcre0XIE, ",1384104022089469959,False,0,0,0,0,Integromat,Eli Lilly And Incyte‚Äôs Baricitinib Fails To Meet Endpoint In Phase 3 COVID-19 Trial https://t.co/yGGFFqBulm #trademoneta #stockmarket https://t.co/favcre0XIE,,,2018-10-27 16:16:04,"London, England",Trade Moneta,https://pbs.twimg.com/profile_images/1381619299274665996/tfXGyJKa_normal.jpg,124,242,1,31094,TradeMoneta,photo
1022473214457348096,2021-04-19 03:32:36,,,"pharmashots.com/58625/lilly-an‚Ä¶, ",1384047264499261447,False,0,0,0,0,Twitter Web App,"Lilly and Incyte Report Results of Baricitinib in P-III COV-BARRIER Study for Hospitalized Patients with COVID-19 @Pharmashot @LillyPad @Incyte 
https://t.co/hEto9EXLta","Pharmashot, LillyPad, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
1325446129325142016,2021-04-19 03:30:34,"LLY, LLY, INCY, ",,"seekingalpha.com/news/3682728-l‚Ä¶, ",1384046749170290688,False,0,0,0,0,Integromat,$LLY $LLY $INCY - Lilly and Incyte's baricitinib fails to meet main goal in late-stage COVID-19 trial https://t.co/pUY4KZQz7X,,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
374729426,2021-04-18 17:25:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2677807, pic.twitter.com/t1kqO4heqU, ",1383894520853516288,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on April 1, 2021. View odds for this and other indicators: https://t.co/n2RKeMutVc #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/t1kqO4heqU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1022006086872821762,2021-04-18 04:01:38,"INCY, INCY, ",,,1383692182117253123,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Fri Apr 16
Closed at 82.68 USD for a -0.62% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
1664222006,2021-04-18 02:03:05,,"IncyteIngenuityAwardProgram, GVHD, ","bit.ly/3goMB3l, ",1383662347932233733,False,1,0,0,1,Twitter Web App,"Expanded 2021 Incyte Ingenuity Award Program
Read more: https://t.co/FVnbn6dPjV
#IncyteIngenuityAwardProgram #GVHD",,,2013-08-12 01:20:15,"Brisbane, Queensland",Health Radio Online,https://pbs.twimg.com/profile_images/378800000381754409/ae483ad62930125687b2c1032aa530b9_normal.png,1288,2397,46,6105,HealthProRadio,
1486117886,2021-04-17 15:35:08,,,"a.msn.com/00/en-us/BB1fJ‚Ä¶, ",1383504319790477317,False,0,0,0,0,Twitter Web App,BRIEF-Lilly And Incyte Announce Results From The Phase 3 Cov-Barrier Study Of Baricitinib In Hospitalized Covid-19 Patients https://t.co/0lyOdPHGfs,,,2013-06-05 17:52:49,,Baronian Consulting,https://pbs.twimg.com/profile_images/1194650962822094849/9ytZKbib_normal.jpg,1219,5001,798,597209,BaronianConsult,
826048234208501760,2021-04-17 11:59:41,,,"financenews.site/todays-roof-le‚Ä¶, ",1383450099024490500,False,0,0,0,0,WordPress.com,Today‚Äôs Roof Leaker Stock Is Incyte¬†(INCY) https://t.co/CBPZuvaHz9,,,2017-01-30 07:43:41,"Toronto, Ontario",StaylI,https://pbs.twimg.com/profile_images/1297237371600150533/Lja90-Wj_normal.jpg,2000,835,1,30740,staylibusiness,
3159953704,2021-04-17 10:49:43,"LLY, INCY, ",,"twitter.com/LillyPad/statu‚Ä¶, ",1383432492271636480,False,2,0,0,1,Twitter for iPhone,$LLY $INCY Eli Lilly and Incyte was another overhyped and rushed phase 3 antiviral trial failure with Baricitinib. Typical! https://t.co/1NmOknYYEg,,,2015-04-12 10:08:08,"New York, NY",ms101phd,https://pbs.twimg.com/profile_images/587945301182251008/r1TmrhyZ_normal.jpg,1026,344,19,37944,ms101phd,
1134049078424162304,2021-04-17 02:10:25,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1383301806910959616,False,0,0,0,0,Newsfilter.io,Incyte: What Falling Off A Cliff Looks Like $INCY https://t.co/pqhRaaKTJ6,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
4873590352,2021-04-16 21:18:27,,,"opusip.co.uk/2021/04/16/inc‚Ä¶, ",1383228328371392512,False,0,0,0,0,OPUSIP_Post2Tweet,"https://t.co/8JA69ud3f5 Incyte: What Falling Off A (Patent) Cliff Looks Like - Seeking Alpha 
Incyte: What Falling Off A (Patent) Cliff ...",,,2016-02-03 04:04:34,"Stockport, Manchester, UK",opusipuk,https://pbs.twimg.com/profile_images/786501742238265345/Aq3SaLiu_normal.jpg,92,21,1,78541,opusipuk,
1280938376099741697,2021-04-16 18:57:15,,"iexStock, ","iexcloud.io, pic.twitter.com/kI5VmBG1g0, ",1383192796471906304,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Arkan Building Materials
-Abu Dhabi Islamic Bank
-National Bank of Ras Al Khaimah
-Incyte Corp.
-Ras Al Khaima Properties Co.

Data provided by https://t.co/oXreiEXTgd https://t.co/kI5VmBG1g0",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1138312924269862916,2021-04-16 18:07:04,,,"pic.twitter.com/vaFfERkrfN, ",1383180166436904960,False,2,0,0,1,Twitter Web App,Happy Anniversary Pemazyre.  Thank you Incyte!!!! This beautiful thank you can be seen on 295 .5 miles from the DE Memorial Bridge in DE.  This was part of the We are Thankful project...a patient led initiative to show thanks to those fighting so hard for us. https://t.co/vaFfERkrfN,,,2019-06-11 01:12:04,,Cholangio Warrior,https://pbs.twimg.com/profile_images/1446242650462556162/3Ol_Cu_a_normal.jpg,185,436,0,1065,Cholangiocarci2,photo
119973528,2021-04-16 17:27:02,,,"seekingalpha.com/article/441865‚Ä¶, ",1383170092339384321,False,0,0,0,0,dlvr.it,Incyte: What Falling Off A (Patent) Cliff Looks Like - Seeking Alpha https://t.co/ePCRAeGvkw,,,2010-03-04 22:15:07,"Tokyo, JAPAN",patesalo,https://pbs.twimg.com/profile_images/947120342325010432/eNf9qdhZ_normal.jpg,1549,4,146,374679,patesalo_e,
1254906887490936845,2021-04-16 16:52:29,"INCY, ",,"quantdata.us/news/20667611, ",1383161396058263559,False,0,0,0,0,Quant Data (Production),"Incyte Corp Trial Did Not Meet Statistical Significance On Primary Endpoint

Related Tickers: $INCY
Read more at: https://t.co/Z7qrfq34mm",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
1134049078424162304,2021-04-16 16:50:23,"LLY, INCY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1383160868028956677,False,0,0,0,0,Newsfilter.io,Lilly and Incyte's baricitinib fails to meet main goal in late-stage COVID-19 trial $LLY $INCY https://t.co/6cNyVOuqiM,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2021-04-16 16:47:21,"LLY, LLY, INCY, ",,"seekingalpha.com/news/3682728-l‚Ä¶, ",1383160103981834242,False,0,0,0,1,SANewsTwitter,$LLY $LLY $INCY - Lilly and Incyte's baricitinib fails to meet main goal in late-stage COVID-19 trial https://t.co/uZWYxz44Yv,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
284054290,2021-04-16 16:46:19,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/medic‚Ä¶, ",1383159843368865794,False,0,0,0,0,BLOX CMS for DEV,"Randomized, double-blind, placebo-controlled study of 1,525 patients did not meet statistical significance on primary composite endpoint (progression to non-invasive ventilation or invasive mechanical ventilation or death). https://t.co/ihnT4tIPXj",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
374729426,2021-04-16 16:12:24,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2673254, pic.twitter.com/cBYHMBSd9n, ",1383151308182482944,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/sQUk4tQh12 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/cBYHMBSd9n,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
963495628545327104,2021-04-16 09:38:29,"INCY, INCY, ",,"stck.pro/news/INCY/1234‚Ä¶, stck.pro/news/INCY, ",1383052176906420228,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte: What Falling Off A (Patent) Cliff Looks Like https://t.co/TCHNd4q0AO Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
23059499,2021-04-16 09:30:31,"INCY, ","trading, economy, finance, ","seekingalpha.com/article/441865‚Ä¶, ",1383050172498776067,False,3,0,0,0,SAArticlesTwitter,$INCY - Incyte: What Falling Off A (Patent) Cliff Looks Like. https://t.co/rlAf3BlMHC #trading #economy #finance,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
219017158,2021-04-16 09:20:54,,"invovation, invention, ","fortune.com/2021/04/16/top‚Ä¶, ",1383047751861202949,False,4,0,0,1,Twitter Web App,"IDEA Pharma‚Äôs 10th annual Pharmaceutical Innovation Index in @Fortune may have @LillyPad at the top, but @Incyte (5 &amp; 2) on #invovation &amp; #invention seems to be getting the most bank for its buck per employee https://t.co/YrMX51DZHb","Fortune, LillyPad, Incyte, ",,2010-11-23 13:21:54,"Erie, PA",Rob Wright,https://pbs.twimg.com/profile_images/1197543129966096385/QO_-BYPG_normal.jpg,7455,135,453,54030,RfwrightLSL,
772471873539977217,2021-04-16 08:29:54,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1383034917332848640,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form DEF 14A https://t.co/gf3YyQXWnu,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
4876582225,2021-04-16 08:26:56,"INCY, ",,"ideas.quantcha.com/2021/04/16/sto‚Ä¶, ",1383034171312918530,False,0,0,0,0,WordPress.com,StockTwits Trending Alert: Trading recent interest in INCYTE¬†$INCY https://t.co/wfb6FB7BrL,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
1171873456276889600,2021-04-16 08:17:50,"INCY, ","INCY, DEFA14A, Incyte, Proxy, ","docoh.com/filing/879169/‚Ä¶, ",1383031879033577474,False,0,0,0,0,Investor Feed,"$INCY  DEFA14A  Incyte   (16 Apr, 8:16am)

üìÑ Additional proxy soliciting materials

https://t.co/w8u0T6rWwc

#INCY #DEFA14A #Incyte #Proxy",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1325115160353103872,2021-04-16 08:17:23,"INCY, ","healthcare, ","quantisnow.com/insight/623625‚Ä¶, ",1383031765955092483,False,0,0,0,0,Twitter,"$INCY üìú SEC Form DEFA14A filed by Incyte Corporation

https://t.co/AgcIHhIjuu

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1325115160353103872,2021-04-16 08:16:41,"INCY, ","healthcare, ","quantisnow.com/insight/623622‚Ä¶, ",1383031589710356480,False,0,0,0,0,Twitter,"$INCY üìú SEC Form DEF 14A filed by Incyte Corporation

https://t.co/RbZRzJBPIk

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
4312114277,2021-04-16 08:16:29,"INCY, ",,"fintel.io/sf/us/incy?utm‚Ä¶, ",1383031542059053057,False,0,0,0,0,Fintel.io,$INCY / Incyte files form DEF 14A https://t.co/Oc4NyYycjO,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
812004702594486272,2021-04-16 05:01:06,,,"checkrare.com/overview-of-sq‚Ä¶, ",1382982371281141760,False,0,0,0,0,Hootsuite Inc.,"Lance Leopold, MD, Group Vice President, Immuno-Oncology, at Incyte gives an overview of squamous cell carcinoma of the anal canal (SCAC).
@Incyte 
https://t.co/HXjJ5sP65q","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
374729426,2021-04-15 17:31:25,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2671020, pic.twitter.com/F51gBHdykD, ",1382808805453430784,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/md46ZxBOrt #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/F51gBHdykD,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
538402387,2021-04-15 14:01:24,,,"pic.twitter.com/9b8zlUf1xf, pic.twitter.com/9b8zlUf1xf, pic.twitter.com/9b8zlUf1xf, ",1382755952231862280,False,6,0,1,0,Hootsuite Inc.,"Congratulations to Faith Skinner from @AppoHigh one of our 2021 Catalyzing Change STEM Talent Conference Prize Winners, with her prize.
@DuPont_News @Incyte @airliquide_de @WSFS @FMCCorp @choosedelaware @NERDiTNOW @FAME_Delaware https://t.co/9b8zlUf1xf","AppoHigh, DuPont_News, Incyte, airliquide_de, WSFS, FMCCorp, choosedelaware, NERDiTNOW, FAME_Delaware, ",,2012-03-27 14:58:09,"Newark, Delaware, USA",DESCA,https://pbs.twimg.com/profile_images/1387774824504823812/S66uJ_x0_normal.jpg,278,179,27,1864,DescaDelaware,photo
24753832,2021-04-15 13:40:00,,"AACR21, Cholangiocarcinoma, ","cancerdiscovery.aacrjournals.org/content/11/2/3‚Ä¶, ",1382750567768940545,False,2,0,0,1,Twitter Web App,"If you're watching the #AACR21 Panel on Biliary Tract Cancers, see this recent @CD_AACR paper: Clinicogenomic analysis of FGFR2-rearranged #Cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib @Incyte https://t.co/4PG7XX5BP5","CD_AACR, Incyte, ",,2009-03-16 15:42:02,"Philadelphia, PA",Elizabeth McKenna,https://pbs.twimg.com/profile_images/1222534020401070085/1pcKirqM_normal.jpg,5802,2563,28,5219,ElizSMcKenna,
373351502,2021-04-14 08:25:27,,"ClinicalResearch, ClinicalTrials, DataManagement, EDC, ","trialstat.com/2021/04/lilly-‚Ä¶, ",1382309020636168192,False,1,0,0,0,TrialStat-WP2Twtr,"Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients

https://t.co/5iZPzlYBFN

#ClinicalResearch #ClinicalTrials #DataManagement #EDC",,,2011-09-14 08:39:14,"Toronto, On, Canada",Trialstat Solutions,https://pbs.twimg.com/profile_images/1225452754673586176/m7P2CQ6-_normal.jpg,11,11,2,700,TrialStatEDC,
1134049078424162304,2021-04-14 01:43:20,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1382207825103966208,False,0,0,0,0,Newsfilter.io,Incyte to Report First Quarter Financial Results $INCY https://t.co/niy9kzmuNb,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
2344420430,2021-04-13 16:29:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1382068420443770887,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/tmYOzRgLpl",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1100450877792370688,2021-04-13 14:57:20,"INCY, ",,"blueequity.io/r/196479/de-in‚Ä¶, ",1382045254195449857,False,0,0,0,0,Blue Equity,$INCY Incyte to Report First Quarter Financial Results https://t.co/2djeO7tkg7,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
374729426,2021-04-13 11:48:21,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2665772, pic.twitter.com/LNoFwbc1Bn, ",1381997696597204993,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator leaves overbought zone. View odds for this and other indicators: https://t.co/XQp4jvIZeT #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/LNoFwbc1Bn,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
976297820532518914,2021-04-13 08:05:37,,,"dlvr.it/RxZBqF, pic.twitter.com/hov9LnKUZD, ",1381941643431972869,False,0,0,0,0,dlvr.it,Incyte to Report First Quarter Financial Results https://t.co/6BR0q195yK https://t.co/hov9LnKUZD,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2021-04-13 08:02:00,"INCY, ",,"s.flashalert.me/4K5fK, ",1381940733318471681,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on April 13, 08:00:00: Incyte to Report First Quarter Financial Results https://t.co/9BLhWdw8Xi",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1254035253104181256,2021-04-13 08:00:27,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1381940342157676553,False,0,0,0,0,stocktitan,"$INCY Incyte to Report First Quarter Financial Results
https://t.co/2NWOB5vbBr",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
244775645,2021-04-13 04:50:31,,,"investor.lilly.com/news-releases/‚Ä¶, bddy.me/34A62hy, pic.twitter.com/FEtJ1ONeFK, ",1381892543118467074,False,1,0,0,0,Twitter for iPhone,"Mixed results for baricitinib trial in COVID-19 inpatients
https://t.co/bsytcJjUlq

Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/FEtJ1ONeFK",,,2011-01-29 22:22:56,,Gerald R. Businaro,https://pbs.twimg.com/profile_images/1262053717630738434/-0KG84gE_normal.jpg,430,481,5,97800,grbusinaro,photo
1252673395931721730,2021-04-13 01:27:44,,,"investor.lilly.com/news-releases/‚Ä¶, pic.twitter.com/bmpCIQwyHX, ",1381841513357832200,False,0,0,0,0,Twitter for iPhone,"Mixed results for baricitinib trial in COVID-19 inpatients
https://t.co/vy5hY7cGuw https://t.co/bmpCIQwyHX",,,2020-04-21 15:00:12,Mumbai/ India,Dr Sandeep Rai,https://pbs.twimg.com/profile_images/1252673838481117185/9Zi6KqHE_normal.jpg,540,1059,1,515,DrSandeepRai2,photo
1188909056272019456,2021-04-12 15:48:42,,"baricitinib, alopecia, hair, Aauthority, ","ow.ly/toIE50EmM4P, pic.twitter.com/4YZNTbNtwP, ",1381695793913077764,False,1,0,0,0,Twitter Web App,"Eli Lilly and Incyte announce results from phase 3 study evaluating #baricitinib 2 mg and 4 mg for the treatment of #alopecia areata, making it the first phase 3 study with top-line results in patients with the #hair disorder. https://t.co/C7bs5KaoKe #Aauthority @LillyPad @Incyte https://t.co/4YZNTbNtwP","LillyPad, Incyte, ",,2019-10-28 16:03:11,"Cleveland, OH / Cranbury, NJ",Aesthetic Authority,https://pbs.twimg.com/profile_images/1402736618298122240/996IOFpP_normal.jpg,873,98,4,973,AestheticAuth,photo
23059499,2021-04-12 15:06:44,"INCY, ","business, stockmarket, finance, ","seekingalpha.com/article/441869‚Ä¶, ",1381685232248623105,False,1,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation (INCY) Presents at AACR Virtual Meeting 2021 - Slideshow. https://t.co/0UtBMJrqFu #business #stockmarket #finance,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1308886229115641858,2021-04-12 06:33:57,"bctx, ",,"pic.twitter.com/ujUJXPOGfI, pic.twitter.com/ujUJXPOGfI, ",1381556187439755264,False,2,0,0,0,Twitter for iPhone,$bctx corporate collaboration with  Incyte ü§îü§î https://t.co/ujUJXPOGfI,,,2020-09-23 17:49:43,"Madrid, Spain",Javi,https://pbs.twimg.com/profile_images/1393666863637401603/R5w6JOIj_normal.jpg,339,53,2,3387,laislaoutofco,photo
633824212,2021-04-12 05:15:02,,,"ift.tt/328xd2W, Theflyonthewall.com, ",1381536324616867840,False,0,0,0,0,IFTTT,"Incyte to hold a conference call https://t.co/Kl1fecqJI2 See the rest of the story here.

https://t.co/tnMXlCjEqv provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, prof‚Ä¶",,,2012-07-12 11:31:45,NYC,flylemurs,https://pbs.twimg.com/profile_images/2393843079/wc5oiacqodhfzivmyvmh_normal.jpeg,37,32,4,129630,flylemurs,
108617488,2021-04-11 22:00:06,,,"invst.ly/ufonf, ",1381426873532571649,False,0,0,0,0,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/R45ANRhpE8,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
108617488,2021-04-11 21:55:13,,,"invst.ly/ufol8, ",1381425641925529601,False,0,0,0,0,FP News Publisher - COM,RBC Capital Stick to Their Hold Rating for Incyte Corp - https://t.co/zfexVFQiki,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
982799243202125824,2021-04-11 21:02:00,,,"prnewswire.com/news-releases/‚Ä¶, ",1381412249080889347,False,0,0,0,0,IFTTT,Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis - PRNewswire https://t.co/UwjCHKTtvt,,,2018-04-07 21:56:13,United States,CRE Health,https://pbs.twimg.com/profile_images/982799950730809345/lBT1QaYq_normal.jpg,8,27,0,5183,crehealth_,
374729426,2021-04-11 18:31:37,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2661840, pic.twitter.com/38PX9Tp1OK, ",1381374406623027201,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 10, 2021. View odds for this and other indicators: https://t.co/RVbh07GjBD #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/38PX9Tp1OK",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2667318770,2021-04-11 09:10:02,,,"buff.ly/3a405h7, pic.twitter.com/gcrJVK5Jx5, ",1381233079331782658,False,0,0,0,0,Buffer,Eli Lilly-Incyte's Baricitinib Study In Hospitalized COVID-19 Patients Fails To Meet Main Goal https://t.co/1DpvdIODIB https://t.co/gcrJVK5Jx5,,,2014-07-21 18:11:39,"Chicago, IL",Piggy Bank People,https://pbs.twimg.com/profile_images/744965091251097600/qu-N-TUY_normal.jpg,5828,4911,290,72096,PiggyBankPeople,photo
49174675,2021-04-11 02:58:54,"BCTX, INCY, GLSI, ","cancercure, Briacell, Incyte, Bria, fuckcancer, ","pic.twitter.com/WTzrgrcZuo, pic.twitter.com/WTzrgrcZuo, ",1381139677894352898,False,1,0,1,0,Twitter for iPhone,$ results from some shit I don‚Äôt understand. $BCTX I understand stock charts not the same level as #cancercure #Briacell #Incyte $INCY COLLABORATED ON #Bria-IMT #fuckcancer $GLSI https://t.co/WTzrgrcZuo,,,2009-06-20 20:41:25,"Highlands Ranch, CO",Wu Tang Financial Technologies,https://pbs.twimg.com/profile_images/1348038906097242113/6cx7mnDm_normal.jpg,186,77,2,760,WuTangFinTech,photo
49174675,2021-04-11 02:45:11,"BCTX, INCY, ","Briacell, INCYTE, ","cattendee.abstractsonline.com/meeting/9325/P‚Ä¶, pic.twitter.com/1I8E3MqYP6, ",1381136225654956035,False,1,0,1,0,Twitter for iPhone,$BCTX #Briacell $INCY #INCYTE collaborate on BRIA-IMT HERES TYE RESULTS FOR &lt;b&gt;Predictors of response to a modified whole tumor cell immunotherapy in patients with advanced breast cancer from two phase I/IIa trials&lt;/b&gt; https://t.co/LL7fthnern https://t.co/1I8E3MqYP6,,,2009-06-20 20:41:25,"Highlands Ranch, CO",Wu Tang Financial Technologies,https://pbs.twimg.com/profile_images/1348038906097242113/6cx7mnDm_normal.jpg,186,77,2,760,WuTangFinTech,animated_gif
2667318770,2021-04-11 02:34:49,,,"bit.ly/2OEFw3l, pic.twitter.com/EOTW3K6hAx, ",1381133620270743552,False,0,0,0,0,Content Carnivores,Eli Lilly-Incyte's Baricitinib Study In Hospitalized COVID-19 Patients Fails To Meet Main Goal https://t.co/e3X3P9ugHi https://t.co/EOTW3K6hAx,,,2014-07-21 18:11:39,"Chicago, IL",Piggy Bank People,https://pbs.twimg.com/profile_images/744965091251097600/qu-N-TUY_normal.jpg,5828,4911,290,72096,PiggyBankPeople,photo
1323078491538034688,2021-04-10 21:40:44,,"biotech, pharma, COVID, AI, NLP, baricitinib, ","prn.to/3uGuJoB, pic.twitter.com/KIzOA85Hvs, ",1381059610082078721,False,0,1,0,0,Twitter Web App,"Top 30 keywords from #biotech #pharma news about #COVID-19 last week (Apr. 5-) using #AI and #NLP
Learn more:
#baricitinib + standard of care, including corticosteroids and remdesivir, resulted in reduction of death from any cause by 38 % https://t.co/1saLvPyZrL https://t.co/KIzOA85Hvs",,,2020-11-01 20:44:39,"Tokyo, Japan",Bio Pharma Innovation Trend,https://pbs.twimg.com/profile_images/1323087971394838528/ah54Nuuy_normal.jpg,75,95,0,255,BioPharmaInnov1,photo
4709735054,2021-04-10 18:22:16,,"baricitinib, covid19, ","pharmaceutical-technology.com/news/lilly-inc‚Ä¶, ",1381009662875725829,False,0,0,0,0,Twitter for iPhone,Lilly and Incyte report Phase 3 COV-BARRIER study of #baricitinib failed to meet statistical significance on the primary endpoint of progression to non-invasive ventilation or invasive mechanical ventilation or death in hospitalised #covid19 patients. https://t.co/X7DFi2QvoZ,,,2016-01-04 12:44:47,"Minnesota, USA",Christina Koutsari ü¶†üíäüë©üèª‚Äç‚öïÔ∏è,https://pbs.twimg.com/profile_images/1179387600727089152/PoIHig2H_normal.jpg,285,356,4,1071,christinakouts3,
374729426,2021-04-10 18:13:18,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2659644, pic.twitter.com/XQ6KFMiubU, ",1381007408785367040,False,0,0,0,1,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 10, 2021. View odds for this and other indicators: https://t.co/qMf1NkTCsA #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/XQ6KFMiubU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2656754371,2021-04-10 16:45:24,,"Massachusetts, SanDiego, SanFrancisco, Biotech, ","j.mp/3s8bSkH, ",1380985285425692672,False,0,0,0,0,SocialPilot.co,COVID-19 tracker: Pfizer asks U.S. to expand vax nod to adolescents; EU eyes deal for 1.8B Pfizer-BioNTech doses | @Pfizer @BioNTech @Moderna @AstraZeneca @Lillypad @Incyte @JNJ @Biogen @Roche #Massachusetts #SanDiego #SanFrancisco #Biotech https://t.co/1pjy5yCoHe,"pfizer, biontech, Moderna, AstraZeneca, LillyPad, Incyte, JNJ, biogen, Roche, ",,2014-07-18 09:20:39,San Diego,Aspen Biosciences,https://pbs.twimg.com/profile_images/1006725217568186368/B34yK1F1_normal.jpg,316,725,33,6079,aspenbio,
1029128656650555393,2021-04-10 16:45:24,,"Massachusetts, SanDiego, SanFrancisco, Biotech, ","j.mp/3s8bSkH, ",1380985285358551040,False,0,0,0,0,SocialPilot.co,COVID-19 tracker: Pfizer asks U.S. to expand vax nod to adolescents; EU eyes deal for 1.8B Pfizer-BioNTech doses | @Pfizer @BioNTech @Moderna @AstraZeneca @Lillypad @Incyte @JNJ @Biogen @Roche #Massachusetts #SanDiego #SanFrancisco #Biotech https://t.co/Pc9Bdyq0Ix,"pfizer, biontech, Moderna, AstraZeneca, LillyPad, Incyte, JNJ, biogen, Roche, ",,2018-08-13 18:12:46,,Pharm2Market,https://pbs.twimg.com/profile_images/1041479880368484353/xr9ZBpXF_normal.jpg,190,849,2,2538,pharm2market,
825684884643573761,2021-04-10 14:12:06,,"AACR21, ","pic.twitter.com/TFlN72hNKo, ",1380946706418786315,False,79,0,2,18,Twitter Web App,Hot off the #AACR21 New Drugs on the Horizon press: Incyte just disclosed INCB086550 - a small molecule PD-L1 inhibitor. Tough target due to no obvious binding pocket; novel binding mode with a pseudo-C2 symmetric PD-L1 dimer. https://t.co/TFlN72hNKo,,,2017-01-29 07:39:51,"Connecticut, USA",Keith Hornberger,https://pbs.twimg.com/profile_images/1439964763778322440/klV02qcI_normal.jpg,1658,202,16,1774,KRHornberger,photo
59310742,2021-04-10 12:00:33,,,"dlvr.it/RxNx8z, pic.twitter.com/uXQRE8R7Yb, ",1380913603197292545,False,0,0,0,0,dlvr.it,"Lilly, Incyte's Olumiant fails in COVID-19 trial https://t.co/SMen6joO52 https://t.co/uXQRE8R7Yb",,,2009-07-22 20:57:49,ANZ,David Ledger,https://pbs.twimg.com/profile_images/621209163566182400/AWY0hAql_normal.jpg,826,1827,26,25935,Vedere_Group,photo
325135887,2021-04-10 11:25:00,"LLY, INCY, ","COVID19, treatment, ","bit.ly/3wEsbcw, ",1380904654532444160,False,3,0,0,0,Twitter Web App,"Lilly and Incyte‚Äôs Olumiant Shows Mixed Results Against COVID-19! Their Phase III study of Olumiant plus SoC vs. placebo plus SoC failed to hit statistical significance against COVID-19 for its primary endpoint! $LLY $INCY #COVID19 #treatment
https://t.co/I4FSCROvg0",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
1224012435872305152,2021-04-10 04:01:41,,,"lifepronow.com/2021/04/10/bar‚Ä¶, pic.twitter.com/S0kuKqxL8f, ",1380793089162240002,False,0,0,0,0,Twitter Web App,"Lilly and Incyte announce results from baricitinib‚Äôs COV-BARRIER study in hospitalized COVID-19 patients

https://t.co/mvhDGSyQrl https://t.co/S0kuKqxL8f",,,2020-02-02 11:51:30,India,LifeProNow-Pharma-Research and News,https://pbs.twimg.com/profile_images/1255897607584411648/z8fpqZQV_normal.jpg,14,28,0,618,LifeProNow1,photo
1097819621619630080,2021-04-09 13:54:03,,,"dlvr.it/RxL7kY, pic.twitter.com/jhmDxTXMSZ, ",1380579776868405251,False,0,0,0,0,dlvr.it,"Lilly, Incyte's Olumiant fails in COVID-19 trial https://t.co/B4emSyBSYx https://t.co/jhmDxTXMSZ",,,2019-02-19 06:26:09,"London, England",PharmaCrowd,https://pbs.twimg.com/profile_images/1123311799561068545/UnJBMgbE_normal.png,29,22,0,2226,PharmaCrowd,photo
325135887,2021-04-09 13:05:00,,"cholangiocarcinoma, ","bit.ly/2PFtMy9, pic.twitter.com/i45kvUyJt2, twitter.com/Incyte/status/‚Ä¶, ",1380567432901840897,False,4,0,0,0,Twitter Web App,"Great science! Keep up the good work! @Incyte @CD_AACR #cholangiocarcinoma 
https://t.co/oNyu3SFPWA https://t.co/i45kvUyJt2 https://t.co/pxn7Z9CDBW","Incyte, CD_AACR, ",,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,photo
2932623329,2021-04-09 13:00:18,,,,1380566248749142019,False,0,0,0,0,Business Man,"It's like Incyte, but for Airplane Flight.",,,2014-12-19 16:12:27,,Business Man,https://pbs.twimg.com/profile_images/546052232966193152/9rhZ2k2Z_normal.jpeg,6,5,0,567,therealbizman,
1254141493780066305,2021-04-09 12:46:29,,,"investor.lilly.com/news-releases/‚Ä¶, ",1380562771704680451,False,25,1,4,10,Twitter Web App,"Some mixed results from Lilly's baricitinib monoclonal antibody in hospitalized patients, missing a primary endpoint of clinical deterioration but showing a 28 day mortality benefit.

Reminder: those antibodies might be easily derailed by new variants.

https://t.co/GxQHnXFkON",,,2020-04-25 16:14:27,,Covid19Crusher,https://pbs.twimg.com/profile_images/1352174641331187713/fUgcRPnd_normal.jpg,72310,37,692,7752,Covid19Crusher,
2570920968,2021-04-09 12:25:00,"LLY, INCY, ","COVID19, treatment, ","bit.ly/3wEsbcw, ",1380557366022799366,False,3,0,0,0,Twitter Web App,"Lilly and Incyte‚Äôs Olumiant Shows Mixed Results Against COVID-19! Their Phase III study of Olumiant plus SoC vs. placebo plus SoC failed to hit statistical significance against COVID-19 for its primary endpoint! $LLY $INCY #COVID19 #treatment
https://t.co/EKRBQ4jdcH",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
17960461,2021-04-09 12:18:00,,"COVID19, PharmaNews, ","bit.ly/3uvW8JC, pic.twitter.com/UM87yB6HpA, ",1380555604473769984,False,1,0,0,1,TweetDeck,"Lily and Incyte Phase III COVID-19 study fails to meet primary endpoint
https://t.co/prFJazlxGH
#COVID19 #PharmaNews https://t.co/UM87yB6HpA",,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
803569643340316672,2021-04-09 12:13:32,,"Lilly, baricitinib, Covid19, Covaxin, Covishield, ","pharmaceutical-technology.com/news/lilly-inc‚Ä¶, ",1380554480467386369,False,0,0,0,0,Twitter for Android,"#Lilly and Incyte report Phase III trial results of #baricitinib in #Covid19 patients

@PMOIndia is still studying the trial papers for #Covaxin and #Covishield @ICMRDELHI

https://t.co/QMrH2ojLHt","PMOIndia, ICMRDELHI, ",,2016-11-29 07:01:47,"Mumbai, India",·ö∑·ö±·õÅ·õó·öæ·õÅ·ö±  ï¬¥‚Ä¢·¥•‚Ä¢` î #DestroyTheAadhaar,https://pbs.twimg.com/profile_images/1405532014996910088/XHumHhIH_normal.jpg,380,698,4,105490,CryoPerSea,
4058194633,2021-04-09 11:29:37,"INCY, ",,"MarketBeat.com, marketbeat.com/instant-alerts‚Ä¶, ",1380543429269065733,False,0,0,0,0,Twitter for iPhone,"$INCY Incyte Given Consensus Recommendation of ""Hold"" by Brokerages | $100.93 Average PT https://t.co/NKb5pRLCDo https://t.co/o7lKhHNXs5",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1344399252923981825,2021-04-09 11:09:19,,"COVID, ",,1380538320434855939,False,0,0,0,0,Twitter Web App,"Lilly and Incyte announced today that their Phase III study of baricitinib (JAK inhibitor) plus SoC compared to placebo plus SoC failed to hit statistical significance against COVID-19 for its primary endpoint, but did reduce overall mortality.  #COVID",,,2020-12-30 16:45:51,,James Erickson,https://pbs.twimg.com/profile_images/1344399438429573120/4bF1jlM3_normal.jpg,12,18,0,109,DrJRErickson,
1281000338246512640,2021-04-09 11:00:19,,"COVID„Éº19, COVIDnews, infusionnews, ","conta.cc/3uC1NxT, ",1380536057062690820,False,0,0,0,0,Constant Contact - Social Posts,"One of the three emergency-use COVID monoclonal antibody (mAb) treatments by Eli Lilly features its Incyte-partnered drug Olumiant, in combination with Gilead‚Äôs remdesivir. #COVID„Éº19 #COVIDnews #infusionnews https://t.co/s05lIPo8s1",,,2020-07-08 19:01:42,300 Great Oaks Blvd Albany NY,Hometa,https://pbs.twimg.com/profile_images/1343951475383410698/1tcAwziR_normal.png,43,702,0,134,HometaHealth,
3124786444,2021-04-09 10:44:08,,"MedicineByPressRelease, COVID19, Baricitinib, ","prnewswire.com/news-releases/‚Ä¶, ",1380531983059537923,False,9,0,1,5,Twitter for iPhone,"New #MedicineByPressRelease results from the COV-BARRIER RCT comparing oral JAK inhibitor vs placebo in #COVID19:
-no Œî in composite of HFNC, IMV, NIPPV or death but
-significant reduction in 28 day mortality w/ #Baricitinib: 8% vs 13% (NNT 20)
https://t.co/RnKduPacwh
1/",,,2015-03-28 16:22:29,"Seattle, WA",Nick Mark MD,https://pbs.twimg.com/profile_images/1083233606430994432/0yKStHsN_normal.jpg,24062,996,293,8583,nickmmark,
1142831555850592256,2021-04-09 09:04:09,,"BayArea, Biotech, ","tinyurl.com/yzbt9ne4, ",1380506819748052998,False,1,0,0,1,FeedBlitz,SFBN Feed: Covid-19 roundup: Lilly/Incyte's Olumiant plus remdesivir combo whiffs PhIII; France recommends mixing vaccines among younger AstraZeneca recipients: Eli Lilly has won three emergency use ... #BayArea #Biotech https://t.co/SiFVIluum7,,,2019-06-23 12:27:30,"San Francisco, CA",San Francisco Biotechnology Network,https://pbs.twimg.com/profile_images/1430570245622693888/y8PFDscc_normal.jpg,1095,3775,7,7847,sfbionetwork,
2676698935,2021-04-09 08:52:24,"BCTX, ",,,1380503863665496071,False,1,0,0,0,Twitter for iPhone,$BCTX 13G filings were 6 x Institutions in MarchüëÄ. Float is 500k. Heavy accumulation going on right now. In bed with Merck &amp; Incyte. Dr Williams is ex Incyte.,,,2014-07-24 08:24:06,"Manchester, England",Fazza,https://pbs.twimg.com/profile_images/1407263248949329923/v_9Gf8fz_normal.jpg,500,74,6,2201,PatientWinner87,
2704905116,2021-04-09 08:02:33,,,"dlvr.it/RxJyNP, ",1380491318669893636,False,0,0,0,0,dlvr.it,"Lilly, Incyte's Olumiant fails in COVID-19 trial https://t.co/dvK9ytjexy",,,2014-08-03 17:01:43,Worldwide,Everything Pharma,https://pbs.twimg.com/profile_images/496040907154534400/7fJoRr4p_normal.jpeg,11,9,0,7417,EveryPharma,
13557562,2021-04-09 07:52:19,,,"m.firstwordpharma.com/lilly-incytes-‚Ä¶, ",1380488744185253891,False,0,0,0,0,Tweetbot for iŒüS,"Lilly, Incyte's Olumiant misses primary endpoint of COVID-19 trial | FirstWord Pharma https://t.co/onU6kSe38D",,,2008-02-16 11:58:12,"iPhone: 35.121323,-89.830750","Michael Blaiss, MD",https://pbs.twimg.com/profile_images/1397602816345186304/FFET4jcx_normal.jpg,3944,811,177,14618,wheezemd,
1280288213102292993,2021-04-09 07:49:21,,,"pharmabox.in/lilly-incytes-‚Ä¶, ",1380487995879481350,False,0,0,0,0,Hootsuite Inc.,"Lilly, Incyte‚Äôs Olumiant fails in COVID-19 trial https://t.co/yStOHTzKHJ",,,2020-07-06 19:51:21,,WWW.PHARMABOX.IN,https://pbs.twimg.com/profile_images/1284027505058381827/7o7Mcyq1_normal.jpg,856,450,0,5397,pharmabox_in,
133504478,2021-04-09 07:46:36,,"strategy, competitiveintelligence, marketing, pharma, pharmaceutical, biotech, productmarketing, healthcare, ","dlvr.it/RxJvzT, pic.twitter.com/lbdjlEy3Ym, ",1380487305299824643,False,0,0,0,1,dlvr.it,Covid-19 roundup: Lilly/Incyte's Olumiant plus remdesivir combo whiffs PhIII; France recommends mixing vaccines among younger AstraZeneca‚Ä¶ https://t.co/POzDgIyP6y #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #productmarketing #healthcare https://t.co/lbdjlEy3Ym,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
46297868,2021-04-09 07:29:05,,,"dlvr.it/RxJrXs, ",1380482895240814593,True,0,0,0,0,dlvr.it,Covid-19 roundup: Lilly/Incyte's Olumiant plus remdesivir combo whiffs PhIII; France recommends mixing vaccines among younger AstraZeneca recipients https://t.co/4z67Bb1Bbw,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
76768831,2021-04-09 07:13:32,,,"dlvr.it/RxJnrs, ",1380478984748605441,False,0,0,0,0,dlvr.it,"Lilly, Incyte's Olumiant fails in COVID-19 trial https://t.co/pWUrb1h7xZ",,,2009-09-23 17:56:06,"London, England",Iceberg Vision,https://pbs.twimg.com/profile_images/922924826712567808/RsSXYuFe_normal.jpg,67,116,5,1221,icebergvision,
52354784,2021-04-09 06:50:19,,"pharmanews, pharma, ","feedproxy.google.com/~r/Pharmatimes‚Ä¶, ",1380473141785419780,False,0,0,0,1,SocialPilot.co,"Lilly, Incyte's Olumiant fails in COVID-19 trial https://t.co/vwT5I60GK0 #pharmanews #pharma",,,2009-06-30 05:46:48,"Surrey, UK",PharmaTimes,https://pbs.twimg.com/profile_images/533273520885616640/vb4_MuJ1_normal.png,53067,1318,1008,19444,PharmaTimes,
3901351277,2021-04-09 05:26:50,,"pharmaceutical, ","bit.ly/3wAOm3f, ",1380452130155298817,False,0,0,0,0,IFTTT,Lily and Incyte Phase III COVID-19 study fails to meet primary endpoint  : https://t.co/MrjWpPDhmO #pharmaceutical,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
1134049078424162304,2021-04-09 05:25:06,"LLY, INCY, ",,"newsfilter.io/articles/eli-l‚Ä¶, ",1380451694924926977,False,0,1,0,0,Newsfilter.io,Eli Lilly-Incyte's Baricitinib Study In Hospitalized COVID-19 Patients Fails To Meet Main Goal $LLY $INCY https://t.co/y6RuRJQxrL,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
374341080,2021-04-09 05:25:03,,,"dlvr.it/RxJNdN, ",1380451684548177926,False,0,0,0,0,dlvr.it,"Lilly, Incyte's Olumiant fails in COVID-19 trial https://t.co/0cCYzMAyP2",,,2011-09-16 00:35:32,,Pharma Trader,https://pbs.twimg.com/profile_images/1544984545/medicinenet_normal.jpg,85,29,1,11673,pharmatraders,
812004702594486272,2021-04-09 05:01:11,,,"checkrare.com/efficacy-of-re‚Ä¶, ",1380445675398266886,False,0,0,0,0,Hootsuite Inc.,"Lance Leopold, MD, Group Vice President, Immuno-Oncology, at Incyte discusses the clinical trial of retifanlimab for the treatment of squamous cell carcinoma of the anal canal (SCAC).
@Incyte 
https://t.co/nHthYjDPYE","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
17960461,2021-04-09 04:58:19,,"COVID19, PharmaNews, ","bit.ly/3uvW8JC, pic.twitter.com/t7ubFZeVaZ, ",1380444956385550339,False,0,0,0,0,TweetDeck,"Lily and Incyte Phase III COVID-19 study fails to meet primary endpoint
https://t.co/prFJazD95h
#COVID19 #PharmaNews https://t.co/t7ubFZeVaZ",,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
1270220114340851712,2021-04-09 04:51:10,,"PharmaTwitter, MedTwitter, MedEd, ","bit.ly/More-Medical-H‚Ä¶, pharmatimes.com/news/lilly,_in‚Ä¶, ",1380443154898423810,False,0,0,0,0,Automate.io,"Lilly, Incyte's Olumiant fails in COVID-19 trial

More medical news at https://t.co/0Knf9q4SKS
#PharmaTwitter #MedTwitter #MedEd
https://t.co/1Bplwgv9fK",,,2020-06-09 01:04:18,Look here üëâ,MedPub Pharmaceutical,https://pbs.twimg.com/profile_images/1443232668716515331/xzljON0s_normal.jpg,2,69,0,3346,PharmaPublisher,
1138376859614212098,2021-04-09 03:30:00,,,"ift.tt/3uyXGCG, ",1380422731565572100,False,0,0,0,0,IFTTT,"Eli Lilly and Incyte say Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal

Eli Lilly &amp; Co. and Incyte Corp. said Thursday a Phase 3 trial of rheumatoid arthritis treatment baricitinib plus standard of care (SoC) ver‚Ä¶ https://t.co/dksr7TOO3n",,,2019-06-11 05:26:08,,XM Market News,https://pbs.twimg.com/profile_images/1138377225848336385/bcPF4uxU_normal.jpg,99,15,2,7989,XM_Market,
1315434407692509184,2021-04-09 00:49:53,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/tUhG4Np4Y8, ",1380382433267302404,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 36.30% ranked 548 out of 5493 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/tUhG4Np4Y8",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
374729426,2021-04-08 21:55:47,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2655303, pic.twitter.com/xsJNcHg6VR, ",1380338620960108546,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 10, 2021. View odds for this and other indicators: https://t.co/LLIK5uh2oe #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xsJNcHg6VR",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
15193667,2021-04-08 21:24:16,,,"investor.lilly.com/news-releases/‚Ä¶, ",1380330692131704834,False,0,0,0,0,Twitter Web App,Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients | Eli Lilly and Company  https://t.co/7E3LVGsFhS,,,2008-06-21 20:09:52,Êñ∞ÊΩüÁúå‰ΩêÊ∏°Â∏Ç,matiere*,https://pbs.twimg.com/profile_images/1187122868/maru_1_normal.jpg,2490,4998,0,1410326,matiere,
25562183,2021-04-08 17:45:12,,,"reuters.com/article/us-hea‚Ä¶, ",1380275561508057090,False,5,0,1,1,True Anthem,Eli Lilly and Co and Incyte Corp said their rheumatoid arthritis drug baricitinib did not meet the main goal of preventing progression to mechanical ventilation in hospitalized COVID-19 patients under a late-stage study.‚Äã https://t.co/aiZRZX7Iq5,,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
4237001954,2021-04-08 17:43:31,,,"investor.lilly.com/news-releases/‚Ä¶, ",1380275137463783424,False,0,0,0,0,Twitter Web App,Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients https://t.co/RAbnw819BK Ï©ù.,,,2015-11-14 13:00:16,,libr99,https://pbs.twimg.com/profile_images/670306337448833024/PkDRrfd8_normal.jpg,911,427,6,9274,libr99,
1338638574414155779,2021-04-08 17:27:06,,"COVID19, covid, baricitinib, ","prnewswire.com/news-releases/‚Ä¶, ",1380271006317748226,False,0,0,1,0,Twitter Web App,"COV-BARRIER (Baricitinib) press release!!  Mixed results! Reduces mortality but did not prevent progression to Intubation.
#COVID19 #covid #baricitinib 
Can't wait to see the data instead of a press release!

https://t.co/9lNm2X22wA",,,2020-12-14 19:15:19,,anand v,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,41,114,0,203,DocViswanathan,
1043393167087882240,2021-04-08 17:22:52,,"baricitinib, ","investor.lilly.com/news-releases/‚Ä¶, ",1380269940125671427,False,29,1,1,7,Twitter Web App,"Oral anti-inflammatory #baricitinib (plus standard of care) greatly reduces the risk of death from Covid at 28 days compared to standard of care (HR: 0.57; 95% CI: 0.41, 0.78).

Press release ‚Äì looking forward to paper (&amp; results from RECOVERY, TACTIC-R)
https://t.co/ohGjML8sMv",,,2018-09-22 02:54:51,"London, England",Andrea Mazzella,https://pbs.twimg.com/profile_images/1409653607499239427/iYKNzFwD_normal.jpg,2377,1485,18,1653,andmazzella,
700264840414285825,2021-04-08 15:30:07,,,"ow.ly/Rc4B50EjEFp, ",1380241566892187656,False,2,2,0,1,Hootsuite Inc.,"ü¶†  Eli Lilly announced that the last trial phase of their COVID-19 drug baricitinib failed to meet statistical significance on the primary endpoint.

 https://t.co/mtLsOs8E8K",,,2016-02-18 05:25:23,"Vienna, Austria",baha,https://pbs.twimg.com/profile_images/1394932326807781377/CH0JY48U_normal.jpg,12599,1426,147,75294,bahabusiness,
3343960821,2021-04-08 15:30:04,,"Announcement, COVID19, ","e.lilly/3dN4Mwz, pic.twitter.com/UYMxkr8Jpp, ",1380241554611245057,False,3,0,1,1,Khoros Publishing,#Announcement: you can find the latest trial data on our #COVID19 treatment. https://t.co/G8S1CWoKfW https://t.co/UYMxkr8Jpp,,,2015-06-24 09:15:26,"Indianapolis, IN",Lilly Medical US,https://pbs.twimg.com/profile_images/1131223601833795585/hf9OH562_normal.png,5517,77,19,336,LillyMedical,photo
204748499,2021-04-08 14:01:04,,,"investor.lilly.com/news-releases/‚Ä¶, ",1380219156704993282,False,26,3,1,18,Twitter for Android,"üí•üí•The Phase 3 COV-BARRIER study of Baricitinib in Hospitalized Patients did NOT meet statistical significance on primary endpoint (progression to non-invasive ventilation or invasive mechanical ventilation or deathüí•üí•
https://t.co/ByceHAqKYv",,,2010-10-19 07:39:07,üåç,Antibiotic Stewa¬ÆÔ∏èxüÜî Bassam Ghanem,https://pbs.twimg.com/profile_images/1274367456610525190/OIDDvaCl_normal.jpg,36194,299,307,33122,ABsteward,
244991712,2021-04-08 13:55:33,,,"dlvr.it/RxGPSy, ",1380217767622705155,False,0,0,0,0,dlvr.it,Eli Lilly and Incyte say Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal https://t.co/w4LbBTS8r5,,,2011-01-30 11:29:43,The FX Holy Land,TheSolidTrader,https://pbs.twimg.com/profile_images/1723879080/image_normal.jpg,3279,2266,225,464963,SolidTrader,
1325446129325142016,2021-04-08 13:30:38,"INCY, LLY, LLY, ",,"seekingalpha.com/news/3680241-l‚Ä¶, ",1380211495783530497,False,0,0,0,0,Integromat,"$INCY $LLY $LLY - Lilly, Incyte's COV-BARRIER study fails to meet primary endpoint in COVID-19 https://t.co/KnGrJVm1kF",,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
25562183,2021-04-08 13:30:23,,,"reuters.com/article/us-hea‚Ä¶, ",1380211432009179140,False,3,0,0,4,True Anthem,Eli Lilly and Co and Incyte Corp said their rheumatoid arthritis drug baricitinib did not meet the main goal of preventing progression to mechanical ventilation in hospitalized COVID-19 patients under a late-stage study.‚Äã https://t.co/Wzb2UIMpcH,,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
2910286079,2021-04-08 12:54:43,,,"prnewswire.com/news-releases/‚Ä¶, ",1380202459096842241,False,8,1,0,2,Twitter for iPhone,Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients - nice reduction in Mortality. 38 %. https://t.co/p8kdQBPWO6,,,2014-12-07 21:29:39,"Miami, FL and Atlanta, GA",Raymond schinazi,https://pbs.twimg.com/profile_images/1243766160560017409/TsBcylRc_normal.jpg,708,144,10,456,drugbuster21,
2926418704,2021-04-08 12:38:44,,"jobs, ","biospace.com/article/lilly-‚Ä¶, ",1380198435987599360,False,0,0,0,0,Twitter Web App,Lilly and Incyte‚Äôs Olumiant Shows Mixed Results Against COVID-19 | BioSpace https://t.co/kEkdKtIsFI #jobs,,,2014-12-16 23:53:36,,Kevin Paul Oge,https://pbs.twimg.com/profile_images/545080446191562752/sd7k8cIO_normal.jpeg,39,782,0,28248,DE3x2ydy_dx,
18026170,2021-04-08 12:30:00,,"ClinicalTrials, baricitinib, COVID19, ventilation, death, JAK, SARSCoV2, InfectiousDiseases, ","clinicaltrials.gov/ct2/show/NCT04‚Ä¶, pic.twitter.com/wNTFtVFGWZ, ",1380196236507025415,False,1,0,0,0,TweetDeck,"Ph3 #ClinicalTrials show adding #baricitinib to SoC did not reduce #COVID19 progression to #ventilation or #death

#JAK inhibitor licensed to @LillyPad by @Incyte did reduce risk of all-cause death by 38% at Day 28

https://t.co/lVdGNNVuJR
#SARSCoV2 #InfectiousDiseases https://t.co/wNTFtVFGWZ","LillyPad, Incyte, ",,2008-12-10 13:29:19,"Midland, ON",DDNews Online,https://pbs.twimg.com/profile_images/1286709262287278080/SHRMveT5_normal.jpg,3372,439,86,13763,DDNewsOnline,photo
1247376635004936192,2021-04-08 12:13:35,,"baricitinib, COVID19, remdesivir, ","investor.lilly.com/news-releases/‚Ä¶, ",1380192108007526402,False,2,0,0,3,Twitter Web App,"Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of #baricitinib in hospitalized #COVID19 patients

Data showed 38% reduction in mortality in patients treated with baricitinib in addition to standard care (corticosteroids+#remdesivir).
https://t.co/AWnWEUHe0r",,,2020-04-07 00:12:30,,EPIDATUM,https://pbs.twimg.com/profile_images/1248078539657805825/sIOuyFlo_normal.jpg,325,0,12,2226,epidatum,
69441276,2021-04-08 11:57:44,,,"newsfile.refinitiv.com/getnewsfile/v1‚Ä¶, ",1380188117034889217,False,1,0,1,0,Twitter Web App,"Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients: did not meet statistical significance on primary endpoint (mech ventil) by showed 38% reduction in mortality
https://t.co/DlEhlxSSig",,,2009-08-27 19:36:57,,Roland Baker,https://pbs.twimg.com/profile_images/1410990542746394624/9J8yW5EH_normal.jpg,7355,5043,155,38084,RolandBakerIII,
875382419251019776,2021-04-08 10:54:33,,,"bit.ly/3g62pIn, pic.twitter.com/bB3XZCn3fs, ",1380172217934176257,False,0,0,0,0,dlvr.it,Lilly and Incyte‚Äôs Olumiant Shows Mixed Results Against COVID-19 https://t.co/k22qpR6WW4 https://t.co/bB3XZCn3fs,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
197007124,2021-04-08 10:31:04,,,"prn.to/3wCEYfp, ",1380166305244938243,False,0,0,0,0,Twitter Web App,Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients https://t.co/imjHfdlib4,,,2010-09-30 08:47:38,Milano,Carlo Centemeri,https://pbs.twimg.com/profile_images/1188403126207950848/ojBHlwRs_normal.jpg,290,869,0,8163,carlo_centemeri,
794498402386083841,2021-04-08 10:22:28,,,"investor.lilly.com/news-releases/‚Ä¶, ",1380164144620527618,False,29,0,2,9,Twitter for iPhone,"Just out - some positive news for baricitinib the Lily oral JAK inhibitor -in hospitalised Covid. Mortality benefit (38%) seen on top of dex and remdesivir. Primary outcome: prevention of niv or intubation missed though. Global study.

https://t.co/0wiXew2g0i",,,2016-11-04 07:15:55,"England, United Kingdom",Tom Wilkinson,https://pbs.twimg.com/profile_images/1327165388992491523/n8rRYYWF_normal.jpg,497,96,2,136,ProfWilko,
4058194633,2021-04-08 09:56:35,"LLY, INCY, ",,"marketwatch.com/story/eli-lill‚Ä¶, ",1380157627989118983,False,0,0,0,0,Twitter for iPhone,$LLY $INCY Eli Lilly and Incyte say Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal https://t.co/cbLfCKyXvR,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1352361882691235841,2021-04-08 09:32:29,"HGEN, ",,"google.com/amp/s/www.mark‚Ä¶, ",1380151565789634562,False,39,3,3,12,StockTwits Web,"$HGEN Baricitinib (already Has EUA) has failed to hit its primary endpoint (progression to IMV) in a 1,500 patient clinical trial. Lenz still the best option for preventing progression to IMV / And VFS. https://t.co/UStsV6RxSk",,,2021-01-21 16:06:21,,üí°Jerry üí°,https://pbs.twimg.com/profile_images/1365815328383643650/Ir8_9cli_normal.jpg,1765,224,16,2736,ItsVeryJerry,
325135887,2021-04-08 09:25:00,"LLY, INCY, PFE, SNY, REGN, ","dermatology, FDA, ","bit.ly/3cWfJg5, ",1380149679824936960,False,5,0,0,1,Twitter Web App,"FDA delays decisions for Eli Lilly and Incyte's Olumiant and Pfizer's Xeljanz! Sanofi and Regeneron can breathe two more sighs of relief for their fast-growing drug in atopic dermatitis, Dupixent! $LLY $INCY $PFE $SNY $REGN #dermatology #FDA 
https://t.co/dcRJsaHGIf",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
25562183,2021-04-08 09:16:33,,,"reuters.com/article/us-hea‚Ä¶, ",1380147552637554690,False,3,0,0,4,True Anthem,Eli Lilly and Co and Incyte Corp said their rheumatoid arthritis drug baricitinib did not meet the main goal of preventing progression to mechanical ventilation in hospitalized COVID-19 patients under a late-stage study.‚Äã https://t.co/dJWjVIt4vl,,,2009-03-20 15:43:34,,Reuters Health,https://pbs.twimg.com/profile_images/869657490895405056/G7IhfjL-_normal.jpg,259866,81,4100,64857,Reuters_Health,
345555340,2021-04-08 09:07:41,,,"shar.es/aoUURu, ",1380145321456570370,False,0,0,0,0,Twitter Web App,News for Medical Independent Sales Representatives and Medical Distributors: Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients https://t.co/x4Kh4Ov27m,,,2011-07-30 15:56:45,USA,HSMN,https://pbs.twimg.com/profile_images/1469889801/globelayer_sm_normal.png,667,1802,92,6275,HSMN_com,
624413,2021-04-08 09:04:47,,,"on.mktw.net/3cZFYTd, ",1380144594101354502,False,7,0,1,3,SocialFlow,Eli Lilly and Incyte say Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal https://t.co/zUhYrq6dtM,,,2007-01-11 00:15:48,"New York, NY",MarketWatch,https://pbs.twimg.com/profile_images/705601245596090368/Z6xUOnRg_normal.jpg,4125163,200,28863,354060,MarketWatch,
72928001,2021-04-08 08:47:35,"LLY, ",,"bit.ly/3cZAlEn, ",1380140263046176774,False,0,0,0,0,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized... https://t.co/tq2I1eNKXR,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1022473214457348096,2021-04-08 08:41:29,,,"pharmashots.com/58260/lilly-an‚Ä¶, ",1380138730187415557,False,0,0,0,0,Twitter Web App,"Lilly and Incyte Report Results of Baricitinib in P-III COV-BARRIER Study for Hospitalized Patients with COVID-19 @Pharmashot @LillyPad @Incyte 
https://t.co/2aB52JACtL","Pharmashot, LillyPad, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
2373909360,2021-04-08 08:27:26,,"lilly, incyte, ","upstract.com/p/3pmdyhbj?ref‚Ä¶, ",1380135193739194368,False,0,0,0,0,News Users,Lilly and Incyte say trial data showed 38% reduction in mortality by Day 28 for baricitinib plus SOC #lilly #incyte https://t.co/bWGgELnKnX,,,2014-03-05 10:12:33,,Upstract News,https://pbs.twimg.com/profile_images/1318142188287627265/4u0Sc4gy_normal.jpg,1690,1,35,174392,upstractcom,
1033587691,2021-04-08 08:21:48,,"COVID19, ","prnewswire.com/news-releases/‚Ä¶, ",1380133774944563201,False,26,1,3,8,Twitter Web App,"COV-BARRIER üóûÔ∏èrelease
Baricitinib for #COVID19 
üìå1525 ü§í 
üìåRCT doubled blind placebo controlled
üìåPrimary endpoint of progression to NIV, IMV or ‚ö∞Ô∏ènot met.
üìå38% ‚¨áÔ∏è in ‚ö∞Ô∏èby 28d (p=0.0018) in addition to SOC including steroids (79%)&amp; Remdesivir(19%)
https://t.co/NM2gdUP6QX",,,2012-12-24 17:32:10,"Atlanta, GA",BK Titanji #ILookLikeAScientist,https://pbs.twimg.com/profile_images/1447277206674235397/twMsMCjI_normal.jpg,9137,976,157,8516,Boghuma,
20780650,2021-04-08 08:05:34,,,"espenz.com/eli-lilly-and-‚Ä¶, pic.twitter.com/O4SaSLQceQ, ",1380129691890245633,False,0,0,0,0,biedexmarkets,"Eli Lilly and Company (NYSE:LLY), Incyte Corporation (NASDAQ:INCY) - Eli Lilly-Incyte's Baricitinib Study In Hospitalized COVID-19 Patients Fails To Meet Main Goal -

               -https://t.co/cZOZqSKFMr https://t.co/O4SaSLQceQ",,,2009-02-13 11:02:18,"London, England",Biedex Markets,https://pbs.twimg.com/profile_images/1288488731654201349/MSrdzFac_normal.jpg,4018,4862,120,362261,biedexmarkets,photo
20780650,2021-04-08 08:05:05,,,"biedexmarkets.com/eli-lilly-and-‚Ä¶, pic.twitter.com/QcxgbNT6Ib, ",1380129570209300480,False,0,0,0,0,biedexmarkets,"Eli Lilly and Company (NYSE:LLY), Incyte Corporation (NASDAQ:INCY) - Eli Lilly-Incyte's Baricitinib Study In Hospitalized COVID-19 Patients Fails To Meet Main Goal -

               -https://t.co/epgYCIETjW https://t.co/QcxgbNT6Ib",,,2009-02-13 11:02:18,"London, England",Biedex Markets,https://pbs.twimg.com/profile_images/1288488731654201349/MSrdzFac_normal.jpg,4018,4862,120,362261,biedexmarkets,photo
25406480,2021-04-08 08:00:05,,,"awesomecapital.blogspot.com/2021/04/lilly-‚Ä¶, ",1380128308751400961,False,0,0,0,1,Twitter Web App,AwesomeCapital: Lilly- Incyte Phase 3 baricitinib in hospitalized ... https://t.co/96SdMFjoKa,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
2334614718,2021-04-08 07:51:20,"INCY, LLY, ",,"ooc.bz/l/73147, ",1380126109350699008,False,0,0,0,0,Open Outcrier,"$INCY (-0.4% pre) Lilly $LLY, Incyte's COV-BARRIER study fails to meet primary endpoint in COVID-19 - SA

https://t.co/KJo0L9nwty",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
1166772455417024512,2021-04-08 07:51:04,,"Biotech, Briefs, ","dlvr.it/RxF9vz, pic.twitter.com/Fsqy3ZaEoB, ",1380126041805520898,False,0,0,0,0,dlvr.it,#Biotech #Briefs Eli Lilly-Incyte's Baricitinib Study In Hospitalized COVID-19 Patients Fails To Meet Main Goal https://t.co/KLwSrCp4sH https://t.co/Fsqy3ZaEoB,,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
3142088601,2021-04-08 07:49:37,"LLY, INCY, ","COVID19, ","prn.to/3wCEYfp, ",1380125675655475202,False,5,1,1,3,Twitter Web App,"Conflicting outcomes: bari didn't help on progression to severe dzz by d28 OR 0.85 [0.67;1.08] but helped reducing mortality OR 0.57 [0.41;0.78]

$LLY &amp; $INCY announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized #COVID19 pts https://t.co/QBXhR7Xu4T",,,2015-04-06 18:27:23,"Lyon, France",Bertrand Delsuc,https://pbs.twimg.com/profile_images/1118239110018273280/DDy8QJv8_normal.png,8047,263,283,59416,BertrandBio,
35789155,2021-04-08 07:49:11,"LLY, INCY, ","COVID19, ","beta.firstwordpharma.com/story/5268845, ",1380125566783873029,False,0,0,0,0,TweetDeck,"Lilly, Incyte's Olumiant misses primary endpoint of #COVID19 trial $LLY $INCY https://t.co/P3kkM48kBw",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
270492072,2021-04-08 07:33:30,,"news, mktw, wsj, ","feeds.marketwatch.com/~r/marketwatch‚Ä¶, ",1380121621164294147,False,0,0,0,0,Microsoft Power Platform,Eli Lilly and Incyte say Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal https://t.co/HoecgLJDa9 via MarketWatch #news #mktw #wsj,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
1134049078424162304,2021-04-08 07:29:02,"LLY, INCY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1380120496692420616,False,0,0,0,0,Newsfilter.io,"Lilly, Incyte's COV-BARRIER study fails to meet primary endpoint in COVID-19 $LLY $INCY https://t.co/JFO18X6MGy",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
891382950436229120,2021-04-08 07:27:41,,,"exbulletin.com/business/84107‚Ä¶, ",1380120157960470530,False,0,0,0,0,WordPress.com,Eli Lilly and Incyte say phase 3 study of baricitinib in hospitalized patients with COVID-19 failed to meet primary¬†goal https://t.co/mpXegIhqzh,,,2017-07-29 15:40:31,UK,ExBulletin,https://pbs.twimg.com/profile_images/1234563899141361665/B6yII4Q6_normal.jpg,509,10,12,683628,ExBulletinUk,
2570920968,2021-04-08 07:25:00,"LLY, INCY, PFE, SNY, REGN, ","dermatology, FDA, ","bit.ly/3cWfJg5, ",1380119480634904580,False,2,0,0,0,Twitter Web App,"FDA delays decisions for Eli Lilly and Incyte's Olumiant and Pfizer's Xeljanz! Sanofi and Regeneron can breathe two more sighs of relief for their fast-growing drug in atopic dermatitis, Dupixent! $LLY $INCY $PFE $SNY $REGN #dermatology #FDA 
https://t.co/Tdhvh8dGB0",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
15296897,2021-04-08 07:23:30,"INCY, LLY, LLY, ",,"seekingalpha.com/news/3680241-l‚Ä¶, ",1380119105315827723,False,0,0,0,1,SANewsTwitter,"$INCY $LLY $LLY - Lilly, Incyte's COV-BARRIER study fails to meet primary endpoint in COVID-19 https://t.co/DILHTlsQBX",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3316713321,2021-04-08 07:20:06,,,"marketwatch.com/news/story/eli‚Ä¶, ",1380118250739097603,False,0,0,0,0,WordPress.com,Eli Lilly and Incyte say Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main¬†goal https://t.co/pX41Ip58ag,,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
270492072,2021-04-08 07:18:55,,"news, ",,1380117949344706561,False,0,0,0,0,Microsoft Power Platform,Lilly and Incyte say trial data showed 38% reduction in mortality by Day 28 for baricitinib plus SOC #news,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
963495628545327104,2021-04-08 07:09:26,"INCY, LLY, INCY, ",,"stck.pro/news/INCY/1215‚Ä¶, stck.pro/news/INCY, pic.twitter.com/vZNN667rDJ, ",1380115565239488512,False,0,0,0,0,STCK.PR0,$INCY $LLY NEW ARTICLE : Eli Lilly and Incyte say Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal https://t.co/TDitBSVGTv Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/vZNN667rDJ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
730032660,2021-04-08 07:08:34,,,"nonsell.com/us-market-news‚Ä¶, pic.twitter.com/6kVZFcpAtG, ",1380115344879091712,False,0,0,0,0,NonSell Twitter,"Eli Lilly and Incyte say results of Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal - The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies.. The Diabetes ... - https://t.co/qCBTgzHEIP https://t.co/6kVZFcpAtG",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,photo
730032660,2021-04-08 07:07:14,,,"nonsell.com/us-market-news‚Ä¶, ",1380115011071188993,False,0,0,0,0,NonSell Twitter,"Lilly and Incyte say trial data showed 38% reduction in mortality by Day 28 for baricitinib plus SOC - The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies.. The Diabetes products include... - https://t.co/foGqnZQrDb",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
2274838086,2021-04-08 07:04:02,"LLY, ",,"prnewswire.com/news-releases/‚Ä¶, ",1380114206406610944,False,0,0,0,0,Twitter Web App,$LLY's baricitinib misses primary endpoint in Phase III COVID-19 trial https://t.co/0HNsi1b10J,,,2014-01-03 12:39:31,,Paul Bonanos,https://pbs.twimg.com/profile_images/438472546187345920/0GrOUC2f_normal.jpeg,538,232,23,1004,BioBonanos,
1328777031299960833,2021-04-08 07:03:40,"LLY, ",,,1380114113506865153,False,0,0,0,0,Twitter Web App,$LLY - MW Eli Lilly and Incyte say Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal,,,2020-11-17 14:08:58,"Alexandria, Virginia",Team of Stock Traders,https://pbs.twimg.com/profile_images/1328777820743450629/0_Yn-EGb_normal.jpg,933,185,12,8168,TeamofStockTra,
284054290,2021-04-08 07:01:37,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/medic‚Ä¶, ",1380113596231917569,False,0,0,0,0,BLOX CMS for DEV,"INDIANAPOLIS,
April
8,
2021 /PRNewswire/
--
Eli
Lilly
and
Company
(NYSE:
LLY)
and
Incyte
(NASDAQ:INCY)
announced
today
results
of
COV-BARRIER,
a
Phase
3
study
evaluating
baricitinib
4
mg
once
daily
plus
standard
of
care
(SoC)
versus
placebo
plus
SoC‚Ä¶ https://t.co/51p2EuWygw",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
1069693680066420736,2021-04-08 07:01:25,"LLY, ",,"s.flashalert.me/vPMIb, ",1380113546789412867,False,0,0,0,0,flashalerts,"$LLY [15s. delayed]: Issued Press Release on April 08, 06:45:00: Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients https://t.co/3eDaeKZ1dI",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
472650465,2021-04-08 07:01:03,"INCY, ",,"otcdynamics.com/incy-lilly-and‚Ä¶, ",1380113452543397890,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients https://t.co/cwZOeyLbZI,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
172496840,2021-04-08 06:52:31,,"COVID19, ","e.lilly/3dN4Mwz, pic.twitter.com/5l0OXw81C8, ",1380111307588972548,False,20,2,1,7,Khoros Publishing,"JUST IN: An update about our randomized, placebo-controlled trial studying a Lilly medicine as a potential #COVID19 treatment for hospitalized patients. Learn more: https://t.co/bcPVnb8K2M https://t.co/5l0OXw81C8",,,2010-07-29 17:24:18,"Indianapolis, IN",Eli Lilly and Company,https://pbs.twimg.com/profile_images/1410270096296136707/VYZKlWDQ_normal.jpg,132353,1341,1576,22121,LillyPad,photo
106823467,2021-04-08 06:51:45,"LLY, INCY, ","EliLilly, Incyte, Coronavirus, COVID19, SARSCoV2, ","crweworld.com/symbol/LLY, ",1380111115422601221,False,0,0,0,0,Twitter Web App,"$LLY, $INCY Reveal findings from late-stage study evaluating baricitinib in hospitalized COVID-19 patients       #EliLilly      #Incyte     #Coronavirus    #COVID19     #SARSCoV2      https://t.co/7OGeEVJAxh",,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
831019099325132801,2021-04-08 06:51:11,"LLY, INCY, ",,,1380110973151903750,False,1,0,0,1,Twitter for iPhone,Lilly ( $LLY ) and Incyte ( $INCY ) report results from the phase 3 cov-barrier study in hospitalised patients; whilst they did not meet statistical significance on primary endpoint,,,2017-02-13 00:56:07,/r/WallStreetBets,WallStreetBets & Co.,https://pbs.twimg.com/profile_images/1073223467468840962/lWY3Dc10_normal.jpg,50487,1535,455,15714,WSBConsensus,
59393368,2021-04-08 06:50:53,"LLY, ",,,1380110895477530624,False,0,1,0,2,StockTwits Web,"$LLY | Lilly, Incyte Cov-Barrier Trial Didn't Meet Primary Endpoint",,,2009-07-23 03:38:43,Global,LiveSquawk,https://pbs.twimg.com/profile_images/1187763465349402624/c0QCLpHK_normal.jpg,213055,2098,5952,312475,LiveSquawk,
3316713321,2021-04-08 06:49:19,,,"marketwatch.com/tools/quotes/q‚Ä¶, ",1380110502370639878,False,0,0,0,0,WordPress.com,Eli Lilly and Incyte say results of Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main¬†goal https://t.co/r25oJIebmG,,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
270492072,2021-04-08 06:48:54,,"news, ",,1380110395826872320,False,0,0,0,0,Microsoft Power Platform,Eli Lilly and Incyte say results of Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal #news,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
2356524462,2021-04-08 06:48:48,"LLY, ",,,1380110371160268800,False,0,0,0,0,Stock News Alerts,"$LLY Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVI
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
3318510966,2021-04-08 06:48:37,,,"crweworld.com/article/news-p‚Ä¶, ",1380110327002492929,False,0,0,0,0,CRWE World,Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patient https://t.co/uluMQxt784,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
47519668,2021-04-08 06:46:46,"LLY, INCY, ",,"tradethenews.com/?twtId=21771, ",1380109861132832769,False,2,0,0,1,Updates Poster,"$LLY Lilly and Incyte $INCY announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients; Trial did NOT meet statistical significance on the primary endpoint (Eli Lilly and Co)
(More at https://t.co/MmpFjJSm5P)",,,2009-06-15 22:37:04,Global,TradeTheNews.com,https://pbs.twimg.com/profile_images/916119563191889920/ylR4h5y0_normal.jpg,21141,1222,761,53590,Trade_The_News,
1134049078424162304,2021-04-08 06:46:02,"LLY, INCY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1380109675807539200,False,0,0,0,0,Newsfilter.io,Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients $LLY $INCY https://t.co/QVj2lwagNI,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1325115160353103872,2021-04-08 06:45:31,"INCY, ","healthcare, ","quantisnow.com/insight/598954‚Ä¶, ",1380109545951817730,False,0,0,0,0,Twitter,"$INCY üìÉ Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients

https://t.co/3ZqE3NF7kw

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1254035253104181256,2021-04-08 06:45:24,"INCY, LLY, ","covid19, ","stocktitan.net/news/INCY/lill‚Ä¶, ",1380109516386275330,False,0,0,0,0,stocktitan,"$INCY $LLY Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients
https://t.co/fXvELQuPZk

#covid19",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1035865990716903425,2021-04-08 01:06:28,,"complement, covid19, masp2inhibition, lectinpathway, endothelialinjury, Narsoplimab, ","biospace.com/article/incyte‚Ä¶, twitter.com/kazemianlab/st‚Ä¶, ",1380024222458781697,False,3,0,0,0,Twitter for Android,"Article seems to miss the fact that both Jak1/2i and downstream #complement C3i/C5i, taking out AP, have missed in #covid19. Need upstream complement inhibition #masp2inhibition #lectinpathway #endothelialinjury #Narsoplimab 
https://t.co/srGgffXDDg https://t.co/e6tdjJYnYm",,,2018-09-01 08:24:32,,CDK,https://pbs.twimg.com/profile_images/1294214786625032192/xONHMDod_normal.jpg,91,107,3,907,d_kreu,
172288755,2021-04-07 21:05:05,,,"fiercepharma.com/marketing/more‚Ä¶, ",1379963475020054529,False,0,0,0,0,Twitter Web App,"More relief for Dupixent as FDA pushes back Lilly, Pfizer eczema decisions on safety concerns https://t.co/f1H8VuJhnn",,,2010-07-29 06:10:36,"Yong-In city, Korea",Kyung Seok Lee,https://pbs.twimg.com/profile_images/922433020748898305/cjOW-D4X_normal.jpg,17,60,0,646,ksloveis,
59548034,2021-04-07 20:55:32,,,"dlvr.it/RxCfFf, ",1379961071591518209,False,0,0,0,0,dlvr.it,"More relief for Dupixent as FDA pushes back Lilly, Pfizer eczema decisions on safety concerns: As the first of the class to enter the market, Xeljanz was required to conduct a long-term post-marketing study to further evaluate those risks. RELATED:¬†... https://t.co/UDN9lbuX6U",,,2009-07-23 14:33:47,Cape Town,Stephan Theron,https://pbs.twimg.com/profile_images/1257639889560129536/ZyiQ5niO_normal.jpg,300,887,7,10838,jst5th,
1280938376099741697,2021-04-07 18:47:54,,"iexStock, ","iexcloud.io, pic.twitter.com/OxWJSredjj, ",1379928949602594816,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Amazon.com Inc.
-Al Khaleej Investment PSC
-Incyte Corp.
-Gulf Cement Co.
-United Airlines Holdings Inc

Data provided by https://t.co/oXreiEXTgd https://t.co/OxWJSredjj",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1217871676156841984,2021-04-07 16:23:02,,"RegulatoryNews, dermatitis, NDA, FDA, drugtherapy, patients, news, regulatory, ","ow.ly/Z2vq50Ej8hb, ",1379892493127409671,False,0,0,0,0,Hootsuite Inc.,"#RegulatoryNews: @LillyPad and @Incyte‚Äôs atopic #dermatitis drug received extended supplemental 
#NDA review by the #FDA for baricitinib, a #drugtherapy intended for #patients with moderate-to-severe conditions. 

#news #regulatory

Read more here: https://t.co/mrFUkDdKhK","LillyPad, Incyte, ",,2020-01-16 13:10:41,"Boston, MA",CSOFT Health Sciences,https://pbs.twimg.com/profile_images/1231940702281568256/Q1ztC5Dl_normal.jpg,33,112,0,514,CSOFTHealth,
875382419251019776,2021-04-07 13:54:03,,,"bit.ly/3cZv1kc, pic.twitter.com/z8t76GghRJ, ",1379855001590194176,False,0,0,0,0,dlvr.it,FDA Extends Supplemental NDA Review Period for Lilly and Incyte‚Äôs Atopic Dermatitis Drug https://t.co/AhxNZpqONH https://t.co/z8t76GghRJ,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
18294275,2021-04-07 13:47:00,,,"fiercepharma.com/marketing/more‚Ä¶, ",1379853226346901506,False,2,0,0,0,TweetDeck,"More relief for Dupixent as FDA pushes back Lilly, Pfizer eczema decisions on safety concerns https://t.co/7ZLDwqOSUs",,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
1359077910,2021-04-07 12:30:10,,,"europharmajobs.com/job_display/19‚Ä¶, ",1379833892866232325,False,0,0,0,1,EPJ Jobs Post,"Medical Manager Hematology, Incyte, Milan, Italy

https://t.co/QshHjA75Oy",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
133504478,2021-04-07 12:29:07,,"strategy, competitiveintelligence, marketing, productmarketing, pharma, biotech, healthcare, pharmaceutical, ","dlvr.it/RxBQ4r, pic.twitter.com/FvtrjVAZ0J, ",1379833627781910529,False,0,0,0,1,dlvr.it,"More relief for Dupixent as FDA pushes back Lilly, Pfizer eczema decisions on safety concerns https://t.co/Cmjk4L0iEE #strategy #competitiveintelligence #marketing #productmarketing #pharma #biotech #healthcare #pharmaceutical https://t.co/FvtrjVAZ0J",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
46297868,2021-04-07 12:02:03,,,"dlvr.it/RxBKDD, ",1379826814332272641,True,0,0,0,0,dlvr.it,"More relief for Dupixent as FDA pushes back Lilly, Pfizer eczema decisions on safety concerns https://t.co/lVmmqDIsDG",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
1126479667442126848,2021-04-07 09:55:35,"INCY, ",,"pic.twitter.com/cuLEe94jZe, ",1379794991279706113,False,0,0,0,0,Twitter Web App,"INCYTE CORPORATION $INCY
UNUSUAL ACTIVITY 

VOLUME 1601.18% 
STRENGTH 504.27% https://t.co/cuLEe94jZe",,,2019-05-09 09:30:56,London,BREAKING STOCK NEWS,https://pbs.twimg.com/profile_images/1436383970774720513/ttpG7KuY_normal.jpg,2727,7,52,8959,UnusuallyActive,photo
1191218876786397184,2021-04-07 09:49:21,,,,1379793420441518081,False,0,0,0,0,TweetDeck,Concert Pharma (NASDAQ: CNCE) on watch on chatter of possible settlement with Incyte (NASDAQ: INCY) on main asset.,,,2019-11-04 00:01:41,,Oracle,https://pbs.twimg.com/profile_images/1438259452457721869/W2JR34gW_normal.jpg,791,492,47,6277,OracleNYSE,
404283686,2021-04-07 09:42:51,,,"firstwordpharma.com/node/1816541, ",1379791784025468931,False,1,0,0,1,Twitter Web App,Check out this FWPharma article : Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis. https://t.co/Lci0ygvBlo,,,2011-11-03 14:07:30,,Tina Witte,https://pbs.twimg.com/profile_images/461513057420599296/oCT2AfYo_normal.jpeg,213,732,12,4444,TinaWitte,
467676108,2021-04-07 09:01:06,"acrs, ",,"investor.incyte.com/press-releases‚Ä¶, ",1379781277881106433,False,0,1,1,0,Twitter Web App,"$acrs The uncertainty around oral JAKs for atopic dermatitis must be seen as a positive for Aclaris, if mid year read out for 1777 is any good.

https://t.co/79iNgYTCBm",,,2012-01-18 13:38:38,Malme,noci,https://pbs.twimg.com/profile_images/1329468478085091331/OujKMIo7_normal.jpg,1043,495,10,2027,nociFTW,
1315927470302879744,2021-04-07 08:03:26,,,"twishort.com/jVboc, ",1379766765513678852,False,0,0,0,0,Twishort,"Thalassemia Market  Size, Share Report To 2022 With Key Players : Celgene Co. &amp; Incyte Co https://t.co/RJdF6EoHMN",,,2020-10-13 04:09:11,Pune,Lopa S,https://pbs.twimg.com/profile_images/1321710322407800832/n2cfm5UT_normal.jpg,150,1219,0,972,LopaS33948521,
1356309939317166080,2021-04-07 05:24:33,,"Pharmaceutical, ","pharmaregnews.com/2021/04/07/us-‚Ä¶, pic.twitter.com/uXqjW920Uo, ",1379726779758219267,False,0,0,0,0,Twitter Web App,"US FDA extend review period of the supplemental NDA for baricitinib of Eli Lilly and Incyte https://t.co/7EP9llAdPJ 

#Pharmaceutical https://t.co/uXqjW920Uo",,,2021-02-01 13:34:36,,Pharmareg News,https://pbs.twimg.com/profile_images/1356583687215702017/12itRSyd_normal.jpg,18,3,0,352,PharmaregN,photo
849417718642159616,2021-04-07 01:47:18,"INCY, ",,"zpr.io/RNDL6, ",1379672110482784258,False,0,0,0,0,Zapier.com,Morgan Stanley Trims Incyte $INCY Target Price to $86.00 https://t.co/oCfeGe34PG,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1325446129325142016,2021-04-06 23:00:15,"INCY, LLY, LLY, ",,"seekingalpha.com/news/3679664-f‚Ä¶, ",1379630068692090881,False,0,0,0,0,Integromat,"$INCY $LLY $LLY - FDA extends review period for Eli Lilly, Incyte's baricitinib atopic dermatitis sNDA https://t.co/MdSE5pfQkr",,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
1301425387369619456,2021-04-06 21:39:39,,,"mednetnews.com/2021/04/07/lil‚Ä¶, ",1379609787642605568,False,0,0,0,0,WordPress.com,Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic¬†dermatitis https://t.co/Kbr4kYFeUY,,,2020-09-03 03:42:57,,mednetnews,https://pbs.twimg.com/profile_images/1301426159247384577/VZsF735N_normal.jpg,5,0,0,13260,mednetnews,
4058194633,2021-04-06 20:27:16,"LLY, iNCY, ",,"pdclarion.com/news/state/lil‚Ä¶, ",1379591571532750853,False,0,0,0,0,Twitter for iPhone,$LLY $iNCY Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis https://t.co/Uw11lIb49m,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1134049078424162304,2021-04-06 18:36:14,"LLY, INCY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1379563628676939782,False,0,0,0,0,Newsfilter.io,Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis $LLY $INCY https://t.co/o6d71tQEaR,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
72928001,2021-04-06 18:33:14,"LLY, ",,"bit.ly/3mripFR, ",1379562874494799874,False,0,0,0,0,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) announce extension of review period for baricitinib sNDA https://t.co/MqmxFZsDDJ,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
374729426,2021-04-06 18:02:19,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2650735, pic.twitter.com/H7n17NHFYq, ",1379555092114726915,False,1,0,0,1,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/TEwIkds60Y #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/H7n17NHFYq,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
25406480,2021-04-06 17:21:34,,,"awesomecapital.blogspot.com/2021/04/lilly-‚Ä¶, ",1379544837213536256,False,0,0,0,1,Twitter Web App,"AwesomeCapital: Lilly, Incyte: FDA review extended for atopic derm... https://t.co/VWQfWvDTTX",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
284054290,2021-04-06 16:47:43,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/townnews/medic‚Ä¶, ",1379536317118300160,False,0,0,0,0,BLOX CMS for DEV,"INDIANAPOLIS, April 6, 2021 /PRNewswire/ --¬†Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) f‚Ä¶ https://t.co/edLoQ6IV8c",,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
284054290,2021-04-06 16:47:38,,,"flex-qa.cms.qa2.vip.inn.mwn.leeent.net/incyte-logo-pr‚Ä¶, ",1379536298533392392,False,0,0,0,0,BLOX CMS for DEV,Incyte logo. (PRNewsfoto/Eli Lilly and Company) https://t.co/sdRfutS1gj,,,2011-04-18 10:50:46,,TownNews Training,https://pbs.twimg.com/profile_images/1488435200/theme-innboard_normal.gif,79,1,1,193256,tntmoline2011,
3318510966,2021-04-06 16:45:44,,,"crweworld.com/article/news-p‚Ä¶, ",1379535820370059264,False,0,0,0,0,CRWE World,Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment https://t.co/vsvnMkP4YF,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
274233761,2021-04-06 16:44:56,,,"investor.incyte.com/press-releases‚Ä¶, ",1379535617177030660,False,3,0,0,1,TweetDeck,"Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis. ""Early Q3"" https://t.co/wvbBpWeXUq",,,2011-03-29 20:20:45,"Lenexa, KS / Venice, FL",Brad Loncar,https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_normal.jpg,45424,346,1007,65536,bradloncar,
425961483,2021-04-06 16:43:32,"LLY, INCY, ",,"investor.lilly.com/news-releases/‚Ä¶, ",1379535265547620358,False,2,0,1,0,Twitter Web App,"Review of $LLY, $INCY approval application for baricitinib for moderate to severe atopic dermatitis extended 3 months, per co. release. Deadline now pushed back to early Q3 2021. https://t.co/ZH234l9o6g",,,2011-12-01 12:20:39,"Washington, DC",Jacob Bell,https://pbs.twimg.com/profile_images/996567868257943552/csvD352D_normal.jpg,1968,433,68,13537,realJacobBell,
472650465,2021-04-06 16:42:44,"LLY, ",,"otcdynamics.com/lly-lilly-and-‚Ä¶, ",1379535062618796037,False,0,0,0,0,OTC Dynamics Twitter Login,$LLY Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis https://t.co/dJbIH3CJ2N,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1134049078424162304,2021-04-06 16:42:14,"LLY, INCY, ",,"newsfilter.io/articles/fda-e‚Ä¶, ",1379534938324750339,False,0,0,0,0,Newsfilter.io,"FDA extends review period for Eli Lilly, Incyte's baricitinib atopic dermatitis sNDA $LLY $INCY https://t.co/3vOBd5GOZq",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2021-04-06 16:39:20,"INCY, LLY, LLY, ",,"seekingalpha.com/news/3679664-f‚Ä¶, ",1379534207135875074,False,0,1,0,1,SANewsTwitter,"$INCY $LLY $LLY - FDA extends review period for Eli Lilly, Incyte's baricitinib atopic dermatitis sNDA https://t.co/Etu8Ti4wob",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
2356524462,2021-04-06 16:37:17,"LLY, ",,,1379533693522485249,False,0,0,0,0,Stock News Alerts,"$LLY Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for t
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1325115160353103872,2021-04-06 16:30:34,"INCY, ","healthcare, ","quantisnow.com/insight/592562‚Ä¶, ",1379532002366398465,False,0,0,0,0,Twitter,"$INCY üìÉ Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis

https://t.co/hLTXxhGu6N

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1254035253104181256,2021-04-06 16:30:24,"LLY, INCY, ",,"stocktitan.net/news/LLY/lilly‚Ä¶, ",1379531961325256731,False,0,0,0,0,stocktitan,"$LLY $INCY Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
https://t.co/tLoZqZO6Rb",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1280938376099741697,2021-04-05 20:57:50,,"iexStock, ","iexcloud.io, pic.twitter.com/5Nfo7Va3T2, ",1379236872388546562,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Intuit Inc
-AMGEN Inc.
-Henry Schein Inc.
-Incyte Corp.
-Cisco Systems, Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/5Nfo7Va3T2",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2021-04-05 18:11:14,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2648449, pic.twitter.com/lS5JZf0OuS, ",1379194946251419654,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/5Lmwf9BKd0 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/lS5JZf0OuS,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1262915121103491074,2021-04-05 16:26:17,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1379168534660489216,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 396 shares on 2021-04-01. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
732361939490312192,2021-04-05 12:51:17,"INCY, ","markets, ","americanbankingnews.com/?p=19291779, ",1379114430408093701,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $86.00 at Morgan Stanley https://t.co/Cf1QWSRSeA #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-04-05 12:51:16,"INCY, ","stocks, ","americanbankingnews.com/?p=19291779, ",1379114427597914116,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $86.00 at Morgan Stanley https://t.co/W8TXttmQil #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1268105553533972481,2021-04-05 11:13:52,"INCY, ",,"pic.twitter.com/HimS7kKxBT, ",1379089915393228801,True,0,0,0,0,Twitter Web App,$INCY Incyte Corp Ltd. Long here to gap. https://t.co/HimS7kKxBT,,,2020-06-03 05:01:43,Swansea - Wales,The Trading Shack,https://pbs.twimg.com/profile_images/1422241017802199042/nxWnhPYF_normal.jpg,1439,41,6,792,TheTradingShack,photo
1325115160353103872,2021-04-05 08:06:33,"INCY, ","healthcare, ","quantisnow.com/insight/584394‚Ä¶, ",1379042774729650178,False,0,0,0,0,Twitter,"$INCY üì° Morgan Stanley reiterated coverage on Incyte with a new price target

https://t.co/hh7JFftuQ2

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
374729426,2021-04-03 17:36:25,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2643681, pic.twitter.com/1FNa7JkQbp, ",1378461408493375489,False,1,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/Fp0OFxap73 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1FNa7JkQbp,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280938376099741697,2021-04-03 00:05:35,,"iexStock, ","iexcloud.io, pic.twitter.com/pekfrhsv35, ",1378196959597633539,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Advanced Micro Devices Inc.
-Autodesk Inc.
-ASML Holding NV - New York Shares
-Intel Corp.
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/pekfrhsv35",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
16341911,2021-04-02 17:12:39,,"ccfac2021, cholangiocarcinoma, Incyte, EMEA, cholangiocarcinoma, ",,1378093040246603777,False,5,1,0,2,Twitter Web App,In the 3 days of the @curecc #ccfac2021 meeting...Futibatinib @TaihoOncology got @FDAOncology breakthrough designation for #cholangiocarcinoma AND Pemigatinib #Incyte got #EMEA approval for #cholangiocarcinoma,"curecc, TaihoOncology, FDAOncology, ",,2008-09-17 23:03:59,"Jacksonville, FL",KModyMD,https://pbs.twimg.com/profile_images/1097258932572180480/2d0wP_3Y_normal.jpg,1252,319,31,2491,kmody29,
1359077910,2021-04-02 12:30:11,,,"europharmajobs.com/job_display/19‚Ä¶, ",1378021954872020999,False,0,0,0,0,EPJ Jobs Post,"Medical Director, Clinical Development, Incyte, Morges, Switzerland

https://t.co/qnhpS25ve3",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
1134049078424162304,2021-04-02 11:29:12,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1378006607708176385,False,0,0,0,0,Newsfilter.io,"Baker Bros. Advisors Lp (Director) acquired new securities, reported in a new form 4 filed with the SEC  $INCY https://t.co/tRkIoeoGW9",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-04-02 08:28:35,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1377961156858548230,False,0,0,0,0,Newsfilter.io,"$24,218.46 of shares acquired by Clancy Paul J (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/pjFRiaycmt",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-04-02 08:07:36,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1377955874317144065,False,0,0,0,0,Newsfilter.io,"$18,285.75 of shares acquired by Dixon Wendy L (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/bj4WIBwWFQ",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-04-02 07:48:36,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1377951094609952768,False,0,0,0,0,Newsfilter.io,"$17,798.13 of shares acquired by Harrigan Edmund (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/9TcRny12fc",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-04-02 06:57:36,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1377938257485385732,False,0,0,0,0,Newsfilter.io,"$20,398.77 of shares acquired by Fouse Jacqualyn A (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/QPLbpTSVH5",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
812004702594486272,2021-04-02 05:01:17,,,"checkrare.com/overview-of-sq‚Ä¶, ",1377908987857895430,False,0,0,0,0,Hootsuite Inc.,"Lance Leopold, MD, Group Vice President, Immuno-Oncology, at Incyte gives an overview of squamous cell carcinoma of the anal canal (SCAC).
@Incyte 
https://t.co/HXjJ5sP65q","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
2344420430,2021-04-02 03:45:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1377889882044039168,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

EDMUND HARRIGAN:

https://t.co/7OnCOhcptp",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-04-02 02:31:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1377871236710141957,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

PAUL J CLANCY:

https://t.co/wKoVYEpsMk",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
374729426,2021-04-01 19:39:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2639162, pic.twitter.com/FrNhZjjQNA, ",1377767641750794245,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on February 16, 2021. View odds for this and other indicators: https://t.co/vNi5HQxe8J #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/FrNhZjjQNA",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2344420430,2021-04-01 19:00:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1377757774055084035,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

WENDY L DIXON:

https://t.co/ofaQYsWy8e",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-04-01 17:17:23,"INCY, ",,"insideri.com/879169_0001638‚Ä¶, ",1377731844867772423,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

10%+ Owner

BAKER BROS. ADVISORS LP:

https://t.co/4C1wLhz1dd",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-03-31 21:26:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1377432130364403714,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Tech. Operations

MICHAEL JAMES MORRISSEY:

https://t.co/AlYDhIiEnN",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2298709746,2021-03-31 16:51:22,"INCY, ",,"zpr.io/RTkwW, ",1377362907881558019,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 20,000 Shares of Stock https://t.co/hDExwKMySV",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1262915121103491074,2021-03-31 16:11:11,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1377352796089905155,False,0,0,0,0,formwhispers,"#FWSells $INCY Morrissey Michael James, EVP, Head of Tech. Operations of INCYTE CORP sold 20,000 shares on 2021-03-29. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
374729426,2021-03-31 14:59:41,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2636353, pic.twitter.com/BoOY7I3CoU, ",1377334802987196418,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 10, 2021. View odds for this and other indicators: https://t.co/3kKMtk06g9 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BoOY7I3CoU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
55654926,2021-03-31 13:45:02,,"ccfac2021, cholangiocarcinoma, ","pic.twitter.com/pfUJI6T1L4, ",1377316016288624642,False,4,0,0,1,Meltwater Social,Thank you to our Sequoia Level sponsor Incyte. Please be sure to visit their booth at the Annual Conference in our Exhibit Hall &amp; Sponsors tab on the platform. #ccfac2021 #cholangiocarcinoma @Incyte https://t.co/pfUJI6T1L4,"Incyte, ",,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,photo
55654926,2021-03-31 12:12:02,,"QEDTherapeutics, PCIBiotech, TerSeraTherapeutics, ccfac2021, ","pic.twitter.com/dzHlNjhwnK, ",1377292611141050368,False,4,0,0,1,Twitter Web App,"Thanks to all of our sponsors!  @Incyte
 #QEDTherapeutics @merckkgaa @AstraZeneca
 @ZymeworksInc @carisls @genentech @AgiosPharma 
 @Merck @TaihoOncology @FoundationATCG 
 @elevationonc @loxooncology @NuCana_news  
 @OncoSil @RedHillBio #PCIBiotech #TerSeraTherapeutics #ccfac2021 https://t.co/dzHlNjhwnK","Incyte, merckkgaa, AstraZeneca, ZymeworksInc, carisls, genentech, AgiosPharma, Merck, TaihoOncology, FoundationATCG, elevationonc, loxooncology, NuCana_news, OncoSil, RedHillBio, ",,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,photo
2384219072,2021-03-31 09:12:25,,"DEBIO, NetDE, ","loom.ly/w9NwCls, pic.twitter.com/swDbMwaanE, ",1377247413111492612,False,1,0,0,0,Loomly,"Congratulations to #DEBIO member company @Incyte on their European Commission approval of Pemazyre for rare bile duct cancer. Read more here: https://t.co/6M5IMfv2Wp
#NetDE https://t.co/swDbMwaanE","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
1325652841520910336,2021-03-31 04:48:25,,"Incyte, ",,1377180974132338689,False,1,0,0,0,Twitter for Android,"You call me wack, I don't take sarcasm #Incyte",,,2020-11-08 23:14:34,,Kasungu Boy,https://pbs.twimg.com/profile_images/1430979432882266114/Byv58nZ4_normal.jpg,860,1077,1,8272,ThomboziChawezi,
1224012435872305152,2021-03-31 03:22:26,,,"lifepronow.com/2021/03/31/inc‚Ä¶, pic.twitter.com/ndfDyU06WO, ",1377159335730573318,False,0,0,0,0,Twitter Web App,"Incyte‚Äôs Pemazyre¬Æ aothorized by EU for Advanced or Metastatic Cholangiocarcinoma

https://t.co/cTQvAbiGeg https://t.co/ndfDyU06WO",,,2020-02-02 11:51:30,India,LifeProNow-Pharma-Research and News,https://pbs.twimg.com/profile_images/1255897607584411648/z8fpqZQV_normal.jpg,14,28,0,618,LifeProNow1,photo
1280938376099741697,2021-03-30 20:13:31,,"iexStock, ","iexcloud.io, pic.twitter.com/3QbZZhvoi6, ",1377051395975692293,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Cintas Corporation
-Incyte Corp.
-Comcast Corp - Class A
-Ras Al Khaimah Poultry Co &amp; Feeding Co
-Charter Communications Inc. - Class A

Data provided by https://t.co/oXreiEXTgd https://t.co/3QbZZhvoi6",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
133504478,2021-03-30 16:22:12,,"strategy, competitiveintelligence, marketing, productmarketing, biotech, pharmaceutical, healthcare, pharma, ","dlvr.it/RwhPt6, pic.twitter.com/f6SrnHZiva, ",1376993180395008001,False,2,0,0,2,dlvr.it,"MorphoSys, Incyte are touting Monjuvi's potential down the line‚Äîbut COVID-19 is slowing its launch now https://t.co/VaSVJVtPup #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharmaceutical #healthcare #pharma https://t.co/f6SrnHZiva",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
18294275,2021-03-30 15:43:00,,,"fiercepharma.com/marketing/firs‚Ä¶, ",1376983315740295175,False,0,0,0,0,TweetDeck,"MorphoSys, Incyte are touting Monjuvi's potential down the line‚Äîbut COVID-19 is slowing its launch now https://t.co/83ATVda8KD",,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
4058194633,2021-03-30 15:25:56,"MOR, INCY, ",,"fiercepharma.com/marketing/firs‚Ä¶, ",1376979021834059776,False,1,0,0,0,Twitter for iPhone,"$MOR $INCY MorphoSys, Incyte are touting Monjuvi's potential down the line‚Äîbut COVID-19 is slowing its launch now https://t.co/RavJyHlhBD",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4838520568,2021-03-30 15:06:03,,"Covid19, Sales, ","bit.ly/3dig8IQ, ",1376974018566361089,False,0,0,0,0,Tiana1,"MorphoSys CEO Jean - Paul Kress pointed the finger at #Covid19 over the #Sales projections for its Incyte - partnered diffuse large B - cell lymphoma drug, Monjuvi . hence the relatively big gap between the two ends of its revenue forecast . https://t.co/rB18V5cxph",,,2016-01-23 08:06:53,Everywhere,Tian_A1,https://pbs.twimg.com/profile_images/977871067883671552/E2ir3mkl_normal.jpg,1491,1382,0,375150,Tian_A1,
140599113,2021-03-30 13:44:33,,,"winway.me/health-remedie‚Ä¶, ",1376953508444958721,False,0,0,0,0,WordPress.com,"MorphoSys, Incyte are touting Monjuvi‚Äôs potential down the line‚Äîbut COVID-19 is slowing its launch¬†now https://t.co/VkghrJAAPb",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
1280288213102292993,2021-03-30 13:01:12,,,"pharmabox.in/morphosys-incy‚Ä¶, ",1376942597525155842,False,0,0,0,0,Hootsuite Inc.,"MorphoSys, Incyte are touting Monjuvi‚Äôs potential down the line‚Äîbut COVID-19 is slowing its launch now https://t.co/bzYWB6Zagh",,,2020-07-06 19:51:21,,WWW.PHARMABOX.IN,https://pbs.twimg.com/profile_images/1284027505058381827/7o7Mcyq1_normal.jpg,856,450,0,5397,pharmabox_in,
46297868,2021-03-30 12:56:04,,,"dlvr.it/Rwgrk7, ",1376941306132320256,True,0,0,0,0,dlvr.it,"MorphoSys, Incyte are touting Monjuvi's potential down the line‚Äîbut COVID-19 is slowing its launch now https://t.co/AYyPjnsUHv",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
17960461,2021-03-30 12:22:00,,"PharmaNews, ","bit.ly/2PgWwNa, pic.twitter.com/8V3z56YTF1, ",1376932732475908097,False,0,0,0,0,TweetDeck,"Incyte receives European Commission approval for Pemazyre
https://t.co/qBTfVoV7t8
#PharmaNews https://t.co/8V3z56YTF1",,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
985228784042377216,2021-03-30 09:08:06,,,"twitter.com/Incyte/status/‚Ä¶, ",1376883935674834954,False,38,0,1,14,Twitter for iPhone,Good news for patients with CCA and FGFR2 genetic alterations! EMA approves the use of Pemigatinib in 2 line. @curecc @CharityAMMF @CcaEns @EASLnews https://t.co/JSWYAHNSlD,"curecc, CharityAMMF, CcaEns, EASLnews, ",,2018-04-14 14:50:21,"Artajona, Espa√±a",Jesus Ba√±ales,https://pbs.twimg.com/profile_images/985272301833916418/rXKfXd-X_normal.jpg,938,465,6,2516,JesusMBanales,
1304774550014615554,2021-03-30 06:27:13,,,"twitter.com/Incyte/status/‚Ä¶, ",1376843447991156739,False,19,0,0,4,Twitter Web App,"So encouraged by this news - to see new, targeted therapies starting to be approved in Europe, giving hope to those in desperate need of alternatives.  Thank you, @Incyte.  Now we need approval in the UK! https://t.co/o5BPgUZ6n0","Incyte, ",,2020-09-12 09:32:06,UK,Helen Morement,https://pbs.twimg.com/profile_images/1304775126232293377/dwFksdw9_normal.jpg,182,299,0,268,HelenMorement,
1889492676,2021-03-30 05:51:54,"INCY, ","Incyte, Pemazyre, Pemigatinib, MetastaticCholangiocarcinoma, FibroblastGrowthFactorReceptor2, FGFR2, Fusion, Rearrangement, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1376834562106347522,False,0,0,0,0,Troi URL Plug-in,#Incyte Announces the European Commission Approval of #Pemazyre (#Pemigatinib) as a Treatment for Adults with Locally Advanced or #MetastaticCholangiocarcinoma with a #FibroblastGrowthFactorReceptor2 (#FGFR2) #Fusion or #Rearrangement $INCY https://t.co/d42eio8SHi,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
17960461,2021-03-30 05:32:02,,"PharmaNews, ","bit.ly/2PgWwNa, pic.twitter.com/ejnMHAy1LR, ",1376829564043866113,False,2,0,0,1,Twitter Web App,"Incyte receives European Commission approval for Pemazyre
https://t.co/qBTfVpcIRI
#PharmaNews https://t.co/ejnMHAy1LR",,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
3901351277,2021-03-30 05:26:16,,"pharmaceutical, ","bit.ly/3u3FtNq, ",1376828111220834305,False,0,0,0,0,IFTTT,Incyte receives EC approval for Pemazyre : https://t.co/ADkwM4eYrw #pharmaceutical,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
1325446129325142016,2021-03-30 00:00:15,"INCY, ",,"seekingalpha.com/news/3677260-i‚Ä¶, ",1376746065106509831,False,0,0,0,0,Integromat,$INCY - Incyte's Pemazyre wins European Commission approval to treat rare form of cancer https://t.co/eswGYN4s0Y,,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
20780650,2021-03-29 20:16:37,,,"biedexmarkets.com/incyte-corpora‚Ä¶, ",1376689788456214530,False,1,0,0,0,biedexmarkets,"Incyte Corporation (NASDAQ:INCY) - Incyte's Pemazyre Wins European Approval For Bile Duct Cancer -

 -https://t.co/vWmKHtnMnY",,,2009-02-13 11:02:18,"London, England",Biedex Markets,https://pbs.twimg.com/profile_images/1288488731654201349/MSrdzFac_normal.jpg,4018,4862,120,362261,biedexmarkets,
4058194633,2021-03-29 18:13:21,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1376658764732846081,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Announces the European Commission Approval of Pemazyre¬Æ (pemigatinib) as a Treatment for Adults with Locally Advanced or Metastatic Cholangiocarcinoma with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangement  | Business Wire https://t.co/Mtp0s7qppH,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
374729426,2021-03-29 17:28:33,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2631938, pic.twitter.com/BbwVD4cg2i, ",1376647490674458626,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on February 16, 2021. View odds for this and other indicators: https://t.co/1Bdd4ab3NY #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BbwVD4cg2i",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3686628867,2021-03-29 15:18:07,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1376614666437341194,False,0,0,0,0,WordPress.com,Incyte Announces the European Commission Approval of Pemazyre¬Æ (pemigatinib) as a Treatment for Adults with Locally Advanced or Metastatic Cholangiocarcinoma with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or¬†Rearrangement https://t.co/CHI01gFMNL,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
963495628545327104,2021-03-29 15:17:02,"INCY, INCY, ",,"stck.pro/news/INCY/1191‚Ä¶, stck.pro/news/INCY, pic.twitter.com/F4tvO45h74, ",1376614395900477448,False,1,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's Pemazyre Wins European Approval For Bile Duct Cancer https://t.co/VwQXrMKQJt Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/F4tvO45h74,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1134049078424162304,2021-03-29 14:44:57,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1376606318602170369,False,1,0,0,0,Newsfilter.io,Incyte's Pemazyre Wins European Approval For Bile Duct Cancer $INCY https://t.co/5awIRBKcXO,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
72928001,2021-03-29 14:07:11,"INCY, ",,"bit.ly/3dfREjw, ",1376596816687337476,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte announces that the European Commission has approved Pemazyre for the treatment of adults with locally... https://t.co/II36Y5dGrn,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1006334607946649600,2021-03-29 13:08:13,,"StockMarket, Stocks, ","dlvr.it/Rwc9nD, ",1376581976207990786,False,0,0,0,0,dlvr.it,Incyte Announces the European Commission Approval of Pemazyre¬Æ (pemigatinib) as a Treatment for Adults with Locally Advanced or Metastatic Cholangiocarcinoma with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangement https://t.co/F8Crza5OO7 #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
121158213,2021-03-29 13:01:34,"INCY, ",,"dlvr.it/Rwc8dt, lddy.no/m67j, ",1376580302819131392,False,0,0,0,0,dlvr.it,REVERSALtoUP: $INCY Incyte Corporation Common Stock https://t.co/NuYyTxxcXl üìà üîú TradeIdeas via ‚ü∂ https://t.co/ZgCyz4rX3x,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
3318510966,2021-03-29 12:51:38,,,"crweworld.com/article/news-p‚Ä¶, ",1376577801847902210,False,0,0,0,0,CRWE World,Incyte Announces the European Commission Approval of Pemazyre¬Æ (pemigatinib) as a Treatment for Adults with Locally https://t.co/A75ckJXOKX,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
166597717,2021-03-29 12:30:00,"INCY, ",,"bit.ly/3diIpiA, ",1376572358668943365,False,0,0,0,0,TweetDeck,Incyte announces European Commission approval of Pemazyre $INCY https://t.co/mKcQLAEyIZ,,,2010-07-14 11:10:34,Greater New York City Area,The Fly,https://pbs.twimg.com/profile_images/885896700472287233/NunLvfQW_normal.jpg,27381,167,0,106350,theflynews,
963495628545327104,2021-03-29 12:23:14,"INCY, INCY, ",,"stck.pro/news/INCY/1191‚Ä¶, stck.pro/news/INCY, ",1376570658071674890,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's Pemazyre wins European Commission approval to treat rare form of cancer https://t.co/6yIKx8B2lM Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
1134049078424162304,2021-03-29 12:20:57,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1376570079496830980,False,0,0,0,0,Newsfilter.io,Incyte's Pemazyre wins European Commission approval to treat rare form of cancer $INCY https://t.co/2b54cx7k1Y,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2021-03-29 12:19:24,"INCY, ",,"seekingalpha.com/news/3677260-i‚Ä¶, ",1376569692555382792,False,0,0,0,1,SANewsTwitter,$INCY - Incyte's Pemazyre wins European Commission approval to treat rare form of cancer https://t.co/ldZ1IUDTc1,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1332189683082674177,2021-03-29 12:17:33,"INCY, ",,"beeken.io/bhlp?utm_conte‚Ä¶, pic.twitter.com/Ac599vGaUx, ",1376569224991100928,False,0,0,0,0,dlvr.it,$INCY - Incyte Announces the European Commission Approval of Pemazyre¬Æ (pemigatinib) as a Treatment for Adults with Locally Advanced or Metastatic Cholangiocarcinoma with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangement https://t.co/XqrwuTNGJ0 https://t.co/Ac599vGaUx,,,2020-11-27 00:09:11,,Beeken Healthcare,https://pbs.twimg.com/profile_images/1332189760132055040/x0dGPU_H_normal.jpg,76,4,4,6579,Beeken_health,photo
1276824218928214017,2021-03-29 12:15:26,,,"impharmanews.com/2021/03/29/inc‚Ä¶, ",1376568693044342785,False,0,0,0,0,IMPharma News,"Incyte Announces the European Commission Approval of Pemazyre¬Æ (pemigatinib) as a Treatment for Adults with Locally Advanced or Metastatic Cholangiocarcinoma with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangement 
https://t.co/D3BUPrEzlz",,,2020-06-27 06:26:45,India,IMPharma News,https://pbs.twimg.com/profile_images/1277193245479456768/5QLoLmr4_normal.jpg,173,1544,2,5944,IMPharmaNews,
2932993913,2021-03-29 12:11:04,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1376567593742569479,False,0,0,0,0,Twitter Web App,"$INCY
https://t.co/GqJpnm3EMN",,,2014-12-19 21:39:11,,Lloyd Christmas,https://pbs.twimg.com/profile_images/1404711859966599170/rIp59hOm_normal.jpg,77,231,0,548,IGotStocks,
1355194932445786112,2021-03-29 12:08:07,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1376566852986548233,False,0,0,0,0,Twitter,"$INCY Incyte Announces the European Commission Approval of Pemazyre¬Æ (pemigatinib) as a Treatment for Adults with Locally Advanced or Metastatic Cholangiocarcinoma with a Fibroblast Growth Factor Receptor 2...
https://t.co/wLkZdi5Q8n",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
741310918496129028,2021-03-29 12:07:43,"INCY, ",,"seekingalpha.com/pr/18249976-in‚Ä¶, ",1376566751861870594,False,0,0,0,0,Twitter for iPhone,ticker symbol $INCY Incyte Announces the European Commission Approval of Pemazyre¬Æ (pemigatinib) as a Treatment for Adults with Locally Advanced or Metastatic Cholangiocarcinoma with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangement https://t.co/M3e22RqjcJ,,,2016-06-10 12:47:51,"Mississippi, USA",Jase Jones,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,880,1593,15,14779,astockwatch1,
1261065948011864064,2021-03-29 12:05:03,"INCY, ",,,1376566079317757958,False,1,0,0,0,StockTwits Web,"Incyte Announces the European Commission Approval of Pemazyre¬Æ (pemigatinib) as a Treatment for Adults with Locally Advanced or Metastatic Cholangiocarcinoma with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangement
$INCY",,,2020-05-14 18:50:34,"Dallas, TX",Print Trading,https://pbs.twimg.com/profile_images/1270530766913572864/362fWEDo_normal.jpg,1346,0,41,14970,print_trading,
1134049078424162304,2021-03-29 12:04:56,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1376566051945730056,False,0,0,0,0,Newsfilter.io,Incyte Announces the European Commission Approval of Pemazyre¬Æ as a Treatment for Adults with Locally Advanced or Metastatic Cho.. $INCY https://t.co/SaDq2oI1d3,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1254035253104181256,2021-03-29 12:04:07,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1376565846047330304,False,0,0,0,0,stocktitan,"$INCY Incyte Announces the European Commission Approval of Pemazyre¬Æ (pemigatinib) as a Treatment for Adults with Locally Advanced or Metastatic Cholangiocarcinoma with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangeme
https://t.co/gPEhl7hsL9",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1022006086872821762,2021-03-28 21:03:00,"INCY, INCY, ",,,1376339072113856513,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was UP ‚¨Ü on Fri Mar 26
Closed at 81.75 USD for a 2.47% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
984134429777031173,2021-03-28 19:04:48,,,"twitter.com/Incyte/status/‚Ä¶, ",1376309325635936258,False,1,0,0,0,Twitter for iPhone,Thank you! I am one of those types! DrG https://t.co/IVzMWCKiA5,,,2018-04-11 14:21:47,"Philadelphia, PA",Geneva Harris PhD,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,2463,5008,2,47262,HartisPhd,
2361204445,2021-03-28 09:00:01,,"CHOSOURCE, BPIWEST, Bioprocess, InspiredCellSolutions, ","bit.ly/3q1ZNMK, ",1376157126389866498,False,0,0,0,0,Semrush Social Media Tool,"1 day until BPI West Virtual! At our session with Jay Sinha from Incyte Corp, he will be presenting the approaches and challenges of bispecific antibody expression using Horizon's CHO-K1 cell line, #CHOSOURCE. 
https://t.co/c2Oig42fIe
#BPIWEST #Bioprocess #InspiredCellSolutions",,,2014-02-25 09:46:42,"Cambridge, UK",Horizon Discovery,https://pbs.twimg.com/profile_images/1225093651044302849/QtHP95re_normal.jpg,9934,397,57,2776,HZDiscovery,
374729426,2021-03-27 19:48:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2627461, pic.twitter.com/1fmKlPIJ7s, ",1375958039400837120,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on February 16, 2021. View odds for this and other indicators: https://t.co/xdRsr1jqBq #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1fmKlPIJ7s",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280938376099741697,2021-03-26 23:04:36,,"iexStock, ","iexcloud.io, pic.twitter.com/YG7CjCTqwm, ",1375644899136126978,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Workday Inc - Class A
-MercadoLibre Inc
-Alexion Pharmaceuticals Inc.
-Incyte Corp.
-Cerner Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/YG7CjCTqwm",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2021-03-26 20:26:41,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2625166, pic.twitter.com/IOu0cpNQ0S, ",1375605158659297280,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/Cq3U2VcHhz #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/IOu0cpNQ0S,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
948505266,2021-03-26 16:01:21,,,"pic.twitter.com/fGwePzFCLI, ",1375538382709874695,False,6,0,0,1,Hootsuite Inc.,We are thrilled to welcome back @Incyte as our 2021 Region Sponsor for the @2021 Maximize Life Gala! https://t.co/fGwePzFCLI,"Incyte, 2021, ",,2012-11-14 16:15:20,"Seattle, WA",The Max Foundation,https://pbs.twimg.com/profile_images/937832721392349184/Srf07Z67_normal.jpg,1447,497,36,2108,stompoutcancer,photo
1315434407692509184,2021-03-26 14:18:19,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/jqhjdCmqXi, ",1375512452608094211,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 36.30% ranked 642 out of 5469 companies in our database. 

https://t.co/AjmQ0qpv6F $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/jqhjdCmqXi",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
812004702594486272,2021-03-26 05:01:14,,,"checkrare.com/efficacy-of-re‚Ä¶, ",1375372260647796740,False,1,0,0,0,Hootsuite Inc.,"Lance Leopold, MD, Group Vice President, Immuno-Oncology, at Incyte discusses the clinical trial of retifanlimab for the treatment of squamous cell carcinoma of the anal canal (SCAC).
@Incyte 
https://t.co/nHthYjDPYE","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
728894570,2021-03-25 15:18:59,,"All_Health_Fitness_Tips, ","iweller.com/all-health-fit‚Ä¶, pic.twitter.com/hHch0CwYWD, ",1375165334961876993,False,0,0,0,0,iweller.com,"Bone marrow transplantation enters ‚Äòthe dawn of a new era‚Äô - #All_Health_Fitness_Tips - Cutler reports consultant/advisory board roles with Generon, Incyte, Jazz Pharmaceuticals, Kadmon, Medsenic and Mesoblast.. Giralt... - https://t.co/YA6uNWnXlM https://t.co/hHch0CwYWD",,,2012-07-31 13:55:29,,iWeller.com,https://pbs.twimg.com/profile_images/1244249406477455360/tl4H1tq0_normal.jpg,121,141,0,264390,iWeller_health,photo
374729426,2021-03-24 18:18:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2620430, pic.twitter.com/zpirUa01Zs, ",1374848156593049601,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on February 16, 2021. View odds for this and other indicators: https://t.co/33afUO6DTP #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/zpirUa01Zs",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
33982855,2021-03-24 17:30:25,,"HBAimpact, HBAWOTY21, ","ow.ly/QgCG50E6hk7, pic.twitter.com/lSvEddd5fL, ",1374836021674831876,False,5,0,0,0,Hootsuite Inc.,"Congrats! Pam Politis, Jennifer Heckman, @Incyte; Megan Zipkin, @InovalonInc; Ruth Fleming, Meera Gopalakrishnan, @integra_life; Whitney Jappe, @intouchg; Jennifer Benenson, Christy Mitchell, @IpsenGroup.
#HBAimpact #HBAWOTY21
https://t.co/RsSMDX4sXo https://t.co/lSvEddd5fL","Incyte, InovalonInc, integra_life, intouchg, IpsenGroup, ",,2009-04-21 14:01:58,,HBAnet,https://pbs.twimg.com/profile_images/926433255267717120/LLuNCVg2_normal.jpg,5446,3803,179,10160,HBAnet,photo
1276528931890515968,2021-03-24 16:33:49,,,"lnkd.in/gcBjZKy, ",1374821776698580994,False,0,0,0,0,LinkedIn,"Stephen Kaufhold Treasurer Incyte
""treasury is not even understood. It's a black box within the company, and if people internally don't understand what treasury is, they're not going to know what questions to ask, they're not going to know how to reach ou‚Ä¶https://t.co/ChPAi6ight",,,2020-06-26 10:53:22,,@treasurytalent,https://pbs.twimg.com/profile_images/1276529149964886022/NLBvljcE_normal.png,21,47,0,758,treasurytalent,
1138312924269862916,2021-03-24 14:52:52,,,,1374796371165843460,False,5,0,0,2,Twitter Web App,Thank you to @RandyDascher @TheJensenShow for inviting me on to talk about thank you billboard for Incyte.Incyte's development of the first&amp;only FDA targeted drug was huge &amp; overshadowed by covid. It is fitting for their one year anniversary we celebrate them. Thank YOU Incyte.,"RandyDascher, TheJensenShow, ",,2019-06-11 01:12:04,,Cholangio Warrior,https://pbs.twimg.com/profile_images/1446242650462556162/3Ol_Cu_a_normal.jpg,185,436,0,1065,Cholangiocarci2,
4058194633,2021-03-24 11:18:06,"INCY, ",,"delawarebusinessnow.com/2021/03/despit‚Ä¶, ",1374742325499293698,False,0,0,0,0,Twitter for iPhone,"$INCY Despite disappointing study results, Incyte will ask FDA to allow use of Jakafi in severely ill Covid-19 patients https://t.co/7SVBuU1rMl via @Delaware Business Now","Delaware, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1022473214457348096,2021-03-24 04:31:40,,,"pharmashots.com/57689/incytes-‚Ä¶, ",1374640044267368450,False,1,0,0,0,Twitter Web App,"Incyte‚Äôs Pemazyre (pemigatinib) Receives MHLW‚Äôs Approval for Unresectable Biliary Tract Cancer with a FGFR2 Fusion Gene @Pharmashot @Incyte 
https://t.co/ejAbOX3CDl","Pharmashot, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
1889492676,2021-03-24 04:01:12,"INCY, ","Incyte, Pemazyre, Pemigatinib, Unresectable, BiliaryTractCancer, FibroblastGrowthFactorReceptor2, FGFR2, FusionGene, Cancer, Chemotherapy, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1374632376014270466,False,0,0,0,0,Troi URL Plug-in,"#Incyte Announces Approval of #Pemazyre (#Pemigatinib) in Japan for the Treatment of Patients with #Unresectable #BiliaryTractCancer (BTC) with a #FibroblastGrowthFactorReceptor2 (#FGFR2) #FusionGene, Worsening After #Cancer #Chemotherapy $INCY https://t.co/d8FlDUQk5J",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1280938376099741697,2021-03-23 19:22:55,,"iexStock, ","iexcloud.io, pic.twitter.com/rCuCL1GUIj, ",1374501946195775497,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Al Qudra Holding
-Micron Technology Inc.
-Ooredoo Q.P.S.C
-Mondelez International Inc. - Class A

Data provided by https://t.co/oXreiEGhRD https://t.co/rCuCL1GUIj",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
4058194633,2021-03-23 19:20:48,"INCY, ",,"MarketBeat.com, marketbeat.com/instant-alerts‚Ä¶, ",1374501413712138248,False,0,0,0,0,Twitter for iPhone,$INCY Analysts Anticipate Incyte Will Post Quarterly Sales of $651.31 Million | https://t.co/NKb5pRLCDo https://t.co/9reh1wXj6p,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
702999329821188096,2021-03-23 19:09:14,,"ScientificSymposium, vitiligo, research, ","pic.twitter.com/Lp3BWxoIEQ, ",1374498501250347008,False,5,0,0,0,Twitter Web App,"Thanks to all who participated in our recent GVF Annual #ScientificSymposium--including our invited speakers, panelists, abstract presenters, attendees + our sponsors, Incyte Dermatology and Pfizer. Watch for the recording from this outstanding #vitiligo #research program! https://t.co/Lp3BWxoIEQ",,,2016-02-25 18:31:16,"Chicago, IL",Global Vitiligo Foundation,https://pbs.twimg.com/profile_images/1235405131098869760/frWX3dp6_normal.jpg,1604,266,10,448,StepUp4Vitiligo,photo
14453501,2021-03-23 17:55:24,,,"delawarebusinessnow.com/2021/03/despit‚Ä¶, ",1374479921477677064,True,0,0,0,0,WordPress.com,"Despite disappointing study results, Incyte will ask FDA to allow use of Jakafi in severely ill Covid-19¬†patients https://t.co/UOpyk08pX0",,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
3911174913,2021-03-23 16:43:15,,"HBAImpact, ","pic.twitter.com/pK9tkBULJR, ",1374461766076297225,False,10,0,0,2,Twitter for Advertisers.,"We‚Äôre proud of Incyte‚Äôs Pam Politis and Jennifer Heckman for receiving the HBA Luminary and Rising Star awards for their outstanding achievements, inspirational leadership and commitment to excellence. Thank you both for all you do to serve our mission and team! #HBAImpact https://t.co/pK9tkBULJR",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
17960461,2021-03-23 13:34:00,,"pharmanews, ","bit.ly/3cXPo05, pic.twitter.com/55TNY2Phuu, ",1374414136939978769,False,0,0,0,0,TweetDeck,"Incyte biliary tract cancer treatment approved in Japan
https://t.co/hX56YCtww2
#pharmanews https://t.co/55TNY2Phuu",,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
55654926,2021-03-23 13:17:15,,"curecca, bileductcancer, cholangiocarcinoma, ","pic.twitter.com/R1Fm1y9JX8, ",1374409923065380876,False,18,1,0,5,Twitter for iPhone,"This beautiful sign is currently in Wilmington, DE. 
Patients express their gratitude for the first FDA approved cholangicarcinoma-specific targeted treatment option. We are SO grateful for this patient-led effort.üíöüíöüíö @Incyte 
#curecca #bileductcancer #cholangiocarcinoma https://t.co/R1Fm1y9JX8","Incyte, ",,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,photo
4058194633,2021-03-23 11:54:17,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1374389044134645760,False,0,0,0,0,Twitter for iPhone,"$INCY Incyte Announces Approval of Pemazyre¬Æ (pemigatinib) in Japan for the Treatment of Patients with Unresectable Biliary Tract Cancer (BTC) with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene, Worsening After Cancer Chemotherapy  https://t.co/ruT67TbgOB",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1325446129325142016,2021-03-23 10:31:02,"INCY, ",,"seekingalpha.com/news/3675094-i‚Ä¶, ",1374368092881518606,False,0,0,0,0,Integromat,$INCY - Incyte's Pemazyre OK'd in Japan for bile duct cancer https://t.co/3EF6k6q0ZE,,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
3901351277,2021-03-23 08:26:04,,"pharmaceutical, ","bit.ly/3sr4a5S, ",1374336644069871618,False,0,0,0,0,IFTTT,Incyte biliary tract cancer treatment approved in Japan : https://t.co/hXcaRIjKW8 #pharmaceutical,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
17960461,2021-03-23 08:14:31,,"pharmanews, ","bit.ly/3cXPo05, pic.twitter.com/H93vsBHwo0, ",1374333736603488260,False,3,0,0,0,Twitter Web App,"Incyte biliary tract cancer treatment approved in Japan
https://t.co/hX56YCL7UC
#pharmanews https://t.co/H93vsBHwo0",,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
72928001,2021-03-23 07:27:34,"INCY, ",,"bit.ly/3w04NG7, ",1374321923946024963,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte receives approval for Pemazyre in Japan https://t.co/ScIeNreY0b,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
163565297,2021-03-23 06:58:00,,"CSCDE, cancersupport, cancerawareness, cancersurvivor, financialcancerassistance, ","cancersupportdelaware.org/resources/incy‚Ä¶, pic.twitter.com/onFHdRzYik, ",1374314479723409410,False,1,0,0,1,Hootsuite Inc.,"#CSCDE‚Äôs Incyte Cancer Care Assistance Fund helps cover costs such as rent, mortgage, co-pays, and utilities. To find out more about the emergency assistance fund, please visit https://t.co/aM35RQ6Zhg #cancersupport #cancerawareness #cancersurvivor #financialcancerassistance https://t.co/onFHdRzYik",,,2010-07-06 14:57:24,"Delaware, USA",Cancer Support DE,https://pbs.twimg.com/profile_images/667430529340473346/FSfER-Bd_normal.jpg,543,542,30,3173,CancerSupportDE,photo
31372539,2021-03-23 06:46:32,,,"dlvr.it/RwBjMk, ",1374311594855833604,False,0,0,0,0,dlvr.it,Incyte's Pemazyre OK'd in Japan for bile duct cancer https://t.co/JpF7iJhzoa,,,2009-04-15 05:08:17,Amsterdam,Stocks tweets,https://pbs.twimg.com/profile_images/138834360/stocks1-avatar_normal.jpg,4407,3020,91,70157,stocks_tweets,
1134049078424162304,2021-03-23 06:42:46,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1374310648339910658,False,0,0,0,0,Newsfilter.io,Incyte's Pemazyre OK'd in Japan for bile duct cancer $INCY https://t.co/pldRABrfTW,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2021-03-23 06:40:57,"INCY, ",,"seekingalpha.com/news/3675094-i‚Ä¶, ",1374310190481166337,False,0,0,0,1,SANewsTwitter,$INCY - Incyte's Pemazyre OK'd in Japan for bile duct cancer https://t.co/E8qbgIEqiZ,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1006334607946649600,2021-03-23 06:15:34,,"StockMarket, Stocks, ","dlvr.it/RwBc9Q, ",1374303802145173507,False,0,0,0,0,dlvr.it,"Incyte Announces Approval of Pemazyre¬Æ (pemigatinib) in Japan for the Treatment of Patients with Unresectable Biliary Tract Cancer (BTC) with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene, Worsening After Cancer‚Ä¶ https://t.co/8cZP3clLJb #StockMarket #Stocks",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
472650465,2021-03-23 05:46:26,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1374296469470056448,False,0,0,0,0,OTC Dynamics Twitter Login,"$INCY Incyte Announces Approval of Pemazyre¬Æ (pemigatinib) in Japan for the Treatment of Patients with Unresectable Biliary Tract Cancer (BTC) with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene, https://t.co/yaTbiC2QZa",,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
3686628867,2021-03-23 05:44:11,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1374295905986301954,False,0,0,0,0,WordPress.com,"Incyte Announces Approval of Pemazyre¬Æ (pemigatinib) in Japan for the Treatment of Patients with Unresectable Biliary Tract Cancer (BTC) with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene, Worsening After Cancer¬†Chemotherapy https://t.co/iqUjObATZG",,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
707983961897611264,2021-03-23 05:30:45,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1374292522420350976,False,0,0,0,0,Twitter for iPhone,"$INCY | Incyte Announces Approval of Pemazyre¬Æ (pemigatinib) in Japan for the Treatment of Patients with Unresectable Biliary Tract Cancer (BTC) with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene, Worsening After Cancer Chemotherapy
https://t.co/JM2OuIVw7F",,,2016-03-10 12:38:25,"Shawnee, OK",TraderZ,https://pbs.twimg.com/profile_images/1446462992934113312/0KCR9vsY_normal.jpg,2602,624,20,15539,MccaslinAndy,
1254906887490936845,2021-03-23 05:30:12,"INCY, ",,"quantdata.us/news/20292517, ",1374292386470375424,False,0,0,0,0,Quant Data (Production),"Incyte Announced Japan Approval of Pemazyre for the Treatment of Patients with Unresectable Biliary Tract Cancer (BTC) with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene, Worsening After Cance...

Related Tickers: $INCY
Read more at: https://t.co/smcAlPamr9",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
3318510966,2021-03-23 05:27:13,,,"crweworld.com/article/news-p‚Ä¶, ",1374291633085157380,False,0,0,0,0,CRWE World,Incyte Announces Approval of Pemazyre¬Æ (pemigatinib) in Japan for the Treatment of Patients with Unresectable Bilia https://t.co/bmn70Mza9g,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1355194932445786112,2021-03-23 05:17:16,"INCY, ","stockmarket, ","stocktitan.net/news/INCY/incy‚Ä¶, ",1374289131912765440,False,0,0,0,0,Twitter,"$INCY Incyte Announces Approval of Pemazyre¬Æ (pemigatinib) in Japan for the Treatment of Patients with Unresectable Biliary Tract Cancer (BTC) with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene,...
https://t.co/KdkqDgZTz8

#stockmarket",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
976297820532518914,2021-03-23 05:16:33,,,"dlvr.it/RwBQMN, pic.twitter.com/mro9N1cCZH, ",1374288950085394432,False,0,0,0,0,dlvr.it,"Incyte Announces Approval of Pemazyre¬Æ (pemigatinib) in Japan for the Treatment of Patients with Unresectable Biliary Tract Cancer (BTC) with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene, Worsening After Cancer Chemotherapy https://t.co/EzYH07eeQp https://t.co/mro9N1cCZH",,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1134049078424162304,2021-03-23 05:13:51,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1374288269366677504,False,0,0,0,0,Newsfilter.io,Incyte Announces Approval of Pemazyre¬Æ in Japan for the Treatment of Patients with Unresectable Biliary Tract Cancer with a Fibroblast Growth Factor Rece.. $INCY https://t.co/pV0A0OwBsk,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1254035253104181256,2021-03-23 05:13:16,"INCY, ","cancer, ","stocktitan.net/news/INCY/incy‚Ä¶, ",1374288126055682054,False,0,0,0,0,stocktitan,"$INCY Incyte Announces Approval of Pemazyre¬Æ (pemigatinib) in Japan for the Treatment of Patients with Unresectable Biliary Tract Cancer (BTC) with a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene, Worsening After Cancer Chemotherapy
https://t.co/ZTR3w4Jchj

#cancer",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1280938376099741697,2021-03-22 23:05:42,,"iexStock, ","iexcloud.io, pic.twitter.com/EFM1BKlsZN, ",1374195621935087616,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Al Ain Ahlia Insurance Co
-Abu Dhabi Shipbuilding
-Trip.com Group Ltd - ADR
-Marriott International, Inc. - Class A
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/EFM1BKlsZN",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
16341911,2021-03-22 19:36:48,,"cholangiocarcinoma, Patients, ","pic.twitter.com/cS2ouOeGb6, ",1374143049555660808,False,28,0,1,9,Twitter for iPhone,Posted on billboard In Delaware by #cholangiocarcinoma patients to thank @Incyte ! Amazing. Thoughtful. Reminds us how much all of our work as a scientific team means to our #Patients ! Keeping our patients / warriors at the forefront! @curecc @MiteshBorad @rachnatshroff https://t.co/cS2ouOeGb6,"Incyte, curecc, MiteshBorad, rachnatshroff, ",,2008-09-17 23:03:59,"Jacksonville, FL",KModyMD,https://pbs.twimg.com/profile_images/1097258932572180480/2d0wP_3Y_normal.jpg,1252,319,31,2491,kmody29,photo
374729426,2021-03-22 19:08:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2615885, pic.twitter.com/SM2lOVeRtO, ",1374135823931645955,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 10, 2021. View odds for this and other indicators: https://t.co/3VNbK7PKDV #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/SM2lOVeRtO",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1325446129325142016,2021-03-22 09:01:06,,,"on.mktw.net/2QdHTKI, ",1373983071901466630,False,0,0,0,0,Integromat,Incyte drug fails in trial as treatment for severely ill COVID-19 patients https://t.co/TsBnkULUse,,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
15974185,2021-03-22 06:04:34,,,"dlvr.it/Rw6q5l, ",1373938644357058560,False,0,0,0,0,dlvr.it,Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial https://t.co/w0fFAxoL32,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
374729426,2021-03-21 15:43:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2613382, pic.twitter.com/3ESVQtElrW, ",1373721856562266112,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 10, 2021. View odds for this and other indicators: https://t.co/uXRyYZ2loK #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/3ESVQtElrW",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
72672017,2021-03-21 14:10:11,,,"biocareers.com/featured/?jn=3‚Ä¶, ",1373698466753445892,False,0,0,0,0,Postcron App,Vanderbilt-Incyte Research Scholars Program https://t.co/2CNhFCDLGT,,,2009-09-08 17:19:02,"Santa Cruz, CA",Bio Careers¬Æ,https://pbs.twimg.com/profile_images/819716826/Copy_of_008_resize_normal.jpg,34317,35305,279,18713,Bio_Careers,
325135887,2021-03-21 10:25:00,"INCY, NVS, ","COVID19, ","bit.ly/3vMaGGw, ",1373641797914664963,False,3,0,0,2,Twitter Web App,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss! Jakafi missed its endpoint in a phase 3 trial in severe COVID-19! $INCY $NVS #COVID19 
https://t.co/lHZ9XV3srW",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
152490125,2021-03-21 09:45:26,,,"fiercepharma.com/pharma/incyte-‚Ä¶, ",1373631841798909956,False,0,0,0,0,Twitter Web App,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss https://t.co/75HXnmcbOx",,,2010-06-05 22:56:48,,ben m,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,3,2,1,28457,ex4090,
2361204445,2021-03-21 09:12:00,,"CHOSOURCE, BPIWEST, Bioprocess, ","bit.ly/3q1ZNMK, ",1373623426078937090,False,0,0,0,0,Semrush Social Media Tool,"Have you registered yet  for BPI West Virtual? Don't miss our session with Jay Sinha from Incyte Corp, presenting the approaches and challenges of bispecific antibody expression using Horizon's CHO-K1 cell line, #CHOSOURCE. 
https://t.co/c2Oig42fIe
#BPIWEST #Bioprocess",,,2014-02-25 09:46:42,"Cambridge, UK",Horizon Discovery,https://pbs.twimg.com/profile_images/1225093651044302849/QtHP95re_normal.jpg,9934,397,57,2776,HZDiscovery,
751020252247519232,2021-03-21 08:51:03,,,"dlvr.it/Rw4Gzs, pic.twitter.com/8K2FSOAqnh, ",1373618153595408387,False,0,0,0,0,dlvr.it,Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021 - Business Wire: Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at‚Ä¶ https://t.co/ciwAMgG6Pm https://t.co/8K2FSOAqnh,,,2016-07-07 07:49:16,,Oncology Board,https://pbs.twimg.com/profile_images/751020873184935936/zNVXlTcR_normal.jpg,857,0,266,40234,mb_Oncology,photo
782954815739527168,2021-03-20 22:39:02,,,"dlvr.it/Rw3CbX, ",1373464137498460162,False,0,0,0,0,dlvr.it,"Executive Director, Clinical Research Scientist Inflammation &amp; Autoimmunity - Incyte Corporation - Wilmington, DE https://t.co/iEonqBQpiN",,,2016-10-03 10:45:49,"Washington, DC",Clinical Research Forum,https://pbs.twimg.com/profile_images/793945936200351744/foN7mcbj_normal.jpg,345,452,1,1449,CRForumUS,
3460109487,2021-03-20 17:00:00,,,"endpts.com/jakafi-failed-‚Ä¶, ",1373378817511854081,False,0,0,0,0,TweetDeck,"Jakafi disappointed Incyte once when it failed to prevent severe complications of Covid-19. The JAK inhibitor has fallen short again in another Phase III study, failing to keep a more critical subgroup of patients from dying.

https://t.co/lkt0C2aInJ",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
325135887,2021-03-20 14:25:00,"INCY, NVS, ","COVID19, ","bit.ly/3vMaGGw, ",1373339807909355520,False,3,0,0,0,Twitter Web App,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss! Jakafi missed its endpoint in a phase 3 trial in severe COVID-19! $INCY $NVS #COVID19 
https://t.co/lHZ9XVl3Qw",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
2570920968,2021-03-20 13:05:00,"INCY, NVS, ","COVID19, ","bit.ly/3vMaGGw, ",1373319675237396480,False,2,0,0,0,Twitter Web App,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss! Jakafi missed its endpoint in a phase 3 trial in severe COVID-19! $INCY $NVS #COVID19 
https://t.co/1ulxMFqjxK",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
140599113,2021-03-20 08:35:24,,,"winway.me/health-remedie‚Ä¶, ",1373251831032393734,False,0,0,0,0,WordPress.com,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial¬†miss https://t.co/ACsKHzONUH",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
21079030,2021-03-20 04:02:05,,"PharmaScrip, ","bit.ly/3eXsSHi, ",1373183047974203394,False,0,0,0,0,Sprinklr,"Incyte Pins Hopes On Phase III Jakafi Analysis In COVID-19 ARDS
https://t.co/w4t8eG6n6m #PharmaScrip",,,2009-02-17 05:33:29,Global,Scrip,https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg,21541,1629,654,35335,PharmaScrip,
367500725,2021-03-20 00:48:46,,,"fiercepharma.com/pharma/incyte-‚Ä¶, ",1373134395863789569,False,0,0,0,0,Twitter Web App,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss https://t.co/lZbDzDlcQA",,,2011-09-03 22:29:08,,vshariharakrishnan,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,9,50,0,6806,drvshkrishnan,
374729426,2021-03-19 18:11:35,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2609214, pic.twitter.com/WvlaDDsTsl, ",1373034442139168768,False,0,0,0,1,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/8QCrQ6ACKe #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/WvlaDDsTsl,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3460109487,2021-03-19 17:00:01,,,"endpts.com/jakafi-failed-‚Ä¶, ",1373016431562944514,False,0,0,0,0,TweetDeck,"Jakafi disappointed Incyte once when it failed to prevent severe complications of Covid-19. The JAK inhibitor has fallen short again in another Phase III study, failing to keep a more critical subgroup of patients from dying.

https://t.co/lkt0C2sjfh",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
18294275,2021-03-19 16:36:00,,,"fiercepharma.com/pharma/incyte-‚Ä¶, ",1373010387264802817,False,4,1,1,0,TweetDeck,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss https://t.co/qeL2O5SL0v",,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
754061769899925504,2021-03-19 16:01:21,,"pharma, biopharma, ","skylandanalytics.net/upcoming-event‚Ä¶, pic.twitter.com/1ELL4q4BL7, ",1373001667482882058,False,1,0,0,0,Hootsuite Inc.,"Be sure to register for Pharma Contract Manufacturing Online and catch great presentations from Skyland‚Äôs CEO Robert Di Scipio, Thermo Fisher, and Incyte: https://t.co/PP9LX4qke4 #pharma #biopharma https://t.co/1ELL4q4BL7",,,2016-07-15 17:15:10,"Boulder, CO",Skyland Analytics,https://pbs.twimg.com/profile_images/1090720914797297664/KomD9c9b_normal.jpg,91,347,0,250,SkylandAnalytic,photo
708370620720025608,2021-03-19 15:30:08,,,"ow.ly/i7gy50E3vki, ",1372993814198112258,False,1,0,0,1,Hootsuite Inc.,"Ruxolitinib (Jakafi¬Æ) for COVID-19-associated ARDS on Mechanical Ventilation Improves Mortality But Does Not Meet Primary Endpoint
https://t.co/KQ2zRy8XDk",,,2016-03-11 14:14:51,"Old Lyme, CT",PILOTforPULMONARY,https://pbs.twimg.com/profile_images/710827343103787008/YlaZ83KA_normal.jpg,776,339,8,3414,PILOTforPULM,
1250680882140086272,2021-03-19 14:46:12,,,"nature.com/articles/s4200‚Ä¶, ",1372982754036613121,False,5,1,1,1,Twitter Web App,"The first library Specifica ever created was with Incyte, asking: is there enough diversity in a single donor to produce a functional antibody library? Answer: yes, if you're very careful, published today. 
https://t.co/KZ1TDo0ukp",,,2020-04-16 03:02:32,,Andrew Bradbury,https://pbs.twimg.com/profile_images/1250953685548425218/RIPM0B5x_normal.jpg,43,21,0,38,Andrew0Bradbury,
760484491555139584,2021-03-19 14:30:04,,,"dlvr.it/RvzQMg, pic.twitter.com/XtEXi69frP, ",1372978697842520065,False,0,0,0,0,dlvr.it,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss https://t.co/iQwPRbW9QG https://t.co/XtEXi69frP",,,2016-08-02 10:36:46,,analyst land news,https://pbs.twimg.com/profile_images/1075066740835606534/NpZYEW5E_normal.jpg,10,0,1,5551,analystlandnews,photo
140599113,2021-03-19 14:17:44,,,"winway.me/health-remedie‚Ä¶, ",1372975593755705344,False,0,0,0,0,WordPress.com,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial¬†miss https://t.co/ACsKHzONUH",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
1280288213102292993,2021-03-19 13:11:04,,,"pharmabox.in/incyte-novarti‚Ä¶, ",1372958816766205961,False,0,0,0,0,Hootsuite Inc.,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss https://t.co/HN3KDG1Ne5",,,2020-07-06 19:51:21,,WWW.PHARMABOX.IN,https://pbs.twimg.com/profile_images/1284027505058381827/7o7Mcyq1_normal.jpg,856,450,0,5397,pharmabox_in,
891382950436229120,2021-03-19 12:22:59,,,"exbulletin.com/business/80354‚Ä¶, ",1372946714617901057,False,0,0,0,0,WordPress.com,Incyte and Novartis aim to make Jakafi available in severe COVID-19 after narrow test¬†failure https://t.co/tvte0lWGw2,,,2017-07-29 15:40:31,UK,ExBulletin,https://pbs.twimg.com/profile_images/1234563899141361665/B6yII4Q6_normal.jpg,509,10,12,683628,ExBulletinUk,
724136801602928640,2021-03-19 12:22:52,,,"marketwatch.com/story/incytes-‚Ä¶, ",1372946686616641541,False,1,0,0,0,Twitter for Android,Incyte's Jakafi failed Phase 3 clinical trial as a treatment for some severely ill COVID-19 patients https://t.co/FNBFCtodnp,,,2016-04-24 03:24:02,,Dr. Sameer Agarwal,https://pbs.twimg.com/profile_images/845891413212643328/l9mdqdma_normal.jpg,74,14,0,1362,AgarwalDrSameer,
133504478,2021-03-19 12:10:36,,"strategy, competitiveintelligence, marketing, pharma, healthcare, pharmaceutical, biotech, productmarketing, ","dlvr.it/Rvz0kr, pic.twitter.com/kLSCG7xav3, ",1372943597830479875,False,0,0,0,1,dlvr.it,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss https://t.co/oXlAPAlQQd #strategy #competitiveintelligence #marketing #pharma #healthcare #pharmaceutical #biotech #productmarketing https://t.co/kLSCG7xav3",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
46297868,2021-03-19 11:48:03,,,"dlvr.it/Rvywl8, ",1372937925264953347,True,0,0,0,0,dlvr.it,"Incyte, Novartis aim to make Jakafi available in severe COVID-19 after narrow trial miss https://t.co/r9hyjsDJTj",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
18026170,2021-03-19 11:30:00,,"ruxolitinib, ClinicalTrials, COVID19, ARDS, mortality, InfectiousDiseases, SARSCoV2, ","clinicaltrials.gov/ct2/show/NCT04‚Ä¶, pic.twitter.com/JZtUzptCgZ, ",1372933381093134343,False,0,0,0,0,TweetDeck,"Adding @Incyte‚Äôs #ruxolitinib to SoC missed 1¬∞ endpoint in Ph3 #ClinicalTrials vs #COVID19-assoc #ARDS

Trend toward #mortality improvement in overall patient pop‚Äôn; significant in US subgroup &amp; in pooled dose pop‚Äôn

https://t.co/jolF15XxYc
#InfectiousDiseases #SARSCoV2 https://t.co/JZtUzptCgZ","Incyte, ",,2008-12-10 13:29:19,"Midland, ON",DDNews Online,https://pbs.twimg.com/profile_images/1286709262287278080/SHRMveT5_normal.jpg,3372,439,86,13763,DDNewsOnline,photo
15974185,2021-03-19 11:04:04,,,"dlvr.it/Rvymys, ",1372926853451636739,False,0,0,0,0,dlvr.it,Jakafi failed the primary endpoint in a Covid-19 study. But Incyte is still going to FDA with a compassionate use pitch https://t.co/LYCHW61z2N,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
4058194633,2021-03-19 10:18:40,"INCY, ",,"marketwatch.com/story/incytes-‚Ä¶, ",1372915431162347523,False,2,0,0,0,Twitter for iPhone,$INCY Incyte‚Äôs Jakafi failed Phase 3 clinical trial as a treatment for some severely ill COVID-19 patients https://t.co/YnzMkvHheL,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1333678078443335680,2021-03-19 10:08:46,,"COVID19, ARDS, ","purepharmanews.com/ruxolitinib-de‚Ä¶, ",1372912937539665932,False,1,0,0,0,Twitter Web App,"Incyte's ruxolitinib misses primary endpoint in trial of patients on mechanical ventilation with #COVID19 associated acute respiratory distress syndrome (#ARDS).

https://t.co/m7C31kI3wD",,,2020-12-01 02:43:37,United Kingdom,Pure Pharma News,https://pbs.twimg.com/profile_images/1333678248337747969/GfdO3iuS_normal.jpg,11,79,0,329,pharma_pure,
624413,2021-03-19 10:07:57,,,"on.mktw.net/2QdHTKI, ",1372912731054075907,False,5,0,1,3,MarketWatch,Incyte drug fails in trial as treatment for severely ill COVID-19 patients https://t.co/ARbR621Wz9,,,2007-01-11 00:15:48,"New York, NY",MarketWatch,https://pbs.twimg.com/profile_images/705601245596090368/Z6xUOnRg_normal.jpg,4125163,200,28863,354060,MarketWatch,
963495628545327104,2021-03-19 09:51:29,"INCY, INCY, ",,"stck.pro/news/INCY/1169‚Ä¶, stck.pro/news/INCY, pic.twitter.com/tzlXqRRBwF, ",1372908586871951361,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's Jakafi failed Phase 3 clinical trial as a treatment for some severely ill COVID-19 patients https://t.co/i6IBZEiVOU Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/tzlXqRRBwF,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
3316713321,2021-03-19 09:50:03,,,"marketwatch.com/news/story/inc‚Ä¶, ",1372908227831205895,False,0,0,0,0,WordPress.com,Incyte‚Äôs Jakafi failed Phase 3 clinical trial as a treatment for some severely ill COVID-19¬†patients https://t.co/mP9S9MIvLG,,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
3223130652,2021-03-19 09:33:58,"INCY, ",,"benzinga.com/general/biotec‚Ä¶, ",1372904179308531714,False,0,0,0,0,Twitter for iPhone,Incyte's Ruxolitinib Fails To Beat Placebo In Improving Mortality In Critically-Ill COVID-19 Patients $INCY  https://t.co/bDNCRLZKpJ,,,2015-05-22 06:43:44, ARR-iz-OH-n…ô üåµüá∫üá∏ üáøüá¶ üáøüáº,Kermit ‚ÄúCOVID19 Scientist üß¨ & $IONS Investor‚Äù,https://pbs.twimg.com/profile_images/1411863701980811268/zqWaP6zO_normal.jpg,4281,4936,63,31146,BatScientist,
831019099325132801,2021-03-19 09:19:20,"INCY, ",,,1372900498098028545,False,1,0,0,0,Twitter for iPhone,Incyte ( $INCY ) said the DEVENT study of Ruxolitinib did not meet the primary endpoint.,,,2017-02-13 00:56:07,/r/WallStreetBets,WallStreetBets & Co.,https://pbs.twimg.com/profile_images/1073223467468840962/lWY3Dc10_normal.jpg,50487,1535,455,15714,WSBConsensus,
1006334607946649600,2021-03-19 08:35:14,,"StockMarket, Stocks, ","dlvr.it/RvyGhR, pic.twitter.com/HiyyEeZqzC, ",1372889397947895808,False,0,0,0,0,dlvr.it,Incyte‚Äôs Ruxolitinib Fails To Beat Placebo In Improving Mortality In Critically-Ill COVID-19 Patients https://t.co/BiRttaUhvq #StockMarket #Stocks https://t.co/HiyyEeZqzC,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
2334614718,2021-03-19 08:07:15,"INCY, ",,"ooc.bz/l/71805, ",1372882355262787586,False,1,0,0,2,Open Outcrier,"$INCY (+0.0% pre) Incyte (INCY) Phase 3 DEVENT Study of Ruxolitinib as Treatment for Patients with COVID-19 Associated ARDS Did Not Meet Its Primary Endpoint - SI

https://t.co/6ksctGRr6H",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
3460109487,2021-03-19 07:56:02,,,"endpts.com/jakafi-failed-‚Ä¶, ",1372879532613586945,False,0,0,0,0,TweetDeck,"Jakafi disappointed Incyte once when it failed to prevent severe complications of Covid-19. The JAK inhibitor has fallen short again in another Phase III study, failing to keep a more critical subgroup of patients from dying.

https://t.co/lkt0C2aInJ",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
133504478,2021-03-19 07:54:05,,"strategy, competitiveintelligence, marketing, healthcare, biotech, pharma, productmarketing, pharmaceutical, ","dlvr.it/Rvy6vy, pic.twitter.com/1JeG6580Ut, ",1372879042530054144,False,0,0,0,1,dlvr.it,Jakafi failed the primary endpoint in a Covid-19 study. But Incyte is still going to FDA with a compassionate use pitch https://t.co/9h4kpMQLWq #strategy #competitiveintelligence #marketing #healthcare #biotech #pharma #productmarketing #pharmaceutical https://t.co/1JeG6580Ut,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1134049078424162304,2021-03-19 07:51:42,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1372878444988620804,False,0,0,0,0,Newsfilter.io,Incyte's Ruxolitinib Fails To Beat Placebo In Improving Mortality In Critically-Ill COVID-19 Patients $INCY https://t.co/z333KwH55k,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
46297868,2021-03-19 07:26:05,,,"dlvr.it/Rvy2T9, ",1372871995579277312,True,0,0,0,0,dlvr.it,Jakafi failed the primary endpoint in a Covid-19 study. But Incyte is still going to FDA with a compassionate use pitch https://t.co/wjJTsbWwko,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
1166772455417024512,2021-03-19 07:23:33,,"Biotech, COVID19Coronavirus, ","dlvr.it/Rvy1hl, pic.twitter.com/t8EsD1oEf5, ",1372871360955904004,False,0,0,0,0,dlvr.it,#Biotech #COVID19Coronavirus Incyte's Ruxolitinib Fails To Beat Placebo In Improving Mortality In Critically-Ill COVID-19 Patients https://t.co/tTHds7hI5p https://t.co/t8EsD1oEf5,,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
963495628545327104,2021-03-19 07:21:10,"INCY, INCY, ",,"stck.pro/news/INCY/1169‚Ä¶, stck.pro/news/INCY, pic.twitter.com/6BSgWFWAqh, ",1372870759853518851,False,1,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's Ruxolitinib Fails To Beat Placebo In Improving Mortality In Critically-Ill COVID-19 Patients https://t.co/90FMVND6ia Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/6BSgWFWAqh,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
812004702594486272,2021-03-19 05:01:26,,,"checkrare.com/overview-of-sq‚Ä¶, ",1372835595555323907,False,0,0,0,0,Hootsuite Inc.,"Lance Leopold, MD, Group Vice President, Immuno-Oncology, at Incyte gives an overview of squamous cell carcinoma of the anal canal (SCAC).
@Incyte Incyte 
https://t.co/HXjJ5sP65q","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1325446129325142016,2021-03-19 02:03:31,"INCY, ",,"seekingalpha.com/news/3674237-i‚Ä¶, ",1372790820319813638,False,0,0,0,0,Integromat,$INCY - Incyte posts late-stage ruxolitinib COVID-19 study results https://t.co/OTHrFZwFlP,,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
3686628867,2021-03-18 23:38:19,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1372754279006576651,False,0,0,0,0,WordPress.com,Incyte Announces Results from the Phase 3 DEVENT Study Evaluating Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) on Mechanical¬†Ventilation https://t.co/6n3RKvoSiE,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1134049078424162304,2021-03-18 20:23:41,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1372705296968220675,False,0,0,0,0,Newsfilter.io,Incyte Announces Results from the Phase 3 DEVENT Study Evaluating Ruxolitinib as a Treatment for Patients with COVID-19 Associated Acute Respiratory Distress Syndrome on M.. $INCY https://t.co/Gh60YY8ROz,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-03-18 19:46:41,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1372695988259934217,False,0,0,0,0,Newsfilter.io,Incyte posts late-stage ruxolitinib COVID-19 study results $INCY https://t.co/RGX4m6z8TK,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
72928001,2021-03-18 18:37:40,"INCY, ",,"bit.ly/3s0PnPt, ",1372678618741022720,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte announces results from Phase 3 DEVENT trial; study did not meet its primary endpoint https://t.co/4SNZ1HZw1q,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1254906887490936845,2021-03-18 16:46:17,"INCY, ",,"quantdata.us/news/20244417, ",1372650588677234692,False,0,0,0,0,Quant Data (Production),"Incyte Announces Phase 3 DEVENT Study Evaluating Ruxolitinib In COVID-19 Associated Acute Respiratory Distress Syndrome Did Not Meet Primary Endpoint

Related Tickers: $INCY
Read more at: https://t.co/n9zjq6EmJB",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
3318510966,2021-03-18 16:44:31,,,"crweworld.com/article/news-p‚Ä¶, ",1372650141870555136,False,0,0,0,0,CRWE World,Incyte Announces Results from the Phase 3 DEVENT Study Evaluating Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients https://t.co/lcBy2wsaA5,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
472650465,2021-03-18 16:39:20,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1372648838117359624,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Results from the Phase 3 DEVENT Study Evaluating Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) on Mechanical Ve https://t.co/xQBEBBDuKU,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
15296897,2021-03-18 16:38:05,"INCY, ",,"seekingalpha.com/news/3674237-i‚Ä¶, ",1372648525616476162,False,1,1,0,2,SANewsTwitter,$INCY - Incyte posts late-stage ruxolitinib COVID-19 study results https://t.co/4rsrGyZdJ2,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
427877977,2021-03-18 16:35:17,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1372647821787205638,False,0,0,0,1,Twitter for iPhone,$INCY. Incyte Announces Results from the Phase 3 DEVENT Study Evaluating Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) on Mechanical Ventilation https://t.co/ND1vb9JicE.,,,2011-12-03 21:43:03,D√ºsseldorf,Volker Schulz,https://pbs.twimg.com/profile_images/1421288833862311941/Xw3abFlt_normal.jpg,4103,3000,238,132534,portefeuillefun,
41458395,2021-03-18 16:30:33,"INCY, ","fail, ",,1372646628176359425,False,8,0,0,5,TweetDeck,"$INCY Incyte Announces Results from the Phase 3 DEVENT Study Evaluating Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) on Mechanical Ventilation 

#fail",,,2009-05-20 17:45:03,,TexMex,https://pbs.twimg.com/profile_images/1051818539991031808/DBloaH2G_normal.jpg,49003,71,1144,7365,TraderTexMex,
369553873,2021-03-18 16:28:09,,,"americanbankingnews.com/2021/03/18/the‚Ä¶, ",1372646023051542535,False,0,0,0,0,Crowdfire App,"The Manufacturers Life Insurance Company Buys 119,078 Shares of Incyte Co. (NASDAQ:INCY) https://t.co/CyzI744te4",,,2011-09-07 11:15:40,,nnamakahenrynwokolo,https://pbs.twimg.com/profile_images/1799246664/VAQUEST_1_normal.jpg,341,4325,4,65861,vaquest,
4058194633,2021-03-18 11:58:31,"CSTL, ",,"google.com/amp/s/www.smar‚Ä¶, ",1372578168117161988,False,3,0,0,0,Twitter for iPhone,"$CSTL Robert W Baird Maintains Buy Rating On Castle Biosciences, $82 PT https://t.co/Mem7k3kLMP",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1280938376099741697,2021-03-17 19:08:06,,"iexStock, ","iexcloud.io, pic.twitter.com/sjLxOGapE2, ",1372323888575737859,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Ras Al Khaimah Cement Co
-Check Point Software Technolgies
-Analog Devices Inc.
-The National Investor Company
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/sjLxOGapE2",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2021-03-17 18:11:44,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2604501, pic.twitter.com/4etC8cRbQG, ",1372309705570222080,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/NR8DzRv5TF #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/4etC8cRbQG,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
289989013,2021-03-17 12:37:42,,"ad, ","nextavenue.org/graft-versus-h‚Ä¶, ",1372225644151648261,False,23,1,0,8,Twitter Web App,Living with a rare and life-threatening condition like acute GVHD presents significant challenges. These tips can help (Sponsored by @Incyte) #ad https://t.co/QXgKaEydSm,"Incyte, ",,2011-04-29 11:22:52,,Next Avenue,https://pbs.twimg.com/profile_images/1321492021287120896/2ImsPiky_normal.jpg,27106,3376,932,48893,NextAvenue,
702999329821188096,2021-03-17 12:08:50,,"GlobalVitiligoFoundation, ScientificSymposium, vitiligo, research, ","bit.ly/3kwOmvg, pic.twitter.com/lfBAq7vqL5, ",1372218378723672070,False,1,0,0,1,Twitter Web App,"We thank sponsors @Incyte @Pfizer for their support to help make this year‚Äôs #GlobalVitiligoFoundation Virtual #ScientificSymposium possible. Register today for this exciting program, featuring latest #vitiligo #research and expert insights: https://t.co/gohPGECrTn https://t.co/lfBAq7vqL5","Incyte, pfizer, ",,2016-02-25 18:31:16,"Chicago, IL",Global Vitiligo Foundation,https://pbs.twimg.com/profile_images/1235405131098869760/frWX3dp6_normal.jpg,1604,266,10,448,StepUp4Vitiligo,photo
2384219072,2021-03-17 08:08:01,,"DEBIO, BioBreakfast, NetDE, ","loom.ly/XxHEKkU, pic.twitter.com/7LYlXtr5m3, ",1372157773065117700,False,0,0,0,0,Loomly,"#DEBIO thanks to March's #BioBreakfast event sponsors @Incyte, @PotterAnderson &amp; @VWR. If you haven't registered there's still time!  https://t.co/k94nixtfKe
#NetDE https://t.co/7LYlXtr5m3","Incyte, PotterAnderson, VWR, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
1315434407692509184,2021-03-17 03:40:10,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/pMGR4XGdbk, ",1372090368129441792,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 36.30% ranked 624 out of 5445 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/pMGR4XGdbk",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
2344420430,2021-03-16 23:47:21,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1372031779461337089,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/3XyTD6nFb1",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
374729426,2021-03-16 16:39:06,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2601995, pic.twitter.com/hmeqHP9dST, ",1371924006534668292,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on February 16, 2021. View odds for this and other indicators: https://t.co/oEAymJHjtI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/hmeqHP9dST",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
14904700,2021-03-16 15:05:59,,,"twitter.com/Incyte/status/‚Ä¶, ",1371900571658158088,False,0,0,0,0,Twitter Web App,You're doing important and great work. I am a beneficiary of your work. Thank you scientists and staff. https://t.co/8YzMKvBdGU,,,2008-05-25 23:26:41,◊ñ◊î ◊í◊û◊ú◊ê ◊ï◊í◊ï◊ú◊ü,Stay at least 6ft deep,https://pbs.twimg.com/profile_images/1330883583716691968/c5vPc6l5_normal.jpg,298,444,0,22634,bxpansive,
96549745,2021-03-16 09:22:23,,,"twitter.com/Incyte/status/‚Ä¶, ",1371814102264377348,False,0,0,0,0,Twitter for iPad,Tell me more üôèüèºüòé https://t.co/ELIuDhfF2x,,,2009-12-13 08:27:46,"Louisa,Virginia",Mary Gerdt Parler:Alvarita1,https://pbs.twimg.com/profile_images/1077702983918456833/4nc5dDJO_normal.jpg,3507,4944,302,148343,marygerdt,
1017061326227570688,2021-03-15 23:10:34,"INCY, ",,,1371660133567135748,False,0,0,0,0,Twitter Web App,$INCY Incyte terminated Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) due to sponsor desicion.,,,2018-07-11 11:01:31,"Springfield, Manitoba",Plaaaaacebo,https://pbs.twimg.com/profile_images/1331590768566235136/tSTbsS36_normal.png,23,245,0,179,plaaaaacebo,
1407780158,2021-03-15 18:03:43,,"GVHD, sponsored, ","bit.ly/2uvja9K, pic.twitter.com/w90C8DMynl, ",1371582909799358473,False,14,1,0,3,Twitter for iPhone,"Very excited to be a judge for the 2021 @Incyte Ingenuity Award program, recognizing innovative ideas for the graft-versus-host disease (#GVHD) community. Review the eligibility requirements and submit your application by June 30! https://t.co/2lFytJ4Xd8. #sponsored https://t.co/w90C8DMynl","Incyte, ",,2013-05-06 09:41:58,"New York, NY",Miguel Perales M.D.,https://pbs.twimg.com/profile_images/1250512673470590981/ldD-7z-v_normal.jpg,15352,2299,358,33645,DrMiguelPerales,photo
289989013,2021-03-15 13:20:04,,"ad, ","nextavenue.org/graft-versus-h‚Ä¶, ",1371511526402756614,False,22,0,0,8,Twitter Web App,Living with a rare and life-threatening condition like graft-versus-host disease (GVHD) presents significant challenges. These tips may help. (Sponsored by @Incyte) #ad https://t.co/EayV61eQF5,"Incyte, ",,2011-04-29 11:22:52,,Next Avenue,https://pbs.twimg.com/profile_images/1321492021287120896/2ImsPiky_normal.jpg,27106,3376,932,48893,NextAvenue,
430889283,2021-03-15 12:12:06,,"WilmU, ESL, ","bit.ly/3aUHlQz, pic.twitter.com/wVJ8c2j2UW, ",1371494424396578817,False,5,0,0,3,Sprout Social,A #WilmU #ESL team proves ‚Äòflexible and nimble‚Äô in developing training for employees of the global corporation @Incyte ‚û°Ô∏è https://t.co/C48mMLmbbu https://t.co/wVJ8c2j2UW,"Incyte, ",,2011-12-07 12:42:16,"New Castle, DE",Wilmington University,https://pbs.twimg.com/profile_images/552195585147559936/aHAuo9Ru_normal.jpeg,3280,125,67,3775,wilmu,photo
782954815739527168,2021-03-14 22:23:03,,,"dlvr.it/RvdW69, ",1371285788453838853,False,1,0,0,0,dlvr.it,"Clinical/Senior Clinical Research Associate, Northeast - Incyte Corporation - , NA https://t.co/9FgUWxMPuF",,,2016-10-03 10:45:49,"Washington, DC",Clinical Research Forum,https://pbs.twimg.com/profile_images/793945936200351744/foN7mcbj_normal.jpg,345,452,1,1449,CRForumUS,
374729426,2021-03-14 19:20:13,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2597821, pic.twitter.com/JTcjtLeHf8, ",1371239773923201027,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on February 16, 2021. View odds for this and other indicators: https://t.co/kTT2dqnfeA #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/JTcjtLeHf8",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3911174913,2021-03-14 08:00:00,,"GVHD, EBMT21, ","pic.twitter.com/7xexKfhdNU, ",1371068592448368642,False,29,1,0,3,Twitter for Advertisers,"We look forward to the 47th Annual @TheEBMT Congress, and the research that will be shared on graft-versus-host disease (#GVHD). Follow along to learn about our efforts to address this potentially serious condition, and our presence at the virtual #EBMT21. https://t.co/7xexKfhdNU","TheEBMT, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1617240518,2021-03-13 06:20:02,,"EBMT21, ","apps.apple.com/us/app/ebmt-20‚Ä¶, play.google.com/store/apps/det‚Ä¶, pic.twitter.com/EmvIw1j7pj, ",1370696146683842561,False,14,1,0,4,Hootsuite Inc.,"Get the #EBMT21 Annual Meeting App for Android and IOS and start planning your personal meeting agenda today! Available in both the: 

üì≤ Apple App Store ‚¨áÔ∏è 
https://t.co/Cd9v5zBpAu

üì≤ Google Play Stores  ‚¨áÔ∏è
https://t.co/GqLzJRTJPg

This year's App is kindly supported by INCYTE. https://t.co/EmvIw1j7pj",,,2013-07-24 04:34:12,View our 2021 Events Calendar:,EBMT,https://pbs.twimg.com/profile_images/1305842179911356416/78i8cvCM_normal.jpg,9048,447,116,4527,TheEBMT,photo
1134049078424162304,2021-03-12 20:18:01,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1370544644564643844,False,0,0,0,0,Newsfilter.io,Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021 $INCY https://t.co/Rpuxg6urEs,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
374729426,2021-03-12 19:28:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2593364, pic.twitter.com/opOJa8PWzv, ",1370532075984408576,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/Xc5PZdledv #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/opOJa8PWzv,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
590518769,2021-03-12 16:37:01,,,"dermatologytimes.com/view/ruxolitin‚Ä¶, ",1370489027120480261,False,2,0,0,1,Twitter Web App,Great news for those suffering from Atopic Dermatitis-Way to go Incyte!  Ruxolitinib Cream NDA Accepted for Priority Review by FDA https://t.co/ICqQLGfqi2 via @DermTimesNow,"DermTimesNow, ",,2012-05-25 22:38:55,"Research Triangle Park, NC",Tergus Pharma,https://pbs.twimg.com/profile_images/2301444471/o8an9gwixkot8xn2dh3j_normal.jpeg,201,86,0,369,TergusPharma,
55642575,2021-03-12 15:46:05,,"NDA, atopicdermatitis, ","buff.ly/3cj0Vqk, pic.twitter.com/a74fmTJeaf, ",1370476211219075077,False,5,1,0,0,Buffer,Incyte announces the @US_FDA has accepted the #NDA for ruxolitinib cream for priority review. Ruxolitinib cream is a topical selective janus kinase (JAK)1/JAK2 inhibitor intended for the treatment of #atopicdermatitis. https://t.co/xldRU13w1T https://t.co/a74fmTJeaf,"US_FDA, ",,2009-07-10 15:27:01,"North Olmsted, Ohio",Dermatology Times,https://pbs.twimg.com/profile_images/1402733466987470848/i_Bjwcxa_normal.jpg,26818,622,341,15262,DermTimesNow,photo
812004702594486272,2021-03-12 05:01:14,,,"checkrare.com/efficacy-of-re‚Ä¶, ",1370313929184923652,False,1,0,0,0,Hootsuite Inc.,"Lance Leopold, MD, Group Vice President, Immuno-Oncology, at Incyte discusses the clinical trial of retifanlimab for the treatment of squamous cell carcinoma of the anal canal (SCAC).
@Incyte Incyte 
https://t.co/nHthYjDPYE","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1889492676,2021-03-12 03:51:59,"INCY, ","Incyte, Oncology, AACR21, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1370296501012811780,False,0,0,0,0,Troi URL Plug-in,#Incyte Announces Data from Multiple Programs Within its #Oncology Portfolio Accepted for Presentation at the #AACR21 Annual Meeting 2021 $INCY https://t.co/NMwGthccYY,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
374729426,2021-03-11 14:09:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2590488, pic.twitter.com/z1AKLzGeQX, ",1370089410218184704,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on February 16, 2021. View odds for this and other indicators: https://t.co/AYFFN6poTp #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/z1AKLzGeQX",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1359077910,2021-03-11 12:30:11,,,"europharmajobs.com/job_display/19‚Ä¶, ",1370064524284399621,False,0,0,0,1,EPJ Jobs Post,"Associate Director, Integrated Area Lead (Rare Diseas), Germany South, Incyte, Germany

https://t.co/d2ttheYEzU",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
4058194633,2021-03-11 10:47:09,"INCY, INCY, PFE, MRK, VRTX, BMRN, RHHBY, REGN, IBB, ","stocks, ","fool.com/investing/2021‚Ä¶, ",1370038593058525189,False,0,0,0,0,Twitter for iPhone,$INCY This Underperforming Biotech Is Ready to Beat the Market @themotleyfool #stocks $INCY $PFE $MRK $VRTX $BMRN $RHHBY $REGN $IBB https://t.co/N6twupvtm0,"themotleyfool, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-03-11 10:06:54,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1370028465118842895,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021 | Business Wire https://t.co/RQ3FwdBCx5,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1355194932445786112,2021-03-11 08:06:49,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1369998243384410113,False,0,0,0,0,Twitter,"$INCY Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021

https://t.co/4x23a53C3H",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1069693680066420736,2021-03-11 08:05:50,"INCY, ",,"s.flashalert.me/DVMzU, ",1369997996587429888,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on March 11, 08:00:00: Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021 https://t.co/8FvBFlkH6W",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2021-03-11 08:05:03,,,"dlvr.it/RvQM9q, pic.twitter.com/3bocAYzGu3, ",1369997798637068297,False,0,0,0,0,dlvr.it,Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021 https://t.co/md5YOpjWbK https://t.co/3bocAYzGu3,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2021-03-11 08:05:00,,,"crweworld.com/article/news-p‚Ä¶, ",1369997786343632897,False,0,0,0,0,CRWE World,Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Ann https://t.co/DeTSK1P4NM,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1325115160353103872,2021-03-11 08:00:55,"INCY, ","healthcare, ","quantisnow.com/insight/499016‚Ä¶, ",1369996759687032837,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021

https://t.co/f7sXfc4nvX

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1254035253104181256,2021-03-11 08:00:49,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1369996733233651716,False,0,0,0,0,stocktitan,"$INCY Incyte Announces Data from Multiple Programs Within its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021
https://t.co/mocuzWjTC5",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1280938376099741697,2021-03-10 17:58:59,,"iexStock, ","iexcloud.io, pic.twitter.com/yRAwSAGZCu, ",1369784882294063113,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Activision Blizzard Inc
-Al Ain Ahlia Insurance Co
-Al Dar Properties
-Sirius XM Holdings Inc

Data provided by https://t.co/oXreiEXTgd https://t.co/yRAwSAGZCu",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2021-03-10 16:03:03,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2588339, pic.twitter.com/fPKruhOBvr, ",1369755705624780801,False,1,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on February 16, 2021. View odds for this and other indicators: https://t.co/WUi2oJUlgn #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/fPKruhOBvr",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1315434407692509184,2021-03-10 11:50:41,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/D4CD0fNEwj, ",1369692196216184837,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 36.30% ranked 643 out of 5438 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/D4CD0fNEwj",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
2361204445,2021-03-10 09:47:00,,"CHOSOURCE, BPIWEST, Bioprocess, ","bit.ly/3q1ZNMK, ",1369661067253719040,False,0,0,0,1,Semrush Social Media Tool,"Planning to attend BPI West Virtual? Don't miss our session where Jay Sinha from Incyte Corp will present the approaches and challenges of bispecific antibody expression using Horizon's CHO-K1 cell line, #CHOSOURCE. https://t.co/c2Oig42fIe
#BPIWEST #Bioprocess",,,2014-02-25 09:46:42,"Cambridge, UK",Horizon Discovery,https://pbs.twimg.com/profile_images/1225093651044302849/QtHP95re_normal.jpg,9934,397,57,2776,HZDiscovery,
781494559608012800,2021-03-10 07:51:42,,,"pic.twitter.com/3QfMXuy9uX, pic.twitter.com/3QfMXuy9uX, pic.twitter.com/3QfMXuy9uX, pic.twitter.com/3QfMXuy9uX, ",1369632050484023296,False,4,0,0,1,Twitter for iPad,"Year 11 Student Investor Club. Amongst the big winners such as Exon +80%, Norwegian Cruises +63% are big losers Tesla -22%, Incyte -11.8%. All 3 teams portfolios are making 10%+ profits with Akshay and Vince topping the BSP leaderboard. All to play for with 4 weeks to go. https://t.co/3QfMXuy9uX",,,2016-09-29 10:03:17,"Croissy-sur-Seine, France",BSP Business & Economics,https://pbs.twimg.com/profile_images/783688507344781312/XxVGI1iv_normal.jpg,123,30,3,210,BSP_SSCBusEcon,photo
1280938376099741697,2021-03-09 21:58:00,,"iexStock, ","iexcloud.io, pic.twitter.com/Uudl9Cq4e0, ",1369482645063819264,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-First Abu Dhabi Bank PJSC
-Incyte Corp.
-American Airlines Group Inc
-Verisign Inc.
-NetEase Inc - ADR

Data provided by https://t.co/oXreiEXTgd https://t.co/Uudl9Cq4e0",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
998915197061488645,2021-03-09 16:17:49,,,"pic.twitter.com/AhQCm6N92g, ",1369397032486572033,False,16,2,1,6,Twitter Web App,"CALLING ALL PHOSPHORUS FANS: it‚Äôs all about P in tomorrow‚Äôs INCyTE seminar! if you ever wonder:
‚ùìwhat we do and don‚Äôt know about global P cycling
üö¶challenges to incorporating P into models
üß©the biggest missing pieces in the P puzzle

‚Ä¶then this seminar is for you! https://t.co/AhQCm6N92g",,,2018-05-22 09:15:16,,INCyTE RCN,https://pbs.twimg.com/profile_images/1063085319887695873/d_uRHryG_normal.jpg,221,32,1,46,IncyteRcn,photo
479661995,2021-03-09 13:08:10,,"skin, inflammation, autoimmune, ","bit.ly/3kZALge, pic.twitter.com/hakCX73wug, ",1369349306675826691,False,3,0,0,1,Twitter Web App,"Here, @wvuscientist et al (@Incyte &amp; @DermTech) describe protocols for using a physiologically human skin model to investigate the effects of inflammatory mediators on the structure and function of #skin cells.

‚û°Ô∏èhttps://t.co/0sI0cRiagT 

#inflammation #autoimmune https://t.co/hakCX73wug","wvuscientist, Incyte, DermTech, ",,2012-01-31 11:41:11,"Hoboken, NJ",Current Protocols,https://pbs.twimg.com/profile_images/1441132981142179851/GqeneyCN_normal.jpg,1790,1164,30,1862,CurrentProtocol,photo
1022006086872821762,2021-03-08 20:03:07,"INCY, INCY, ",,,1369091345462267904,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Mon Mar 08
Closed at 77.84 USD for a -3.02% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
727527038,2021-03-08 15:12:04,"BCTX, ",,,1369018096997068801,False,3,0,0,3,TweetDeck,$BCTX immuno-oncology therapies for advanced breast cancer. currently in Ph 1/2a using combo w/ Merck's Keytruda .small trial had 86% response rate. also has combo study approved with Incyte's epacadostat coming. total o/s 5.62 mil. 5 13g filings since 2/23 for 2.34 mil or 49.8%,,,2012-07-31 00:09:31,Murica,Tony  Bailey,https://pbs.twimg.com/profile_images/1004545445681664000/mtn5bFyU_normal.jpg,199,366,5,2928,_efbailey,
1315434407692509184,2021-03-08 12:17:00,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/VLHTl5zkfe, ",1368974041248391169,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 36.30% ranked 643 out of 5439 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/VLHTl5zkfe",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1313517451817050113,2021-03-07 15:37:35,"INCY, ",,,1368662131084685317,False,0,0,0,0,Twitter Web App,$INCY--FDA Accepted Incyte's Ruxolitinib Cream US Application For Chronic Skin Disease last month--Its stock is steadily rising! ‚ò∫Ô∏è,,,2020-10-06 12:32:30,,IsitArt,https://pbs.twimg.com/profile_images/1313517774153502720/RY_EXjlp_normal.jpg,244,6,8,3818,art_isit,
374729426,2021-03-07 15:00:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2581316, pic.twitter.com/dA1FjAfWwt, ",1368652914114265089,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/yirdelyBOo #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/dA1FjAfWwt,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
374729426,2021-03-06 19:25:24,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2579432, pic.twitter.com/QwV2ayQvBr, ",1368357077999964164,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/3mhzDtAAd3 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/QwV2ayQvBr,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2344420430,2021-03-06 04:11:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1368127064348450824,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/lw3utmzjEY",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
374729426,2021-03-05 17:22:08,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2576880, pic.twitter.com/22rJjG70nb, ",1367963668881711104,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on February 16, 2021. View odds for this and other indicators: https://t.co/x1KJgOBVsS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/22rJjG70nb",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
950010035396136962,2021-03-05 17:04:54,,"INCY, ",,1367959329287110664,False,1,0,0,0,Cresus AI,"Incyte Corporation (#INCY.US) closed at 80.26, score +230, credit rating AA",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
1359077910,2021-03-05 12:30:14,,,"europharmajobs.com/job_display/19‚Ä¶, ",1367890206704164874,False,0,0,0,0,EPJ Jobs Post,"Director, Global R&amp;D QA - Qualified Person, Incyte, Netherlands

https://t.co/ErBQAwfbKg",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
1189175707542401024,2021-03-05 09:08:12,,"Alopecia, ","prn.to/3kL2kdk, ",1367839364005433348,False,0,0,0,0,Twitter Web App,"Baricitinib, First JAK-Inhibitor Demonstrates Hair Regrowth in Phase 3 #Alopecia Areata (AA) Phase 3 Trial by @LillyPad &amp; @Incyte  https://t.co/nP8gZqAzCV","LillyPad, Incyte, ",,2019-10-29 09:42:48,,Karolina Chwalek,https://pbs.twimg.com/profile_images/1204860424635764737/GrrwqL1x_normal.jpg,130,393,1,322,ChwalekKarolina,
1022473214457348096,2021-03-05 07:40:33,,,"pharmashots.com/56887/eli-lill‚Ä¶, ",1367817307049717766,False,2,0,0,0,Twitter Web App,"Eli Lilly and Incyte Report Results of Olumiant (baricitinib) in P-III BRAVE-AA2 Study for Severe Alopecia Areata @Pharmashot @LillyPad @Incyte 
https://t.co/SCBkelhPVC","Pharmashot, LillyPad, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
812004702594486272,2021-03-05 05:01:15,,,"checkrare.com/overview-of-sq‚Ä¶, ",1367777218668204033,False,1,0,0,0,Hootsuite Inc.,"Lance Leopold, MD, Group Vice President, Immuno-Oncology, at Incyte gives an overview of squamous cell carcinoma of the anal canal (SCAC).
@Incyte Incyte 
https://t.co/HXjJ5sP65q","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
67054382,2021-03-04 18:00:03,,,"lnkd.in/gPTHZk5, ",1367610820536897536,False,1,0,0,0,LinkedIn,"""New Phase III data for announced today for Olumiant (baricitinib), already marketed by Eli Lilly and Incyte for rheumatoid arthritis, shows efficacy for the Janus kinase 1 (JAK1)/JASK2 inhibitor in severe alopecia areata."" https://t.co/NfNEFE1kAQ",,,2009-08-19 13:03:37,"Santa Barbara, CA",USDM Life Sciences,https://pbs.twimg.com/profile_images/1181714863816691712/NeiuiywC_normal.png,301,238,8,2694,USDMLifeScience,
538402387,2021-03-04 15:30:22,,,"catalyzingchange.vfairs.com/en/, pic.twitter.com/etaflZR6E0, ",1367573153489317889,False,1,0,0,1,Hootsuite Inc.,"Don't miss out. Register today. Be among the already 400 registrants. 
https://t.co/bHckKpDfJr
Registration closes on March 13.
@DuPont_News 
@airliquide_de 
@WSFS 
@Incyte 
@FMCCorp 
@choosedelaware 
@drone_workforce 
@NERDiTNOW https://t.co/etaflZR6E0","DuPont_News, airliquide_de, WSFS, Incyte, FMCCorp, choosedelaware, drone_workforce, NERDiTNOW, ",,2012-03-27 14:58:09,"Newark, Delaware, USA",DESCA,https://pbs.twimg.com/profile_images/1387774824504823812/S66uJ_x0_normal.jpg,278,179,27,1864,DescaDelaware,photo
3308093475,2021-03-04 11:31:05,,,"biopharmadive.com/news/lilly-inc‚Ä¶, ",1367512935367606274,False,0,0,0,0,Twitter Web App,"Lilly drug regrows hair in autoimmune disease study, but safety questions linger https://t.co/tMNyORjOU2 via @BioPharmaDive","BioPharmaDive, ",,2015-06-04 08:33:03,"Lisbon, Portugal",Claude Waddington,https://pbs.twimg.com/profile_images/1435688032678682633/Z0ex7zyN_normal.jpg,828,1913,141,11615,Mr_C_Wadd,
1262915121103491074,2021-03-03 23:20:45,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1367329142388056072,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 395 shares on 2021-03-01. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
2315971404,2021-03-03 20:30:02,,,"lnkd.in/gEHukgN, ",1367286179247267842,False,1,0,0,0,LinkedIn,"""New Phase III data for announced today for Olumiant (baricitinib), already marketed by Eli Lilly and Incyte for rheumatoid arthritis, shows efficacy for the Janus kinase 1 (JAK1)/JASK2 inhibitor in severe alopecia areata."" https://t.co/LBlh3AB7e0",,,2014-01-28 14:30:38,"Santa Barbara, CA, USA",Shelli Kenlein Papke,https://pbs.twimg.com/profile_images/1442957181578473475/d4z8c4sV_normal.jpg,61,211,2,1561,USDMRECRUITER,
3460109487,2021-03-03 19:30:00,,,"endpts.com/eli-lilly-clai‚Ä¶, ",1367271071242543104,False,4,0,0,1,TweetDeck,"Eli Lilly and its biotech partner Incyte announced Wednesday that their JAK inhibitor baricitinib effectively regrew patients‚Äô hair in a Phase III trial for alopecia areata, an autoimmune condition that can cause sudden, severe and patchy hair loss.

https://t.co/Rs9wCo2ArS",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
386042607,2021-03-03 18:14:59,,"hair, hairloss, hairtreatment, dermatolgoy, hairregrowth, ","hubs.ly/H0HCWjf0, ",1367252192961380353,False,0,0,0,0,HubSpot,".@LillyPad and @Incyte's baricitinib is the first JAK inhibitor to demonstrate hair regrowth in a Phase 3 alopecia areata (AA) trial. https://t.co/FMLGGwpeRt
#hair #hairloss #hairtreatment #dermatolgoy #hairregrowth","LillyPad, Incyte, ",,2011-10-06 11:34:39,,Practical Derm,https://pbs.twimg.com/profile_images/1172186203099189249/6ZV9TJxF_normal.jpg,2800,888,49,4503,Practical_Derm,
25406480,2021-03-03 17:22:31,,,"awesomecapital.blogspot.com/2021/03/incyte‚Ä¶, ",1367238986952040449,False,0,0,0,1,Twitter Web App,"AwesomeCapital: Incyte, Eli Lilly: Baricitinib Meets Main Endpoint... https://t.co/pI7kuljFXk",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
1029128656650555393,2021-03-03 15:30:41,,"jakinhibitor, baricitinib, alopeciaareata, autoimmune, hairloss, breakthroughdesignation, lupus, Indianapolis, Indiana, Delaware, ","j.mp/3sOaDIe, ",1367210843004354565,False,1,0,0,0,SocialPilot.co,Eli Lilly claims success in a new JAK indication: hair loss | @Lillypad @Incyte #jakinhibitor #baricitinib #alopeciaareata #autoimmune #hairloss #breakthroughdesignation #lupus #Indianapolis #Indiana #Delaware https://t.co/5rzN7lv1fp,"LillyPad, Incyte, ",,2018-08-13 18:12:46,,Pharm2Market,https://pbs.twimg.com/profile_images/1041479880368484353/xr9ZBpXF_normal.jpg,190,849,2,2538,pharm2market,
2656754371,2021-03-03 15:30:41,,"jakinhibitor, baricitinib, alopeciaareata, autoimmune, hairloss, breakthroughdesignation, lupus, Indianapolis, Indiana, Delaware, ","j.mp/3sOaDIe, ",1367210842840825857,False,1,0,0,0,SocialPilot.co,Eli Lilly claims success in a new JAK indication: hair loss | @Lillypad @Incyte #jakinhibitor #baricitinib #alopeciaareata #autoimmune #hairloss #breakthroughdesignation #lupus #Indianapolis #Indiana #Delaware https://t.co/xx3m487eGj,"LillyPad, Incyte, ",,2014-07-18 09:20:39,San Diego,Aspen Biosciences,https://pbs.twimg.com/profile_images/1006725217568186368/B34yK1F1_normal.jpg,316,725,33,6079,aspenbio,
1134049078424162304,2021-03-03 15:20:42,"LLY, INCY, ",,"newsfilter.io/articles/eli-l‚Ä¶, ",1367208332809838595,False,0,0,0,0,Newsfilter.io,Eli Lilly/Incyte's Baricitinib Shows Benefit In Patchy Hair Loss Disorder $LLY $INCY https://t.co/VBaAPNJXuW,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
35789155,2021-03-03 13:32:13,"LLY, INCY, ",,"beta.firstwordpharma.com/story/5239385, ",1367181032252993546,False,4,0,0,0,Twitter Web App,"Lilly, Incyte's JAK inhibitor baricitinib hits main goal in hair loss study https://t.co/13CdS39lOS $LLY $INCY",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
1270220114340851712,2021-03-03 12:16:17,,"PharmaTwitter, MedTwitter, MedEd, ","bit.ly/More-Medical-H‚Ä¶, biopharmadive.com/news/lilly-inc‚Ä¶, ",1367161921053618176,False,0,0,0,0,Automate.io,"Lilly drug regrows hair in autoimmune disease study, but safety questions linger

More medical news at https://t.co/0Knf9q4SKS
#PharmaTwitter #MedTwitter #MedEd
https://t.co/QyieAOwDCe",,,2020-06-09 01:04:18,Look here üëâ,MedPub Pharmaceutical,https://pbs.twimg.com/profile_images/1443232668716515331/xzljON0s_normal.jpg,2,69,0,3346,PharmaPublisher,
1330055544,2021-03-03 12:07:39,"LLY, INCY, PFE, CNCE, ",,"biopharmadive.com/news/lilly-inc‚Ä¶, ",1367159750853541893,False,0,0,0,0,Twitter Web App,"Lilly drug regrows hair in autoimmune disease study, but safety questions linger https://t.co/yia5cTg5Ul $LLY $INCY $PFE $CNCE",,,2013-04-05 16:58:03,Virginia,Ben Fidler,https://pbs.twimg.com/profile_images/1370960622293225472/D0Zpicim_normal.jpg,6730,425,300,5195,BentheFidler,
78745126,2021-03-03 11:56:51,,"REACH3, cGVHD, Cancer, Research, ","oncologytube.com/video/39829/ro‚Ä¶, pic.twitter.com/nXP7qMj55B, ",1367157033439387654,False,0,0,0,0,TweetDeck,"Acceptance and Priority Review Of sNDA For Ruxolitinib As A Treatment For Patients With cGVHD Robert Zeiser, MD @UniFreigurb @Incyte #REACH3 #cGVHD #Cancer #Research 

Link To FULL Video:
https://t.co/0HZvxoaK8O https://t.co/nXP7qMj55B","Incyte, ",,2009-09-30 19:55:07,"Temecula, CA",Oncology Tube,https://pbs.twimg.com/profile_images/774339957087346688/z5zor-v9_normal.jpg,15103,750,368,136422,oncologytube,video
3460109487,2021-03-03 11:10:51,,,"endpts.com/eli-lilly-clai‚Ä¶, ",1367145457236013062,False,3,0,0,2,TweetDeck,"Eli Lilly and its biotech partner Incyte announced Wednesday that their JAK inhibitor baricitinib effectively regrew patients‚Äô hair in a Phase III trial for alopecia areata, an autoimmune condition that can cause sudden, severe and patchy hair loss. 

https://t.co/Rs9wCnKZAk",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
15974185,2021-03-03 11:10:02,,,"dlvr.it/Rttn4m, ",1367145250590875655,False,0,0,0,0,dlvr.it,"Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment https://t.co/8TEMnFReXx",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1166772455417024512,2021-03-03 09:56:03,,"AlopeciaAreata, Biotech, ","dlvr.it/RttVh4, pic.twitter.com/fJv16SA44b, ",1367126630582288392,False,0,0,0,0,dlvr.it,#AlopeciaAreata #Biotech Eli Lilly/Incyte's Baricitinib Shows Benefit In Patchy Hair Loss Disorder https://t.co/TvyZHtTG7U https://t.co/fJv16SA44b,,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
266312205,2021-03-03 08:59:46,,"alopeciaareata, ÂÜÜÂΩ¢ËÑ±ÊØõÁóá, ","seekingalpha.com/news/3668631-l‚Ä¶, ",1367112465855569930,False,0,0,0,0,Twitter Web App,"#alopeciaareata, #ÂÜÜÂΩ¢ËÑ±ÊØõÁóá
Lilly, Incyte's baricitinib successful in alopecia areata study | Seeking Alpha https://t.co/DadgvFZidf",,,2011-03-14 21:18:53,,h takag,https://pbs.twimg.com/profile_images/1201008316765200385/TM_1wUHl_normal.jpg,4,56,0,243,h_takag,
2334614718,2021-03-03 07:51:31,"INCY, LLY, ",,"ooc.bz/l/70703, ",1367095291112022024,False,1,0,0,0,Open Outcrier,"$INCY (+1.6% pre) Lilly $LLY, Incyte's baricitinib shows hair regrowth in late-stage alopecia areata study - SA

https://t.co/ijtv4O5j3L",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
1325446129325142016,2021-03-03 07:05:03,"LLY, INCY, ",,"seekingalpha.com/news/3668631-l‚Ä¶, ",1367083598919180295,False,0,0,0,0,Integromat,"$LLY $INCY - Lilly, Incyte's baricitinib shows hair regrowth in late-stage alopecia areata study https://t.co/HTOBKc5WPd",,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
15296897,2021-03-03 07:04:53,"LLY, INCY, ",,"seekingalpha.com/news/3668631-l‚Ä¶, ",1367083556153925633,False,0,0,0,1,SANewsTwitter,"$LLY $INCY - Lilly, Incyte's baricitinib shows hair regrowth in late-stage alopecia areata study https://t.co/0ueuW9tD6O",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
2704294333,2021-03-03 06:45:54,"LLY, ",,,1367078778887897090,False,38,2,1,5,TweetDeck,"*Eli Lilly, Incyte: Baricitinib Is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata Trial
$LLY",,,2014-08-03 10:34:52,Switzerland,*Walter Bloomberg,https://pbs.twimg.com/profile_images/1282648991348527104/A8HCjqZk_normal.jpg,392435,34,6566,104545,DeItaone,
374729426,2021-03-02 16:08:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2569811, pic.twitter.com/bLSiyjgyUV, ",1366858060736565248,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on February 16, 2021. View odds for this and other indicators: https://t.co/Egn2IFE6tQ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/bLSiyjgyUV",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1140762699002871808,2021-03-02 15:58:16,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1366855397034795009,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2021-03-02 15:58 ET. *Closed/Sold:
$INCY at $78.50 for 10.87 loss (-12.17%). Incyte Corporation - Common Stock
Trade Id: 66580260303047481.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
1065610145026191361,2021-03-02 07:01:10,,"antibody, antibodydiscovery, antibodyengineering, biologics, pharma, drugdiscovery, biotech, lifesciences, ","bit.ly/36E4dT7, pic.twitter.com/P6pFMb8VsA, ",1366720231704559618,False,1,0,0,1,Hootsuite Inc.,"Meet your facilitators hosting interactive virtual roundtables on Lead Identification &amp; Optimization @Incyte  @mersana @bmsnews Register: https://t.co/sk0WF8tOxm 
#antibody #antibodydiscovery #antibodyengineering #biologics #pharma #drugdiscovery #biotech #lifesciences https://t.co/P6pFMb8VsA","Incyte, mersana, bmsnews, ",,2018-11-22 09:17:11,"London, England",hubXchange,https://pbs.twimg.com/profile_images/1067719314667683840/U7v1ns7j_normal.jpg,51,75,0,528,hub_xchange,photo
172254012,2021-03-02 00:27:01,,,"ahlam-sa.com/dana/?p=227654, ",1366621042274353152,False,0,0,0,0,ahlam ahlam,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 - https://t.co/MGeKqiacB1",,,2010-07-29 03:26:40,,x55555x,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,521,1103,0,114804,hamed1399,
1149164527625236480,2021-03-01 19:49:50,"BCTX, ",,,1366551285726552065,False,2,0,0,0,Twitter for iPhone,"700k float, 15% held by insiders, brand new to Nasdaq, breast cancer play, $BCTX. They were supposed to have trails completed in Dec 2020. Watching the interview with ceo on LinkedIn from 2 years ago, they are talking about a combo drug with incyte, Thoughts? @yatesinvesting","yatesinvesting, ",,2019-07-10 23:52:28,,Nuhbellos,https://pbs.twimg.com/profile_images/1453134151075307522/m8Y-xePj_normal.jpg,113,122,1,2963,nuhbello,
374729426,2021-03-01 14:54:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2567341, pic.twitter.com/B5MYDY4uZP, ",1366477071908675587,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/Q3yhVb91Ru #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/B5MYDY4uZP,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
843921016212652037,2021-03-01 12:40:07,,"atopicdermatitis, ","ow.ly/hKbi50DL8LX, ",1366443142464045056,False,0,0,0,0,Hootsuite Inc.,The @US_FDA has accepted for Priority Review the New Drug Application for ruxolitinib cream (Incyte) for the treatment of #atopicdermatitis. https://t.co/O4wkSMv82W,"US_FDA, ",,2017-03-20 16:23:44,,Dermatology Advisor,https://pbs.twimg.com/profile_images/911307615191396353/f-JTnsd2_normal.jpg,317,32,8,1472,DermAdvisor,
374729426,2021-02-28 13:43:22,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2564877, pic.twitter.com/0PbqoxqBkF, ",1366096674251100160,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/IPuWLzYChB #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0PbqoxqBkF,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1889492676,2021-02-27 06:50:54,"INCY, ","Incyte, EuropeanMedicinesAgency, Retifanlimab, SquamousCellAnalCarcinoma, SCAC, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1365630484072460289,False,0,0,0,0,Troi URL Plug-in,#Incyte Announces the Validation by the #EuropeanMedicinesAgency of its Marketing Authorization Application for #Retifanlimab as a Treatment for Patients with #SquamousCellAnalCarcinoma (#SCAC) $INCY https://t.co/qqhDsTHlya,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
14133281,2021-02-26 23:12:47,,,,1365515198090465283,False,0,0,0,0,Twitter Web App,"Incyte's Jakafi, or ruxolitinib, will undergo priority review as a treatment for adults and pediatric patients age 12 or older who have steroid-refractory chronic graft-versus-host disease.",,,2008-03-12 12:33:01,Hyderabad,Dr.  Amit Dang,https://pbs.twimg.com/profile_images/1244646825627250691/jmIyfbBm_normal.jpg,453,237,9,923,dramitdang,
23184067,2021-02-26 19:00:09,,,"buff.ly/2Ms5uFY, pic.twitter.com/QuZCainuYd, ",1365451618695675904,False,1,0,0,5,Buffer,"‚ÄúA new drug application under priority review for ruxolitinib cream for the treatment of atopic dermatitis has been accepted by the FDA, Incyte announced in a press release.‚Äù https://t.co/8QISxAScKQ https://t.co/QuZCainuYd",,,2009-03-07 05:56:51,Buenos Aires,Juan C Ivancevich MD,https://pbs.twimg.com/profile_images/1427600321505857539/-m2-zdWi_normal.jpg,6820,603,249,84875,Aller_MD,photo
3686628867,2021-02-26 15:41:57,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1365401740259033093,False,0,0,0,0,WordPress.com,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma¬†(SCAC) https://t.co/SHBXLZfiXK,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
153322637,2021-02-26 15:29:26,,,"abdullahfarhan.com/research-inves‚Ä¶, ",1365398590818951169,False,0,0,0,0,WordPress.com,Research Investigator Chemistry ‚Äì Careers At Incyte¬†Corporation https://t.co/yZaVvbpqxq,,,2010-06-08 03:13:32,"Cleveland, Ohio, USA",Dr. Abdullah Farhan Saeed,https://pbs.twimg.com/profile_images/1212572315109724161/1hMhrbQA_normal.jpg,336,755,1,4653,abdullah_farhan,
1359077910,2021-02-26 12:30:11,,,"europharmajobs.com/job_display/19‚Ä¶, ",1365353481851265024,False,0,0,0,0,EPJ Jobs Post,"Associate Director, Integrated Area Lead, Medical, Incyte, Italy

https://t.co/5an7acFtbp",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
4058194633,2021-02-26 10:53:21,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1365329111040684039,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC) | Business Wire https://t.co/8HoF6KkaeV,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
53097729,2021-02-26 09:16:43,"INCY, ",,"newsfilter.io/a/b5c9988caeac‚Ä¶, ",1365304794169159686,False,1,0,0,0,Twitter Web App,$INCY Incyte's retifanlimab application validated in Europe for anal cancer https://t.co/vELCQCLFKs,,,2009-07-02 11:44:23,"Toronto, Ontario",Stockwits‚Ñ¢ Ó®Ä,https://pbs.twimg.com/profile_images/1408587167111303171/Qrn1abyM_normal.jpg,26206,983,189,29344,mikalche,
325135887,2021-02-26 09:05:00,"INCY, ","cancer, cholangiocarcinoma, WorldCCADay, ","bit.ly/2MqI9EE, pic.twitter.com/qhev111mT0, twitter.com/Incyte/status/‚Ä¶, ",1365301843988008964,False,1,0,0,0,Twitter Web App,"Excellent! Keep up the good work! @Incyte $INCY #cancer #cholangiocarcinoma #WorldCCADay.
https://t.co/xjDSTqskfZ https://t.co/qhev111mT0 https://t.co/fcO9c5xSIO","Incyte, ",,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,photo
2334614718,2021-02-26 07:20:12,"INCY, ",,"ooc.bz/l/70334, ",1365275470770671620,False,1,0,0,0,Open Outcrier,"$INCY (+0.4% pre) Incyte (INCY) Announces Validation by EMA of its MAA for Retifanlimab as Treatment for Patients with Squamous Cell Anal Carcinoma - SI

https://t.co/doegF4Yupu",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
72928001,2021-02-26 07:05:01,"INCY, ",,"bit.ly/3uyO9wn, ",1365271650078367747,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte receives validation by the European Medicines Agency of its Marketing Authorization Application for... https://t.co/gz47ZMKazo,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
112872946,2021-02-26 06:08:44,"INCY, ",,"investor.incyte.com/press-releases‚Ä¶, ",1365257484307468288,False,1,0,0,0,Twitter Web App,"$INCY EMA validates MAA for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC)

https://t.co/wycEJ2SYdx",,,2010-02-09 19:09:48,Toronto,Bio Stocks‚Ñ¢,https://pbs.twimg.com/profile_images/1345176821185306624/4OaDT_lb_normal.jpg,58832,77,1249,48782,BioStocks,
48713626,2021-02-26 06:06:22,,,"efogator.com/incyte-announc‚Ä¶, ",1365256889748045825,False,0,0,0,0,WordPress.com,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma¬†(SCAC) https://t.co/KqlTO6ZkvY,,,2009-06-19 10:05:54,Nigeria,Efogator News,https://pbs.twimg.com/profile_images/1332364516168962049/ECUzX2bg_normal.jpg,818,1255,27,38945,efogatormedia,
812004702594486272,2021-02-26 05:01:13,,,"checkrare.com/efficacy-of-re‚Ä¶, ",1365240494385750017,False,0,0,0,0,Hootsuite Inc.,"Lance Leopold, MD, Group Vice President, Immuno-Oncology, at Incyte discusses the clinical trial of retifanlimab for the treatment of squamous cell carcinoma of the anal canal (SCAC).
@Incyte Incyte 
https://t.co/nHthYjDPYE","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
270492072,2021-02-26 04:59:03,,"news, SeekingAlpha, ","seekingalpha.com/news/3666998-i‚Ä¶, ",1365239950422106113,False,0,0,0,0,Microsoft Power Platform,Incyte's retifanlimab application validated in Europe for anal cancer https://t.co/9nkix7rt26 via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
630623731,2021-02-26 04:59:02,,,"dlvr.it/RtX6tq, medfirst.co.uk, ",1365239944667566088,False,0,0,0,0,dlvr.it,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC) - Valdosta Daily Times https://t.co/hVpFBsJa3q ‚Ä¢ https://t.co/le73xfO7Nb,,,2012-07-08 19:50:01,UK,MedFirst - MedComms,https://pbs.twimg.com/profile_images/2419856333/ogazqcv37cf1689831z5_normal.jpeg,180,1,13,28568,MedFirstLtd,
31372539,2021-02-26 04:47:02,,,"dlvr.it/RtX5HG, ",1365236925238448130,False,0,0,0,0,dlvr.it,Incyte's retifanlimab application validated in Europe for anal cancer https://t.co/Jfrq1SzxTs,,,2009-04-15 05:08:17,Amsterdam,Stocks tweets,https://pbs.twimg.com/profile_images/138834360/stocks1-avatar_normal.jpg,4407,3020,91,70157,stocks_tweets,
1134049078424162304,2021-02-26 04:42:20,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1365235743677960193,False,0,0,0,0,Newsfilter.io,Incyte's retifanlimab application validated in Europe for anal cancer $INCY https://t.co/OdK6c5rzOK,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
472650465,2021-02-26 03:16:08,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1365214048917274629,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC) https://t.co/5zYliXWvxu,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1006334607946649600,2021-02-26 03:11:09,,"StockMarket, Stocks, ","dlvr.it/RtWq4t, ",1365212793989853184,False,0,0,0,0,dlvr.it,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC) https://t.co/TZbwkHXw36 #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1355194932445786112,2021-02-26 03:06:28,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1365211615340208128,False,0,0,0,0,Twitter,"$INCY Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC)

https://t.co/52hWVAf5FN",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1134049078424162304,2021-02-26 03:05:20,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1365211332396646404,False,0,0,0,0,Newsfilter.io,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Ana.. $INCY https://t.co/QToyXAVPhV,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
976297820532518914,2021-02-26 03:04:32,,,"dlvr.it/RtWnzn, pic.twitter.com/aFDo19GQKS, ",1365211132089094146,False,0,0,0,0,dlvr.it,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC) https://t.co/FKxDwgjkfy https://t.co/aFDo19GQKS,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1089978712685273090,2021-02-26 03:03:07,"INTC, ","Incyte, StockMarket, ","dlvr.it/RtWnq0, ",1365210772398202882,False,0,0,0,1,dlvr.it,#Incyte $INTC Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC) https://t.co/MCbKyOtQGJ #StockMarket,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
213137160,2021-02-26 03:03:06,,,"dlvr.it/RtWnkL, pic.twitter.com/GD4grWvkzp, ",1365210770263339011,False,0,0,0,0,dlvr.it,Incyte : Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC) https://t.co/pskY8ut8EX https://t.co/GD4grWvkzp,,,2010-11-07 21:12:11,"San Diego, CA",Sniff Out Stocks,https://pbs.twimg.com/profile_images/1162213671/big_dog_nose_normal.jpg,3611,3936,82,49949,SniffOutStocks,photo
3318510966,2021-02-26 03:02:59,,,"crweworld.com/article/news-p‚Ä¶, ",1365210741234569216,False,0,0,0,0,CRWE World,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Reti https://t.co/jMWTK3zc74,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1325115160353103872,2021-02-26 03:00:34,"INCY, ","healthcare, ","quantisnow.com/insight/443860‚Ä¶, ",1365210129902182401,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC)

https://t.co/E0EnAkndhK

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1254035253104181256,2021-02-26 03:00:28,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1365210107164962817,False,0,0,0,0,stocktitan,"$INCY Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC)
https://t.co/zsqwDZJXjJ",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
374729426,2021-02-25 19:34:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2558389, pic.twitter.com/B0CZeoRCva, ",1365097772865581056,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average broke below its 50-day Moving Average on February 16, 2021. View odds for this and other indicators: https://t.co/5zZ1PAwzf8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/B0CZeoRCva",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
22195223,2021-02-25 14:35:06,,,"cancernetwork.com/view/fda-grant‚Ä¶, ",1365022530537480198,False,0,0,0,0,Hootsuite Inc.,"The @FDAOncology has accepted and granted priority review to an sNDA for ruxolitinib (Jakafi) for the treatment of steroid-refractory chronic graft-versus-host disease in adult and pediatric patients 12 years and older. | @Incyte 
https://t.co/Lbx8IkVPQz","FDAOncology, Incyte, ",,2009-02-27 16:48:14,"Cranbury, NJ","CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",https://pbs.twimg.com/profile_images/1196832187376685056/BU2C0XFo_normal.jpg,23603,452,498,13559,CancerNetwrk,
2812632288,2021-02-25 06:20:27,,,"invst.ly/typcv, ",1364898048212688898,False,0,0,0,0,ForexPros News & Analysis,"The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Incyte, Nektar Therapeutics, Immunome an... - https://t.co/5ocDaxDkQD",,,2014-09-16 03:56:03,Worldwide,Investing.com Stocks,https://pbs.twimg.com/profile_images/1108338732019695616/CAvg-ixc_normal.png,20430,38,256,339289,InvestingStockz,
1177946425780424704,2021-02-24 22:48:35,,,,1364784331957313538,False,0,0,0,0,structureinfinancialdata,"INCY, Incyte Corporation, Healthcare, Biotechnology: Hoppenot Herve, Chairman / CEO, BUYS for $1000.0K at $77.37 on 2021-02-23",,,2019-09-28 10:02:20,,structureinfinancialdata,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,5,0,1,2514,structureinfin1,
4028839455,2021-02-24 21:15:02,,,"stocktrot.com/company/incyte‚Ä¶, ",1364760789182210049,False,0,0,0,0,StockTrot1,"$59,171.38: largest sell-off of Incyte Corp shares for Dhanak Dashyant in 6 months. https://t.co/Glm3Ox59RC",,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
950010035396136962,2021-02-24 17:19:28,,"INCY, ",,1364701507359236098,False,0,0,0,0,Cresus AI,"Incyte Corporation (#INCY.US) closed at 80.61, score +223, credit rating AA",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
374729426,2021-02-24 16:22:52,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2555726, pic.twitter.com/NokEbXPYcG, ",1364687261325873152,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on February 2, 2021. View odds for this and other indicators: https://t.co/FhBonk38nw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/NokEbXPYcG",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1069486704,2021-02-24 16:22:25,"INCY, ",,,1364687146699882512,False,11,0,0,1,TweetDeck,"Incyte $INCY CEO bought $1M in stock yesterday at $77.37, biggest individual buy in the name ever",,,2013-01-07 18:51:59,,Wolfmetric,https://pbs.twimg.com/profile_images/581681759848427520/iZkwyUEX_normal.jpg,10002,149,442,11108,Wolfmetric,
386042607,2021-02-24 11:08:40,,,"hubs.ly/H0H7NQp0, pic.twitter.com/A7rYWVKCV1, ",1364608191124889602,False,1,0,0,0,HubSpot,"The @US_FDA has accepted the NDA of @Incyte's ruxolitinib cream for atopic dermatitis for priority review. The PDUFA target action date is June 21, 2021. https://t.co/hg1Cf0bOfz https://t.co/A7rYWVKCV1","US_FDA, Incyte, ",,2011-10-06 11:34:39,,Practical Derm,https://pbs.twimg.com/profile_images/1172186203099189249/6ZV9TJxF_normal.jpg,2800,888,49,4503,Practical_Derm,photo
45543166,2021-02-24 08:30:22,,"fda, GVHD, ","pmlive.com/pharma_news/fd‚Ä¶, ",1364568354019811333,False,0,0,0,0,SocialPilot.co,FDA fast-tracks review of Incyte‚Äôs Jakafi for chronic GVHD https://t.co/Uy5nbUiLK8 #fda #GVHD,,,2009-06-08 07:07:45,"Surrey, UK",Pharmaceutical Market Europe,https://pbs.twimg.com/profile_images/378800000806601474/9cf87bf47a70fe715664e76280625c82_normal.jpeg,14407,3838,368,16661,PMLiVEcom,
1262915121103491074,2021-02-23 23:19:53,"INCY, ","FWBuys, ","formwhispers.com/s?t=INCY, ",1364429820843622400,False,0,0,0,0,formwhispers,"#FWBuys $INCY Hoppenot Herve, Chairman / CEO of INCYTE CORP bought 12,925 shares on 2021-02-23. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1287941427138199552,2021-02-23 23:00:00,,"lawsuit, legal, justice, ","reuters.com/article/health‚Ä¶, ",1364424817047441409,False,0,0,0,0,Twitter Web App,"Incyte is to face Novartis contract claims in blood drug royalty fight.
https://t.co/rXcUoOWoKt
#lawsuit #legal #justice",,,2020-07-27 22:42:29,"Montana, USA",Burns Litigation,https://pbs.twimg.com/profile_images/1308218420987486208/e7yL1Xm0_normal.jpg,13,75,0,1886,BlgLitigation,
868108468087115776,2021-02-23 22:53:11,"INCY, INCY, ",,,1364423099425320963,False,1,0,0,0,Twitter Web App,"On 2021-02-23, Hoppenot Herve, Director, Chairman / CEO of INCYTE CORP $INCY, bought 12,925 shares at an average price of $77.37 per share for a total of $1,000,010.00. He owns 284,231 shares of $INCY Common Stock following this transaction. Reported on 2021-02-23.",,,2017-05-26 10:16:02,"Toronto, Ontario",insider trading,https://pbs.twimg.com/profile_images/868175792798355457/lqLS9cDa_normal.jpg,1119,537,14,996,insider_daily,
374729426,2021-02-23 17:50:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2553514, pic.twitter.com/xvIBMeQakv, ",1364346966801403907,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on February 2, 2021. View odds for this and other indicators: https://t.co/QWn9yy4Qap #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xvIBMeQakv",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2344420430,2021-02-23 17:49:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1364346644007948291,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Chairman / CEO

HERVE HOPPENOT:

https://t.co/eNGmICHHoN",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1278474376074145795,2021-02-23 17:00:46,"INCY, ","stock2020, ","insiderdrop.com, ",1364334410372382727,False,0,0,0,0,Twitter,"An executive and/or major shareholder of $INCY (INCYTE CORP) reportedly bought ~$ 1,000,007 worth of shares

‚û°Ô∏è https://t.co/EUocy7ZmFg ‚¨ÖÔ∏è

 #stock2020",,,2020-07-01 19:43:59,,insiderdrop,https://pbs.twimg.com/profile_images/1280996191443001345/mul90PPh_normal.jpg,92,0,0,7424,insiderdrop,
1337331316845662208,2021-02-23 17:00:09,"INCY, ",,"finance.yahoo.com/quote/INCY, ",1364334258228256769,False,2,0,0,0,Twitter,"$INCY (Incyte Corp) üöÄüöÄüöÄ 

Hoppenot Herve (COB ,  CEO) bought +12,925 shares at $77.37 for a total of +$1,000,007, increasing their ownership by +4%. 

https://t.co/jWlAkMvBfI 

üóì Published on Feb 23 (Traded on Feb 23)",,,2020-12-11 04:40:15,New York,Insider Bot,https://pbs.twimg.com/profile_images/1337331391688830981/QKf2ZMLX_normal.jpg,1870,11,37,182,TheInsiderBot,
1099039801397964802,2021-02-23 16:55:10,"INCY, ",,,1364333000889090048,False,0,0,0,0,EarningsAlley,"*INSIDER BUY ALERT*
Hoppenot Herve, Chairman / CEO, purchased 12,925 shares of $INCY at $77.37.
Hoppenot Herve now owns 284,231 shares worth $22,459,930 of INCYTE CORP stock.",,,2019-02-22 15:14:42,,Earnings Alley,https://pbs.twimg.com/profile_images/1113489113435508737/ulSmYR9O_normal.png,1802,1,33,87697,EarningsAlley,
27645777,2021-02-23 12:10:00,,"GVHD, ","bit.ly/3aJcwQb, pic.twitter.com/KVczRv62bQ, ",1364261236834140160,False,0,0,0,1,TweetDeck,The FDA granted priority review to ruxolitinib for the treatment of adults and children aged 12 years or older with steroid-refractory chronic graft-versus-host disease https://t.co/nNllxDgDxL #GVHD @Incyte https://t.co/KVczRv62bQ,"Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
15974185,2021-02-23 11:13:32,,,"dlvr.it/RtKFy3, ",1364247026972598275,False,0,0,0,0,dlvr.it,FDA to quickly review Incyte‚Äôs Jakafi in chronic GVHD https://t.co/tNjDd4h58E,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
4058194633,2021-02-23 10:57:21,"INCY, ",,"pharmaphorum.com/?p=77690, ",1364242955708469248,False,1,0,0,0,Twitter for iPhone,$INCY FDA to quickly review Incyte‚Äôs Jakafi in chronic GVHD https://t.co/5ARadWHAge via @pharmaphorum,"pharmaphorum, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-02-23 10:56:18,"INCY, NVS, ",,"reuters.com/article/health‚Ä¶, ",1364242692390088705,False,0,0,0,0,Twitter for iPhone,$INCY $NVS Incyte must face Novartis contract claims in blood drug royalty fight | Article [AMP] | Reuters https://t.co/pH1J1CDoSN,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
391492257,2021-02-23 09:00:11,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, fdatracker.com/fda-calendar/, ",1364213470179192842,False,0,0,0,0,FDA Tracker,$INCY New PDUFA Date 2021-06-22 INCYTE Link:https://t.co/FjUtlSpHHy Calendar:https://t.co/sCt1qKoMdr,,,2011-10-15 13:01:13,San Francisco,FDA Tracker,https://pbs.twimg.com/profile_images/1667207308/square_logo_normal.png,4992,14,113,4060,fda_tracker,
334944709,2021-02-23 08:20:00,,,"reut.rs/3uyBf1w, pic.twitter.com/5K3FEQb8MH, ",1364203355791388681,False,1,0,0,3,TweetDeck,Delaware drug company Incyte Corp must face a lawsuit by Novartis Pharma AG accusing it of breaching a contract by reducing royalties it paid on a drug used to treat blood disorders the two companies developed together. @brenpiers https://t.co/P4mugV20aK ($) https://t.co/5K3FEQb8MH,"brenpiers, ",,2011-07-13 18:28:32,New York,Reuters Legal,https://pbs.twimg.com/profile_images/877491866706395139/QnLtTu2w_normal.jpg,79678,556,1877,89501,ReutersLegal,photo
94365736,2021-02-23 07:30:14,,"Incyte, PriorityReview, Eczema, Cream, ","finance.yahoo.com/news/incyte-sa‚Ä¶, ",1364190831725453313,False,0,0,0,0,Hootsuite Inc.,#Incyte Says FDA Grants #PriorityReview For #Eczema #Cream; Street Sees 20% Upside https://t.co/qobjX29500 via @Yahoo,"Yahoo, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
1022473214457348096,2021-02-23 03:32:30,,,"pharmashots.com/56446/incyte-r‚Ä¶, ",1364131005645262852,False,0,0,0,0,Twitter Web App,"Incyte Reports the US FDA‚Äôs Acceptance of sNDA for Priority Review of Jakafi (ruxolitinib) to Treat Chronic Graft Versus Host Disease @Pharmashot @Incyte 
https://t.co/CAduGX317b","Pharmashot, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
227778014,2021-02-22 23:00:00,,"COVID19, ","buff.ly/3bzzhVI, ",1364062427797741569,False,1,0,0,0,Buffer,"Feb. 22 Quick Takes: Sanofi enters #COVID19 vaccine manufacturing deal with J&amp;J; plus updates from AZ, Regeneron-Sanofi, Incyte, Ascletis, Novo Holdings and Regor https://t.co/spayfHQ1PH",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
1596829382,2021-02-22 19:36:35,,,"dlvr.it/RtGbP1, pic.twitter.com/Lc4LojGP6w, ",1364011237839753217,False,0,0,0,1,dlvr.it,Incyte must face Novartis contract claims in blood drug royalty fight https://t.co/WFmKapv2Bz https://t.co/Lc4LojGP6w,,,2013-07-15 17:45:17,http://www.zyite.com/,Zyite.news,https://pbs.twimg.com/profile_images/1254426764144553985/vbZXp86B_normal.jpg,3028,4807,154,1641732,ZyiteGadgets,photo
334944709,2021-02-22 19:20:00,,,"reut.rs/3uyBf1w, pic.twitter.com/1C16AEQHiP, ",1364007062208991232,False,1,0,0,0,TweetDeck,Incyte must face Novartis contract claims in blood drug royalty fight https://t.co/P4mugV20aK @brenpiers ($) https://t.co/1C16AEQHiP,"brenpiers, ",,2011-07-13 18:28:32,New York,Reuters Legal,https://pbs.twimg.com/profile_images/877491866706395139/QnLtTu2w_normal.jpg,79678,556,1877,89501,ReutersLegal,photo
27645777,2021-02-22 15:47:23,,"GVHD, ","bit.ly/3aJcwQb, pic.twitter.com/wyq6xLcaMn, ",1363953558215876611,False,0,0,0,1,TweetDeck,.@US_FDA grants priority review to Jakafi for chronic graft-versus-host disease https://t.co/nNllxDyeWl #GVHD @Incyte https://t.co/wyq6xLcaMn,"US_FDA, Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
15974185,2021-02-22 12:18:32,,,"dlvr.it/RtFQXN, ",1363900995420397571,False,0,0,0,0,dlvr.it,Incyte Says FDA Grants Priority Review For Eczema Cream https://t.co/0VKlOqGv5i,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
4058194633,2021-02-22 12:17:38,"INCY, ",,"finance.yahoo.com/news/incyte-sa‚Ä¶, ",1363900769477386240,False,1,0,0,0,Twitter for iPhone,$INCY Incyte Says FDA Grants Priority Review For Eczema Cream; Street Sees 20% Upside https://t.co/HgI13BM4Mf,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
25406480,2021-02-22 11:17:17,,,"awesomecapital.blogspot.com/2021/02/incyte‚Ä¶, ",1363885583886598149,False,0,0,0,1,Twitter Web App,AwesomeCapital: Incyte Gets Priority Review for Jakafi in Chronic ... https://t.co/v7X8k4gylU,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
4058194633,2021-02-22 11:05:55,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1363882723681595395,False,2,0,0,0,Twitter for iPhone,$INCY Incyte Announces Acceptance and Priority Review of sNDA for Jakafi¬Æ (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease | Business Wire https://t.co/rxBWjrWC7c,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
72928001,2021-02-22 10:06:12,"INCY, ",,"bit.ly/3aIITOO, ",1363867694294966281,False,1,0,0,1,BriefingInPlayLimited,$INCY: Incyte announces that the U.S. Food and Drug Administration has accepted for Priority Review the supplemental... https://t.co/RtCcWb4Lzu,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
725577499,2021-02-22 09:47:46,,,"tipranks.com/news/incyte-sa‚Ä¶, ",1363863054673395717,False,1,0,0,0,Twitter Web App,Incyte Says FDA Grants Priority Review For Eczema Cream; Street Sees 20% Upside https://t.co/tDdsoH450t,,,2012-07-30 03:57:38,,TipRanks,https://pbs.twimg.com/profile_images/1445275766195884032/dO0joyh1_normal.jpg,25516,1242,436,23612,TipRanks,
3686628867,2021-02-22 09:43:48,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1363862056449966080,False,0,0,0,0,WordPress.com,Incyte Announces Acceptance and Priority Review of sNDA for Jakafi¬Æ (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease https://t.co/KI64J1z7MG,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
391492257,2021-02-22 09:00:12,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, fdatracker.com/fda-calendar/, ",1363851085593546752,False,0,0,0,0,FDA Tracker,$INCY New PDUFA Date 2021-06-21 INCYTE Link:https://t.co/1Cctnk4Fqt Calendar:https://t.co/sCt1qKoMdr,,,2011-10-15 13:01:13,San Francisco,FDA Tracker,https://pbs.twimg.com/profile_images/1667207308/square_logo_normal.png,4992,14,113,4060,fda_tracker,
988050189385633793,2021-02-22 08:36:03,"INCY, KDMN, ",,"investor.incyte.com/press-releases‚Ä¶, ",1363845007283740675,False,2,0,2,1,Twitter for iPhone,"Good news for $INCY. 

However, $KDMN has a 6 month advantage to establish KD025 in transplant centers with a drug that is safer and better tolerated than Jakafi.  https://t.co/glaBdVk73X",,,2018-04-22 09:41:37,"Manhattan, NY",Gridiron Equities,https://pbs.twimg.com/profile_images/988506258566254592/q42WEEHM_normal.jpg,456,97,7,1158,GridironEq,
1355194932445786112,2021-02-22 08:12:43,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1363839136197705734,False,0,0,0,0,Twitter,"$INCY Incyte Announces Acceptance and Priority Review of sNDA for Jakafi¬Æ (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease

https://t.co/ll7jue9zIK",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
3318510966,2021-02-22 08:08:24,,,"crweworld.com/article/news-p‚Ä¶, ",1363838047998017536,False,0,0,0,0,CRWE World,Incyte Announces Acceptance and Priority Review of sNDA for Jakafi¬Æ (ruxolitinib) as a Treatment for Patients with  https://t.co/a9zrNmFptT,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2021-02-22 08:06:43,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1363837625363234816,False,0,0,0,0,stocktitan,"$INCY Incyte Announces Acceptance and Priority Review of sNDA for Jakafi¬Æ (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease
https://t.co/xQR4dOqvDV",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
976297820532518914,2021-02-22 08:06:38,,,"dlvr.it/RtDWxN, pic.twitter.com/e2Q4YYb36X, ",1363837604572008448,False,0,0,0,0,dlvr.it,Incyte Announces Acceptance and Priority Review of sNDA for Jakafi¬Æ (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease https://t.co/8gJcmY9N2x https://t.co/e2Q4YYb36X,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2021-02-22 08:05:41,"INCY, ",,"s.flashalert.me/Re5fQJ, ",1363837364423000065,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on February 22, 08:00:00: Incyte Announces Acceptance and Priority Review of sNDA for Jakafi¬Æ (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease https://t.co/NhTeNufhf8",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
2196092280,2021-02-22 08:03:36,"INCY, ",,,1363836840038572033,False,0,0,0,0,StockTwits Web,$INCY: Incyte Announces Acceptance and Priority Review of sNDA for Jakafi¬Æ (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease,,,2013-11-15 09:38:14,New York City/Connecticut,TradeXchange,https://pbs.twimg.com/profile_images/1442949647085883394/cdjIO2jB_normal.jpg,13483,365,350,23077,TheTradeXchange,
1006334607946649600,2021-02-22 08:03:34,,"StockMarket, Stocks, ","dlvr.it/RtDWKs, ",1363836833457598465,False,0,0,0,0,dlvr.it,Incyte Announces Acceptance and Priority Review of sNDA for Jakafi¬Æ (ruxolitinib) as a Treatment for Patients with Chronic Graft-Versus-Host Disease https://t.co/JJhfh1IRPh #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1022473214457348096,2021-02-22 05:31:51,,,"pharmashots.com/56408/incyte-r‚Ä¶, ",1363798651303174145,False,2,0,0,0,Twitter Web App,"Incyte Reports the US FDA‚Äôs Acceptance of NDA for Priority Review of Ruxolitinib Cream to Treat Atopic Dermatitis @Pharmashot @Incyte 
https://t.co/UDGRzatyrL","Pharmashot, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
1315434407692509184,2021-02-21 22:19:15,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/RzIwk9If01, ",1363689785299259395,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 36.30% ranked 664 out of 5480 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/RzIwk9If01",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1134049078424162304,2021-02-21 09:57:05,"INCY, ",,"newsfilter.io/articles/8-k-f‚Ä¶, ",1363503011180511233,False,0,0,0,0,Newsfilter.io,"Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On February 18, 2021, the Board .. $INCY https://t.co/mBZsiiL3Xa",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
374729426,2021-02-21 01:05:08,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2547476, pic.twitter.com/6ZTR5kOI9N, ",1363369142368149506,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/Hzcmbw1P4I #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/6ZTR5kOI9N,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
374729426,2021-02-20 00:40:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2545078, pic.twitter.com/fMGZnOMyid, ",1363000666365382657,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on February 16, 2021. View odds for this and other indicators: https://t.co/0twv84eUmE #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/fMGZnOMyid",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1134049078424162304,2021-02-19 22:04:02,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1362961180151709698,False,0,0,0,0,Newsfilter.io,Incyte Announces Acceptance and Priority Review of NDA for Ruxolitinib Cream for Atopic Dermatitis $INCY https://t.co/aDR6NQjRz1,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1325446129325142016,2021-02-19 20:36:23,"INCY, ",,"seekingalpha.com/news/3663913-f‚Ä¶, ",1362939121438765058,False,0,0,0,0,Integromat,$INCY - FDA accepts Incyte's ruxolitinib NDA with Priority Review https://t.co/nVPBJqv0uk,,,2020-11-08 09:32:48,Telegram Wall St,Money Message,https://pbs.twimg.com/profile_images/1346181161177985030/EgOCIHTS_normal.jpg,213,172,2,22808,moneymessage_,
950010035396136962,2021-02-19 17:11:29,,"INCY, ",,1362887557781065731,False,0,0,0,0,Cresus AI,"Incyte Corporation (#INCY.US) closed at 80.54, score +219, credit rating AA",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
538402387,2021-02-19 14:01:56,,,"catalyzingchange.vfairs.com/en/, pic.twitter.com/nxSThB4I6V, ",1362839855017910273,False,3,0,0,1,Hootsuite Inc.,"Learn about the evolving talent and skills needs of today's companies and consider the best options for you once you graduate.
https://t.co/bHckKpDfJr
Meet the speaker Jess Stinson
@DuPont_News  @FMCCorp  @Incyte  @airliquide_de  @WSFS  @dpp @FAME_Delaware https://t.co/nxSThB4I6V","DuPont_News, FMCCorp, Incyte, airliquide_de, WSFS, dpp, FAME_Delaware, ",,2012-03-27 14:58:09,"Newark, Delaware, USA",DESCA,https://pbs.twimg.com/profile_images/1387774824504823812/S66uJ_x0_normal.jpg,278,179,27,1864,DescaDelaware,photo
1231650459187732480,2021-02-19 12:34:37,,"losangeles, biotech, ","tinyurl.com/yb4nrmfe, ",1362817882179084290,False,0,0,0,0,FeedBlitz,LABN Feed: Incyte scores speedy FDA review for JAK cream in atopic dermatitis; Lilly backs $90M raise for Regor: Incyte‚Äôs stalwart JAK inhibitor Jakafi has raced out to blockbuster sales without the ... #losangeles #biotech https://t.co/FkQkGQwW1l,,,2020-02-23 13:42:36,"Los Angeles, California",Los Angeles Biotechnology Network,https://pbs.twimg.com/profile_images/1403379542597672963/ovXNVtwK_normal.png,511,2509,3,1763,LABioNetwork,
3460109487,2021-02-19 12:10:41,,"FDA, ","endpts.com/incyte-scores-‚Ä¶, ",1362811857292169216,False,1,0,0,0,TweetDeck,"In today's News Briefing: The #FDA will give a priority review to Incyte‚Äôs topical cream reformulation of JAK inhibitor Jakafi in atopic dermatitis, the drugmaker announced Friday.

https://t.co/oay2TWfYDz",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
133504478,2021-02-19 11:53:07,,"strategy, competitiveintelligence, marketing, pharma, biotech, productmarketing, pharmaceutical, healthcare, ","dlvr.it/Rt3nJf, pic.twitter.com/LPwCI5Hrft, ",1362807436269162499,False,2,0,0,1,dlvr.it,Incyte scores speedy FDA review for JAK cream in atopic dermatitis; Lilly backs $90M raise for Regor https://t.co/tYwY6AdozA #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #pharmaceutical #healthcare https://t.co/LPwCI5Hrft,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
46297868,2021-02-19 11:10:03,,,"dlvr.it/Rt3dDX, ",1362796598355369987,True,0,0,0,0,dlvr.it,Incyte scores speedy FDA review for JAK cream in atopic dermatitis; Lilly backs $90M raise for Regor https://t.co/ES2427x0E0,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
1072336749462982656,2021-02-19 10:33:17,"INCY, ",,,1362787348426219524,False,0,0,0,0,Twitter Web App,$INCY FDA Accepts Incyte's Ruxolitinib Cream US Application For Chronic Skin Disease,,,2018-12-10 22:46:18,"Menlo Park, CA",üí∞ùêäùêàùêçùêÜ ùêàùêçùêïùêÑùêíùêìeùêë üí∞,https://pbs.twimg.com/profile_images/1451699036411596807/5sCLzmta_normal.jpg,135,25,1,1928,KingInvesters,
72928001,2021-02-19 10:05:35,"INCY, ",,"bit.ly/2M3VdzC, ",1362780375009796098,False,1,1,0,1,BriefingInPlayLimited,"$INCY: Incyte has accepted for Priority Review the NDA for ruxolitinib cream, as a treatment for atopic dermatitis;... https://t.co/245JVYs340",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
53097729,2021-02-19 09:27:41,"INCY, ",,"newsfilter.io/a/c8f00eded403‚Ä¶, ",1362770836046958593,False,1,0,0,0,Twitter Web App,$INCY FDA accepts Incyte's ruxolitinib NDA with Priority Review https://t.co/Rl5lMwiZDW,,,2009-07-02 11:44:23,"Toronto, Ontario",Stockwits‚Ñ¢ Ó®Ä,https://pbs.twimg.com/profile_images/1408587167111303171/Qrn1abyM_normal.jpg,26206,983,189,29344,mikalche,
15296897,2021-02-19 09:26:09,"INCY, ",,"seekingalpha.com/news/3663913-f‚Ä¶, ",1362770450300854274,False,0,0,0,1,SANewsTwitter,$INCY - FDA accepts Incyte's ruxolitinib NDA with Priority Review https://t.co/RoP3Mw79K6,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3911174913,2021-02-19 08:09:18,,"News, atopicdermatitis, eczema, ",,1362751111162126339,False,6,0,0,2,Twitter for Advertisers,"#News: The @US_FDA has accepted for priority review the NDA for Incyte‚Äôs topical JAK inhibitor cream under development for #atopicdermatitis, a type of #eczema","US_FDA, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
1069693680066420736,2021-02-19 08:06:15,"INCY, ",,"s.flashalert.me/JyEteH, ",1362750343336124416,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on February 19, 08:00:00: Incyte Announces Acceptance and Priority Review of NDA for Ruxolitinib Cream for Atopic Dermatitis https://t.co/Gg3TPWC0ax",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
112872946,2021-02-19 08:01:57,"INCY, ",,,1362749263260885004,False,5,0,0,0,Twitter Web App,"$INCY Announces Acceptance and Priority Review of NDA for Ruxolitinib Cream for Atopic Dermatitis.
 Incyte submitted a PRV along with the NDA.

PDUFA 06/21/21",,,2010-02-09 19:09:48,Toronto,Bio Stocks‚Ñ¢,https://pbs.twimg.com/profile_images/1345176821185306624/4OaDT_lb_normal.jpg,58832,77,1249,48782,BioStocks,
772471873539977217,2021-02-19 07:14:35,"INCY, ",,"sec.gov/ix?doc=/Archiv‚Ä¶, ",1362737340221968387,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 8-K https://t.co/MC117xTRUA,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
1171873456276889600,2021-02-19 07:02:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1362734383669592065,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (19 Feb, 7:01am)

üì∞ Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

https://t.co/BkgWpAbvAV

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
4312114277,2021-02-19 07:02:49,"INCY, ",,"fintel.io/sfs/us/incy?ut‚Ä¶, ",1362734381329223681,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 8-K - Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year -  FORM 8-K https://t.co/xljeWddlXw,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
812004702594486272,2021-02-19 05:01:06,,,"checkrare.com/overview-of-sq‚Ä¶, ",1362703749165289475,False,2,0,0,0,Hootsuite Inc.,"Lance Leopold, MD, Group Vice President, Immuno-Oncology, at Incyte gives an overview of squamous cell carcinoma of the anal canal (SCAC).
@Incyte Incyte 
https://t.co/HXjJ5sP65q","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
374729426,2021-02-18 22:47:03,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2542544, pic.twitter.com/RbrUMzvsHE, ",1362609615825866755,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/tKJHg8FaMt #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/RbrUMzvsHE,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2344420430,2021-02-18 22:45:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1362609195661541376,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/eyD49bT9ND",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
23059499,2021-02-18 08:01:27,"INCY, ","investing, business, trading, ","seekingalpha.com/article/440694‚Ä¶, ",1362386747540131845,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Q4 2020 Shows Strength; Stock At An Attractive Price. https://t.co/YGZ8uANeOm #investing #business #trading,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1280938376099741697,2021-02-17 16:57:59,,"iexStock, ","iexcloud.io, pic.twitter.com/5xHqp3aBNC, ",1362159383107543040,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Manazel Real Estate PJSC
-Incyte Corp.
-Sharjah Group
-PepsiCo Inc
-Gulf Cement Co.

Data provided by https://t.co/oXreiEXTgd https://t.co/5xHqp3aBNC",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1137138575374503936,2021-02-17 13:08:02,,"finance, financial, finanzas, finanza, ","investing.com/news/stock-mar‚Ä¶, ",1362101513200431107,False,0,0,0,0,Twitter,"Incyte Earnings, Revenue Beat in Q4 https://t.co/qOZTjCjh2s #finance #financial #finanzas #finanza",,,2019-06-07 19:25:38,"Bedford, TX",Liquidity Lighthouse,https://pbs.twimg.com/profile_images/1137208270479921152/egBhK8_a_normal.png,332,113,13,73503,LiquidityL,
1022006086872821762,2021-02-17 09:03:00,"INCY, INCY, ",,,1362039849423888385,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Tue Feb 16
Closed at 82.13 USD for a -2.61% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
1350913509379493890,2021-02-17 09:02:09,"INCY, ",,"HedgyAnalytics.com, pic.twitter.com/ZYEcYCm1Cs, ",1362039637804535810,False,0,0,0,0,HedgyAnalytics,Wall Street analysts love Incyte in Biotechnology. $INCY https://t.co/tv2m8X8Ri0 https://t.co/ZYEcYCm1Cs,,,2021-01-17 16:11:12,"New York, New York",Hedgy,https://pbs.twimg.com/profile_images/1352664199596560390/dae2kp6s_normal.jpg,122,118,4,3250,HedgyAnalytics,photo
1280938376099741697,2021-02-16 17:07:58,,"iexStock, ","iexcloud.io, pic.twitter.com/u36KEFPSlW, ",1361799508087230464,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-American Airlines Group Inc
-National Bank of Fujairah.
-Incyte Corp.
-Al Buhaira National Insuranc
-Verisign Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/u36KEFPSlW",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
963495628545327104,2021-02-16 10:04:26,"INCY, INCY, ",,"stck.pro/news/INCY/1104‚Ä¶, stck.pro/news/INCY, ",1361692924455624707,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte: Another Buy Opportunity https://t.co/nuCpYAGt5j Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
490204452,2021-02-16 09:36:02,,,"seekingalpha.com/article/440528‚Ä¶, ",1361685774463356934,False,0,0,0,0,Twitter for iPhone,Incyte: Another Buy Opportunity https://t.co/lt8GU159PE,,,2012-02-12 04:57:14,United States,LARRY ELKAN,https://pbs.twimg.com/profile_images/697901377079664640/fGcgHcTF_normal.jpg,15043,16988,7857,553853,LElkan,
23059499,2021-02-16 09:15:08,"INCY, ","trading, markets, stockmarket, ","seekingalpha.com/article/440528‚Ä¶, ",1361680514034241536,False,4,0,0,1,SAArticlesTwitter,$INCY - Incyte: Another Buy Opportunity. https://t.co/jDkHPmOYpN #trading #markets #stockmarket,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1022006086872821762,2021-02-16 05:04:05,"INCY, INCY, ",,,1361617336332075008,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Fri Feb 12
Closed at 84.33 USD for a -0.78% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
374729426,2021-02-16 00:42:12,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2536436, pic.twitter.com/FF5B4MX1T5, ",1361551433712066562,False,0,0,0,2,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/voLZufls0E #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/FF5B4MX1T5,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280938376099741697,2021-02-15 18:12:03,,"iexStock, ","iexcloud.io, pic.twitter.com/PzZ1SwFORs, ",1361453245877616649,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Mylan NV
-Wynn Resorts Ltd.
-Fujairah Building Industries
-Methaq Takaful Insurance Co
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/PzZ1SwFORs",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2021-02-15 15:55:42,,"iexStock, ","iexcloud.io, pic.twitter.com/FlpT28cbPN, ",1361418934642122753,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-National Takaful Company
-Incyte Corp.
-Ras Al Khaima for White Cement Co
-Lam Research Corp.
-Micron Technology Inc.

Data provided by https://t.co/oXreiEGhRD https://t.co/FlpT28cbPN",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2021-02-15 00:20:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2534048, pic.twitter.com/GTlUYbYgVT, ",1361183539790708736,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/vvXnZb6VKf #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GTlUYbYgVT,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1979190776,2021-02-14 01:27:26,"INCY, ",,"tickerreport.com/?p=7071045, ",1360838038893563905,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Forecasted to Earn Q1 2021 Earnings of $0.54 Per Share https://t.co/Nxdfe0693Y,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1022006086872821762,2021-02-13 10:01:20,"INCY, INCY, ",,,1360604977245392898,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Fri Feb 12
Closed at 84.33 USD for a -0.78% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
374729426,2021-02-13 03:39:24,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2529661, pic.twitter.com/GHOQwOUph8, ",1360508860667027460,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 10, 2021. View odds for this and other indicators: https://t.co/Hlu6tL6MEz #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GHOQwOUph8",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1134049078424162304,2021-02-13 02:19:12,"MGNX, ",,"newsfilter.io/articles/macro‚Ä¶, ",1360488678154469378,False,0,0,0,0,Newsfilter.io,MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte $MGNX https://t.co/450EMw2ysC,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-02-13 01:18:12,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1360473326385324033,False,0,0,0,0,Newsfilter.io,Incyte to Present at Upcoming Investor Conference $INCY https://t.co/x56j8CkKxg,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1250830691824283648,2021-02-12 18:19:04,"TWTR, ILMN, ZBRA, HBI, AMAT, KLAC, AKAM, TAP, NWL, INCY, FMC, CERN, ",,,1360367849718571014,False,20,0,1,2,Twitter Web App,"Best and worst performing S&amp;P 500 stocks from this week

Best:
1 Twitter $TWTR +27%
2 Illumina $ILMN +18%
3 Zebra $ZBRA +17%
4 Hanes $HBI +17%
5 $AMAT +16%
6 $KLAC +15%

Worst:
1 Akamai $AKAM -11%
2 Coors $TAP -10%
3 Newell $NWL -7%
4 Incyte $INCY -7%
5 $FMC -7%
6 $CERN -6%",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
55700354,2021-02-12 13:31:38,,,,1360295516102352902,False,2,0,0,1,Twitter Web App,"Does this sound fun to work on:

- Hasura @HasuraHQ 
- Postgres @PostgreSQL (PL/pgSQL)
- Vue @vuejs 
- Apollo @apollographql 
- Typescript @typescript 
- Python @ThePSF 
- AWS @awscloud  

Incyte Studios is hiring remote US based employees. 

email: mbenin@incytestudios.com","HasuraHQ, PostgreSQL, vuejs, apollographql, typescript, ThePSF, awscloud, ",,2009-07-10 19:45:10,Saint Petersburg FL,Michael L. Benin,https://pbs.twimg.com/profile_images/506791553491144705/nfWqtVpW_normal.jpeg,599,1988,90,8984,michaelbenin,
4824391750,2021-02-12 11:55:39,,"WorldCCADay, ","twitter.com/Incyte/status/‚Ä¶, ",1360271361038499842,False,4,0,0,1,Twitter Web App,Thank you @Incyte for shining a light! #WorldCCADay https://t.co/U0XG20it9v,"Incyte, ",,2016-01-18 10:17:44,Worldwide,WorldCCADay,https://pbs.twimg.com/profile_images/880382784652664832/eyMk2Y2D_normal.jpg,496,492,2,394,WorldCCADay,
1197835492303220736,2021-02-12 11:53:10,,"cholangiocarcinoma, clinicaltrial, bileductcancer, FGRF2, pemigatinib, ","ancora.ai/details/NCT036‚Ä¶, twitter.com/pashtoonkasi/s‚Ä¶, ",1360270733558054912,False,10,0,2,6,Twitter Web App,"Definitely!
A recruiting #cholangiocarcinoma #clinicaltrial to check out is: https://t.co/X7qD5lo6bM

The trial is looking for metastatic #bileductcancer patients w/ #FGRF2 mutation &amp; evaluates #pemigatinib from @Incyte 

Phase 3 trial is at 189 location including @UIowaCancer https://t.co/Nf0EdLGVrz","Incyte, UIowaCancer, ",,2019-11-22 06:13:44,,Ancora.ai Cancer Clinical Trials for All,https://pbs.twimg.com/profile_images/1197836564958777344/wYIZWwW8_normal.jpg,1070,5002,9,3525,Ancora_AI,
3911174913,2021-02-12 10:20:13,,"cholangiocarcinoma, WorldCCADay, ",,1360247342167957504,False,41,2,1,5,Twitter for Advertisers.,"At Incyte, we develop treatments for cancers, including rare cancers like #cholangiocarcinoma. Through our unique discovery process, we continue to Solve On. for patients this #WorldCCADay.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
1188416386172903424,2021-02-12 09:11:00,,,"pic.twitter.com/mSRyajmx7j, ",1360229923474997250,False,0,0,0,0,Twitter Web App,"Incyte Corporation

Incyte Corp actual stock price üî•üìàüôå

Follow us for more updates.
@fedholdinggroup

Your trusted management fund - FED HOLDING GROUP üìäüè¢ https://t.co/mSRyajmx7j","fedholdinggroup, ",,2019-10-27 07:25:34,,FED Holding Group,https://pbs.twimg.com/profile_images/1281694942109278209/2pULSiQg_normal.jpg,9,0,0,236,fedholdinggroup,photo
732361939490312192,2021-02-12 07:15:11,"INCY, ","markets, ","americanbankingnews.com/?p=18406590, ",1360200779953537026,False,0,0,0,0,Zapier.com,Incyte Co. Expected to Earn Q1 2021 Earnings of $0.54 Per Share $INCY https://t.co/19y9lIVIRV #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-02-12 07:15:11,"INCY, ","stocks, ","americanbankingnews.com/?p=18406590, ",1360200778103853058,False,0,0,0,0,Zapier.com,Incyte Co. Expected to Earn Q1 2021 Earnings of $0.54 Per Share $INCY https://t.co/IaPoVNPSle #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
849417718642159616,2021-02-12 05:57:07,"INCY, ",,"zpr.io/RHqkN, ",1360181133179289601,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by SVB Leerink https://t.co/TfX8oDdSq3,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
812004702594486272,2021-02-12 05:01:10,,,"checkrare.com/efficacy-of-re‚Ä¶, ",1360167051097235459,False,0,0,0,0,Hootsuite Inc.,"Lance Leopold, MD, Group Vice President, Immuno-Oncology, at Incyte discusses the clinical trial of retifanlimab for the treatment of squamous cell carcinoma of the anal canal (SCAC).
@Incyte Incyte 
https://t.co/nHthYjDPYE","Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1276528931890515968,2021-02-12 04:44:51,,,"lnkd.in/gFbQ4JD, ",1360162946098208769,False,0,0,0,0,LinkedIn,"Stephen Kaufhold Treasurer, Incyte 
""the biggest achievement was when I started at Allergan, the company had about $850m of debt on the books. After we've gone through all these transformational transactions we peaked at about $44b of debt. Over that peri‚Ä¶https://t.co/ua4jNWZwL3",,,2020-06-26 10:53:22,,@treasurytalent,https://pbs.twimg.com/profile_images/1276529149964886022/NLBvljcE_normal.png,21,47,0,758,treasurytalent,
598251794,2021-02-12 03:57:10,,"WorldCCADay, cholangiocarcinoma, ","bit.ly/3iGlMXx, ",1360150945112481792,False,10,0,0,6,Twitter for iPhone,"This #WorldCCADay, I'm proud to join with my colleagues at @Incyte in raising awareness of #cholangiocarcinoma, a rare cancer that forms in the bile duct. Learn more about how you can support the community: https://t.co/E6uePjqlIf","Incyte, ",,2012-06-03 07:16:54,,Dr. Luis F√©liz,https://pbs.twimg.com/profile_images/1135315461468512256/VsiKnHW-_normal.jpg,84,342,1,359,lrfeliz,
1889492676,2021-02-12 03:37:14,"MGNX, ","MacroGenics, Retifanlimab, Incyte, ","1stoncology.com/blog/macrogeni‚Ä¶, ",1360145927353167875,False,0,0,0,1,Troi URL Plug-in,#MacroGenics Announces Achievement of $10 Million Milestone Related to #Retifanlimab Collaboration with #Incyte $MGNX https://t.co/dobIVgHnXd,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2021-02-12 03:22:22,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1360142187401338882,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/mDg6HFUvqC,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
218042800,2021-02-12 00:58:25,,"WorldCCADay, cholangiocarcinoma, ","bit.ly/3iGlMXx, pic.twitter.com/bejmMmO1iG, ",1360105962699390976,False,33,1,1,10,Twitter for iPhone,"This #WorldCCADay, I'm proud to join with my colleagues at @Incyte in raising awareness of #cholangiocarcinoma, a rare cancer that forms in the bile duct. Learn more about how you can support the community:¬†https://t.co/SELuyykigm https://t.co/bejmMmO1iG","Incyte, ",,2010-11-21 02:44:46,Sesto Fiorentino,Davide Boy,https://pbs.twimg.com/profile_images/1360106672845443075/FLC6IDKT_normal.jpg,120,291,4,313,DavideBoy77,photo
44330196,2021-02-12 00:28:18,,,"finance.yahoo.com/news/zacks-ana‚Ä¶, ",1360098382409269248,False,0,0,0,0,Twitter for Android,"Stocks recently featured in the blog include: Biogen Inc. BIIB, Gilead Sciences, Inc. GILD, Regeneron Pharmaceuticals, Inc. REGN, Bristol-Myers Squibb Company BMY and Incyte Corporation INCY.
https://t.co/GfQ8wSXYDl",,,2009-06-03 05:57:13,United States,MetricSmart,https://pbs.twimg.com/profile_images/1147827985455730688/09tE6FzE_normal.jpg,865,73,0,67008,WisdomChannel,
1100450877792370688,2021-02-11 17:38:58,"INCY, ",,"blueequity.io/r/191238/de-in‚Ä¶, ",1359995372580470786,False,0,0,0,0,Blue Equity,$INCY Incyte to Present at Upcoming Investor Conference https://t.co/d5Rih9qbXd,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
27645777,2021-02-11 16:47:53,,"TCTM21, GVHD, ","bit.ly/3jETuNw, pic.twitter.com/oCuLTlTIP8, ",1359982514224451587,False,3,0,0,3,TweetDeck,"‚≠êNEW from #TCTM21 - Results from phase 3 REACH study show ruxolitinib improves response rate, failure-free survival in chronic graft-versus-host disease https://t.co/zfW0OVmslt #GVHD @CIBMTR @ASTCT @Incyte / study led by @StephanieLeeMD @fredhutch @UWMedicine @SeattleCCA https://t.co/oCuLTlTIP8","CIBMTR, ASTCT, Incyte, StephanieLeeMD, fredhutch, UWMedicine, SeattleCCA, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
799069924450766848,2021-02-11 16:20:07,"AGEN, ",,"itunes.apple.com/us/app/apple-s‚Ä¶, ",1359975528313352195,False,1,0,0,0,InsiderForms,"$AGEN INCyte CORP has filed Form SC 13G/A with SEC. Reporting 7.4% Ownership.

https://t.co/t5CkFUZh7T",,,2016-11-16 21:01:30,United States,Insider Forms,https://pbs.twimg.com/profile_images/1448375542013628418/Dbx6hCfO_normal.jpg,2877,0,67,46526,InsiderForms,
1148421960948281345,2021-02-11 15:52:48,,,"news.freeptomaineradio.com/?p=79231, ",1359968651965784072,False,0,0,0,0,ArthurPotatoeHammer,"https://t.co/QwFFAusZSw
MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte
NEWS.FREEPTOMAINERADIO.COMROCKVILLE, MD, Feb. 11, 2021 (GLOBE NEWSWIRE) -- ¬†MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focu...",,,2019-07-08 22:41:46,United States,ArthurPotatoeHammer,https://pbs.twimg.com/profile_images/1184265779983847425/STYm7fen_normal.jpg,1205,1158,5,129965,KingNormies,
2755108144,2021-02-11 15:13:32,,"MPNsm, ","pubs.acs.org/doi/full/10.10‚Ä¶, ",1359958771867484161,False,5,1,0,0,Twitter Web App,"Excited our @LLSusa-funded project led to the 1st co-crystal structures of JAK2 bound to ruxolitinib &amp; fedratinib - led by Ernst Schonbrunn @MoffittNews. These may aid in the understanding &amp; development of JAK2-targeted therapies. @MPN_RF @Incyte #MPNsm

https://t.co/XqrscN07QP","LLSusa, MoffittNews, MPN_RF, Incyte, ",,2014-08-29 17:15:56,"Tampa, FL",Gary Reuther,https://pbs.twimg.com/profile_images/1252798720799903744/N3ChfHQR_normal.jpg,60,142,0,128,reuthergw,
4058194633,2021-02-11 14:00:55,"GNCA, ",,"google.com/amp/s/www.smar‚Ä¶, ",1359940496185905153,False,1,0,0,0,Twitter for iPhone,"$GNCA Needham Maintains Buy Rating On Genocea Biosciences, $6 PT https://t.co/gCdJzGRxCI",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
4058194633,2021-02-11 13:59:37,"INCY, ",,"google.com/amp/s/www.smar‚Ä¶, ",1359940168124276738,False,0,0,0,0,Twitter for iPhone,"$INCY JP Morgan Assigns A Hold Rating On Incyte, $98 PT https://t.co/gCdJzGRxCI",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
998915197061488645,2021-02-11 12:25:53,,,,1359916580994502657,False,13,1,1,2,Twitter Web App,"Great q's from yesterday's INCyTE seminar meeting!
üçÉ How do we quantify stoichiometric flexibility across temporal and spatial scales?
üå≤What do we *really* know about wood stoichiometric flexibility?
üåé And what does it all mean for global models?",,,2018-05-22 09:15:16,,INCyTE RCN,https://pbs.twimg.com/profile_images/1063085319887695873/d_uRHryG_normal.jpg,221,32,1,46,IncyteRcn,
1065838258528104448,2021-02-11 11:35:43,"MGNX, ","smallcapsdaily, smallcaps, microcap, stocks, trading, profits, ","finance.yahoo.com/news/macrogeni‚Ä¶, ",1359903954524594178,False,0,0,0,0,Twitter,$MGNX MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte GlobeNewswire https://t.co/2RgiXPsfGP #smallcapsdaily #smallcaps #microcap #stocks #trading #profits,,,2018-11-23 00:23:37,"New York, NY",SmallCapsDaily,https://pbs.twimg.com/profile_images/1237502128110759936/r5CB3eME_normal.jpg,1067,13,18,30984,SmallCapsDaily,
1021733442269143040,2021-02-11 11:10:05,,"pentatherapy, Tcell, Treg, ","bit.ly/3cXzcO6, pic.twitter.com/LSnr1Pe08N, ",1359897505123737606,False,6,0,0,1,Khoros Publishing App,"Treatment of established tumors with a combination #pentatherapy regimen leads to #Tcell activation while decreasing #Treg suppression. Learn more: 
@NCIResearchCtr @immunitybio @nantkwest @DrPatSoonShiong @nciccr_gmb @NantOmics @Incyte 
https://t.co/0k7C1PHD8c https://t.co/LSnr1Pe08N","NCIResearchCtr, ImmunityBio, NantKwest, DrPatSoonShiong, nciccr_gmb, NantOmics, Incyte, ",,2018-07-24 08:26:50,,Cancer Immunology Research,https://pbs.twimg.com/profile_images/1072194305664651264/1qg_EVD0_normal.jpg,1608,229,18,1512,CIR_AACR,photo
4058194633,2021-02-11 09:59:35,"MGNX, INCY, ","jobs, ","biospace.com/article/releas‚Ä¶, ",1359879761154121729,False,0,0,0,0,Twitter for iPhone,$MGNX $INCY MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte | BioSpace https://t.co/qbTuntPXuw #jobs,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
849417718642159616,2021-02-11 09:59:08,"INCY, ",,"zpr.io/RtBqB, ",1359879650172952576,False,0,0,0,0,Zapier.com,Incyte $INCY Lifted to ‚ÄúB-‚Äù at TheStreet https://t.co/eJ8U30uCSA,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
627695874,2021-02-11 09:12:16,"MGNX, ",,"investorsobserver.com/symbols/mgnx, ",1359867853793595399,False,1,0,0,0,Twitter Web App,"$MGNX +1.2% (announces that a $10 mln milestone has been achieved related to development progress of retifanlimab outside the U.S., under its exclusive global collaboration and license agreement with Incyte) 

https://t.co/kreODFWbFc",,,2012-07-05 14:32:58,,InvestorsObserver,https://pbs.twimg.com/profile_images/1389624586346631184/oPmFX5sq_normal.jpg,2110,48,47,13548,IOInvestors,
1021485047977832449,2021-02-11 09:00:09,,"Cholangiocarcinoma, PrecisionMedicine, LungCancer, Immunotherapy, ","bit.ly/2Z8w2yY, pic.twitter.com/oi0QOvRGok, ",1359864806719840257,False,5,0,0,3,Khoros Publishing App,"From the February issue: Clinicogenomic analysis of FGFR2-rearranged #Cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib. 
@Incyte #PrecisionMedicine @MIT_CSAIL @WeillCornell #LungCancer #Immunotherapy 
https://t.co/lkDkCrj5fI https://t.co/oi0QOvRGok","Incyte, MIT_CSAIL, WeillCornell, ",,2018-07-23 15:59:48,,Cancer Discovery,https://pbs.twimg.com/profile_images/1351622122272124934/bOgWtTKh_normal.jpg,6661,217,66,4244,CD_AACR,photo
976297820532518914,2021-02-11 08:08:40,,,"dlvr.it/RsTwsW, pic.twitter.com/E3y1DZPpkO, ",1359851848954355714,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conference https://t.co/OU9UMdxow0 https://t.co/E3y1DZPpkO,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1355194932445786112,2021-02-11 08:04:47,"INCY, ",,,1359850872843436032,False,0,0,0,0,Twitter,$INCY Incyte to Present at Upcoming Investor Conference,,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1254035253104181256,2021-02-11 08:00:47,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1359849865623330820,False,0,0,0,0,stocktitan,"$INCY Incyte to Present at Upcoming Investor Conference
https://t.co/gOFqWcam6V",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
185663478,2021-02-11 07:48:30,"MGNX, ",,"globenewswire.com/news-release/2‚Ä¶, ",1359846774760996864,False,0,0,0,0,Twitter for iPhone,$MGNX MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte  https://t.co/7WtypyJAKv,,,2010-09-01 10:52:28,"Chicago, IL",CHItraders,https://pbs.twimg.com/profile_images/623935252357058560/AaeCRlHB_normal.jpg,1253,501,63,45319,CHItraders,
472650465,2021-02-11 07:47:13,"MGNX, ",,"otcdynamics.com/mgnx-macrogeni‚Ä¶, ",1359846450717409282,False,0,0,0,0,OTC Dynamics Twitter Login,$MGNX MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte https://t.co/UTg5lBoB3f,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
963495628545327104,2021-02-11 07:35:38,"MGNX, MGNX, ",,"stck.pro/news/MGNX/1093‚Ä¶, stck.pro/news/MGNX, pic.twitter.com/RlbzBMR5lq, ",1359843535726538754,False,0,0,0,0,STCK.PR0,$MGNX NEW ARTICLE : MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte https://t.co/yJm7FKN06f Get all the latest $MGNX related news here : https://t.co/jwWVxxWPVx https://t.co/RlbzBMR5lq,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
3318510966,2021-02-11 07:35:14,,,"crweworld.com/article/news-p‚Ä¶, ",1359843436333965313,False,0,0,0,0,CRWE World,MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte https://t.co/xx60W4Br6I,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1355194932445786112,2021-02-11 07:34:01,"MGNX, ",,,1359843129768222723,False,0,0,0,0,Twitter,$MGNX MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte,,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
1069693680066420736,2021-02-11 07:32:26,"MGNX, ",,"s.flashalert.me/N369m, ",1359842733280616452,False,0,0,0,0,flashalerts,"$MGNX [15s. delayed]: Issued Press Release on February 11, 07:30:00: MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte https://t.co/CnQYxWxXHx",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
176597920,2021-02-11 07:31:41,"MGNX, INCY, ",,,1359842541198262274,False,0,0,0,0,Twitter Web App,"$MGNX Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte 

$INCY",,,2010-08-09 19:33:23,"Ghent, Belgium",Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,https://pbs.twimg.com/profile_images/957256474018934784/1n7evwD2_normal.jpg,943,137,17,37474,kevinjaybe,
1325115160353103872,2021-02-11 07:31:24,"MGNX, ","majorpharmaceuticals, healthcare, ","quantisnow.com/insight/381160‚Ä¶, ",1359842473359544324,False,0,0,0,0,Twitter,"$MGNX üìë MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte

https://t.co/vXXYy7pUoZ

#majorpharmaceuticals #healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
1330511446992691206,2021-02-11 07:30:03,"MGNX, ",,"marketbit.pro/news/2021/02/1‚Ä¶, ",1359842133121851395,False,0,0,0,0,Tweetmark - Share & bookmark,"$MGNX: MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte
https://t.co/5XXDc0zxjz",,,2020-11-22 09:00:29,,Testson,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,5,0,0,16464,Testson15,
1254035253104181256,2021-02-11 07:30:01,"MGNX, ",,"stocktitan.net/news/MGNX/macr‚Ä¶, ",1359842122623549442,False,0,0,0,0,stocktitan,"$MGNX MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte
https://t.co/R7veEZa8C8",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
374729426,2021-02-11 01:50:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2524770, pic.twitter.com/ecL3u5VM3B, ",1359756794529083392,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/2r7b0J2hTX #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ecL3u5VM3B,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2266388972,2021-02-10 20:19:30,"INCY, ","stocks, ","dailypolitical.com/?p=5174779, ",1359673381109592070,False,0,0,0,0,Zapier.com,"Incyte $INCY Announces Quarterly Earnings Results, Beats Estimates By $0.30 EPS https://t.co/K4wBkHmQjH #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2021-02-10 20:19:29,"INCY, ",,"dailypolitical.com/?p=5174779, ",1359673377913454600,False,0,0,0,0,Zapier.com,"Incyte $INCY Announces Quarterly Earnings Results, Beats Estimates By $0.30 EPS https://t.co/kJVz3q9MNR",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1250830691824283648,2021-02-10 15:40:13,"QCOM, BMY, DD, PGR, ALL, CLX, INCY, UWMC, HAS, TAP, BEPC, GLPG, GRUB, RBA, PHI, RAMP, ",,,1359603098851942412,False,16,0,4,5,Twitter Web App,"The largest stocks that hit new 1 month lows so far today

Qualcomm $QCOM
Bristol-Myers $BMY
Dupont $DD
Progressive $PGR
Allstate $ALL
Clorox $CLX
Incyte $INCY
$UWMC
Hasbro $HAS
Molson Coors $TAP
Brookfield $BEPC
Galapagos $GLPG
Grubhub $GRUB
Ritchie $RBA
PLDT $PHI
LiveRamp $RAMP",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
852931863547084801,2021-02-10 12:44:56,"INCY, ",,"zpr.io/Rtr6E, ",1359558986148818944,False,0,0,0,0,Zapier.com,Incyte $INCY Releases Quarterly Earnings Results https://t.co/fV7vWFAsQi,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
1359077910,2021-02-10 12:30:13,,,"europharmajobs.com/job_display/19‚Ä¶, ",1359555282637107201,False,0,0,0,0,EPJ Jobs Post,"Director, Regulatory Affairs Europe, Incyte, Morges, Switzerland

https://t.co/kIRzVuR16R",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
1022046043796631553,2021-02-10 12:11:21,,"shares, Incyte, biotechnology, ","investopro.com/en/news-home/i‚Ä¶, ",1359550536526290952,False,0,0,0,0,Twitter Web App,"With #shares rising only 19.12% over the last 12 months, #Incyte has not been exactly a winner in recent times. For the fourth quarter, the US #biotechnology company saw its revenue grow 36% to $ 789.5 million
https://t.co/XmGABJRuwM",,,2018-07-25 05:09:00,,InvestoPro.com,https://pbs.twimg.com/profile_images/1336949904107835392/J-qMSa1j_normal.jpg,4198,325,9,2168,InvestoPro_Com,
25406480,2021-02-10 12:08:19,,,"awesomecapital.blogspot.com/2021/02/incyte‚Ä¶, ",1359549773221658629,False,0,0,0,1,Twitter Web App,AwesomeCapital: Incyte cut to Underperform by Leerink https://t.co/qARBFfJlxn,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
772471873539977217,2021-02-10 11:10:22,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1359535188318040065,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form SC 13G/A https://t.co/T5C4kZ1ZZC,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
1250830691824283648,2021-02-10 10:20:40,"MSTR, CDAY, EXPI, AKAM, BLDP, IPG, TEVA, FMC, GM, CSCO, INCY, CME, SPCE, PLTR, ZI, SE, TSLA, ",,,1359522681922744322,False,4,0,2,1,Twitter Web App,"Worst performing large cap stocks in today's early trading

MicroStrategy $MSTR
Ceridian $CDAY
eXp $EXPI
Akamai $AKAM
Ballard $BLDP
Interpublic $IPG
$TEVA
$FMC
General Motors $GM
Cisco $CSCO
Incyte $INCY
$CME
Virgin Galactic $SPCE
Palantir $PLTR
Zoominfo $ZI
Sea Limited $SE
$TSLA",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
732361939490312192,2021-02-10 09:43:00,"INCY, ","markets, ","americanbankingnews.com/?p=18372099, ",1359513200715259906,False,0,0,0,0,Zapier.com,Morgan Stanley Cuts Incyte $INCY Price Target to $93.00 https://t.co/i5CvSVOq5Z #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-02-10 09:42:52,"INCY, ","stocks, ","americanbankingnews.com/?p=18372099, ",1359513167584444418,False,0,0,0,0,Zapier.com,Morgan Stanley Cuts Incyte $INCY Price Target to $93.00 https://t.co/FBPs0fgK6X #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
15296897,2021-02-10 09:05:29,"INCY, ",,"seekingalpha.com/news/3660538-i‚Ä¶, ",1359503758363774983,False,0,0,0,1,SANewsTwitter,$INCY - Incyte is weighed down by SVB downgrade following Q4 earnings release https://t.co/BgsJbznorh,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
849417718642159616,2021-02-10 08:25:22,"INCY, ",,"zpr.io/RtwSe, ",1359493664368648192,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $93.00 at Morgan Stanley https://t.co/i0sR8HUWih,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1302451484345405442,2021-02-10 08:20:41,"INCY, ","Charter1, ",,1359492487631486977,False,1,0,0,0,Twitter Web App,"$INCY

Analyst Actions: Morgan Stanley Adjusts Incyte's Price Target to $93 From $97, Keeps Equal-Weight Rating
08:16 AM EST, 02/10/2021 (MT Newswires)
#Charter1",,,2020-09-05 23:40:17,"Houston, TX",Oil Stocker,https://pbs.twimg.com/profile_images/1302452451900108801/UwfE2PX8_normal.jpg,121,181,1,1385,OilStocker,
732361939490312192,2021-02-10 07:49:05,"INCY, ","markets, ","americanbankingnews.com/?p=18369813, ",1359484533893189641,False,0,0,0,0,Zapier.com,SVB Leerink Lowers Incyte $INCY to Market Perform https://t.co/i2bOLsdymu #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-02-10 07:49:05,"INCY, ","stocks, ","americanbankingnews.com/?p=18369813, ",1359484531720527875,False,0,0,0,0,Zapier.com,SVB Leerink Lowers Incyte $INCY to Market Perform https://t.co/CuR1S2y9Hh #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1254906887490936845,2021-02-10 07:21:24,"INCY, ",,"quantdata.us/news/19583061, ",1359477568534179841,False,0,0,0,0,Quant Data (Production),"SVB Leerink Downgrades Incyte to Underperform, Lowers Price Target to $70

Related Tickers: $INCY
Read more at: https://t.co/GtBVlGlF0X",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
15974185,2021-02-10 05:49:02,,,"dlvr.it/RsPWs8, ",1359454321952182274,False,0,0,0,1,dlvr.it,What's Behind Incyte's Better-Than-Expected Q4 Earnings https://t.co/jCylc8UnWX,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1188416386172903424,2021-02-10 03:00:01,,,"pic.twitter.com/CTqB8xYYV3, ",1359411785879719945,False,0,0,0,0,Twitter Web App,"Incyte Corporation

Incyte Corp actual stock price üî•üìàüôå

Follow us for more updates.
@fedholdinggroup

Your trusted management fund - FED HOLDING GROUP üìäüè¢ https://t.co/CTqB8xYYV3","fedholdinggroup, ",,2019-10-27 07:25:34,,FED Holding Group,https://pbs.twimg.com/profile_images/1281694942109278209/2pULSiQg_normal.jpg,9,0,0,236,fedholdinggroup,photo
374729426,2021-02-09 23:37:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2522208, pic.twitter.com/urCKpr9bpZ, ",1359360944741093378,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/sKFMgAuvbA #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/urCKpr9bpZ,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
773578537764851712,2021-02-09 17:40:03,"INCY, ",,"sitefocus.com/cif/ei/CM_incy‚Ä¶, ",1359270866291314688,False,0,0,0,0,CIF-QBA,"$INCY Earnings Intelligence Analysis of recent earnings identified Incyte Corp.  (NASDAQ: INCY ) business focus on (rux,suboptimal), (follow-up,rux), (population,rux,vitiligo)

https://t.co/BvZryb45Gi",,,2016-09-07 13:47:50,"Cupertino, CA",SiteFocus,https://pbs.twimg.com/profile_images/908465036598820864/6ZQsC4KD_normal.jpg,195,35,8,57439,SiteFocusHQ,
1250830691824283648,2021-02-09 16:49:29,"CVAC, CARR, TTWO, FOX, BEPC, JKHY, OZON, INCY, XM, TTM, ET, CVE, ",,,1359258141410660353,False,10,0,1,1,Twitter Web App,"Worst performing large cap stocks from today

CureVac $CVAC -9.5%
Carrier $CARR -6.2%
Take-Two $TTWO -6.1%
$FOX -5.9%
Brookfield $BEPC -5.7%
Jack Henry $JKHY -5.5%
$OZON -5.5%
Incyte $INCY -4.4%
Qualtrics $XM -4.4%
Tata $TTM -4.2%
Energy Transfer $ET -4%
Cenovus $CVE -3.9%",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
1068561714055012352,2021-02-09 16:11:09,"INCY, ","AnnualReport, ","sec.report/Document/00015‚Ä¶, ",1359248496214167552,False,0,0,0,0,Edgar Filings,New Form 10-K  #AnnualReport  entry filed by  $INCY INCYTE CORP  https://t.co/enkatq4fZ4,,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
4312114277,2021-02-09 16:08:40,"INCY, ",,"fintel.io/sf/us/incy?utm‚Ä¶, ",1359247868440285184,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 10-K https://t.co/Oc4NyYycjO,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
1140762699002871808,2021-02-09 15:52:35,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1359243823512055808,False,1,0,0,0,Deus Ex Trader,"Optimus v4
2021-02-09 15:52 ET. Bought/Opened:
$INCY at $89.34. 
Incyte Corporation - Common Stock
Win Chance: 66%. Avg Win: 5%. Avg Loss: 6.24%. Avg Hold: 7d.
Trade Id: 66580260303047481.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
23059499,2021-02-09 14:35:42,"INCY, ","markets, trading, economy, ","seekingalpha.com/article/440467‚Ä¶, ",1359224472281075713,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation's (INCY) CEO Herv√© Hoppenot on Q4 2020 Results - Earnings Call Transcript. https://t.co/9pIRk3o16x #markets #trading #economy,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
72045316,2021-02-09 14:26:16,,,"espacioteca.com/2021/02/09/inc‚Ä¶, ",1359222100268097536,False,0,0,0,0,WordPress.com,Incyte Corp (INCY) Q4 2020 Earnings Call¬†Transcript https://t.co/iZAgXAzBCO,,,2009-09-06 10:32:07,,ESPACIOteca,https://pbs.twimg.com/profile_images/870744735878705153/GdmSfNs7_normal.jpg,3115,4333,22,46363,islasmalvinas01,
72045316,2021-02-09 14:26:16,,,"espacioteca.com/2021/02/09/wha‚Ä¶, ",1359222100012187650,False,0,0,0,0,WordPress.com,What‚Äôs Behind Incyte‚Äôs Better-Than-Expected Q4¬†Earnings https://t.co/dbTML8wedK,,,2009-09-06 10:32:07,,ESPACIOteca,https://pbs.twimg.com/profile_images/870744735878705153/GdmSfNs7_normal.jpg,3115,4333,22,46363,islasmalvinas01,
1250830691824283648,2021-02-09 14:22:03,"HBI, IT, NLOK, RE, DXC, SPG, ANTM, JKHY, TTWO, FOX, CARR, INCY, NCLH, GLW, ",,,1359221040992387080,False,9,0,1,0,Twitter Web App,"Best and worst performing S&amp;P 500 stocks so far today

Best:
1 Hanes $HBI
2 Gartner $IT
3 NortonLifeLock $NLOK
4 Everest $RE
5 $DXC
6 Simon $SPG
7 Anthem $ANTM

Worst:
1 Jack Henry $JKHY
2 Take-Two $TTWO
3 $FOX
4 Carrier $CARR
5 Incyte $INCY
6 Norwegian $NCLH
7 Corning $GLW",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
963495628545327104,2021-02-09 14:12:37,"INCY, INCY, ",,"stck.pro/news/INCY/1089‚Ä¶, stck.pro/news/INCY, pic.twitter.com/qLZ7ABHNIK, ",1359218665732902918,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : What's Behind Incyte's Better-Than-Expected Q4 Earnings https://t.co/nS4Iv9XDRB Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/qLZ7ABHNIK,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1099039801397964802,2021-02-09 13:45:41,"INCY, ",,,1359211886768701446,False,0,0,1,0,EarningsAlley,Incyte Corporation $INCY held an earnings call on 2/9/2021. Here are the highlights:,,,2019-02-22 15:14:42,,Earnings Alley,https://pbs.twimg.com/profile_images/1113489113435508737/ulSmYR9O_normal.png,1802,1,33,87697,EarningsAlley,
756062949865693186,2021-02-09 12:33:44,,,"youtu.be/gII0eczyZlU, ",1359193780465905675,False,0,0,0,0,IFTTT,"INCY Stock | Incyte Corp. Q4 2020 Earnings Call

https://t.co/XQkPJpbe2e",,,2016-07-21 05:47:09,"Fremont, CA",Earnings Call Transcripts,https://pbs.twimg.com/profile_images/1026811763407253504/eawg2UBo_normal.jpg,807,1650,13,12490,EarningsTrans,
1100450877792370688,2021-02-09 11:10:32,"INCY, ",,"blueequity.io/r/190373/de-in‚Ä¶, ",1359172841120309249,False,0,0,0,0,Blue Equity,"$INCY Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on Key Clinical Programs https://t.co/99ymVWjUco",,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
72928001,2021-02-09 09:04:00,"INCY, ",,"bit.ly/3a0RSus, ",1359140998908047360,False,0,0,0,0,BriefingInPlayLimited,"$INCY: Incyte beats by $0.16, beats on revs https://t.co/GmrOU4jGa1",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
111384669,2021-02-09 08:38:19,,,"twitter.com/PhilaPACT/stat‚Ä¶, ",1359134535208820739,False,8,0,0,1,Twitter Web App,Congratulations to @Incyte for the well-deserved recognition as an emerging healthcare and life sciences leader. @SAP is proud to run with such an industry innovator! https://t.co/gzh1QfDNW9,"Incyte, SAP, ",,2010-02-04 13:53:03,"Haddonfield, NJ",Lloyd Adams,https://pbs.twimg.com/profile_images/923639407441301504/Jx65zw1K_normal.jpg,907,540,18,734,Lloyd_Adams,
108617488,2021-02-09 08:30:11,,,"invst.ly/trh2v, ",1359132489109958657,False,0,0,0,0,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/WZXKHwY9i8,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
2334614718,2021-02-09 08:09:39,"INCY, ",,"ooc.bz/l/68985, ",1359127321710575620,False,0,0,0,0,Open Outcrier,"$INCY (+1.0% pre) Incyte (INCY) Q4 Earnings and Revenues Top Estimates

https://t.co/Ao8jwMZZh4",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
3103803095,2021-02-09 08:05:10,"INCY, ",,,1359126194785054721,False,2,0,0,0,Twitter Web App,"Incyte Q4 EPS $0.93 Beats $0.75 Estimate, Sales $789.51M Beat $662.94M Estimate $INCY",,,2015-03-22 03:21:55,"New York, USA",Options-Ricky,https://pbs.twimg.com/profile_images/1324809860442148871/OHwkq_9b_normal.jpg,1210,150,37,3456,Options_Ricky24,
778267752679235585,2021-02-09 08:05:04,,,"stockmarketdaily.co/2021/02/09/inc‚Ä¶, pic.twitter.com/xkia3tTKob, ",1359126166427357184,False,0,0,0,0,StockMarketDaily,Analysts Estimate Report : What to Look Out for Incyte (NASDAQ:INCY) - https://t.co/u3Y5Y5K63f https://t.co/xkia3tTKob,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
3318510966,2021-02-09 08:00:08,,,"crweworld.com/article/market‚Ä¶, ",1359124925408108549,False,0,0,0,0,CRWE World,Incyte Q4 Results Top Estimates - Quick Facts  https://t.co/AWvhdms9nE,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1134049078424162304,2021-02-09 07:57:34,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1359124279909101568,False,0,0,0,0,Newsfilter.io,"Incyte Q4 topline up 36%, posts 2021 forecast $INCY https://t.co/UiYYlMttKI",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2021-02-09 07:54:49,"INCY, ",,"seekingalpha.com/news/3659912-i‚Ä¶, ",1359123589715296258,False,0,0,0,1,SANewsTwitter,"$INCY - Incyte Q4 topline up 36%, posts 2021 forecast https://t.co/wUWQTXw71n",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
430841130,2021-02-09 07:38:11,,,,1359119402117984256,False,1,0,0,1,Twitter Web App,"Incyte Q4 EPS $0.93 Beats $0.75 Estimate, Sales $789.51M Beat $662.94M Estimate",,,2011-12-07 11:39:43,United States,CtheLightTrading,https://pbs.twimg.com/profile_images/1057431443020767232/y25rFAkx_normal.jpg,100927,1524,2546,13069,canuck2usa,
772471873539977217,2021-02-09 07:37:19,"INCY, ",,"sec.gov/ix?doc=/Archiv‚Ä¶, ",1359119182634303491,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 8-K https://t.co/sQPqHuSYXI,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
1288418053441695744,2021-02-09 07:32:32,,"Markets, ","dlvr.it/RsKwG8, ",1359117981050044419,False,0,0,0,0,dlvr.it,#Markets Incyte Corporation Q4 adjusted earnings Beat Estimates https://t.co/V0QGv008cJ,,,2020-07-29 06:16:25,"Seoul, Korea",Bastion Balance Seoul Korea,https://pbs.twimg.com/profile_images/1288418172987678720/sEHDV1sf_normal.jpg,98,10,0,7219,BalanceSeoul,
1166772455417024512,2021-02-09 07:30:37,,"BZIRecaps, Earnings, ","dlvr.it/RsKw06, pic.twitter.com/8z9GnT2Lo8, ",1359117497367056392,False,0,0,0,0,dlvr.it,#BZIRecaps #Earnings Recap: Incyte Q4 Earnings https://t.co/lMylhQX4Yj https://t.co/8z9GnT2Lo8,,,2019-08-28 14:00:19,,dailytradingapp,https://pbs.twimg.com/profile_images/1166993805675048960/l5yma6Q-_normal.jpg,327,266,4,40310,dailytradingapp,photo
2432028553,2021-02-09 07:27:28,,,"lnkd.in/d-mffGp, ",1359116704887037952,False,0,0,0,0,LinkedIn,"Notable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include FIS (FIS), consensus $1.56... S&amp;P Global (SPGI), consensus $2.51... Centene (CNC), consensus 47c... Incyte (INCY), cons‚Ä¶https://t.co/yHtWS63OOv",,,2014-04-07 09:08:56,"Boynton Beach, FL",Hot Stocks NYC,https://pbs.twimg.com/profile_images/1130845412888260610/96sTWPTi_normal.png,7925,1215,90,39280,HotStocks_NYC,
98736295,2021-02-09 07:27:03,"INCY, INCY, ",,"tinyurl.com/y6fqj9ur, ",1359116601203785730,False,1,0,0,0,Benzinga.com,"$INCY, $INCY Recap: Incyte Q4 Earnings - https://t.co/KXXaBLNYxN",,,2009-12-22 17:40:36,,BenzingaWire,https://pbs.twimg.com/profile_images/1599159142/bztwitter_normal.png,4970,126,260,340311,BenzingaMedia,
1254906887490936845,2021-02-09 07:26:06,"INCY, ",,"quantdata.us/news/19558489, ",1359116362346553347,False,0,0,0,0,Quant Data (Production),"Incyte Q4 EPS $0.93 Beats $0.75 Estimate, Sales $789.51M Beat $662.94M Estimate

Related Tickers: $INCY
Read more at: https://t.co/0zCK2yLGsr",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
3316713321,2021-02-09 07:19:27,,,"ca.investing.com/news/stock-mar‚Ä¶, ",1359114687187681280,False,0,0,0,0,WordPress.com,"Incyte Earnings, Revenue beat in¬†Q4 https://t.co/fNOholUv22",,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
1043975488429993984,2021-02-09 07:18:03,,,"dlvr.it/RsKsf1, pic.twitter.com/CUrflGeBjL, ",1359114336443092993,False,0,0,0,0,dlvr.it,"Incyte Earnings, Revenue Beat in Q4 https://t.co/scq8ruXvPf https://t.co/CUrflGeBjL",,,2018-09-23 17:28:47, Nevada,Trade the journey,https://pbs.twimg.com/profile_images/1214596940962254848/9mkSD-4p_normal.jpg,362,187,4,52870,JourneyTrade,photo
108617488,2021-02-09 07:15:12,,,"invst.ly/trf9h, ",1359113616964931584,False,0,0,0,0,FP News Publisher - COM,"Incyte Earnings, Revenue Beat in Q4 - https://t.co/gKc3mJGy5Z",,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
1068561714055012352,2021-02-09 07:14:51,"INCY, ",,"sec.report/Document/00011‚Ä¶, ",1359113532004913154,False,0,0,0,0,Edgar Filings,"Filing Alert, FORM 8-K [Press/News Current Report] available.  $INCY INCYTE CORP  https://t.co/Dnhmo1acLB",,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
1171873456276889600,2021-02-09 07:12:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1359113021558300673,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (9 Feb, 7:11am)

üì∞ Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on Key Clinical Programs

https://t.co/0l7d1sIU31

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
789582770955702272,2021-02-09 07:12:04,,,"dlvr.it/RsKrYB, pic.twitter.com/Xl0mciVgpP, ",1359112830029426690,False,0,0,0,0,dlvr.it,"Incyte Earnings, Revenue Beat in Q4 https://t.co/tX7vz2z5MI https://t.co/Xl0mciVgpP",,,2016-10-21 17:42:57,"Michigan, USA",Jesse,https://pbs.twimg.com/profile_images/1318988385202196482/bK4S5NLu_normal.jpg,1965,2937,9,77548,jlwoods0241,photo
4312114277,2021-02-09 07:12:02,"INCY, ",,"fintel.io/sfs/us/incy?ut‚Ä¶, ",1359112821984944130,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 8-K - Results of Operations and Financial Condition -  FORM 8-K https://t.co/xljeWddlXw,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
1355194932445786112,2021-02-09 07:06:56,"INCY, ",,,1359111536468504576,False,0,0,0,0,Twitter,"$INCY Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on Key Clinical Programs",,,2021-01-29 11:43:57,,Stock News Bot,https://pbs.twimg.com/profile_images/1448381247219240963/yKVvq_HB_normal.jpg,291,0,8,110914,StockNewsBot2,
2812632288,2021-02-09 07:06:17,,,"invst.ly/trf9h, ",1359111376485175296,False,1,0,0,0,ForexPros News & Analysis,"Incyte Earnings, Revenue Beat in Q4 - https://t.co/0Z3cvhx1eP",,,2014-09-16 03:56:03,Worldwide,Investing.com Stocks,https://pbs.twimg.com/profile_images/1108338732019695616/CAvg-ixc_normal.png,20430,38,256,339289,InvestingStockz,
756169655178235908,2021-02-09 07:05:52,"INCY, ",,"news.alphastreet.com/earnings/incy-‚Ä¶, ",1359111269467320324,False,0,0,0,0,Twitter Web App,$INCY Incyte Corp Q4 2020 Earnings Call https://t.co/wSsONXrziH,,,2016-07-21 12:51:09,,Earnings Concalls,https://pbs.twimg.com/profile_images/1325761625173880832/-Bdm9yBq_normal.jpg,730,1978,5,9202,earningsinfo,
1069693680066420736,2021-02-09 07:05:36,"INCY, ",,"s.flashalert.me/XNPjJE, ",1359111204426366978,False,0,0,0,0,flashalerts,"$INCY [15s. delayed, acc.~90%, always check] Earnings Release February 09, 07:00:00: Q4: Non-GAAP EPS of $0.93, GAAP EPS of $0.68, Revenue $789.50M. 2020: EPS of -$0.42, GAAP EPS of -$1.36, Revenue $2,666.70M. https://t.co/FzPI8QEmAd",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1069693680066420736,2021-02-09 07:05:33,"INCY, ",,"s.flashalert.me/gic36b, ",1359111191088496640,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on February 09, 07:00:00: Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on Key Clinical Programs https://t.co/zSVfWbaYE6",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2021-02-09 07:05:06,,,"dlvr.it/RsKps3, pic.twitter.com/yXzNsGOCyg, ",1359111077426991104,False,0,0,0,0,dlvr.it,"Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on Key Clinical Programs https://t.co/u7wcr16zUQ https://t.co/yXzNsGOCyg",,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2021-02-09 07:03:32,,,"crweworld.com/article/news-p‚Ä¶, ",1359110684844326912,False,0,0,0,0,CRWE World,"Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on K https://t.co/BXdp6SesDL",,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2021-02-09 07:02:56,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1359110531903332354,False,0,0,0,0,stocktitan,"$INCY Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on Key Clinical Programs
https://t.co/aKu6HL4qUw",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
15296897,2021-02-09 07:02:02,"INCY, ",,"seekingalpha.com/news/3659867-i‚Ä¶, ",1359110305511399426,False,0,0,0,1,SANewsTwitter,"$INCY - Incyte EPS beats by $0.16, beats on revenue https://t.co/YLtC6hQGUQ",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1325115160353103872,2021-02-09 07:00:58,"INCY, ","healthcare, ","quantisnow.com/insight/366626‚Ä¶, ",1359110036295876608,False,0,0,0,0,Twitter,"$INCY üì∞ Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on Key Clinical Programs

https://t.co/VMFs5OxdjA

#healthcare",,,2020-11-07 11:37:37,,Quantisnow,https://pbs.twimg.com/profile_images/1325115268729724928/LCMWheWW_normal.jpg,399,16,29,266576,quantisnow,
266143766,2021-02-09 06:15:22,"INCY, ",,"accesswire.com/628315/Incyte-‚Ä¶, ",1359098563138093057,False,0,0,0,0,Accesswire,$INCY Incyte Corp. to Host Earnings Call https://t.co/aXN1HzL3Op,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
1022006086872821762,2021-02-08 19:02:34,"INCY, INCY, ",,,1358929246052302850,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was UP ‚¨Ü on Mon Feb 08
Closed at 93.62 USD for a 3.75% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
1250830691824283648,2021-02-08 17:42:02,"CSCO, FIS, SPGI, FISV, TWTR, CNC, CARR, TDG, WLTR, ENPH, INCY, AKAM, FOX, LYFT, CGC, COTY, CRSR, COTY, NRZ, ",,,1358908980496654340,False,16,0,0,1,Twitter Web App,"Some of the largest stocks that report earnings tomorrow

Cisco $CSCO
Fidelity $FIS
S&amp;P Global $SPGI
Fiserv $FISV
Twitter $TWTR
Centene $CNC
Carrier $CARR
Transdigm $TDG
Welltower $WLTR
Enphase $ENPH
Incyte $INCY
Akamai $AKAM
$FOX
$LYFT
Canopy $CGC
$COTY
Corsair $CRSR
$COTY
$NRZ",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
3331555937,2021-02-08 16:59:51,"INCY, ",,"stocknews.com/news/incy-is-i‚Ä¶, ",1358898364969062404,False,0,0,0,0,StockNews.com News Feed,"$INCY Though Incyte (INCY) is not directly involved in developing a vaccine for COVID-19, two drugs from its exist‚Ä¶ https://t.co/U54am2Oru6",,,2015-06-17 13:45:17,NJ / CA,StockNews.com,https://pbs.twimg.com/profile_images/1255517201899098112/fZBf5Tj3_normal.jpg,3949,32,121,216672,stocknewsdotcom,
963495628545327104,2021-02-08 13:50:34,"INCY, INCY, ",,"stck.pro/news/INCY/1086‚Ä¶, stck.pro/news/INCY, ",1358850727175716866,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Q4 2020 Earnings Preview https://t.co/OszNVbMQHX Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
15296897,2021-02-08 12:03:06,"INCY, ",,"seekingalpha.com/news/3659533-i‚Ä¶, ",1358823683163258883,False,0,0,0,1,SANewsTwitter,$INCY - Incyte Q4 2020 Earnings Preview https://t.co/e1SowVYFHa,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
374729426,2021-02-08 04:13:19,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2517928, pic.twitter.com/1YcaiDpe1L, ",1358705458660352001,False,0,0,0,1,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/6UcrXUlnXD #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1YcaiDpe1L,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1315434407692509184,2021-02-08 00:52:30,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/QTfhXbyi3M, ",1358654921818710019,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 12.50% ranked 1302 out of 5433 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/QTfhXbyi3M",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
3402982469,2021-02-07 09:39:45,,"MedicalEducation, CME, dermatology, ","go.livderm.org/3tz1jJj, pic.twitter.com/HfeL5g9qLn, ",1358425221699674114,False,6,0,0,1,HubSpot,"Have you checked out E-Poster Gallery Showcase sponsored by @Incyte at the 19th Annual South Beach Symposium (SBS) The Medical Dermatology Summit?
Learn more about upcoming educational opportunities with LiVDerm: https://t.co/k3RAjFqHfN
#MedicalEducation #CME #dermatology https://t.co/HfeL5g9qLn","Incyte, ",,2015-08-04 13:13:28,,LiVDerm,https://pbs.twimg.com/profile_images/1289163935422308352/JIiNt7uf_normal.jpg,637,958,5,1752,LiVDerm,photo
405141209,2021-02-06 22:05:56,,,"biocentury.com/article/633989, ",1358250616724676609,False,4,0,0,2,Twitter for iPhone,Chk out @StephenPHansen s article @BioCentury on how ‚ÄúIncyte continues layering on new opportunities‚Äù. https://t.co/1uSHIj4BDe,"StephenPHansen, BioCentury, ",,2011-11-04 18:31:15,"California, USA",matt krebs,https://pbs.twimg.com/profile_images/835961286403862528/M7u_rYUG_normal.jpg,5199,5677,85,3655,krebs_matt,
374729426,2021-02-06 02:02:32,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2512985, pic.twitter.com/qFKBzJduSR, ",1357947768740868097,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on January 7, 2021. View odds for this and other indicators: https://t.co/GgHVuRwFSE #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/qFKBzJduSR",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
227778014,2021-02-05 21:00:08,,"Jakafi, ","buff.ly/3oVepx1, ",1357871666706206729,False,1,0,0,2,Buffer,"Changing the narrative: while #Jakafi remains the headliner for @Incyte, 2 recent cancer launches and four more new indications coming soon will quickly expand Incyte's commercial portfolio; @StephenPHansen chats with @IloveIncyte https://t.co/TJe0svAruy","Incyte, StephenPHansen, IloveIncyte, ",,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
1280938376099741697,2021-02-05 08:04:29,,"iexStock, ","iexcloud.io, pic.twitter.com/vtJuhcuR1i, ",1357676471297470464,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Cognizant Technology Solutions Corp. - C
-Ras Al Khaimah Poultry Co &amp; Feeding Co
-Incyte Corp.
-Gulf Medical Projects Co.
-Baidu Inc - ADR

Data provided by https://t.co/oXreiEXTgd https://t.co/vtJuhcuR1i",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2021-02-04 21:42:59,,"iexStock, ","iexcloud.io, pic.twitter.com/PpzhWnSpP4, ",1357520065508372481,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Emirates Driving Company
-Facebook Inc - Class A
-Incyte Corp.
-Ras Al Khaimah Poultry Co &amp; Feeding Co
-Paychex Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/PpzhWnSpP4",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1315434407692509184,2021-02-04 20:23:30,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/1Htc6o1UIM, ",1357500060158820353,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 12.50% ranked 1250 out of 5433 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/1Htc6o1UIM",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
538402387,2021-02-04 14:01:55,,,"catalyzingchange.vfairs.com, pic.twitter.com/P0CjjBkFKD, ",1357404033028390912,False,0,0,0,0,Hootsuite Inc.,"Learn about &amp; network w companies and individuals that are developing &amp; manufacturing products of the future. Meet the speakers From Research to Business discussion.
https://t.co/kEWa7UWRcT
@DuPont_News  @FMCCorp @WSFS DPP @Incyte  @airliquide_de @FAME_Delaware https://t.co/P0CjjBkFKD","DuPont_News, FMCCorp, WSFS, Incyte, airliquide_de, FAME_Delaware, ",,2012-03-27 14:58:09,"Newark, Delaware, USA",DESCA,https://pbs.twimg.com/profile_images/1387774824504823812/S66uJ_x0_normal.jpg,278,179,27,1864,DescaDelaware,photo
2344420430,2021-02-04 11:51:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1357371156475613185,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/N5SBE7RATM",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
374729426,2021-02-04 08:18:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2508899, pic.twitter.com/ysRYMhBMTK, ",1357317728512528389,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/61TvGzr591 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ysRYMhBMTK,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1116983957017567232,2021-02-04 01:10:34,"NVDA, INCY, SQ, ","GrowthStocks, stocks, ","fool.com/investing/2021‚Ä¶, ",1357209917766123521,True,1,0,1,0,Twitter Web App,"1.@nvidia ,2.@Square &amp; 3.@Incyte 

3 Top #GrowthStocks to Buy Right Now @themotleyfool #stocks $NVDA $INCY $SQ https://t.co/ivGacXopny","nvidia, Square, Incyte, themotleyfool, ",,2019-04-13 04:38:22,"Phoenix, AZ",Black Wealth Voltüßéüèøü¶Äüêï‚Äçü¶∫üêäüêü‚úäüèø‚úäüèø,https://pbs.twimg.com/profile_images/1437111868561104900/QWSYfxD2_normal.jpg,447,3663,2,12660,sobek_anubis,
1252006784,2021-02-03 21:29:38,,"cancer, cd19, hematology, incyte, lymphoma, morphosys, tafasitamab, ","spreaker.com/user/7078249/t‚Ä¶, ",1357154318751838210,False,0,0,0,0,Spreaker,"üì£ New Podcast! ""Developing Transformative Therapies for Patients with Diffuse Large B-cell Lymphoma"" on @Spreaker #cancer #cd19 #hematology #incyte #lymphoma #morphosys #tafasitamab https://t.co/ysK1k9IMDZ","spreaker, ",,2013-03-08 10:18:40,"Phoenix, AZ (USA)",ADC Review,https://pbs.twimg.com/profile_images/535671578449543168/mKUF_pbA_normal.png,934,1552,48,3294,ADCReview,
1280938376099741697,2021-02-03 20:18:13,,"iexStock, ","iexcloud.io, pic.twitter.com/FRAsmMXGxK, ",1357136345173536770,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Comcast Corp - Class A
-Walgreens Boots Alliance Inc
-Oman &amp; Emirates Investment Holding Co. S
-Incyte Corp.
-Idexx Laboratories, Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/FRAsmMXGxK",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1262915121103491074,2021-02-03 16:28:18,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1357078485844459521,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 1,356 shares on 2021-02-01. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
777067733531914240,2021-02-03 12:32:47,,,"cfc.umt.edu/research/incyt‚Ä¶, cfc.umt.edu/research/incyt‚Ä¶, pic.twitter.com/BIRvEWYLL3, ",1357019213865644037,False,8,0,1,2,Twitter Web App,"Fantastic @IncyteRcn discussion group about biological N fixation (BNF), following last week's presentations: https://t.co/TGrN7sfBjM! üôÇ

Can we really predict that there'll be a 4-time increase in BNF in the future (https://t.co/CSgTwHP1I1)? Check out the seminar recording ‚¨ÜÔ∏è https://t.co/BIRvEWYLL3","IncyteRcn, ",,2016-09-17 04:52:39,"Southampton, UK",Juniper Kiss üá™üá∫üåøüë©‚Äçüî¨ (she/her),https://pbs.twimg.com/profile_images/1304430150319255552/46WNEf4-_normal.jpg,4748,4181,31,9697,GOESbyJuniper,photo
374729426,2021-02-03 05:53:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2506287, pic.twitter.com/Y4Aoe7ypyR, ",1356918819122409472,False,1,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator remains in oversold zone for 1 day. View odds for this and other indicators: https://t.co/dfSUQLBnVs #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Y4Aoe7ypyR,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
15974185,2021-02-02 10:39:32,,,"dlvr.it/RrsH61, ",1356628326471766016,False,0,0,0,0,dlvr.it,Incyte makes bid to join the checkpoint inhibitor club https://t.co/RJ64SMkX67,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
27254739,2021-02-02 06:24:38,,"immunooncology, biotech, ","bit.ly/39JWV2p, ",1356564176907497475,False,0,0,0,0,Sprout Social,"FDA sets 25 July action date for @Incyte #immunooncology candidate retifanlimab, which could become the first drug approved for squamous cell carcinoma of the anal canal (SCAC) after chemotherapy #biotech https://t.co/lRg3UOYMOR","Incyte, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
1280938376099741697,2021-02-01 22:50:11,,"iexStock, ","iexcloud.io, pic.twitter.com/gnttpWv4vW, ",1356449810140848128,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-AL-Fujairah Cement Industries Co.
-Incyte Corp.
-Xcel Energy, Inc.
-Emirates Driving Company
-Ras Al Khaima Properties Co.

Data provided by https://t.co/oXreiEXTgd https://t.co/gnttpWv4vW",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
479993172,2021-02-01 15:02:15,,"GSK, ","twitter.com/arc_advisory/s‚Ä¶, ",1356332051570552832,False,1,0,0,0,Twitter for iPhone,Join us for a presentation with #GSK on vaccines. @Incyte @AlexionPharma @biogen @Regeneron @VertexPharma @abbvie @abbott @biomarin @LonzaPB @Merck https://t.co/w3qXxB6izJ,"Incyte, AlexionPharma, biogen, Regeneron, VertexPharma, abbvie, Abbott, BioMarin, Merck, ",,2012-01-31 19:44:33,"Boston, MA",Janice Abel,https://pbs.twimg.com/profile_images/811957021868060672/WR2siecw_normal.jpg,326,644,10,2321,jabel411,
563084750,2021-02-01 14:57:06,"SPX, LRCX, CHRW, MATX, INCY, AMAT, ",,"traderscommunity.com/index.php/mark‚Ä¶, pic.twitter.com/B9Mm8uTVhx, ",1356330755027296260,False,1,0,1,2,Twitter Web App,"Worse Performing $SPX stocks last week
Lam Research $LRCX
CH Robinson $CHRW
Matson $MATX
Incyte $INCY
Applied Materials $AMAT
Put a fork in 'em or opportunity?
https://t.co/R8uI53cl0H https://t.co/B9Mm8uTVhx",,,2012-04-25 14:17:17,,Traders Community,https://pbs.twimg.com/profile_images/1359537033971183617/bnLftW2a_normal.jpg,18045,5625,918,94381,TradersCom,photo
1218480193725091840,2021-02-01 11:35:00,,"mellaltameet, ","mellalta.com, businesswire.com/news/home/2021‚Ä¶, ",1356279895991545856,False,0,0,0,0,Twitter Web App,"https://t.co/O1jfYdv5O6 Incyte announces a favorable opinion from the CHMP on pemigatinib for the treatment of adults with locally advanced or metastatic unresectable cholangiocarcinoma¬† &gt;&gt;RFP@‚ÄØbd@mellalta.com&gt;¬†#mellaltameet

https://t.co/C8cAgJZTOj",,,2020-01-18 05:28:28,,Mellalta Meets,https://pbs.twimg.com/profile_images/1239854909308039168/ZiS9Gw38_normal.jpg,63,346,0,1580,mellaltameets,
1022006086872821762,2021-02-01 11:01:33,"INCY, INCY, ",,,1356271478631784450,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY is DOWN ‚¨á on Mon Feb 01
Currently at 89.58 USD for a -0.19% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
1022473214457348096,2021-02-01 07:32:08,,,"pharmashots.com/55665/incyte-r‚Ä¶, ",1356218778833408002,False,0,0,0,0,Twitter Web App,"Incyte Receive Positive CHMP‚Äôs Opinion for Pemigatinib @Pharmashot @Incyte 
https://t.co/XfGCaulGVQ","Pharmashot, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
374729426,2021-02-01 00:46:35,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2501552, pic.twitter.com/SJPb0yPvqx, ",1356116717722714113,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/wFQ5OHuQUN #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/SJPb0yPvqx,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1260332023,2021-01-31 12:59:29,,"Animation, incyte, eyecandy, dermatology, models, video, education, medical, medicalanimation, 3D, graphics, medicalanimators, professionaleducation, medicaleducation, scientificanimation, biology, molecularbio, cellbio, ","buff.ly/2RShdLs, pic.twitter.com/PQu6sVmEKo, ",1355938768348442625,False,8,0,0,2,Buffer,"*Incyte* #Animation by @3FXinc 
-
View more: https://t.co/BzjPXLDGUR
-
#incyte #eyecandy #dermatology #models #video #education #medical #medicalanimation #3D #graphics #medicalanimators #professionaleducation #medicaleducation #scientificanimation #biology #molecularbio #cellbio https://t.co/PQu6sVmEKo","3FXinc, ",,2013-03-11 16:16:15,,Medical Illustration & Animation,https://pbs.twimg.com/profile_images/895351541325897728/3dTQSqLk_normal.jpg,5149,1239,0,3114,Medillustrates,video
1355378009990189063,2021-01-31 05:35:47,,,"seekingalpha.com/article/414091‚Ä¶, ",1355827108384276482,False,0,0,0,0,Twitter Web App,"GERN may challenge Celgene with their superior drug. 

https://t.co/qSssbQwAGb",,,2021-01-29 23:51:29,,Seeker of Truth,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,0,11,0,24,Seekero13590688,
301890257,2021-01-31 04:01:28,,,"sco.lt/5hOaSe, ",1355803373681963022,False,0,0,0,0,Scoop.it,"Novartis subcutaneous mAb for MS, Incyte and Karyopharm oral cancer therapies backed by CHMP https://t.co/3TC8RIllgu",,,2011-05-20 03:29:21,Geneva and New York,Krishan Maggon,https://pbs.twimg.com/profile_images/1247796373950304256/eskxrohr_normal.jpg,1076,501,40,50478,kkmaggon,
1134049078424162304,2021-01-30 08:42:27,"INCY, ",,"newsfilter.io/articles/sc-13‚Ä¶, ",1355511695469404161,False,0,0,0,0,Newsfilter.io,Form SC 13G/A (statement of acquisition of beneficial ownership by individuals) filed with the SEC $INCY https://t.co/o169Yd24HG,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1889492676,2021-01-30 08:19:16,"INCY, ","Incyte, Pemigatinib, Unresectable, LocallyAdvanced, Metastatic, Cholangiocarcinoma, FibroblastGrowthFactorReceptor2, FGFR2, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1355505863935447042,False,0,0,0,0,Troi URL Plug-in,"#Incyte Announces Positive CHMP Opinion for #Pemigatinib for the Treatment of Adults With Previously Treated, #Unresectable #LocallyAdvanced or #Metastatic #Cholangiocarcinoma With a #FibroblastGrowthFactorReceptor2 (#FGFR2) Fusion or Rearrangement $INCY https://t.co/qnXXCAcCN7",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
985090779965255681,2021-01-30 06:11:09,"INCY, ",,"pic.twitter.com/lUkkDcpXlA, ",1355473620512993284,False,0,0,0,1,Twitter Web App,"Take Profit on Incyte: +15% and +0,21% per day 
It's much harder to hit the Top than the Bottom. But if it works the feeling is great. $INCY https://t.co/lUkkDcpXlA",,,2018-04-14 05:41:58,,Stock-ETF-CFD and Crypto-Trader,https://pbs.twimg.com/profile_images/1180123345708355586/8-73rSGH_normal.jpg,2972,4914,0,24012,AktienTrader1,photo
886841806666612736,2021-01-30 04:40:49,"ONCS, MRK, INCY, IBB, XBI, T, BMY, AFMD, ADAP, ","NewData, HeadAndNeckCancer, SCCHN, TrifectaStudy, TAVO, Keytruda, Epacadostat, ","clinicaltrials.gov/ct2/show/NCT03‚Ä¶, pic.twitter.com/7xIzx5Ycgq, pic.twitter.com/7xIzx5Ycgq, pic.twitter.com/7xIzx5Ycgq, pic.twitter.com/7xIzx5Ycgq, twitter.com/OncoSec/status‚Ä¶, ",1355450886978301952,False,2,1,0,1,Twitter for iPhone,"IMO, @OncoSec $ONCS, @Merck $MRK, &amp; @Incyte $INCY, will be reporting #NewData VERY soon for the #HeadAndNeckCancer #SCCHN trial, &amp; I believe the data is going to be great!üöÄüìà

#TrifectaStudy üêé

#TAVO #Keytruda #Epacadostat

$IBB $XBI $T $BMY $AFMD $ADAP

https://t.co/ZlIibTcgTN https://t.co/7xIzx5Ycgq https://t.co/9pd583kuFE","OncoSec, Merck, Incyte, ",,2017-07-17 02:55:38,"San Francisco, CA",ADAPLONG,https://pbs.twimg.com/profile_images/886859398051528704/8yoFXHAC_normal.jpg,86,3,0,1979,LONGADAP,photo
374729426,2021-01-30 01:58:18,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2496946, pic.twitter.com/LLGTXkE8Fu, ",1355409991260246016,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/DjC22wAm8I #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/LLGTXkE8Fu,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1100450877792370688,2021-01-29 23:59:57,"INCY, ",,"blueequity.io/r/187945/de-in‚Ä¶, ",1355380206798684166,False,0,0,0,0,Blue Equity,"$INCY Incyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma With a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangement https://t.co/v04o8JB9gr",,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
227778014,2021-01-29 23:30:04,"NVS, INCY, KPTI, ","MS, COVID19, ","buff.ly/3j0ia2F, ",1355372683932925958,False,0,0,0,0,Buffer,"January recs by EMA's CHMP includes positive opinions for #MS, cancer drugs from Novartis, Incyte, Karyopharm with convenient RoAs on top of support for AZ's #COVID19 vaccine $NVS $INCY $KPTI https://t.co/VUvuhhAaRD",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
1280938376099741697,2021-01-29 18:42:28,,"iexStock, ","iexcloud.io, pic.twitter.com/hQgHGtySLt, ",1355300308843429893,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-National Bank of Umm Al-Qaiwain
-Invest Bank
-Incyte Corp.
-Cisco Systems, Inc.
-Comcast Corp - Class A

Data provided by https://t.co/oXreiEXTgd https://t.co/hQgHGtySLt",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
4058194633,2021-01-29 16:05:42,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1355260857307942912,False,0,0,0,0,Twitter for iPhone,"$INCY Incyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma With a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or... | Business Wire https://t.co/zVOhSN5eYg",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
72928001,2021-01-29 15:43:49,"INCY, ",,"bit.ly/3r4Fgbq, ",1355255351768039424,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte confirms positive CHMP opinion recommending conditional marketing authorization of pemigatinib https://t.co/9l4huWgXCu,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
963495628545327104,2021-01-29 15:15:18,"INCY, INCY, ",,"stck.pro/news/INCY/1065‚Ä¶, stck.pro/news/INCY, ",1355248171539181568,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's pemigatinib gets positive recommendation from CHMP https://t.co/MVeK4keyrZ Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
1138312924269862916,2021-01-29 15:13:24,,,,1355247694021844992,False,8,0,0,2,Twitter Web App,"DID YOU KNOW? That Incyte, whose US Headquarters are right here in Wilmington DE developed the first FDA approved drug for Cholangiocarcinoma in April 2020 which was sadly overshadowed by Covid...THIS IS HUGE!",,,2019-06-11 01:12:04,,Cholangio Warrior,https://pbs.twimg.com/profile_images/1446242650462556162/3Ol_Cu_a_normal.jpg,185,436,0,1065,Cholangiocarci2,
1134049078424162304,2021-01-29 15:10:24,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1355246941010087939,False,0,0,0,0,Newsfilter.io,Incyte's pemigatinib gets positive recommendation from CHMP $INCY https://t.co/wTClIUcMeZ,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
270492072,2021-01-29 15:10:17,,"news, SeekingAlpha, ","seekingalpha.com/news/3656331-i‚Ä¶, ",1355246910009819136,False,0,0,0,0,Microsoft Power Platform,Incyte's pemigatinib gets positive recommendation from CHMP https://t.co/KTIHN4JSLN via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
3524211082,2021-01-29 15:08:19,,,"twib.in/l/ALo7qGk9Rgg5, ",1355246416998903815,False,0,0,0,0,Twibble.io,Incyte's pemigatinib gets positive recommendation from CHMP https://t.co/kBRZtk3F1W,,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
15296897,2021-01-29 15:06:23,"INCY, ",,"seekingalpha.com/news/3656331-i‚Ä¶, ",1355245929670995969,False,0,0,0,0,SANewsTwitter,$INCY - Incyte's pemigatinib gets positive recommendation from CHMP https://t.co/Hk10JENBYl,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3686628867,2021-01-29 14:32:51,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1355237492535009281,False,0,0,0,0,WordPress.com,"Incyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma With a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or¬†Rearrangement https://t.co/sNGw1cLHfR",,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
3686628867,2021-01-29 14:32:51,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1355237492472107008,False,0,0,0,0,WordPress.com,"Incyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma With a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or¬†Rearrangement https://t.co/IAwA9xunK5",,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
3686628867,2021-01-29 14:32:51,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1355237492010713090,False,0,0,0,0,WordPress.com,"Incyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma With a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or¬†Rearrangement https://t.co/AqwdQlc8HE",,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1006334607946649600,2021-01-29 14:04:03,,"StockMarket, Stocks, ","dlvr.it/RrcqQ5, ",1355230240868429827,False,0,0,0,0,dlvr.it,"Incyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma With a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or‚Ä¶ https://t.co/WV4eNuRLPQ #StockMarket #Stocks",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
3318510966,2021-01-29 14:02:13,,,"crweworld.com/article/news-p‚Ä¶, ",1355229781848014854,False,0,0,0,0,CRWE World,"Incyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresect https://t.co/Co3uhLdT5C",,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1089978712685273090,2021-01-29 13:52:03,"INTC, ","Incyte, StockMarket, ","dlvr.it/RrcnX2, ",1355227221120610305,False,0,0,0,1,dlvr.it,"#Incyte $INTC Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma With a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or‚Ä¶ https://t.co/wGRATxjgzi #StockMarket",,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
1276824218928214017,2021-01-29 13:45:26,,,"impharmanews.com/2021/01/29/inc‚Ä¶, ",1355225558741749762,False,0,0,0,0,IMPharma News,"Incyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma With a Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion or Rearrangement 
https://t.co/O4PaP1SiTp",,,2020-06-27 06:26:45,India,IMPharma News,https://pbs.twimg.com/profile_images/1277193245479456768/5QLoLmr4_normal.jpg,173,1544,2,5944,IMPharmaNews,
472650465,2021-01-29 13:40:12,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1355224242497925123,False,0,0,0,0,OTC Dynamics Twitter Login,"$INCY Incyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma With a Fibroblast Growth Fact https://t.co/RRPP9m47VD",,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1134049078424162304,2021-01-29 13:37:24,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1355223536307232775,False,0,0,0,0,Newsfilter.io,"Incyte Announces Positive CHMP Opinion for Pemigatinib for the Treatment of Adults With Previously Treated, Unresectable Locally Advanced.. $INCY https://t.co/V1cM2Oi3Kf",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
374729426,2021-01-29 00:10:01,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2494428, pic.twitter.com/efM7sgbvo3, ",1355020350883434497,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on January 27, 2021. View odds for this and other indicators: https://t.co/x2w1dlLyUn #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/efM7sgbvo3",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
974702003828948993,2021-01-28 22:05:02,,,"dlvr.it/RrZ4TB, ",1354988896774361088,False,0,0,0,0,dlvr.it,"Dermatology Business Director - New England - Incyte Corporation - , NA https://t.co/u1J2bTXBe6",,,2018-03-16 13:40:41,"Savannah, GA",NP Nation,https://pbs.twimg.com/profile_images/974703217056583681/iEUvh-fT_normal.jpg,191,74,0,5127,NPNationnow,
768933983539331073,2021-01-28 11:23:29,,,"twitter.com/FabrizioRomano‚Ä¶, ",1354827445807968256,False,2,0,1,0,Twitter for Android,Alexis being passed about like he's a Nike Incyte 13/14 premier league match ball at the Emirates https://t.co/HpR8aMfvx9,,,2016-08-25 18:12:02,,Alƒìx,https://pbs.twimg.com/profile_images/1451175758768992259/yW93Qd2A_normal.jpg,1459,898,4,35561,AIexAFC,
1140762699002871808,2021-01-28 09:47:30,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1354803293466189829,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2021-01-28 09:38 ET. *Closed/Sold:
$INCY at $93.96 for 0.87 profit (0.94%). Incyte Corporation - Common Stock
Trade Id: 65457301503029620.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
761550144869437440,2021-01-28 09:02:50,,,"ter.li/cd289z, pic.twitter.com/LnQepswn8O, ",1354792053209759745,False,0,0,0,0,Hootsuite Inc.,"Incyte has announced that the FDA has accepted for Priority Review its BLA for retifanlimab based on data from the Phase 2 POD1UM-202 trial evaluating ...

Subscribe to our Weekly Checkpoint newsletter and discover how Beacon Checkpoint can help you. https://t.co/mm8UcuNb70 https://t.co/LnQepswn8O",,,2016-08-05 09:11:18,"London, England",Beacon Targeted Therapies,https://pbs.twimg.com/profile_images/910893558541975552/Ze_8N4v9_normal.jpg,449,1418,6,1677,BeaconIntel,photo
732361939490312192,2021-01-28 07:11:18,"INCY, ","markets, ","americanbankingnews.com/?p=18156155, ",1354763982117203969,False,0,0,0,0,Zapier.com,FY2020 EPS Estimates for Incyte Co. $INCY Raised by Oppenheimer https://t.co/2AN7R01EKA #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-01-28 07:11:17,"INCY, ","stocks, ","americanbankingnews.com/?p=18156155, ",1354763980015808515,False,0,0,0,0,Zapier.com,FY2020 EPS Estimates for Incyte Co. $INCY Raised by Oppenheimer https://t.co/cJlaAxjEFY #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2344420430,2021-01-27 21:18:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1354614773019795456,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Tech. Operations

MICHAEL JAMES MORRISSEY:

https://t.co/jc3kfACfR3",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1280938376099741697,2021-01-27 21:12:38,,"iexStock, ","iexcloud.io, pic.twitter.com/9s8q4SSZKm, ",1354613324487536644,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-PayPal Holdings Inc
-Incyte Corp.
-National Takaful Company
-Ras Al Khaimah Poultry Co &amp; Feeding Co
-Dollar Tree Inc

Data provided by https://t.co/oXreiEXTgd https://t.co/9s8q4SSZKm",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2344420430,2021-01-27 20:40:21,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1354605199965515782,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Discovery Chem

YAO WENQING:

https://t.co/vrWid3rVA6",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-27 18:02:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1354565444271804420,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Medical Officer

STEVEN H STEIN:

https://t.co/wr3eU0NNqb",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1278474376074145795,2021-01-27 17:40:20,"INCY, ","stocks, ","insiderdrop.com, ",1354559896562376707,False,0,0,0,0,Twitter,"An executive and/or major shareholder of $INCY (INCYTE CORP) reportedly sold ~$ 2,154,500 worth of shares

‚û°Ô∏è https://t.co/EUocy7ZmFg ‚¨ÖÔ∏è

 #stocks",,,2020-07-01 19:43:59,,insiderdrop,https://pbs.twimg.com/profile_images/1280996191443001345/mul90PPh_normal.jpg,92,0,0,7424,insiderdrop,
1188117778567454720,2021-01-27 17:40:11,"INCY, ",,"jodie.ai/shareholder/16‚Ä¶, ",1354559857815334914,False,0,0,0,0,jodietheai,"Yao Wenqing, EVP, Head of Discovery Chem of INCYTE CORP - $INCY sold 21545 shares to now own a total of 143784, anomalous of their normal trading pattern.

https://t.co/ZQYHzWvHN8",,,2019-10-26 11:38:58,London,Jodie Insights,https://pbs.twimg.com/profile_images/1310896987466760198/cVg3gmLj_normal.jpg,624,1781,16,28832,jodietheai,
772471873539977217,2021-01-27 17:35:19,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1354558633393197059,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/mYjhXD0vcQ,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
1262915121103491074,2021-01-27 17:32:49,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1354558003928657921,False,0,0,0,0,formwhispers,"#FWSells $INCY Wenqing Yao, EVP, Head of Discovery Chem of INCYTE CORP sold 21,545 shares on 2021-01-25. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
2344420430,2021-01-27 17:28:21,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1354556879570145281,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Manager US

BARRY P FLANNELLY:

https://t.co/mYWOblCE0E",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-27 17:24:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1354555879241216004,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP GPS, BD, &amp; Licensing

VIJAY K IYENGAR:

https://t.co/nhrbPeeeib",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1188117778567454720,2021-01-27 17:10:16,"INCY, ",,"jodie.ai/shareholder/16‚Ä¶, ",1354552328142151680,False,0,0,0,0,jodietheai,"Vijay K Iyengar, EVP GPS, BD, &amp; Licensing of INCYTE CORP - $INCY sold 5116 shares to now own a total of 26158, anomalous of their normal trading pattern.

https://t.co/JSu0wtEzZk",,,2019-10-26 11:38:58,London,Jodie Insights,https://pbs.twimg.com/profile_images/1310896987466760198/cVg3gmLj_normal.jpg,624,1781,16,28832,jodietheai,
1262915121103491074,2021-01-27 17:09:47,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1354552207157288965,False,0,0,0,0,formwhispers,"#FWSells $INCY Stein Steven H, EVP &amp; Chief Medical Officer of INCYTE CORP sold 3,795 shares on 2021-01-25. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1262915121103491074,2021-01-27 17:03:58,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1354550743127134209,False,0,0,0,0,formwhispers,"#FWSells $INCY Iyengar Vijay K, EVP GPS, BD, &amp; Licensing of INCYTE CORP sold 5,116 shares on 2021-01-25. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
772471873539977217,2021-01-27 16:57:30,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1354549117666656258,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/bvVVyyhWhp,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
2344420430,2021-01-27 16:55:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1354548580539916289,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, General Manager, Europe

JONATHAN ELLIOTT DICKINSON:

https://t.co/91XbSUbJ7S",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1262915121103491074,2021-01-27 16:52:50,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1354547941793435649,False,0,0,0,0,formwhispers,"#FWSells $INCY Flannelly Barry P, EVP &amp; General Manager US of INCYTE CORP sold 2,744 shares on 2021-01-25. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1140762699002871808,2021-01-27 15:40:08,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1354529647115923457,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2021-01-27 15:40 ET. Bought/Opened:
$INCY at $92.84. 
Incyte Corporation - Common Stock
Win Chance: 76%. Avg Win: 6%. Avg Loss: 12.75%. Avg Hold: 6d.
Trade Id: 65457301503029620.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
1298258877247496196,2021-01-27 15:15:58,,,"umontana.zoom.us/meeting/regist‚Ä¶, ",1354523565291409409,False,6,0,3,0,Twitter Web App,"Today's @IncyteRcn talk by Will Weider &amp; @TDaviesBarnard was the best academic hour I've spent in a long time. So much food for thought on incorporating N fixation into global models! 

Sign up for future INCyTE sessions here: https://t.co/CcKh3Cxy7L","IncyteRcn, TDaviesBarnard, ",,2020-08-25 10:01:20,"Cambridge, MA",Taylor Lab - Harvard OEB & AA,https://pbs.twimg.com/profile_images/1298259348846592009/uLZv4T7c_normal.jpg,348,300,1,78,taylor_eco_lab,
1304490431036751872,2021-01-27 12:46:17,,"StockMarket, Growth, Value, Investing, ",,1354485895697747973,False,0,0,0,0,Twitter for Android,"#StockMarket 

‚òÜAnthem Inc
‚òÜIncyte Co. 
‚òÜNvidia Corporation 
‚òÜNXP Semiconductors 
‚òÜParker-Hannifin 
‚òÜSkyworks Solutions 

#Growth #Value #Investing",,,2020-09-11 14:42:50,,Taipan,https://pbs.twimg.com/profile_images/1419781944984936458/Ne7NevAW_normal.jpg,142,140,0,687,TaipanTran,
374729426,2021-01-27 04:51:44,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2490214, pic.twitter.com/c8stbxVzRq, ",1354366471468589062,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on January 7, 2021. View odds for this and other indicators: https://t.co/HgmPVe9xkf #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/c8stbxVzRq",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1315434407692509184,2021-01-26 15:34:52,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/XKz5odFdTq, ",1354165932705329155,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 12.50% ranked 1212 out of 5418 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/XKz5odFdTq",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
569242704,2021-01-26 15:00:00,,,"bit.ly/2KyGyM5, pic.twitter.com/j9ty0ollyI, pic.twitter.com/j9ty0ollyI, ",1354157161195085832,False,0,0,0,0,TweetDeck,"The @OncoZine Brief with Peter Hofland, Ph.D on @ukhealthradio - Malte Peters @MorphoSys &amp; Peter Langmuir @Incyte. Transformative therapies for patients diagnosed with Diffuse Large B-cell Lymphoma, that returned or did'nt respond to previous treatment‚Ä¶ üëâhttps://t.co/6BVvHrbB92 https://t.co/j9ty0ollyI","OncoZine, ukhealthradio, MorphoSys, Incyte, ",,2012-05-02 10:47:36,London UK and the world,UK Health Radio‚Ñ¢,https://pbs.twimg.com/profile_images/1156230608898658310/29ye6Trp_normal.jpg,35015,29099,628,60681,ukhealthradio,photo
1315434407692509184,2021-01-26 08:08:45,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/1pncb6cISm, ",1354053666546864128,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 12.50% ranked 1212 out of 5418 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/1pncb6cISm",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
163565297,2021-01-26 06:10:04,,"CSCDE, Incyte, Delaware, cancerpatients, cancersupport, ","cancersupportdelaware.org, pic.twitter.com/GNOUEgSfXx, ",1354023798463455232,False,2,0,0,1,Hootsuite Inc.,"#CSCDE &amp; our community partner, #Incyte, find it critical to continue to provide support for our #Delaware #cancerpatients  to help maintain their financial health during these uncertain times. To apply or find out more please visit https://t.co/7DdQ9Ybsbw  #cancersupport https://t.co/GNOUEgSfXx",,,2010-07-06 14:57:24,"Delaware, USA",Cancer Support DE,https://pbs.twimg.com/profile_images/667430529340473346/FSfER-Bd_normal.jpg,543,542,30,3173,CancerSupportDE,photo
108617488,2021-01-25 23:15:04,,,"invst.ly/tkzto, ",1353919357286572034,False,0,0,0,0,FP News Publisher - COM,Oppenheimer Stick to Their Buy Rating for Incyte Corp - https://t.co/psF1BuxUGn,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
1280938376099741697,2021-01-25 20:27:02,,"iexStock, ","iexcloud.io, pic.twitter.com/2tJRIHuBkC, ",1353877071823560710,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-NortonLifeLock Inc
-Xcel Energy, Inc.
-Exelon Corp.
-Incyte Corp.
-Sharjah Insurance Co.

Data provided by https://t.co/oXreiEXTgd https://t.co/2tJRIHuBkC",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
247585711,2021-01-25 19:05:02,,"MSL, medicalaffairs, oncology, ","buff.ly/3c41B4E, pic.twitter.com/Q2HH6ZEByG, ",1353856437794050049,False,0,0,0,0,Buffer,"Checkpoint inhibitors are already used as second-line treatments of metastatic anal cancer but this dataset may provide for first-line treatment and in HIV patients.
#MSL #medicalaffairs #oncology https://t.co/BhQzpAe6II https://t.co/Q2HH6ZEByG",,,2011-02-04 22:28:55,"Houston, TX",Dr. Melody Davis,https://pbs.twimg.com/profile_images/977758698163630080/votWl1oP_normal.jpg,1310,4968,211,37021,mrdphd,photo
731998140430094336,2021-01-25 17:23:40,,,"news.wsu.edu/2021/01/22/wsu‚Ä¶, ",1353830927399411713,False,1,0,0,1,Twitter Web App,WSU launches new COVID-19 dashboard https://t.co/XeqrvX5Mlu via @WSUNews @Incyte @WSUGlobalHealth,"WSUNews, Incyte, WSUGlobalHealth, ",,2016-05-15 20:02:11,"Pullman, WA",WSU Global Health,https://pbs.twimg.com/profile_images/875066669533609984/PsZP3I2__normal.jpg,692,425,10,649,WSUGlobalHealth,
2344420430,2021-01-25 17:12:23,"MRUS, ",,"insideri.com/1651311_000110‚Ä¶, ",1353828085863485440,False,0,0,0,0,Insider Alerts,"$MRUS:

New Insider Filing on Merus N.V.'s

10%+ Owner

INCYTE CORP:

https://t.co/pfesG2taFZ",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
799069924450766848,2021-01-25 16:20:16,"MRUS, ",,"itunes.apple.com/us/app/apple-s‚Ä¶, ",1353814970048393218,False,0,0,0,0,InsiderForms,"$MRUS INCyte CORP has filed Form SC 13D/A with SEC. Reporting 9.4% Ownership.

https://t.co/t5CkFUZh7T",,,2016-11-16 21:01:30,United States,Insider Forms,https://pbs.twimg.com/profile_images/1448375542013628418/Dbx6hCfO_normal.jpg,2877,0,67,46526,InsiderForms,
998915197061488645,2021-01-25 14:21:37,,,"umontana.zoom.us/meeting/regist‚Ä¶, pic.twitter.com/7wygi1MwoV, ",1353785113495146496,False,12,1,1,6,Twitter Web App,"If you're like Bernie and keep asking how to best represent nitrogen fixation in models, join the INCyTE seminar series Wed 1/27 at 11am EST! We'll have insightful (ü•Å) talks by Will Wieder and @TDaviesBarnard on modeling BNF. Don't miss it!

Register: https://t.co/P1yBf6zqcM https://t.co/7wygi1MwoV","TDaviesBarnard, ",,2018-05-22 09:15:16,,INCyTE RCN,https://pbs.twimg.com/profile_images/1063085319887695873/d_uRHryG_normal.jpg,221,32,1,46,IncyteRcn,photo
569242704,2021-01-25 11:00:02,,,"bit.ly/2KyGyM5, pic.twitter.com/qRyVxd6nrI, pic.twitter.com/qRyVxd6nrI, ",1353734380275912707,False,0,0,0,0,TweetDeck,"The @OncoZine Brief with Peter Hofland, Ph.D on @ukhealthradio - Malte Peters @MorphoSys &amp; Peter Langmuir @Incyte. Transformative therapies for patients diagnosed with Diffuse Large B-cell Lymphoma, that returned or did'nt respond to previous treatment‚Ä¶ üëâhttps://t.co/6BVvHrbB92 https://t.co/qRyVxd6nrI","OncoZine, ukhealthradio, MorphoSys, Incyte, ",,2012-05-02 10:47:36,London UK and the world,UK Health Radio‚Ñ¢,https://pbs.twimg.com/profile_images/1156230608898658310/29ye6Trp_normal.jpg,35015,29099,628,60681,ukhealthradio,photo
1022473214457348096,2021-01-25 06:37:18,,,"pharmashots.com/55415/incyte-r‚Ä¶, ",1353668261225742338,False,0,0,0,0,Twitter Web App,"Incyte Reports Acceptance and Priority Review of BLA for Retifanlimab to Treat Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) @Pharmashot @Incyte 
https://t.co/NigKlFuD4r","Pharmashot, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
374729426,2021-01-25 00:22:02,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2485082, pic.twitter.com/5S2gq0MHa2, ",1353573822461448192,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/W4WARQhEz0 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5S2gq0MHa2,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
889321711966998528,2021-01-24 19:46:55,,"Cancer, immunotherapy, PD1, GeneOnline, ","geneonline.news/en/2021/01/24/‚Ä¶, ",1353504587504824323,False,1,0,0,1,Twitter Web App,"Another Checkpoint Inhibitor Set to Make Market Appearance as @US_FDA Grants Priority Review

#Cancer #immunotherapy #PD1 #GeneOnline @Incyte 

https://t.co/JSSghbCGqX","US_FDA, Incyte, ",,2017-07-23 23:09:53,"Santa Clara, CA",GeneOnline,https://pbs.twimg.com/profile_images/1290669170913312769/KyH5AwCK_normal.jpg,4796,4702,12,3813,GeneOnlineNews,
14562968,2021-01-24 18:44:02,,,"fiercebiotech.com/biotech/incyte‚Ä¶, ",1353488763008245762,False,0,0,0,0,Twitter Web App,Incyte lands priority review for PD-1 inhibitor in anal cancer https://t.co/1rN93FYjn1,,,2008-04-27 19:44:29,Pennsylvania,"Wafik S. El-Deiry, MD, PhD, FACP",https://pbs.twimg.com/profile_images/1423352521800699905/QAB54p61_normal.jpg,8804,6116,347,41415,weldeiry,
1029128656650555393,2021-01-24 17:00:57,,"retifanlimab, immunotherapy, checkpointinhibitors, clinicalresearch, clinicaltrials, ","fiercebiotech.com/biotech/incyte‚Ä¶, ",1353462823570042888,False,0,0,0,0,SocialPilot.co,Incyte lands priority review for PD-1 inhibitor in anal cancer | @Incyte @US_FDA @MacroGenics #retifanlimab #immunotherapy #checkpointinhibitors #clinicalresearch #clinicaltrials https://t.co/yq8InxWbhW,"Incyte, US_FDA, MacroGenics, ",,2018-08-13 18:12:46,,Pharm2Market,https://pbs.twimg.com/profile_images/1041479880368484353/xr9ZBpXF_normal.jpg,190,849,2,2538,pharm2market,
2656754371,2021-01-24 17:00:57,,"retifanlimab, immunotherapy, checkpointinhibitors, clinicalresearch, clinicaltrials, ","j.mp/399uryH, ",1353462823565864960,False,0,0,0,0,SocialPilot.co,Incyte lands priority review for PD-1 inhibitor in anal cancer | @Incyte @US_FDA @MacroGenics #retifanlimab #immunotherapy #checkpointinhibitors #clinicalresearch #clinicaltrials https://t.co/BwCDzaBHVH,"Incyte, US_FDA, MacroGenics, ",,2014-07-18 09:20:39,San Diego,Aspen Biosciences,https://pbs.twimg.com/profile_images/1006725217568186368/B34yK1F1_normal.jpg,316,725,33,6079,aspenbio,
569242704,2021-01-24 07:00:01,,,"bit.ly/2KyGyM5, pic.twitter.com/OhcPmFzgsx, pic.twitter.com/OhcPmFzgsx, ",1353311591924527104,False,1,0,0,0,TweetDeck,"The @OncoZine Brief with Peter Hofland, Ph.D on @ukhealthradio - Malte Peters @MorphoSys &amp; Peter Langmuir @Incyte. Transformative therapies for patients diagnosed with Diffuse Large B-cell Lymphoma, that returned or did'nt respond to previous treatment‚Ä¶ üëâhttps://t.co/6BVvHrbB92 https://t.co/OhcPmFzgsx","OncoZine, ukhealthradio, MorphoSys, Incyte, ",,2012-05-02 10:47:36,London UK and the world,UK Health Radio‚Ñ¢,https://pbs.twimg.com/profile_images/1156230608898658310/29ye6Trp_normal.jpg,35015,29099,628,60681,ukhealthradio,photo
374729426,2021-01-24 03:50:41,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2483471, pic.twitter.com/MyxZiBdznl, ",1353263944769523713,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/7b0l7p9x7t #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MyxZiBdznl,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1315434407692509184,2021-01-23 20:03:07,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/RiIoi8cHl4, ",1353146277488451586,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 12.50% ranked 1212 out of 5416 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/RiIoi8cHl4",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
3460109487,2021-01-23 15:00:00,,,"endpts.com/incytes-pd-1-p‚Ä¶, ",1353069996927307776,False,4,0,0,1,TweetDeck,"The latest entrant to the checkpoint inhibitor ring is Incyte, whose retifanlimab is slated for a decision by July 25 (likely just after GlaxoSmithKline‚Äôs dostarlimab) thanks to a priority review.

https://t.co/oIIVebn3Bv",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
325135887,2021-01-23 13:25:00,"INCY, ","cancer, healthcare, ","bit.ly/2MlVjCn, ",1353046087263805443,False,1,0,0,0,Twitter Web App,"Incyte lands priority review for PD-1 inhibitor in anal cancer! It secured global rights to retifanlimab, then known as MGA012, from MacroGenics for $150 million upfront in 2017! $INCY #cancer #healthcare 
https://t.co/aSeGRAGOY0",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
569242704,2021-01-23 03:00:00,,,"bit.ly/2KyGyM5, pic.twitter.com/YVzKg8KYEW, pic.twitter.com/YVzKg8KYEW, ",1352888801249517574,False,0,0,0,0,TweetDeck,"The @OncoZine Brief with Peter Hofland, Ph.D on @ukhealthradio - Malte Peters @MorphoSys &amp; Peter Langmuir @Incyte. Transformative therapies for patients diagnosed with Diffuse Large B-cell Lymphoma, that returned or did'nt respond to previous treatment‚Ä¶ üëâhttps://t.co/6BVvHrbB92 https://t.co/YVzKg8KYEW","OncoZine, ukhealthradio, MorphoSys, Incyte, ",,2012-05-02 10:47:36,London UK and the world,UK Health Radio‚Ñ¢,https://pbs.twimg.com/profile_images/1156230608898658310/29ye6Trp_normal.jpg,35015,29099,628,60681,ukhealthradio,photo
1134049078424162304,2021-01-23 01:04:41,"INCY, NVS, MGNX, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1352859779954315264,False,0,0,0,0,Newsfilter.io,Incyte's BLA for Cancer Drug Accepted for Priority Review $INCY $NVS $MGNX $MOR https://t.co/8srLcpyZCM,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
20109018,2021-01-22 17:55:31,"SIVB, FANG, INCY, PHB, ","valueinvesting, WarrenBuffett, investing, stocks, Market, ","pic.twitter.com/OkaLzvCcCS, pic.twitter.com/OkaLzvCcCS, pic.twitter.com/OkaLzvCcCS, pic.twitter.com/OkaLzvCcCS, ",1352751778245337088,False,1,0,2,1,Twitter Web App,"Market Movers in the S&amp;P 500:
SVB Financial Group (5.39%) $SIVB
Diamondback Energy Inc (4.87%) $FANG
Incyte Corp (4.24%) $INCY
Pultegroup Inc (2.79%) $PHB
#valueinvesting #WarrenBuffett #investing #stocks #Market https://t.co/OkaLzvCcCS",,,2009-02-04 19:15:37,United States,GuruFocus,https://pbs.twimg.com/profile_images/1238147123998310402/xlOiSkeR_normal.jpg,9359,185,337,74737,gurufocus,photo
3460109487,2021-01-22 16:00:00,,,"endpts.com/incytes-pd-1-p‚Ä¶, ",1352722707226398720,False,0,0,0,0,TweetDeck,"The latest entrant to the checkpoint inhibitor ring is Incyte, whose retifanlimab is slated for a decision by July 25 (likely just after GlaxoSmithKline‚Äôs dostarlimab) thanks to a priority review.

https://t.co/oIIVeb5scV",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
2177744681,2021-01-22 15:00:35,,,"ow.ly/bKD130rtJ0W, ",1352707755988164608,False,0,0,0,0,Hootsuite Inc.,Incyte‚Äôs PD-1 priority review draws muted cheer ‚Äî but analysts say it‚Äôs all about getting a foot in the door ‚Äì Endpoints News https://t.co/T56DHQBPLN,,,2013-11-11 23:56:36,"Atlanta, GA",Lampgen Clinical Research,https://pbs.twimg.com/profile_images/451196302588526592/iSb1JnS6_normal.png,24,45,0,804,Lampgen_CR,
210246551,2021-01-22 14:56:14,,,"finance.yahoo.com/news/incyte-an‚Ä¶, ",1352706659429265409,False,0,0,0,0,Twitter for Android,Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/omUY3lDu7x,,,2010-10-30 19:25:21,"Tucson, Az",Aloysius Pendergast,https://pbs.twimg.com/profile_images/459563937856385025/3RXl6oem_normal.jpeg,843,875,0,12373,sheik2411,
82115262,2021-01-22 14:28:14,,,"bit.ly/396y1cE, ",1352699615578001408,False,0,0,0,0,StockMarketUpdate,Incyte outperforms following BLA acceptance https://t.co/kfSXIWv2sz,,,2009-10-13 11:05:23,"Chicago, IL",Briefing.com,https://pbs.twimg.com/profile_images/614056279/SMU_logo2_normal.jpg,1881,84,101,54070,BriefingcomSMU,
22195223,2021-01-22 13:22:05,,"BREAKING, ","cancernetwork.com/view/fda-grant‚Ä¶, ",1352682966871322630,False,0,0,0,0,Twitter Web App,"#BREAKING: The @FDAOncology has accepted and granted priority review to the BLA for retifanlimab as a possible treatment for adult patients with locally advanced or metastatic SCAC. | @Incyte 
https://t.co/PVOGMSS0NX","FDAOncology, Incyte, ",,2009-02-27 16:48:14,"Cranbury, NJ","CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",https://pbs.twimg.com/profile_images/1196832187376685056/BU2C0XFo_normal.jpg,23603,452,498,13559,CancerNetwrk,
1218480193725091840,2021-01-22 12:07:00,,"mellaltameet, ","mellalta.com, businesswire.com/news/home/2021‚Ä¶, ",1352664070185484291,False,0,0,0,0,Twitter Web App,"https://t.co/O1jfYdduWy Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) &gt;&gt;RFP@‚ÄØbd@mellalta.com&gt;¬†#mellaltameet

https://t.co/dolTzLCy3Y",,,2020-01-18 05:28:28,,Mellalta Meets,https://pbs.twimg.com/profile_images/1239854909308039168/ZiS9Gw38_normal.jpg,63,346,0,1580,mellaltameets,
27645777,2021-01-22 11:39:19,,,"bit.ly/3iBzyL3, pic.twitter.com/HOk1oEh6WV, ",1352657105711456267,False,0,0,0,1,TweetDeck,.@US_FDA grants priority review to retifanlimab for anal cancer subset https://t.co/usc5OyoHFr @Incyte https://t.co/HOk1oEh6WV,"US_FDA, Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
15974185,2021-01-22 10:55:32,,,"dlvr.it/Rr74VQ, ",1352646084854599682,False,0,0,0,0,dlvr.it,Incyte lands priority review for PD-1 inhibitor in anal cancer https://t.co/L7LHRremKq,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1289196501516812289,2021-01-22 09:28:43,,"PharmaTopNews, ImmunoOncologyTopNews, CancerImmunotherapy, Immunotherapy, Oncology, ImmunoOncology, OncologyTopNews, CheckpointInhibitors, ","endpts.com/incytes-pd-1-p‚Ä¶, ",1352624237920612352,False,0,0,0,1,Twitter for iPhone,Incyte‚Äôs PD-1 priority review draws muted cheer ‚Äî but analysts say it‚Äôs all about getting a foot in the door #PharmaTopNews #ImmunoOncologyTopNews #CancerImmunotherapy #Immunotherapy #Oncology #ImmunoOncology #OncologyTopNews #CheckpointInhibitors  https://t.co/DC0RcQYK41,,,2020-07-31 09:49:56,,Pharma Top News,https://pbs.twimg.com/profile_images/1289222230552072195/Fb5XMFYC_normal.jpg,16,0,0,2134,PharmaTopNews1,
26759915,2021-01-22 09:16:35,,,"dlvr.it/Rr6lWL, pic.twitter.com/FayscyQmt2, ",1352621185075277828,False,3,0,0,0,dlvr.it,Incyte lands priority review for PD-1 inhibitor in anal cancer https://t.co/2wVFYEY8E1 https://t.co/FayscyQmt2,,,2009-03-26 10:26:33,United States,Biotech World,https://pbs.twimg.com/profile_images/114801338/BiotechWorldv5_normal.jpg,38033,0,596,34960,BiotechWorld,photo
391492257,2021-01-22 09:00:12,"INCY, ",,"businesswire.com/news/home/2021‚Ä¶, fdatracker.com/fda-calendar/, ",1352617062531653638,False,0,0,0,0,FDA Tracker,$INCY New PDUFA Date 2021-07-25 INCYTE Link:https://t.co/QKVItHNbiB Calendar:https://t.co/sCt1qKoMdr,,,2011-10-15 13:01:13,San Francisco,FDA Tracker,https://pbs.twimg.com/profile_images/1667207308/square_logo_normal.png,4992,14,113,4060,fda_tracker,
133504478,2021-01-22 08:25:33,,"strategy, competitiveintelligence, marketing, pharma, biotech, pharmaceutical, healthcare, productmarketing, ","dlvr.it/Rr6ZbG, pic.twitter.com/LIiiqFokVD, ",1352608342942773253,False,0,0,0,1,dlvr.it,Incyte's PD-1 priority review draws muted cheer ‚Äî but analysts say it's all about getting a foot in the door https://t.co/jCXVF387ad #strategy #competitiveintelligence #marketing #pharma #biotech #pharmaceutical #healthcare #productmarketing https://t.co/LIiiqFokVD,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
875382419251019776,2021-01-22 08:20:33,,,"bit.ly/39Pwabu, pic.twitter.com/3RWdA5f1hW, ",1352607081828769794,False,0,0,0,0,dlvr.it,Incyte lands priority review for PD-1 inhibitor in anal cancer https://t.co/Ge0W1hew59 https://t.co/3RWdA5f1hW,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
3460109487,2021-01-22 07:58:49,,,"endpts.com/incytes-pd-1-p‚Ä¶, ",1352601612825538560,False,2,0,0,0,TweetDeck,"The latest entrant to the checkpoint inhibitor ring is Incyte, whose retifanlimab is slated for a decision by July 25 (likely just after GlaxoSmithKline‚Äôs dostarlimab) thanks to a priority review.

https://t.co/oIIVebn3Bv",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
46297868,2021-01-22 07:39:05,,,"dlvr.it/Rr6QCn, ",1352596647709011968,True,0,0,0,0,dlvr.it,Incyte's PD-1 priority review draws muted applause ‚Äî but analysts say it's all about getting a foot in the door https://t.co/QEp3owMIHL,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
873399943,2021-01-22 04:43:08,"INCY, GSK, ",,"bit.ly/3c0lOIm, ",1352552370346086403,False,12,0,1,0,TweetDeck,$INCY throws down the gauntlet to $GSK. Who will be seventh to market?! https://t.co/ZRmOVgL8Am,,,2012-10-11 06:45:00,"London, UK",Jacob Plieth,https://pbs.twimg.com/profile_images/453547761401462784/a2Lp0d3m_normal.jpeg,17753,328,0,20982,JacobPlieth,
1889492676,2021-01-22 04:19:22,"INCY, ","Incyte, BLA, Retifanlimab, SquamousCellCarcinoma, AnalCanal, SCAC, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1352546385770344449,False,0,0,0,0,Troi URL Plug-in,#Incyte Announces Acceptance and Priority Review of #BLA for #Retifanlimab as a Potential Treatment for Patients with #SquamousCellCarcinoma of the #AnalCanal (#SCAC) $INCY https://t.co/GkNmn55feK,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
569242704,2021-01-21 23:00:00,,,"bit.ly/2KyGyM5, pic.twitter.com/RLzfgzAh7h, pic.twitter.com/RLzfgzAh7h, ",1352466017172168705,False,0,0,0,0,TweetDeck,"The @OncoZine Brief with Peter Hofland, Ph.D on @ukhealthradio - Malte Peters @MorphoSys &amp; Peter Langmuir @Incyte. Transformative therapies for patients diagnosed with Diffuse Large B-cell Lymphoma, that returned or did'nt respond to previous treatment‚Ä¶ üëâhttps://t.co/6BVvHrbB92 https://t.co/RLzfgzAh7h","OncoZine, ukhealthradio, MorphoSys, Incyte, ",,2012-05-02 10:47:36,London UK and the world,UK Health Radio‚Ñ¢,https://pbs.twimg.com/profile_images/1156230608898658310/29ye6Trp_normal.jpg,35015,29099,628,60681,ukhealthradio,photo
374729426,2021-01-21 22:20:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2477457, pic.twitter.com/rkNtdJmgxK, ",1352456157852389377,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/UspoiJVwL6 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/rkNtdJmgxK,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
227778014,2021-01-21 22:00:17,,"COVID19, ","buff.ly/2M8Fqzg, ",1352450988460941312,False,2,0,0,0,Buffer,"BioCentury's latest roundup of regulatory news for biopharmas: FDA approves ViiV‚Äôs long-acting HIV therapy; plus¬†Menarini wins EC approval for rare blood disorder therapy, PDUFA dates for Incyte, Genentech &amp; Moderna's #COVID19 therapy in Japan trial https://t.co/LKS1riotbw",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
4759239404,2021-01-21 19:20:22,,,"Investing.com, fundswift.com/2021/01/22/miz‚Ä¶, ",1352410743984058368,False,0,0,0,0,App for FundSwift,New post (Mizuho Securities Stick to Their Hold Rating for Incyte Corp By https://t.co/D7lTItLjqO) has been published on FUNDSWIFT - https://t.co/0YCZqjx6Tz,,,2016-01-14 13:18:11,,FundSwift,https://pbs.twimg.com/profile_images/1051584741151891456/6NhcqNAx_normal.jpg,99,0,2,45528,fundswift,
1134049078424162304,2021-01-21 19:19:07,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1352410429792915456,False,0,0,0,0,Newsfilter.io,Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal $INCY https://t.co/bGyGBbN824,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-01-21 18:58:07,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1352405145036988417,False,1,0,0,0,Newsfilter.io,Incyte's retifanlimab wins FDA's Priority Review status $INCY https://t.co/Y3Eatxt1nS,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1314571691197116416,2021-01-21 18:56:00,,,"investing.com/news/mizuho-se‚Ä¶, ",1352404609671823362,False,0,0,0,0,Twitter for Android,"""Mizuho Securities Stick to Their Hold Rating for Incyte Corp""

https://t.co/xm3ew31TYV",,,2020-10-09 10:21:37,,Bradley White,https://pbs.twimg.com/profile_images/1356279072276566017/meu0R9hT_normal.jpg,45,126,2,17146,WHITEFX84,
108617488,2021-01-21 18:55:03,,,"invst.ly/tjmch, ",1352404373922525187,False,0,0,0,0,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/S5Y62d2cY5,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
72928001,2021-01-21 18:45:49,"INCY, ",,"bit.ly/395GYmJ, ",1352402050001244161,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte: FDA accepts BLA for retifanlimab as potential treatment for patients with SCAC for priority review https://t.co/SwRkVhXX9p,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
4058194633,2021-01-21 18:02:29,"INCY, ",,"manchestertimes.com/news/business/‚Ä¶, ",1352391142084550659,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/BRTnAudu0h via @manchestertimes,"ManchesterTimes, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
3318510966,2021-01-21 17:31:58,,,"crweworld.com/article/news-p‚Ä¶, ",1352383464473944065,False,0,0,0,0,CRWE World,Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with S https://t.co/2O5Vb0pbjy,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3686628867,2021-01-21 17:29:46,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1352382912067469313,False,0,0,0,0,WordPress.com,Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal¬†(SCAC) https://t.co/xuYhnODe7O,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
38920802,2021-01-21 16:54:54,"MGNX, INCY, ",,"businesswire.com/news/home/2021‚Ä¶, ",1352374134697730049,False,1,0,0,0,Twitter Web App,$MGNX $INCY Priority review for first potential indication..... https://t.co/GNDqBfPv7W,,,2009-05-09 16:23:52,,Spontonic,https://pbs.twimg.com/profile_images/1132813877513560065/G7Q68pBw_normal.png,406,197,17,2815,spontonic,
336116161,2021-01-21 16:52:28,"INCY, ",,,1352373525307396096,False,0,0,0,0,Twitter Web App,"$INCY
Incyte's retifanlimab wins FDA's Priority Review status
Today, 4:37 PM",,,2011-07-15 15:25:29,,c lark,https://pbs.twimg.com/profile_images/593198460075048961/RIcFfJ-m_normal.jpg,1079,1437,87,86094,7LadyQ,
472650465,2021-01-21 16:50:07,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1352372931427520525,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/aMBoH0Copy,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
3524211082,2021-01-21 16:43:10,,,"twib.in/l/59677aKXjoMB, ",1352371182738272256,False,0,0,0,0,Twibble.io,Incyte's retifanlimab wins FDA's Priority Review status https://t.co/AqJAqbe3nW,,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
963495628545327104,2021-01-21 16:39:06,"INCY, INCY, ",,"stck.pro/news/INCY/1048‚Ä¶, stck.pro/news/INCY, pic.twitter.com/vbDJg6f1nr, ",1352370159844012042,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) https://t.co/P95yR8tPQ4 Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/vbDJg6f1nr,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
4674596893,2021-01-21 16:38:59,,"CTE, SVCTE, Spokane, school, technicaleducation, teched, STEM, teaching, ","eventbrite.com/e/teaching-the‚Ä¶, ",1352370132140453890,False,0,0,0,0,Twitter Web App,"Teaching the Teachers from Greater Spokane Incorporated has an event next month! Come learn from the Vitalant Components Processing Team and the Lab Manager of Incyte Diagnostics!

https://t.co/Lht0dZwTsb

#CTE #SVCTE #Spokane #school #technicaleducation #teched #STEM #teaching",,,2015-12-29 15:39:59,"Spokane, WA",Spokane Valley CTE,https://pbs.twimg.com/profile_images/1009871627666853888/g3cljaEi_normal.jpg,344,494,15,1367,SpokaneVCTE,
15296897,2021-01-21 16:37:42,"INCY, ",,"seekingalpha.com/news/3653339-i‚Ä¶, ",1352369806461202433,False,1,0,0,1,SANewsTwitter,$INCY - Incyte's retifanlimab wins FDA's Priority Review status https://t.co/jzmG4YPOVV,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1370906497,2021-01-21 16:35:25,"INCY, ",,,1352369232286199808,False,0,0,0,1,Twitter Web App,"$INCY Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)

The Prescription Drug User Fee Act (PDUFA) target action date for retifanlimab is July 25, 2021.",,,2013-04-21 20:38:27,U.S.A,MAISA,https://pbs.twimg.com/profile_images/3557296223/a73cb8bb8effbfd1f90590ab48523b10_normal.jpeg,2858,7,76,70211,MaisaCorp,
1254035253104181256,2021-01-21 16:31:10,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1352368164194054146,False,0,0,0,0,stocktitan,"$INCY Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)
https://t.co/L7V6CExJsY",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1301425387369619456,2021-01-21 11:50:37,,,"mednetnews.com/2021/01/21/glo‚Ä¶, ",1352297558543126531,False,0,0,0,0,WordPress.com,"Global Hodgkin Lymphoma Drug Market Strategic Assessment 2021: Emerging Players Are Ono Pharmaceutical Co. Ltd, Merck &amp; Co. Inc., Bristol-Myers Squibb Company, Novartis AG, Incyte Corporation ‚Äì¬†KSU https://t.co/Q2i1EmEKRw",,,2020-09-03 03:42:57,,mednetnews,https://pbs.twimg.com/profile_images/1301426159247384577/VZsF735N_normal.jpg,5,0,0,13260,mednetnews,
1134049078424162304,2021-01-21 05:51:02,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352207066291695619,False,0,0,0,0,Newsfilter.io,"12,743 shares acquired by Dhanak Dashyant (EVP &amp; Chief Scientific Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/BszqLUQOhV",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-01-21 05:43:03,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352205059392741378,False,0,0,0,0,Newsfilter.io,"12,743 shares acquired by Swain Paula J (EVP, Human Resources), reported in a new form 4 filed with the SEC  $INCY https://t.co/qKRk2q3Pvq",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-01-21 05:00:03,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352194236125507584,False,0,0,0,0,Newsfilter.io,"12,743 shares acquired by Iyengar Vijay K (EVP GPS, BD, &amp; Licensing), reported in a new form 4 filed with the SEC  $INCY https://t.co/rnr1z8UNfY",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
2344420430,2021-01-21 04:58:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352193822504214529,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Principal Accounting Officer

PAUL TROWER:

https://t.co/kazbN0LYph",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1134049078424162304,2021-01-21 04:54:02,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352192723395162113,False,0,0,0,0,Newsfilter.io,"12,743 shares acquired by Pasquale Maria E (EVP &amp; General Counsel), reported in a new form 4 filed with the SEC  $INCY https://t.co/SoUDfYjqyt",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-01-21 04:45:02,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352190459716792321,False,0,0,0,0,Newsfilter.io,"74,720 shares acquired by Hoppenot Herve (Chairman / CEO), reported in a new form 4 filed with the SEC  $INCY https://t.co/7UsmfSliFV",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-01-21 04:29:57,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352186662466547712,False,0,0,0,0,Newsfilter.io,"$16,349.04 of shares sold by Dickinson Jonathan Elliott (EVP, General Manager, Europe), reported in a new form 4 filed with the SEC  $INCY https://t.co/ok2VRL1nx1",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-01-21 04:18:57,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352183896138514433,False,0,0,0,0,Newsfilter.io,"4,032 shares acquired by Trower Paul (Principal Accounting Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/p08hNpkc3g",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-01-21 03:58:58,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352178863783223297,False,0,0,0,0,Newsfilter.io,"$16,349.04 of shares sold by Morrissey Michael James (EVP, Head of Tech. Operations), reported in a new form 4 filed with the SEC  $INCY https://t.co/lIufvt3gO9",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-01-21 03:53:57,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352177604451823618,False,0,0,0,0,Newsfilter.io,"11,522 shares acquired by Flannelly Barry P (EVP &amp; General Manager US), reported in a new form 4 filed with the SEC  $INCY https://t.co/SKFfepz8md",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-01-21 03:40:57,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352174331774849024,False,0,0,0,0,Newsfilter.io,"23,044 shares acquired by Stein Steven H (EVP &amp; Chief Medical Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/bHS9HEY6b1",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
2344420430,2021-01-21 03:22:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352169668774154240,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/lJns32fauk",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1134049078424162304,2021-01-21 02:52:56,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352162247318056960,False,0,0,0,0,Newsfilter.io,"11,522 shares acquired by Wenqing Yao (EVP, Head of Discovery Chem), reported in a new form 4 filed with the SEC  $INCY https://t.co/c9zAQ4dFl4",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2021-01-21 02:19:56,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1352153942529085441,False,0,0,0,0,Newsfilter.io,"11,522 shares acquired by Stamoulis Christiana (EVP &amp; Chief Financial Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/UYZSPoLYeq",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
2344420430,2021-01-21 02:10:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352151535548059649,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, General Manager, Europe

JONATHAN ELLIOTT DICKINSON:

https://t.co/aMirWpHKsQ",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
569242704,2021-01-21 00:31:50,,,"bit.ly/2KyGyM5, pic.twitter.com/wAYIq5soHq, pic.twitter.com/wAYIq5soHq, ",1352126739825233922,False,1,0,0,0,TweetDeck,"The @OncoZine Brief with Peter Hofland, Ph.D on @ukhealthradio - Malte Peters @MorphoSys &amp; Peter Langmuir @Incyte. Transformative therapies for patients diagnosed with Diffuse Large B-cell Lymphoma, that returned or did'nt respond to previous treatment‚Ä¶ üëâhttps://t.co/6BVvHrtcxC https://t.co/wAYIq5soHq","OncoZine, ukhealthradio, MorphoSys, Incyte, ",,2012-05-02 10:47:36,London UK and the world,UK Health Radio‚Ñ¢,https://pbs.twimg.com/profile_images/1156230608898658310/29ye6Trp_normal.jpg,35015,29099,628,60681,ukhealthradio,photo
2344420430,2021-01-20 23:46:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352115298237894658,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Financial Officer

CHRISTIANA STAMOULIS:

https://t.co/eRUrms4ILe",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-20 22:12:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352091646293372929,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Manager US

BARRY P FLANNELLY:

https://t.co/7haXmnwk2i",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-20 22:09:26,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352090900869091330,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Tech. Operations

MICHAEL JAMES MORRISSEY:

https://t.co/5iYMzOZQaE",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-20 20:44:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352069503677591553,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Medical Officer

STEVEN H STEIN:

https://t.co/ntr5j0qojj",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-20 20:41:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352068751609495558,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Chairman / CEO

HERVE HOPPENOT:

https://t.co/uvMcxrEJQl",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-20 19:18:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352047856979423235,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Discovery Chem

YAO WENQING:

https://t.co/kETgdYofst",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
772471873539977217,2021-01-20 18:06:38,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1352029800471408642,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/1mA9LwUXMt,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
772471873539977217,2021-01-20 17:43:04,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1352023871436820480,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/DVoIYInKLz,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
772471873539977217,2021-01-20 17:05:37,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1352014444830797829,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/gJ0Irleakh,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
2344420430,2021-01-20 17:05:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352014390107795457,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/1UUAN5VKGT",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-20 16:56:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352012128648048643,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Human Resources

PAULA J SWAIN:

https://t.co/BITGO1vllS",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-20 16:34:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1352006583870509065,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP GPS, BD, &amp; Licensing

VIJAY K IYENGAR:

https://t.co/s8EPoLnvpc",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
705203551966920705,2021-01-20 13:12:59,,,"fiercepharma.com/pharma/jpm-est‚Ä¶, ",1351955901784068096,False,0,0,0,0,Twitter Web App,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says https://t.co/QJwlblbWlC",,,2016-03-02 20:30:03,"Los Angeles, CA",Brielan Smiechowski,https://pbs.twimg.com/profile_images/1201197887834603520/Y2_5wysK_normal.jpg,161,433,13,3097,brielanbs,
1315434407692509184,2021-01-20 10:57:15,"INCY, ",,"earningsfly.com/stocks/incy?so‚Ä¶, pic.twitter.com/W1JOZbno3k, ",1351921741564702727,False,0,0,0,0,Twitter,"Incyte Corporation current quarter revenue growth YoY of 12.50% ranked 1206 out of 5414 companies in our database. 

https://t.co/AjmQ0q7Uf7 $INCY

üöÄüöÄüöÄüöÄüöÄ https://t.co/W1JOZbno3k",,,2020-10-11 19:29:43,,Earningsfly Stock Research Bot,https://pbs.twimg.com/profile_images/1315434762245373952/ETz2Zymw_normal.jpg,2901,55,59,110115,earningsflyinc,photo
1134049078424162304,2021-01-20 03:30:47,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1351809385169887233,False,0,0,0,0,Newsfilter.io,Incyte to Report Fourth Quarter and Year-End 2020 Financial Results $INCY https://t.co/T44oFgifXy,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
374729426,2021-01-20 01:21:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2473047, pic.twitter.com/C4z7sINmy2, ",1351776953494249474,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on January 7, 2021. View odds for this and other indicators: https://t.co/bTUErWeH4E #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/C4z7sINmy2",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
976297820532518914,2021-01-19 08:07:35,,,"dlvr.it/RqtnQF, pic.twitter.com/l1sSy88h0i, ",1351516655797501952,False,0,0,0,0,dlvr.it,Incyte to Report Fourth Quarter and Year-End 2020 Financial Results https://t.co/7T9IOIaQlr https://t.co/l1sSy88h0i,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2021-01-19 08:06:30,,,"crweworld.com/article/news-p‚Ä¶, ",1351516381653602304,False,0,0,0,0,CRWE World,Incyte to Report Fourth Quarter and Year-End 2020 Financial Results https://t.co/RFUNS7BoQY,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2021-01-19 08:01:12,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1351515048603074564,False,0,0,0,0,stocktitan,"$INCY Incyte to Report Fourth Quarter and Year-End 2020 Financial Results
https://t.co/Kg3llVaCYb",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
374729426,2021-01-18 10:25:06,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2469227, pic.twitter.com/dU6bcGmKKb, ",1351188874291261441,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on January 7, 2021. View odds for this and other indicators: https://t.co/XdLTVD49TY #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/dU6bcGmKKb",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
812004702594486272,2021-01-18 09:05:20,,,"checkrare.com/a-comic-book-a‚Ä¶, ",1351168802466254850,False,0,0,0,0,Hootsuite Inc.,"J.G. Jones, comic book artist known for his work with DC Comics  and Marvel, discusses his journey with a myeloproliferative neoplasm (MPN).¬†

https://t.co/Hff3Lb2Es8

@MPNVoice
@VoicesofMPN 
Voices of MPN 
@Incyte 
Incyte","MPNVoice, VoicesofMPN, Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1029128656650555393,2021-01-17 16:01:02,,"JPM2021, Covid19, cancer, Pemazyre, Monjuvi, Alapocas, Delaware, ","fiercepharma.com/pharma/jpm-est‚Ä¶, ",1350911029610508289,False,0,0,0,0,SocialPilot.co,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says | @Incyte  #JPM2021 #Covid19 #cancer #Pemazyre #Monjuvi #Alapocas #Delaware https://t.co/ffV9gdXKqE","Incyte, ",,2018-08-13 18:12:46,,Pharm2Market,https://pbs.twimg.com/profile_images/1041479880368484353/xr9ZBpXF_normal.jpg,190,849,2,2538,pharm2market,
2656754371,2021-01-17 16:01:02,,"JPM2021, Covid19, cancer, Pemazyre, Monjuvi, Alapocas, Delaware, ","j.mp/2XV0zPT, ",1350911029610500100,False,0,0,0,0,SocialPilot.co,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says | @Incyte  #JPM2021 #Covid19 #cancer #Pemazyre #Monjuvi #Alapocas #Delaware https://t.co/EgWjB1dwDy","Incyte, ",,2014-07-18 09:20:39,San Diego,Aspen Biosciences,https://pbs.twimg.com/profile_images/1006725217568186368/B34yK1F1_normal.jpg,316,725,33,6079,aspenbio,
15974185,2021-01-17 06:20:32,,,"dlvr.it/Rqlg5X, ",1350764941997862912,False,0,0,0,0,dlvr.it,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says https://t.co/7TpMrxiIUk",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
374729426,2021-01-17 03:42:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2466173, pic.twitter.com/MhnaxVdh0f, ",1350725291115573250,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on January 7, 2021. View odds for this and other indicators: https://t.co/VxlQKOdtIH #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MhnaxVdh0f",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
29549589,2021-01-17 02:52:03,,"Yverdon, Construction, Management, Jobs, ","g.drctry.biz/r/4ZATV, ",1350712474467770369,False,0,0,0,0,Engineering Daily ,[Job] Production Operator/Technician | Company: Incyte Corporation | Location: Yverdon-Les-Bains VD  Switzerland | #Yverdon-Les-Bains #Construction #Management #Jobs | More info at  https://t.co/0beMFMcDZ0,,,2009-04-07 17:25:22,"Atlanta, GA USA",Engineering Daily,https://pbs.twimg.com/profile_images/445765099626582016/cXn6S9kL_normal.png,16933,1915,385,1338778,EngineersDay,
325135887,2021-01-16 11:25:00,"INCY, ","cancer, pharma, ","bit.ly/3oTWVSg, ",1350479173198856194,False,1,0,0,0,Twitter Web App,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says! Incyte's sales team had built up relationships with doctors that helped with two cancer drug launches last year, CEO Herv√© Hoppenot said! $INCY #cancer #pharma
https://t.co/gUtGTeTyry",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
2570920968,2021-01-16 10:25:00,"INCY, ","cancer, pharma, ","bit.ly/3oTWVSg, ",1350464073700401155,False,0,0,0,0,Twitter Web App,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says! Incyte's sales team had built up relationships with doctors that helped with two cancer drug launches last year, CEO Herv√© Hoppenot said! $INCY #cancer #pharma
https://t.co/6zrnyRR75y",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
1097819621619630080,2021-01-16 06:26:04,,,"dlvr.it/RqhvcX, pic.twitter.com/u8HB2f5u52, ",1350403946771148801,False,0,0,0,0,dlvr.it,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says https://t.co/ODeBNxoD9p https://t.co/u8HB2f5u52",,,2019-02-19 06:26:09,"London, England",PharmaCrowd,https://pbs.twimg.com/profile_images/1123311799561068545/UnJBMgbE_normal.png,29,22,0,2226,PharmaCrowd,photo
2604756709,2021-01-15 21:15:43,,,"infiniti-cs-news.com/2021/01/15/jpm‚Ä¶, ",1350265444972818432,False,0,0,0,0,WordPress.com,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO¬†says https://t.co/WmC8hiFvUM",,,2014-07-05 00:16:29,"Watford, England",Infiniti Cloud,https://pbs.twimg.com/profile_images/485277951814938624/4HiGmXE7_normal.png,391,816,2,15842,infiniticloud,
4058194633,2021-01-15 16:47:15,"INCY, ",,"fiercepharma.com/pharma/jpm-est‚Ä¶, ",1350197883270701058,False,1,0,0,0,Twitter for iPhone,"$INCY JPM: Established relationships were key to pandemic drug launches, Incyte CEO says https://t.co/UGCUPRFFhu",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
133504478,2021-01-15 14:31:05,,"strategy, competitiveintelligence, marketing, pharma, productmarketing, pharmaceutical, biotech, healthcare, ","dlvr.it/Rqfxqy, pic.twitter.com/be6jaPyemU, ",1350163617497317377,False,1,0,0,1,dlvr.it,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says https://t.co/79xNdb5dpo #strategy #competitiveintelligence #marketing #pharma #productmarketing #pharmaceutical #biotech #healthcare https://t.co/be6jaPyemU",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
760484491555139584,2021-01-15 13:32:03,,,"dlvr.it/RqfnTK, pic.twitter.com/dDwhAB36sy, ",1350148761629036545,False,0,0,0,0,dlvr.it,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says https://t.co/xx2lqvJDHQ https://t.co/dDwhAB36sy",,,2016-08-02 10:36:46,,analyst land news,https://pbs.twimg.com/profile_images/1075066740835606534/NpZYEW5E_normal.jpg,10,0,1,5551,analystlandnews,photo
140599113,2021-01-15 11:59:13,,,"winway.me/health-remedie‚Ä¶, ",1350125396629577732,False,0,0,0,0,WordPress.com,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO¬†says https://t.co/hLZBCp6eRX",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
46297868,2021-01-15 11:29:02,,,"dlvr.it/RqfPJh, ",1350117802963656707,True,0,0,0,0,dlvr.it,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says https://t.co/uR4rClKcLf",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
1280288213102292993,2021-01-15 11:27:27,,,"pharmabox.in/jpm-establishe‚Ä¶, ",1350117401904472074,False,0,0,0,0,Hootsuite Inc.,"JPM: Established relationships were key to pandemic drug launches, Incyte CEO says https://t.co/uwSAyPPTii",,,2020-07-06 19:51:21,,WWW.PHARMABOX.IN,https://pbs.twimg.com/profile_images/1284027505058381827/7o7Mcyq1_normal.jpg,856,450,0,5397,pharmabox_in,
374729426,2021-01-15 01:33:45,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2461252, pic.twitter.com/MyjPEw5bSG, ",1349967995108376577,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on January 7, 2021. View odds for this and other indicators: https://t.co/8Vhp9dIbwe #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MyjPEw5bSG",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
108617488,2021-01-14 04:15:50,,,"invst.ly/tgiud, ",1349646395356164101,False,0,0,0,0,FP News Publisher - COM,RBC Capital Stick to Their Hold Rating for Incyte Corp - https://t.co/VkjffzVR0q,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
1134049078424162304,2021-01-14 03:41:39,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1349637792171761664,False,0,0,0,0,Newsfilter.io,"$8,300.72 of shares acquired by Pasquale Maria E (EVP &amp; General Counsel), reported in a new form 4 filed with the SEC  $INCY https://t.co/VQN80vSg2x",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3068641671,2021-01-13 19:27:06,"INCY, ","Incyte, equity, stocks, ","dlvr.it/RqWvlm, pic.twitter.com/fBa0GsOLNf, ",1349513334333140995,False,0,0,0,0,dlvr.it,"$INCY #Incyte Corp. INCY - Embedded Expectations Analysis - 2021 01 13: Incyte Corporation (INCY:USA) currently trades near recent averages relative to UAFRS-based (Uniform) earnings, with a 16.7x Uniform P/E. At these levels, the market‚Ä¶ https://t.co/uAnMS3MdPk #equity #stocks https://t.co/fBa0GsOLNf",,,2015-03-03 17:15:05,"Paris, France",ResearchPool,https://pbs.twimg.com/profile_images/932829644558016512/Godn_LkX_normal.jpg,8971,4234,0,405156,ResearchPool,photo
531508324,2021-01-13 17:40:33,,,,1349486520269373442,False,0,0,0,0,Twitter for iPhone,POTUS did NOT Incyte anything!    Rioters not at speech.  WAKE up!   Check it out!!!!! Grrrrrrrrr,,,2012-03-20 14:11:12,"California, USA",Hopeful for 2022 Grandma,https://pbs.twimg.com/profile_images/847877829987454976/yotrU8-R_normal.jpg,159,101,1,7815,nenefled,
2344420430,2021-01-13 17:12:18,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1349479410827743233,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/J6tPsbUw2u",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
19265251,2021-01-13 13:41:15,,,"trainitright.com/incyte-and-mor‚Ä¶, pic.twitter.com/qvtVvEQLVi, ",1349426297806737413,False,0,0,0,0,New Blog Twitter Auto,Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab - https://t.co/rPH5DxPrSF https://t.co/qvtVvEQLVi,,,2009-01-20 18:46:03,"Toronto, Canada",Alicia Bell IFBB Pro,https://pbs.twimg.com/profile_images/1156307318520373250/BWD1YKuW_normal.jpg,9352,1372,264,79263,TrainItRight,photo
37016034,2021-01-13 11:08:38,,,"pic.twitter.com/5iAvOkIkAy, ",1349387891957321731,False,6,0,0,0,Twitter Web App,"Joining the @Incyte seminar series online today. This group is aiming to connect researchers working to better understand, and model, how nutrients (N, P) are connected to C cycling in the Earth system. https://t.co/5iAvOkIkAy","Incyte, ",,2009-05-01 15:13:16,"Flathead Lake, Montana","Dr. Jim Elser, PhD üá∫üá∏",https://pbs.twimg.com/profile_images/1430284433517473796/UGNImkAo_normal.jpg,4300,714,73,21352,DrLimnology,photo
4058194633,2021-01-13 10:54:34,"MOR, INCY, ","jobs, ","biospace.com/article/releas‚Ä¶, ",1349384351474020354,False,0,0,0,0,Twitter for iPhone,$MOR $INCY Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab | BioSpace https://t.co/vJrLosVZ8G #jobs,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1171873456276889600,2021-01-13 06:10:50,"MOR, ","MOR, 6K, Morphosys, News, ","docoh.com/filing/1340243‚Ä¶, ",1349312946384596992,False,0,0,0,0,Investor Feed,"$MOR  6-K  Morphosys   (13 Jan, 6:09am)

üì∞ MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab

https://t.co/bhrEoTWgBg

#MOR #6K #Morphosys #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1889492676,2021-01-13 04:19:19,"MOR, INCY, ","MorphoSys, Incyte, Tafasitamab, ","1stoncology.com/blog/morphosys‚Ä¶, ",1349284882971652098,False,0,0,0,0,Troi URL Plug-in,#MorphoSys and #Incyte Announce Acceptance by Health Canada of the New Drug Submission for #Tafasitamab $MOR $INCY https://t.co/NrHt234yrr,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
374729426,2021-01-13 00:26:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2456643, pic.twitter.com/K9oVpj2NgB, ",1349226391200428034,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on January 7, 2021. View odds for this and other indicators: https://t.co/S9zftvVLfw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/K9oVpj2NgB",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
620487016,2021-01-12 23:49:02,,,"dlvr.it/RqSThk, ",1349216866510786561,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab - BioSpace https://t.co/iGuN55ZBkv,,,2012-06-27 20:41:16,"USA, Alaska",Stem cell Watch,https://pbs.twimg.com/profile_images/2974988642/252972fe389b7bcf03c80859a4650e4c_normal.jpeg,3374,2235,73,21743,StemcellWatch,
208053736,2021-01-12 22:50:31,,,"chineselgz.com/2021/01/13/inc‚Ä¶, ",1349202137167912967,False,0,0,0,0,theglobe,(Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab ‚Äì BioSpace) has been published on chineselgz - https://t.co/Ea7coJKKA3,,,2010-10-26 10:57:19,Zieglerville PA,Wellcome-home,https://pbs.twimg.com/profile_images/1269342722/Becky_mug__428x640__normal.jpg,127,10,2,348028,Wellcome_Home,
1134049078424162304,2021-01-12 19:42:35,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1349154842028216324,False,0,0,0,0,Newsfilter.io,Incyte/MorphoSys' tafasitamab Canada application accepted for review $INCY $MOR https://t.co/nErX64TaBg,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
72928001,2021-01-12 19:12:54,"MOR, ",,"bit.ly/3seZiBv, ",1349147375734964224,False,0,0,0,0,BriefingInPlayLimited,$MOR: MorphoSys and Incyte announce that Health Canada has accepted the New Drug Submission for tafasitamab https://t.co/uDB1eJxA1c,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
208053736,2021-01-12 18:18:55,,,"PharmiWeb.com, chineselgz.com/2021/01/12/mor‚Ä¶, ",1349133789155483652,False,0,0,0,0,theglobe,(MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab ‚Äì https://t.co/OVxHk4a53S) has been published on chineselgz - https://t.co/iB9eUBNKuV,,,2010-10-26 10:57:19,Zieglerville PA,Wellcome-home,https://pbs.twimg.com/profile_images/1269342722/Becky_mug__428x640__normal.jpg,127,10,2,348028,Wellcome_Home,
1006334607946649600,2021-01-12 17:35:31,,,"dlvr.it/RqRjdm, ",1349122868504784898,False,0,0,0,0,dlvr.it,MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab https://t.co/cMe827Ao9v,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
531508324,2021-01-12 17:33:39,,,,1349122396934979587,False,0,0,0,0,Twitter for iPhone,Hey ........the rioters could NOT have been or heart POTUS speech Wed!!!!!!!!   You don‚Äôt know what you are doing Nancy!  Check it out ppl.  He did NOT Incyte anything.,,,2012-03-20 14:11:12,"California, USA",Hopeful for 2022 Grandma,https://pbs.twimg.com/profile_images/847877829987454976/yotrU8-R_normal.jpg,159,101,1,7815,nenefled,
166597717,2021-01-12 17:30:00,"MOR, INCY, ",,"bit.ly/38DqHoT, ",1349121477828898819,False,0,0,0,0,TweetDeck,"MorphoSys, Incyte say Health Canada accepts tafasitamab new drug submission $MOR $INCY https://t.co/vBWmUGHEKa",,,2010-07-14 11:10:34,Greater New York City Area,The Fly,https://pbs.twimg.com/profile_images/885896700472287233/NunLvfQW_normal.jpg,27381,167,0,106350,theflynews,
3318510966,2021-01-12 17:26:35,,,"crweworld.com/article/news-p‚Ä¶, ",1349120616855572480,False,0,0,0,0,CRWE World,MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab https://t.co/KMizy3mx5V,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
31720614,2021-01-12 16:44:47,,"news, pharma, clinicalresearch, biotech, lifesciences, medical, healthcare, pharmiweb, ","zpr.io/HW6n2, pic.twitter.com/8cy8gZ8rb7, ",1349110097704837120,False,0,0,0,0,Zapier.com,"MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
https://t.co/HNDmdSAA9k
#news #pharma #clinicalresearch #biotech #lifesciences #medical #healthcare #pharmiweb https://t.co/8cy8gZ8rb7",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,photo
1332189683082674177,2021-01-12 16:40:33,"INCY, MOR, ",,"beeken.io/bhlp?utm_conte‚Ä¶, pic.twitter.com/lSRA0ybEOk, ",1349109034826092545,False,0,0,0,0,dlvr.it,$INCY $MOR - MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab https://t.co/XqrwuTNGJ0 https://t.co/lSRA0ybEOk,,,2020-11-27 00:09:11,,Beeken Healthcare,https://pbs.twimg.com/profile_images/1332189760132055040/x0dGPU_H_normal.jpg,76,4,4,6579,Beeken_health,photo
1006334607946649600,2021-01-12 16:39:04,,"StockMarket, Stocks, ","dlvr.it/RqRZpt, ",1349108661168181250,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab https://t.co/RfPzgR2UX0 #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1245123506632830980,2021-01-12 16:37:52,"INCY, ",,,1349108358918381573,False,0,0,0,0,Twitter Web App,MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab $INCY,,,2020-03-31 19:00:01,,Zap_Trades,https://pbs.twimg.com/profile_images/1378048489205170176/yqhZY1JR_normal.jpg,12455,17,205,1530,Zap_Trades,
266143766,2021-01-12 16:31:38,"MOR, ",,"accesswire.com/624050/MorphoS‚Ä¶, ",1349106791196618754,False,0,0,0,0,Accesswire,$MOR MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab https://t.co/LnpI4Dz4Zi,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
1254035253104181256,2021-01-12 16:30:17,"MOR, ",,"stocktitan.net/news/MOR/morph‚Ä¶, ",1349106450019192832,False,0,0,0,0,stocktitan,"$MOR MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
https://t.co/rvOd65wLxf",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
3524211082,2021-01-12 16:22:05,,,"twib.in/l/K8BnxjrkoXo7, ",1349104385255731202,False,0,0,0,0,Twibble.io,Incyte/MorphoSys' tafasitamab Canada application accepted for review https://t.co/nijfMsLCWg,,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
3318510966,2021-01-12 16:20:54,,,"crweworld.com/article/news-p‚Ä¶, ",1349104087178960897,False,0,0,0,0,CRWE World,Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab https://t.co/ttKhwltp0Y,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
15296897,2021-01-12 16:15:15,"INCY, MOR, ",,"seekingalpha.com/news/3650854-i‚Ä¶, ",1349102667193217024,False,0,0,0,0,SANewsTwitter,$INCY $MOR - Incyte/MorphoSys' tafasitamab Canada application accepted for review https://t.co/jh7HuH99qk,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
176597920,2021-01-12 16:02:35,"INCY, ",,"newswire.ca/en/releases/ar‚Ä¶, ",1349099478096207874,False,0,0,0,2,Twitter Web App,$INCY and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab https://t.co/ECnlrfS1PO,,,2010-08-09 19:33:23,"Ghent, Belgium",Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,https://pbs.twimg.com/profile_images/957256474018934784/1n7evwD2_normal.jpg,943,137,17,37474,kevinjaybe,
1316039813745774593,2021-01-12 16:01:23,"INCY, ",,,1349099176966180864,False,1,0,0,0,Twitter Web App,$INCY - INCYTE AND MORPHOSYS ANNOUNCE ACCEPTANCE BY HEALTH CANADA OF THE NEW DRUG SUBMISSION FOR TAFASITAMAB,,,2020-10-13 11:36:04,,Inara Bright,https://pbs.twimg.com/profile_images/1327624325596327938/1aRR7fed_normal.jpg,550,60,23,9755,InaraBright,
42410755,2021-01-12 16:01:22,,,"dgap.de/dgap/News/corp‚Ä¶, ",1349099171853324289,False,0,1,0,0,DGAP_News_Int,MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab... https://t.co/iYcG70URHV,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
1344392231218679809,2021-01-12 14:44:27,,,,1349079814926319616,False,0,0,0,0,Twitter Web App,"If you are looking for a postdoc position, we have a really exciting opportunity through the Vanderbilt-Incyte alliance!",,,2020-12-30 16:17:53,Nashville is an amazing place!,Scott Hiebert,https://pbs.twimg.com/profile_images/1385262589819506688/YpJ3rSue_normal.jpg,27,59,1,21,ScottHiebert1,
374729426,2021-01-11 23:14:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2454353, pic.twitter.com/oXk1USuqeD, ",1348845784242872327,False,0,0,0,1,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on January 7, 2021. View odds for this and other indicators: https://t.co/gLUz4WV3fm #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/oXk1USuqeD",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
54713716,2021-01-11 16:23:04,"INCY, ","NASDAQ, Incyte, daVinci, algorithmic, daytrading, ","pic.twitter.com/dzJ9ApxZkg, ",1348742246418567169,False,1,0,0,0,Twitter Web App,"#NASDAQ | #Incyte Corp., $INCY, 3 out of 3, (+$3,610) today with #daVinci III, our 100% #algorithmic #daytrading model for all liquid markets! Trade with confidence, trade algorithms! Last end user licenses are available for MultiCharts, NinjaTrader Ecosystem or TradeStation... https://t.co/dzJ9ApxZkg",,,2009-07-07 19:07:52,"Miami, Florida  USA ",The Clockwork Group,https://pbs.twimg.com/profile_images/1180213543351803905/rLlPm7h__normal.jpg,1052,844,46,8572,ClockworkAlerts,photo
998915197061488645,2021-01-11 13:17:41,,,"cfc.umt.edu/research/incyt‚Ä¶, pic.twitter.com/iidBS3ODs3, ",1348695594538307584,False,21,1,0,16,Twitter Web App,"Our seminar series on nutrient cycles in Earth system models starts THIS WEDNESDAY! Be sure to register if you haven't already!

https://t.co/LGbjNtskHW https://t.co/iidBS3ODs3",,,2018-05-22 09:15:16,,INCyTE RCN,https://pbs.twimg.com/profile_images/1063085319887695873/d_uRHryG_normal.jpg,221,32,1,46,IncyteRcn,photo
1246206121087586311,2021-01-11 08:26:52,"ONCY, ",,"twitter.com/Mossytrading/s‚Ä¶, ",1348622405305061378,False,2,0,0,0,Twitter for iPhone,"Would not be surprised if someday Pfizer bought out $ONCY especially if collab on P2/P3 of Bracelet go well. ONCY is research, not commercial. That‚Äôs why they work with Big Pharma and to be derisked. Other big Pharma partners include Merck, BMS, Incyte, Celgene, and Aldai Nortye https://t.co/pUmKW7ZFEf",,,2020-04-03 18:41:16,"Florida, USA",Mossy,https://pbs.twimg.com/profile_images/1288465787817263105/xE365B_v_normal.jpg,547,35,11,532,Mossytrading,
732361939490312192,2021-01-11 01:24:54,"INCY, ","markets, ","americanbankingnews.com/?p=17917415, ",1348516216365871108,False,0,0,0,0,Zapier.com,Incyte Co. Expected to Earn FY2020 Earnings of -$1.32 Per Share $INCY https://t.co/QiXDfZv4M5 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-01-11 01:24:54,"INCY, ","stocks, ","americanbankingnews.com/?p=17917415, ",1348516214075756544,False,0,0,0,0,Zapier.com,Incyte Co. Expected to Earn FY2020 Earnings of -$1.32 Per Share $INCY https://t.co/651waRHPV5 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
801116888,2021-01-10 15:13:09,"INCY, ",,"pic.twitter.com/duq0liKQzW, ",1348362262399090689,False,5,0,0,0,Twitter Web App,"$INCY Incyte Corporation

retakes 200d MA and breaks out of value https://t.co/duq0liKQzW",,,2012-09-03 16:04:20,"New York, NY",Christian Fromhertz,https://pbs.twimg.com/profile_images/1088570898012090374/s1LnJoO-_normal.jpg,51418,1226,1638,51498,cfromhertz,photo
849417718642159616,2021-01-10 07:47:01,"INCY, ",,"zpr.io/HBAnn, ",1348249990129442816,False,0,0,0,0,Zapier.com,Incyte $INCY Research Coverage Started at Truist https://t.co/Oe7iARyERJ,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
969965639719931905,2021-01-10 06:31:41,,"ASH20, ","twitter.com/chanyooncheah/‚Ä¶, ",1348231029472059392,False,0,0,0,0,Twitter for iPhone,Excellent option for relapsed BTK naive Mantle Cell Lymphoma @Incyte #ASH20 https://t.co/fc4T6Fegv0,"Incyte, ",,2018-03-03 11:00:04,"Birmingham, AL","Amitkumar Mehta, MD",https://pbs.twimg.com/profile_images/969966673989050369/s-GUZ_nt_normal.jpg,412,828,5,495,Lymphoma_MD,
374729426,2021-01-09 23:13:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2449598, pic.twitter.com/LQERbNktql, ",1348120648363634691,False,0,0,0,1,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on January 7, 2021. View odds for this and other indicators: https://t.co/Ixfxjon1cd #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/LQERbNktql",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
4028839455,2021-01-09 21:15:04,,,"stocktrot.com/company/incyte‚Ä¶, ",1348090953375035395,False,0,0,0,0,StockTrot1,Confident Baker Bros Advisors Llc buys 686 of Incyte Corp shares. Largest in 2 months. https://t.co/Glm3Ox59RC,,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
20109018,2021-01-08 17:49:30,"TSLA, FFIV, NRG, INCY, ","valueinvesting, WarrenBuffett, investing, stocks, Marketing, ","pic.twitter.com/QDUZkJRAIO, pic.twitter.com/QDUZkJRAIO, pic.twitter.com/QDUZkJRAIO, pic.twitter.com/QDUZkJRAIO, ",1347676834570375168,False,1,0,0,1,Twitter Web App,"Market Movers in the S&amp;P 500:
Tesla Inc (7.84%) $TSLA
F5 Networks Inc (6.18%) $FFIV
NRG Energy Inc (4.30%) $NRG
Incyte Corp (4.19%) $INCY
#valueinvesting #WarrenBuffett #investing #stocks #Marketing https://t.co/QDUZkJRAIO",,,2009-02-04 19:15:37,United States,GuruFocus,https://pbs.twimg.com/profile_images/1238147123998310402/xlOiSkeR_normal.jpg,9359,185,337,74737,gurufocus,photo
17108702,2021-01-08 14:42:59,,"COVID19, SpoCougs, ","bit.ly/3rJ0VHe, pic.twitter.com/5TcvMOGuZC, ",1347629893467598848,False,2,0,0,0,TweetDeck,"Lots of #COVID19 tests today on campus! Testing continues through Jan. 22 for students and certain campus personnel.

More: https://t.co/HhHpu32pX4

Huge thanks to InCyte Diagnostics for their partnership!

#SpoCougs https://t.co/5TcvMOGuZC",,,2008-11-01 21:58:08,"Spokane, WA",WSU Spokane,https://pbs.twimg.com/profile_images/1438156757482622978/qY2opr2F_normal.jpg,6051,1306,202,13702,WSUSpokane,photo
3911174913,2021-01-08 14:00:01,,"dermatology, ",,1347619083961856001,False,13,0,0,3,Twitter for Advertisers.,"Our work in #dermatology is rooted in our expertise of the JAK-STAT pathway, implicated in a number of immune-mediated dermatologic conditions. Today, Incyte CEO Herv√© Hoppenot, spoke about our dermatology portfolio at the 2021 Dermatology Summit.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
732361939490312192,2021-01-08 07:29:35,"INCY, ","markets, ","americanbankingnews.com/?p=17892953, ",1347520828192206853,False,0,0,0,0,Zapier.com,Incyte Co. Expected to Earn FY2024 Earnings of $7.93 Per Share $INCY https://t.co/DvQHpQQwSt #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-01-08 07:29:35,"INCY, ","stocks, ","americanbankingnews.com/?p=17892953, ",1347520826376155139,False,1,0,0,0,Zapier.com,Incyte Co. Expected to Earn FY2024 Earnings of $7.93 Per Share $INCY https://t.co/nBbw1QlkCr #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2021-01-08 07:28:52,"INCY, ",,"tickerreport.com/?p=6906373, ",1347520647656841217,False,0,0,0,0,Zapier.com,Incyte Co. Expected to Earn FY2024 Earnings of $7.93 Per Share $INCY https://t.co/hneHLhCKO4,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
20109018,2021-01-07 17:52:42,"DXC, TSLA, INCY, EOG, ","valueinvesting, WarrenBuffett, investing, stocks, Marketing, ","pic.twitter.com/uSkdLfIITZ, pic.twitter.com/uSkdLfIITZ, pic.twitter.com/uSkdLfIITZ, pic.twitter.com/uSkdLfIITZ, ",1347315253193945089,False,3,0,0,2,Twitter Web App,"Market Movers in the S&amp;P 500:
DXC Technology Co (9.30%) $DXC
Tesla Inc (7.94%) $TSLA
Incyte Corp (6.80%) $INCY
EOG Resources Inc (6.46%) $EOG
#valueinvesting #WarrenBuffett #investing #stocks #Marketing https://t.co/uSkdLfIITZ",,,2009-02-04 19:15:37,United States,GuruFocus,https://pbs.twimg.com/profile_images/1238147123998310402/xlOiSkeR_normal.jpg,9359,185,337,74737,gurufocus,photo
2521230416,2021-01-07 16:44:51,,"WHY, ","twitter.com/MollyJongFast/‚Ä¶, ",1347298175359594496,False,0,0,0,0,Twitter for iPhone,"January 07th. 2021 {Thursday}
Mollyü§ÆJong-Fast, IS CROOKED DONALD J. TRUMP, INCYTE THIS TUGS AND MOB STORMED INSIDE THE US CAPITAL YESTERDAY? WHY SHOULD THE CONGRESS 435 MEMBERS TO IMPEACHING HIM AGAIN-??? THE BIG $1,000,000.00
QUESTION? #WHY?
THAT IS UP TO THE SENATE &amp; CONGRESS https://t.co/LWCwTLU4be",,,2014-05-24 15:55:23,,TesLu,https://pbs.twimg.com/profile_images/586636599984664576/7UvbeAP3_normal.jpg,168,1970,15,12006,loveusa808,
1250830691824283648,2021-01-07 14:57:39,"DXC, TSLA, MTB, LB, EOG, TER, INCY, CAG, OMC, CNP, ATO, FOX, TWTR, FDX, ",,,1347271198196043776,False,6,0,0,0,Twitter Web App,"Best and worst performing S&amp;P 500 stocks so far today

Best:
1 $DXC
2 Tesla $TSLA
3 M&amp;T Bank $MTB
4 L Brands $LB
5 $EOG
6 Teradyne $TER
7 Incyte $INCY

Worst:
1 Conagra $CAG
2 Omnicom $OMC
3 CenterPoint $CNP
4 Atmos $ATO
5 $FOX
6 Twitter $TWTR
7 FedEx $FDX",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
374729426,2021-01-07 14:47:30,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2444047, pic.twitter.com/x0np2u8gBh, ",1347268644879757313,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on January 6, 2021. View odds for this and other indicators: https://t.co/M9aCA04nd7 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/x0np2u8gBh",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
270492072,2021-01-07 11:36:12,,"news, ",,1347220501492424705,False,0,0,0,0,Microsoft Power Platform,Incyte initiated at buy with $120 price target at Truist Securities #news,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
3316713321,2021-01-07 11:17:47,,,"marketwatch.com/tools/quotes/q‚Ä¶, ",1347215867591839744,False,0,0,0,0,WordPress.com,Incyte initiated at buy with $120 price target at Truist¬†Securities https://t.co/qaoqUN9V6p,,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
1254906887490936845,2021-01-07 09:39:03,"INCY, ",,"quantdata.us/news/19058667, ",1347191019381600257,False,0,0,0,0,Quant Data (Production),"Truist Securities Initiates Coverage On Incyte with Buy Rating, Announces Price Target of $120

Related Tickers: $INCY
Read more at: https://t.co/fw4fMaBnE0",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
732361939490312192,2021-01-07 08:29:29,"INCY, ","markets, ","americanbankingnews.com/?p=17881537, ",1347173513849954309,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Analysts at Truist https://t.co/96Lck4QwNj #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-01-07 08:29:29,"INCY, ","stocks, ","americanbankingnews.com/?p=17881537, ",1347173512151228419,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Analysts at Truist https://t.co/m5rKw4rM3x #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2021-01-07 02:25:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2442864, pic.twitter.com/GqjkGuzeDL, ",1347081818730684417,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/bDocsYfzza #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GqjkGuzeDL,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1022006086872821762,2021-01-07 00:01:43,"INCY, INCY, ",,,1347045731128004608,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Wed Jan 06
Closed at 84.31 USD for a -1.82% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
1241782098739920897,2021-01-06 19:13:07,,,"deasilex.com/incyte-signs-d‚Ä¶, ",1346973099472924673,False,0,0,0,0,WordPress.com,Incyte signs development deal that aims to widen uses for blockbuster drug Jakafi ‚Äì Delaware Business¬†Now https://t.co/Kmn9oMwcMv,,,2020-03-22 13:41:50,,Lokesh Jaral,https://pbs.twimg.com/profile_images/1443127386803879936/GCD2wm-T_normal.jpg,22,13,0,85944,lokeshjaral1,
14453501,2021-01-06 18:25:38,,,"delawarebusinessnow.com/2021/01/incyte‚Ä¶, ",1346961150928445441,True,0,0,0,0,WordPress.com,Incyte signs development deal that aims to widen uses for blockbuster drug¬†Jakafi https://t.co/L4nSJls8iO,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
2344420430,2021-01-06 15:32:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1346917555043262468,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JACQUALYN A FOUSE:

https://t.co/CeHObdsd7C",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-06 15:18:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1346914032981323776,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

PAUL J CLANCY:

https://t.co/7J3BNWnF7h",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-06 10:49:22,"INCY, ",,"insideri.com/879169_0001638‚Ä¶, ",1346846328064770050,False,1,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

10%+ Owner

BAKER BROS. ADVISORS LP:

https://t.co/pcGUWajBqe",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1889492676,2021-01-06 04:05:36,"MOR, ","MorphoSys, Incyte, Swissmedic, MarketingAuthorizationApplication, Tafasitamab, ","1stoncology.com/blog/morphosys‚Ä¶, ",1346744715706654720,False,0,0,0,0,Troi URL Plug-in,#MorphoSys and #Incyte Announce the Acceptance of the #Swissmedic #MarketingAuthorizationApplication for #Tafasitamab $MOR https://t.co/cqs6POJ2B2,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
2344420430,2021-01-06 03:59:18,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1346743130268303361,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JEAN JACQUES BIENAIME:

https://t.co/CbhbteWkCj",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2021-01-06 02:02:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1346713710547656705,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

EDMUND HARRIGAN:

https://t.co/0Pevtpgrin",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
108617488,2021-01-05 19:00:09,,,"invst.ly/tct45, ",1346607450099765250,False,0,0,0,0,FP News Publisher - COM,Oppenheimer Stick to Their Buy Rating for Incyte Corp - https://t.co/PiwC6Z1RQe,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
772471873539977217,2021-01-05 16:47:08,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1346573977259487238,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/JetiDPCWKn,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
4058194633,2021-01-05 13:48:29,"MOR, INCY, ",,"uk.finance.yahoo.com/news/morphosys‚Ä¶, ",1346529015641698306,False,0,0,0,0,Twitter for iPhone,$MOR $INCY MorphoSys and Incyte Announce the Acceptance of the Swissmedic Marketing Authorization Application for Tafasitamab https://t.co/SyYIrR9uSk,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
72928001,2021-01-05 10:58:27,"MOR, ",,"bit.ly/3pUMvBV, ",1346486225117429760,False,0,0,0,0,BriefingInPlayLimited,$MOR: MorphoSys and Incyte (INCY) announce the acceptance of the Swissmedic Marketing Authorization Application for... https://t.co/d23r01m1Kw,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1250830691824283648,2021-01-05 10:58:16,"LAZR, FSLR, LI, XPEV, EBR, BBD, NIO, INCY, MRNA, FTNT, VRSN, GDRX, GSX, WPP, SUZ, ITUB, AU, VTRS, MRTX, ",,,1346486178506289165,False,6,0,0,0,Twitter Web App,"Worst performing large cap stocks so far today

Luminar $LAZR
First Solar $FSLR
LI Auto $LI
XPeng $XPEV
Centrais $EBR
Bradesco $BBD
$NIO
Incyte $INCY
Moderna $MRNA
Fortinet $FTNT
VeriSign $VRSN
GoodRx $GDRX
$GSX
$WPP
Suzano $SUZ
$ITUB
AngloGold $AU
Viatris $VTRS
Mirati $MRTX",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
261473143,2021-01-05 03:50:43,,,"morphosys.com/media-investor‚Ä¶, life-sciences-germany.com/news/vlfm-iito‚Ä¶, pic.twitter.com/MPIdeh2gxm, ",1346378583506362378,False,0,0,0,0,Twitter Web App,"MorphoSys and Incyte Announce Acceptance of Swissmedic Marketing Authorization Application for Tafasitamab https://t.co/MRZhdNzAxu @MorphoSys @Incyte More DACH Region life science business news at [LSG] at 
https://t.co/eHohMHA39N https://t.co/MPIdeh2gxm","MorphoSys, Incyte, ",,2011-03-05 20:26:19,"Bremen, Germany",[iito] Life Science,https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_normal.jpeg,2596,238,89,29254,iitoLifeScience,photo
221961207,2021-01-05 02:47:27,,,,1346362662784028672,False,0,0,0,0,IFTTT,MorphoSys and Incyte Announce the Acceptance of the Swissmedic Marketing Authorization Application for Tafasitamab - Yahoo Finance UK,,,2010-12-01 21:38:35,Switzerland,LGT Capital,https://pbs.twimg.com/profile_images/433244425427226624/Q5tCy83y_normal.jpeg,403,450,23,55072,lgtcaptial,
42410755,2021-01-05 02:01:40,,,"dgap.de/dgap/News/corp‚Ä¶, ",1346351139760046080,False,0,1,0,0,DGAP_News_Int,MorphoSys and Incyte Announce the Acceptance of the Swissmedic Marketing Authorization Application f... https://t.co/A7yWcseZHx,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
374729426,2021-01-05 00:29:43,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2438062, pic.twitter.com/hYnxMWdk3U, ",1346327999382052864,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/3K1h4WfjIH #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/hYnxMWdk3U,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1359077910,2021-01-04 12:30:12,,,"europharmajobs.com/job_display/19‚Ä¶, ",1346146926715166722,False,0,0,0,1,EPJ Jobs Post,"Director, Development Project Management, Incyte, Morges, Switzerland

https://t.co/zI4kTxoQ6E",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
1319230901969182720,2021-01-04 09:15:43,"INCY, ","INCY, Incyte, Guggenheim, ",,1346097986066124802,False,0,0,0,0,Twitter for iPhone,"Incyte (#INCY, $INCY) upgraded by Guggenheim from Neutral to Buy rating.
#Incyte #Guggenheim",,,2020-10-22 06:55:39,Europe,Karl Pikner,https://pbs.twimg.com/profile_images/1374487770022875139/kpLzo-ib_normal.jpg,58,271,0,4780,karlpikner,
732361939490312192,2021-01-04 08:28:29,"INCY, ","markets, ","americanbankingnews.com/?p=17841956, ",1346086098737520646,False,0,0,0,0,Zapier.com,Incyte $INCY Raised to ‚ÄúBuy‚Äù at Guggenheim https://t.co/UaVYMHs4mm #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2021-01-04 08:28:29,"INCY, ","stocks, ","americanbankingnews.com/?p=17841956, ",1346086096845893632,False,0,0,0,0,Zapier.com,Incyte $INCY Raised to ‚ÄúBuy‚Äù at Guggenheim https://t.co/T97xJridgV #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
15374640,2021-01-04 08:00:12,,,"twitter.com/Incyte/status/‚Ä¶, ",1346078978642227201,False,7,0,0,0,Twitter for Android,Did a double-take at the name of this business!! https://t.co/Y68UV175Cg,,,2008-07-10 02:06:28,"Stillwater, MN",Mac Wilson,https://pbs.twimg.com/profile_images/1428543255105445892/9r-iOWXM_normal.jpg,5421,1891,125,83588,cinatyte,
1280938376099741697,2021-01-03 21:56:13,,"iexStock, ","iexcloud.io, pic.twitter.com/LMxRyokecC, ",1345926983365103617,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Xcel Energy, Inc.
-Fiserv, Inc.
-National Bank of Ras Al Khaimah
-Commercial Bank International
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/LMxRyokecC",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2021-01-03 00:40:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2433534, pic.twitter.com/xO2NQdO6PN, ",1345606024208650244,False,1,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/vCgjP1KFwZ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xO2NQdO6PN,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2308886760,2021-01-02 18:28:50,,,"bit.ly/3864eQP, ",1345512406244585472,False,0,0,0,0,Twitter Web App,"Cancer Drug Therapy Market May See a Big Move : Major Giants Exelixis, Incyte, Merck https://t.co/d5zBIdgGEN",,,2014-01-24 14:57:59,,Cancer Drug Funding,https://pbs.twimg.com/profile_images/426807554472022016/0JT3z_do_normal.jpeg,70,73,5,263,CANAFFORD,
374729426,2021-01-02 01:02:15,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2431212, pic.twitter.com/7TZI6trZ3x, ",1345249023817441280,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/6NgVbS7qMt #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/7TZI6trZ3x,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280288213102292993,2020-12-31 15:12:50,,,"pharmabox.in/incyte-collabo‚Ä¶, ",1344738303791292430,False,0,0,0,0,Hootsuite Inc.,Incyte Collaborates with Cellenkos for CK0804 to Treat Myelofibrosis https://t.co/TRdi669Tot,,,2020-07-06 19:51:21,,WWW.PHARMABOX.IN,https://pbs.twimg.com/profile_images/1284027505058381827/7o7Mcyq1_normal.jpg,856,450,0,5397,pharmabox_in,
1134049078424162304,2020-12-31 12:01:42,"INCY, NVS, HALO, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1344690202300862464,False,0,0,0,0,Newsfilter.io,Incyte Partners With Cellenkos for Myelofibrosis Treatment $INCY $NVS $HALO $MOR https://t.co/AQfAz9LA3Z,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1022473214457348096,2020-12-31 08:12:08,,,"pharmashots.com/54234/incyte-c‚Ä¶, pic.twitter.com/2CZWwrODHM, ",1344632432994131968,False,0,0,0,0,Twitter Web App,"Incyte Collaborates with Cellenkos for CK0804 to Treat Myelofibrosis @Incyte 
https://t.co/hqk62YLkXG https://t.co/2CZWwrODHM","Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,photo
1889492676,2020-12-31 05:12:25,"INCY, ","Incyte, Cellenkos, CK0804, ","1stoncology.com/blog/incytecel‚Ä¶, ",1344587204828356608,False,1,0,0,0,Troi URL Plug-in,#Incyte and #Cellenkos Enter into Global Development Collaboration Agreement for #CK0804 $INCY https://t.co/icfWwMqfTO,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
227778014,2020-12-30 21:30:00,"YMAB, MRNA, RECI, ZLAB, INCY, ","COVID19, ","buff.ly/34ZC3RE, ",1344470835768119297,False,0,0,0,0,Buffer,"Dec. 30 Deal Quick Takes: Covaxx grants Aurobindo India, UNICEF exclusive rights to #COVID19 vax; plus Moderna-Recipharm, Y-mAbs-United Therapeutics, Zai-Cullinan &amp; Incyte-Cellenkos $YMAB $MRNA $RECI-B $ZLAB $INCY https://t.co/D98aE1vgx8",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
374729426,2020-12-30 17:55:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2425930, pic.twitter.com/EqfvV3cmOX, ",1344416967344570370,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on December 14, 2020. View odds for this and other indicators: https://t.co/BWl1wEWnr9 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/EqfvV3cmOX",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
916787510822436864,2020-12-30 15:55:51,"INCY, ",,"thestreet.com/investing/incy‚Ä¶, ",1344386743961837569,False,0,0,0,0,StockTwits Web,"$INCY Incyte Higher on Plan to Develop Treatment for Myelofibrosis

https://t.co/KQQqQ6rErE",,,2017-10-07 18:09:10,"New York, USA",Top Stock Alerts,https://pbs.twimg.com/profile_images/917029562432872449/VJbFmEQ0_normal.jpg,93095,0,955,158453,TopStockAlerts1,
15281391,2020-12-30 15:10:52,"INCY, ",,"thestreet.com/investing/incy‚Ä¶, ",1344375420582572034,False,2,0,0,0,Buffer,"Incyte ( $INCY ) and closely held biotech Cellenkos will work together to develop a therapy for patients with myelofibrosis, a rare blood cancer.
https://t.co/8L534u6HBW",,,2008-06-30 15:12:38,"New York, NY",TheStreet,https://pbs.twimg.com/profile_images/1438558308164644866/JLxN88qJ_normal.jpg,804747,1161,7179,215649,TheStreet,
270492072,2020-12-30 11:24:47,,"news, SeekingAlpha, ","seekingalpha.com/news/3647862-i‚Ä¶, ",1344318524005646337,False,0,0,0,0,Microsoft Power Platform,Incyte and Cellenkos inks global pact for development for CK0804 in MF patients https://t.co/oXLDYcqdfN via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
3063963289,2020-12-30 11:19:34,,,"seekingalpha.com/news/3647862-i‚Ä¶, ",1344317213306744835,False,0,0,0,0,Circleboom Twitter Management,‚ñ∂Ô∏é Incyte and Cellenkos inks global pact for development for CK0804 in MF patients https://t.co/MEqlBIeh9U VIŒõ WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö FINŒõNCIŒõL REŒõDS,,,2015-03-05 22:29:44,United States,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,https://pbs.twimg.com/profile_images/1131561059075145728/T_Tj4P-S_normal.jpg,2718,210,0,36814,WickedSplits,
3524211082,2020-12-30 11:18:16,,,"twib.in/l/GL4aRBoBXpLp, ",1344316886369128453,False,0,0,0,0,Twibble.io,Incyte and Cellenkos inks global pact for development for CK0804 in MF patients https://t.co/pDKHdWeuCg,,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
1134049078424162304,2020-12-30 11:12:33,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1344315446061916168,False,0,0,0,0,Newsfilter.io,Incyte and Cellenkos inks global pact for development for CK0804 in MF patients $INCY https://t.co/fXjZ7Za385,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1100450877792370688,2020-12-30 10:09:05,"INCY, ",,"blueequity.io/r/180420/de-in‚Ä¶, ",1344299474877698048,False,0,0,0,0,Blue Equity,$INCY Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804 https://t.co/toK4ut3zXU,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
3686628867,2020-12-30 10:03:59,,,"pharmaceuticaldaily.com/incyte-and-cel‚Ä¶, ",1344298192825933824,False,0,0,0,0,WordPress.com,Incyte and Cellenkos Enter into Global Development Collaboration Agreement for¬†CK0804 https://t.co/utHVAjIyQD,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
72928001,2020-12-30 09:34:14,"INCY, ",,"bit.ly/2MlH2px, ",1344290703707279360,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte and Cellenkos enter into global development collaboration agreement for CK0804 https://t.co/oNTdk3wMJD,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
3142088601,2020-12-30 08:21:03,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1344272287747420161,False,0,0,0,1,Twitter Web App,"Small deal in early Treg cell therapy space. Here they say it's off-the-shelf with no need of HLA-matching. I'm not sure I understand why.

Incyte $INCY and Cellenkos Enter into Global Development Collaboration Agreement for CK0804
https://t.co/aXd3XGHnO6",,,2015-04-06 18:27:23,"Lyon, France",Bertrand Delsuc,https://pbs.twimg.com/profile_images/1118239110018273280/DDy8QJv8_normal.png,8047,263,283,59416,BertrandBio,
472650465,2020-12-30 07:51:06,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1344264749979209728,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804 https://t.co/OadyNWkCiS,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1254906887490936845,2020-12-30 07:46:54,"INCY, ",,"quantdata.us/news/18964078, ",1344263695812202498,False,0,0,0,0,Quant Data (Production),"Incyte And Cellenkos Enter Into A Development Collaboration To Investigate The Combination Of Ruxolitinib And CK0804

Related Tickers: $INCY
Read more at: https://t.co/ERMbPhBMvh",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
1134049078424162304,2020-12-30 07:37:34,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1344261345362014215,False,0,0,0,0,Newsfilter.io,Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804 $INCY https://t.co/9FFJQEFFaZ,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3318510966,2020-12-30 07:35:03,,,"crweworld.com/article/news-p‚Ä¶, ",1344260712223309825,False,0,0,0,0,CRWE World,Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804 https://t.co/w2uAdL4bx7,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
976297820532518914,2020-12-30 07:33:05,,,"dlvr.it/RpbzcD, pic.twitter.com/5expwERJ44, ",1344260215412166656,False,0,0,0,0,dlvr.it,Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804 https://t.co/AA5eeTjQlM https://t.co/5expwERJ44,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2020-12-30 07:32:56,"INCY, ",,"s.flashalert.me/kEQlQJ, ",1344260177076383745,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on December 30, 07:30:00: Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804 https://t.co/7D07QNtO8W",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
47519668,2020-12-30 07:31:15,"INCY, ",,"tradethenews.com/?twtId=18902, ",1344259755313942529,False,2,0,0,0,Updates Poster,"$INCY Incyte and Cellenkos enter into global development collaboration agreement for CK0804; Incyte has an exclusive option to acquire sole rights to CK0804 (Incyte Corporation)
(More at https://t.co/kg0hMKAnx0)",,,2009-06-15 22:37:04,Global,TradeTheNews.com,https://pbs.twimg.com/profile_images/916119563191889920/ylR4h5y0_normal.jpg,21141,1222,761,53590,Trade_The_News,
176597920,2020-12-30 07:30:33,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1344259578540785665,False,0,0,0,0,Twitter Web App,$INCY Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804 https://t.co/vLAitY4XeR,,,2010-08-09 19:33:23,"Ghent, Belgium",Kevin Jacobs üáßüá™ üáµüá± üáÆüáπ üá™üá∫,https://pbs.twimg.com/profile_images/957256474018934784/1n7evwD2_normal.jpg,943,137,17,37474,kevinjaybe,
1254035253104181256,2020-12-30 07:30:24,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1344259543002279936,False,0,0,0,0,stocktitan,"$INCY Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804 
https://t.co/Ft3iqY7BLJ",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1282743073961803776,2020-12-29 12:30:04,"MRUS, ","tradingstocks, stockmarkets, ",,1343972566713720833,False,1,0,0,0,WallStreetSizingUp,"üö® Buy Alert
$52,800,000 or 11.0% worth of $MRUS - Merus N.V. shares were purchased or held on Dec 21 by INCYTE CORP totaling 3,200,000 shares!

Be the first to know about hedge fund trades stocktrade .tips #tradingstocks #stockmarkets",,,2020-07-13 14:26:33,Value to the grave,Face Ripper Mattx,https://pbs.twimg.com/profile_images/1441137255486160905/wFVwgqzR_normal.jpg,800,830,8,4388,Tradingheavy,
91353230,2020-12-29 09:00:00,,"MPNs, ","MPNUnlocked.org, pic.twitter.com/6wvLOCWEHl, ",1343919702267973640,False,7,0,1,3,Twitter Web App,"Unlocking Answers in MPN can help empower your community with knowledge so those impacted can make better and more informed decisions about their care. https://t.co/KkUJiF7nJL @CancerSupportHQ  #MPNs
@cancercare @MPN_RF @RareDiseases @power4patients @LLSusa @PVReporter &amp; @Incyte https://t.co/6wvLOCWEHl","CancerSupportHQ, CancerCare, MPN_RF, RareDiseases, power4patients, LLSusa, PVReporter, Incyte, ",,2009-11-20 09:41:50,1-888-793-9355,Cancer Support Community,https://pbs.twimg.com/profile_images/1402654851302047755/MCB5mCuz_normal.jpg,18438,2423,346,11316,CancerSupportHQ,video
185663478,2020-12-29 07:05:11,"MRUS, INCY, ",,"seekingalpha.com/news/3647634-m‚Ä¶, ",1343890805866569729,False,0,0,0,0,Twitter for iPhone,$MRUS rises 4% on Incyte stake disclosure. $INCY https://t.co/xGhCHk6bmS,,,2010-09-01 10:52:28,"Chicago, IL",CHItraders,https://pbs.twimg.com/profile_images/623935252357058560/AaeCRlHB_normal.jpg,1253,501,63,45319,CHItraders,
1370906497,2020-12-29 06:48:06,"MRUS, INCY, MRUS, ",,,1343886510119137281,False,0,0,0,0,Twitter Web App,"$MRUS  Incyte $INCY reported an 11% stake in $MRUS

Incyte and Merus entered into a collaboration and license agreement in December 2016 to conduct research, discover and develop up to 11 bispecific or monospecific antibodies using Merus' proprietary Biclonics technology platform",,,2013-04-21 20:38:27,U.S.A,MAISA,https://pbs.twimg.com/profile_images/3557296223/a73cb8bb8effbfd1f90590ab48523b10_normal.jpeg,2858,7,76,70211,MaisaCorp,
270492072,2020-12-29 06:24:15,,"news, SeekingAlpha, ","seekingalpha.com/news/3647634-m‚Ä¶, ",1343880507637960704,False,0,0,0,0,Microsoft Power Platform,Merus rises 4% on Incyte stake disclosure https://t.co/KUTQomjvlG via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
31372539,2020-12-29 05:59:32,,,"dlvr.it/RpXL83, ",1343874284729483265,False,0,0,0,0,dlvr.it,Merus rises 4% on Incyte stake disclosure https://t.co/VS4Bw1sMzR,,,2009-04-15 05:08:17,Amsterdam,Stocks tweets,https://pbs.twimg.com/profile_images/138834360/stocks1-avatar_normal.jpg,4407,3020,91,70157,stocks_tweets,
3524211082,2020-12-29 05:58:02,,,"twib.in/l/BKxpg9eaadjg, ",1343873908148228096,False,0,0,0,0,Twibble.io,Merus rises 4% on Incyte stake disclosure https://t.co/Wf3cd78mPn,,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
25406480,2020-12-29 05:55:48,,,"awesomecapital.blogspot.com/2020/12/merus-‚Ä¶, ",1343873348263141381,False,0,0,0,1,Twitter Web App,AwesomeCapital: Merus rises on Incyte stake disclosure https://t.co/bVeeS4Dljx,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
1134049078424162304,2020-12-29 05:53:45,"MRUS, INCY, ",,"newsfilter.io/articles/merus‚Ä¶, ",1343872830849605633,False,0,0,0,0,Newsfilter.io,Merus rises 4% on Incyte stake disclosure $MRUS $INCY https://t.co/NGlflE0TXy,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2020-12-29 05:51:45,"MRUS, INCY, ",,"seekingalpha.com/news/3647634-m‚Ä¶, ",1343872325846888448,False,1,0,0,0,SANewsTwitter,$MRUS $INCY - Merus rises 4% on Incyte stake disclosure https://t.co/BieddjysEk,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1134049078424162304,2020-12-28 22:54:44,"INCY, ",,"newsfilter.io/articles/sc-13‚Ä¶, ",1343767380082778112,False,0,0,0,0,Newsfilter.io,Form SC 13D (general statement of acquisition of beneficial ownership) filed with the SEC $INCY https://t.co/QZYjju57xx,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
374729426,2020-12-28 17:53:34,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2422018, pic.twitter.com/xuSe7Pzy8f, ",1343691592192860160,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/OmMsCunugI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xuSe7Pzy8f,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
799069924450766848,2020-12-28 16:20:07,"MRUS, ",,"itunes.apple.com/us/app/apple-s‚Ä¶, ",1343668074390630400,False,1,0,0,0,InsiderForms,"$MRUS INCyte CORP has filed Form SC 13D with SEC. Reporting 11.0% Ownership.

https://t.co/t5CkFUZh7T",,,2016-11-16 21:01:30,United States,Insider Forms,https://pbs.twimg.com/profile_images/1448375542013628418/Dbx6hCfO_normal.jpg,2877,0,67,46526,InsiderForms,
1319637643739750401,2020-12-28 16:15:17,"MRUS, ",,,1343666857379770371,False,0,0,0,0,Twitter Web App,"$MRUS
BZ: Merus 13D Shows 11% Active Stake From Incyte Corporation",,,2020-10-23 09:51:54,Earth,The Stock Dude,https://pbs.twimg.com/profile_images/1319641163998105600/Oh_cqzRc_normal.jpg,122,6,3,3013,TheStockWire,
4312114277,2020-12-28 16:09:57,"MRUS, ",,"fintel.io/so/us/mrus?utm‚Ä¶, ",1343665516783816711,False,1,0,0,0,Fintel.io,"Incyte Corp has filed a new activist 13D, reporting 11.0% ownership in $MRUS - https://t.co/TyZbSV1AAa",,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
374729426,2020-12-26 17:02:29,"INCY, ","Incyte, stockmarket, stock, money, trading, investing, daytrading, news, today, ","srnk.us/go/2419401, pic.twitter.com/95zVGcMIMw, ",1342953959271530497,False,0,0,0,0,Tickeron,A.I.dvisor is predicting $INCY is about to move higher. View odds of uptrend. #Incyte #stockmarket #stock #money #trading #investing #daytrading #news #today https://t.co/BUJaHYkEJ2 https://t.co/95zVGcMIMw,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1359077910,2020-12-24 12:30:10,,,"europharmajobs.com/job_display/19‚Ä¶, ",1342160654262800384,False,0,0,0,0,EPJ Jobs Post,"Manager/Senior Manager QA GCP, Incyte, Morges, Switzerland

https://t.co/G8Q9ghDKaE",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
373351502,2020-12-24 06:48:19,,"ClinicalResearch, ClinicalTrials, DataManagement, EDC, ","trialstat.com/2020/12/incyte‚Ä¶, ",1342074624423702536,False,1,0,0,0,TrialStat-WP2Twtr,"Incyte Announces Results of Phase 3 December 24, 2020 https://t.co/EMeu0Sqymr #ClinicalResearch #ClinicalTrials #DataManagement #EDC",,,2011-09-14 08:39:14,"Toronto, On, Canada",Trialstat Solutions,https://pbs.twimg.com/profile_images/1225452754673586176/m7P2CQ6-_normal.jpg,11,11,2,700,TrialStatEDC,
105211066,2020-12-24 05:46:55,,"IT, advancedmanufacturing, Delaware, ","twitter.com/DelawareGlobal‚Ä¶, ",1342059170334441472,False,3,0,0,0,Twitter for Android,Congratulations @UDelaware for @NIH support. @NIIMBL  @Delaware_Bio  @DE_Innovates and all the @biopharma  #IT #advancedmanufacturing  @GeneEditingDE companies like @Incyte  @ILCDover and more makes #Delaware the place to locate. @WTCDelaware @choosedelaware @ChooseCentralDE https://t.co/GXorBwKGTo,"UDelaware, NIH, NIIMBL, Delaware_Bio, DE_Innovates, Biopharma, GeneEditingDE, Incyte, ILCDover, WTCDelaware, choosedelaware, ChooseCentralDE, ",,2010-01-15 13:04:08,USA,Carla Sydney Stone,https://pbs.twimg.com/profile_images/1410306106904154122/VaGs1oHM_normal.png,497,1482,39,6167,carlastoneintl,
1280938376099741697,2020-12-23 16:17:49,,"iexStock, ","iexcloud.io, pic.twitter.com/C7nhipPat9, ",1341855553790853123,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Oman &amp; Emirates Investment Holding Co. S
-Cognizant Technology Solutions Corp. - C
-ASML Holding NV - New York Shares
-Incyte Corp.
-Waha Capital PJSC.

Data provided by https://t.co/oXreiEXTgd https://t.co/C7nhipPat9",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2020-12-23 12:28:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2414943, pic.twitter.com/WwKQqLUVJB, ",1341797967062126592,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/ufLy3th8RW #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/WwKQqLUVJB,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
374729426,2020-12-23 12:07:27,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","srnk.us/go/2414909, pic.twitter.com/AHQ3XPKUwU, ",1341792547962642437,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on December 14, 2020. View odds for this and other indicators: https://t.co/yxjibZccSv #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/AHQ3XPKUwU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280938376099741697,2020-12-22 17:56:02,,"iexStock, ","iexcloud.io, pic.twitter.com/EVKEaX1tH9, ",1341517882728046594,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Xcel Energy, Inc.
-National Bank of Ras Al Khaimah
-Trip.com Group Ltd - ADR
-NXP Semiconductors NV
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/EVKEaX1tH9",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
4597733961,2020-12-22 02:44:01,"INCY, ","lymphoma, clinicaltrials, parsaclisib, ",,1341288367514914816,False,1,0,0,0,Twitter Web App,"Demiurge AI-based #lymphoma #clinicaltrials outcome predictions put to the public test (285_2020): 

SUCCESS for 
#parsaclisib / NCT03144674 / @Incyte $INCY","Incyte, ",,2015-12-25 02:43:29,Switzerland,DemiurgeTech,https://pbs.twimg.com/profile_images/1227148848386265089/aqLPaCF4_normal.jpg,303,540,4,569,DemiurgeTech,
1280938376099741697,2020-12-21 22:17:46,,"iexStock, ","iexcloud.io, pic.twitter.com/O5lVryk7In, ",1341221364330541058,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Emirates Driving Company
-Baidu Inc - ADR
-Incyte Corp.
-Check Point Software Technolgies
-Amazon.com Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/O5lVryk7In",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-12-21 20:51:05,,"iexStock, ","iexcloud.io, pic.twitter.com/WoqdRXUjXu, ",1341199547603820544,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Verisk Analytics Inc
-Incyte Corp.
-United Arab Bank
-AL-Fujairah Cement Industries Co.
-Microchip Technology, Inc.

Data provided by https://t.co/oXreiEXTgd https://t.co/WoqdRXUjXu",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
948362732,2020-12-21 14:07:57,,,"delawarebusinesstimes.com/news-briefs/in‚Ä¶, ",1341098097116639236,False,0,0,0,0,Twitter Web App,"Thank you, @Incyte!  Incyte donates $150,000 to Food Bank of Delaware https://t.co/4GahPZnOs9","Incyte, ",,2012-11-14 14:39:39,,MidAtLocal,https://pbs.twimg.com/profile_images/1349383823981748224/dH59lLK4_normal.jpg,10,325,0,3881,OrnamentalGlee,
374729426,2020-12-21 11:26:03,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2411595, pic.twitter.com/eS4GkMuy0z, ",1341057352057831429,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on December 14, 2020. View odds for this and other indicators: https://t.co/QgsTcuLoth #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/eS4GkMuy0z",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
14586896,2020-12-21 06:00:08,,,"wdel.com/news/delaware-‚Ä¶, ",1340975335828013058,False,0,1,0,0,BLOX CMS,Delaware-based Incyte said a study using their commercially available drug ruxolitinib¬†(Jakafi¬Æ) did not meet desired results in treating symptoms of COVID-19. https://t.co/QYQyzRW8Lr,,,2008-04-29 12:27:52,"Wilmington, DE",101.7FM / 1150AM WDEL,https://pbs.twimg.com/profile_images/1166719920442396677/Iq8iWG3__normal.jpg,16412,1230,366,60576,WDEL,
1280938376099741697,2020-12-20 16:59:15,,"iexStock, ","iexcloud.io, pic.twitter.com/XcsXGJGyZ4, ",1340778817468686342,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-JD.com Inc - ADR
-Insurance House P.S.C
-Take-Two Interactive Software, Inc.
-Costco Wholesale Corp

Data provided by https://t.co/oXreiEXTgd https://t.co/XcsXGJGyZ4",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2020-12-20 10:08:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2408524, pic.twitter.com/pvrKhJwpg1, ",1340675353908400128,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on December 14, 2020. View odds for this and other indicators: https://t.co/sTqiJrquit #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/pvrKhJwpg1",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1241782098739920897,2020-12-20 01:23:43,,,"deasilex.com/study-incyte-d‚Ä¶, ",1340543382540718080,False,0,0,0,0,WordPress.com,Study: Incyte drug ineffective in fighting COVID-19 effects ‚Äì¬†DBT https://t.co/slaj7QW0T5,,,2020-03-22 13:41:50,,Lokesh Jaral,https://pbs.twimg.com/profile_images/1443127386803879936/GCD2wm-T_normal.jpg,22,13,0,85944,lokeshjaral1,
1280938376099741697,2020-12-19 20:13:50,,"iexStock, ","iexcloud.io, pic.twitter.com/Xvig2KI6En, ",1340465398504931334,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Al-Wathba Insurance
-Al Qudra Holding
-Mylan N.V.
-Cognizant Technology Solutions Corp. - C

Data provided by https://t.co/oXreiEXTgd https://t.co/Xvig2KI6En",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2020-12-19 16:24:35,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2406312, pic.twitter.com/x0fdvEX7Ua, ",1340407708336312320,False,1,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on December 14, 2020. View odds for this and other indicators: https://t.co/hyI2QFXb2g #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/x0fdvEX7Ua",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280938376099741697,2020-12-19 09:40:09,,"iexStock, ","iexcloud.io, pic.twitter.com/6SRAp7UUgq, ",1340305927392604162,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Applied Materials Inc.
-Incyte Corp.
-Ulta Beauty Inc
-Sharjah Insurance Co.
-Abu Dhabi National Co. for Building Mate

Data provided by https://t.co/oXreiEXTgd https://t.co/6SRAp7UUgq",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
29549589,2020-12-19 03:52:43,,"Yverdon, Construction, Management, Jobs, ","g.drctry.biz/r/stwHE, ",1340218493183135747,False,0,0,0,0,Engineering Daily ,[Job] Production Operator/Technician | Company: Incyte Corporation | Location: Yverdon-Les-Bains VD  Switzerland | #Yverdon-Les-Bains #Construction #Management #Jobs | More info at  https://t.co/LyWKDNnJEi,,,2009-04-07 17:25:22,"Atlanta, GA USA",Engineering Daily,https://pbs.twimg.com/profile_images/445765099626582016/cXn6S9kL_normal.png,16933,1915,385,1338778,EngineersDay,
1309949778197962752,2020-12-18 19:15:38,"KSPILI, TDOC, TAK, SURF, SDGR, IONS, INCY, CDXS, BLI, U, KMTUY, CRSP, ARCT, XONE, ",,"pic.twitter.com/RHSxI0UdLA, ",1340088365081911302,False,53,1,0,9,Twitter Web App,"Cathie Wood &amp; @ARKInvest trade activity from today 12/18

Bought: $KSPILI Teladoc $TDOC Takeda $TAK Surface Oncology $SURF Schrodinger $SDGR Ionis $IONS Incyte $INCY Codexis $CDXS Berkely $BLI Unity $U Komatsu $KMTUY

Sold: Crispr $CRSP Arctrurus $ARCT Exone $XONE https://t.co/RHSxI0UdLA","ARKInvest, ",,2020-09-26 16:15:48,,Ark invest activity (Not affiliated with Ark),https://pbs.twimg.com/profile_images/1363187693816012806/0BZEmb6R_normal.jpg,78268,182,1006,1529,ArkkDaily,photo
1280938376099741697,2020-12-18 18:27:40,,"iexStock, ","iexcloud.io, pic.twitter.com/yNRYabyfVx, ",1340076294759993360,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Incyte Corp.
-Sharjah Group
-Foodco Holding
-American Airlines Group Inc
-Liberty Global plc - Class A

Data provided by https://t.co/oXreiEXTgd https://t.co/yNRYabyfVx",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
19347960,2020-12-18 12:44:17,,"netde, covid19relief, ","ow.ly/d4pa50CPuM2, ",1339989879225266178,False,3,0,0,0,Hootsuite Inc.,"New blog post: @Incyte donates $150,000 to Food Bank of Delaware - THANK YOU! #netde #covid19relief https://t.co/D52PsJGh3T","Incyte, ",,2009-01-22 12:03:05,"√úT: 30.16336,-97.44502",Food Bank of DE,https://pbs.twimg.com/profile_images/79342306/TwitterLogo_normal.jpg,7518,2389,257,10759,FoodBankofDE,
374729426,2020-12-18 11:12:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2403266, pic.twitter.com/w54tZ5Yg5O, ",1339966684187095045,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on December 14, 2020. View odds for this and other indicators: https://t.co/BQyKUdQgzw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/w54tZ5Yg5O",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
244775645,2020-12-18 07:45:16,,,"businesswire.com/news/home/2020‚Ä¶, bddy.me/34A62hy, pic.twitter.com/H8DYs4OwkU, ",1339914630228029441,False,0,0,0,0,Twitter for iPhone,"Ruxolitinib fails to show benefit in COVID-19-associated cytokine storm
https://t.co/3H62OLIvCs

Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/H8DYs4OwkU",,,2011-01-29 22:22:56,,Gerald R. Businaro,https://pbs.twimg.com/profile_images/1262053717630738434/-0KG84gE_normal.jpg,430,481,5,97800,grbusinaro,photo
374729426,2020-12-17 15:20:21,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2400816, pic.twitter.com/NnJGF8guvP, ",1339666766956355584,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on November 18, 2020. View odds for this and other indicators: https://t.co/2s8c0A84oW #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/NnJGF8guvP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
27645777,2020-12-17 14:27:15,,"ASH20, ","bit.ly/38tk8Eb, pic.twitter.com/2pmWw7IRcv, ",1339653401295151105,False,1,0,0,2,TweetDeck,"NEW Perspective from #ASH20 - Sergio A. Giralt, MD (@sgiraltbmtdoc)
@sloan_kettering analyses study showing ruxolitinib is effective as second-line therapy for chronic GVHD https://t.co/CrwOHw7Iza @ASH_hematology @Incyte https://t.co/2pmWw7IRcv","sgiraltbmtdoc, sloan_kettering, ASH_hematology, Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
1314280236679270401,2020-12-17 00:14:36,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1339438828696825857,False,0,0,0,1,Twitter,"12/16/2020
üî•üî• 13 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $2,917,161 | 33830 Shares
Streak Total: $25,720,730 | 306460 Shares
Daily Close: $86.23 (-0.05%) ‚¨áÔ∏è
Prev Close: $86.27
W.Avg Streak Price: $83.93
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
1001523981500014592,2020-12-16 20:10:32,,"jobs, hiring, Wilmington, Delaware, USA, ","dlvr.it/Rnnthk, ",1339377406939865088,False,0,0,0,0,dlvr.it,"#jobs #hiring #Wilmington #Delaware #USA Desktop Support Analyst: Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical needs in oncology and inflammation and‚Ä¶ https://t.co/R9oxaX2HaQ",,,2018-05-29 14:01:39,United States,Empleos.io,https://pbs.twimg.com/profile_images/1002198831470178305/0-DY_Jrn_normal.jpg,127,76,6,95846,EmpleosIO,
1280938376099741697,2020-12-16 15:35:47,,"iexStock, ","iexcloud.io, pic.twitter.com/BmsTG1pQ70, ",1339308263544909827,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Activision Blizzard Inc
-Expedia Group Inc
-Sharjah Group
-Incyte Corp.
-CSX Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/BmsTG1pQ70",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1337510302167019520,2020-12-16 15:01:39,,,"beta.firstwordpharma.com/story/5176235, ",1339299672293314560,False,0,0,0,0,Twitter Web App,"Novartis, Incyte's Jakafi fails to hit main study goal in COVID-19-associated cytokine storm https://t.co/wxNkMouBXo via @fwpharma","fwpharma, ",,2020-12-11 16:31:51,,Luis Sales,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1,58,0,325,LuisSal74810411,
600761096,2020-12-16 13:10:06,,"COVID19, ","twitter.com/Incyte/status/‚Ä¶, ",1339271601204981763,False,3,0,0,0,Sprout Social,Congrats to @Incyte and @LillyPad on the new #COVID19 combination treatment data! https://t.co/yDebcEzYbX,"Incyte, LillyPad, ",,2012-06-06 03:22:16,"San Francisco, Boston, Zurich",Benchling,https://pbs.twimg.com/profile_images/1410630701054152712/aMVPvSOB_normal.jpg,7631,2033,182,3926,benchling,
374729426,2020-12-16 12:37:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2397802, pic.twitter.com/3YGJXz4eG2, ",1339263393350369281,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/fY211Bdutx #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/3YGJXz4eG2,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1314280236679270401,2020-12-16 01:48:36,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1339100092691869696,False,0,1,0,0,Twitter,"12/15/2020
üî•üî• 12 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $1,373,418 | 15920 Shares
Streak Total: $22,803,569 | 272630 Shares
Daily Close: $86.27 (-0.62%) ‚¨áÔ∏è
Prev Close: $86.81
W.Avg Streak Price: $83.64
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
1280938376099741697,2020-12-16 00:06:39,,"iexStock, ","iexcloud.io, pic.twitter.com/wbvWSJ2lWu, ",1339074437304504321,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
-Abu Dhabi National Oil Company For Distr
-Monster Beverage Corp.
-Apple Inc
-Commercial Bank International
-Incyte Corp.

Data provided by https://t.co/oXreiEXTgd https://t.co/wbvWSJ2lWu",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2344420430,2020-12-15 16:57:26,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1338966420768628737,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/WMQTck4ZSH",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
374729426,2020-12-15 13:07:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2394997, pic.twitter.com/Gx367IKmgZ, ",1338908647510851585,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators: https://t.co/EsyR4Aj2IW #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Gx367IKmgZ,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
128675087,2020-12-15 11:13:20,,"COVID19, ","biospace.com/article/incyte‚Ä¶, ",1338879826107772930,False,0,0,0,0,Twitter Web App,Incyte and Novartis' Jakafi Fails to Reduce COVID-19 Associated Cytokine Storm Complications  | BioSpace https://t.co/mln5YuEZ1d #COVID19,,,2010-04-01 17:21:22,"Bloomingdale, IL",Alex Keown,https://pbs.twimg.com/profile_images/980604478796779520/cK-5jyo__normal.jpg,1482,1089,38,18662,alexkeown,
888490605848010752,2020-12-15 10:09:02,,"ruxolitinib, COVID19, ","bit.ly/2IPVuEK, ",1338863645908877317,False,1,0,0,0,Sprout Social,"I have had the privilege to partner with @Novartis and @Incyte on the RUXCOVID study, a study of #ruxolitinib for COVID-19. I'm recognizing my colleagues and why not every treatment will be approved for #COVID19 on my blog, https://t.co/DQB4d3ZhrV.","Novartis, Incyte, ",,2017-07-21 16:07:22,,MeiLan Han,https://pbs.twimg.com/profile_images/1284188364024025088/lAASqZty_normal.jpg,1127,901,7,574,meilan_han,
1156133747852374016,2020-12-15 07:28:15,,"Gannex, US, NASH, drug, ASC42, FXR, Incyte, Ruxolitinib, RUXCOVID, COVID19, Cytokine, ",,1338823183034580992,False,0,0,1,0,Twitter Web App,"Recent Pharma News and Updates:
#Gannex received #US @US_FDA fast track designation for its #NASH #drug, #ASC42 an #FXR Agonist.

#Incyte‚Äôs #Ruxolitinib failed to meet Primary Endpoint in the Phase 3 #RUXCOVID Study for #COVID19 Associated #Cytokine Storm.","US_FDA, ",,2019-07-30 05:25:40,New Delhi,DelveInsight,https://pbs.twimg.com/profile_images/1222806973487255552/pWZKXuZ9_normal.jpg,122,1363,1,2930,delve_insight,
2269169061,2020-12-15 07:27:43,,,"newsbreakapp.com/n/0Y06t0bX?s=a‚Ä¶, ",1338823048556924928,False,0,0,0,0,Twitter for Android,"Another company that's rushing to get 
a vaccine on the market 

Study: Incyte drug ineffective in fighting COVID-19 effects https://t.co/pTRkfurqSg",,,2014-01-08 12:25:33,somewherelse and wereever the ,hameen tariq,https://pbs.twimg.com/profile_images/1302111928353992710/MhsipAxh_normal.jpg,1338,3939,3,11761,hameentariq,
1079749795823214594,2020-12-15 05:10:19,"FOLD, INCY, REGN, BMRM, ","biotech, Amicus, Incyte, Regeneron, Biomarin, NASDAQ, SP500, trading, investing, stocks, fintech, fintwit, USA, ","pic.twitter.com/ybAmYe6BMh, pic.twitter.com/ybAmYe6BMh, pic.twitter.com/ybAmYe6BMh, pic.twitter.com/ybAmYe6BMh, ",1338788469204783104,False,0,0,0,0,Twitter Web App,"Some big movers in the #biotech world yesterday. #Amicus up 8% #Incyte up 6% #Regeneron up 4% &amp; #Biomarin up 4%. 

See charts. Key: above the cloud ""In Buy Below ""In Sell"" 
$FOLD $INCY $REGN $BMRM #NASDAQ #SP500 #trading #investing #stocks #fintech #fintwit #USA https://t.co/ybAmYe6BMh",,,2018-12-31 09:43:06,Leeds,The Flying Stocksman,https://pbs.twimg.com/profile_images/1338104605901807616/mj9Jjtta_normal.jpg,3283,178,59,13749,flyingstocksman,photo
991050830194331649,2020-12-15 04:52:51,,"jobs, ","biospace.com/article/releas‚Ä¶, ",1338784076493447170,False,0,0,0,0,Twitter Web App,Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm | BioSpace https://t.co/ikwFClyRVK #jobs,,,2018-04-30 16:25:05,"Brighton, England",Vikesh Gudka,https://pbs.twimg.com/profile_images/1001956773903917057/eyhfx3MY_normal.jpg,142,369,0,3158,PharmaVik,
4035355935,2020-12-15 02:42:52,,,,1338751365120606215,False,0,0,0,0,WPTS Playlist,Incyte - Numbers,,,2015-10-24 21:01:50,"Pittsburgh, PA",WPTS Playlist,https://pbs.twimg.com/profile_images/658129792408023041/8nflCFL-_normal.jpg,478,5,38,638221,WPTSPlaylist,
977218325968244738,2020-12-15 01:49:05,"ARGX, ",,"bloomberg.com/news/articles/‚Ä¶, ",1338737827203457024,False,14,2,0,4,Twitter for iPad,"Argenx: potential acquisition target $ARGX
‚ÄúNotable outperformers ranged from Arvinas Inc. to Apellis Pharmaceuticals Inc., Argenx SE, and Incyte Corp. all of which Wall Street is betting on as potential acquisition targets as deals pick up.‚Äù
https://t.co/HcEZzHAlHh",,,2018-03-23 12:19:39,,Lama Daila,https://pbs.twimg.com/profile_images/977220741920944129/VBNq6vs__normal.jpg,1265,87,13,3165,Lama_Daila,
1151214967577829376,2020-12-15 01:22:32,,"Novartis, Incyte, Jakafi, COVID, ","ow.ly/7pFo50CLA4K, pic.twitter.com/YJXsPPMnTQ, ",1338731145207418880,False,0,0,0,0,Hootsuite Inc.,"#Novartis-#Incyte's #Jakafi fails to cut severe complications in #COVID-19 study 
https://t.co/JAjQysiXxY https://t.co/YJXsPPMnTQ",,,2019-07-16 15:40:11,Global,Market Intelligence: Healthcare,https://pbs.twimg.com/profile_images/1176596064096391169/Mf7mREWc_normal.jpg,473,410,13,3475,SPGMIHealthcare,photo
1211359842805268480,2020-12-14 23:14:39,,,"fxnews24.co.uk/stock/buzz-u-s‚Ä¶, ",1338698963340455937,False,0,0,0,0,WordPress.com,"BUZZ-U.S. STOCKS ON THE MOVE-Incyte, Veru,¬†Doordash https://t.co/9504UctNdh",,,2019-12-29 13:54:34,,FXNews24.co.uk,https://pbs.twimg.com/profile_images/1213129219066269701/Tw0PNtTi_normal.png,91,0,0,92075,DavidGr52957428,
1314280236679270401,2020-12-14 21:27:36,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1338672022801559553,False,1,0,0,1,Twitter,"12/14/2020
üî•üî• 11 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $3,195,910 | 36815 Shares
Streak Total: $21,430,152 | 256710 Shares
Daily Close: $86.81 (6.78%) ‚¨ÜÔ∏è
Prev Close: $81.30
W.Avg Streak Price: $83.48
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
227778014,2020-12-14 19:30:09,"INCY, INO, CVAC, ","COVID19, ","buff.ly/2Wi5Tw9, ",1338642466476535809,False,0,0,0,0,Buffer,"In .@BioCentury's latest #COVID19 roundup, Ph3 cytokine storm miss for $INCY-$NVS's Jakafi, vax-induced anti-HIV antibodies doom University of Queensland's COVID vaccine, plus Sputnik V final efficacy &amp; Ph2 starts for $INO, $CVAC vaccines https://t.co/4ptAVzj5Di","BioCentury, ",,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13037,1543,387,33073,BioCentury,
3460109487,2020-12-14 19:30:00,,"Covid19, ","endpts.com/covid-19-round‚Ä¶, ",1338642429969305601,False,1,0,0,0,TweetDeck,"Don't miss today's #Covid19 roundup: As Americans wait to receive the first doses of Pfizer and BioNTech‚Äôs recently authorized vaccine, President Donald Trump is walking back plans for White House staffers to be prioritized first.

https://t.co/Pbh1YTiBcL",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
14453501,2020-12-14 19:10:05,,,"delawarebusinessnow.com/2020/12/incyte‚Ä¶, ",1338637414743601152,True,0,0,0,0,WordPress.com,Incyte announces disappointing results in using Jakafi to treat Covid-19‚Äôs cytokine¬†storm https://t.co/SSYQoXCE9c,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
20109018,2020-12-14 17:54:21,"ALXN, INCY, ROL, REGN, ","valueinvesting, WarrenBuffett, investing, stocks, Marketing, ","pic.twitter.com/eHUuqKiG6p, pic.twitter.com/eHUuqKiG6p, pic.twitter.com/eHUuqKiG6p, pic.twitter.com/eHUuqKiG6p, ",1338618357348700161,False,2,0,0,1,Twitter Web App,"Market Movers in the S&amp;P 500:
Alexion Pharmaceuticals Inc (29.20%) $ALXN
Incyte Corp (6.77%) $INCY
Rollins Inc (4.88%) $ROL
Regeneron Pharmaceuticals Inc (4.29%) $REGN
#valueinvesting #WarrenBuffett #investing #stocks #Marketing https://t.co/eHUuqKiG6p",,,2009-02-04 19:15:37,United States,GuruFocus,https://pbs.twimg.com/profile_images/1238147123998310402/xlOiSkeR_normal.jpg,9359,185,337,74737,gurufocus,photo
1217159999304163334,2020-12-14 17:11:57,,"netde, ","delawarebusinesstimes.com/news/incyte-co‚Ä¶, ",1338607686397603841,False,0,0,0,0,Twitter Web App,"Today @Incyte reported 'disappointing' results of its COVID-19 study of Jakafi, as the Phase 3 trial didn't show any efficacy in treating cytokine storm associated with the virus. #netde  https://t.co/ZU3Mkd6CIh","Incyte, ",,2020-01-14 14:02:27,"Wilmington, DE",Jake Owens,https://pbs.twimg.com/profile_images/1309584095681425408/vL6Qco1b_normal.jpg,88,117,4,376,DBTjowens,
2344420430,2020-12-14 16:49:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1338602002713108487,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/aCXnfn7I25",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1250830691824283648,2020-12-14 16:41:43,"ALXN, INCY, ROL, REGN, NFLX, XLNX, OXY, FANG, HFC, MPC, PWR, APA, ",,,1338600078978789379,False,5,0,0,0,Twitter Web App,"Here are the best and worst performing S&amp;P 500 stocks from today

Best:
1 Alexion $ALXN
2 Incyte $INCY
3 Rollins $ROL
4 Regeneron $REGN
5 Netflix $NFLX
6 Xiliinx $XLNX

Worst:
1 Occidental $OXY
2 Diamondback $FANG
3 HollyFrontier $HFC
4 Marathon $MPC
5 Quanta $PWR
6 Apache $APA",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
1410125744,2020-12-14 16:11:48,,,"realmoney.thestreet.com/investing/stoc‚Ä¶, ",1338592552400920578,False,1,0,0,0,Twitter Web App,Is Incyte Ready for a Sustained Turn to the Upside? https://t.co/aeQYsbyLjB via @RealMoney,"realmoney, ",,2013-05-07 08:21:08,,"Bruce Kamich, CMT",https://pbs.twimg.com/profile_images/425681160170000384/HbbyBzs5_normal.jpeg,12257,191,236,37745,BruceKamich,
43901066,2020-12-14 16:05:08,,"COVID, ","ow.ly/p1bu50CLaCE, ",1338590874490515456,False,0,0,0,0,Hootsuite Inc.,The failure of Incyte‚Äôs Ruxcovid study means that the jury is still out on JAK inhibition for severe #COVID-19: https://t.co/xfQSNzEKHu,,,2009-06-01 11:15:46,"London, Boston & Tokyo",Evaluate Pharma,https://pbs.twimg.com/profile_images/1246069080672440323/AVg9th41_normal.jpg,6283,624,187,6706,evaluatepharma,
409241995,2020-12-14 13:25:06,,,"twitter.com/choosedelaware‚Ä¶, ",1338550600531841024,False,1,0,0,0,Twitter for iPad,Well done @Incyte and @IloveIncyte! https://t.co/8jMeM6nmsD,"Incyte, IloveIncyte, ",,2011-11-10 08:27:16,United States,Michael Marquardt,https://pbs.twimg.com/profile_images/885564840844169218/97wDd1qt_normal.jpg,12939,494,159,10283,MarquardtGlobal,
17960461,2020-12-14 13:00:01,,"COVID19, pharma, ","bit.ly/3gI1kVk, pic.twitter.com/z3H72oMiCV, ",1338544286137139202,False,1,0,0,0,TweetDeck,Novartis and Incyte's ruxolitinib fails to show benefit in #COVID19 at Phase 3: https://t.co/GKDgE62kKm #pharma https://t.co/z3H72oMiCV,,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
1319230901969182720,2020-12-14 12:53:44,"MCD, INTC, AMGN, ALXN, INCY, BMRN, MOS, ","MCD, INTC, AMGN, ALXN, INCY, BMRN, MOS, Dow, Nasdaq, SPX500, ",,1338542703982882819,False,0,1,0,0,Twitter for iPhone,"Stock Market Leaders:

‚Ä¢ Dow leaders: McDonald‚Äôs (#MCD, $MCD), Intel (#INTC, $INTC), Amgen (#AMGN, $AMGN)
‚Ä¢ Nasdaq leaders: Alexion (#ALXN, $ALXN), Incyte (#INCY, $INCY), Biomarin (#BMRN, $BMRN)
‚Ä¢ S&amp;P 500 leaders: Alexion, Incyte, Mosaic (#MOS, $MOS)
#Dow #Nasdaq #SPX500",,,2020-10-22 06:55:39,Europe,Karl Pikner,https://pbs.twimg.com/profile_images/1374487770022875139/kpLzo-ib_normal.jpg,58,271,0,4780,karlpikner,
1151214967577829376,2020-12-14 12:31:15,"NOVN, INCY, ","COVID19, ","ow.ly/FFam50CL3CL, pic.twitter.com/s9BduJHgUn, ",1338537047108235264,False,1,0,0,2,Hootsuite Inc.,"Novartis and Incyte's Jakafi did not significantly reduce the number of #COVID19 patients with severe complications, failing to meet the main goal of a late-stage study
https://t.co/QVBA8WOuRE 
$NOVN $INCY https://t.co/s9BduJHgUn",,,2019-07-16 15:40:11,Global,Market Intelligence: Healthcare,https://pbs.twimg.com/profile_images/1176596064096391169/Mf7mREWc_normal.jpg,473,410,13,3475,SPGMIHealthcare,photo
1280320154,2020-12-14 12:19:26,"GSK, INCY, LLY, KNSA, ",,"evaluate.com/vantage/articl‚Ä¶, pic.twitter.com/smeJQDLDIv, ",1338534071958446092,False,5,0,0,2,Twitter Web App,"As Incyte‚Äôs Jakafi disappoints in severe Covid-19, we have a look at other immunosuppressive mechanisms still to read out. Sneak preview of table below $GSK $INCY $LLY $KNSA  https://t.co/k88KVyxiw5 https://t.co/smeJQDLDIv",,,2013-03-19 08:42:19,,Amy Brown,https://pbs.twimg.com/profile_images/378800000345756557/fd27a6fb54ac4f3dfdd5cfb3b3fd94a7_normal.jpeg,2808,478,90,2255,ByAmyBrown,photo
1250830691824283648,2020-12-14 12:13:59,"ALXN, PENN, Z, PAGS, NVTA, INCY, BEPC, CRSP, LYG, BCS, BMRN, STNE, RKT, ARGX, BILI, PTON, ENPH, XPEV, ",,,1338532703352860674,False,0,0,0,0,Twitter Web App,"Best performing large cap stocks so far today

Alexion $ALXN
$PENN
Zillow $Z
PagSeguro $PAGS
Invitae $NVTA
Incyte $INCY
Brookfield $BEPC
Crispr $CRSP
Lloyds $LYG
Barclays $BCS
BioMarin $BMRN
StoneCo $STNE
Rocket $RKT
Argenx $ARGX
Bilibili $BILI
Peloton $PTON
Enphase $ENPH
$XPEV",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
4058194633,2020-12-14 11:58:42,"INCY, NVS, GSK, KNSA, HGEN, LLY, ALXN, RIGL, RHHBY, AMGN, TAK, ABBV, ",,"evaluate.com/vantage/articl‚Ä¶, ",1338528855296917505,False,1,1,0,0,Twitter for iPhone,$INCY $NVS $GSK $KNSA $HGEN $LLY $ALXN $RIGL $RHHBY $AMGN $TAK $ABBV Incyte‚Äôs Jakafi disappoints in severe Covid-19 https://t.co/Jzhl0jZ1rl,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
108617488,2020-12-14 11:45:54,,,"invst.ly/t4mth, ",1338525635422134288,False,0,0,0,1,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/ZY7xJ1LGrF,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133611,1545,1526,291367,newsinvesting,
32450040,2020-12-14 11:27:55,"INCY, NVS, ",,"evaluate.com/vantage/articl‚Ä¶, ",1338521108820189185,False,0,0,1,0,Twitter Web App,Incyte‚Äôs Jakafi disappoints in severe Covid-19 https://t.co/7LAeo5Ow4r $INCY $NVS,,,2009-04-17 11:37:01,"London, UK",Evaluate Vantage,https://pbs.twimg.com/profile_images/1246341890452193282/YN-iBs1e_normal.jpg,6999,481,186,6859,evaluatevantage,
1250830691824283648,2020-12-14 11:15:52,"TSLA, ALXN, INCY, GLW, TTWO, LUMN, ADSK, MOS, REGN, SCHW, VRTX, ",,,1338518075726041093,False,8,0,1,0,Twitter Web App,"If Tesla $TSLA were in the S&amp;P 500 it would currently be the 11 best performing stock so far today behind

Alexion $ALXN
Incyte $INCY
Corning $GLW
Take-Two $TTWO
Lumen $LUMN
Autodesk $ADSK
Mosaic $MOS
Regeneron $REGN
Schwab $SCHW
Vertex $VRTX",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123336,211,1299,33044,StockMKTNewz,
875382419251019776,2020-12-14 10:58:04,,,"bit.ly/3oNt39O, pic.twitter.com/HqVHxC2jBX, ",1338513598021214209,False,0,0,0,0,dlvr.it,Incyte and Novartis' Jakafi Fails to Reduce COVID-19 Associated Cytokine Storm Complications https://t.co/hgBKVcC0qh https://t.co/HqVHxC2jBX,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
325058854,2020-12-14 10:28:12,,,"twitter.com/choosedelaware‚Ä¶, ",1338506082470268935,False,0,0,0,0,Twitter Web App,"It's always refreshing to see Delaware-based companies and organizations leading the way! Thank you, Incyte! @Incyte https://t.co/VYmBD6ajie","Incyte, ",,2011-06-27 13:31:43,"Wilmington, Delaware",The Ministry of Caring,https://pbs.twimg.com/profile_images/730113831108681728/SbqSn4UV_normal.jpg,750,345,21,2856,MinistryCaring,
926019795472060416,2020-12-14 10:24:42,,,"businesswire.com/news/home/2020‚Ä¶, ",1338505199619608578,False,0,0,0,0,Twitter for iPhone,Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm | Business Wire https://t.co/SHWAB1GSia,,,2017-11-02 05:34:58,"Murrells Inlet, SC",Robert Sobczyk,https://pbs.twimg.com/profile_images/1334683200224948224/xtKyEDGA_normal.jpg,41,145,0,537,Firstof9kids,
1328802645897867268,2020-12-14 10:20:42,,"covid, therapeutic, cytokine, ","Briefing.com, ",1338504193741615104,False,5,0,0,1,Twitter for iPhone,"Another drug fails as a #covid #therapeutic. Incyte says results of Phase 3 RUXCOVID Study of Ruxolitinib did not prevent complications in patients with COVID-19 associated #cytokine storm
https://t.co/MV0fF98Rpr @picardonhealth @HelenBranswell @MedicineMatters @CTV_AvisFavaro","picardonhealth, HelenBranswell, MedicineMatters, CTV_AvisFavaro, ",,2020-11-17 15:51:59,"Quebec/ Ontario, Canada",Dr. Guy Chamberland,https://pbs.twimg.com/profile_images/1329449127210577924/pn4D9v_F_normal.jpg,1172,245,0,443,DrGChamberland,
392413519,2020-12-14 09:44:36,,,"pharmaphorum.com/?p=75235, pic.twitter.com/dBtMmxO8Ea, ",1338495109197914114,False,12,2,1,2,Twitter Web App,"On COVID19 repurposing, Novartis have reported that their Jak inhibitor ruxolitinib failed to reduce complications or death in a phase 3 trial 

https://t.co/I9JyNrCiQ3 https://t.co/dBtMmxO8Ea",,,2011-10-16 20:32:31,"Darnestown, MD",Matt Hall,https://pbs.twimg.com/profile_images/1211451902350618624/Av6KNGzn_normal.jpg,2615,2051,58,33697,cispt2,photo
1188416386172903424,2020-12-14 09:11:22,,,"pic.twitter.com/GWM0UvqM0w, ",1338486746686906368,False,0,0,0,0,Twitter Web App,"Incyte Corporation

Incyte Corp actual stock price üî•üìàüôå

Follow us for more updates.
@fedholdinggroup

Your trusted management fund - FED HOLDING GROUP üìäüè¢ https://t.co/GWM0UvqM0w","fedholdinggroup, ",,2019-10-27 07:25:34,,FED Holding Group,https://pbs.twimg.com/profile_images/1281694942109278209/2pULSiQg_normal.jpg,9,0,0,236,fedholdinggroup,photo
812004702594486272,2020-12-14 09:05:22,,,"checkrare.com/a-comic-book-a‚Ä¶, ",1338485235294613508,False,1,0,0,0,Hootsuite Inc.,"J.G. Jones, comic book artist known for his work with DC Comics  and Marvel, discusses his journey with a myeloproliferative neoplasm (MPN).¬†

https://t.co/Hff3Lb2Es8

@MPNVoice
@VoicesofMPN 
Voices of MPN 
@Incyte 
Incyte","MPNVoice, VoicesofMPN, Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
812004702594486272,2020-12-14 09:05:22,,,"checkrare.com/a-comic-book-a‚Ä¶, ",1338485235260985345,False,1,0,0,0,Hootsuite Inc.,"J.G. Jones, comic book artist known for his work with DC Comics  and Marvel, discusses his journey with a myeloproliferative neoplasm (MPN).¬†

https://t.co/Hff3Lb2Es8

@MPNVoice
@VoicesofMPN 
Voices of MPN 
@Incyte 
Incyte 
Incyte","MPNVoice, VoicesofMPN, Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1004375641171603458,2020-12-14 08:59:59,,"Delaware, COVID19, PPE, ChooseDelaware, NetDE, ","hubs.ly/H0BGVfh0, ",1338483878944759812,False,5,2,0,1,HubSpot,"An @Incyte insider discusses how the #Delaware-born biopharma company adapted to the #COVID19 pandemic, ensured patients got the meds they needed and reached out to the community with #PPE and other resources. https://t.co/7ytOBSHsmz #ChooseDelaware #NetDE","Incyte, ",,2018-06-06 10:53:08,,Delaware Prosperity Partnership @choosedelaware,https://pbs.twimg.com/profile_images/1059872509540134913/PX_tVV7O_normal.jpg,4337,1030,21,2792,choosedelaware,
1108388301646544898,2020-12-14 08:55:03,"INCY, ",,,1338482638512939008,False,0,0,0,0,StockTwits Web,Incyte ( $INCY ) reports results of Phase 3 RUXCOVID Study of Ruxolitinib; did not prevent complications in patients with COVID-19 associated cytokine storm,,,2019-03-20 11:22:18,Your Closet,Towelie ‚ú® Link in Bio,https://pbs.twimg.com/profile_images/1410814904198647811/Cy_yw4mb_normal.jpg,2407,988,21,36319,TowelieTrades,
1233901069366771712,2020-12-14 08:43:30,"NVS, INCY, GILD, ","treatment, COVID19, stocks, investing, ","bit.ly/3a99ULj, ",1338479730731999234,False,1,0,1,1,Blog2Social APP,"Novartis-Incyte Jakafi Failed to Save Lives or Cut Complications In COVID-19 TrialüòØ

Finding an effective #treatment for severe #COVID19 patients that actually saves lives or reduces complications has been unsuccessful

$NVS $INCY $GILD #stocks #investing https://t.co/rmaXLHYhDK",,,2020-02-29 18:45:28,Toronto,invesBrain,https://pbs.twimg.com/profile_images/1384261823403204610/n7RB2zkK_normal.jpg,624,454,0,3631,invesBrain,
133504478,2020-12-14 08:18:04,,"strategy, competitiveintelligence, marketing, biotech, healthcare, productmarketing, pharmaceutical, pharma, ","dlvr.it/RncW72, pic.twitter.com/iHbtYTfFIa, ",1338473332111417345,False,1,0,0,2,dlvr.it,"Covid-19 roundup: Incyte, Novartis report PhIII flop for repurposed Jakafi; US to distribute first vaccines Monday https://t.co/btAMX9bPuj #strategy #competitiveintelligence #marketing #biotech #healthcare #productmarketing #pharmaceutical #pharma https://t.co/iHbtYTfFIa",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
25406480,2020-12-14 08:00:04,,,"awesomecapital.blogspot.com/2020/12/incyte‚Ä¶, ",1338468800057012227,False,0,0,0,1,Twitter Web App,AwesomeCapital: Incyte/Novartis' Jakafi study in COVID-19 misses e... https://t.co/HXbZUIuDav,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
2334614718,2020-12-14 07:55:49,"NVS, INCY, ",,"ooc.bz/l/65539, ",1338467732585668610,False,0,0,0,0,Open Outcrier,"$NVS (-0.9% pre) $INCY Incyte/Novartis' Jakafi study in COVID-19 fails to meet endpoints - SA

https://t.co/824Zfum9zp",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
17960461,2020-12-14 07:31:33,,"COVID19, pharma, ","bit.ly/3gI1kVk, pic.twitter.com/TeIJdtinY8, ",1338461624676528131,False,1,0,0,0,Twitter Web App,Novartis and Incyte's ruxolitinib fails to show benefit in #COVID19 at Phase 3 https://t.co/h45MH6je4J #pharma https://t.co/TeIJdtinY8,,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
72928001,2020-12-14 07:29:00,"INCY, ",,"bit.ly/3qX3kgU, ",1338460984596332546,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte reports results of Phase 3 RUXCOVID Study of Ruxolitinib; did not prevent complications in patients... https://t.co/8flf68u9Jg,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
3901351277,2020-12-14 07:26:11,,"pharmaceutical, ","bit.ly/3nmGvRK, ",1338460275377385472,False,0,0,0,0,IFTTT,Novartis and Incyte's ruxolitinib fails to show benefit in COVID-19 at Phase 3 : https://t.co/UuTTMl9ftW #pharmaceutical,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
185663478,2020-12-14 07:14:51,"INCY, NVS, ",,"seekingalpha.com/news/3643920-i‚Ä¶, ",1338457421027684352,False,0,0,0,0,Twitter for iPhone,Incyte/Novartis' Jakafi study in COVID-19 fails to meet endpoints. $INCY $NVS https://t.co/bronGK0IXN,,,2010-09-01 10:52:28,"Chicago, IL",CHItraders,https://pbs.twimg.com/profile_images/623935252357058560/AaeCRlHB_normal.jpg,1253,501,63,45319,CHItraders,
3460109487,2020-12-14 06:59:51,,,"endpts.com/covid-19-round‚Ä¶, ",1338453647466917888,False,3,0,2,0,Buffer,"Covid-19 roundup: Incyte, Novartis report PhIII flop for repurposed Jakafi; US to distribute first vaccines Monday https://t.co/Pbh1YTiBcL",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
46297868,2020-12-14 06:59:33,,,"dlvr.it/RncF0d, ",1338453570383826946,True,0,0,0,0,dlvr.it,"Covid-19 roundup: Incyte, Novartis report PhIII flop for repurposed Jakafi; US to distribute first vaccines Monday https://t.co/IDOsUaYM8o",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
35789155,2020-12-14 06:04:45,"NVS, INCY, ","COVID19, ","beta.firstwordpharma.com/story/5176235, ",1338439782863679488,False,1,0,0,0,TweetDeck,"Novartis, Incyte's Jakafi fails to hit main study goal in #COVID19 associated cytokine storm https://t.co/LwmCu55fCT $NVS $INCY",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
3142088601,2020-12-14 05:54:39,"INCY, NVS, ","COVID19, ","businesswire.com/news/home/2020‚Ä¶, ",1338437241249607680,False,3,0,0,2,Twitter Web App,"Another repurposing failure, this time for a JAK1/2 inhibitor

Incyte $INCY $NVS Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi) as a Treatment for Patients with #COVID19 Associated Cytokine Storm  https://t.co/WPPGxUlFhH",,,2015-04-06 18:27:23,"Lyon, France",Bertrand Delsuc,https://pbs.twimg.com/profile_images/1118239110018273280/DDy8QJv8_normal.png,8047,263,283,59416,BertrandBio,
27254739,2020-12-14 05:41:33,,"COVID19, pharma, ","bit.ly/3nhkS5t, ",1338433944207896583,False,0,0,1,1,Sprout Social,"Novartis/Incyte‚Äôs Jakafi (ruxolitinib) looks unlikely to be added to the list of therapies that can be used against #COVID19, after it failed to cut complications or death in a phase 3 trial https://t.co/CDCPvYbFQe #pharma",,,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
4876582225,2020-12-14 05:16:35,"INCY, ",,"ideas.quantcha.com/2020/12/14/sto‚Ä¶, ",1338427658862989312,False,0,0,0,0,WordPress.com,StockTwits Trending Alert: Trading recent interest in INCYTE¬†$INCY https://t.co/yrJW84vZxT,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
1319637643739750401,2020-12-14 04:02:57,"INCY, ",,,1338409128918708225,False,0,0,0,1,Twitter Web App,"$INCY
Incyte Phase 3 Study of Potential Treatment for COVID-19-Related Cytokine Storm Fails to Meet Primary Endpoint",,,2020-10-23 09:51:54,Earth,The Stock Dude,https://pbs.twimg.com/profile_images/1319641163998105600/Oh_cqzRc_normal.jpg,122,6,3,3013,TheStockWire,
270492072,2020-12-14 03:47:49,,"news, SeekingAlpha, ","seekingalpha.com/news/3643920-i‚Ä¶, ",1338405321232896001,False,0,0,0,0,Microsoft Power Platform,Incyte/Novartis' Jakafi study in COVID-19 fails to meet endpoints https://t.co/ZWPUI2ABlw via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
31372539,2020-12-14 03:25:02,,,"dlvr.it/Rnbbkc, ",1338399585593511936,False,0,0,0,0,dlvr.it,Incyte/Novartis' Jakafi study in COVID-19 fails to meet endpoints https://t.co/mrqaYLIeRH,,,2009-04-15 05:08:17,Amsterdam,Stocks tweets,https://pbs.twimg.com/profile_images/138834360/stocks1-avatar_normal.jpg,4407,3020,91,70157,stocks_tweets,
3524211082,2020-12-14 03:18:14,,,"twib.in/l/p6BR9bdLnReA, ",1338397876054073344,False,0,0,0,0,Twibble.io,Incyte/Novartis' Jakafi study in COVID-19 fails to meet endpoints https://t.co/g8i2EejHHS,,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
1134049078424162304,2020-12-14 03:17:27,"INCY, NVS, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1338397679949410304,False,0,0,0,0,Newsfilter.io,Incyte/Novartis' Jakafi study in COVID-19 fails to meet endpoints $INCY $NVS https://t.co/iQ0tDP10KD,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2020-12-14 03:14:43,"INCY, NVS, ",,"seekingalpha.com/news/3643920-i‚Ä¶, ",1338396992284708864,False,2,0,0,0,SANewsTwitter,$INCY $NVS - Incyte/Novartis' Jakafi study in COVID-19 fails to meet endpoints https://t.co/YUiwdKiQg1,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
472650465,2020-12-14 02:30:35,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1338385882873782272,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/RuCWLgjBan,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1006334607946649600,2020-12-14 02:06:04,,"StockMarket, Stocks, ","dlvr.it/RnbPkd, ",1338379712465235968,False,0,0,0,0,dlvr.it,Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/DpTOb2zQkC #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
3318510966,2020-12-14 01:58:58,,,"crweworld.com/article/news-p‚Ä¶, ",1338377925947637761,False,0,0,0,0,CRWE World,Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID- https://t.co/lYR6ZLFiGE,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1100450877792370688,2020-12-14 01:34:19,"INCY, ",,"blueequity.io/r/176100/de-in‚Ä¶, ",1338371726401368069,False,0,0,0,0,Blue Equity,$INCY Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/0r9FnwiPgl,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
1132875708,2020-12-14 01:32:45,"INCY, NVS, ",,"investor.incyte.com/press-releases‚Ä¶, ",1338371329335185408,False,1,1,1,1,Twitter for Android,"Wow ruxolitinib really does nothing at all for Covid cytokine Storm. $INCY $NVS, Baricitinib looked way better in the European studies... Cc:@RolandBakerIII
https://t.co/nYpE3SBaVv","RolandBakerIII, ",,2013-01-29 23:00:04,,Simon Lackner,https://pbs.twimg.com/profile_images/3258994470/18725880e636963fdb4982c775597e44_normal.png,989,831,33,15432,SnupSnus,
1089978712685273090,2020-12-14 01:32:03,"INTC, ","Incyte, StockMarket, ","dlvr.it/RnbKpz, ",1338371153992159232,False,0,0,0,0,dlvr.it,#Incyte $INTC Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/TESxKCILdc #StockMarket,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
472650465,2020-12-14 01:27:23,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1338369980749012992,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/dZH51Sjvs5,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1069693680066420736,2020-12-14 01:20:06,"INCY, ",,"s.flashalert.me/nE5G2t, ",1338368147460599809,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on December 14, 01:15:00: Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/c2HoMq77LK",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2020-12-14 01:17:32,,,"dlvr.it/RnbJGC, pic.twitter.com/NIFGjcn8PG, ",1338367500543660033,False,0,0,0,0,dlvr.it,Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/CCXJBEWUOT https://t.co/NIFGjcn8PG,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
274233761,2020-12-14 01:17:00,"INCY, ",,"investor.incyte.com/press-releases‚Ä¶, ",1338367368301588482,False,21,1,5,9,TweetDeck,$INCY Jakafi failed as a treatment for COVID cytokine storm. https://t.co/D2sgylmCgW,,,2011-03-29 20:20:45,"Lenexa, KS / Venice, FL",Brad Loncar,https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_normal.jpg,45424,346,1007,65536,bradloncar,
1134049078424162304,2020-12-14 01:16:27,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1338367229235179523,False,0,0,0,0,Newsfilter.io,Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib as a Treatment for Patients with COVID-19 Associated Cytokine Storm $INCY https://t.co/IP1z7mBPDb,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1254035253104181256,2020-12-14 01:15:18,"INCY, ","covid19, ","stocktitan.net/news/INCY/incy‚Ä¶, ",1338366939677134848,False,0,0,0,0,stocktitan,"$INCY Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm
https://t.co/Uf79kuAQiq

#covid19",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1280938376099741697,2020-12-13 00:19:00,,"iexStock, ","iexcloud.io, pic.twitter.com/IDlspBB9Eb, ",1337990382383194113,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
 
-Incyte Corp.
-Check Point Software Technolgies
-Abu Dhabi National Takaful Co.
-Abu Dhabi National Energy Company PJSC
-T-Mobile US Inc

Data provided by https://t.co/oXreiEXTgd https://t.co/IDlspBB9Eb",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
4876582225,2020-12-12 20:36:42,"INCY, ",,"ideas.quantcha.com/2020/12/12/sto‚Ä¶, ",1337934440438362113,False,0,0,0,0,WordPress.com,StockTwits Trending Alert: Trading recent interest in INCYTE¬†$INCY https://t.co/PFcQ43nRjB,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
204748499,2020-12-12 07:08:30,,"COVID19, ","twitter.com/ABsteward/stat‚Ä¶, ",1337731050479509505,False,12,0,0,4,Twitter for Android,"Baricitinib was discovered by Incyte and licensed to Eli Lilly and Company, and marketed under the brand name Olumiant. It is approved in more than 70 countries as a treatment for adults with moderately-to-severely active rheumatoid arthritis. #COVID19 https://t.co/K5hDOcNooy",,,2010-10-19 07:39:07,üåç,Antibiotic Stewa¬ÆÔ∏èxüÜî Bassam Ghanem,https://pbs.twimg.com/profile_images/1274367456610525190/OIDDvaCl_normal.jpg,36194,299,307,33122,ABsteward,
25406480,2020-12-11 18:25:54,,,"awesomecapital.blogspot.com/2020/12/lillyi‚Ä¶, ",1337539134978744322,False,0,0,0,1,Twitter Web App,AwesomeCapital: Lilly/Incyte announce peer-reviewed publication of... https://t.co/cZbcuXL11I,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
3524211082,2020-12-11 14:51:02,,,"twib.in/l/q95aARbr6prG, ",1337485062556749825,False,0,0,0,0,Twibble.io,Eli Lilly/Incyte announce peer-reviewed publication of Baricitinib/remdesivir trial data https://t.co/JX6H6saQyS,,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
1134049078424162304,2020-12-11 14:46:23,"LLY, INCY, ",,"newsfilter.io/articles/eli-l‚Ä¶, ",1337483889422577668,False,0,0,0,0,Newsfilter.io,Eli Lilly/Incyte announce peer-reviewed publication of Baricitinib/remdesivir trial data $LLY $INCY https://t.co/YB5ThlWBfu,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3911174913,2020-12-11 14:31:39,,"News, COVID19, ",,1337480184069500935,False,6,1,0,1,Twitter for Advertisers.,#News: @NEJM published results from the @NIAIDNews sponsored ACTT-2 study of an Incyte-discovered medicine for certain patients hospitalized with #COVID19.,"NEJM, NIAIDNews, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
812004702594486272,2020-12-11 12:10:17,,,"checkrare.com/renowned-comic‚Ä¶, ",1337444607043440640,False,1,0,0,0,Hootsuite Inc.,"J.G. Jones, comic book artist known for his work with Marvel and DC Comics discusses Rare Reflections: MPNs Unmasked, an initiative focused on raising awareness about Myeloproliferative Neoplasms.
@Incyte @VoicesofMPN @MPN_RF 
JG Jones Art Page 
Incyte 
https://t.co/Ssu4kPqZft","Incyte, VoicesofMPN, MPN_RF, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
3435682714,2020-12-11 07:41:09,"ATNM, ",,"twitter.com/COILPOD/status‚Ä¶, ",1337376879301582849,False,1,2,0,0,Twitter for Android,Agreed! Its shame that big pharmaceuticals @JNJInnovation @ScienceAtBMS @abbvie @AstellasUS @pfizer @Amgen @Incyte @biogen @VertexPharma  are not paying attention to promising radiopharmaceuticals pipeline of @ActiniumPharma $ATNM which is better than @Novartis AAA &amp; @endocyte https://t.co/7NUwufv3Dg,"JNJInnovation, ScienceAtBMS, abbvie, AstellasUS, pfizer, Amgen, Incyte, biogen, VertexPharma, ActiniumPharma, Novartis, ",,2015-08-22 12:15:30,"New York, USA",Biotech,https://pbs.twimg.com/profile_images/1336863494373859328/lSWUKPa5_normal.jpg,688,16,16,7065,ej23ny,
1889492676,2020-12-10 03:24:41,"INCY, ","Incyte, JPMorganVirtualHealthcareConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1336949946516271105,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming Investor Conference #JPMorganVirtualHealthcareConference $INCY https://t.co/3GG3MoSmUy,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1280938376099741697,2020-12-10 02:44:26,,"iexStock, ","iexcloud.io, pic.twitter.com/5ESQYbSyuF, ",1336939816433356800,False,0,0,0,0,robby.ae,"#iexStock Latest Prices:
 
-Gilead Sciences, Inc.
-Applied Materials Inc.
-Foodco Holding
-Incyte Corp.
-NVIDIA Corp

Data provided by https://t.co/oXreiEXTgd https://t.co/5ESQYbSyuF",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1134049078424162304,2020-12-10 01:52:52,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1336926840955564033,False,0,0,0,0,Newsfilter.io,Incyte to Present at Upcoming Investor Conference $INCY https://t.co/2nXo4R6TJc,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1314280236679270401,2020-12-09 21:09:35,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1336855549720342531,False,0,0,0,0,Twitter,"12/09/2020
üî•üî• 8 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $2,416,656 | 29850 Shares
Streak Total: $15,156,556 | 182085 Shares
Daily Close: $80.96 (-2.28%) ‚¨áÔ∏è
Prev Close: $82.85
W.Avg Streak Price: $83.24
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
108617488,2020-12-09 21:00:19,,,"invst.ly/t2x5o, ",1336853218488365057,False,0,0,0,1,FP News Publisher - COM,RBC Capital Stick to Their Hold Rating for Incyte Corp - https://t.co/xNBZEmGv0Y,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
1021485047977832449,2020-12-09 13:00:15,,"Cholangiocarcinoma, PrecisionMedicine, ","bit.ly/37ODN0P, pic.twitter.com/pabPLM3yxF, ",1336732406267711491,False,3,0,0,1,Khoros Publishing App,"ICYMI: Clinicogenomic analysis of FGFR2-rearranged #Cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib. 
@Incyte #PrecisionMedicine 
https://t.co/RJgxlLOQeM https://t.co/pabPLM3yxF","Incyte, ",,2018-07-23 15:59:48,,Cancer Discovery,https://pbs.twimg.com/profile_images/1351622122272124934/bOgWtTKh_normal.jpg,6661,217,66,4244,CD_AACR,photo
976297820532518914,2020-12-09 08:07:07,,,"dlvr.it/RnHxLP, pic.twitter.com/pgxRFjVjCQ, ",1336658637503098883,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conference https://t.co/gKg3jnjmqb https://t.co/pgxRFjVjCQ,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2020-12-09 08:06:24,"INCY, ",,"s.flashalert.me/uscQwC, ",1336658455344582656,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on December 09, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/aSjY7HqtBp",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
3318510966,2020-12-09 08:02:58,,,"crweworld.com/article/news-p‚Ä¶, ",1336657593817681920,False,0,0,0,0,CRWE World,Incyte to Present at Upcoming Investor Conference https://t.co/yQeVoMIr7U,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2020-12-09 08:02:46,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1336657540478771201,False,0,0,0,0,stocktitan,"$INCY Incyte to Present at Upcoming Investor Conference
https://t.co/eVi7k4TTDu",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
21079030,2020-12-09 05:02:11,,"PharmaScrip, ","bit.ly/3lXtm04, ",1336612097669685249,False,0,0,0,0,Sprinklr,"Incyte, TG's PI3K Inhibitors Show Safety Advantage In Indolent NHL
https://t.co/FttqY2UGRP #PharmaScrip",,,2009-02-17 05:33:29,Global,Scrip,https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg,21541,1629,654,35335,PharmaScrip,
23059499,2020-12-09 03:34:00,"INCY, ","stocks, finance, economy, ","seekingalpha.com/article/439375‚Ä¶, ",1336589904562671618,False,0,0,0,1,SAArticlesTwitter,$INCY - Incyte (INCY) Presents At American Society of Hematology Meeting - Slideshow. https://t.co/IFhx6liyNP #stocks #finance #economy,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1280938376099741697,2020-12-08 20:10:35,,,"iexcloud.io, pic.twitter.com/PYaORQCVq6, ",1336478315067092993,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-ASML Holding NV - New York Shares
-Eshraq Investments PJSC
-Cadence Design Systems, Inc.
-KLA Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/PYaORQCVq6",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
915371022039310336,2020-12-08 17:59:12,"INCY, TGTX, ","lymphoma, ASH20, ","scrip.pharmaintelligence.informa.com/SC143451/Incyt‚Ä¶, ",1336445252832538625,False,6,0,0,2,Twitter Web App,"Incyte's parsaclisib and TG Therapeutics' umbralisib show strong efficacy and favorable safety relative to approved oral PI3K inhibitors in follicular &amp; marginal zone #lymphoma at #ASH20. @PharmaScrip $INCY $TGTX 
https://t.co/MR3ucVSbcc","PharmaScrip, ",,2017-10-03 20:20:33,"New York, NY",Alaric DeArment,https://pbs.twimg.com/profile_images/1419455188046331904/-e6kjqB__normal.jpg,888,197,42,3980,biotechvisigoth,
998915197061488645,2020-12-08 16:04:01,,,"cfc.umt.edu/research/incyt‚Ä¶, pic.twitter.com/4lhfMLBsog, ",1336416265225826307,False,15,2,0,14,Twitter Web App,"Registration is now open for our 2021 virtual seminar series on the representation of nutrient cycles in Earth system models! üå≤üåéü¶†

Check out the schedule and register ‚¨áÔ∏è
https://t.co/LGbjNtskHW https://t.co/4lhfMLBsog",,,2018-05-22 09:15:16,,INCyTE RCN,https://pbs.twimg.com/profile_images/1063085319887695873/d_uRHryG_normal.jpg,221,32,1,46,IncyteRcn,photo
702999329821188096,2020-12-08 14:29:42,,"VitiligoInternationalSymposium, VIS2020, vitiligo, ","pic.twitter.com/ZDrS6fOKfO, ",1336392528380088320,False,1,0,0,1,Twitter Web App,"We gratefully acknowledge @Incyte @SunPharma_Live  and Alkem as sponsors of our recent #VitiligoInternationalSymposium. Thank you for your support to make this program possible! #VIS2020 #vitiligo 
.
.
. https://t.co/ZDrS6fOKfO","Incyte, SunPharma_Live, ",,2016-02-25 18:31:16,"Chicago, IL",Global Vitiligo Foundation,https://pbs.twimg.com/profile_images/1235405131098869760/frWX3dp6_normal.jpg,1604,266,10,448,StepUp4Vitiligo,photo
163565297,2020-12-08 12:30:12,,"CSCDE, Incyte, ","cancersupportdelaware.org, pic.twitter.com/wuRKCkP7fi, ",1336362454000001026,False,1,0,0,1,Hootsuite Inc.,"#CSCDE &amp; our community partner, #Incyte, continue to provide help to cover costs like rent, mortgage, co-pays, and utilities through the Incyte Cancer Care Assistance Fund. To find out more about the emergency assistance fund or how to apply please visit https://t.co/7DdQ9Ybsbw https://t.co/wuRKCkP7fi",,,2010-07-06 14:57:24,"Delaware, USA",Cancer Support DE,https://pbs.twimg.com/profile_images/667430529340473346/FSfER-Bd_normal.jpg,543,542,30,3173,CancerSupportDE,photo
108617488,2020-12-08 05:45:04,,,"invst.ly/t23sd, ",1336260499529404416,False,2,0,0,1,FP News Publisher - COM,Oppenheimer Stick to Their Buy Rating for Incyte Corp - https://t.co/V005kRtq20,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
1889492676,2020-12-08 04:47:22,"INCY, MOR, ","Incyte, MorphoSysAG, Tafasitamab, Lenalidomide, RCHOP, DLBCL, ASH2020, ","1stoncology.com/blog/data-eval‚Ä¶, ",1336245979553570817,False,0,0,0,0,Troi URL Plug-in,#Incyte and #MorphoSysAG reported Data Evaluating #Tafasitamab with and without #Lenalidomide in Combination with #RCHOP in Patients with #DLBCL Presented at #ASH2020 $INCY $MOR https://t.co/Ii8fR9rUBg,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2020-12-08 04:44:53,"INCY, ","Incyte, Parsaclisib, Relapsed, Refractory, BCell, NonHodgkinLymphomas, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1336245355759849473,False,0,0,0,0,Troi URL Plug-in,#Incyte Announces #Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with #Relapsed or #Refractory #BCell #NonHodgkinLymphomas $INCY https://t.co/ovQNJRBCm0,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
30593431,2020-12-08 04:40:15,,,"invst.ly/t21t8, twitter.com/newsinvesting/‚Ä¶, ",1336244187717570560,False,0,0,0,0,IFTTT,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/LvKYSb9skZ [ https://t.co/PVvcVSg7Uo ],,,2009-04-11 23:37:12,Worldwide,iNews24,https://pbs.twimg.com/profile_images/880592849561104384/tYoTVJlm_normal.jpg,2419,2097,179,360375,iNews24,
108617488,2020-12-08 04:25:05,,,"invst.ly/t21t8, ",1336240370544422913,False,1,1,0,1,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/0M85JSezui,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
1134049078424162304,2020-12-07 14:48:33,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1336034885581070340,False,0,0,0,0,Newsfilter.io,Incyte Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas $INCY https://t.co/RKN5YJOsMC,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1276824218928214017,2020-12-07 13:40:34,,,"impharmanews.com/2020/12/07/inc‚Ä¶, ",1336017778004828160,False,0,0,0,0,IMPharma News,"Incyte Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas 
https://t.co/VloS5xBh6m",,,2020-06-27 06:26:45,India,IMPharma News,https://pbs.twimg.com/profile_images/1277193245479456768/5QLoLmr4_normal.jpg,173,1544,2,5944,IMPharmaNews,
374729426,2020-12-07 12:07:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2385795, pic.twitter.com/1EeHnrgwh9, ",1335994450590363649,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/iCV23qBVaZ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1EeHnrgwh9",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3686628867,2020-12-07 10:45:25,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1335973696490627074,False,0,0,0,0,WordPress.com,Incyte Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin¬†Lymphomas https://t.co/GlH4QUJtPt,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1006334607946649600,2020-12-07 10:18:33,,"StockMarket, Stocks, ","dlvr.it/Rn91T7, ",1335966936459440134,False,0,0,0,0,dlvr.it,Incyte Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas https://t.co/NrH6QbEKE5 #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1254035253104181256,2020-12-07 10:05:06,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1335963552780152832,False,0,0,0,0,stocktitan,"$INCY Incyte Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
https://t.co/Zn8DFImJz1",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
472650465,2020-12-07 10:02:51,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1335962987614629890,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas https://t.co/rXH3tzxfAX,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1407780158,2020-12-06 12:27:33,,"ASH20, bmtsm, gvhd, ","pic.twitter.com/RrGnsAPeGW, ",1335637012045508615,False,3,0,0,1,Twitter Web App,"Next session #ASH20 Abs 356 A Single-Arm, Open-Label Phase 1 Study of Itacitinib with CNI‚ÄìBased Interventions for Prophylaxis of GVHD (GRAVITAS-119). Happy to see results of this study @sloan_kettering participated in - Note: I have COI with Incyte #bmtsm #gvhd https://t.co/RrGnsAPeGW","sloan_kettering, ",,2013-05-06 09:41:58,"New York, NY",Miguel Perales M.D.,https://pbs.twimg.com/profile_images/1250512673470590981/ldD-7z-v_normal.jpg,15352,2299,358,33645,DrMiguelPerales,photo
374729426,2020-12-06 11:51:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2382806, pic.twitter.com/OpVnbE93vg, ",1335627945931538433,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/oAsXuJdNr3 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/OpVnbE93vg",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
742132906127183872,2020-12-05 15:40:08,,"Patients, ","twitter.com/AcuteLeuk/stat‚Ä¶, ",1335323088515436547,False,16,1,2,5,Twitter for iPhone,"Would be nice to hear from some of the patient-centric pharma companies... do you support @ASH_hematology charging #Patients excessive fees?

@Amgen @AstraZeneca @bmsnews @Incyte @JazzPharma @novartis @pfizer @abbvie @DaiichiSankyo @GileadSciences @JanssenUS @KitePharma https://t.co/oIyIwSujCM","ASH_hematology, Amgen, AstraZeneca, bmsnews, Incyte, JazzPharma, Novartis, pfizer, abbvie, DaiichiSankyo, GileadSciences, JanssenUS, KitePharma, ",,2016-06-12 19:14:07,United Kingdom,Zack Pemberton-Whiteley (he/him),https://pbs.twimg.com/profile_images/1433083092160352264/Fr1Re2Wt_normal.jpg,1358,1134,14,6235,ZPWLC,
2809497047,2020-12-05 15:39:22,,"ASH20, GVHD, clecliniccancer, ","ash.confex.com/ash/2020/webpr‚Ä¶, pic.twitter.com/EL5cVgsMWZ, ",1335322897297104897,False,43,2,2,5,Twitter for iPhone,"#ASH20 my 30 sec take on REACH3 trial of ruxolitinib vs other Rx for steroid refractory chronic #GVHD; üëç 50% 24-wk ORR (vs 25%), but then 50% w/no response üòû ‚û°Ô∏è need to more work on ü§¨ complication: https://t.co/ePHwJfm4yH
(‚ö†Ô∏è I have COI w/@Incyte) #clecliniccancer @CleClinicMD https://t.co/EL5cVgsMWZ","Incyte, CleClinicMD, ",,2014-10-05 23:06:52,"Nashville, TN","Navneet Majhail, MD, MS",https://pbs.twimg.com/profile_images/1447967367594643470/9jzMSdvz_normal.jpg,16661,890,0,39555,BldCancerDoc,video
325135887,2020-12-05 11:39:11,"INCY, NVS, ","healthcare, pharma, ","bit.ly/3mQ18FG, ",1335262451567226881,False,0,0,1,0,Twitter Web App,"1/3 ASH: Incyte, Novartis eye Jakafi approval with chronic graft vs. host win! $INCY $NVS  #healthcare #pharma
https://t.co/Uxv9p3yCrZ",,,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
2570920968,2020-12-05 11:25:00,"INCY, NVS, ","healthcare, pharma, ","bit.ly/3mQ18FG, ",1335258883011448845,False,0,0,0,0,Twitter Web App,"Well done! ASH: Incyte, Novartis eye Jakafi approval with chronic graft vs. host win! $INCY $NVS  #healthcare #pharma
https://t.co/ZzVAm4LrvI",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
374729426,2020-12-05 10:37:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2379823, pic.twitter.com/SALzPgZ8VR, ",1335246889986392065,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/15XbwIvhos #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/SALzPgZ8VR",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
210246551,2020-12-05 10:31:42,,,"fiercepharma.com/pharma/ash-inc‚Ä¶, ",1335245468767383552,False,0,0,0,0,Twitter for Android,"ASH: Incyte, Novartis eye Jakafi approval with chronic graft vs. host win https://t.co/G0v4Ew6TL7",,,2010-10-30 19:25:21,"Tucson, Az",Aloysius Pendergast,https://pbs.twimg.com/profile_images/459563937856385025/3RXl6oem_normal.jpeg,843,875,0,12373,sheik2411,
477131488,2020-12-05 09:33:04,,"cancer, immunology, ROCKSTAR, London, vaccine, Roche, bridge20, ","pic.twitter.com/jCrczkL00p, pic.twitter.com/jCrczkL00p, pic.twitter.com/jCrczkL00p, pic.twitter.com/jCrczkL00p, twitter.com/BernardAFox/st‚Ä¶, ",1335230715823177730,False,3,0,0,1,Twitter for iPhone,5) Tour de force! Prof @squezadd #cancer #immunology #ROCKSTAR @QuezadaLab #London @CancerResearchU /#vaccine + anti-IL2 improves response to cold tumors/ next generation Treg depleting MAb now in #Roche clinical trials! #bridge20 @BMS_ImmunOnc_US @Incyte @ubivac @Merck https://t.co/jCrczkL00p https://t.co/O8httDjryE,"squezadd, QuezadaLab, CancerResearchU, BMS_ImmunOnc_US, Incyte, UbiVac, Merck, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
477131488,2020-12-05 09:30:54,,"cancer, immunology, ROCKSTAR, London, vaccine, Roche, bridge20, ","pic.twitter.com/XvLmkOz6CT, pic.twitter.com/XvLmkOz6CT, pic.twitter.com/XvLmkOz6CT, pic.twitter.com/XvLmkOz6CT, twitter.com/BernardAFox/st‚Ä¶, ",1335230171608039426,False,1,1,0,0,Twitter for iPhone,4) Tour de force! Prof @squezadd #cancer #immunology #ROCKSTAR @QuezadaLab #London @CancerResearchU /#vaccine + anti-IL2 improves response to cold tumors/ next generation Treg depleting MAb now in #Roche clinical trials! #bridge20 @BMS_ImmunOnc_US @Incyte @ubivac @Merck https://t.co/XvLmkOz6CT https://t.co/JVLt3eX5nS,"squezadd, QuezadaLab, CancerResearchU, BMS_ImmunOnc_US, Incyte, UbiVac, Merck, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
477131488,2020-12-05 09:26:20,,"cancer, immunology, ROCKSTAR, London, Roche, bridge20, ","pic.twitter.com/Lvn1GC7geo, pic.twitter.com/Lvn1GC7geo, pic.twitter.com/Lvn1GC7geo, pic.twitter.com/Lvn1GC7geo, twitter.com/BernardAFox/st‚Ä¶, ",1335229022410690562,False,4,1,0,0,Twitter for iPhone,3) Tour de force! Prof @squezadd #cancer #immunology #ROCKSTAR @QuezadaLab #London @CancerResearchU /unravels complexities of anti-IL2 anticancer activ/explains so much &amp; has next generation Treg depleting MAb now in #Roche clinical trials! #bridge20 @BMS_ImmunOnc_US @Incyte https://t.co/Lvn1GC7geo https://t.co/rUtUZoQQm4,"squezadd, QuezadaLab, CancerResearchU, BMS_ImmunOnc_US, Incyte, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
477131488,2020-12-05 09:24:45,,"cancer, immunology, ROCKSTAR, London, Roche, bridge20, ","pic.twitter.com/Fwtdet2bSf, pic.twitter.com/Fwtdet2bSf, pic.twitter.com/Fwtdet2bSf, pic.twitter.com/Fwtdet2bSf, twitter.com/BernardAFox/st‚Ä¶, ",1335228622873919489,False,4,1,0,1,Twitter for iPhone,2) Tour de force! Prof @squezadd #cancer #immunology #ROCKSTAR @QuezadaLab #London @CancerResearchU /unravels complexities of anti-IL2 anticancer activ/explains so much &amp; has next generation Treg depleting MAb now in #Roche clinical trials! #bridge20 @BMS_ImmunOnc_US @Incyte https://t.co/Fwtdet2bSf https://t.co/aBXq0wSMTM,"squezadd, QuezadaLab, CancerResearchU, BMS_ImmunOnc_US, Incyte, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
477131488,2020-12-05 09:23:33,,"cancer, immunology, ROCKSTAR, London, Roche, bridge20, ","pic.twitter.com/hnLInq52FP, pic.twitter.com/hnLInq52FP, pic.twitter.com/hnLInq52FP, pic.twitter.com/hnLInq52FP, ",1335228320460406784,False,16,1,0,2,Twitter for iPhone,1) Tour de force! Prof @squezadd #cancer #immunology #ROCKSTAR @QuezadaLab #London @CancerResearchU /unravels complexities of anti-IL2 anticancer activ/explains so much &amp; has next generation Treg depleting MAb now in #Roche clinical trials! #bridge20 @BMS_ImmunOnc_US @Incyte https://t.co/hnLInq52FP,"squezadd, QuezadaLab, CancerResearchU, BMS_ImmunOnc_US, Incyte, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
477131488,2020-12-05 09:00:50,,"cancer, immunotherapy, MEK, Bridge20, melanoma, ","pic.twitter.com/RRAUQEvuwU, pic.twitter.com/RRAUQEvuwU, pic.twitter.com/RRAUQEvuwU, pic.twitter.com/RRAUQEvuwU, ",1335222605104566272,False,3,0,0,1,Twitter for iPhone,3) GREAT TALK! @jasonlukemd #cancer #immunotherapy Guru @UPMCHillmanCC BRAF+MEK+PD1/L1/Need something for pts with hi LDH/Optimal sequence unknown/new QUAD Study/ Is #MEK having negative effect? #Bridge20 #melanoma @BMS_ImmunOnc_US @Merck @Roche @Incyte https://t.co/RRAUQEvuwU,"jasonlukemd, UPMCHillmanCC, BMS_ImmunOnc_US, Merck, Roche, Incyte, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
3667775956,2020-12-05 07:42:25,,"mpnsm, MPNHeroes, ","twitter.com/MJHLifeScience‚Ä¶, ",1335202867263705093,False,6,0,0,0,Twitter for iPhone,Thank you @Dev_Still71 and Leah for your courageous message of hope and love! We are stronger together! @cure_magazine @MJHLifeSciences @Incyte #mpnsm #MPNHeroes @VoicesofMPN https://t.co/WvapoZnPWi,"Dev_Still71, cure_magazine, MJHLifeSciences, Incyte, VoicesofMPN, ",,2015-09-15 17:02:25,,Nicholas Napolitano,https://pbs.twimg.com/profile_images/1303304979101503491/GjlAKqml_normal.jpg,97,548,1,379,NickNap22,
2398845223,2020-12-05 03:52:02,,,"ow.ly/jm9i102tHe4, ",1335144892713070592,False,0,0,0,0,Hootsuite Inc.,"ASH: Incyte, Novartis eye Jakafi approval with chronic graft vs. host win https://t.co/eX0eV4qhKL",,,2014-03-19 23:11:51,Maryland,Continental Clinical,https://pbs.twimg.com/profile_images/673876383358062593/qyzjJcMn_normal.jpg,669,521,13,5348,Conti_Clinical,
760484491555139584,2020-12-05 03:02:32,,,"dlvr.it/Rn2KnX, pic.twitter.com/rqabPSObNs, ",1335132435118317568,False,0,0,0,0,dlvr.it,"ASH: Incyte, Novartis eye Jakafi approval with chronic graft vs. host win https://t.co/i5yekrHnmP https://t.co/rqabPSObNs",,,2016-08-02 10:36:46,,analyst land news,https://pbs.twimg.com/profile_images/1075066740835606534/NpZYEW5E_normal.jpg,10,0,1,5551,analystlandnews,photo
1280288213102292993,2020-12-05 02:51:21,,,"pharmabox.in/ash-incyte-nov‚Ä¶, ",1335129617745793026,False,0,0,0,0,Hootsuite Inc.,"ASH: Incyte, Novartis eye Jakafi approval with chronic graft vs. host win https://t.co/tbMxnPjuhS",,,2020-07-06 19:51:21,,WWW.PHARMABOX.IN,https://pbs.twimg.com/profile_images/1284027505058381827/7o7Mcyq1_normal.jpg,856,450,0,5397,pharmabox_in,
133504478,2020-12-05 02:50:32,,"strategy, competitiveintelligence, marketing, pharmaceutical, biotech, productmarketing, healthcare, pharma, ","dlvr.it/Rn2JgF, pic.twitter.com/lKJZw92LEv, ",1335129414120525824,False,0,0,0,1,dlvr.it,"ASH: Incyte, Novartis eye Jakafi approval with chronic graft vs. host win https://t.co/smnj6v8ieQ #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #productmarketing #healthcare #pharma https://t.co/lKJZw92LEv",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
140599113,2020-12-05 02:44:32,,,"winway.me/health-remedie‚Ä¶, ",1335127904066424832,False,0,0,0,0,WordPress.com,"ASH: Incyte, Novartis eye Jakafi approval with chronic graft vs. host¬†win https://t.co/EtNa4GD923",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
46297868,2020-12-05 02:29:02,,,"dlvr.it/Rn2GZX, ",1335124002604371968,True,0,0,0,0,dlvr.it,"ASH: Incyte, Novartis eye Jakafi approval with chronic graft vs. host win https://t.co/9TCIGIeCIH",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
27714116,2020-12-05 01:58:36,,"innovation, dermatology, dermatologia, ","dermsummit.com/2021/ds/, pic.twitter.com/d3VafKUwhI, ",1335116346493980673,False,6,1,1,2,Twitter Web App,"Next Dermatology Summit will take place on 8th January 2021 - save the date!
https://t.co/UuSnpp7xwY
The mission of this summit is to build a community of people who are excited about innovation in dermatology 
#innovation in #dermatology #dermatologia 
@AdvancingDerm @Incyte https://t.co/d3VafKUwhI","AdvancingDerm, Incyte, ",,2009-03-30 15:58:02,,Dominique du Crest,https://pbs.twimg.com/profile_images/1252494190283558917/lMl69akW_normal.jpg,8165,5264,345,23380,ducrest,photo
1314280236679270401,2020-12-04 20:54:36,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1335039839880802308,False,0,0,0,1,Twitter,"12/04/2020
üî•üî• 5 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $2,895,351 | 34825 Shares
Streak Total: $8,116,812 | 96515 Shares
Daily Close: $83.14 (0.29%) ‚¨ÜÔ∏è
Prev Close: $82.90
W.Avg Streak Price: $84.10
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
374729426,2020-12-04 20:03:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2378070, pic.twitter.com/Hhha6cd6fb, ",1335026871763828736,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/bn0mViOcYh #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Hhha6cd6fb",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
21411180,2020-12-04 18:56:39,,"mpnHEROES, ","pic.twitter.com/3gd4yQkmSx, ",1335010158569775105,False,2,0,1,0,Twitter Web App,The 2020 MPN Heroes Virtual Celebration is about to begin! Join us and our sponsor @Incyte as we celebrate the heroes who have made differences in the lives of people with MPNs. #mpnHEROES https://t.co/3gd4yQkmSx,"Incyte, ",,2009-02-20 11:40:58,United States,CURE Magazine,https://pbs.twimg.com/profile_images/1442487920871411721/0Hbi4cbf_normal.png,25007,1750,706,23817,cure_magazine,photo
27645777,2020-12-04 18:10:40,,"ASH20, GVHD, ","bit.ly/3mKXdK6, pic.twitter.com/rDE96qp1T0, ",1334998585843310593,False,1,0,0,2,TweetDeck,"Practice-changing NEWS from #ASH20 @ASH_hematology - Ruxolitinib @Incyte effective as second-line therapy for chronic #GVHD https://t.co/2Qu6FHiSz5 REACH3 study data presented by Robert Zeiser, PhD @Klinik_Freiburg https://t.co/rDE96qp1T0","ASH_hematology, Incyte, Klinik_Freiburg, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
72928001,2020-12-04 14:32:56,"INCY, ",,"bit.ly/33KdjMM, ",1334943791095037954,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte presents results from the pivotal Phase 3 REACH3 study demonstratingJakafi significantly improved... https://t.co/dQsxP5cAwU,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
3686628867,2020-12-04 14:08:48,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1334937719705841667,False,0,0,0,0,WordPress.com,Incyte Announces First Data from REACH3 Trial Showing Ruxolitinib (Jakafi¬Æ) Significantly Improved Outcomes in Patients with Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease https://t.co/ytk3TRfvEd,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
35789155,2020-12-04 13:39:28,"NOVN, INCY, ",,"beta.firstwordpharma.com/story/5169701, ",1334930335386234882,False,2,0,0,0,Twitter Web App,"Nearly half of chronic GvHD patients achieve response with Novartis, Incyte's Jakafi in Phase III study https://t.co/g7cnOSsBH5
$NOVN $INCY",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
3318510966,2020-12-04 13:10:03,,,"crweworld.com/article/news-p‚Ä¶, ",1334922934440271873,False,0,0,0,0,CRWE World,Incyte Announces First Data from REACH3 Trial Showing Ruxolitinib (Jakafi¬Æ) Significantly Improved Outcomes in Pati https://t.co/zz7uWv4dYF,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1006334607946649600,2020-12-04 12:59:02,,"StockMarket, Stocks, ","dlvr.it/Rn0j7T, ",1334920161430630400,False,0,0,0,0,dlvr.it,Incyte Announces First Data from REACH3 Trial Showing Ruxolitinib (Jakafi¬Æ) Significantly Improved Outcomes in Patients with Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease https://t.co/YGjbDvH9oL #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
4058194633,2020-12-04 12:55:52,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1334919362088640512,False,0,0,0,0,Twitter for iPhone,$INCY Incyte Announces First Data from REACH3 Trial Showing Ruxolitinib (Jakafi¬Æ) Significantly Improved Outcomes in Patients with Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease  | Business Wire https://t.co/A46k3YqfWe,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
3911174913,2020-12-04 12:37:17,,"GVHD, ASH20, ",,1334914684886151171,False,5,0,0,1,Twitter for Advertisers.,Data from the REACH3 trial showing an Incyte therapy significantly improved outcomes in patients with steroid-refractory or steroid-dependent chronic graft-versus-host disease (#GVHD) will be presented at @ASH_hematology. #ASH20,"ASH_hematology, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
472650465,2020-12-04 12:32:50,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1334913566328107009,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces First Data from REACH3 Trial Showing Ruxolitinib (Jakafi¬Æ) Significantly Improved Outcomes in Patients with Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease https://t.co/F4Vfg45KdE,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1254035253104181256,2020-12-04 12:32:47,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1334913553342480384,False,0,0,0,0,stocktitan,"$INCY Incyte Announces First Data from REACH3 Trial Showing Ruxolitinib (Jakafi¬Æ) Significantly Improved Outcomes in Patients with Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease
https://t.co/YDltYKNskZ",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1134049078424162304,2020-12-04 12:31:25,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1334913211661955078,False,0,0,0,0,Newsfilter.io,Incyte Announces First Data from REACH3 Trial Showing Ruxolitinib Significantly Improved Outcomes in Patients with Steroid-Refractory or.. $INCY https://t.co/fsJNRCzpb0,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1174328900815638530,2020-12-04 09:05:39,,,"pic.twitter.com/cLqQthnaHg, ",1334861427157458945,False,2,0,0,0,Twitter Web App,"Thank you again to our sponsors, who make these webinars possible! @DeBusinessTimes @ENVintel @Incyte @SallieMae @christianacare @choosedelaware @RichardsLayton https://t.co/cLqQthnaHg","DeBusinessTimes, ENVintel, Incyte, SallieMae, christianacare, choosedelaware, RichardsLayton, ",,2019-09-18 10:26:52,University of Delaware,UD Women's Leadership Initiative,https://pbs.twimg.com/profile_images/1308487443373584385/9gVTndil_normal.jpg,328,272,3,735,udwomenlead,photo
1280938376099741697,2020-12-04 08:29:10,,,"iexcloud.io, pic.twitter.com/0cqMpCiYNf, ",1334852245062553600,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Umm Al-Qaiwain General Investments Co. P
-National Marine Dredging
-Facebook Inc - Class A
-Pepsico Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/0cqMpCiYNf",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
477131488,2020-12-04 07:39:46,,"TNBC, breastcancer, HNSCC, Bridge20, ","pic.twitter.com/2JDAOouBjR, pic.twitter.com/2JDAOouBjR, pic.twitter.com/2JDAOouBjR, pic.twitter.com/2JDAOouBjR, twitter.com/BernardAFox/st‚Ä¶, ",1334839815934599168,False,6,0,0,2,Twitter for iPhone,4) Excited! Triplet IO trial for #TNBC #breastcancer led by @davidbpage is now enrolling @ProvHealth @RoswellPark &amp; @HackensackUMC &amp; triplet IO #HNSCC trial led by @MarcusCouey &amp; @romleidner opening soon @BMS_ImmunOnc_US #Bridge20 @FondMelanoma @Incyte @UbiVac @ChilesResearch https://t.co/2JDAOouBjR https://t.co/Robu71IRqM,"davidbpage, ProvHealth, RoswellPark, HackensackUMC, MarcusCouey, romleidner, BMS_ImmunOnc_US, FondMelanoma, Incyte, UbiVac, ChilesResearch, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
1314280236679270401,2020-12-03 23:18:36,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1334713689442750466,False,0,0,0,0,Twitter,"12/03/2020
üî• 4 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $329,942 | 3980 Shares
Streak Total: $5,221,462 | 61690 Shares
Daily Close: $82.90 (0.77%) ‚¨ÜÔ∏è
Prev Close: $82.27
W.Avg Streak Price: $84.64
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
374729426,2020-12-03 16:40:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2375019, pic.twitter.com/eAG0IGZVq4, ",1334613589181620225,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on December 2, 2020. View odds for this and other indicators: https://t.co/vrV4dhRzHC #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/eAG0IGZVq4",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
14617444,2020-12-03 14:06:04,,,"pic.twitter.com/ZiinOY5eja, ",1334574639918559241,False,2,0,0,2,Khoros Publishing App,"Congratulations to Nicoletta Cieri, MD, PhD, the 2020 AACR-Incyte Immuno-oncology Fellowship recipient. We look forward to her progress on developing a treatment strategy for AML that combines whole tumor vaccination with subsequent adoptive transfer of AML-reactive T cells. https://t.co/ZiinOY5eja",,,2008-05-01 14:13:40,"Philadelphia, Pennsylvania",AACR,https://pbs.twimg.com/profile_images/483648447971463168/J-CUuLt4_normal.jpeg,94579,1983,1440,25485,AACR,photo
133504478,2020-12-03 12:12:02,,"strategy, competitiveintelligence, marketing, productmarketing, healthcare, pharma, biotech, pharmaceutical, ","dlvr.it/Rmwt0N, ",1334545943467761665,False,0,0,0,1,dlvr.it,"Impact Of Covid-19 On Essential Thrombocythemia Drug Market Revenue Strategy 2020 | AbbVie Inc, Aop Orphan Pharmaceuticals AG, F. Hoffmann-La‚Ä¶ https://t.co/4iznJ8fBQX #strategy #competitiveintelligence #marketing #productmarketing #healthcare #pharma #biotech #pharmaceutical",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
477131488,2020-12-03 11:31:22,,"immunotherapy, Bridge20, ","pic.twitter.com/yH6bPar2YN, pic.twitter.com/yH6bPar2YN, pic.twitter.com/yH6bPar2YN, pic.twitter.com/yH6bPar2YN, ",1334535710678781954,False,3,1,0,1,Twitter for iPhone,Prof Ryan Sullivan #immunotherapy    ROCKSTAR @MGHCancerCenter THE GREAT DEBATE! Argues PD-1 is backbone for cancer treatments/ #Bridge20 @BMS_ImmunOnc_US @Incyte @Merck @pfizer @UbiVac https://t.co/yH6bPar2YN,"MGHCancerCenter, BMS_ImmunOnc_US, Incyte, Merck, pfizer, UbiVac, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
1180787148837933056,2020-12-03 10:45:02,,"careersaas, incyte, jobsearch, jobs, ","app.careersaas.com/portal/company‚Ä¶, ",1334524050497040384,False,0,0,0,0,Twitter,96 jobs available at Incyte in #careersaas #incyte #jobsearch visit https://t.co/YML9JiOVtp if you are interested! #jobs,,,2019-10-06 06:09:39,,Careersaas,https://pbs.twimg.com/profile_images/1329149919848849408/S3lHwCHU_normal.jpg,1992,298,0,1500,careersaas,
477131488,2020-12-03 08:38:54,,"immunotherapy, Bridge20, ","pic.twitter.com/dIrOm9GXrc, pic.twitter.com/dIrOm9GXrc, pic.twitter.com/dIrOm9GXrc, pic.twitter.com/dIrOm9GXrc, ",1334492308490702849,False,17,0,0,4,Twitter for iPhone,Prof @SamirNKhleif #immunotherapy    ROCKSTAR @Georgetown Remarkable &amp; critical insights into PD1 treated T cells /shows they morph into dysfunctional T cells/express PD1 &amp; CD38/timing with vaccine is critical/ #Bridge20 @BMS_ImmunOnc_US @Incyte @Merck @pfizer @UbiVac https://t.co/dIrOm9GXrc,"SamirNKhleif, Georgetown, BMS_ImmunOnc_US, Incyte, Merck, pfizer, UbiVac, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
1001523981500014592,2020-12-03 00:13:34,,"jobs, hiring, Wilmington, Delaware, USA, ","dlvr.it/Rmtm6h, ",1334365136782385152,False,0,0,0,0,dlvr.it,"#jobs #hiring #Wilmington #Delaware #USA Assoc. Dir. Robotic Process Automation (RPA) Technical Architect: Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet‚Ä¶ https://t.co/Pavkcf0hJ7",,,2018-05-29 14:01:39,United States,Empleos.io,https://pbs.twimg.com/profile_images/1002198831470178305/0-DY_Jrn_normal.jpg,127,76,6,95846,EmpleosIO,
1314280236679270401,2020-12-02 20:22:37,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1334307015355584519,False,0,0,0,0,Twitter,"12/02/2020
üî• 3 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $491,152 | 5970 Shares
Streak Total: $4,891,520 | 57710 Shares
Daily Close: $82.27 (-3.69%) ‚¨áÔ∏è
Prev Close: $85.42
W.Avg Streak Price: $84.76
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
3300738796,2020-12-02 13:32:11,,"InnovationsAwards20, ","pic.twitter.com/XhD4rHm61U, ",1334203728962985986,False,1,0,0,0,Twitter Web App,Thank you to the Partnering sponsors of our 2020 Innovations in Regulatory Science Awards celebration on December 8. #InnovationsAwards20 @AdaptiveBiotech @GrailBio @HarvardPilgrim @gloverparkgroup @KraftHeinzCo @illumina @Incyte @onemedical https://t.co/XhD4rHm61U,"AdaptiveBiotech, GrailBio, HarvardPilgrim, gloverparkgroup, KraftHeinzCo, illumina, Incyte, onemedical, ",,2015-05-27 13:56:23,"Washington, DC",Foundation for FDA,https://pbs.twimg.com/profile_images/1240643240233140224/u16L-BMd_normal.jpg,815,452,33,1579,reaganudall,photo
374729426,2020-12-02 12:55:27,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2371936, pic.twitter.com/1e88tqxSbb, ",1334194483026563074,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on November 27, 2020. View odds for this and other indicators: https://t.co/5GiKaHn0Eh #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1e88tqxSbb",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
4058194633,2020-12-02 12:39:17,"INCY, ",,"seekingalpha.com/article/439228‚Ä¶, ",1334190415013003265,False,0,0,0,0,Twitter for iPhone,$INCY  Incyte: Wait No More - Time To Buy https://t.co/vVmqYQMhMI,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1359077910,2020-12-02 12:30:10,,,"europharmajobs.com/job_display/19‚Ä¶, ",1334188122100232192,False,0,0,0,0,EPJ Jobs Post,"Manager, Sr Manager, Commercial QA Distribution, Incyte, Morges, Switzerland

https://t.co/UfeeRYrLE3",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
770087685738340353,2020-12-02 09:21:01,,"INCY, RobertHoneywill, ","dlvr.it/RmrWyX, ",1334140520147259394,False,0,0,0,0,dlvr.it,#INCY #RobertHoneywill Incyte: Wait No More - Time To Buy https://t.co/AQs9LhcjBv,,,2016-08-28 22:36:26,Creative Land Of Metaverse,Creative Hybrid Nftüì°,https://pbs.twimg.com/profile_images/1435970649168695311/EKCoXgjP_normal.jpg,2014,4998,11,38480,thecreativenft,
23059499,2020-12-02 09:15:08,"INCY, ","business, markets, economy, ","seekingalpha.com/article/439228‚Ä¶, ",1334139039952236544,False,0,0,0,1,SAArticlesTwitter,$INCY - Incyte: Wait No More - Time To Buy. https://t.co/H1ETB3sgal #business #markets #economy,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1218480193725091840,2020-12-02 07:05:00,"MGNX, ","mellaltameet, ","mellalta.com, globenewswire.com/news-release/2‚Ä¶, ",1334106288448532481,False,0,0,0,0,Twitter Web App,"https://t.co/O1jfYdduWy $MGNX MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte &gt;&gt;RFP@‚ÄØbd@mellalta.com&gt;¬†#mellaltameet

https://t.co/TQWdfPWOvs",,,2020-01-18 05:28:28,,Mellalta Meets,https://pbs.twimg.com/profile_images/1239854909308039168/ZiS9Gw38_normal.jpg,63,346,0,1580,mellaltameets,
1148421960948281345,2020-12-02 04:27:17,,,"news.freeptomaineradio.com/?p=63435, ",1334066597837873155,False,0,0,0,0,ArthurPotatoeHammer,"https://t.co/Ny6qzboqbY
MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte
NEWS.FREEPTOMAINERADIO.COMROCKVILLE, MD, Nov. 30, 2020 (GLOBE NEWSWIRE) -- ¬† MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmac...",,,2019-07-08 22:41:46,United States,ArthurPotatoeHammer,https://pbs.twimg.com/profile_images/1184265779983847425/STYm7fen_normal.jpg,1205,1158,5,129965,KingNormies,
1314280236679270401,2020-12-01 22:06:35,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1333970793110384645,False,0,0,0,0,Twitter,"12/01/2020
üü¢ 2 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $2,549,787 | 29850 Shares
Streak Total: $4,400,368 | 51740 Shares
Daily Close: $85.42 (1.04%) ‚¨ÜÔ∏è
Prev Close: $84.54
W.Avg Streak Price: $85.05
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
3426014292,2020-12-01 19:05:07,"INCY, ",,,1333925126040129537,False,1,0,0,2,Twitter for iPhone,"$INCY Monday Dec 7, 2020 4pm, Incyte Analyst meeting:",,,2015-09-02 09:10:37,,dough,https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_normal.jpg,32805,529,852,59439,semodough,
477131488,2020-12-01 18:54:32,,"Cancer, Vaccines, WVIC2020, ","pic.twitter.com/No6cnAumlk, ",1333922460484259840,False,14,0,1,3,Twitter for iPhone,It Started! Can #Cancer #Vaccines Hold their PROMISE? #WVIC2020 Great being interviewed with Prof. Lei Zheng @bloombergkimmel @HopkinsMedicine &amp; I @ChilesResearch @ubivac /Dr Lauren Wood @PDSBiotech led the interview @BMS_ImmunOnc_US @Incyte @Merck @Boehringer @JanssenUS @pfizer https://t.co/No6cnAumlk,"bloombergkimmel, HopkinsMedicine, ChilesResearch, UbiVac, PDSBiotech, BMS_ImmunOnc_US, Incyte, Merck, Boehringer, JanssenUS, pfizer, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
374729426,2020-12-01 12:32:11,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2368959, pic.twitter.com/Oy6F7j6aYQ, ",1333826241669910529,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators: https://t.co/iJHd9DzX7r #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Oy6F7j6aYQ,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
851849189176856576,2020-12-01 11:09:32,,,"dlvr.it/Rmn7vh, pic.twitter.com/CeoIvaytEi, ",1333805440421879809,False,1,0,0,1,dlvr.it,MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte https://t.co/FP3aiJ6fd4 https://t.co/CeoIvaytEi,,,2017-04-11 13:27:28,DC/Maryland/Virginia,BioHealth Cap Region,https://pbs.twimg.com/profile_images/851849919627395073/7hLLtpIU_normal.jpg,829,83,12,1951,BioHealthCR,photo
1280938376099741697,2020-12-01 07:45:55,,,"iexcloud.io, pic.twitter.com/IMJYvKgFDq, ",1333754196454215681,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Workday Inc - Class A
-Take-Two Interactive Software, Inc.
-Texas Instruments Inc.
-Arkan Building Materials

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/IMJYvKgFDq",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1889492676,2020-12-01 02:59:46,"MGNX, ","MacroGenics, Retifanlimab, Incyte, ","1stoncology.com/blog/macrogeni‚Ä¶, ",1333682185266597891,False,0,0,0,0,Troi URL Plug-in,#MacroGenics Announces Achievement of $25 Million in Milestones Related to #Retifanlimab Collaboration with #Incyte $MGNX https://t.co/FkEk4pufE8,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1280938376099741697,2020-12-01 01:55:58,,,"iexcloud.io, pic.twitter.com/isny8dCATn, ",1333666129538129920,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Wynn Resorts Ltd.
-Incyte Corp.
-Intuit Inc
-Analog Devices Inc.
-Apple Inc

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/isny8dCATn",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1134049078424162304,2020-11-30 22:12:20,"MGNX, INCY, ",,"newsfilter.io/articles/macro‚Ä¶, ",1333609850203467777,False,0,0,0,0,Newsfilter.io,MacroGenics secures $25M milestone payment from Incyte $MGNX $INCY https://t.co/6Is2c8ZB9x,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
374729426,2020-11-30 10:53:22,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2365964, pic.twitter.com/kFQVoB5X9M, ",1333438982814744584,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/iq518vzywv #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kFQVoB5X9M",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
4058194633,2020-11-30 10:48:55,"MGNX, ",,"globenewswire.com/news-release/2‚Ä¶, ",1333437862977572866,False,0,0,0,1,Twitter for iPhone,$MGNX MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte https://t.co/kpsasyPLbZ,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
3524211082,2020-11-30 09:01:16,,,"twib.in/l/L6AXRaxXraAz, ",1333410774182727681,False,0,0,0,0,Twibble.io,MacroGenics secures $25M milestone payment from Incyte https://t.co/qv2prHuAdB,,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
15296897,2020-11-30 08:53:29,"MGNX, MGNX, INCY, ",,"seekingalpha.com/news/3639935-m‚Ä¶, ",1333408814293413888,False,0,0,0,0,SANewsTwitter,$MGNX $MGNX $INCY - MacroGenics secures $25M milestone payment from Incyte https://t.co/YZdV7ABAXY,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3686628867,2020-11-30 08:24:22,,,"pharmaceuticaldaily.com/macrogenics-an‚Ä¶, ",1333401488534736897,False,0,0,0,0,WordPress.com,MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with¬†Incyte https://t.co/PFPvkoN2ww,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
3686628867,2020-11-30 08:23:22,,,"pharmaceuticaldaily.com/macrogenics-an‚Ä¶, ",1333401233667878912,False,0,0,0,0,WordPress.com,MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with¬†Incyte https://t.co/bcDK9JXOR3,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1006334607946649600,2020-11-30 07:57:32,,"StockMarket, ","dlvr.it/Rmhn6L, ",1333394733180194819,False,0,0,0,0,dlvr.it,MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte https://t.co/TtWMeCdTHX #StockMarket,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1188117778567454720,2020-11-30 07:53:51,"MGNX, ",,"jodie.ai/company/MGNX, ",1333393805739954176,False,0,0,0,0,jodietheai,"üìâ $MGNX: MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte

https://t.co/EebV5WfD3t",,,2019-10-26 11:38:58,London,Jodie Insights,https://pbs.twimg.com/profile_images/1310896987466760198/cVg3gmLj_normal.jpg,624,1781,16,28832,jodietheai,
106823467,2020-11-30 07:39:28,"MGNX, INCY, ","MacroGenics, Incyte, ","crweworld.com/symbol/MGNX, ",1333390185300541441,False,0,0,0,0,Twitter Web App,$MGNX Achieves $25M in Milestones Related to Retifanlimab Collaboration with $INCY          #MacroGenics        #Incyte      https://t.co/I2UCpLYcry,,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
3318510966,2020-11-30 07:35:05,,,"crweworld.com/article/news-p‚Ä¶, ",1333389083532349442,False,0,0,0,0,CRWE World,MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte https://t.co/DWDm1r8s2r,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1134049078424162304,2020-11-30 07:32:19,"MGNX, ",,"newsfilter.io/articles/macro‚Ä¶, ",1333388386875420673,False,0,0,0,0,Newsfilter.io,MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte $MGNX https://t.co/oTY6NLmNal,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1069693680066420736,2020-11-30 07:31:51,"MGNX, ",,"s.flashalert.me/GFJlUK, ",1333388269158096899,False,0,0,0,0,flashalerts,"$MGNX [15s. delayed]: Issued Press Release on November 30, 07:30:00: MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte https://t.co/c3ItNmduE0",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
33371707,2020-11-30 07:30:39,"MGNX, ","NASDAQ, ","globenewswire.com/news-release/2‚Ä¶, ",1333387969995055117,False,0,0,0,0,xool,"$MGNX #NASDAQ News: MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte [B/A=0/0 - Bid/Ask Size=0/0  Volume=293,699  AverageVol=469,508  Outstanding=0] https://t.co/eS9cxxH9sU",,,2009-04-19 21:38:45,,tweeter no more. jack dorsey is a nazi,https://pbs.twimg.com/profile_images/1288570978516127744/0O_9eGqP_normal.jpg,497,633,11,84299,bbiittccooiinn,
1254035253104181256,2020-11-30 07:30:01,"MGNX, ",,"stocktitan.net/news/MGNX/macr‚Ä¶, ",1333387808812244992,False,0,0,0,0,stocktitan,"$MGNX MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with Incyte
https://t.co/1XWsmZaQ0S",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
17108702,2020-11-29 13:42:00,,"COVID19, Spokane, SpoCougs, GoCougs, ","bit.ly/33kAexQ, pic.twitter.com/4uWdmE0nWp, ",1333119032753459200,False,0,0,0,0,TweetDeck,"WSU Chief Compliance and Risk Officer Sharyl Kammerzell is quite busy during the #COVID19 pandemic, but she couldn't do it without the help of partners like #Spokane company Incyte Diagnostics.

Background: https://t.co/fF1kOuExst

#SpoCougs #GoCougs https://t.co/4uWdmE0nWp",,,2008-11-01 21:58:08,"Spokane, WA",WSU Spokane,https://pbs.twimg.com/profile_images/1438156757482622978/qY2opr2F_normal.jpg,6051,1306,202,13702,WSUSpokane,video
374729426,2020-11-29 12:26:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2363187, pic.twitter.com/iDO83j3LRN, ",1333100108188065792,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/b5yobsL3y4 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/iDO83j3LRN",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
786038665625554944,2020-11-29 05:13:24,"INCY, ","NotRealStockAdvice, ",,1332991042082267136,False,0,0,0,0,SFE Robot1,"A series of technical analyses and random guesses suggest you buy, sell, and hold Incyte $INCY #NotRealStockAdvice",,,2016-10-11 22:59:56,The Markets,Stock Advicebot 2000,https://pbs.twimg.com/profile_images/786041984376983553/Zkm6Ab6h_normal.jpg,1797,69,38,43757,StockTipRobot,
1280938376099741697,2020-11-29 02:37:20,,,"iexcloud.io, pic.twitter.com/n3Fjsh4emk, ",1332951764434300929,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-NVIDIA Corp.
-Incyte Corp.
-Walgreens Boots Alliance, Inc.
-Marriott International, Inc.
-Fiserv, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/n3Fjsh4emk",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
17108702,2020-11-28 19:34:00,,"Spokane, COVID19, SpoCougs, GoCougs, ","pic.twitter.com/jTo2unPgGm, ",1332845228781432832,False,3,0,0,0,TweetDeck,"Wendy Williams-Gilbert of @WSUNursing gives a shoutout to Incyte Diagnostics in #Spokane for its dogged work in fighting #COVID19 

#SpoCougs #GoCougs https://t.co/jTo2unPgGm","WSUNursing, ",,2008-11-01 21:58:08,"Spokane, WA",WSU Spokane,https://pbs.twimg.com/profile_images/1438156757482622978/qY2opr2F_normal.jpg,6051,1306,202,13702,WSUSpokane,video
1280938376099741697,2020-11-28 17:15:33,,,"iexcloud.io, pic.twitter.com/VamU4b6qHZ, ",1332810387264311298,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Trip.com Group Ltd.
-Tesla, Inc.
-Incyte Corp.
-Emirates Driving Co.
-IDEXX Laboratories, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/VamU4b6qHZ",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1301425387369619456,2020-11-28 14:06:34,,,"mednetnews.com/2020/11/28/pae‚Ä¶, ",1332762828529426434,False,0,0,0,0,WordPress.com,"Paediatric Hodgkin Lymphoma Market 2020-2027 New Informative Study || Leading Players ‚Äì Novartis AG, Incyte Corporation, Affimed GmbH, Aeterna Zentaris Inc. Actinium¬†Pharmaceuticals https://t.co/mNn7KArZDv",,,2020-09-03 03:42:57,,mednetnews,https://pbs.twimg.com/profile_images/1301426159247384577/VZsF735N_normal.jpg,5,0,0,13260,mednetnews,
374729426,2020-11-28 14:00:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2360629, pic.twitter.com/r8Bk7xLaJi, ",1332761398171078657,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/gCBYZ1xAxL #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/r8Bk7xLaJi",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
950863475613421568,2020-11-28 12:39:31,,,"twitter.com/WSUSpokane/sta‚Ä¶, ",1332740919859183617,False,12,0,0,0,Twitter for Android,InCyte Diagnostics and WSU One Health Diagnostics--a team effort https://t.co/n1vmTR0gqu,,,2018-01-09 17:54:53,"Spokane, WA",Daryll DeWald,https://pbs.twimg.com/profile_images/950867739974905856/pPOuNuv4_normal.jpg,440,171,3,550,WSUHealthSciVP,
1280938376099741697,2020-11-28 02:16:26,,,"iexcloud.io, pic.twitter.com/C4yMC4SvWC, ",1332584116588572678,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Fiserv, Inc.
-Broadcom, Inc.
-Ross Stores, Inc.
-Sharjah Insurance Co.
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/C4yMC4SvWC",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
17108702,2020-11-27 14:25:00,,"COVID19, SpoCougs, GoCougs, ","pic.twitter.com/9JFUOY9h3X, ",1332405078469332999,False,9,1,0,1,TweetDeck,".@WSUHealthSciVP Daryll DeWald expresses his gratitude for Incyte Diagnostics and its partnership in fighting #COVID19.

#SpoCougs #GoCougs https://t.co/9JFUOY9h3X","WSUHealthSciVP, ",,2008-11-01 21:58:08,"Spokane, WA",WSU Spokane,https://pbs.twimg.com/profile_images/1438156757482622978/qY2opr2F_normal.jpg,6051,1306,202,13702,WSUSpokane,video
374729426,2020-11-27 11:31:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2357642, pic.twitter.com/IN2S6SRWha, ",1332361514288779264,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/7PZCiCHft8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/IN2S6SRWha",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280938376099741697,2020-11-27 00:27:48,,,"iexcloud.io, pic.twitter.com/TabWPxsBH8, ",1332194391662997505,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Dollar Tree, Inc.
-Incyte Corp.
-Union Cement Co. PSC
-Abu Dhabi National Energy Co. PJSC
-Netflix, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/TabWPxsBH8",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
20067285,2020-11-26 22:06:01,,,"buff.ly/2URUr9z, pic.twitter.com/9wfKN4E7QQ, ",1332158710773403648,False,1,0,0,0,Buffer,"Eli Lilly, and Incyte have received Emergency Use Authorization from the FDA for the distribution and emergency use of baricitinib to be used in combination with remdesivir in patients with suspected or laboratory-confirmed COVID-19. https://t.co/sZXoT6BLRw https://t.co/9wfKN4E7QQ",,,2009-02-04 11:40:09,"New York, NY",Drug Store News,https://pbs.twimg.com/profile_images/1449075795281031169/WZevJXO6_normal.jpg,11961,897,327,31332,DrugStoreNews,photo
17108702,2020-11-26 11:54:00,,"Spokane, SpoCougs, GoCougs, Thanksgiving, ","bit.ly/33kAexQ, pic.twitter.com/EWK71wWZ1u, ",1332004690221961219,False,2,0,0,1,TweetDeck,"A brief message from Colleen Kerr, WSU VP External Affairs and Government Relations.

We're thankful for Incyte Diagnostics in #Spokane for its partnership in running COVID-19 tests for Eastern Washington!

Background: https://t.co/fF1kOuExst

#SpoCougs #GoCougs #Thanksgiving https://t.co/EWK71wWZ1u",,,2008-11-01 21:58:08,"Spokane, WA",WSU Spokane,https://pbs.twimg.com/profile_images/1438156757482622978/qY2opr2F_normal.jpg,6051,1306,202,13702,WSUSpokane,video
374729426,2020-11-26 11:14:32,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2354661, pic.twitter.com/z7IXbcsN75, ",1331994760161107968,False,0,0,0,1,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/oZvtaYhsT1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/z7IXbcsN75",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
374729426,2020-11-25 11:10:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2351665, pic.twitter.com/iLiHe4BN5t, ",1331631391629471746,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on November 24, 2020. View odds for this and other indicators: https://t.co/2sR8BRTbZo #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/iLiHe4BN5t",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
21268553,2020-11-25 05:00:02,,,"stock-market-newsfeed.blogspot.com/2020/11/the-za‚Ä¶, ",1331538126636986370,False,0,0,0,0,SS Auto Tweet App,"The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer
 https://t.co/OJrjlXnVHK",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
69603938,2020-11-25 01:09:54,,,"twitter.com/BillProvine/st‚Ä¶, ",1331480208545894400,False,5,1,0,1,Twitter for iPhone,Feeding the ecosystem produces great local companies like @Incyte. Congratulations Bill. https://t.co/Y1fm37PQuK,"Incyte, ",,2009-08-28 10:41:28,Delaware,Ben duPont,https://pbs.twimg.com/profile_images/1363527332011589633/EjuDPUEJ_normal.jpg,9486,6249,142,5442,BenjaminduPont,
21268553,2020-11-24 14:30:04,,,"stock-market-newsfeed.blogspot.com/2020/11/the-za‚Ä¶, ",1331319189450203136,False,1,0,0,1,SS Auto Tweet App,"The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer
 https://t.co/OJrjlXnVHK",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
18187409,2020-11-24 14:16:34,,,"ift.tt/3m3vDro, pic.twitter.com/djDYfhaKmc, ",1331315795268341774,False,0,0,0,0,IFTTT,"The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer https://t.co/P92WBJIW31 https://t.co/djDYfhaKmc",,,2008-12-17 06:46:23,CFL -NFL- AFL,Ken Robinson,https://pbs.twimg.com/profile_images/1193565075/Leo_Spears_-_Scouting_Report_normal.png,1310,2689,46,159756,superscoutken,photo
1260878696270962688,2020-11-24 10:16:32,,,"dlvr.it/RmKy5p, ",1331255386658148352,False,0,0,0,0,dlvr.it,Market Access Director ‚Äì Incyte Corporation ‚Äì Amsterdam https://t.co/5ogOtMxsnI,,,2020-05-14 06:24:53,,Werk Amsterdam,https://pbs.twimg.com/profile_images/1261654565461594112/tlNHP86x_normal.jpg,87,70,0,2200,amsterdam_werk,
374729426,2020-11-24 09:32:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2348616, pic.twitter.com/KgLsrezjuT, ",1331244218451329025,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/FqfxOUTlQx #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/KgLsrezjuT,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1250830691824283648,2020-11-23 21:10:23,"FE, BMRN, INTC, TEVA, ET, VRTX, VLO, GILD, PSX, IFF, BIIB, INCY, ILMN, XOM, BP, SRPT, CHL, ",,,1331057545570553858,False,5,0,1,2,Twitter Web App,"Worst performing large cap stocks for the past 6 months

First Energy $FE
BioMarin $BMRN
Intel $INTC
$TEVA
Energy Transfer $ET
Vertex $VRTX
Valero $VLO
Gilead $GILD
Phillips $PSX
International Flavors $IFF
Biogen $BIIB
Incyte $INCY
Illumina $ILMN
Exxon $XOM
$BP
Sarepta $SRPT
$CHL",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123337,211,1299,33044,StockMKTNewz,
1120631024306802688,2020-11-23 15:50:02,"INCY, ","stockstotrade, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, ",1330976925448351745,False,0,0,0,0,DataSwarm Markets,"$INCY We have detected a noticeable rise in the Zeitgeist for Incyte Corporation at  https://t.co/OxItqO0RgL
Visit DataSwarm Markets for more information
#stockstotrade #NASDAQ
DataSwarm ref: 114590",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
94794805,2020-11-23 12:54:44,,,"hospimedica.com/covid-19/artic‚Ä¶, pic.twitter.com/EAJYeNQ2yg, ",1330932809700159492,False,0,0,1,0,Globetech twi-connect,Eli Lilly and Incyte‚Äôs Baricitinib Receives FDA EUA for Treatment of Hospitalized COVID-19 Patients:The US Food... https://t.co/5rdkAEus4k https://t.co/EAJYeNQ2yg,,,2009-12-05 08:48:51,,HospiMedica.com,https://pbs.twimg.com/profile_images/843924355079979009/StpNpJz7_normal.jpg,901,0,14,6177,HospiMedica,photo
374729426,2020-11-23 11:40:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2345917, pic.twitter.com/SCAhxHlgjR, ",1330914218757918733,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/xIbVczFB8J #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/SCAhxHlgjR",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1304501212486815749,2020-11-22 14:10:18,,,"nasdaq.com/articles/lilly‚Ä¶, ",1330589440272642054,False,0,0,0,0,Feeder.co,"Lilly, Incyte Report Positive New Data For Baricitinib In Adult Patients With Alopecia Areata https://t.co/CoRcBSnUFl",,,2020-09-11 15:25:17,,Anonymous,https://pbs.twimg.com/profile_images/1357190877857341441/3Py1kOuL_normal.jpg,5,54,0,4902,WCIKM_Bot,
374729426,2020-11-22 11:53:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2343003, pic.twitter.com/MhWpTNbmkL, ",1330555130970738689,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/47ICxpyKPo #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MhWpTNbmkL",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
23545500,2020-11-22 02:48:10,,,"pharmaceutical-technology.com/news/fda-eua-l‚Ä¶, ",1330417776876457985,False,0,0,0,0,Twitter Web App,FDA grants EUA for Lilly and Incyte‚Äôs baricitinib for Covid-19 treatment https://t.co/Q9iUxbP247 via @PharmaTechFocus,"PharmaTechFocus, ",,2009-03-09 22:37:29,Canada,Innovative by nature,https://pbs.twimg.com/profile_images/848004580491366401/pBNfRIyD_normal.jpg,1148,3203,28,37349,Rosie_C_Cares,
2570920968,2020-11-21 16:45:00,"INCY, ","biotech, dermatology, ","twitter.com/Incyte/status/‚Ä¶, ",1330265983336947712,False,0,0,0,0,Twitter Web App,"Interesting! Keep up the good work! @Incyte
$INCY #biotech #dermatology https://t.co/5Kl1uteQnu","Incyte, ",,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
374729426,2020-11-21 11:20:01,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2340036, pic.twitter.com/e8VFlu1Fl6, ",1330184198905360391,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average broke below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/kGkPf8YoVO #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/e8VFlu1Fl6",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
213788861,2020-11-21 11:18:48,,,,1330183895409692673,False,4,1,0,0,Twitter Web App,"FOP family gathering: clear overview during almost 3 hours on Friday session of clinical trials for FOP from 4 Pharma (Ipsen, Regeneron, Keros, Incyte and 1 Academia driven consortium with support from European Union). Promising and creating much hope...@STOPFOPEU @IFOPA","STOPFOPEU, ifopa, ",,2010-11-09 15:15:27,Netherlands,Osteoporosis NL,https://pbs.twimg.com/profile_images/2728406935/efab446976f8d9558a2dd15208f7a5a6_normal.jpeg,2353,535,66,15826,Osteoporosis_NL,
1001523981500014592,2020-11-21 07:17:05,,"jobs, hiring, Wilmington, Delaware, USA, ","dlvr.it/Rm85b8, ",1330123062344364033,False,0,0,0,0,dlvr.it,"#jobs #hiring #Wilmington #Delaware #USA Manager, US Prod Strategy, External Expert Liaison: Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical needs in‚Ä¶ https://t.co/cbe1rXO2N7",,,2018-05-29 14:01:39,United States,Empleos.io,https://pbs.twimg.com/profile_images/1002198831470178305/0-DY_Jrn_normal.jpg,127,76,6,95846,EmpleosIO,
1134049078424162304,2020-11-21 02:09:17,"PFE, GILD, INCY, LLY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1330045601443160064,False,0,0,0,0,Newsfilter.io,Lilly/Incyte's Olumiant Gets FDA Emergency Nod for COVID-19 $PFE $GILD $INCY $LLY https://t.co/UawMhQyUQC,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1280288213102292993,2020-11-20 21:48:19,,,"pharmabox.in/eli-lilly-and-‚Ä¶, ",1329979927953887232,False,0,0,0,0,Hootsuite Inc.,Eli Lilly and Incyte Receive FDA‚Äôs EUA for Baricitinib + Remdesivir to Treat Hospitalized Patients with COVID-19 https://t.co/7zBSa6N41R,,,2020-07-06 19:51:21,,WWW.PHARMABOX.IN,https://pbs.twimg.com/profile_images/1284027505058381827/7o7Mcyq1_normal.jpg,856,450,0,5397,pharmabox_in,
1314280236679270401,2020-11-20 20:34:16,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1329961291562283014,False,0,1,0,0,Twitter,"11/20/2020
üî•üî• 13 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $815,204 | 9950 Shares
Streak Total: $14,648,619 | 176008 Shares
Daily Close: $81.93 (0.29%) ‚¨ÜÔ∏è
Prev Close: $81.69
W.Avg Streak Price: $83.23
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
159071535,2020-11-20 14:57:55,,,"pmlive.com/pharma_news/li‚Ä¶, ",1329876648343326725,False,0,0,0,0,Twitter Web App,Eli Lilly and Incyte‚Äôs baricitinib scored an emergency use authorisation (EUA) from the FDA in combination with Gilead‚Äôs remdesivir. (ENG) https://t.co/tKtI8Gm5Au,,,2010-06-24 07:08:50,Moscow,Pharma & Healthcare News: Russia and beyond,https://pbs.twimg.com/profile_images/883302378681896960/BhdeYeJH_normal.jpg,183,6,7,9465,RuPharma,
1021485047977832449,2020-11-20 14:18:03,,"OnlineFirst, Cholangiocarcinoma, PrecisionMedicine, ","bit.ly/36XIlkS, pic.twitter.com/WYLuaC7MAb, ",1329866617191346187,False,4,0,0,1,Khoros Publishing App,"Just published #OnlineFirst: Clinicogenomic analysis of FGFR2-rearranged #Cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib. 
@Incyte #PrecisionMedicine 
https://t.co/iyWp8j9e7i https://t.co/WYLuaC7MAb","Incyte, ",,2018-07-23 15:59:48,,Cancer Discovery,https://pbs.twimg.com/profile_images/1351622122272124934/bOgWtTKh_normal.jpg,6661,217,66,4244,CD_AACR,photo
1250830691824283648,2020-11-20 12:38:00,"D, REGN, AEP, INCY, FE, AGR, LNT, NLOK, AAP, GSX, JAZZ, IQ, EXEL, STAG, TREE, ",,,1329841435982622726,False,2,0,1,1,Twitter Web App,"Some of the largest stocks making 1-month lows so far today

Dominion Energy $D
Regeneron $REGN
American Electric $AEP
Incyte $INCY
FirstEnergy $FE
Avangrid $AGR
Alliant $LNT
NortonLifeLock $NLOK
Advanced Auto Parts $AAP
$GSX
$JAZZ
IQIYI $IQ
Exelixis $EXEL
$STAG
LendingTree $TREE",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123337,211,1299,33044,StockMKTNewz,
24753832,2020-11-20 12:21:58,,"Cholangiocarcinoma, PrecisionMedicine, ","cancerdiscovery.aacrjournals.org/content/early/‚Ä¶, ",1329837403205459975,False,18,0,0,5,Twitter Web App,Now online in @CD_AACR: Clinicogenomic analysis of FGFR2-rearranged #Cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib @Incyte #PrecisionMedicine https://t.co/X1JdRNybbH,"CD_AACR, Incyte, ",,2009-03-16 15:42:02,"Philadelphia, PA",Elizabeth McKenna,https://pbs.twimg.com/profile_images/1222534020401070085/1pcKirqM_normal.jpg,5802,2563,28,5219,ElizSMcKenna,
374729426,2020-11-20 10:38:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2337057, pic.twitter.com/wZJcZJ0aRm, ",1329811482188476418,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/0JhkJo0vqq #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wZJcZJ0aRm",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1174328900815638530,2020-11-20 09:05:08,,,"pic.twitter.com/ProjtfVKhj, ",1329787868533972993,False,2,0,0,0,Twitter Web App,Thank you to our sponsors that make these webinars happen! @DeBusinessTimes @ENVintel @Incyte @SallieMae @christianacare @choosedelaware @RichardsLayton https://t.co/ProjtfVKhj,"DeBusinessTimes, ENVintel, Incyte, SallieMae, christianacare, choosedelaware, RichardsLayton, ",,2019-09-18 10:26:52,University of Delaware,UD Women's Leadership Initiative,https://pbs.twimg.com/profile_images/1308487443373584385/9gVTndil_normal.jpg,328,272,3,735,udwomenlead,photo
1299866813128273922,2020-11-20 07:22:09,"LLY, INCY, ",,"stocktwits.com/sbiswas/messag‚Ä¶, ",1329761950109224960,False,2,0,0,0,StockTwits Web,"$LLY $INCY
[Yesterday AH News]
Eli Lilly (NYSE:LLY) and Incyte (NASDAQ:INCY) say the U.S. Food and Drug Administration issued an emergency use authorization for their baricitinib arthritis drug in combination with Gilead Science... https://t.co/3XNxP3jxKL",,,2020-08-29 20:29:46,,Soumyajyoti Biswas,https://pbs.twimg.com/profile_images/1299867914208571392/LCF5DxeK_normal.jpg,358,77,11,7429,soumyajyoti_b,
1022473214457348096,2020-11-20 03:49:07,,,"pharmashots.com/52436/eli-lill‚Ä¶, pic.twitter.com/Ox8nNTcxU1, ",1329708340599898115,False,1,0,0,1,Twitter Web App,"Eli Lilly and Incyte Receive FDA‚Äôs EUA for Baricitinib + Remdesivir to Treat Hospitalized Patients with COVID-19 @LillyPad 
https://t.co/9Z0Sy8fHge https://t.co/Ox8nNTcxU1","LillyPad, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,photo
14453501,2020-11-19 23:45:07,,,"delawarebusinessnow.com/2020/11/lily-i‚Ä¶, ",1329646932504027137,True,0,0,0,0,WordPress.com,Lily-Incyte drug gets emergency use OK for treatment of severe cases of¬†Covid-19 https://t.co/rhVN709pNW,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
1250830691824283648,2020-11-19 23:27:55,"LLY, INCY, ",,,1329642607002202304,False,1,0,0,0,Twitter for iPhone,Eli Lilly $LLY and Incyte $INCY said earlier today the U.S. Food and Drug Administration has issued an emergency use authorization for their baricitinib arthritis drug in combination with other drugs to help hospitalized COVID patients,,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123337,211,1299,33044,StockMKTNewz,
1314280236679270401,2020-11-19 22:34:16,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1329629104224735235,False,0,0,0,0,Twitter,"11/19/2020
üî•üî• 12 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $162,400 | 1988 Shares
Streak Total: $13,833,415 | 166058 Shares
Daily Close: $81.69 (-1.27%) ‚¨áÔ∏è
Prev Close: $82.74
W.Avg Streak Price: $83.30
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
3911174913,2020-11-19 20:17:34,,"News, COVID19, ",,1329594704267186177,False,10,0,1,5,Twitter for Advertisers.,#News: The @US_FDA has granted an Incyte-discovered medicine Emergency Use Authorization to treat certain patients hospitalized with #COVID19.,"US_FDA, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
1280938376099741697,2020-11-19 18:35:55,,,"iexcloud.io, pic.twitter.com/DB7NJ4OeC9, ",1329569122691198978,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Sharjah Cement &amp; Industrial Development 
-T-Mobile US, Inc.
-Microsoft Corp.
-Incyte Corp.
-United Arab Bank PJSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/DB7NJ4OeC9",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
106823467,2020-11-19 18:24:28,"LLY, INCY, ","EliLilly, Incyte, Coronavirus, COVID19, SARSCoV2, ","crweworld.com/symbol/LLY, ",1329566240419897344,False,0,0,0,0,Twitter Web App,"FDA OKs $LLY, $INCY 's Baricitinib for the Treatment of Hospitalized Patients with COVID-19       #EliLilly    #Incyte      #Coronavirus    #COVID19     #SARSCoV2   https://t.co/7OGeEVJAxh",,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
260776231,2020-11-19 18:12:02,,,"dlvr.it/Rm2yp5, ",1329563111167201280,False,0,0,0,0,dlvr.it,"Ofertas Trabajo Regional CFSP Line Manager Incyte/AZ en Espa√±a: Primary Location: Milan, Milano, Italy Additonal Locations: Amsterdam, Netherlands (NLAMS1, 40, H),NLD;Antwerp, Belgium (BEANT2, 40, H),BEL;Basel, Switzerland (CHBAS2, 40, H),CHE;Madrid,‚Ä¶ https://t.co/CJb11wgKvo",,,2011-03-04 10:39:40,"espana,mexico,argentina,chile",Ofertas de Trabajo,https://pbs.twimg.com/profile_images/1607480281/123trabajo_twitter_normal.jpg,15593,2,290,799372,123trabajo,
374729426,2020-11-19 09:34:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2334080, pic.twitter.com/aH6ORX7BYL, ",1329432989030248449,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/jO46x3o46f #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/aH6ORX7BYL",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2344420430,2020-11-19 04:24:27,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1329354843425792000,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Chairman / CEO

HERVE HOPPENOT:

https://t.co/Ue6aIEvLsE",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-11-19 03:24:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1329339731684036608,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Medical Officer

STEVEN H STEIN:

https://t.co/k2ebIqDoue",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1314280236679270401,2020-11-18 20:35:16,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1329236769385144322,False,0,0,0,0,Twitter,"11/18/2020
üî•üî• 11 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $1,234,895 | 14925 Shares
Streak Total: $13,671,015 | 164070 Shares
Daily Close: $82.74 (-0.29%) ‚¨áÔ∏è
Prev Close: $82.98
W.Avg Streak Price: $83.32
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
2344420430,2020-11-18 19:46:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1329224443999170560,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Discovery Chem

YAO WENQING:

https://t.co/FR6fvtEmZv",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-11-18 19:45:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1329224223252951042,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP GPS, BD, &amp; Licensing

VIJAY K IYENGAR:

https://t.co/0l2BR0sVwP",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-11-18 19:28:26,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1329219951647985669,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Manager US

BARRY P FLANNELLY:

https://t.co/NZDPwI3STo",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-11-18 19:08:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1329214912862806018,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Human Resources

PAULA J SWAIN:

https://t.co/UJu3rwwY3H",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-11-18 18:58:26,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1329212398905995265,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/FnERIG9WAy",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-11-18 17:55:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1329196531426205696,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/FNgKmTWlNM",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-11-18 17:45:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1329194012763447301,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Financial Officer

CHRISTIANA STAMOULIS:

https://t.co/eVfyg7FclF",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
772471873539977217,2020-11-18 17:07:47,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1329184554486263808,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/Ne4zgSZrpl,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
35306978,2020-11-18 13:29:36,,,"broad.io/DepMap2020, pic.twitter.com/beJu2uSf2l, ",1329129647552999424,False,23,5,0,7,Twitter Web App,"Broad welcomes 8 new members to its Cancer Dependency Map Consortium: @Amgen, @IBMResearch, Ideaya Biosciences, @Incyte, @Merck, @Pfizer, @_ScorpionTx, and Loxo Oncology at Lilly. The 8 new partners join the initial group of 10 companies in the consortium. https://t.co/rdJ0bgzFNV https://t.co/beJu2uSf2l","Amgen, IBMResearch, Incyte, Merck, pfizer, ",,2009-04-25 16:50:27,"Cambridge, MA, USA",Broad Institute,https://pbs.twimg.com/profile_images/183382156/broadlogo_normal.jpg,79573,3845,1181,13512,broadinstitute,photo
4597733961,2020-11-18 12:05:04,"INCY, ","COVID19, clinicaltrial, Ruxolitinib, ",,1329108374185799681,False,1,0,1,0,Twitter Web App,"Demiurge AI-based #COVID19 #clinicaltrial outcome predictions put to the public test (225_2020): 

FAILURE for 
#Ruxolitinib / NCT04377620 / @Incyte $INCY","Incyte, ",,2015-12-25 02:43:29,Switzerland,DemiurgeTech,https://pbs.twimg.com/profile_images/1227148848386265089/aqLPaCF4_normal.jpg,303,540,4,569,DemiurgeTech,
374729426,2020-11-18 09:40:43,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2331134, pic.twitter.com/WqKUemOnXn, ",1329072047046049795,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/xmxYHXuXTi #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/WqKUemOnXn,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
803229596225335297,2020-11-18 07:43:54,,,"inquirer.com/news/philly-bi‚Ä¶, ",1329042647919456256,False,0,0,0,0,Twitter Web App,"Immunome IPO on target as investors bet big on gene, cell therapies
https://t.co/LaSqKqa24O",,,2016-11-28 08:30:33,,Immunome Research,https://pbs.twimg.com/profile_images/816216674156232705/7pvLhJ4-_normal.jpg,104,478,0,738,ImmunomResearch,
1314280236679270401,2020-11-17 21:12:15,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1328883688357105665,False,0,0,0,0,Twitter,"11/17/2020
üî•üî• 10 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $330,260 | 3980 Shares
Streak Total: $12,436,121 | 149145 Shares
Daily Close: $82.98 (-1.62%) ‚¨áÔ∏è
Prev Close: $84.35
W.Avg Streak Price: $83.38
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
1043127646828355584,2020-11-17 17:56:36,,"RAD, ","revolutionizingad.com, pic.twitter.com/kRDBDZIYFd, ",1328834450776580100,False,0,0,0,0,Twitter Web App,"THANK YOU to the Gold Sponsors of the December 13 &amp; 14 Revolutionizing Atopic Dermatitis (#RAD) Virtual Conference. We truly appreciate your support. There is still time to register: https://t.co/Z88Hpq2bb8
Learn more about our sponsors:
@incyte @LEOHealthySkin @lillypad https://t.co/kRDBDZIYFd","Incyte, LEOHealthySkin, LillyPad, ",,2018-09-21 09:19:46,Virtual Conference,Revolutionizing AD,https://pbs.twimg.com/profile_images/1044231557936963585/_NEg06uK_normal.jpg,151,37,2,326,RevAtopicDerm,photo
374729426,2020-11-17 12:18:54,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2328509, pic.twitter.com/22qwON3568, ",1328749465004429313,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average broke below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/tw672Hc5W1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/22qwON3568",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
289989013,2020-11-16 19:13:11,,"ad, ","nextavenue.org/caring-rare-ch‚Ä¶, ",1328491335528173569,False,58,0,0,7,Twitter Web App,"When Linda‚Äôs health took an unexpected turn, David knew without reservation that he would do anything to support and care for her. (Sponsored by @Incyte) #ad https://t.co/wwqpq79XRv","Incyte, ",,2011-04-29 11:22:52,,Next Avenue,https://pbs.twimg.com/profile_images/1321492021287120896/2ImsPiky_normal.jpg,27106,3376,932,48893,NextAvenue,
2344420430,2020-11-16 17:07:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1328459680742596610,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/UBl5ffyKtO",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
374729426,2020-11-16 12:21:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2325253, pic.twitter.com/hFrwpnbc7m, ",1328387647006359554,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/UTopSRyguf #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/hFrwpnbc7m",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
985090779965255681,2020-11-16 10:19:43,"INCY, ",,"pic.twitter.com/uWjkJTva9w, ",1328357085218824195,False,0,0,0,0,Twitter Web App,Mid-Term-Investment: Incyte $INCY https://t.co/uWjkJTva9w,,,2018-04-14 05:41:58,,Stock-ETF-CFD and Crypto-Trader,https://pbs.twimg.com/profile_images/1180123345708355586/8-73rSGH_normal.jpg,2972,4914,0,24012,AktienTrader1,photo
812004702594486272,2020-11-16 09:05:18,,,"checkrare.com/a-comic-book-a‚Ä¶, ",1328338359706673156,False,1,0,0,0,Hootsuite Inc.,"J.G. Jones, comic book artist known for his work with DC Comics  and Marvel, discusses his journey with a myeloproliferative neoplasm (MPN).¬†

https://t.co/Hff3Lb2Es8

@MPNVoice
@VoicesofMPN 
Voices of MPN 
@Incyte 
Incyte 
Incyte","MPNVoice, VoicesofMPN, Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1280938376099741697,2020-11-16 02:22:29,,,"iexcloud.io, pic.twitter.com/oDMTYz9odl, ",1328236985643905025,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Cisco Systems, Inc.
-Abu Dhabi National Oil Co. for Distribut
-Microsoft Corp.
-Incyte Corp.
-Finance House PJSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/oDMTYz9odl",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1889492676,2020-11-15 11:19:54,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1328009844071165952,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/cQ5nqNpnow,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
374729426,2020-11-15 09:40:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2321438, pic.twitter.com/ljUVuBYKN4, ",1327984868626599942,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/oto0kAHEzx #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ljUVuBYKN4",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
907694266029301760,2020-11-14 16:55:01,,"GVCC20, ","GVCC20.com, pic.twitter.com/KKL44bVlVp, ",1327731791239770113,False,2,0,0,0,Sprout Social,"And that‚Äôs a wrap on #GVCC20! We hope you feel even more empowered than before you joined! Thank you again to our amazing partners and sponsors - @Bristol Myers Squibb, @Amgen, @Incyte, @SeattleGenetics, @LabCorp, @Bayer and @Guardant Health. https://t.co/v5cnpu8Z7b https://t.co/KKL44bVlVp","Bristol, Amgen, Incyte, SeattleGenetics, Labcorp, Bayer, guardant, ",,2017-09-12 15:55:51,"Rochester, NY",GRYT Health,https://pbs.twimg.com/profile_images/1410587914615111683/mWWMGlYo_normal.jpg,998,1558,18,4395,GRYTHealth,photo
374729426,2020-11-14 14:19:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2318250, pic.twitter.com/mIcyojESXC, ",1327692691849629697,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/ePCUaJqzLG #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/mIcyojESXC",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
985090779965255681,2020-11-14 07:18:30,"INCY, ",,"pic.twitter.com/WRlDbqh5mB, ",1327586704425963527,False,0,0,0,0,Twitter Web App,Incyte looks also quite cheap. Next Midterm-Investment. $INCY https://t.co/WRlDbqh5mB,,,2018-04-14 05:41:58,,Stock-ETF-CFD and Crypto-Trader,https://pbs.twimg.com/profile_images/1180123345708355586/8-73rSGH_normal.jpg,2972,4914,0,24012,AktienTrader1,photo
25326286,2020-11-13 18:52:05,,"lymphoma, ","bit.ly/3eT9Lfv, pic.twitter.com/j7XSsUsKq7, ",1327398861942501376,False,1,0,0,0,Sprout Social,"Xencor, @MorphoSys and @Incyte have announced a clinical collaboration to investigate the combination of tafasitamab, plamotamab and lenalidomide in patients with relapsed or refractory diffuse large B-cell #lymphoma.

https://t.co/CUPN2sblHu https://t.co/j7XSsUsKq7","MorphoSys, Incyte, ",,2009-03-19 12:07:44,,Cell Therapy News,https://pbs.twimg.com/profile_images/1280896142750834694/HjcJHP_G_normal.jpg,9969,285,204,13036,celltherapynews,photo
55654926,2020-11-13 18:47:09,,"curecca, cholangiocarcinoma, ","youtube.com/watch?v=BtaChr‚Ä¶, ",1327397620570963969,False,2,0,0,1,Twitter Web App,"https://t.co/HlQH2n0sft

Recently, we broadcasted our Facebook Live, ""Living with Cholangiocarcinoma - Journey to Diagnosis &amp; Beyond."" If you missed the event, head over to our YouTube Channel to hear the discussion and audience Q&amp;A. #curecca #cholangiocarcinoma @Incyte","Incyte, ",,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,
812004702594486272,2020-11-13 12:10:17,,,"checkrare.com/renowned-comic‚Ä¶, ",1327297745565208576,False,1,0,0,0,Hootsuite Inc.,"J.G. Jones, comic book artist known for his work with Marvel and DC Comics discusses Rare Reflections: MPNs Unmasked, an initiative focused on raising awareness about Myeloproliferative Neoplasms.
@Incyte @VoicesofMPN @MPN_RF 
JG Jones Art Page 
Incyte 
https://t.co/Ssu4kPqZft","Incyte, VoicesofMPN, MPN_RF, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
33467057,2020-11-13 10:49:36,,"patients, ","bit.ly/2L3vmGA, pic.twitter.com/pBon74ulEE, ",1327277444169146368,False,10,0,0,0,Twitter Web App,"MorphoSys, together with its partners Xencor and @Incyte, announced a Global Development Collaboration aiming to help #patients in areas of unmet need.
https://t.co/VpHBJwMe7R https://t.co/pBon74ulEE","Incyte, ",,2009-04-20 05:13:43,"Planegg, Germany",MorphoSys,https://pbs.twimg.com/profile_images/1414967751538511873/dOJDE_2G_normal.jpg,1563,205,37,315,MorphoSys,photo
374729426,2020-11-13 09:56:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2314470, pic.twitter.com/SsUQ16EMRP, ",1327263972018380800,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/DGmNqjSWXY #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/SsUQ16EMRP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
907694266029301760,2020-11-13 09:01:23,,"GRYTHealth, GVCC20, ","vepimg.b8cdn.com/uploads/vjfnew‚Ä¶, pic.twitter.com/FTAJqUPmNP, ",1327250207134855168,False,8,1,0,5,Hootsuite Inc.,"It is going to be a great  day!   
Global Virtual Cancer Conference  #GRYTHealth
Thank you to those who support us bringing you #GVCC20
@bmsnews @Amgen @Incyte @SeagenGlobal @LabCorp @GuardantHealth @BayerUS 

Here is our program https://t.co/d5iqk0kgeu https://t.co/FTAJqUPmNP","bmsnews, Amgen, Incyte, SeagenGlobal, Labcorp, GuardantHealth, BayerUS, ",,2017-09-12 15:55:51,"Rochester, NY",GRYT Health,https://pbs.twimg.com/profile_images/1410587914615111683/mWWMGlYo_normal.jpg,998,1558,18,4395,GRYTHealth,photo
2384219072,2020-11-13 08:21:00,,"DEBIO, DEBIO, IIW2020, ","loom.ly/AUYhIPU, pic.twitter.com/1jQDYghH9c, ",1327240047821729793,False,0,0,0,0,Loomly,"#DEBIO thanks @Incyte for their Innovation Sponsorship of #DEBIO's #IIW2020 Grand Finale program today! If you missed it, check it out here: https://t.co/4CIxWfIabd https://t.co/1jQDYghH9c","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
2384219072,2020-11-13 06:04:17,,"DEBIO, IIW2020, netde, ","pic.twitter.com/p1pthYPcht, ",1327205639723118593,False,0,0,0,0,Loomly,It's Friday the 13th...and the final day of #DEBIO's Ignting Innovation Week! Make sure to join us at 9AM this morning for the Grand Finale broadcast (sponsored by @Incyte) and LIVE giveaway drawing!  See you there!  #IIW2020 #netde https://t.co/p1pthYPcht,"Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
21268553,2020-11-13 01:07:04,,,"stock-market-newsfeed.blogspot.com/2020/11/incyte‚Ä¶, ",1327130841345101826,False,0,0,0,0,SS Auto Tweet App,"Incyte (INCY), Xencor and MorphoSys Ink Collaboration Deal
 https://t.co/ySjne4Z6M9",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
2344420430,2020-11-12 23:16:31,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1327103022472769537,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JEAN JACQUES BIENAIME:

https://t.co/EAT8TnW0um",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
19772521,2020-11-12 17:12:19,,,"creativeinferno.com/helping-a-new-‚Ä¶, ",1327011367946215429,False,0,0,0,0,Twitter Web App,"We partnered with Incyte to create a brand identity that matches the cutting-edge security solutions they offer. From crafting the brand guidelines to designing their logo,  every element points back to what they do best ‚Äì inspiring trust and recognition. https://t.co/8Lfptf6hX9",,,2009-01-30 10:44:36,Memphis,"inferno, LLC",https://pbs.twimg.com/profile_images/1352396757431410688/qFaheuV8_normal.jpg,1374,1215,125,1786,creativeinferno,
1262915121103491074,2020-11-12 16:42:17,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1327003810137403392,False,0,0,0,0,formwhispers,"#FWSells $INCY BIENAIME JEAN JACQUES, Director of INCYTE CORP sold 798 shares on 2020-11-10. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
21621749,2020-11-12 14:26:15,,,"pub.webull.com/us/news-html/5‚Ä¶, ",1326969575565561864,False,0,0,0,0,Twitter for Android,"The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
Follow us @WebullGlobal
  https://t.co/4i2X2II3Nn","WebullGlobal, ",,2009-02-22 20:58:53,beefentertainment@mail.com,Beef Ent.,https://pbs.twimg.com/profile_images/1338275717289742336/rPKe_S8l_normal.jpg,148712,442903,1416,508282,BeefEnt,
907694266029301760,2020-11-12 14:00:52,,"GVCC20, ","vepimg.b8cdn.com/uploads/vjfnew‚Ä¶, pic.twitter.com/OjrvErPFHK, ",1326963189603590145,False,3,0,0,0,Hootsuite Inc.,"Thank you to those who support us bringing you #GVCC20
@bmsnews @Amgen @Incyte @SeagenGlobal @LabCorp @GuardantHealth @BayerUS 

Here is our program https://t.co/d5iqk0kgeu https://t.co/OjrvErPFHK","bmsnews, Amgen, Incyte, SeagenGlobal, Labcorp, GuardantHealth, BayerUS, ",,2017-09-12 15:55:51,"Rochester, NY",GRYT Health,https://pbs.twimg.com/profile_images/1410587914615111683/mWWMGlYo_normal.jpg,998,1558,18,4395,GRYTHealth,photo
3911174913,2020-11-12 11:27:10,,"News, DLBCL, lymphoma, ","bit.ly/2Ul92dv, ",1326924506611527680,False,0,0,0,0,Twitter Web App,#News: We‚Äôve announced a global clinical collaboration with @MorphoSys and Xencor to investigate a combination treatment option for patients with diffuse large B-cell lymphoma (#DLBCL) and follicular #lymphoma (FL). https://t.co/FmyUNvwoVd,"MorphoSys, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
21268553,2020-11-12 10:40:02,,,"stock-market-newsfeed.blogspot.com/2020/11/incyte‚Ä¶, ",1326912648554967042,False,0,0,0,0,SS Auto Tweet App,"Incyte (INCY), Xencor and MorphoSys Ink Collaboration Deal
 https://t.co/ySjne4Z6M9",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
374729426,2020-11-12 10:06:02,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2310739, pic.twitter.com/eIvTLYKB2l, ",1326904089469399042,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average broke below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/Vrc0QmpQuR #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/eIvTLYKB2l",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
976297820532518914,2020-11-12 08:04:08,,,"dlvr.it/RlXFQ6, pic.twitter.com/TAtiODrHla, ",1326873413558755329,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conference https://t.co/MHbvZuVJGc https://t.co/TAtiODrHla,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1134049078424162304,2020-11-12 07:58:29,"BEAM, BHVN, CLDX, DNLI, FATE, ",,"newsfilter.io/articles/the-d‚Ä¶, ",1326871990825848834,False,0,0,0,0,Newsfilter.io,"The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal $BEAM $BHVN $CLDX $DNLI $FATE https://t.co/GTocEPkxLX",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
972364208108163074,2020-11-12 07:45:29,"ACHV, ADCT, AGRX, ",,"benzinga.com/z/18334935#.X6‚Ä¶, ",1326868721105768450,False,1,0,0,0,Twitter Web App,"The Daily Biotech Pulse: AstraZenecas Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal $ACHV $ADCT $AGRX https://t.co/60CPVLh5b1 via @benzinga","Benzinga, ",,2018-03-10 01:51:07,South Africa & Europe,thegreenisback,https://pbs.twimg.com/profile_images/972367018946191361/ywzowTW8_normal.jpg,141,5,6,22777,thegreenisback,
1171873456276889600,2020-11-12 06:28:50,"MOR, ","MOR, 6K, MorphoSys, News, ","docoh.com/filing/1340243‚Ä¶, ",1326849430394449920,False,0,0,0,0,Investor Feed,"$MOR  6-K  MorphoSys   (12 Nov, 6:27am)

üì∞ Xencor, MorphoSys and Incyte Enter into Global Development

https://t.co/1KWRJNkLLK

#MOR #6K #MorphoSys #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1889492676,2020-11-12 05:47:33,"XNCR, MOR, INCY, ","Xencor, MorphoSys, Incyte, Tafasitamab, Plamotamab, ","1stoncology.com/blog/xencor-mo‚Ä¶, ",1326839041392701440,False,0,0,0,0,Troi URL Plug-in,"#Xencor, #MorphoSys and #Incyte Enter into Global Development Collaboration for #Tafasitamab in Combination with #Plamotamab $XNCR $MOR $INCY https://t.co/FnuzC3473T",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1134049078424162304,2020-11-12 03:39:28,"MOR, ",,"newsfilter.io/articles/xenco‚Ä¶, ",1326806808510521344,False,0,0,0,0,Newsfilter.io,"Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab $MOR https://t.co/u1vFUbxTy9",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1301425387369619456,2020-11-11 21:04:32,,,"mednetnews.com/2020/11/12/xen‚Ä¶, ",1326707419188236289,False,0,0,0,0,WordPress.com,"Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with¬†Plamotamab https://t.co/C3jLTFltKh",,,2020-09-03 03:42:57,,mednetnews,https://pbs.twimg.com/profile_images/1301426159247384577/VZsF735N_normal.jpg,5,0,0,13260,mednetnews,
1134049078424162304,2020-11-11 20:43:21,"XNCR, MOR, INCY, ",,"newsfilter.io/articles/xenco‚Ä¶, ",1326702089058344960,False,0,0,0,0,Newsfilter.io,"Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotama.. $XNCR $MOR $INCY https://t.co/WZKVlLsRLP",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1314280236679270401,2020-11-11 20:13:59,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1326694698279383042,False,0,0,0,0,Twitter,"11/11/2020
üî•üî• 6 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $411,317 | 4970 Shares
Streak Total: $10,689,977 | 128267 Shares
Daily Close: $82.76 (-0.37%) ‚¨áÔ∏è
Prev Close: $83.07
W.Avg Streak Price: $83.34
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
72928001,2020-11-11 18:51:30,"INCY, ",,"bit.ly/2Ir0QFW, ",1326673939880321024,False,0,0,0,0,BriefingInPlayLimited,"$INCY: Incyte, Xencor (XNCR), and MorphoSys (MOR) announce global collaboration for tafasitamab in combination with... https://t.co/6WyYV8Skem",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
106823467,2020-11-11 18:23:13,"XNCR, MOR, INCY, ","Xencor, MorphoSys, Incyte, ","crweworld.com/symbol/XNCR, ",1326666820774817792,False,0,0,0,0,Twitter Web App,"$XNCR, $MOR, $INCY ink clinical collaboration to investigate combo tafasitamab, plamotamab and lenalidomide    #Xencor    #MorphoSys    #Incyte   https://t.co/usIJ97ajnN",,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
1006334607946649600,2020-11-11 17:58:33,,,"dlvr.it/RlV9wN, ",1326660613427191808,False,0,0,0,0,dlvr.it,"Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab https://t.co/8Toqz0BVaq",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1176160335042088960,2020-11-11 17:48:32,,"BlogArchive, Markets, ","dlvr.it/RlV8rr, pic.twitter.com/TI1cV44bOt, ",1326658096433754112,False,0,0,0,0,dlvr.it,"Xencor, MorphoSys And Incyte Ink Collaboration Deal: (RTTNews) - Xencor (XNCR), MorphoSys AG (MORMOR) and Incyte (INCY) Wednesday announced a clinical collaboration to investigate the combination of tafasitamab,‚Ä¶ https://t.co/j2m5B2OsWG #BlogArchive #Markets Seoul, Korea https://t.co/TI1cV44bOt",,,2019-09-23 11:44:20,"Seoul, Korea",Global Asset Management Seoul Korea,https://pbs.twimg.com/profile_images/1176160426226311168/ZyzL6lGx_normal.jpg,150,9,1,14134,GAMSeoulKorea,photo
907694266029301760,2020-11-11 17:30:05,,"GVCC20, ","vepimg.b8cdn.com/uploads/vjfnew‚Ä¶, pic.twitter.com/qTgvFgPUPd, ",1326653452328570883,False,2,0,0,0,Hootsuite Inc.,"Thank you to those who support us bringing you #GVCC20
@bmsnews @Amgen @Incyte @SeagenGlobal @LabCorp @GuardantHealth @BayerUS 

Here is our program https://t.co/d5iqk0kgeu https://t.co/qTgvFgPUPd","bmsnews, Amgen, Incyte, SeagenGlobal, Labcorp, GuardantHealth, BayerUS, ",,2017-09-12 15:55:51,"Rochester, NY",GRYT Health,https://pbs.twimg.com/profile_images/1410587914615111683/mWWMGlYo_normal.jpg,998,1558,18,4395,GRYTHealth,photo
1231650459187732480,2020-11-11 17:04:07,,"losangeles, biotech, ","tinyurl.com/y69264tx, ",1326646915509915649,False,0,0,0,0,FeedBlitz,"LABN Feed: Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab: MONROVIA, Calif. &amp; PLANEGG/MUNICH, Germany &amp; WILMINGTON, ... #losangeles #biotech https://t.co/nd2xw865WF",,,2020-02-23 13:42:36,"Los Angeles, California",Los Angeles Biotechnology Network,https://pbs.twimg.com/profile_images/1403379542597672963/ovXNVtwK_normal.png,511,2509,3,1763,LABioNetwork,
31720614,2020-11-11 16:37:53,,"news, pharma, clinicalresearch, biotech, lifesciences, medical, healthcare, pharmiweb, ","zpr.io/Hrv8d, pic.twitter.com/MLLNuRWEiY, ",1326640314916999175,False,0,0,0,0,Zapier.com,"Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab
https://t.co/thUTNRdt97
#news #pharma #clinicalresearch #biotech #lifesciences #medical #healthcare #pharmiweb https://t.co/MLLNuRWEiY",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,photo
3686628867,2020-11-11 16:30:00,,,"pharmaceuticaldaily.com/xencor-morphos‚Ä¶, ",1326638330826678274,False,0,0,0,0,WordPress.com,"Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with¬†Plamotamab https://t.co/YevtNvX73K",,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
266143766,2020-11-11 16:25:44,"MOR, ",,"accesswire.com/616166/Xencor-‚Ä¶, ",1326637257034489856,False,0,0,0,0,Accesswire,"$MOR Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with ... https://t.co/nivmfBT9sL",,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
1254035253104181256,2020-11-11 16:24:51,"MOR, ",,"stocktitan.net/news/MOR/xenco‚Ä¶, ",1326637035340222465,False,0,0,0,0,stocktitan,"$MOR Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab
https://t.co/upeBzyIIcp",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
426660182,2020-11-11 16:23:43,"XNCR, MOR, INCY, ",,"investors.xencor.com/news-releases/‚Ä¶, ",1326636748617756672,False,2,0,0,0,Twitter for iPhone,"$XNCR $MOR $INCY Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab | Xencor, Inc. https://t.co/8MjmFV6AwC",,,2011-12-02 09:36:53,Hewlett NY,Michael G King Jr,https://pbs.twimg.com/profile_images/760202160143470592/tV-c8Va4_normal.jpg,768,4708,11,857,MichaelGKingJr,
261473143,2020-11-11 16:20:10,,"Xencor, ","morphosys.com/media-investor‚Ä¶, life-sciences-usa.com/news/vlfm-iito‚Ä¶, pic.twitter.com/NVnRnQgkZu, ",1326635857428746240,False,0,0,0,0,Twitter Web App,"Xencor, MorphoSys &amp; Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab https://t.co/6WcZTlU4NH @MorphoSys #Xencor @Incyte More Transatlantic Life Science Business News at [LSUS] at https://t.co/HEEySVNQN8 https://t.co/NVnRnQgkZu","MorphoSys, Incyte, ",,2011-03-05 20:26:19,"Bremen, Germany",[iito] Life Science,https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_normal.jpeg,2596,238,89,29254,iitoLifeScience,photo
4058194633,2020-11-11 16:14:03,"XNCR, MOR, INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1326634318806962176,False,0,0,0,0,Twitter for iPhone,"$XNCR $MOR $INCY Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab | Business Wire https://t.co/liguptdgGa",,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
472650465,2020-11-11 16:12:44,"INCY, ",,"otcdynamics.com/incy-xencor-mo‚Ä¶, ",1326633985716445186,False,0,0,0,0,OTC Dynamics Twitter Login,"$INCY Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab https://t.co/gkEzlAUVTi",,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1069693680066420736,2020-11-11 16:08:56,"XNCR, ",,"s.flashalert.me/v1YtzN, ",1326633030396555267,False,0,0,0,0,flashalerts,"$XNCR [15s. delayed]: Issued Press Release on November 11, 16:02:00: Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab https://t.co/2Vz01UeZT4",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
16261631,2020-11-11 16:08:35,,,"businesswire.com/news/home/2020‚Ä¶, ",1326632942534189056,False,0,0,0,0,Twitter Web App,"Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab | Business Wire https://t.co/jdnMOHDbTz",,,2008-09-12 15:07:24,"Los Angeles, CA",Jeff Shulman,https://pbs.twimg.com/profile_images/2627989207/735da00cfb18f798462c42eee90e753f_normal.jpeg,346,466,9,3711,JeffShulman,
3318510966,2020-11-11 16:07:59,,,"crweworld.com/article/news-p‚Ä¶, ",1326632788750053376,False,0,0,0,0,CRWE World,"Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamota https://t.co/EB8lbtv4VB",,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1063180083769176064,2020-11-11 16:04:31,"XNCR, MOR, ",,"businesswire.com/news/home/2020‚Ä¶, ",1326631919757389824,False,4,0,1,5,TweetDeck,"$XNCR $MOR Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab

https://t.co/hLri2uvnWV",,,2018-11-15 16:20:59,"California, USA",Michelle Solly,https://pbs.twimg.com/profile_images/1085656586184355840/AnkrtFux_normal.jpg,10025,50,244,11872,MSollender,
1254035253104181256,2020-11-11 16:03:59,"XNCR, ",,"stocktitan.net/news/XNCR/xenc‚Ä¶, ",1326631783153115136,False,0,0,0,0,stocktitan,"$XNCR Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab
https://t.co/KXYaqbMPhi",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
42410755,2020-11-11 16:02:27,,,"dgap.de/dgap/News/corp‚Ä¶, ",1326631396534874116,False,0,1,0,0,DGAP_News_Int,"Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combinat... https://t.co/DW1V6XPtZL",,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
374729426,2020-11-11 10:17:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2307008, pic.twitter.com/MLk3YmdGln, ",1326544547388665858,False,0,0,0,1,Tickeron,"$INCY's 10-day Moving Average broke below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/VqJVw1YySQ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MLk3YmdGln",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1889492676,2020-11-11 03:09:11,"INCY, ","Incyte, Oncology, SITC20, ","1stoncology.com/blog/data-from‚Ä¶, ",1326436798369832962,False,0,0,0,0,Troi URL Plug-in,Data from #Incyte‚Äôs #Oncology Portfolio Accepted for Presentation at the #SITC20 $INCY https://t.co/L75gwbIBsV,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
2344420430,2020-11-11 01:44:16,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1326415430697832448,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/pxTN4PP7i5",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1314280236679270401,2020-11-10 20:48:15,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1326340932652961794,False,0,0,0,0,Twitter,"11/10/2020
üî•üî• 5 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $6,542,261 | 78756 Shares
Streak Total: $10,278,660 | 123297 Shares
Daily Close: $83.07 (2.20%) ‚¨ÜÔ∏è
Prev Close: $81.28
W.Avg Streak Price: $83.37
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
1309949778197962752,2020-11-10 18:06:12,"ARCT, CSTL, INCY, TDOC, ZM, TWST, ROKU, NTDOY, CGEN, SSYS, XONE, MCRB, SPLK, Z, ",,"pic.twitter.com/z45KQZJQzD, ",1326300152890585093,False,15,2,2,1,Twitter Web App,"Cathie Wood &amp; @ARKInvest trade activity from today 11/10

Bought: Arcturus $ARCT Castle Bio $CSTL Incyte $INCY Teladoc $TDOC Zoom $ZM Twist $TWST $ROKU Nintendo $NTDOY

Sold: Compugen $CGEN Stratasys $SSYS Exone $XONE Seres $MCRB Splunk $SPLK Zillow $Z https://t.co/z45KQZJQzD","ARKInvest, ",,2020-09-26 16:15:48,,Ark invest activity (Not affiliated with Ark),https://pbs.twimg.com/profile_images/1363187693816012806/0BZEmb6R_normal.jpg,78268,182,1006,1529,ArkkDaily,photo
950010035396136962,2020-11-10 17:03:55,,"Incyte, ","zonebourse.com/INCYTE-CORPORA‚Ä¶, ",1326284480231989256,False,0,0,0,0,Cresus AI,"#Incyte closed at 83.07. Score +150, credit rating AA https://t.co/XMro31aTzT",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
1262915121103491074,2020-11-10 16:27:38,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1326275346803535873,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 961 shares on 2020-11-06. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
28806585,2020-11-10 12:52:08,,,"pic.twitter.com/F1sIdMcXYo, ",1326221114142453760,False,15,0,0,2,Twitter Web App,Honored to lead this international trial (GOG3038) for @GOG Presenting @sitc Trials in Progress. Novel immunotherapy trial for recurrent endometrial cancer. Will be open @Browardhealth @rcoledude @copebuckeye @omalleygynonc @drleslie214  @BrowardGynOnc @Incyte https://t.co/F1sIdMcXYo,"GOG, sitc, BrowardHealth, rcoledude, copebuckeye, omalleygynonc, drleslie214, BrowardGynOnc, Incyte, ",,2009-04-04 10:58:27,"Miami Beach, FL","Brian Slomovitz, MD, MS, FACOG",https://pbs.twimg.com/profile_images/1414289842788253697/nV7RVkgW_normal.jpg,1346,1113,18,598,GynCancerMD,photo
374729426,2020-11-10 11:49:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2303452, pic.twitter.com/eKoOEtcyD8, ",1326205257387401216,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on October 23, 2020. View odds for this and other indicators: https://t.co/dRy7E1KwFA #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/eKoOEtcyD8",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1140762699002871808,2020-11-10 10:40:16,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1326187929404780544,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-11-10 10:40 ET. *Closed/Sold:
$INCY at $83.42 for 0.71 profit (0.86%). Incyte Corporation - Common Stock
Trade Id: 58632457203017697.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
1272364687942979587,2020-11-10 08:36:20,,"Oncology, MedTwitter, MedEd, ","businesswire.com/news/home/2020‚Ä¶, ",1326156740333891584,False,0,0,0,0,Automate.io,"Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the Society for Immunotherapy of Cancer 2020 Annual Meeting
#Oncology #MedTwitter #MedEd
https://t.co/glXmdieDCW",,,2020-06-14 23:06:06,Look here üëâ,MedPub Oncology,https://pbs.twimg.com/profile_images/1443227584813277186/-pkdEYop_normal.jpg,812,158,3,7006,OncoPublisher,
1889492676,2020-11-10 07:21:35,,"Incyte, ICLUSIG, ","1stoncology.com/blog/incyte-re‚Ä¶, ",1326137930549653506,False,0,0,0,0,Troi URL Plug-in,"#Incyte World-Wide Sales for #ICLUSIG was 26.38m USD in 3 mnth, SEP 30 2020 (Up 28%) https://t.co/IVSi1VdEZD",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2020-11-10 07:20:06,,"Incyte, JAKAFI, ","1stoncology.com/blog/incyte-re‚Ä¶, ",1326137555486531586,False,0,0,0,0,Troi URL Plug-in,"#Incyte World-Wide Sales for #JAKAFI was 487.78m USD in 3 mnth, SEP 30 2020 (Up 13%) https://t.co/IVSi1VdEZD",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
75042285,2020-11-10 03:03:26,,,"bit.ly/3eN0bee, ",1326072965591691264,False,0,0,0,0,IFTTT,"Incyte Gearing Up for Solo Marketing in Japan, Set to Double Workforce to 70 Staffers US biotech Incyte is poised to bolster its Japan operations as it gears up for stand-alone developme... https://t.co/r8NxNH8ioE",,,2009-09-17 11:47:03,,„ÅÑ„Å°„Åà„Å≥,https://pbs.twimg.com/profile_images/1388645801891491840/8wj8Yfv0_normal.jpg,3688,2273,212,155662,medinfoa2z,
1314280236679270401,2020-11-09 20:25:32,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1325972827988762624,False,0,0,0,0,Twitter,"11/09/2020
üî• 4 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $1,773,204 | 21816 Shares
Streak Total: $3,736,399 | 44541 Shares
Daily Close: $81.28 (-2.25%) ‚¨áÔ∏è
Prev Close: $83.15
W.Avg Streak Price: $83.89
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
1280938376099741697,2020-11-09 17:56:00,,,"iexcloud.io, pic.twitter.com/Nvukq9cQQG, ",1325935199201398784,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Fujairah Cement Industries Co.
-Applied Materials, Inc.
-Incyte Corp.
-Sharjah Group Co.
-Abu Dhabi Commercial Bank

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/Nvukq9cQQG",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
4058194633,2020-11-09 13:10:54,"INCY, ",,"valdostadailytimes.com/news/business/‚Ä¶, ",1325863449247666176,False,0,0,0,0,Twitter for iPhone,https://t.co/YhM8lqzfEX | $INCY Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the Society for Immunotherapy of Cancer 2020 Annual Meeting,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
374729426,2020-11-09 11:20:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2299657, pic.twitter.com/ZX0TR6Mpvl, ",1325835781223559168,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/Me3rAlN11a #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZX0TR6Mpvl",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3686628867,2020-11-09 11:14:59,,,"pharmaceuticaldaily.com/data-from-incy‚Ä¶, ",1325834278098382849,False,0,0,0,0,WordPress.com,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the Society for Immunotherapy of Cancer 2020 Annual¬†Meeting https://t.co/L25pMz4b5T,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1140762699002871808,2020-11-09 09:56:11,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1325814446543958019,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-11-09 09:48 ET. Bought/Opened:
$INCY at $82.48. 
Incyte Corporation - Common Stock
Win Chance: 65%. Avg Win: 5%. Avg Loss: 7.56%. Avg Hold: 9d.
Trade Id: 58632457203017697.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
1304490431036751872,2020-11-09 06:43:55,,"Biotechnology, Pharmaceutical, ",,1325766062407901184,False,0,0,0,0,Twitter for Android,"#Biotechnology.#Pharmaceutical.

‚òÜExact Sciences 
‚òÜGilead Sciences 
‚òÜGlaxosmithkline 
‚òÜIDEXX Laboratories 
‚òÜIncyte Co.
‚òÜIntegra Lifescience.
‚òÜIqvia Holdings 
‚òÜJohnson &amp;Johnson 
‚òÜMedpace Holdings 
‚òÜMerck &amp; Co.
‚òÜNeogen Co.
‚òÜNeurocrine Biosciences 

‚òÜNo Liability *",,,2020-09-11 14:42:50,,Taipan,https://pbs.twimg.com/profile_images/1419781944984936458/Ne7NevAW_normal.jpg,142,140,0,687,TaipanTran,
1167101144557973504,2020-11-09 06:02:00,,,"pic.twitter.com/CKMiM5dQF9, ",1325755513007640578,False,1,0,0,2,Twitter Web App,"Dr. Wenqing Yao (Executive Vice President of Discovery Chemistry at Incyte) will be giving a colloquium talk today at 4 PM. If you would like to attend, please email the Chem office for the Zoom link @Incyte @BrandeisScience https://t.co/CKMiM5dQF9","Incyte, BrandeisScience, ",,2019-08-29 11:46:22,"Waltham, MA",Brandeis Chemistry Department,https://pbs.twimg.com/profile_images/1167107360604581889/B_cgBnGm_normal.jpg,120,144,4,107,brandeischem,photo
108617488,2020-11-08 21:30:06,,,"invst.ly/sre4i, ",1325626690354221057,False,1,0,0,1,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/8WNOTaszck,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
374729426,2020-11-08 11:41:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2295925, pic.twitter.com/449cPRCLcV, ",1325478607519588352,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/TP4G0K4B5k #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/449cPRCLcV",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
49404200,2020-11-07 18:05:53,,,"americanconsultantsrx.services/incyte-q3-adj-‚Ä¶, ",1325212910612750337,False,0,0,0,0,WordPress.com,"Incyte Q3 Adj. Earnings, Revenue Miss Estimates ‚Äì Quick¬†Facts https://t.co/kWZSR9GVUH",,,2009-06-21 15:35:30,"Atlanta,GA",Charles Myrick -CEO,https://pbs.twimg.com/profile_images/665563257/Steiff-Teddy-Bear-Doctor-Fynn-Bear-with-Medical-Kit_0_0_W0BA_normal.jpg,1349,1850,54,1644339,medicinehelp,
716868896314105856,2020-11-07 12:00:03,,"IncyteCorporation, UAFRS, ","youtube.com/watch?v=UafljQ‚Ä¶, ",1325120844033527811,False,1,0,0,0,Twitter Web App,"Incyte‚Äôs P/E is really 15x, not 38x like as-reported shows...

#IncyteCorporation #UAFRS

https://t.co/2bOwCiCj1P",,,2016-04-04 02:03:58,"Cambridge, MA",Valens Research,https://pbs.twimg.com/profile_images/1029504271421661184/5ShVfCkl_normal.jpg,886,949,5,7560,valensresearch,
374729426,2020-11-07 11:09:00,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2292295, pic.twitter.com/BGR8RWMebb, ",1325107998109233152,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/PX8rQYi0t5 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BGR8RWMebb",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1250830691824283648,2020-11-06 22:07:21,"SEDG, SRPT, OKE, VMC, WMB, CCEP, MTB, INCY, MLM, KMI, PXD, EXR, HBAN, ",,,1324911289454440450,False,9,0,1,0,Twitter Web App,"Worst performing large-cap stocks ($10B+ MKT Cap) from this past week

SolarEdge $SEDG (-7.83%)
Sarepta $SRPT
OneOk $OKE
Vulcan $VMC
Williams $WMB
Coca-Cola EU $CCEP
M&amp;T Bank $MTB
Incyte $INCY
Martin $MLM
Kinder Morgan $KMI
Pioneer $PXD
Extra Space $EXR
Huntington $HBAN (-2.78%)",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123337,211,1299,33044,StockMKTNewz,
1314280236679270401,2020-11-06 20:10:51,"INCY, ","ARKInvest, markets, trading, stocks, investing, ",,1324881970715910146,False,0,0,0,0,Twitter,"11/06/2020
üî• 3 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $453,500 | 5454 Shares
Streak Total: $1,963,195 | 22725 Shares
Daily Close: $83.15 (-1.77%) ‚¨áÔ∏è
Prev Close: $84.65
W.Avg Streak Price: $86.39
#ARKInvest #markets #trading #stocks #investing",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
1314280236679270401,2020-11-06 18:39:51,"INCY, ","ARKInvest, markets, trading, stocks, investing, finance, ",,1324859068016693249,False,0,0,0,0,Twitter,"11/05/2020
üü¢ 2 Day Buy Streak: 
$INCY - INCYTE CORP
Buy Volume: $846,415 | 9999 Shares
Streak Total: $1,509,694 | 17271 Shares
Daily Close: $84.65 (-7.19%) ‚¨áÔ∏è
Prev Close: $91.21
W.Avg Streak Price: $87.41
#ARKInvest #markets #trading #stocks #investing #finance",,,2020-10-08 15:04:01,,Lucid - ARK Invest ETF & Portfolio Tracker,https://pbs.twimg.com/profile_images/1314713532777127936/BJqka3Fu_normal.png,5503,14,87,2223,lucidtracking,
3435682714,2020-11-06 17:38:10,,,,1324843547418308613,False,0,0,0,0,Twitter Web App,"Deprecate companies that needs acquisition ASAP.
@biogen @VertexPharma @abbvie @Amgen @Incyte @sanofi @JNJNews @roche 

2 companies No-Brainer should be acquired: Great pipeline
1) @ExelixisInc $1B in Rev,$1.5B in Cash $6.4B MCAP
2) @ActiniumPharma Phase 3 Readout 4Q20 $155M MCAP","biogen, VertexPharma, abbvie, Amgen, Incyte, sanofi, JNJNews, Roche, ExelixisInc, ActiniumPharma, ",,2015-08-22 12:15:30,"New York, USA",Biotech,https://pbs.twimg.com/profile_images/1336863494373859328/lSWUKPa5_normal.jpg,688,16,16,7065,ej23ny,
1276528931890515968,2020-11-06 16:05:24,,,"lnkd.in/ggKNxqk, ",1324820199724339200,False,0,0,0,0,LinkedIn,"Stephen Kaufhold Treasurer, Incyte
 ""the biggest achievement was when I started at Allegan, the company had about $850m of debt on the books. After we've gone through all these transformational transactions we peaked at about $44b of debt. Over that perio‚Ä¶https://t.co/JlqUnMAYIY",,,2020-06-26 10:53:22,,@treasurytalent,https://pbs.twimg.com/profile_images/1276529149964886022/NLBvljcE_normal.png,21,47,0,758,treasurytalent,
620483863,2020-11-06 14:35:33,,,"dlvr.it/Rl8MyR, ",1324797589355696128,False,0,0,0,0,dlvr.it,Is Incyte Corporation (INCY) the Top Pick in the Biotechnology Industry? - InvestorsObserver https://t.co/dVsbYQa12k,,,2012-06-27 20:36:57,"USA, Montana",Biotechnology,https://pbs.twimg.com/profile_images/2910487643/ab58fa33ff0f3707656266e142cdc5cd_normal.jpeg,4260,3959,61,19973,Biotechnology19,
998915197061488645,2020-11-06 12:51:22,,,"cfc.umt.edu/research/incyt‚Ä¶, pic.twitter.com/tZYy6buOT1, ",1324771370731937792,False,34,3,0,27,Twitter Web App,"Save the dates for the INCyTE 2021 remote seminar series: Nutrient cycles in Earth system models - challenges, opportunities, and frontiers!

Wednesdays at 9-10:30am US MST/4-5:30pm UTC, Jan 13th-April 7th.

Please share widely - more info to come! https://t.co/LGbjNtaJjm https://t.co/tZYy6buOT1",,,2018-05-22 09:15:16,,INCyTE RCN,https://pbs.twimg.com/profile_images/1063085319887695873/d_uRHryG_normal.jpg,221,32,1,46,IncyteRcn,photo
975137522346053634,2020-11-06 12:21:49,,,"bit.ly/Pharmadelic, ",1324763932171665408,False,0,0,0,0,Twitter Web App,"üíº Incyte - Medical Science Liaison

üìä Career level: Graduates and Junior

üìç  Germany

üí¨ Language(s): üá©üá™ and üá¨üáß (fluent)

‚ÑπÔ∏è https://t.co/Oz1fPH7p35",,,2018-03-17 18:31:17,,Pharmadelic,https://pbs.twimg.com/profile_images/975139143926861824/eaGWb8cr_normal.jpg,219,179,0,1171,ThePharmadelic,
374729426,2020-11-06 11:30:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2288541, pic.twitter.com/oDWNN1fW85, ",1324751016026255360,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on November 5, 2020. View odds for this and other indicators: https://t.co/Jb8pkPaXcx #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/oDWNN1fW85",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1267945916494868480,2020-11-06 11:11:33,,,"seekingalpha.com/article/437516‚Ä¶, ",1324746252643229696,False,0,0,0,0,Twitter for Android,Incyte FDA Approvals To Propel Future Growth https://t.co/sNc1xlbGUu,,,2020-06-02 18:28:03,"New York, USA",Minotaur Bruin Investment Management,https://pbs.twimg.com/profile_images/1297619910823043072/IWcGbn_x_normal.jpg,36,104,0,7467,InvestmentMb,
84675341,2020-11-06 10:15:07,,"AONN2020, GrowingOurCommunityTogether, ",,1324732048054099968,False,1,0,0,0,Sprout Social,"Join us for our product theaters this morning from 10:30 am-11:30 am ET! 
-Product theater 1: Incyte Intervening with Jakafi (ruxolitinib) 
-Product theater 2: Lilly Oncology 

#AONN2020 #GrowingOurCommunityTogether",,,2009-10-23 16:03:50,"Cranbury, NJ",AONN+,https://pbs.twimg.com/profile_images/825021507873161217/z_VlUvhe_normal.jpg,1571,893,31,3743,OncNav,
1174328900815638530,2020-11-06 09:03:58,,,"pic.twitter.com/uQYteXd1Mu, ",1324714145531547650,False,3,0,1,0,Twitter Web App,Thank you to our sponsors! @DeBusinessTimes @Incyte @christianacare @RichardsLayton @choosedelaware @ENVintel https://t.co/uQYteXd1Mu,"DeBusinessTimes, Incyte, christianacare, RichardsLayton, choosedelaware, ENVintel, ",,2019-09-18 10:26:52,University of Delaware,UD Women's Leadership Initiative,https://pbs.twimg.com/profile_images/1308487443373584385/9gVTndil_normal.jpg,328,272,3,735,udwomenlead,photo
730032660,2020-11-05 20:38:53,,,"nonsell.com/us-market-news‚Ä¶, ",1324526638009257984,False,0,0,0,0,NonSell Twitter,"Incyte Corp (INCY) Q3 2020 Earnings Call Transcript - [US Market News], Source: Nasdaq News - https://t.co/tNCO5jrwUs",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
1099039801397964802,2020-11-05 20:15:51,"INCY, ",,,1324520840860491783,False,0,0,1,0,EarningsAlley,Incyte Corporation $INCY held an earnings call on 11/5/2020. Here are the highlights:,,,2019-02-22 15:14:42,,Earnings Alley,https://pbs.twimg.com/profile_images/1113489113435508737/ulSmYR9O_normal.png,1802,1,33,87697,EarningsAlley,
325487054,2020-11-05 19:00:23,,,"s.einnews.com/fASlUzdfpR, ",1324501847986622471,False,0,0,0,0,EIN Presswire,Incyte Corporation (INCY) CEO Herv√© Hoppenot on Q3 2020 Results - Earnings Call Transcript https://t.co/oZ9RJM0YFH,,,2011-06-28 07:24:24,"Washington, D.C.",EIN Presswire: Cosmetics & Beauty Newswire,https://pbs.twimg.com/profile_images/1288503537903833088/52DEW_5Y_normal.jpg,555,749,26,35522,EINCosmetics,
3096702665,2020-11-05 18:22:23,,"Hanesbrands, ","jenke.rs/k6U2Ot, ",1324492286437302272,False,0,0,0,0,Jenkers Eng Posting,"Qualcomm, Upwork rise; #Hanesbrands, Incyte fall https://t.co/Ca83g0b1N0",,,2015-03-19 08:47:40,San Francisco,Jenkers News (ENG),https://pbs.twimg.com/profile_images/588324718677254145/-y5BbeY4_normal.png,1316,234,1265,990172,jenkers_en,
2763140335,2020-11-05 18:12:15,,,"postintrend.com/breaking/qualc‚Ä¶, ",1324489736669548544,False,0,0,0,0,WordPress.com,"Qualcomm, Upwork Rise; Hanesbrands, Incyte¬†Fall https://t.co/eGsib6bwSi",,,2014-08-24 12:43:49,"Pune, India",Manish Ransubhe,https://pbs.twimg.com/profile_images/1357936355913863168/Qu30ofoW_normal.jpg,79,224,1,115170,manishransubhe,
1280938376099741697,2020-11-05 18:08:58,,,"iexcloud.io, pic.twitter.com/qR5Ua9eBm1, ",1324488911289257990,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Gulf Pharmaceutical Industries
-Al-Buhaira National Insurance Co.
-Sharjah Group Co.
-Biogen, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/qR5Ua9eBm1",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
3088796493,2020-11-05 17:22:15,,"LatestComments, ","latestcommentary.com/qualcomm-upwor‚Ä¶, pic.twitter.com/DRIhsjKkug, ",1324477151362560002,False,0,0,0,0,Latest Commentary,"Qualcomm, Upwork rise; Hanesbrands, Incyte fall - https://t.co/3NH6wnk0rJ #LatestComments https://t.co/DRIhsjKkug",,,2015-03-12 09:19:49,Washington D.C,Latest Commentary - #LatestComments,https://pbs.twimg.com/profile_images/576760403469828097/D54BkNc8_normal.jpeg,13797,278,140,298044,LatestComments,photo
1319538411372384261,2020-11-05 17:18:12,,,"techiazi.com/qualcomm-upwor‚Ä¶, ",1324476132964577284,False,0,0,0,0,WordPress.com,"Qualcomm, Upwork Rise; Hanesbrands, Incyte¬†Fall https://t.co/ls50tzclWR",,,2020-10-23 03:18:15,,TechiUpdate,https://pbs.twimg.com/profile_images/1319538755137536000/MHsWzSz3_normal.jpg,131,0,0,37504,TechiUpdate,
911339992194134016,2020-11-05 16:57:30,,"LatestComments, ","vixc.com/qualcomm-upwor‚Ä¶, pic.twitter.com/EJ5QU8LCqo, ",1324470923748085760,False,0,0,0,0,VIXC_News Auto Tweet,"Qualcomm, Upwork rise; Hanesbrands, Incyte fall - https://t.co/aUWOrK837c #LatestComments https://t.co/EJ5QU8LCqo",,,2017-09-22 17:22:40,"Washington, DC",VIXC News - @VIXC_News,https://pbs.twimg.com/profile_images/911345975310143488/jvza6Ali_normal.jpg,677,31,7,133959,VIXC_News,photo
953788131601502208,2020-11-05 16:31:22,,,"abcnews.go.com/Business/wireS‚Ä¶, pic.twitter.com/ihY3Mk73CD, ",1324464348279017479,False,0,0,0,0,Wall St Solver Auto-Tweeter,"Qualcomm, Upwork rise; Hanesbrands, Incyte fall

üì∞ ¬ª https://t.co/9Y1wKMA588 https://t.co/ihY3Mk73CD",,,2018-01-17 19:36:25,,Wall St Solver,https://pbs.twimg.com/profile_images/1029252349716512769/HAdlBHZA_normal.jpg,472,39,12,58222,wallstsolver,photo
20780650,2020-11-05 16:30:59,,"corporate_news, earnings, earnings_estimates, earnings_reports, earnings_surprises, fall, financi, ","biedex.markets/qualcomm-upwor‚Ä¶, ",1324464249301798912,False,0,0,0,0,FS Poster,"Qualcomm, Upwork rise; Hanesbrands, Incyte fall#stockmarkets#business #corporate_news #earnings #earnings_estimates #earnings_reports #earnings_surprises #fall #financi...
https://t.co/XxvHCed3zs",,,2009-02-13 11:02:18,"London, England",Biedex Markets,https://pbs.twimg.com/profile_images/1288488731654201349/MSrdzFac_normal.jpg,4018,4862,120,362261,biedexmarkets,
4312114277,2020-11-05 16:05:51,"INCY, ",,"fintel.io/sf/us/incy?utm‚Ä¶, ",1324457926547984386,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 10-Q https://t.co/Oc4NyYycjO,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
33371707,2020-11-05 16:05:30,"INCY, ","NASDAQ, ","sec.gov/Archives/edgar‚Ä¶, ",1324457839625072640,False,0,0,0,0,xool,"$INCY #NASDAQ  10-Q - INCYTE CORP  [B/A=0/0 - Bid/Ask Size=0/0  Volume=1,517,834  AverageVol=1,039,593  Outstanding=0] https://t.co/YMmgd4gJkW",,,2009-04-19 21:38:45,,tweeter no more. jack dorsey is a nazi,https://pbs.twimg.com/profile_images/1288570978516127744/0O_9eGqP_normal.jpg,497,633,11,84299,bbiittccooiinn,
21268553,2020-11-05 15:30:02,,,"stock-market-newsfeed.blogspot.com/2020/11/incyte‚Ä¶, ",1324448913785573378,False,0,0,0,0,SS Auto Tweet App,"Incyte (INCY) Q3 Earnings &amp; Sales Miss, Jakafi Demand Strong
 https://t.co/DXlqxOnnaD",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
773578537764851712,2020-11-05 15:15:03,"INCY, ",,"sitefocus.com/ei-product, ",1324445143475261441,False,0,0,0,0,CIF-QBA,"$INCY Earnings Intelligence Analysis of recent earnings identified Incyte Corp.  (NASDAQ: INCY ) business focus on (atopic,dermatitis,ruxolitinib,voucher), (atopic,dermatitis,fda,ruxolitinib), (growth,jakafi,revenues)

https://t.co/4nOHfhdno3",,,2016-09-07 13:47:50,"Cupertino, CA",SiteFocus,https://pbs.twimg.com/profile_images/908465036598820864/6ZQsC4KD_normal.jpg,195,35,8,57439,SiteFocusHQ,
1250830691824283648,2020-11-05 15:14:52,"XPEV, COUP, TECH, ENPH, QCOM, SEDG, PLTR, MELI, W, PODD, DKNG, BIIB, NBIX, ZNFA, INCY, PAYC, PCTY, ",,,1324445097434533891,False,4,0,1,1,Twitter Web App,"Large cap stocks making the biggest moves so far today

Gainers: $XPEV Coupa $COUP $TECH Enphase $ENPH Qualcomm $QCOM SolarEdge $SEDG Palantir $PLTR $MELI Wayfair $W $PODD Draftkings $DKNG

Decliners: Biogen $BIIB $NBIX Zynga $ZNFA Incyte $INCY Paycom $PAYC Paylocity $PCTY",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123337,211,1299,33044,StockMKTNewz,
23059499,2020-11-05 14:53:16,"INCY, ","business, trading, economy, ","seekingalpha.com/article/438543‚Ä¶, ",1324439660991442944,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation (INCY) CEO Herv√© Hoppenot on Q3 2020 Results - Earnings Call Transcript. https://t.co/lr9uNkLEBw #business #trading #economy,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
172496840,2020-11-05 14:15:09,,"RheumatoidArthritis, ACR20, ","e.lilly/2JE7U2E, pic.twitter.com/qeKTcxaYdc, ",1324430068198899718,False,5,1,0,0,Khoros Publishing,"At Lilly, patient safety is at the center of our commitment to improve the #RheumatoidArthritis treatment experience. Learn more about the long-term benefits and safety profile of a Lilly medicine: https://t.co/W28xWuFbNm #ACR20 https://t.co/qeKTcxaYdc",,,2010-07-29 17:24:18,"Indianapolis, IN",Eli Lilly and Company,https://pbs.twimg.com/profile_images/1410270096296136707/VYZKlWDQ_normal.jpg,132353,1341,1576,22121,LillyPad,video
1004375641171603458,2020-11-05 13:59:59,,"COVID19, barcitinib, remdesivir, choosedelaware, netde, ","hubs.ly/H0zghxZ0, pic.twitter.com/nSNGobZlYP, ",1324426252145598466,False,2,0,0,3,HubSpot,"A drug developed by Delaware's @Incyte and licensed to @lillypad continues to show promise treating #COVID19. The companies report the drug, #barcitinib, boosted the effectiveness of #remdesivir in hospitalized patients. https://t.co/kYeVodCxqr 
#choosedelaware #netde https://t.co/nSNGobZlYP","Incyte, LillyPad, ",,2018-06-06 10:53:08,,Delaware Prosperity Partnership @choosedelaware,https://pbs.twimg.com/profile_images/1059872509540134913/PX_tVV7O_normal.jpg,4337,1030,21,2792,choosedelaware,photo
36418102,2020-11-05 13:13:56,"INCY, ",,"investors.com/news/technolog‚Ä¶, ",1324414660464926720,False,1,0,0,0,Twitter Web App,"$INCY new guide range for Jakafi means upside is lower, but midpoint higher https://t.co/AqBD59GdSa",,,2009-04-29 13:35:32,"Campbell, CA",Mike Krey,https://pbs.twimg.com/profile_images/206951944/mike4_croplg_normal.JPG,687,169,34,3173,MichaelKrey,
1100450877792370688,2020-11-05 12:23:27,"INCY, ",,"blueequity.io/r/165528/de-in‚Ä¶, ",1324401956962537472,False,0,0,0,0,Blue Equity,$INCY More than 40 Abstracts from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual Meeting https://t.co/dnF8p1bhw1,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
1140762699002871808,2020-11-05 12:05:12,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1324397363247546368,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-11-05 12:05 ET. Bought/Opened:
$INCY at $86.01. 
Incyte Corporation - Common Stock
Win Chance: 70%. Avg Win: 4%. Avg Loss: 10.05%. Avg Hold: 5d.
Trade Id: 58294801903048662.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
374729426,2020-11-05 11:49:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2284825, pic.twitter.com/tl2CdawinU, ",1324393497588162561,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on November 2, 2020. View odds for this and other indicators: https://t.co/EexB2odZ1n #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/tl2CdawinU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
244316903,2020-11-05 11:08:11,,"2020FOPGathering, cureFOP, ","a.org/incb000928, pic.twitter.com/ePVEPBpFvj, ",1324383014844092416,False,1,0,0,0,Twitter Web App,We are grateful to Incyte for joining the FOP Virtual Family Gathering as a Leadership Partner sponsor. Incyte is conducting a Phase I FOP clinical trial in healthy volunteers without FOP. You can learn more at ifop https://t.co/PhUuD0GuDe #2020FOPGathering #cureFOP https://t.co/ePVEPBpFvj,,,2011-01-28 20:35:55,Global,IFOPA,https://pbs.twimg.com/profile_images/1219724067785363458/cqr97day_normal.jpg,697,680,11,2607,ifopa,photo
3318510966,2020-11-05 11:00:06,,,"crweworld.com/article/market‚Ä¶, ",1324380981709557760,False,0,0,0,0,CRWE World,"Incyte Q3 Adj. Earnings, Revenue Miss Estimates - Quick Facts  https://t.co/N3fqWBq3l8",,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3686628867,2020-11-05 09:52:10,,,"pharmaceuticaldaily.com/incyte-reports‚Ä¶, ",1324363884116037634,False,0,0,0,0,WordPress.com,Incyte Reports 2020 Third Quarter Financial Results and Provides Updates on Key Clinical¬†Programs https://t.co/IfL4SbIkqT,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
730032660,2020-11-05 09:47:48,,,"nonsell.com/us-market-news‚Ä¶, ",1324362786202288128,False,0,0,0,0,NonSell Twitter,"Incyte Q3 Adj. Earnings, Revenue Miss Estimates - Quick Facts - [US Market News], Source: Nasdaq News - https://t.co/2Bs7A0amAe",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
335191510,2020-11-05 09:00:23,,,"s.einnews.com/CwY6LEcNEX, ",1324350855567605760,False,0,0,0,0,EIN Presswire,Incyte Reports 2020 Third Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/gypg1O4sUi,,,2011-07-14 05:01:11,"Washington, D.C.",EIN Presswire: Finance Newswire,https://pbs.twimg.com/profile_images/1288509755053543426/adbtpSlZ_normal.jpg,1384,1744,67,41228,EINFinanceNews,
3063963289,2020-11-05 08:37:29,,,"feedproxy.google.com/~r/InternetTec‚Ä¶, ",1324345092040138754,False,0,0,0,0,Circleboom Twitter Management,‚ñ∂Ô∏é  Incyte Earnings Miss Expectations; Tightens Outlook For Top Product https://t.co/ddsSW3Tjpj VIŒõ WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö FINŒõNCIŒõL REŒõDS,,,2015-03-05 22:29:44,United States,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,https://pbs.twimg.com/profile_images/1131561059075145728/T_Tj4P-S_normal.jpg,2718,210,0,36814,WickedSplits,
963495628545327104,2020-11-05 08:37:06,"INCY, INCY, ",,"stck.pro/news/INCY/8950‚Ä¶, stck.pro/news/INCY, pic.twitter.com/DovMKiUIGn, ",1324344993092349954,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Earnings Miss Expectations; Tightens Outlook For Top Product https://t.co/Gsack5Yiem Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/DovMKiUIGn,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
770087685738340353,2020-11-05 08:12:32,,"INCY, SATranscripts, ","dlvr.it/Rl3FyP, ",1324338811690573824,False,0,0,0,0,dlvr.it,#INCY #SATranscripts Incyte Corporation 2020 Q3 - Results - Earnings Call Presentation https://t.co/t714dj6X07,,,2016-08-28 22:36:26,Creative Land Of Metaverse,Creative Hybrid Nftüì°,https://pbs.twimg.com/profile_images/1435970649168695311/EKCoXgjP_normal.jpg,2014,4998,11,38480,thecreativenft,
23059499,2020-11-05 08:09:18,"INCY, ","business, markets, investing, ","seekingalpha.com/article/438519‚Ä¶, ",1324337997349707777,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation 2020 Q3 - Results - Earnings Call Presentation. https://t.co/aYnDCinoDs #business #markets #investing,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
778267752679235585,2020-11-05 07:50:07,,,"stockmarketdaily.co/incyte-should-‚Ä¶, pic.twitter.com/xnbzXYC8TK, ",1324333169211068416,False,0,0,0,0,StockMarketDaily,Should you short it before the Earnings result? : Incyte (NASDAQ:INCY) - https://t.co/9vQOZ9oWQG https://t.co/xnbzXYC8TK,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
2612788123,2020-11-05 07:37:59,"INCY, ",,,1324330116290404353,False,0,0,0,0,TweetDeck,"$INCY Incyte Q3 Adj. EPS $0.23 vs, $.75 Est., Sales $620.64M Miss $623.31M Est.",,,2014-07-08 22:13:20,,MStang,https://pbs.twimg.com/profile_images/486698998728642560/jI7DiDYR_normal.jpeg,212,573,7,8251,StockJock22,
3318510966,2020-11-05 07:12:13,,,"crweworld.com/article/news-p‚Ä¶, ",1324323634970722304,False,0,0,0,0,CRWE World,Incyte Reports 2020 Third Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/FAvy6eqYSN,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
976297820532518914,2020-11-05 07:11:35,,,"dlvr.it/Rl32wT, pic.twitter.com/zn4ZkENbmh, ",1324323472332394498,False,0,0,0,0,dlvr.it,Incyte Reports 2020 Third Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/cMleUHSQwf https://t.co/zn4ZkENbmh,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
108617488,2020-11-05 07:10:05,,,"invst.ly/sq4xn, ",1324323096187252738,False,0,0,0,0,FP News Publisher - COM,"Incyte Earnings, Revenue Miss in Q3 - https://t.co/lld7HeUzoh",,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
1171873456276889600,2020-11-05 07:09:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1324323031574040577,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (5 Nov, 7:08am)

üì∞ Incyte Reports 2020 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

https://t.co/czPJT1nLpx

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1068561714055012352,2020-11-05 07:09:34,"INCY, ",,"sec.report/Document/00011‚Ä¶, ",1324322967967330304,False,1,0,0,0,Edgar Filings,"Filing Alert, FORM 8-K [Press/News Current Report] available.  $INCY INCYTE CORP  https://t.co/roA7y6TKuR",,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
3524211082,2020-11-05 07:09:18,,,"twib.in/l/gGBjkBM4g596, ",1324322898878832645,False,0,0,0,0,Twibble.io,"Incyte EPS misses by $0.53, misses on revenue https://t.co/kmcu80ggCN",,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
33371707,2020-11-05 07:09:03,"INCY, ","NASDAQ, ","sec.gov/Archives/edgar‚Ä¶, ",1324322835368587265,False,0,0,0,0,xool,"$INCY #NASDAQ  8-K - INCYTE CORP  [B/A=0/0 - Bid/Ask Size=0/0  Volume=2,087,441  AverageVol=1,039,593  Outstanding=0] https://t.co/dj5RYI8QxV",,,2009-04-19 21:38:45,,tweeter no more. jack dorsey is a nazi,https://pbs.twimg.com/profile_images/1288570978516127744/0O_9eGqP_normal.jpg,497,633,11,84299,bbiittccooiinn,
770087685738340353,2020-11-05 07:09:02,,,"dlvr.it/Rl32Jl, ",1324322833414062082,False,0,0,0,0,dlvr.it,"Incyte Earnings, Revenue Miss in Q3 https://t.co/IajQQBKpxN",,,2016-08-28 22:36:26,Creative Land Of Metaverse,Creative Hybrid Nftüì°,https://pbs.twimg.com/profile_images/1435970649168695311/EKCoXgjP_normal.jpg,2014,4998,11,38480,thecreativenft,
15296897,2020-11-05 07:05:46,"INCY, ",,"seekingalpha.com/news/3631986-i‚Ä¶, ",1324322011124936705,False,1,0,0,0,SANewsTwitter,"$INCY - Incyte EPS misses by $0.53, misses on revenue https://t.co/4JGd4Z8EDx",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
2812632288,2020-11-05 07:04:43,,,"invst.ly/sq4xn, ",1324321745214574592,False,0,0,0,0,ForexPros News & Analysis,"Incyte Earnings, Revenue Miss in Q3 - https://t.co/ZSdXcDIrIg",,,2014-09-16 03:56:03,Worldwide,Investing.com Stocks,https://pbs.twimg.com/profile_images/1108338732019695616/CAvg-ixc_normal.png,20430,38,256,339289,InvestingStockz,
1069693680066420736,2020-11-05 07:04:16,"INCY, ",,"s.flashalert.me/HvmFZe, ",1324321632958271488,False,0,0,0,0,flashalerts,"$INCY [15s. delayed, acc.~90%, always check] Earnings Release November 05, 07:00:00: Q3: Non-GAAP EPS of $0.23, GAAP EPS of -$0.07, Revenue $620.64M. https://t.co/X4cUr8DfEU",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1069693680066420736,2020-11-05 07:04:09,"INCY, ",,"s.flashalert.me/UtVLiQ, ",1324321602268467200,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on November 05, 07:00:00: Incyte Reports 2020 Third Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/ZaXCZTHyRz",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
266143766,2020-11-05 06:21:09,"ICY, ",,"accesswire.com/614559/Incyte-‚Ä¶, ",1324310781572354050,False,0,0,0,0,Accesswire,$ICY Incyte Corp. to Host Earnings Call https://t.co/REVj6lSUpj,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
1889492676,2020-11-05 06:20:25,"INCY, ","Incyte, Oncology, ASH20, ","1stoncology.com/blog/more-than‚Ä¶, ",1324310597270298624,False,0,0,0,0,Troi URL Plug-in,More than 40 Abstracts from #Incyte‚Äôs #Oncology Portfolio Accepted for Presentation at the 62nd Annual #ASH20 Virtual Meeting $INCY https://t.co/1bPR47yuXq,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
778267752679235585,2020-11-05 05:29:27,,,"stockmarketdaily.co/incyte-should-‚Ä¶, ",1324297771021729792,False,0,0,0,0,StockMarketDaily,Should you short it before the Earnings result? : Incyte (NASDAQ:INCY) - https://t.co/XwnccWzmC5,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,
631661989,2020-11-05 04:00:00,,"COVID19, choosedelaware, globalde, ","hubs.ly/H0z5B-_0, pic.twitter.com/Fgig0K5oKi, ",1324275261010042882,False,2,0,0,0,HubSpot,"A drug developed by Delaware's @Incyte and licensed to @lillypad continues to show promise treating in #COVID19. The companies report the drug, baricitinib, boosted the effectiveness of remdesivir in hospitalized patients. https://t.co/5YhKvPGXLa 
#choosedelaware #globalde https://t.co/Fgig0K5oKi","Incyte, LillyPad, ",,2012-07-09 23:54:36,"Wilmington, Delaware",Global Delaware,https://pbs.twimg.com/profile_images/1059868013459992577/IjSZsC14_normal.jpg,5389,1817,222,6107,DelawareGlobal,photo
1092394610393935872,2020-11-05 00:02:20,,,"stockmarketintellects.com/incyte-corpora‚Ä¶, ",1324215447793868801,False,0,0,0,0,WordPress.com,Incyte Corporation ($INCY) 3Q20 Earnings Sneak¬†Preview https://t.co/Z6DY5hfNv5,,,2019-02-04 07:09:05,,Stock Market Intellects,https://pbs.twimg.com/profile_images/1116923358124204032/4YIC8b0k_normal.png,149,0,1,36884,smintellects,
1250830691824283648,2020-11-04 19:51:35,"BABA, AZN, BMY, ZTS, CI, D, BDX, DUK, REGN, GM, GOLD, BCE, BLL, PH, PPL, ABC, INCY, CNQ, ",,,1324152344821616640,False,10,1,1,2,Twitter Web App,"Here are the largest companies that report earnings tomorrow morning

Alibaba $BABA
AstraZeneca $AZN
Bristol-Myers $BMY
Zoetis $ZTS
Cigna $CI
Dominion $D
Becton $BDX
Duke $DUK
Regeneron $REGN
General Motors $GM
Barrick $GOLD
$BCE
Ball $BLL
Parker $PH
$PPL
$ABC
Incyte $INCY
$CNQ",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123337,211,1299,33044,StockMKTNewz,
4058194633,2020-11-04 18:09:06,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1324126553219870720,False,1,0,0,0,Twitter for iPhone,$INCY More than 40 Abstracts from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual Meeting | Business Wire https://t.co/jsjawBHxu0,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1176558075798380544,2020-11-04 16:44:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1324105229609148416,False,0,0,0,0,InsiderActionMonitor,$INCY Barry Flannelly sells $1.7M Worth Of Incyte Stock https://t.co/4DF34otnHq,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
2344420430,2020-11-04 16:42:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1324104727915909121,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Manager US

BARRY P FLANNELLY:

https://t.co/wM8q5wMNAG",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1272364687942979587,2020-11-04 16:22:50,,"Oncology, MedTwitter, MedEd, ","businesswire.com/news/home/2020‚Ä¶, ",1324099813525331968,False,0,0,0,0,Automate.io,"More than 40 Abstracts from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual Meeting
#Oncology #MedTwitter #MedEd
https://t.co/jFEgPVocSt",,,2020-06-14 23:06:06,Look here üëâ,MedPub Oncology,https://pbs.twimg.com/profile_images/1443227584813277186/-pkdEYop_normal.jpg,812,158,3,7006,OncoPublisher,
1278474376074145795,2020-11-04 16:20:20,"INCY, ","stocks, ","insiderdrop.com, ",1324099184367144968,False,0,0,0,0,Twitter,"An executive and/or major shareholder of $INCY (INCYTE CORP) reportedly sold ~$ 1,732,000 worth of shares

‚û°Ô∏è https://t.co/EUocy7ZmFg ‚¨ÖÔ∏è

 #stocks",,,2020-07-01 19:43:59,,insiderdrop,https://pbs.twimg.com/profile_images/1280996191443001345/mul90PPh_normal.jpg,92,0,0,7424,insiderdrop,
1188117778567454720,2020-11-04 16:20:09,"INCY, ",,"jodie.ai/shareholder/16‚Ä¶, ",1324099136195612679,False,0,0,0,0,jodietheai,"Barry P Flannelly, EVP &amp; General Manager US of INCYTE CORP - $INCY sold 20000 shares to now own a total of 39984, anomalous of their normal trading pattern.

https://t.co/l7a6Auk0fS",,,2019-10-26 11:38:58,London,Jodie Insights,https://pbs.twimg.com/profile_images/1310896987466760198/cVg3gmLj_normal.jpg,624,1781,16,28832,jodietheai,
1280938376099741697,2020-11-04 16:19:04,,,"iexcloud.io, pic.twitter.com/YR8htOBDWP, ",1324098862404042755,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Verisk Analytics, Inc.
-Sharjah Group Co.
-Biogen, Inc.
-Foodco Holding PJSC
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/YR8htOBDWP",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1262915121103491074,2020-11-04 16:16:16,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1324098159350489088,False,0,0,0,0,formwhispers,"#FWSells $INCY Flannelly Barry P, EVP &amp; General Manager US of INCYTE CORP sold 20,000 shares on 2020-11-02. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
963495628545327104,2020-11-04 16:05:26,"INCY, INCY, ",,"stck.pro/news/INCY/8938‚Ä¶, stck.pro/news/INCY, pic.twitter.com/RC3WucXh6q, ",1324095433996705797,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : More than 40 Abstracts from Incyte's Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual Meeting https://t.co/L8Nwx5fF83 Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/RC3WucXh6q,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
3686628867,2020-11-04 16:05:13,,,"pharmaceuticaldaily.com/more-than-40-a‚Ä¶, ",1324095378581499907,False,0,0,0,0,WordPress.com,More than 40 Abstracts from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual¬†Meeting https://t.co/gHNc8RvXoy,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
472650465,2020-11-04 15:58:57,"INCY, ",,"otcdynamics.com/incy-more-than‚Ä¶, ",1324093803796570112,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY More than 40 Abstracts from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual Meeting https://t.co/PGvTjoGS2N,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1254035253104181256,2020-11-04 15:58:20,"INCY, ",,"stocktitan.net/news/INCY/more‚Ä¶, ",1324093647134945281,False,0,0,0,0,stocktitan,"$INCY More than 40 Abstracts from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual Meeting
https://t.co/uPcuvzbUnY",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1069693680066420736,2020-11-04 15:56:33,"INCY, ",,"s.flashalert.me/aefL2, ",1324093197002383361,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on November 04, 15:55:00: More than 40 Abstracts from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual Meeting https://t.co/euq086oMFS",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1134049078424162304,2020-11-04 15:56:07,"INCY, ",,"newsfilter.io/articles/more-‚Ä¶, ",1324093087208165376,False,0,0,0,0,Newsfilter.io,More than 40 Abstracts from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual Meeting $INCY https://t.co/ZEBbUXgeGX,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
963495628545327104,2020-11-04 13:18:23,"INCY, INCY, ",,"stck.pro/news/INCY/8935‚Ä¶, stck.pro/news/INCY, ",1324053394064068608,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Q3 2020 Earnings Preview https://t.co/9d7PO6GoIW Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
3524211082,2020-11-04 13:18:01,,,"twib.in/l/jpXa88n5n8pK, ",1324053302301130753,False,0,0,0,0,Twibble.io,Incyte Q3 2020 Earnings Preview https://t.co/jjprHTTU0i,,,2015-09-02 10:37:50,,Gordon Gekko,https://pbs.twimg.com/profile_images/1238098160972705792/kZaLxGnV_normal.jpg,195,1831,3,28977,Gordon_Gekko_WS,
15296897,2020-11-04 13:12:15,"INCY, ",,"seekingalpha.com/news/3631333-i‚Ä¶, ",1324051851461881856,False,0,0,0,0,SANewsTwitter,$INCY - Incyte Q3 2020 Earnings Preview https://t.co/dCUYXX20do,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
121158213,2020-11-04 11:18:37,"INCY, ",,"dlvr.it/RkzwhN, AlertTrade.us, ",1324023255024365568,False,0,0,0,0,dlvr.it,DYNAMO GAP UP $INCY - Incyte Corporation - Common Stock https://t.co/4aDNO8HMVz via ‚ü∂ https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
374729426,2020-11-04 11:11:16,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2281008, pic.twitter.com/ZO89ih91Lz, ",1324021403067146241,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/uvSdMBGgtu #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZO89ih91Lz",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1301425387369619456,2020-11-04 08:43:31,,,"mednetnews.com/2020/11/04/mar‚Ä¶, ",1323984221875118090,False,0,0,0,0,WordPress.com,"Marginal Zone Lymphoma Treatment Market Share 2020: Covid-19 Growth Analysis, Latest Innovation, And Technology, Top Players-AbbVie, Incyte, Bristol Myers Squibb and Company, Astellas¬†Pharma https://t.co/fhSe5RrhUS",,,2020-09-03 03:42:57,,mednetnews,https://pbs.twimg.com/profile_images/1301426159247384577/VZsF735N_normal.jpg,5,0,0,13260,mednetnews,
625439521,2020-11-04 04:48:17,,,"incyteinternational.uk/news, ",1323925021706866689,False,0,0,0,0,Twitter Web App,"Free bite-size education seminars from Incyte
5th   - Neurodiversity: raising awareness of the impact of prematurity on education  more info https://t.co/1tNBvC09v7
#freeeducationseminars#ChangeCurriculumDirectionNow",,,2012-07-03 06:07:50,Virtual,Incyte International,https://pbs.twimg.com/profile_images/2363424702/Incyte_Logo_457_png_normal.PNG,130,383,5,1478,IncyteInt,
461141340,2020-11-04 04:44:24,,,"incyteinternational.uk/news, ",1323924046292148225,False,0,0,0,0,Twitter Web App,"Free bite-size education seminars from Incyte
5th   - Neurodiversity: raising awareness of the impact of prematurity on education  more info https://t.co/tzjdVdYNbX
#freeeducationseminars#ChangeCurriculumDirectionNow",,,2012-01-11 09:01:52,UK,Malcolm Greenhalgh,https://pbs.twimg.com/profile_images/1750104870/Malc_Incyte_Mobile_normal.JPG,52,81,0,69,MalcolmGreenha2,
1224012435872305152,2020-11-04 02:18:52,,,"lifepronow.com/2020/11/04/olu‚Ä¶, pic.twitter.com/ySs89jNrBU, ",1323887422506115072,False,2,0,0,0,Twitter Web App,"Lilly and Incyte Highlight Positive Data for Olumiant¬Æ in Rheumatoid Arthritis
https://t.co/rgiGspskAb https://t.co/ySs89jNrBU",,,2020-02-02 11:51:30,India,LifeProNow-Pharma-Research and News,https://pbs.twimg.com/profile_images/1255897607584411648/z8fpqZQV_normal.jpg,14,28,0,618,LifeProNow1,photo
950010035396136962,2020-11-03 17:03:38,,"Incyte, ","zonebourse.com/INCYTE-CORPORA‚Ä¶, ",1323747690627403782,False,0,0,0,0,Cresus AI,"#Incyte closed at 84.95. Score +145, credit rating AA https://t.co/XMro31aTzT",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
94365736,2020-11-03 15:35:02,,"Lilly, Incyte, Baricitinib, Dermatitis, ","nasdaq.com/press-release/‚Ä¶, ",1323725395414364161,False,0,0,0,0,Hootsuite Inc.,EADV 2020: #Lilly and #Incyte Showcase New Data for #Baricitinib for the Treatment of Moderate to Severe Atopic #Dermatitis | NASDAQ https://t.co/ftbVuULUdt @Nasdaq @LillyPad @Incyte,"Nasdaq, LillyPad, Incyte, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
17292623,2020-11-03 15:00:08,,"biotech, pharma, SCTopEmployer, ","fcld.ly/e3oz61f, ",1323716613997289472,False,10,0,0,5,Facelift-Cloud,"Each year, @ScienceCareers surveys industry scientists to discover what they value in #biotech &amp; #pharma employers. Here are the #SCTopEmployer results from 2020, a year like no other.

Congrats to @Regeneron, @Incyte, @Alnylam, and more! https://t.co/YVuOhBkqCh","ScienceCareers, Regeneron, Incyte, Alnylam, ",,2008-11-10 14:14:39,"Washington, D.C.",AAAS,https://pbs.twimg.com/profile_images/486933718544547840/Tr7rEpWY_normal.jpeg,135143,434,2553,14677,aaas,
29409437,2020-11-03 12:19:07,,,"paper.li/javimelero/145‚Ä¶, ",1323676091408650244,False,0,0,0,0,Paper.li,The Fresh e-Health Daily from @javimelero  https://t.co/0vmVf3DeMd Gracias a @b_labarge @tech4me @Incyte,"javimelero, b_labarge, tech4me, Incyte, ",,2009-04-07 04:12:07,"Madrid, Spain",Fco Javier Melero,https://pbs.twimg.com/profile_images/1325737441463046147/KKBAWpW0_normal.jpg,2269,2235,484,16648,javimelero,
374729426,2020-11-03 09:48:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2277155, pic.twitter.com/Q83E9AxUA4, ",1323638263056277505,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/gb6AySAfZ2 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Q83E9AxUA4",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2384219072,2020-11-03 08:32:01,,"IIW2020, Delaware, bioscience, ","bit.ly/3l314kO, pic.twitter.com/hTggZ082I9, pic.twitter.com/hTggZ082I9, ",1323618939339968512,False,0,0,0,0,Loomly,We thank @Incyte &amp; @VWR for their Innovation Sponsorship of #IIW2020 a celebration of #Delaware's thriving #bioscience community!  https://t.co/tZCsMsCqg4 https://t.co/hTggZ082I9,"Incyte, VWR, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
4228892458,2020-11-03 06:51:56,,"SCTopEmployer, science, ","bit.ly/31WOdJy, ",1323593752959746048,False,3,0,0,0,Twitter Web App,"Excited that @Incyte has again been named a #SCTopEmployer by @ScienceCareers! I‚Äôm proud to work for a company that is committed to the well-being of its employees and supporting our teams as we follow the #science to find solutions for patients.

https://t.co/MF36anrQE7","Incyte, ScienceCareers, ",,2015-11-19 14:55:04,,Simon Dumbleton,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,16,132,0,7,simon_dumbleton,
1280938376099741697,2020-11-02 16:50:54,,,"iexcloud.io, pic.twitter.com/603KVr7pmV, ",1323382101559922690,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Xilinx, Inc.
-Insurance House PSC
-Alexion Pharmaceuticals, Inc.
-Booking Holdings, Inc.
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/603KVr7pmV",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
72928001,2020-11-02 16:17:40,"LLY, ",,"bit.ly/3kUAvOM, ",1323373735005491200,False,0,0,0,1,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) announced data for Olumiant will be presented at ACR Convergence 2020 https://t.co/RRvjCn67Ez,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
3318510966,2020-11-02 14:24:15,,,"crweworld.com/article/news-p‚Ä¶, ",1323345193387520002,False,0,0,0,0,CRWE World,ACR 2020: Lilly and Incyte Highlight Positive Data for Olumiant¬Æ in Rheumatoid Arthritis https://t.co/8yENdWOELQ,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1069693680066420736,2020-11-02 14:19:48,"LLY, ",,"s.flashalert.me/NjMHJr, ",1323344075769188352,False,1,0,1,0,flashalerts,"$LLY [15s. delayed]: Issued Press Release on November 02, 14:00:00: ACR 2020: Lilly and Incyte Highlight Positive Data for Olumiant¬Æ in Rheumatoid Arthritis https://t.co/H8IwrwKi5W",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
472650465,2020-11-02 14:08:07,"INCY, ",,"otcdynamics.com/incy-acr-2020-‚Ä¶, ",1323341134152802305,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY ACR 2020: Lilly and Incyte Highlight Positive Data for Olumiant¬Æ in Rheumatoid Arthritis https://t.co/ODohuiC6J0,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1134049078424162304,2020-11-02 14:04:53,"LLY, INCY, ",,"newsfilter.io/articles/acr-2‚Ä¶, ",1323340318457188356,False,1,0,0,0,Newsfilter.io,ACR 2020: Lilly and Incyte Highlight Positive Data for Olumiant¬Æ in Rheumatoid Arthritis $LLY $INCY https://t.co/dMEACxtpCg,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
2356524462,2020-11-02 14:02:40,"LLY, ",,,1323339760497315842,False,1,0,0,0,Stock News Alerts,"$LLY ACR 2020: Lilly and Incyte Highlight Positive Data for Olumiant¬Æ in Rheumatoid Arthritis
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1254035253104181256,2020-11-02 14:00:34,"INCY, LLY, ",,"stocktitan.net/news/INCY/acr-‚Ä¶, ",1323339234367868928,False,1,0,0,0,stocktitan,"$INCY $LLY ACR 2020: Lilly and Incyte Highlight Positive Data for Olumiant¬Æ in Rheumatoid Arthritis
https://t.co/PRINwB6Pnv",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
1582593798,2020-11-02 10:06:02,,"LymHubSS, ","pic.twitter.com/I4nlUwyTnN, ",1323280211878825992,False,3,0,0,0,Twitter Web App,We would like to thank Incyte &amp; Bristol Myers Squibb for supporting the Lymphoma Hub Satellite Symposium. @Incyte and @bmsnews have provided grants to support the symposium but have not had any input into the development or content of the educational materials produced #LymHubSS https://t.co/I4nlUwyTnN,"Incyte, bmsnews, ",,2013-07-10 04:56:22,Global,Lymphoma Hub,https://pbs.twimg.com/profile_images/1294318671918243841/J3IVO4p1_normal.png,6464,2144,114,8613,lymphomahub,photo
812004702594486272,2020-11-02 09:05:19,,,"checkrare.com/a-comic-book-a‚Ä¶, ",1323264930922012672,False,0,0,0,0,Hootsuite Inc.,"J.G. Jones, comic book artist known for his work with DC Comics  and Marvel, discusses his journey with a myeloproliferative neoplasm (MPN).¬†

https://t.co/Hff3Lb2Es8

@MPNVoice
@VoicesofMPN 
Voices of MPN 
@Incyte 
Incyte 
Incyte","MPNVoice, VoicesofMPN, Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
374729426,2020-11-02 09:03:45,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2273395, pic.twitter.com/Y4MEIzvjRE, ",1323264538486038528,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/4JVBtIIRRF #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Y4MEIzvjRE",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3911174913,2020-11-02 09:02:22,,,"bit.ly/37ZVOee, ",1323264189499117569,False,31,1,0,5,Twitter Web App,"Thank you @DeBusinessTimes for featuring perspective from Incyte‚Äôs Peg Squier, Group VP, US Medical Affairs, on how our teams come together to strive to make a global impact during times of crisis and beyond. https://t.co/Y03i1G1YL5","DeBusinessTimes, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
373424571,2020-11-02 07:57:23,,,"finance.yahoo.com/news/eadv-2020‚Ä¶, tweetedtimes.com/worldallergy?s‚Ä¶, ",1323247835941359617,False,0,0,0,0,The Tweeted Times,"Top story: Yahoo is now a part of Verizon Media https://t.co/c9JOSYP6r5, see more https://t.co/yY235TM04T",,,2011-09-14 11:15:20,Worldwide,World Allergy Organization,https://pbs.twimg.com/profile_images/1766890487/wao-1clr-log-federation-square_normal.jpg,8980,104,156,8628,worldallergy,
13557562,2020-11-01 16:05:35,,,"finance.yahoo.com/news/eadv-2020‚Ä¶, ",1323008306596765698,False,1,0,0,5,Tweetbot for iŒüS,EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis https://t.co/pXbjphG4dO,,,2008-02-16 11:58:12,"iPhone: 35.121323,-89.830750","Michael Blaiss, MD",https://pbs.twimg.com/profile_images/1397602816345186304/FFET4jcx_normal.jpg,3944,811,177,14618,wheezemd,
633824212,2020-11-01 15:15:04,,,"ift.tt/2TIo64F, Theflyonthewall.com, ",1322995592965095424,False,0,0,0,0,IFTTT,"Eli Lilly, Incyte showcase new data for Baricitinib in moderate to several AD https://t.co/eY7axZxaMp See the rest of the story here.

https://t.co/tnMXlCjEqv provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streami‚Ä¶",,,2012-07-12 11:31:45,NYC,flylemurs,https://pbs.twimg.com/profile_images/2393843079/wc5oiacqodhfzivmyvmh_normal.jpeg,37,32,4,129630,flylemurs,
15974185,2020-11-01 13:59:01,,,"dlvr.it/Rkn9JH, ",1322976457119838208,False,0,0,0,0,dlvr.it,EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis https://t.co/oOL0rwmWNI,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
106823467,2020-11-01 10:57:20,"LLY, INCY, ","EliLilly, Incyte, AtopicDermatitis, eczema, skindisorder, ","crweworld.com/symbol/LLY, ",1322930731996258306,False,0,0,0,0,Twitter Web App,"$LLY, $INCY Reveals New Findings for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis     #EliLilly     #Incyte      #AtopicDermatitis     #eczema      #skindisorder        https://t.co/7OGeEVJAxh",,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
374729426,2020-11-01 08:08:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2269587, pic.twitter.com/AVCqeAFBx5, ",1322888135282315270,False,1,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/s8UsaT1M0E #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/AVCqeAFBx5",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
707270913448919041,2020-11-01 08:00:01,,,,1322886109488156672,False,0,0,0,1,Twitter for Advertisers.,Hear feedback from Incyte Oncology Clinical Nurse Educators (OCNEs). Register for a patient meeting to talk with them live!,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
598251794,2020-10-31 12:48:50,,"SCTopEmployer, science, ","bit.ly/31WOdJy, ",1322581306979553283,False,1,0,0,0,Twitter for iPhone,"Excited that @Incyte has again been named a #SCTopEmployer by @ScienceCareers! I‚Äôm proud to work for a company that is committed to the well-being of its employees and supporting our teams as we follow the #science to find solutions for patients. ¬†
https://t.co/IPLTfXPrMh","Incyte, ScienceCareers, ",,2012-06-03 07:16:54,,Dr. Luis F√©liz,https://pbs.twimg.com/profile_images/1135315461468512256/VsiKnHW-_normal.jpg,84,342,1,359,lrfeliz,
3318510966,2020-10-31 11:46:06,,,"crweworld.com/article/news-p‚Ä¶, ",1322565518826508288,False,0,0,0,0,CRWE World,EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermati https://t.co/djTpQ8AZVc,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
31720614,2020-10-31 11:19:40,,"news, pharma, clinicalresearch, biotech, lifesciences, medical, healthcare, pharmiweb, ","zpr.io/HCUcF, pic.twitter.com/UqtulUumK8, ",1322558866576580609,False,1,0,0,0,Zapier.com,"EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis
https://t.co/7M01ZBb1Og
#news #pharma #clinicalresearch #biotech #lifesciences #medical #healthcare #pharmiweb https://t.co/UqtulUumK8",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,photo
31720614,2020-10-31 11:19:39,,"news, pharma, clinicalresearch, biotech, lifesciences, medical, healthcare, pharmiweb, ","zpr.io/HCUc3, pic.twitter.com/FSBvBcoxkp, ",1322558862164185089,False,0,0,0,0,Zapier.com,"EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis
https://t.co/xrU2s54ObR
#news #pharma #clinicalresearch #biotech #lifesciences #medical #healthcare #pharmiweb https://t.co/FSBvBcoxkp",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,photo
472650465,2020-10-31 11:08:59,"INCY, ",,"otcdynamics.com/incy-eadv-2020‚Ä¶, ",1322556177075634178,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis https://t.co/C0i2Tse5qz,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1466082392,2020-10-31 11:05:21,"LLY, ","Clinical, Trials, Discoveries, ","blueequity.io/r/162975, ",1322555262226477066,False,0,0,0,0,Blue Equity,$LLY EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis #Clinical #Trials/Medical #Discoveries https://t.co/x4V9NrvQxD,,,2013-05-28 21:11:22,"Los Angeles, CA",Investor Press Releases,https://pbs.twimg.com/profile_images/1211118602893459456/pOpdzBdr_normal.jpg,105,0,0,16353,KingsSaddle,
2356524462,2020-10-31 10:46:42,"LLY, ",,,1322550569823838208,False,0,0,0,0,Stock News Alerts,"$LLY EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe At
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1134049078424162304,2020-10-31 10:46:28,"LLY, INCY, ",,"newsfilter.io/articles/eadv-‚Ä¶, ",1322550510390530048,False,0,0,0,0,Newsfilter.io,EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis $LLY $INCY https://t.co/d64lfPjxvH,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1254035253104181256,2020-10-31 10:45:27,"INCY, LLY, ",,"stocktitan.net/news/INCY/eadv‚Ä¶, ",1322550257633251329,False,0,0,0,0,stocktitan,"$INCY $LLY EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis
https://t.co/vuhkyuvsWV",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
374729426,2020-10-31 09:35:01,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2265906, pic.twitter.com/QwklZ5Q3pg, ",1322532530613063680,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/v8Z6Oz6xTk #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/QwklZ5Q3pg",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1134049078424162304,2020-10-31 06:06:25,"CNCE, ",,"newsfilter.io/articles/8-k-f‚Ä¶, ",1322480036771844096,False,0,0,0,0,Newsfilter.io,"Form 8-K: On October 28, 2020, Incyte filed a post grant review petition with the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office challeng.. $CNCE https://t.co/K9eiK9FwzH",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2020-10-30 23:22:18,"LLY, INCY, ",,"newsfilter.io/articles/fall-‚Ä¶, ",1322378336421687296,False,0,0,0,0,Newsfilter.io,Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Patients with .. $LLY $INCY https://t.co/VHqRekuoft,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
172496840,2020-10-30 15:30:10,,"alopeciaareata, FC20, ","e.lilly/31Zw9yt, pic.twitter.com/ODbaGqAvhI, ",1322259521482489856,False,8,1,0,2,Khoros Publishing,"We‚Äôre bringing our latest #alopeciaareata research to more people, including the scientific community at #FC20: https://t.co/eBkdkD9oBq https://t.co/ODbaGqAvhI",,,2010-07-29 17:24:18,"Indianapolis, IN",Eli Lilly and Company,https://pbs.twimg.com/profile_images/1410270096296136707/VYZKlWDQ_normal.jpg,132353,1341,1576,22121,LillyPad,video
1134049078424162304,2020-10-30 13:57:12,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1322236123796672512,False,0,0,0,0,Newsfilter.io,Incyte Ranked Second Among Science Magazine‚Äôs 2020 Top Biopharma Employers $INCY https://t.co/8CQ4nRyGHo,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3911174913,2020-10-30 13:00:01,,"SCTopEmployer, science, ",,1322221732355190785,False,35,0,2,6,Twitter for Advertisers,"We‚Äôre honored to be listed as a #SCTopEmployer by @ScienceMagazine. Paula Swain, Executive VP, Human Resources, describes how this recognition underscores our commitment to being #science-driven, patient-focused which defines Incyte‚Äôs culture.","ScienceMagazine, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
3686628867,2020-10-30 12:04:19,,,"pharmaceuticaldaily.com/incyte-ranked-‚Ä¶, ",1322207715364667396,False,0,0,0,0,WordPress.com,Incyte Ranked Second Among Science Magazine‚Äôs 2020 Top Biopharma¬†Employers https://t.co/BLWUAVFt7K,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
912335487536377857,2020-10-30 10:42:05,,"SCTopEmployer, science, ",,1322187020916183041,False,2,0,0,0,Twitter for iPhone,Excited that @Incyte has again been named a #SCTopEmployer by @ScienceCareers! I‚Äôm proud to work for a company that is committed to the well-being of its employees and supporting our teams as we follow the #science to find solutions for patients.,"Incyte, ScienceCareers, ",,2017-09-25 11:18:25,"Delaware, USA",Evan Cimino,https://pbs.twimg.com/profile_images/968852666133680128/4tb1kI4q_normal.jpg,3,36,0,4,EJcimino16,
138929490,2020-10-30 10:40:42,,"SCTopEmployer, science, ","bit.ly/31WOdJy, ",1322186671664881664,False,1,0,0,0,Twitter Web App,Excited that @Incyte has again been named a #SCTopEmployer by @ScienceCareers! I‚Äôm proud to work for a company that is committed to the well-being of its employees and supporting our teams as we follow the #science to find solutions for patients. https://t.co/mcBDJ6DIVg,"Incyte, ScienceCareers, ",,2010-04-30 21:54:03,"Berwyn, PA",Jenifer Antonacci,https://pbs.twimg.com/profile_images/1055851811083415554/mvV0998N_normal.jpg,99,180,3,424,JenAntonacci,
2573864968,2020-10-30 10:33:32,,,"investor.incyte.com/press-releases‚Ä¶, ",1322184867380187136,False,0,0,0,0,Twitter for iPhone,Incyte - Incyte Ranked Second Among Science Magazine‚Äôs 2020 Top Biopharma Employers https://t.co/nWLCAtCwvs,,,2014-05-31 09:28:41,"Wilmington, DE",Dr Sandy Geeganage,https://pbs.twimg.com/profile_images/1328161684125609989/uoJVTENK_normal.jpg,29,131,0,272,SandyGeeganage,
374729426,2020-10-30 10:16:33,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2262286, pic.twitter.com/B93mGJpQKP, ",1322180595619803139,False,0,0,0,1,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/NNVZyWz27X #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/B93mGJpQKP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1128239740329705472,2020-10-30 09:31:39,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1322169297070821376,False,0,0,0,0,Twitter for Android,"""Pooled results from the TRuE-AD studies reinforce the potential of ruxolitinib cream to become an important antipruritic and anti-inflammatory treatment option for patients with atopic dermatitis.""

$INCY
@Incyte
https://t.co/qiZtPyGzAo","Incyte, ",,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
963495628545327104,2020-10-30 09:19:25,"INCY, INCY, ",,"stck.pro/news/INCY/8839‚Ä¶, stck.pro/news/INCY, ",1322166218309181440,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Ranked Second Among Science Magazine's 2020 Top Biopharma Employers https://t.co/CesCtT07mY Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
3318510966,2020-10-30 09:16:05,,,"crweworld.com/article/news-p‚Ä¶, ",1322165377263042566,False,0,0,0,0,CRWE World,Incyte Ranked Second Among Science Magazine‚Äôs 2020 Top Biopharma Employers https://t.co/lwKoKqs7Xz,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1006334607946649600,2020-10-30 09:09:03,,"StockMarket, Stocks, ","dlvr.it/RkfMNq, ",1322163607463817216,False,0,0,0,0,dlvr.it,Incyte Ranked Second Among Science Magazine‚Äôs 2020 Top Biopharma Employers https://t.co/IwX2wZppof #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
976297820532518914,2020-10-30 09:08:06,,,"dlvr.it/RkfM9t, pic.twitter.com/TFgXJRHa1x, ",1322163368682168321,False,0,0,0,0,dlvr.it,Incyte Ranked Second Among Science Magazine‚Äôs 2020 Top Biopharma Employers https://t.co/lk3xlw0qUT https://t.co/TFgXJRHa1x,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2020-10-30 09:05:31,"INCY, ",,"s.flashalert.me/TRpnsf, ",1322162718120488968,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on October 30, 09:00:00: Incyte Ranked Second Among Science Magazine‚Äôs 2020 Top Biopharma Employers https://t.co/iXFhsRHOBg",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1254035253104181256,2020-10-30 09:00:57,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1322161570059743233,False,0,0,0,0,stocktitan,"$INCY Incyte Ranked Second Among Science Magazine‚Äôs 2020 Top Biopharma Employers
https://t.co/YkTWinOAJI",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
72928001,2020-10-30 08:58:59,"LLY, ",,"bit.ly/2HNZjK7, ",1322161076083945472,False,0,0,0,0,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) showcase positive new data for baricitinib in adult patients with alopecia areata... https://t.co/8MckK4G9ps,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
4058194633,2020-10-30 08:34:58,"LLY, INCY, ",,"google.com/amp/s/www.nasd‚Ä¶, ",1322155031483674625,False,0,0,0,0,Twitter for iPhone,$LLY $INCY Lilly &amp; Incyte Report Positive New Data For Baricitinib In Adult Patients With Alopecia https://t.co/OY6ySIkFWT,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1100450877792370688,2020-10-30 07:26:43,"INCY, ",,"blueequity.io/r/162046/de-in‚Ä¶, ",1322137855515271168,False,0,0,0,0,Blue Equity,$INCY Pooled Results from Incyte‚Äôs TRuE-AD1 and TRuE-AD2 Atopic Dermatitis Studies of Ruxolitinib Cream Show Clinically Meaningful Improvements in Patient-Reported Quality of Life Assessments https://t.co/kQuQXug06T,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
1069693680066420736,2020-10-30 07:10:23,"LLY, ",,"s.flashalert.me/wsyEaN, ",1322133744363491329,False,0,0,0,0,flashalerts,"$LLY [15s. delayed]: Issued Press Release on October 30, 06:45:00: Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Patients with Alopecia Areata https://t.co/dgIMJXb4lp",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
963495628545327104,2020-10-30 06:57:07,"INCY, LLY, INCY, ",,"stck.pro/news/INCY/8836‚Ä¶, stck.pro/news/INCY, pic.twitter.com/ynhj9Cyldi, ",1322130405861019648,False,0,0,0,0,STCK.PR0,$INCY $LLY NEW ARTICLE : Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Patients with Alopecia Areata https://t.co/uUqZgnnVcQ Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/ynhj9Cyldi,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
2356524462,2020-10-30 06:47:58,"LLY, ",,,1322128102869389312,False,0,0,0,0,Stock News Alerts,"$LLY Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Pat
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
3318510966,2020-10-30 06:47:39,,,"crweworld.com/article/news-p‚Ä¶, ",1322128023030648832,False,0,0,0,0,CRWE World,Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Patients with A https://t.co/uoU1FdEPOH,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1254035253104181256,2020-10-30 06:45:25,"INCY, LLY, ",,"stocktitan.net/news/INCY/fall‚Ä¶, ",1322127462692651008,False,0,0,0,0,stocktitan,"$INCY $LLY Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Patients with Alopecia Areata
https://t.co/gKbO7zRn8K",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
921027039146266629,2020-10-29 14:57:40,,,"cameroonmagazine.com/actualite-inte‚Ä¶, ",1321888950949236737,False,0,0,0,0,WordPress.com,"World News ‚Äì AU ‚Äì Global Tyrosine Kinase JAK Inhibitors Market 2020 Growth Factors ‚Äì Pfizer, AbbVie, Eli Lilly, Incyte, Galapagos, Novartis, Teva ‚Äì The¬†Courier https://t.co/LM6CjyOZdl",,,2017-10-19 10:55:32,Cameroon,Cameroon Magazine,https://pbs.twimg.com/profile_images/921033806643171335/uSwuBh5s_normal.jpg,574,287,6,152027,cameroonmag,
72272550,2020-10-29 14:24:32,,"TopEmployer, pharma, biotech, ","fcld.ly/5yczilf, pic.twitter.com/U5uCl9hbQY, ",1321880615659184131,False,2,0,0,0,Twitter for iPhone,".@ScienceCareers @ScienceMagazine has just published the latest #TopEmployer ranking for #pharma and #biotech. @merckgroup remains a Top10 company, @Regeneron leads with @Incyte 2nd and @Alnylam 3rd.

https://t.co/u8VjADXIvq https://t.co/U5uCl9hbQY","ScienceCareers, ScienceMagazine, merckgroup, Regeneron, Incyte, Alnylam, ",,2009-09-07 08:43:56,"Hessen, Germay",Gangolf Schrimpf,https://pbs.twimg.com/profile_images/1316330601176236032/svjCzqp2_normal.jpg,983,3102,25,4533,GangolfSchrimpf,photo
3911174913,2020-10-29 12:59:53,,"atopicdermatitis, ","pic.twitter.com/u44oADhDDV, ",1321859309874143232,False,2,0,0,0,Twitter for Advertisers,We will have an encore presentation at the Society of Dermatology Physician Assistants (SDPA) Digital Conference and the Fall Clinical Dermatology Conference of our Phase 3 data for patients with #atopicdermatitis. Learn more at @dermPA and @fallclinical. https://t.co/u44oADhDDV,"dermPA, fallclinical, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
72928001,2020-10-29 10:10:48,"INCY, ",,"bit.ly/34FOMtg, ",1321816760438333442,False,0,0,0,0,BriefingInPlayLimited,"$INCY: Incyte announced efficacy and safety results from a pooled analysis of two randomized, double-blind,... https://t.co/MzmSKPJBjp",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
374729426,2020-10-29 09:51:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2258449, pic.twitter.com/ZZ5yFKOmBa, ",1321812012209373184,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/WwMGiHWs32 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZZ5yFKOmBa",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3686628867,2020-10-29 09:45:23,,,"pharmaceuticaldaily.com/pooled-results‚Ä¶, ",1321810364917555200,False,0,0,0,0,WordPress.com,Pooled Results from Incyte‚Äôs TRuE-AD1 and TRuE-AD2 Atopic Dermatitis Studies of Ruxolitinib Cream Show Clinically Meaningful Improvements in Patient-Reported Quality of Life¬†Assessments https://t.co/V54CBoUcuA,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
4058194633,2020-10-29 09:40:20,"INCY, ",,"finance.yahoo.com/news/pooled-re‚Ä¶, ",1321809094664089600,False,1,0,0,0,Twitter for iPhone,$INCY Pooled Results from Incyte‚Äôs TRuE-AD1 and TRuE-AD2 Atopic Dermatitis Studies of Ruxolitinib Cream Show Clinically Meaningful Improvements in Patient-Reported Quality of Life Assessments https://t.co/RJbNTul0dG,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
33993130,2020-10-29 09:35:47,"INCY, ",,"finance.yahoo.com/news/pooled-re‚Ä¶, ",1321807947652042752,False,1,0,0,1,Twitter Web App,$INCY Atopic Dermatitis Studies of Ruxolitinib Cream Show Clinically Meaningful Improvements in Patient-Reported QoL Assessments. https://t.co/hu1SLMOi28,,,2009-04-21 14:34:45,,Mazeraski,https://pbs.twimg.com/profile_images/1175371444722778113/7hVSkeuY_normal.png,2181,504,61,1459,Mazeraski,
3318510966,2020-10-29 08:07:22,,,"crweworld.com/article/news-p‚Ä¶, ",1321785695569027073,False,0,0,0,0,CRWE World,Pooled Results from Incyte‚Äôs TRuE-AD1 and TRuE-AD2 Atopic Dermatitis Studies of Ruxolitinib Cream Show Clinically  https://t.co/PgEykXv22N,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3254642543,2020-10-29 07:57:20,,,"bankers-tribune.com/2020/10/29/q3-‚Ä¶, ",1321783173777379328,False,0,0,0,0,WordPress.com,Q3 Earnings Preview for Incyte¬†(NasdaqGS:INCY) https://t.co/3qXZgmEqOJ,,,2015-05-14 16:07:26,"Chicago, IL",Margin Hunt,https://pbs.twimg.com/profile_images/1136008336636338176/6aR1q75J_normal.png,2382,854,90,44447,MarginHunt,
1280938376099741697,2020-10-28 17:58:38,,,"iexcloud.io, pic.twitter.com/HYTP87vTvI, ",1321572104719028225,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Trip.com Group Ltd.
-Intuit, Inc.
-Al Dhafra Insurance Co. PSC
-Al Wathba National Insurance Co. PJSC
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/HYTP87vTvI",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
3301684581,2020-10-28 14:35:04,,,"hcp.jakafi.com/polycythemia-v‚Ä¶, pic.twitter.com/bfcRoH5q5u, ",1321520878878969856,False,0,0,0,0,Twitter Web App,IncyteCARES is a comprehensive program created by @Incyte to connect eligible patients with myelofibrosis to continuing support and resources during their treatment with Jakafi. Learn more at https://t.co/KT5hpHdb9u. https://t.co/bfcRoH5q5u,"Incyte, ",,2015-05-28 09:25:56,"Troy, MI",MSHO,https://pbs.twimg.com/profile_images/609440725072261120/fNwcRP4D_normal.jpg,433,216,11,1776,MSHO1985,photo
948362732,2020-10-28 11:39:34,,"Delaware, netde, choosedelaware, ","delawarebusinesstimes.com/news/incyte-ma‚Ä¶, ",1321476709619798018,False,0,0,0,0,Twitter Web App,"There goes #Delaware again, being awesome! #netde #choosedelaware https://t.co/NuRFodNjpj",,,2012-11-14 14:39:39,,MidAtLocal,https://pbs.twimg.com/profile_images/1349383823981748224/dH59lLK4_normal.jpg,10,325,0,3881,OrnamentalGlee,
3911174913,2020-10-28 11:20:08,,"dermatology, EADV2020, EADVVirtual, ","pic.twitter.com/9kaR1K9RkZ, ",1321471822613893120,False,3,0,0,1,Twitter for Advertisers,We're at the 29th @eadv Virtual Congress sharing data from our #dermatology trials with the scientific community. #EADV2020 #EADVVirtual https://t.co/9kaR1K9RkZ,"eadv, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
374729426,2020-10-28 09:46:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2254650, pic.twitter.com/OWrprgPuBj, ",1321448369152167938,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/lJ1LZt4Ez8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/OWrprgPuBj",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
108617488,2020-10-28 00:55:03,,,"invst.ly/sm2yr, ",1321314511899549696,False,1,0,0,0,FP News Publisher - COM,Oppenheimer Stick to Their Buy Rating for Incyte Corp - https://t.co/2jUrAobeTZ,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
1301425387369619456,2020-10-27 14:55:33,,,"mednetnews.com/2020/10/27/pae‚Ä¶, ",1321163643472486401,False,0,0,0,0,WordPress.com,"Paediatric Hodgkin Lymphoma Market 2020-2027 Size In Terms Of Volume And Value || Leading Players ‚Äì Novartis AG, Incyte Corporation, Affimed GmbH, Aeterna Zentaris Inc. Actinium¬†Pharmaceuticals https://t.co/38OI3JzyLF",,,2020-09-03 03:42:57,,mednetnews,https://pbs.twimg.com/profile_images/1301426159247384577/VZsF735N_normal.jpg,5,0,0,13260,mednetnews,
374729426,2020-10-27 09:09:52,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2250806, pic.twitter.com/K3cN8fYclB, ",1321076649052434432,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/Pr2zbkidGn #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/K3cN8fYclB",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1254906887490936845,2020-10-27 06:06:25,"INCY, ",,,1321030482813980672,False,1,0,0,0,Quant Data (Production),"Incyte Received FDA Orphan Drug Designation for Retifanlimab for Treatment of Merkel Cell Carcinomaon October 26

Related Tickers: $INCY",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
900607693236215808,2020-10-26 23:14:41,,,"thecanadian.news/2020/10/27/inc‚Ä¶, ",1320926868187459587,False,0,0,0,0,FS Poster,"Incyte practically unchanged...
https://t.co/s4tx5kZULo",,,2017-08-24 02:36:21,,Nob Ody,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,23,121,1,191651,nobodytweetnob,
1280938376099741697,2020-10-26 22:47:43,,,"iexcloud.io, pic.twitter.com/6jio0c4ET2, ",1320920082609000453,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Ras Al Khaimah Ceramic Co.
-Gilead Sciences, Inc.
-Incyte Corp.
-Autodesk, Inc.
-Dollar Tree, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/6jio0c4ET2",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
4297427919,2020-10-26 21:38:32,,,"dlvr.it/RkPQMz, ",1320902668517216256,True,0,1,0,2,dlvr.it,"Oncology Therapeutic Specialist - NJ South - Incyte Corporation - Southern NJ, NA https://t.co/BwDhzhbCmX via @HBCUCareerCntr","HBCUCareerCntr, ",,2015-11-27 10:24:50,IG : the_hbcu_career_center,The HBCU Career Center,https://pbs.twimg.com/profile_images/1341049548890918913/s1XRMkYg_normal.jpg,1113,1681,7,11369,HBCUCareerCntr,
1280938376099741697,2020-10-26 19:17:16,,,"iexcloud.io, pic.twitter.com/lzV14cBuAm, ",1320867118087364614,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-National Takaful Co.
-Agthia Group PJSC
-Incyte Corp.
-Mylan NV
-lululemon athletica, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/lzV14cBuAm",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
900607693236215808,2020-10-26 18:03:35,,,"thecanadian.news/2020/10/26/inc‚Ä¶, ",1320848577988497409,False,0,0,0,0,FS Poster,"Incyte with little movement...
https://t.co/3v5mSogI2a",,,2017-08-24 02:36:21,,Nob Ody,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,23,121,1,191651,nobodytweetnob,
1280938376099741697,2020-10-26 16:20:32,,,"iexcloud.io, pic.twitter.com/PM9Q2uHQUu, ",1320822642375622657,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-BioMarin Pharmaceutical, Inc.
-Incyte Corp.
-Gulf Medical Projects Co.
-Starbucks Corp.
-Take-Two Interactive Software, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/PM9Q2uHQUu",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
19265251,2020-10-26 13:32:45,,,"trainitright.com/incyte-announc‚Ä¶, pic.twitter.com/IWQpa25I5u, ",1320780418447142912,False,0,0,0,0,New Blog Twitter Auto,Incyte Announces Health Canada Acceptance of the New Drug Submission for Pemigatinib as a Treatment for Patients with Cholangiocarcinoma - https://t.co/83Uozym19k https://t.co/IWQpa25I5u,,,2009-01-20 18:46:03,"Toronto, Canada",Alicia Bell IFBB Pro,https://pbs.twimg.com/profile_images/1156307318520373250/BWD1YKuW_normal.jpg,9352,1372,264,79263,TrainItRight,photo
270492072,2020-10-26 10:09:02,,"news, SeekingAlpha, ","seekingalpha.com/news/3625781-h‚Ä¶, ",1320729150760517632,False,0,0,0,0,Microsoft Power Platform,Health Canada accepts Incyte's pemigatinib application for bile duct cancer https://t.co/2Tlix5GNDb via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
1126479667442126848,2020-10-26 10:07:28,"INCY, ",,,1320728759117504513,False,0,0,0,0,Twitter Web App,"INCYTE CORPORATION $INCY
UNUSUAL ACTIVITY 

VOLUME 2628.51% 
STRENGTH 3669.33%",,,2019-05-09 09:30:56,London,BREAKING STOCK NEWS,https://pbs.twimg.com/profile_images/1436383970774720513/ttpG7KuY_normal.jpg,2727,7,52,8959,UnusuallyActive,
1134049078424162304,2020-10-26 10:04:50,"INCY, ",,"newsfilter.io/articles/healt‚Ä¶, ",1320728094609756161,False,0,0,0,1,Newsfilter.io,Health Canada accepts Incyte's pemigatinib application for bile duct cancer $INCY https://t.co/e973kyac5u,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3318510966,2020-10-26 09:02:07,,,"crweworld.com/article/news-p‚Ä¶, ",1320712310323736577,False,0,0,0,0,CRWE World,Incyte Announces Health Canada Acceptance of the New Drug Submission for Pemigatinib as a Treatment for Patients wit https://t.co/zHyByu89w3,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
374729426,2020-10-26 08:54:54,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2247052, pic.twitter.com/yrkLorbbVY, ",1320710497600106501,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on October 21, 2020. View odds for this and other indicators: https://t.co/IsluH3Gasa #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/yrkLorbbVY",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1664222006,2020-10-25 22:14:36,,"GVHD, HorizonMobileApp, ","bit.ly/2J6Y49h, pic.twitter.com/TypJZ3n43z, ",1320549357431656448,False,0,0,0,0,Twitter Web App,"Inaugural Incyte Ingenuity Award Recipient - Massachusetts General Cancer Center
Read more: https://t.co/XiQ4FGEI1h
#GVHD #HorizonMobileApp https://t.co/TypJZ3n43z",,,2013-08-12 01:20:15,"Brisbane, Queensland",Health Radio Online,https://pbs.twimg.com/profile_images/378800000381754409/ae483ad62930125687b2c1032aa530b9_normal.png,1288,2397,46,6105,HealthProRadio,photo
374729426,2020-10-25 09:06:08,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2243320, pic.twitter.com/Ssj0NyofOV, ",1320350936137490434,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on October 21, 2020. View odds for this and other indicators: https://t.co/UMKxp4JXcu #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Ssj0NyofOV",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2525892205,2020-10-25 04:33:59,"INCY, ","investingnews, ","modernreaders.com/?p=4177627, ",1320282446244577281,False,0,0,0,0,Zapier.com,"Louisiana State Employees Retirement System Has $844,000 Stake in Incyte Co. $INCY  https://t.co/IsKjM1SLAM #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1280938376099741697,2020-10-24 20:02:58,,,"iexcloud.io, pic.twitter.com/MoB39lhAKE, ",1320153846098821126,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Al Fujairah National Insurance Co. PSC
-Check Point Software Technologies Ltd.
-National Marine Dredging Co.
-Trip.com Group Ltd.
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/MoB39lhAKE",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-10-24 20:02:43,,,"iexcloud.io, pic.twitter.com/EFEvIFqa3P, ",1320153779732447233,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Al Fujairah National Insurance Co. PSC
-Check Point Software Technologies Ltd.
-National Marine Dredging Co.
-Trip.com Group Ltd.
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/EFEvIFqa3P",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-10-24 20:02:31,,,"iexcloud.io, pic.twitter.com/BVGKGi6ak0, ",1320153730646446080,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Al Fujairah National Insurance Co. PSC
-Check Point Software Technologies Ltd.
-National Marine Dredging Co.
-Trip.com Group Ltd.
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/BVGKGi6ak0",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-10-24 18:52:43,,,"iexcloud.io, pic.twitter.com/n4xDZlT534, ",1320136165832429570,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Fujairah Building Industries PSC
-Paychex, Inc.
-Tesla, Inc.
-Sirius XM Holdings, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/n4xDZlT534",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-10-24 18:52:28,,,"iexcloud.io, pic.twitter.com/ttfBgBhyxH, ",1320136103073075200,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Fujairah Building Industries PSC
-Paychex, Inc.
-Tesla, Inc.
-Sirius XM Holdings, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/ttfBgBhyxH",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-10-24 18:52:18,,,"iexcloud.io, pic.twitter.com/mSmnuNzXOu, ",1320136062853840897,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Fujairah Building Industries PSC
-Paychex, Inc.
-Tesla, Inc.
-Sirius XM Holdings, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/mSmnuNzXOu",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2416188264,2020-10-24 11:11:17,"INCY, ","markets, ","thestockobserver.com/?p=3618823, ",1320020043720253441,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY to Announce $0.72 Earnings Per Share  https://t.co/VKVULPEcKg #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2416188264,2020-10-24 11:11:13,"INCY, ","markets, ","thestockobserver.com/?p=3618827, ",1320020026762629121,False,0,0,0,0,Zapier.com,Zacks: Brokerages Anticipate Incyte Co. $INCY Will Announce Earnings of $0.72 Per Share  https://t.co/VbQWK0iQbd #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2181281054,2020-10-24 11:11:12,"INCY, ","markets, ","wkrb13.com/?p=2326754, ",1320020019342958594,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY to Post $0.72 EPS https://t.co/cLElGgElvv #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
852931863547084801,2020-10-24 11:08:50,"INCY, ",,"zpr.io/HDWFe, ",1320019426054373379,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY to Post $0.72 EPS https://t.co/HvtiqhduWM,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
966006214818697218,2020-10-24 11:07:24,"INCY, ",,"theenterpriseleader.com/?p=4000729, ",1320019065180741636,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY to Post $0.72 EPS  https://t.co/q97e9HiDoI,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2181281054,2020-10-24 10:30:34,"INCY, ","markets, ","wkrb13.com/?p=2326514, ",1320009795160727559,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY to Announce $0.72 Earnings Per Share https://t.co/pphwlDCB3t #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
852931863547084801,2020-10-24 10:29:35,"INCY, ",,"zpr.io/HDWx2, ",1320009548778950661,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY to Announce $0.72 Earnings Per Share https://t.co/YtE136DDPv,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
374729426,2020-10-24 09:28:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2239608, pic.twitter.com/i60r9LWG3A, ",1319994264089063427,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on October 21, 2020. View odds for this and other indicators: https://t.co/EfyiUJSogH #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/i60r9LWG3A",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280938376099741697,2020-10-23 19:35:48,,,"iexcloud.io, pic.twitter.com/NjubuODrYA, ",1319784620540514306,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Ras Al-Khaimah Poultry &amp; Feeding Co.
-American Airlines Group, Inc.
-Adobe, Inc.
-Incyte Corp.
-Netflix, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/NjubuODrYA",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
812004702594486272,2020-10-23 12:10:17,,,"checkrare.com/renowned-comic‚Ä¶, ",1319672504177332225,False,0,0,0,0,Hootsuite Inc.,"J.G. Jones, comic book artist known for his work with Marvel and DC Comics discusses Rare Reflections: MPNs Unmasked, an initiative focused on raising awareness about Myeloproliferative Neoplasms.
@Incyte @VoicesofMPN @MPN_RF 
JG Jones Art Page 
Incyte 
https://t.co/Ssu4kPqZft","Incyte, VoicesofMPN, MPN_RF, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
374729426,2020-10-23 11:43:18,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2236126, pic.twitter.com/TkrrXauAru, ",1319665711661236226,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/1lY2GMp5AJ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/TkrrXauAru",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
732361939490312192,2020-10-23 04:43:17,"INCY, ","markets, ","americanbankingnews.com/?p=16705955, ",1319560008858820610,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $623.80 Million https://t.co/2WkrDsdeKp #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-10-23 04:43:16,"INCY, ","stocks, ","americanbankingnews.com/?p=16705955, ",1319560006585491457,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $623.80 Million https://t.co/zOc8e6zo0g #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-10-23 04:43:08,"INCY, ","markets, ","americanbankingnews.com/?p=16705982, ",1319559974796800001,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $623.80 Million https://t.co/Y2pgX10SLm #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-10-23 04:43:08,"INCY, ","stocks, ","americanbankingnews.com/?p=16705982, ",1319559972959694848,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $623.80 Million https://t.co/SR3niVUjfn #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2266388972,2020-10-23 04:41:54,"INCY, ","stocks, ","dailypolitical.com/?p=4727226, ",1319559664829403136,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $623.80 Million https://t.co/vcU3ehVJ2w #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-10-23 04:41:54,"INCY, ",,"dailypolitical.com/?p=4727226, ",1319559662740623361,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $623.80 Million https://t.co/TztT0iJe1j,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2266388972,2020-10-23 04:41:50,"INCY, ","stocks, ","dailypolitical.com/?p=4727236, ",1319559647460839424,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $623.80 Million https://t.co/l6blFh7kxV #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-10-23 04:41:50,"INCY, ",,"dailypolitical.com/?p=4727236, ",1319559645476814848,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $623.80 Million https://t.co/wGOLTgRQD9,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2298709746,2020-10-23 04:40:36,"INCY, ",,"zpr.io/HDrMG, ",1319559335169695747,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $623.80 Million https://t.co/sAqlSJA6Dp,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2298709746,2020-10-23 04:40:32,"INCY, ",,"zpr.io/HDrMt, ",1319559317553557504,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $623.80 Million https://t.co/Mn1BWod1Qd,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
930803511918411776,2020-10-23 04:40:19,"INCY, ",,"thelincolnianonline.com/?p=4907532, ",1319559264130764803,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $623.80 Million https://t.co/IcJmAxOnYm,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-10-23 04:39:40,"INCY, ",,"tickerreport.com/?p=6532324, ",1319559099588202496,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $623.80 Million https://t.co/SKQTpHo8WO,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1979190776,2020-10-23 04:39:28,"INCY, ",,"tickerreport.com/?p=6532355, ",1319559048753258496,False,0,0,0,0,Zapier.com,$623.80 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/FYwp44pQ0y,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
374729426,2020-10-22 09:40:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2232333, pic.twitter.com/nmzkpTecn3, ",1319272311866810369,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/tOeX5d5cfd #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/nmzkpTecn3",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
374729426,2020-10-21 11:12:42,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2228759, pic.twitter.com/wLtBGTbLuO, ",1318933234827231233,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/ZoAXaDnHnp #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wLtBGTbLuO,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1134049078424162304,2020-10-21 02:25:42,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1318800609181601792,False,0,0,0,0,Newsfilter.io,Incyte to Report Third Quarter Financial Results $INCY https://t.co/Qn0QQA4jt5,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
930803511918411776,2020-10-21 01:15:44,"INCY, ",,"thelincolnianonline.com/?p=4892195, ",1318783004232372224,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Earnings of $0.72 Per Share https://t.co/BMldaMVn3R,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2266388972,2020-10-21 01:14:49,"INCY, ","stocks, ","dailypolitical.com/?p=4711867, ",1318782772983566337,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Earnings of $0.72 Per Share https://t.co/QiRIglCNOC #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-10-21 01:14:49,"INCY, ",,"dailypolitical.com/?p=4711867, ",1318782770815053824,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Earnings of $0.72 Per Share https://t.co/zxQUYgY85t,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2298709746,2020-10-21 01:14:45,"INCY, ",,"zpr.io/H8hSJ, ",1318782755744919553,False,0,0,0,0,Zapier.com,$0.72 EPS Expected for Incyte Co. $INCY This Quarter https://t.co/NujyY8uekp,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
732361939490312192,2020-10-21 01:14:06,"INCY, ","markets, ","americanbankingnews.com/?p=16676381, ",1318782593786138624,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Earnings of $0.72 Per Share https://t.co/8SbJ5mQzn4 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-10-21 01:14:06,"INCY, ","stocks, ","americanbankingnews.com/?p=16676381, ",1318782591416356867,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Earnings of $0.72 Per Share https://t.co/T5xuGyaxto #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
812004702594486272,2020-10-20 09:05:06,,,"checkrare.com/a-comic-book-a‚Ä¶, ",1318538735328395264,False,4,0,0,1,Hootsuite Inc.,"J.G. Jones, comic book artist known for his work with DC Comics  and Marvel, discusses his journey with a myeloproliferative neoplasm (MPN).¬†

https://t.co/Hff3Lb2Es8

@MPNVoice
@VoicesofMPN 
Voices of MPN 
@Incyte 
Incyte 
Incyte","MPNVoice, VoicesofMPN, Incyte, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
374729426,2020-10-20 08:56:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2224921, pic.twitter.com/kk4FYYHilu, ",1318536484094234624,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/SLzfHXfnPu #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kk4FYYHilu,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3318510966,2020-10-20 08:22:10,,,"crweworld.com/article/news-p‚Ä¶, ",1318527931069558785,False,0,0,0,0,CRWE World,Incyte to Report Third Quarter Financial Results https://t.co/dsLFThSHCh,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1069693680066420736,2020-10-20 08:03:30,"INCY, ",,"s.flashalert.me/HA8sjF, ",1318523234980069378,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on October 20, 08:00:00: Incyte to Report Third Quarter Financial Results https://t.co/JMKqDXDAQQ",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2020-10-20 08:03:07,,,"dlvr.it/Rjyv4s, pic.twitter.com/V2yWQ7RsEB, ",1318523137185570816,False,0,0,0,0,dlvr.it,Incyte to Report Third Quarter Financial Results https://t.co/nzllvZhNdz https://t.co/V2yWQ7RsEB,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1254035253104181256,2020-10-20 08:01:37,"INCY, ",,"stocktitan.net/news/INCY/incy‚Ä¶, ",1318522760453267460,False,0,0,0,0,stocktitan,"$INCY Incyte to Report Third Quarter Financial Results
https://t.co/Nzf0vLFRtK",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
2920258887,2020-10-20 07:36:30,"INCY, INTI, ",,"dakotafinancialnews.com/?p=2629146, ",1318516439620472833,False,0,0,0,0,Zapier.com,Reviewing Incyte $INCY &amp; Inhibitor Therapeutics $INTI https://t.co/rqaqrZSM9t,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
2525892205,2020-10-20 05:08:22,"INCY, ","investingnews, ","modernreaders.com/?p=4149053, ",1318479160122216448,False,0,0,0,0,Zapier.com,"IFM Investors Pty Ltd Purchases 1,050 Shares of Incyte Co. $INCY  https://t.co/7znBvb1cak #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
701480029,2020-10-19 18:00:04,,"RPA, automation, BeCognizant, ","lnkd.in/gcATQ5s, ",1318310976685445121,False,0,0,0,0,LinkedIn,Citizen developers play a key role in scaling and unlocking #RPA potential. Tune in on Oct 8th to hear Incyte and Cognizant outcomes of leveraging a citizen development program. #automation #BeCognizant https://t.co/XKRlElNo1x,,,2012-07-17 13:51:15,"Langley, British Columbia",Santosh Ganga,https://pbs.twimg.com/profile_images/902795657043296256/C6IVMLAX_normal.jpg,25,165,0,1914,skganga24,
849417718642159616,2020-10-19 11:01:43,"INCY, ",,"zpr.io/Hbrxv, ",1318205696941428736,False,0,0,0,0,Zapier.com,Brokerages Set Incyte Co. $INCY Target Price at $103.21 https://t.co/An8jmToAwd,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2181281054,2020-10-19 10:59:32,"INCY, ","markets, ","wkrb13.com/?p=2306253, ",1318205146824888322,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $103.21 Average Price Target from Brokerages https://t.co/i6ULo3e9nx #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
2416188264,2020-10-19 10:58:58,"INCY, ","markets, ","thestockobserver.com/?p=3598330, ",1318205002767388672,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $103.21 Average Price Target from Brokerages  https://t.co/Ap79mmVKKL #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2020-10-19 09:27:02,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2221274, pic.twitter.com/ZxtgVcSQbI, ",1318181867753934848,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on October 15, 2020. View odds for this and other indicators: https://t.co/EsCDYvY1TM #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZxtgVcSQbI",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2298709746,2020-10-19 05:24:22,"INCY, ",,"zpr.io/HbEbR, ",1318120800361320453,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $110.00 https://t.co/1r4bSs0rRX,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
966006214818697218,2020-10-19 05:23:16,"INCY, ",,"theenterpriseleader.com/?p=3978308, ",1318120521809219585,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $110.00  https://t.co/iSXOvECdSW,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
900607693236215808,2020-10-18 15:03:14,,,"thecanadian.news/2020/10/18/inc‚Ä¶, ",1317904087220768768,False,0,0,0,0,FS Poster,"Incyte practically unchanged...
https://t.co/d5Y3kM5Pq5",,,2017-08-24 02:36:21,,Nob Ody,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,23,121,1,191651,nobodytweetnob,
374729426,2020-10-18 08:48:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2217517, pic.twitter.com/ayw1hBI2Si, ",1317809814127271937,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on October 15, 2020. View odds for this and other indicators: https://t.co/nf31qlZnPc #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ayw1hBI2Si",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
930803511918411776,2020-10-18 07:09:05,"INCY, ",,"thelincolnianonline.com/?p=4879461, ",1317784761335767040,False,0,0,0,0,Zapier.com,Bank of America Trims Incyte $INCY Target Price to $110.00 https://t.co/EXpybmDbI1,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2266388972,2020-10-18 07:08:54,"INCY, ","stocks, ","dailypolitical.com/?p=4699117, ",1317784717735923712,False,0,0,0,0,Zapier.com,Bank of America Trims Incyte $INCY Target Price to $110.00 https://t.co/IgJCo4HeOG #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-10-18 07:08:54,"INCY, ",,"dailypolitical.com/?p=4699117, ",1317784715533877250,False,0,0,0,0,Zapier.com,Bank of America Trims Incyte $INCY Target Price to $110.00 https://t.co/aiCKLIk1ng,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2525892205,2020-10-18 04:25:19,"INCY, ","investingnews, ","modernreaders.com/?p=4135665, ",1317743549220257792,False,0,0,0,0,Zapier.com,"Assenagon Asset Management S.A. Purchases 3,652 Shares of Incyte Co. $INCY  https://t.co/ZZqrP9PwJa #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1280938376099741697,2020-10-18 00:24:45,,,"iexcloud.io, pic.twitter.com/swF0ikToAg, ",1317683007889833986,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Emirates Insurance Co. PSC
-Incyte Corp.
-Amazon.com, Inc.
-NortonLifeLock, Inc.
-Dana Gas PJSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/swF0ikToAg",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
3166193421,2020-10-17 13:00:00,,"graftversushostdisease, GvHD, ","bit.ly/34QKii5, ",1317510688319938565,False,1,0,0,0,Twitter Web App,Congratulations to the @MGHCancerCenter for receiving the First Incyte Ingenuity Award for GvHD. https://t.co/WSRiY22yhB #graftversushostdisease #GvHD,"MGHCancerCenter, ",,2015-04-14 12:35:25,,Patient Worthy,https://pbs.twimg.com/profile_images/611916132937633792/ZUIkQ1np_normal.png,4930,4436,100,18455,PatientWorthy,
3426014292,2020-10-17 12:15:44,"INCY, ",,"pic.twitter.com/TYHUDMl3As, ",1317499545345982466,False,4,0,1,2,Twitter for iPhone,$INCY Incyte Pipeline + Expected 2H20 News Flow https://t.co/TYHUDMl3As,,,2015-09-02 09:10:37,,dough,https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_normal.jpg,32805,529,852,59439,semodough,photo
374729426,2020-10-17 10:06:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2214045, pic.twitter.com/fnfE4iRnmr, ",1317466980736069634,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on October 15, 2020. View odds for this and other indicators: https://t.co/1MzewQ8pkK #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/fnfE4iRnmr",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
849417718642159616,2020-10-17 06:29:22,"INCY, ",,"zpr.io/Hu997, ",1317412378766659584,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $135,185.00 in Stock https://t.co/pCBf8Z4iFM",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2181281054,2020-10-17 06:27:11,"INCY, ","markets, ","wkrb13.com/?p=2296556, ",1317411831183454208,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $135,185.00 in Stock https://t.co/hJ9lDPbZ87 #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
515561535,2020-10-17 05:49:31,,,"linkedin.com/company/incyte‚Ä¶, ",1317402352543059968,False,3,0,0,2,Twitter Web App,"Some great work being done by Incyte. Take a look! Join the page!

https://t.co/s4Bn2swToJ",,,2012-03-05 10:14:41,Felixstowe,Gulshan K,https://pbs.twimg.com/profile_images/1273331511270551552/wTY66gPL_normal.jpg,298,654,0,951,GulshanK2,
2920258887,2020-10-17 03:03:34,"INCY, ",,"dakotafinancialnews.com/?p=2613291, ",1317360587115008002,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $103.00 Price Target at Morgan Stanley https://t.co/TsUKjzTf2y,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
1370906497,2020-10-16 18:28:16,"MGNX, INCY, ",,,1317230907984588800,False,0,0,0,0,Twitter Web App,$MGNX Macrogenics Says Entered Into Commercial Supply Agreement With Incyte Corp $INCY,,,2013-04-21 20:38:27,U.S.A,MAISA,https://pbs.twimg.com/profile_images/3557296223/a73cb8bb8effbfd1f90590ab48523b10_normal.jpeg,2858,7,76,70211,MaisaCorp,
25406480,2020-10-16 16:36:17,,,"awesomecapital.blogspot.com/2020/10/lillyi‚Ä¶, ",1317202727294959616,False,0,0,0,1,Twitter Web App,AwesomeCapital: Lilly/Incyte's baricitinib shows additional benefi... https://t.co/TUlwG59AW1,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
954340891233259520,2020-10-16 16:12:52,,"MarketLive, ","seekingalpha.com/news/3623006-l‚Ä¶, ",1317196836218769417,False,0,0,0,0,Sociallymap,Lilly/Incyte's baricitinib shows additional benefit in hospitalized COVID-19 patients #MarketLive https://t.co/YLHhkur9B8,,,2018-01-19 08:12:54,,Koceila d'Aures,https://pbs.twimg.com/profile_images/1417174011105136647/woi-6rhz_normal.jpg,897,28,29,11125,KDaures,
31372539,2020-10-16 16:09:33,,,"dlvr.it/RjlkpV, ",1317195998876160001,False,0,0,0,0,dlvr.it,Lilly/Incyte's baricitinib shows additional benefit in hospitalized COVID-19 patients https://t.co/HvnIRqD5lu,,,2009-04-15 05:08:17,Amsterdam,Stocks tweets,https://pbs.twimg.com/profile_images/138834360/stocks1-avatar_normal.jpg,4407,3020,91,70157,stocks_tweets,
1134049078424162304,2020-10-16 16:05:26,"LLY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1317194965605339136,False,0,0,0,0,Newsfilter.io,Lilly/Incyte's baricitinib shows additional benefit in hospitalized COVID-19 patients $LLY https://t.co/hISHmEIRpu,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
852931863547084801,2020-10-16 11:44:01,"INCY, ",,"zpr.io/HuM9i, ",1317129175753510914,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $110.00 by Analysts at Bank of America https://t.co/bEvNCvuOJf,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2416188264,2020-10-16 11:42:05,"INCY, ","markets, ","thestockobserver.com/?p=3587248, ",1317128689382031361,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $110.00 by Analysts at Bank of America  https://t.co/nSsdyZGWSo #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2020-10-16 10:15:42,"INCY, ",,"zpr.io/HuaVy, ",1317106952380579841,False,0,0,0,0,Zapier.com,Morgan Stanley Boosts Incyte $INCY Price Target to $103.00 https://t.co/Y96B4TyWDs,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
374729426,2020-10-16 10:11:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2210494, pic.twitter.com/cjolEirQKY, ",1317105933441323008,False,1,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on October 15, 2020. View odds for this and other indicators: https://t.co/uEH5dIAOd0 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/cjolEirQKY",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
3435682714,2020-10-16 08:27:32,"atnm, ",,"twitter.com/ej23ny/status/‚Ä¶, ",1317079729615273986,False,2,0,0,1,Twitter for Android,"Big pharma with depleted pipeline that needs acquisition badly. @abbvie @Amgen @biogen @VertexPharma @Incyte @sanofi 
@ActiniumPharma $atnm promising pipeline in blood cancer would fit the void very nicely. Don't miss the opportunity. https://t.co/AJr54DuyaS","abbvie, Amgen, biogen, VertexPharma, Incyte, sanofi, ActiniumPharma, ",,2015-08-22 12:15:30,"New York, USA",Biotech,https://pbs.twimg.com/profile_images/1336863494373859328/lSWUKPa5_normal.jpg,688,16,16,7065,ej23ny,
1296737210423816192,2020-10-16 05:30:02,,,,1317035058969149442,False,0,0,0,0,Twitter,"üñï Fuck Incyte, from United States üá∫üá∏",,,2020-08-21 05:13:47,,Fuck Every Company,https://pbs.twimg.com/profile_images/1296739052394340353/bEnyFkvp_normal.jpg,31,1,0,1993,FuckEveryCo,
1188416386172903424,2020-10-16 05:27:07,,,"pic.twitter.com/feT9gfzLXe, ",1317034327096627200,False,0,0,0,0,Twitter Web App,"INCYTE CORP latest report.

Quote of the day!ement fund - FED HOLDING GROUP üìäüè¢ https://t.co/feT9gfzLXe",,,2019-10-27 07:25:34,,FED Holding Group,https://pbs.twimg.com/profile_images/1281694942109278209/2pULSiQg_normal.jpg,9,0,0,236,fedholdinggroup,photo
108617488,2020-10-16 05:15:28,,,"invst.ly/shixr, ",1317031393403305984,False,0,0,0,0,FP News Publisher - COM,Merrill Lynch Stick to Their Buy Rating for Incyte Corp - https://t.co/X9lGH1vp67,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
930803511918411776,2020-10-16 04:37:56,"INCY, ",,"thelincolnianonline.com/?p=4864932, ",1317021950594719744,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Rating of ‚ÄúHold‚Äù by Brokerages https://t.co/Vc1pRXeKFk,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
732361939490312192,2020-10-16 04:36:41,"INCY, ","markets, ","americanbankingnews.com/?p=16607947, ",1317021633509494785,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Rating of ‚ÄúHold‚Äù by Brokerages https://t.co/GFD4XpFhVK #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-10-16 04:36:40,"INCY, ","stocks, ","americanbankingnews.com/?p=16607947, ",1317021631483609088,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Rating of ‚ÄúHold‚Äù by Brokerages https://t.co/hxJvIyAvej #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2266388972,2020-10-16 04:34:40,"INCY, ","stocks, ","dailypolitical.com/?p=4684611, ",1317021127127060482,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Rating of ‚ÄúHold‚Äù by Brokerages https://t.co/LV9AOdNw8D #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-10-16 04:34:39,"INCY, ",,"dailypolitical.com/?p=4684611, ",1317021125088546816,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Rating of ‚ÄúHold‚Äù by Brokerages https://t.co/0uxoQ8TCL2,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
477131488,2020-10-16 01:21:08,,"CCFDIE, Immunotherapy, cancer, vaccine, cancer, TCGA, ","pic.twitter.com/E0EVPa1ofX, pic.twitter.com/E0EVPa1ofX, pic.twitter.com/E0EVPa1ofX, pic.twitter.com/E0EVPa1ofX, twitter.com/BernardAFox/st‚Ä¶, ",1316972422977982464,False,3,0,1,0,Twitter for iPhone,2/3 Present at #CCFDIE #Immunotherapy Workshop our #cancer #vaccine strategy to generate vaccine &amp; stimulate response to dominant shared #cancer Ags that are associated with worse survival/ #TCGA /data shown   @ChilesResearch @UbiVac @bmsnews @Incyte @JanssenUS @moderna_tx https://t.co/E0EVPa1ofX https://t.co/aSgYQSiVOU,"ChilesResearch, UbiVac, bmsnews, Incyte, JanssenUS, moderna_tx, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
1120631024306802688,2020-10-15 12:25:02,"INCY, ","trading, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, ",1316777112758554624,False,0,0,0,0,DataSwarm Markets,"$INCY We have detected a noticeable fall in the Zeitgeist for Incyte Corporation at  https://t.co/OxItqO0RgL
Visit DataSwarm Markets for more information
#trading #NASDAQ
DataSwarm ref: 112141",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
2920258887,2020-10-15 12:23:43,"INCY, ",,"dakotafinancialnews.com/?p=2606040, ",1316776779768639491,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $110.00 Price Target at Bank of America https://t.co/tLrfCha1yS,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
732361939490312192,2020-10-15 12:20:36,"INCY, ","markets, ","americanbankingnews.com/?p=16600162, ",1316775993894490117,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $110.00 at Bank of America https://t.co/W0mhdI2jzm #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-10-15 12:20:35,"INCY, ","stocks, ","americanbankingnews.com/?p=16600162, ",1316775991243673601,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $110.00 at Bank of America https://t.co/shbcZIwp3w #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-10-15 09:46:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2206962, pic.twitter.com/BmW1Hoe7qy, ",1316737174318927872,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on October 5, 2020. View odds for this and other indicators: https://t.co/VuRbtBvI3e #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BmW1Hoe7qy",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
29549589,2020-10-15 08:21:41,,"Yverdon, Construction, Management, Jobs, ","g.drctry.biz/r/NdKDq, ",1316715869062541312,False,0,0,0,0,Engineering Daily ,[Job] Specialist Production Downstream | Company: Incyte Corporation | Location: Yverdon-Les-Bains VD  Switzerland | #Yverdon-Les-Bains #Construction #Management #Jobs | More info at  https://t.co/72sKzhUb4p,,,2009-04-07 17:25:22,"Atlanta, GA USA",Engineering Daily,https://pbs.twimg.com/profile_images/445765099626582016/cXn6S9kL_normal.png,16933,1915,385,1338778,EngineersDay,
930803511918411776,2020-10-15 05:23:05,"INCY, INTI, ",,"thelincolnianonline.com/?p=4859797, ",1316670922506596353,False,0,0,0,0,Zapier.com,Critical Analysis: Incyte $INCY vs. Inhibitor Therapeutics $INTI https://t.co/vzX4M20cmG,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2266388972,2020-10-15 05:23:01,"INCY, INTI, ","stocks, ","dailypolitical.com/?p=4679454, ",1316670907964948480,False,0,0,0,0,Zapier.com,Critical Analysis: Incyte $INCY vs. Inhibitor Therapeutics $INTI https://t.co/QDk6sVmMhb #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-10-15 05:22:59,"INCY, INTI, ",,"dailypolitical.com/?p=4679454, ",1316670897214849024,False,0,0,0,0,Zapier.com,Critical Analysis: Incyte $INCY vs. Inhibitor Therapeutics $INTI https://t.co/ZCHVagwn8o,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1979190776,2020-10-15 05:21:54,"INCY, INTI, ",,"tickerreport.com/?p=6484564, ",1316670624555823105,False,0,0,0,0,Zapier.com,Critical Analysis: Incyte $INCY vs. Inhibitor Therapeutics $INTI https://t.co/fCctFQTO3f,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
849417718642159616,2020-10-15 03:54:30,"INCY, ",,"zpr.io/HKiJ5, ",1316648629722124288,False,0,0,0,0,Zapier.com,Morgan Stanley Increases Incyte $INCY Price Target to $103.00 https://t.co/pJ0uW4w9SR,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2416188264,2020-10-15 03:54:28,"INCY, ","markets, ","thestockobserver.com/?p=3580123, ",1316648621014691841,False,0,0,0,0,Zapier.com,Morgan Stanley Increases Incyte $INCY Price Target to $103.00  https://t.co/YFpXZP6YSL #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2020-10-14 10:18:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2203525, pic.twitter.com/fPobFmqYdJ, ",1316382775692324865,False,0,0,0,1,Tickeron,"$INCY in +5.3% Uptrend, growing for three consecutive days on October 12, 2020. View odds for this and other indicators: https://t.co/HNwdtwdRmR #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/fPobFmqYdJ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2525892205,2020-10-14 08:12:08,"INCY, ","investingnews, ","modernreaders.com/?p=4114543, ",1316351079295131649,False,0,0,0,0,Zapier.com,Redpoint Investment Management Pty Ltd Sells 377 Shares of Incyte Co. $INCY  https://t.co/cihWuhyyMd #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2298709746,2020-10-14 05:36:19,"INCY, ",,"zpr.io/HKuPX, ",1316311867300687878,False,0,0,0,0,Zapier.com,Morgan Stanley Boosts Incyte $INCY Price Target to $103.00 https://t.co/w0ffPIjUAG,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
963495628545327104,2020-10-14 05:35:02,"INCY, INCY, ",,"stck.pro/news/INCY/8459‚Ä¶, stck.pro/news/INCY, pic.twitter.com/CCLgFUhOL3, ",1316311545161363456,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Biopharma Firm Incyte‚Äôs Stock Jumped 10% ‚Äì Time To Get In? https://t.co/mHRPWYPiKL Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ https://t.co/CCLgFUhOL3,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
2525892205,2020-10-14 05:33:57,"INCY, ","investingnews, ","modernreaders.com/?p=4113201, ",1316311270073790465,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $103.00 Price Target at Morgan Stanley  https://t.co/BKPrqyZZm9 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2020-10-14 04:17:40,"INCY, ","markets, ","americanbankingnews.com/?p=16576227, ",1316292071452532736,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $135,185.00 in Stock https://t.co/osjoVCyBrj #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-10-14 04:17:39,"INCY, ","stocks, ","americanbankingnews.com/?p=16576227, ",1316292069061791745,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $135,185.00 in Stock https://t.co/lr3lKxJcl9 #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2525892205,2020-10-14 04:16:10,"INCY, ","investingnews, ","modernreaders.com/?p=4111463, ",1316291696045502465,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 1,423 Shares of Stock  https://t.co/GCEtgF3aH0 #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2525892205,2020-10-14 04:16:09,"INCY, ","investingnews, ","modernreaders.com/?p=4111459, ",1316291691033264128,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $135,185.00 in Stock  https://t.co/UKYWE5mahU #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2298709746,2020-10-14 04:15:16,"INCY, ",,"zpr.io/HKKnh, ",1316291469041373184,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $135,185.00 in Stock https://t.co/dM8XBCoey8",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1979190776,2020-10-14 04:13:27,"INCY, ",,"tickerreport.com/?p=6477329, ",1316291012957011968,False,0,0,0,0,Zapier.com,"Maria E. Pasquale Sells 1,423 Shares of Incyte Co. $INCY Stock https://t.co/2OahzX7n2H",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1979190776,2020-10-14 04:13:26,"INCY, ",,"tickerreport.com/?p=6477330, ",1316291009660227584,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $135,185.00 in Stock https://t.co/tKD0f8Vqgq",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-10-14 04:13:10,"INCY, ",,"thelincolnianonline.com/?p=4852505, ",1316290939829260291,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 1,423 Shares of Stock https://t.co/F2A3MBx4cU",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
930803511918411776,2020-10-14 04:13:08,"INCY, ",,"thelincolnianonline.com/?p=4852508, ",1316290931298111489,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $135,185.00 in Stock https://t.co/broObilLj0",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
975337043944407040,2020-10-13 19:46:26,"INCY, ","Incyte, INCY, ","finscreener.com/tittech/techni‚Ä¶, ",1316163415841406979,False,0,0,0,0,StockTwits Web,"Technical analysis of #Incyte #INCY $INCY 
https://t.co/49okr63VA7",,,2018-03-18 07:44:06,,Finscreener,https://pbs.twimg.com/profile_images/976083323347984384/71mUunXo_normal.jpg,652,202,12,15317,Finscreener_com,
2344420430,2020-10-13 18:57:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1316151067600728064,False,1,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/vfXHiERHJa",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-10-13 18:07:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1316138486026645511,False,0,0,0,0,InsiderActionMonitor,$INCY Maria Pasquale Dumps 1.4K Shares of Incyte https://t.co/KNYtPOU3ft,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1262915121103491074,2020-10-13 17:11:40,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1316124467316178944,False,0,0,0,0,formwhispers,"#FWSells $INCY Pasquale Maria E, EVP &amp; General Counsel of INCYTE CORP sold 1,423 shares on 2020-10-12. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
209528657,2020-10-13 15:05:03,,,"ow.ly/HHTK50BQcjQ, ",1316092605520900096,False,0,0,0,0,Hootsuite Inc.,"Delaware-based Incyte has a promising Covid-19 treatment. It was found the Incyte drug with an Eli Lilly drug together reduced time to recovery and improved clinical outcomes for patients with Covid-19.  Go Delaware Pharma!   
https://t.co/KfEFV2tT3O",,,2010-10-29 07:05:22,"Wilmington, Delaware","TechSolutions, Inc.",https://pbs.twimg.com/profile_images/1139180764485095424/4GSuLaq8_normal.png,40,5,1,2274,TechSolutionsDE,
108617488,2020-10-13 12:30:37,,,"invst.ly/sg7x4, ",1316053741167095808,False,0,0,0,0,FP News Publisher - COM,Morgan Stanley Stick to Their Hold Rating for Incyte Corp - https://t.co/TJ6iQvBfDl,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
732361939490312192,2020-10-13 11:31:44,"INCY, ","markets, ","americanbankingnews.com/?p=16563426, ",1316038922657574914,False,0,0,0,0,Zapier.com,Morgan Stanley Boosts Incyte $INCY Price Target to $103.00 https://t.co/HFgvEGvrKj #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-10-13 11:31:43,"INCY, ","stocks, ","americanbankingnews.com/?p=16563426, ",1316038916261244928,False,0,0,0,0,Zapier.com,Morgan Stanley Boosts Incyte $INCY Price Target to $103.00 https://t.co/B6XqaNEKMO #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-10-13 10:15:34,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2200252, pic.twitter.com/0kw8IA2dVP, ",1316019754952392705,False,0,0,0,1,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on October 1, 2020. View odds for this and other indicators: https://t.co/KzMQRjE0FX #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0kw8IA2dVP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
966006214818697218,2020-10-13 10:13:09,"INCY, ",,"theenterpriseleader.com/?p=3955882, ",1316019146895757312,False,0,0,0,0,Zapier.com,Morgan Stanley Increases Incyte $INCY Price Target to $103.00  https://t.co/0YKSrCjcwV,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1280938376099741697,2020-10-12 17:33:52,,,"iexcloud.io, pic.twitter.com/WPwzg2l3Rz, ",1315767669992370178,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-J.B. Hunt Transport Services, Inc.
-CSX Corp.
-Ras Al Khaimah Co. for White Cement &amp; Co
-Broadcom, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/WPwzg2l3Rz",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1312371707764707330,2020-10-12 06:30:56,,,,1315600835200647168,False,0,0,0,0,Twitter Web App,"UK Patents Court says machines can't be inventors. In the late 1990's when I was working at Incyte Genomics, we filed hundreds of applications based on consensus sequences. The inventors were the programmers. Was this legitimate at the time? Is it legitimate now? Should it be?",,,2020-10-03 08:39:54,,Patent Pathway,https://pbs.twimg.com/profile_images/1356244372405301256/TMaAo9ci_normal.jpg,8,34,0,37,PatentPathway,
2525892205,2020-10-12 05:35:08,"INCY, ","investingnews, ","modernreaders.com/?p=4099027, ",1315586792205189120,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Position Increased by Exane Derivatives  https://t.co/ETkAhs9vys #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1280938376099741697,2020-10-12 02:08:08,,,"iexcloud.io, pic.twitter.com/UuRJaiU9Az, ",1315534698442043392,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Synopsys, Inc.
-Ras Al Khaimah Co. for White Cement &amp; Co
-Gilead Sciences, Inc.
-Incyte Corp.
-Cisco Systems, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/UuRJaiU9Az",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2020-10-11 09:20:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2196099, pic.twitter.com/9vha8t6hPy, ",1315281116866195456,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/5iedSPZmst #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/9vha8t6hPy,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1280938376099741697,2020-10-10 23:33:11,,,"iexcloud.io, pic.twitter.com/z8AT4Fq2F5, ",1315133318053195777,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Apple, Inc.
-Abu Dhabi National Co. for Building Mate
-Gulf Cement Co. PSC
-Gulf Pharmaceutical Industries

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/z8AT4Fq2F5",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-10-10 23:32:59,,,"iexcloud.io, pic.twitter.com/wIPoCINkw2, ",1315133267696398336,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Apple, Inc.
-Abu Dhabi National Co. for Building Mate
-Gulf Cement Co. PSC
-Gulf Pharmaceutical Industries

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/wIPoCINkw2",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-10-10 23:32:47,,,"iexcloud.io, pic.twitter.com/BByQtuGU01, ",1315133218518114309,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Apple, Inc.
-Abu Dhabi National Co. for Building Mate
-Gulf Cement Co. PSC
-Gulf Pharmaceutical Industries

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/BByQtuGU01",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2020-10-10 09:20:03,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2192408, pic.twitter.com/llIKvzjAcN, ",1314918621001334784,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/ih1OI3jk8B #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/llIKvzjAcN,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
1134049078424162304,2020-10-09 23:42:38,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1314773307984678919,False,0,0,0,0,Newsfilter.io,"$25,514.55 of shares sold by Dhanak Dashyant (EVP &amp; Chief Scientific Officer), reported in a new form 4 filed with th.. $INCY https://t.co/hpBtgemvwl",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1309949778197962752,2020-10-09 18:03:48,"IPOB, INCY, TAK, WORK, GBTC, Z, ZG, CBMG, XONE, XLNX, ",,"pic.twitter.com/cU7oMY4wyq, ",1314688037864058882,False,40,2,5,11,Twitter Web App,"Cathie Wood and Ark Invests trade activity from today 10/9

Bought: $IPOB Incyte $INCY Takeda $TAK Slack $WORK Grayscale $GBTC

Sold: Zillow $Z $ZG Cellular Biomedicine $CBMG Exone $XONE Xilinx $XLNX https://t.co/cU7oMY4wyq",,,2020-09-26 16:15:48,,Ark invest activity (Not affiliated with Ark),https://pbs.twimg.com/profile_images/1363187693816012806/0BZEmb6R_normal.jpg,78268,182,1006,1529,ArkkDaily,photo
277077039,2020-10-09 15:00:03,,"automation, RPA, ","lnkd.in/ghzf8pp, ",1314641794961866752,False,0,0,0,0,LinkedIn,Give power to your people and boost process #automation ‚Äî learn how to launch a successful citizen development program here [Webinar]. #RPA Cognizant UiPath Incyte https://t.co/1PdNVwNVcN,,,2011-04-04 13:09:00,"Roselle Park, NJ",Karen McCall,https://pbs.twimg.com/profile_images/1042054424309456898/OdgY_8I-_normal.jpg,298,347,15,3816,mccallmommy,
948505266,2020-10-09 14:53:21,,"maxathon, ","pic.twitter.com/BFi46hCqek, ",1314640108537094144,False,10,0,0,0,Twitter Web App,"Shout out to @Incyte's teams across the globe who met up for a final Max-A-Thon walk to raise awareness for cancer patients worldwide. They logged over 12,000 minutes of activity‚Äîwe're extremely grateful and proud! #maxathon https://t.co/BFi46hCqek","Incyte, ",,2012-11-14 16:15:20,"Seattle, WA",The Max Foundation,https://pbs.twimg.com/profile_images/937832721392349184/Srf07Z67_normal.jpg,1447,497,36,2108,stompoutcancer,photo
69877309,2020-10-09 13:51:17,,"NORDSummit, ","pic.twitter.com/PjiIhWrx2K, ",1314624488772956160,False,5,0,0,1,Twitter Web App,"Precision medicine, oncology edition! Currently watching @targetcancer E.D. Jim Palma chairs a panel of experts from Cincinnati Children's Hospital, @Incyte and Foundation Medicine Inc. #NORDSummit https://t.co/PjiIhWrx2K","targetcancer, Incyte, ",,2009-08-29 10:23:45,"Washington, DC",Debbie Drell,https://pbs.twimg.com/profile_images/941417883850166274/loT_WsWh_normal.jpg,705,619,12,867,DebbieDrell,photo
812004702594486272,2020-10-09 12:10:03,,,"checkrare.com/renowned-comic‚Ä¶, ",1314599014562660352,False,2,0,0,0,Hootsuite Inc.,"J.G. Jones, comic book artist known for his work with Marvel and DC Comics discusses Rare Reflections: MPNs Unmasked, an initiative focused on raising awareness about Myeloproliferative Neoplasms.
@Incyte @VoicesofMPN @MPN_RF 
JG Jones Art Page 
Incyte 
https://t.co/Ssu4kPqZft","Incyte, VoicesofMPN, MPN_RF, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
374729426,2020-10-09 09:49:35,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2188773, pic.twitter.com/tbfFj35lCM, ",1314563661831139329,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/m442T3wscz #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/tbfFj35lCM,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390858,Tickeron,photo
2344420430,2020-10-09 09:22:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1314556793482338305,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/ZerWygtJ8B",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
874197231217381378,2020-10-09 09:00:05,,"automation, RPA, ","lnkd.in/dT8F73y, ",1314551205264228354,False,0,0,0,0,LinkedIn,Develop and scale robotic process #automation with citizen developers ‚Äî get the roadmap here. [Webinar] #RPA Cognizant UiPath Incyte https://t.co/CTOcgsAmNK,,,2017-06-12 05:30:36,"Z√ºrich, Schweiz",Simon Erdmann,https://pbs.twimg.com/profile_images/874226431001341952/yFFq526D_normal.jpg,169,127,8,4648,simerdmann,
1280288213102292993,2020-10-09 03:22:42,,,"pharmabox.in/lilly-and-incy‚Ä¶, ",1314466302866546689,False,0,0,0,0,Twitter for iPhone,Lilly and Incyte‚Äôs Olumiant (baricitinib) Reports Additional Data Demonstrating Reduction in COVID-19 Recovery Time https://t.co/lsmmPHwnKT via @pharmabox_in,"pharmabox_in, ",,2020-07-06 19:51:21,,WWW.PHARMABOX.IN,https://pbs.twimg.com/profile_images/1284027505058381827/7o7Mcyq1_normal.jpg,856,450,0,5397,pharmabox_in,
1022473214457348096,2020-10-09 02:33:50,,,"pharmashots.com/50080/lilly-an‚Ä¶, pic.twitter.com/SB9IJXHbmf, ",1314454004944891904,False,0,0,0,0,Twitter Web App,"Lilly and Incyte‚Äôs Olumiant (baricitinib) Reports Additional Data Demonstrating Reduction in COVID-19 Recovery Time
@Pharmashot @LillyPad 
https://t.co/7WoZtXnko8 https://t.co/SB9IJXHbmf","Pharmashot, LillyPad, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,photo
1176558075798380544,2020-10-08 16:28:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1314301631840821265,False,0,0,0,0,InsiderActionMonitor,$INCY  Incyte https://t.co/MLjEcxNrUp,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1262915121103491074,2020-10-08 16:22:21,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1314300118447738880,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 961 shares on 2020-10-06. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
172496840,2020-10-08 16:13:54,,"COVID19, ","e.lilly/30OG4qe, pic.twitter.com/UgJSc5OLBx, ",1314297992048975876,False,23,1,4,11,Khoros Publishing,New: Lilly and @Incyte are sharing additional data showing reduced time to recovery and improved clinical outcomes for patients with #COVID19 infection requiring oxygen. Learn more: https://t.co/TrN0RoYbj4 https://t.co/UgJSc5OLBx,"Incyte, ",,2010-07-29 17:24:18,"Indianapolis, IN",Eli Lilly and Company,https://pbs.twimg.com/profile_images/1410270096296136707/VYZKlWDQ_normal.jpg,132353,1341,1576,22121,LillyPad,photo
35789155,2020-10-08 15:41:15,"LLY, INCY, ","covid19, ","beta.firstwordpharma.com/story/5124665, ",1314289773700317197,False,3,0,0,0,Twitter Web App,"Lilly, Incyte's Olumiant shows ""significant effect"" on #covid19 recovery times https://t.co/txFkYiQ2XA $LLY $INCY",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
1132875708,2020-10-08 15:39:15,"LLY, INCY, ","covid19, ","investor.incyte.com/press-releases‚Ä¶, ",1314289273655496707,False,0,0,0,0,Twitter for Android,"$LLY $INCY baricitinic for #covid19 ACCT-2 trial: 
https://t.co/5AnXwkYhdj",,,2013-01-29 23:00:04,,Simon Lackner,https://pbs.twimg.com/profile_images/3258994470/18725880e636963fdb4982c775597e44_normal.png,989,831,33,15432,SnupSnus,
60018034,2020-10-08 15:00:03,,"automation, RPA, ","lnkd.in/gz4xPEe, ",1314279406110556161,False,0,0,0,0,LinkedIn,Develop and scale robotic process #automation with citizen developers ‚Äî get the roadmap here. [Webinar] #RPA Cognizant UiPath Incyte https://t.co/ISi7MkYhuP,,,2009-07-25 04:47:53,Chennai,Anand Sivaraman,https://pbs.twimg.com/profile_images/1344004165454852097/rrtn9qCt_normal.jpg,347,236,5,20706,aanandsivaraman,
14453501,2020-10-08 14:29:38,,,"delawarebusinessnow.com/2020/10/lilly-‚Ä¶, ",1314271754584555523,True,0,0,0,0,WordPress.com,Lilly-Incyte drug continues to show promise in aiding hospitalized Covid-19¬†patients https://t.co/ZZpZjDhx4y,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
72928001,2020-10-08 13:42:31,"LLY, ",,"bit.ly/2Ia9HM9, ",1314259893788966914,False,1,0,0,1,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) announce data showing baricitinib in combination with remdesivir reduced time to... https://t.co/n1zk0SosOz,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1140762699002871808,2020-10-08 11:45:10,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1314230363539922945,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-10-08 11:45 ET. *Closed/Sold:
$INCY at $92.66 for 4.58 profit (5.21%). Incyte Corporation - Common Stock
Trade Id: 55345561603033830.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
374729426,2020-10-08 09:46:34,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2185057, pic.twitter.com/GGeBx5G52Y, ",1314200515371102209,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/HMARxBmUG4 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GGeBx5G52Y,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-10-08 07:30:37,"INCY, ","investingnews, ","modernreaders.com/?p=4078753, ",1314166302202892288,False,0,0,0,0,Zapier.com,"Exane Derivatives Has $118,000 Holdings in Incyte Co. $INCY  https://t.co/ac4bAnTkw4 #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
69687111,2020-10-08 05:00:01,,"automation, RPA, ",,1314128403398717440,False,11,0,0,1,Twitter for Advertisers.,Give power to your people and boost process #automation ‚Äî learn how to launch a successful citizen development program here. #RPA @uipath @incyte,"UiPath, Incyte, ",,2009-08-28 16:31:48,"Global (HQ: Teaneck, N.J.)",Cognizant,https://pbs.twimg.com/profile_images/1410586159894388740/XjXbesNZ_normal.jpg,750026,2934,3032,49031,Cognizant,
69687111,2020-10-07 18:00:07,,"automation, RPA, ","cogniz.at/3nu0TAY, pic.twitter.com/lAVcS7espC, ",1313962333484482560,False,3,1,1,3,Khoros Publishing App,Develop and scale robotic process #automation with citizen developers ‚Äî get the roadmap here. [Webinar] #RPA @UiPath @Incyte https://t.co/5GPwPq64dA https://t.co/lAVcS7espC,"UiPath, Incyte, ",,2009-08-28 16:31:48,"Global (HQ: Teaneck, N.J.)",Cognizant,https://pbs.twimg.com/profile_images/1410586159894388740/XjXbesNZ_normal.jpg,750026,2934,3032,49031,Cognizant,photo
127708877,2020-10-07 16:00:00,,"RPA, ",,1313932105210949632,False,5,0,0,1,Twitter for Advertisers.,"üî•1 day left until you can explore crucial tactics on building your own team of citizen developers and scale #RPA. 

Join @Incyte and @Cognizant to hear their approach on leveraging a citizen development program.","Incyte, Cognizant, ",,2010-03-29 21:11:04,"New York, USA",UiPath,https://pbs.twimg.com/profile_images/1258045723720835073/GRJvut46_normal.jpg,92445,5305,468,8864,UiPath,
917471604,2020-10-07 14:00:02,,"automation, Webinar, RPA, ","lnkd.in/dukVXx6, ",1313901917127536640,False,0,0,0,0,LinkedIn,Develop and scale robotic process #automation with citizen developers ‚Äî get the roadmap here. [#Webinar] #RPA Cognizant UiPath Incyte https://t.co/ayHrCvSaOP,,,2012-10-31 15:08:15,Pune,Sarab Anand,https://pbs.twimg.com/profile_images/2790044945/f2cf3484717e97d9768d340ab929ba2c_normal.jpeg,213,290,20,2252,sarabanand,
846558746,2020-10-07 13:46:05,,"RPA, UiPathEmployee, ","dy.si/Hdh9L, pic.twitter.com/mdpbGHgA4t, ",1313898405194682368,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/GPo3YPTEW9 https://t.co/mdpbGHgA4t","UiPath, Incyte, Cognizant, ",,2012-09-25 21:38:43,Houston,Tamara Moya,https://pbs.twimg.com/profile_images/378800000043814579/02163c8f32e702f91cfc288bdb4370b4_normal.jpeg,174,340,35,1878,TamaraPMoya,photo
374729426,2020-10-07 09:51:26,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2181356, pic.twitter.com/kxpRJCoeU1, ",1313839352946987008,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on September 10, 2020. View odds for this and other indicators: https://t.co/dBtUVc6i0f #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kxpRJCoeU1",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
60018034,2020-10-07 01:00:02,,"automation, RPA, ","lnkd.in/gQT5g4q, ",1313705622492180480,False,0,0,0,0,LinkedIn,Develop and scale robotic process #automation with citizen developers ‚Äî get the roadmap here. [Webinar] #RPA Cognizant UiPath Incyte https://t.co/29hCkD4W4c,,,2009-07-25 04:47:53,Chennai,Anand Sivaraman,https://pbs.twimg.com/profile_images/1344004165454852097/rrtn9qCt_normal.jpg,347,236,5,20706,aanandsivaraman,
2181281054,2020-10-06 20:02:56,"INCY, ","markets, ","wkrb13.com/?p=2257238, ",1313630854476902400,False,0,0,0,0,Zapier.com,Brokerages Expect Incyte Co. $INCY Will Post Quarterly Sales of $623.75 Million https://t.co/xJSaaggYUP #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
898911319,2020-10-06 20:00:01,,,"bit.ly/3iDJIt5, ",1313630119462793216,False,1,0,0,0,TweetDeck,Nimble Therapeutics Partners With Incyte: https://t.co/3vt8YBGUgm,,,2012-10-22 21:46:44,"Madison, Wis.",Madison Startups,https://pbs.twimg.com/profile_images/2764466532/81c1bd37fad558f7d9ed6381d38238c9_normal.png,3233,1992,106,2526,MadisonStartups,
69687111,2020-10-06 18:00:00,,"automation, RPA, ",,1313599918892818432,False,4,0,0,1,Twitter for Advertisers.,Give power to your people and boost process #automation ‚Äî learn how to launch a successful citizen development program here. #RPA  @uipath @incyte,"UiPath, Incyte, ",,2009-08-28 16:31:48,"Global (HQ: Teaneck, N.J.)",Cognizant,https://pbs.twimg.com/profile_images/1410586159894388740/XjXbesNZ_normal.jpg,750026,2934,3032,49031,Cognizant,
3677832616,2020-10-06 17:17:54,,,"immunome.com, inquirer.com/news/philly-bi‚Ä¶, ",1313589322650660866,False,1,0,0,1,Twitter Web App,"Immunome IPO on target as investors bet big on gene, cell therapies - Jefferson startup closes $45M on their IPO - 

https://t.co/roHy9riMSr

https://t.co/UIVP90gBdJ",,,2015-09-16 15:12:37,"Philadelphia, PA",Jefferson Innovation,https://pbs.twimg.com/profile_images/1288947849762414593/JyQhRF55_normal.jpg,2376,666,44,3751,JeffInnovation,
46711832,2020-10-06 10:39:02,,"RPA, UiPathEmployee, ","dy.si/3nk2X, pic.twitter.com/xQjjByxMfj, ",1313488945515311115,False,4,0,0,2,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/a79LN4tlf8 https://t.co/xQjjByxMfj","UiPath, Incyte, Cognizant, ",,2009-06-12 14:18:37,"Bucharest, Romania",Venu Kannan,https://pbs.twimg.com/profile_images/1362476503401922562/_dOq8BWQ_normal.jpg,396,284,6,677,venfranc,photo
374729426,2020-10-06 10:21:41,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2177692, pic.twitter.com/njwLlzhXvE, ",1313484579085451267,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on October 1, 2020. View odds for this and other indicators: https://t.co/Yuw6aAdEm3 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/njwLlzhXvE",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
60018034,2020-10-06 08:30:02,,"automation, RPA, ","lnkd.in/gmbf7fj, ",1313456481786753025,False,0,0,0,0,LinkedIn,Give power to your people and boost process #automation ‚Äî learn how to launch a successful citizen development program here [Webinar]. #RPA Cognizant UiPath Incyte https://t.co/SZP7ftFFKT,,,2009-07-25 04:47:53,Chennai,Anand Sivaraman,https://pbs.twimg.com/profile_images/1344004165454852097/rrtn9qCt_normal.jpg,347,236,5,20706,aanandsivaraman,
263666960,2020-10-06 08:10:15,,"RPA, UiPathEmployee, ","dy.si/dfRs4X2, pic.twitter.com/3tMgPyh1pi, ",1313451500761313280,False,1,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/MRScwfROOB https://t.co/3tMgPyh1pi","UiPath, Incyte, Cognizant, ",,2011-03-10 09:06:59,,Graham Watt,https://pbs.twimg.com/profile_images/1239998142071869440/Z7B8f9_V_normal.jpg,82,386,4,420,grahamwatt,photo
21197219,2020-10-06 03:00:02,,"RPA, automation, BeCognizant, ","lnkd.in/gVshAbz, ",1313373435427352579,False,0,0,0,0,LinkedIn,Citizen developers play a key role in scaling and unlocking #RPA potential. Tune in on October 8th to hear Incyte and Cognizant's tactics and outcomes of leveraging a citizen development program. #automation #BeCognizant https://t.co/n75nA5Ls7z,,,2009-02-18 08:55:19,"Hamburg, Hamburg DE",mediarausch,https://pbs.twimg.com/profile_images/1452613684656803840/zHbb69Br_normal.png,343,404,40,7255,mediarausch,
1280938376099741697,2020-10-06 01:16:21,,,"iexcloud.io, pic.twitter.com/LZuG4FH2hP, ",1313347341395652608,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Broadcom, Inc.
-Incyte Corp.
-Vertex Pharmaceuticals, Inc.
-Facebook, Inc.
-Exelon Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/LZuG4FH2hP",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
108617488,2020-10-05 21:55:06,,,"invst.ly/sd2a-, ",1313296692997955584,False,1,0,0,0,FP News Publisher - COM,RBC Capital Stick to Their Hold Rating for Incyte Corp - https://t.co/RDUPnHsjhK,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
106823467,2020-10-05 20:58:32,"INCY, ","NimbleTherapeutics, Incyte, ","crweworld.com/symbol/INCY, ",1313282460461924352,False,0,0,0,0,Twitter Web App,Nimble Therapeutics Inks Strategic Research Collaboration with $INCY to Discover Novel Peptide-Based Therapeutics       #NimbleTherapeutics     #Incyte       https://t.co/x9QsKSOMBZ,,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
60018034,2020-10-05 16:00:02,,"RPA, automation, BeCognizant, ","lnkd.in/gvGSU_f, ",1313207338988232706,False,0,0,0,0,LinkedIn,Citizen developers play a key role in scaling and unlocking #RPA potential. Tune in on October 8th to hear Incyte and Cognizant's tactics and outcomes of leveraging a citizen development program. #automation #BeCognizant https://t.co/Uwa2nkpC5b,,,2009-07-25 04:47:53,Chennai,Anand Sivaraman,https://pbs.twimg.com/profile_images/1344004165454852097/rrtn9qCt_normal.jpg,347,236,5,20706,aanandsivaraman,
3686628867,2020-10-05 15:03:00,,,"pharmaceuticaldaily.com/nimble-announc‚Ä¶, ",1313192986654715906,False,0,0,0,0,WordPress.com,Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based¬†Therapeutics https://t.co/ReNlgG5ZHb,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
72928001,2020-10-05 14:54:54,"INCY, ",,"bit.ly/34mkI4m, ",1313190947493044224,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte enters into strategic collaboration with Nimble Therapeutics Inc. to discover first-in-class peptide... https://t.co/GAHMK4jp9b,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1132875708,2020-10-05 13:54:57,"INCY, LLY, ",,,1313175860493590528,False,0,0,0,0,Twitter for Android,"Instead of 1 well controlled trial in cancer cachexia patients only, we have as of today  249 (!) ruxolitinib trials listed on CT gov. $INCY $LLY @Incyte @Novartis @NovartisOncCT @LillyPad JAK-inhibitors trial with OS as endpoint in cachexia only! Sad this hasn't been done yet!!","Incyte, Novartis, NovartisOncCT, LillyPad, ",,2013-01-29 23:00:04,,Simon Lackner,https://pbs.twimg.com/profile_images/3258994470/18725880e636963fdb4982c775597e44_normal.png,989,831,33,15432,SnupSnus,
1006334607946649600,2020-10-05 13:02:03,,"StockMarket, Stocks, ","dlvr.it/Rj0F6g, ",1313162547592224768,False,0,0,0,0,dlvr.it,Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics https://t.co/XXKUX7lfK8 #StockMarket #Stocks,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
270492072,2020-10-05 13:00:04,,"news, SeekingAlpha, ","seekingalpha.com/news/3619870-i‚Ä¶, ",1313162050659475456,False,0,0,0,0,Microsoft Power Platform,Incyte inks peptide-based therapies pact with Nimble Therapeutics https://t.co/Tz0KRgUbua via SeekingAlpha #news #SeekingAlpha,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
4058194633,2020-10-05 12:42:14,"INCY, ",,"valdostadailytimes.com/news/business/‚Ä¶, ",1313157559709097984,False,0,0,0,0,Twitter for iPhone,$INCY Incyte &amp; Nimble Therapeutics To Collaborate On Peptide-Baed Therapeutics https://t.co/GHOaxyoaaJ,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1134049078424162304,2020-10-05 12:38:40,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1313156661658423296,False,0,0,0,0,Newsfilter.io,Incyte inks peptide-based therapies pact with Nimble Therapeutics $INCY https://t.co/sZn3lAiT0p,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2020-10-05 12:37:39,"INCY, ",,"seekingalpha.com/news/3619870-i‚Ä¶, ",1313156407038861313,False,0,0,0,0,SANewsTwitter,$INCY - Incyte inks peptide-based therapies pact with Nimble Therapeutics https://t.co/DidCy8AnNH,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3318510966,2020-10-05 12:35:53,,,"crweworld.com/article/news-p‚Ä¶, ",1313155964527288321,False,0,0,0,0,CRWE World,Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics https://t.co/Gxo2zkZ6Dr,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1134049078424162304,2020-10-05 12:05:40,"INCY, ",,"newsfilter.io/articles/nimbl‚Ä¶, ",1313148356777123842,False,0,0,0,0,Newsfilter.io,Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics $INCY https://t.co/2uQhB5yBAq,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1069693680066420736,2020-10-05 12:05:08,"INCY, ",,"s.flashalert.me/tqaMI, ",1313148222534230023,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on October 05, 12:00:00: Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics https://t.co/C8VFBU7VnD",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
472650465,2020-10-05 12:05:04,"INCY, ",,"otcdynamics.com/incy-nimble-an‚Ä¶, ",1313148207887716353,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics https://t.co/eQ6EtcyYJu,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1254035253104181256,2020-10-05 12:02:14,"INCY, ",,"stocktitan.net/news/INCY/nimb‚Ä¶, ",1313147493484580864,False,0,0,0,0,stocktitan,"$INCY Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics
https://t.co/MhvINy4ZyC",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
701480029,2020-10-05 12:00:05,,"RPA, automation, BeCognizant, ","lnkd.in/gBSgbfV, ",1313146952754753539,False,0,0,0,0,LinkedIn,Citizen developers play a key role in scaling and unlocking #RPA potential. Tune in on October 8th to hear Incyte and Cognizant's tactics and outcomes of leveraging a citizen development program. #automation #BeCognizant https://t.co/PUWT9MCrME,,,2012-07-17 13:51:15,"Langley, British Columbia",Santosh Ganga,https://pbs.twimg.com/profile_images/902795657043296256/C6IVMLAX_normal.jpg,25,165,0,1914,skganga24,
576853647,2020-10-05 11:05:35,,"biotechnology, ","bit.ly/2F2WCmF, pic.twitter.com/1z7gd1BIAb, ",1313133236302774273,False,3,0,0,0,Twitter Web App,"We're thrilled to announce that Immunome, a company that was founded by LIMR Professor Scott Dessain, MD, PhD, and spun out of LIMR's #biotechnology incubator, went public last week. https://t.co/F9V76CVgsV https://t.co/1z7gd1BIAb",,,2012-05-10 22:38:00,"Wynnewood, PA (Philadelphia)",Lankenau Institute for Medical Research,https://pbs.twimg.com/profile_images/2209217786/LIMRlogo_normal.png,450,459,8,719,LIMR_,photo
175782459,2020-10-05 10:21:30,,,"lnkd.in/gzPBVpR, ",1313122142968373253,False,1,0,0,2,LinkedIn,"I am honored to have facilitated Incyte Diagnostics annual group retreat. Approximately 40 Incyte pathologists and senior managers participated in this event via Zoom. The level of engagement, respect for each other, and disciplined interaction with such‚Ä¶https://t.co/b7DtbrT8P6",,,2010-08-07 12:06:37,"Denver, CO","Karim Sirgi MD, MBA, FCAP",https://pbs.twimg.com/profile_images/864258362094919680/FjuwY4Ck_normal.jpg,1584,1412,44,3474,ksirgimd,
374729426,2020-10-05 09:19:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2174171, pic.twitter.com/JabixKivDo, ",1313106537095733250,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on September 10, 2020. View odds for this and other indicators: https://t.co/v9z2hkz0jX #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/JabixKivDo",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
183547744,2020-10-05 03:22:54,,"RPA, automation, BeCognizant, ","lnkd.in/gaMdxPg, ",1313016799160528901,False,0,0,0,0,LinkedIn,Citizen developers play a key role in scaling and unlocking #RPA potential. Tune in on October 8th to hear Incyte and Cognizant's tactics and outcomes of leveraging a citizen development program. #automation #BeCognizant https://t.co/EqIQ5vD6ON,,,2010-08-27 04:00:58,New York City,Bala AR,https://pbs.twimg.com/profile_images/1057611698025115648/F915Hhyk_normal.jpg,203,47,9,1170,bala_ar,
2416188264,2020-10-04 19:43:37,"INCY, ","markets, ","thestockobserver.com/?p=3540599, ",1312901216842780672,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Post Earnings of $0.73 Per Share  https://t.co/U2LnuJEo4b #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2416188264,2020-10-04 19:43:35,"INCY, ","markets, ","thestockobserver.com/?p=3540602, ",1312901208223383554,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Announce Quarterly Sales of $623.75 Million  https://t.co/umXCkWmuDX #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2020-10-04 08:51:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2170571, pic.twitter.com/n96bQj8YCn, ",1312737196076535808,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on September 10, 2020. View odds for this and other indicators: https://t.co/a8XzlbkBzn #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/n96bQj8YCn",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
58909755,2020-10-04 05:23:54,,"RPA, UiPathEmployee, ","dy.si/sNY86z, pic.twitter.com/79FRUu3pgx, ",1312684861363159046,True,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/ptz7VGtqf4 https://t.co/79FRUu3pgx","UiPath, Incyte, Cognizant, ",,2009-07-21 16:26:23,Stockholm,Onat Atayer,https://pbs.twimg.com/profile_images/1054032619640373248/Bm1jEtob_normal.jpg,107,234,0,1735,onatatayer,photo
477131488,2020-10-03 12:04:46,,"OX40, GITR, Combination, immunotherapy, HNSCC, neoadjuvant, CD39, GITR, PD1, cancer, ","pic.twitter.com/ajEiCVyiFk, pic.twitter.com/ajEiCVyiFk, pic.twitter.com/ajEiCVyiFk, pic.twitter.com/ajEiCVyiFk, twitter.com/BernardAFox/st‚Ä¶, ",1312423356583428097,False,6,0,0,1,Twitter for iPhone,3/3 @rbryanbell talks T cell agonists/ #OX40 &amp; #GITR as #Combination #immunotherapy for #HNSCC/#neoadjuvant OX40 incr #CD39/CD103 CD8 TIL in 4/14 pts &amp; incr surv/Noted Combo trial vaccine + #GITR + #PD1 4 adv #cancer @bmsnews @Incyte @UbiVac @NIBITSIENA @parkerici @ProvHealth https://t.co/ajEiCVyiFk https://t.co/8fuD8IWB2c,"rbryanbell, bmsnews, Incyte, UbiVac, NIBITSIENA, parkerici, ProvHealth, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
2344420430,2020-10-03 11:09:25,"INCY, ",,"insideri.com/879169_0001638‚Ä¶, ",1312409427287384065,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

10%+ Owner

BAKER BROS. ADVISORS LP:

https://t.co/FsVXku0v55",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
374729426,2020-10-03 10:10:32,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2167017, pic.twitter.com/nf8FKLPgXl, ",1312394608014315520,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on September 10, 2020. View odds for this and other indicators: https://t.co/ft2E5ewxwB #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/nf8FKLPgXl",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3459793708,2020-10-03 09:26:25,,"CornCon, getshyfted, bringinghumansback, ","corncon.net/corncon-vi-inc‚Ä¶, ",1312383505377226754,False,0,0,0,0,Twitter Web App,WHAT ARE YOU DOING TODAY?  Come play with me! Register for #CornCon and play the coolest game ever made (for cybersecurity awareness).  (Don't laugh)  (Its true) https://t.co/LBHFrn8p8b The game is InCyt and all the @GetShyftED team will be there! #getshyfted #bringinghumansback,"GetShyftED, ",,2015-08-27 13:11:46,"Washington, DC","Slayer Skelly, International Cybr Crmnl Dstroyrüó°",https://pbs.twimg.com/profile_images/1451305904662630404/1SqmxKs7_normal.jpg,1451,823,38,6160,KeenanSkelly,
625439521,2020-10-03 07:27:57,,,,1312353694806048778,False,2,1,0,1,Twitter Web App,"Incyte's free bite size one hour discussion seminars Oct/Nov begin next week.  These are one hour discussion seminars for teacher, school leaders, advisers and consultants covering a wide range of topics. Want to know the topics? Please get back to me numbers are restricted to 16",,,2012-07-03 06:07:50,Virtual,Incyte International,https://pbs.twimg.com/profile_images/2363424702/Incyte_Logo_457_png_normal.PNG,130,383,5,1478,IncyteInt,
461141340,2020-10-03 07:16:27,,,,1312350798110748674,False,0,0,0,2,Twitter Web App,"Incyte's free bite size one hour discussion seminars Oct/Nov begin next week.  These are one hour discussion seminars for teacher, school leaders, advisers and consultants covering a wide range of topics. Want to know the topics: please get back to me numbers are restricted to 16",,,2012-01-11 09:01:52,UK,Malcolm Greenhalgh,https://pbs.twimg.com/profile_images/1750104870/Malc_Incyte_Mobile_normal.JPG,52,81,0,69,MalcolmGreenha2,
1134049078424162304,2020-10-03 05:26:15,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1312323065829888002,False,0,0,0,0,Newsfilter.io,"$22,793.96 of shares acquired by Bienaime Jean Jacques (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/6tZiesBu16",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2020-10-03 05:20:15,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1312321556371189760,False,0,0,0,0,Newsfilter.io,"$23,332.40 of shares acquired by Clancy Paul J (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/feBGUtcppQ",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2020-10-03 05:15:15,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1312320297312411648,False,0,0,0,0,Newsfilter.io,"$17,678.78 of shares acquired by Dixon Wendy L (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/OPETeuMpAy",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2020-10-03 05:11:15,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1312319291585425410,False,0,0,0,0,Newsfilter.io,"$19,653.06 of shares acquired by Fouse Jacqualyn A (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/EokccUsQ8s",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2020-10-03 05:01:15,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1312316774147403776,False,0,0,0,0,Newsfilter.io,"$16,781.38 of shares acquired by Harrigan Edmund (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/Xec034SrGD",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1134049078424162304,2020-10-02 22:16:11,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1312214837166915585,False,0,0,0,0,Newsfilter.io,"Baker Bros. Advisors Lp (Director) acquired new securities, reported in a new form 4 filed with the SEC  $INCY https://t.co/VoJUHGW6nX",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
2356524462,2020-10-02 19:08:49,"INCY, ",,,1312167684419715072,False,0,0,0,0,Stock News Alerts,"$INCY New Form 4 for Incyte Corporation
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
46266590,2020-10-02 12:13:00,,,"inquirer.com/news/philly-bi‚Ä¶, ",1312063042025385985,False,0,0,0,0,Twitter Web App,"No recession for cell-therapy investors: Cancer-fighter Immunome is the latest no-sales, no-profits Pa. biotech to go public https://t.co/7K4OSDIkvV",,,2009-06-10 20:18:17,solvitur ambulando ,Joseph N. DiStefano,https://pbs.twimg.com/profile_images/1383609703582760965/3uKTAek4_normal.jpg,4323,256,171,26504,PhillyJoeD,
1140762699002871808,2020-10-02 11:55:12,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1312058559782219778,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-10-02 11:55 ET. Bought/Opened:
$INCY at $88.03. 
Incyte Corporation - Common Stock
Win Chance: 71%. Avg Win: 5%. Avg Loss: 10.44%. Avg Hold: 6d.
Trade Id: 55345561603033830.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
19254622,2020-10-02 10:20:01,,,"bit.ly/36sORBU, ",1312034609295654918,False,5,0,0,2,Sprout Social,Biotech firm Immunome uses technology developed by @LIMR_'s Scott Dessain to target tumors in patients who have been diagnosed with cancer.  https://t.co/BMNfkWAzNC,"LIMR_, ",,2009-01-20 15:08:51,Western Philadelphia Suburbs,Main Line Health,https://pbs.twimg.com/profile_images/1138058767768137728/S9ayF0V__normal.png,8201,640,156,17510,mainlinehealth,
25326286,2020-10-02 10:18:02,,"JAK, CAR, CellTherapy, ","bit.ly/30pnpAO, pic.twitter.com/VFOc5UCxvK, ",1312034107552133126,False,2,0,0,0,Sprout Social,"Perelman School of Medicine (@PennMedicine) and @Incyte investigators study the effect of blocking #JAK pathway signaling on #CAR T-cell proliferation, anti-tumor activity and cytokine levels. #CellTherapy @CCR_AACR

üîì Open access https://t.co/aXvlVRR7Iv https://t.co/VFOc5UCxvK","PennMedicine, Incyte, CCR_AACR, ",,2009-03-19 12:07:44,,Cell Therapy News,https://pbs.twimg.com/profile_images/1280896142750834694/HjcJHP_G_normal.jpg,9969,285,204,13036,celltherapynews,photo
374729426,2020-10-02 10:14:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2163285, pic.twitter.com/r6hY4dsH5z, ",1312033302648254467,False,0,0,0,1,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on September 10, 2020. View odds for this and other indicators: https://t.co/Ii3cSoagVH #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/r6hY4dsH5z",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
14689197,2020-10-02 06:06:31,,,"trib.al/WIgDAtu, ",1311970812560367616,False,5,1,0,1,SocialFlow,"Daily News |  More Philly biotech firms go public, seeking cancer fighting therapies and more https://t.co/4eDfO3zMro",,,2008-05-07 13:36:54,"Philadelphia, PA, US",Philly Daily News,https://pbs.twimg.com/profile_images/1134105054183600128/atg3iBrx_normal.png,179949,728,1877,153466,PhillyDailyNews,
2344420430,2020-10-01 23:32:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1311871628565938176,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JACQUALYN A FOUSE:

https://t.co/CGt02gZU2J",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1280938376099741697,2020-10-01 20:48:33,,,"iexcloud.io, pic.twitter.com/7v1dQateVQ, ",1311830394036203521,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Abu Dhabi National Hotels
-Cerner Corp.
-Al Qudra Holding PJSC
-Electronic Arts, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/7v1dQateVQ",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2344420430,2020-10-01 20:07:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1311820039792754690,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

WENDY L DIXON:

https://t.co/HyDSGajFKK",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-10-01 19:30:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1311810734121201665,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

EDMUND HARRIGAN:

https://t.co/rcBCFiQh2l",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-10-01 18:25:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1311794368630730753,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

PAUL J CLANCY:

https://t.co/dG8s0p7k5R",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-10-01 17:18:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1311777513669095428,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JEAN JACQUES BIENAIME:

https://t.co/jcE2nK0cLw",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2356524462,2020-10-01 16:49:18,"INCY, ",,,1311770187557933059,False,0,0,0,0,Stock News Alerts,"$INCY New Form 4 for Incyte Corporation
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1120631024306802688,2020-10-01 14:10:02,"INCY, ","stockmarket, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, ",1311730106172346368,False,0,0,0,0,DataSwarm Markets,"$INCY We have detected a noticeable rise in the Zeitgeist for Incyte Corporation at  https://t.co/OxItqO0RgL
Visit DataSwarm Markets for more information
#stockmarket #NASDAQ
DataSwarm ref: 111001",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
323924833,2020-10-01 08:53:26,,"RPA, UiPathEmployee, ","dy.si/jNpiP, pic.twitter.com/055aBTCbhv, ",1311650428904370181,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/rOzmKlmwfE https://t.co/055aBTCbhv","UiPath, Incyte, Cognizant, ",,2011-06-25 13:33:38,"Kansas City, MO",Charles Wheeler,https://pbs.twimg.com/profile_images/1141780222406209542/Uj4w_NC2_normal.png,7927,0,242,2766,CFWheelerIII,photo
110940455,2020-10-01 07:23:02,,"RPA, UiPathEmployee, ","dy.si/DFMfg, pic.twitter.com/qohswCFF0c, ",1311627679175593986,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/v8QsbpB18a https://t.co/qohswCFF0c","UiPath, Incyte, Cognizant, ",,2010-02-03 03:19:25,Paris,Jerome Brodin,https://pbs.twimg.com/profile_images/1192027268958347264/xsEtCVN4_normal.jpg,99,216,62,1180,JeromeBrodin,photo
260671291,2020-10-01 07:13:18,,"RPA, UiPathEmployee, ","dy.si/uFf65X, pic.twitter.com/YNIbQGIG0a, ",1311625231564328961,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/Td5M4VTME3 https://t.co/YNIbQGIG0a","UiPath, Incyte, Cognizant, ",,2011-03-04 05:27:15,Frankfurt,Joachim Grouven,https://pbs.twimg.com/profile_images/1377594625385463808/EdV106iX_normal.jpg,30,27,1,205,JoachimGrouven,photo
8400122,2020-10-01 05:19:11,,"RPA, UiPathEmployee, ","dy.si/ubVM4, pic.twitter.com/FRhfDQntG5, ",1311596511298428930,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/v2nvKQFEB5 https://t.co/FRhfDQntG5","UiPath, Incyte, Cognizant, ",,2007-08-24 04:13:17,,Dragos Apostu,https://pbs.twimg.com/profile_images/1252260193037103104/oJbex8Jx_normal.jpg,261,259,7,1636,dragosh,photo
4213095184,2020-10-01 05:06:02,,"RPA, UiPathEmployee, ","dy.si/51x26, pic.twitter.com/NiOgftsLoT, ",1311593201329864706,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/RpgHuFKOIP https://t.co/NiOgftsLoT","UiPath, Incyte, Cognizant, ",,2015-11-17 16:45:12,"Leamington Spa, England",John Smith,https://pbs.twimg.com/profile_images/666741512705822721/pzcKQOKB_normal.jpg,157,329,7,1441,JASmith_RPA,photo
963049522120351744,2020-10-01 03:32:07,,"RPA, UiPathEmployee, ","dy.si/yZoLQ, pic.twitter.com/TZonlNs3qQ, ",1311569566787497984,False,1,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/X3wOecWeBD https://t.co/TZonlNs3qQ","UiPath, Incyte, Cognizant, ",,2018-02-12 08:57:53,,Kristin Wall,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,2,6,0,134,kristinwall1179,photo
1073414480133017605,2020-10-01 02:15:51,,"RPA, UiPathEmployee, ","dy.si/yZoAX, pic.twitter.com/ziPa3DVs7Y, ",1311550375086833664,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/FsQWQnad65 https://t.co/ziPa3DVs7Y","UiPath, Incyte, Cognizant, ",,2018-12-13 22:08:49,,Dimple Vohra,https://pbs.twimg.com/profile_images/1128179478683742208/kXvcJUVs_normal.jpg,45,116,1,2660,DimpleVohra1,photo
2166151730,2020-10-01 01:05:48,,"RPA, UiPathEmployee, ","dy.si/XtE7N, pic.twitter.com/eFUle09PPM, ",1311532747840610309,False,1,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/QIwIRTwmwd https://t.co/eFUle09PPM","UiPath, Incyte, Cognizant, ",,2013-10-31 03:04:13,Delhi,devikaa,https://pbs.twimg.com/profile_images/1093428708378054657/ZKomNPqk_normal.jpg,69,50,3,294,devikaap,photo
148230164,2020-10-01 00:50:51,,"RPA, UiPathEmployee, ","dy.si/R11iRy, pic.twitter.com/O36Y1W9Kck, ",1311528985046573056,False,4,0,0,1,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/PiBAaB7FLn https://t.co/O36Y1W9Kck","UiPath, Incyte, Cognizant, ",,2010-05-26 01:01:17,"Bengaluru, India",Vibhor Shrivastava,https://pbs.twimg.com/profile_images/1327578314140123136/mDe-6I1u_normal.jpg,341,190,1,825,vibs_sri,photo
1296394452496392194,2020-09-30 18:25:35,,"adenoidcysticcarcinoma, rarecancerday, ","accoi.org, twitter.com/Incyte/status/‚Ä¶, ",1311432028533911553,False,0,0,0,0,Twitter Web App,Patients with rare cancer share how they've become  patient advocates for themselves.  Visit our website to  learn more about #adenoidcysticcarcinoma and connect with others https://t.co/COPelkV25C    #rarecancerday https://t.co/KxcmXEW3gS,,,2020-08-20 06:32:02,"Lake Forest, CA ",Adenoid Cystic Carcinoma,https://pbs.twimg.com/profile_images/1296406595815919616/W_7ZHWY2_normal.jpg,192,203,1,470,AccoiOrg,
3524665875,2020-09-30 18:07:53,,"RPA, UiPathEmployee, ","dy.si/7eqrFG, pic.twitter.com/4F0rJfgxPC, ",1311427572987699200,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/nx3BZcEUgK https://t.co/4F0rJfgxPC","UiPath, Incyte, Cognizant, ",,2015-09-02 11:52:51,"Paris, Ile-de-France",Florence Feve Vallot,https://pbs.twimg.com/profile_images/639194996298678273/DLTysuxt_normal.jpg,320,514,42,923,F_FeveVallot,photo
1280938376099741697,2020-09-30 17:46:45,,,"iexcloud.io, pic.twitter.com/8GxGM3pTmK, ",1311422257500164096,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-lululemon athletica, Inc.
-Sudan Telecom Group Ltd.
-Fiserv, Inc.
-Incyte Corp.
-Walgreens Boots Alliance, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/8GxGM3pTmK",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
55654926,2020-09-30 16:48:24,,"RareCancerDay, advocacy, cholangiocarcinoma, ","pic.twitter.com/UfLBIDQmg5, ",1311407571794886657,False,7,0,1,4,Meltwater Social,Thank you Incyte for producing this video to help us spread awareness of #RareCancerDay.  This video features patients with rare cancer and how they advocate for their health. #advocacy #cholangiocarcinoma https://t.co/UfLBIDQmg5,,,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,video
524012470,2020-09-30 15:47:26,,"RPA, UiPathEmployee, ","dy.si/sY1Ko, pic.twitter.com/3exHEq5TJL, ",1311392227965374464,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA across the enterprise, as they know their processes best. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/nUV4PcwTnx https://t.co/3exHEq5TJL","UiPath, Incyte, Cognizant, ",,2012-03-14 00:43:42,Cincinnati,Paul Bruning,https://pbs.twimg.com/profile_images/1363145101258747913/1pB7xMXD_normal.jpg,110,408,8,1396,paulmbruning,photo
94543804,2020-09-30 15:44:41,,"RPA, UiPathEmployee, ","dy.si/V5kh7f, pic.twitter.com/JJnhfmmD72, ",1311391534969843712,False,12,0,0,3,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/Stto8Jhm64 https://t.co/JJnhfmmD72","UiPath, Incyte, Cognizant, ",,2009-12-04 06:56:23,"Istanbul, Turkey",Tansu YEƒûEN,https://pbs.twimg.com/profile_images/1224777565782659073/DjhiuQSY_normal.jpg,445967,922,1023,26138,TansuYegen,photo
55654926,2020-09-30 14:53:02,,,"pic.twitter.com/zSScmspIy8, ",1311378537245560833,False,5,0,0,1,Meltwater Social,"‚ÄúWe are so appreciative of the opportunity Rare Cancer Day provides to foster education, connectivity, and support for the global rare cancer community."" At @Incyte, we are committed to improving the lives of those living with rare cancers, including CCA."" -Peg Squier https://t.co/zSScmspIy8","Incyte, ",,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,photo
143588914,2020-09-30 14:47:02,,"RPA, UiPathEmployee, ","dy.si/Fp6tF6, pic.twitter.com/BF7VDNj31N, ",1311377026691952640,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/h52OHIdocy https://t.co/BF7VDNj31N","UiPath, Incyte, Cognizant, ",,2010-05-13 18:01:45,Mexico,Haig Hanessian MBA,https://pbs.twimg.com/profile_images/516749895307632640/njOYuPGw_normal.jpeg,366,2132,5,9457,HHanessian,photo
3911174913,2020-09-30 14:00:01,,"RareCancerDay, ",,1311365198452846593,False,53,0,0,8,Twitter for Advertisers.,"At Incyte, we Solve On. Today and every day we continue to innovate to find new solutions for patients, including those with rare cancers. #RareCancerDay",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
167098748,2020-09-30 13:35:13,,"RPA, UiPathEmployee, ","dy.si/7QvX2, pic.twitter.com/SgbehX3LDD, ",1311358954161627136,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/gogeqs6LiB https://t.co/SgbehX3LDD","UiPath, Incyte, Cognizant, ",,2010-07-15 15:12:48,NY,James Droskoski,https://pbs.twimg.com/profile_images/2754582865/80908a0ae1854384840bc68164701d1f_normal.png,118,144,8,1604,JamesDroskoski,photo
23652949,2020-09-30 13:31:57,,"RPA, UiPathEmployee, ","dy.si/RMP6H, pic.twitter.com/W0DF9mn9BD, ",1311358131813801984,False,1,0,0,1,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/tYotxcT7BM https://t.co/W0DF9mn9BD","UiPath, Incyte, Cognizant, ",,2009-03-10 16:44:09,"Boston, MA",Maria Voloh,https://pbs.twimg.com/profile_images/997386472528531456/HK57ZZXp_normal.jpg,332,266,14,1242,mariavoloh,photo
83661985,2020-09-30 13:31:56,,"incyte, habitatncc, habitatforhumanity, philanthropy, corporateresponsibility, wilmingtonde, ",,1311358127556694021,False,1,0,0,1,Twitter Web App,"Thank you to our sponsor @Incyte for your generous support as we strive to build homes, community, and hope! Your impact is far-reaching and we could not fulfill our mission without you. #incyte #habitatncc #habitatforhumanity #philanthropy #corporateresponsibility #wilmingtonde","Incyte, ",,2009-10-19 14:45:04,"Wilmington, DE",Habitat NCCo Del,https://pbs.twimg.com/profile_images/888033663027486720/SucjsdLG_normal.jpg,890,465,65,2185,HabitatNCC,
114290494,2020-09-30 13:22:21,,"RPA, UiPathEmployee, ","dy.si/FLeDC, pic.twitter.com/Mhn5DynI3E, ",1311355718268669954,False,0,0,0,0,Dynamic Signal,"Citizen developers play a key role in scaling #RPA, as they know best their processes. Join @UiPath, @Incyte and @Cognizant on Oct. 8 to hear their approach to leveraging a citizen development program. #UiPathEmployee https://t.co/rQMuyn7OeU https://t.co/Mhn5DynI3E","UiPath, Incyte, Cognizant, ",,2010-02-14 16:47:08,"Bucharest, Romania",Roxana Ivan,https://pbs.twimg.com/profile_images/1270752989154861062/BW5PjRtk_normal.jpg,654,186,0,1551,roxanaivan,photo
3911174913,2020-09-30 12:08:14,,"RareCancerDay, CCA, ","pic.twitter.com/RxHXtxpQiP, ",1311337065116831747,False,132,2,1,33,Twitter Web App,"This #RareCancerDay, hear from patients with an MPN and #CCA who share their stories and how they advocate for their health. https://t.co/RxHXtxpQiP",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
312149882,2020-09-30 11:50:03,,,"dlvr.it/RhgWcq, ",1311332488682201089,False,0,0,0,0,dlvr.it,"Renowned artist J.G. Jones, Incyte raising MPN awareness with 'Rare Reflections' initiative https://t.co/NpWMynrF33 via @6abc","6abc, ",,2011-06-06 13:20:55,"Philadelphia PA, USA",Chris üá∫üá∏,https://pbs.twimg.com/profile_images/1451741099660283906/z4FSbvNS_normal.jpg,62807,26248,895,1651398,Chris_1791,
374729426,2020-09-30 09:52:08,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2155847, pic.twitter.com/3GdtcYxtkX, ",1311302813570408448,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/lJq9sW1HIm #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/3GdtcYxtkX,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2266388972,2020-09-30 09:42:12,"ARFXF, INCY, ","stocks, ","dailypolitical.com/?p=4596901, ",1311300314767785986,False,0,0,0,0,Zapier.com,Head-To-Head Analysis: ProMIS Neurosciences $ARFXF vs. Incyte $INCY https://t.co/XcAcKPatqO #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-09-30 09:42:11,"ARFXF, INCY, ",,"dailypolitical.com/?p=4596901, ",1311300312368648193,False,0,0,0,0,Zapier.com,Head-To-Head Analysis: ProMIS Neurosciences $ARFXF vs. Incyte $INCY https://t.co/WDFAHI7otg,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2181281054,2020-09-30 09:38:35,"ARFXF, INCY, ","markets, ","wkrb13.com/?p=2232015, ",1311299405455261703,False,0,0,0,0,Zapier.com,Head-To-Head Analysis: ProMIS Neurosciences $ARFXF vs. Incyte $INCY https://t.co/8L5hnT9oZc #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
2266388972,2020-09-30 08:02:11,"INCY, ","stocks, ","dailypolitical.com/?p=4596416, ",1311275145143758850,False,0,0,0,0,Zapier.com,Brokerages Expect Incyte Co. $INCY to Announce $0.73 Earnings Per Share https://t.co/c0K36BK9Hq #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-09-30 08:02:10,"INCY, ",,"dailypolitical.com/?p=4596416, ",1311275142664912896,False,0,0,0,0,Zapier.com,Brokerages Expect Incyte Co. $INCY to Announce $0.73 Earnings Per Share https://t.co/gsdmg9iTMc,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
852931863547084801,2020-09-30 08:01:57,"INCY, ",,"zpr.io/Hhfps, ",1311275084640907265,False,0,0,0,0,Zapier.com,Brokerages Expect Incyte Co. $INCY to Post $0.73 EPS https://t.co/erb97YC3lK,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
35203319,2020-09-29 23:00:03,,"automation, RPA, ","bit.ly/3f7GtZR, pic.twitter.com/vpEu7bPK22, ",1311138713569841153,False,1,0,0,0,Buffer,From @UiPath - The golden key to unlock #automation at scale comes from citizen developers. Hear from @Incyte and @Cognizant crucial tactics to launch a citizen development program and key components for long-term scalability: https://t.co/q8nmuCvZ47 #RPA https://t.co/vpEu7bPK22,"UiPath, Incyte, Cognizant, ",,2009-04-25 08:45:16,#RemoteWork #Boston ,Evan Kirstel #B2B #TechFluencer,https://pbs.twimg.com/profile_images/1446099070326648832/SO9nsmVy_normal.jpg,309523,279365,13104,1055182,EvanKirstel,photo
3911174913,2020-09-29 13:00:01,,"science, RareCancerDay, cholangiocarcinoma, ",,1310987710899736576,False,25,1,2,4,Twitter for Advertisers.,"At Incyte, we follow the #science to find solutions for serious unmet medical needs. As we head into #RareCancerDay, learn about our discovery efforts in #cholangiocarcinoma, a rare and aggressive cancer.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
312149882,2020-09-29 11:04:32,,,"dlvr.it/RhbVpR, ",1310958646344511491,False,0,0,0,0,dlvr.it,"Renowned illustrator J.G. Jones, Incyte create 'Rare Reflections: MPNs Unmasked' series to raise MPN awareness https://t.co/BybnV94621 via @6abc","6abc, ",,2011-06-06 13:20:55,"Philadelphia PA, USA",Chris üá∫üá∏,https://pbs.twimg.com/profile_images/1451741099660283906/z4FSbvNS_normal.jpg,62807,26248,895,1651398,Chris_1791,
374729426,2020-09-29 09:21:17,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2152130, pic.twitter.com/zTcPTpAKpy, ",1310932663549661185,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on September 10, 2020. View odds for this and other indicators: https://t.co/9ANxzrDOHi #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/zTcPTpAKpy",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1004375641171603458,2020-09-29 09:00:10,,"COVID19, Wilmington, ChooseDelaware, NetDE, ","hubs.ly/H0w_zjV0, pic.twitter.com/v2aJCtIAAe, ",1310927348615778305,False,0,0,0,0,HubSpot,"A #COVID19 treatment developed by #Wilmington-based @Incyte and @LillyPad resulted in a one-day reduction in median recovery time in a 1,000-person trial sponsored by @NIH. 
https://t.co/bAUH6YuNQk 
#ChooseDelaware #NetDE https://t.co/v2aJCtIAAe","Incyte, LillyPad, NIH, ",,2018-06-06 10:53:08,,Delaware Prosperity Partnership @choosedelaware,https://pbs.twimg.com/profile_images/1059872509540134913/PX_tVV7O_normal.jpg,4337,1030,21,2792,choosedelaware,photo
959038667514957824,2020-09-29 08:47:04,,"MSI, Assay, ","bit.ly/3cFx5w9, pic.twitter.com/A55IHUCZyg, ",1310924051918073857,False,1,0,0,1,Khoros Publishing,"Promega and @Incyte intend to work together in the future to develop the Promega OncoMate #MSI #Assay as a companion diagnostic. 

More at: https://t.co/MLS7676zCG https://t.co/A55IHUCZyg","Incyte, ",,2018-02-01 07:20:11,"Southampton, England",PromegaUK,https://pbs.twimg.com/profile_images/969530103582642176/kRB3a1oV_normal.jpg,1929,3331,5,7232,promegauk,photo
127708877,2020-09-29 08:00:01,,"automation, ",,1310912209829199872,False,3,1,0,1,Twitter for Advertisers.,The golden keyüóù to unlock #automation at scale comes from citizen developers. Hear from @Incyte and @Cognizant crucial tactics to launch a citizen development program and key components for long-term scalability.,"Incyte, Cognizant, ",,2010-03-29 21:11:04,"New York, USA",UiPath,https://pbs.twimg.com/profile_images/1258045723720835073/GRJvut46_normal.jpg,92445,5305,468,8864,UiPath,
2298709746,2020-09-29 04:02:03,"INCY, ",,"zpr.io/Hm3D7, ",1310852326069022720,False,0,0,0,0,Zapier.com,Analysts Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $623.26 Million https://t.co/VDvLNLn9ZN,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
732361939490312192,2020-09-29 04:01:26,"INCY, ","markets, ","americanbankingnews.com/?p=16398965, ",1310852169004920833,False,0,0,0,0,Zapier.com,Analysts Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $623.26 Million https://t.co/FIkpKirTKN #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-09-29 04:01:25,"INCY, ","stocks, ","americanbankingnews.com/?p=16398965, ",1310852166752628736,False,0,0,0,0,Zapier.com,Analysts Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $623.26 Million https://t.co/yxlLSUgQmu #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2416188264,2020-09-28 21:27:15,"INCY, ","markets, ","thestockobserver.com/?p=3518573, ",1310752970468974594,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $101.63 Consensus Price Target from Brokerages  https://t.co/Xvgq0J5Rvg #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1280938376099741697,2020-09-28 20:30:24,,,"iexcloud.io, pic.twitter.com/BTf0OB6xKg, ",1310738663060516867,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Microchip Technology, Inc.
-National Bank of Umm Al-Qaiwain PSC
-Sharjah Insurance Co.
-KLA Corp.
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/BTf0OB6xKg",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
975337043944407040,2020-09-28 18:59:46,"INCY, ","Incyte, INCY, ","finscreener.com/tittech/techni‚Ä¶, ",1310715855123156996,False,0,0,0,0,StockTwits Web,"Technical analysis of #Incyte #INCY $INCY 
https://t.co/49okr63VA7",,,2018-03-18 07:44:06,,Finscreener,https://pbs.twimg.com/profile_images/976083323347984384/71mUunXo_normal.jpg,652,202,12,15317,Finscreener_com,
28815461,2020-09-28 11:03:59,,"clinicaltrials, ","bit.ly/3jn8caU, pic.twitter.com/CcaCF6nvoo, ",1310596120079470598,False,2,0,0,1,Twitter Web App,"Don't forget to register for our @PharmExec webinar tomorrow where @Incyte, @IQVIA_global, @CSLBehring, and @Parexel will discuss COVID-19's impact on the digital transformation of #clinicaltrials. https://t.co/qL2ju5uDzK https://t.co/CcaCF6nvoo","PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2009-04-04 11:50:45,"Austin, TX",Oracle Health Sciences,https://pbs.twimg.com/profile_images/1171816913523159045/a75gOGmX_normal.jpg,6391,1171,285,8128,OracleHealthSci,photo
374729426,2020-09-28 08:53:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2148528, pic.twitter.com/5b7GxIFuN6, ",1310563402129969153,False,0,0,0,0,Tickeron,"$INCY in -2.14% Downtrend, sliding for three consecutive days on September 24, 2020. View odds for this and other indicators: https://t.co/YDvDuQzZiT #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5b7GxIFuN6",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1280938376099741697,2020-09-27 17:34:20,,,"iexcloud.io, pic.twitter.com/SOzgQzaPxO, ",1310331968442322944,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-O'Reilly Automotive, Inc.
-Cadence Design Systems, Inc.
-Expedia Group, Inc.
-Incyte Corp.
-Exelon Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/SOzgQzaPxO",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
35203319,2020-09-27 10:15:07,,"citizen, RPA, government, FEDGOV, tech, ","bit.ly/2YvumA0, pic.twitter.com/7YlvVftO2P, ",1310221433449205763,False,0,0,0,0,Buffer,"Citizen Development: Giving Power to the People - Join @UiPath on October 8, 11am EDT / 4pm BST for a webinar with Incyte and Cognizant to learn about best practices for launching a successful #citizen development program.
https://t.co/lxsfqJ3FaX
#RPA #government #FEDGOV #tech https://t.co/7YlvVftO2P","UiPath, ",,2009-04-25 08:45:16,#RemoteWork #Boston ,Evan Kirstel #B2B #TechFluencer,https://pbs.twimg.com/profile_images/1446099070326648832/SO9nsmVy_normal.jpg,309523,279365,13104,1055182,EvanKirstel,photo
374729426,2020-09-27 08:05:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2145012, pic.twitter.com/zRBltLMcNN, ",1310188904859852800,False,0,0,0,0,Tickeron,"$INCY in -2.14% Downtrend, sliding for three consecutive days on September 24, 2020. View odds for this and other indicators: https://t.co/w9hW6ihCqS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/zRBltLMcNN",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-09-27 07:28:07,"INCY, ","markets, ","americanbankingnews.com/?p=16376684, ",1310179409433894912,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.73 Per Share https://t.co/A77RIGiGhR #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-09-27 07:28:07,"INCY, ","stocks, ","americanbankingnews.com/?p=16376684, ",1310179407420682240,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.73 Per Share https://t.co/t9q5LY7eyM #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
68559732,2020-09-27 07:28:00,"INCY, ",,"zpr.io/HmqSF, ",1310179378391912449,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.73 Per Share https://t.co/beKRDm4sXN,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1022006086872821762,2020-09-27 05:00:49,"INCY, INCY, ",,,1310142340397445122,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was UP ‚¨Ü on Fri Sep 25
Closed at 86.55 USD for a 1.74% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
2181281054,2020-09-26 14:40:30,"INCY, ","markets, ","wkrb13.com/?p=2216575, ",1309925833314885633,False,0,0,0,0,Zapier.com,Analysts Set Incyte Co. $INCY Target Price at $101.63 https://t.co/LZG6iF6LSZ #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
2445528445,2020-09-26 14:00:49,,"EndometrialCancer, ","ow.ly/TWq850BBRbq, pic.twitter.com/q3gy31SUvY, ",1309915846668673025,False,0,0,0,0,Hootsuite Inc.,.@promega Inks CDx Agreement with .@Incyte for #EndometrialCancer Drug Candidate. Learn more: https://t.co/atoqIYzfiL https://t.co/q3gy31SUvY,"promega, Incyte, ",,2014-04-15 10:23:41,"New Rochelle, NY",Clinical OMICs,https://pbs.twimg.com/profile_images/1072611724614926336/AumbGNxC_normal.jpg,2836,1407,98,10977,ClinicalOMICs,photo
28806585,2020-09-26 11:43:12,,"gcam, ","pic.twitter.com/cC8c5pyH7s, ",1309881212631216131,False,6,0,0,0,Twitter for iPhone,A great way to launch this important immunotherapy trial in endometrial cancer. Accepted for presentation as Trials in Progress @sitcancer @GOG @BrowardHealth @rcoledude @Incyte #gcam @SGO_org @copebuckeye https://t.co/cC8c5pyH7s,"sitcancer, GOG, BrowardHealth, rcoledude, Incyte, SGO_org, copebuckeye, ",,2009-04-04 10:58:27,"Miami Beach, FL","Brian Slomovitz, MD, MS, FACOG",https://pbs.twimg.com/profile_images/1414289842788253697/nV7RVkgW_normal.jpg,1346,1113,18,598,GynCancerMD,photo
374729426,2020-09-26 09:26:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2141570, pic.twitter.com/AXQAi3xKWo, ",1309846724370812929,False,0,0,0,0,Tickeron,"$INCY in -2.14% Downtrend, sliding for three consecutive days on September 24, 2020. View odds for this and other indicators: https://t.co/taLDjpmAqh #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/AXQAi3xKWo",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
950010035396136962,2020-09-25 17:03:46,,"Incyte, ","zonebourse.com/INCYTE-CORPORA‚Ä¶, ",1309599498784649216,False,0,0,0,0,Cresus AI,"#Incyte closed at 86.55. Score +118, credit rating AA https://t.co/XMro31aTzT",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
23059499,2020-09-25 13:49:57,"INCY, ","finance, trading, stockmarket, ","seekingalpha.com/article/437636‚Ä¶, ",1309550724024471554,False,1,0,0,1,SAArticlesTwitter,$INCY - Incyte (INCY) Presents at ESMO Virtual Congress - Slideshow. https://t.co/8mY3sveQJJ #finance #trading #stockmarket,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
31720614,2020-09-25 13:39:02,,"news, pharma, p, ","zpr.io/HM4YT, ",1309547978043031552,False,0,0,0,0,Zapier.com,"Global Myeloproliferative Disorders Drugs Market Future Trends Analysis, Industry Growth, Status, Trends, Revenue, Top Companies:-Incyte, Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc, Incyte, Takeda Pharmaceuticals Company Limited
https://t.co/IjRv12f0pv
#news #pharma #p",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,
108617488,2020-09-25 13:30:03,,,"invst.ly/s9c8n, ",1309545715446800389,False,0,0,0,0,FP News Publisher - COM,Credit Suisse Stick to Their Hold Rating for Incyte Corp - https://t.co/TgEt7ERqmK,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
35203319,2020-09-25 11:40:04,,"citizen, RPA, government, FEDGOV, ","bit.ly/2YvumA0, pic.twitter.com/wVdDeo3G7U, ",1309518037314400256,False,0,0,0,0,Buffer,"Citizen Development: Giving Power to the People - Join @UiPath on October 8, 11am EDT / 4pm BST for a webinar with Incyte and Cognizant to learn about best practices for launching a successful #citizen development program.
https://t.co/lxsfqJ3FaX
#RPA #government #FEDGOV https://t.co/wVdDeo3G7U","UiPath, ",,2009-04-25 08:45:16,#RemoteWork #Boston ,Evan Kirstel #B2B #TechFluencer,https://pbs.twimg.com/profile_images/1446099070326648832/SO9nsmVy_normal.jpg,309523,279365,13104,1055182,EvanKirstel,photo
1290396465949548546,2020-09-25 11:16:08,,"ClinicalTrials, ","bit.ly/3cA8qsL, pic.twitter.com/7qRa9xR6en, ",1309512013060603910,False,1,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/IYoFilQfod https://t.co/7qRa9xR6en","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2020-08-03 17:18:02,Mexico,Carmen Nava,https://pbs.twimg.com/profile_images/1290396780580962304/D8D-Neq1_normal.jpg,2,2,0,88,OracleNava,photo
374729426,2020-09-25 09:14:42,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2137986, pic.twitter.com/mqWvz1Xgey, ",1309481454682820609,False,0,0,0,1,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/LCFYF6CM2q #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/mqWvz1Xgey,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
959038667514957824,2020-09-25 08:11:12,,"MSI, LynchSyndrome, Assay, ","bit.ly/2S0DwQZ, pic.twitter.com/JS3WSoYZdJ, ",1309465475991179270,False,2,0,0,1,Khoros Publishing,"#MSI-high is a key feature of #LynchSyndrome tumours, but can arise sporadically in cancers. The Promega OncoMate‚Ñ¢ MSI #Assay is planned to be developed as a companion diagnostic test for retifanlimab, @Incyte‚Äôs anti-PD-1 drug candidate. 

More at: https://t.co/Hv15T5WLGt https://t.co/JS3WSoYZdJ","Incyte, ",,2018-02-01 07:20:11,"Southampton, England",PromegaUK,https://pbs.twimg.com/profile_images/969530103582642176/kRB3a1oV_normal.jpg,1929,3331,5,7232,promegauk,photo
586116334,2020-09-25 01:07:42,"INCY, ELY, GULTU, GEATF, UURAF, PUFXF, NVLN, RVLT, RVSB, METpA, MPV, GBOOF, PKBK, ",,"askwarrenhq.blogspot.com/p/breaking-new‚Ä¶, ",1309358898730553344,False,0,0,0,0,Twitter Web App,"Incyte Corp $INCY to release detailed information on new JV with Eli Lilly $ELY
https://t.co/Mv3xmUJu9A

$GULTU $GEATF $UURAF $PUFXF $NVLN $RVLT $RVSB $METpA $MPV $GBOOF $PKBK",,,2012-05-20 20:39:27,Read disclaimer at:,Ask Warren HQ,https://pbs.twimg.com/profile_images/1140029514187067392/Pnk0p5mL_normal.png,35639,24,149,92686,askwarrenbuffet,
966006214818697218,2020-09-24 13:01:21,"INCY, ",,"theenterpriseleader.com/?p=3856336, ",1309176104725483521,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $101.63 Average Price Target from Analysts  https://t.co/99nw0zecCS,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
852931863547084801,2020-09-24 12:27:38,"INCY, ",,"zpr.io/HMKeP, ",1309167619958804486,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $101.63 Average Price Target from Analysts https://t.co/pN3oDxi8HP,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
976887386939510785,2020-09-24 11:39:09,,,,1309155419659665409,False,0,0,0,0,Twitter Web App,"Thank you exhibitors for your support of the 32nd Annual Fall Foliage Cancer Conference Oct 23-24, 2020 @ExelixisInc  @AstraZenecaUS @MyriadOncology @SanofiGenzyme @GenesisCare @TakedaOncology @Merck @Provistaco @genentech @Incyte","ExelixisInc, AstraZenecaUS, MyriadOncology, SanofiGenzyme, GenesisCare, TakedaOncology, Merck, Provistaco, genentech, Incyte, ",,2018-03-22 14:24:37,,Annual Fall Foliage Cancer Conference,https://pbs.twimg.com/profile_images/976890065535168512/_aC05x9p_normal.jpg,8,92,0,30,fallfoliagecc,
3911174913,2020-09-24 11:00:01,,,,1309145571232342018,False,61,0,0,18,Twitter for Advertisers.,"At Incyte, we Solve On. In our work, there's no finish line.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
374729426,2020-09-24 09:30:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2134449, pic.twitter.com/JDNKhHN3FQ, ",1309123045752295432,False,0,0,0,0,Tickeron,"$INCY in -5.56% Downtrend, falling for three consecutive days on September 21, 2020. View odds for this and other indicators: https://t.co/FN2zqOgwuI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/JDNKhHN3FQ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
38146434,2020-09-23 13:27:35,,"endometrial, gyncsm, ",,1308820319042285568,False,2,0,0,0,Twitter Web App,"Promega to develop MSI-H Cdx (OncoMate MSI) for retifanlimab, Incyte‚Äôs anti-PD-1, in #endometrial cancer #gyncsm

‚ñ™Ô∏è PCR based test with CE mark in EU. Soon to seek regulatory clearance in US and China",,,2009-05-06 05:28:47,India,Anand Prabu,https://pbs.twimg.com/profile_images/1069396209410826240/HZxUP3fn_normal.jpg,175,555,4,2056,anandprabu,
959038667514957824,2020-09-23 11:52:04,,"Assay, ","bit.ly/361fOfG, pic.twitter.com/YhcH7ww1jj, ",1308796283029786625,False,1,0,0,2,Khoros Publishing,"Promega has just announced its intention to develop the Promega OncoMate‚Ñ¢ microsatellite instability (MSI) #Assay as a companion diagnostic test for retifanlimab, @Incyte‚Äôs anti-PD-1 drug candidate, in endometrial cancer. 

More at: https://t.co/AzoqmyE4vY https://t.co/YhcH7ww1jj","Incyte, ",,2018-02-01 07:20:11,"Southampton, England",PromegaUK,https://pbs.twimg.com/profile_images/969530103582642176/kRB3a1oV_normal.jpg,1929,3331,5,7232,promegauk,photo
412192084,2020-09-23 10:24:22,,"retifanlimab, drug, EndometrialCancer, MSI, OncoMate, ","ow.ly/RRuk50Bz1mT, pic.twitter.com/A0GPsfjeuJ, ",1308774213088620546,False,0,0,0,0,Hootsuite Inc.,"üì≤ Promega Developing OncoMate‚Ñ¢ MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate from Incyte
üìå@promega_es 
üëâüèª https://t.co/ohIzoTvGnS
#retifanlimab #drug #EndometrialCancer #MSI #OncoMate https://t.co/A0GPsfjeuJ","promega_es, ",,2011-11-14 06:19:29,"Barcelona, Espa√±a",Professional Newco,https://pbs.twimg.com/profile_images/1080809777901551616/h2bOh6mI_normal.jpg,331,690,29,48620,ProfessionalNe,photo
2445298345,2020-09-23 10:04:47,,"retifanlimab, drug, EndometrialCancer, MSI, OncoMate, ","ow.ly/RRuk50Bz1mT, pic.twitter.com/jxE4uivAWK, ",1308769284034789378,False,0,0,0,0,Hootsuite Inc.,"üì≤ Promega Developing OncoMate‚Ñ¢ MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate from Incyte
üìå@promega_es 
üëâüèª https://t.co/5qZHzIJjP2
#retifanlimab #drug #EndometrialCancer #MSI #OncoMate https://t.co/jxE4uivAWK","promega_es, ",,2014-04-15 07:11:00,Barcelona,Biotech-Spain.com,https://pbs.twimg.com/profile_images/1148244795082575872/I1SlBUHl_normal.png,3893,3666,96,22229,Biotech_Spain,photo
374729426,2020-09-23 09:12:13,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2130903, pic.twitter.com/dt1G2WMqmb, ",1308756054562332672,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/HcvJj3RHDN #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/dt1G2WMqmb,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
761550144869437440,2020-09-23 09:02:02,,,"ter.li/cd289z, pic.twitter.com/HcPxFR6l6o, ",1308753491813335041,False,0,0,0,0,Hootsuite Inc.,"Oncolytics Biotech announced the first patient has been dosed in the multi-centre, phase 2 IRENE study of pelareorep in combination with Incyte's anti-PD-1 checkpoint inhibitor retifanlimab in unresectable...

Find out how we're tracking Checkpoint trials: https://t.co/mm8UcuNb70 https://t.co/HcPxFR6l6o",,,2016-08-05 09:11:18,"London, England",Beacon Targeted Therapies,https://pbs.twimg.com/profile_images/910893558541975552/Ze_8N4v9_normal.jpg,449,1418,6,1677,BeaconIntel,photo
1889492676,2020-09-23 07:14:59,,"Promega, OncoMate, MSIAssay, CompanionDiagnostic, EndometrialCancer, Incyte, ","1stoncology.com/blog/promega-d‚Ä¶, ",1308726550305492993,False,0,0,0,0,Troi URL Plug-in,"#Promega Developing #OncoMate‚Ñ¢ #MSIAssay as #CompanionDiagnostic for #EndometrialCancer Drug Candidate from #Incyte https://t.co/jI8YWsboS7",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
2570920968,2020-09-22 18:03:55,,,"twitter.com/Incyte/status/‚Ä¶, ",1308527472732930050,False,0,0,0,0,Twitter for iPad,Excellent! Congrats @MassGeneralNews @Incyte https://t.co/rhkPUoS7Ij,"MassGeneralNews, Incyte, ",,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
950010035396136962,2020-09-22 17:03:54,,"Incyte, ","zonebourse.com/INCYTE-CORPORA‚Ä¶, ",1308512368129970178,False,0,0,0,0,Cresus AI,"#Incyte closed at 86.93. Score +115, credit rating AA https://t.co/XMro31aTzT",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
2445528445,2020-09-22 17:00:50,,"EndometrialCancer, ","ow.ly/F5JY50ByjGX, pic.twitter.com/3GZA86rycE, ",1308511596579348480,False,2,0,0,1,Hootsuite Inc.,.@promega Inks CDx Agreement with .@Incyte for #EndometrialCancer Drug Candidate. Learn more: https://t.co/Ct3MUR0SLI https://t.co/3GZA86rycE,"promega, Incyte, ",,2014-04-15 10:23:41,"New Rochelle, NY",Clinical OMICs,https://pbs.twimg.com/profile_images/1072611724614926336/AumbGNxC_normal.jpg,2836,1407,98,10977,ClinicalOMICs,photo
28294124,2020-09-22 16:03:57,,"incyte, bladdercancer, cancerGRACE, cancertreatment, oncology, cancer, ","cancergrace.org/post/bladder-c‚Ä¶, pic.twitter.com/g5ItHH92J7, ",1308497282786979840,False,1,0,0,0,Twitter Web App,"In this new video, Drs. Sedhom and Grivas discuss muscle invasive bladder cancer.

https://t.co/mHd2N5s7js

#incyte #bladdercancer #cancerGRACE #cancertreatment #oncology #cancer https://t.co/g5ItHH92J7",,,2009-04-02 02:23:31,"Based in Seattle, WA",GRACE,https://pbs.twimg.com/profile_images/1171570877231587328/1nxukHJD_normal.jpg,2068,374,121,4944,cancerGRACE,photo
1702834627,2020-09-22 15:37:08,,"covid19, ","healthbiz.substack.com, ",1308490535435407362,False,0,0,0,0,Twitter Web App,"Christine Lennon of Incyte on launching a multinational pharmaceutical company unit during #covid19 ‚Äî in today‚Äôs edition of NPC Healthbiz Weekly.
No alt text provided for this image
Building a life sci business during Covid-19
https://t.co/rnwYRMX7ki ‚Ä¢ 2 min read",,,2013-08-26 15:59:51,"Toronto, Ontario",Healthcare Marketing,https://pbs.twimg.com/profile_images/1259942911501897728/3rDgm6M6_normal.jpg,450,551,20,582,hcmchronicle,
1172297575,2020-09-22 15:03:15,,"ClinicalTrials, ","bit.ly/32SSLBL, pic.twitter.com/BOpiZlWzK0, ",1308482007849033728,False,0,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/esg9GG4Pz8 https://t.co/BOpiZlWzK0","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2013-02-12 10:25:07,,AnnieC,https://pbs.twimg.com/profile_images/483263728775745536/BNIOMvl__normal.jpeg,29,181,0,1082,Love_RSA,photo
18026170,2020-09-22 13:30:00,,"OncoMate, MicrosatelliteInstability, CompanionDiagnostic, retifanlimab, immunotherapy, EndometrialCancer, immunooncology, diagnostics, CDx, ","promega.com/products/micro‚Ä¶, pic.twitter.com/JinB9HiaOS, ",1308458538562281473,False,1,0,0,0,TweetDeck,".@Incyte taps @promega to develop #OncoMate #MicrosatelliteInstability assay as #CompanionDiagnostic for #retifanlimab

Anti-PD-1 #immunotherapy is being developed vs #EndometrialCancer. Financial terms not disclosed

https://t.co/igTqJuSzKl
#immunooncology #diagnostics #CDx https://t.co/JinB9HiaOS","Incyte, promega, ",,2008-12-10 13:29:19,"Midland, ON",DDNews Online,https://pbs.twimg.com/profile_images/1286709262287278080/SHRMveT5_normal.jpg,3372,439,86,13763,DDNewsOnline,photo
28815461,2020-09-22 11:31:48,,"clinicaltrial, ","ora.cl/Qp3u2, pic.twitter.com/MJwi7dUm5E, ",1308428792898166790,False,5,0,0,4,Twitter Web App,"How has COVID-19 transformed the #clinicaltrial landscape and helped to re-imagine clinical studies? 

Tune into our September 29 @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/NWxmmnpxru https://t.co/MJwi7dUm5E","PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2009-04-04 11:50:45,"Austin, TX",Oracle Health Sciences,https://pbs.twimg.com/profile_images/1171816913523159045/a75gOGmX_normal.jpg,6391,1171,285,8128,OracleHealthSci,photo
1290396465949548546,2020-09-22 11:16:02,,"ClinicalTrials, ","bit.ly/2ZZiGpD, pic.twitter.com/Ykow6xTKAk, ",1308424824448933888,False,0,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/TeeV3XXE9R https://t.co/Ykow6xTKAk","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2020-08-03 17:18:02,Mexico,Carmen Nava,https://pbs.twimg.com/profile_images/1290396780580962304/D8D-Neq1_normal.jpg,2,2,0,88,OracleNava,photo
374729426,2020-09-22 10:07:19,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2127382, pic.twitter.com/Z52eYlldqW, ",1308407533212782594,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/iFz5WEGZNh #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Z52eYlldqW,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
325678041,2020-09-22 09:50:45,,,"360dx.com/pcr/promega-de‚Ä¶, ",1308403364431093761,False,0,0,0,0,Twitter Web App,Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug https://t.co/VklgMyUYcq,,,2011-06-28 13:54:43,,360Dx,https://pbs.twimg.com/profile_images/779386999325224960/0OtQrBR2_normal.jpg,1234,711,30,12885,360DxNews,
840583400,2020-09-22 06:38:22,,,"twitter.com/Walu_Mwasi/sta‚Ä¶, ",1308354948757884928,False,1,0,1,1,Twitter for Android,"Off the top, in no particular order
Third
Kananji
Incyte
Hyphen
D1
David
Marvel
Daredevilz
Engola https://t.co/zkkVF76Hra",,,2012-09-22 18:54:51,Jaffu's Dungeon,Mr. Mayhem ‚ò†Ô∏è,https://pbs.twimg.com/profile_images/1444320243938119684/nphx-Bm7_normal.jpg,827,773,3,33614,ElChubbinho,
1889492676,2020-09-22 05:15:39,"MGNX, ","MacroGenics, Retifanlimab, MGA012, Incyte, ","1stoncology.com/blog/macrogeni‚Ä¶, ",1308334134402506753,False,0,0,0,1,Troi URL Plug-in,#MacroGenics Announces Development Milestone Achieved in #Retifanlimab (#MGA012) Collaboration with #Incyte $MGNX https://t.co/A00aLkGe39,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
631661989,2020-09-22 04:00:05,,"COVID19, Delaware, ChooseDelaware, globalde, ","hubs.ly/H0wwTM20, pic.twitter.com/rVz4SDEO4o, ",1308315117440950278,False,1,0,0,0,HubSpot,"A #COVID19 treatment developed by #Delaware-based @Incyte and @LillyPad resulted in a one-day reduction in median recovery time in a 1,000-person trial sponsored by @NIH. 
https://t.co/g5k0nDLC0D 
#ChooseDelaware #globalde https://t.co/rVz4SDEO4o","Incyte, LillyPad, NIH, ",,2012-07-09 23:54:36,"Wilmington, Delaware",Global Delaware,https://pbs.twimg.com/profile_images/1059868013459992577/IjSZsC14_normal.jpg,5389,1817,222,6107,DelawareGlobal,photo
1022006086872821762,2020-09-22 03:03:51,"INCY, INCY, ",,,1308300965120933888,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Mon Sep 21
Closed at 85.39 USD for a -1.61% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
1280938376099741697,2020-09-22 00:58:13,,,"iexcloud.io, pic.twitter.com/qCyksK8Gef, ",1308269346779787264,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Emirates Insurance Co. PSC
-Sharjah Insurance Co.
-Incyte Corp.
-Invest Bank
-Methaq Takaful Insurance Co.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/qCyksK8Gef",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1134049078424162304,2020-09-22 00:30:02,"MGNX, ",,"newsfilter.io/articles/macro‚Ä¶, ",1308262256359223296,False,0,0,0,0,Newsfilter.io,MacroGenics announces development milestone achieved in retifanlimab collaboration with Incyte $MGNX https://t.co/c7CuRFa6D9,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
28294124,2020-09-21 19:26:06,,"cancer, health, healthcare, oncology, bladdercancer, incyte, elderly, cancerGRACE, ","cancergrace.org/post/bladder-c‚Ä¶, pic.twitter.com/zPEAN0M7GK, ",1308185767055818753,False,0,0,0,0,Twitter Web App,"In the second part of this two part conversation, Drs. Sedhom and Kessler continue the discussion on muscle invasive bladder cancer in the elderly. 

https://t.co/9JhpLvaOis

#cancer #health #healthcare #oncology #bladdercancer

#incyte #elderly #cancerGRACE https://t.co/zPEAN0M7GK",,,2009-04-02 02:23:31,"Based in Seattle, WA",GRACE,https://pbs.twimg.com/profile_images/1171570877231587328/1nxukHJD_normal.jpg,2068,374,121,4944,cancerGRACE,photo
1208381581758488577,2020-09-21 18:09:31,"MGNX, ",,,1308166493146882051,False,0,0,1,1,Twitter for iPhone,"Odd movements in $MGNX given a milestone was met today. $15mm doesn‚Äôt make or break...but -12% on + news seems odd.

‚ÄúMacroGenics (MGNX) said Monday it achieved a milestone payment of $15 million under its collaboration and license agreement with Incyte (INCY) for retifanlimab.‚Äù",,,2019-12-21 08:40:03,,BeachBumCapital,https://pbs.twimg.com/profile_images/1412941164089679872/4XK4Sm32_normal.jpg,925,2822,20,3172,beachbumcapital,
28294124,2020-09-21 17:41:07,,"bladdercancer, cancerGRACE, incyte, elderlypatients, ","cancergrace.org/post/bladder-c‚Ä¶, pic.twitter.com/RdgphspkyT, ",1308159345306161153,False,0,0,0,0,Twitter Web App,"Drs. Sedhom and Kessler discuss muscle invasive bladder cancer in the elderly.
https://t.co/36APfV8qhK

#bladdercancer #cancerGRACE #incyte #elderlypatients https://t.co/RdgphspkyT",,,2009-04-02 02:23:31,"Based in Seattle, WA",GRACE,https://pbs.twimg.com/profile_images/1171570877231587328/1nxukHJD_normal.jpg,2068,374,121,4944,cancerGRACE,photo
19651092,2020-09-21 14:30:12,,,"bit.ly/2ZWTBM2, ",1308111301768548355,False,0,0,0,0,Blog2Social APP,"Eli Lilly and Company¬†LLY and partner Incyte INCY announced that the Committee for Medicinal Products for Human Use (""CHMP"") of the European Medicines Agency has adopted a positive opinion recommending approval of Olumiant (baricitinib) for https://t.co/b73apbsfvd",,,2009-01-28 08:26:49,"Chicago, IL",MrTopStep,https://pbs.twimg.com/profile_images/378800000264951777/fdcb2fffc58110f966d01c65c5daf7df_normal.png,27001,442,1191,247002,MrTopStep,
2800569714,2020-09-21 12:09:25,,"ClinicalTrials, ","bit.ly/3cuDBG9, pic.twitter.com/bfyNvEw0jJ, ",1308075870960058370,False,1,0,0,1,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/fMd9hMNiqB https://t.co/bfyNvEw0jJ","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2014-09-09 17:41:33,,Scott Tiazkun,https://pbs.twimg.com/profile_images/509459403045490688/7x6_u4bg_normal.png,61,22,0,37,scotttiazkun,photo
15586175,2020-09-21 10:36:10,,"ClinicalTrials, ","bit.ly/32Np1pF, pic.twitter.com/VNyer8uZeP, ",1308052404877754369,False,2,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/wQw9bMsSDo https://t.co/VNyer8uZeP","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2008-07-24 14:18:01,S√£o Paulo,Diogo BRUNACCI üÖ∞Ô∏è+,https://pbs.twimg.com/profile_images/1288218093441908744/nmAzHpdx_normal.jpg,383,2918,4,5306,diogobrunacci,photo
4058194633,2020-09-21 10:22:22,"MGNX, INCY, ",,"globenewswire.com/news-release/2‚Ä¶, ",1308048931402649610,False,0,0,0,0,Twitter for iPhone,$MGNX $INCY MacroGenics Announces Development Milestone Achieved in Retifanlimab (MGA012) Collaboration with Incyte https://t.co/abWlDSG9qo,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
3686628867,2020-09-21 09:55:20,,,"pharmaceuticaldaily.com/macrogenics-an‚Ä¶, ",1308042129713901570,False,0,0,0,0,WordPress.com,MacroGenics Announces Development Milestone Achieved in Retifanlimab (MGA012) Collaboration with¬†Incyte https://t.co/Z0ovINeZHA,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
72928001,2020-09-21 09:35:13,"MGNX, ",,"bit.ly/3mEsDSX, ",1308037066807078913,False,0,0,0,0,BriefingInPlayLimited,$MGNX: MacroGenics Announces development milestone achieved in Retifanlimab (MGA012) collaboration with Incyte https://t.co/dnKIMcIpoW,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
374729426,2020-09-21 09:01:01,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2123910, pic.twitter.com/ECBuHVSuaY, ",1308028458333659136,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/7IEyT1w9eU #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ECBuHVSuaY,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
33371707,2020-09-21 08:00:15,"MGNX, ","NASDAQ, ","globenewswire.com/news-release/2‚Ä¶, ",1308013166941466625,False,0,0,0,0,xool,"$MGNX #NASDAQ News: MacroGenics Announces Development Milestone Achieved in Retifanlimab (MGA012) Collaboration with Incyte [B/A=0/0 - Bid/Ask Size=0/0  Volume=1,983,439  AverageVol=558,664  Outstanding=0] https://t.co/TPxwu8dEa1",,,2009-04-19 21:38:45,,tweeter no more. jack dorsey is a nazi,https://pbs.twimg.com/profile_images/1288570978516127744/0O_9eGqP_normal.jpg,497,633,11,84299,bbiittccooiinn,
106823467,2020-09-21 07:59:55,"MGNX, INCY, ","MacroGenics, Incyte, NSCLC, ","crweworld.com/symbol/MGNX, ",1308013081625161728,False,0,0,0,0,Twitter Web App,$MGNX Earns $15M milestone payment triggered by initiation of late-stage clinical trial in NSCLC by $INCY     #MacroGenics      #Incyte        #NSCLC     https://t.co/I2UCpLYcry,,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
3063963289,2020-09-21 07:58:17,,,"seekingalpha.com/news/3615619-m‚Ä¶, ",1308012672932347906,False,0,0,0,0,Circleboom Twitter Management,‚ñ∂Ô∏é MacroGenics announces development milestone achieved in retifanlimab collaboration with Incyte https://t.co/kBsyDGikdt VIŒõ WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö FINŒõNCIŒõL REŒõDS,,,2015-03-05 22:29:44,United States,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,https://pbs.twimg.com/profile_images/1131561059075145728/T_Tj4P-S_normal.jpg,2718,210,0,36814,WickedSplits,
15296897,2020-09-21 07:52:27,"MGNX, ",,"seekingalpha.com/news/3615619-m‚Ä¶, ",1308011203382243335,False,0,0,0,0,SANewsTwitter,$MGNX - MacroGenics announces development milestone achieved in retifanlimab collaboration with Incyte https://t.co/f6ixpeUQnE,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1148421960948281345,2020-09-21 07:50:49,,,"news.freeptomaineradio.com/?p=48892, ",1308010794995658755,False,0,0,0,0,ArthurPotatoeHammer,"https://t.co/2SHTFSyoGt
MacroGenics Announces Development Milestone Achieved in Retifanlimab (MGA012) Collaboration with Incyte
NEWS.FREEPTOMAINERADIO.COMROCKVILLE, MD, Sept. 21, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical co...",,,2019-07-08 22:41:46,United States,ArthurPotatoeHammer,https://pbs.twimg.com/profile_images/1184265779983847425/STYm7fen_normal.jpg,1205,1158,5,129965,KingNormies,
3318510966,2020-09-21 07:35:05,,,"crweworld.com/article/news-p‚Ä¶, ",1308006833638928384,False,0,0,0,0,CRWE World,MacroGenics Announces Development Milestone Achieved in Retifanlimab (MGA012) Collaboration with Incyte https://t.co/x6M6PI3Ilx,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1134049078424162304,2020-09-21 07:33:55,"MGNX, ",,"newsfilter.io/articles/macro‚Ä¶, ",1308006539316400128,False,0,0,0,0,Newsfilter.io,MacroGenics Announces Development Milestone Achieved in Retifanlimab Collaboration with Incyte $MGNX https://t.co/94DJd3eNuH,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1254035253104181256,2020-09-21 07:31:19,"MGNX, ",,"stocktitan.net/news/MGNX/macr‚Ä¶, ",1308005884434550785,False,0,0,0,0,stocktitan,"$MGNX MacroGenics Announces Development Milestone Achieved in Retifanlimab (MGA012) Collaboration with Incyte
https://t.co/6WTuNsgdFo",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
732361939490312192,2020-09-21 04:21:11,"INCY, ","markets, ","americanbankingnews.com/?p=16296818, ",1307958038511452165,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Analysts https://t.co/7XBaOy3Hw0 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-09-21 04:21:11,"INCY, ","stocks, ","americanbankingnews.com/?p=16296818, ",1307958036208717824,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Analysts https://t.co/cnBdmrSBIa #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
68559732,2020-09-21 04:20:21,"INCY, ",,"zpr.io/HxcDJ, ",1307957827332460545,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Brokerages https://t.co/FNdMyKik7c,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2525892205,2020-09-21 04:18:49,"INCY, ","investingnews, ","modernreaders.com/?p=3973531, ",1307957442777690112,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Analysts  https://t.co/CPq3L5P9qi #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
930803511918411776,2020-09-21 04:18:48,"INCY, ",,"thelincolnianonline.com/?p=4713640, ",1307957437874536448,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Analysts https://t.co/Y322pWps6g,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1280938376099741697,2020-09-20 13:00:07,,,"iexcloud.io, pic.twitter.com/I21N9VVieF, ",1307726242465054721,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-PepsiCo, Inc.
-First Abu Dhabi Bank PJSC
-Incyte Corp.
-ASML Holding NV
-Xilinx, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/I21N9VVieF",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2020-09-20 08:56:41,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2120536, pic.twitter.com/BeT3NekfiS, ",1307664983300345857,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/02inrLh0NY #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BeT3NekfiS,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1889492676,2020-09-20 03:59:33,"INCY, ","Incyte, Retifanlimab, INCMGA0012, SquamousCellCarcinoma, AnalCanal, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1307590205684109312,False,0,0,0,1,Troi URL Plug-in,"#Incyte Announces Encouraging Results From Phase 2 Trial of #Retifanlimab (#INCMGA0012) in Patients With Previously Treated, Advanced #SquamousCellCarcinoma of the #AnalCanal $INCY https://t.co/wgE2OYjO0N",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2020-09-20 03:45:24,"INCY, ","Incyte, MorphoSys, Tafasitamab, NonHodgkinLymphomas, ","1stoncology.com/blog/incytemor‚Ä¶, ",1307586643944120320,False,0,0,0,1,Troi URL Plug-in,#Incyte and #MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for #Tafasitamab in #NonHodgkinLymphomas $INCY https://t.co/tyL1IWYlV4,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1280938376099741697,2020-09-19 23:03:13,,,"iexcloud.io, pic.twitter.com/rcVzAG9n4o, ",1307515632133513216,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-RAK Properties PJSC
-Incyte Corp.
-Reem Investment PSC
-IDEXX Laboratories, Inc.
-Abu Dhabi National Energy Co. PJSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/rcVzAG9n4o",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-09-19 23:03:04,,,"iexcloud.io, pic.twitter.com/18MfPPsld5, ",1307515594078597125,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-RAK Properties PJSC
-Incyte Corp.
-Reem Investment PSC
-IDEXX Laboratories, Inc.
-Abu Dhabi National Energy Co. PJSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/18MfPPsld5",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-09-19 23:02:38,,,"iexcloud.io, pic.twitter.com/9nt0mznvOg, ",1307515483076399109,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-RAK Properties PJSC
-Incyte Corp.
-Reem Investment PSC
-IDEXX Laboratories, Inc.
-Abu Dhabi National Energy Co. PJSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/9nt0mznvOg",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2809497047,2020-09-19 16:51:03,,"BMTsm, GVHD, ","nucleus.astct.org/Full-Article/i‚Ä¶, ",1307421972540915712,False,3,0,0,2,Twitter Web App,Congratulations @Areejmd for receiving @Incyte Ingenuity Award #BMTsm #GVHD https://t.co/XQjw8YYbqA,"Areejmd, Incyte, ",,2014-10-05 23:06:52,"Nashville, TN","Navneet Majhail, MD, MS",https://pbs.twimg.com/profile_images/1447967367594643470/9jzMSdvz_normal.jpg,16661,890,0,39555,BldCancerDoc,
1029128656650555393,2020-09-19 15:35:04,,"ESMO20, Oncology, ovariancancer, Cancer, SouthSanFrancisco, Delaware, Wilmington, NewJersey, CambridgeMa, ","biospace.com/article/esmo-r‚Ä¶, ",1307402848293072907,False,0,0,0,0,SocialPilot.co,ESMO: Merck and AstraZeneca's 5-Year Lynparza Data in Ovarian Cancer and More | @myESMO @Merk @AstraZeneca @Incyte @AtaraBio @EisaiUS @TakedaOncology #ESMO20  #Oncology #ovariancancer #Cancer #SouthSanFrancisco #Delaware #Wilmington #NewJersey #CambridgeMa https://t.co/fKpF9XauBZ,"myESMO, Merk, AstraZeneca, Incyte, Atarabio, EisaiUS, TakedaOncology, ",,2018-08-13 18:12:46,,Pharm2Market,https://pbs.twimg.com/profile_images/1041479880368484353/xr9ZBpXF_normal.jpg,190,849,2,2538,pharm2market,
2656754371,2020-09-19 15:33:20,,"ESMO20, Oncology, ovariancancer, Cancer, SouthSanFrancisco, Delaware, Wilmington, NewJersey, CambridgeMa, ","j.mp/35OtCKd, ",1307402411921887232,False,0,0,0,0,SocialPilot.co,ESMO: Merck and AstraZeneca's 5-Year Lynparza Data in Ovarian Cancer and More | @myESMO @Merk @AstraZeneca @Incyte @AtaraBio @EisaiUS @TakedaOncology #ESMO20  #Oncology #ovariancancer #Cancer #SouthSanFrancisco #Delaware #Wilmington #NewJersey #CambridgeMa https://t.co/YsugOhbgHk,"myESMO, Merk, AstraZeneca, Incyte, Atarabio, EisaiUS, TakedaOncology, ",,2014-07-18 09:20:39,San Diego,Aspen Biosciences,https://pbs.twimg.com/profile_images/1006725217568186368/B34yK1F1_normal.jpg,316,725,33,6079,aspenbio,
374729426,2020-09-19 09:09:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2117106, pic.twitter.com/GJxji8MWFd, ",1307305853704310789,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/Th0tPRADKy #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GJxji8MWFd,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-09-19 00:15:36,"MOR, INCY, ",,"newsfilter.io/articles/morph‚Ä¶, ",1307171459916333056,False,0,0,0,0,Newsfilter.io,MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas $MOR $INCY https://t.co/Ajwi0EiDJm,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3068641671,2020-09-18 21:54:06,"INCY, ","Incyte, equity, stocks, ","dlvr.it/RgvylG, pic.twitter.com/VovpvjHYMq, ",1307135850417975299,False,0,0,0,0,dlvr.it,"$INCY #Incyte Corp. INCY - Embedded Expectations Analysis - 2020 09 18: Incyte Corporation (INCY:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) earnings, with an 18.7x Uniform P/E. At these levels, the‚Ä¶ https://t.co/WXXgjAysSm #equity #stocks https://t.co/VovpvjHYMq",,,2015-03-03 17:15:05,"Paris, France",ResearchPool,https://pbs.twimg.com/profile_images/932829644558016512/Godn_LkX_normal.jpg,8971,4234,0,405156,ResearchPool,photo
1134049078424162304,2020-09-18 21:43:36,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1307133208283230210,False,0,0,0,0,Newsfilter.io,Incyte FDA Approvals To Propel Future Growth $INCY https://t.co/k5pIeCos0a,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
1280938376099741697,2020-09-18 20:10:57,,,"iexcloud.io, pic.twitter.com/dfsGskHYqY, ",1307109889869713408,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Marriott International, Inc.
-Incyte Corp.
-United Arab Bank PJSC
-Ras Al-Khaimah Poultry &amp; Feeding Co.
-Amgen, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V1UepI https://t.co/dfsGskHYqY",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1100450877792370688,2020-09-18 19:52:37,"INCY, ",,"blueequity.io/r/151061/de-in‚Ä¶, ",1307105277905457153,False,0,0,0,0,Blue Equity,"$INCY Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal https://t.co/xLDF94NS6U",,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
334585053,2020-09-18 16:00:31,,,"s.einnews.com/5e4-pPSt3n, ",1307046868199895043,False,0,0,0,0,EIN Presswire,Incyte FDA Approvals To Propel Future Growth https://t.co/dQKzr1GVeq,,,2011-07-13 06:16:51,"Washington, D.C.",EIN Presswire: Lung Cancer Newswire,https://pbs.twimg.com/profile_images/1288514359396904962/bd9OSmiA_normal.jpg,718,415,28,35060,EINLungCancer,
821471891013640192,2020-09-18 13:43:05,,"YourVelocity, COVID19, ","pic.twitter.com/zhuFTAm6P0, ",1307012282032041984,False,5,2,1,1,Twitter Web App,"We are grateful to our #YourVelocity sponsors for helping to make this year‚Äôs event possible! Thank you to The Crimson Lion/Lavine Family Foundation, @FundLoveOrg, @Regeneron, @EisaiUS, @NHL, @RBC, @MorphoSys, @BayerUS, @Incyte, &amp; @Novocure for helping us fight cancer &amp; #COVID19 https://t.co/zhuFTAm6P0","FundLoveOrg, Regeneron, EisaiUS, NHL, RBC, MorphoSys, BayerUS, Incyte, Novocure, ",,2017-01-17 16:38:55,"New York, USA",Velocity Ride,https://pbs.twimg.com/profile_images/1101203026583478272/ekhDgPv3_normal.png,175,203,0,538,velocity_ride,photo
23059499,2020-09-18 13:28:08,"INCY, ","business, markets, trading, ","seekingalpha.com/article/437516‚Ä¶, ",1307008519334293506,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte FDA Approvals To Propel Future Growth. https://t.co/EQpgoF6eBU #business #markets #trading,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
254797638,2020-09-18 12:38:20,,"checkpoint, GITR, ","twitter.com/DrCrystalD/sta‚Ä¶, ",1306995984430374912,False,5,0,0,3,TweetDeck,Continuing our work on new #checkpoint inhibitors #GITR @OmidHamidMD @Incyte @FoxChaseCancer https://t.co/cQGo5MCVr1,"OmidHamidMD, Incyte, FoxChaseCancer, ",,2011-02-19 20:25:12,"Los Angeles, CA",The Angeles Clinic,https://pbs.twimg.com/profile_images/669417949229424642/ZG0HWQeB_normal.jpg,542,295,5,524,angelesclinic,
948544453,2020-09-18 12:05:07,,"ClinicalTrials, ","bit.ly/32HHaFt, pic.twitter.com/YaGVj7ZF4J, ",1306987627141185538,False,0,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/ILhLCS9z9Z https://t.co/YaGVj7ZF4J","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2012-11-14 16:32:33,,monte gomillion,https://pbs.twimg.com/profile_images/2852608762/4f9475af6146f6e3029f6ed284e0f860_normal.jpeg,38,107,0,351,montegomillion,photo
15646702,2020-09-18 11:56:51,,"ClinicalTrials, ","bit.ly/33IQY14, pic.twitter.com/PQkDLyBIvl, ",1306985546313474051,False,0,0,0,0,Dynamic Signal,"The COVID-19‚Äôs impact digital transformation of #ClinicalTrials will be discusses on the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel. Check it out! https://t.co/3K0SahIYkK https://t.co/PQkDLyBIvl","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2008-07-29 10:25:51,Brazil,vhelfenstein,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,20,33,2,128,vhelfenstein,photo
2838003948,2020-09-18 10:50:45,,"ClinicalTrials, ","bit.ly/3066mnB, pic.twitter.com/p6W198tq9T, ",1306968913507352577,False,1,0,0,1,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/x8m1WTQrM6 https://t.co/p6W198tq9T","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2014-10-02 09:32:14,,Clare,https://pbs.twimg.com/profile_images/875793628215595008/ns-ZkrGz_normal.jpg,44,66,17,1088,catkinson47,photo
374729426,2020-09-18 09:48:33,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2113691, pic.twitter.com/CqdRUImSTu, ",1306953260238950408,False,0,0,0,0,Tickeron,"$INCY in -3.45% Downtrend, falling for three consecutive days on September 16, 2020. View odds for this and other indicators: https://t.co/6ie16QVs7Y #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/CqdRUImSTu",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
602816340,2020-09-18 08:55:30,,"ClinicalTrials, ","bit.ly/33A8l4k, pic.twitter.com/TJWkwldZFn, ",1306939906858516481,False,2,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/p7phUW1r2z https://t.co/TJWkwldZFn","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2012-06-08 08:54:38,,Liz Bennett,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,2,24,0,33,lizbennett78,photo
2215534260,2020-09-18 08:38:17,,"ClinicalTrials, ","bit.ly/2RErcG0, pic.twitter.com/iQEPp4pujd, ",1306935573362352130,False,1,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/gCFiMeYkfj https://t.co/iQEPp4pujd","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2013-11-26 06:06:44,,Eric Ghirardi,https://pbs.twimg.com/profile_images/690554009908834304/3CMPO2dW_normal.jpg,1254,1321,430,9396,GhirardiEric,photo
1171873456276889600,2020-09-18 08:13:50,"MOR, ","MOR, 6K, MorphoSys, News, ","docoh.com/filing/1340243‚Ä¶, ",1306929421677408257,False,0,0,0,0,Investor Feed,"$MOR  6-K  MorphoSys   (18 Sep, 8:12am)

üì∞ MorphoSys and Incyte to Host Investor Event to Discuss the Unmet

https://t.co/rxiSyIT1OH

#MOR #6K #MorphoSys #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
72928001,2020-09-18 08:03:36,"INCY, ",,"bit.ly/3iOiot6, ",1306926848123699200,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte reports results from Phase 2 trial of Retifanlimab https://t.co/oQUqiLLq2l,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
334585053,2020-09-18 08:00:30,,,"s.einnews.com/IMgmjyFEy6, ",1306926067022802945,False,0,0,0,0,EIN Presswire,"Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal https://t.co/9DEg083H9x",,,2011-07-13 06:16:51,"Washington, D.C.",EIN Presswire: Lung Cancer Newswire,https://pbs.twimg.com/profile_images/1288514359396904962/bd9OSmiA_normal.jpg,718,415,28,35060,EINLungCancer,
3686628867,2020-09-18 07:37:40,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1306920319580606464,False,0,0,0,0,WordPress.com,"Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal¬†Canal https://t.co/JtJMUNGJ5H",,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1134049078424162304,2020-09-18 07:06:30,"INCY, MGNX, ZLAB, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1306912476483776513,False,0,0,0,0,Newsfilter.io,Incyte PD-1 inhibitor shows benefit in mid-stage anal cancer study $INCY $MGNX $ZLAB https://t.co/86lTdiXmr1,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
15296897,2020-09-18 07:04:52,"INCY, MGNX, ZLAB, ",,"seekingalpha.com/news/3615245-i‚Ä¶, ",1306912065118859264,False,0,0,0,0,SANewsTwitter,$INCY $MGNX $ZLAB - Incyte PD-1 inhibitor shows benefit in mid-stage anal cancer study https://t.co/vybMhOOSbw,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1006334607946649600,2020-09-18 06:58:02,,"StockMarket, ","dlvr.it/RgsXjS, ",1306910345512980480,False,0,0,0,0,dlvr.it,"Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal https://t.co/AVDFOGPcNP #StockMarket",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
472650465,2020-09-18 06:10:54,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1306898485254463488,False,0,0,0,0,OTC Dynamics Twitter Login,"$INCY Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal https://t.co/ONrmqRqjk8",,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
112872946,2020-09-18 06:09:17,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1306898078071508992,False,0,0,0,4,Twitter Web App,"$INCY Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal

https://t.co/7hodV0HRRM",,,2010-02-09 19:09:48,Toronto,Bio Stocks‚Ñ¢,https://pbs.twimg.com/profile_images/1345176821185306624/4OaDT_lb_normal.jpg,58832,77,1249,48782,BioStocks,
1069693680066420736,2020-09-18 06:06:08,"INCY, ",,"s.flashalert.me/9jb2xR, ",1306897285746434050,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on September 18, 06:00:00: Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal https://t.co/fDg2Ljv5ra",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2020-09-18 06:06:07,,,"dlvr.it/RgsN9j, pic.twitter.com/mFsvG7yilp, ",1306897281296166917,False,0,0,0,0,dlvr.it,"Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal https://t.co/hHUrHflGID https://t.co/mFsvG7yilp",,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2020-09-18 06:04:22,,,"crweworld.com/article/news-p‚Ä¶, ",1306896840705470464,False,0,0,0,0,CRWE World,Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With Previously Tre https://t.co/tPSrcsT63H,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
2356524462,2020-09-18 06:03:35,"INCY, ",,,1306896644085108736,False,0,0,0,0,Stock News Alerts,"$INCY Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab (INCMGA0012) in Patients With P
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1134049078424162304,2020-09-18 06:03:30,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1306896623872638976,False,0,0,0,0,Newsfilter.io,"Incyte Announces Encouraging Results From Phase 2 Trial of Retifanlimab in Patients With Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Cana.. $INCY https://t.co/MCO1JZpR7M",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
768822661078192128,2020-09-18 05:33:01,,"ClinicalTrials, ","bit.ly/2EckmnQ, pic.twitter.com/DXM05kcKLv, ",1306888952889057283,False,1,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/IGETZNMrJ1 https://t.co/DXM05kcKLv","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2016-08-25 10:49:41,,Pedro Parada,https://pbs.twimg.com/profile_images/1255389625461420032/Cnq5oSh7_normal.jpg,52,32,59,3407,pparada_oracle,photo
2443154664,2020-09-18 04:54:02,,"ClinicalTrials, ","bit.ly/2HdfuA4, pic.twitter.com/8zNdDnWcWK, ",1306879140868632576,False,1,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/2FLJz9Zi69 https://t.co/8zNdDnWcWK","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2014-04-13 22:35:58,China,Gang Shi,https://pbs.twimg.com/profile_images/932461249249517568/Wt7pOiNX_normal.jpg,53,60,17,5570,shigang19762000,photo
146136115,2020-09-18 03:26:25,,"ClinicalTrials, ","bit.ly/32Gild1, pic.twitter.com/D4IA5X0FE8, ",1306857092431540224,False,1,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/sjgBA2tzxt https://t.co/D4IA5X0FE8","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2010-05-20 13:44:49,Madrid,Carmen Pizarro,https://pbs.twimg.com/profile_images/537153142995955712/Pi3z4dzU_normal.jpeg,1230,1673,268,7658,Carmenpizarro,photo
4272272235,2020-09-18 03:07:39,,"ClinicalTrials, ","bit.ly/3iGlu20, pic.twitter.com/o5yjltfkhH, ",1306852370802864128,False,1,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/KPPt1mlKou https://t.co/o5yjltfkhH","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2015-11-25 02:58:28,"ƒ∞stanbul, T√ºrkiye",Burak Gorsev,https://pbs.twimg.com/profile_images/993827721326325762/ZbkUXkpQ_normal.jpg,419,421,211,6347,bgorsev_oracle,photo
217608681,2020-09-18 03:05:28,,"ClinicalTrials, ","bit.ly/2RB53Ii, pic.twitter.com/7kYRHVzCx4, ",1306851821088956416,False,1,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/tR17i1DXrh https://t.co/7kYRHVzCx4","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2010-11-19 19:27:44,Derry,Darren Deehan,https://pbs.twimg.com/profile_images/1240561460687888385/89u_oRlu_normal.jpg,970,2040,32,1922,darrendeehan,photo
3047356972,2020-09-18 02:11:48,,"ClinicalTrials, ","bit.ly/3mHubf4, pic.twitter.com/tUmnQh3gsV, ",1306838314293407744,False,1,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/KiFPa5OXDY https://t.co/tUmnQh3gsV","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2015-02-20 11:58:46,"Stoke-on-Trent, England",Ian Rowley,https://pbs.twimg.com/profile_images/1110910887546769408/KcEWxGFv_normal.jpg,16,16,1,281,1IanRowley,photo
1156095377747128320,2020-09-18 01:49:38,,"HEMO, ","marketwatch.com/press-release/‚Ä¶, ",1306832735642832897,False,2,0,0,0,Twitter Web App,"Following Vlad's Tweet this  morning I'm wondering what, if any, contribution Hemogenyx has had with the NIAID-Sponsored ACTT-2 Trial with Eli Lilly. The EL collaborator I can find mentioned is Incyte. I guess we'll find out in time.
 
#HEMO 

https://t.co/XfuPsnmO37",,,2019-07-30 02:53:12,England,Squirrel,https://pbs.twimg.com/profile_images/1438085423436288005/0yHgprA8_normal.jpg,49,82,0,334,jibberingjabber,
289989013,2020-09-17 23:00:58,,"ad, ","nextavenue.org/what-a-rare-bl‚Ä¶, ",1306790287596019712,False,55,0,2,28,Twitter Web App,"Initially, Jim dismissed his symptoms as signs of stress. (Sponsored by @Incyte ) #ad https://t.co/1NzFg2cDbq","Incyte, ",,2011-04-29 11:22:52,,Next Avenue,https://pbs.twimg.com/profile_images/1321492021287120896/2ImsPiky_normal.jpg,27106,3376,932,48893,NextAvenue,
925877580397387776,2020-09-17 22:52:53,,"ClinicalTrials, ","bit.ly/32GpUR5, pic.twitter.com/PV3cTaN15m, ",1306788252729462786,False,1,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/kN2cJP3rQd https://t.co/PV3cTaN15m","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2017-11-01 20:09:51,,Teresa McFarlane,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,4,107,1,206,t_j_mcfarlane,photo
106823467,2020-09-17 20:57:06,"MOR, INCY, ","MorphoSys, Incyte, Lymphomas, ","crweworld.com/symbol/MOR, ",1306759116870672389,False,0,0,0,0,Twitter Web App,"$MOR, $INCY to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas          #MorphoSys       #Incyte      #Lymphomas       https://t.co/hLo39Cfar8",,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
1134049078424162304,2020-09-17 19:51:13,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1306742538691399680,False,0,0,0,0,Newsfilter.io,Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas $INCY $MOR https://t.co/7Bbxp0Vtv6,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
3318510966,2020-09-17 19:11:22,,,"crweworld.com/article/news-p‚Ä¶, ",1306732506138386432,False,0,0,0,0,CRWE World,MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in No https://t.co/SNLPvw9N5M,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3318510966,2020-09-17 18:33:16,,,"crweworld.com/article/news-p‚Ä¶, ",1306722918538174466,False,0,0,0,0,CRWE World,Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in No https://t.co/tjjSIOCmPM,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3686628867,2020-09-17 17:45:58,,,"pharmaceuticaldaily.com/incyte-and-mor‚Ä¶, ",1306711016408076295,False,0,0,0,0,WordPress.com,Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin¬†Lymphomas https://t.co/NTe7Pao946,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
3686628867,2020-09-17 17:45:58,,,"pharmaceuticaldaily.com/incyte-and-mor‚Ä¶, ",1306711016085086209,False,0,0,0,0,WordPress.com,Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin¬†Lymphomas https://t.co/7Po6w8VCJy,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
4058194633,2020-09-17 17:20:11,"INCY, MOR, ",,"businesswire.com/news/home/2020‚Ä¶, ",1306704528230637568,False,0,0,0,0,Twitter for iPhone,$INCY $MOR Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas | Business Wire https://t.co/MA1On5wZh8,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1254035253104181256,2020-09-17 16:38:16,"MOR, ",,"stocktitan.net/news/MOR/morph‚Ä¶, ",1306693979812114435,False,0,0,0,0,stocktitan,"$MOR MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas
https://t.co/FOZIuJe8se",,,2020-04-25 09:11:29,,Stock Titan,https://pbs.twimg.com/profile_images/1255208154645901313/_9stGSsY_normal.jpg,5654,0,156,177947,stock_titan,
266143766,2020-09-17 16:38:14,"MOR, ",,"accesswire.com/606634/MorphoS‚Ä¶, ",1306693969200451584,False,0,0,0,0,Accesswire,$MOR MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab ... https://t.co/toY8xT5yRR,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
426660182,2020-09-17 16:18:53,,,"investor.incyte.com/news-releases/‚Ä¶, ",1306689102604050435,False,0,0,0,0,Twitter for iPhone,Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas | Incyte Corporation https://t.co/LVWa1DeZEt,,,2011-12-02 09:36:53,Hewlett NY,Michael G King Jr,https://pbs.twimg.com/profile_images/760202160143470592/tV-c8Va4_normal.jpg,768,4708,11,857,MichaelGKingJr,
31720614,2020-09-17 16:18:39,,"news, pharma, pharmiweb, ","zpr.io/HxZ6U, ",1306689040859701260,False,1,0,0,0,Zapier.com,"MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas (news with additional features)
https://t.co/mbPBuolxFi
#news #pharma #pharmiweb",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,
2356524462,2020-09-17 16:18:25,"INCY, ",,,1306688985004212225,False,1,0,0,0,Stock News Alerts,"$INCY Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafa
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1290396465949548546,2020-09-17 16:16:02,,"ClinicalTrials, ","bit.ly/3iHtvnw, pic.twitter.com/6UpY2RLxgq, ",1306688382701981696,False,1,0,0,1,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/IQ96wjiK7F https://t.co/6UpY2RLxgq","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2020-08-03 17:18:02,Mexico,Carmen Nava,https://pbs.twimg.com/profile_images/1290396780580962304/D8D-Neq1_normal.jpg,2,2,0,88,OracleNava,photo
472650465,2020-09-17 16:07:16,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1306686179014832131,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas https://t.co/gSUrl04G3p,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
42410755,2020-09-17 16:06:13,,,"tinyurl.com/y6fddcol, ",1306685914735931392,False,0,1,0,0,DGAP_News_Int,MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for T... https://t.co/BBH61ZArmA,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
1069693680066420736,2020-09-17 16:05:54,"INCY, ",,"s.flashalert.me/wsQCL, ",1306685834209435650,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on September 17, 16:03:00: Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas https://t.co/BOEMD4DXkM",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
72928001,2020-09-17 15:46:28,"LLY, ",,"bit.ly/3ksMaE4, ",1306680942283558912,False,1,0,0,2,BriefingInPlayLimited,$LLY: Eli Lilly and and Incyte (INCY) announced initial data emerging from the Adaptive COVID-19 Treatment Trial... https://t.co/SDxYYN9VBj,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1304774550014615554,2020-09-17 13:26:43,,"ESMO20, Patient, centricity, cholangiocarcinoma, ","pic.twitter.com/05uLGQ8nYF, ",1306645772201492480,False,11,0,0,2,Twitter Web App,"Great to be part of this panel at #ESMO20 Incyte Symposium on #Patient #centricity in #cholangiocarcinoma. Many thanks to Profs Juan Valle (UK), Lorenza Rimassa (Italy) &amp; Peter Schirmacher (Germany) for such good discussions!
@myESMO @Incyte @HUNIMED  @CharityAMMF https://t.co/05uLGQ8nYF","myESMO, Incyte, HUNIMED, CharityAMMF, ",,2020-09-12 09:32:06,UK,Helen Morement,https://pbs.twimg.com/profile_images/1304775126232293377/dwFksdw9_normal.jpg,182,299,0,268,HelenMorement,photo
3911174913,2020-09-17 09:26:33,,"DLBCL, BCAM, ","pic.twitter.com/5CjdJ6bbKF, ",1306585334277459977,False,44,0,0,9,Twitter for Advertisers.,"Today and every day, we are committed to supporting those impacted by #DLBCL. #BCAM https://t.co/5CjdJ6bbKF",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
374729426,2020-09-17 09:16:02,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2110223, pic.twitter.com/JCSYba5N6V, ",1306582688577384450,False,0,0,0,1,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on August 26, 2020. View odds for this and other indicators: https://t.co/TDMvaFeBLV #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/JCSYba5N6V",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
151965668,2020-09-17 08:26:21,,,"incyteingenuityawards.com/recipients, ",1306570183906033665,False,3,0,0,2,Hootsuite Inc.,"Congratulations! Massachusetts General Cancer Center!  
2020 Incyte Ingenuity Award Recipient!
https://t.co/vNwBUy3234
@MGHCancerCenter @MassGeneralNews","MGHCancerCenter, MassGeneralNews, ",,2010-06-04 14:20:07,"Boston, MA","Ali S. Raja, MD",https://pbs.twimg.com/profile_images/786579864186916864/TycJld1R_normal.jpg,118455,2878,210,55571,AliRaja_MD,
897806394811961346,2020-09-17 08:24:39,,,"incyteingenuityawards.com/recipients, pic.twitter.com/L5Fiz93tdc, ",1306569756720410625,False,0,0,0,0,Hootsuite Inc.,"Introducing the 2020 Incyte Ingenuity Award Recipient!
Congratulations! Massachusetts General Cancer Center!
https://t.co/2K4LiNONfq
@MGHCancerCenter @MassGeneralNews https://t.co/L5Fiz93tdc","MGHCancerCenter, MassGeneralNews, ",,2017-08-16 09:04:59,"Boston, MA","Randy C. Miles, MD, MPH",https://pbs.twimg.com/profile_images/1048228113119944704/OEYY8Pvn_normal.jpg,2537,1289,44,25048,RMilesMD,photo
23308544,2020-09-17 07:06:14,,"ClinicalTrials, ","bit.ly/3mubIT4, pic.twitter.com/Fa94ArA0Yu, ",1306550021110640640,False,0,0,0,0,Dynamic Signal,"What has COVID-19‚Äôs impact been on the digital transformation of #ClinicalTrials? Tune in to the @OracleHealthSci and @PharmExec webinar with @Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/mkkqZUtqGs https://t.co/Fa94ArA0Yu","OracleHealthSci, PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2009-03-08 09:41:04,,Bryan,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,10,0,0,2460,oxhenry339,photo
14133281,2020-09-17 05:16:57,,"Olumiant, baricitinib, remdesivir, ",,1306522520623878144,False,0,0,0,0,Twitter Web App,"Eli Lilly &amp; @Incyte announced of seeking emergency use authorization for #Olumiant or #baricitinib, a RA drug tested in combination with #remdesivir as a treatment for COVID-19. Patients treated with both drugs recovered more quickly than those treated with remdesivir alone","Incyte, ",,2008-03-12 12:33:01,Hyderabad,Dr.  Amit Dang,https://pbs.twimg.com/profile_images/1244646825627250691/jmIyfbBm_normal.jpg,453,237,9,923,dramitdang,
1280938376099741697,2020-09-16 19:13:33,,,"iexcloud.io, pic.twitter.com/t0nE7KXS4q, ",1306370671413465091,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-NVIDIA Corp.
-Incyte Corp.
-Sharjah Cement &amp; Industrial Development 
-Cadence Design Systems, Inc.
-Insurance House PSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/t0nE7KXS4q",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
28815461,2020-09-16 15:02:12,,"clinicaltrials, ","ora.cl/Qp3u2, pic.twitter.com/ftFqnKa0PF, ",1306307416032673792,False,3,0,0,3,Twitter Web App,"What has COVID-19‚Äôs impact been on the digital transformation of #clinicaltrials?

Tune into our September 29 @PharmExec webinar with 
@Incyte, @IQVIA_global, @CSLBehring, and @Parexel to find out. https://t.co/NWxmmnpxru https://t.co/ftFqnKa0PF","PharmExec, Incyte, IQVIA_global, CSLBehring, Parexel, ",,2009-04-04 11:50:45,"Austin, TX",Oracle Health Sciences,https://pbs.twimg.com/profile_images/1171816913523159045/a75gOGmX_normal.jpg,6391,1171,285,8128,OracleHealthSci,photo
374729426,2020-09-16 09:42:03,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2106793, pic.twitter.com/aJgMQNWv4z, ",1306226849001873409,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on August 26, 2020. View odds for this and other indicators: https://t.co/ehFMxuoIYC #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/aJgMQNWv4z",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-09-16 04:55:00,"INCY, ",,"zpr.io/HXdKq, ",1306154606792237058,False,0,0,0,0,Zapier.com,"Maria E. Pasquale Sells 2,193 Shares of Incyte Co. $INCY Stock https://t.co/SZwGHlynTR",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
3402544414,2020-09-16 04:25:44,,"ESMO20, Patient, centricity, cholangiocarcinoma, ","pic.twitter.com/blaBZYZIsl, ",1306147242827489280,False,16,1,0,2,Twitter for iPhone,#ESMO20 Incyte Symposium on #Patient #centricity in #cholangiocarcinoma. Great presentations and panel discussion. Important results but still a lot of work to do! Thank you @CharityAMMF! @myESMO @HUNIMED https://t.co/blaBZYZIsl,"CharityAMMF, myESMO, HUNIMED, ",,2015-08-04 05:57:47,"Milan, Italy ",Lorenza Rimassa,https://pbs.twimg.com/profile_images/1140987670417629184/CCejApO8_normal.jpg,955,1163,6,2433,LorenzaRimassa,photo
631661989,2020-09-16 02:00:00,,"lungcancer, Delaware, ChooseDelaware, GlobalDE, ","hubs.ly/H0w7Jvw0, pic.twitter.com/7HjSRV1VBb, ",1306110567669788672,False,0,0,0,0,HubSpot,"A #lungcancer treatment first discovered by #Delaware-based @Incyte is highlighted in the latest @NEJM following promising results in a Phase 2 trial. 
https://t.co/2kanZcJE4B 
#ChooseDelaware #GlobalDE https://t.co/7HjSRV1VBb","Incyte, NEJM, ",,2012-07-09 23:54:36,"Wilmington, Delaware",Global Delaware,https://pbs.twimg.com/profile_images/1059868013459992577/IjSZsC14_normal.jpg,5389,1817,222,6107,DelawareGlobal,photo
14453501,2020-09-15 16:42:43,,,"delawarebusinessnow.com/2020/09/drug-d‚Ä¶, ",1305970321321852928,True,0,0,0,0,WordPress.com,Drug developed by Incyte shows promise in treating hospitalized patients with¬†Covid-19 https://t.co/1p4qE77nHJ,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
1280938376099741697,2020-09-15 15:26:53,,,"iexcloud.io, pic.twitter.com/PBDRAoKiG1, ",1305951239407120386,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Abu Dhabi National Hotels
-Gulf Pharmaceutical Industries
-Sirius XM Holdings, Inc.
-Invest Bank

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/PBDRAoKiG1",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
30246985,2020-09-15 14:41:53,"GILD, ","ARMRreport, ","investors.com/news/technolog‚Ä¶, armrreport.com, ",1305939914689785858,False,0,0,0,0,StockTwits Web,"$GILD Eli Lilly, Incyte Combine Covid Drug With Gilead's, Post Positive Data https://t.co/hOi9UVJQWS via @IBDinvestors 
#ARMRreport https://t.co/UfDOanatJV","IBDinvestors, ",,2009-04-10 12:09:58,South Florida,ARMR Report,https://pbs.twimg.com/profile_images/497096822989410304/bYTCzRlS_normal.jpeg,1969,99,67,24960,BretRosenthal,
1004375641171603458,2020-09-15 14:00:10,,"lungcancer, Wilmington, ChooseDelaware, NetDe, ","hubs.ly/H0w7Jvq0, pic.twitter.com/wI7gLCZbn7, ",1305929417609314305,False,0,0,0,0,HubSpot,"A #lungcancer treatment first discovered by #Wilmington-based @Incyte is highlighted in the latest @NEJM following promising results in a Phase 2 trial. 
https://t.co/T9UqJPgaBg 
#ChooseDelaware #NetDe https://t.co/wI7gLCZbn7","Incyte, NEJM, ",,2018-06-06 10:53:08,,Delaware Prosperity Partnership @choosedelaware,https://pbs.twimg.com/profile_images/1059872509540134913/PX_tVV7O_normal.jpg,4337,1030,21,2792,choosedelaware,photo
1280938376099741697,2020-09-15 12:11:12,,,"iexcloud.io, pic.twitter.com/7YV3JKhnXj, ",1305901994239025155,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-First Abu Dhabi Bank PJSC
-Ras Al Khaimah Co. for White Cement &amp; Co
-Abu Dhabi National Takaful Co. PJSC
-Incyte Corp.
-Union Cement Co. PSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/7YV3JKhnXj",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
43414578,2020-09-15 11:48:57,,"ONSBridge, ",,1305896393610014720,False,8,0,0,4,Twitter for iPhone,Thank you to the many companies helping to sponsor #ONSBridge including @AstraZeneca @bmsnews @genentech @abbvie @Amgen @AstellasUS @Bayer @BBraunUSA @cvspharmacy @ExelixisInc @GSK @ICU_Medical @Incyte @KitePharma @LillyPad @Merck @NovartisScience @pfizer_news @TakedaOncology,"AstraZeneca, bmsnews, genentech, abbvie, Amgen, AstellasUS, Bayer, BBraunUSA, cvspharmacy, ExelixisInc, GSK, ICU_Medical, Incyte, KitePharma, LillyPad, Merck, NovartisScience, pfizer_news, TakedaOncology, ",,2009-05-29 17:32:14,"Washington, DC","Kristin Ferguson, DNP, RN, OCN",https://pbs.twimg.com/profile_images/1289371969390075909/AxJX8YvO_normal.jpg,1757,4137,32,4075,KFerg86,
1255587054328655874,2020-09-15 11:30:12,,,"finance.yahoo.com/m/39be74f0-673‚Ä¶, ",1305891676456546304,False,0,0,0,0,Twitter for iPhone,"Eli Lilly, Incyte Combine Covid Drug With Gilead's, Post Positive Data 

https://t.co/hTWeZd2D9X 

via @YahooFinance","YahooFinance, ",,2020-04-29 15:57:54,,MacKenzie,https://pbs.twimg.com/profile_images/1270414400726290432/hk6G3mBt_normal.jpg,3291,3285,33,59586,Smackenziekerr,
3911174913,2020-09-15 10:15:00,,"GVHD, ",,1305872751253749760,False,15,0,1,3,Twitter for Advertisers.,Incyte is honored to fund the implementation of @MassGeneralNews' innovative project for the betterment of the graft-versus-host disease (#GVHD) community.,"MassGeneralNews, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
55591587,2020-09-15 09:57:34,,,"twitter.com/Incyte/status/‚Ä¶, ",1305868365844623362,False,0,0,0,0,Twitter for iPhone,Bruh I thought this was John Fox for a min üòÇüòÇüòÇ https://t.co/IC1XP8nSmF,,,2009-07-10 11:38:06,"Atlanta, GA","Mr. T-Time, MS üéì",https://pbs.twimg.com/profile_images/1447068213309808645/mNppvw_Q_normal.jpg,2431,1135,19,277343,Ayo_TTime9,
374729426,2020-09-15 08:51:23,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2103357, pic.twitter.com/vv6VqKK49S, ",1305851706698207232,False,0,0,0,0,Tickeron,"$INCY in -3.84% Downtrend, sliding for three consecutive days on September 11, 2020. View odds for this and other indicators: https://t.co/28An3U5t31 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/vv6VqKK49S",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1280938376099741697,2020-09-15 05:52:18,,,"iexcloud.io, pic.twitter.com/1MOgUOxjG9, ",1305806640340439040,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Union Insurance Co.
-JD.com, Inc.
-Ooredoo QPSC
-Wynn Resorts Ltd.
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/1MOgUOxjG9",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
68559732,2020-09-15 04:49:14,"INCY, ",,"zpr.io/HX8mi, ",1305790768385269760,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 2,193 Shares of Stock https://t.co/OLgNQQxCl7",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1022473214457348096,2020-09-15 03:41:58,,,"pharmashots.com/48479/eli-lill‚Ä¶, pic.twitter.com/V9Gc4bLxbP, ",1305773843185762304,False,0,0,0,0,Twitter Web App,"Eli Lilly and Incyte‚Äôs Olumiant + Gilead‚Äôs Veklury Reduce Time to Recovery in Hospitalized Patients with COVID-19 @LillyPad @GileadSciences @Incyte 
https://t.co/68lsUFuOPL https://t.co/V9Gc4bLxbP","LillyPad, GileadSciences, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,photo
1262915121103491074,2020-09-14 23:21:39,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1305708331315548161,False,0,0,0,0,formwhispers,"#FWSells $INCY Pasquale Maria E, EVP &amp; General Counsel of INCYTE CORP sold 2193 shares on 2020-09-11. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
732361939490312192,2020-09-14 21:51:43,"INCY, ","markets, ","americanbankingnews.com/?p=16206909, ",1305685698054369280,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Up 5.9% https://t.co/HvGx65ujHf #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-09-14 21:51:42,"INCY, ","stocks, ","americanbankingnews.com/?p=16206909, ",1305685695491649538,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Up 5.9% https://t.co/7Y9NhzvdXr #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-09-14 18:40:44,"INCY, ","markets, ","americanbankingnews.com/?p=16203867, ",1305637634841161728,False,1,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 2,193 Shares of Stock https://t.co/DmBiyMp3r0 #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-09-14 18:40:43,"INCY, ","stocks, ","americanbankingnews.com/?p=16203867, ",1305637632802803713,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 2,193 Shares of Stock https://t.co/EVwSMXspp1 #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1122222044,2020-09-14 18:00:55,,,"investors.com/news/technolog‚Ä¶, ",1305627614544113665,False,1,0,0,0,Twitter Web App,"Eli Lilly, Incyte Combine Covid Drug With Gilead's, Post Positive Data https://t.co/vww1iMddHU via @IBDinvestors","IBDinvestors, ",,2013-01-26 09:49:23,,Marcia Sessler,https://pbs.twimg.com/profile_images/1023641901935648768/5x3JGI8S_normal.jpg,7381,8058,23,96677,MarciaSessler,
950010035396136962,2020-09-14 17:01:40,,"Incyte, ","zonebourse.com/INCYTE-CORPORA‚Ä¶, ",1305612706448396288,False,0,0,0,0,Cresus AI,"#Incyte closed at 93.15. Score +105, credit rating AA https://t.co/XMro31aTzT",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
1176558075798380544,2020-09-14 16:33:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1305605580820807688,False,0,0,0,0,InsiderActionMonitor,$INCY Maria Pasquale Dumps 2.2K Shares of Incyte https://t.co/EQ3sRXX66d,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
2356524462,2020-09-14 16:25:41,"INCY, ",,,1305603646848106496,False,0,0,0,0,Stock News Alerts,"$INCY New Form 4 for Incyte Corporation
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
2570920968,2020-09-14 15:09:10,"LLY, INCY, GILD, ","COVID19, coronavirus, ","bit.ly/3mlBpFq, ",1305584391893258245,False,0,0,0,0,Twitter Web App,"Eli Lilly, Incyte Combine Covid Drug With Gilead's, Post Positive Data! $LLY $INCY $GILD #COVID19 #coronavirus
https://t.co/FEsZWEW7lg",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
334331653,2020-09-14 13:56:03,,,"investor.incyte.com/news-releases/‚Ä¶, ",1305565992853045248,False,6,0,0,0,Twitter Web App,"possible new drug to add to tool kit.  Incyte announced positive 1k hospitalized patient P3 this morning.  recovery time benefit ~1day.  while not a big number, together with other drugs adds up.      

https://t.co/U6xLjxUBxS",,,2011-07-12 18:52:26,,"Rod Wong, MD",https://pbs.twimg.com/profile_images/1240969051356233728/T-jZqrYf_normal.jpg,1468,123,21,442,docrodwong,
4876582225,2020-09-14 12:08:36,"INCY, ",,"ideas.quantcha.com/2020/09/14/big‚Ä¶, ",1305538951931990017,False,0,0,0,0,WordPress.com,Big Gainer Alert: Trading today‚Äôs 7.1% move in INCYTE¬†$INCY https://t.co/KseANLeXKd,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
2384219072,2020-09-14 12:02:34,,,"loom.ly/To6tbPM, ",1305537431349981186,False,0,0,0,0,Loomly,"Member companies @LillyPad and @Incyte announced Baricitinib in combination with remdesivir met the primary endpoint of reduction of time to recovery in comparison with remdesivir.
READ MORE: https://t.co/BIqyND0IEI","LillyPad, Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,
1151214967577829376,2020-09-14 11:36:31,"LLY, GILD, INCY, ","remdesivir, COVID19, ","ow.ly/Tj6r50BqeKD, pic.twitter.com/HuX7HlhulA, ",1305530879528316929,False,0,0,0,1,Hootsuite Inc.,".@LillyPad and @Incyte's Olumiant combined with @GileadSciences' #remdesivir reduced the recovery time of #COVID19 patients by a day on average, meeting the main goal of a late-stage trial
https://t.co/n2mbBEbmZj 
$LLY $GILD $INCY https://t.co/HuX7HlhulA","LillyPad, Incyte, GileadSciences, ",,2019-07-16 15:40:11,Global,Market Intelligence: Healthcare,https://pbs.twimg.com/profile_images/1176596064096391169/Mf7mREWc_normal.jpg,473,410,13,3475,SPGMIHealthcare,photo
295746612,2020-09-14 11:26:40,,,"investor.lilly.com/news-releases/‚Ä¶, ",1305528400187195394,False,4,0,1,0,TweetDeck,"Eli Lilly &amp; Incyte join the parade of science by press release, claiming that Olumiant helps patients hospitalized with Covid recover one day faster. The industry is not covering itself in glory here. How long would it have taken to get a publication? https://t.co/jEVLX9CkP8",,,2011-05-09 12:03:38,Hong Kong,Michelle Fay Cortez,https://pbs.twimg.com/profile_images/1199169437921882112/_BIdxYDK_normal.jpg,17086,1351,650,7258,FayCortez,
374729426,2020-09-14 10:55:30,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2100193, pic.twitter.com/l50tzgi6Ut, ",1305520555022409729,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on August 26, 2020. View odds for this and other indicators: https://t.co/BkgK7miBwS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/l50tzgi6Ut",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
15974185,2020-09-14 10:36:33,,,"dlvr.it/RgZpmq, ",1305515788216889344,False,0,0,0,0,dlvr.it,Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time https://t.co/lxbJbfZRBS,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
3911174913,2020-09-14 09:00:00,,"atopiceczema, AtopicEczemaDay, ",,1305491490471399425,False,1,0,0,0,Twitter for Advertisers.,Incyte is committed to addressing the unmet needs of patients with #atopiceczema. Join us in advocating for these patients this #AtopicEczemaDay and every day.,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
35789155,2020-09-14 08:37:34,"LLY, INCY, ","COVID19, ","beta.firstwordpharma.com/story/5105325, ",1305485845584138241,False,1,0,0,1,TweetDeck,"Eli Lilly, Incyte's Olumiant plus Veklury reduces time to recovery in hospitalised #COVID19 patients https://t.co/PbKk3kY5x0 $LLY $INCY",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
72928001,2020-09-14 08:32:43,"LLY, ",,"bit.ly/3ms4n6D, ",1305484623867076609,False,0,0,0,0,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) report baricitinib in combination with remdesivir reduces time to recovery in... https://t.co/O9IVrhltAY,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
270492072,2020-09-14 08:20:08,,"news, mktw, wsj, ","feeds.marketwatch.com/~r/marketwatch‚Ä¶, ",1305481456676823041,False,0,0,0,0,Microsoft Power Platform,Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time https://t.co/MCmSt8EMbu via MarketWatch #news #mktw #wsj,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
3316713321,2020-09-14 08:02:43,,,"marketwatch.com/news/story/sha‚Ä¶, ",1305477072006066181,False,0,0,0,0,WordPress.com,Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery¬†time https://t.co/IMbydRDSTZ,,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
2837784071,2020-09-14 08:00:39,"spy, gspc, aapl, nflx, goog, tsla, ",,"zpr.io/HXXCn, ",1305476554600984576,False,0,0,0,0,Zapier.com,$spy $gspc $aapl $nflx $goog $tsla Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time  https://t.co/CAjrf9MU0S,,,2014-10-19 21:22:48,"Toronto, Ontario",FaisamTrader,https://pbs.twimg.com/profile_images/856700180950904832/K-8u6osz_normal.jpg,4206,15,57,21629,FaisamTrader,
1288418053441695744,2020-09-14 07:40:01,,,"dlvr.it/RgZDJN, ",1305471361821802497,False,0,0,0,0,dlvr.it,"Lilly, Incyte Announce Initial Data From Adaptive COVID-19 Treatment Trial ‚Äì Quick Facts https://t.co/6gCqf5HXMs",,,2020-07-29 06:16:25,"Seoul, Korea",Bastion Balance Seoul Korea,https://pbs.twimg.com/profile_images/1288418172987678720/sEHDV1sf_normal.jpg,98,10,0,7219,BalanceSeoul,
1254906887490936845,2020-09-14 06:49:52,"GILD, INCY, LLY, ",,,1305458738996883457,False,0,0,0,0,Quant Data (Production),"Eli Lilly and Incyte Announce Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial; Announce Study Met Primary Endpoint of Reduction of Time to Recovery

Related Tickers: $GILD $INCY $LLY",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
106823467,2020-09-14 06:42:00,"LLY, INCY, GILD, ","EliLilly, Incyte, Coronavirus, COVID19, SARSCoV2, ","crweworld.com/symbol/INCY, ",1305456760132575233,False,0,0,0,0,Twitter Web App,"Trial Findings Show $LLY, $INCY 's Baricitinib + $GILD 's Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19     #EliLilly     #Incyte   #Coronavirus    #COVID19      #SARSCoV2   https://t.co/x9QsKSOMBZ",,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
864584576,2020-09-14 06:36:29,"INCY, ",,,1305455372384317440,False,0,0,0,0,Twitter Web App,"$INCY(88.00) up 2.60 thin (NYSE: LLY) and  Incyte  (NASDAQ: INCY) announced today initial data emerging from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the  National Institute of Allergy and Infectious Diseases  (NIAID), part of the  National Institutes of Health",,,2012-10-06 08:06:29,Currently planet Earth.,Palmer,https://pbs.twimg.com/profile_images/943970836431671298/vn0Vf4ma_normal.jpg,7364,93,153,16468,BankTheTrade,
47519668,2020-09-14 06:33:51,"INCY, LLY, ",,"tradethenews.com/?twtId=16386, ",1305454708707004417,False,1,0,0,0,Updates Poster,"$INCY Baricitinib in combination with Remdesivir reduces time to recovery in hospitalized patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial (Incyte Corp)

- Study Met Primary Endpoint of Reduction of Time to Recovery $LLY
(More at https://t.co/9tD0QjIyiv)",,,2009-06-15 22:37:04,Global,TradeTheNews.com,https://pbs.twimg.com/profile_images/916119563191889920/ylR4h5y0_normal.jpg,21141,1222,761,53590,Trade_The_News,
2704294333,2020-09-14 06:31:53,"INCY, ",,,1305454214580232195,False,11,2,0,4,TweetDeck,"Lilly, Incyte: Baricitinib in Combination With Remdesivir Reduces Time to Recovery in Hospitalized Patients With COVID-19 in NIAID-Sponsored ACTT-2 Trial 
$INCY",,,2014-08-03 10:34:52,Switzerland,*Walter Bloomberg,https://pbs.twimg.com/profile_images/1282648991348527104/A8HCjqZk_normal.jpg,392435,34,6566,104545,DeItaone,
3004639432,2020-09-13 23:25:52,,,"twitter.com/Incyte/status/‚Ä¶, ",1305347003770195975,False,1,0,0,0,Twitter for iPhone,Sigh ... my blood is my daily battle. Tomorrow I will wake again and be courageous üí™üèº https://t.co/0tgCSg1AoA,,,2015-01-29 19:04:54," Planet Earth, East Coast,USA",swoman672,https://pbs.twimg.com/profile_images/1374409886243512322/BNen-k1c_normal.jpg,236,294,9,8350,TracyLynne672,
2570920968,2020-09-13 10:11:00,"INCY, ","DLBCL, lymsm, MPNs, ","twitter.com/Incyte/status/‚Ä¶, ",1305146967861932032,False,0,0,0,0,Twitter Web App,"Interesting! Thanks @Incyte
""Our inflammation &amp; autoimmunity (IAI) research team utilizes its cross-functional knowledge of our programs to discover, develop &amp; deliver innovative approaches to treating immune-mediated diseases"" $INCY #DLBCL #lymsm #MPNs @american_skin1 https://t.co/kWGhaHjaJW","Incyte, american_skin1, ",,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
374729426,2020-09-13 09:54:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2096777, pic.twitter.com/5lCnuaKPFY, ",1305142774170148871,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on August 26, 2020. View odds for this and other indicators: https://t.co/DFcpYi0Y75 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5lCnuaKPFY",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
875107384535900161,2020-09-13 07:33:01,,"JobSearch, jobseekers, Jobs, ","jobs.frontend.la/i/us/all/1/063‚Ä¶, ",1305107210628857856,False,0,0,0,0,FrontendLA,"New opportunity in Wilmington, DE - Clinical Trial Manager @ Incyte Corporation  https://t.co/v2oX5TnbhG #JobSearch #jobseekers #Jobs",,,2017-06-14 17:47:14,,Frontend.LA,https://pbs.twimg.com/profile_images/1275071694609080320/lPHtH4S__normal.jpg,234,24,5,590801,FrontendLA,
3145540510,2020-09-12 13:25:02,,,,1304833411174068228,False,0,0,0,0,Hootsuite Inc.,"Next, Join us for our first Product Theater: Intervening with Jaka¬≠ (ruxolitinib) to Achieve Durable Count Control: Real World Patient Case Discussion | Focus on Adults With Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea - Presented by Incyte Corporation",,,2015-04-07 17:03:14,Virtual Conference,ONA Virtual Navigation Summit,https://pbs.twimg.com/profile_images/1278848327145205764/W0NwDUKi_normal.png,451,544,10,645,OncNavSum,
39557537,2020-09-12 10:58:14,,"autoimmune, toxic, vaccine, ingredients, ","vaccinesafety.edu/thi-table.htm, twitter.com/Incyte/status/‚Ä¶, ",1304796466595147777,False,0,0,0,0,Twitter for iPad,"#autoimmune disease caused by #toxic #vaccine #ingredients! You think? 
https://t.co/GGtYaJPAyJ https://t.co/ctQJrBGQir",,,2009-05-12 14:12:01,L.I. New York ,dianne gill,https://pbs.twimg.com/profile_images/3722932167/0c2f9fa19c7dbbde566cd44511b68697_normal.jpeg,375,2334,4,21493,discangirl,
374729426,2020-09-12 08:12:37,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2093286, pic.twitter.com/C6ylgHUU9n, ",1304754788651819011,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on August 26, 2020. View odds for this and other indicators: https://t.co/dRNsvR3vQb #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/C6ylgHUU9n",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-09-12 06:45:06,"INCY, ","investingnews, ","modernreaders.com/?p=3921517, ",1304732764739194882,False,0,0,0,0,Zapier.com,Dashyant Dhanak Sells 961 Shares of Incyte Co. $INCY Stock  https://t.co/gNvUKes2F5 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1280938376099741697,2020-09-12 06:16:27,,,"iexcloud.io, pic.twitter.com/gGJBpQRGBl, ",1304725554445324288,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Arkan Building Materials Co. PJSC
-Sharjah Cement &amp; Industrial Development 
-ASML Holding NV
-Ooredoo QPSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/gGJBpQRGBl",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1134049078424162304,2020-09-11 23:04:51,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1304616938463793153,False,0,0,0,0,Newsfilter.io,"$22,602.72 of shares sold by Dhanak Dashyant (EVP &amp; Chief Scientific Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/cJiOuTUljM",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
210198539,2020-09-11 18:02:21,,"oncopharm, ",,1304540812592779270,False,9,0,0,0,Twitter for iPhone,Thanks everyone for attending the virtual @HOPArx Practice Management Meeting! Thank you @Incyte for sponsoring the event and I can‚Äôt wait until we can all be together again in person! #oncopharm,"HOPArx, Incyte, ",,2010-10-30 16:29:40,"Manhattan, NY",Larry W. Buie,https://pbs.twimg.com/profile_images/742857279389765633/s_Vab3Ev_normal.jpg,748,1808,5,1147,LarryBuie,
1232350410826010625,2020-09-11 17:24:23,,,,1304531257070628864,False,4,0,0,0,Twitter Web App,"Thank you, @Incyte for your sponsorship of an incredible virtual meeting: @HOPArx 2020 Practice Management!","Incyte, HOPArx, ",,2020-02-25 12:03:42,"Ann Arbor, MI",Emily Mackler (she/her),https://pbs.twimg.com/profile_images/1401367998074662912/Hwvx3E9F_normal.jpg,322,351,3,254,EmilyMackler,
374729426,2020-09-11 08:30:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2089851, pic.twitter.com/klujYKF3KZ, ",1304396860921008128,False,0,0,0,0,Tickeron,"$INCY in -2.01% Downtrend, falling for three consecutive days on September 8, 2020. View odds for this and other indicators: https://t.co/1ybGZk3R3i #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/klujYKF3KZ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
477131488,2020-09-10 20:40:46,,,"twitter.com/ChrisHeery/sta‚Ä¶, ",1304218290508591104,False,5,0,0,0,Twitter for iPhone,I ALSO AGREE! Hope some of the people with capacity to make or facilitate these options are paying attention! @genentech @AstraZeneca @Merck @EMDSerono @bmsnews @AstellasUS @Boehringer @pfizer @NovartisOncCT @Incyte @MacroGenics @sitcancer @UbiVac @NCIDirector @FDAOncology https://t.co/PRf7JIFMmn,"genentech, AstraZeneca, Merck, EMDSerono, bmsnews, AstellasUS, Boehringer, pfizer, NovartisOncCT, Incyte, MacroGenics, sitcancer, UbiVac, NCIDirector, FDAOncology, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,
1176558075798380544,2020-09-10 16:39:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1304157539089735681,False,0,0,0,0,InsiderActionMonitor,$INCY  Incyte https://t.co/oWl26kquuh,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
2356524462,2020-09-10 16:26:05,"INCY, ",,,1304154197353472000,False,0,0,0,0,Stock News Alerts,"$INCY New Form 4 for Incyte Corporation
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1262915121103491074,2020-09-10 16:22:16,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1304153237172363264,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 961 shares on 2020-09-08. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
270544210,2020-09-10 14:31:20,,"MPNAwarenessDay, cancer, ","bagitcancer.org/order/, pic.twitter.com/UofTvyeVNy, pic.twitter.com/UofTvyeVNy, ",1304125320002498560,False,5,0,0,1,Twitter for iPhone,"Today is MPN Awareness Day. Together with @PatientPower and @mpnadvocacy, Bag It created a single Bag just for individuals with a MPN diagnosis-use the code MPN2020 to order a free bag through a generous sponsorship from @Incyte: https://t.co/XEzUjqzmAJ #MPNAwarenessDay #cancer https://t.co/UofTvyeVNy","PatientPower, mpnadvocacy, Incyte, ",,2011-03-22 16:27:51,"Tucson, AZ",Bag It - Cancer Support,https://pbs.twimg.com/profile_images/1104027437984231424/wDug0ljw_normal.jpg,314,446,8,2444,bagitcancer,photo
374729426,2020-09-10 10:48:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2086563, pic.twitter.com/oHJNAuvHgH, ",1304069155071483904,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on September 3, 2020. View odds for this and other indicators: https://t.co/zJiejaY1fP #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/oHJNAuvHgH",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1140762699002871808,2020-09-10 09:33:11,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1304050287871578112,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-09-10 09:33 ET. *Closed/Sold:
$INCY at $90.95 for 1.33 profit (1.48%). Incyte Corporation - Common Stock
Trade Id: 53357464103023124.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
39549428,2020-09-10 08:00:20,"GWPH, ",,,1304026920829542401,False,14,0,1,0,Twitter Web App,"$GWPH names David Gryska to Board

Mr. Gryska was Chief Financial Officer at Incyte Corporation, Celgene Corporation, Scios, Inc. 

Must-follow @apfeff56: CELG &amp; SCIO both got bought out.  Not trying to feed your theory, just sayin'.

My theory: efficient market.

/position","apfeff56, ",,2009-05-12 13:34:21,"New York, USA",Todd Harrison,https://pbs.twimg.com/profile_images/1405651184573165574/DcvxzY9U_normal.jpg,42397,1898,1089,56450,todd_harrison,
1134049078424162304,2020-09-09 23:30:22,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1303898586032336896,False,0,0,0,0,Newsfilter.io,Incyte Announces Recipient of the Inaugural Incyte Ingenuity Award to Recognize Innovative Solutions that Address Needs in the GVHD Community $INCY https://t.co/v2cei50z5U,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880677,newsfilterio,
2809497047,2020-09-09 21:32:36,,"sponsored, ","bit.ly/2QIZbME, ",1303868949537398785,False,3,0,0,0,Twitter for iPhone,Congratulations to @MGHCancerCenter on being this year‚Äôs recipient of @Incyte Ingenuity Award program. It‚Äôs been an honor to serve as a judge on the award panel. Learn more about the award-winning project. https://t.co/d9CWA7rup9 #sponsored,"MGHCancerCenter, Incyte, ",,2014-10-05 23:06:52,"Nashville, TN","Navneet Majhail, MD, MS",https://pbs.twimg.com/profile_images/1447967367594643470/9jzMSdvz_normal.jpg,16661,890,0,39555,BldCancerDoc,
950010035396136962,2020-09-09 17:01:42,,"Incyte, ","zonebourse.com/INCYTE-CORPORA‚Ä¶, ",1303800771708882946,False,0,0,0,0,Cresus AI,"#Incyte closed at 91.51. Score +101, credit rating AA https://t.co/XMro31aTzT",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
2875316246,2020-09-09 14:47:31,,,"twitter.com/Incyte/status/‚Ä¶, ",1303767004655095808,False,11,0,0,1,Twitter for iPhone,Thank you @Incyte for supporting our work to improve the lives of patients with chronic GVHD @MGHCancerCenter https://t.co/oK3bYdtj7h,"Incyte, MGHCancerCenter, ",,2014-10-24 10:31:35,"Boston, MA",Areej El-Jawahri,https://pbs.twimg.com/profile_images/673526914129113088/wxIbkSU1_normal.png,1069,389,22,1854,Areejmd,
325135887,2020-09-09 11:25:00,,"DLBCL, BloodCancerAwarenessMonth, lymsm, ","twitter.com/Incyte/status/‚Ä¶, ",1303716039063146498,False,1,0,0,0,Twitter Web App,"Thanks for raising awareness! @Incyte
""Approximately 30% of non-Hodgkin lymphoma cases are #DLBCL! Please join us in raising continued awareness of this serious disease"" #BloodCancerAwarenessMonth #lymsm https://t.co/oJT52884T4","Incyte, ",,2011-06-27 16:02:23,"Toronto, ON",Helix BioPharma,https://pbs.twimg.com/profile_images/1293297959094956032/F97JCcsC_normal.jpg,264,542,3,4204,HelixBioPharma,
243805548,2020-09-09 11:14:51,,"STEM, Biopharma, ","ow.ly/oZTm50Bm4Z6, pic.twitter.com/5qvjXUQhtO, ",1303713484522295306,False,0,0,0,0,Hootsuite Inc.,"Delaware is one of the strongest states for STEM-based industries. Learn how @Incyte and others are leading the way! #STEM, #Biopharma

https://t.co/C9h2YGjnSj https://t.co/5qvjXUQhtO","Incyte, ",,2011-01-27 16:15:51,Delaware,WeWorkForHealth,https://pbs.twimg.com/profile_images/378800000246557599/53a936eb6b2f1196eea42e8abfda803d_normal.jpeg,586,476,42,2854,WWFH_DE,photo
1280938376099741697,2020-09-09 11:09:11,,,"iexcloud.io, pic.twitter.com/5p1OYfNwrg, ",1303712060237381640,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Cadence Design Systems, Inc.
-Biogen, Inc.
-Cintas Corp.
-Incyte Corp.
-Invest Bank

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/5p1OYfNwrg",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2356524462,2020-09-09 11:06:52,"INCY, ",,,1303711474951610370,False,0,0,0,0,Stock News Alerts,"$INCY Incyte Announces Recipient of the Inaugural Incyte Ingenuity Award to Recognize Innovative Solutions th
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1006334607946649600,2020-09-09 11:02:33,,"StockMarket, ","dlvr.it/RgGzFM, ",1303710392443572225,False,0,0,0,0,dlvr.it,Incyte Announces Recipient of the Inaugural Incyte Ingenuity Award to Recognize Innovative Solutions that Address Needs in the GVHD Community https://t.co/sspMC10RmY #StockMarket,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
3911174913,2020-09-09 10:30:00,,"GVHD, ",,1303702199063674880,False,11,2,0,1,Twitter for Advertisers.,We're proud to announce that @MassGeneralNews is the recipient of the 2020 Incyte Ingenuity Award. Their innovative idea shows a commitment to improving the lives of those affected by graft-versus-host disease (#GVHD).,"MassGeneralNews, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
3318510966,2020-09-09 10:27:18,,,"crweworld.com/article/news-p‚Ä¶, ",1303701519577956353,False,0,0,0,0,CRWE World,Incyte Announces Recipient of the Inaugural Incyte Ingenuity Award to Recognize Innovative Solutions that Address Ne https://t.co/imE4MOTaRf,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3686628867,2020-09-09 10:20:23,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1303699777582960641,False,0,0,0,0,WordPress.com,Incyte Announces Recipient of the Inaugural Incyte Ingenuity Award to Recognize Innovative Solutions that Address Needs in the GVHD¬†Community https://t.co/80nBKJFzaf,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
976297820532518914,2020-09-09 10:16:11,,,"dlvr.it/RgGqdB, pic.twitter.com/lNKqwKSApG, ",1303698722946052096,False,0,0,0,0,dlvr.it,Incyte Announces Recipient of the Inaugural Incyte Ingenuity Award to Recognize Innovative Solutions that Address Needs in the GVHD Community https://t.co/00VvIENuqC https://t.co/lNKqwKSApG,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
472650465,2020-09-09 10:10:55,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1303697395516084226,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Recipient of the Inaugural Incyte Ingenuity Award to Recognize Innovative Solutions that Address Needs in the GVHD Community https://t.co/mrizzoByHw,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1069693680066420736,2020-09-09 10:08:23,"INCY, ",,"s.flashalert.me/lIMDai, ",1303696758002851840,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on September 09, 10:05:00: Incyte Announces Recipient of the Inaugural Incyte Ingenuity Award to Recognize Innovative Solutions that Address Needs in the GVHD Community https://t.co/xtSzPegmrt",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1140762699002871808,2020-09-09 09:32:10,"INCY, ",,"deustrader.com/optimus_mixus5‚Ä¶, ",1303687646351253504,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-09-09 09:32 ET. Bought/Opened:
$INCY at $89.59. 
Incyte Corporation - Common Stock
Win Chance: 76%. Avg Win: 3%. Avg Loss: 10.08%. Avg Hold: 6d.
Trade Id: 53357464103023124.
Stats: https://t.co/oAX4hq6SAg",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
374729426,2020-09-09 02:12:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2082455, pic.twitter.com/Gk6iRAbeuw, ",1303577111836336128,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/Mo4dEQZnI1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Gk6iRAbeuw,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1024815120,2020-09-08 13:47:55,,,"bizjournals.com/sanfrancisco/n‚Ä¶, ",1303389617576652802,False,1,0,0,1,Twitter Web App,"From Friday ‚Ä¶
As half-billion-dollar biotech partnership unravels, Peninsula drug maker switches up cancer drug deal https://t.co/luD6IKejZk via @SFBusinessTimes","SFBusinessTimes, ",,2012-12-20 14:00:15,San Francisco Bay Area,Ron Leuty,https://pbs.twimg.com/profile_images/3121280400/e26dc37cd9792a400c40c4d8d9ad2e79_normal.jpeg,816,80,59,3140,SFBIZronleuty,
3911174913,2020-09-08 12:20:00,,"DLBCL, BloodCancerAwarenessMonth, lymsm, ","pic.twitter.com/jkZJuOMzTP, ",1303367492492877825,False,0,1,0,2,Twitter for Advertisers.,Approximately 30% of non-Hodgkin lymphoma (NHL) cases are #DLBCL. Please join us in raising continued awareness of this serious disease. #BloodCancerAwarenessMonth #lymsm https://t.co/jkZJuOMzTP,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1291051117422489602,2020-09-08 10:45:27,,,"youtu.be/AUyzzke6i_4, instagram.com/p/CE4R9EHjDIJ/‚Ä¶, ",1303343697967243266,False,1,0,0,1,Instagram,"Excitement is building for our Virtual Gala tonight honoring @drdorisday Dr. Mark Lebwohl, Incyte, and pfizerinc and featuring @DrOz as MC!

Please tune-in Tonight at 6:30 pm! https://t.co/GhSQpfHHdO https://t.co/qjrrYWQbYN","DrDorisDay, DrOz, ",,2020-08-05 12:39:36,,AmericanSkinAssociation,https://pbs.twimg.com/profile_images/1291051467349123073/vhQdRMvk_normal.jpg,65,48,1,114,american_skin1,
374729426,2020-09-08 08:04:43,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2079011, pic.twitter.com/Aau84GofG1, ",1303303247264755712,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/3zwzRDAmZ8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Aau84GofG1,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1275755924410585088,2020-09-08 07:18:07,,"pharmanews, Cancer, lungcancer, ","delawarebusinessnow.com/2020/09/incyte‚Ä¶, ",1303291520896958465,False,0,0,0,0,Twitter Web App,"Incyte-Novartis lung cancer drug shows promising results in Phase 2 trial

https://t.co/5qAo145fv0

#pharmanews #Cancer #lungcancer",,,2020-06-24 07:41:39,,Antibiotic & Pharmaceutical News,https://pbs.twimg.com/profile_images/1313763543897067525/ekuQoR_G_normal.jpg,67,34,1,1044,AntibioticNews,
1280938376099741697,2020-09-08 06:44:26,,,"iexcloud.io, pic.twitter.com/VyBdjwJFc2, ",1303283044099534849,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Eshraq Investments PJSC
-First Abu Dhabi Bank PJSC
-Fastenal Co.
-Cognizant Technology Solutions Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/VyBdjwJFc2",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-09-07 17:03:40,,,"iexcloud.io, pic.twitter.com/54mix1nx08, ",1303076492889518080,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Netflix, Inc.
-Al Wathba National Insurance Co. PJSC
-Starbucks Corp.
-Dana Gas PJSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/54mix1nx08",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2020-09-07 09:01:23,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2076449, pic.twitter.com/q7UgMcJGsg, ",1302955121655967744,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/rNBOZEvHJR #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/q7UgMcJGsg,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-09-07 07:23:59,"INCY, ","investingnews, ","modernreaders.com/?p=3895957, ",1302930612630753280,False,0,0,0,0,Zapier.com,Nordea Investment Management AB Boosts Position in Incyte Co. $INCY  https://t.co/X1UPN4mf2j #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
944584021840887808,2020-09-07 04:30:26,,"AI, SmartCities, techblog, ","bit.ly/2GsO4Wo, ",1302886936344956928,False,0,0,0,0,Smart_home_diy_rdg,"Incyte Co. (NASDAQ:INCY) Expected to Announce Earnings of $0.73 Per Share
The firm is expected to announce its next quarterly earnings report on...

#AI #SmartCities via @1nterestingTech 
https://t.co/mWL93Okv1g
#techblog","1nterestingTech, ",,2017-12-23 10:02:35,"South East, England",AI & Smart Home Tech News,https://pbs.twimg.com/profile_images/944626379928276993/c-Lhhsz6_normal.jpg,37,3,1,44121,SmartHomeDiy,
930803511918411776,2020-09-07 03:35:12,"INCY, ",,"thelincolnianonline.com/?p=4629339, ",1302873037210083328,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY Will Post Quarterly Sales of $623.26 Million https://t.co/lgvW9XJeP1,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-09-07 03:34:00,"INCY, ",,"tickerreport.com/?p=6254120, ",1302872734754627584,False,0,0,0,0,Zapier.com,$623.26 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/6nECaOmp4G,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2298709746,2020-09-07 03:33:26,"INCY, ",,"zpr.io/Ha84i, ",1302872591640809472,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY Will Post Quarterly Sales of $623.26 Million https://t.co/uHjcSv6E16,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
732361939490312192,2020-09-07 03:33:08,"INCY, ","markets, ","americanbankingnews.com/?p=16076744, ",1302872514759217152,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY Will Post Quarterly Sales of $623.26 Million https://t.co/D9tsHrBtDx #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-09-07 03:33:07,"INCY, ","stocks, ","americanbankingnews.com/?p=16076744, ",1302872512552984579,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY Will Post Quarterly Sales of $623.26 Million https://t.co/fHlGpPx8Gg #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
19560636,2020-09-06 12:00:01,"INCY, ",,"bizjournals.com/sanfrancisco/n‚Ä¶, ",1302637687170629632,False,0,0,0,1,True Anthem,"As biotech partnership sours, one company opts to switch up cancer drug development deal
$INCY $CALA‚Äã https://t.co/0ou6mD1uSF",,,2009-01-26 16:53:18,San Francisco,San Francisco Business Times,https://pbs.twimg.com/profile_images/456849053133725697/U_NFM6pS_normal.png,41158,1760,2648,175608,SFBusinessTimes,
374729426,2020-09-06 07:48:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2072200, pic.twitter.com/bLugpfgUdE, ",1302574501150957571,False,0,0,1,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/DyyjmJhMZL #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/bLugpfgUdE,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
68559732,2020-09-06 03:14:40,"INCY, ",,"zpr.io/HaEn7, ",1302505478757453829,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Sees Large Increase in Short Interest https://t.co/6UHNk3h9KV,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
849417718642159616,2020-09-06 03:14:23,"INCY, ",,"zpr.io/HaEPr, ",1302505408674828288,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Sees Large Increase in Short Interest https://t.co/7sShFKqc9n,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
852931863547084801,2020-09-06 03:14:23,"INCY, ",,"zpr.io/HaEPS, ",1302505406917488641,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Sees Large Increase in Short Interest https://t.co/dz0dbQ0Sas,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
966006214818697218,2020-09-06 03:12:52,"INCY, ",,"theenterpriseleader.com/?p=3775612, ",1302505028461252608,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Sees Large Increase in Short Interest  https://t.co/p0MCiS3Ppx,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1280938376099741697,2020-09-06 00:43:41,,,"iexcloud.io, pic.twitter.com/FpgfeXSDZV, ",1302467485254463488,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Fujairah Building Industries PSC
-Emirates Driving Co.
-Sudan Telecom Group Ltd.
-Wynn Resorts Ltd.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/FpgfeXSDZV",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
19560636,2020-09-05 23:00:05,"INCY, ",,"bizjournals.com/sanfrancisco/n‚Ä¶, ",1302441413997666304,False,0,0,0,0,True Anthem,"As biotech partnership sours, one company opts to switch up cancer drug development deal
$INCY $CALA‚Äã https://t.co/QkOMeR9pQO",,,2009-01-26 16:53:18,San Francisco,San Francisco Business Times,https://pbs.twimg.com/profile_images/456849053133725697/U_NFM6pS_normal.png,41158,1760,2648,175608,SFBusinessTimes,
760593734983557120,2020-09-05 21:08:03,,,"reddit.com/r/shavedheadgi‚Ä¶, ",1302413215981277184,False,0,0,0,0,Reddit Official,"I just posted ""Shaved head means I get to try all the looks"" on Reddit

https://t.co/ciGvYmiV1i",,,2016-08-02 17:50:52,,WickedWillow,https://pbs.twimg.com/profile_images/1303878028519497728/WmLvslKi_normal.jpg,665,550,0,1810,marie_flaquita,
374729426,2020-09-05 11:57:52,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2066827, pic.twitter.com/aAMNMyveKy, ",1302274761439940608,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/S84EQnOvKP #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/aAMNMyveKy,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
19560636,2020-09-05 07:00:13,"INCY, ",,"bizjournals.com/sanfrancisco/n‚Ä¶, ",1302199854286991363,False,0,0,0,1,True Anthem,"As biotech partnership sours, one company opts to switch up cancer drug development deal
$INCY $CALA‚Äã https://t.co/CXS5e2awhk",,,2009-01-26 16:53:18,San Francisco,San Francisco Business Times,https://pbs.twimg.com/profile_images/456849053133725697/U_NFM6pS_normal.png,41158,1760,2648,175608,SFBusinessTimes,
334585053,2020-09-05 06:00:31,,,"s.einnews.com/xrpXfGLTSs, ",1302184828708761601,False,0,0,0,0,EIN Presswire,Incyte-Novartis lung cancer drug shows promising results in Phase 2 trial https://t.co/OLj0sl8Kgh,,,2011-07-13 06:16:51,"Washington, D.C.",EIN Presswire: Lung Cancer Newswire,https://pbs.twimg.com/profile_images/1288514359396904962/bd9OSmiA_normal.jpg,718,415,28,35060,EINLungCancer,
930803511918411776,2020-09-05 04:45:19,"INCY, ",,"thelincolnianonline.com/?p=4619236, ",1302165906773151744,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.73 Per Share https://t.co/mqcHJYAiCR,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2298709746,2020-09-05 04:44:40,"INCY, ",,"zpr.io/Hazsc, ",1302165742142525440,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.73 Per Share https://t.co/lVkt6jItez,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1979190776,2020-09-05 04:43:53,"INCY, ",,"tickerreport.com/?p=6244033, ",1302165544574087168,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Post Earnings of $0.73 Per Share https://t.co/hCWldLUReD,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2020-09-05 04:43:26,"INCY, ","markets, ","americanbankingnews.com/?p=16049656, ",1302165432179347456,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.73 Per Share https://t.co/nC2VFVAkv5 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-09-05 04:43:26,"INCY, ","stocks, ","americanbankingnews.com/?p=16049656, ",1302165430052827136,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.73 Per Share https://t.co/8pFXSZWISa #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2266388972,2020-09-05 01:44:01,"INCY, ","stocks, ","dailypolitical.com/?p=4489739, ",1302120280668635136,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/D5LI5APvJY #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-09-05 01:43:57,"INCY, ",,"dailypolitical.com/?p=4489739, ",1302120263853707264,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/G7S3zpytER,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2298709746,2020-09-05 01:43:38,"INCY, ",,"zpr.io/HaGYu, ",1302120182832390146,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/VslDquGKrA,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2920258887,2020-09-05 01:42:30,"INCY, ",,"dakotafinancialnews.com/?p=2426651, ",1302119896202055681,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/IX4btes301,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
14453501,2020-09-04 20:43:55,,,"delawarebusinessnow.com/2020/09/incyte‚Ä¶, ",1302044755459805189,True,0,0,0,0,WordPress.com,Incyte-Novartis lung cancer drug shows promising results in Phase 2¬†trial https://t.co/xNfsgB8Rhg,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
1024815120,2020-09-04 20:02:45,"CALA, INCY, ",,"bizjournals.com/sanfrancisco/n‚Ä¶, ",1302034398133522433,False,0,0,0,0,Twitter Web App,"As half-billion-dollar biotech partnership unravels, Peninsula drug maker switches up cancer drug deal https://t.co/vxiBAVj98W via @SFBusinessTimes 
$CALA $INCY","SFBusinessTimes, ",,2012-12-20 14:00:15,San Francisco Bay Area,Ron Leuty,https://pbs.twimg.com/profile_images/3121280400/e26dc37cd9792a400c40c4d8d9ad2e79_normal.jpeg,816,80,59,3140,SFBIZronleuty,
194343133,2020-09-04 20:01:43,"CALA, INCY, ",,"bizjournals.com/sanfrancisco/n‚Ä¶, ",1302034137717641219,False,0,0,0,0,Twitter Web App,"As half-billion-dollar biotech partnership unravels, Peninsula drug maker switches up cancer drug deal https://t.co/2ZooHOG65j via @SFBusinessTimes 
$CALA $INCY","SFBusinessTimes, ",,2010-09-23 18:19:15,San Francisco,Ron Leuty,https://pbs.twimg.com/profile_images/1282470797164990465/hLCS-eo6_normal.jpg,10810,1332,526,25964,rleuty_biotech,
19560636,2020-09-04 18:00:11,"INCY, ",,"bizjournals.com/sanfrancisco/n‚Ä¶, ",1302003552441823233,False,0,0,0,0,True Anthem,"As biotech partnership sours, one company opts to switch up cancer drug development deal
$INCY $CALA‚Äã https://t.co/5QtmtFoZtr",,,2009-01-26 16:53:18,San Francisco,San Francisco Business Times,https://pbs.twimg.com/profile_images/456849053133725697/U_NFM6pS_normal.png,41158,1760,2648,175608,SFBusinessTimes,
15433228,2020-09-04 13:28:32,,,"buff.ly/3i4YFVu, pic.twitter.com/Wlsnj3rinC, ",1301935187555737601,False,24,0,2,10,Buffer,"Superstar artist J.G. Jones uses his art to raise awareness about rare disease
https://t.co/vWhxIjMh2i
@JG_JONESfanpage @VoicesofMPN @Incyte https://t.co/Wlsnj3rinC","JG_JONESfanpage, VoicesofMPN, Incyte, ",,2008-07-14 18:24:27,NYC,Newsarama,https://pbs.twimg.com/profile_images/875830893021204480/0qA6Aeuk_normal.jpg,71485,6930,2236,71204,Newsarama,photo
1889492676,2020-09-04 10:22:18,"INCY, ","Incyte, GEOMETRY, Capmatinib, Tabrecta, METex14, NonSmallCellLungCancer, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1301888322894094337,False,0,0,0,0,Troi URL Plug-in,#Incyte Announces Pivotal #GEOMETRY mono-1 Study Results of #Capmatinib (#Tabrecta‚Ñ¢) in Patients with #METex14 Metastatic #NonSmallCellLungCancer Published in NEJM $INCY https://t.co/9Xud15N5QD,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
374729426,2020-09-04 10:16:18,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2064120, pic.twitter.com/73iM6OLsDz, ",1301886812109979649,False,0,0,0,1,Tickeron,"$INCY's price moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/Dsw5cVx3bI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/73iM6OLsDz",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-09-04 09:48:00,"INCY, ","investingnews, ","modernreaders.com/?p=3878923, ",1301879690718859265,False,0,0,0,0,Zapier.com,American International Group Inc. Has $8.89 Million Stock Holdings in Incyte Co. $INCY  https://t.co/VLonRemcEY #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1134049078424162304,2020-09-04 08:44:20,"CALA, INCY, ",,"newsfilter.io/articles/calit‚Ä¶, ",1301863669635178496,False,0,0,0,0,Newsfilter.io,Calithera nixes 2017 collaboration deal with Incyte $CALA $INCY https://t.co/LQvLXie7j2,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
15296897,2020-09-04 08:40:49,"CALA, INCY, ",,"seekingalpha.com/news/3611725-c‚Ä¶, ",1301862783781232640,False,1,0,0,0,SANewsTwitter,$CALA $INCY - Calithera nixes 2017 collaboration deal with Incyte https://t.co/t8xBNaJmVl,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
930803511918411776,2020-09-04 05:10:14,"INCY, ",,"thelincolnianonline.com/?p=4613323, ",1301809786493775873,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Increases By 11.9% https://t.co/t3KgPpBsrb,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
732361939490312192,2020-09-04 05:07:38,"INCY, ","markets, ","americanbankingnews.com/?p=16034290, ",1301809132606025728,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 11.9% in August https://t.co/HDHH0phFnj #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-09-04 05:07:36,"INCY, ","stocks, ","americanbankingnews.com/?p=16034290, ",1301809126083891201,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 11.9% in August https://t.co/M7rbGn6EbU #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2020-09-04 05:07:24,"INCY, ",,"tickerreport.com/?p=6238140, ",1301809072879087616,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 11.9% in August https://t.co/vz1wMtvHSc,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
3108471493,2020-09-03 18:53:41,,"SpeakerBook, Pharma, Jakafi, Incyte, KOLs, PikevilleMedicalCenter, CRM, ","speakerbookapp.com/Dr-Mohamad-Kha‚Ä¶, pic.twitter.com/xDjQ8y1Jvl, ",1301654628333953026,False,0,0,0,0,Twitter Web App,"Dr. Mohamad Khair Fayez Khasawneh of Pikeville Medical Center is today‚Äôs featured Incyte Jakafi Pharma KOL

https://t.co/79Jnfa8paX

#SpeakerBook #Pharma #Jakafi #Incyte #KOLs #PikevilleMedicalCenter #CRM https://t.co/xDjQ8y1Jvl",,,2015-03-26 12:31:57,"San Francisco, CA",SpeakerBookApp,https://pbs.twimg.com/profile_images/1276213672910548993/58yV0vbi_normal.png,93,1786,0,276,SpeakerBookApp,photo
1134049078424162304,2020-09-03 17:17:04,"CALA, ",,"newsfilter.io/articles/8-k-f‚Ä¶, ",1301630314977124358,False,0,0,0,0,Newsfilter.io,"Form 8-K: In January 2017, Calithera Biosciences and Incyte entered into a Collaboration and License Agreement, or the Incyte Agreeme.. $CALA https://t.co/X86slNyJIL",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1128239740329705472,2020-09-03 10:21:05,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1301525628550742021,False,0,0,0,1,Twitter for Android,"""The GEOMETRY mono-1 study results published in The New England Journal of Medicine further highlight the clinical benefit that Tabrecta can provide to patients with metastatic METex14 NSCLC.""

$INCY 
https://t.co/fIlgru5sks",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
374729426,2020-09-03 09:38:06,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2059837, pic.twitter.com/eac3HZZl0Y, ",1301514811172253696,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on August 20, 2020. View odds for this and other indicators: https://t.co/JBsFZLJ3w7 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/eac3HZZl0Y",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1280938376099741697,2020-09-03 06:56:48,,,"iexcloud.io, pic.twitter.com/QPBwj97kHi, ",1301474218182410240,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Abu Dhabi National Hotels
-Dollar Tree, Inc.
-Gulf Medical Projects Co.
-AXA Green Crescent Insurance Co. PJSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/QPBwj97kHi",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-09-02 23:47:22,,,"iexcloud.io, pic.twitter.com/1gyuEgrCP3, ",1301366146327818242,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Sharjah Cement &amp; Industrial Development 
-Al Qudra Holding PJSC
-Hasbro, Inc.
-Autodesk, Inc.
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/1gyuEgrCP3",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
334585053,2020-09-02 20:00:29,,,"s.einnews.com/AHB4d56lof, ",1301309049485627395,False,0,0,0,0,EIN Presswire,Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib (Tabrecta‚Ñ¢) in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in NEJM https://t.co/GsbLTPjAOj,,,2011-07-13 06:16:51,"Washington, D.C.",EIN Presswire: Lung Cancer Newswire,https://pbs.twimg.com/profile_images/1288514359396904962/bd9OSmiA_normal.jpg,718,415,28,35060,EINLungCancer,
2356524462,2020-09-02 19:06:17,"INCY, ",,,1301295408874950656,False,0,0,0,0,Stock News Alerts,"$INCY Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib (Tabrecta‚Ñ¢) in Patients with METex
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1006334607946649600,2020-09-02 18:12:02,,"StockMarket, ","dlvr.it/RfsMGp, ",1301281758495739904,False,0,0,0,0,dlvr.it,Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib (Tabrecta‚Ñ¢) in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in NEJM https://t.co/tB7wvwPnxY #StockMarket,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
3911174913,2020-09-02 17:13:10,,"Breaking, lungcancer, ",,1301266946151809024,False,2,0,0,1,Twitter for Advertisers.,#Breaking: @NEJM published pivotal results from the GEOMETRY mono-1 study of an Incyte-discovered therapy for patients with METex14 metastatic non-small cell #lungcancer (NSCLC).,"NEJM, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
472650465,2020-09-02 17:11:02,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1301266406856630273,False,1,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib (Tabrecta‚Ñ¢) in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in NEJM https://t.co/GrG2G2l9cY,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
3318510966,2020-09-02 17:06:15,,,"crweworld.com/article/news-p‚Ä¶, ",1301265203384840192,False,0,0,0,0,CRWE World,Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib (Tabrecta‚Ñ¢) in Patients with METex14 Metastat https://t.co/i9uP00poIy,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1134049078424162304,2020-09-02 17:05:04,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1301264904024883202,False,0,0,0,0,Newsfilter.io,Incyte Announces Pivotal GEOMETRY mono-1 Study Results of Capmatinib in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in.. $INCY https://t.co/C5l82xzjX2,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2570920968,2020-09-02 12:17:00,,,"twitter.com/Incyte/status/‚Ä¶, ",1301192410345553920,False,0,0,0,0,Twitter Web App,"Congrats @Incyte! Keep up good work! ""Our inflammation &amp; autoimmunity research team utilizes its cross-functional knowledge of our programs to discover, develop &amp; deliver innovative approaches to treating immune-mediated diseases"" https://t.co/kWGhaHALBu","Incyte, ",,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
374729426,2020-09-02 09:59:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2055710, pic.twitter.com/Hhw4E5j8E4, ",1301157842192277507,False,1,0,0,0,Tickeron,"$INCY's 10-day Moving Average broke below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/NP3OBJj9j7 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Hhw4E5j8E4",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
365454476,2020-09-02 09:05:59,,"automation, AI, Analytics, ","hubs.ly/H0vrJCy0, ",1301144339725332480,False,0,0,0,0,HubSpot,"What‚Äôs your post-crisis #automation plan? ‚Äì it's time to speed up your journey! Listen to @ElenaLChristoph as we showcased the power of the Triple-A trifecta with real examples from NextEra Energy, Incyte Pharma &amp; @Cognizant. #AI #Analytics 

https://t.co/DMjKXyeN2R","ElenaLChristoph, Cognizant, ",,2011-08-31 09:32:19,"Cambridge, England [HQ]",HFS Research,https://pbs.twimg.com/profile_images/1019581946039545856/DezsjDVr_normal.jpg,11997,1528,783,25484,HFSResearch,
1280938376099741697,2020-09-02 09:01:08,,,"iexcloud.io, pic.twitter.com/FbzagsQF4b, ",1301143120147632128,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Sudan Telecom Group Ltd.
-Costco Wholesale Corp.
-Illumina, Inc.
-Analog Devices, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/FbzagsQF4b",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1889492676,2020-09-02 08:10:43,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1301130430746300419,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/jTkKCz7j5T,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1134049078424162304,2020-09-02 01:46:36,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1301033764697649152,False,0,0,0,0,Newsfilter.io,Incyte to Present at Upcoming Investor Conference $INCY https://t.co/DrYgrypc1i,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
3911174913,2020-09-01 15:53:42,,"BloodCancerAwarenessMonth, ","pic.twitter.com/kXKiCoEusq, ",1300884557961592834,False,36,0,3,13,Twitter Web App,"We Solve On. for the blood cancer community. This #BloodCancerAwarenessMonth, we're reflecting on memorable milestones that have supported the blood cancer community over the years. https://t.co/kXKiCoEusq",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
19277975,2020-09-01 15:25:43,,"BakerBrothers, biotechinvesting, investing, biotech, incyte, seattlegenetics, beigene, ","onefamilysblog.com/2020/09/tracki‚Ä¶, ",1300877515775500288,False,0,0,0,0,Twitter Web App,Baker Brothers Portfolio - Q2 2020 Update @ https://t.co/chcVno7vQu #BakerBrothers #biotechinvesting #investing #biotech #incyte #seattlegenetics #beigene,,,2009-01-21 00:45:56,"Williamsville, NY, USA",John Vincent,https://pbs.twimg.com/profile_images/72255905/SantaCruzBoardWalk_normal.JPG,364,110,38,1881,OneFamilysBlog,
2920258887,2020-09-01 14:52:31,"INCY, ",,"dakotafinancialnews.com/?p=2411079, ",1300869161820844032,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Brokerages https://t.co/3cS6sMXuzn,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
852931863547084801,2020-09-01 14:49:07,"INCY, ",,"zpr.io/HTsCe, ",1300868306342162440,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Brokerages https://t.co/m2L95L4BvZ,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
19772521,2020-09-01 11:55:03,,,"pic.twitter.com/zn06KYyJUL, ",1300824500536250368,False,0,0,0,0,Twitter Web App,Incyte Intelligent Security is on a mission to make communities safer by blending artificial intelligence with security systems to make your cameras smarter. Our team helped them launch a new site that details their solutions for proactive and preventative security measures https://t.co/zn06KYyJUL,,,2009-01-30 10:44:36,Memphis,"inferno, LLC",https://pbs.twimg.com/profile_images/1352396757431410688/qFaheuV8_normal.jpg,1374,1215,125,1786,creativeinferno,video
1029353745472266240,2020-09-01 11:00:26,,,"twitter.com/HartungIngo/st‚Ä¶, ",1300810756624199681,False,2,0,0,1,Twitter Web App,We're really pleased to see the final article published. Great to collaborate with colleagues @Incyte on this. https://t.co/8VXixNMhPM,"Incyte, ",,2018-08-14 09:07:12,United Kingdom,Hypha Discovery,https://pbs.twimg.com/profile_images/1418248116910886916/yp6x9K3X_normal.jpg,49,46,2,77,HyphaD,
374729426,2020-09-01 08:51:02,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2051534, pic.twitter.com/D84t17RWyy, ",1300778192316243974,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/t4vciw2294 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/D84t17RWyy",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1069693680066420736,2020-09-01 08:05:50,"INCY, ",,"s.flashalert.me/hvUzO6, ",1300766814150983680,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on September 01, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/u8agewLR9T",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2020-09-01 08:04:33,,,"dlvr.it/Rfltss, pic.twitter.com/2o0bgx8yVz, ",1300766492158357504,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conference https://t.co/v2J86ehYGo https://t.co/2o0bgx8yVz,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2020-09-01 08:04:10,,,"crweworld.com/article/news-p‚Ä¶, ",1300766396171743234,False,0,0,0,0,CRWE World,Incyte to Present at Upcoming Investor Conference https://t.co/hYlkmympYq,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
472650465,2020-09-01 08:03:40,"INCY, ",,"otcdynamics.com/incy-incyte-to‚Ä¶, ",1300766270934192128,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte to Present at Upcoming Investor Conference https://t.co/cQa32L5WQg,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
2356524462,2020-09-01 08:03:23,"INCY, ",,,1300766200696369153,False,0,0,0,0,Stock News Alerts,"$INCY Incyte to Present at Upcoming Investor Conference
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1134049078424162304,2020-09-01 04:34:27,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1300713619374714880,False,0,0,0,0,Newsfilter.io,"$1,510,800.00 of shares sold by Dixon Wendy L (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/QKflCmzvVo",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1280938376099741697,2020-08-31 22:48:38,,,"iexcloud.io, pic.twitter.com/n5u19Rm9Zd, ",1300626591400288258,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Liberty Global Plc
-NetApp, Inc.
-Alphabet, Inc.
-Cintas Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/n5u19Rm9Zd",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2344420430,2020-08-31 16:48:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1300535935591952386,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

WENDY L DIXON:

https://t.co/IbadPUenrZ",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-08-31 16:40:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1300533913086025728,False,0,0,0,0,InsiderActionMonitor,$INCY Wendy Dixon sells $1.9M Worth Of Incyte Stock https://t.co/hrVlR4Zaj0,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
2356524462,2020-08-31 16:32:13,"INCY, ",,,1300531864059424768,False,0,0,0,0,Stock News Alerts,"$INCY New Form 4 for Incyte Corporation
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1278474376074145795,2020-08-31 16:30:15,,"INCY, stockmarketnews, stock2020, trading, Finance, stockstowatch, YahooFinance, ","insiderdrop.com, ",1300531369571999747,False,0,0,0,0,Twitter,"An executive and/or major shareholder of #INCY (INCYTE CORP) sold ~$ 1,890,200 worth of its shares.

Check more @ https://t.co/EUocy7ZmFg

 #stockmarketnews #stock2020 #trading #Finance #stockstowatch #YahooFinance",,,2020-07-01 19:43:59,,insiderdrop,https://pbs.twimg.com/profile_images/1280996191443001345/mul90PPh_normal.jpg,92,0,0,7424,insiderdrop,
1262915121103491074,2020-08-31 16:27:01,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1300530556145262592,False,0,0,0,0,formwhispers,"#FWSells $INCY DIXON WENDY L, Director of INCYTE CORP sold 20000 shares on 2020-08-27. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
3301684581,2020-08-31 16:06:02,,,"msho.org/aws/MSHO/pt/sd‚Ä¶, pic.twitter.com/3UiJFR0XE6, ",1300525272052178945,False,0,0,0,0,Twitter Web App,"Beginning Tuesday, September 1, join @Incyte for their virtual Monjuvi Speaker Program. This event offers several days and times to tune in. To learn more or to register, please visit https://t.co/ZtCSKEpfYs. https://t.co/3UiJFR0XE6","Incyte, ",,2015-05-28 09:25:56,"Troy, MI",MSHO,https://pbs.twimg.com/profile_images/609440725072261120/fNwcRP4D_normal.jpg,433,216,11,1776,MSHO1985,photo
374729426,2020-08-31 10:15:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2047655, pic.twitter.com/VppzjV7C6A, ",1300437146080165888,False,0,0,0,1,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on August 26, 2020. View odds for this and other indicators: https://t.co/qSK13WD8f5 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/VppzjV7C6A",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-08-31 09:27:23,"INCY, ","investingnews, ","modernreaders.com/?p=3857473, ",1300424952085184513,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Shares Sold by Bank of New York Mellon Corp  https://t.co/lmfYQ3BHRS #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
3363332327,2020-08-30 22:30:06,,,"buff.ly/2QxhYe4, pic.twitter.com/dLWYMHJwa9, ",1300259540223561728,False,0,0,0,0,Buffer,"FDA Action Alert: PTC and Roche, Lipocine, Incyte and Morphosys, and BMS https://t.co/flCYVGnul3 https://t.co/dLWYMHJwa9",,,2015-07-06 20:15:16,"Stockholm, Sweden",Swedish Biotech,https://pbs.twimg.com/profile_images/825044879411650560/BVzozrPt_normal.jpg,2794,2365,25,25407,BiotechSweden,photo
3363291113,2020-08-30 19:50:02,,,"buff.ly/2QxhYe4, pic.twitter.com/VA4IHuY4e0, ",1300219256504823808,False,0,0,0,0,Buffer,"FDA Action Alert: PTC and Roche, Lipocine, Incyte and Morphosys, and BMS https://t.co/B2GOxGhVcF https://t.co/VA4IHuY4e0",,,2015-07-06 19:40:06,"Chicago, IL",Julie Lakeview,https://pbs.twimg.com/profile_images/926542318190104576/eZp4RhRN_normal.jpg,897,892,10,17512,LakeviewJulie,photo
765563638048395269,2020-08-30 19:50:01,,,"buff.ly/2QxhYe4, pic.twitter.com/EvtoipZjrf, ",1300219254940332032,False,0,0,0,0,Buffer,"FDA Action Alert: PTC and Roche, Lipocine, Incyte and Morphosys, and BMS https://t.co/X9GC6I08f4 https://t.co/EvtoipZjrf",,,2016-08-16 10:59:29,"Illinois, USA",Financial Carnivores,https://pbs.twimg.com/profile_images/765582076095574016/gWTrUTCM_normal.jpg,1790,1856,113,24792,HowieRegay,photo
2956378806,2020-08-30 19:14:01,,,"buff.ly/2QxhYe4, pic.twitter.com/FnuWattcyn, ",1300210195285643265,False,0,0,0,0,Buffer,"FDA Action Alert: PTC and Roche, Lipocine, Incyte and Morphosys, and BMS https://t.co/p3vgpxmhgW https://t.co/FnuWattcyn",,,2015-01-02 13:41:09,"Chicago, IL",Truth Studio,https://pbs.twimg.com/profile_images/1095825450553663489/V4th0Ouy_normal.png,1984,2087,22,20090,TheTruthStudio,photo
374729426,2020-08-30 16:48:25,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2044258, pic.twitter.com/nwFfG78GuO, ",1300173552864223233,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on August 26, 2020. View odds for this and other indicators: https://t.co/Ml1JCJdGzP #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/nwFfG78GuO",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2298709746,2020-08-30 11:27:12,"INCY, ",,"zpr.io/HYdy7, ",1300092716861329410,False,0,0,0,0,Zapier.com,Brokerages Set Incyte Co. $INCY Price Target at $101.63 https://t.co/hbfkUopw8O,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
849417718642159616,2020-08-30 11:27:10,"INCY, ",,"zpr.io/HYdyR, ",1300092708246237191,False,0,0,0,0,Zapier.com,Brokerages Set Incyte Co. $INCY Price Target at $101.63 https://t.co/EJFzvuJFMV,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2525892205,2020-08-30 11:25:14,"INCY, ","investingnews, ","modernreaders.com/?p=3855741, ",1300092220440182785,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $101.63 Consensus PT from Analysts  https://t.co/iuMoKwDVpf #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
966006214818697218,2020-08-30 11:23:33,"INCY, ",,"theenterpriseleader.com/?p=3744520, ",1300091795867611139,False,0,0,0,0,Zapier.com,Brokerages Set Incyte Co. $INCY Price Target at $101.63  https://t.co/8wJmviadpt,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
875107384535900161,2020-08-30 08:57:01,,"JobSearch, jobseekers, Jobs, ","jobs.frontend.la/i/us/all/1/053‚Ä¶, ",1300054918250688512,False,0,0,0,0,FrontendLA,"New opportunity in Wilmington, DE - Research Investigator, Chemistry (Computational) @ Incyte Corporation  https://t.co/qBdKK5G6Cn #JobSearch #jobseekers #Jobs",,,2017-06-14 17:47:14,,Frontend.LA,https://pbs.twimg.com/profile_images/1275071694609080320/lPHtH4S__normal.jpg,234,24,5,590801,FrontendLA,
1280938376099741697,2020-08-29 21:02:21,,,"iexcloud.io, pic.twitter.com/rrYfOq59Kr, ",1299875068206559232,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Agthia Group PJSC
-NXP Semiconductors NV
-Al Wathba National Insurance Co. PJSC
-Incyte Corp.
-American Airlines Group, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/rrYfOq59Kr",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1022006086872821762,2020-08-29 06:01:32,"INCY, INCY, ",,,1299648369904816128,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Fri Aug 28
Closed at 93.90 USD for a -0.42% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
875107384535900161,2020-08-29 05:24:00,,"JobSearch, jobseekers, Jobs, ","jobs.frontend.la/i/us/all/1/04c‚Ä¶, ",1299638926534008833,False,0,0,0,0,FrontendLA,"New opportunity in Pullman, WA - Phlebotomist @ InCyte Diagnostics  https://t.co/KyC34MgjA5 #JobSearch #jobseekers #Jobs",,,2017-06-14 17:47:14,,Frontend.LA,https://pbs.twimg.com/profile_images/1275071694609080320/lPHtH4S__normal.jpg,234,24,5,590801,FrontendLA,
1280938376099741697,2020-08-28 23:04:54,,,"iexcloud.io, pic.twitter.com/73UVKgbw7S, ",1299543521897132033,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Charter Communications, Inc.
-Mylan NV
-National Bank of Fujairah PJSC
-Incyte Corp.
-Paychex, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/73UVKgbw7S",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-08-28 20:43:55,,,"iexcloud.io, pic.twitter.com/y1WpcB1FeS, ",1299508040471900160,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Ras Al-Khaimah National Insurance Co.
-Incyte Corp.
-National Bank of Umm Al-Qaiwain PSC
-Apple, Inc.
-Umm Al-Qaiwain General Investments Co. P

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/y1WpcB1FeS",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
55654926,2020-08-28 17:47:12,,,"cholangiocarcinoma.org/five-for-frida‚Ä¶, ",1299463569600180224,False,4,0,0,2,Twitter Web App,"https://t.co/5JvO4z2Iue

DO THE FIVE ü§ö

During our 2020 AC, Incyte shared the results from a 700 patient survey that found that patients with CCA are heavily impacted by depression.

This week we'd like to offer 5 reliable resources to help navigate through depression.",,,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,
22195223,2020-08-28 13:35:02,,,"cancernetwork.com/view/nccn-adds‚Ä¶, ",1299400110766514176,False,0,0,0,0,Hootsuite Inc.,"The National Comprehensive Cancer Network has added tafasitamab-cxix (Monjuvi) to the Clinical Practice Guidelines in Oncology for B-cell Lymphomas. | @NCCN @MorphoSys @Incyte 
https://t.co/Z6OmAOvpN4","NCCN, MorphoSys, Incyte, ",,2009-02-27 16:48:14,"Cranbury, NJ","CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",https://pbs.twimg.com/profile_images/1196832187376685056/BU2C0XFo_normal.jpg,23603,452,498,13559,CancerNetwrk,
374729426,2020-08-28 11:13:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2040106, pic.twitter.com/6Jzr4RBuaM, ",1299364532125462529,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/J3nb9uPB7F #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/6Jzr4RBuaM",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2956378806,2020-08-28 06:25:02,,,"buff.ly/2QxhYe4, pic.twitter.com/vBSW8y0CXg, ",1299291896934694914,False,0,0,0,0,Buffer,"FDA Action Alert: PTC and Roche, Lipocine, Incyte and Morphosys, and BMS https://t.co/p3vgpxmhgW https://t.co/vBSW8y0CXg",,,2015-01-02 13:41:09,"Chicago, IL",Truth Studio,https://pbs.twimg.com/profile_images/1095825450553663489/V4th0Ouy_normal.png,1984,2087,22,20090,TheTruthStudio,photo
2920258887,2020-08-28 05:17:18,"INCY, ",,"dakotafinancialnews.com/?p=2392341, ",1299274851417456640,False,0,0,0,0,Zapier.com,Incyte $INCY Cut to Strong Sell at BidaskClub https://t.co/EtllqrMT4s,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
2416188264,2020-08-28 04:46:10,"INCY, ","markets, ","thestockobserver.com/?p=3390333, ",1299267016377937921,False,0,0,0,0,Zapier.com,Incyte $INCY Cut to Strong Sell at BidaskClub  https://t.co/GV3lLud57g #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2020-08-28 04:43:59,"INCY, ",,"zpr.io/HYAAE, ",1299266466378903554,False,0,0,0,0,Zapier.com,Incyte $INCY Cut to Strong Sell at BidaskClub https://t.co/6RIfxcmMUH,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
72824727,2020-08-28 04:33:32,,,"dlvr.it/RfW26C, pic.twitter.com/7TQuS4uNAn, ",1299263837158350848,False,0,0,0,0,dlvr.it,Incyte Corporation: Oncology Nurse Educator ‚Äì Midwest ‚Äì United States https://t.co/xFiBbDa2Ez https://t.co/7TQuS4uNAn,,,2009-09-09 06:53:05,,fauzi wong,https://pbs.twimg.com/profile_images/406045186/batasai_normal.jpg,1776,751,19,35310,fauziwong,photo
1199578004634165248,2020-08-27 13:42:53,,,"primefeed.in/news/3843714/c‚Ä¶, ",1299039696480112640,False,1,0,0,0,Twitter Web App,"COVID-19 Impact on Global Market Share 2020 | Ascletis Pharma Inc., OncoImmune, FUJIFILM Toyama Chemical Co., Ltd.; Sanofi, Gilead Sciences, Incyte Corporation, Hoffmann La Roche, Vanda Pharmaceuticals, Apeiron Biologics https://t.co/XmxkTmjTkV",,,2019-11-27 01:37:48,india,Market Research,https://pbs.twimg.com/profile_images/1199581004240809984/t8nPviiS_normal.jpg,205,42,0,4192,PrimaryResearc2,
374729426,2020-08-27 11:51:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2034490, pic.twitter.com/HKSKGDh3R7, ",1299011789288386562,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/s3qldbX0Ma #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/HKSKGDh3R7",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-08-27 04:27:45,"INCY, ","markets, ","americanbankingnews.com/?p=15907497, ",1298899994691489792,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Analysts https://t.co/hoJDHveCtd #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-08-27 04:27:42,"INCY, ","stocks, ","americanbankingnews.com/?p=15907497, ",1298899979034144768,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Analysts https://t.co/O7RVVVDjPD #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
930803511918411776,2020-08-27 04:26:11,"INCY, ",,"thelincolnianonline.com/?p=4564756, ",1298899598170370048,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Analysts https://t.co/T5UaexIr3S,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-08-27 04:23:32,"INCY, ",,"tickerreport.com/?p=6189527, ",1298898931053723648,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Analysts https://t.co/kvLYiN4hfh,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
68559732,2020-08-27 04:23:24,"INCY, ",,"zpr.io/HYzjU, ",1298898900015816704,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Analysts https://t.co/YkU3NcOFdG,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2525892205,2020-08-27 03:53:53,"INCY, ","investingnews, ","modernreaders.com/?p=3836889, ",1298891470171181056,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Strong Sell at BidaskClub  https://t.co/MuRtwbyq9i #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
966006214818697218,2020-08-27 03:51:02,"INCY, ",,"theenterpriseleader.com/?p=3725714, ",1298890754023137280,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Strong Sell at BidaskClub  https://t.co/cU3e8y8Nea,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
875107384535900161,2020-08-27 01:51:30,,"JobSearch, jobseekers, Jobs, ","jobs.frontend.la/i/us/all/1/04b‚Ä¶, ",1298860673313542145,False,0,0,0,0,FrontendLA,"New opportunity in Wilmington, DE - Associate Director, Global Medical Affairs Operations @ Incyte Corporation  https://t.co/ZI5cCPRkvM #JobSearch #jobseekers #Jobs",,,2017-06-14 17:47:14,,Frontend.LA,https://pbs.twimg.com/profile_images/1275071694609080320/lPHtH4S__normal.jpg,234,24,5,590801,FrontendLA,
1134049078424162304,2020-08-26 21:16:56,"ONCY, INCY, ",,"newsfilter.io/articles/dosin‚Ä¶, ",1298791576781586432,False,0,0,0,0,Newsfilter.io,Dosing underway in Oncolytics Bio/Incyte IRENE study in breast cancer $ONCY $INCY https://t.co/ByzWIICbPe,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1259512942611042304,2020-08-26 20:00:16,,,,1298772281343311873,False,0,0,0,1,ARK Tracker,"ü§ë On Wednesday, August 26th, ARK Invest sold:

ARCTURUS THERAPEUTICS HOLDIN
GUARDANT HEALTH INC
CAREDX INC
CELLECTIS - ADR
INCYTE CORP
FATE THERAPEUTICS INC
CODEXIS INC
PERSONALIS INC
CASTLE BIOSCIENCES INC
10X GENOMICS INC-CLASS A
IONIS PHARMACEUTICALS INC
CEL...",,,2020-05-10 11:57:58,,ARK Portfolio Update,https://pbs.twimg.com/profile_images/1261199027644911616/LHe9RHIo_normal.jpg,562,1,10,309,ARKTracker,
374729426,2020-08-26 14:43:49,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2032249, pic.twitter.com/SvRHiyYcGY, ",1298692645946966016,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/HP7wUHERKG #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/SvRHiyYcGY",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3063963289,2020-08-26 08:17:18,,,"seekingalpha.com/news/3608914-d‚Ä¶, ",1298595371787194368,False,0,0,0,0,Circleboom Twitter Management,‚ñ∂Ô∏é Dosing underway in Oncolytics Bio/Incyte IRENE study in breast cancer https://t.co/NdqW2zFxkh VIŒõ WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö FINŒõNCIŒõL REŒõDS,,,2015-03-05 22:29:44,United States,WIC“ö∆∏Ô∏éƒê‚úß»òPƒøI“¨≈ö,https://pbs.twimg.com/profile_images/1131561059075145728/T_Tj4P-S_normal.jpg,2718,210,0,36814,WickedSplits,
2298709746,2020-08-26 03:59:55,"INCY, ",,"zpr.io/HsQug, ",1298530603151892480,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded to Strong Sell at BidaskClub https://t.co/ibSUXId3sT,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
849417718642159616,2020-08-26 03:57:19,"INCY, ",,"zpr.io/HsQy4, ",1298529946047000581,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded to Strong Sell at BidaskClub https://t.co/sQ1uOhAapI,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1280938376099741697,2020-08-25 20:21:50,,,"iexcloud.io, pic.twitter.com/kjEzMLXXiI, ",1298415319682342912,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Baidu, Inc.
-Incyte Corp.
-J.B. Hunt Transport Services, Inc.
-Charter Communications, Inc.
-Liberty Global Plc

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/kjEzMLXXiI",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1140762699002871808,2020-08-25 16:02:55,"INCY, ",,"deustrader.com/optimus_mixus4‚Ä¶, ",1298350160255180800,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-08-25 15:58 ET. *Closed/Sold:
$INCY at $95.10 for 1.96 loss (-2.03%). Incyte Corporation - Common Stock
Trade Id: 50259474803044344.
Stats: https://t.co/JZ1yafbugd",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
852592522165710848,2020-08-25 13:18:56,,"MPNHeroes, ","bit.ly/3gt9lM2, twitter.com/VoicesofMPN/st‚Ä¶, ",1298308893609787397,False,4,0,0,3,Twitter Web App,"Nominate your heroes for the #MPNHeroes awards program! Annual program recognize individuals, institutions, and organizations who go above and beyond in their efforts to support patients with MPNs. Submit your nomination by Sept.10: https://t.co/bdySmqQUvG @cure_magazine @Incyte https://t.co/BiGLr1ycp4","cure_magazine, Incyte, ",,2017-04-13 14:41:12,"Cranbury, NJ",MJH Life Sciences,https://pbs.twimg.com/profile_images/1156907434289586181/DeRSnQDU_normal.jpg,959,2752,9,2155,MJHLifeSciences,
2525892205,2020-08-25 11:07:47,"INCY, ","investingnews, ","modernreaders.com/?p=3830619, ",1298275890581901313,False,0,0,0,0,Zapier.com,"Bank of Nova Scotia Sells 262,265 Shares of Incyte Co. $INCY  https://t.co/RqXUOePEgT #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
374729426,2020-08-25 10:26:19,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2026521, pic.twitter.com/DFtpsy7QqT, ",1298265455560232960,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/WBONwtzPKb #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/DFtpsy7QqT",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
68559732,2020-08-25 05:38:54,"INCY, ",,"zpr.io/HsLXw, ",1298193122824986625,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Strong Sell at BidaskClub https://t.co/9S6K84egxl,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
21793154,2020-08-24 15:06:39,,"biospace, lifesciences, biotechnology, pharmaceuticals, fda, actionalert, ","hubs.ly/H0tZm140, ",1297973615359598594,False,4,0,0,1,HubSpot,"FDA Action Alert: PTC and Roche, Lipocine, Incyte and Morphosys, and BMS

#biospace #lifesciences #biotechnology #pharmaceuticals #fda #actionalert

https://t.co/rivYXhqavf",,,2009-02-24 15:27:40,"Des Moines, IA",BioSpace,https://pbs.twimg.com/profile_images/1042117112020389888/8MCBEVkx_normal.jpg,21738,2830,509,25196,biospace,
374729426,2020-08-24 11:38:16,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2024195, pic.twitter.com/0Tb9wfwKUE, ",1297921172206624769,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/YlwVfYPbiJ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0Tb9wfwKUE",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
875382419251019776,2020-08-24 11:34:37,,,"bit.ly/32ivzeM, pic.twitter.com/TYZaz4LVMB, ",1297920255935696898,False,0,0,0,0,dlvr.it,"FDA Action Alert: PTC and Roche, Lipocine, Incyte and Morphosys, and BMS https://t.co/bafd81B2n0 https://t.co/TYZaz4LVMB",,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
777467401629753344,2020-08-23 16:57:53,,,"forbes.com/sites/greatspe‚Ä¶, ",1297639217561034761,False,2,0,0,1,Twitter Web App,"Here is the short-term outlook and a pair of trading recommendations‚Ä¶

https://t.co/DhNGx9bzei",,,2016-09-18 07:20:48,Austria,Bill Sarubbi,https://pbs.twimg.com/profile_images/819997437947420672/QlRk9nHI_normal.jpg,582,27,5,404,cyclesresearch7,
2416188264,2020-08-23 15:36:10,"INCY, ","markets, ","thestockobserver.com/?p=3371970, ",1297618652515246080,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Sees Significant Decrease in Short Interest  https://t.co/Y7pmiW4ST3 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1248679277815631875,2020-08-23 14:46:32,,,"dlvr.it/RfBwtK, ",1297606163068882944,False,0,0,0,0,dlvr.it,Stocks This Week: Buy Qualcomm And Sell Short Incyte https://t.co/Cysn39KI8D,,,2020-04-10 14:29:12,"New York, New York ",Michael Arteca,https://pbs.twimg.com/profile_images/1248680705791492097/uiKYUKzg_normal.jpg,8,37,0,568,arteca_michael,
1288407401612312577,2020-08-23 14:28:32,,,"dlvr.it/RfBv1d, ",1297601634957012992,False,0,0,0,0,dlvr.it,Stocks This Week: Buy Qualcomm And Sell Short Incyte https://t.co/63mGPPhhag,,,2020-07-29 05:34:09,,accumulateALGO,https://pbs.twimg.com/profile_images/1352568524045242370/tlu1LPci_normal.jpg,412,111,5,1454,accumulate_algo,
354537587,2020-08-23 14:01:37,,,"dlvr.it/RfBr6K, pic.twitter.com/5Az0IeQGni, ",1297594860082352135,True,0,0,0,1,dlvr.it,Stocks This Week: Buy Qualcomm And Sell Short Incyte https://t.co/FiCTVekLKs https://t.co/5Az0IeQGni,,,2011-08-13 18:02:26,,George Mentz JD MBA CWM,https://pbs.twimg.com/profile_images/645305436032229376/OLzZNOQD_normal.png,169213,798,54,280565,GeorgeMentz,photo
2920258887,2020-08-23 13:00:36,"INCY, ",,"dakotafinancialnews.com/?p=2374711, ",1297579506350333952,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/mNeUlIDtlv,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
852931863547084801,2020-08-23 12:59:56,"INCY, ",,"zpr.io/HsEdm, ",1297579338540425217,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/kI7aH5hktx,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
19824937,2020-08-23 12:50:32,,,"dlvr.it/RfBj1F, ",1297576971849707521,False,0,0,0,0,dlvr.it,"Stocks This Week: Buy Qualcomm And Sell Short Incyte (Bill Sarubbi, Contributor/Forbes.com Market News) https://t.co/5CH5PHpkQw",,,2009-01-31 13:19:30,San Francisco,Tech Investor News,https://pbs.twimg.com/profile_images/1859471018/TINFavicon2012-FINAL_normal.png,3009,83,647,167423,TechInvestNews,
3534222021,2020-08-23 12:36:34,,"Stocks, Week, ","Forbes.com, newsoneplace.com/27957711911/st‚Ä¶, pic.twitter.com/ESe4ou5Yan, ",1297573456712732678,False,0,0,0,0,Newsoneplace To Twitter,(https://t.co/eOsQVakj6c):#Stocks This #Week: Buy Qualcomm And Sell Short Incyte : The S&amp;P is likely to rally for one more week before pulling back in September. .. https://t.co/cgOTzAI35K https://t.co/ESe4ou5Yan,,,2015-09-03 09:15:22,,NewsOnePlace.com,https://pbs.twimg.com/profile_images/1393992289446412290/YHcCY0t3_normal.jpg,887,139,1483,1520718,newsoneplace,photo
374729426,2020-08-23 09:05:22,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2018695, pic.twitter.com/NNCQnqPsLb, ",1297520305703751680,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/9EvCMGLrdO #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/NNCQnqPsLb",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1220931352486404096,2020-08-22 10:47:43,,,,1297183675520618497,False,3,0,0,0,Twitter for iPhone,"Thank you to our sponsors! Sanofi Genzyme, Alexion, BTG, Incyte, Takeda, Ipsen, AstraZeneca and Janssen!! We appreciate your support!",,,2020-01-24 23:48:21,,Oncology Education Specialists,https://pbs.twimg.com/profile_images/1230602320590888974/3sTesXcO_normal.jpg,20,13,1,31,OncEdSpec,
374729426,2020-08-22 09:06:45,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2016023, pic.twitter.com/kxhwZXnLFw, ",1297158266804269056,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average broke below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/iM0vDLpfGN #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kxhwZXnLFw",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
365454476,2020-08-22 06:09:00,,"automation, AI, Analytics, ","hubs.ly/H0tXk190, pic.twitter.com/4rDCPdPVwY, ",1297113533008814082,False,0,0,0,0,HubSpot,"What‚Äôs your post-crisis #automation plan? ‚Äì it's time to speed up your journey! Listen to @ElenaLChristoph as we showcased the power of the Triple-A trifecta with real examples from NextEra Energy, Incyte Pharma &amp; @Cognizant. #AI #Analytics 

https://t.co/UdhY74NZII https://t.co/4rDCPdPVwY","ElenaLChristoph, Cognizant, ",,2011-08-31 09:32:19,"Cambridge, England [HQ]",HFS Research,https://pbs.twimg.com/profile_images/1019581946039545856/DezsjDVr_normal.jpg,11997,1528,783,25484,HFSResearch,photo
2229740180,2020-08-21 15:17:32,"INCY, ",,"sadifanalytics.com/reports/find/I‚Ä¶, ",1296889190639112192,False,0,0,0,0,SADIF - Analytics,Will Incyte Corp Deliver Long-Term Returns? $INCY https://t.co/dCRT67GWDz,,,2013-12-04 06:21:56,Portugal,SADIF - Analytics,https://pbs.twimg.com/profile_images/656072062906343424/byfeHd57_normal.png,1619,190,23,236674,SADIFAnalytics,
1280938376099741697,2020-08-21 15:16:53,,,"iexcloud.io, pic.twitter.com/fA7hbcmBYf, ",1296889027279429634,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Autodesk, Inc.
-Ooredoo QPSC
-Ulta Beauty, Inc.
-Incyte Corp.
-Wynn Resorts Ltd.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/fA7hbcmBYf",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2020-08-21 10:28:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2010541, pic.twitter.com/KRMDqFTNXj, ",1296816354666790913,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/ztgiBujK6w #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/KRMDqFTNXj",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-08-21 07:46:05,"INCY, ","markets, ","americanbankingnews.com/?p=15824848, ",1296775578369101829,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/aGDvRJw8I4 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-08-21 07:46:04,"INCY, ","stocks, ","americanbankingnews.com/?p=15824848, ",1296775576192155649,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/hNcfmDN38i #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2298709746,2020-08-21 07:41:55,"INCY, ",,"zpr.io/Hstsq, ",1296774529340059648,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/nIt6l6BrXN,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
108617488,2020-08-20 22:10:18,,,"invst.ly/rvmem, ",1296630677736128515,False,0,0,0,0,FP News Publisher - COM,RBC Capital Stick to Their Hold Rating for Incyte Corp - https://t.co/r4ctkqpLg3,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
374729426,2020-08-20 12:43:02,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2008241, pic.twitter.com/Va4PfXzl2b, ",1296487921697132544,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/r6fmJlRggI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Va4PfXzl2b",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1198066808,2020-08-20 05:57:37,,,"investors.com/market-trend/s‚Ä¶, twitter.com/iPicNews/statu‚Ä¶, ",1296385893171896320,True,0,0,0,0,Twitter Web App,"https://t.co/KytCp0Kpno
nes-pares-gains-stock-rally-fades-apple-earnings-this-week/
Dow and Nasdaq are reaching new hights, all time hights. https://t.co/IRUTsUFppW",,,2013-02-19 12:15:57,"Warsaw, Poland",peter calka,https://pbs.twimg.com/profile_images/432433934446514178/LSS8RHLE_normal.png,870,3121,6,37557,CalkaPeter,
1128239740329705472,2020-08-19 12:27:49,"INCY, MOR, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1296121705337774080,False,0,0,0,0,Twitter for Android,"""There is no other FDA-approved second line treatment for these patients with a 2A designation within the NCCN guidelines.""

$INCY $MOR 
https://t.co/PXLl9rc4R3",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
33467057,2020-08-19 10:45:22,,"DLBCL, ","bit.ly/2L3vmGA, pic.twitter.com/qCYU6vgGlo, ",1296095922984804352,False,12,0,0,5,Twitter Web App,"The @NCCN added our FDA approved therapy, co-marketed with @Incyte, for adult patients in the U.S. with relapsed or refractory diffuse large B-cell lymphoma (#DLBCL), who are not eligible for stem cell transplant, to its clinical practice guidelines. https://t.co/VpHBJwMe7R https://t.co/qCYU6vgGlo","NCCN, Incyte, ",,2009-04-20 05:13:43,"Planegg, Germany",MorphoSys,https://pbs.twimg.com/profile_images/1414967751538511873/dOJDE_2G_normal.jpg,1563,205,37,315,MorphoSys,photo
374729426,2020-08-19 09:59:19,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2002692, pic.twitter.com/JeVRFZD5iq, ",1296084331299971073,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on August 11, 2020. View odds for this and other indicators: https://t.co/1bgJWx2hiV #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/JeVRFZD5iq",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
875107384535900161,2020-08-19 04:57:00,,"JobSearch, jobseekers, Jobs, ","jobs.frontend.la/i/us/all/1/02a‚Ä¶, ",1296008251310407682,False,0,0,0,0,FrontendLA,"New opportunity in Wilmington, DE - Director, US Product Strategy, IAI @ Incyte Corporation  https://t.co/38kVIvA54C #JobSearch #jobseekers #Jobs",,,2017-06-14 17:47:14,,Frontend.LA,https://pbs.twimg.com/profile_images/1275071694609080320/lPHtH4S__normal.jpg,234,24,5,590801,FrontendLA,
72928001,2020-08-18 18:14:48,"INCY, ",,"bit.ly/3g5IQMB, ",1295846636548055040,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte and Morphosys (MOR) announce inclusion of Monjuvi in latest NCCN Guidelines in Oncology for B-cell... https://t.co/YZxVvSvF7d,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1199800417821048834,2020-08-18 16:10:02,,"Company_News_, ","dlvr.it/Rdv8rK, bit.ly/2OvmW9Z, ",1295815239141744640,False,0,0,0,0,dlvr.it,Incyte : National Comprehensive Cancer Network¬Æ Adds Monjuvi¬Æ (tafasitamab-cxix) to its Clinical Practice Guidelines in Oncology for B-cell Lymphomas https://t.co/cFzBlOKThh #Company_News_ https://t.co/eMN9RGkODB,,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,
1267477446556897284,2020-08-18 16:06:43,,,"thefly.com/n.php?id=31482‚Ä¶, ",1295814402025938954,False,0,0,0,0,Twitter Web App,"Incyte, Morphosys announce Monjuvi included in NCCN guidelines¬†16:06 INCY, MOR Morp

Read more at:
https://t.co/Ns4BD4M5hZ",,,2020-06-01 11:25:52,,WallStBetsDotCom,https://pbs.twimg.com/profile_images/1270171714568237056/sx7E9nBZ_normal.jpg,281,6,5,26304,WallStBetsDotC1,
426660182,2020-08-18 16:04:36,,,"investor.incyte.com/news-releases/‚Ä¶, ",1295813868753768448,False,0,0,0,0,Twitter for iPhone,National Comprehensive Cancer Network¬Æ Adds Monjuvi¬Æ (tafasitamab-cxix) to its Clinical Practice Guidelines in Oncology for B-cell Lymphomas | Incyte Corporation https://t.co/212D8MZq70,,,2011-12-02 09:36:53,Hewlett NY,Michael G King Jr,https://pbs.twimg.com/profile_images/760202160143470592/tV-c8Va4_normal.jpg,768,4708,11,857,MichaelGKingJr,
2416188264,2020-08-18 13:21:16,"INCY, ","markets, ","thestockobserver.com/?p=3350311, ",1295772764817821698,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY Will Post Quarterly Sales of $623.26 Million  https://t.co/Q8VHmKrKOy #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2920258887,2020-08-18 11:32:37,"INCY, ",,"dakotafinancialnews.com/?p=2353960, ",1295745424955977735,False,0,0,0,0,Zapier.com,Recent Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/tWCvla61rv,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
732361939490312192,2020-08-18 11:30:40,"INCY, ","markets, ","americanbankingnews.com/?p=15776994, ",1295744932020445185,False,0,0,0,0,Zapier.com,Recent Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/XbFMnUsiKr #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-08-18 11:30:39,"INCY, ","stocks, ","americanbankingnews.com/?p=15776994, ",1295744928702758913,False,0,0,0,0,Zapier.com,Recent Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/UIFAV1gECh #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-08-18 10:52:26,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/2000326, pic.twitter.com/5yHQAMHK6z, ",1295735310765064193,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/fuQIm9MMeK #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5yHQAMHK6z",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
163565297,2020-08-18 09:15:14,,"CSCDE, Incyte, ","cancersupportdelaware.org, pic.twitter.com/G0DTTD0FGM, ",1295710850494406661,False,4,0,0,1,Hootsuite Inc.,"#CSCDE &amp; our community partner, #Incyte, find it critical and necessary to continue to provide support for our Delaware cancer patients in efforts to help maintain their financial health during these uncertain times. To find out more visit https://t.co/7DdQ9Ybsbw https://t.co/G0DTTD0FGM",,,2010-07-06 14:57:24,"Delaware, USA",Cancer Support DE,https://pbs.twimg.com/profile_images/667430529340473346/FSfER-Bd_normal.jpg,543,542,30,3173,CancerSupportDE,photo
879641797202513920,2020-08-18 02:47:50,,"pg1937, INCY, IncyteCorporation, NASDAQ100, NASDAQ, ","pg1937.blogspot.com/2020/08/incy-n‚Ä¶, ",1295613358104809478,False,0,0,0,0,Twitter Web App,"#pg1937 is a free financial blog in Italian. It provides trading signals to make money in the financial markets, for free. The success of this blog reaches 97%. Today we present another success: https://t.co/2dZRLHjxpz  

#INCY 
#IncyteCorporation 
#NASDAQ100 
#NASDAQ",,,2017-06-27 06:05:22,"Nocera Inferiore, Campania",pg1937,https://pbs.twimg.com/profile_images/906941836341776385/MQm0s4hY_normal.jpg,71,281,1,876,pg1937,
44418062,2020-08-17 15:02:53,,"Pemazyre, ","rdcu.be/b6jNa, pic.twitter.com/X9F28Hff4W, ",1295435950127042571,False,15,0,0,4,Twitter Web App,"Our 2Q20 drug pipeline Data Page shows @US_FDA accelerated approvals for cancer indications, including two small molecules ‚Äî @Incyte‚Äôs #Pemazyre and @Novartis‚Äôs @TABRECTA_US ‚Äî approved with companion diagnostics from @FoundationATCG https://t.co/ubNlimmAQc https://t.co/X9F28Hff4W","US_FDA, Incyte, Novartis, TABRECTA_US, FoundationATCG, ",,2009-06-03 14:18:32,NY/CA/London/Heidelberg/Berlin,Nature Biotechnology,https://pbs.twimg.com/profile_images/1187012354820771841/vljm59PQ_normal.jpg,195256,908,2844,10574,NatureBiotech,photo
1359077910,2020-08-17 12:30:10,,,"europharmajobs.com/job_display/18‚Ä¶, ",1295397520961671169,False,0,0,0,0,EPJ Jobs Post,"Director, Global R&amp;D QA - Qualified Person, Incyte, Netherlands

https://t.co/l1TQxLkIKp",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
374729426,2020-08-17 10:21:11,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1994843, pic.twitter.com/lJxTNxqiZH, ",1295365059644817410,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on July 28, 2020. View odds for this and other indicators: https://t.co/2gJuixwngm #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/lJxTNxqiZH",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-08-16 22:55:01,"INCY, ","markets, ","americanbankingnews.com/?p=15751200, ",1295192377909534721,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 14.7% in January https://t.co/LDFJtjid9G #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-08-16 22:55:00,"INCY, ","stocks, ","americanbankingnews.com/?p=15751200, ",1295192375892090881,False,1,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 14.7% in January https://t.co/lZhwQms9YF #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-08-16 08:12:15,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1992700, pic.twitter.com/jpIGB5sDii, ",1294970222588260352,False,0,0,1,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on July 28, 2020. View odds for this and other indicators: https://t.co/MvnvJeYQwo #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/jpIGB5sDii",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-08-16 07:34:27,"INCY, ",,"zpr.io/HZvkr, ",1294960712683524098,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Post Earnings of $0.73 Per Share https://t.co/876iiOvGMK,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
29549589,2020-08-16 07:22:42,,"Yverdon, Environmental, Engineering, Jobs, ","g.drctry.biz/r/cwyOH, ",1294957753602052096,False,0,0,0,1,Engineering Daily ,[Job] Associate Director Engineering | Company: Incyte Corporation | Location: Yverdon-Les-Bains VD  Switzerland | #Yverdon-Les-Bains #Environmental #Engineering #Jobs | More info at  https://t.co/6wSbEmLEcY,,,2009-04-07 17:25:22,"Atlanta, GA USA",Engineering Daily,https://pbs.twimg.com/profile_images/445765099626582016/cXn6S9kL_normal.png,16933,1915,385,1338778,EngineersDay,
374729426,2020-08-15 08:20:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1987534, pic.twitter.com/IiEBfN4jpx, ",1294609956407111690,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on July 28, 2020. View odds for this and other indicators: https://t.co/Wmszi8FpRt #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/IiEBfN4jpx",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-08-15 02:35:42,"INCY, ","markets, ","americanbankingnews.com/?p=15723661, ",1294523140006195200,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Announce Quarterly Sales of $623.26 Million https://t.co/3H8aNGdhM7 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-08-15 02:35:37,"INCY, ","stocks, ","americanbankingnews.com/?p=15723661, ",1294523121492533248,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Announce Quarterly Sales of $623.26 Million https://t.co/UgWFKaeNb0 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2525892205,2020-08-15 02:35:32,"INCY, ","investingnews, ","modernreaders.com/?p=3771455, ",1294523100760080384,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Quarterly Sales of $623.26 Million  https://t.co/K53BXAFTMd #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
68559732,2020-08-15 02:31:15,"INCY, ",,"zpr.io/HZrqT, ",1294522021976715265,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Announce Quarterly Sales of $623.26 Million https://t.co/0Jqr3yN6Q4,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1280938376099741697,2020-08-14 20:04:21,,,"iexcloud.io, pic.twitter.com/ukWut7Bl3a, ",1294424654363398144,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-NXP Semiconductors NV
-Incyte Corp.
-O'Reilly Automotive, Inc.
-Monster Beverage Corp.
-PayPal Holdings, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/ukWut7Bl3a",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-08-14 17:43:07,,,"iexcloud.io, pic.twitter.com/n0nhIFgRN2, ",1294389110388523010,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Abu Dhabi Commercial Bank
-Netflix, Inc.
-International Holdings Co. PJSC
-Incyte Corp.
-QUALCOMM, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/n0nhIFgRN2",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
113373418,2020-08-14 11:45:00,,"Monjuvi, oncology, ","bit.ly/30yy7pk, ",1294298987848179714,False,0,0,0,1,TweetDeck,#Monjuvi approval in relapsed/refractory DLBCL could lead home run for Morphosys/Incyte against big players - https://t.co/B9Y0ABZtok #oncology,,,2010-02-11 10:09:21,Worldwide,GlobalData Pharma,https://pbs.twimg.com/profile_images/826032229780451328/ax8xozhi_normal.jpg,2553,897,92,5394,Pharma_GD,
374729426,2020-08-14 08:00:01,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1985446, pic.twitter.com/bFxHa9o2qP, ",1294242368372105216,False,1,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on August 11, 2020. View odds for this and other indicators: https://t.co/RkC8xoJE5y #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/bFxHa9o2qP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1040625566972604417,2020-08-13 10:56:21,,,"linkedin.com/groups/134723/, ",1293924357459255302,False,1,0,0,0,Twitter Web App,"Check out the BGS Alumni &amp; Current Students LinkedIn page for recent job openings! The latest include a Sr. Research / Principal Investigator position at Incyte and a Cell Biologist reviewer position at the FDA: 

https://t.co/qjUXdmY2Ju",,,2018-09-14 11:37:23,"Philadelphia, PA",BGS Career Development,https://pbs.twimg.com/profile_images/1041744646907420672/XemQMO2X_normal.jpg,450,391,6,918,BGS_Career,
2416188264,2020-08-13 10:24:04,"INCY, ","markets, ","thestockobserver.com/?p=3331302, ",1293916235143372803,False,0,0,0,0,Zapier.com,$0.73 EPS Expected for Incyte Co. $INCY This Quarter  https://t.co/w7HJ5ODyeG #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
732361939490312192,2020-08-13 10:23:13,"INCY, ","markets, ","americanbankingnews.com/?p=15696378, ",1293916018771992576,False,0,0,0,0,Zapier.com,$0.73 EPS Expected for Incyte Co. $INCY This Quarter https://t.co/fqaBjWzfwV #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-08-13 10:23:12,"INCY, ","stocks, ","americanbankingnews.com/?p=15696378, ",1293916016381054982,False,0,0,0,0,Zapier.com,$0.73 EPS Expected for Incyte Co. $INCY This Quarter https://t.co/1uXJIGWz4g #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-08-13 08:23:22,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1980305, pic.twitter.com/Dp7EN29ozA, ",1293885858412552193,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/87NV5VrfRO #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Dp7EN29ozA,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
852931863547084801,2020-08-13 01:58:41,"INCY, ",,"zpr.io/HZjCf, ",1293789049447227392,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Cowen https://t.co/IhpVTCLlRC,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2298709746,2020-08-13 01:58:01,"INCY, ",,"zpr.io/HZjFv, ",1293788881716944896,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Cowen https://t.co/FDLubx2GzN,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
68559732,2020-08-13 01:56:22,"INCY, ",,"zpr.io/HZjFp, ",1293788468024418305,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Cowen https://t.co/8m1wLA65CZ,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2344420430,2020-08-12 20:58:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1293713451240640512,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/dqaCgDDr3V",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1280938376099741697,2020-08-12 19:37:28,,,"iexcloud.io, pic.twitter.com/LKFcofbTS8, ",1293693112234254337,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Abu Dhabi Ship Building Co.
-Incyte Corp.
-Citrix Systems, Inc.
-Applied Materials, Inc.
-Eshraq Investments PJSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/LKFcofbTS8",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2356524462,2020-08-12 16:13:16,"INCY, ",,,1293641725362221058,False,0,0,0,0,Stock News Alerts,"$INCY New Form 4 for Incyte Corporation
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
374729426,2020-08-12 08:48:15,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1978266, pic.twitter.com/jj81MVz1Hu, ",1293529733179695105,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/wDAZ7liGLQ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/jj81MVz1Hu,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
879641797202513920,2020-08-12 06:25:52,,"pg1937, Americanstock, INCY, IncyteCorporation, NASDAQ, DowJones, ","pg1937.blogspot.com/2020/08/incy-n‚Ä¶, pic.twitter.com/p6yYknz4uV, ",1293493901421088769,False,0,0,0,0,Twitter Web App,"#pg1937 is a free financial blog, in Italian. It provides trading signals to make money in the financial markets, for free. The success of this blog reaches 97%. We present the analysis of an #Americanstock: https://t.co/2dZRLHjxpz 

#INCY 
#IncyteCorporation 
#NASDAQ 
#DowJones https://t.co/p6yYknz4uV",,,2017-06-27 06:05:22,"Nocera Inferiore, Campania",pg1937,https://pbs.twimg.com/profile_images/906941836341776385/MQm0s4hY_normal.jpg,71,281,1,876,pg1937,animated_gif
849417718642159616,2020-08-12 05:56:19,"INCY, ",,"zpr.io/HZtyr, ",1293486465809358850,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at Cowen https://t.co/qUTyCTurWO,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1055982930,2020-08-11 11:28:02,,"cancer, innovation, ","buff.ly/2XIsOSb, pic.twitter.com/IDB3POgkJk, ",1293207554798030851,False,0,0,0,0,Buffer,"MorphoSys, Incyte get early FDA nod for antibody alternative to CAR-T https://t.co/qKVR6SWNj4 #cancer #innovation https://t.co/IDB3POgkJk",,,2013-01-02 15:11:00,"New Jersey, USA",Ozmosi,https://pbs.twimg.com/profile_images/902262079821946880/-D0GJyvZ_normal.jpg,425,260,47,1814,OzmosiHealth,photo
374729426,2020-08-11 09:46:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1973180, pic.twitter.com/u6VM2PQUB2, ",1293182110191124484,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/MveOJQayrE #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/u6VM2PQUB2,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
113373418,2020-08-11 06:44:00,,"Monjuvi, oncology, ","bit.ly/30yy7pk, ",1293136074903105537,False,0,0,0,1,TweetDeck,#Monjuvi approval in relapsed/refractory DLBCL could lead home run for Morphosys/Incyte against big players - https://t.co/B9Y0ABZtok #oncology,,,2010-02-11 10:09:21,Worldwide,GlobalData Pharma,https://pbs.twimg.com/profile_images/826032229780451328/ax8xozhi_normal.jpg,2553,897,92,5394,Pharma_GD,
852931863547084801,2020-08-11 05:47:33,"INCY, ",,"zpr.io/HpdXz, ",1293121871622307845,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Sell at BidaskClub https://t.co/xQIinyEzQB,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
930803511918411776,2020-08-11 01:50:49,"INCY, ",,"thelincolnianonline.com/?p=4471441, ",1293062292704092160,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Cowen https://t.co/37G4hZE11y,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2344420430,2020-08-10 20:44:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1292985176344203265,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/s3Q6N3Y3rX",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2298709746,2020-08-10 20:35:11,"INCY, ",,"zpr.io/Hp24D, ",1292982863764258822,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Sell at BidaskClub https://t.co/c6Q1VIP6wU,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
849417718642159616,2020-08-10 20:34:12,"INCY, ",,"zpr.io/Hp24n, ",1292982614899466240,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Sell at BidaskClub https://t.co/eTnHG93wVc,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1176558075798380544,2020-08-10 17:08:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1292930814443913220,False,0,0,0,0,InsiderActionMonitor,$INCY  Incyte https://t.co/KEfn8K8FFV,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
2356524462,2020-08-10 16:26:12,"INCY, ",,,1292920204218032129,False,0,0,0,0,Stock News Alerts,"$INCY New Form 4 for Incyte Corporation
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1262915121103491074,2020-08-10 16:21:35,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1292919041955213312,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 961 shares on 2020-08-06. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
707270913448919041,2020-08-10 15:06:13,,,,1292900076193566722,False,7,0,0,0,Twitter for Advertisers.,Hear feedback from Incyte Oncology Clinical Nurse Educators (OCNEs). Register for a patient meeting to talk with them live!,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-08-10 15:06:07,,,,1292900049874227200,False,5,0,2,0,Twitter for Advertisers.,Hear feedback from Incyte Oncology Clinical Nurse Educators (OCNEs). Register for a patient meeting to talk with them live!,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-08-10 15:05:58,,,,1292900010410090496,False,10,1,0,0,Twitter for Advertisers.,Meet the Incyte Oncology Clinical Nurse Educators (OCNEs) who host patient meetings about myeloproliferative neoplasms (MPNs).,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-08-10 15:05:49,,,,1292899975534391297,False,9,0,0,1,Twitter for Advertisers.,Meet the Incyte Oncology Clinical Nurse Educators (OCNEs) who host patient meetings about myeloproliferative neoplasms (MPNs).,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
524587400,2020-08-10 15:01:03,,"Monjuvi, Revlimid, fda, DLBCL, ","clinicaloncology.com/FDA-Watch/Arti‚Ä¶, ",1292898775288164353,False,0,0,0,0,Hootsuite Inc.,.@US_FDA grants accelerated approval to #Monjuvi plus #Revlimid for DLBCL. https://t.co/KVDr3CQfVw @Incyte @MorphoSys #fda #DLBCL,"US_FDA, Incyte, MorphoSys, ",,2012-03-14 14:07:07,New York City,ClinicalOncologyNews,https://pbs.twimg.com/profile_images/1896943910/ClinOnc_MobileApp_Thumbnail_normal.jpg,3500,1039,107,3959,ClinOncNews,
966006214818697218,2020-08-10 13:27:27,"INCY, ",,"theenterpriseleader.com/?p=3636239, ",1292875220630609920,False,0,0,0,0,Zapier.com,Incyte $INCY Coverage Initiated at Mizuho  https://t.co/f1SME0ItH5,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1250830691824283648,2020-08-10 10:38:30,"AMGN, TEAM, MSCI, SGEN, QSR, DDOG, BMRN, INCY, MKTX, ALNY, TDOC, MDB, NBIX, DT, CDAY, ",,"pic.twitter.com/TYDpWFBFOq, ",1292832703474212877,False,3,0,0,1,Twitter Web App,"Stocks that have made 1-Month lows so far today

Amgen $AMGN
Atlassian $TEAM
$MSCI
Seattle Genetics $SGEN
Restaurant Brands $QSR
Datadog $DDOG
Biomarin $BMRN
Incyte $INCY
Markettaxess $MKTX
Alnylam $ALNY
Telasoc $TDOC
MongoDB $MDB
Neurocrine $NBIX
Dynatrace $DT
Ceridian $CDAY https://t.co/TYDpWFBFOq",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123337,211,1299,33044,StockMKTNewz,photo
374729426,2020-08-10 08:59:34,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1971055, pic.twitter.com/mwZXwTu6Ca, ",1292807803694796801,False,1,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on July 28, 2020. View odds for this and other indicators: https://t.co/n0nxjVpMhT #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/mwZXwTu6Ca",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3298379074,2020-08-10 08:46:58,,"3dprinting, ","redandblackonline.com/research-on-3d‚Ä¶, ",1292804634994769920,False,0,0,0,0,3D Printing News Feed,Research on 3D Printing Plastics Market #3dprinting https://t.co/AqxmnYT5ia,,,2015-05-25 15:30:36,,3D Printing News,https://pbs.twimg.com/profile_images/602921690318786560/FVC_WcM4_normal.png,6464,2924,208,69547,3DPrintMaven,
849417718642159616,2020-08-10 05:51:17,"INCY, ",,"zpr.io/Hp9jQ, ",1292760422261690369,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $87.00 https://t.co/7zbUOs8NqR,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
68559732,2020-08-10 05:50:44,"INCY, ",,"zpr.io/Hp9jh, ",1292760283774160901,False,0,0,0,0,Zapier.com,SVB Leerink Boosts Incyte $INCY Price Target to $87.00 https://t.co/BfHmYGgoWs,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2298709746,2020-08-10 05:49:19,"INCY, ",,"zpr.io/Hp9Zy, ",1292759925098192897,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $87.00 https://t.co/rCepvJjTvU,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
208053736,2020-08-10 00:42:15,,,"theglobe.co.com/2020/08/10/fda‚Ä¶, ",1292682651267141633,False,0,0,0,0,theglobe,(FDA Approves MorphoSys and Incyte‚Äôs DLBCL Drug Monjuvi ‚Äì BioSpace) has been published on The Globe - https://t.co/OZHxR3n2gD,,,2010-10-26 10:57:19,Zieglerville PA,Wellcome-home,https://pbs.twimg.com/profile_images/1269342722/Becky_mug__428x640__normal.jpg,127,10,2,348028,Wellcome_Home,
732361939490312192,2020-08-09 17:31:38,"INCY, ","markets, ","americanbankingnews.com/?p=15638087, ",1292574282258755584,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at Cowen https://t.co/BizHW7OBb1 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-08-09 17:31:37,"INCY, ","stocks, ","americanbankingnews.com/?p=15638087, ",1292574280065196032,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at Cowen https://t.co/6hLTftNZDT #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
68559732,2020-08-09 15:38:06,"INCY, ",,"zpr.io/HphFa, ",1292545709011537920,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $92.00 https://t.co/X28oUykaH3,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
21411180,2020-08-09 14:45:03,,,"curetoday.com/articles/numer‚Ä¶, ",1292532359707885568,False,7,0,0,3,Hootsuite Inc.,"A survey administered by pharmaceutical company Incyte and the nonprofit Cholangiocarcinoma Foundation found that patients with bile duct cancer face more than a dozen symptoms or treatment-related side effects that negatively affect their daily lives.
 https://t.co/zF7nz8bpZw",,,2009-02-20 11:40:58,United States,CURE Magazine,https://pbs.twimg.com/profile_images/1442487920871411721/0Hbi4cbf_normal.png,25007,1750,706,23817,cure_magazine,
552066959,2020-08-09 12:30:00,,"NetDE, COVID19, ","delawarepublic.org/post/incyte-co‚Ä¶, ",1292498373510148098,False,0,0,0,0,TweetDeck,Check out The Green this afternoon at 2pm - our @Nick_Ciolino checks in with @Incyte on its work to see if one of its drugs can help treat severe COVID-19 cases. https://t.co/xQDnP8TATd #NetDE #COVID19,"Nick_Ciolino, Incyte, ",,2012-04-12 14:28:59,"Dover, DE",Delaware Public Media,https://pbs.twimg.com/profile_images/1308052313421025280/ETKfCwkX_normal.jpg,8235,742,203,13788,DelawarePublic,
68559732,2020-08-09 08:45:07,"INCY, ",,"zpr.io/HpxVP, ",1292441780009537538,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub https://t.co/6BmlnU9oDA,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
374729426,2020-08-09 08:13:17,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1965130, pic.twitter.com/ZOxGKKoIuk, ",1292433768523866113,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on July 28, 2020. View odds for this and other indicators: https://t.co/Y7pEqyD2Qv #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZOxGKKoIuk",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-08-09 07:40:32,"INCY, ",,"zpr.io/HpxMw, ",1292425526716641280,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub https://t.co/Pz5UTJZumU,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2298709746,2020-08-09 07:39:45,"INCY, ",,"zpr.io/HpxMn, ",1292425331111071745,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub https://t.co/ALlJNyYztJ,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1001523981500014592,2020-08-09 07:16:35,,"jobs, hiring, Wilmington, Delaware, USA, ","dlvr.it/RdHw87, ",1292419498503372800,False,0,0,0,0,dlvr.it,"#jobs #hiring #Wilmington #Delaware #USA Executive Director, Corporate Counsel, Global Technical Operations: Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet‚Ä¶ https://t.co/6bHVRZ3fw9",,,2018-05-29 14:01:39,United States,Empleos.io,https://pbs.twimg.com/profile_images/1002198831470178305/0-DY_Jrn_normal.jpg,127,76,6,95846,EmpleosIO,
852931863547084801,2020-08-09 06:22:21,"INCY, ",,"zpr.io/HpXeG, ",1292405851609759746,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $100.00 https://t.co/rNaRJQXqjE,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2416188264,2020-08-09 06:18:11,"INCY, ","markets, ","thestockobserver.com/?p=3313675, ",1292404805059706881,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $100.00 Price Target at Morgan Stanley  https://t.co/1GJzJTqA7R #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2181281054,2020-08-09 03:53:52,"INCY, ","markets, ","wkrb13.com/?p=2031732, ",1292368484014399488,False,0,0,0,0,Zapier.com,Incyte $INCY Announces Quarterly Earnings Results https://t.co/o7S8W55V7r #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1280938376099741697,2020-08-09 00:24:23,,,"iexcloud.io, pic.twitter.com/ziXVWmPZJX, ",1292315765400653829,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Texas Instruments Incorporated
-Foodco Holding PJSC
-Incyte Corp.
-CSX Corp.
-PayPal Holdings, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/ziXVWmPZJX",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1280938376099741697,2020-08-08 16:18:30,,,"iexcloud.io, pic.twitter.com/012y01DuUO, ",1292193488990359564,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Ras Al-Khaimah National Insurance Co.
-Alexion Pharmaceuticals, Inc.
-Incyte Corp.
-Adobe, Inc.
-Henry Schein, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/012y01DuUO",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2522931816,2020-08-08 14:36:22,,,"fda.gov/drugs/drug-app‚Ä¶, ",1292167786853273602,False,0,0,0,0,Twitter for iPhone,CD19 CAR-T killer? Congrats @MorphoSys and @Incyte FDA grants accelerated approval to tafasitamab-cxix for diffuse large B-cell lymphoma https://t.co/XV9smidJZD,"MorphoSys, Incyte, ",,2014-05-25 11:33:56,"Princeton, NJ",J.AlexYu,https://pbs.twimg.com/profile_images/1358246336529895424/qqtGLLpt_normal.jpg,56,284,3,760,JAlexYu,
102754598,2020-08-08 13:36:11,,,"endpts.com/fda-oks-morpho‚Ä¶, ",1292152640697229317,False,9,0,0,9,TweetDeck,"#5
FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative
By @Jasonmmast 
https://t.co/RV136CamSe","Jasonmmast, ",,2010-01-07 13:33:18,VT and TX (yes),John Carroll,https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_normal.jpeg,61485,280,1456,48410,JohnCendpts,
47513933,2020-08-08 11:52:20,,,"delawarepublic.org/post/incyte-co‚Ä¶, ",1292126505380839425,False,0,0,0,0,Twitter Web App,Incyte continues examining one of its drugs' ability to treat COVID-19 https://t.co/QvMdVuIsWR,,,2009-06-15 22:11:48,"Newark, Delaware",Nancy Willing,https://pbs.twimg.com/profile_images/276978662/powmiaLOGOsm_normal.gif,871,1115,82,96415,nannyfat,
374729426,2020-08-08 10:29:25,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1962385, pic.twitter.com/MELCUWLKps, ",1292105639682928641,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on July 28, 2020. View odds for this and other indicators: https://t.co/SFG7zeVJJn #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MELCUWLKps",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
112729091,2020-08-08 06:25:56,"MOR, ",,,1292044365309702144,False,0,0,0,0,Twitter for Android,"$MOR one bit of new info from CC that was not clear to me b4: MOR does not have to cover the XNCR royalties from ex-US, i.e. Incyte has to. Leaves MOR with the 15-25% for these markets w/o any spendings, so not that bad (US as most important market is 50/50)",,,2010-02-09 09:26:11,Earth,The Pathfinder,https://pbs.twimg.com/profile_images/424632323913420801/LlbdOdG8_normal.jpeg,801,173,23,4304,path1finder,
1280938376099741697,2020-08-08 00:34:02,,,"iexcloud.io, pic.twitter.com/eHdHKwr33r, ",1291955806678716416,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Ooredoo QPSC
-Baidu, Inc.
-Microchip Technology, Inc.
-Incyte Corp.
-Agthia Group PJSC

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/eHdHKwr33r",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
25406480,2020-08-07 16:56:02,,,"awesomecapital.blogspot.com/2020/08/incyte‚Ä¶, ",1291840546093268997,False,0,0,0,1,Twitter Web App,"AwesomeCapital: Incyte/Morphosys take on CAR-Ts with $198,000 per ... https://t.co/BEduj2QQqU",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
872379820973457414,2020-08-07 14:00:05,"INCY, ","Incyte, ","bidaskclub.com/news/company/2‚Ä¶, ",1291796269795610624,False,0,0,0,0,BidaskClubAllScoreChangesBot,#Incyte $INCY BidaskScore is Downgraded to Sold https://t.co/oVGdLQ8AE6,,,2017-06-07 05:08:52,Luxembourg,BACAllScoreChanges,https://pbs.twimg.com/profile_images/872380691010510848/9DEqosBk_normal.jpg,198,1338,5,58331,BACScoreChanges,
226828258,2020-08-07 11:09:38,,,"financialbuzz.com/incyte-announc‚Ä¶, ",1291753375382478848,False,0,0,0,0,Financialbuzz Feed,New post (Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints) has been published on Financial Buzz - https://t.co/pbKpIciP6H,,,2010-12-15 00:20:46,"New York, New York",Financial Buzz,https://pbs.twimg.com/profile_images/1009537056022900736/9CryGRSB_normal.jpg,28281,21,670,656751,financialbuzz,
226828258,2020-08-07 11:09:35,,,"financialbuzz.com/incyte-announc‚Ä¶, ",1291753359192408070,False,0,0,0,0,Financialbuzz Feed,New post (Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints) has been published on Financial Buzz - https://t.co/aUqiZrWxMp,,,2010-12-15 00:20:46,"New York, New York",Financial Buzz,https://pbs.twimg.com/profile_images/1009537056022900736/9CryGRSB_normal.jpg,28281,21,670,656751,financialbuzz,
226828258,2020-08-07 11:09:15,,,"financialbuzz.com/incyte-announc‚Ä¶, ",1291753277420220419,False,0,0,0,0,Financialbuzz Feed,New post (Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints) has been published on Financial Buzz - https://t.co/QPSaUKz3Vq,,,2010-12-15 00:20:46,"New York, New York",Financial Buzz,https://pbs.twimg.com/profile_images/1009537056022900736/9CryGRSB_normal.jpg,28281,21,670,656751,financialbuzz,
226828258,2020-08-07 11:08:28,,,"financialbuzz.com/incyte-announc‚Ä¶, ",1291753081399463937,False,0,0,0,0,Financialbuzz Feed,New post (Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints) has been published on Financial Buzz - https://t.co/xqJLU97TXf,,,2010-12-15 00:20:46,"New York, New York",Financial Buzz,https://pbs.twimg.com/profile_images/1009537056022900736/9CryGRSB_normal.jpg,28281,21,670,656751,financialbuzz,
1014927366265692161,2020-08-07 10:40:03,,,"pic.twitter.com/K8tf6AF4v5, ",1291745928227897345,False,0,0,0,0,dlvr.it,Incyte bullish about virtual launch of rival to CAR-T therapies https://t.co/K8tf6AF4v5,,,2018-07-05 13:41:55,United States,biosimilars,https://pbs.twimg.com/profile_images/1014928013538914304/0HecI_6F_normal.jpg,286,68,0,1671,biosims,photo
374729426,2020-08-07 10:05:08,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1956233, pic.twitter.com/RID4iSUgHu, ",1291737140737347586,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/l0rWZbOGFA #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/RID4iSUgHu",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3018464404,2020-08-06 22:00:00,,"cancer, ","zcu.io/tcFe, pic.twitter.com/rLsXiK7anl, ",1291554657509072901,False,1,0,0,0,Zoho Social,"Xconomy: MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T https://t.co/dH8Um5zKUt #cancer https://t.co/rLsXiK7anl",,,2015-02-04 14:21:37,Texas,HHF,https://pbs.twimg.com/profile_images/563055455874727936/E7Dpqeek_normal.jpeg,47,118,12,1026,heapyhughes,photo
732361939490312192,2020-08-06 13:10:02,"INCY, ","markets, ","americanbankingnews.com/?p=15597695, ",1291421285856227328,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $94.00 https://t.co/8W90Bg7Uz2 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-08-06 13:10:02,"INCY, ","stocks, ","americanbankingnews.com/?p=15597695, ",1291421283931041797,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $94.00 https://t.co/ax2rATq0vt #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1036930364659265538,2020-08-06 11:55:57,,,"updownratings.com/index.php/599-‚Ä¶, ",1291402640882954243,False,0,0,0,0,Twitter Web App,Morgan Stanley increases PT on Incyte Corp to $100. https://t.co/dwbWIyGJX0,,,2018-09-04 06:53:58,,Updownratings,https://pbs.twimg.com/profile_images/1116339970065616898/q9qQra-u_normal.png,19,0,0,605,updownratings,
374729426,2020-08-06 09:13:37,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1953194, pic.twitter.com/WBFD4YSjB3, ",1291361787611242496,False,1,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/DNeSlojMb6 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/WBFD4YSjB3",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
94365736,2020-08-06 08:01:07,,"Karuna, Incyte, ","endpts.com/karuna-and-inc‚Ä¶, ",1291343542389035008,False,0,0,0,0,Hootsuite Inc.,#Karuna and #Incyte scrap programs; More cash for the SPACs - https://t.co/pgd1AZMTYE  @endpts @KarunaPharma @Incyte,"endpts, KarunaPharma, Incyte, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
365454476,2020-08-06 06:01:45,,"automation, AI, Analytics, ","hubs.ly/H0tjsvg0, pic.twitter.com/1ECtobkhgl, ",1291313503886811136,False,2,0,0,1,HubSpot,"What‚Äôs your post-crisis #automation plan? ‚Äì it's time to speed up your journey! Listen to @ElenaLChristoph as we showcased the power of the Triple-A trifecta with real examples from NextEra Energy, Incyte Pharma &amp; @Cognizant. #AI #Analytics 

https://t.co/POhM5GJFCk https://t.co/1ECtobkhgl","ElenaLChristoph, Cognizant, ",,2011-08-31 09:32:19,"Cambridge, England [HQ]",HFS Research,https://pbs.twimg.com/profile_images/1019581946039545856/DezsjDVr_normal.jpg,11997,1528,783,25484,HFSResearch,photo
38197752,2020-08-06 05:35:04,,,"dlvr.it/Rd5zy0, pic.twitter.com/inPehAPdSW, ",1291306787480596481,False,2,0,0,0,dlvr.it,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma population https://t.co/rmQ6GWCnDO https://t.co/inPehAPdSW",,,2009-05-06 11:14:22,"Dubai, United Arab Emirates",Dr. Osama Ahmed,https://pbs.twimg.com/profile_images/1351682680111423493/wUfRGAIf_normal.jpg,1854,3669,106,9628,DrOsamaAhmed,photo
1280938376099741697,2020-08-05 21:49:57,,,"iexcloud.io, pic.twitter.com/pMeps5LSmt, ",1291189739194916865,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Netflix, Inc.
-Cerner Corp.
-MercadoLibre, Inc.
-T-Mobile US, Inc.
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/pMeps5LSmt",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
860184308,2020-08-05 21:05:02,,"lymphoma, ","bit.ly/2XwfPTL, pic.twitter.com/oTntBrmxwo, ",1291178434845188096,False,1,0,0,2,Sprout Social,"MorphoSys AG and Incyte announced that the FDA has approved Monjuvi in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell #lymphoma.
https://t.co/Mcq1VtH6rH https://t.co/oTntBrmxwo",,,2012-10-03 15:00:13,,Human Immunology News,https://pbs.twimg.com/profile_images/1280905916729049088/0Dalna8F_normal.jpg,10945,512,169,9402,humanimmunenews,photo
194586164,2020-08-05 14:10:02,,"lymphoma, DLBCL, lymsm, ","buff.ly/3kcjyzv, pic.twitter.com/06wxtFO3Qj, ",1291073996436447233,False,0,0,0,0,Buffer,"In a first, MorphoSys, Incyte win Monjuvi FDA nod in #lymphoma to challenge Roche‚Äôs Polivy. With the only FDA-approved second-line regimen for #DLBCL, how much market share can MorphoSys and Incyte capture? #lymsm 
https://t.co/GONMoaLyQH https://t.co/06wxtFO3Qj",,,2010-09-24 10:12:02,"New York, Paris",Bionest Partners,https://pbs.twimg.com/profile_images/1271043069698326528/K-dF7hlM_normal.jpg,349,512,0,2306,BionestPartners,photo
1159146763229507584,2020-08-05 13:53:55,,,"fiercepharma.com/marketing/a-fi‚Ä¶, ",1291069939948965888,False,0,0,0,0,Twitter Web App,"In a first, MorphoSys, Incyte win Monjuvi FDA nod in lymphoma to challenge Roche‚Äôs Polivy | FiercePharma https://t.co/ktbR479lj4",,,2019-08-07 12:58:19,"Miami Fl, London U K, Madrid ",R Mandy Alcuria,https://pbs.twimg.com/profile_images/1220781792334110721/LT-6vyu3_normal.jpg,52,933,1,14134,AlcuriaRudolph,
1889492676,2020-08-05 12:36:48,,"incyte, ICLUSIG, ","1stoncology.com/blog/incyte-re‚Ä¶, ",1291050533134819330,False,0,0,0,0,Troi URL Plug-in,"#incyte World-Wide Sales for #ICLUSIG was 22.8m USD in 3 mnth, JUN 30 2020 (Down 7%) https://t.co/L5wb6Ynmsj",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2020-08-05 12:35:48,,"incyte, JAKAFI, ","1stoncology.com/blog/incyte-re‚Ä¶, ",1291050283926093825,False,0,0,0,0,Troi URL Plug-in,"#incyte World-Wide Sales for #JAKAFI was 473.71m USD in 3 mnth, JUN 30 2020 (Up 16%) https://t.co/L5wb6Ynmsj",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
47513933,2020-08-05 11:57:34,,,"delawareonline.com/story/money/20‚Ä¶, ",1291040658560557056,False,0,0,0,0,Twitter Web App,Incyte progresses on Covid treatment. Other big Delaware companies slog through tough economy https://t.co/hsTNUb0q9g via @delawareonline,"delawareonline, ",,2009-06-15 22:11:48,"Newark, Delaware",Nancy Willing,https://pbs.twimg.com/profile_images/276978662/powmiaLOGOsm_normal.gif,871,1115,82,96415,nannyfat,
1250830691824283648,2020-08-05 11:54:48,"BAX, MCHP, INCY, TDOC, EVRH, ENIA, IONS, PRGO, REYN, HRC, PLNT, HE, HAE, NEWR, ENR, ORA, ",,"pic.twitter.com/Gsd877H1qN, ",1291039962297769984,False,1,0,0,1,Twitter Web App,"Stocks with $3B+ MKT Cap that made 1-Month lows so far today

Baxter $BAX
Microchip $MCHP
Incyte $INCY
Teledoc $TDOC
Evergy $EVRH
$ENIA
Ionis $IONS
Perrigo $PRGO
Reynolds $REYN
Hill-Rom $HRC
Planet Fitness $PLNT
Hawaiian $HE
Haemonetics $HAE
New Relic $NEWR
Energizer $ENR
$ORA https://t.co/Gsd877H1qN",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123337,211,1299,33044,StockMKTNewz,photo
374729426,2020-08-05 09:44:24,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1947135, pic.twitter.com/XpgxVkiTI4, ",1291007148822945793,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on August 4, 2020. View odds for this and other indicators: https://t.co/ityezz6wcR #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/XpgxVkiTI4",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
33985283,2020-08-05 09:12:17,,,"bit.ly/39V2hpU, pic.twitter.com/ko6bcUL0wm, ",1290999066336337922,False,0,0,0,1,Fanbooster by Traject,"Incyte beats on earnings, revenue‚Äìbut drops on lack of improved guidance
https://t.co/FiF47KdRIa https://t.co/ko6bcUL0wm",,,2009-04-21 14:09:41,New York,Jim Jubak,https://pbs.twimg.com/profile_images/425668877/jim_facebook_normal.jpg,5125,3357,151,3890,JubaksPicks,photo
1702834627,2020-08-05 09:10:36,,"NPCpodcast, ","lnkd.in/gXCt_Wu, ",1290998640413224960,False,1,0,0,1,Twitter Web App,"The 5th episode of the #NPCpodcast is out now! This week, our host Peter Brenders talks with Christine Lennon, General Manager of Incyte Biosciences Canada, about starting companies and bringing products to Canada during a pandemic.

https://t.co/dNhEjKiOhh",,,2013-08-26 15:59:51,"Toronto, Ontario",Healthcare Marketing,https://pbs.twimg.com/profile_images/1259942911501897728/3rDgm6M6_normal.jpg,450,551,20,582,hcmchronicle,
3911174913,2020-08-05 09:00:01,,"DLBCL, ","pic.twitter.com/jn7HkJW9Vi, ",1290995976858083328,False,1,0,0,0,Twitter for Advertisers.,"In collaboration with @MorphoSys, we are proud to offer a new targeted treatment option for patients with relapsed or refractory diffuse large B-cell lymphoma (#DLBCL). https://t.co/jn7HkJW9Vi","MorphoSys, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
849417718642159616,2020-08-05 08:11:59,"INCY, ",,"zpr.io/Hz8ny, ",1290983892363685892,False,0,0,0,0,Zapier.com,Incyte $INCY Research Coverage Started at Mizuho https://t.co/0uFfUoPSHd,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
732361939490312192,2020-08-05 06:53:34,"INCY, ","markets, ","americanbankingnews.com/?p=15576147, ",1290964155734925312,False,0,0,0,0,Zapier.com,Incyte $INCY Receives New Coverage from Analysts at Mizuho https://t.co/cM5zpWnjHZ #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-08-05 06:53:33,"INCY, ","stocks, ","americanbankingnews.com/?p=15576147, ",1290964153444728834,False,0,0,0,0,Zapier.com,Incyte $INCY Receives New Coverage from Analysts at Mizuho https://t.co/p60mjz0N9H #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
818081647,2020-08-05 06:18:25,"INCY, ",,"streetinsider.com/r/17197878, ",1290955308924391424,False,0,0,0,0,StreetInsider.com Integration,Incyte $INCY PT Raised to $96 at RBC Capital https://t.co/NJjDxzEdZM,,,2012-09-11 15:57:26,,SIAnalystWire,https://pbs.twimg.com/profile_images/2600218874/alkkkjlbds18yu6ld9xj_normal.png,4980,1,230,118501,AnalystWire,
15974185,2020-08-05 06:04:33,,,"dlvr.it/Rd2MBv, ",1290951822002122752,False,0,0,0,0,dlvr.it,Karuna and Incyte scrap programs; More cash for the SPACs https://t.co/K1pZQxSovu,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
930803511918411776,2020-08-05 04:36:09,"INCY, ",,"thelincolnianonline.com/?p=4449476, ",1290929572763054082,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $92.00 https://t.co/ZbnFByOAdV,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2266388972,2020-08-05 04:34:15,"INCY, ","stocks, ","dailypolitical.com/?p=4319235, ",1290929094360805376,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $92.00 https://t.co/a6SKUPFHs6 #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-08-05 04:34:14,"INCY, ",,"dailypolitical.com/?p=4319235, ",1290929092267773954,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $92.00 https://t.co/zyUxgtTTwf,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1979190776,2020-08-05 04:33:21,"INCY, ",,"tickerreport.com/?p=6070394, ",1290928868447191041,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $92.00 https://t.co/XlCfpAJ8nF,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1188117778567454720,2020-08-05 01:30:26,"INCY, ",,"jodie.ai/company/INCY, ",1290882836048818180,False,0,0,0,0,jodietheai,"Incyte Corporation $INCY

EPS $1.33 vs $0.49 YoY. Rev up 29% ($688.04M) YoY.

Language vs Biotechnology:
3.03% more positive
2.56% more negative
1.24% more uncertainty

https://t.co/q9dumdaYzF",,,2019-10-26 11:38:58,London,Jodie Insights,https://pbs.twimg.com/profile_images/1310896987466760198/cVg3gmLj_normal.jpg,624,1781,16,28832,jodietheai,
108617488,2020-08-04 21:10:04,,,"invst.ly/roiu8, ",1290817314938662912,False,0,0,0,0,FP News Publisher - COM,Oppenheimer Stick to Their Buy Rating for Incyte Corp - https://t.co/cCDXQNUOQY,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
1280938376099741697,2020-08-04 20:21:45,,,"iexcloud.io, pic.twitter.com/B43zhSLoMH, ",1290805154342674433,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Incyte Corp.
-Abu Dhabi National Co. for Building Mate
-Emirates Driving Co.
-Cisco Systems, Inc.
-Alphabet, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/B43zhSLoMH",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
1068561714055012352,2020-08-04 18:26:00,"INCY, ",,"sec.report/Document/00015‚Ä¶, ",1290776027015180288,False,0,0,0,0,Edgar Filings,"Filing Alert, FORM 10-Q [Quarterly Report] available.  $INCY INCYTE CORP  https://t.co/0WaU6Ed0xL",,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
827357694315098114,2020-08-04 17:47:40,,,"lnkd.in/ek2Wx2i, lnkd.in/esrZZrZ, ",1290766380254593025,False,0,0,0,0,LinkedIn,"""Last month saw three early FDA approvals, including that of Morphosys and Incyte‚Äôs Monjuvi, an anti-CD19 antibody that last week won a better-than-expected second line label to treat large B-cell lymphoma...A second Car-T approval‚Ä¶https://t.co/rgp1y7wili https://t.co/QU3syTye1Z",,,2017-02-02 22:27:00,,Sherine Abdelmawla,https://pbs.twimg.com/profile_images/863528220284653570/uF773FSI_normal.jpg,98,454,5,381,Sabdelmawla1,
1280938376099741697,2020-08-04 17:35:14,,,"iexcloud.io, pic.twitter.com/M9f7XLaJ5d, ",1290763251031191552,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Analog Devices, Inc.
-National Bank of Ras Al Khaimah
-Dollar Tree, Inc.
-Incyte Corp.
-Vertex Pharmaceuticals, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/M9f7XLaJ5d",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
2356524462,2020-08-04 17:00:50,"INCY, ",,,1290754590921633798,False,0,0,0,0,Stock News Alerts,"$INCY New Form 10-Q for Incyte Corporation
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1171873456276889600,2020-08-04 16:58:50,"INCY, ","INCY, 10Q, Incyte, Earnings, ","docoh.com/filing/879169/‚Ä¶, ",1290754090121809920,False,0,0,0,0,Investor Feed,"$INCY  10-Q  Incyte   (4 Aug, 4:56pm)

üìä 2020 Q2 Earnings

https://t.co/1oZHhoF6oV

#INCY #10Q #Incyte #Earnings",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
4058194633,2020-08-04 16:04:53,"INCY, ",,"investors.com/news/technolog‚Ä¶, ",1290740510936584192,False,0,0,0,0,Twitter for iPhone,"$INCY  Earnings Soar 65%, Easily Beating Views https://t.co/iodrBoAbP2 via @IBDinvestors","IBDinvestors, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
1099039801397964802,2020-08-04 15:15:29,"INCY, ",,,1290728079606898691,False,0,0,1,0,EarningsAlley,Incyte Corporation $INCY held an earnings call on 8/4/2020. Here are the highlights:,,,2019-02-22 15:14:42,,Earnings Alley,https://pbs.twimg.com/profile_images/1113489113435508737/ulSmYR9O_normal.png,1802,1,33,87697,EarningsAlley,
19651092,2020-08-04 15:12:07,,,"mrtopstep.com/incyte-incy-be‚Ä¶, pic.twitter.com/YEDstQPbNN, ",1290727232395251718,False,1,0,0,1,NextScript SNAP Auto Post Plugin,Incyte (INCY) Beats on Q2 Earnings and Sales on Strong Jakafi - https://t.co/RMn8iITRI9 https://t.co/YEDstQPbNN,,,2009-01-28 08:26:49,"Chicago, IL",MrTopStep,https://pbs.twimg.com/profile_images/378800000264951777/fdcb2fffc58110f966d01c65c5daf7df_normal.png,27001,442,1191,247002,MrTopStep,photo
732361939490312192,2020-08-04 14:44:35,"INCY, ","markets, ","americanbankingnews.com/?p=15565517, ",1290720301819604996,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $87.00 at SVB Leerink https://t.co/0IAXSatauc #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-08-04 14:44:34,"INCY, ","stocks, ","americanbankingnews.com/?p=15565517, ",1290720299617529858,False,1,0,0,0,Zapier.com,Incyte $INCY PT Raised to $87.00 at SVB Leerink https://t.co/sV9bAsKMrC #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
94365736,2020-08-04 14:25:05,,"FDA, MorphoSys, Incyte, lymphoma, ","medcitynews.com/2020/08/fda-ap‚Ä¶, ",1290715394404167680,False,0,0,0,0,Hootsuite Inc.,"#FDA approves #MorphoSys, #Incyte‚Äôs drug for vulnerable #lymphoma population https://t.co/tQqgFN5DE2  @medcitynews @MorphoSys @Incyte","medcitynews, MorphoSys, Incyte, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
1100450877792370688,2020-08-04 13:59:07,"INCY, ",,"blueequity.io/r/139406/de-in‚Ä¶, ",1290708863759446018,False,0,0,0,0,Blue Equity,$INCY Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/6vMvzTu303,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
773578537764851712,2020-08-04 13:55:02,"INCY, ",,"sitefocus.com/ei-product, ",1290707834972196865,False,0,0,0,0,CIF-QBA,"$INCY Earnings Intelligence Analysis of recent earnings identified Incyte Corp.  (NASDAQ: INCY ) business focus on (myelofibrosis,parsaclisib,ruxolitinib), (jakafi,parsaclisib,ruxolitinib), (gvhd,parsaclisib,ruxolitinib)

https://t.co/4nOHfhdno3",,,2016-09-07 13:47:50,"Cupertino, CA",SiteFocus,https://pbs.twimg.com/profile_images/908465036598820864/6ZQsC4KD_normal.jpg,195,35,8,57439,SiteFocusHQ,
2181281054,2020-08-04 13:51:27,"INCY, ","markets, ","wkrb13.com/?p=2022080, ",1290706932144250881,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $87.00 at SVB Leerink https://t.co/rw52COfifX #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1001783685484564480,2020-08-04 13:00:22,,"fda, oncology, Pharmaceutical, ","buff.ly/3fvvF7c, pic.twitter.com/iQ7FoMZlW9, ",1290694077604925442,False,0,0,0,0,Buffer,"https://t.co/6DjU72vfX2
MorphoSys and Incyte celebrate a successful collaboration after winning FDA approval for a new treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma. 

#fda #oncology #Pharmaceutical https://t.co/iQ7FoMZlW9",,,2018-05-30 07:13:37,"London, UK & New York, US",Leaman Life Sciences,https://pbs.twimg.com/profile_images/1280805477039947777/jSVf1UMe_normal.png,28,286,0,103,LeamanLife,photo
14453501,2020-08-04 12:42:56,,,"delawarebusinessnow.com/2020/08/incyte‚Ä¶, ",1290689688152547329,True,0,0,0,0,WordPress.com,Incyte earnings beat¬†estimates https://t.co/AZ8dQUtkE4,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
23059499,2020-08-04 12:22:09,"INCY, ","business, finance, investing, ","seekingalpha.com/article/436418‚Ä¶, ",1290684461231640583,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation (INCY) CEO Herv√© Hoppenot on Q2 2020 Results - Earnings Call Transcript. https://t.co/1Mm18V6VeB #business #finance #investing,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1250830691824283648,2020-08-04 11:36:47,"NVO, ECL, BAX, STZ, PBR, PBR.A, ITUB, INCY, CERN, EQR, FCX, ESS, CBRE, IFFT, ENIA, ",,"pic.twitter.com/jZ3zCtkh58, ",1290673040964059141,False,1,0,0,1,Twitter Web App,"Stocks with $10B+ MKT Cap that made 1-month lows so far today

Novo $NVO
Ecolab $ECL
Baxter $BAX
Constellation Brands $STZ
Petrolero Brasileiro $PBR $PBR.A
Itau $ITUB
Incyte $INCY
Cerner $CERN
Equity $EQR
Freeport-Mcmoran $FCX
Essex $ESS
$CBRE
$IFFT
$ENIA https://t.co/jZ3zCtkh58",,,2020-04-16 12:57:54,"New York, NY",Stock Market News,https://pbs.twimg.com/profile_images/1366208150211350534/GfAPwpyD_normal.jpg,123337,211,1299,33044,StockMKTNewz,photo
133504478,2020-08-04 11:30:36,,"strategy, competitiveintelligence, marketing, pharmaceutical, productmarketing, pharma, healthcare, biotech, ","dlvr.it/RczlJ1, lqventures.com, pic.twitter.com/ndjvxhUxo5, ",1290671484415832064,False,0,0,0,1,dlvr.it,Karuna and Incyte scrap programs; More cash for the SPACs https://t.co/l6ZjbbbPYd &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharmaceutical #productmarketing #pharma #healthcare #biotech https://t.co/ndjvxhUxo5,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
46297868,2020-08-04 10:33:33,,,"dlvr.it/RczX6T, ",1290657127204360193,True,0,0,0,0,dlvr.it,Karuna and Incyte scrap programs; More cash for the SPACs https://t.co/eGGKcEFBJW,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
3686628867,2020-08-04 10:15:06,,,"pharmaceuticaldaily.com/incyte-reports‚Ä¶, ",1290652486102122504,False,0,0,0,0,WordPress.com,Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical¬†Programs https://t.co/4K2LvrMB8p,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1001192245,2020-08-04 09:55:26,"INCY, ","Incyte, ","talkmarkets.com/content/stocks‚Ä¶, ",1290647536269754368,False,0,0,0,0,TalkMarketsApp,#Incyte Q2 Earnings and Revenues Beat Estimates $INCY https://t.co/stSbPXn8Hj,,,2012-12-10 02:55:31,,TalkMarkets,https://pbs.twimg.com/profile_images/876851529990512641/zRRSWFBW_normal.jpg,4911,1136,597,292822,TalkMarkets,
32492934,2020-08-04 09:36:51,,,"bioworld.com/articles/49642‚Ä¶, ",1290642858668564480,False,1,0,0,0,TweetDeck,"Morphosys AG finally has some heft to put behind its U.S. commercialization ambitions following FDA approval for its long-nurtured anti-CD19 antibody, Monjuvi (tafasitamab-cxix) in relapsed or refractory diffuse large B-cell lymphoma. https://t.co/jDWtKptGZ4",,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
23059499,2020-08-04 09:24:04,"INCY, ","economy, stockmarket, stocks, ","seekingalpha.com/article/436411‚Ä¶, ",1290639644594278402,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation 2020 Q2 - Results - Earnings Call Presentation. https://t.co/XH1RgUqhzh #economy #stockmarket #stocks,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
72928001,2020-08-04 09:11:56,"INCY, ",,"bit.ly/30r2OwA, ",1290636588318248962,False,0,0,0,2,BriefingInPlayLimited,"$INCY: Incyte beats by $0.37, beats on revs https://t.co/kEmCt40WT0",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
2177744681,2020-08-04 09:05:11,,,"ow.ly/BUg330r2yYc, ",1290634892716498945,False,0,0,0,0,Hootsuite Inc.,FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative ‚Äì Endpoints News https://t.co/uvTM41XQwo,,,2013-11-11 23:56:36,"Atlanta, GA",Lampgen Clinical Research,https://pbs.twimg.com/profile_images/451196302588526592/iSb1JnS6_normal.png,24,45,0,804,Lampgen_CR,
2416188264,2020-08-04 09:01:34,"INCY, ","markets, ","thestockobserver.com/?p=3303045, ",1290633978769276936,False,0,0,0,0,Zapier.com,Incyte $INCY Posts Quarterly Earnings Results  https://t.co/O99iJFBWKj #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2920258887,2020-08-04 08:59:04,"INCY, ",,"dakotafinancialnews.com/?p=2305023, ",1290633350118612992,False,0,0,0,0,Zapier.com,Incyte $INCY Posts Quarterly Earnings Results https://t.co/OSO2Pqz8ne,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
374729426,2020-08-04 08:43:32,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1944057, pic.twitter.com/MnzG2cXGMP, ",1290629441333338114,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator is sitting in oversold zone for 5 days. View odds for this and other indicators: https://t.co/RW7Eugs7HN #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MnzG2cXGMP,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
75337774,2020-08-04 08:14:59,,,"medcitynews.com/2020/08/fda-ap‚Ä¶, ",1290622257686093825,False,0,0,0,0,Twitter Web App,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma population https://t.co/RV7lc40UmA",,,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
75337774,2020-08-04 08:14:23,,,"medcitynews.com/2020/08/fda-ap‚Ä¶, ",1290622107857096706,False,0,0,0,0,Twitter Web App,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma population https://t.co/RV7lc40UmA",,,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
1282308994866966529,2020-08-04 08:06:11,,,"contentoflifer.wordpress.com/2020/08/04/inc‚Ä¶, ",1290620042405609472,False,0,0,0,0,WordPress.com,Incyte Q2 Profit Tops Estimates ‚Äì Quick¬†Facts https://t.co/cIqDRNsZs7,,,2020-07-12 09:41:16,,Contentoflifer,https://pbs.twimg.com/profile_images/1282309129818615809/pAhUgPll_normal.jpg,7,2,0,101151,contentoflifer,
33371707,2020-08-04 08:00:59,"INCY, ","NASDAQ, ","sec.gov/Archives/edgar‚Ä¶, ",1290618732448890880,False,0,0,0,0,xool,"$INCY #NASDAQ  8-K - INCYTE CORP  [B/A=0/0 - Bid/Ask Size=0/0  Volume=1,943,142  AverageVol=1,423,009  Outstanding=0] https://t.co/Knphx1nfLh",,,2009-04-19 21:38:45,,tweeter no more. jack dorsey is a nazi,https://pbs.twimg.com/profile_images/1288570978516127744/0O_9eGqP_normal.jpg,497,633,11,84299,bbiittccooiinn,
44144586,2020-08-04 07:23:05,,"b√∂rse, aktien, ","gmtr.ly/dYCQl7XA0, pic.twitter.com/hAsLZ3yxdK, ",1290609195943895040,False,0,0,0,0,GodmodeTrader Twitter AutoPress,INCYTE - Der Widerstand hat Bestand #b√∂rse #aktien https://t.co/Juhvc7WRmw https://t.co/hAsLZ3yxdK,,,2009-06-02 11:58:56,"M√ºnchen, Deutschland",GodmodeTrader.de,https://pbs.twimg.com/profile_images/466932117843095552/3U3jGoYm_normal.jpeg,9258,143,356,185824,godmodetrader,photo
3911174913,2020-08-04 07:21:08,,,,1290608704367267841,False,2,0,0,0,Twitter for Advertisers.,Incyte reports 2020 Q2 financial results &amp; updates on key clinical programs. Read our press release.,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
2356524462,2020-08-04 07:14:16,"INCY, ",,,1290606978272841728,False,0,0,0,0,Stock News Alerts,"$INCY New Form 8-K for Incyte Corporation
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1156133747852374016,2020-08-04 07:12:08,,"FDA, Monjuvi, CAR_T, B_cell, acquisition, cancercare, ",,1290606441380712448,False,0,0,1,0,Twitter Web App,"Recent pharma happenings:

@MorphoSys, @Incyte gets an early #FDA nod for #Monjuvi, an alternative to #CAR_T for #B_cell malignancies;

With the #acquisition of @VarianMedSys in the cue, @SiemensHealth delves deeper into #cancercare;","MorphoSys, Incyte, VarianMedSys, SiemensHealth, ",,2019-07-30 05:25:40,New Delhi,DelveInsight,https://pbs.twimg.com/profile_images/1222806973487255552/pWZKXuZ9_normal.jpg,122,1363,1,2930,delve_insight,
108617488,2020-08-04 07:10:19,,,"invst.ly/ro83w, ",1290605982154924032,False,0,0,0,0,FP News Publisher - COM,"Incyte Earnings, Revenue Beat in Q2 - https://t.co/27dCKVQy2v",,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
778267752679235585,2020-08-04 07:10:04,,,"stockmarketdaily.co/2020/08/04/inc‚Ä¶, pic.twitter.com/X2wUMQawDL, ",1290605921442430976,False,0,0,0,0,StockMarketDaily,Is it time to Buy before this week‚Äôs earning report Incyte (NASDAQ:INCY) - https://t.co/zTiuDdWB2O https://t.co/X2wUMQawDL,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
1171873456276889600,2020-08-04 07:09:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1290605861245784064,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (4 Aug, 7:08am)

üì∞ Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

https://t.co/2iWY5H2yc0

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
4312114277,2020-08-04 07:09:38,"INCY, ",,"fintel.io/sfs/us/incy?ut‚Ä¶, ",1290605810381447168,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 8-K - Results of Operations and Financial Condition -  FORM 8-K https://t.co/xljeWddlXw,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
1068561714055012352,2020-08-04 07:09:35,"INCY, ",,"sec.report/Document/00011‚Ä¶, ",1290605800122019842,False,0,0,0,0,Edgar Filings,FORM 8-K [Press/News Current Report] recently SEC filed.  $INCY INCYTE CORP  https://t.co/5cANXZZHHs,,,2018-11-30 12:45:40,,SEC.report,https://pbs.twimg.com/profile_images/1268972521941946368/GnspOt5e_normal.jpg,20487,32,183,169683,EdgarInsider,
976297820532518914,2020-08-04 07:09:06,,,"dlvr.it/RcysPR, pic.twitter.com/18lenK87wo, ",1290605677266649088,False,0,1,0,0,dlvr.it,Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/GbfnxNvsEH https://t.co/18lenK87wo,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2020-08-04 07:06:13,,,"crweworld.com/article/news-p‚Ä¶, ",1290604950599266304,False,0,0,0,0,CRWE World,Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/4CSYktrLX8,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
2356524462,2020-08-04 07:04:42,"INCY, ",,,1290604568993292288,False,0,0,0,0,Stock News Alerts,"$INCY Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
1184025479084331008,2020-08-04 07:03:09,"INCY, ",,"pic.twitter.com/bygN6MjHjD, ",1290604179564761088,False,0,0,0,0,pythonmehabe,"(Earnings) Incyte( $INCY ) Actual.EPS=1.24 vs Est.EPS=0.5, Actual.Rev=688M vs Est.Rev=608.61M https://t.co/bygN6MjHjD",,,2019-10-15 04:37:33,Germany,Jeremy,https://pbs.twimg.com/profile_images/1242903623446626304/g1A5BLr2_normal.jpg,2523,2,61,191178,mehabecapital,photo
21079030,2020-08-04 07:03:05,,"PharmaScrip, ","bit.ly/31fl5fr, ",1290604163697704960,False,0,0,0,0,Sprinklr,"Morphosys/Incyte‚Äôs Monjuvi Wins Early US FDA Approval In Second-Line DLBCL
https://t.co/vgYsx03rIQ #PharmaScrip",,,2009-02-17 05:33:29,Global,Scrip,https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg,21541,1629,654,35335,PharmaScrip,
2812632288,2020-08-04 07:03:04,,,"invst.ly/ro83w, ",1290604159973101574,False,0,0,0,0,ForexPros News & Analysis,"Incyte Earnings, Revenue Beat in Q2 - https://t.co/BZq9f5iRf2",,,2014-09-16 03:56:03,Worldwide,Investing.com Stocks,https://pbs.twimg.com/profile_images/1108338732019695616/CAvg-ixc_normal.png,20430,38,256,339289,InvestingStockz,
1237039780225060865,2020-08-04 03:56:05,,,"ift.tt/39Uo4Oz, ",1290557103908818944,False,0,0,0,0,IFTTT,FDA hands MorphoSys and Incyte a quick OKAY on their prospective hit CAR-T alternative https://t.co/TZfqXSmXH3,,,2020-03-09 11:37:45,,deambig22022,https://pbs.twimg.com/profile_images/1237040627893837827/LtB-vWH1_normal.jpg,5,14,0,3881,deambig22022,
1228709143982301187,2020-08-04 03:55:18,,,"ift.tt/39Uo4Oz, ",1290556906797400064,False,0,0,0,0,IFTTT,FDA hands MorphoSys and Incyte a quick OKAY on their prospective hit CAR-T alternative https://t.co/4LhbRRgGiR,,,2020-02-15 10:54:34,,sara,https://pbs.twimg.com/profile_images/1228709518214909952/t0dRmx05_normal.jpg,19,166,0,4414,sara12686418,
1236956625300271110,2020-08-04 03:52:30,,,"ift.tt/39Uo4Oz, ",1290556201646690306,False,0,0,0,0,IFTTT,FDA hands MorphoSys and Incyte a quick OKAY on their prospective hit CAR-T alternative https://t.co/46QfYlpxZV,,,2020-03-09 06:07:08,,jacquelyneblohm42945,https://pbs.twimg.com/profile_images/1236957370514882560/9ePuUBZH_normal.jpg,1,13,0,3870,jacquelynebloh1,
1236734923966427141,2020-08-04 03:27:14,,,"ift.tt/39Uo4Oz, ",1290549842872283138,False,0,0,0,0,IFTTT,FDA hands MorphoSys and Incyte a quick OKAY on their prospective hit CAR-T alternative https://t.co/injudKjVoO,,,2020-03-08 15:26:07,,saramark112200,https://pbs.twimg.com/profile_images/1236735846222610439/lCqQnhH9_normal.jpg,3,14,0,3876,saramark112200,
1236288107131142145,2020-08-04 03:12:18,,,"ift.tt/39Uo4Oz, ",1290546085707030528,False,0,0,0,0,IFTTT,FDA hands MorphoSys and Incyte a quick OKAY on their prospective hit CAR-T alternative https://t.co/McumUnGK9c,,,2020-03-07 08:50:37,,beeesmith112200,https://pbs.twimg.com/profile_images/1236288965969354752/Pv-vY64W_normal.jpg,2,12,0,3888,beeesmith112200,
1229487999802650625,2020-08-04 03:05:36,,,"ift.tt/39Uo4Oz, ",1290544400448262144,False,0,0,0,0,IFTTT,FDA hands MorphoSys and Incyte a quick OKAY on their prospective hit CAR-T alternative https://t.co/wOPQiu0gFV,,,2020-02-17 14:29:25,,sarasmith1144,https://pbs.twimg.com/profile_images/1229488499189002241/GNhNVL-u_normal.jpg,22,124,0,4333,sarasmith1144,
1237639612786499584,2020-08-04 03:02:07,,,"ift.tt/39Uo4Oz, ",1290543521468997632,False,0,0,0,0,IFTTT,FDA hands MorphoSys and Incyte a quick OKAY on their prospective hit CAR-T alternative https://t.co/YbHEgjrdJM,,,2020-03-11 03:21:00,,Jobe65king654et,https://pbs.twimg.com/profile_images/1237640474787274752/ucOrqud7_normal.jpg,1,16,0,3805,jobe65king654et,
1092394610393935872,2020-08-04 01:17:24,,,"stockmarketintellects.com/incyte-corpora‚Ä¶, ",1290517169390989315,False,0,0,0,0,WordPress.com,Incyte Corporation ($INCY) 2Q20 Investor Call On 4th August 2020 At 8:00 AM Eastern¬†Time https://t.co/uSA5WahDyc,,,2019-02-04 07:09:05,,Stock Market Intellects,https://pbs.twimg.com/profile_images/1116923358124204032/4YIC8b0k_normal.png,149,0,1,36884,smintellects,
1092394610393935872,2020-08-04 00:42:14,,,"stockmarketintellects.com/will-incyte-co‚Ä¶, ",1290508319350755329,False,0,0,0,0,WordPress.com,Will Incyte Corporation ($INCY) Beat Analysts¬†View? https://t.co/OVZ4Dv7BkE,,,2019-02-04 07:09:05,,Stock Market Intellects,https://pbs.twimg.com/profile_images/1116923358124204032/4YIC8b0k_normal.png,149,0,1,36884,smintellects,
563084750,2020-08-03 19:42:36,"DIS, SNE, BAYRY, DEO, KKR, EXC, INCY, CYBR, ATI, VMC, ATVI, ","Disney, BP, AMC, Activision, ","traderscommunity.com/index.php/mark‚Ä¶, pic.twitter.com/l0H7TSFT5s, ",1290432914623275009,False,5,0,1,2,Twitter Web App,"Tuesday, August 4, 2020 Earnings 
1/2
Walt #Disney $DIS 
Sony $SNE 
Bayer $BAYRY
#BP
Diageo $DEO
$KKR 
#AMC Networks 
Exelon $EXC
Incyte $INCY 
Cyberark Software $CYBR
Allegheny Tech $ATI
Vulcan Materials $VMC
#Activision Blizzard $ATVI
https://t.co/7KybjJ3tc4 https://t.co/l0H7TSFT5s",,,2012-04-25 14:17:17,,Traders Community,https://pbs.twimg.com/profile_images/1359537033971183617/bnLftW2a_normal.jpg,18045,5625,918,94381,TradersCom,photo
3460109487,2020-08-03 18:19:01,,,"endpts.com/fda-oks-morpho‚Ä¶, ",1290411878691282944,False,0,0,0,0,Buffer,FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative  https://t.co/zq1z5YW3yY,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
1279763869,2020-08-03 18:01:19,,,"ow.ly/ikiO30r2raa, pic.twitter.com/wWerB6Fh6P, ",1290407426567659521,False,0,0,0,0,Hootsuite Inc.,"MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T https://t.co/8Vj8dhcrYU https://t.co/wWerB6Fh6P",,,2013-03-19 03:07:32,,Ethical Recruiters,https://pbs.twimg.com/profile_images/3399772862/774dd87f0960517bf14aa33d290e6c24_normal.jpeg,116,458,11,8233,Ethical421,photo
102754598,2020-08-03 17:45:36,,,"endpts.com/fda-oks-morpho‚Ä¶, ",1290403469560631297,False,1,0,0,0,TweetDeck,"Top 3 today starts with:
FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative
By @Jasonmmast
https://t.co/RV136CamSe","Jasonmmast, ",,2010-01-07 13:33:18,VT and TX (yes),John Carroll,https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_normal.jpeg,61485,280,1456,48410,JohnCendpts,
29881875,2020-08-03 17:21:57,"MOR, INCY, ",,"xconomy.com/europe/2020/08‚Ä¶, ",1290397519692931072,False,0,0,0,1,TweetDeck,".@MorphoSys, @Incyte Get Early FDA Nod for Antibody Alternative to CAR-T
- by @frankvinluan
https://t.co/as48M3R7ja $MOR $INCY","MorphoSys, Incyte, frankvinluan, ",,2009-04-08 21:24:43,United States,Xconomy,https://pbs.twimg.com/profile_images/1218178322347282434/gvnH_9q2_normal.png,26411,2671,1396,23941,Xconomy,
2570920968,2020-08-03 15:03:22,"INCY, MOR, ",,"bit.ly/2XlQqMg, ",1290362642234855424,False,0,0,0,0,Twitter Web App,"Great news! FDA Approves MorphoSys and Incyte's DLBCL Drug Monjuvi! 8-month after inking their partnership, MorphoSys &amp; Incyte won approval for new treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma! $INCY $MOR 
https://t.co/xGsf4DjXpz",,,2014-06-16 09:22:42,"New York, NY",AlphaBronze,https://pbs.twimg.com/profile_images/478602792601280513/B8WeKP_u_normal.jpeg,1954,4717,25,14751,Alpha_Bronze,
2315971404,2020-08-03 14:30:03,,"Monjuvi, ","lnkd.in/gceAezh, ",1290354259154804736,False,0,0,0,0,LinkedIn,FDA Approves MorphoSysys and Incyte DLBCL Drug #Monjuvi https://t.co/w6GLXoFxZ5,,,2014-01-28 14:30:38,"Santa Barbara, CA, USA",Shelli Kenlein Papke,https://pbs.twimg.com/profile_images/1442957181578473475/d4z8c4sV_normal.jpg,61,211,2,1561,USDMRECRUITER,
133504478,2020-08-03 14:09:33,,"strategy, competitiveintelligence, marketing, pharmaceutical, healthcare, biotech, competitivemarketing, pharma, ","dlvr.it/RcwcBf, lqventures.com, pic.twitter.com/pFZIPhcOTQ, ",1290349097933656069,False,3,0,0,2,dlvr.it,"MorphoSys, Incyte Get Early FDA Nod for Antibody Alternative to CAR-T https://t.co/Y9oVNORYmg &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #biotech #competitivemarketing #pharma https://t.co/pFZIPhcOTQ",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1281425464733716481,2020-08-03 14:00:00,"ZBH, TDG, INCY, AME, VMC, WMG, EXPD, LDOS, IT, ","Earnings, ",,1290346694907838464,False,1,0,0,0,Twitter Web App,"#Earnings Notable Companies reporting on TUE, AUG 04
Pre-Market :

$ZBH       Zimmer Biomet 
$TDG       Transdigm 
$INCY      Incyte 
$AME      AMTEK
$VMC      Vulcan Materials 
$WMG    Warner Music Group 
$EXPD    Expeditors International 
$LDOS     Leidos 
$IT         Gartner",,,2020-07-09 23:10:34,,Upgrades Downgrades,https://pbs.twimg.com/profile_images/1281426299194572804/7-zTTAQ7_normal.jpg,836,1903,13,4766,UDowngrades,
1159146763229507584,2020-08-03 13:59:42,,,"fiercepharma.com/marketing/a-fi‚Ä¶, ",1290346620027047937,False,0,0,0,0,Twitter Web App,"In a first, MorphoSys, Incyte win Monjuvi FDA nod in lymphoma to challenge Roche‚Äôs Polivy | FiercePharma https://t.co/uwvH51MogE",,,2019-08-07 12:58:19,"Miami Fl, London U K, Madrid ",R Mandy Alcuria,https://pbs.twimg.com/profile_images/1220781792334110721/LT-6vyu3_normal.jpg,52,933,1,14134,AlcuriaRudolph,
3566494516,2020-08-03 13:56:34,,,"dlvr.it/RcwZLl, pic.twitter.com/i4LpTb85HK, ",1290345832881954816,False,0,0,0,1,dlvr.it,"In a first, MorphoSys, Incyte win Monjuvi FDA nod in lymphoma to challenge Roche‚Äôs Polivy https://t.co/n5v3TEnyqS https://t.co/i4LpTb85HK",,,2015-09-06 09:12:57,"NYC, London, RTP",RxDataScience Inc.,https://pbs.twimg.com/profile_images/827327728064016384/aC5C1yau_normal.jpg,178,87,7,1443,RxDataScience,photo
25406480,2020-08-03 13:50:49,,,"awesomecapital.blogspot.com/2020/08/fda-ap‚Ä¶, ",1290344387017428994,False,0,0,0,1,Twitter Web App,AwesomeCapital: FDA Approves MorphoSys and Incyte‚Äôs DLBCL Drug Mon... https://t.co/SnSOtL3jxx,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
963495628545327104,2020-08-03 13:23:08,"INCY, INCY, ",,"stck.pro/news/INCY/6745‚Ä¶, stck.pro/news/INCY, ",1290337420433653762,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Q2 2020 Earnings Preview https://t.co/ZFjU4xMmrV Get all the latest $INCY related news here : https://t.co/MBjnAUHmJZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
15296897,2020-08-03 13:20:39,"INCY, ",,"seekingalpha.com/news/3599117-i‚Ä¶, ",1290336792776851456,False,0,0,0,0,SANewsTwitter,$INCY - Incyte Q2 2020 Earnings Preview https://t.co/d4iAu95JHf,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
2236425032,2020-08-03 13:15:54,,,"fiercepharma.com/marketing/a-fi‚Ä¶, ",1290335597651996673,False,0,0,0,0,Twitter Web App,"In a first, MorphoSys, Incyte win Monjuvi FDA nod in lymphoma to challenge Roche‚Äôs Polivy https://t.co/2lEO4wEA2n",,,2013-12-08 13:35:25,Delaware,MB Devine,https://pbs.twimg.com/profile_images/1080973438460674048/-uzWh-F2_normal.jpg,144,987,29,25721,devine_mb,
133504478,2020-08-03 13:07:38,,"strategy, competitiveintelligence, marketing, biotech, pharmaceutical, healthcare, pharma, productmarketing, ","dlvr.it/RcwQz0, lqventures.com, pic.twitter.com/NZOu3qQdkq, ",1290333517788794880,False,0,0,0,1,dlvr.it,"In a first, MorphoSys, Incyte win Monjuvi FDA nod in lymphoma to challenge Roche‚Äôs Polivy https://t.co/BnNmZvi30V &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #healthcare #pharma #productmarketing https://t.co/NZOu3qQdkq",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1289196501516812289,2020-08-03 12:46:30,,"PharmaTopNews, ImmunoOncologyTopNews, CancerImmunotherapy, Immunotherapy, Oncology, ImmunoOncology, ","fiercepharma.com/marketing/a-fi‚Ä¶, ",1290328197729574912,False,0,0,0,0,Twitter for iPhone,"In a first, MorphoSys, Incyte win Monjuvi FDA nod in lymphoma to challenge Roche‚Äôs Polivy | FiercePharma

#PharmaTopNews #ImmunoOncologyTopNews #CancerImmunotherapy #Immunotherapy #Oncology #ImmunoOncology https://t.co/xlcuKMUDaR",,,2020-07-31 09:49:56,,Pharma Top News,https://pbs.twimg.com/profile_images/1289222230552072195/Fb5XMFYC_normal.jpg,16,0,0,2134,PharmaTopNews1,
18834912,2020-08-03 12:08:17,"INCY, ","FDA, lymphoma, ","medcitynews.com/2020/08/fda-ap‚Ä¶, ",1290318579917819912,False,0,0,0,0,Twitter Web App,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma population, writes @biotechvisigoth @medcitynews  https://t.co/aLAFk6y3iE $INCY #FDA #lymphoma","biotechvisigoth, medcitynews, ",,2009-01-10 09:09:33,"MedCity, USA",MedCity News,https://pbs.twimg.com/profile_images/598875829976834048/MLQosVo1_normal.png,32781,7502,1628,37912,medcitynews,
17746732,2020-08-03 12:07:40,"INCY, ","FDA, lymphoma, ","medcitynews.com/2020/08/fda-ap‚Ä¶, ",1290318427299684354,False,0,0,0,0,Twitter Web App,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma population, writes @biotechvisigoth @medcitynews  https://t.co/bDpKjEOi05 $INCY #FDA #lymphoma","biotechvisigoth, medcitynews, ",,2008-11-29 21:08:31,"Philadelphia, PA",Stephanie L Baum,https://pbs.twimg.com/profile_images/758908587267661825/Xg-Y10LO_normal.jpg,6358,2695,496,10476,StephLBaum,
46297868,2020-08-03 12:04:03,,,"dlvr.it/RcwDcH, ",1290317518209339392,True,0,0,0,0,dlvr.it,"In a first, MorphoSys, Incyte win Monjuvi FDA nod in lymphoma to challenge Roche‚Äôs Polivy https://t.co/bcXz81p6Tc",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
354472149,2020-08-03 11:24:43,,,"investors.com/market-trend/s‚Ä¶, ",1290307616963346432,True,0,0,0,0,Twitter Web App,"8-3-20 
Dow Jones Today, Stocks Rise As Microsoft Courts TikTok; Varian Soars On Siemens Deal; Incyte, Co-Diagnostics https://t.co/sTYCW7JNc2",,,2011-08-13 15:39:20,USA Columbia MD,litetechstudio,https://pbs.twimg.com/profile_images/1404035883846746112/IfLr8LXA_normal.jpg,1638,1362,27,73774,FeroldTorchenot,
27645777,2020-08-03 11:10:35,,"lymphoma, ","bit.ly/3gswPlo, pic.twitter.com/kSWAiKIYr1, ",1290304061015617538,False,0,0,0,0,TweetDeck,.@US_FDA approves Monjuvi (@MorphoSys @Incyte) as part of combination regimen for relapsed or refractory diffuse large B-cell #lymphoma https://t.co/3bwaLMIZee https://t.co/kSWAiKIYr1,"US_FDA, MorphoSys, Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
1266113547060350977,2020-08-03 10:55:23,,,"timesofbritain.com/2020/08/03/fda‚Ä¶, ",1290300234669518850,False,0,0,0,0,WordPress.com,FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T¬†alternative https://t.co/0CpE2xvuiQ,,,2020-05-28 17:06:16,United Kingdom,Times of Britain,https://pbs.twimg.com/profile_images/1266119599713669128/iO4Ejf2V_normal.jpg,26,139,0,34237,TimesBritain,
33467057,2020-08-03 10:54:35,,"DLBCL, ","pic.twitter.com/Jixnvvrpo7, ",1290300033083101185,False,16,0,0,5,Twitter Web App,"In partnership with @Incyte, we're proud to bring a new treatment option to adult patients with relapsed or refractory #DLBCL. https://t.co/Jixnvvrpo7","Incyte, ",,2009-04-20 05:13:43,"Planegg, Germany",MorphoSys,https://pbs.twimg.com/profile_images/1414967751538511873/dOJDE_2G_normal.jpg,1563,205,37,315,MorphoSys,photo
605170194,2020-08-03 10:44:15,"INCY, MOR, IBB, QQQ, SPY, XBI, XNCR, ",,"finance.yahoo.com/news/incyte-mo‚Ä¶, ",1290297436087308289,False,1,0,0,0,Twitter Web App,"$INCY $MOR $IBB $QQQ $SPY $XBI Hidden gem is $XNCR who will receive double digit royalties on sales. This will likely be $2B drug as other indications and 1L approvals.

Incyte, MorphoSys Win FDA Nod For ‚ÄòKey Revenue Driver‚Äô Tafasitamab https://t.co/OhqeIF1YcE via @YahooFinance","YahooFinance, ",,2012-06-10 23:53:22,,biogemfinder,https://pbs.twimg.com/profile_images/378800000638150591/410d30fe548cf9d66941bc8a9ddda0a4_normal.png,192,53,7,3374,biogemfinder,
133504478,2020-08-03 10:40:34,,"strategy, competitiveintelligence, marketing, pharma, biotech, productmarketing, pharmaceutical, healthcare, ","dlvr.it/Rcvxk2, lqventures.com, pic.twitter.com/0RSh44db2r, ",1290296508680531968,False,0,0,0,1,dlvr.it,FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative https://t.co/i3lFq3zmLb &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #pharmaceutical #healthcare https://t.co/0RSh44db2r,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
15974185,2020-08-03 10:28:33,,,"dlvr.it/Rcvvst, ",1290293483987558405,False,0,0,0,0,dlvr.it,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma population https://t.co/T5u4sgvRj5",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
33081747,2020-08-03 10:25:18,,,"celebznews.com/2020/08/03/fda‚Ä¶, ",1290292665980878849,False,0,0,0,0,WordPress.com,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma¬†population https://t.co/CfID1SB2Zy",,,2009-04-18 21:25:45,"Hyderabad, India",maxkrish,https://pbs.twimg.com/profile_images/643324046/nitin_normal.jpg,101,0,1,97782,hscelebrities,
3901351277,2020-08-03 10:22:05,,"healthnews, ","bit.ly/2XE6cCH, ",1290291854190112768,False,0,0,0,0,IFTTT,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma population : https://t.co/8dDaBXy7kg #healthnews",,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
911779625071759366,2020-08-03 10:00:33,,,"investors.com/market-trend/s‚Ä¶, ",1290286436369874944,False,0,0,0,2,dlvr.it,"Dow Jones Today, Stocks Rise As Microsoft Courts TikTok; Varian Soars On Siemens Deal; Incyte ,Co-Diagnostics FDA News - Investor's Business Daily https://t.co/TJgrjXhZvD",,,2017-09-23 22:29:37,Worldwide,Observatory,https://pbs.twimg.com/profile_images/1254052272717344769/GCTl9XGI_normal.jpg,126,110,0,59871,BankforBanks,
1250156125053423619,2020-08-03 09:57:00,,,"endpts.com/fda-oks-morpho‚Ä¶, ",1290285542567895042,False,0,0,0,0,PyMarketWatch,FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative - Endpoints News https://t.co/pgZZsbviS8,,,2020-04-14 16:17:09,,PyMarketWatch,https://pbs.twimg.com/profile_images/1251051867263598592/hU5UXcPw_normal.jpg,377,0,4,34632,PyMarketWatch,
140599113,2020-08-03 09:54:26,,,"winway.me/health-care/fd‚Ä¶, ",1290284897140002816,False,0,0,0,0,WordPress.com,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma¬†population https://t.co/O3TdiRPCXx",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,
407212567,2020-08-03 09:47:05,,"eHealth, ","ift.tt/2XkRZKo, ",1290283047061827585,False,0,0,0,0,IFTTT,"Mi seguimiento üì° sobre #eHealth FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma population: https://t.co/ArblQh9M7o",,,2011-11-07 14:56:05,Espa√±a,Eugenio Ghirardi,https://pbs.twimg.com/profile_images/378800000532943977/0f99af81bf68382f40a90e89c7ca525c_normal.png,341,485,32,19973,GhirardiEugenio,
33081747,2020-08-03 09:41:26,,,"safetyhealthnews.com/2020/08/03/fda‚Ä¶, ",1290281627273195536,False,0,0,0,0,WordPress.com,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma¬†population https://t.co/h2Td7U7fN6",,,2009-04-18 21:25:45,"Hyderabad, India",maxkrish,https://pbs.twimg.com/profile_images/643324046/nitin_normal.jpg,101,0,1,97782,hscelebrities,
4058194633,2020-08-03 09:40:22,"INCY, MOR, ",,"pharmaphorum.com/?p=70576, ",1290281356287545345,False,0,0,0,0,Twitter for iPhone,"$INCY $MOR Incyte/Morphosys take on CAR-Ts with $198,000 per year antibody https://t.co/TZFf4O64HB via @pharmaphorum","pharmaphorum, ",,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
372879078,2020-08-03 09:29:04,,,"dlvr.it/Rcvk9k, pic.twitter.com/yLpex5MOzP, ",1290278513136680967,False,0,0,0,0,dlvr.it,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma population https://t.co/vo6vhx6zqz - @MedCityNews https://t.co/yLpex5MOzP","medcitynews, ",,2011-09-13 11:51:51,"Montgomery County, MD",AE Eckert,https://pbs.twimg.com/profile_images/1381608105021165568/io8VhV9J_normal.jpg,558,355,50,50180,AndrewEEckert,photo
437085904,2020-08-03 09:21:33,,,"dlvr.it/RcvhzK, pic.twitter.com/wTglGQRWRT, ",1290276620213788672,False,0,0,0,1,dlvr.it,"FDA approves MorphoSys, Incyte‚Äôs drug for vulnerable lymphoma population https://t.co/QfpHjEDwIi https://t.co/wTglGQRWRT",,,2011-12-14 19:20:30,"Hudson Valley, New York",Bruce Judson Telemed,https://pbs.twimg.com/profile_images/904040523580661760/7sz5Ry6z_normal.jpg,5677,1562,245,82548,JudsonTelemed,photo
108617488,2020-08-03 09:10:08,,,"invst.ly/rntsq, ",1290273749082677248,False,0,0,0,0,FP News Publisher - COM,RBC Capital Stick to Their Hold Rating for Incyte Corp - https://t.co/LTWEcfZNqj,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
1142831555850592256,2020-08-03 09:04:43,,"BayArea, Biotech, ","tinyurl.com/yxhr83af, ",1290272384629366785,False,0,0,0,0,FeedBlitz,"SFBN Feed: FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative: Nearly three years after okaying the CAR-Ts Yescarta and Kymriah, the FDA has approved a new CD19 ... #BayArea #Biotech https://t.co/lc7SB96Vlp",,,2019-06-23 12:27:30,"San Francisco, CA",San Francisco Biotechnology Network,https://pbs.twimg.com/profile_images/1430570245622693888/y8PFDscc_normal.jpg,1095,3775,7,7847,sfbionetwork,
3549429319,2020-08-03 09:01:16,,,"latesttoday.news/2020/08/03/bus‚Ä¶, ",1290271519235428353,False,0,0,0,0,WordPress.com,FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative ‚Äì Endpoints¬†News https://t.co/yqx8pbpOzJ,,,2015-09-13 09:07:51,America,Today's news summary,https://pbs.twimg.com/profile_images/1303326591678775296/uX9wI_0D_normal.jpg,280,1140,1,257461,k29664911,
27254739,2020-08-03 08:42:07,,"DLBCL, ","bit.ly/33of9DA, ",1290266699908804610,False,0,0,0,0,TweetDeck,"Update to our story on Incyte/Morphosys' NHL drug  Monjuvi: Incyte says it will cost $16,500 per month in the first year, $13,000 per month in subsequent years https://t.co/xbzTC3H1Gp #DLBCL",,,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
374729426,2020-08-03 08:14:43,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1938096, pic.twitter.com/sCPeZTL4Nx, ",1290259803244175362,False,0,0,0,1,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/JyTRNAfafm #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/sCPeZTL4Nx,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
42660725,2020-08-03 08:08:57,,,"bitly.com/39SwlCu, ",1290258353570996233,False,0,0,0,0,Bitly,FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative ‚Äì Endpoints News https://t.co/p637Odg0EK,,,2009-05-26 12:34:32,United States,"Patricia Farrell, Ph.D.",https://pbs.twimg.com/profile_images/1193120866508460037/t81e5U_H_normal.jpg,9547,10344,460,549239,drpatfarrell,
2334614718,2020-08-03 08:08:10,"INCY, MOR, ",,"ooc.bz/l/57921, ",1290258155989942272,False,2,0,0,0,Open Outcrier,"$INCY (+6.2% pre) FDA OKs Incyte/Morphosys' tafasitamab for treatment-resistant lymphoma

$MOR (+4.3% Pre)

https://t.co/HRlFY31lUG",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
1288463175076241410,2020-08-03 07:55:15,,,"europenewsonline.com/2020/08/03/inc‚Ä¶, ",1290254902313119744,False,0,0,0,0,WordPress.com,"Incyte, MorphoSys Win FDA Nod For ‚ÄòKey Revenue Driver‚Äô¬†Tafasitamab https://t.co/7MN5k2US7y",,,2020-07-29 09:15:48,Belgium,Europe News Online,https://pbs.twimg.com/profile_images/1288463462197272578/3e2bebEa_normal.jpg,9,25,0,2587,Europe_News_ONL,
3460109487,2020-08-03 07:30:32,,,"endpts.com/fda-oks-morpho‚Ä¶, ",1290248682663600128,False,1,0,0,0,Buffer,FDA hands MorphoSys and Incyte a quick OK on their potential blockbuster CAR-T alternative https://t.co/zq1z5ZdEqw,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
46297868,2020-08-03 07:23:33,,,"dlvr.it/RcvKSZ, ",1290246924847599616,True,0,0,0,0,dlvr.it,"FDA OKs MorphoSys, Incyte‚Äôs potential blockbuster CAR-T alternative https://t.co/MpScmapKTX",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
575910168,2020-08-03 07:22:43,,"YahooFinance, Traffic, Transportation, Shipping, Logistics, Trucking, ","truckingnews.us/incyte-morphos‚Ä¶, ",1290246714478084102,False,0,0,0,0,Trucking News,"Incyte, MorphoSys Win FDA Nod For ‚ÄòKey Revenue Driver‚Äô Tafasitamab https://t.co/5CSoxRqGa6
#YahooFinance #Traffic #Transportation #Shipping #Logistics
Follow @AFTvitaliy for #Trucking News","AFTvitaliy, ",,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
72928001,2020-08-03 06:55:42,"INCY, ",,"bit.ly/33lEoGA, ",1290239919550377985,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte and MorphoSys receive FDA approval for Monjuvi in combination with Lenalidomide https://t.co/CzfvLTH7DN,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
27254739,2020-08-03 06:52:44,,"DLBCL, ","bit.ly/33of9DA, ",1290239169856278529,False,0,0,0,0,Sprout Social,".@Incyte and @MorphoSys‚Äô Monjuvi antibody therapy has been approved for certain patients with lymphoma, as the companies hope to provide a more convenient alternative to expensive and cumbersome CAR-T therapy https://t.co/KamWoFokZc #DLBCL","Incyte, MorphoSys, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
2840228735,2020-08-03 06:52:23,,,"investor.lilly.com/news-releases/‚Ä¶, ",1290239082619006976,False,2,0,0,1,Twitter for Android,"The first patient has been enrolled in a Phase 3 randomized, double-blind, placebo‚Äìcontrolled study to evaluate the efficacy and safety of baricitinib, an oral JAK1/JAK2 inhibitor licensed from Incyte, in hospitalized adults with COVID-19

https://t.co/gBZVAgFhEb",,,2014-10-21 11:50:44,"London, UK ",Przemek Suchorab üè¥Û†ÅßÛ†Å¢Û†Å•Û†ÅÆÛ†ÅßÛ†Åø ‚öõÔ∏è,https://pbs.twimg.com/profile_images/1194665750667112449/cgmNcPf5_normal.jpg,2437,2658,0,8155,suchorabprzem5k,
1370906497,2020-08-03 06:18:16,"XNCR, MOR, MOR, INCY, ",,,1290230496056639488,False,0,0,0,0,Twitter Web App,$XNCR $MOR MorphoSys $MOR previously teamed up with Incyte $INCY to commercialize Monjuvi in the US.,,,2013-04-21 20:38:27,U.S.A,MAISA,https://pbs.twimg.com/profile_images/3557296223/a73cb8bb8effbfd1f90590ab48523b10_normal.jpeg,2858,7,76,70211,MaisaCorp,
2416188264,2020-08-03 04:31:23,"INCY, ","markets, ","thestockobserver.com/?p=3298300, ",1290203597590781957,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday  https://t.co/rVbyf1313J #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2298709746,2020-08-03 04:31:19,"INCY, ",,"zpr.io/HzgPD, ",1290203581531009024,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/Ig3qNYFufk,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2920258887,2020-08-03 04:28:58,"INCY, ",,"dakotafinancialnews.com/?p=2300309, ",1290202989014081540,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/bUOPKJM0Fe,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
725577499,2020-08-03 02:06:19,"INCY, MOR, ",,"tipranks.com/news/incyte-mo‚Ä¶, ",1290167092373852162,False,0,0,0,0,Twitter Web App,"Incyte, MorphoSys Win FDA Nod For ‚ÄòKey Revenue Driver‚Äô Tafasitamab $INCY $MOR  https://t.co/UzZJiz26xy",,,2012-07-30 03:57:38,,TipRanks,https://pbs.twimg.com/profile_images/1445275766195884032/dO0joyh1_normal.jpg,25516,1242,436,23612,TipRanks,
839808536,2020-08-02 15:21:17,,,"managedhealthcareexecutive.com/view/fda-updat‚Ä¶, ",1290004763766030337,False,4,0,0,1,Twitter Web App,"FDA Updates: Blood Cancers, Orphan Drug Designations Get Priority  @incyte @KitePharma @bluebirdbio @Inovio @PKDFoundation https://t.co/2I4L2HNCNS via @MHExecutive","Incyte, KitePharma, bluebirdbio, inovio, PKDFoundation, MHExecutive, ",,2012-09-22 10:02:20,Robbinsville by way of Pascagoula and Levittown,Mary Caffrey,https://pbs.twimg.com/profile_images/732985233314861056/6UwY2nv1_normal.jpg,754,1729,44,10788,MaryKCaffrey,
374729426,2020-08-02 08:30:30,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1934979, pic.twitter.com/LEFQTjc2ql, ",1289901384817508352,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/eSMsHL1DB3 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/LEFQTjc2ql,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2338882843,2020-08-02 05:00:14,"INCY, ",,"dailypolitical.com/?p=4301805, ",1289848469855727617,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Recommendation of ‚ÄúHold‚Äù by Brokerages https://t.co/VJVAxqXU4K,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
68559732,2020-08-02 04:28:52,"INCY, ",,"zpr.io/H7463, ",1289840579602345984,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Recommendation of ‚ÄúHold‚Äù by Brokerages https://t.co/VjFmilMfJV,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
966006214818697218,2020-08-02 04:28:47,"INCY, ",,"theenterpriseleader.com/?p=3597535, ",1289840558509187072,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Recommendation of ‚ÄúHold‚Äù by Brokerages  https://t.co/WOSr86EwHi,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1134049078424162304,2020-08-01 15:00:37,"MOR, INCY, ",,"newsfilter.io/articles/fda-o‚Ä¶, ",1289637173927411712,False,0,0,0,0,Newsfilter.io,FDA OKs Incyte/Morphosys' tafasitamab for treatment-resistant lymphoma $MOR $INCY https://t.co/1rYdm9XNvk,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
25406480,2020-08-01 12:11:22,,,"awesomecapital.blogspot.com/2020/08/fda-ok‚Ä¶, ",1289594582544584707,False,0,0,0,1,Twitter Web App,AwesomeCapital: FDA OKs Incyte/Morphosys‚Äô tafasitamab for treatmen... https://t.co/RHRaM3ivO4,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
374729426,2020-08-01 11:26:24,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1929625, pic.twitter.com/mPYVJS0zF2, ",1289583265515372550,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/9TcylTx5CL #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/mPYVJS0zF2,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
106823467,2020-08-01 11:06:35,"MOR, INCY, ","MorphoSys, Incyte, BcellLymphoma, Lymphoma, DLBCL, ","crweworld.com/symbol/MOR, ",1289578277741277186,False,0,0,0,0,Twitter Web App,"FDA OKs $MOR, $INCY 's Monjuvi + Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma    #MorphoSys       #Incyte     #BcellLymphoma       #Lymphoma      #DLBCL      https://t.co/hLo39Cfar8",,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
2239893372,2020-08-01 04:52:02,,,"twitter.com/Incyte/status/‚Ä¶, ",1289484018069602304,False,7,0,0,3,Twitter for iPhone,Well let‚Äôs see how it fares in the world of mostly high risk relapsed DLBCL. https://t.co/xAoheHBMpK,,,2013-12-10 18:23:39,Opinions are mine,Graham Collins,https://pbs.twimg.com/profile_images/1200904594160865280/LgjE6Tlz_normal.png,7881,1106,77,6349,graham74GC,
236987449,2020-08-01 03:15:04,,"CML, CommunityAdvisoryBoard, CAB, CMLCAB, ","ow.ly/NjP450ANCjX, pic.twitter.com/9JucUTcoaJ, ",1289459618310000640,False,8,0,0,5,Hootsuite Inc.,"On July 23, #CML Advocates Network held its 20th #CommunityAdvisoryBoard #CAB meeting where we as a patient community invited the companies @TakedaOncology and @Incyte to an open dialogue. 
Know more about the #CMLCAB: https://t.co/G1diQXlFlN https://t.co/9JucUTcoaJ","TakedaOncology, Incyte, ",,2011-01-11 15:38:41,Worldwide,CML AdvocatesNetwork,https://pbs.twimg.com/profile_images/1438524332825665538/TtqJD-B6_normal.jpg,1840,677,0,6114,cmlnet,photo
2992526786,2020-07-31 22:58:28,,,"twitter.com/Incyte/status/‚Ä¶, ",1289395041748672512,False,29,0,0,5,Twitter for iPhone,FDA Approves Monjuvi¬Æ (tafasitamab-cxix) in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL).  It is a CD19 antibody plus lenalidomide. We are going to try this in mantle cell lymphoma! https://t.co/BmsFjeQ49U,,,2015-01-22 14:16:23,"Houston, Texas","Michael Wang, MD",https://pbs.twimg.com/profile_images/1113563698742870017/1Hlg0y7b_normal.jpg,4275,3053,70,2376,michaelwangmd,
1280938376099741697,2020-07-31 20:55:27,,,"iexcloud.io, pic.twitter.com/jUUYuEnmog, ",1289364085037907970,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Align Technology, Inc.
-Incyte Corp.
-Analog Devices, Inc.
-Al Khazna Insurance Co.
-Gilead Sciences, Inc.

Data provided by IEX Cloud
https://t.co/8wD2V1UepI https://t.co/jUUYuEnmog",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
3911174913,2020-07-31 20:25:06,,"Breaking, DLBCL, ",,1289356444563775488,False,16,3,0,7,Twitter for Advertisers.,#Breaking: Incyte and @MorphoSys announced that the @US_FDA has approved a new targeted treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma (#DLBCL).,"MorphoSys, US_FDA, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
33467057,2020-07-31 20:12:21,,"DLBCL, ","bit.ly/2L3vmGA, pic.twitter.com/44AjLXGKwJ, ",1289353238832189440,False,30,1,1,10,Twitter Web App,"Together with @Incyte, we've announced that the @US_FDA has approved a new targeted treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma (#DLBCL): https://t.co/VpHBJwMe7R https://t.co/44AjLXGKwJ","Incyte, US_FDA, ",,2009-04-20 05:13:43,"Planegg, Germany",MorphoSys,https://pbs.twimg.com/profile_images/1414967751538511873/dOJDE_2G_normal.jpg,1563,205,37,315,MorphoSys,photo
261473143,2020-07-31 19:52:25,,,"morphosys.com/media-investor‚Ä¶, life-sciences-usa.com/news/vlfm-iito‚Ä¶, pic.twitter.com/spYfWHYMKA, ",1289348222461177859,False,1,0,0,0,Twitter Web App,MorphoSys &amp; Incyte: FDA Approves Monjuvi (tafasitamab-cxix) in Combi with Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma https://t.co/Q8zyYSB75q @MorphoSys @Incyte More Transatlantic Life Science Business News at [LSUS] at https://t.co/HEEySVwfoy https://t.co/spYfWHYMKA,"MorphoSys, Incyte, ",,2011-03-05 20:26:19,"Bremen, Germany",[iito] Life Science,https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_normal.jpeg,2596,238,89,29254,iitoLifeScience,photo
23059499,2020-07-31 12:43:19,"INCY, ","trading, markets, economy, ","seekingalpha.com/article/436297‚Ä¶, ",1289240233389592576,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte: Time Again To Wait And Watch. https://t.co/aHsx47ALSr #trading #markets #economy,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
374729426,2020-07-31 12:06:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1925198, pic.twitter.com/QLK1ZXowcQ, ",1289231046857256960,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/lUKpTPjm1I #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/QLK1ZXowcQ,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
108617488,2020-07-31 05:15:16,,,"invst.ly/rmvld, ",1289127477290381313,False,0,0,0,0,FP News Publisher - COM,Mizuho Securities Stick to Their Hold Rating for Incyte Corp - https://t.co/S7ZEozOC4A,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
3911174913,2020-07-30 18:46:44,,"COVID19, ",,1288969305288331271,False,3,0,0,0,Twitter for Advertisers.,"We‚Äôre continuing to advance Phase 3 trials of our investigational treatment for people w/ #COVID19 associated cytokine storm. The Delaware Journal of Public Health, in collaboration w/ Incyte, published details on the trial design of RUXCOVID &amp; 369-DEVENT.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
968871413082816513,2020-07-30 16:37:22,"ACAD, ",,"tinyurl.com/y2xnaax3, tinyurl.com/y5vlkej2, ",1288936748626538496,False,3,0,0,0,Twitter Web App,"$ACAD Frivolous litigation has been brought against other top Baker holdings in the past. For example:

SGEN: https://t.co/jvNk3Vcgva
INCY: https://t.co/wfWc7jTVMS

It is best to take all such ""news"" cum grano salis.",,,2018-02-28 10:32:00,,FTR,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,99,4,0,818,ForTheRecord01,
1267477446556897284,2020-07-30 15:25:41,,,"thefly.com/landingPageNew‚Ä¶, ",1288918708069572611,False,0,0,0,0,Twitter Web App,"Incyte awarded $541M contract with U.S. Department of Veterans Affairs¬†15:25 INCY Incyt

Read more at:
https://t.co/GS1qK497Yq",,,2020-06-01 11:25:52,,WallStBetsDotCom,https://pbs.twimg.com/profile_images/1270171714568237056/sx7E9nBZ_normal.jpg,281,6,5,26304,WallStBetsDotC1,
31546412,2020-07-30 15:18:24,"INCY, ",,"beta.sam.gov/opp/14523a6563‚Ä¶, ",1288916872709066752,False,9,0,2,2,Twitter Web App,$INCY Incyte has been awarded a five year Veterans Affairs federal supply schedule contract worth $541 million.  https://t.co/lULMGzIJJ2,,,2009-04-15 18:39:06,,TradeHawk,https://pbs.twimg.com/profile_images/139747067/green_normal.jpg,66861,14,1360,4311,TradeHawk,
374729426,2020-07-30 08:50:41,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1921868, pic.twitter.com/Whl0EG0YlH, ",1288819302682910720,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on July 28, 2020. View odds for this and other indicators: https://t.co/LyeCGzpd60 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Whl0EG0YlH",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1280938376099741697,2020-07-30 07:46:40,,,"iexcloud.io, pic.twitter.com/5tcvEnHfPd, ",1288803190352248833,False,0,0,0,0,robby.ae,"iexStock Latest Prices
 
-Paychex, Inc.
-Sharjah Islamic Bank
-Gulf Cement Co. PSC
-Al Fujairah National Insurance Co. PSC
-Incyte Corp.

Data provided by IEX Cloud
https://t.co/8wD2V2bPOi https://t.co/5tcvEnHfPd",,,2020-07-08 14:55:03,Dubai,iexStock,https://pbs.twimg.com/profile_images/1280939320224989184/_8k3vDdM_normal.jpg,16,6,0,6386,rb_iexstock,video
374729426,2020-07-29 08:56:44,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1915802, pic.twitter.com/3lKXccXRGn, ",1288458435663556615,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on July 28, 2020. View odds for this and other indicators: https://t.co/ZM0Bi1Z9Fa #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/3lKXccXRGn",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2920258887,2020-07-29 08:03:22,"INCY, ",,"dakotafinancialnews.com/?p=2280648, ",1288445005405868037,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Hold Rating Reaffirmed at JPMorgan Chase &amp; Co. https://t.co/avDmkOMN0M,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
1148923757886676992,2020-07-28 13:05:02,,"ai, aijobs, artificialintelligence, techjobs, datascience, jobsearch, jobs, ml, computervision, recruiting, hire, ","aijobs.com/jobs/principal‚Ä¶, ",1288158538091528193,False,0,0,0,0,Twitter Web App,"Incyte Corporation is looking for a PRINCIPAL INVESTIGATOR, SCIENTIFIC DATA ENGINEER (United States,Delaware, Wilmington) apply here:

https://t.co/pLNDYJuvPe

#ai #aijobs #artificialintelligence #techjobs #datascience #jobsearch #jobs #ml #computervision #recruiting #hire",,,2019-07-10 07:55:44,Worldwide,aijobs,https://pbs.twimg.com/profile_images/1248173697271095296/VpMEPUhV_normal.jpg,422,461,7,10422,Aijobs_com,
732361939490312192,2020-07-28 09:32:29,"INCY, ","markets, ","americanbankingnews.com/?p=15458293, ",1288105046421495808,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Hold Rating Reiterated at JPMorgan Chase &amp; Co. https://t.co/7zJdio7uuw #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-28 09:32:28,"INCY, ","stocks, ","americanbankingnews.com/?p=15458293, ",1288105043951067138,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Hold Rating Reiterated at JPMorgan Chase &amp; Co. https://t.co/M1B0dY8ECu #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-07-28 09:11:26,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1912861, pic.twitter.com/ahZWBot4xs, ",1288099748574949376,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator reaches oversold zone View odds for this and other indicators: https://t.co/HyjyPkZ2VL #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ahZWBot4xs,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
852931863547084801,2020-07-28 09:00:05,"INCY, ",,"zpr.io/HqCMJ, ",1288096892497403904,False,0,0,0,0,Zapier.com,Incyte $INCY Given Hold Rating at JPMorgan Chase &amp; Co. https://t.co/Vhz9fMvui6,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2416188264,2020-07-28 08:57:22,"INCY, ","markets, ","thestockobserver.com/?p=3274949, ",1288096209085911042,False,0,0,0,0,Zapier.com,Incyte $INCY Given Hold Rating at JPMorgan Chase &amp; Co.  https://t.co/4XSnaWcBoS #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
68559732,2020-07-28 06:44:30,"INCY, ",,"zpr.io/Hq3DS, ",1288062769938538496,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/4z5Ks7Mrbf,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
930803511918411776,2020-07-28 06:44:27,"INCY, ",,"thelincolnianonline.com/?p=4405449, ",1288062760199356416,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/BVgRfb2jcS,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
849417718642159616,2020-07-28 06:43:05,"INCY, ",,"zpr.io/Hq38J, ",1288062415687634947,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/EPBHHLzrTF,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
732361939490312192,2020-07-28 06:41:20,"INCY, ","markets, ","americanbankingnews.com/?p=15455730, ",1288061973868027909,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/XYuEPodQFe #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-28 06:41:19,"INCY, ","stocks, ","americanbankingnews.com/?p=15455730, ",1288061971787636737,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/AtBdHa6r6Z #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2920258887,2020-07-28 03:58:47,"INCY, ",,"dakotafinancialnews.com/?p=2276227, ",1288021069249511425,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at William Blair https://t.co/NG4mY3lYmV,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
1233901069366771712,2020-07-27 17:45:08,"RLF, MSB, AKBA, INCY, RHHBY, SNY, ","COVID19, ARDS, treatments, stockmarket, investments, ","bit.ly/3jIx79D, ",1287866636142174209,False,3,0,0,1,Blog2Social APP,"Some examples of #COVID19 related #ARDS #treatments are as follows:
Relief $RLF - aviptadil
Mesoblast $MSB - remestemcil-L
Akebia $AKBA - vadadustat
Incyte $INCY - ruxolitnib
Roche $RHHBY - tocilizumab
Sanofi $SNY -sarilumab

#stockmarket #investments https://t.co/QBN5phLHGU",,,2020-02-29 18:45:28,Toronto,invesBrain,https://pbs.twimg.com/profile_images/1384261823403204610/n7RB2zkK_normal.jpg,624,454,0,3631,invesBrain,
3331555937,2020-07-27 10:34:13,"INCY, ",,"stocknews.com/news/incy-char‚Ä¶, ",1287758196048826369,False,0,0,0,0,StockNews.com News Feed,$INCY INCY has hit a ceiling at $110. Look for when the stock closes above this resistance level. https://t.co/px4UwGSudN,,,2015-06-17 13:45:17,NJ / CA,StockNews.com,https://pbs.twimg.com/profile_images/1255517201899098112/fZBf5Tj3_normal.jpg,3949,32,121,216672,stocknewsdotcom,
819248203958775808,2020-07-27 10:14:00,,,"pic.twitter.com/rVsxRI5p5x, ",1287753107632422912,False,5,1,3,4,Twitter Web App,"Drugmaker Incyte is the latest to hike up the price of a cancer drug in the middle of a pandemic, bringing its chemotherapy treatment Jakafi up to nearly $14,000 for a 30-day supply. https://t.co/rVsxRI5p5x",,,2017-01-11 13:22:47,"Washington, DC",Patients For Affordable Drugs,https://pbs.twimg.com/profile_images/830074449701531648/LGL3gy3b_normal.jpg,5254,4737,61,1792,P4AD_,photo
374729426,2020-07-27 07:39:08,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1906770, pic.twitter.com/D1iV8swVMO, ",1287714134503481345,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on July 24, 2020. View odds for this and other indicators: https://t.co/qGaBfCVCst #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/D1iV8swVMO",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-07-27 04:51:41,"INCY, ","investingnews, ","modernreaders.com/?p=3675649, ",1287671993060544514,False,0,0,0,0,Zapier.com,Envestnet Asset Management Inc. Decreases Stock Position in Incyte Co. $INCY  https://t.co/nRveMyNUHV #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
68559732,2020-07-27 03:47:01,"INCY, ",,"zpr.io/HqTCv, ",1287655719001567233,False,0,0,0,0,Zapier.com,William Blair Reaffirms Buy Rating for Incyte $INCY https://t.co/9YJnflGZtZ,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
849417718642159616,2020-07-27 03:16:00,"INCY, ",,"zpr.io/HqTx2, ",1287647914781794305,False,0,0,0,0,Zapier.com,William Blair Reaffirms Buy Rating for Incyte $INCY https://t.co/iN0p500O8F,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
930803511918411776,2020-07-27 03:15:21,"INCY, ",,"thelincolnianonline.com/?p=4399242, ",1287647747559104513,False,0,0,0,0,Zapier.com,William Blair Reaffirms Buy Rating for Incyte $INCY https://t.co/ol3iNLZ5OL,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
374729426,2020-07-26 08:02:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1903965, pic.twitter.com/WIjeCsnFy3, ",1287357701299662849,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on July 24, 2020. View odds for this and other indicators: https://t.co/TgNXiCJgeZ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/WIjeCsnFy3",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
966006214818697218,2020-07-26 02:03:59,"INCY, ",,"theenterpriseleader.com/?p=3553748, ",1287267402804273154,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by William Blair  https://t.co/2Xf8I8UbqI,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2266388972,2020-07-26 01:33:08,"INCY, ","stocks, ","dailypolitical.com/?p=4257020, ",1287259636496834560,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by William Blair https://t.co/v8wbrHtGvt #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-07-26 01:33:07,"INCY, ",,"dailypolitical.com/?p=4257020, ",1287259634265456641,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by William Blair https://t.co/bO2oBG63lm,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1001523981500014592,2020-07-25 11:20:07,,"jobs, hiring, Wilmington, Delaware, USA, ","dlvr.it/RcLn0t, ",1287044969375531008,False,0,0,0,0,dlvr.it,"#jobs #hiring #Wilmington #Delaware #USA Research Expert / Investigator, Large Molecule Bioanalytical: Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical‚Ä¶ https://t.co/NNVpgQXALf",,,2018-05-29 14:01:39,United States,Empleos.io,https://pbs.twimg.com/profile_images/1002198831470178305/0-DY_Jrn_normal.jpg,127,76,6,95846,EmpleosIO,
2181281054,2020-07-25 10:58:30,"INCY, ","markets, ","wkrb13.com/?p=1991942, ",1287039530286096385,False,0,0,0,0,Zapier.com,Incyte $INCY Receives Buy Rating from William Blair https://t.co/4dF790zxBL #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
374729426,2020-07-25 08:07:12,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1899566, pic.twitter.com/6KyzkOoj7h, ",1286996420784820224,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on July 24, 2020. View odds for this and other indicators: https://t.co/U8UNyVmcSh #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/6KyzkOoj7h",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-07-24 19:33:16,"INCY, ","markets, ","americanbankingnews.com/?p=15412416, ",1286806688805396481,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at William Blair https://t.co/ykBiehgppV #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-24 19:33:16,"INCY, ","stocks, ","americanbankingnews.com/?p=15412416, ",1286806686590803971,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at William Blair https://t.co/Ngf62vaq0N #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
3911174913,2020-07-24 15:54:07,,"PrixGalien, ",,1286751534764654592,False,3,0,0,0,Twitter for Advertisers.,"We‚Äôre excited to share that an Incyte-discovered medicine has been nominated for the 2020 #PrixGalien USA Awards from the @GalienFdn, which recognizes impactful 2020 global health innovation, in the Best Pharmaceutical Agent category.","GalienFdn, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
3911174913,2020-07-24 13:00:01,,"COVID19, ","bit.ly/3buRLpr, pic.twitter.com/Tpsln8y4Xg, ",1286707724252717056,False,2,0,0,1,Twitter for Advertisers.,Cytokine storm is a severe immune overreaction that can be triggered by viral infection &amp; can lead to serious complications. Learn more about how #COVID19 related cytokine storm affects the lungs. https://t.co/vpbx6zHtvn https://t.co/Tpsln8y4Xg,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
32450040,2020-07-24 12:13:52,"INCY, ",,"evaluate.com/vantage/articl‚Ä¶, pic.twitter.com/3gEFZbKtW5, ",1286696106781478918,False,2,0,0,0,Twitter Web App,Incyte‚Äôs Jak is a dull boy https://t.co/xLr6VhdM5A $INCY https://t.co/3gEFZbKtW5,,,2009-04-17 11:37:01,"London, UK",Evaluate Vantage,https://pbs.twimg.com/profile_images/1246341890452193282/YN-iBs1e_normal.jpg,6999,481,186,6859,evaluatevantage,photo
16273048,2020-07-24 11:58:57,,,"twitter.com/DavidSteensma/‚Ä¶, ",1286692355219828737,False,3,0,0,0,Twitter for iPhone,"It‚Äôs not ok to see @Incyte trying to guilt physicians into using Jakafi for routine PV care when phlebotomy is still an effective, safe, less-expensive, and time-honored tool in the management of Polycythemia Vera. https://t.co/Bl9UgwZnha","Incyte, ",,2008-09-13 12:21:06,"Boston, MA",Amar Kelkar MD,https://pbs.twimg.com/profile_images/1204134693916028934/i8GacOzX_normal.jpg,2655,3977,39,11045,amarkelkar,
374729426,2020-07-24 08:29:43,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1895205, pic.twitter.com/6R62mx9FEq, ",1286639700359299072,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on July 21, 2020. View odds for this and other indicators: https://t.co/tpftnEELmc #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/6R62mx9FEq",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2920258887,2020-07-24 07:17:44,"INCY, ",,"dakotafinancialnews.com/?p=2260593, ",1286621584325783555,False,0,0,0,0,Zapier.com,Credit Suisse Group Raises Incyte $INCY Price Target to $100.00 https://t.co/W1F23KXKkG,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
1001523981500014592,2020-07-24 07:17:05,,"jobs, hiring, Wilmington, Delaware, USA, ","dlvr.it/RcGyCK, ",1286621421867634688,False,0,0,0,0,dlvr.it,"#jobs #hiring #Wilmington #Delaware #USA Director to Sr. Director, Clinical Research Scientist: Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical needs in‚Ä¶ https://t.co/ogDCpNvVKc",,,2018-05-29 14:01:39,United States,Empleos.io,https://pbs.twimg.com/profile_images/1002198831470178305/0-DY_Jrn_normal.jpg,127,76,6,95846,EmpleosIO,
1273082235885846531,2020-07-24 03:53:19,,,"stem-cells.in-the.news/therapy/incyte‚Ä¶, ",1286570140713324545,False,0,0,0,0,IFTTT,Incyte's Jakafi Hits Mark in Phase III Graft-Versus-Host Disease Trial https://t.co/Fw140sLNLh,,,2020-06-16 22:37:25,,Stem Cells in the News,https://pbs.twimg.com/profile_images/1273083439563104256/57AcLMwU_normal.png,253,125,0,6666,StemCellsITN,
4058194633,2020-07-23 16:24:49,"INCY, ","jobs, ","biospace.com/article/incyte‚Ä¶, ",1286396874665017344,False,0,0,0,0,Twitter for iPhone,$INCY Incyte‚Äôs Jakafi Hits Mark in Phase III Graft-Versus-Host Disease Trial | BioSpace https://t.co/myZzOmgjbh #jobs,,,2015-10-29 09:51:43,,Biotech & Tech Stock Focus,https://pbs.twimg.com/profile_images/1286331384802377728/3__BEBZa_normal.jpg,2233,374,51,35470,MarcJacksonLA,
21793154,2020-07-23 16:08:59,,"biospace, lifesciences, biotechnology, pharmaceuticals, ","hubs.ly/H0sV23W0, ",1286392888906133504,False,1,0,0,1,HubSpot,"Incyte‚Äôs Jakafi Hits Mark in Phase III Graft-Versus-Host Disease Trial https://t.co/K1KjsgGEF7

#biospace #lifesciences #biotechnology #pharmaceuticals",,,2009-02-24 15:27:40,"Des Moines, IA",BioSpace,https://pbs.twimg.com/profile_images/1042117112020389888/8MCBEVkx_normal.jpg,21738,2830,509,25196,biospace,
875382419251019776,2020-07-23 13:31:39,,,"bit.ly/2WSLG0G, pic.twitter.com/y2BE9gLkEa, ",1286353295359975425,False,0,0,0,0,dlvr.it,Incyte‚Äôs Jakafi Hits Mark in Phase III Graft-Versus-Host Disease Trial https://t.co/AHIYPTZKWQ https://t.co/y2BE9gLkEa,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
1151214967577829376,2020-07-23 12:30:10,"NOVN, INCY, ","Jakavi, ","ow.ly/sdlA50AGlfD, pic.twitter.com/KN776oIYcx, ",1286337820953542657,False,0,0,0,0,Hootsuite Inc.,".@Novartis and @Incyte said their medicine #Jakavi was found to be better at treating chronic graft-versus-host disease in phase 3 study
https://t.co/KFqZXaOpqp 
$NOVN $INCY https://t.co/KN776oIYcx","Novartis, Incyte, ",,2019-07-16 15:40:11,Global,Market Intelligence: Healthcare,https://pbs.twimg.com/profile_images/1176596064096391169/Mf7mREWc_normal.jpg,473,410,13,3475,SPGMIHealthcare,photo
15974185,2020-07-23 12:02:03,,,"dlvr.it/RcD9P6, ",1286330746085363713,False,0,0,0,0,dlvr.it,"Ruxolitinib passes another PhIII test for graft-versus-host disease, a win for Incyte and Novartis https://t.co/5bGLR75tKj",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1100450877792370688,2020-07-23 11:52:33,"INCY, ",,"blueequity.io/r/136020/de-in‚Ä¶, ",1286328355088764928,False,0,0,0,0,Blue Equity,$INCY Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi¬Æ) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints https://t.co/Gy2DWRWEbH,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
15232532,2020-07-23 11:10:34,,,"dlvr.it/RcD0B5, pic.twitter.com/NwyzpocivC, ",1286317788374503424,False,0,0,0,0,dlvr.it,"Ruxolitinib passes another PhIII test for graft-versus-host disease, a win for Incyte and Novartis https://t.co/wU1EeUc3SH https://t.co/NwyzpocivC",,,2008-06-25 11:32:12,"Cape Cod, MA",DennisPartners,https://pbs.twimg.com/profile_images/777939023461511168/Lqtz-Jal_normal.jpg,415,425,13,7177,DennisPartners,photo
46297868,2020-07-23 10:53:02,,,"dlvr.it/RcCwkT, ",1286313379246690304,True,0,0,0,0,dlvr.it,"Ruxolitinib passes another PhIII test for graft-versus-host disease, a win for Incyte and Novartis https://t.co/spd4cn2mm3",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
27645777,2020-07-23 10:34:53,,,"bit.ly/2CWOkvg, pic.twitter.com/HGPUNtChQ3, ",1286308808583778305,False,0,0,0,1,TweetDeck,"TOPLINE results of the phase 3, randomized REACH3 study show that ruxolitinib (@Incyte) improves response, failure-free survival in chronic GVHD https://t.co/8lfOBbn842 https://t.co/HGPUNtChQ3","Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
1128239740329705472,2020-07-23 09:09:36,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1286287346061647872,False,0,0,0,0,Twitter for Android,"""These positive results from the REACH3 study are significant as they underscore the potential for Jakafi to provide a meaningful treatment option, not only for patients with acute GVHD, but also for the chronic form of the condition.""

$INCY 
https://t.co/QMeGgAdAIL",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
3686628867,2020-07-23 08:45:07,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1286281187233861632,False,0,0,0,0,WordPress.com,Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi¬Æ) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary¬†Endpoints https://t.co/FmKcoF7pcy,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
374729426,2020-07-23 07:53:47,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1889405, pic.twitter.com/63dCud5wTa, ",1286268269494587392,False,1,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/BMws9s6wXh #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/63dCud5wTa,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
472650465,2020-07-23 07:40:50,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1286265007659941888,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi¬Æ) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints https://t.co/ywb6mEXOYN,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1134049078424162304,2020-07-23 07:37:55,"INCY, NVS, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1286264274151768070,False,0,0,0,0,Newsfilter.io,Incyte's Jakafi successful in another graft-versus-host disease study $INCY $NVS https://t.co/NztLRAWZ7L,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2612788123,2020-07-23 07:37:11,"INCY, ",,,1286264089602400256,False,0,0,0,0,TweetDeck,$INCY Incyte Announces REACH3 Trial Of Ruxolitinib (Jakafi) In Patients With Chronic Graft-Versus-Host Disease Met Primary And Both Key Secondary Endpoints,,,2014-07-08 22:13:20,,MStang,https://pbs.twimg.com/profile_images/486698998728642560/jI7DiDYR_normal.jpeg,212,573,7,8251,StockJock22,
15296897,2020-07-23 07:36:09,"INCY, NVS, ",,"seekingalpha.com/news/3594181-i‚Ä¶, ",1286263830843027457,False,0,0,0,0,SANewsTwitter,$INCY $NVS - Incyte's Jakafi successful in another graft-versus-host disease study https://t.co/0Njirrys33,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
403855355,2020-07-23 07:30:55,"INCY, ",,,1286262513240350720,False,1,0,0,0,Twitter Web App,$INCY: Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi¬Æ) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints,,,2011-11-02 22:53:29,https://thetradexchange.com,ZoZoTrader,https://pbs.twimg.com/profile_images/1032734699569864704/GbU8IYwT_normal.jpg,17972,580,442,78954,ZoZoStockwatch,
112872946,2020-07-23 07:23:09,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1286260557872607233,False,3,0,0,3,Twitter Web App,"$INCY Announces REACH3 Trial Of Ruxolitinib (Jakafi) In Patients With Chronic GVHD Met Primary And Both Key Secondary Endpoints

https://t.co/TfpBJj0fXl",,,2010-02-09 19:09:48,Toronto,Bio Stocks‚Ñ¢,https://pbs.twimg.com/profile_images/1345176821185306624/4OaDT_lb_normal.jpg,58832,77,1249,48782,BioStocks,
2356524462,2020-07-23 07:16:35,"INCY, ",,,1286258907283890176,False,0,0,0,0,Stock News Alerts,"$INCY Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi¬Æ) in Patients with Chronic Graft-Versus-Host Disea
From our Stock News Alerts App",,,2014-02-22 10:38:57,,$Stocknewsalerts,https://pbs.twimg.com/profile_images/467006854074077185/XoHDWrMG_normal.png,4443,8,229,906472,Allstocknews,
976297820532518914,2020-07-23 07:16:32,,,"dlvr.it/RcCBzh, pic.twitter.com/tiacy50XGs, ",1286258895602634753,False,0,0,0,0,dlvr.it,Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi¬Æ) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints https://t.co/Suviw47uW9 https://t.co/tiacy50XGs,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2020-07-23 07:15:41,"INCY, ",,"s.flashalert.me/zE2zfh, ",1286258678887325696,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on July 23, 07:15:00: Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi¬Æ) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints https://t.co/Np9wHA2MLy",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
2338882843,2020-07-23 05:05:50,"INCY, ",,"dailypolitical.com/?p=4242282, ",1286226000360222720,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Announce Earnings of $0.79 Per Share https://t.co/y7DMsiUhTa,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
930803511918411776,2020-07-23 05:04:38,"INCY, ",,"thelincolnianonline.com/?p=4380983, ",1286225699964096514,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Announce Earnings of $0.79 Per Share https://t.co/Q6TTHS5VgO,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2020-07-23 05:03:34,"INCY, ",,"theenterpriseleader.com/?p=3538651, ",1286225432036204544,False,0,0,0,0,Zapier.com,Analysts Expect Incyte Co. $INCY Will Announce Earnings of $0.79 Per Share  https://t.co/PZCobQqBTK,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2416188264,2020-07-23 04:24:49,"INCY, ","markets, ","thestockobserver.com/?p=3254400, ",1286215680799453185,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $100.00 at Credit Suisse Group  https://t.co/OfVFRMRJLc #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
806610983137529857,2020-07-22 14:10:12,,"Cyber, cyberrisk, AXISCyberINCYTE, AXISInsurance, ","pic.twitter.com/zb1ssHwuEc, ",1286000608269475840,False,2,0,0,1,TweetDeck,"The AXIS #Cyber Insurance Center of Excellence joined McGriff and their clients to discuss cyber insurance innovation, training &amp; advisory services at our inaugural  AXIS Cyber INCYTE INCYDE event, to better understand the totality of #cyberrisk. #AXISCyberINCYTE #AXISInsurance https://t.co/zb1ssHwuEc",,,2016-12-07 16:26:59,"Pembroke, HM - Bermuda (HQ)",AXIS (AXIS Capital),https://pbs.twimg.com/profile_images/1321422578045648898/Ebb9O4yx_normal.png,947,186,22,917,AXIS_Capital,photo
374729426,2020-07-22 08:02:45,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1886412, pic.twitter.com/zdXy1BKFCt, ",1285908136298074113,False,1,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved above its 50-day Moving Average on June 23, 2020. View odds for this and other indicators: https://t.co/TV7RmKsKnG #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/zdXy1BKFCt",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
966006214818697218,2020-07-22 01:45:47,"INCY, ",,"theenterpriseleader.com/?p=3529760, ",1285813271686152193,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Up 5.4% on Analyst Upgrade  https://t.co/hLocR3zE9O,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
68559732,2020-07-22 01:44:55,"INCY, ",,"zpr.io/HGfe9, ",1285813050197651458,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Up 5.4% on Analyst Upgrade https://t.co/Y2gxg7ZOC1,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2298709746,2020-07-22 01:43:25,"INCY, ",,"zpr.io/HGfdd, ",1285812674828341250,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Up 5.4% on Analyst Upgrade https://t.co/MK5uFp7r4m,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2266388972,2020-07-22 01:13:11,"INCY, ","stocks, ","dailypolitical.com/?p=4232969, ",1285805066402881536,False,0,0,0,0,Zapier.com,$593.10 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/si1QB9Ezbe #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-07-22 01:13:11,"INCY, ",,"dailypolitical.com/?p=4232969, ",1285805064708411392,False,0,0,0,0,Zapier.com,$593.10 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/AUUBTaoWVX,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
966006214818697218,2020-07-22 01:11:13,"INCY, ",,"theenterpriseleader.com/?p=3529333, ",1285804572578058241,False,0,0,0,0,Zapier.com,$593.10 Million in Sales Expected for Incyte Co. $INCY This Quarter  https://t.co/dM70BooqYH,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2020-07-22 01:11:04,"INCY, ",,"thelincolnianonline.com/?p=4371686, ",1285804533642387456,False,0,0,0,0,Zapier.com,$593.10 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/kbXjS49hue,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-07-22 01:10:52,"INCY, ",,"tickerreport.com/?p=5984213, ",1285804483373604864,False,0,0,0,0,Zapier.com,Brokerages Expect Incyte Co. $INCY Will Announce Quarterly Sales of $593.10 Million https://t.co/c5jgQeraik,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2020-07-22 01:10:04,"INCY, ","markets, ","americanbankingnews.com/?p=15367492, ",1285804283456364547,False,0,0,0,0,Zapier.com,$593.10 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/EsmUs2N61S #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-22 01:10:04,"INCY, ","stocks, ","americanbankingnews.com/?p=15367492, ",1285804281640161282,False,0,0,0,0,Zapier.com,$593.10 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/dymDRkMHRr #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
884592030,2020-07-21 18:47:42,,,"stocktwits.com/bevacizumab/me‚Ä¶, ",1285708055603290112,False,0,0,0,0,StockTwits Web,@Lean_Mean_Meme_Machine @Unraveltrading This stock rarely moves. 6 years ago a lady named Irish in yahoo boards pumped this stock. Still we have a few pumpers. JNJ designed a bad trial which was predestined to fail. Incyte o... https://t.co/1P97pI87kn,"UnravelTrading, ",,2012-10-16 10:49:08,,joc jan,https://pbs.twimg.com/profile_images/2725556083/d26107cec385cc580ad18aac43bb5ee2_normal.jpeg,4,2,0,679,joc_jan,
855102260514127872,2020-07-21 18:36:15,,"PeepTheSideburns, ","pic.twitter.com/PC9TeeZv0P, ",1285705175181733890,False,22,2,0,1,Twitter for iPhone,"Shed a few tears as we bid farewell to the one and only Dr. Robert Susick. Best wishes to him as he begins his career in medicinal chemistry at @Incyte in Wilmington, DE! @robsus220 @uclachem #PeepTheSideburns https://t.co/PC9TeeZv0P","Incyte, robsus220, uclachem, ",,2017-04-20 12:54:00,,Garg Lab UCLA,https://pbs.twimg.com/profile_images/855161884172894208/acb8-Zwj_normal.jpg,5300,705,30,459,GargLab,photo
1571840346,2020-07-21 18:09:44,,,,1285698499548524544,False,0,0,0,0,Twitter for Android,Nike incyte ball is prob my favorite,,,2013-07-05 23:17:06,,Steven Garcia,https://pbs.twimg.com/profile_images/1348492197432328193/c3zKBi2r_normal.jpg,267,238,1,8864,garcia_steven12,
374729426,2020-07-21 08:26:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1880516, pic.twitter.com/k7RHJr9qeH, ",1285551638040637440,False,0,0,0,0,Tickeron,"$INCY in +7.98% Uptrend, rising for three consecutive days on July 20, 2020. View odds for this and other indicators: https://t.co/VJMJ06SbVa #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/k7RHJr9qeH",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-07-21 07:18:05,"INCY, ","investingnews, ","modernreaders.com/?p=3642945, ",1285534507559460865,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Shares Bought by Tributary Capital Management LLC  https://t.co/PNV9NLbS49 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
966006214818697218,2020-07-21 06:04:07,"INCY, ",,"theenterpriseleader.com/?p=3527635, ",1285515894953775104,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $100.00 at Credit Suisse Group  https://t.co/Dc36V5HrO6,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1979190776,2020-07-21 01:38:00,"INCY, ",,"tickerreport.com/?p=5978497, ",1285448924493479936,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Price Up 5.4% After Analyst Upgrade https://t.co/zt5HJm5flW,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-07-21 01:36:24,"INCY, ",,"thelincolnianonline.com/?p=4366011, ",1285448521458552832,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Price Up 5.4% After Analyst Upgrade https://t.co/xgkgnUjN4a,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2266388972,2020-07-21 01:35:51,"INCY, ","stocks, ","dailypolitical.com/?p=4227278, ",1285448381939298304,False,0,0,0,0,Zapier.com,Incyte $INCY Trading Up 5.4% on Analyst Upgrade https://t.co/i17UZu0CSh #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-07-21 01:35:50,"INCY, ",,"dailypolitical.com/?p=4227278, ",1285448380047663104,False,0,0,0,0,Zapier.com,Incyte $INCY Trading Up 5.4% on Analyst Upgrade https://t.co/4g2y7K0xxe,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2525892205,2020-07-21 01:34:02,"INCY, ","investingnews, ","modernreaders.com/?p=3637879, ",1285447926299459584,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Price Up 5.4% After Analyst Upgrade  https://t.co/TCuTunqB2A #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2020-07-20 23:18:47,"INCY, ","markets, ","americanbankingnews.com/?p=15351831, ",1285413887576346625,False,0,0,0,0,Zapier.com,Analysts Anticipate Incyte Co. $INCY Will Announce Earnings of $0.76 Per Share https://t.co/uTe5oVasYq #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-20 23:18:46,"INCY, ","stocks, ","americanbankingnews.com/?p=15351831, ",1285413885802160133,False,0,0,0,0,Zapier.com,Analysts Anticipate Incyte Co. $INCY Will Announce Earnings of $0.76 Per Share https://t.co/A88ieoGE8w #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-07-20 18:20:45,"INCY, ","markets, ","americanbankingnews.com/?p=15347836, ",1285338885501988864,False,0,0,0,0,Zapier.com,Incyte $INCY Trading 5.4% Higher Following Analyst Upgrade https://t.co/BOHb5WyRww #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-20 18:20:44,"INCY, ","stocks, ","americanbankingnews.com/?p=15347836, ",1285338883337658368,False,0,0,0,0,Zapier.com,Incyte $INCY Trading 5.4% Higher Following Analyst Upgrade https://t.co/lAX70CgYGU #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1410125744,2020-07-20 12:56:37,,,"realmoney.thestreet.com/investing/stoc‚Ä¶, ",1285257315411791873,False,2,0,0,0,Twitter Web App,Incyte Could Rise Another 15% From Here https://t.co/8GPeOVEuhg via @RealMoney,"realmoney, ",,2013-05-07 08:21:08,,"Bruce Kamich, CMT",https://pbs.twimg.com/profile_images/425681160170000384/HbbyBzs5_normal.jpeg,12257,191,236,37745,BruceKamich,
16178342,2020-07-20 11:02:31,,"biotech, stocks, fintech, ","macroaxis.com/invest/market/‚Ä¶, ",1285228601734914051,False,1,0,0,0,dlvr.it,"Incyte ($INCY) current daily volatility is 3.82%, with beta of 0.71 and alpha of 0.59 over DOW https://t.co/SJAADMWwKG #biotech #stocks #fintech",,,2008-09-07 22:35:32,San Francisco,Macroaxis,https://pbs.twimg.com/profile_images/378800000273197267/8e5af5ad945489e06413368ae6579304_normal.png,9327,5047,138,36975,macroaxis,
732361939490312192,2020-07-20 10:38:17,"INCY, ","markets, ","americanbankingnews.com/?p=15342924, ",1285222501048627202,False,0,0,0,0,Zapier.com,Recent Research Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/n1CqCqZZL1 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-20 10:38:16,"INCY, ","stocks, ","americanbankingnews.com/?p=15342924, ",1285222499115044865,False,0,0,0,0,Zapier.com,Recent Research Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/sn6mcGBPXE #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
849417718642159616,2020-07-20 10:36:33,"INCY, ",,"zpr.io/HfS2d, ",1285222066468409346,False,0,0,0,0,Zapier.com,Recent Research Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/vk837GAdCM,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
68559732,2020-07-20 10:35:50,"INCY, ",,"zpr.io/HfSrH, ",1285221886805368837,False,0,0,0,0,Zapier.com,Recent Research Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/cpoayFkEfg,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1128239740329705472,2020-07-20 09:21:31,,,"twitter.com/Incyte/status/‚Ä¶, ",1285203184747638790,False,0,0,0,0,Twitter for Android,Starts soon! üëá https://t.co/5MUlygSorF,,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
732361939490312192,2020-07-20 08:56:10,"INCY, ","markets, ","americanbankingnews.com/?p=15341807, ",1285196802342498304,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Increased to $100.00 by Analysts at Credit Suisse Group https://t.co/AcALegfNp3 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-20 08:56:09,"INCY, ","stocks, ","americanbankingnews.com/?p=15341807, ",1285196799913926656,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Increased to $100.00 by Analysts at Credit Suisse Group https://t.co/xwFADFptKD #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
68559732,2020-07-20 08:21:10,"INCY, ",,"zpr.io/HfFYp, ",1285187995889537025,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $100.00 https://t.co/hBCvQ3bXVP,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
374729426,2020-07-20 08:17:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1877717, pic.twitter.com/XhLPdluKHe, ",1285186964669345797,False,0,0,0,1,Tickeron,"$INCY in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on June 19, 2020. View odds for this and other indicators: https://t.co/jHynKcs9NA #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/XhLPdluKHe",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1979190776,2020-07-20 06:30:20,"INCY, ",,"tickerreport.com/?p=5976599, ",1285160102937468929,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $79,533.78 in Stock https://t.co/wVYMWnJacv",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2416188264,2020-07-20 05:48:00,"INCY, ","markets, ","thestockobserver.com/?p=3242500, ",1285149451502399489,False,0,0,0,0,Zapier.com,Oppenheimer Reaffirms Buy Rating for Incyte $INCY  https://t.co/0KP0rnXIbp #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
68559732,2020-07-20 05:47:26,"INCY, ",,"zpr.io/HfwSV, ",1285149308950544387,False,0,0,0,0,Zapier.com,Incyte $INCY Given Buy Rating at Oppenheimer https://t.co/c30h1JIYYM,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
849417718642159616,2020-07-20 05:10:54,"INCY, ",,"zpr.io/HfwNA, ",1285140115686404097,False,0,0,0,0,Zapier.com,BidaskClub Lowers Incyte $INCY to Hold https://t.co/EfuS6EFBvS,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
236987449,2020-07-20 03:15:56,,"PatientAdvocates, CMLCAB, CML, ","cmladvocates.net/cml-cab, pic.twitter.com/ivcdUSgNfz, ",1285111181334765568,False,11,0,0,7,Twitter Web App,"Last week, 16 CML #PatientAdvocates from 15 countries joined the preparatory meeting to prepare for the #CMLCAB meeting on 'Access' with the pharmaceutical companies Takeda &amp; Incyte taking place next Thursday
üëèIt will be the 20th meeting of its kind.
https://t.co/FJUqqD8rb4 #CML https://t.co/ivcdUSgNfz",,,2011-01-11 15:38:41,Worldwide,CML AdvocatesNetwork,https://pbs.twimg.com/profile_images/1438524332825665538/TtqJD-B6_normal.jpg,1840,677,0,6114,cmlnet,photo
365454476,2020-07-19 09:10:00,,"automation, AI, Analytics, ","hubs.ly/H0sHRLC0, pic.twitter.com/qAxOdAMs7W, ",1284837896189616130,False,1,0,0,2,HubSpot,"What‚Äôs your post-crisis #automation plan? ‚Äì it's time to speed up your journey! Listen to @ElenaLChristoph as we showcased the power of the Triple-A trifecta with real examples from NextEra Energy, Incyte Pharma &amp; @Cognizant. #AI #Analytics 

https://t.co/ZpeeUBNEJO https://t.co/qAxOdAMs7W","ElenaLChristoph, Cognizant, ",,2011-08-31 09:32:19,"Cambridge, England [HQ]",HFS Research,https://pbs.twimg.com/profile_images/1019581946039545856/DezsjDVr_normal.jpg,11997,1528,783,25484,HFSResearch,photo
374729426,2020-07-19 07:33:27,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1871806, pic.twitter.com/H6m1owdorU, ",1284813598657667072,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on June 19, 2020. View odds for this and other indicators: https://t.co/oOPfur0EyF #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/H6m1owdorU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-07-19 02:47:20,"INCY, ",,"zpr.io/HfMsr, ",1284741597138165760,False,0,0,0,0,Zapier.com,Oppenheimer Reiterates ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/tTjmpspbgW,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
68559732,2020-07-19 01:56:22,"INCY, ",,"zpr.io/HfMU3, ",1284728771216576515,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Hold at BidaskClub https://t.co/319uQdhQYy,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2298709746,2020-07-19 01:54:00,"INCY, ",,"zpr.io/HfEQR, ",1284728176145465345,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Hold at BidaskClub https://t.co/7VLDXhnTjK,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2266388972,2020-07-19 01:51:24,"INCY, ","stocks, ","dailypolitical.com/?p=4215389, ",1284727520810676227,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Hold at BidaskClub https://t.co/9MLBHdTDeQ #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-07-19 01:51:24,"INCY, ",,"dailypolitical.com/?p=4215389, ",1284727518579372032,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Hold at BidaskClub https://t.co/aY8RK2v6KS,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
22346163,2020-07-18 11:41:54,"INCY, ","INCY, Incyte, ","loom.com/share/2ba957f0‚Ä¶, ",1284513737844678657,False,2,0,0,0,Twitter Web App,$INCY: 104.11 (0.00%) ‚Äî Weekly Chart Request https://t.co/TX5mXvLXjl #INCY #Incyte,,,2009-03-01 04:39:32,"Brooklyn, NY",‚ÄúThe Pup‚Äù Danny Naz üö¢,https://pbs.twimg.com/profile_images/1436700560674148354/kZhzeD2n_normal.jpg,19538,155,558,24095,ThePupOfWallSt,
852931863547084801,2020-07-18 10:12:08,"INCY, ",,"zpr.io/HfNR2, ",1284491145133907969,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúBuy‚Äù Rating at Oppenheimer https://t.co/4dyLOPzsiW,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2920258887,2020-07-18 10:11:14,"INCY, ",,"dakotafinancialnews.com/?p=2238999, ",1284490921367744512,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúBuy‚Äù Rating at Oppenheimer https://t.co/u4rfHk8AjZ,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
2920258887,2020-07-18 09:28:47,"INCY, ",,"dakotafinancialnews.com/?p=2238186, ",1284480237242384385,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Hold at BidaskClub https://t.co/NSjstxdKIb,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
852931863547084801,2020-07-18 09:28:35,"INCY, ",,"zpr.io/Hfad6, ",1284480184691953670,False,0,0,0,0,Zapier.com,BidaskClub Downgrades Incyte $INCY to Hold https://t.co/KwHCh3nkQx,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2416188264,2020-07-18 09:28:16,"INCY, ","markets, ","thestockobserver.com/?p=3235295, ",1284480106371649537,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Hold at BidaskClub  https://t.co/RNG0vXQkBi #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2020-07-18 08:09:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1869045, pic.twitter.com/RKde1wpU26, ",1284460380807294977,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on June 19, 2020. View odds for this and other indicators: https://t.co/v7Fe9jKVkl #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/RKde1wpU26",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
68559732,2020-07-18 07:33:59,"INCY, ",,"zpr.io/Hfa6R, ",1284451347459444736,False,0,0,0,0,Zapier.com,Incyte Co. $INCY EVP Steven H. Stein Sells 766 Shares https://t.co/AzKbRzcoQN,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
849417718642159616,2020-07-18 07:32:48,"INCY, ",,"zpr.io/Hfanp, ",1284451046375424000,False,0,0,0,0,Zapier.com,Incyte Co. $INCY EVP Steven H. Stein Sells 766 Shares https://t.co/sulXinXDhD,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2298709746,2020-07-18 07:32:24,"INCY, ",,"zpr.io/HfaPw, ",1284450946249039872,False,0,0,0,0,Zapier.com,Incyte Co. $INCY EVP Steven H. Stein Sells 766 Shares https://t.co/29lffjdJ21,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1599180145,2020-07-18 06:23:32,,,"dlvr.it/RbswHL, ",1284433616286564353,False,0,0,0,0,dlvr.it,Were Hedge Funds Right About Incyte Corporation (INCY)? - Yahoo Finance https://t.co/EEUcxvxjfM,,,2013-07-16 15:54:48,,‰∏ñÁïå„ÅÆ„Éò„ÉÉ„Ç∏„Éï„Ç°„É≥„ÉâNews,https://pbs.twimg.com/profile_images/378800000149017611/78bb5db147876ad73f4dd2c2db8d953e_normal.jpeg,870,88,34,27571,WorldHFnews,
2344420430,2020-07-17 23:38:16,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1284331628588937217,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Discovery Chem

YAO WENQING:

https://t.co/9Q0gpY1BcC",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-17 21:14:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1284295420143964166,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Chairman / CEO

HERVE HOPPENOT:

https://t.co/7TT4cvjNvW",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
189364778,2020-07-17 20:32:30,,"chemjobs, nmrchat, ","incyte.hrmdirect.com/employment/vie‚Ä¶, ",1284284879136415744,False,4,1,0,4,TweetDeck,"Incyte (Wilmington, DE) is looking for an experienced NMR scientist (PhD, 5-10 years experience):  https://t.co/AcikAKhVAR #chemjobs #nmrchat",,,2010-09-10 22:05:38,United States of America,Chemjobber,https://pbs.twimg.com/profile_images/1348511242625847300/TrC1Lyrj_normal.jpg,34183,6008,411,159792,Chemjobber,
1120631024306802688,2020-07-17 20:00:04,"incy, ","STOCKS, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, ",1284276716760903685,False,0,0,0,0,DataSwarm Markets,"$incy We have detected a noticeable fall in the Zeitgeist for Incyte Corporation at  https://t.co/OxItqO0RgL
Visit DataSwarm Markets for more information
#STOCKS #NASDAQ
DataSwarm ref: 105401",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
1134049078424162304,2020-07-17 19:25:35,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1284268039656091648,False,0,0,0,0,Newsfilter.io,"$66,615.75 of shares sold by Flannelly Barry P (EVP &amp; General Manager US), reported in a new form 4 filed with the SEC  $INCY https://t.co/kJNwJdBTaz",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-17 19:17:36,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1284266029816918017,False,0,0,0,0,Newsfilter.io,"$252,285.00 of shares sold by Hoppenot Herve (Chairman / CEO), reported in a new form 4 filed with the SEC  $INCY https://t.co/pC6YIlOS9n",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-17 19:09:36,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1284264014512562177,False,0,0,0,0,Newsfilter.io,"$144,481.53 of shares sold by Stein Steven H (EVP &amp; Chief Medical Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/MBM9bLIcFu",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-17 19:07:36,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1284263511749787649,False,0,0,0,0,Newsfilter.io,"$65,260.50 of shares sold by Swain Paula J (EVP, Human Resources), reported in a new form 4 filed with the SEC  $INCY https://t.co/Nh5uTkcaCH",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-17 19:00:36,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1284261749601034245,False,0,0,0,0,Newsfilter.io,"$21,162.75 of shares sold by Trower Paul (Principal Accounting Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/kxS0f68m79",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-17 18:50:35,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1284259230330114048,False,0,0,0,0,Newsfilter.io,"$66,615.75 of shares sold by Wenqing Yao (EVP, Head of Discovery Chem), reported in a new form 4 filed with the SEC  $INCY https://t.co/5QLQt5QR4Y",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
732361939490312192,2020-07-17 18:33:54,"INCY, ","markets, ","americanbankingnews.com/?p=15319128, ",1284255029566803969,False,0,0,0,0,Zapier.com,Steven H. Stein Sells 766 Shares of Incyte Co. $INCY Stock https://t.co/B7NWLMNgCl #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-17 18:33:53,"INCY, ","stocks, ","americanbankingnews.com/?p=15319128, ",1284255027201224709,False,0,0,0,0,Zapier.com,Steven H. Stein Sells 766 Shares of Incyte Co. $INCY Stock https://t.co/xD6aXLS1NH #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
226828258,2020-07-17 18:22:54,,,"financialbuzz.com/incyte-to-repo‚Ä¶, ",1284252265465786368,False,0,0,0,0,Financialbuzz Feed,New post (Incyte to Report Second Quarter Financial Results) has been published on Financial Buzz - https://t.co/n2Cd8EoOOx,,,2010-12-15 00:20:46,"New York, New York",Financial Buzz,https://pbs.twimg.com/profile_images/1009537056022900736/9CryGRSB_normal.jpg,28281,21,670,656751,financialbuzz,
2344420430,2020-07-17 17:26:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1284238037095010305,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Principal Accounting Officer

PAUL TROWER:

https://t.co/8nCNHrBbDe",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-07-17 17:14:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1284235015790956545,False,0,0,0,0,InsiderActionMonitor,$INCY  Incyte https://t.co/WvDHFDtawg,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
2344420430,2020-07-17 16:39:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1284226208432041984,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Manager US

BARRY P FLANNELLY:

https://t.co/HZf1LgUmw5",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1262915121103491074,2020-07-17 16:26:34,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1284222987101560834,False,0,0,0,0,formwhispers,"#FWSells $INCY Stein Steven H, EVP &amp; Chief Medical Officer of INCYTE CORP sold 766 shares on 2020-07-16. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
374729426,2020-07-17 08:02:14,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1863388, pic.twitter.com/gpoZlM2hUG, ",1284096065600282625,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on July 16, 2020. View odds for this and other indicators: https://t.co/fpvZwD0lVr #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/gpoZlM2hUG",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-07-17 06:27:27,"INCY, ","markets, ","americanbankingnews.com/?p=15310393, ",1284072215886139395,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at Oppenheimer https://t.co/0rOoPIddfO #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-17 06:27:27,"INCY, ","stocks, ","americanbankingnews.com/?p=15310393, ",1284072213902131200,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at Oppenheimer https://t.co/Sq2A5EYPGZ #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
966006214818697218,2020-07-17 03:18:14,"INCY, ",,"theenterpriseleader.com/?p=3501151, ",1284024595050356736,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Oppenheimer  https://t.co/CN0LbDad43,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2525892205,2020-07-17 03:15:28,"INCY, ","investingnews, ","modernreaders.com/?p=3615379, ",1284023898263171077,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Oppenheimer  https://t.co/tPf2Om7207 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
16693051,2020-07-17 03:07:12,,,"invst.ly/rh1hj, ",1284021819465441280,False,0,0,0,0,IFTTT,Oppenheimer Stick to Their Buy Rating for Incyte Corp - https://t.co/XXtwq28GGx,,,2008-10-11 00:23:58,Worldwide,iNewsroom,https://pbs.twimg.com/profile_images/1336947540508348418/L_93pZQv_normal.png,3911,3555,276,128272,iNewsroom,
4876582225,2020-07-17 01:47:15,"INCY, ",,"ideas.quantcha.com/2020/07/16/sto‚Ä¶, ",1284001700500647936,False,0,0,0,0,WordPress.com,StockTwits Trending Alert: Trading recent interest in INCYTE¬†$INCY https://t.co/w5lne2izhm,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,
930803511918411776,2020-07-17 01:21:44,"INCY, ",,"thelincolnianonline.com/?p=4341979, ",1283995276844335104,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub to ‚ÄúHold‚Äù https://t.co/kKamUFrd3s,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2020-07-17 01:19:41,"INCY, ",,"theenterpriseleader.com/?p=3499555, ",1283994764124270592,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub to ‚ÄúHold‚Äù  https://t.co/TYqvbo923D,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1979190776,2020-07-17 01:17:23,"INCY, ",,"tickerreport.com/?p=5954427, ",1283994185037680644,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub to ‚ÄúHold‚Äù https://t.co/T91ly7ys1z,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1134049078424162304,2020-07-17 00:55:57,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1283988789124374529,False,0,0,0,0,Newsfilter.io,Incyte to Report Second Quarter Financial Results $INCY https://t.co/0XqJasF4vd,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
108617488,2020-07-17 00:25:02,,,"invst.ly/rh1hj, ",1283981009155956737,False,1,0,0,0,FP News Publisher - COM,Oppenheimer Stick to Their Buy Rating for Incyte Corp - https://t.co/TmP1l9VR5D,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
2525892205,2020-07-16 17:56:50,"INCY, ","investingnews, ","modernreaders.com/?p=3612841, ",1283883316475723778,False,0,0,0,0,Zapier.com,"IFM Investors Pty Ltd Sells 5,490 Shares of Incyte Co. $INCY  https://t.co/eNYbA3TzoE #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1100450877792370688,2020-07-16 13:15:36,"INCY, ",,"blueequity.io/r/134245/de-in‚Ä¶, ",1283812541001379840,False,0,0,0,0,Blue Equity,$INCY Incyte to Report Second Quarter Financial Results https://t.co/o2CsDoC1H0,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
2296645992,2020-07-16 11:50:31,,,"pic.twitter.com/3EmnW8aa1e, ",1283791127024332800,False,1,0,0,1,Twitter for iPhone,".@ElenaLChristoph isn‚Äôt a scientist and she doesn‚Äôt play one on tv, but she is one heck of a researcher and driving amazing discussion on the use of the Triple-A trifecta with the implantation and utilization of integrated automation. @Incyte @HFSResearch https://t.co/3EmnW8aa1e","ElenaLChristoph, Incyte, HFSResearch, ",,2014-01-17 14:24:13,Mexico,Hailey Corr,https://pbs.twimg.com/profile_images/1161054212563689472/auc7JBTL_normal.jpg,523,628,52,4204,HaileyCorr1,photo
2296645992,2020-07-16 11:43:41,,,"pic.twitter.com/KMuYePu4Aj, ",1283789410945789952,False,0,0,0,0,Twitter for iPhone,".@Incyte sharing their automation journey, model and mission on today‚Äôs @HFSResearch webinar. It‚Äôs all about giving scientists back time so they can focus on releasing lifesaving medications! https://t.co/KMuYePu4Aj","Incyte, HFSResearch, ",,2014-01-17 14:24:13,Mexico,Hailey Corr,https://pbs.twimg.com/profile_images/1161054212563689472/auc7JBTL_normal.jpg,523,628,52,4204,HaileyCorr1,photo
3318510966,2020-07-16 08:51:23,,,"crweworld.com/article/news-p‚Ä¶, ",1283746047177572353,False,0,0,0,0,CRWE World,Incyte to Report Second Quarter Financial Results https://t.co/r2hMxhHFz7,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
976297820532518914,2020-07-16 08:08:11,,,"dlvr.it/Rbkxzn, pic.twitter.com/CRX6kjVNnu, ",1283735175378026496,False,0,0,0,0,dlvr.it,Incyte to Report Second Quarter Financial Results https://t.co/mkoTXd83oQ https://t.co/CRX6kjVNnu,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2020-07-16 08:01:52,"INCY, ",,"s.flashalert.me/35I0oh, ",1283733588475875330,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on July 16, 08:00:00: Incyte to Report Second Quarter Financial Results https://t.co/lb2tNsoIaq",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
374729426,2020-07-16 07:55:47,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1860474, pic.twitter.com/ZSMjdbN9WO, ",1283732054509641729,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed above its 50-day Moving Average on June 23, 2020. View odds for this and other indicators: https://t.co/iefjQ8m8xr #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZSMjdbN9WO",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
909777341815115777,2020-07-15 18:00:25,,,"hfsresearch.com/webinars/Tripl‚Ä¶, ",1283521830628851715,False,2,0,0,0,Twitter Web App,"Webinar alert! Join us for a spirited webinar where we‚Äôll do more than just repeatedly show our cool Triple-A Venn diagram, we‚Äôll showcase the power of ‚Äúand‚Äù with real enterprise examples from NEXTEra Energy, Incyte, and Cognizant.
https://t.co/movQgHCGR7",,,2017-09-18 09:53:15,,Elena Christopher,https://pbs.twimg.com/profile_images/1203093390839169024/ftI0INNl_normal.jpg,591,192,17,1742,ElenaLChristoph,
365454476,2020-07-15 10:46:00,,"automation, AI, Analytics, ","hubs.ly/H0sqCc_0, pic.twitter.com/3S8Umbhmuy, ",1283412505889574919,False,2,0,0,1,HubSpot,"What‚Äôs your post-crisis #automation plan? ‚Äì it's time to speed up your journey! Join @ElenaLChristoph tomorrow as we showcase the power of the Triple-A trifecta with real enterprise examples from NextEra Energy, Incyte Pharma &amp; @Cognizant. #AI #Analytics 

https://t.co/CEMFevFqzy https://t.co/3S8Umbhmuy","ElenaLChristoph, Cognizant, ",,2011-08-31 09:32:19,"Cambridge, England [HQ]",HFS Research,https://pbs.twimg.com/profile_images/1019581946039545856/DezsjDVr_normal.jpg,11997,1528,783,25484,HFSResearch,photo
374729426,2020-07-15 08:48:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1854634, pic.twitter.com/K8OCvVSovQ, ",1283383021899415554,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/xd3iGTWbUT #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/K8OCvVSovQ,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-07-15 02:59:38,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1283295139096600576,False,0,0,0,0,Newsfilter.io,"$158,250.98 of shares acquired by Dhanak Dashyant (EVP &amp; Chief Scientific Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/cSoOLDcMJH",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-15 02:41:38,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1283290608673619968,False,0,0,0,0,Newsfilter.io,"$8,300.72 of shares acquired by Pasquale Maria E (EVP &amp; General Counsel), reported in a new form 4 filed with the SEC  $INCY https://t.co/zT3ILKi0e1",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2344420430,2020-07-14 19:21:16,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1283179788698517505,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/REP0BrU6Bv",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-14 16:46:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1283140784037003264,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/tnz65gDWdI",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
374729426,2020-07-14 10:43:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1852035, pic.twitter.com/WYOFvfy5h9, ",1283049485095112707,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/pp9z9Q99aF #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/WYOFvfy5h9,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
365454476,2020-07-14 10:07:00,,"automation, AI, Analytics, ","hubs.ly/H0sqJzf0, pic.twitter.com/IEIougFBQ2, ",1283040300538134530,False,3,0,0,1,HubSpot,"What‚Äôs your post-crisis #automation plan? ‚Äì it's time to speed up your journey! Join @ElenaLChristoph this Thursday as we showcase the power of the Triple-A trifecta with real examples from NextEra Energy, Incyte Pharma &amp; @Cognizant. #AI #Analytics 

https://t.co/xbvIiIJE8o https://t.co/IEIougFBQ2","ElenaLChristoph, Cognizant, ",,2011-08-31 09:32:19,"Cambridge, England [HQ]",HFS Research,https://pbs.twimg.com/profile_images/1019581946039545856/DezsjDVr_normal.jpg,11997,1528,783,25484,HFSResearch,photo
1100876847573798913,2020-07-14 08:47:07,,"COVID19, AVBCCCovid19, ",,1283020200770785287,False,1,0,0,0,Twitter Web App,"When writing a trial given the #COVID19 pandemic, one of the most important things to remember is that standards of care are going to change, explains Dr. Kevin O‚ÄôHayer, @Incyte. You have to be flexibile with your study designs. #AVBCCCovid19","Incyte, ",,2019-02-27 16:54:28,,Value-Based Cancer Care,https://pbs.twimg.com/profile_images/1317947871526899712/RSghxkJp_normal.jpg,209,137,3,2613,VBCancerCare,
402284409,2020-07-14 01:40:37,,,"goo.gl/fb/KcJzGE, ",1282912865498943491,False,0,0,0,0,Google,"Job Delaware:  Director, Global Medical Affairs Lead - Incyte Corporation - Wilmington, DE‚Ä¶ https://t.co/wDi6o6uLmh",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
724788629403525120,2020-07-13 20:45:07,,,"twitter.com/Incyte/status/‚Ä¶, ",1282838500778401792,False,0,0,0,0,Twitter for iPhone,Cute name. What do you do? Code? Bundle? ?? https://t.co/Q054VNzreX,,,2016-04-25 22:34:09,"Colleyville, TX",George H,https://pbs.twimg.com/profile_images/761188765352267777/xSNNPzIG_normal.jpg,1462,4095,39,78005,hammegk,
2920258887,2020-07-13 15:08:29,"INCY, ",,"dakotafinancialnews.com/?p=2216840, ",1282753783311863809,False,0,0,0,0,Zapier.com,Analysts Set Incyte Co. $INCY Target Price at $99.89 https://t.co/ybTaXMiWFB,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
849417718642159616,2020-07-13 15:07:23,"INCY, ",,"zpr.io/HRfK5, ",1282753510006829062,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Average Rating of ‚ÄúBuy‚Äù from Brokerages https://t.co/rnio0wnmqt,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
121158213,2020-07-13 10:21:02,"INCY, ",,"AlertTrade.us, ",1282681447665393666,False,0,0,0,0,dlvr.it,REVERSALtoDOWN: $INCY Incyte Corporation Common Stock üìâ TradeIdeas via üëá  https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
374729426,2020-07-13 08:09:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1847688, pic.twitter.com/3tMuR4w0uZ, ",1282648465940508672,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on July 10, 2020. View odds for this and other indicators: https://t.co/UUStYn6qmT #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/3tMuR4w0uZ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-07-13 06:22:21,"INCY, ",,"zpr.io/HRPdV, ",1282621381646131201,False,0,0,0,0,Zapier.com,Incyte $INCY Raised to ‚ÄúBuy‚Äù at BidaskClub https://t.co/kAifnH21qZ,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2920258887,2020-07-13 05:53:54,"INCY, ",,"dakotafinancialnews.com/?p=2214373, ",1282614220794847233,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by BidaskClub to ‚ÄúBuy‚Äù https://t.co/zozwzCEnPj,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
852931863547084801,2020-07-13 05:51:57,"INCY, ",,"zpr.io/HRPXV, ",1282613730879188994,False,0,0,0,0,Zapier.com,Incyte $INCY Raised to ‚ÄúBuy‚Äù at BidaskClub https://t.co/Aa0NhJFe3h,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
374729426,2020-07-13 04:27:01,"INCY, ","Incyte, stockmarket, stock, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1845726, ",1282592354327654403,False,0,0,0,0,Tickeron,"3 Insiders at Incyte sold 108,135 shares last week for $11.9M $INCY #Incyte #stockmarket #stock #money #trading #investing #daytrading #news #today https://t.co/5eBjmJeMzP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,
415486412,2020-07-12 09:47:10,,"cheapfootballs, nike, ","galaxyfootball.co.uk/nike-incyte-hi‚Ä¶, ",1282310536055726080,False,3,0,0,1,Twitter Web App,"SAVE over 50% - Nike FIFA Hi Viz Matchball Size 5. 
Was now ¬£100 now just ¬£49.95 #cheapfootballs #nike
https://t.co/l4MuN0AAAe",,,2011-11-18 06:59:10,"Croston, Leyland",Galaxy Football,https://pbs.twimg.com/profile_images/1385154378114510848/QT8QCJkV_normal.jpg,1389,3581,2,742,Galaxy_Football,
374729426,2020-07-12 07:33:47,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1841858, pic.twitter.com/PdBrVX8y2G, ",1282276968906371072,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on July 10, 2020. View odds for this and other indicators: https://t.co/ql2sWPANSP #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/PdBrVX8y2G",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2298709746,2020-07-12 06:14:08,"INCY, ",,"zpr.io/HHJQe, ",1282256923795095552,False,0,0,0,0,Zapier.com,BidaskClub Upgrades Incyte $INCY to Buy https://t.co/4lmdVGLwjU,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
68559732,2020-07-12 06:10:40,"INCY, ",,"zpr.io/HHJBi, ",1282256051845378048,False,0,0,0,0,Zapier.com,BidaskClub Upgrades Incyte $INCY to Buy https://t.co/EUrSwp3E2m,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2525892205,2020-07-12 06:09:58,"INCY, ","investingnews, ","modernreaders.com/?p=3589155, ",1282255874581581826,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by BidaskClub to ‚ÄúBuy‚Äù  https://t.co/3RnnGul5so #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
14325612,2020-07-12 05:00:12,,,"khq.com/the_630/incyte‚Ä¶, pic.twitter.com/X29NZu481v, ",1282238316058992641,False,0,0,0,0,True Anthem,Incyte Diagnostics helping return COVID-19 results faster https://t.co/pScUYw7GGS https://t.co/X29NZu481v,,,2008-04-07 14:37:38,"Spokane, WA",KHQ Local News,https://pbs.twimg.com/profile_images/1062140887793188864/sKkTCTa-_normal.jpg,71985,3292,783,136627,KHQLocalNews,photo
402284409,2020-07-12 01:15:03,,,"goo.gl/fb/ifQtBc, ",1282181657341169664,False,0,0,0,0,Google,"Job Delaware:  Scientific Director, Heme-onc - Incyte Corporation - Wilmington, DE‚Ä¶ https://t.co/eWsTKVGCho",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
402284409,2020-07-12 01:14:58,,,"goo.gl/fb/A1Xqbd, ",1282181634675093505,False,0,0,0,0,Google,"Job Delaware:  Scientific Director, Heme-onc - Incyte Corporation - Wilmington, DE‚Ä¶ https://t.co/dpHraghWNO",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
133504478,2020-07-11 20:08:02,,"strategy, competitiveintelligence, marketing, productmarketing, healthcare, pharma, biotech, pharmaceutical, ","dlvr.it/RbR6wQ, lqventures.com, ",1282104392892600320,False,1,0,0,1,dlvr.it,Massive Growth in Vitiligo Treatment Market During 2020-2026 Future Growth Prospects Focusing Emerging Key Players:‚Ä¶ https://t.co/Gdr1lsDRjf &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #productmarketing #healthcare #pharma #biotech #pharmaceutical,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
852931863547084801,2020-07-11 12:57:52,"INCY, ",,"zpr.io/HH26L, ",1281996138661449728,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Increased to Buy at BidaskClub https://t.co/7AaG52pjAM,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2416188264,2020-07-11 12:56:58,"INCY, ","markets, ","thestockobserver.com/?p=3211313, ",1281995911825166339,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded to ‚ÄúBuy‚Äù at BidaskClub  https://t.co/c44yP58P1m #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2020-07-11 12:24:01,"INCY, ",,"zpr.io/HHriA, ",1281987618440466433,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $99.89 Consensus PT from Analysts https://t.co/dX1O2tO5EH,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
852931863547084801,2020-07-11 11:53:48,"INCY, ",,"zpr.io/HHrbU, ",1281980017103319041,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $99.89 Consensus PT from Analysts https://t.co/Kb8xSy5nzp,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
374729426,2020-07-11 07:56:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1839214, pic.twitter.com/6pmroeqr4Q, ",1281920321814097920,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on July 10, 2020. View odds for this and other indicators: https://t.co/EhgNct7q5q #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/6pmroeqr4Q",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
68559732,2020-07-11 07:07:01,"INCY, ",,"zpr.io/HHFvY, ",1281907843520765952,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $66,221.60 in Stock https://t.co/TqGmS449Uj",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2416188264,2020-07-11 07:06:01,"INCY, ","markets, ","thestockobserver.com/?p=3208131, ",1281907593632460805,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $66,221.60 in Stock  https://t.co/vTDx2AXb5b #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2020-07-11 07:03:35,"INCY, ",,"zpr.io/HHFeM, ",1281906980433670145,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $66,221.60 in Stock https://t.co/RniG24VTJb",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2416188264,2020-07-11 05:51:31,"INCY, ","markets, ","thestockobserver.com/?p=3207901, ",1281888844120559616,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $1,776,467.96 in Stock  https://t.co/gZPnakrxLW #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2020-07-11 05:05:47,"INCY, ",,"zpr.io/HH3uD, ",1281877336657403905,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY CEO Sells $9,874,810.00 in Stock https://t.co/SHODearLOs",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
14325612,2020-07-11 04:00:13,,,"khq.com/the_630/incyte‚Ä¶, pic.twitter.com/sz6GECPUZA, ",1281860835086864384,False,0,0,0,0,True Anthem,Incyte Diagnostics helping return COVID-19 results faster https://t.co/ym6RImQsZQ https://t.co/sz6GECPUZA,,,2008-04-07 14:37:38,"Spokane, WA",KHQ Local News,https://pbs.twimg.com/profile_images/1062140887793188864/sKkTCTa-_normal.jpg,71985,3292,783,136627,KHQLocalNews,photo
4560035135,2020-07-10 09:15:05,,,"pic.twitter.com/Z0JfDpOk8L, ",1281577684645171201,False,1,0,0,0,Buffer,Meet a chemistry alum! Brandon Smith graduated from Penn State in 2010. He is now a research investigator at Incyte Pharmaceuticals. https://t.co/Z0JfDpOk8L,,,2015-12-21 14:29:58,"University Park, PA",Penn State Chemistry,https://pbs.twimg.com/profile_images/1131249607814668288/2sXFnDeW_normal.png,1762,159,7,1945,psu_chemistry,photo
61537399,2020-07-10 08:58:35,,"incyte, ",,1281573532237889536,False,1,0,0,0,Twitter for iPhone,One of my Medicare patients has an FGFR2 mutation in his cholangiocarcinoma. Tried to place him on pemigatinib. Incyte choosing to not provide co-pay assistance for Medicare pts with PT D. Cannot afford the $2200/mo OOP. Such a tragedy. #incyte,,,2009-07-30 12:58:39,"Scottsdale, AZ",CancerDocAZ,https://pbs.twimg.com/profile_images/511146522919337987/vsWUsZrc_normal.jpeg,24,61,0,232,mgordonaz,
374729426,2020-07-10 07:52:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1834955, pic.twitter.com/0xphlp20zR, ",1281556899884707840,False,0,0,0,0,Tickeron,"$INCY in -0.72% Downtrend, declining for three consecutive days on July 9, 2020. View odds for this and other indicators: https://t.co/Ql2CMCaqV0 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0xphlp20zR",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
930803511918411776,2020-07-10 07:48:40,"INCY, ",,"thelincolnianonline.com/?p=4306565, ",1281555939456438272,False,0,0,0,0,Zapier.com,Steven H. Stein Sells 610 Shares of Incyte Co. $INCY Stock https://t.co/Ig1JUB8nni,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
852931863547084801,2020-07-10 05:57:56,"INCY, ",,"zpr.io/HHEyD, ",1281528070608957440,False,0,0,0,0,Zapier.com,"Yao Wenqing Sells 16,553 Shares of Incyte Co. $INCY Stock https://t.co/HdjWQBafBw",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
970955720563806209,2020-07-10 05:30:11,,"EHQ, ","ggba-switzerland.ch/en/incyte-inau‚Ä¶, ",1281521088271396864,False,7,0,0,2,Twitter Web App,"Earlier this week, üá∫üá∏ biopharma @Incyte inaugurated its new #EHQ in Morges, üá®üá≠. Congratulations! üëè

The hub will house more than 150 employees from Incyte's regulatory, clinical development, commercial, medical affairs and technical operations groups.

https://t.co/LqHggXK3lE","Incyte, ",,2018-03-06 04:34:18,Switzerland,Greater Geneva Bern area,https://pbs.twimg.com/profile_images/970956808822108161/2b4xkmwQ_normal.jpg,844,568,18,726,GGBa_Invest,
1001523981500014592,2020-07-10 05:17:03,,"jobs, hiring, Wilmington, Delaware, USA, ","dlvr.it/RbKs2f, ",1281517781079298049,False,0,0,0,0,dlvr.it,"#jobs #hiring #Wilmington #Delaware #USA Sr, Manager/Associate Director, US Medical Information: Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical needs in‚Ä¶ https://t.co/HD5ylvl82S",,,2018-05-29 14:01:39,United States,Empleos.io,https://pbs.twimg.com/profile_images/1002198831470178305/0-DY_Jrn_normal.jpg,127,76,6,95846,EmpleosIO,
966006214818697218,2020-07-10 05:10:27,"INCY, ",,"theenterpriseleader.com/?p=3460964, ",1281516120286035968,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Upgraded by BidaskClub  https://t.co/VWvAlyA5F2,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2020-07-10 05:10:07,"INCY, ",,"thelincolnianonline.com/?p=4303795, ",1281516038329376769,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Upgraded by BidaskClub https://t.co/NsWNg7y0Kz,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2416188264,2020-07-10 04:30:35,"INCY, ","markets, ","thestockobserver.com/?p=3203745, ",1281506089549389824,False,0,0,0,0,Zapier.com,"Herve Hoppenot Sells 89,771 Shares of Incyte Co. $INCY Stock  https://t.co/j3ULEpLq4K #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
730032660,2020-07-09 23:50:36,,,"nonsell.com/us-market-news‚Ä¶, pic.twitter.com/pybtciAW2u, ",1281435626823282688,False,0,0,0,0,NonSell Twitter,"Here's Why Incyte Rose 19.1% in the First Half of 2020 - [US Market News], Source: Nasdaq News - https://t.co/fin6M61YlQ https://t.co/pybtciAW2u",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,photo
2817332702,2020-07-09 21:57:22,,"vitiligo, ","authors.elsevier.com/c/1bNN4V-4XAkY‚Ä¶, ",1281407133377007616,False,260,15,36,41,Twitter Web App,"Our Phase 2 clinical trial to test topical ruxolitinib as a treatment for #vitiligo is published! Strong efficacy, well-tolerated - great day for individuals with vitiligo and their providers. @TheLancet @Incyte  https://t.co/8DPOsQPd8x","TheLancet, Incyte, ",,2014-09-18 12:50:29,UMass Medical School,"John E. Harris, MD, PhD",https://pbs.twimg.com/profile_images/716619871493210112/t88Vh-d3_normal.jpg,3705,476,19,2802,HarrisVitiligo,
975337043944407040,2020-07-09 18:04:55,"INCY, ","Incyte, INCY, ","finscreener.com/title/insiders‚Ä¶, ",1281348633716240385,False,0,0,0,0,StockTwits Web,"Insider summary of #Incyte #INCY $INCY 
https://t.co/CHKTxflObH",,,2018-03-18 07:44:06,,Finscreener,https://pbs.twimg.com/profile_images/976083323347984384/71mUunXo_normal.jpg,652,202,12,15317,Finscreener_com,
576434817,2020-07-09 14:10:02,"INCY, SPY, ",,"dlvr.it/RbHqZH, ",1281289526204182528,False,0,0,0,0,dlvr.it,Here's Why Incyte Rose 19.1% in the First Half of 2020 $INCY https://t.co/I6HtLPUyp3 $SPY,,,2012-05-10 12:05:50,,Market Follows,https://pbs.twimg.com/profile_images/1128009565268795397/Cld5SPIf_normal.jpg,1489,840,25,20861,MarketFollows,
1359077910,2020-07-09 12:30:11,,,"europharmajobs.com/job_display/18‚Ä¶, ",1281264394878496768,False,0,0,0,0,EPJ Jobs Post,"Senior Director, Quality Assurance Bioplant, Incyte, Yverdon, Switzerland

https://t.co/7CMkJYZkiG",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
1140762699002871808,2020-07-09 11:30:16,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1281249319052431362,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-07-09 11:30 ET. *Closed/Covered previously shorted:
$INCY at $106.72 for 0.14 profit (0.13%). Incyte Corporation - Common Stock
Trade Id: 47743268503053123.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
374729426,2020-07-09 08:48:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1830807, pic.twitter.com/P4jzhqQlEn, ",1281208501495148545,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on June 19, 2020. View odds for this and other indicators: https://t.co/8RqWZ2KH2h #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/P4jzhqQlEn",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2298709746,2020-07-09 08:35:35,"INCY, ",,"zpr.io/HHqrp, ",1281205357486895106,False,0,0,0,0,Zapier.com,Incyte Co. $INCY EVP Steven H. Stein Sells 610 Shares of Stock https://t.co/KHtiOaJDMk,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
849417718642159616,2020-07-09 08:00:14,"INCY, ",,"zpr.io/HHqGw, ",1281196460881698818,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 16,553 Shares of Stock https://t.co/SZBFH8pWk4",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
68559732,2020-07-09 07:58:19,"INCY, ",,"zpr.io/HHqfx, ",1281195977223921671,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY CEO Sells 89,771 Shares of Stock https://t.co/UlZOxXTHXy",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
68559732,2020-07-09 07:58:18,"INCY, ",,"zpr.io/HHqfX, ",1281195973600063488,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 16,553 Shares of Stock https://t.co/TUdy0line7",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2920258887,2020-07-09 07:57:58,"INCY, ",,"dakotafinancialnews.com/?p=2195694, ",1281195889105788928,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY CEO Herve Hoppenot Sells 89,771 Shares of Stock https://t.co/oq0ZYUjdYB",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
2298709746,2020-07-09 07:55:45,"INCY, ",,"zpr.io/HHqRn, ",1281195333079445505,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY CEO Herve Hoppenot Sells 89,771 Shares of Stock https://t.co/hqGBwOklSz",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
930803511918411776,2020-07-09 07:16:45,"INCY, ",,"thelincolnianonline.com/?p=4300169, ",1281185516734603270,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 12-Month High at $110.37 https://t.co/0dEzPCl8WE,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2020-07-09 07:15:36,"INCY, ",,"theenterpriseleader.com/?p=3457381, ",1281185230708183041,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 12-Month High at $110.37  https://t.co/5iBesOq0uh,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2525892205,2020-07-09 07:13:45,"INCY, ","investingnews, ","modernreaders.com/?p=3575955, ",1281184763009736704,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 12-Month High at $110.37  https://t.co/gkcmKzCynd #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2920258887,2020-07-09 06:38:45,"INCY, ",,"dakotafinancialnews.com/?p=2194549, ",1281175953776029696,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $1,776,467.96 in Stock https://t.co/KkBwAN9wjW",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
1134049078424162304,2020-07-09 00:58:46,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1281090396584640513,False,0,0,0,0,Newsfilter.io,"$653,064.13 of shares sold by Stein Steven H (EVP &amp; Chief Medical Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/c0EecnLRBD",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-09 00:57:46,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1281090145236717569,False,0,0,0,0,Newsfilter.io,"$388,463.60 of shares sold by Iyengar Vijay K (EVP GPS, BD, &amp; Licensing), reported in a new form 4 filed with the SE.. $INCY https://t.co/fvFBVVkuaL",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
3351841413,2020-07-08 22:52:02,,,"dlvr.it/RbF7Q0, pic.twitter.com/Tk8DhuZr1j, ",1281058503012974593,False,1,0,0,0,dlvr.it,"Hedge Fund and Insider Trading News: Bill Ackman, Anthony Scaramucci, Crispin Odey, Toscafund Asset Management, Incyte Corporation (INCY), Intellicheck Inc (IDN), and More - Insider Monkey https://t.co/BnkarSiWJc https://t.co/Tk8DhuZr1j",,,2015-06-30 11:00:36,,Bill Ackman Blog,https://pbs.twimg.com/profile_images/615898472747679744/MmMl4cmp_normal.png,5395,45,34,1360,BillAckmanBlog,photo
1034088467096068098,2020-07-08 21:25:17,"INCY, ","Investing, StockMarket, trade, ","aistockfinder.com/stock-forecast‚Ä¶, ",1281036672872914946,False,0,0,0,0,AIStockFinder,$INCY https://t.co/tjE9M45414 Incyte Corp. The AI lets us believe the value of this company has a neutral short term outlook in a negative short term market setup and has a neutral long term outlook in a neutral long term market setup #Investing #StockMarket #trade,,,2018-08-27 10:41:17,,aistockfinder,https://pbs.twimg.com/profile_images/1034088771858452480/KGLi41bO_normal.jpg,674,1,13,21547,aistockfinder,
2344420430,2020-07-08 18:19:21,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280989879560798215,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP GPS, BD, &amp; Licensing

VIJAY K IYENGAR:

https://t.co/TA8Os2PzUL",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
732361939490312192,2020-07-08 18:18:17,"INCY, ","markets, ","americanbankingnews.com/?p=15217278, ",1280989609099493378,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $66,221.60 in Stock https://t.co/mV8UZktb09 #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-08 18:18:16,"INCY, ","stocks, ","americanbankingnews.com/?p=15217278, ",1280989607069351937,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $66,221.60 in Stock https://t.co/Gkt0SHJPp4 #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2181281054,2020-07-08 18:16:51,"INCY, ","markets, ","wkrb13.com/?p=1951752, ",1280989250020876293,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $66,221.60 in Stock https://t.co/04of9MePfF #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
2344420430,2020-07-08 18:01:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280985332402577408,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Medical Officer

STEVEN H STEIN:

https://t.co/dwA8tbaWeC",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-07-08 17:50:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1280982583430524928,False,0,0,0,0,InsiderActionMonitor,$INCY  Incyte https://t.co/F6EKmMAETW,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1262915121103491074,2020-07-08 17:31:52,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1280977928545685505,False,0,0,0,0,formwhispers,"#FWSells $INCY Iyengar Vijay K, EVP GPS, BD, &amp; Licensing of INCYTE CORP sold 3595 shares on 2020-07-08. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1262915121103491074,2020-07-08 17:28:18,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1280977030171914240,False,0,0,0,0,formwhispers,"#FWSells $INCY Stein Steven H, EVP &amp; Chief Medical Officer of INCYTE CORP sold 14769 shares on 2020-07-08. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1199800417821048834,2020-07-08 16:14:04,,"Hedge_Funds, Insider_Trading, Anthony_Scaramucci, ","dlvr.it/RbDJBB, bit.ly/2tNWL7k, ",1280958349970833409,False,0,0,0,0,dlvr.it,"Hedge Fund and Insider Trading News: Bill Ackman, Anthony Scaramucci, Crispin Odey, Toscafund Asset Management, Incyte Corporation (INCY), Intellicheck Inc (IDN), and More https://t.co/pmJPofTsdI #Hedge_Funds #Insider_Trading #Anthony_Scaramucci https://t.co/D9hc6egqxq",,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,
1199800417821048834,2020-07-08 14:47:32,,"Hedge_Funds, News, ","dlvr.it/RbD3H5, bit.ly/2tNWL7k, ",1280936575732527105,False,0,0,0,0,dlvr.it,Were Hedge Funds Right About Incyte Corporation (INCY)? https://t.co/vtfYYrRtio #Hedge_Funds #News https://t.co/D9hc6dYPFS,,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,
25844659,2020-07-08 13:50:44,,"GoBucs, ","spokesman.com/stories/2020/j‚Ä¶, ",1280922281473007618,False,14,0,0,3,Twitter for iPhone,Whitworth is partnering with WSU and Incyte Diagnostics for its testing protocols this fall. We‚Äôve been planning with them and SRHD for weeks to put a comprehensive strategy together. #GoBucs üè¥‚Äç‚ò†Ô∏è  https://t.co/KtXRxt4ERB,,,2009-03-22 13:13:15,,Beck A. Taylor,https://pbs.twimg.com/profile_images/1399721514405093385/yiFm8F5H_normal.jpg,3362,264,88,12166,BeckTaylor,
3355837633,2020-07-08 13:34:13,,"4NewsNow, ","pic.twitter.com/aqPzLrbl0e, ",1280918122090749953,False,1,0,0,3,Twitter Web App,"COVID SAMPLE TESTING: Researchers with WSU and Incyte Diagnostics are teaming up to collect COVID-19 samples from patients for testing. According to the university, they'll run as many as 2,000 COVID-19 tests per day for the eastern part of the state. #4NewsNow https://t.co/aqPzLrbl0e",,,2015-08-27 00:39:26,"Los Angeles, CA",Katerina Chryssafis,https://pbs.twimg.com/profile_images/1445068088681009153/18TiADic_normal.jpg,1179,875,18,3041,kchryssafis,photo
374729426,2020-07-08 09:37:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1826680, pic.twitter.com/tpZUvwCuhb, ",1280858665994424320,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on June 18, 2020. View odds for this and other indicators: https://t.co/Owb7ofati1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/tpZUvwCuhb",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
625439521,2020-07-08 07:38:46,,,,1280828672442798080,False,2,0,0,1,Twitter Web App,Incyte has just agreed a contract with a large secondary school to close the capacity gap for providing personalised support for Y10 and Y11 pupils. If this type of support is of interest get in touch.,,,2012-07-03 06:07:50,Virtual,Incyte International,https://pbs.twimg.com/profile_images/2363424702/Incyte_Logo_457_png_normal.PNG,130,383,5,1478,IncyteInt,
625439521,2020-07-08 07:36:51,,,,1280828187270840320,False,0,0,0,1,Twitter Web App,Incyte has just completed a very successful online subject review with one of outstanding schools. If you are interested in this type of school support please get in touch.,,,2012-07-03 06:07:50,Virtual,Incyte International,https://pbs.twimg.com/profile_images/2363424702/Incyte_Logo_457_png_normal.PNG,130,383,5,1478,IncyteInt,
625439521,2020-07-08 07:34:26,,"ChangeCurriculumDirectionNow, ",,1280827578677420033,False,0,0,0,1,Twitter Web App,Incyte is now organising a new free discussion seminar schedule for the autumn term. If you are interested hear more just get in touch. #ChangeCurriculumDirectionNow,,,2012-07-03 06:07:50,Virtual,Incyte International,https://pbs.twimg.com/profile_images/2363424702/Incyte_Logo_457_png_normal.PNG,130,383,5,1478,IncyteInt,
625439521,2020-07-08 07:32:43,,,,1280827148710920192,False,1,0,0,0,Twitter Web App,"Incyte has just completed 100+ highly successful free bite size discussion seminars for consultants, school leaders and teachers. I just want to thank all of our consultants who delivered these. Brilliant!",,,2012-07-03 06:07:50,Virtual,Incyte International,https://pbs.twimg.com/profile_images/2363424702/Incyte_Logo_457_png_normal.PNG,130,383,5,1478,IncyteInt,
67013771,2020-07-08 06:23:59,,"biopharma, ","s-ge.com/en/article/new‚Ä¶, ",1280809850847596544,False,6,0,0,0,Twitter Web App,"The US #biopharma company @Incyte has inaugurated its European headquarters in Morges, @GGBa_Invest. The facility will soon house more than 150 employees &amp; the company plans to further expand its Swiss operations with a production plant. Welcome to üá®üá≠!
https://t.co/nfPnzqBDzB","Incyte, GGBa_Invest, ",,2009-08-19 10:29:54,Switzerland,Invest Switzerland,https://pbs.twimg.com/profile_images/1222504605491306498/geIRHBpa_normal.png,4251,560,125,2960,investCH,
732361939490312192,2020-07-08 06:08:33,"INCY, ","markets, ","americanbankingnews.com/?p=15210084, ",1280805965634383872,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Analysts https://t.co/YnaQiGyilM #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-08 06:08:32,"INCY, ","stocks, ","americanbankingnews.com/?p=15210084, ",1280805963528916992,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Analysts https://t.co/Gr0TPc3bfW #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-07-08 04:55:44,"INCY, ","markets, ","americanbankingnews.com/?p=15209425, ",1280787643157094400,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 16,553 Shares https://t.co/CRrefse4Tk #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-08 04:55:42,"INCY, ","stocks, ","americanbankingnews.com/?p=15209425, ",1280787635951280129,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 16,553 Shares https://t.co/2ZfxccYCro #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
966006214818697218,2020-07-08 04:53:03,"INCY, ",,"theenterpriseleader.com/?p=3449002, ",1280786968494866433,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 16,553 Shares  https://t.co/2sBymxiaLQ",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2020-07-08 04:24:01,"INCY, ",,"thelincolnianonline.com/?p=4291078, ",1280779659135852550,False,0,0,0,0,Zapier.com,"Herve Hoppenot Sells 89,771 Shares of Incyte Co. $INCY Stock https://t.co/kpzGCz1duu",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2020-07-08 04:23:32,"INCY, ",,"theenterpriseleader.com/?p=3448166, ",1280779537173884930,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY CEO Sells 89,771 Shares of Stock  https://t.co/zbQ5ucBVST",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
732361939490312192,2020-07-08 04:21:26,"INCY, ","markets, ","americanbankingnews.com/?p=15209231, ",1280779009224294400,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY CEO Sells 89,771 Shares of Stock https://t.co/Wh6cTuLMX8 #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-07-08 04:21:25,"INCY, ","stocks, ","americanbankingnews.com/?p=15209231, ",1280779007034884096,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY CEO Sells 89,771 Shares of Stock https://t.co/ZRhHkqD1si #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1134049078424162304,2020-07-08 01:54:42,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1280742083884654593,False,0,0,0,0,Newsfilter.io,"$152,093.55 of shares sold by Dhanak Dashyant (EVP &amp; Chief Scientific Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/kengxRbkU0",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-08 01:53:42,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1280741831312113664,False,0,0,0,0,Newsfilter.io,"$232,637.88 of shares sold by Flannelly Barry P (EVP &amp; General Manager US), reported in a new form 4 filed with the SEC  $INCY https://t.co/avIWDkj3Jh",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-08 01:52:42,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1280741581063172096,False,0,0,0,0,Newsfilter.io,"$4,705,984.64 of shares sold by Hoppenot Herve (Chairman / CEO), reported in a new form 4 filed with the SEC  $INCY https://t.co/DzLlI43BcW",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-08 01:51:43,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1280741331359412225,False,0,0,0,0,Newsfilter.io,"$217,838.55 of shares sold by Iyengar Vijay K (EVP GPS, BD, &amp; Licensing), reported in a new form 4 filed with the SEC  $INCY https://t.co/lsNihowTbN",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-08 01:50:42,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1280741079202086913,False,0,0,0,0,Newsfilter.io,"$252,653.31 of shares sold by Pasquale Maria E (EVP &amp; General Counsel), reported in a new form 4 filed with the SEC  $INCY https://t.co/chEwBt7pmd",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-08 01:49:42,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1280740826960867334,False,0,0,0,0,Newsfilter.io,"6,661 shares acquired by Stamoulis Christiana (EVP &amp; Chief Financial Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/DOBEalrf57",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-08 01:48:42,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1280740573729734659,False,0,0,0,0,Newsfilter.io,"$1,522,646.54 of shares sold by Stein Steven H (EVP &amp; Chief Medical Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/9RNvfw1nde",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-08 01:42:42,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1280739063318941696,False,0,0,0,0,Newsfilter.io,"$186,412.59 of shares sold by Swain Paula J (EVP, Human Resources), reported in a new form 4 filed with the SEC  $INCY https://t.co/7VbMhOATOw",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-08 01:41:42,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1280738812315021315,False,0,0,0,0,Newsfilter.io,"$71,259.24 of shares sold by Trower Paul (Principal Accounting Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/kzJVpshceJ",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-08 01:40:42,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1280738561361350657,False,0,0,0,0,Newsfilter.io,"$984,368.86 of shares sold by Wenqing Yao (EVP, Head of Discovery Chem), reported in a new form 4 filed with the SEC  $INCY https://t.co/LWI0vSivpo",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2344420430,2020-07-07 20:19:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280657702323212294,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Financial Officer

CHRISTIANA STAMOULIS:

https://t.co/yfP9J2HXVB",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-07 19:50:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280650403697364992,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Chairman / CEO

HERVE HOPPENOT:

https://t.co/ALoUXctzFR",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-07 19:47:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280649642456342529,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Human Resources

PAULA J SWAIN:

https://t.co/byXSalnl4l",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-07 19:40:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280647884816384000,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Discovery Chem

YAO WENQING:

https://t.co/Qj0K1vCHaB",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-07 19:38:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280647381424508929,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Principal Accounting Officer

PAUL TROWER:

https://t.co/FMYBlKVO1K",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-07 19:36:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280646880695922690,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP GPS, BD, &amp; Licensing

VIJAY K IYENGAR:

https://t.co/I00zsWUeos",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-07 19:35:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280646626781155329,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Medical Officer

STEVEN H STEIN:

https://t.co/GACfba7qlO",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-07 19:32:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280645866823581698,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Manager US

BARRY P FLANNELLY:

https://t.co/J6XoRpwDah",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1262915121103491074,2020-07-07 19:30:39,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1280645432985575424,False,0,0,0,0,formwhispers,"#FWSells $INCY Wenqing Yao, EVP, Head of Discovery Chem of INCYTE CORP sold 16553 shares on 2020-07-06. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
2344420430,2020-07-07 19:28:18,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280644842482171904,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/VtFlKxvVzp",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1262915121103491074,2020-07-07 19:26:32,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1280644399404167168,False,0,0,0,0,formwhispers,"#FWSells $INCY Stein Steven H, EVP &amp; Chief Medical Officer of INCYTE CORP sold 36124 shares on 2020-07-06. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
2344420430,2020-07-07 19:25:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1280644109422731266,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/x3GBSMtkyv",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-07-07 19:19:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1280642593228021764,False,0,0,0,0,InsiderActionMonitor,$INCY  Incyte https://t.co/ZhFlm7CkQq,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1262915121103491074,2020-07-07 19:19:00,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1280642502811320320,False,0,0,0,0,formwhispers,"#FWSells $INCY Hoppenot Herve, Chairman / CEO of INCYTE CORP sold 89771 shares on 2020-07-07. https://t.co/JfyHtviDqH",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1262915121103491074,2020-07-07 19:14:08,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1280641279534067712,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 961 shares on 2020-07-06. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
523832475,2020-07-07 14:50:19,"AEZS, ",,"marketwatch.com/press-release/‚Ä¶, ",1280574886650544129,False,0,0,0,0,Twitter for iPhone,"Paediatric Hodgkin Lymphoma Market 2020 Moving Towards Brighter Future | Major Giants - Seattle Genetics, Pfizer, Novartis AG, Incyte Corporation, Affimed GmbH, F. Hoffmann-La Roche Ltd, Takeda Pharmaceuticals https://t.co/Z0B88WajFi

$AEZS",,,2012-03-13 20:15:28,The Moon,Brian,https://pbs.twimg.com/profile_images/1028020944026198017/OUV0UW7h_normal.jpg,10,155,0,366,blohme88,
587766370,2020-07-07 13:36:40,,,"twitter.com/Incyte/status/‚Ä¶, ",1280556351543009288,False,1,0,0,0,Twitter for Android,This is the most baffling promoted ad I've seen. I don't even feel icky sharing it because I don't know how it means to manipulate. https://t.co/78zLOvpbqM,,,2012-05-22 17:29:34,"Wisconsin, USA",Bad Creature,https://pbs.twimg.com/profile_images/1392475897123454990/4fBR-QS0_normal.jpg,64,366,1,4308,SL128t,
849417718642159616,2020-07-07 12:25:17,"INCY, ",,"zpr.io/HtFLP, ",1280538385921212418,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 1-Year High at $110.37 https://t.co/R7qs8Kh72j,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
68559732,2020-07-07 12:23:02,"INCY, ",,"zpr.io/HtF2U, ",1280537821426716674,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 1-Year High at $110.37 https://t.co/zd7BwcUxno,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2920258887,2020-07-07 12:22:20,"INCY, ",,"dakotafinancialnews.com/?p=2186685, ",1280537643319791617,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 12-Month High at $110.37 https://t.co/aoZSru1EkS,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
374729426,2020-07-07 11:39:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1822819, pic.twitter.com/Ad8D00tyen, ",1280526982166401024,False,0,0,1,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on June 18, 2020. View odds for this and other indicators: https://t.co/C6r9njvQrs #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Ad8D00tyen",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
518311705,2020-07-07 11:39:33,,"Morges, VDtech, swisstech, biotech, ","bit.ly/2O3nCmS, pic.twitter.com/shMWDtkPm7, ",1280526880110776320,False,9,0,0,1,Twitter Web App,"Congratulations to @Incyte ! Supported by @Innovaud for the installation of its production site and its European headquarters in the region, Incyte announced last night the opening of its new European headquarters in #Morges. https://t.co/nSczU2ddCG #VDtech #swisstech  #biotech https://t.co/shMWDtkPm7","Incyte, Innovaud, ",,2012-03-08 03:28:25,"Lausanne, Switzerland",Innovaud,https://pbs.twimg.com/profile_images/1272786812147314688/T2w2Talu_normal.jpg,7055,2298,391,14093,Innovaud,photo
102680887,2020-07-07 09:09:16,,"cytokinesstorm, COVID„Éº19, ","heidi.news/sante/incyte-s‚Ä¶, ",1280489058184069120,False,1,0,0,0,Twitter Web App,Where you learn also how @Incyte @IloveIncyte develop anti #cytokinesstorm treatments for #COVID„Éº19 https://t.co/ASyO7KjWoO,"Incyte, IloveIncyte, ",,2010-01-07 08:38:09,,Fabrice Delaye,https://pbs.twimg.com/profile_images/1374619732628885504/oakqUCEs_normal.jpg,566,747,47,5521,fabricedelaye,
3154096965,2020-07-06 22:00:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1280320648024293378,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 107.2500 up 4.4812% 18:24 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
3317366626,2020-07-06 20:03:56,,,"pic.twitter.com/Iu5WzvyQZy, ",1280291421640146945,False,4,0,0,1,Twitter Web App,"Incyte is a global biopharmaceutical company in Wilmington, DE. Tremendous progress on a new research lab which will contribute to great developments from inside these walls. A hub of innovation helping sick people get well, we're proud being a part of that. @Incyte @L2P_Arch https://t.co/Iu5WzvyQZy","Incyte, L2P_Arch, ",,2015-06-10 09:17:41,"Delaware, USA",MacIntoshEngineering,https://pbs.twimg.com/profile_images/608625186972127233/3fYSlvmV_normal.jpg,102,190,1,477,MacIntoshEng,video
3154096965,2020-07-06 12:45:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1280180977516507136,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 107.2500 up 4.4812% 18:24 https://t.co/Pa7hloe5u9  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
3911174913,2020-07-06 11:52:33,,,"pic.twitter.com/1R7PxlAQA9, ",1280167760321040384,False,213,2,6,58,Twitter Web App,We're thrilled to open our new European headquarters in the Swiss city of Morges. We are looking forward to the increased collaboration &amp; innovation this building will foster. https://t.co/1R7PxlAQA9,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
108617488,2020-07-06 11:15:11,,,"invst.ly/rctyy, ",1280158357958070272,False,0,0,0,0,FP News Publisher - COM,RBC Capital Stick to Their Hold Rating for Incyte Corp - https://t.co/1Wfy9riLbl,,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
68559732,2020-07-06 11:07:37,"INCY, ",,"zpr.io/HtT3s, ",1280156455329562625,False,0,0,0,0,Zapier.com,Incyte $INCY ‚Äì Investment Analysts‚Äô Recent Ratings Changes https://t.co/SP9LXSL58E,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1140762699002871808,2020-07-06 10:02:13,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1280139995479633923,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-07-06 10:02 ET. Shorted/Opened:
$INCY at $107.14. 
Incyte Corporation - Common Stock
Win Chance: 65%. Avg Win: 8%. Avg Loss: 11.73%. Avg Hold: 5d.
Trade Id: 47743268503053123.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
3154096965,2020-07-06 10:00:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1280139453110116352,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 107.2500 up 4.4812% 18:24 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
374729426,2020-07-06 07:36:25,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1818750, pic.twitter.com/TZvJILRI1n, ",1280103304387682305,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/jnm7CYTzCL #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/TZvJILRI1n,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3154096965,2020-07-05 22:00:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1279958261169602567,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 107.2500 up 4.4812% 18:24 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
374729426,2020-07-05 20:28:18,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1816025, pic.twitter.com/lNMAxRmeOE, ",1279935166777978880,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/pfKjByQaZV #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/lNMAxRmeOE,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2416188264,2020-07-05 19:33:09,"INCY, ","markets, ","thestockobserver.com/?p=3185390, ",1279921287234752514,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Quarterly Sales of $593.10 Million  https://t.co/TXacqOWnVh #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
19277975,2020-07-05 17:14:01,,"BakerBrothers, HedgeFunds, biotech, incyte, acadia, seattleGenetics, beigene, ","onefamilysblog.com/2020/07/tracki‚Ä¶, ",1279886271997935622,False,0,0,0,0,Twitter Web App,Baker Brothers Portfolio - Q1 2020 Update @ https://t.co/hCxDHSVUfJ #BakerBrothers #HedgeFunds #biotech #incyte #acadia #seattleGenetics #beigene,,,2009-01-21 00:45:56,"Williamsville, NY, USA",John Vincent,https://pbs.twimg.com/profile_images/72255905/SantaCruzBoardWalk_normal.JPG,364,110,38,1881,OneFamilysBlog,
1079749795823214594,2020-07-05 06:34:29,"DHR, INCY, MOH, TMO, ","biotech, Pharma, Danahger, Incyte, Molina, ThermoFisher, fintech, trading, investing, stocks, investment, SP500, USA, ","pic.twitter.com/XaP1g4YwLP, pic.twitter.com/XaP1g4YwLP, pic.twitter.com/XaP1g4YwLP, pic.twitter.com/XaP1g4YwLP, ",1279725331100979200,False,3,0,0,1,Twitter Web App,"In the #biotech / #Pharma field #Danahger $DHR #Incyte $INCY #Molina $MOH &amp; #ThermoFisher $TMO all had strong weeks &amp; all firmly in BUY on our system. See charts. Key: above the cloud ""In Buy"" below ""In Sell"". #fintech  #trading #investing #stocks #investment #SP500 #USA https://t.co/XaP1g4YwLP",,,2018-12-31 09:43:06,Leeds,The Flying Stocksman,https://pbs.twimg.com/profile_images/1338104605901807616/mj9Jjtta_normal.jpg,3283,178,59,13749,flyingstocksman,photo
365454476,2020-07-04 09:01:00,,"automation, AI, Analytics, ","hubs.ly/H0s0nTp0, pic.twitter.com/G0o95oOCvR, ",1279399812488671232,False,1,0,0,3,HubSpot,"What‚Äôs your post-crisis #automation plan? ‚Äì it's time to speed up your journey! Join @ElenaLChristoph &amp; gang as we showcase the power of the Triple-A trifecta with real enterprise examples from NextEra Energy, Incyte Pharma &amp; @Cognizant. #AI #Analytics 

https://t.co/yPlquh7YKO https://t.co/G0o95oOCvR","ElenaLChristoph, Cognizant, ",,2011-08-31 09:32:19,"Cambridge, England [HQ]",HFS Research,https://pbs.twimg.com/profile_images/1019581946039545856/DezsjDVr_normal.jpg,11997,1528,783,25484,HFSResearch,photo
2344420430,2020-07-03 20:12:22,"INCY, ",,"insideri.com/879169_0001638‚Ä¶, ",1279206382558986245,False,2,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

10%+ Owner

BAKER BROS. ADVISORS LP:

https://t.co/Q2NAzDZzSH",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
374729426,2020-07-03 10:11:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1811810, pic.twitter.com/xTB2Dechh9, ",1279055289447137281,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/R6ZkaCfsMA #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xTB2Dechh9,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3154096965,2020-07-03 10:00:03,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1279052286279528451,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 106.4800 up 3.7311% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
1027508410374340608,2020-07-03 09:33:14,,,"twitter.com/Peachey631/sta‚Ä¶, ",1279045536717377539,False,1,0,0,1,Twitter for Android,"See this, @senatemajldr @realDonaldTrump?!!! It's criminal!!!! (@SenSchumer @SpeakerPelosi)
@Merck @GSK_bio @pfizer @Amgen @EliLillyCo @AbbieVie @BristolMeyers @AlexionPharma @Zoetis @VertexPharma @BaxterLabs @Regeneron @Incyte @biomarine https://t.co/rcPDy14rQ8","realDonaldTrump, SenSchumer, SpeakerPelosi, Merck, GSK_bio, pfizer, Amgen, EliLillyCo, AbbieVie, BristolMeyers, AlexionPharma, Zoetis, VertexPharma, BaxterLabs, Regeneron, Incyte, biomarine, ",,2018-08-09 06:54:29,United States,üåäüåπüê¥ Caryn üêéüåπüåä,https://pbs.twimg.com/profile_images/1375178716410740740/EdxaOJfg_normal.jpg,11149,10545,5,43123,Loves_Equines,
3154096965,2020-07-03 07:45:03,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1279018312534376448,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 106.4800 up 3.7311% 16:00 https://t.co/Pa7hloe5u9  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
68559732,2020-07-03 04:31:26,"INCY, ",,"zpr.io/Hgrp6, ",1278969589074997252,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY CEO Sells 124,148 Shares of Stock https://t.co/9D41vxFo1K",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
461141340,2020-07-03 01:49:38,,"ChangeCurriculumDirectionNow, ",,1278928867940544512,False,1,0,0,1,Twitter Web App,Incyte has a growing concern about the teacher-centred direction the govt. et al is moving. There is has to be collective resistance to this. #ChangeCurriculumDirectionNow,,,2012-01-11 09:01:52,UK,Malcolm Greenhalgh,https://pbs.twimg.com/profile_images/1750104870/Malc_Incyte_Mobile_normal.JPG,52,81,0,69,MalcolmGreenha2,
1134049078424162304,2020-07-03 00:18:54,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1278906035307241472,False,0,0,0,0,Newsfilter.io,"Baker Bros. Advisors Lp (Director) acquired new securities, reported in a new form 4 filed with the SEC  $INCY https://t.co/eLbKPzFvHJ",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
3154096965,2020-07-02 22:00:03,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1278871094305398785,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 106.4800 up 3.7311% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
2441992010,2020-07-02 11:49:15,"NKLA, XOMA, ","options, stocks, invest, ",,1278717378864406533,False,0,0,1,0,Twitter for Android,"SPOTLIGHT
$NKLA I wanted to sell more naked put #options, but no premium. Likely a bankrupt #stocks . 

$XOMA $19.40, buying on dip. Small biotech has huge pipeline in trials by Bayer, Novartis, Merck, Incyte &amp; others. CEO &amp; very astute money M Lampert brought $14 - $18 #invest",,,2014-04-13 13:21:36,,Dalvin Varnado,https://pbs.twimg.com/profile_images/1264519824945774593/UFtUQBLs_normal.jpg,48,113,0,1260,DalvinVarnado,
374729426,2020-07-02 09:00:30,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1807628, pic.twitter.com/F8kkfaILcL, ",1278674914749239297,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/JUOsCiwKr4 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/F8kkfaILcL,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
930803511918411776,2020-07-02 04:32:44,"INCY, ",,"thelincolnianonline.com/?p=4255997, ",1278607527828238342,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY CEO Sells 124,148 Shares of Stock https://t.co/j1RCYqAdRU",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2298709746,2020-07-02 04:32:17,"INCY, ",,"zpr.io/HgAAL, ",1278607415647363072,False,0,0,0,0,Zapier.com,"Herve Hoppenot Sells 124,148 Shares of Incyte Co. $INCY Stock https://t.co/gIF3GNGtDa",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2920258887,2020-07-02 04:29:37,"INCY, ",,"dakotafinancialnews.com/?p=2158314, ",1278606741572333568,False,0,0,0,0,Zapier.com,"Herve Hoppenot Sells 124,148 Shares of Incyte Co. $INCY Stock https://t.co/HFiBDezjQo",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
1134049078424162304,2020-07-02 03:32:40,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1278592411846021121,False,0,0,0,0,Newsfilter.io,"$21,625.76 of shares acquired by Bienaime Jean Jacques (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/cZuCmRtNro",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-02 03:25:40,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1278590649483374593,False,0,0,0,0,Newsfilter.io,"$23,809.13 of shares acquired by Clancy Paul J (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/x6770NrrO7",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-02 03:22:40,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1278589895687262209,False,0,0,0,0,Newsfilter.io,"$18,922.54 of shares acquired by Dixon Wendy L (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/bwZ8cJF31B",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-02 03:03:40,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1278585113954136064,False,0,0,0,0,Newsfilter.io,"$15,803.44 of shares acquired by Harrigan Edmund (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/d74YUFHHCT",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-07-02 02:27:40,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1278576053569585153,False,0,0,0,0,Newsfilter.io,"$21,001.94 of shares acquired by Fouse Jacqualyn A (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/G0HRTEMwcD",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2344420430,2020-07-02 00:02:58,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1278539640119660545,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

PAUL J CLANCY:

https://t.co/GOzPDQRJ8p",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-01 23:46:06,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1278535392719966214,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

EDMUND HARRIGAN:

https://t.co/EVcubTlROH",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-01 19:50:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1278476074989518849,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JEAN JACQUES BIENAIME:

https://t.co/JkJlh5NlRd",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-01 19:25:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1278469755310137349,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JACQUALYN A FOUSE:

https://t.co/kBWjlXoUIE",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-07-01 18:50:21,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1278460967614124033,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

WENDY L DIXON:

https://t.co/xHtHtS85F8",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1241286375346970625,2020-07-01 15:41:26,,,"prospertrading.com/is-incyte-corp‚Ä¶, ",1278413421273366533,False,0,0,0,0,Twitter Web App,Is Incyte Corporation Set To Explode? - Prosper Trading Academy https://t.co/T3pCjBqpf3,,,2020-03-21 04:52:52,,Anna Slatten,https://pbs.twimg.com/profile_images/1446420588134866944/Y28_MkdF_normal.jpg,6,30,0,159,AnnaSlatten,
374729426,2020-07-01 08:44:43,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1805015, pic.twitter.com/TG5LZGiZQx, ",1278308552096878594,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/zsnO1N1zlQ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/TG5LZGiZQx,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2338882843,2020-07-01 05:30:08,"INCY, ",,"dailypolitical.com/?p=4111639, ",1278259585850257409,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY CEO Herve Hoppenot Sells 124,148 Shares https://t.co/vecU2W59Uz",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1134049078424162304,2020-07-01 03:45:36,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1278233278206611456,False,0,0,0,0,Newsfilter.io,"$4,762,317.28 of shares sold by Hoppenot Herve (Chairman / CEO), reported in a new form 4 filed with the SEC  $INCY https://t.co/0hwzUxqqMb",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2416188264,2020-06-30 17:37:41,"INCY, ","markets, ","thestockobserver.com/?p=3164815, ",1278080291039518720,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY CEO Herve Hoppenot Sells 124,148 Shares  https://t.co/FfdxNcfZsJ #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2344420430,2020-06-30 17:15:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1278074681078222853,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Chairman / CEO

HERVE HOPPENOT:

https://t.co/vbXNgTN4gc",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-06-30 16:12:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1278058818115645441,False,0,0,0,0,InsiderActionMonitor,$INCY Herve Hoppenot sells $13M Worth Of Incyte Stock https://t.co/S5Dzfsm0Fd,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1262915121103491074,2020-06-30 16:07:21,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1278057556724727811,False,0,0,0,0,formwhispers,"#FWSells $INCY Hoppenot Herve, Chairman / CEO of INCYTE CORP sold 124148 shares on 2020-06-26. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
374729426,2020-06-30 12:40:32,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1801294, pic.twitter.com/jJ9AAOxVQq, ",1278005510134886408,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on June 18, 2020. View odds for this and other indicators: https://t.co/IgRkk7KdO1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/jJ9AAOxVQq",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1889492676,2020-06-30 05:09:17,"INCY, ","Incyte, Tabrecta, Capmatinib, NonSmallCellLungCancer, METex14, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1277891948016136192,False,1,0,0,1,Troi URL Plug-in,#Incyte Announces Approval of #Tabrecta‚Ñ¢ (#Capmatinib) in Japan for the Treatment of Patients with Advanced #NonSmallCellLungCancer with #METex14 $INCY https://t.co/5PxOUMhIKl,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1134049078424162304,2020-06-30 00:33:40,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1277822587024834560,False,0,0,0,0,Newsfilter.io,Incyte Announces Approval of Tabrecta‚Ñ¢ in Japan for the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with METex14 $INCY https://t.co/sDPbD13fUz,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1100450877792370688,2020-06-29 10:43:01,"INCY, ",,"blueequity.io/r/130197/de-in‚Ä¶, ",1277613547782934529,False,0,0,0,0,Blue Equity,$INCY Incyte Announces Approval of Tabrecta‚Ñ¢ (capmatinib) in Japan for the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with METex14 https://t.co/77XRtY98FR,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
1128239740329705472,2020-06-29 10:39:09,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1277612576755421188,False,0,0,0,0,Twitter for Android,"""This approval highlights the strength of the Incyte in-house discovery program, and our commitment to finding solutions for serious medical needs.""

$INCY 
https://t.co/qAfnNAWxwE",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
3154096965,2020-06-29 10:00:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1277602740416450561,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 101.4900 down -4.2095% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
374729426,2020-06-29 09:39:13,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1797235, pic.twitter.com/fqsqwJM5Mu, ",1277597494092824577,False,0,0,1,0,Tickeron,"$INCY's Aroon indicator drops into Downtrend on May 27, 2020. View odds for this and other indicators: https://t.co/p60d55ZhCp #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/fqsqwJM5Mu",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
72928001,2020-06-29 09:10:55,"INCY, ",,"bit.ly/2VsXXbv, ",1277590369874530306,False,0,0,0,2,BriefingInPlayLimited,"$INCY: Incyte: Japanese Ministry of Health, Labour and Welfare approved Tabrecta for MET exon 14 skipping (METex14)... https://t.co/OrKHw6C7zp",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1006334607946649600,2020-06-29 07:26:02,,,"dlvr.it/RZZqXs, ",1277563977447337987,False,0,0,0,0,dlvr.it,Incyte Announces Approval of Tabrecta‚Ñ¢ (capmatinib) in Japan for the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with METex14 https://t.co/I0qhsOqd5Z,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
3318510966,2020-06-29 07:19:02,,,"crweworld.com/article/news-p‚Ä¶, ",1277562214040301568,False,0,0,0,0,CRWE World,Incyte Announces Approval of Tabrecta‚Ñ¢ (capmatinib) in Japan for the Treatment of Patients with Advanced Non-Small https://t.co/At8IsViuSi,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
472650465,2020-06-29 07:15:47,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1277561394502807554,False,0,0,0,1,OTC Dynamics Twitter Login,$INCY Incyte Announces Approval of Tabrecta‚Ñ¢ (capmatinib) in Japan for the Treatment of Patients with Advanced N https://t.co/kFQ39gatIR,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
976297820532518914,2020-06-29 07:11:06,,,"dlvr.it/RZZnQF, pic.twitter.com/9t0IoiFYog, ",1277560216528187392,False,0,0,0,0,dlvr.it,Incyte Announces Approval of Tabrecta‚Ñ¢ (capmatinib) in Japan for the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with METex14 https://t.co/PZ0jmdC4Ho https://t.co/9t0IoiFYog,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1089978712685273090,2020-06-29 07:11:03,"INTC, ","Incyte, ","dlvr.it/RZZnN1, ",1277560203341266944,False,0,0,0,0,dlvr.it,#Incyte $INTC Announces Approval of Tabrecta‚Ñ¢ (capmatinib) in Japan for the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with METex14 https://t.co/A8lJKGxSu5,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
1069693680066420736,2020-06-29 07:05:57,"INCY, ",,"s.flashalert.me/xYCp27, ",1277558921599868928,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on June 29, 07:05:00: Incyte Announces Approval of Tabrecta‚Ñ¢ (capmatinib) in Japan for the Treatment of Patients with Advanced Non-Small Cell Lung Cancer with METex14 https://t.co/pwF70zfRse",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1107455939089567746,2020-06-29 03:09:12,,,"re-how.net/all/538929/, ",1277499341368782848,False,0,0,0,0,WordPress.com,Incyte announces that Tabrector (R) has been approved for manufacturing and marketing in Japan as a therapeutic drug for advanced non-small cell lung cancer with METex14¬†mutation https://t.co/piVB3AIpVu,,,2019-03-17 21:37:26,,re-how.net,https://pbs.twimg.com/profile_images/1144077529319260160/k8RdPpV1_normal.png,397,231,4,243979,rehownet2,
3154096965,2020-06-29 02:00:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1277481944914132992,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 101.4900 down -4.2095% 16:00 https://t.co/Pa7hloe5u9  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
3154096965,2020-06-28 22:00:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1277421547456811008,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 101.4900 down -4.2095% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
2416188264,2020-06-28 09:17:34,"INCY, ","markets, ","thestockobserver.com/?p=3155667, ",1277229657499336705,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Earnings of $0.76 Per Share  https://t.co/adYYAjwagD #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
732361939490312192,2020-06-28 09:13:43,"INCY, ","markets, ","americanbankingnews.com/?p=15113724, ",1277228686794805255,False,1,0,0,0,Zapier.com,Zacks: Brokerages Anticipate Incyte Co. $INCY Will Announce Earnings of $0.76 Per Share https://t.co/9YN1c9Mqww #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-28 09:13:42,"INCY, ","stocks, ","americanbankingnews.com/?p=15113724, ",1277228684441763841,False,0,0,0,0,Zapier.com,Zacks: Brokerages Anticipate Incyte Co. $INCY Will Announce Earnings of $0.76 Per Share https://t.co/JqBusnjAhp #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1134049078424162304,2020-06-28 09:13:33,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1277228647280250885,False,0,0,0,0,Newsfilter.io,Incyte Expected to Post Earnings of $0.76 Per Share $INCY https://t.co/BdnUvCP4DS,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
374729426,2020-06-28 07:36:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1791653, pic.twitter.com/aWgyoJCKAA, ",1277204219284434944,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on June 18, 2020. View odds for this and other indicators: https://t.co/YspUdlGYBn #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/aWgyoJCKAA",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
852931863547084801,2020-06-28 04:36:34,"INCY, ",,"zpr.io/H6wQs, ",1277158940862750722,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Sells $763,730.00 in Stock https://t.co/d8amzQ5TnD",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2266388972,2020-06-28 04:32:58,"INCY, ","stocks, ","dailypolitical.com/?p=4092219, ",1277158032884011009,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Sells $763,730.00 in Stock https://t.co/fy4d1FQGxV #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-06-28 04:32:57,"INCY, ",,"dailypolitical.com/?p=4092219, ",1277158030635937799,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Sells $763,730.00 in Stock https://t.co/QuVSeNYCAj",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1642424330,2020-06-27 15:10:17,"OAT, ","arginases, OncoArendi, ","fiercebiotech.com/biotech/incyte‚Ä¶, ",1276956032040828928,False,2,0,0,0,Twitter Web App,Phase I #arginases partnering deal in 2017: USD 53m upfront + USD 430m plus in milestone payments #OncoArendi $OAT https://t.co/MDx5lyaBuY,,,2013-08-03 04:56:18,Berlin & Warsaw,Adrian Kowollik,https://pbs.twimg.com/profile_images/892744016164524033/OisRRDQ9_normal.jpg,2791,1165,47,8071,AdrianKowollik,
875107384535900161,2020-06-27 09:35:30,,"JobSearch, jobseekers, Jobs, ","jobs.frontend.la/i/us/all/1/260‚Ä¶, ",1276871782541045760,False,0,0,0,0,FrontendLA,"New opportunity in Wilmington, DE - Sr. Research Scientist, Bioanalytical (Regulated) @ Incyte Corporation  https://t.co/tPlkX3v8Tp #JobSearch #jobseekers #Jobs",,,2017-06-14 17:47:14,,Frontend.LA,https://pbs.twimg.com/profile_images/1275071694609080320/lPHtH4S__normal.jpg,234,24,5,590801,FrontendLA,
374729426,2020-06-27 08:35:08,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1789254, pic.twitter.com/Ce2S2gdUSO, ",1276856591803838465,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on June 18, 2020. View odds for this and other indicators: https://t.co/ARxYPhKzz6 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Ce2S2gdUSO",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
930803511918411776,2020-06-27 05:29:20,"INCY, ",,"thelincolnianonline.com/?p=4231026, ",1276809833262579713,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Insider Sells 6,943 Shares of Stock https://t.co/j6tLfqziwc",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-06-27 04:59:46,"INCY, ",,"tickerreport.com/?p=5838515, ",1276802389660454912,False,0,0,0,0,Zapier.com,"Paul Trower Sells 6,943 Shares of Incyte Co. $INCY Stock https://t.co/v6DXCU5GEH",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
849417718642159616,2020-06-27 04:57:51,"INCY, ",,"zpr.io/H6yBX, ",1276801907747520513,False,0,0,0,0,Zapier.com,"Paul Trower Sells 6,943 Shares of Incyte Co. $INCY Stock https://t.co/Uvc9BnKddX",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
852931863547084801,2020-06-27 03:42:14,"INCY, ",,"zpr.io/H6yye, ",1276782878005825536,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 52-Week High at $110.25 https://t.co/PgT7t4R5KN,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
966006214818697218,2020-06-27 03:41:30,"INCY, ",,"theenterpriseleader.com/?p=3383404, ",1276782695197130753,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 12-Month High at $110.25  https://t.co/l4YiessFOh,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1134049078424162304,2020-06-27 02:33:27,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1276765570164285441,False,0,0,0,0,Newsfilter.io,"Incyte EVP Sells $142,300.00 in Stock $INCY https://t.co/wjpbcPXj1c",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
133504478,2020-06-26 17:17:07,,"strategy, competitiveintelligence, marketing, productmarketing, biotech, pharmaceutical, pharma, healthcare, ","dlvr.it/RZRkqh, lqventures.com, ",1276625561318653952,False,1,0,0,1,dlvr.it,"Comprehensive Report on Vitiligo Treatment Market 2020 | Size, Growth, Demand, Opportunities &amp; Forecast To 2026 |‚Ä¶ https://t.co/GcO3qYsF2Q &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharmaceutical #pharma #healthcare",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
1140762699002871808,2020-06-26 16:03:33,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1276607050454163456,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-06-26 16:01 ET. *Closed/Covered previously shorted:
$INCY at $101.54 for 3.18 profit (3.03%). Incyte Corporation - Common Stock
Trade Id: 46713910603000761.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
15486468,2020-06-26 11:47:23,,,"youtube.com/watch?v=ZI6GEV‚Ä¶, ",1276542584190652416,False,6,0,0,4,Hootsuite Inc.,"Clinical trial results can be tricky for patients and caregivers to understand. We highly recommend this patient-friendly video explainer. Our thanks to @Curecc, @TargetCancer, &amp; @Incyte for their work on this. 
https://t.co/M1sxfWlb3v","curecc, targetcancer, Incyte, ",,2008-07-18 17:11:22,USA- National,LUNGevity Foundation,https://pbs.twimg.com/profile_images/1101590913808252929/TxUWiJ_S_normal.jpg,32266,1456,340,28171,LUNGevity,
374729426,2020-06-26 10:51:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1783903, pic.twitter.com/oBltsYuVue, ",1276528639832514565,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on June 18, 2020. View odds for this and other indicators: https://t.co/vqmonsPJX7 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/oBltsYuVue",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2298709746,2020-06-26 08:34:32,"INCY, ",,"zpr.io/H6NxN, ",1276494051479519237,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Sells $763,730.00 in Stock https://t.co/taf1SJJsWw",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2920258887,2020-06-26 07:47:19,"INCY, ",,"dakotafinancialnews.com/?p=2129626, ",1276482170228543490,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 6,943 Shares of Stock https://t.co/KjJFrpU0eu",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
966006214818697218,2020-06-26 05:20:34,"INCY, ",,"theenterpriseleader.com/?p=3378391, ",1276445238232522752,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $142,300.00 in Stock  https://t.co/LlViKO3aMz",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2416188264,2020-06-26 05:17:59,"INCY, ","markets, ","thestockobserver.com/?p=3147344, ",1276444587893182465,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $142,300.00 in Stock  https://t.co/eyDfqw8AMc #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2416188264,2020-06-26 04:46:23,"INCY, ","markets, ","thestockobserver.com/?p=3147166, ",1276436634955845632,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $947,790.00 in Stock  https://t.co/9Q4zEEtctq #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2020-06-26 04:44:56,"INCY, ",,"zpr.io/H6Y9W, ",1276436271754293250,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $947,790.00 in Stock https://t.co/6dyeTsChkC",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
966006214818697218,2020-06-26 04:44:46,"INCY, ",,"theenterpriseleader.com/?p=3378304, ",1276436229148598272,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $947,790.00 in Stock  https://t.co/uzi9Hc81Wz",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1134049078424162304,2020-06-26 04:43:23,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1276435881914662912,False,0,0,0,0,Newsfilter.io,"Incyte EVP Sells $947,790.00 in Stock $INCY https://t.co/AxOQRNKIb5",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
974533459744931842,2020-06-26 02:22:28,,,"tradesoftheday.com/2020/06/25/thi‚Ä¶, ",1276400418784899073,False,0,0,0,0,Twitter Web App,"This latest options pick of the day by Rick on Incyte (Nasdaq: INCY) could give you 75% returns by mid-August! Check out the complete trade setup here.
https://t.co/YCTQO4CmWI",,,2018-03-16 02:30:57,,Trades Of The Day,https://pbs.twimg.com/profile_images/974544745539059712/d6QxEkbv_normal.jpg,94,0,0,1920,Trades_OfTheDay,
2344420430,2020-06-25 19:37:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1276298468911390724,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Principal Accounting Officer

PAUL TROWER:

https://t.co/NQH3kJxxmL",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-06-25 18:57:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1276288408462262272,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Manager US

BARRY P FLANNELLY:

https://t.co/GWTcNwg11f",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
732361939490312192,2020-06-25 17:55:21,"INCY, ","markets, ","americanbankingnews.com/?p=15081969, ",1276272798122627076,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 6,943 Shares https://t.co/M8vnWXjyMD #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-25 17:55:21,"INCY, ","stocks, ","americanbankingnews.com/?p=15081969, ",1276272796142895105,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 6,943 Shares https://t.co/w7HSG78LJ1 #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1176558075798380544,2020-06-25 17:21:21,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1276264242740637697,False,0,0,0,0,InsiderActionMonitor,$INCY Paul Trower Dumps 6.9K Shares of Incyte https://t.co/P8o5OOidd7,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1262915121103491074,2020-06-25 17:16:35,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1276263042334863360,False,0,0,0,0,formwhispers,"#FWSells $INCY Trower Paul, Principal Accounting Officer of INCYTE CORP sold 6943 shares on 2020-06-23. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1176558075798380544,2020-06-25 17:15:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1276262733810405376,False,0,0,0,0,InsiderActionMonitor,$INCY  Incyte https://t.co/ehbzzT15N9,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1262915121103491074,2020-06-25 17:10:34,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1276261527868207104,False,0,0,0,0,formwhispers,"#FWSells $INCY Flannelly Barry P, EVP &amp; General Manager US of INCYTE CORP sold 400 shares on 2020-06-23. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
3911174913,2020-06-25 16:19:17,,,"bit.ly/2ZdCLr3, pic.twitter.com/qBKZMp5gJY, ",1276248622124982287,False,1,0,0,0,Twitter Web App,"At Incyte, we take the health of our employees very seriously &amp; we're thrilled to be recognized as a finalist by @PHLBizJournal for the 2020 Healthiest Employer award. https://t.co/y81EeOm7WI https://t.co/qBKZMp5gJY","PHLBizJournal, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
3911174913,2020-06-25 10:00:01,,"vitiligo, VirtualWorldVitiligoDayUSA, ","pic.twitter.com/WZLPqmBEWP, ",1276153174261260288,False,207,2,3,62,Twitter for Advertisers.,"Kimberly Boyd sheds light on the need for #vitiligo patient support and why she advocates for the vitiligo community, as a patient and member of the @StepUp4Vitiligo team. #VirtualWorldVitiligoDayUSA https://t.co/WZLPqmBEWP","StepUp4Vitiligo, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
374729426,2020-06-25 08:35:49,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1781361, pic.twitter.com/I1FLYUOsXs, ",1276131986264883207,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on June 18, 2020. View odds for this and other indicators: https://t.co/JMiqHC1Lts #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/I1FLYUOsXs",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1979190776,2020-06-25 07:23:35,"INCY, ",,"tickerreport.com/?p=5828917, ",1276113806310232064,False,0,0,0,0,Zapier.com,"Maria E. Pasquale Sells 1,423 Shares of Incyte Co. $INCY Stock https://t.co/giv2h7zSlb",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1979190776,2020-06-25 05:10:17,"INCY, ",,"tickerreport.com/?p=5826365, ",1276080260778528778,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 12-Month High at $110.25 https://t.co/9p3mrphMQ7,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
849417718642159616,2020-06-25 04:39:55,"INCY, ",,"zpr.io/H6UnL, ",1276072617842270208,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 12-Month High at $110.25 https://t.co/dG65O5qgyk,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
930803511918411776,2020-06-25 04:37:49,"INCY, ",,"thelincolnianonline.com/?p=4217276, ",1276072092719513601,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 1-Year High at $110.25 https://t.co/bNMuMo1gKR,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1658013217,2020-06-24 21:59:42,,,"delawarestem.org/symposium-educ‚Ä¶, pic.twitter.com/tZ2XpLtyYw, ",1275971901907755008,False,1,0,0,0,TweetDeck,"Delaware STEM Educator Awards Application Available NOW for 2020. 

Application available here: https://t.co/qTW2VPCrAJ¬†@AshlandInc 

@chemours @EDiSCompany @Agilent @EnergizeDel
@Bloom_Energy
@DelmarvaConnect @AstraZeneca
@OrbitalATK
@AIAA_DE @Incyte
@Nemours https://t.co/tZ2XpLtyYw","AshlandInc, chemours, EDiSCompany, Agilent, EnergizeDel, Bloom_Energy, DelmarvaConnect, AstraZeneca, OrbitalATK, AIAA_DE, Incyte, Nemours, ",,2013-08-09 11:25:03,"Delaware, USA",Delaware STEM,https://pbs.twimg.com/profile_images/550264409814077440/j7foiFJ3_normal.png,1306,1624,84,2324,delawarestem,photo
1658013217,2020-06-24 21:14:41,,,"delawarestem.org/symposium-educ‚Ä¶, pic.twitter.com/lSQBn9fyt4, ",1275960574803873793,False,0,0,0,0,TweetDeck,"Delaware STEM Educator Awards Application Available NOW for 2020. 

Application available here: https://t.co/qTW2VPCrAJ¬†@AshlandInc 

@DuPont_News @AstraZeneca
@AstraZenecaUS @Incyte @DFMNews
@wboc @WHYYNews @47abc
@delbiz
@AshtonReports
@6abc
@NBCPhiladelphia
@KYWNewsradio https://t.co/lSQBn9fyt4","AshlandInc, DuPont_News, AstraZeneca, AstraZenecaUS, Incyte, DFMNews, wboc, WHYYNews, 47abc, delbiz, AshtonReports, 6abc, NBCPhiladelphia, KYWNewsradio, ",,2013-08-09 11:25:03,"Delaware, USA",Delaware STEM,https://pbs.twimg.com/profile_images/550264409814077440/j7foiFJ3_normal.png,1306,1624,84,2324,delawarestem,photo
1140762699002871808,2020-06-24 12:10:19,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1275823579859304449,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-06-24 12:10 ET. Shorted/Opened:
$INCY at $105.01. 
Incyte Corporation - Common Stock
Win Chance: 56%. Avg Win: 8%. Avg Loss: 5.78%. Avg Hold: 2d.
Trade Id: 46713910603000761.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
112838571,2020-06-24 12:06:45,,"Covid19, ","news.wisc.edu/uw-madison-and‚Ä¶, ",1275822682857234432,False,20,1,0,8,TweetDeck,"With the recent addition of a clinical drug trial with @Novartis and @Incyte, @UWMadison, @UWHealth and @uwsmph have moved at record pace to understand and combat #Covid19 https://t.co/abIluJ6PH0","Novartis, Incyte, UWMadison, UWHealth, uwsmph, ",,2010-02-09 16:44:02,"Madison, Wis.",UW‚ÄìMadison Science,https://pbs.twimg.com/profile_images/872515191770030080/88aAcRId_normal.jpg,10966,2103,328,9777,UWMadScience,
374729426,2020-06-24 09:53:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1775877, pic.twitter.com/9s2OoKgNfU, ",1275789231596527616,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/DDJQESF3Zc #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/9s2OoKgNfU,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2920258887,2020-06-24 07:47:55,"INCY, ",,"dakotafinancialnews.com/?p=2120217, ",1275757544779251712,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 1,423 Shares https://t.co/M9eJhrkbjz",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
852931863547084801,2020-06-24 07:47:52,"INCY, ",,"zpr.io/Hn5Jk, ",1275757531961442304,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 1,423 Shares https://t.co/Q5owj8zMFt",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
849417718642159616,2020-06-24 07:47:48,"INCY, ",,"zpr.io/Hn5J9, ",1275757515041619968,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $142,300.00 in Stock https://t.co/229sPMta11",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2298709746,2020-06-24 06:59:26,"INCY, ",,"zpr.io/Hn5Nz, ",1275745342168891392,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Jonathan Elliott Dickinson Sells 9,000 Shares https://t.co/jz84RKz42u",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
966006214818697218,2020-06-24 06:16:08,"INCY, ",,"theenterpriseleader.com/?p=3371315, ",1275734445895692290,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Price Up 3.2%  https://t.co/SfAuvkHpYL,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1134049078424162304,2020-06-24 05:47:25,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1275727220443668487,False,0,0,0,0,Newsfilter.io,"$228,283.99 of shares sold by Flannelly Barry P (EVP &amp; General Manager US), reported in a new form 4 filed with the SEC  $INCY https://t.co/wrNRQxkE0s",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-06-24 05:20:26,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1275720427202101249,False,0,0,0,0,Newsfilter.io,"$252,813.24 of shares sold by Iyengar Vijay K (EVP GPS, BD, &amp; Licensing), reported in a new form 4 filed with the SEC  $INCY https://t.co/0HHpTYoZtC",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-06-24 05:14:26,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1275718916384468994,False,0,0,0,0,Newsfilter.io,"$39,459.79 of shares sold by Pasquale Maria E (EVP &amp; General Counsel), reported in a new form 4 filed with the SEC  $INCY https://t.co/jA8odLh0kj",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1262915121103491074,2020-06-23 20:00:54,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1275579616074149890,False,0,0,0,0,formwhispers,"#FWSells $INCY Pasquale Maria E, EVP &amp; General Counsel of INCYTE CORP sold 1423 shares on 2020-06-19. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
2344420430,2020-06-23 19:39:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1275574202632896513,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP GPS, BD, &amp; Licensing

VIJAY K IYENGAR:

https://t.co/Vg9NKM7V12",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
732361939490312192,2020-06-23 18:58:46,"INCY, ","markets, ","americanbankingnews.com/?p=15051857, ",1275563979218341890,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $947,790.00 in Stock https://t.co/tGMNQx3RGF #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-23 18:58:45,"INCY, ","stocks, ","americanbankingnews.com/?p=15051857, ",1275563976802344960,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $947,790.00 in Stock https://t.co/xEkyGyVV7H #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-06-23 17:54:01,"INCY, ","markets, ","americanbankingnews.com/?p=15051366, ",1275547687648202753,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 1,423 Shares of Stock https://t.co/K0RN6iDT1Y #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-23 17:54:01,"INCY, ","stocks, ","americanbankingnews.com/?p=15051366, ",1275547684963864578,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 1,423 Shares of Stock https://t.co/k2e78FDe3j #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2344420430,2020-06-23 16:50:21,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1275531663704051718,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/eXZi3NhlUS",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-06-23 16:45:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1275530410051751936,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Manager US

BARRY P FLANNELLY:

https://t.co/A39wpMmW9T",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-06-23 16:45:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1275530408189444098,False,0,0,0,0,InsiderActionMonitor,$INCY Jonathan Elliott Dickinson Dumps 9K Shares of Incyte https://t.co/1SvNmWdJen,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1188117778567454720,2020-06-23 16:34:07,"INCY, ",,"jodie.ai/shareholder/16‚Ä¶, ",1275527577365553153,False,0,0,0,0,jodietheai,"Vijay K Iyengar, EVP GPS, BD, &amp; Licensing of INCYTE CORP - $INCY sold 7866 shares to now own a total of 24901, anomalous of their normal trading pattern.

https://t.co/JSu0wtEzZk",,,2019-10-26 11:38:58,London,Jodie Insights,https://pbs.twimg.com/profile_images/1310896987466760198/cVg3gmLj_normal.jpg,624,1781,16,28832,jodietheai,
1262915121103491074,2020-06-23 16:34:02,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1275527557794807809,False,0,0,0,0,formwhispers,"#FWSells $INCY Iyengar Vijay K, EVP GPS, BD, &amp; Licensing of INCYTE CORP sold 7866 shares on 2020-06-19. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
2344420430,2020-06-23 16:29:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1275526383029178369,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, General Manager, Europe

JONATHAN ELLIOTT DICKINSON:

https://t.co/IO8ODEm7WH",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1188117778567454720,2020-06-23 16:24:07,"INCY, ",,"jodie.ai/shareholder/16‚Ä¶, ",1275525062989398018,False,0,0,0,0,jodietheai,"Barry P Flannelly, EVP &amp; General Manager US of INCYTE CORP - $INCY sold 7181 shares to now own a total of 35862, anomalous of their normal trading pattern.

https://t.co/l7a6Auk0fS",,,2019-10-26 11:38:58,London,Jodie Insights,https://pbs.twimg.com/profile_images/1310896987466760198/cVg3gmLj_normal.jpg,624,1781,16,28832,jodietheai,
1262915121103491074,2020-06-23 16:23:38,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1275524938921676800,False,0,0,0,0,formwhispers,"#FWSells $INCY Flannelly Barry P, EVP &amp; General Manager US of INCYTE CORP sold 7181 shares on 2020-06-19. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
1188117778567454720,2020-06-23 16:18:11,"INCY, ",,"jodie.ai/shareholder/17‚Ä¶, ",1275523567107612677,False,0,0,0,0,jodietheai,"Jonathan Elliott Dickinson, EVP, General Manager, Europe of INCYTE CORP - $INCY sold 9000 shares to now own a total of 21762, anomalous of their normal trading pattern.

https://t.co/1Lio39slJp",,,2019-10-26 11:38:58,London,Jodie Insights,https://pbs.twimg.com/profile_images/1310896987466760198/cVg3gmLj_normal.jpg,624,1781,16,28832,jodietheai,
1262915121103491074,2020-06-23 16:18:09,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1275523561952735232,False,0,0,0,0,formwhispers,"#FWSells $INCY Dickinson Jonathan Elliott, EVP, General Manager, Europe of INCYTE CORP sold 9000 shares on 2020-06-22. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
3154096965,2020-06-23 10:30:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1275435961833283586,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 108.9100 up 3.3302% 16:00 https://t.co/Pa7hloe5u9  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
3154096965,2020-06-23 10:00:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1275428412367265794,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 108.9100 up 3.3302% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
374729426,2020-06-23 09:46:35,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1773461, pic.twitter.com/iJXhGaqO5O, ",1275425020781576193,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on June 18, 2020. View odds for this and other indicators: https://t.co/OOjr4i4IiJ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/iJXhGaqO5O",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3086873679,2020-06-23 09:31:09,"INCY, ","Wyckoff, trading, stocktowatch, wyckoffmethod, ","tinyurl.com/yc72p387, ",1275421133769183232,False,4,0,0,0,Hootsuite Inc.,"üÜï  Anatomy of a Trade #38 - $INCY (Incyte Corp.) and ATVI (Activision Blizzard Inc.) üòâ 
The intent of this video series is trade post-analysis from a #Wyckoff perspective with the goal of future trade optimization. 
#trading #stocktowatch #wyckoffmethod https://t.co/D3hhbQpzWP",,,2015-03-11 10:23:48,,Wyckoff Analytics,https://pbs.twimg.com/profile_images/580117765467471872/S2mzrwMd_normal.jpg,14054,159,183,4741,WyckoffAnalysis,
631661989,2020-06-23 08:06:04,,"pharma, Delaware, choosedelaware, globalde, ","hubs.ly/H0rNn_B0, ",1275399723223060480,False,2,0,0,0,HubSpot,"Eight projects, including one by #pharma innovator @Incyte, have been recommended for $8.8M in Delaware Transportation Infrastructure Investment Fund grants. The fund makes it faster and easier for business to grow in #Delaware.
https://t.co/dsaWJBxLtr
#choosedelaware #globalde","Incyte, ",,2012-07-09 23:54:36,"Wilmington, Delaware",Global Delaware,https://pbs.twimg.com/profile_images/1059868013459992577/IjSZsC14_normal.jpg,5389,1817,222,6107,DelawareGlobal,
3154096965,2020-06-23 00:00:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1275277417683140609,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 108.9100 up 3.3302% 16:00 https://t.co/Pa7hloe5u9  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
3154096965,2020-06-22 22:00:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1275247217922760711,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 108.9100 up 3.3302% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
1259512942611042304,2020-06-22 19:00:12,,,,1275201951983075335,False,1,1,0,0,ARK Tracker,"üö® On Monday, June 22nd, ARK Invest bought/sold the following shares:

VIRGIN GALACTIC HOLDINGS INC (‚¨ÜÔ∏è by 95%)
AQUABOUNTY TECHNOLOGIES (‚¨ÜÔ∏è by 62%)
SCHRODINGER INC (‚¨ÜÔ∏è by 51%)
SPOTIFY TECHNOLOGY SA (‚¨ÜÔ∏è by 48%)
NETFLIX INC (‚¨ÜÔ∏è by 29%)
INCYTE CORP (ÔøΩ...",,,2020-05-10 11:57:58,,ARK Portfolio Update,https://pbs.twimg.com/profile_images/1261199027644911616/LHe9RHIo_normal.jpg,562,1,10,309,ARKTracker,
2344420430,2020-06-22 17:19:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1275176582924156929,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP, Head of Discovery Chem

YAO WENQING:

https://t.co/wq2nM1DFAH",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-06-22 16:36:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1275165762903314434,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Medical Officer

STEVEN H STEIN:

https://t.co/BfX4OAnTcF",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
68559732,2020-06-22 16:35:41,"INCY, ",,"zpr.io/HnswY, ",1275165586323111943,False,0,0,0,0,Zapier.com,Incyte $INCY Raised to Hold at BidaskClub https://t.co/5uHZE0lO4x,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2416188264,2020-06-22 15:33:20,"INCY, ","markets, ","thestockobserver.com/?p=3133492, ",1275149894391681034,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Up 3.2%  https://t.co/or31AGbURz #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
4035355935,2020-06-22 12:12:08,,,,1275099260292227072,False,0,0,0,0,WPTS Playlist,Incyte - The Slide,,,2015-10-24 21:01:50,"Pittsburgh, PA",WPTS Playlist,https://pbs.twimg.com/profile_images/658129792408023041/8nflCFL-_normal.jpg,478,5,38,638221,WPTSPlaylist,
374729426,2020-06-22 11:36:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1769416, pic.twitter.com/VHuKTNpblj, ",1275090333504684033,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/dItpROIkZj #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/VHuKTNpblj,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3154096965,2020-06-22 11:15:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1275084899029041153,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 105.3850 up 8.2426% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
2525892205,2020-06-22 10:55:27,"INCY, ","investingnews, ","modernreaders.com/?p=3485385, ",1275079963373264898,False,0,0,0,0,Zapier.com,"Capital World Investors Sells 165,894 Shares of Incyte Co. $INCY  https://t.co/ckjzwuGvFb #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2525892205,2020-06-22 09:55:44,"INCY, ","investingnews, ","modernreaders.com/?p=3484675, ",1275064935144275968,False,0,0,0,0,Zapier.com,"Tower Research Capital LLC TRC Has $556,000 Position in Incyte Co. $INCY  https://t.co/lKdEZEGYCO #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
3911174913,2020-06-22 09:42:34,,"vitiligo, VitiligoAwarenessMonth, ","pic.twitter.com/KAtpB5r8Hx, ",1275061618871689219,False,3,0,0,1,Twitter Web App,"Erika Page, Living Dappled Founder &amp; Editor, was inspired to start her own advocacy organization to help uplift &amp; educate others with #vitiligo. #VitiligoAwarenessMonth https://t.co/KAtpB5r8Hx",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
2525892205,2020-06-22 08:56:56,"INCY, ","investingnews, ","modernreaders.com/?p=3483709, ",1275050137610530816,False,0,0,0,0,Zapier.com,"Tudor Investment Corp Et Al Has $619,000 Stock Holdings in Incyte Co. $INCY  https://t.co/ZjTNmReCVD #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
133504478,2020-06-22 04:09:02,,"strategy, competitiveintelligence, marketing, pharmaceutical, pharma, biotech, healthcare, productmarketing, ","dlvr.it/RZ68fr, lqventures.com, ",1274977685496713216,False,0,0,0,1,dlvr.it,"Marginal Zone Lymphoma Treatment Market (impact of COVID-19) with Top Players: AbbVie,GSK,Astellas Pharma,Incyte‚Ä¶ https://t.co/LmRIs7tx0m &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #biotech #healthcare #productmarketing",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
3154096965,2020-06-21 23:45:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1274911254973300737,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 105.3850 up 8.2426% 16:00 https://t.co/Pa7hloe5u9  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
3154096965,2020-06-21 22:00:05,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1274884833081208832,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 105.3850 up 8.2426% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
1134049078424162304,2020-06-21 12:58:44,"INCY, ",,"newsfilter.io/articles/inter‚Ä¶, ",1274748600006950919,False,0,0,0,0,Newsfilter.io,International Biotechnology Trust Raises Holdings in Incyte $INCY https://t.co/rj2zMWtqxB,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-06-21 11:38:44,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1274728466181734400,False,0,0,0,0,Newsfilter.io,Incyte Lifted to ‚ÄúHold‚Äù at BidaskClub $INCY https://t.co/Ux6NJpiMgS,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2416188264,2020-06-21 11:37:38,"INCY, ","markets, ","thestockobserver.com/?p=3129008, ",1274728190792122368,False,0,0,0,0,Zapier.com,Incyte $INCY Lifted to ‚ÄúHold‚Äù at BidaskClub  https://t.co/HraLgWPzI0 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2020-06-21 07:46:17,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1763254, pic.twitter.com/vs0dsNx94X, ",1274669969272221696,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/2nh3Z4cUTd #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/vs0dsNx94X,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2298709746,2020-06-21 04:54:29,"AGEN, ",,"zpr.io/HnUFV, ",1274626734848163840,False,0,0,0,0,Zapier.com,"Corp Incyte Sells 214,000 Shares of Agenus Inc $AGEN Stock https://t.co/Vra5iXvDIw",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
849417718642159616,2020-06-21 04:29:46,"INCY, ",,"zpr.io/HnUba, ",1274620514129117186,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at William Blair https://t.co/0LqSxE8Rxs,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
852931863547084801,2020-06-21 04:29:39,"INCY, ",,"zpr.io/HnUbf, ",1274620483456184322,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at William Blair https://t.co/Uj6nJdJlym,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2266388972,2020-06-21 02:27:50,"INCY, ","stocks, ","dailypolitical.com/?p=4048656, ",1274589828429099008,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 52-Week High at $106.22 https://t.co/9fegjNP2JD #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-06-21 02:27:46,"INCY, ",,"dailypolitical.com/?p=4048656, ",1274589813790904321,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 52-Week High at $106.22 https://t.co/WYyI7cWmFF,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1979190776,2020-06-21 02:27:45,"INCY, ",,"tickerreport.com/?p=5799838, ",1274589807847657474,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 1-Year High at $106.22 https://t.co/wdZPLv5ngc,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
966006214818697218,2020-06-21 02:27:42,"INCY, ",,"theenterpriseleader.com/?p=3348913, ",1274589796883664896,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 52-Week High at $106.22  https://t.co/rRMFSLu5cM,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
68559732,2020-06-20 17:04:16,"INCY, ",,"zpr.io/HPWFt, ",1274448001126346757,False,0,0,0,0,Zapier.com,Incyte $INCY Coverage Initiated by Analysts at Benchmark https://t.co/K1C6PWOavd,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1134049078424162304,2020-06-20 14:43:43,"INCY, ",,"newsfilter.io/articles/squar‚Ä¶, ",1274412631693111296,False,0,0,0,0,Newsfilter.io,Squarepoint Ops Has $7.50 Million Stake in Incyte $INCY https://t.co/eX6NYoSIVJ,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1248904924697632768,2020-06-20 10:57:29,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, newsfilter.io/articles/incyt‚Ä¶, ",1274355700009926656,False,0,0,0,0,Index_alert,"Incyte Shares Sold by FinTrust Capital Advisors $INCY &lt;a href=""https://t.co/XJsHHh0BWM""&gt;https://t.co/XJsHHh0BWM

Trade_YuMi_News",,,2020-04-11 05:25:20,,YuMiStocksTrade,https://pbs.twimg.com/profile_images/1292092955327639553/puHJ9dxY_normal.jpg,1532,692,14,37532,YuMiStocksTrade,
1134049078424162304,2020-06-20 10:56:43,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1274355505209782274,False,0,0,0,0,Newsfilter.io,Incyte Shares Sold by FinTrust Capital Advisors $INCY https://t.co/RwkZXjgvFk,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2298709746,2020-06-20 09:17:33,"INCY, ",,"zpr.io/HPVyK, ",1274330549608484874,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Increased to Hold at BidaskClub https://t.co/GkT1316k5e,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
374729426,2020-06-20 08:36:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1760952, pic.twitter.com/3AYB6L4iT0, ",1274320324725665793,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/irMFnPORbM #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/3AYB6L4iT0,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
19143910,2020-06-20 07:42:00,"INCY, ","IBDCharts, IBDPartner, ","research.investors.com/ibd-charts.asp‚Ä¶, ",1274306505257422848,False,2,0,0,1,Twitter Web App,"INCY - Stock Investment Research, IBD Stock Charts https://t.co/LBoDs4ejYi #IBDCharts via @IBDinvestors #IBDPartner $INCY Strong move Friday above double bottom pivot of 103.08. Great digestion last couple months after the big rise from 3/24-4/24 which fell just 4 times","IBDinvestors, ",,2009-01-18 08:15:28,"Astoria, NY/North Fork LI",Douglas Busch CMT,https://pbs.twimg.com/profile_images/1433948976055832576/Uf9byCPi_normal.jpg,11282,995,401,17586,chartsmarter,
966006214818697218,2020-06-20 06:27:39,"AGEN, ",,"theenterpriseleader.com/?p=3347275, ",1274287791954972673,False,0,0,0,0,Zapier.com,"Corp Incyte Sells 214,000 Shares of Agenus Inc $AGEN Stock  https://t.co/LZMQxdQFqJ",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1219514987485335552,2020-06-20 04:25:16,,"business, Economy, Market, StockMarket, stockstowatch, TrendingNews, Investing, PROBAY, ","fxstreet.com/news/sp-500-to‚Ä¶, ",1274256992786247681,False,0,0,0,0,Twitter Web App,"S&amp;P 500 top movers: Incyte Corp (INCY) surges above $102, gains nearly 5% #business #Economy #Market #StockMarket #stockstowatch
#TrendingNews #Investing #PROBAY
https://t.co/7QMm3ghU05",,,2020-01-21 02:00:38,"Connaught Place,New Delhi",PROBAY,https://pbs.twimg.com/profile_images/1228949153897533446/TXcg3Nm__normal.jpg,446,131,5,5975,probaycorp,
1248904924697632768,2020-06-20 01:20:08,"AGEN, ",,"newsfilter.io/articles/agenu‚Ä¶, newsfilter.io/articles/agenu‚Ä¶, ",1274210401694167040,False,0,0,0,0,Index_alert,"Agenus Inc Major Shareholder Corp Incyte Sells 214,000 Shares $AGEN &lt;a href=""https://t.co/OWqvuxkxUb""&gt;https://t.co/OWqvuxkxUb

Trade_YuMi_News",,,2020-04-11 05:25:20,,YuMiStocksTrade,https://pbs.twimg.com/profile_images/1292092955327639553/puHJ9dxY_normal.jpg,1532,692,14,37532,YuMiStocksTrade,
1134049078424162304,2020-06-20 01:19:14,"AGEN, ",,"newsfilter.io/articles/agenu‚Ä¶, ",1274210178003501056,False,0,0,0,0,Newsfilter.io,"Agenus Inc Major Shareholder Corp Incyte Sells 214,000 Shares $AGEN https://t.co/Zarc5lYAQV",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1248904924697632768,2020-06-19 23:19:43,"INCY, ",,"newsfilter.io/articles/weiss‚Ä¶, newsfilter.io/articles/weiss‚Ä¶, ",1274180100699885570,False,0,0,0,0,Index_alert,"Weiss Multi Stregy Advisers Grows Stock Position in Incyte $INCY &lt;a href=""https://t.co/9miYlamCqb""&gt;https://t.co/9miYlamCqb

Trade_YuMi_News",,,2020-04-11 05:25:20,,YuMiStocksTrade,https://pbs.twimg.com/profile_images/1292092955327639553/puHJ9dxY_normal.jpg,1532,692,14,37532,YuMiStocksTrade,
1134049078424162304,2020-06-19 23:19:15,"INCY, ",,"newsfilter.io/articles/weiss‚Ä¶, ",1274179980398821376,False,0,0,0,0,Newsfilter.io,Weiss Multi Strategy Advisers Grows Stock Position in Incyte $INCY https://t.co/ypy5Xz1VT4,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
975337043944407040,2020-06-19 18:57:26,"INCY, ","Incyte, INCY, ","finscreener.com/title/financia‚Ä¶, ",1274114095676108801,False,0,0,0,0,StockTwits Web,"Financials of #Incyte #INCY $INCY 
https://t.co/Exsy3FikDe",,,2018-03-18 07:44:06,,Finscreener,https://pbs.twimg.com/profile_images/976083323347984384/71mUunXo_normal.jpg,652,202,12,15317,Finscreener_com,
68559732,2020-06-19 16:51:16,"INCY, ",,"zpr.io/HPeUt, ",1274082344752775174,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 52-Week High at $106.22 https://t.co/v2j08im1EO,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2181281054,2020-06-19 16:51:12,"INCY, ","markets, ","wkrb13.com/?p=1912695, ",1274082324158742529,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 52-Week High at $106.22 https://t.co/og8vVGTOvv #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
732361939490312192,2020-06-19 16:08:38,"INCY, ","markets, ","americanbankingnews.com/?p=14998194, ",1274071614586585090,False,0,0,0,0,Zapier.com,Recent Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/AnJFPwj41l #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-19 16:08:37,"INCY, ","stocks, ","americanbankingnews.com/?p=14998194, ",1274071611583447041,False,0,0,0,0,Zapier.com,Recent Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/gOihSXSuHM #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2181281054,2020-06-19 16:07:09,"INCY, ","markets, ","wkrb13.com/?p=1911999, ",1274071242254036993,False,0,0,0,0,Zapier.com,Recent Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/DdpnQsnZ18 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
68559732,2020-06-19 16:06:46,"INCY, ",,"zpr.io/HPdr2, ",1274071143746600961,False,0,0,0,0,Zapier.com,Recent Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/5KYAvQPM96,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1140762699002871808,2020-06-19 16:00:28,"INCY, ",,"deustrader.com/optimus_mixus4‚Ä¶, ",1274069560505729024,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-06-19 15:56 ET. *Closed/Sold:
$INCY at $105.51 for 4.40 profit (4.35%). Incyte Corporation - Common Stock
Trade Id: 44717534003017975.
Stats: https://t.co/JZ1yafbugd",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
762348422,2020-06-19 15:56:49,"INCY, ",,,1274068639793270790,False,0,0,0,0,StockTwits Web,$INCY is there a news on Incyte? Why it went up suddenly?,,,2012-08-16 17:17:33,,NTaj,https://pbs.twimg.com/profile_images/1406702278346776578/dfz-rdNJ_normal.jpg,14,158,0,1571,JippuTaj,
434064748,2020-06-19 14:24:19,,"forex, fx, ","fxstreet.com/news/sp-500-to‚Ä¶, ",1274045363205410820,False,0,0,0,0,Microsoft Power Platform,"S&amp;P 500 top movers: Incyte Corp (INCY) surges above $102, gains nearly 5% https://t.co/1tPoUGnvnr via FXStreet #forex #fx",,,2011-12-11 06:13:09,,BlackCentaurFX,https://pbs.twimg.com/profile_images/1281546465857490946/DQx0OKkJ_normal.jpg,1520,156,91,988180,BlackCentaurFX,
983527219,2020-06-19 14:20:02,,,"fxb.cm/W4OP, ",1274044285395111938,False,0,0,0,0,FxBookLTTG,"https://t.co/CHyw8jR6Gt S&amp;P 500 top movers: Incyte Corp (INCY) surges above $102, gains nearly 5%",,,2012-12-01 18:25:15,Estonia,FxBook,https://pbs.twimg.com/profile_images/537829734688624640/Zd8-reO6_normal.png,793,90,98,669565,FxBookLTTG,
1142020602724835330,2020-06-19 14:19:02,,"Live_News, ","dlvr.it/RYzKt5, bit.ly/2Wwmiyt, ",1274044032939745280,False,0,0,0,1,dlvr.it,"S&amp;P 500 top movers: Incyte Corp (INCY) surges above $102, gains nearly 5% https://t.co/hKr8zA7sQn #Live_News https://t.co/M71P5NFvLt",,,2019-06-21 06:45:04,Trading Strategies,"Bitcoin, Forex & Stock Market Headline News",https://pbs.twimg.com/profile_images/1371501642806398977/IrPO2pl3_normal.jpg,532,525,5,76995,BTCTradeIdeas,
953788131601502208,2020-06-19 14:15:33,,,"fxstreet.com/news/sp-500-to‚Ä¶, pic.twitter.com/snZGfMOWDC, ",1274043153520214018,False,0,0,0,0,Wall St Solver Auto-Tweeter,"S&amp;P 500 top movers: Incyte Corp (INCY) surges above $102, gains nearly 5%

üì∞ ¬ª https://t.co/GX0II2C91J https://t.co/snZGfMOWDC",,,2018-01-17 19:36:25,,Wall St Solver,https://pbs.twimg.com/profile_images/1029252349716512769/HAdlBHZA_normal.jpg,472,39,12,58222,wallstsolver,photo
27652717,2020-06-19 14:11:37,,"Equities, SP500, ","s68mv.app.goo.gl/e6y29, ",1274042166394990592,False,1,0,0,2,FXstreet.com,"S&amp;P 500 top movers: Incyte Corp (INCY) surges above $102, gains nearly 5% By @eren_fxstreet https://t.co/qvCQk0iPu5 #Equities #SP500","eren_fxstreet, ",,2009-03-30 11:05:53,Barcelona,FXStreet News,https://pbs.twimg.com/profile_images/900669341171056640/06pIS4h4_normal.jpg,213799,279,3575,403963,FXstreetNews,
1134049078424162304,2020-06-19 14:11:03,"INCY, ",,"newsfilter.io/articles/inves‚Ä¶, ",1274042020999413761,False,0,0,0,0,Newsfilter.io,Invesco Decreases Stock Holdings in Incyte $INCY https://t.co/T2bHQnnyWb,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1249788032305201152,2020-06-19 14:10:08,,"sp500, ",,1274041791206088712,False,1,0,0,0,rstats2twitter,"Summary of Standard &amp; Poor's 500 today viernes, the 5 companies that have most increased their stock price are: 
HollyFrontier Corp : 6.44%
Hess Corporation : 4.27%
Incyte : 3.8%
FleetCor Technologies Inc : 3.65%
TransDigm Group : 2.47%
#sp500, Standard &amp; Poor's 500",,,2020-04-13 15:55:10,Madrid,AI Consulting,https://pbs.twimg.com/profile_images/1249790279231700993/ik6xOY81_normal.jpg,210,1426,4,2665,AIConsulting2,
2416188264,2020-06-19 10:43:19,"AGEN, ","markets, ","thestockobserver.com/?p=3118820, ",1273989746272976897,False,0,0,0,0,Zapier.com,"Agenus Inc $AGEN Major Shareholder Corp Incyte Sells 214,000 Shares  https://t.co/FJd5t9Jn8n #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
3086873679,2020-06-19 10:30:30,"INCY, ","Wyckoff, trading, stocktowatch, wyckoffmethod, ","tinyurl.com/yc72p387, ",1273986518684762112,False,2,0,1,0,Hootsuite Inc.,"üÜï  Anatomy of a Trade #38 - $INCY (Incyte Corp.) and ATVI (Activision Blizzard Inc.) üòâ 
The intent of this video series is trade post-analysis from a #Wyckoff perspective with the goal of future trade optimization. 
#trading #stocktowatch #wyckoffmethod
https://t.co/D3hhbQpzWP",,,2015-03-11 10:23:48,,Wyckoff Analytics,https://pbs.twimg.com/profile_images/580117765467471872/S2mzrwMd_normal.jpg,14054,159,183,4741,WyckoffAnalysis,
1092394610393935872,2020-06-19 09:37:45,,,"stockmarketintellects.com/agenus-inc-age‚Ä¶, ",1273973242752053249,False,0,0,0,0,WordPress.com,"Agenus Inc. ($AGEN) 10% Owner, Incyte Corp sold 141.92 K shares on June 17, 2020 at an average price of $¬†3.66 https://t.co/QMzUleRSlp",,,2019-02-04 07:09:05,,Stock Market Intellects,https://pbs.twimg.com/profile_images/1116923358124204032/4YIC8b0k_normal.png,149,0,1,36884,smintellects,
374729426,2020-06-19 08:38:01,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1756655, pic.twitter.com/JodzzvjN6n, ",1273958211796627456,False,0,0,0,0,Tickeron,"$INCY in +1.92% Uptrend, growing for three consecutive days on June 18, 2020. View odds for this and other indicators: https://t.co/s2rHLZnMEz #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/JodzzvjN6n",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1248904924697632768,2020-06-19 06:42:46,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, newsfilter.io/articles/incyt‚Ä¶, ",1273929209233244160,False,0,0,0,0,Index_alert,"Incyte Earns Buy Ring from Analysts  Oppenheimer $INCY &lt;a href=""https://t.co/pu1ymAJ6e8""&gt;https://t.co/pu1ymAJ6e8

Trade_YuMi_News",,,2020-04-11 05:25:20,,YuMiStocksTrade,https://pbs.twimg.com/profile_images/1292092955327639553/puHJ9dxY_normal.jpg,1532,692,14,37532,YuMiStocksTrade,
1134049078424162304,2020-06-19 06:42:00,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1273929015854850050,False,0,0,0,0,Newsfilter.io,Incyte Earns Buy Rating from Analysts at Oppenheimer $INCY https://t.co/i7RWNo7W8T,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2416188264,2020-06-19 06:21:19,"INCY, ","markets, ","thestockobserver.com/?p=3118373, ",1273923812447391749,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Analysts at Oppenheimer  https://t.co/Y370rTb85p #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2920258887,2020-06-19 05:01:57,"INCY, ",,"dakotafinancialnews.com/?p=2092579, ",1273903836177014785,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by William Blair https://t.co/2kRbOQJsUK,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
966006214818697218,2020-06-19 05:00:00,"INCY, ",,"theenterpriseleader.com/?p=3339098, ",1273903344998854657,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by William Blair  https://t.co/xHjjt5SckV,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1248904924697632768,2020-06-19 02:11:23,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, newsfilter.io/articles/4-for‚Ä¶, ",1273860912315879424,False,0,0,0,0,Index_alert,"$783,240.00 of shares sold by Incyte Corp (10% Owner), reported in a new form 4 filed with the SEC  $INCY &lt;a href=""https://t.co/Rf3pCDT9cs""&gt;https://t.co/Rf3pCDT9cs

Trade_YuMi_News",,,2020-04-11 05:25:20,,YuMiStocksTrade,https://pbs.twimg.com/profile_images/1292092955327639553/puHJ9dxY_normal.jpg,1532,692,14,37532,YuMiStocksTrade,
1134049078424162304,2020-06-19 02:10:58,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1273860807932162048,False,0,0,0,0,Newsfilter.io,"$783,240.00 of shares sold by Incyte Corp (10% Owner), reported in a new form 4 filed with the SEC  $INCY https://t.co/7hfOXkE2Nk",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1248904924697632768,2020-06-19 02:10:20,"AGEN, ",,"newsfilter.io/articles/4-for‚Ä¶, newsfilter.io/articles/4-for‚Ä¶, ",1273860649983115264,False,0,0,0,0,Index_alert,"$783,240.00 of shares sold by Incyte Corp (10% Owner), reported in a new form 4 filed with the SEC  $AGEN &lt;a href=""https://t.co/c6TimjRFcn""&gt;https://t.co/c6TimjRFcn

Trade_YuMi_News",,,2020-04-11 05:25:20,,YuMiStocksTrade,https://pbs.twimg.com/profile_images/1292092955327639553/puHJ9dxY_normal.jpg,1532,692,14,37532,YuMiStocksTrade,
1134049078424162304,2020-06-19 02:09:58,"AGEN, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1273860558501142528,False,0,0,0,0,Newsfilter.io,"$783,240.00 of shares sold by Incyte Corp (10% Owner), reported in a new form 4 filed with the SEC  $AGEN https://t.co/JIf24ePNIa",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
732361939490312192,2020-06-18 20:39:29,"AGEN, ","markets, ","americanbankingnews.com/?p=14985816, ",1273777386300063747,False,0,0,0,0,Zapier.com,"Corp Incyte Sells 214,000 Shares of Agenus Inc $AGEN Stock https://t.co/VJwO0D9bU6 #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-18 20:39:28,"AGEN, ","stocks, ","americanbankingnews.com/?p=14985816, ",1273777384215515141,False,0,0,0,0,Zapier.com,"Corp Incyte Sells 214,000 Shares of Agenus Inc $AGEN Stock https://t.co/5ENISpxVGk #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2344420430,2020-06-18 19:30:24,"AGEN, ",,"insideri.com/1098972_000110‚Ä¶, ",1273760003137167360,False,0,0,0,0,Insider Alerts,"$AGEN:

New Insider Filing on AGENUS INC's

10%+ Owner

INCYTE CORP:

https://t.co/nC4d5wqUcN",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
4312114277,2020-06-18 19:20:58,"AGEN, ",,"fintel.io/n/us/agen/incy‚Ä¶, ",1273757627143593984,False,0,0,0,0,Fintel.io,"Insider Corp Incyte reports selling 214,000 shares of $AGEN for a total cost of $782,838.55 https://t.co/qKSoqCUma7",,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
374729426,2020-06-18 18:42:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1753339, pic.twitter.com/YG7GZ8liyf, ",1273747852129218560,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/gyYv0wVOJn #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/YG7GZ8liyf,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
68559732,2020-06-18 18:40:02,"INCY, ",,"zpr.io/HP8H6, ",1273747328067874818,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúBuy‚Äù Rating at William Blair https://t.co/fJs1xosvx8,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1176558075798380544,2020-06-18 17:53:22,"AGEN, ",,"chartexe.com/article/latest‚Ä¶, ",1273735581827239939,False,0,0,0,0,InsiderActionMonitor,$AGEN INCYTE CORP Dumps 142K Shares of AGENUS INC https://t.co/WOOWkB4lMZ,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
778267752679235585,2020-06-18 17:48:08,,,"stockmarketdaily.co/2020/06/18/inc‚Ä¶, pic.twitter.com/sMwXka9h1t, ",1273734265730142208,False,0,0,0,0,StockMarketDaily,Incyte (NASDAQ:INCY) Upgraded by BidaskClub to Hold - https://t.co/RKh40aAiD3 https://t.co/sMwXka9h1t,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
1262915121103491074,2020-06-18 17:30:54,"AGEN, ","FWSells, ","formwhispers.com/s?t=AGEN, ",1273729928005996546,False,0,0,0,0,formwhispers,"#FWSells $AGEN INCYTE CORP, 10%-owner of AGENUS INC sold 214000 shares on 2020-06-17. https://t.co/Z00QtFOEwS",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
2181281054,2020-06-18 17:21:14,"INCY, ","markets, ","wkrb13.com/?p=1911014, ",1273727497549549569,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $99.89 Average PT from Analysts https://t.co/AS4hYfF2RV #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
3911174913,2020-06-18 14:15:32,,,,1273680764866048009,False,11,0,0,0,Twitter for Advertisers.,"Our Executive Vice President, General Manager, U.S., Barry Flannelly, provides an overview of the Incyte Ingenuity Award program, currently accepting applicants.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
1140762699002871808,2020-06-18 13:20:15,"INCY, ",,"deustrader.com/optimus_mixus4‚Ä¶, ",1273666852091092992,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-06-18 13:20 ET. *Closed/Sold:
$INCY at $97.42 for 5.83 profit (6.37%). Incyte Corporation - Common Stock
Trade Id: 45322264303056444.
Stats: https://t.co/JZ1yafbugd",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
221775604,2020-06-18 12:00:02,,"cancercare, ThankfulThursday, COVID19, ","fal.cn/38HuO, ",1273646664591572994,False,1,0,0,0,Falcon Social Media Management ,Thanks to @Incyte¬†for supporting our COVID Impacts Cancer initiative &amp; the #cancercare community https://t.co/67ywv8jna8 #ThankfulThursday #COVID19,"Incyte, ",,2010-12-01 10:42:50,"Alexandria, VA","Conquer Cancer, the ASCO Foundation",https://pbs.twimg.com/profile_images/992446921481641985/uTJut7PD_normal.jpg,11592,815,202,5939,ConquerCancerFd,
4597733961,2020-06-18 05:56:44,,"COVID19, clinicaltrials, Ruxolitinib, ",,1273555237849255936,False,1,0,1,0,Twitter Web App,"Demiurge AI-based #COVID19 #clinicaltrials outcome predictions put to the public test (059_2020): 

FAILURE for 
#Ruxolitinib / NCT04362137 / @Incyte and @Novartis","Incyte, Novartis, ",,2015-12-25 02:43:29,Switzerland,DemiurgeTech,https://pbs.twimg.com/profile_images/1227148848386265089/aqLPaCF4_normal.jpg,303,540,4,569,DemiurgeTech,
1889492676,2020-06-18 04:57:00,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-in‚Ä¶, ",1273540203127300099,False,0,0,0,0,Troi URL Plug-in,#Incyte #InvestorConference Update $INCY https://t.co/FYkp2couC8,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
778267752679235585,2020-06-18 03:32:20,,,"pic.twitter.com/r3TFzgtjOQ, ",1273518897040424960,False,0,0,0,0,StockMarketDaily,Coverage Initiated by Benchmark Co. for Incyte (NASDAQ:INCY) - http://107.20.85.142/2020/06/17/coverage-initiated-by-benchmark-co-for-incyincyte/ https://t.co/r3TFzgtjOQ,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
1248904924697632768,2020-06-17 22:07:57,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, newsfilter.io/articles/incyt‚Ä¶, ",1273437262760620034,False,0,0,0,0,Index_alert,"Incyte Investor Conference Upde $INCY &lt;a href=""https://t.co/Na0tdOP6CU""&gt;https://t.co/Na0tdOP6CU

Trade_YuMi_News",,,2020-04-11 05:25:20,,YuMiStocksTrade,https://pbs.twimg.com/profile_images/1292092955327639553/puHJ9dxY_normal.jpg,1532,692,14,37532,YuMiStocksTrade,
1134049078424162304,2020-06-17 22:07:46,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1273437218997260293,False,0,0,0,0,Newsfilter.io,Incyte Investor Conference Update $INCY https://t.co/cTu2qjrZbO,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
374729426,2020-06-17 15:59:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1749250, pic.twitter.com/YoBzloMIRb, ",1273344432213901312,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average broke below its 50-day Moving Average on June 12, 2020. View odds for this and other indicators: https://t.co/qfJ2p3py6u #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/YoBzloMIRb",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1100450877792370688,2020-06-17 15:19:31,"INCY, ",,"blueequity.io/r/127780/de-in‚Ä¶, ",1273334478316777475,False,0,0,0,0,Blue Equity,$INCY Incyte Investor Conference Update https://t.co/Yy08jEaUhe,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
55654926,2020-06-17 12:28:45,,,"cholangiocarcinoma.org/professionals/‚Ä¶, ",1273291503142486017,False,2,0,0,1,Twitter Web App,"https://t.co/OJSXauDHgn

We are excited to share a new released video, Understanding Your Clinical Trials Results. Produced in partnership with Incyte, CCF and Target Cancer Foundation, the video is an invaluable resource to help patients understand their clinical trial results.",,,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,
19052568,2020-06-17 08:54:14,"INCY, ",,,1273237518368948227,False,3,0,0,0,Twitter Web App,"$INCY
Incyte
Reiterated byWilliam Blair$95.53
+2.1%Buy",,,2009-01-15 22:19:58,,cybercash28,https://pbs.twimg.com/profile_images/1078129658384723969/DKaZn_lH_normal.jpg,43172,449,1113,63130,MadMraket,
3318510966,2020-06-17 08:10:54,,,"crweworld.com/article/news-p‚Ä¶, ",1273226614436802562,False,0,0,0,0,CRWE World,Incyte Investor Conference Update https://t.co/Tl9ohl4QsC,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
976297820532518914,2020-06-17 08:05:11,,,"dlvr.it/RYpdGv, pic.twitter.com/hqZBTyodVB, ",1273225172376367104,False,0,0,0,0,dlvr.it,Incyte Investor Conference Update https://t.co/1goEijm0Rn https://t.co/hqZBTyodVB,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2020-06-17 08:02:02,"INCY, ",,"s.flashalert.me/QN76o, ",1273224380299063296,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on June 17, 08:00:00: Incyte Investor Conference Update https://t.co/sM7V2Dl3l7",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
732361939490312192,2020-06-17 06:12:43,"INCY, ","markets, ","americanbankingnews.com/?p=14960295, ",1273196872010739712,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from William Blair https://t.co/tHTlhA9ZAB #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-17 06:12:41,"INCY, ","stocks, ","americanbankingnews.com/?p=14960295, ",1273196863827705861,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from William Blair https://t.co/fuueTKSUE5 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2266388972,2020-06-17 05:21:02,"INCY, ","stocks, ","dailypolitical.com/?p=4026487, ",1273183862638723073,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by William Blair https://t.co/O3JgUMqVCW #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-06-17 05:20:56,"INCY, ",,"dailypolitical.com/?p=4026487, ",1273183839762907137,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by William Blair https://t.co/3QAcPiFWCx,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
930803511918411776,2020-06-17 05:20:39,"INCY, ",,"thelincolnianonline.com/?p=4169383, ",1273183768078102528,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by William Blair https://t.co/p05bZSwBhM,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
849417718642159616,2020-06-17 05:20:19,"AGEN, ",,"zpr.io/HPzNP, ",1273183685265719299,False,0,0,0,0,Zapier.com,"Corp Incyte Sells 183,875 Shares of Agenus Inc $AGEN Stock https://t.co/E6mbLC7zQD",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
849417718642159616,2020-06-17 05:20:18,"AGEN, ",,"zpr.io/HPzaW, ",1273183680916316165,False,0,0,0,0,Zapier.com,"Corp Incyte Sells 384,025 Shares of Agenus Inc $AGEN Stock https://t.co/ObV3rqRHk8",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
461141340,2020-06-17 04:36:13,,"Letschangetheschoolcurriculum, ",,1273172584054632450,False,3,0,0,0,Twitter Web App,#Letschangetheschoolcurriculum Incyte is dedicated to changing the school curriculum so that it reflects cultural capital of all and not just a few.,,,2012-01-11 09:01:52,UK,Malcolm Greenhalgh,https://pbs.twimg.com/profile_images/1750104870/Malc_Incyte_Mobile_normal.JPG,52,81,0,69,MalcolmGreenha2,
778267752679235585,2020-06-17 04:20:17,,,"stockmarketdaily.co/2020/06/17/cov‚Ä¶, pic.twitter.com/5kYe6E8vkK, ",1273168576904658944,False,0,0,0,0,StockMarketDaily,Coverage Initiated by Benchmark Co. for Incyte (NASDAQ:INCY) - https://t.co/LD2NpUEANf https://t.co/5kYe6E8vkK,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
461141340,2020-06-17 04:11:24,,"Letschangetheschoolcurriculum, ",,1273166338580721665,False,1,0,0,0,Twitter Web App,#Letschangetheschoolcurriculum Incyte is dedicated to making the school curriculum relevant to all so that the younger generation can change society long term.,,,2012-01-11 09:01:52,UK,Malcolm Greenhalgh,https://pbs.twimg.com/profile_images/1750104870/Malc_Incyte_Mobile_normal.JPG,52,81,0,69,MalcolmGreenha2,
852931863547084801,2020-06-17 03:49:49,"INCY, ",,"zpr.io/HP7K2, ",1273160907632361474,False,0,0,0,0,Zapier.com,Incyte $INCY Receives New Coverage from Analysts at Oppenheimer https://t.co/F6jNReDflP,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
461141340,2020-06-17 02:41:48,,,"twitter.com/GeorgeThePoet/‚Ä¶, ",1273143790921043968,False,0,0,0,0,Twitter Web App,Incyte is dedicated to changing the curriculum in schools. Changing the curriculum is crucially important in getting a different message across to the young generation that can make change happen long term. https://t.co/C65sY8ly4u,,,2012-01-11 09:01:52,UK,Malcolm Greenhalgh,https://pbs.twimg.com/profile_images/1750104870/Malc_Incyte_Mobile_normal.JPG,52,81,0,69,MalcolmGreenha2,
402284409,2020-06-17 01:14:30,,,"goo.gl/fb/RcWQAn, ",1273121822666559488,False,0,0,0,0,Google,"Job Delaware:  Lead Biostatistical Programmer I, II or III - Incyte Corporation‚Ä¶ https://t.co/tAHLdXZyFM",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
2344420430,2020-06-16 18:49:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1273024903474806784,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/N6f2iE3mLy",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
374729426,2020-06-16 17:36:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1745268, pic.twitter.com/RTpVC9a4Xp, ",1273006645300178945,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator is remaining in oversold zone for 6 days. View odds for this and other indicators: https://t.co/gI6Qaar0UO #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/RTpVC9a4Xp,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2416188264,2020-06-16 13:11:08,"INCY, ","markets, ","thestockobserver.com/?p=3109428, ",1272939780863602689,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $99.89 Average Price Target from Analysts  https://t.co/1n9grEKfot #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2020-06-16 13:08:08,"INCY, ",,"zpr.io/HPtWB, ",1272939027981877249,False,0,0,0,0,Zapier.com,Analysts Set Incyte Co. $INCY Price Target at $99.89 https://t.co/x9LJ11P4LD,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
732361939490312192,2020-06-16 11:04:30,"INCY, ","markets, ","americanbankingnews.com/?p=14945574, ",1272907910864146435,False,0,0,0,0,Zapier.com,Incyte $INCY Coverage Initiated by Analysts at Benchmark https://t.co/cImO4zvIRM #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-16 11:04:29,"INCY, ","stocks, ","americanbankingnews.com/?p=14945574, ",1272907908548898816,False,0,0,0,0,Zapier.com,Incyte $INCY Coverage Initiated by Analysts at Benchmark https://t.co/I1zOlkikrF #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
849417718642159616,2020-06-16 09:29:06,"INCY, ",,"zpr.io/HP6MU, ",1272883906124165120,False,0,0,0,0,Zapier.com,Incyte $INCY Now Covered by Analysts at Benchmark https://t.co/rq44AQ3Oig,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2920258887,2020-06-16 09:27:21,"INCY, ",,"dakotafinancialnews.com/?p=2080074, ",1272883462194651136,False,0,0,0,0,Zapier.com,Incyte $INCY Now Covered by Analysts at Benchmark https://t.co/PjN1U9MK7q,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
732361939490312192,2020-06-16 06:54:35,"INCY, ","markets, ","americanbankingnews.com/?p=14941113, ",1272845020849192961,False,0,0,0,0,Zapier.com,Oppenheimer Initiates Coverage on Incyte $INCY https://t.co/EiCdz3z4wg #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-16 06:54:35,"INCY, ","stocks, ","americanbankingnews.com/?p=14941113, ",1272845018441691139,False,0,0,0,0,Zapier.com,Oppenheimer Initiates Coverage on Incyte $INCY https://t.co/iodd8GoGuy #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
930803511918411776,2020-06-16 05:50:28,"AGEN, ",,"thelincolnianonline.com/?p=4164084, ",1272828882404720640,False,0,0,0,0,Zapier.com,"Agenus Inc $AGEN Major Shareholder Corp Incyte Sells 183,875 Shares of Stock https://t.co/2ybUu4fhsE",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-06-16 05:49:40,"AGEN, ",,"tickerreport.com/?p=5772389, ",1272828680553848835,False,0,0,0,0,Zapier.com,"Agenus Inc $AGEN Major Shareholder Corp Incyte Sells 183,875 Shares of Stock https://t.co/7ucJA4scY9",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2266388972,2020-06-16 05:46:46,"AGEN, ","stocks, ","dailypolitical.com/?p=4021171, ",1272827950413631489,False,0,0,0,0,Zapier.com,"Corp Incyte Sells 183,875 Shares of Agenus Inc $AGEN Stock https://t.co/GrAoE8KXCW #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-06-16 05:46:45,"AGEN, ",,"dailypolitical.com/?p=4021171, ",1272827948605870080,False,0,0,0,0,Zapier.com,"Corp Incyte Sells 183,875 Shares of Agenus Inc $AGEN Stock https://t.co/YUSbP3P7zJ",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
930803511918411776,2020-06-16 05:20:51,"INCY, ",,"thelincolnianonline.com/?p=4163546, ",1272821428212183040,False,0,0,0,0,Zapier.com,Incyte $INCY Receives New Coverage from Analysts at Oppenheimer https://t.co/c77IoC1xM6,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2298709746,2020-06-16 05:20:50,"INCY, ",,"zpr.io/HUQ35, ",1272821426903552002,False,0,0,0,0,Zapier.com,Oppenheimer Initiates Coverage on Incyte $INCY https://t.co/OccU6GR7NG,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2920258887,2020-06-16 05:20:14,"INCY, ",,"dakotafinancialnews.com/?p=2077367, ",1272821275870793729,False,0,0,0,0,Zapier.com,Incyte $INCY Receives New Coverage from Analysts at Oppenheimer https://t.co/N4WsS6B99F,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
2266388972,2020-06-16 04:49:31,"AGEN, ","stocks, ","dailypolitical.com/?p=4019886, ",1272813544380211200,False,0,0,0,0,Zapier.com,"Agenus Inc $AGEN Major Shareholder Corp Incyte Sells 384,025 Shares of Stock https://t.co/sVw7hRhihE #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-06-16 04:49:30,"AGEN, ",,"dailypolitical.com/?p=4019886, ",1272813541628747776,False,0,0,0,0,Zapier.com,"Agenus Inc $AGEN Major Shareholder Corp Incyte Sells 384,025 Shares of Stock https://t.co/M4DEZ9Ua4D",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
930803511918411776,2020-06-16 04:45:22,"AGEN, ",,"thelincolnianonline.com/?p=4162794, ",1272812502351560706,False,0,0,0,0,Zapier.com,"Agenus Inc $AGEN Major Shareholder Corp Incyte Sells 384,025 Shares of Stock https://t.co/CuBYrsmu8F",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1134049078424162304,2020-06-15 21:54:31,"INCY, ",,"Incyte.com, newsfilter.io/articles/incyt‚Ä¶, ",1272709107682852864,False,0,0,0,0,Newsfilter.io,Incyte Launches New Global Responsibility Section on https://t.co/s2oNScVa9h $INCY https://t.co/0gEkIj6tGL,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2344420430,2020-06-15 21:11:25,"AGEN, ",,"insideri.com/1098972_000110‚Ä¶, ",1272698259581140994,False,0,0,0,0,Insider Alerts,"$AGEN:

New Insider Filing on AGENUS INC's

10%+ Owner

INCYTE CORP:

https://t.co/LIeLxOpGW4",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-06-15 20:55:22,"AGEN, ",,"chartexe.com/article/latest‚Ä¶, ",1272694219174563844,False,0,0,0,0,InsiderActionMonitor,$AGEN INCYTE CORP sells $1.4M Worth Of AGENUS INC Stock https://t.co/7YTOQBHVGu,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
4312114277,2020-06-15 20:50:48,"AGEN, ",,"fintel.io/n/us/agen/incy‚Ä¶, ",1272693069880705024,False,0,0,0,0,Fintel.io,"Insider Corp Incyte reports selling 577,000 shares of $AGEN for a total cost of $2,097,501.72 https://t.co/qKSoqCUma7",,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
1069693680066420736,2020-06-15 20:48:26,"INCY, ",,"s.flashalert.me/Mncdb, ",1272692474708996098,False,0,0,0,0,flashalerts,"$INCY [15s. delayed] filed SEC form 4: 10% Owner INCYTE CORP: 
Disposed 577,000 of Common Stock at average price $3.64 between 2020-06-11 and 2020-06-15, decreased holding by 3% to 17,186,968 shares  https://t.co/XrHmQEdy0p",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1069693680066420736,2020-06-15 20:48:25,"AGEN, ",,"s.flashalert.me/8Yc7a, ",1272692470594273280,False,0,0,0,0,flashalerts,"$AGEN [15s. delayed] filed SEC form 4: 10% Owner INCYTE CORP: 
Disposed 577,000 of Common Stock at average price $3.64 between 2020-06-11 and 2020-06-15, decreased holding by 3% to 17,186,968 shares  https://t.co/gWjYMYjMvY",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1262915121103491074,2020-06-15 20:48:07,"AGEN, ","FWSells, ","formwhispers.com/s?t=AGEN, ",1272692395683926017,False,0,0,0,0,formwhispers,"#FWSells $AGEN INCYTE CORP, 10%-owner of AGENUS INC sold 577000 shares on 2020-06-15. https://t.co/Z00QtFOEwS",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
374729426,2020-06-15 20:19:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1741299, pic.twitter.com/s6HpZP1Hcx, ",1272685200158322688,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator sits in oversold zone for 5 days. View odds for this and other indicators: https://t.co/Peq6LqmfDc #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/s6HpZP1Hcx,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
950010035396136962,2020-06-15 17:01:50,,"Incyte, ","zonebourse.com/INCYTE-CORPORA‚Ä¶, ",1272635448691736579,False,0,0,0,0,Cresus AI,"#Incyte closed at 93.51. Score +40, credit rating AAA https://t.co/XMro31aTzT",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
39928970,2020-06-15 13:01:30,,"Lilly, baricitinib, Incyte, Covid, ","pharmanewsdaily.com/lilly-covid-dr‚Ä¶, ",1272574967192961029,False,0,0,0,0,WordPress.com,Lilly Covid drug trial : US pharma giant launches phase 3 trial of baricitinib #Lilly #baricitinib #Incyte #Covid https://t.co/0idPp2efa1,,,2009-05-14 00:40:33,Hyderabad,OyeCricket.com,https://pbs.twimg.com/profile_images/590370768514486272/bZssEsY4_normal.png,1299,78,25,51757,cricket_fundas,
976297820532518914,2020-06-15 08:10:09,,,"Incyte.com, dlvr.it/RYg4Q2, pic.twitter.com/HjrdmBYejM, ",1272501648288448513,False,0,0,0,0,dlvr.it,Incyte Launches New Global Responsibility Section on https://t.co/T7wwuk7fo7 https://t.co/agbgJMpArR https://t.co/HjrdmBYejM,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2020-06-15 08:03:01,,,"Incyte.com, crweworld.com/article/news-p‚Ä¶, ",1272499850915926017,False,0,0,0,0,CRWE World,Incyte Launches New Global Responsibility Section on https://t.co/0SxoHoQrtj https://t.co/s4gu3tjv37,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1069693680066420736,2020-06-15 08:00:52,"INCY, ",,"Incyte.com, s.flashalert.me/I8ju9s, ",1272499312103211015,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on June 15, 08:00:00: Incyte Launches New Global Responsibility Section on https://t.co/XT8nvPYIDf https://t.co/WyGZaJ3HZy",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
4312114277,2020-06-15 07:43:47,"INCY, ",,"fintel.io/sf/us/incy?utm‚Ä¶, ",1272495011326840833,False,0,0,0,0,Fintel.io,$INCY / Incyte files S-8 registration statement (stock option plan) https://t.co/Oc4NyYycjO,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,164,418542,fintel_io,
1171873456276889600,2020-06-15 07:33:50,"INCY, ","INCY, S8, Incyte, ","docoh.com/filing/879169/‚Ä¶, ",1272492507033677824,False,0,0,0,0,Investor Feed,"$INCY  S-8  Incyte   (15 Jun, 7:32am)

üìÑ Registration of securities for employees

https://t.co/HkUXDeIcwt

#INCY #S8 #Incyte",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
4035355935,2020-06-15 03:40:24,,,,1272433763809550337,False,0,0,0,0,WPTS Playlist,Incyte - Numbers,,,2015-10-24 21:01:50,"Pittsburgh, PA",WPTS Playlist,https://pbs.twimg.com/profile_images/658129792408023041/8nflCFL-_normal.jpg,478,5,38,638221,WPTSPlaylist,
1134049078424162304,2020-06-14 14:46:04,"INCY, ",,"newsfilter.io/articles/eaton‚Ä¶, ",1272238897725165569,False,0,0,0,0,Newsfilter.io,"Eaton Vance Management Acquires 178,295 Shares of Incyte $INCY https://t.co/0BikiVcybF",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-06-14 12:46:03,"INCY, ",,"newsfilter.io/articles/geode‚Ä¶, ",1272208693875150848,False,0,0,0,0,Newsfilter.io,Geode Capital Management Increases Holdings in Incyte $INCY https://t.co/pRP4Fjy6gF,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-06-14 09:44:04,"INCY, ",,"newsfilter.io/articles/nomur‚Ä¶, ",1272162893975429120,False,0,0,0,0,Newsfilter.io,Nomura Asset Management Boosts Stock Position in Incyte $INCY https://t.co/yI0ARVya9y,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2525892205,2020-06-14 05:35:41,"INCY, ","investingnews, ","modernreaders.com/?p=3440745, ",1272100387466752001,False,0,0,0,0,Zapier.com,Victory Capital Management Inc. Lowers Holdings in Incyte Co. $INCY  https://t.co/C7PtE9Ar2y #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1134049078424162304,2020-06-13 10:20:59,"INCY, ",,"newsfilter.io/articles/fort-‚Ä¶, ",1271809796161916931,False,0,0,0,0,Newsfilter.io,Fort L.P. Takes Position in Incyte $INCY https://t.co/BBT9VL41vk,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2525892205,2020-06-13 08:43:52,"INCY, ","investingnews, ","modernreaders.com/?p=3437227, ",1271785359391838211,False,0,0,0,0,Zapier.com,Connor Clark &amp; Lunn Investment Management Ltd. Reduces Position in Incyte Co. $INCY  https://t.co/KcoAlrEZjF #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
966006214818697218,2020-06-13 06:56:09,"INCY, ",,"theenterpriseleader.com/?p=3305275, ",1271758251659493376,False,0,0,0,0,Zapier.com,BidaskClub Downgrades Incyte $INCY to Sell  https://t.co/jyHAFbL2mc,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2298709746,2020-06-13 06:55:08,"INCY, ",,"zpr.io/HUAAS, ",1271757992304803845,False,0,0,0,0,Zapier.com,BidaskClub Downgrades Incyte $INCY to Sell https://t.co/8Wg4se4fti,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2525892205,2020-06-13 05:14:17,"INCY, ","investingnews, ","modernreaders.com/?p=3434661, ",1271732614668390400,False,0,0,0,0,Zapier.com,Commonwealth Equity Services LLC Acquires 245 Shares of Incyte Co. $INCY  https://t.co/Mx2CAfhOrk #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2020-06-13 03:46:23,"INCY, ","markets, ","americanbankingnews.com/?p=14899402, ",1271710491379990530,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Brokerages https://t.co/wmhSEYvrM7 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-13 03:46:22,"INCY, ","stocks, ","americanbankingnews.com/?p=14899402, ",1271710489450622977,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Brokerages https://t.co/dOlNw16A4e #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2298709746,2020-06-13 03:45:57,"INCY, ",,"zpr.io/HUhaT, ",1271710383305261061,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Brokerages https://t.co/yveg4qh2IE,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1134049078424162304,2020-06-13 01:18:58,"INCY, ",,"newsfilter.io/articles/aviva‚Ä¶, ",1271673395797790720,False,0,0,0,0,Newsfilter.io,Aviva Grows Stock Holdings in Incyte $INCY https://t.co/j1VFCnigCx,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-06-12 23:07:58,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1271640428400558082,False,0,0,0,0,Newsfilter.io,"$100,734.10 of shares sold by Pasquale Maria E (EVP &amp; General Counsel), reported in a new form 4 filed with the SEC  $INCY https://t.co/85xH6827ES",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2344420430,2020-06-12 19:05:36,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1271579435171446784,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/X3oyyo0dUT",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-06-12 16:40:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1271542883380854785,False,0,0,0,0,InsiderActionMonitor,$INCY Maria Pasquale Dumps 3.6K Shares of Incyte https://t.co/lR3oRbAmMJ,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1262915121103491074,2020-06-12 16:11:54,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1271535719584956416,False,0,0,0,0,formwhispers,"#FWSells $INCY Pasquale Maria E, EVP &amp; General Counsel of INCYTE CORP sold 3615 shares on 2020-06-10. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
23059499,2020-06-12 14:45:08,"INCY, ","markets, trading, stocks, ","seekingalpha.com/article/435358‚Ä¶, ",1271513883899883525,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte (INCY) Presents At European Hematology Association Congress - Slideshow. https://t.co/vi6DQwfI8I #markets #trading #stocks,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
95165334,2020-06-12 13:07:28,,"Mediscience, ",,1271489305484169217,False,1,0,0,0,Twitter Web App,Congratulations to @MorphoSys on being shortlisted for the 2020 #Mediscience ‚ÄúCapital Market Transaction of the Year Award‚Äù. MorphoSys signed a $2 billion global collaboration and license agreement for its lead candidate with Incyte in January 2020.,"MorphoSys, ",,2009-12-07 03:53:59,Munich/Dusseldorf,MC Services AG,https://pbs.twimg.com/profile_images/510095774332383232/zJw8hAE1_normal.jpeg,459,1057,0,3699,MCServicesAG,
3911174913,2020-06-12 10:16:23,,"DLBCL, EHA25Virtual, ","pic.twitter.com/DYUGygMWUb, ",1271446253906341888,False,13,0,1,3,Twitter Web App,"We're proud to share data around an investigational treatment for patients with relapsed or refractory diffuse large B-cell lymphoma (r/r #DLBCL) during the virtual 25th @EHA_Hematology Annual Congress, which kicks off today. #EHA25Virtual https://t.co/DYUGygMWUb","EHA_Hematology, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
374729426,2020-06-12 08:50:17,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1736091, pic.twitter.com/XSrWOZrXOV, ",1271424584487591936,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator remains in oversold zone for 4 days. View odds for this and other indicators: https://t.co/NzebeTLq1c #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/XSrWOZrXOV,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1251500205117042688,2020-06-11 13:59:11,,,"intrinsicvalueindex.com, ",1271139933558697985,False,0,0,0,0,Twitter Web App,"New intrinsic values added for:

EXR - Extra Space Storage
INCY - Incyte Corp
LMT - Lockheed Martin
PSX - Phillips 66
ZBH - Zimmer Biomet Holdings
TJX - TJX Companies

For these values &amp; more visit:

https://t.co/SyKqQ4h4m6",,,2020-04-18 09:18:24,,Intrinsic Value Index,https://pbs.twimg.com/profile_images/1251500570629640192/V5_DjmTy_normal.jpg,7,6,0,74,IV_Index,
374729426,2020-06-11 10:57:18,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1730039, pic.twitter.com/AF7dZBMC93, ",1271094160892649477,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator is sitting in oversold zone for 3 days. View odds for this and other indicators: https://t.co/7s32cz5jBJ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/AF7dZBMC93,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2181281054,2020-06-10 18:49:43,"INCY, ","markets, ","wkrb13.com/?p=1886845, ",1270850659865243649,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Sell at BidaskClub https://t.co/twmVyK3CFC #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
2344420430,2020-06-10 18:21:31,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1270843563836932096,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/EEVWsmD02M",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-06-10 18:21:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1270843524880257034,False,0,0,0,0,InsiderActionMonitor,$INCY  Incyte https://t.co/zIGIbqjQuI,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1262915121103491074,2020-06-10 16:35:58,"INCY, ","FWSells, ","formwhispers.com/s?t=INCY, ",1270817000730722304,False,0,0,0,0,formwhispers,"#FWSells $INCY Dhanak Dashyant, EVP &amp; Chief Scientific Officer of INCYTE CORP sold 961 shares on 2020-06-08. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
3911174913,2020-06-10 13:49:44,,"oncology, EHA25, ","pic.twitter.com/trBmbTQPEI, ",1270775165874552838,False,1,0,0,0,Twitter Web App,We're pleased to be a part of the virtual 25th @EHA_Hematology Annual Congress to continue sharing #oncology data with the scientific community. #EHA25 https://t.co/trBmbTQPEI,"EHA_Hematology, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
1029128656650555393,2020-06-10 12:15:29,,"cancer, ","ow.ly/Gy6250A3hYZ, ",1270751450055028742,False,0,0,0,0,Hootsuite Inc.,"Lilly, Incyte-allied Chinese drugmaker Innovent bags Roche as partner in deal that could yield billions |@lillypad #cancer https://t.co/2n428XhKg4","LillyPad, ",,2018-08-13 18:12:46,,Pharm2Market,https://pbs.twimg.com/profile_images/1041479880368484353/xr9ZBpXF_normal.jpg,190,849,2,2538,pharm2market,
2656754371,2020-06-10 12:15:08,,"cancer, ","ow.ly/PZLh50A3hXy, ",1270751360619876352,False,0,0,0,0,Hootsuite Inc.,"Lilly, Incyte-allied Chinese drugmaker Innovent bags Roche as partner in deal that could yield billions |@lillypad #cancer https://t.co/y0LmihIVin","LillyPad, ",,2014-07-18 09:20:39,San Diego,Aspen Biosciences,https://pbs.twimg.com/profile_images/1006725217568186368/B34yK1F1_normal.jpg,316,725,33,6079,aspenbio,
374729426,2020-06-10 08:35:37,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1727801, pic.twitter.com/R0xBykq4Ma, ",1270696115583610881,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator stays in oversold zone for 2 days. View odds for this and other indicators: https://t.co/71ZTePXCRx #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/R0xBykq4Ma,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3460109487,2020-06-09 16:19:00,,"drugmaker, Roche, ","endpts.com/lilly-incyte-a‚Ä¶, ",1270450345144127490,False,0,0,0,0,Buffer,"Lilly, Incyte-allied Chinese #drugmaker Innovent bags #Roche as partner in deal that could yield billions https://t.co/CegwgnG3E4",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
1017610177141526528,2020-06-09 12:46:44,,,"bit.ly/2NaOZxi, ",1270396923762130957,False,0,0,0,0,AutoPostingFromHealthCare,"Lilly, Incyte-allied Chinese drugmaker Innovent bags Roche as partner in deal that could yield billions... https://t.co/sIo4TsgZQ5",,,2018-07-12 23:22:27,"New York, NY",HEALTHCARE REPORT,https://pbs.twimg.com/profile_images/1042889061478932480/WFoyrJtF_normal.jpg,67,34,0,12613,HCREPORT2022,
2416188264,2020-06-09 12:13:41,"INCY, ","markets, ","thestockobserver.com/?p=3078454, ",1270388609561083905,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded to ‚ÄúSell‚Äù at BidaskClub  https://t.co/elOzNHhD9H #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2020-06-09 12:13:38,"INCY, ",,"zpr.io/tQ8Ak, ",1270388594067353606,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub to Sell https://t.co/zyDPcssneg,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
374729426,2020-06-09 08:11:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1723436, pic.twitter.com/1b3PSyD0qd, ",1270327654059667457,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator sits in oversold zone for 1 day. View odds for this and other indicators: https://t.co/HL8RiCcVlR #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1b3PSyD0qd,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
133504478,2020-06-09 07:34:34,,"strategy, competitiveintelligence, marketing, pharma, healthcare, biotech, productmarketing, pharmaceutical, ","dlvr.it/RYH5tH, lqventures.com, pic.twitter.com/nb49agRto6, ",1270318367975464960,False,0,0,0,1,dlvr.it,"Lilly, Incyte-allied Chinese drugmaker Innovent bags Roche as partner in deal that could yield billions https://t.co/Df1P0QJFQM &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #productmarketing #pharmaceutical https://t.co/nb49agRto6",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
46297868,2020-06-09 06:35:04,,,"dlvr.it/RYGvbH, ",1270303393521664001,True,0,0,0,0,dlvr.it,"Lilly, Incyte-allied Chinese drugmaker Innovent bags Roche as partner in deal that could yield billions https://t.co/Hd0hkBhTbz",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
3460109487,2020-06-09 06:34:01,,,"endpts.com/lilly-incyte-a‚Ä¶, ",1270303127024041984,False,5,0,0,2,Buffer,"Lilly, Incyte-allied Chinese drugmaker Innovent bags Roche as partner in deal that could yield billions https://t.co/CegwgnG3E4",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
950010035396136962,2020-06-08 17:01:54,,"Incyte, ","zonebourse.com/INCYTE-CORPORA‚Ä¶, ",1270098750271303683,False,0,0,0,0,Cresus AI,"#Incyte closed at 94.58. Score +35, credit rating AAA https://t.co/XMro31aTzT",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
2181281054,2020-06-08 13:24:47,"INCY, ","markets, ","wkrb13.com/?p=1878063, ",1270044113031880712,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $124.00 at Argus https://t.co/S5pZq7P25Q #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1022006086872821762,2020-06-08 11:02:52,"INCY, INCY, ",,,1270008400672362497,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY is DOWN ‚¨á on Mon Jun 08
Currently at 93.26 USD for a -0.27% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
1140762699002871808,2020-06-08 09:34:11,"INCY, ",,"deustrader.com/optimus_mixus4‚Ä¶, ",1269986081383956482,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-06-08 09:34 EST. Bought/Opened:
$INCY at $91.51. 
Incyte Corporation - Common Stock
Win Chance: 65%. Avg Win: 4%. Avg Loss: 8.35%. Avg Hold: 7d.
Trade Id: 45322264303056444.
Stats: https://t.co/JZ1yafbugd",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
374729426,2020-06-08 08:27:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1719205, pic.twitter.com/eG9gCL74rK, ",1269969323252084736,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator entering oversold zone View odds for this and other indicators: https://t.co/XR5yMq8uxB #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/eG9gCL74rK,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
966006214818697218,2020-06-08 03:33:45,"INCY, ",,"theenterpriseleader.com/?p=3270085, ",1269895374816280577,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $593.10 Million  https://t.co/KOKJvXbIiK,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2298709746,2020-06-08 03:32:52,"INCY, ",,"zpr.io/tQz8G, ",1269895150882430976,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $593.10 Million https://t.co/gt1pQjXCX0,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
732361939490312192,2020-06-08 03:30:55,"INCY, ","markets, ","americanbankingnews.com/?p=14827894, ",1269894661004550146,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $593.10 Million https://t.co/ULwTmb1keN #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-08 03:30:54,"INCY, ","stocks, ","americanbankingnews.com/?p=14827894, ",1269894658387214336,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $593.10 Million https://t.co/yZQTlfNRcV #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1228725160376664064,2020-06-07 10:07:43,"INCY, ",,"pic.twitter.com/pyZ5N3AwJH, ",1269632129815764993,False,5,0,1,0,Twitter Web App,"$INCY Incyte is a biotech I am considering shorting this week. Down Friday on a huge market up day. Closed at $93.51 with 50 day mov ave at $93.46. It looks like it is breaking down and hitting 6 week lows below $93.22. This looks ripe to tank. No position yet, but watching. https://t.co/pyZ5N3AwJH",,,2020-02-15 11:58:14,USA,Jim Lewis üí∞‚öíüí∞,https://pbs.twimg.com/profile_images/1318559508868829185/7KN2ng2y_normal.jpg,18076,315,255,6827,Galactic_Trader,photo
374729426,2020-06-07 07:55:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1714472, pic.twitter.com/T7bYDVUrDL, ",1269598882255667201,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator reaching into oversold zone View odds for this and other indicators: https://t.co/PoBWZUxDDv #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/T7bYDVUrDL,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
575910168,2020-06-07 07:52:47,,"YahooFinance, Traffic, Transportation, Shipping, Logistics, Trucking, ","truckingnews.us/markets-yf-pre‚Ä¶, ",1269598176194867200,False,0,0,0,0,Trucking News,"MARKETS: YF Premium Investment Idea: Incyte Corporation (INCY) https://t.co/fs1conOiER
#YahooFinance #Traffic #Transportation #Shipping #Logistics
Follow @AFTvitaliy for #Trucking News","AFTvitaliy, ",,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
707270913448919041,2020-06-06 17:00:00,,"MPN, ",,1269373497345740800,False,0,0,0,1,Twitter for Advertisers.,Don‚Äôt skip Incyte‚Äôs #MPN Voices Out Loud! Stream the podcast crafted to support and educate people living with myeloproliferative neoplasms (MPNs) and their support team.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
732361939490312192,2020-06-06 12:56:28,"INCY, ","markets, ","americanbankingnews.com/?p=14811616, ",1269312212214185985,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Announce Earnings of $0.76 Per Share https://t.co/yR7tUduvmr #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-06-06 12:56:28,"INCY, ","stocks, ","americanbankingnews.com/?p=14811616, ",1269312210402258944,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Announce Earnings of $0.76 Per Share https://t.co/N1xteOhSzY #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
852931863547084801,2020-06-06 12:52:43,"INCY, ",,"zpr.io/tQnyG, ",1269311266373480450,False,0,0,0,0,Zapier.com,Zacks: Brokerages Anticipate Incyte Co. $INCY to Announce $0.76 EPS https://t.co/uT1LpYXqmY,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
1134049078424162304,2020-06-06 12:50:12,"INCY, ",,"newsfilter.io/articles/zacks‚Ä¶, ",1269310634317012993,False,0,0,0,0,Newsfilter.io,Zacks: Analysts Anticipate Incyte Will Announce Earnings of $0.76 Per Share $INCY https://t.co/bXv1qrEPS7,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2416188264,2020-06-06 12:48:30,"INCY, ","markets, ","thestockobserver.com/?p=3069011, ",1269310204329496576,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Announce Earnings of $0.76 Per Share  https://t.co/Vz987eAGfS #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1134049078424162304,2020-06-06 11:34:08,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1269291493111599105,False,0,0,0,0,Newsfilter.io,Incyte Shares Sold by AlphaCrest Capital Management $INCY https://t.co/n92k5B0RSz,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
374729426,2020-06-06 08:18:44,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1709753, pic.twitter.com/j7Tuxyusuj, ",1269242317904334850,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator entering oversold zone View odds for this and other indicators: https://t.co/Z8cAE3LKqz #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/j7Tuxyusuj,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-06-06 08:15:03,"INCY, ",,"zpr.io/tQUis, ",1269241391965757441,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $124.00 at Argus https://t.co/D49LTNWQDs,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
32131398,2020-06-05 14:41:50,,"Spring2020DHA, ","pic.twitter.com/2Tx2eLmb3Q, ",1268976339475763201,False,0,0,0,0,Twitter Web App,SILVER | Incyte and W2O Group | A Rare Reality: My MPN Story (Digital Health Media / Publications: Video) #Spring2020DHA https://t.co/2Tx2eLmb3Q,,,2009-04-16 16:00:05,"Libertyville, IL",DigitalHealthAwards,https://pbs.twimg.com/profile_images/1268220514637508608/BRlxnVKq_normal.jpg,2978,2556,126,9463,DHealthAwards,photo
707270913448919041,2020-06-05 13:14:30,,"MPN, ",,1268954361071382537,False,0,0,0,0,Twitter for Advertisers.,"Listen to Incyte‚Äôs #MPN Voices Out Loud, a podcast developed to support and educate the myeloproliferative neoplasm community.",,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-06-05 13:14:14,,"MPN, ",,1268954293899575298,False,0,0,0,0,Twitter for Advertisers.,"Listen to Incyte‚Äôs #MPN Voices Out Loud, a podcast developed to support and educate the myeloproliferative neoplasm community.",,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-06-05 13:13:41,,"MPN, ",,1268954157500727298,False,0,0,0,0,Twitter for Advertisers.,Start listening to the new #MPN Voices Out Loud podcast sponsored by Incyte Corporation on the Google Podcasts app NOW!,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-06-05 13:13:27,,"MPN, ",,1268954098327486465,False,0,0,0,0,Twitter for Advertisers.,Start listening to the new #MPN Voices Out Loud podcast sponsored by Incyte Corporation on the Google Podcasts app NOW!,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
3154096965,2020-06-05 11:30:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1268928080359424001,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 93.8200 down -5.0693% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
1140762699002871808,2020-06-05 10:03:14,"INCY, ",,"deustrader.com/optimus_mixus4‚Ä¶, ",1268906228685537280,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-06-05 10:03 EST. *Closed/Sold:
$INCY at $96.29 for 1.87 profit (1.98%). Incyte Corporation - Common Stock
Trade Id: 44977806403013134.
Stats: https://t.co/JZ1yafbugd",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
374729426,2020-06-05 08:25:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1704999, pic.twitter.com/QsUSci07aw, ",1268881739511820289,False,0,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average broke above 200-day Moving Average on May 4, 2020. View odds for this and other indicators: https://t.co/QQhb3Surki #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/QsUSci07aw",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
575910168,2020-06-05 08:22:56,,"YahooFinance, Traffic, Transportation, Shipping, Logistics, Trucking, ","truckingnews.us/hedge-funds-so‚Ä¶, ",1268880984977489921,False,0,0,0,0,Trucking News,"Hedge Funds Souring On Incyte Corporation (INCY) https://t.co/ubGhp3T8sK
#YahooFinance #Traffic #Transportation #Shipping #Logistics
Follow @AFTvitaliy for #Trucking News","AFTvitaliy, ",,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
1193779847727894529,2020-06-05 08:09:32,,,"pic.twitter.com/Rx0hvj3fJJ, ",1268877615177162752,False,0,0,0,0,dlvr.it,Hedge Funds Souring On Incyte Corporation (INCY) https://t.co/Rx0hvj3fJJ,,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,photo
60224553,2020-06-05 07:56:04,,,"dlvr.it/RY2fZM, pic.twitter.com/Zz3Jg4bkoj, ",1268874224241799168,False,0,0,0,0,dlvr.it,Hedge Funds Souring On Incyte Corporation (INCY) - Yahoo Finance https://t.co/nKZkFJrXLO https://t.co/Zz3Jg4bkoj,,,2009-07-25 23:46:54,"NYC, NY, USA",Peter Went,https://pbs.twimg.com/profile_images/1216976432825540608/1d7laUNR_normal.jpg,9226,81,306,124562,HedgeFundRisk,photo
3154096965,2020-06-05 06:00:04,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1268845032364052481,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 93.8200 down -5.0693% 16:00 https://t.co/Pa7hloe5u9  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
252546993,2020-06-05 04:32:00,,"Covid19, ","pharma.nridigital.com/pharma_jun20/r‚Ä¶, ",1268822869032624128,False,0,0,0,0,TweetDeck,"We find out how repurposed existing medicines could help to combat the escalating #Covid19 pandemic, with candidates from @Roche, @Novartis, @Incyte, @GileadSciences, @AstraZenecaUS and others.

https://t.co/YbUW6XPT2J","Roche, Novartis, Incyte, GileadSciences, AstraZenecaUS, ",,2011-02-15 07:21:36,,Pharma Tech Focus,https://pbs.twimg.com/profile_images/1263845495425896448/HWH1Fkn6_normal.jpg,4160,2099,95,5874,PharmaTechFocus,
1889492676,2020-06-05 04:15:18,"INCY, ","Incyte, InvestorConferences, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1268818667711557633,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConferences  $INCY https://t.co/59hgtvbfcg,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
182520985,2020-06-05 02:45:10,,,"finance.yahoo.com/news/hedge-fun‚Ä¶, ",1268795985389588481,False,0,0,0,0,Twitter for Android,Hedge Funds Souring On Incyte Corporation (INCY) https://t.co/nTRHvi4fUg via @YahooFinance,"YahooFinance, ",,2010-08-24 16:00:48,"New York, NY","VAIBHAV NARANG, MBA",https://pbs.twimg.com/profile_images/1440986980691562503/zpsLLw-T_normal.jpg,138,53,24,4914,vaiby03,
1199800417821048834,2020-06-04 22:40:34,,"Hedge_Funds, News, ","dlvr.it/RY1JZQ, bit.ly/2tNWL7k, pic.twitter.com/FxzoFbpTgy, ",1268734429830082562,False,0,0,0,0,dlvr.it,Hedge Funds Souring On Incyte Corporation (INCY) https://t.co/jg5nDeZEuk #Hedge_Funds #News https://t.co/D9hc6egqxq https://t.co/FxzoFbpTgy,,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,photo
3154096965,2020-06-04 22:00:05,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1268724239277973504,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 93.8200 down -5.0693% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
778267752679235585,2020-06-04 19:54:06,,,"stockmarketdaily.co/2020/06/05/inc‚Ä¶, pic.twitter.com/MhtPRxZyGy, ",1268692537151303687,False,0,0,0,0,StockMarketDaily,Incyte (NASDAQ:INCY) Target Raised by Argus to $124.00 - https://t.co/FLaHvXT1rr https://t.co/MhtPRxZyGy,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
1140762699002871808,2020-06-04 15:10:17,"INCY, ",,"deustrader.com/optimus_mixus4‚Ä¶, ",1268621109718446085,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-06-04 15:10 EST. Bought/Opened:
$INCY at $94.38. 
Incyte Corporation - Common Stock
Win Chance: 68%. Avg Win: 4%. Avg Loss: 6.52%. Avg Hold: 5d.
Trade Id: 44977806403013134.
Stats: https://t.co/JZ1yafbugd",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
2416188264,2020-06-04 11:30:54,"INCY, ","markets, ","thestockobserver.com/?p=3058724, ",1268565900581535744,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $124.00  https://t.co/PpQr5IWlAL #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2020-06-04 08:59:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1700297, pic.twitter.com/EMQPjpu3Rq, ",1268527898643673088,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on May 27, 2020. View odds for this and other indicators: https://t.co/wuiltsDT7a #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/EMQPjpu3Rq",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1267477446556897284,2020-06-04 07:55:05,,,,1268511588937601024,False,0,0,0,0,Twitter Web App,Incyte price target raised to $124 from $92 at Argus¬†07:54 INCY Argus analyst Jasper Hellweg raised the firm's price target on Incyte to $124 from $92 and keeps a Buy rating on the shares. The company has multiple products on the m,,,2020-06-01 11:25:52,,WallStBetsDotCom,https://pbs.twimg.com/profile_images/1270171714568237056/sx7E9nBZ_normal.jpg,281,6,5,26304,WallStBetsDotC1,
1268410241022132224,2020-06-04 04:47:31,,,,1268464386143850498,False,0,0,0,0,Twitter Web App,Incyte has begun 21 June Free Bitesize PD seminars for school leaders and teachers if you want details malcolmg@incyteinternational.com,,,2020-06-04 01:12:39,,Malcolm Greenhalgh,https://pbs.twimg.com/profile_images/1268410628890406913/B1lNMeZc_normal.jpg,0,1,0,2,MalcolmGreenh11,
3664556061,2020-06-04 00:00:11,,"FLASCONews, FLASCO, Oncology, ","incyte.com, ",1268392078628847619,False,2,0,0,1,Hootsuite Inc.,"The FLASCO leadership is pleased to acknowledge Incyte Corporation as a FLASCO Diamond Corporate Member for 2020.  Please welcome and THANK them for their support, when they call or e-mail you.
 
 https://t.co/Z8SJa1YLp8

#FLASCONews #FLASCO #Oncology",,,2015-09-15 10:10:46,Florida,FLASCO,https://pbs.twimg.com/profile_images/643789553975865344/l5WwzXik_normal.png,506,280,11,1013,FLASCO_ORG,
1134049078424162304,2020-06-03 22:02:59,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1268362584564137986,False,0,0,0,0,Newsfilter.io,Incyte to Present at Upcoming Investor Conferences $INCY https://t.co/cGKJ8rv4kO,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1001523981500014592,2020-06-03 18:16:05,,"jobs, hiring, Central, Alaska, USA, ","dlvr.it/RXx4JF, ",1268305481472204800,False,0,0,0,0,dlvr.it,"#jobs #hiring #Central #Alaska #USA Oncology Therapeutic Specialist, Minneapolis N, MN: Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical needs in oncology‚Ä¶ https://t.co/Ovy4x7j3Hs",,,2018-05-29 14:01:39,United States,Empleos.io,https://pbs.twimg.com/profile_images/1002198831470178305/0-DY_Jrn_normal.jpg,127,76,6,95846,EmpleosIO,
1100450877792370688,2020-06-03 12:13:57,"INCY, ",,"blueequity.io/r/124505/de-in‚Ä¶, ",1268214348230451200,False,0,0,0,0,Blue Equity,$INCY Incyte to Present at Upcoming Investor Conferences https://t.co/84cwHbZcRq,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
374729426,2020-06-03 09:45:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1695623, pic.twitter.com/dDL5TXgWN7, ",1268177063346724864,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on May 27, 2020. View odds for this and other indicators: https://t.co/yM72MBz6ia #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/dDL5TXgWN7",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
976297820532518914,2020-06-03 08:07:11,,,"dlvr.it/RXvClC, pic.twitter.com/H0FhUXOUpR, ",1268152246350475265,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conferences https://t.co/yjRF61q5Ur https://t.co/H0FhUXOUpR,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2020-06-03 08:03:08,"INCY, ",,"s.flashalert.me/CoxYhI, ",1268151229705838592,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on June 03, 08:00:00: Incyte to Present at Upcoming Investor Conferences https://t.co/25xtnHMEbA",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
3318510966,2020-06-03 08:02:36,,,"crweworld.com/article/news-p‚Ä¶, ",1268151094783303681,False,0,0,0,0,CRWE World,Incyte to Present at Upcoming Investor Conferences https://t.co/uBWF6ihQlV,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
2338882843,2020-06-03 03:07:08,"SPHRY, INCY, ",,"dailypolitical.com/?p=3950239, ",1268076737977606146,False,0,0,0,0,Zapier.com,STARPHARMA HOLD/S $SPHRY &amp; Incyte $INCY Critical Survey https://t.co/ERKk33rQ94,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
20147730,2020-06-02 15:35:05,,"EmergingPharmaLeader, EPL2020, pharma, clinicaltrials, lifesciences, ","pharmexec.com/pharm-execs-em‚Ä¶, pic.twitter.com/JdRuu1LES5, ",1267902577095643138,False,1,0,0,1,Hootsuite Inc.,"üî∂Patients at the Foreüî∂
Read the profile of #EmergingPharmaLeader Peter O‚ÄôNeill, Director and Senior Clinical Trial Head at  @Incyte, here
‚û°Ô∏è https://t.co/BSiNZszwA8

#EPL2020 #pharma #clinicaltrials #lifesciences https://t.co/JdRuu1LES5","Incyte, ",,2009-02-05 08:32:04,London & New Jersey,Pharm Exec Magazine,https://pbs.twimg.com/profile_images/1350166922160173056/C8Z7WdVb_normal.jpg,32833,638,760,23597,PharmExec,photo
1140762699002871808,2020-06-02 11:05:25,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1267834712803782656,False,1,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-06-02 11:05 EST. *Closed/Covered previously shorted:
$INCY at $99.58 for 2.09 profit (2.05%). Incyte Corporation - Common Stock
Trade Id: 44721007403003901.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
374729426,2020-06-02 08:23:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1690713, pic.twitter.com/GoPr1Bzv7V, ",1267793868667252741,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/CLz6ZrBGm8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GoPr1Bzv7V,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1140762699002871808,2020-06-01 16:02:14,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1267547021281394688,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-06-01 16:01 EST. *Closed/Covered previously shorted:
$INCY at $101.85 for 0.25 loss (-0.25%). Incyte Corporation - Common Stock
Trade Id: 44401402503026766.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
1140762699002871808,2020-06-01 10:35:27,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1267464782757519360,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-06-01 10:35 EST. Shorted/Opened:
$INCY at $101.96. 
Incyte Corporation - Common Stock
Win Chance: 64%. Avg Win: 8%. Avg Loss: 11.49%. Avg Hold: 5d.
Trade Id: 44721007403003901.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
1140762699002871808,2020-06-01 09:34:25,"INCY, ",,"deustrader.com/optimus_mixus4‚Ä¶, ",1267449426332618758,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-06-01 09:33 EST. Bought/Opened:
$INCY at $100.99. 
Incyte Corporation - Common Stock
Win Chance: 70%. Avg Win: 5%. Avg Loss: 10.34%. Avg Hold: 6d.
Trade Id: 44717534003017975.
Stats: https://t.co/JZ1yafbugd",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
374729426,2020-06-01 07:36:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1686095, pic.twitter.com/yWSXxbHMUo, ",1267419785916112896,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on May 27, 2020. View odds for this and other indicators: https://t.co/ivmJSayybl #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/yWSXxbHMUo",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2920258887,2020-06-01 01:51:25,"SPHRY, INCY, ",,"dakotafinancialnews.com/?p=2000640, ",1267332905325518848,False,0,0,0,0,Zapier.com,Head-To-Head Contrast: STARPHARMA HOLD/S $SPHRY &amp; Incyte $INCY https://t.co/iIdTwWkjVr,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
325678041,2020-05-31 13:12:34,,,"360dx.com/regulatory-new‚Ä¶, ",1267141935057317888,False,0,0,0,0,Twitter Web App,"Incyte's Pemazyre, Foundation Medicine CDx Get FDA Approval for FGFR2-Mutated Bile Duct Cancer https://t.co/4xwensjsIp",,,2011-06-28 13:54:43,,360Dx,https://pbs.twimg.com/profile_images/779386999325224960/0OtQrBR2_normal.jpg,1234,711,30,12885,360DxNews,
838389180484898816,2020-05-31 13:02:25,,"ASCO20, ","twitter.com/DrSGraff/statu‚Ä¶, ",1267139380642226177,False,0,0,0,0,Twitter for iPhone,"Challenging some of the amazing physician/scientist colleagues at pharma biotech to add their names to that scrolling list of donors! üôåüèªüíû #ASCO20 

@genentech @Novartis @LillyTrials @Incyte @USCelgProducts @Roche @AstraZeneca @Merck @abbvie @pfizer @FlatironNY @bmsnews https://t.co/yR1Isbekv3","genentech, Novartis, LillyTrials, Incyte, Roche, AstraZeneca, Merck, abbvie, pfizer, FlatironNY, bmsnews, ",,2017-03-05 09:02:11,"Barrington, RI","Stephanie Graff, MD, FACP",https://pbs.twimg.com/profile_images/1366904269690068997/jTdr8jZt_normal.jpg,11965,3458,142,10839,DrSGraff,
1022006086872821762,2020-05-31 08:00:59,"INCY, INCY, ",,,1267063523852587009,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was UP ‚¨Ü on Fri May 29
Closed at 101.91 USD for a 1.35% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
374729426,2020-05-31 07:18:33,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1681512, pic.twitter.com/nJtU3RSGXa, ",1267052842595921920,False,0,0,0,1,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on May 27, 2020. View odds for this and other indicators: https://t.co/lzg93wgocI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/nJtU3RSGXa",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
930803511918411776,2020-05-31 03:05:25,"SPHRY, INCY, ",,"thelincolnianonline.com/?p=4064226, ",1266989141570584576,False,0,0,0,0,Zapier.com,STARPHARMA HOLD/S $SPHRY &amp; Incyte $INCY Head-To-Head Review https://t.co/1uYMHtVaGu,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
374729426,2020-05-30 08:24:37,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1676999, pic.twitter.com/DZn3VXXbEf, ",1266707083891630080,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on May 27, 2020. View odds for this and other indicators: https://t.co/eHiFd83C9o #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/DZn3VXXbEf",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2920258887,2020-05-30 07:11:11,"INCY, ",,"dakotafinancialnews.com/?p=1991570, ",1266688604136452101,False,0,0,0,0,Zapier.com,Goldman Sachs Group Downgrades Incyte $INCY to Buy https://t.co/B37eKARfbh,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
930803511918411776,2020-05-30 03:26:16,"INCY, SPHRY, ",,"thelincolnianonline.com/?p=4058886, ",1266632000300920832,False,0,0,0,0,Zapier.com,Financial Analysis: Incyte $INCY &amp; STARPHARMA HOLD/S $SPHRY https://t.co/0ZMDUPdZjO,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
326315947,2020-05-29 17:55:56,"INCY, ",,"pic.twitter.com/mjDHgP9ik9, ",1266488471658663937,False,18,1,6,3,Wildmoka,Time for some insight into Incyte. @Optionsplay‚Äôs Tony Zhang updates his trade. $INCY https://t.co/mjDHgP9ik9,"OptionsPlay, ",,2011-06-29 14:32:15,NASDAQ MarketSite ,Options Action,https://pbs.twimg.com/profile_images/735428760258916352/oc3ItiMc_normal.jpg,99099,1014,1606,11108,OptionsAction,video
852931863547084801,2020-05-29 12:26:35,"INCY, ",,"zpr.io/tBC3b, ",1266405588516339714,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by Goldman Sachs Group https://t.co/xMArIcGimI,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
72928001,2020-05-29 10:44:11,"INCY, ",,"bit.ly/2XFqNpl, ",1266379819786231808,False,1,0,0,0,BriefingInPlayLimited,$INCY: Incyte announces data from Phase 2 OPTIC trial https://t.co/WONwaxLbc9,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
374729426,2020-05-29 10:14:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1672558, pic.twitter.com/P1fdbmwUWr, ",1266372258152411138,False,0,0,0,1,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on May 27, 2020. View odds for this and other indicators: https://t.co/e7Jvdv9hnB #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/P1fdbmwUWr",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
20147730,2020-05-29 08:35:05,,"EmergingPharmaLeader, EPL2020, pharma, clinicaltrials, lifesciences, ","pharmexec.com/pharm-execs-em‚Ä¶, pic.twitter.com/t0tBB1NXmq, ",1266347330627829767,False,0,0,0,1,Hootsuite Inc.,"üî∂Patients at the Foreüî∂
Read the profile of #EmergingPharmaLeader Peter O‚ÄôNeill, Director and Senior Clinical Trial Head at  @Incyte, here
‚û°Ô∏è https://t.co/BSiNZszwA8

#EPL2020 #pharma #clinicaltrials #lifesciences https://t.co/t0tBB1NXmq","Incyte, ",,2009-02-05 08:32:04,London & New Jersey,Pharm Exec Magazine,https://pbs.twimg.com/profile_images/1350166922160173056/C8Z7WdVb_normal.jpg,32833,638,760,23597,PharmExec,photo
2525892205,2020-05-29 07:03:29,"INCY, ","investingnews, ","modernreaders.com/?p=3345581, ",1266324277139320833,False,0,0,0,0,Zapier.com,Oppenheimer &amp; Co. Inc. Takes Position in Incyte Co. $INCY  https://t.co/N9GgzVTafJ #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2266388972,2020-05-29 04:01:32,"SPHRY, INCY, ","stocks, ","dailypolitical.com/?p=3925098, ",1266278489067413504,False,0,0,0,0,Zapier.com,Financial Contrast: STARPHARMA HOLD/S $SPHRY vs. Incyte $INCY https://t.co/DyN28fWe4G #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-05-29 04:01:31,"SPHRY, INCY, ",,"dailypolitical.com/?p=3925098, ",1266278485456113664,False,0,0,0,0,Zapier.com,Financial Contrast: STARPHARMA HOLD/S $SPHRY vs. Incyte $INCY https://t.co/f46xJHdGDZ,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2920258887,2020-05-29 04:00:03,"SPHRY, INCY, ",,"dakotafinancialnews.com/?p=1985771, ",1266278114553819136,False,0,0,0,0,Zapier.com,Financial Contrast: STARPHARMA HOLD/S $SPHRY vs. Incyte $INCY https://t.co/ngiYEXQoH5,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
1134049078424162304,2020-05-29 02:57:48,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1266262448853532679,False,0,0,0,0,Newsfilter.io,"$205.10 of shares acquired by Baker Bros. Advisors Lp (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/Pi4ctd9RkU",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2344420430,2020-05-29 01:10:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1266235411593965569,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

WENDY L DIXON:

https://t.co/Sxq2aISRUn",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-05-29 00:46:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1266229373021143040,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

PAUL J CLANCY:

https://t.co/CxzZmEa0gb",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-05-29 00:40:24,"INCY, ",,"insideri.com/879169_0001638‚Ä¶, ",1266227872064307201,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

10%+ Owner

BAKER BROS. ADVISORS LP:

https://t.co/u5o7i279rM",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-05-28 21:08:22,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1266174511176704000,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

KATHERINE A HIGH:

https://t.co/ipCp6qWJim",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1262915121103491074,2020-05-28 20:09:04,"INCY, ","FWBuys, ","formwhispers.com/s?t=INCY, ",1266159588606271488,False,0,0,0,0,formwhispers,"#FWBuys $INCY BAKER BROS. ADVISORS LP, 10%-owner,Director of INCYTE CORP bought 2 shares on 2020-05-28. https://t.co/JfyHtv1227",,,2020-05-19 21:16:52,NYC,FormWhispers,https://pbs.twimg.com/profile_images/1262916709889052674/RFMmgJhJ_normal.jpg,757,0,16,69392,formwhisperscom,
2344420430,2020-05-28 18:58:24,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1266141803264315395,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

EDMUND HARRIGAN:

https://t.co/yTk5aDo8gM",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1140762699002871808,2020-05-28 17:43:58,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1266123071733166080,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-05-28 14:40 EST. Shorted/Opened:
$INCY at $101.89. 
Incyte Corporation - Common Stock
Win Chance: 57%. Avg Win: 8%. Avg Loss: 5.96%. Avg Hold: 2d.
Trade Id: 44401402503026766.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
2344420430,2020-05-28 17:20:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1266117147350183936,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JACQUALYN A FOUSE:

https://t.co/ib3X42TLKi",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-05-28 17:04:25,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1266113120357027859,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

PAUL A FRIEDMAN:

https://t.co/ODM7XJyR9V",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-05-28 16:39:23,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1266106819715297280,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JEAN JACQUES BIENAIME:

https://t.co/WJEz9O7cik",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1248601569173450754,2020-05-28 13:29:01,"INCY, ",,"pic.twitter.com/zIfioWJ0Dk, ",1266058911032807424,False,0,0,0,0,Twitter Web App,"$INCY I really like the look of this biotech stock. Incyte has been trading sideways for a month, but is now breaking higher. I went long this stock today. https://t.co/zIfioWJ0Dk",,,2020-04-10 09:21:25,"Honolulu, HI",Daniel Nunes ü§ô,https://pbs.twimg.com/profile_images/1339681720841293824/ENmZ7NiY_normal.jpg,8,18,0,94,DayTrader808,photo
1578929666,2020-05-28 08:08:40,,,,1265978293901316099,False,2,0,1,0,Hootsuite Inc.,"The ruxolitinib for COVID protocol has an exclusion for ""co-ventilating"" patients.  

Whoever @Incyte that thought of that was really preparing for worst.","Incyte, ",,2013-07-08 19:49:14,Boston MA,J Mark Sloan,https://pbs.twimg.com/profile_images/1404880639078305800/izQhq55Y_normal.jpg,2133,2623,27,1225,Jmarksloan,
374729426,2020-05-28 07:56:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1667809, pic.twitter.com/EujJJw9iFG, ",1265975352259604480,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on May 27, 2020. View odds for this and other indicators: https://t.co/v2M8kQxZXN #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/EujJJw9iFG",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1979190776,2020-05-28 04:32:18,"INCY, ",,"tickerreport.com/?p=5655825, ",1265923841232175104,False,0,0,0,0,Zapier.com,Investors Buy High Volume of Incyte Call Options $INCY https://t.co/DcXYjAlb2s,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
849417718642159616,2020-05-28 03:59:25,"INCY, ",,"zpr.io/tBX92, ",1265915567506108416,False,0,0,0,0,Zapier.com,Investors Buy High Volume of Incyte Call Options $INCY https://t.co/6fmTnezR5D,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
966006214818697218,2020-05-28 03:55:07,"INCY, ",,"theenterpriseleader.com/?p=3203512, ",1265914486604603392,False,0,0,0,0,Zapier.com,Investors Buy High Volume of Incyte Call Options $INCY  https://t.co/IxLWmviJPm,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1134049078424162304,2020-05-28 03:10:43,"INCY, ",,"newsfilter.io/articles/goldm‚Ä¶, ",1265903313238835202,False,0,0,0,0,Newsfilter.io,Goldman Sachs Group Downgrades Incyte to Buy $INCY https://t.co/9cBxJu9vBq,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2266388972,2020-05-28 03:04:13,"INCY, ","stocks, ","dailypolitical.com/?p=3919919, ",1265901674373287936,False,0,0,0,0,Zapier.com,Goldman Sachs Group Downgrades Incyte $INCY to Buy https://t.co/luqpFb9JMX #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-05-28 03:04:12,"INCY, ",,"dailypolitical.com/?p=3919919, ",1265901672116740096,False,0,0,0,0,Zapier.com,Goldman Sachs Group Downgrades Incyte $INCY to Buy https://t.co/If1RQ1o80h,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2416188264,2020-05-28 03:01:52,"INCY, ","markets, ","thestockobserver.com/?p=3028909, ",1265901084310220800,False,0,0,0,0,Zapier.com,Goldman Sachs Group Downgrades Incyte $INCY to Buy  https://t.co/zNBxWRd3ke #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2920258887,2020-05-28 03:01:32,"INCY, ",,"dakotafinancialnews.com/?p=1980459, ",1265901002286301185,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by Goldman Sachs Group https://t.co/epq6OaAAht,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
2181281054,2020-05-27 18:15:51,"INCY, SPHRY, ","markets, ","wkrb13.com/?p=1844724, ",1265768709123170304,False,0,0,0,0,Zapier.com,Head to Head Survey: Incyte $INCY &amp; STARPHARMA HOLD/S $SPHRY https://t.co/Pr7uvfAWD6 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
3911174913,2020-05-27 18:05:09,,"ASCO20, ","pic.twitter.com/DtvCuwruH1, ",1265766016308654082,False,53,0,0,4,Twitter Web App,"While we won't be connecting live this year, we look forward to sharing data from our oncology portfolio with the scientific community virtually at #ASCO20. https://t.co/DtvCuwruH1",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
1171873456276889600,2020-05-27 16:09:51,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1265736999421575168,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (27 May, 4:07pm)

üì∞ Departure of Directors or Certain Officers; Election of Directors

https://t.co/un5Bn5UyX5

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
374729426,2020-05-27 07:45:21,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1663143, pic.twitter.com/DU9l9F02mp, ",1265610037189210112,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on May 26, 2020. View odds for this and other indicators: https://t.co/zMkki1EN3j #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/DU9l9F02mp",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2266388972,2020-05-27 07:28:57,"INCY, ","stocks, ","dailypolitical.com/?p=3915816, ",1265605908375240705,False,0,0,0,0,Zapier.com,Incyte Sees Unusually High Options Volume $INCY https://t.co/JyJpqNdDkP #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-05-27 07:28:53,"INCY, ",,"dailypolitical.com/?p=3915816, ",1265605893158207491,False,0,0,0,0,Zapier.com,Incyte Sees Unusually High Options Volume $INCY https://t.co/HhQAGHLpPL,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
732361939490312192,2020-05-27 07:28:43,"INCY, ","markets, ","americanbankingnews.com/?p=14681118, ",1265605852477689856,False,0,0,0,0,Zapier.com,Incyte Sees Unusually High Options Volume $INCY https://t.co/s2uU6OXONV #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-27 07:28:41,"INCY, ","stocks, ","americanbankingnews.com/?p=14681118, ",1265605844835713024,False,0,0,0,0,Zapier.com,Incyte Sees Unusually High Options Volume $INCY https://t.co/trH6XqByoZ #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2920258887,2020-05-27 07:28:01,"INCY, ",,"dakotafinancialnews.com/?p=1976686, ",1265605673586429952,False,0,0,0,0,Zapier.com,Incyte Sees Unusually High Options Volume $INCY https://t.co/lkwN6Ih507,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
930803511918411776,2020-05-27 07:27:37,"INCY, ",,"thelincolnianonline.com/?p=4044191, ",1265605572830904323,False,0,0,0,0,Zapier.com,Incyte Sees Unusually High Options Volume $INCY https://t.co/uWyEyMDFlX,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
849417718642159616,2020-05-27 05:45:31,"INCY, ",,"zpr.io/tB79W, ",1265579880491765760,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Buy at Goldman Sachs Group https://t.co/lNNwDrotLh,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
966006214818697218,2020-05-27 05:08:08,"INCY, ",,"theenterpriseleader.com/?p=3198973, ",1265570474584616960,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by Goldman Sachs Group to ‚ÄúBuy‚Äù  https://t.co/PWsHbFI5aQ,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
778267752679235585,2020-05-26 17:25:07,,,"stockmarketdaily.co/2020/05/26/inc‚Ä¶, pic.twitter.com/OTktLLc0DT, ",1265393550902079491,False,0,0,0,0,StockMarketDaily,Incyte (NASDAQ:INCY) Downgraded by Goldman Sachs Group Inc to Buy - https://t.co/LoDyswbKNE https://t.co/OTktLLc0DT,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
963495628545327104,2020-05-26 10:55:36,"SGEN, INCY, SGEN, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1265295528704856064,False,0,0,0,0,STCK.PR0,$SGEN $INCY NEW ARTICLE : Seattle Genetics added to Goldman's Conviction List; Incyte pulled https://t.co/IBAyiIxZLm Get all the latest $SGEN related news here : https://t.co/Vu7WhO0hLk,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
31372539,2020-05-26 10:42:32,,,"dlvr.it/RXNTqQ, ",1265292240185745410,False,0,0,0,0,dlvr.it,Seattle Genetics added to Goldman's Conviction List; Incyte pulled https://t.co/mukFWnG10i,,,2009-04-15 05:08:17,Amsterdam,Stocks tweets,https://pbs.twimg.com/profile_images/138834360/stocks1-avatar_normal.jpg,4407,3020,91,70157,stocks_tweets,
1134049078424162304,2020-05-26 10:39:23,"SGEN, ",,"newsfilter.io/articles/seatt‚Ä¶, ",1265291445424074758,False,0,0,0,0,Newsfilter.io,Seattle Genetics added to Goldman's Conviction List; Incyte pulled $SGEN https://t.co/g8S1fbJ7Az,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
15296897,2020-05-26 10:35:32,"SGEN, INCY, ",,"seekingalpha.com/news/3577541-s‚Ä¶, ",1265290477995061248,False,1,0,0,1,SANewsTwitter,$SGEN $INCY - Seattle Genetics added to Goldman's Conviction List; Incyte pulled https://t.co/cJaQIA1Yqh,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
732361939490312192,2020-05-26 09:26:11,"INCY, ","markets, ","americanbankingnews.com/?p=14670141, ",1265273023260655617,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Buy at Goldman Sachs Group https://t.co/i9vCzpEfYX #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-26 09:26:10,"INCY, ","stocks, ","americanbankingnews.com/?p=14670141, ",1265273020995768321,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Buy at Goldman Sachs Group https://t.co/1fBqPvtqaU #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2525892205,2020-05-26 08:11:04,"INCY, ","investingnews, ","modernreaders.com/?p=3325345, ",1265254121227067393,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to ‚ÄúBuy‚Äù at Goldman Sachs Group  https://t.co/HBGdYfFB9r #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
930803511918411776,2020-05-26 08:09:20,"INCY, ",,"thelincolnianonline.com/?p=4039766, ",1265253683761164291,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to ‚ÄúBuy‚Äù at Goldman Sachs Group https://t.co/UMxsNMZ2S9,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
374729426,2020-05-26 07:15:10,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1658522, pic.twitter.com/fuRMq99MXB, ",1265240054764429314,False,0,0,0,1,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on May 20, 2020. View odds for this and other indicators: https://t.co/fzUTSyzX9Z #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/fuRMq99MXB",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-05-25 23:59:19,"INCY, ",,"newsfilter.io/articles/teza-‚Ä¶, ",1265130369499742208,False,0,0,0,0,Newsfilter.io,Teza Capital Management Decreases Stock Holdings in Incyte $INCY https://t.co/Jr1oEma7TN,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
55642575,2020-05-25 14:15:05,,"atopicdermatitis, ","buff.ly/2vFn8gL, pic.twitter.com/zkf6vgUDp7, ",1264983341209726982,False,4,1,0,0,Buffer,Eli Lilly and Incyte announces positive results of two phase 3 clinical trials investigating the use of JAK inhibitor baricitinib as both a monotherapy and combination therapy for moderate-to-severe #atopicdermatitis. https://t.co/OZFU4zXjeY https://t.co/zkf6vgUDp7,,,2009-07-10 15:27:01,"North Olmsted, Ohio",Dermatology Times,https://pbs.twimg.com/profile_images/1402733466987470848/i_Bjwcxa_normal.jpg,26818,622,341,15262,DermTimesNow,photo
1238003406536609793,2020-05-25 11:20:24,,,"eyewire.news/?p=11548, ",1264939379992207361,False,0,0,0,0,Twitter Web Client,"NIAID Launches ACTT 2 Trial Testing Gilead‚Äôs Remdesivir Plus Eli Lilly, Incyte‚Äôs JAK Inhibitor Olumiant in COVID-19 on @EyeWireNews https://t.co/dWI1JuEJc2",,,2020-03-12 03:26:34,Istanbul,Ertugrul,https://pbs.twimg.com/profile_images/1238005372461383682/4M1VwCif_normal.jpg,52,648,0,312,ecz_ecelebi,
2525892205,2020-05-25 08:42:56,"INCY, ","investingnews, ","modernreaders.com/?p=3320809, ",1264899751788642304,False,0,0,0,0,Zapier.com,AGF Investments LLC Increases Stock Position in Incyte Co. $INCY  https://t.co/j0v7sl5Ven #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
374729426,2020-05-25 07:52:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1654034, pic.twitter.com/pEObHSQFUo, ",1264887166498254854,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on May 20, 2020. View odds for this and other indicators: https://t.co/FgrSN2NQWz #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/pEObHSQFUo",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1184381512713682944,2020-05-25 05:12:23,,,"ift.tt/2TEBjfk, ",1264846766232539136,False,0,0,0,0,IFTTT,Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for Tafasitamab https://t.co/wSn7mI8wdq,,,2019-10-16 04:12:51,,Pressemeldinger fra Mynewsdesk Norge,https://pbs.twimg.com/profile_images/1184440129324273664/zPX0n_a6_normal.png,78,1,0,10247,Pressemeldingar,
2181281054,2020-05-24 20:20:03,"INCY, SPHRY, ","markets, ","wkrb13.com/?p=1835196, ",1264712800770969603,False,0,0,0,0,Zapier.com,Incyte $INCY versus STARPHARMA HOLD/S $SPHRY Head-To-Head Survey https://t.co/4Ic0R3TGZY #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
374729426,2020-05-24 06:50:34,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1649332, pic.twitter.com/1qwjnd3YIs, ",1264509085644468224,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on May 20, 2020. View odds for this and other indicators: https://t.co/K46FL6TEpS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1qwjnd3YIs",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1264298144688246784,2020-05-23 17:23:10,,,,1264305898777796608,False,0,0,0,0,Twitter Web App,"Regeneron plans to begin testing a COVID-19 cocktail therapy in June that could potentially be given before exposure to coronavirus and to treat patients who have already been infected. Alexion's Ultomiris, Incyte's Jakafi, and Roche's Actemra are all being evaluated.",,,2020-05-23 16:52:31,,BelowSeaLevel,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,107,568,0,16208,below_level,
2416188264,2020-05-23 12:52:58,"INCY, ","markets, ","thestockobserver.com/?p=3014858, ",1264237901061259264,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $100.00 at Cantor Fitzgerald  https://t.co/TDvoWvAFJy #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1134049078424162304,2020-05-23 12:50:14,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1264237214113939456,False,0,0,0,0,Newsfilter.io,Incyte Price Target Raised to $100.00 at Cantor Fitzgerald $INCY https://t.co/edDjpL5x8Z,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1188416386172903424,2020-05-23 09:28:45,,"company, fx, realestate, forex, cfd, bitcoin, ","instagram.com/p/CAiDUx5jpMw/‚Ä¶, ",1264186507201560579,False,0,0,0,0,Instagram,"Incyte Corporation is a biopharmaceutical company. The Company discovers, develops, and commercializes proprietary small molecule drugs, primarily used in oncology.  #company #fx #realestate #forex #cfd #bitcoin‚Ä¶ https://t.co/IDW7z6Ygsw",,,2019-10-27 07:25:34,,FED Holding Group,https://pbs.twimg.com/profile_images/1281694942109278209/2pULSiQg_normal.jpg,9,0,0,236,fedholdinggroup,
2525892205,2020-05-23 08:21:35,"INCY, ","investingnews, ","modernreaders.com/?p=3311377, ",1264169603187564546,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Shares Bought by Swiss National Bank  https://t.co/L7QIDmIXOO #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
374729426,2020-05-23 07:15:33,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1644738, pic.twitter.com/LXYd36sTTl, ",1264152984914497537,False,0,0,0,1,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on May 20, 2020. View odds for this and other indicators: https://t.co/Kw0bFMt1Pc #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/LXYd36sTTl",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
930803511918411776,2020-05-23 01:58:42,"INCY, ",,"thelincolnianonline.com/?p=4022798, ",1264073247135596544,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Earn Q2 2020 Earnings of $0.60 Per Share https://t.co/58R7ozOu3i,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1022006086872821762,2020-05-22 20:02:06,"INCY, INCY, ",,,1263983505425522688,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was UP ‚¨Ü on Fri May 22
Closed at 99.37 USD for a 0.70% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
326315947,2020-05-22 17:45:22,"INCY, ",,"pic.twitter.com/ChC2cYzqKA, ",1263949096643166209,False,20,1,4,2,TweetDeck,"The insight on Tony Zhang's Incyte trade, below. $INCY @OptionsPlay https://t.co/ChC2cYzqKA","OptionsPlay, ",,2011-06-29 14:32:15,NASDAQ MarketSite ,Options Action,https://pbs.twimg.com/profile_images/735428760258916352/oc3ItiMc_normal.jpg,99099,1014,1606,11108,OptionsAction,photo
374729426,2020-05-22 09:19:17,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1640327, pic.twitter.com/ZXSkkVyAR8, ",1263821735679295488,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/P0CPSfHt4U #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZXSkkVyAR8,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1171873456276889600,2020-05-22 06:25:50,"MOR, ","MOR, 6K, Morphosys, News, ","docoh.com/filing/1340243‚Ä¶, ",1263778085511593984,False,0,0,0,0,Investor Feed,"$MOR  6-K  Morphosys   (22 May, 6:24am)

üì∞ MorphoSys and Incyte Announce the Validation of the European Marketing Authorization Application for Tafasitamab

https://t.co/bwRC8sIrKA

#MOR #6K #Morphosys #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1889492676,2020-05-22 05:52:40,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1263769739693715456,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/SNyhNw9Jj1,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2020-05-22 05:41:39,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1263766968504467459,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/4BOCk5JOzm,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1979190776,2020-05-22 01:40:28,"INCY, ",,"tickerreport.com/?p=5618164, ",1263706271489949697,False,0,0,0,0,Zapier.com,Research Analysts Offer Predictions for Incyte Co.‚Äôs Q2 2020 Earnings $INCY https://t.co/e5U1H9rYms,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2298709746,2020-05-22 01:35:48,"INCY, ",,"zpr.io/tVXdy, ",1263705099618131969,False,0,0,0,0,Zapier.com,Q2 2020 EPS Estimates for Incyte Co. $INCY Increased by Analyst https://t.co/1OKRjWNiB8,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2266388972,2020-05-22 01:35:26,"INCY, ","stocks, ","dailypolitical.com/?p=3884782, ",1263705006689091595,False,0,0,0,0,Zapier.com,Research Analysts Offer Predictions for Incyte Co.‚Äôs Q2 2020 Earnings $INCY https://t.co/1OaaY06gNt #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-05-22 01:35:26,"INCY, ",,"dailypolitical.com/?p=3884782, ",1263705004134850560,False,0,0,0,0,Zapier.com,Research Analysts Offer Predictions for Incyte Co.‚Äôs Q2 2020 Earnings $INCY https://t.co/bdPaiCTkWx,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1134049078424162304,2020-05-22 00:17:50,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1263685475195379712,False,0,0,0,0,Newsfilter.io,Incyte to Present at Upcoming Investor Conference $INCY https://t.co/UTWunuVDjX,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
227778014,2020-05-21 22:00:05,"KDMN, SRNE, NVS, INCY, MOR, ZNTL, ",,"buff.ly/2A4feQ7, ",1263650810547798016,False,2,0,0,1,Buffer,"Get up-to-date with Thursday‚Äôs latest quick takes: With EC approval of Zolgensma for SMA, immediate access in France; plus Kadmon, Sorrento, Novartis, Incyte, MorphoSys and Zentalis $KDMN $SRNE $NVS $INCY $MOR $ZNTL https://t.co/4zrFKA7ktK",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13038,1543,387,33073,BioCentury,
1121062360100241408,2020-05-21 13:49:22,"AGEN, ",,,1263527316124295171,False,0,0,2,0,Twitter for iPhone,"$AGEN @Agenus_Bio is dead money because of its useless CEO, CFO and CCO. No data. No partnerships. No return to investors. What shall be thinking @Incyte and @GileadSciences after buying @$6 and now Garo is selling shares @$2.70 to his friends in Boston?","Agenus_Bio, Incyte, GileadSciences, ",,2019-04-24 10:44:29,"Madrid, Spain",BioRich,https://pbs.twimg.com/profile_images/1141565800995840000/2xs6MsiF_normal.jpg,25,20,1,564,BioRich3,
1128239740329705472,2020-05-21 13:24:49,"INCY, MOR, ",,"businesswire.com/news/home/2020‚Ä¶, ",1263521141206941698,False,0,0,0,1,Twitter for Android,"""We are pleased to have achieved this important milestone, which moves tafasitamab in combination with lenalidomide into the formal regulatory review process in the European Union.""

$INCY $MOR
https://t.co/3tknKWvzd4",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
1100450877792370688,2020-05-21 11:19:12,"INCY, ",,"blueequity.io/r/120880/de-in‚Ä¶, ",1263489529018634242,False,0,0,0,0,Blue Equity,$INCY Incyte to Present at Upcoming Investor Conference https://t.co/xNpg3FtIzQ,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
3154096965,2020-05-21 10:15:05,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1263473390347857923,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 98.3800 up 3.6452% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
966006214818697218,2020-05-21 09:13:08,"INCY, ",,"theenterpriseleader.com/?p=3166313, ",1263457799952089088,False,0,0,0,0,Zapier.com,Incyte Co. Forecasted to Earn Q2 2020 Earnings of $0.60 Per Share $INCY  https://t.co/NhvaRUh9F3,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
849417718642159616,2020-05-21 09:12:03,"INCY, ",,"zpr.io/tVZwG, ",1263457530895884298,False,0,0,0,0,Zapier.com,Incyte Co. Forecasted to Earn Q2 2020 Earnings of $0.60 Per Share $INCY https://t.co/8kcwtZrypz,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
732361939490312192,2020-05-21 09:09:36,"INCY, ","markets, ","americanbankingnews.com/?p=14609396, ",1263456913322381313,False,0,0,0,0,Zapier.com,Incyte Co. Forecasted to Earn Q2 2020 Earnings of $0.60 Per Share $INCY https://t.co/znKfqna6Gj #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-21 09:09:36,"INCY, ","stocks, ","americanbankingnews.com/?p=14609396, ",1263456910843482115,False,0,0,0,0,Zapier.com,Incyte Co. Forecasted to Earn Q2 2020 Earnings of $0.60 Per Share $INCY https://t.co/C6pqgHh9CB #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
3318510966,2020-05-21 08:08:33,,,"crweworld.com/article/news-p‚Ä¶, ",1263441549750198273,False,0,0,0,0,CRWE World,Incyte to Present at Upcoming Investor Conference https://t.co/sTaKQaJ9UU,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
976297820532518914,2020-05-21 08:08:09,,,"dlvr.it/RX4sK8, pic.twitter.com/H623sHbSWY, ",1263441449640587266,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conference https://t.co/OmREj0r7rX https://t.co/H623sHbSWY,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
374729426,2020-05-21 08:05:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1635609, pic.twitter.com/fSYpMsNaZJ, ",1263440673270685696,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators: https://t.co/6WscnMAFG8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/fSYpMsNaZJ,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1069693680066420736,2020-05-21 08:03:52,"INCY, ",,"s.flashalert.me/b8d8xE, ",1263440370026852353,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on May 21, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/IrFLq7EjeG",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1889492676,2020-05-21 07:29:27,"INCY, ","Incyte, MorphoSys, EuropeanMarketingAuthorization, Tafasitamab, ","1stoncology.com/blog/incytemor‚Ä¶, ",1263431707522297857,False,0,0,0,0,Troi URL Plug-in,#Incyte and #MorphoSys Announce the Validation of the #EuropeanMarketingAuthorization Application for #Tafasitamab $INCY https://t.co/dOKa9H1AbJ,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1100450877792370688,2020-05-21 02:37:04,"INCY, ",,"blueequity.io/r/120660/de-in‚Ä¶, ",1263358126645886978,False,0,0,0,0,Blue Equity,$INCY Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for Tafasitamab https://t.co/nfTXU96ger,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
930803511918411776,2020-05-21 01:54:18,"INCY, ",,"thelincolnianonline.com/?p=4011968, ",1263347367618719744,False,0,0,0,0,Zapier.com,Q3 2020 EPS Estimates for Incyte Co. Boosted by Analyst $INCY https://t.co/PSiB0xlUpx,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2266388972,2020-05-21 01:54:03,"INCY, ","stocks, ","dailypolitical.com/?p=3878919, ",1263347302242168832,False,0,0,0,0,Zapier.com,Q3 2020 EPS Estimates for Incyte Co. Boosted by Analyst $INCY https://t.co/Sb8eeNPPuB #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-05-21 01:54:00,"INCY, ",,"dailypolitical.com/?p=3878919, ",1263347291190149120,False,0,0,0,0,Zapier.com,Q3 2020 EPS Estimates for Incyte Co. Boosted by Analyst $INCY https://t.co/EcrMnpXXmS,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1979190776,2020-05-21 01:52:16,"INCY, ",,"tickerreport.com/?p=5612387, ",1263346854265323520,False,0,0,0,0,Zapier.com,Q3 2020 EPS Estimates for Incyte Co. Boosted by Analyst $INCY https://t.co/sGsNOkUPv8,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
3154096965,2020-05-20 22:00:07,"INCY, ","stocks, ","itunes.apple.com/app/apple-stor‚Ä¶, ",1263288429619617793,False,0,0,0,0,Stocks Creamun,Huge variation: Incyte Corporation $INCY 98.3800 up 3.6452% 16:00 https://t.co/Pa7hlovGSJ  #stocks,,,2015-04-10 13:43:47,,Stocks Creamun,https://pbs.twimg.com/profile_images/586591866268864513/JCA1FhAV_normal.png,740,940,60,148185,StocksCreamun,
3686628867,2020-05-20 19:14:30,,,"pharmaceuticaldaily.com/incyte-and-mor‚Ä¶, ",1263246753354088451,False,0,0,0,0,WordPress.com,Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for¬†Tafasitamab https://t.co/SIga1K6YZK,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
2181281054,2020-05-20 16:44:27,"INCY, ","markets, ","wkrb13.com/?p=1821726, ",1263208989573165056,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $100.00 at Cantor Fitzgerald https://t.co/tMnpF0skv8 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
72928001,2020-05-20 16:04:20,"MOR, ",,"bit.ly/2WNbZW9, ",1263198896152408064,False,0,0,0,1,BriefingInPlayLimited,$MOR: MorphoSys and Incyte (INCY) announce the validation of the European MAA for tafasitamab https://t.co/wq6bs6LKkp,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
427877977,2020-05-20 15:11:01,"MOR, INCY, ","MorphoSys, Incyte, Tafasitamab, ","accesswire.com/590724/MorphoS‚Ä¶, ",1263185478041419778,False,0,0,0,1,Twitter Web App,$MOR $INCY. #MorphoSys and #Incyte Announce the Validation of the European Marketing Authorization Application for #Tafasitamab https://t.co/vNFO67ICO9.,,,2011-12-03 21:43:03,D√ºsseldorf,Volker Schulz,https://pbs.twimg.com/profile_images/1421288833862311941/Xw3abFlt_normal.jpg,4103,3000,238,132534,portefeuillefun,
3318510966,2020-05-20 15:00:24,,,"crweworld.com/article/news-p‚Ä¶, ",1263182806806458369,False,0,0,0,0,CRWE World,MorphoSys and Incyte Announce the Validation of the European Marketing Authorization Application for Tafasitamab https://t.co/WIa4ArgBTT,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1006334607946649600,2020-05-20 15:00:04,,,"dlvr.it/RX2bTj, ",1263182723004329984,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for Tafasitamab https://t.co/49AvJX1h3H,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
266143766,2020-05-20 14:31:05,"MOR, ",,"accesswire.com/590724/MorphoS‚Ä¶, ",1263175428921004037,False,0,0,0,0,Accesswire,$MOR MorphoSys and Incyte Announce the Validation of the European Marketing Authorization Application for Tafasitamab ... https://t.co/S0wgrma7Qi,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
31720614,2020-05-20 14:28:02,,"news, pharma, pharmiweb, ","zpr.io/tVRNV, ",1263174663053750278,False,0,0,0,0,Zapier.com,"MorphoSys and Incyte Announce the Validation of the European Marketing Authorization Application for Tafasitamab (news with additional features)
https://t.co/9iut3cqxK2
#news #pharma #pharmiweb",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,
3318510966,2020-05-20 14:23:01,,,"crweworld.com/article/news-p‚Ä¶, ",1263173397506211840,False,0,0,0,0,CRWE World,Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for Tafasitamab https://t.co/5rg4ZffopB,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
472650465,2020-05-20 14:07:31,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1263169495960600576,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for https://t.co/6YktlAOmWa,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1069693680066420736,2020-05-20 14:05:42,"INCY, ",,"s.flashalert.me/J8lJs, ",1263169041604247554,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on May 20, 14:00:00: Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for Tafasitamab https://t.co/Vyq8xTWOOL",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1134049078424162304,2020-05-20 14:04:36,"INCY, MOR, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1263168765883305984,False,0,0,0,1,Newsfilter.io,Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for Tafasitamab $INCY $MOR https://t.co/6JQ3OKCmpA,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1254906887490936845,2020-05-20 14:03:29,"INCY, ",,,1263168481262014467,False,0,0,0,0,Quant Data (Production),"Incyte and MorphoSys Announce the Validation of the European Marketing Authorization Application for Tafasitamab
2:02:21pm
Related Tickers: $INCY",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
42410755,2020-05-20 14:01:18,,,"tinyurl.com/y9jcxsry, ",1263167931577438208,False,1,0,0,1,DGAP_News_Int,MorphoSys and Incyte Announce the Validation of the European Marketing Authorization Application for... https://t.co/zYb9ft92Y1,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
1182839944756240384,2020-05-20 10:04:15,,,,1263108279137447937,False,0,0,1,0,Twitter for Android,"World's most innovative company.
 Company.    Innovation Premium.
1. ServiceNow @servicenow - 89.22
2. Workday @Workday - 82.84
3. Salesforce @salesforce - 82.27
4.Tesla @Tesla - 78.27
5. Amazon @amazon - 77.4
6. Netflix @netflix - 71.23
7. Incyte @Incyte- 70.59","servicenow, Workday, salesforce, Tesla, amazon, netflix, Incyte, ",,2019-10-11 22:06:58,Earth,Timmy De' Phenom‚Ñ¢¬†üêò,https://pbs.twimg.com/profile_images/1277178150699634695/YGQkNlb5_normal.jpg,7738,6074,3,28114,IamTimmypr,
732361939490312192,2020-05-20 09:28:04,"INCY, ","markets, ","americanbankingnews.com/?p=14594553, ",1263099172309413888,False,0,0,0,0,Zapier.com,Equities Analysts Offer Predictions for Incyte Co.‚Äôs Q3 2020 Earnings $INCY https://t.co/9GWhabTtDh #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-20 09:28:04,"INCY, ","stocks, ","americanbankingnews.com/?p=14594553, ",1263099170153529346,False,0,0,0,0,Zapier.com,Equities Analysts Offer Predictions for Incyte Co.‚Äôs Q3 2020 Earnings $INCY https://t.co/lGDsH38T2e #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-05-20 07:37:22,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1630919, pic.twitter.com/DPv93GziZK, ",1263071311913345027,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/b5cXVSlFl9 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/DPv93GziZK,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
946344102194327552,2020-05-20 06:20:10,,,"globalmarketresearch123.wordpress.com/2020/05/20/vit‚Ä¶, ",1263051883427610624,False,0,0,0,0,WordPress.com,"Vitiligo Treatment Market Huge Growth and Demand (2020-2027) | Incyte, Astellas Pharma, Bausch¬†Health https://t.co/EOmkOKeMNM",,,2017-12-28 06:36:30,,amykim123,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,8,146,0,3023,amykim1231,
1140762699002871808,2020-05-19 14:35:18,"INCY, ",,"deustrader.com/optimus_mixus4‚Ä¶, ",1262814100809109506,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-05-19 14:35 EST. *Closed/Sold:
$INCY at $94.73 for 3.74 loss (-3.80%). Incyte Corporation - Common Stock
Trade Id: 41780172503063794.
Stats: https://t.co/JZ1yafbugd",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
1238121032067801088,2020-05-19 13:19:17,,,"viralflex.co/?p=42030, ",1262794970697740291,False,0,0,0,0,WordPress.com,Incyte Co. (NASDAQ:INCY) Shares Acquired by Chicago Equity Partners¬†LLC https://t.co/GDgPfGyWUU,,,2020-03-12 11:14:01,,VIRALFLEX,https://pbs.twimg.com/profile_images/1238121175508758528/9mrIoees_normal.jpg,4,3,0,48640,shopfle,
732361939490312192,2020-05-19 09:39:08,"INCY, ","markets, ","americanbankingnews.com/?p=14581413, ",1262739567515504640,False,0,0,0,0,Zapier.com,Cantor Fitzgerald Raises Incyte $INCY Price Target to $100.00 https://t.co/6DXBWFho8B #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-19 09:39:07,"INCY, ","stocks, ","americanbankingnews.com/?p=14581413, ",1262739565615427585,False,0,0,0,0,Zapier.com,Cantor Fitzgerald Raises Incyte $INCY Price Target to $100.00 https://t.co/eTdEkIbrAt #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
966006214818697218,2020-05-19 08:58:31,"INCY, ",,"theenterpriseleader.com/?p=3156530, ",1262729346378235904,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $100.00  https://t.co/CTa8nqY0IX,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2525892205,2020-05-19 08:23:06,"INCY, ","investingnews, ","modernreaders.com/?p=3291243, ",1262720436594511873,False,0,0,0,0,Zapier.com,"Zurcher Kantonalbank Zurich Cantonalbank Buys 9,237 Shares of Incyte Co. $INCY  https://t.co/BitOLQto0J #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
374729426,2020-05-19 07:57:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1626327, pic.twitter.com/W0fZw6DkBx, ",1262714088695586818,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators: https://t.co/O0jayngp51 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/W0fZw6DkBx,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1254906887490936845,2020-05-19 07:28:55,"INCY, ",,,1262706801000230917,False,0,0,0,0,Quant Data (Production),"Cantor Fitzgerald Maintains Neutral on Incyte, Raises Price Target to $100
7:28:34am
Related Tickers: $INCY",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
2525892205,2020-05-19 06:52:52,"INCY, ","investingnews, ","modernreaders.com/?p=3289303, ",1262697728460632064,False,0,0,0,0,Zapier.com,New York State Common Retirement Fund Has $23.17 Million Stock Holdings in Incyte Co. $INCY  https://t.co/EbpZaJXuSf #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2020-05-19 04:58:05,"INCY, ","markets, ","americanbankingnews.com/?p=14578491, ",1262668838958759936,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Average Recommendation of ‚ÄúHold‚Äù from Analysts https://t.co/WINa4KoVLu #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-19 04:58:00,"INCY, ","stocks, ","americanbankingnews.com/?p=14578491, ",1262668819744653312,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Average Recommendation of ‚ÄúHold‚Äù from Analysts https://t.co/5sBDjVuyzp #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2298709746,2020-05-19 04:53:47,"INCY, ",,"zpr.io/tviNm, ",1262667759835627521,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Average Recommendation of ‚ÄúHold‚Äù from Analysts https://t.co/MDHG2aa1iK,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
20147730,2020-05-18 12:11:24,,"EmergingPharmaLeader, EPL2020, pharma, clinicaltrials, lifesciences, ","pharmexec.com/pharm-execs-em‚Ä¶, pic.twitter.com/indIPKY8GP, ",1262415499520094208,False,3,0,0,2,Hootsuite Inc.,"üî∂Patients at the Foreüî∂
Read the profile of #EmergingPharmaLeader Peter O‚ÄôNeill, Director and Senior Clinical Trial Head at  @Incyte, here
‚û°Ô∏è https://t.co/BSiNZszwA8

#EPL2020 #pharma #clinicaltrials #lifesciences https://t.co/indIPKY8GP","Incyte, ",,2009-02-05 08:32:04,London & New Jersey,Pharm Exec Magazine,https://pbs.twimg.com/profile_images/1350166922160173056/C8Z7WdVb_normal.jpg,32833,638,760,23597,PharmExec,photo
1001516954916618241,2020-05-18 10:38:12,,"biotech, Merger, acquisitions, stocks, stock, StocksToTrade, stockstowatch, StockMarket, stockmarkets, finance, StockTrading, trading, investing, investingnews, banking, investors, news, USA, ","biotech-investments.com/the-top-biotec‚Ä¶, pic.twitter.com/KXmaR0FA8X, ",1262392046637252613,False,0,0,0,1,Twitter Web App,"Top Biotech Takeover Targets for 2020. Best Stocks to Buy Now?
https://t.co/D3FDmRNGcF

#biotech #Merger #acquisitions #stocks #stock #StocksToTrade #stockstowatch 
#StockMarket #stockmarkets #finance #StockTrading #trading #investing #investingnews #banking #investors #news #USA https://t.co/KXmaR0FA8X",,,2018-05-29 13:33:44,Switzerland,Biotech Investments,https://pbs.twimg.com/profile_images/1201182180975661056/y9NlME8P_normal.jpg,6338,124,23,153,BiotechInvsts,photo
2384190034,2020-05-18 08:41:40,"SPX, NEM, REGN, MKTZ, CLX, FTNT, CTXS, INCY, GIS, COG, PYPL, ",,,1262362718775971842,False,0,0,0,0,Twitter for iPhone,"Top 10 $SPX returns since 2/19 high:
Newmont $NEM  46.4%
Regeneron $REGN  44.15%
MarketAxess $MKTZ  41.9%
Clorox $CLX  27.8%
Fortinet $FTNT  19.6%
Citrix Systems $CTXS  19.31%
Incyte $INCY  17.45%
General Mills $GIS  17.37%
Cabot Oil&amp;Gas $COG  17.36%
PayPal $PYPL  17.17%",,,2014-03-04 22:22:43,"Buffalo, NY",Matt Hayes,https://pbs.twimg.com/profile_images/1355341950862438400/G5X9ZSTg_normal.jpg,133,189,1,4901,hayes_matt7,
374729426,2020-05-18 07:17:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1621808, pic.twitter.com/Vu4ZYPh1Jz, ",1262341528858460160,False,0,0,0,1,Tickeron,$INCY in Downtrend: Stochastic indicator stays in oversold zone for 1 day. View odds for this and other indicators: https://t.co/iEu9j1btOs #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Vu4ZYPh1Jz,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-05-17 23:50:22,"INCY, ",,"newsfilter.io/articles/data-‚Ä¶, ",1262229012828618754,False,0,0,0,0,Newsfilter.io,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual Meetings $INCY https://t.co/viT2CqAMon,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
886220179851665408,2020-05-17 21:19:13,"INCY, ",,"pic.twitter.com/qkG6K0G4pa, ",1262190974178123784,False,15,0,2,1,Twitter Web App,$INCY Incyte and now a nice orderly consolidation. It tried to breakdown and was supported immediately. I like the r/r in this one. I rarely buy individual biotechs so I'm passing but it is a nice looking chart https://t.co/qkG6K0G4pa,,,2017-07-15 09:45:30,"Florida, USA",Jack,https://pbs.twimg.com/profile_images/950164381429633025/N3n1snsI_normal.jpg,35592,87,1138,25408,alphacharts365,photo
1175125948716519430,2020-05-17 17:22:30,,"harvard, COVID19, coronavirus, biotech, pharma, biomedical, ",,1262131402264342529,False,0,0,0,0,Twitter for Android,"Is it too farfetched to create a breathalyzer test for Covid19? It's non-invasive. People can test themselves everyday, any time of the day. 

@MIT @Caltech @Incyte @CRISPR_News @Regeneron @celularity @FansSorrento #harvard #COVID19 #coronavirus #biotech #pharma #biomedical","MIT, Caltech, Incyte, CRISPR_News, Regeneron, celularity, ",,2019-09-20 15:14:04,,bumbleBee,https://pbs.twimg.com/profile_images/1267902420186566656/jQ3FLxou_normal.jpg,39,495,0,1239,cr3ativ2,
2525892205,2020-05-17 07:41:39,"INCY, ","investingnews, ","modernreaders.com/?p=3280129, ",1261985226877734913,False,0,0,0,0,Zapier.com,"Rhumbline Advisers Acquires 12,670 Shares of Incyte Co. $INCY  https://t.co/nGsZhyQXKM #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
374729426,2020-05-17 07:03:24,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1617294, pic.twitter.com/7c6wTszN9z, ",1261975603281981445,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator is staying in oversold zone for 1 day. View odds for this and other indicators: https://t.co/kMxnmwSUnd #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/7c6wTszN9z,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-05-17 04:50:49,"INCY, ","markets, ","americanbankingnews.com/?p=14554301, ",1261942236779999234,False,0,0,0,0,Zapier.com,Brokerages Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $581.45 Million https://t.co/36buzC8X90 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-17 04:50:49,"INCY, ","stocks, ","americanbankingnews.com/?p=14554301, ",1261942234691317762,False,0,0,0,0,Zapier.com,Brokerages Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $581.45 Million https://t.co/mgXoqKCCmI #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2298709746,2020-05-17 04:47:44,"INCY, ",,"zpr.io/tvMrJ, ",1261941460015951873,False,0,0,0,0,Zapier.com,Brokerages Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $581.45 Million https://t.co/v0OGt9qD5m,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1134049078424162304,2020-05-16 11:08:16,"INCY, ",,"newsfilter.io/articles/morga‚Ä¶, ",1261674838474833920,False,0,0,0,0,Newsfilter.io,Morgan Stanley Raises Incyte Price Target to $95.00 $INCY https://t.co/KRbTgnAL8h,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
3301684581,2020-05-16 11:00:43,,,"msho.org/aws/MSHO/asset‚Ä¶, pic.twitter.com/WE0uGfvrW7, ",1261672938341896196,False,0,0,0,0,Hootsuite Inc.,"Tune in on Wednesday, May 27 at 12pm EST to a webinar on Steroid-Refractory Acute GVHD and the Role of Jakafi (ruxolitinib) sponsored by @Incyte: https://t.co/vXlAPJjhJr https://t.co/WE0uGfvrW7","Incyte, ",,2015-05-28 09:25:56,"Troy, MI",MSHO,https://pbs.twimg.com/profile_images/609440725072261120/fNwcRP4D_normal.jpg,433,216,11,1776,MSHO1985,photo
2416188264,2020-05-16 09:55:29,"INCY, ","markets, ","thestockobserver.com/?p=2987594, ",1261656520313487360,False,0,0,0,0,Zapier.com,Morgan Stanley Raises Incyte $INCY Price Target to $95.00  https://t.co/05y2dRuC2m #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2020-05-16 07:28:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1612849, pic.twitter.com/yhyKruxxWr, ",1261619520885518337,False,0,0,0,1,Tickeron,$INCY in Downtrend: Stochastic indicator is remaining in oversold zone for 1 day. View odds for this and other indicators: https://t.co/wo6Db8RD9E #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/yhyKruxxWr,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
767350043863027712,2020-05-15 15:03:53,,,"bizkaffee.com/jak-inhibitor-‚Ä¶, ",1261371744008335360,False,0,0,0,0,WordPress.com,JAK inhibitor edge for Incyte and Eli Lilly over Pfizer for Covid-19 ‚Äì Pharmaceutical¬†Technology https://t.co/RNRf3gyLqp,,,2016-08-21 09:18:01,"North Carolina, USA",Gorila Travel,https://pbs.twimg.com/profile_images/767350794316292096/N1IA1MOx_normal.jpg,178,78,23,137028,gorilatravels,
707270913448919041,2020-05-15 12:05:05,,"MPN, ",,1261326746244300800,False,1,0,0,0,Twitter for Advertisers.,Start listening to #MPN Voices Out Loud sponsored by Incyte Corporation on the Apple Podcast app‚Äîa podcast made to support and educate the myeloproliferative neoplasm (MPN) community.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-05-15 12:04:57,,"MPN, ",,1261326713201594370,False,0,0,0,0,Twitter for Advertisers.,Start listening to #MPN Voices Out Loud sponsored by Incyte Corporation on the Apple Podcast app‚Äîa podcast made to support and educate the myeloproliferative neoplasm (MPN) community.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-05-15 12:04:42,,"MPN, ",,1261326652430331911,False,0,0,0,0,Twitter for Advertisers.,Subscribe to #MPN Voices Out Loud sponsored by Incyte Corporation on the Apple Podcast app NOW! The podcast crafted for the myeloproliferative neoplasm (MPN) community.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-05-15 12:04:26,,"MPN, ",,1261326585560522752,False,1,0,0,0,Twitter for Advertisers.,Subscribe to #MPN Voices Out Loud sponsored by Incyte Corporation on the Apple Podcast app NOW! The podcast crafted for the myeloproliferative neoplasm (MPN) community.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
852931863547084801,2020-05-15 11:34:49,"INCY, ",,"zpr.io/tv7SW, ",1261319131971887110,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Rises By 17.6% https://t.co/xr3IPCGh5Q,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
68559732,2020-05-15 11:03:38,"INCY, ",,"zpr.io/tv7Xu, ",1261311280796876800,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Rises By 17.6% https://t.co/EjiZ4Uz7yx,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1237478511801073664,2020-05-15 11:02:46,,"lungcancer, FDAApproved, regulatory, cancer, ","pic.twitter.com/ypL2u0rFtf, ",1261311063317868549,False,0,0,0,0,Twitter Web App,"FDA granted accelerated approval to @Novartis' and @Incyte's Tabrecta (capmatinib) for metastatic non-small cell #lungcancer with METex14 mutations. This is the first and only drug approved for patients battling lung cancer with this mutation. #FDAApproved, #regulatory, #cancer https://t.co/ypL2u0rFtf","Novartis, Incyte, ",,2020-03-10 16:41:05,"Boulder, CO",Headwaters Communications,https://pbs.twimg.com/profile_images/1237480859894071296/59flr73J_normal.jpg,5,62,0,36,HeadwatersComm1,photo
2416188264,2020-05-15 10:59:43,"INCY, ","markets, ","thestockobserver.com/?p=2983589, ",1261310298750885888,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Rises By 17.6%  https://t.co/Z6OjAlsSeI #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1171873456276889600,2020-05-15 10:20:50,"MOR, ","MOR, 6K, Morphosys, News, ","docoh.com/filing/1340243‚Ä¶, ",1261300510038134784,False,0,0,0,0,Investor Feed,"$MOR  6-K  Morphosys   (15 May, 10:19am)

üì∞ MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patients with r/r DLBCL

https://t.co/l3FeDQhVat

#MOR #6K #Morphosys #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1001523981500014592,2020-05-15 09:19:35,,"jobs, hiring, Wilmington, Delaware, USA, ","dlvr.it/RWjNQr, ",1261285096838975488,False,0,0,0,0,dlvr.it,"#jobs #hiring #Wilmington #Delaware #USA Sr. Research Investigator, Applied Technology: Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of novel medicines to meet serious unmet medical needs in oncology‚Ä¶ https://t.co/DwovjR9yQM",,,2018-05-29 14:01:39,United States,Empleos.io,https://pbs.twimg.com/profile_images/1002198831470178305/0-DY_Jrn_normal.jpg,127,76,6,95846,EmpleosIO,
374729426,2020-05-15 08:11:42,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1608419, pic.twitter.com/GE7XjQFKAK, ",1261268016278323200,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on May 14, 2020. View odds for this and other indicators: https://t.co/JHz4wgRXv6 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GE7XjQFKAK",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1889492676,2020-05-15 08:02:01,"INCY, ","Incyte, Oncology, ASCO20, EHA20, ","1stoncology.com/blog/data-from‚Ä¶, ",1261265575948386304,False,0,0,0,0,Troi URL Plug-in,Data from #Incyte‚Äôs #Oncology Portfolio Accepted for Presentation at the #ASCO20 and #EHA20 Virtual Meetings $INCY https://t.co/dazPYtGfl8,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2020-05-15 07:52:11,"MOR, INCY, ","MorphoSys, Incyte, LMIND, Tafasitamab, DLBCL, ","1stoncology.com/blog/morphosys‚Ä¶, ",1261263101996879873,False,1,0,0,1,Troi URL Plug-in,#MorphoSys and #Incyte Announce Long-term Follow-up Results from #LMIND Study of #Tafasitamab in Patients with r/r #DLBCL $MOR $INCY https://t.co/UlJDLmQMr7,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2020-05-15 07:34:12,"INCY, ","Incyte, Oncology, ASCO20, EHA20, ","1stoncology.com/blog/data-from‚Ä¶, ",1261258576053452800,False,0,0,0,0,Troi URL Plug-in,Data from #Incyte‚Äôs #Oncology Portfolio Accepted for Presentation at the #ASCO20 and #EHA20 Virtual Meetings $INCY https://t.co/UOiaCjkP1A,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2020-05-15 07:26:38,"MOR, ","MorphoSys, Incyte, LMIND, Tafasitamab, DLBCL, ","1stoncology.com/blog/morphosys‚Ä¶, ",1261256674838319104,False,1,0,0,0,Troi URL Plug-in,#MorphoSys and #Incyte Announce Long-term Follow-up Results from #LMIND Study of #Tafasitamab in Patients with r/r #DLBCL $MOR https://t.co/07cPnz6Pzw,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
2920258887,2020-05-15 06:39:41,"INCY, ",,"dakotafinancialnews.com/?p=1915872, ",1261244856623673349,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 17.6% in April https://t.co/4cCe4YcWmg,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
849417718642159616,2020-05-15 06:38:26,"INCY, ",,"zpr.io/tvfdx, ",1261244541585305600,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 17.6% in April https://t.co/1BNo73axM1,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
966006214818697218,2020-05-15 06:36:48,"INCY, ",,"theenterpriseleader.com/?p=3133586, ",1261244133513015296,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 17.6% in April  https://t.co/LdsXjJJokJ,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1979190776,2020-05-15 05:51:19,"INCY, ",,"tickerreport.com/?p=5579930, ",1261232686758150144,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 17.6% in April https://t.co/uYyLMLYN5Q,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2020-05-15 05:50:06,"INCY, ","markets, ","americanbankingnews.com/?p=14530142, ",1261232378393001984,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 17.6% in April https://t.co/A23OeXkR7b #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-15 05:50:05,"INCY, ","stocks, ","americanbankingnews.com/?p=14530142, ",1261232375918399488,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Up 17.6% in April https://t.co/3pevjoBqOP #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
930803511918411776,2020-05-15 04:34:01,"INCY, ",,"thelincolnianonline.com/?p=3977685, ",1261213232859090944,False,0,0,0,0,Zapier.com,Recent Investment Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/QceqE0j9vZ,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
732361939490312192,2020-05-15 04:32:43,"INCY, ","markets, ","americanbankingnews.com/?p=14529614, ",1261212906563272704,False,0,0,0,0,Zapier.com,Recent Investment Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/QSDJqLJPSc #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-15 04:32:42,"INCY, ","stocks, ","americanbankingnews.com/?p=14529614, ",1261212900317937664,False,0,0,0,0,Zapier.com,Recent Investment Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/7NDkqMK3hq #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2298709746,2020-05-15 04:32:20,"INCY, ",,"zpr.io/tvHMm, ",1261212808622022656,False,0,0,0,0,Zapier.com,Recent Investment Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/dxbV4qZkmm,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
732361939490312192,2020-05-15 02:32:27,"INCY, ","markets, ","americanbankingnews.com/?p=14529215, ",1261182639999979521,False,0,0,0,0,Zapier.com,Brokerages Expect Incyte Co. $INCY to Post $0.73 EPS https://t.co/nzof9PTeN9 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-15 02:32:27,"INCY, ","stocks, ","americanbankingnews.com/?p=14529215, ",1261182638032850944,False,0,0,0,0,Zapier.com,Brokerages Expect Incyte Co. $INCY to Post $0.73 EPS https://t.co/wMjy84Xoru #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1171873456276889600,2020-05-14 16:18:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1261028219437887493,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (14 May, 4:17pm)

üì∞ Departure of Directors or Certain Officers; Election of Directors

https://t.co/b7tD1cO4oz

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1128239740329705472,2020-05-14 15:43:44,"INCY, ","ASCO20, ","biospace.com/article/releas‚Ä¶, ",1261019383997972480,False,0,0,0,1,Twitter for Android,"Incyte's abstracts with data from its clinical trials will be presented at #ASCO20 and at the virtual 25th Congress of the European Hematology Association. 
$INCY 
https://t.co/Eb3RB6Z7lz",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
3686628867,2020-05-14 14:32:15,,,"pharmaceuticaldaily.com/data-from-incy‚Ä¶, ",1261001395882405890,False,0,0,0,0,WordPress.com,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual¬†Meetings https://t.co/3D6AAG6Exr,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
2229740180,2020-05-14 13:35:49,,,"sadifanalytics.com/reports/find/I‚Ä¶, ",1260987192010252291,False,0,0,0,0,SADIF - Analytics,Will Incyte Corp Deliver Long-Term Returns? ($INCY) https://t.co/dCRT67GWDz,,,2013-12-04 06:21:56,Portugal,SADIF - Analytics,https://pbs.twimg.com/profile_images/656072062906343424/byfeHd57_normal.png,1619,190,23,236674,SADIFAnalytics,
1089978712685273090,2020-05-14 12:50:02,,"Incyte, ","dlvr.it/RWfSF6, ",1260975670860996614,False,0,0,0,0,dlvr.it,Data from #Incyte $INTC‚Äôs Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual Meetings https://t.co/KvSUARzUmm,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
1006334607946649600,2020-05-14 12:48:05,,,"dlvr.it/RWfRcq, ",1260975182446919681,False,0,0,0,0,dlvr.it,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual Meetings https://t.co/NUemJCJ9A6,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
3318510966,2020-05-14 12:41:57,,,"crweworld.com/article/news-p‚Ä¶, ",1260973638011895808,False,0,0,0,0,CRWE World,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual Meetings https://t.co/wlO6qqDN3s,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
472650465,2020-05-14 12:28:40,"INCY, ",,"otcdynamics.com/incy-data-from‚Ä¶, ",1260970292584873988,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual Meetings https://t.co/Z3MSl5GgGS,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1254906887490936845,2020-05-14 12:22:52,"INCY, ",,,1260968832740589573,False,0,0,0,0,Quant Data (Production),"Incyte Highlights Oral, Poster Discussions At ASCO At Virtual ASCO Starting May 29
12:22:33pm
Related Tickers: $INCY",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
1069693680066420736,2020-05-14 12:20:35,"INCY, ",,"s.flashalert.me/cteyA, ",1260968261992230913,False,0,0,0,0,flashalerts,"$INCY [15s. delayed]: Issued Press Release on May 14, 12:18:00: Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual Meetings https://t.co/NsOptsn8r9",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1134049078424162304,2020-05-14 12:19:58,"INCY, ",,"newsfilter.io/articles/data-‚Ä¶, ",1260968105880236033,False,0,0,0,0,Newsfilter.io,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the ASCO and EHA Virtual Meetings $INCY https://t.co/viT2CqAMon,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
112729091,2020-05-14 11:31:45,"MOR, INCY, ",,"morphosys.com/media-investor‚Ä¶, ",1260955970668298245,False,1,0,1,0,Twitter for Android,$MOR $INCY Tafasitamab with LEN r/r DLBCL 2 year follow-up data - seems pretty strong to my untrained eye. PDUFA August 30 this year. https://t.co/jiuOylh8fO,,,2010-02-09 09:26:11,Earth,The Pathfinder,https://pbs.twimg.com/profile_images/424632323913420801/LlbdOdG8_normal.jpeg,801,173,23,4304,path1finder,
949657442241130497,2020-05-14 10:14:18,"MOR, INCY, ","tafasitamab, Morphosys, ","morphosys.com/media-investor‚Ä¶, ",1260936480815329282,False,0,0,1,0,Twitter Web App,"L-Mind Study Updated date: 
mDOR 34.6 months (before 21.7), 
mPFS 16.2 months (before 12.1) 
mOS 31.6 months (not reached before)

ORR 58.8% (47 of 80 before 48 of 80)
CR 41.3% (33 of 80 before 34 of 80). 

One CR less.

$MOR $INCY #tafasitamab #Morphosys

https://t.co/v1jQedagS2",,,2018-01-06 10:02:32,,Orange Apple,https://pbs.twimg.com/profile_images/1218476621402923009/3BE0SgQ0_normal.jpg,315,99,8,931,ainge_man,
1006334607946649600,2020-05-14 10:07:02,,,"dlvr.it/RWdtq3, ",1260934652509868033,False,0,0,0,0,dlvr.it,MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patients with r/r DLBCL https://t.co/6dq9hC8wn6,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
3318510966,2020-05-14 10:00:06,,,"crweworld.com/article/news-p‚Ä¶, ",1260932907608076294,False,0,0,0,0,CRWE World,MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patients with r/r DLBC https://t.co/Kb4fy0NxK5,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
266143766,2020-05-14 09:50:08,"MOR, ",,"accesswire.com/589875/MorphoS‚Ä¶, ",1260930398080716801,False,0,0,0,0,Accesswire,$MOR MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patients with ... https://t.co/BFwEA6I7Py,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
31720614,2020-05-14 09:40:24,,"news, pharma, pharmiweb, ","zpr.io/t4WHv, ",1260927948581896193,False,0,0,0,0,Zapier.com,"MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patients with r/r DLBCL (news with additional features)
https://t.co/WOSZcn1Tlf
#news #pharma #pharmiweb",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,
42410755,2020-05-14 09:26:18,,,"tinyurl.com/y75jpkvl, ",1260924401211584512,False,0,0,0,2,DGAP_News_Int,MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patien... https://t.co/ssaRLT9pUI,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
1156133747852374016,2020-05-14 09:01:18,,,"delveinsight.com/report-store/T‚Ä¶, pic.twitter.com/RU8AjmAK95, ",1260918108287635456,False,0,0,0,0,Twitter Web App,"The TIM-3-Next Generation Immunotherapy market is expected to generate USD 1,218 Million in the year 2035.
The key players in TIM-3-Next Generation Immunotherapy market include @GSKUS @Novartis @bmsnews @BeiGeneUSA @Incyte @Agenus_Bio @Roche and @LillyPad.
https://t.co/VVTY5aG2nE https://t.co/RU8AjmAK95","GSKUS, Novartis, bmsnews, Incyte, Agenus_Bio, Roche, LillyPad, ",,2019-07-30 05:25:40,New Delhi,DelveInsight,https://pbs.twimg.com/profile_images/1222806973487255552/pWZKXuZ9_normal.jpg,122,1363,1,2930,delve_insight,photo
374729426,2020-05-14 07:26:35,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1603998, pic.twitter.com/BfYGkBH4nm, ",1260894271948771328,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/rtVly9fO7R #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BfYGkBH4nm,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
852800287559475200,2020-05-14 05:55:05,,"earnings, Novartis, clinicaltrial, Jakavi, Incyte, ","ow.ly/FlB730qDWlw, pic.twitter.com/49xfFSLlvh, ",1260871245580689408,False,0,0,0,0,Hootsuite Inc.,"Novartis, Incyte will take Jakafi into 2nd trial for COVID-19 patients on ventilators | FiercePharma https://t.co/EPVQeTCHBq #earnings #Novartis #clinicaltrial #Jakavi #Incyte https://t.co/49xfFSLlvh",,,2017-04-14 04:26:47,Boulogne-Billancourt,Excelya,https://pbs.twimg.com/profile_images/1277614848583532544/jVaWVLEI_normal.png,1163,799,11,3983,ExcelyaPharma,photo
2344420430,2020-05-14 04:09:18,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1260844622710018048,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/EWUF1nZsnc",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1259512942611042304,2020-05-14 00:32:51,,"ARK, ",,1260790151334199301,False,0,0,0,0,ARK Tracker,"üö® On Wednesday, May 13th, #ARK bought/sold the following shares:

ADAPTIVE BIOTECHNOLOGIES (‚¨ÜÔ∏è by 93%)
INOVIO PHARMACEUTICALS INC (‚¨áÔ∏è by 24%)
ZILLOW GROUP INC - C (‚¨ÜÔ∏è by 16%)
INCYTE CORP (‚¨áÔ∏è by 8%)
TWIST BIOSCIENCE CORP (‚¨ÜÔ∏è by 5%)
MERCADOLIBRE INC...",,,2020-05-10 11:57:58,,ARK Portfolio Update,https://pbs.twimg.com/profile_images/1261199027644911616/LHe9RHIo_normal.jpg,562,1,10,309,ARKTracker,
374729426,2020-05-13 10:39:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1599955, pic.twitter.com/XERMaqK1cB, ",1260580330295234560,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators: https://t.co/2QlHP9Z2n1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/XERMaqK1cB,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
852931863547084801,2020-05-12 11:39:51,"INCY, ",,"zpr.io/t4u9m, ",1260233233599549441,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $95.00 Price Target at Morgan Stanley https://t.co/7avI9Vz9Cg,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
68559732,2020-05-12 11:37:44,"INCY, ",,"zpr.io/t4uu9, ",1260232699639484418,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $95.00 Price Target at Morgan Stanley https://t.co/VWrGDOWDBD,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
773578537764851712,2020-05-12 10:15:03,"MPSYF, ",,"sitefocus.com/ei-product, ",1260211892540239878,False,0,0,0,0,CIF-QBA,"$MPSYF Earnings Intelligence Analysis of recent earnings identified MorphoSys AG ( OTCPK:MPSYF ) business focus on (in-licensing,tafasitamab), (eur,income,incyte), (revenues,tafasitamab)

https://t.co/4nOHfhdno3",,,2016-09-07 13:47:50,"Cupertino, CA",SiteFocus,https://pbs.twimg.com/profile_images/908465036598820864/6ZQsC4KD_normal.jpg,195,35,8,57439,SiteFocusHQ,
374729426,2020-05-12 09:40:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1595467, pic.twitter.com/eJwaqHc9Lx, ",1260203235236667394,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator remains in oversold zone for 2 days. View odds for this and other indicators: https://t.co/taTPdR1CnR #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/eJwaqHc9Lx,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-05-12 09:24:23,"INCY, ","markets, ","americanbankingnews.com/?p=14490268, ",1260199143202525185,False,0,0,0,0,Zapier.com,Morgan Stanley Boosts Incyte $INCY Price Target to $95.00 https://t.co/TqGUFtVMqK #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-12 09:24:23,"INCY, ","stocks, ","americanbankingnews.com/?p=14490268, ",1260199141105455107,False,0,0,0,0,Zapier.com,Morgan Stanley Boosts Incyte $INCY Price Target to $95.00 https://t.co/EZzq0dVODo #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
966006214818697218,2020-05-12 06:02:27,"INCY, ",,"theenterpriseleader.com/?p=3118583, ",1260148322423263238,False,0,0,0,0,Zapier.com,Incyte $INCY Cut to Hold at BidaskClub  https://t.co/kmy8y0efqE,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
852931863547084801,2020-05-12 06:00:00,"INCY, ",,"zpr.io/t4hdN, ",1260147707970310144,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub https://t.co/xcIBYFUBcO,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2266388972,2020-05-12 05:59:12,"INCY, ","stocks, ","dailypolitical.com/?p=3831719, ",1260147504122912768,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub https://t.co/79CX9gAiDv #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-05-12 05:59:11,"INCY, ",,"dailypolitical.com/?p=3831719, ",1260147501950275584,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub https://t.co/4tjSFbBr2k,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2525892205,2020-05-12 02:32:03,"INCY, ","investingnews, ","modernreaders.com/?p=3253085, ",1260095376448765953,False,0,0,0,0,Zapier.com,Q2 2020 EPS Estimates for Incyte Co. Boosted by Analyst $INCY  https://t.co/sDK2boWGt3 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2920258887,2020-05-12 02:29:57,"INCY, ",,"dakotafinancialnews.com/?p=1899924, ",1260094848260091908,False,0,0,0,0,Zapier.com,Q2 2020 EPS Estimates for Incyte Co. Boosted by Analyst $INCY https://t.co/Snbod6DrqE,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
740333972270555136,2020-05-12 00:41:09,,,,1260067467315068928,False,13,0,1,4,Twitter for iPhone,"Check out @OncoKB newest release w/ updated content that incl 4 new @US_FDA approvals:
 1) FGFR1/2/3 targeted pemigatinib  (@Incyte) 
2) RET fusion targeted selpercatinib (@LillyPad) &amp; 
3&amp;4) HER2 amplified targeted tucatinib (@SeattleGenetics) &amp; DS8201a (@DaiichiSankyoUS)","OncoKB, US_FDA, Incyte, LillyPad, SeattleGenetics, DaiichiSankyoUS, ",,2016-06-07 20:05:48,"New York, NY","Debyani Chakravarty, PhD",https://pbs.twimg.com/profile_images/1212847130269888512/k2GtqDfn_normal.jpg,1290,547,5,2200,CDebyaniPhD,
3911174913,2020-05-11 18:47:13,,"COVID19, ",,1259978395477311490,False,3,0,0,1,Twitter for Advertisers.,We‚Äôre proud that another Incyte discovered treatment is being tested as a potential therapy for patients with #COVID19. Read the details on the @NIAIDNews study.,"NIAIDNews, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
772471873539977217,2020-05-11 13:25:04,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1259897324236615688,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form SC 13G/A https://t.co/Rt4HHqLAxl,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
374729426,2020-05-11 08:25:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1591026, pic.twitter.com/nbdGRrivdR, ",1259822024274243585,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator is staying in oversold zone for 1 day. View odds for this and other indicators: https://t.co/wu5pk6Hh6k #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/nbdGRrivdR,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
850712117573537793,2020-05-11 07:01:16,,,"medcitynews.com/2020/04/incyte‚Ä¶, ",1259800739565666306,False,0,0,0,0,Twitter Web Client,Incyte plans Phase III trial of blood cancer drug as potential Covid-19 cytokine storm therapy - MedCity News https://t.co/FCVJvh9Zkw,,,2017-04-08 10:09:09,,Cheryl Amber Dotson,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1257,4691,2,308159,GODZILLASLAYS65,
76913784,2020-05-11 05:38:00,,"clinicaltrials, pharma, ","bit.ly/2WjhE6k, ",1259779782348353547,False,0,0,0,0,Semrush Social Media Tool,"NIAID launches ACTT 2 trial testing Gilead's remdesivir plus Eli Lilly, Incyte's JAK inhibitor Olumiant in COVID-19 https://t.co/oXWWPo4vQJ #clinicaltrials #pharma",,,2009-09-24 07:10:21,UK,Cpl Life Sciences,https://pbs.twimg.com/profile_images/1321422353969090561/TxMp7fL7_normal.jpg,1611,417,129,10431,CPLLifeSciences,
2298709746,2020-05-11 05:22:33,"INCY, ",,"zpr.io/t4ZiM, ",1259775895855861760,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $93,063.24 in Stock https://t.co/IGOd3gqy6E",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
966006214818697218,2020-05-11 05:17:36,"INCY, ",,"theenterpriseleader.com/?p=3112730, ",1259774651259064321,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $93,063.24 in Stock  https://t.co/vmdudoLNl1",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
68559732,2020-05-11 05:17:27,"INCY, ",,"zpr.io/t4ZkH, ",1259774609681002497,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $93,063.24 in Stock https://t.co/kbkWYaz319",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2298709746,2020-05-11 03:05:13,"INCY, ",,"zpr.io/t4pKD, ",1259741333754908673,False,0,0,0,0,Zapier.com,Oppenheimer Analysts Raise Earnings Estimates for Incyte Co. $INCY https://t.co/1rnMQOG3uO,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
930803511918411776,2020-05-11 02:34:08,"INCY, ",,"thelincolnianonline.com/?p=3951768, ",1259733511331856384,False,0,0,0,0,Zapier.com,Oppenheimer Analysts Raise Earnings Estimates for Incyte Co. $INCY https://t.co/h0sg9cWh4i,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
849417718642159616,2020-05-11 02:33:11,"INCY, ",,"zpr.io/t4ppz, ",1259733270461366272,False,0,0,0,0,Zapier.com,Oppenheimer Analysts Raise Earnings Estimates for Incyte Co. $INCY https://t.co/hYNwmx7UYN,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
732361939490312192,2020-05-11 02:31:24,"INCY, ","markets, ","americanbankingnews.com/?p=14470895, ",1259732822941667335,False,0,0,0,0,Zapier.com,Oppenheimer Analysts Raise Earnings Estimates for Incyte Co. $INCY https://t.co/0rB9J1EGre #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-11 02:31:23,"INCY, ","stocks, ","americanbankingnews.com/?p=14470895, ",1259732820949417985,False,0,0,0,0,Zapier.com,Oppenheimer Analysts Raise Earnings Estimates for Incyte Co. $INCY https://t.co/kBqIop33m5 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2020-05-11 02:31:08,"INCY, ",,"tickerreport.com/?p=5552264, ",1259732757309251584,False,0,0,0,0,Zapier.com,Oppenheimer Analysts Raise Earnings Estimates for Incyte Co. $INCY https://t.co/8yQUxCd0vc,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
133504478,2020-05-10 20:58:34,,"strategy, competitiveintelligence, marketing, pharma, biotech, productmarketing, healthcare, pharmaceutical, ","dlvr.it/RWNw2v, lqventures.com, ",1259649061864345601,False,0,0,0,1,dlvr.it,"What is driving the Essential Thrombocythemia Drug? Market size? Key players are AbbVie Inc, Aop Orphan‚Ä¶ https://t.co/uBV95Govhk &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #healthcare #pharmaceutical",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
800362127840022528,2020-05-10 16:26:51,,,"businesswire.com/news/home/2020‚Ä¶, ",1259580685284544513,False,2,0,0,2,Twitter for iPhone,"Hear Ye, hear Ye.   METexon14 bites the dust.  Incyte Announces FDA Approval of Tabrecta‚Ñ¢ (capmatinib) for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with METex14 | Business Wire https://t.co/Xq5zrSJsCa",,,2016-11-20 10:36:16,"San Diego, CA","Razelle Kurzrock, MD",https://pbs.twimg.com/profile_images/1385625625327587334/9e0ibeMV_normal.jpg,4658,3331,51,4377,Dr_R_Kurzrock,
930803511918411776,2020-05-10 07:26:48,"INCY, ",,"thelincolnianonline.com/?p=3950642, ",1259444776266416133,False,0,0,0,0,Zapier.com,Dashyant Dhanak Sells 961 Shares of Incyte Co. $INCY Stock https://t.co/eSMf6hx8LS,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-05-10 07:26:01,"INCY, ",,"tickerreport.com/?p=5551126, ",1259444578807164930,False,0,0,0,0,Zapier.com,Dashyant Dhanak Sells 961 Shares of Incyte Co. $INCY Stock https://t.co/PxDVevixfI,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
849417718642159616,2020-05-10 07:25:37,"INCY, ",,"zpr.io/t4ffB, ",1259444479444082689,False,0,0,0,0,Zapier.com,Dashyant Dhanak Sells 961 Shares of Incyte Co. $INCY Stock https://t.co/PEFLCv9NmP,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
374729426,2020-05-10 06:59:30,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1586543, pic.twitter.com/S3mqaeBnAI, ",1259437905644146688,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator stays in oversold zone for 1 day. View odds for this and other indicators: https://t.co/Tm8akoseZF #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/S3mqaeBnAI,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2416188264,2020-05-10 06:30:35,"INCY, ","markets, ","thestockobserver.com/?p=2960124, ",1259430630112272384,False,0,0,0,0,Zapier.com,BidaskClub Downgrades Incyte $INCY to Hold  https://t.co/4GQyieNfno #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1134049078424162304,2020-05-10 06:28:34,"INCY, ",,"newsfilter.io/articles/bidas‚Ä¶, ",1259430120110129152,False,0,0,0,0,Newsfilter.io,BidaskClub Downgrades Incyte to Hold $INCY https://t.co/ONGrPqtIRC,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2298709746,2020-05-10 05:52:08,"INCY, ",,"zpr.io/t4RYV, ",1259420951520911361,False,0,0,0,0,Zapier.com,BidaskClub Downgrades Incyte $INCY to Hold https://t.co/mlzqeW0hzF,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2525892205,2020-05-10 05:50:46,"INCY, ","investingnews, ","modernreaders.com/?p=3244233, ",1259420607088918528,False,0,0,0,0,Zapier.com,BidaskClub Downgrades Incyte $INCY to Hold  https://t.co/2rOJrpM6aK #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2920258887,2020-05-10 05:50:37,"INCY, ",,"dakotafinancialnews.com/?p=1891090, ",1259420569197559809,False,0,0,0,0,Zapier.com,BidaskClub Downgrades Incyte $INCY to Hold https://t.co/RUDp6ovAhS,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
1134049078424162304,2020-05-10 04:10:34,"INCY, ",,"newsfilter.io/articles/oppen‚Ä¶, ",1259395389947621377,False,0,0,0,0,Newsfilter.io,Oppenheimer Research Analysts Decrease Earnings Estimates for Incyte $INCY https://t.co/J6CIf3kFoS,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1022006086872821762,2020-05-10 00:02:11,"INCY, INCY, ",,,1259332882075717632,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Fri May 08
Closed at 95.92 USD for a -0.57% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
896877581940781056,2020-05-09 20:12:14,,,"fool.com/earnings/call-‚Ä¶, ",1259275014047625218,False,0,0,0,0,boutlineprod,"https://t.co/lgZTYMURsO  
  In the U.S., MorphoSys and Incyte will co-commercialize tafasitamab, with MorphoSys recording all revenues generated from tafasitamab sales..",,,2017-08-13 19:34:13,"Austin, TX",Eager Beaver,https://pbs.twimg.com/profile_images/896879927286530049/06qmSNcs_normal.jpg,121,0,6,205300,eagerbeavertech,
1134049078424162304,2020-05-09 12:12:32,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1259154296232390657,False,0,0,0,0,Newsfilter.io,"$30,194.62 of shares sold by Dhanak Dashyant (EVP &amp; Chief Scientific Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/qHm5epxuSr",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-05-09 08:43:25,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1259101667880026112,False,0,0,0,0,Newsfilter.io,Incyte EVP Dashyant Dhanak Sells 961 Shares of Stock $INCY https://t.co/j5cinh30ia,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2920258887,2020-05-09 08:08:53,"INCY, ",,"dakotafinancialnews.com/?p=1887374, ",1259092978217431042,False,0,0,0,0,Zapier.com,Incyte Co. $INCY EVP Dashyant Dhanak Sells 961 Shares of Stock https://t.co/CnZbEotHRq,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
2416188264,2020-05-09 08:06:44,"INCY, ","markets, ","thestockobserver.com/?p=2956279, ",1259092437529776129,False,0,0,0,0,Zapier.com,Incyte Co. $INCY EVP Dashyant Dhanak Sells 961 Shares of Stock  https://t.co/vjVIsc7GDI #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2020-05-09 07:59:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1582233, pic.twitter.com/AMWnAUJjtk, ",1259090739490729986,False,1,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator remains in oversold zone for 1 day. View odds for this and other indicators: https://t.co/ki2BeFmqwY #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/AMWnAUJjtk,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-05-09 05:43:04,"INCY, ",,"zpr.io/t4UzT, ",1259056282176311297,False,0,0,0,0,Zapier.com,Oppenheimer Weighs in on Incyte Co.‚Äôs Q4 2020 Earnings $INCY https://t.co/ILDIv7x0WC,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2298709746,2020-05-09 05:42:06,"INCY, ",,"zpr.io/t4U7h, ",1259056040857014273,False,0,0,0,0,Zapier.com,Oppenheimer Weighs in on Incyte Co.‚Äôs Q4 2020 Earnings $INCY https://t.co/CdPjrVK8OJ,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2920258887,2020-05-09 03:31:37,"INCY, ",,"dakotafinancialnews.com/?p=1884973, ",1259023202870800385,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Lowered by JPMorgan Chase &amp; Co. https://t.co/Bhhbp1fj7o,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
2266388972,2020-05-09 03:30:48,"INCY, ","stocks, ","dailypolitical.com/?p=3819717, ",1259022995185643523,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded to ‚ÄúNeutral‚Äù at JPMorgan Chase &amp; Co. https://t.co/W0KvskkIfd #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-05-09 03:30:47,"INCY, ",,"dailypolitical.com/?p=3819717, ",1259022992920711169,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded to ‚ÄúNeutral‚Äù at JPMorgan Chase &amp; Co. https://t.co/YbS1a04s2q,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
68559732,2020-05-09 03:30:04,"INCY, ",,"zpr.io/tcQR9, ",1259022809860276224,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded to ‚ÄúNeutral‚Äù at JPMorgan Chase &amp; Co. https://t.co/TEOoa9DsX0,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1134049078424162304,2020-05-09 03:29:19,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1259022621104115715,False,0,0,0,0,Newsfilter.io,Incyte Downgraded to ‚ÄúNeutral‚Äù at JPMorgan Chase &amp; $INCY https://t.co/FPUhsw9pRl,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2416188264,2020-05-09 03:28:57,"INCY, ","markets, ","thestockobserver.com/?p=2953901, ",1259022529710166016,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded to ‚ÄúNeutral‚Äù at JPMorgan Chase &amp; Co.  https://t.co/NJQvJpmw6y #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
3167134549,2020-05-09 03:19:37,,,"beta.firstwordpharma.com/story/5012649, ",1259020181486972928,False,1,0,0,1,Twitter Web Client,"NIAID launches ACTT 2 trial testing Gilead's remdesivir plus Eli Lilly, Incyte's JAK inhibitor Olumiant in COVID-19 https://t.co/y4xlxEfB7V via @fwpharma","fwpharma, ",,2015-04-22 05:34:31,,Dragon Fire,https://pbs.twimg.com/profile_images/1263394507053084673/Z9CvUGjn_normal.jpg,12,343,0,152,1dragon_winter,
732361939490312192,2020-05-08 20:10:30,"INCY, ","markets, ","americanbankingnews.com/?p=14444423, ",1258912189819355137,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $93,063.24 in Stock https://t.co/HLaFEslPnc #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-08 20:10:29,"INCY, ","stocks, ","americanbankingnews.com/?p=14444423, ",1258912187382448129,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $93,063.24 in Stock https://t.co/IngCYSX8Ih #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2344420430,2020-05-08 17:58:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1258878916556709889,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/4IkmhZxHzQ",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-05-08 17:45:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1258875666503589888,False,0,0,0,0,InsiderActionMonitor,$INCY  Incyte https://t.co/QLtmThdhwn,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1321508892,2020-05-08 17:14:26,,"clinicaltrials, COVID19, ","fiercepharma.com/pharma/novarti‚Ä¶, ",1258867882823258112,False,1,0,0,0,TweetDeck,.@Novartis and @Incyte are moving onto the next stage in #clinicaltrials for a potential #COVID19 treatment. https://t.co/0IioDWrlfE,"Novartis, Incyte, ",,2013-04-01 21:42:06,Texas,WWFHTX,https://pbs.twimg.com/profile_images/574936206095450113/vj7WOpeg_normal.jpeg,362,830,28,3106,WWFHTX,
2181281054,2020-05-08 16:32:29,"INCY, ","markets, ","wkrb13.com/?p=1785551, ",1258857324619485184,False,0,0,0,0,Zapier.com,"Incyte $INCY Posts Quarterly Earnings Results, Misses Expectations By $3.17 EPS https://t.co/HOFq2J8VZD #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1140762699002871808,2020-05-08 15:59:52,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1258849118618742785,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-05-08 15:58 EST. *Closed/Covered previously shorted:
$INCY at $95.96 for 2.60 profit (2.63%). Incyte Corporation - Common Stock
Trade Id: 40842008303024008.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
732361939490312192,2020-05-08 15:30:15,"INCY, ","markets, ","americanbankingnews.com/?p=14440548, ",1258841664774340613,False,0,0,0,0,Zapier.com,Q4 2020 EPS Estimates for Incyte Co. Lowered by Oppenheimer $INCY https://t.co/DHIBFbmJEX #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-08 15:30:15,"INCY, ","stocks, ","americanbankingnews.com/?p=14440548, ",1258841662823989251,False,0,0,0,0,Zapier.com,Q4 2020 EPS Estimates for Incyte Co. Lowered by Oppenheimer $INCY https://t.co/n07tVIcDPY #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
86982190,2020-05-08 09:22:15,,"SAR, ","twitter.com/Incyte/status/‚Ä¶, ",1258749052138795010,False,1,0,1,0,Twitter for Android,"Big pharma spending big money on a JAK inhibitor, #SAR have a JAK inhibitor with greater selectivity, rapid PI trial pending, potentially grant funded upto 80% or license to major within the month. It's too big not to hedge your bets. https://t.co/Nv4Qts7uRO",,,2009-11-02 12:07:28,"Newcastle Upon Tyne, England",Paul,https://pbs.twimg.com/profile_images/1267033500743499776/xW85ZBp-_normal.jpg,81,300,1,952,Num4,
374729426,2020-05-08 09:01:27,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1578442, pic.twitter.com/H1oRqd1I61, ",1258743819723407361,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator reaches oversold zone View odds for this and other indicators: https://t.co/SuaCsHv2NS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/H1oRqd1I61,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
966006214818697218,2020-05-08 06:01:25,"INCY, ",,"theenterpriseleader.com/?p=3098075, ",1258698513417998336,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Lowered by JPMorgan Chase &amp; Co.  https://t.co/vZSQRyCR7F,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2020-05-08 04:26:24,"INCY, ",,"thelincolnianonline.com/?p=3935002, ",1258674598859718657,False,0,0,0,0,Zapier.com,BidaskClub Downgrades Incyte $INCY to Hold https://t.co/8eVxmcrk0r,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1481745314,2020-05-07 15:02:38,,"pharmashots, novartis, incyte, Tabrecta, capmatinib, usfda, approval, nsclc, ","lnkd.in/gyBX8mj, ",1258472325353099264,False,1,0,0,0,LinkedIn,"Novartis and Incyte‚Äôs Tabrecta (capmatinib, INC280) Receives the US FDA‚Äôs Approval for Metastatic Non-Small Cell Lung Cancer with METex14 | #pharmashots #novartis #incyte 
#Tabrecta #capmatinib #usfda #approval #nsclc https://t.co/9E9JIJbxoQ",,,2013-06-04 04:42:08,"New Delhi, India",Adi Singh,https://pbs.twimg.com/profile_images/1047542247204446208/zYzlZzdK_normal.jpg,600,2106,12,1659,adisingh_,
575910168,2020-05-07 13:33:17,,"YahooFinance, Traffic, Transportation, Shipping, Logistics, Trucking, ","truckingnews.us/incyte-corpora‚Ä¶, ",1258449840930865153,False,0,0,0,0,Trucking News,"Incyte Corporation (NASDAQ:INCY) First-Quarter Results: Here's What Analysts Are Forecasting For This Year https://t.co/waJZnq5JC7
#YahooFinance #Traffic #Transportation #Shipping #Logistics
Follow @AFTvitaliy for #Trucking News","AFTvitaliy, ",,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
1193779847727894529,2020-05-07 13:20:03,,,"pic.twitter.com/9Mj8RTvQGR, ",1258446511748210689,False,0,0,0,0,dlvr.it,Incyte Corporation (NASDAQ:INCY) First-Quarter Results: Here's What Analysts Are Forecasting For This Year https://t.co/9Mj8RTvQGR,,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,photo
18641491,2020-05-07 12:20:04,,"AACR20, lcsm, ","goo.gl/alerts/coze6, ",1258431416016220160,False,6,0,0,2,Twitter Web Client,#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients - https://t.co/fS7vBdvLHU #lcsm,,,2009-01-05 14:13:54,"Colleyville, TX",Katie Brown,https://pbs.twimg.com/profile_images/1064569671519629315/gc2DUNrc_normal.jpg,6569,616,92,12240,brownbeansprout,
1087563377889763329,2020-05-07 12:15:22,,"Novartis, Incyte, Jakafi, ventilators, COVID19, clinicalresearch, Coronavirus, Vaccine, clinicaltrials, ","ow.ly/g9WC30qDstZ, ",1258430232551469058,False,0,0,0,0,Hootsuite Inc.,"#Novartis, #Incyte will take #Jakafi into 2nd trial for COVID-19 patients on #ventilators | FiercePharma https://t.co/VThJuu6ePi #COVID19 #clinicalresearch #Coronavirus #Vaccine #clinicaltrials",,,2019-01-21 23:11:30,"Bradenton, FL","Synergy Healthcare, LLC",https://pbs.twimg.com/profile_images/1255687146624692224/hdDn-7ye_normal.jpg,19,135,1,1173,SynergyHealthCR,
1128239740329705472,2020-05-07 12:11:45,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1258429321066057728,False,0,0,0,0,Twitter for Android,"""Having a therapy that targets the recognized oncogenic driver will provide a much needed treatment option for patients with METex14 NSCLC who currently have limited treatment options.""

$INCY 
https://t.co/4Std4iLeIH",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
617258499,2020-05-07 11:35:16,,"Pharma, ",,1258420142658269184,False,1,0,0,1,Twitter Web App,#Pharma: @MorphoSys achieved dramatic increase in liquidity in Q1 after deal with @Incyte for co-commercialisation of tafasitamab. FDA decision expected in August. see @MedNous,"MorphoSys, Incyte, MedNous, ",,2012-06-24 10:42:02,,MedNous,https://pbs.twimg.com/profile_images/2337032664/buz4y1axh5918k6qjrai_normal.jpeg,514,399,26,2395,MedNous,
374729426,2020-05-07 11:08:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1575950, pic.twitter.com/giDgkx2dsU, ",1258413510935015430,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators: https://t.co/cCyF9FR5Nn #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/giDgkx2dsU,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
750646032258793472,2020-05-07 10:59:39,,,"endpts.com/novartis-lands‚Ä¶, ",1258411175974494208,False,0,0,0,0,Twitter Web Client,"Novartis lands capmatinib approval, giving them a second potential blockbuster from Incyte - https://t.co/9STtWxe4rq",,,2016-07-06 07:02:15,"Paris, France",Mazars,https://pbs.twimg.com/profile_images/1238543616617963521/RBlZCFrU_normal.jpg,114,616,22,8618,CrMazars,
211220879,2020-05-07 09:59:37,"NVS, INCY, ","cancer, capmatinib, Tabrecta, NSCLC, ","xconomy.com/national/2020/‚Ä¶, ",1258396071300120577,False,2,0,0,2,Twitter Web Client,"In #cancer drug news, the FDA granted accelerated approval to @Novartis drug #capmatinib (#Tabrecta) for #NSCLC w/ a certain genetic mutation. $NVS licensed rights to the drug from @Incyte https://t.co/0Wix6t5ySc $INCY","Novartis, Incyte, ",,2010-11-02 13:20:59,North Carolina,Frank Vinluan,https://pbs.twimg.com/profile_images/1503948370/billy_3_normal.jpg,1579,716,105,5339,frankvinluan,
2525892205,2020-05-07 09:09:13,"INCY, ","investingnews, ","modernreaders.com/?p=3231195, ",1258383385883533313,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Shares Bought by Robeco Institutional Asset Management B.V.  https://t.co/MhItsgEtOJ #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2196742020,2020-05-07 08:08:26,,,"endpts.com/novartis-lands‚Ä¶, ",1258368088090828801,False,0,0,0,0,Twitter Web Client,"Novartis lands capmatinib approval, giving them a second potential blockbuster from Incyte - https://t.co/TTtyFEUamW",,,2013-11-15 17:52:52,,Ken Checicki,https://pbs.twimg.com/profile_images/649668229535764480/BfSrqULL_normal.jpg,33,24,0,7167,KenChecicki,
15232532,2020-05-07 06:19:06,,,"dlvr.it/RW9kSm, pic.twitter.com/BYNIbHYR9T, ",1258340575268331520,False,0,0,0,0,dlvr.it,"Novartis lands capmatinib approval, giving them a second potential blockbuster from Incyte https://t.co/105l9jxXMj https://t.co/BYNIbHYR9T",,,2008-06-25 11:32:12,"Cape Cod, MA",DennisPartners,https://pbs.twimg.com/profile_images/777939023461511168/Lqtz-Jal_normal.jpg,415,425,13,7177,DennisPartners,photo
3426014292,2020-05-07 06:13:10,"INCY, ",,"twitter.com/semodough/stat‚Ä¶, ",1258339080200491008,False,0,0,0,0,Twitter for iPhone,Baml $INCY US: Incyte Corporation: Price Objective Change - Raising PO to 108 after strong 1Q; Reiterate Buy https://t.co/joy18qTkKz,,,2015-09-02 09:10:37,,dough,https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_normal.jpg,32805,529,852,59439,semodough,
3426014292,2020-05-07 06:08:22,,,,1258337872601546752,False,4,1,0,1,Twitter for iPhone,Baml &amp;INCY US: Incyte Corporation: Price Objective Change - Raising PO to 108 after strong 1Q; Reiterate Buy,,,2015-09-02 09:10:37,,dough,https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_normal.jpg,32805,529,852,59439,semodough,
2298709746,2020-05-07 05:19:32,"INCY, ",,"zpr.io/tc9PZ, ",1258325582808526849,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Neutral at JPMorgan Chase &amp; Co. https://t.co/rRdH5eqtTP,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1022473214457348096,2020-05-07 04:32:38,,,"pharmashots.com/32622/novartis‚Ä¶, pic.twitter.com/eX5GesUk7V, ",1258313782566109184,False,2,0,0,0,Twitter Web App,"Novartis and Incyte‚Äôs Tabrecta (capmatinib, INC280) Receives the US FDA‚Äôs Approval for Metastatic Non-Small Cell Lung Cancer with METex14 @Novartis @Incyte 
https://t.co/3cHbbYCzGx https://t.co/eX5GesUk7V","Novartis, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,photo
1479442159,2020-05-07 02:08:09,,,,1258277420475408385,False,0,0,0,0,Twitter Web App,COVID 19: Cost of ruxolitinib 5mg one box is approximately Rs.185000.Incyte announced that they are working with FDA to initiate a phase III clinical trial to assess ruxolitinib plus standard-of-care in patients with coronavirus disease 2019 (COVID-19) induced cytokine storm.,,,2013-06-03 06:51:07,"Allahabad,U.P.,India",Dr.Virendra Singh,https://pbs.twimg.com/profile_images/3767381202/99d598cfb2c950db95172abfa161ada0_normal.png,3090,3202,7,8005,singhv2003,
424089030,2020-05-06 22:40:58,,,"endpts.com/novartis-lands‚Ä¶, ",1258225282143707136,False,0,0,0,0,Twitter Web Client,"Novartis lands capmatinib approval, giving them a second potential blockbuster from Incyte - https://t.co/5SLxlVo46j",,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
838428908336734208,2020-05-06 19:50:38,,,"twitter.com/Incyte/status/‚Ä¶, ",1258182414830120960,False,2,0,0,0,Twitter for iPhone,"Congrats to the @Incyte team. That's four approved medicines for those counting, all discovered by a remarkably talented group of only ~150 drug discovery scientists! https://t.co/Fp7iZbwjQC","Incyte, ",,2017-03-05 11:40:03,"Boston, MA",Reid Huber,https://pbs.twimg.com/profile_images/1450546865947099140/yJtYSl44_normal.jpg,182,164,3,134,ReidHuber,
2181281054,2020-05-06 17:43:49,"INCY, ","markets, ","wkrb13.com/?p=1779763, ",1258150499397914624,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Credit Suisse Group https://t.co/FHtiUobL28 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
133504478,2020-05-06 17:34:36,,"strategy, competitiveintelligence, marketing, pharma, biotech, healthcare, productmarketing, pharmaceutical, ","dlvr.it/RW88YC, lqventures.com, pic.twitter.com/R9KvimLcgU, ",1258148180245413888,False,0,0,0,1,dlvr.it,"Novartis lands capmatinib approval, giving them a second potential blockbuster from Incyte https://t.co/GbAitmfJtS &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharma #biotech #healthcare #productmarketing #pharmaceutical https://t.co/R9KvimLcgU",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
732361939490312192,2020-05-06 17:04:53,"INCY, ","markets, ","americanbankingnews.com/?p=14412814, ",1258140704318111745,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúHold‚Äù Rating Reiterated at Credit Suisse Group https://t.co/Pu7Kze3IyO #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-06 17:04:53,"INCY, ","stocks, ","americanbankingnews.com/?p=14412814, ",1258140702183129090,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúHold‚Äù Rating Reiterated at Credit Suisse Group https://t.co/TU7OvAV1CH #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2525892205,2020-05-06 16:28:13,"INCY, ","investingnews, ","modernreaders.com/?p=3227363, ",1258131474378903555,False,0,0,0,0,Zapier.com,Royal Bank of Canada Boosts Incyte $INCY Price Target to $91.00  https://t.co/SKmFWGCuUX #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
46297868,2020-05-06 16:26:32,,,"dlvr.it/RW80Hk, ",1258131050821070849,True,0,0,0,0,dlvr.it,"Novartis lands capmatinib approval, giving them a second potential blockbuster from Incyte https://t.co/HfijYF8YPY",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
102754598,2020-05-06 16:21:21,,,"endpts.com/novartis-lands‚Ä¶, ",1258129748825460736,False,7,0,0,0,TweetDeck,"Novartis lands capmatinib approval, giving them a second potential blockbuster from Incyte
From @Jasonmmast
https://t.co/qRs5ZfNikq","Jasonmmast, ",,2010-01-07 13:33:18,VT and TX (yes),John Carroll,https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_normal.jpeg,61485,280,1456,48410,JohnCendpts,
1215344216798310402,2020-05-06 15:58:54,"INCY, NVS, ","NSCLC, ",,1258124098699497479,False,0,0,0,0,Twitter Web App,$INCY Incyte announces that the FDA has approved exclusive licensee $NVS Novartis' Tabrecta for the treatment of adult patients with metastatic non-small cell lung cancer #NSCLC whose tumors have a mutation that leads to MET exon 14 skipping as detected by an FDA-approved test,,,2020-01-09 13:47:07,,Stock Market Society,https://pbs.twimg.com/profile_images/1215344591282458624/6OSzLTru_normal.jpg,669,8,5,2210,StockFanatic,
2283601764,2020-05-06 15:38:05,,"capmatinib, ","fda.gov/news-events/pr‚Ä¶, ",1258118859338350592,False,3,0,0,0,Twitter Web App,"Today MET has completed the long journey from biomarker discovery to FDA approval with today‚Äôs approval of #capmatinib in METex14+ NSCLC based on GEOMETRY mono-1 study. F1CDx is the approved CDx. Bravo: @NovartisCancer @Incyte @FoundationATCG 

https://t.co/yrkIYEuFwx","NovartisCancer, Incyte, FoundationATCG, ",,2014-01-09 08:44:36,"Seattle, WA",Mason Israel,https://pbs.twimg.com/profile_images/421279866319687680/5pgb1TcX_normal.jpeg,301,626,1,244,MasonIsraelPhD,
1006334607946649600,2020-05-06 15:22:02,,,"dlvr.it/RW7qbq, ",1258114819510562817,False,0,0,0,0,dlvr.it,Incyte Announces FDA Approval of Tabrecta‚Ñ¢ (capmatinib) for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with METex14 https://t.co/IUtpxRpBFI,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
3318510966,2020-05-06 14:57:40,,,"crweworld.com/article/news-p‚Ä¶, ",1258108689208111104,False,0,0,0,0,CRWE World,Incyte Announces FDA Approval of Tabrecta‚Ñ¢ (capmatinib) for the Treatment of Patients with Metastatic Non-Small Ce https://t.co/CT3BrqcslX,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
472650465,2020-05-06 14:47:15,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1258106067969605632,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces FDA Approval of Tabrecta‚Ñ¢ (capmatinib) for the Treatment of Patients with Metastatic N https://t.co/nMoasvoLvM,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1254906887490936845,2020-05-06 14:42:21,"INCY, ",,,1258104835330768896,False,0,0,0,0,Quant Data (Production),"BZ NOTE: Tabrecta Is Molecule Discovery By Incyte Scientists
2:42:13pm
Related Tickers: $INCY",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
1134049078424162304,2020-05-06 14:42:17,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1258104818482241536,False,0,0,0,0,Newsfilter.io,Incyte Announces FDA Approval of Tabrecta‚Ñ¢ for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with METex14 $INCY https://t.co/FqmMIsHfBL,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1254906887490936845,2020-05-06 14:42:00,"INCY, ",,,1258104747837526017,False,0,0,0,0,Quant Data (Production),"Incyte Issues Press Release Highlighting FDA Approval Of Novartis' Tabrecta
2:41:40pm
Related Tickers: $INCY +1",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
852931863547084801,2020-05-06 14:37:42,"INCY, ",,"zpr.io/tchVx, ",1258103662691463173,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to $120.00 https://t.co/VahylYbmvA,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
852931863547084801,2020-05-06 14:37:41,"INCY, ",,"zpr.io/tchVX, ",1258103659432480769,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $90.00 at BMO Capital Markets https://t.co/gagbuE2K8w,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
852931863547084801,2020-05-06 14:37:40,"INCY, ",,"zpr.io/tchVN, ",1258103654369853441,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at Nomura https://t.co/4BQrPJsa4F,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2525892205,2020-05-06 14:36:35,"INCY, ","investingnews, ","modernreaders.com/?p=3227005, ",1258103383883501570,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at Nomura  https://t.co/yu4kAken5M #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
952915431123312640,2020-05-06 14:01:58,,"clinicaltrial, pemigatinib, cholangiocarcinoma, cancer, oncology, ","twitter.com/FDA_Drug_Info/‚Ä¶, ",1258094669378043906,False,2,0,0,0,Twitter for Android,"The @US_FDA snapshot is a great tool for understanding the #clinicaltrial design behind new drug approvals.
See below for details about the trial which led to approval of #pemigatinib for metastatic #cholangiocarcinoma with FGFR2 gene abnormalities

@Incyte #cancer #oncology https://t.co/m4I7Xb6jZ9","US_FDA, Incyte, ",,2018-01-15 09:48:37,"Somerset, NJ",Kognitic,https://pbs.twimg.com/profile_images/963572647190847490/XZrEjsbM_normal.jpg,26,108,0,80,KogniticAi,
732361939490312192,2020-05-06 13:50:30,"INCY, ","markets, ","americanbankingnews.com/?p=14410941, ",1258091783302627328,False,0,0,0,0,Zapier.com,Nomura Reiterates Buy Rating for Incyte $INCY https://t.co/yjPumuvwpm #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-06 13:50:29,"INCY, ","stocks, ","americanbankingnews.com/?p=14410941, ",1258091781264195585,False,0,0,0,0,Zapier.com,Nomura Reiterates Buy Rating for Incyte $INCY https://t.co/RVXZoiM6kw #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
778915554472169473,2020-05-06 13:21:59,"MGNX, Incy, AGEN, ","stock, PLUS, ",,1258084608165453824,False,3,0,1,0,Twitter Web App,"$MGNX Spectacular last hours of skyrocketing #stock' price. 
#PLUS 259%.  
Partnership with @Incyte $Incy, for MGA012, its investigational anti-PD-1, is bearing fruit. 
Let us hope that someday, @Agenus_Bio $AGEN partnership with @Incyte give the same results.","Incyte, Agenus_Bio, Incyte, ",,2016-09-22 07:15:14,,Kananda Barrons,https://pbs.twimg.com/profile_images/800651069789454336/4_nrntG0_normal.jpg,225,10,3,1928,KanandaBarrons,
732361939490312192,2020-05-06 11:59:59,"INCY, ","markets, ","americanbankingnews.com/?p=14410090, ",1258063971866853378,False,0,0,0,0,Zapier.com,BMO Capital Markets Increases Incyte $INCY Price Target to $90.00 https://t.co/EJhEYoBZUt #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-06 11:59:58,"INCY, ","stocks, ","americanbankingnews.com/?p=14410090, ",1258063970029756416,False,0,0,0,0,Zapier.com,BMO Capital Markets Increases Incyte $INCY Price Target to $90.00 https://t.co/I64ypaA1jq #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1254906887490936845,2020-05-06 11:21:11,"INCY, ",,,1258054208982519809,False,0,0,0,0,Quant Data (Production),"BMO Capital Maintains Market Perform on Incyte, Raises Price Target to $90
11:20:53am
Related Tickers: $INCY",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
2416188264,2020-05-06 11:18:44,"INCY, ","markets, ","thestockobserver.com/?p=2942951, ",1258053591815917568,False,0,0,0,0,Zapier.com,"Incyte $INCY Posts Quarterly Earnings Results, Misses Estimates By $3.24 EPS  https://t.co/T7bI0lhasu #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2920258887,2020-05-06 11:18:35,"INCY, ",,"dakotafinancialnews.com/?p=1873983, ",1258053555937857537,False,0,0,0,0,Zapier.com,Incyte $INCY Announces Earnings Results https://t.co/oqGJKEX9Gx,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
966006214818697218,2020-05-06 11:15:18,"INCY, ",,"theenterpriseleader.com/?p=3091595, ",1258052726535192576,False,0,0,0,0,Zapier.com,Incyte $INCY Announces Earnings Results  https://t.co/kVNTzVY52i,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
732361939490312192,2020-05-06 09:55:08,"INCY, ","markets, ","americanbankingnews.com/?p=14409495, ",1258032553178664961,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Increased to $91.00 by Analysts at Royal Bank of Canada https://t.co/7dZBECly6N #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-06 09:55:07,"INCY, ","stocks, ","americanbankingnews.com/?p=14409495, ",1258032550670467073,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Increased to $91.00 by Analysts at Royal Bank of Canada https://t.co/7tGOZ5mZY1 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-05-06 09:23:49,"INCY, ","markets, ","americanbankingnews.com/?p=14409362, ",1258024673482326016,False,0,0,0,0,Zapier.com,Oppenheimer Reaffirms ‚ÄúOutperform‚Äù Rating for Incyte $INCY https://t.co/LNQEVtGpvA #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-06 09:23:49,"INCY, ","stocks, ","americanbankingnews.com/?p=14409362, ",1258024671469088768,False,0,0,0,0,Zapier.com,Oppenheimer Reaffirms ‚ÄúOutperform‚Äù Rating for Incyte $INCY https://t.co/X9HgGlfbrN #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
391492257,2020-05-06 09:00:12,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, fdatracker.com/fda-calendar/, ",1258018729088016387,False,0,0,0,0,FDA Tracker,$INCY New PDUFA Date 2020-08-30 INCYTE CORP Link:https://t.co/kniz2tZt8X Calendar:https://t.co/sCt1qKoMdr,,,2011-10-15 13:01:13,San Francisco,FDA Tracker,https://pbs.twimg.com/profile_images/1667207308/square_logo_normal.png,4992,14,113,4060,fda_tracker,
192932393,2020-05-06 08:51:53,,,"fiercepharma.com/pharma/novarti‚Ä¶, ",1258016637300637698,False,0,0,0,1,Scoop.it,"Novartis, Incyte will take Jakafi into 2nd trial for COVID-19 patients on ventilators | @scoopit https://t.co/9AMLXQLxn7","scoopit, ",,2010-09-20 11:07:16,San Vito al Tagliamento (Italy,Emilio Mordini,https://pbs.twimg.com/profile_images/964259628019265537/eGSR2rvM_normal.jpg,431,966,11,30017,emiliomordini,
1254906887490936845,2020-05-06 08:39:47,"INCY, ",,,1258013588893073408,False,0,0,0,0,Quant Data (Production),"Incyte shares are trading lower after JP Morgan analysts downgraded the company's stock from Overweight to Neutral.
8:39:25am
Related Tickers: $INCY",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
374729426,2020-05-06 08:12:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1571616, pic.twitter.com/B4SF94l9wy, ",1258006751233753090,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/LrbfUfTF5g #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/B4SF94l9wy,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3426014292,2020-05-06 08:06:22,"InCY, ",,,1258005180517359618,False,1,1,0,0,Twitter for iPhone,"JP $InCY Incyte Corporation
1Q Snapshot - Downgrading to Neutral as We've JAK'd Up the Valuation as Much as We Can for Now",,,2015-09-02 09:10:37,,dough,https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_normal.jpg,32805,529,852,59439,semodough,
725577499,2020-05-06 07:16:29,"INCY, ",,"blog.tipranks.com/incyte-reports‚Ä¶, ",1257992627426938880,False,0,0,0,0,Twitter Web App,"Incyte Reports Strong Jakafi Sales, But Recent Rally Sparks Downgrades $INCY https://t.co/n8IKFTxiQa",,,2012-07-30 03:57:38,,TipRanks,https://pbs.twimg.com/profile_images/1445275766195884032/dO0joyh1_normal.jpg,25516,1242,436,23612,TipRanks,
2612788123,2020-05-06 06:28:05,"INCY, ",,,1257980447071428609,False,0,0,0,0,TweetDeck,$INCY JP Morgan Downgrades Incyte to Neutral,,,2014-07-08 22:13:20,,MStang,https://pbs.twimg.com/profile_images/486698998728642560/jI7DiDYR_normal.jpeg,212,573,7,8251,StockJock22,
818081647,2020-05-06 06:25:27,"INCY, ",,"streetinsider.com/r/16839400, ",1257979783146848256,False,0,0,0,0,StreetInsider.com Integration,Incyte $INCY PT Raised to $91 at RBC Capital https://t.co/8vRZ2Zv4T5,,,2012-09-11 15:57:26,,SIAnalystWire,https://pbs.twimg.com/profile_images/2600218874/alkkkjlbds18yu6ld9xj_normal.png,4980,1,230,118501,AnalystWire,
15974185,2020-05-06 05:48:33,,,"dlvr.it/RW5zlJ, ",1257970500745089029,False,0,0,0,0,dlvr.it,Why Incyte's Q1 Loss Isn't As Bad As It Looks https://t.co/04HqsOUUkz,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1254906887490936845,2020-05-06 05:18:04,"INCY, ",,,1257962826368516096,False,0,0,0,0,Quant Data (Production),"JP Morgan Downgrades Incyte to Neutral
5:17:42am
Related Tickers: $INCY",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
730032660,2020-05-06 05:17:56,,,"nonsell.com/us-market-news‚Ä¶, pic.twitter.com/Miwl37nCzx, ",1257962794227388423,False,0,0,0,0,NonSell Twitter,"Why Incyte's Q1 Loss Isn't As Bad As It Looks - [US Market News], Source: Motley Fool Market News - https://t.co/kQuzdEEW8b https://t.co/Miwl37nCzx",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,photo
392647517,2020-05-06 04:21:28,"SAR.L, ","AIM, biotech, Covid, ","fiercepharma.com/pharma/novarti‚Ä¶, ",1257948584777039872,False,31,2,2,19,Twitter Web App,"""Now, seeing promise in another category of coronavirus-afflicted patients, the partners will take [JAK inhibitor] Jakafi into a 2nd late-stage trial.""  https://t.co/hmtkE9sTgg
Sareum $SAR.L #AIM #biotech #Covid-19",,,2011-10-17 07:07:07,"Cambridge, UK",Sareum Holdings plc,https://pbs.twimg.com/profile_images/1721874255/Blue2_normal.jpg,1577,431,0,429,Sareumplc,
732361939490312192,2020-05-05 23:10:48,"INCY, ","markets, ","americanbankingnews.com/?p=14405265, ",1257870401818025984,False,0,0,0,0,Zapier.com,Incyte $INCY Announces Earnings Results https://t.co/RYArDZRZJq #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-05 23:10:48,"INCY, ","stocks, ","americanbankingnews.com/?p=14405265, ",1257870400001900544,False,0,0,0,0,Zapier.com,Incyte $INCY Announces Earnings Results https://t.co/KQprsyiNXA #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-05-05 22:36:43,"INCY, ","markets, ","americanbankingnews.com/?p=14404969, ",1257861822499237889,False,0,0,0,0,Zapier.com,JPMorgan Chase &amp; Co. Downgrades Incyte $INCY to Neutral https://t.co/Wu1js7Lnub #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-05-05 22:36:42,"INCY, ","stocks, ","americanbankingnews.com/?p=14404969, ",1257861820171390976,False,0,0,0,0,Zapier.com,JPMorgan Chase &amp; Co. Downgrades Incyte $INCY to Neutral https://t.co/YlEOFHW5nG #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
424089030,2020-05-05 21:19:56,,,"fiercepharma.com/pharma/novarti‚Ä¶, ",1257842500645130242,False,0,0,0,0,Twitter Web Client,"Novartis, Incyte will take Jakafi into 2nd trial for COVID-19 patients on ventilators https://t.co/gkaAS1SHtK",,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
896877581940781056,2020-05-05 20:24:23,,,"oleantimesherald.com/business/incyt‚Ä¶, ",1257828522908807168,False,0,0,0,0,boutlineprod,"https://t.co/7ySi5fiwLp  
  All Access members receive unlimited access to our website and e-edition..",,,2017-08-13 19:34:13,"Austin, TX",Eager Beaver,https://pbs.twimg.com/profile_images/896879927286530049/06qmSNcs_normal.jpg,121,0,6,205300,eagerbeavertech,
94092819,2020-05-05 17:12:51,,"Incyte, ","finance.yahoo.com/news/incyte-in‚Ä¶, ",1257780321195606019,False,0,0,0,0,Twitter for Android,"#Incyte (INCY) Reports Q1 Loss, Tops Revenue Estimates https://t.co/Y4JwYP9zU1",,,2009-12-02 08:47:46,"Ferrara, Emilia Romagna",AndreaF87 üìàü¶Å,https://pbs.twimg.com/profile_images/918080528468803584/W3Men4iF_normal.jpg,1774,2392,173,90837,Andreacocco87,
94092819,2020-05-05 17:10:55,,"Incyte, ","businesswire.com/news/home/2020‚Ä¶, ",1257779832278208514,False,0,0,0,0,Twitter for Android,#Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs | Business Wire https://t.co/h5Ar2Nugfu,,,2009-12-02 08:47:46,"Ferrara, Emilia Romagna",AndreaF87 üìàü¶Å,https://pbs.twimg.com/profile_images/918080528468803584/W3Men4iF_normal.jpg,1774,2392,173,90837,Andreacocco87,
1100450877792370688,2020-05-05 17:09:24,"INCY, ",,"blueequity.io/r/107705/de-in‚Ä¶, ",1257779453368733701,False,0,0,0,0,Blue Equity,$INCY Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/XNRsUZFHni,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
773578537764851712,2020-05-05 16:35:03,"INCY, ",,"sitefocus.com/ei-product, ",1257770806265827328,False,0,0,0,0,CIF-QBA,"$INCY Earnings Intelligence Analysis of recent earnings identified Incyte Corp.  (NASDAQ: INCY ) business focus on (fda,positive,ruxolitinib), (fda,global,ruxolitinib), (itch,ruxolitinib)

https://t.co/4nOHfhdno3",,,2016-09-07 13:47:50,"Cupertino, CA",SiteFocus,https://pbs.twimg.com/profile_images/908465036598820864/6ZQsC4KD_normal.jpg,195,35,8,57439,SiteFocusHQ,
23059499,2020-05-05 16:21:22,"INCY, ","economy, investing, stocks, ","seekingalpha.com/article/434325‚Ä¶, ",1257767362792525825,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation (INCY) CEO Herv√© Hoppenot on Q1 2020 Results - Earnings Call Transcript. https://t.co/BLrQZPImGA #economy #investing #stocks,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
1029128656650555393,2020-05-05 16:20:10,,"covid19, ","fiercepharma.com/pharma/novarti‚Ä¶, ",1257767064258961408,False,0,0,0,0,Hootsuite Inc.,"Novartis, Incyte will take Jakafi into 2nd trial for COVID-19 patients on ventilators | @novartis #covid19 https://t.co/GBheKyxHZo","Novartis, ",,2018-08-13 18:12:46,,Pharm2Market,https://pbs.twimg.com/profile_images/1041479880368484353/xr9ZBpXF_normal.jpg,190,849,2,2538,pharm2market,
2656754371,2020-05-05 16:15:04,,"covid19, ","fiercepharma.com/pharma/novarti‚Ä¶, ",1257765778859974656,False,0,0,0,0,Hootsuite Inc.,"Novartis, Incyte will take Jakafi into 2nd trial for COVID-19 patients on ventilators | @novartis #covid19 https://t.co/RhF4AtdGwu","Novartis, ",,2014-07-18 09:20:39,San Diego,Aspen Biosciences,https://pbs.twimg.com/profile_images/1006725217568186368/B34yK1F1_normal.jpg,316,725,33,6079,aspenbio,
3300865039,2020-05-05 15:16:06,"INCY, NVS, ","stocks, investingnews, biotech, ","investors.com/news/technolog‚Ä¶, ",1257750938816843779,False,1,0,0,0,Hootsuite Inc.,"$INCY stock dips back into buy zone on surprise loss, delayed study. #stocks #investingnews #biotech $NVS https://t.co/NcJ7YBoH3M",,,2015-07-29 15:22:19,"California, USA",Allison Gatlin,https://pbs.twimg.com/profile_images/1379079645480378371/V22zIHh9_normal.jpg,6295,1000,201,6646,IBD_AGatlin,
963495628545327104,2020-05-05 14:43:06,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/Fra09zgmMz, ",1257742635646832640,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Why Incyte's Q1 Loss Isn't As Bad As It Looks https://t.co/1VlcPwkkUV Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/Fra09zgmMz,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
4312114277,2020-05-05 14:08:54,"INCY, ",,"fintel.io/sfs/us/incy?ut‚Ä¶, ",1257734027429187585,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 8-K - Results of Operations and Financial Condition -  FORM 8K https://t.co/xljeWddlXw,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,163,418542,fintel_io,
1085216451491971072,2020-05-05 13:40:21,,,"fiercepharma.com/pharma/novarti‚Ä¶, ",1257726841999196162,False,0,0,0,1,Twitter Web Client,"Novartis, Incyte will take Jakafi into 2nd phase III trial for COVID-19 patients on ventilators https://t.co/dwI1uE535N",,,2019-01-15 11:45:39,"Philadelphia, PA",Drug Discovery & Development Master's at Drexel,https://pbs.twimg.com/profile_images/1085220957206261760/8Ety37pg_normal.jpg,184,516,1,424,DDDatDrexel,
46297868,2020-05-05 11:33:32,,,"dlvr.it/RW3QX7, ",1257694927741259776,True,0,0,0,1,dlvr.it,"Novartis, Incyte will take Jakafi into 2nd trial for COVID-19 patients on ventilators https://t.co/gg5Tq0Vww0",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
963495628545327104,2020-05-05 11:09:18,"INCY, MOR, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/NtDgroYMQZ, ",1257688828732682246,False,0,0,0,0,STCK.PR0,$INCY $MOR NEW ARTICLE : Incyte Reports a Q1 Loss Due to MorphoSys Deal https://t.co/62g1MkEcFf Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/NtDgroYMQZ,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
3686628867,2020-05-05 10:22:01,,,"pharmaceuticaldaily.com/incyte-reports‚Ä¶, ",1257676930394009603,False,0,0,0,0,WordPress.com,Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical¬†Programs https://t.co/yS6OGwHs2x,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
3686628867,2020-05-05 10:22:01,,,"pharmaceuticaldaily.com/incyte-reports‚Ä¶, ",1257676930180165637,False,0,0,0,0,WordPress.com,Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical¬†Programs https://t.co/hWuShbxIsr,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
72928001,2020-05-05 09:06:07,"INCY, ",,"bit.ly/3fkgZsJ, ",1257657830724624384,False,0,0,0,0,BriefingInPlayLimited,"$INCY: Incyte misses by $2.50, beats on revs; reaffirms FY 20 guidance for Jakafi and Iclusig net product revs https://t.co/qwLVdsEe7N",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
3318510966,2020-05-05 09:00:19,,,"crweworld.com/article/market‚Ä¶, ",1257656368523120641,False,0,0,0,0,CRWE World,"Incyte Slips To Loss In Q1, Despite Higher Revenues - Quick Facts  https://t.co/mfOy5Dx5ML",,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
23059499,2020-05-05 08:56:55,"INCY, ","markets, stockmarket, investing, ","seekingalpha.com/article/434300‚Ä¶, ",1257655516404150272,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation 2020 Q1 - Results - Earnings Call Presentation. https://t.co/NQ8hOVUyZm #markets #stockmarket #investing,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
201778326,2020-05-05 08:53:38,,"COVID19, MedTech, Treatment, Development, ","twitter.com/DeepTech_VC/st‚Ä¶, ",1257654687471480833,False,0,0,0,0,Twitter Web App,"üëèüëèüëè
‚öï  #COVID19 #MedTech Industry Landscape by sector:
- #Treatment #Development 

@CytoDyn @GileadSciences @Regeneron @sanofi @TakedaPharma @Vir_Biotech @Synairgenplc @BioCrystPharma  @MateonTX @distributedbio @Incyte @athersys @Bayer @celularity https://t.co/ZegzhLPneR","CytoDyn, GileadSciences, Regeneron, sanofi, TakedaPharma, Vir_Biotech, Synairgenplc, BioCrystPharma, Incyte, athersys, Bayer, celularity, ",,2010-10-12 12:10:00,London,Tanya B.,https://pbs.twimg.com/profile_images/1290699276562108417/dxh9CKCD_normal.jpg,140,2095,0,6188,Tessa_DKV,
963495628545327104,2020-05-05 08:10:06,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1257643731827798018,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Q1 Jakafi sales up 22%; guidance affirmed https://t.co/9AuiTJag8Q Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
374729426,2020-05-05 08:07:15,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1567395, pic.twitter.com/Bi7A21KEIy, ",1257643014429667328,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators: https://t.co/1OCsj3Gb3G #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Bi7A21KEIy,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1573321154,2020-05-05 07:55:19,"INCY, ",,"eps.sh/d/INCY, ",1257640013598253056,False,0,0,0,0,Twitter for Android,Incyte $INCY reported 1Q 2020 loss of ($2.86) via @eWhispers  https://t.co/weBKZJLLL2,"eWhispers, ",,2013-07-06 13:52:11,"Buenos Aires, Argentina",Ariel Gonzalez,https://pbs.twimg.com/profile_images/378800000096793503/23ba6f00eb37e37b20649e0479c1acd9_normal.jpeg,457,1857,5,35989,argonzalez89,
4876582225,2020-05-05 07:50:32,"INCY, ",,"ideas.quantcha.com/2020/05/05/sto‚Ä¶, pic.twitter.com/cirMqXDwI8, ",1257638810223022083,False,0,0,0,0,WordPress.com,StockTwits Trending Alert: Trading recent interest in INCYTE¬†$INCY https://t.co/d6whKO7Ohh https://t.co/cirMqXDwI8,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,photo
472650465,2020-05-05 07:40:34,"INCY, ",,"otcdynamics.com/incy-incyte-re‚Ä¶, ",1257636299755991041,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/Mhhtv2VbV7,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
25406480,2020-05-05 07:23:39,,,"awesomecapital.blogspot.com/2020/05/incyte‚Ä¶, ",1257632044085129216,False,0,0,0,1,Twitter Web Client,"AwesomeCapital: Incyte EPS misses by $2.50, beats on revenue https://t.co/X5gJ6Y1hxM",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
772471873539977217,2020-05-05 07:23:11,"INCY, ",,"sec.gov/ix?doc=/Archiv‚Ä¶, ",1257631926485213184,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 8-K https://t.co/5C5WcCr8Kq,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
963495628545327104,2020-05-05 07:21:14,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/mKAbOyjsiG, ",1257631433339928576,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Revenue Beats Despite Surprise Q1 Loss https://t.co/azz50KE9xU Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/mKAbOyjsiG,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
19419395,2020-05-05 07:18:35,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1257630768253276160,False,0,0,0,0,TweetDeck,"$INCY
https://t.co/VBtKHRaMVe",,,2009-01-23 18:01:59,"Burlington, MA",Raul Ramirez,https://pbs.twimg.com/profile_images/1363988607/dna_helix_next_generation_istock_000004837646small_normal.jpg,760,121,31,4411,biotechtrader34,
3318510966,2020-05-05 07:16:52,,,"crweworld.com/article/news-p‚Ä¶, ",1257630334692159493,False,0,0,0,0,CRWE World,Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/P47d3olZjR,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1171873456276889600,2020-05-05 07:15:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1257630075526266882,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (5 May, 7:14am)

üì∞ Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs

https://t.co/GULyuA9wm9

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1637027690,2020-05-05 07:13:21,,,"ift.tt/2YAlUjj, ",1257629450570792960,False,0,0,0,0,IFTTT,"Incyte EPS misses by $2.50, beats on revenue https://t.co/NYLJwgL8ww",,,2013-07-31 23:30:55,Everywhere,Ashish Aggarwal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,557,0,4776,AggarwalTweets,
2612788123,2020-05-05 07:11:42,"INCY, ",,,1257629037603815424,False,0,0,0,0,TweetDeck,"$INCY Incyte Q1 Adj. EPS $(2.86) Vs. $0.61 Est., Sales $569.00M Beat $556.04M Est.",,,2014-07-08 22:13:20,,MStang,https://pbs.twimg.com/profile_images/486698998728642560/jI7DiDYR_normal.jpeg,212,573,7,8251,StockJock22,
108617488,2020-05-05 07:10:02,,,"invst.ly/qolui, ",1257628617703673856,False,0,0,0,0,FP News Publisher - COM,"Incyte Earnings Miss, Revenue Beats In Q1 - https://t.co/BPnimRHZrb",,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
185663478,2020-05-05 07:09:51,"INCY, ",,"seekingalpha.com/news/3568967-i‚Ä¶, ",1257628571708899329,False,0,0,0,0,Twitter for iPhone,"$INCY Q1 Non-GAAP EPS of -$2.86 misses by $2.50; GAAP EPS of -$3.33 misses by $2.08.
Revenue of $568.51M (+14.2% Y/Y) beats by $15.27M. https://t.co/RUVlqKFJFl",,,2010-09-01 10:52:28,"Chicago, IL",CHItraders,https://pbs.twimg.com/profile_images/623935252357058560/AaeCRlHB_normal.jpg,1253,501,63,45319,CHItraders,
963495628545327104,2020-05-05 07:09:24,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1257628459171545095,False,0,0,0,0,STCK.PR0,"$INCY NEW ARTICLE : Incyte EPS misses by $2.50, beats on revenue https://t.co/8csQZ8jUrO Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
976297820532518914,2020-05-05 07:08:39,,,"dlvr.it/RW2cbw, pic.twitter.com/r3m0jer0V9, ",1257628268145983488,False,0,0,0,0,dlvr.it,Incyte Reports 2020 First Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/cH9E8d3Wcm https://t.co/r3m0jer0V9,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3911174913,2020-05-05 07:07:34,,,,1257627996443283456,False,3,0,0,0,Twitter for Advertisers.,Incyte reports 2020 Q1 financial results &amp; provides updates on key clinical programs. Read our press release.,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
15296897,2020-05-05 07:06:30,"INCY, ",,"seekingalpha.com/news/3568967-i‚Ä¶, ",1257627727831547909,False,1,0,0,0,SANewsTwitter,"$INCY - Incyte EPS misses by $2.50, beats on revenue https://t.co/qr7OCGppzw",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1254906887490936845,2020-05-05 07:04:25,"INCY, ",,,1257627204994899968,False,0,0,0,0,Quant Data (Production),"Incyte Q1 Adj. EPS $(2.860) Does Not Compare To $0.610 Estimate, Sales $569.000M Beat $555.720M Estimate
7:04:10am
Related Tickers: $INCY",,,2020-04-27 18:55:07,"Florida, U.S.",Quant Data,https://pbs.twimg.com/profile_images/1313651546211733505/o_KuWA_y_normal.jpg,8194,57,160,97190,QuantData,
2812632288,2020-05-05 07:03:03,,,"invst.ly/qolui, ",1257626857924689923,False,0,0,0,0,ForexPros News & Analysis,"Incyte Earnings Miss, Revenue Beats In Q1 - https://t.co/QNn0ZROnIt",,,2014-09-16 03:56:03,Worldwide,Investing.com Stocks,https://pbs.twimg.com/profile_images/1108338732019695616/CAvg-ixc_normal.png,20430,38,256,339289,InvestingStockz,
2236026002,2020-05-04 19:05:02,,,"dlvr.it/RW16Gk, ",1257446164460376065,False,0,0,0,0,dlvr.it,"Hypopharyngeal Cancer Treatment Market Insights 2020: Business Analysis By 2028 With Leading Players:Celldex Therapeutics Inc, Incyte Corp, Madrigal Pharmaceuticals Inc., Merck &amp; Co Inc ‚Äì Cole Reports - Cole of Duty https://t.co/nIJIjWrqwt",,,2013-12-08 08:11:27,Also see: @Cancer_Buzz,Swallow This - The War On Cancer! üò∑,https://pbs.twimg.com/profile_images/834284957979856897/L5SV0js3_normal.jpg,493,35,23,8734,miracle_cures,
963495628545327104,2020-05-04 17:33:09,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1257423039555346435,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Q1 2020 Earnings Preview https://t.co/6nlVk901Hg Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
15296897,2020-05-04 17:30:32,"INCY, ",,"seekingalpha.com/news/3568496-i‚Ä¶, ",1257422381787856898,False,0,0,0,0,SANewsTwitter,$INCY - Incyte Q1 2020 Earnings Preview https://t.co/kojgejYKUg,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1193779847727894529,2020-05-04 17:15:02,,,"pic.twitter.com/1YY1QjhYq5, ",1257418484155322368,False,0,0,0,0,dlvr.it,Were Hedge Funds Right About Incyte Corporation (INCY)? https://t.co/1YY1QjhYq5,,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,photo
778267752679235585,2020-05-04 12:31:41,,,"stockmarketdaily.co/2020/05/04/inc‚Ä¶, pic.twitter.com/YF4hbeyNKQ, ",1257347174100340737,False,0,0,0,0,StockMarketDaily,Incyte Corporation may delivered a positive earnings surprise (NASDAQ:INCY) - https://t.co/xaWuBZV91c https://t.co/YF4hbeyNKQ,,,2016-09-20 12:21:06,"London, England",StockMarketDaily,https://pbs.twimg.com/profile_images/778269172304412672/i_uC_akM_normal.jpg,334,36,4,45471,SMDailyCo,photo
1140762699002871808,2020-05-04 09:56:17,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1257308066397093890,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-05-04 09:56 EST. *Closed/Sold:
$INCY at $99.71 for 0.01 loss (-0.01%). Incyte Corporation - Common Stock
Trade Id: 41781669503009053.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
374729426,2020-05-04 07:51:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1563156, pic.twitter.com/Jl4BD38kgw, ",1257276688976633857,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator driving into oversold zone View odds for this and other indicators: https://t.co/Yn8fVL698q #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Jl4BD38kgw,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
17975357,2020-05-04 06:01:14,"INCY, LLY, TBPH, ","JAK, COVID19, ","pharmaceutical-technology.com/comment/incyte‚Ä¶, ",1257248913695760384,False,0,0,1,0,Twitter Web App,$INCY &amp; $LLY #JAK Inhibitors Jakafi and Olumiant may have a mechanistic edge over $PFE‚Äôs Xeljanz in #COVID19. $TBPH pan-JAK TD-0903 nebulised delivery stands out but there is uncertainty about its value. Check out our coverage here: https://t.co/4L8s1QQVZ2,,,2008-12-08 17:16:08,"Boston, New York, London",BioPharm Insight,https://pbs.twimg.com/profile_images/712713024058953728/Di3cK2Xf_normal.jpg,5697,1090,205,2579,BioPharmInsight,
2525892205,2020-05-04 05:24:37,"INCY, ","investingnews, ","modernreaders.com/?p=3214031, ",1257239699091075072,False,0,0,0,0,Zapier.com,Incyte $INCY Set to Announce Earnings on Tuesday  https://t.co/NwUKVloJuU #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
374729426,2020-05-04 04:34:20,"INCY, ","Incyte, stockmarket, stock, earnings, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1560916, ",1257227045609693186,False,0,0,0,0,Tickeron,"Incyte Corp. to report earnings on May 05, 2020. Earnings per share (EPS) estimate: $0.34 $INCY #Incyte #stockmarket #stock #earnings #money #trading #investing #daytrading #news #today https://t.co/n33cjB9kAS",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,
1134049078424162304,2020-05-03 12:31:31,"INCY, ",,"newsfilter.io/articles/twin-‚Ä¶, ",1256984745994522624,False,0,0,0,0,Newsfilter.io,Twin Capital Management Boosts Stock Position in Incyte $INCY https://t.co/EBhIUCZbue,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2525892205,2020-05-03 08:09:53,"INCY, ","investingnews, ","modernreaders.com/?p=3212143, ",1256918904225611776,False,0,0,0,0,Zapier.com,"New York State Teachers Retirement System Acquires 4,400 Shares of Incyte Co. $INCY  https://t.co/dr86cj0nuM #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
374729426,2020-05-03 06:40:54,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1558867, pic.twitter.com/xK9MBHXXAl, ",1256896510731546625,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator soaring into oversold zone View odds for this and other indicators: https://t.co/9cocQqKz4m #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xK9MBHXXAl,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2298709746,2020-05-03 03:17:26,"INCY, ",,"zpr.io/teY5w, ",1256845306769092609,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/J4Bhm7aQ1J,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
83423943,2020-05-02 20:41:11,,,"pharmaceutical-technology.com/comment/incyte‚Ä¶, ",1256745584796430336,False,0,0,0,0,Twitter Web Client,Incyte and Eli Lilly may have JAK inhibitor edge over Pfizer for Covid-19 https://t.co/YtRwORMkBu via @PharmaTechFocus,"PharmaTechFocus, ",,2009-10-18 15:15:57,N 22¬∞35' 0'' / E 88¬∞24' 0'',Aniruddha Bose,https://pbs.twimg.com/profile_images/1182185233086500864/enScBv0e_normal.jpg,574,327,16,25230,aniruddhabose,
2511590083,2020-05-02 14:17:49,,,"pharmaceutical-technology.com/comment/incyte‚Ä¶, ",1256649107973656577,False,0,0,0,0,Twitter Web App,Incyte and Eli Lilly may have JAK inhibitor edge over Pfizer for Covid-19 https://t.co/rPXAZB4hse via @PharmaTechFocus,"PharmaTechFocus, ",,2014-05-20 23:14:43,"Ponte Vedra Bch, Fl and Santa Barbara, Ca",Don Hanks,https://pbs.twimg.com/profile_images/505736203740528641/ZF6Y0DM1_normal.jpeg,141,1008,3,41488,donfhanks,
968745468,2020-05-02 12:12:34,,,"pharmaceutical-technology.com/comment/incyte‚Ä¶, ",1256617588576092164,False,0,0,0,0,Twitter Web App,Incyte and Eli Lilly may have JAK inhibitor edge over Pfizer for Covid-19. https://t.co/D5S7u6whYk via @PharmaTechFocus,"PharmaTechFocus, ",,2012-11-24 15:32:49,S√ÉO PAULO.,PLASTIC BRAZIL,https://pbs.twimg.com/profile_images/1129723866635472897/kTS4ydD-_normal.jpg,732,4925,10,85518,PROFESSOREUCIMA,
968745468,2020-05-02 12:12:28,,"Covid19, ","pharmaceutical-technology.com/comment/incyte‚Ä¶, ",1256617564920262656,False,0,0,0,0,Twitter Web App,Incyte and Eli Lilly may have JAK inhibitor edge over Pfizer for #Covid19 https://t.co/D5S7u6whYk via @PharmaTechFocus,"PharmaTechFocus, ",,2012-11-24 15:32:49,S√ÉO PAULO.,PLASTIC BRAZIL,https://pbs.twimg.com/profile_images/1129723866635472897/kTS4ydD-_normal.jpg,732,4925,10,85518,PROFESSOREUCIMA,
968745468,2020-05-02 12:12:14,,,"pharmaceutical-technology.com/comment/incyte‚Ä¶, ",1256617504581058564,False,0,0,0,0,Twitter Web App,Incyte and Eli Lilly may have JAK inhibitor edge over Pfizer for Covid-19 https://t.co/D5S7u6whYk via @PharmaTechFocus,"PharmaTechFocus, ",,2012-11-24 15:32:49,S√ÉO PAULO.,PLASTIC BRAZIL,https://pbs.twimg.com/profile_images/1129723866635472897/kTS4ydD-_normal.jpg,732,4925,10,85518,PROFESSOREUCIMA,
906328017986899968,2020-05-02 12:03:36,"INCY, ",,"pic.twitter.com/wgw6xH1mOt, twitter.com/the_chart_life‚Ä¶, ",1256615331562500097,False,15,0,2,0,Twitter Web App,$INCY Incyte ...Potential BRB setup. https://t.co/wgw6xH1mOt https://t.co/1vmav0NvUY,,,2017-09-08 21:26:53,"Charlotte, NC","Ian McMillan, CMT",https://pbs.twimg.com/profile_images/1407164505247956993/vDCOcrML_normal.jpg,60662,447,1750,38631,the_chart_life,photo
1134049078424162304,2020-05-02 10:17:22,"INCY, ",,"newsfilter.io/articles/fishe‚Ä¶, ",1256588595806208000,False,0,0,0,0,Newsfilter.io,"Fisher Asset Management Sells 4,839 Shares of Incyte $INCY https://t.co/NjMtUW96Lp",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
374729426,2020-05-02 07:32:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1554718, pic.twitter.com/k0Ad2Z4mhw, ",1256547205407821825,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator reaches into oversold zone View odds for this and other indicators: https://t.co/7d7HArUuAb #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/k0Ad2Z4mhw,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-05-02 06:12:23,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1256526943916371970,False,0,0,0,0,Newsfilter.io,Incyte Sees Large Growth in Short Interest $INCY https://t.co/69k9kZr8U7,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
975337043944407040,2020-05-01 21:36:07,"INCY, ",,"finscreener.com/incy-incyte-co‚Ä¶, ",1256397020258078725,False,0,0,0,0,StockTwits Web,"Stock with the last quarter  NEGATIVE earnings surprise : Incyte Corporation $INCY
https://t.co/ScIHbT9VZx",,,2018-03-18 07:44:06,,Finscreener,https://pbs.twimg.com/profile_images/976083323347984384/71mUunXo_normal.jpg,652,202,12,15317,Finscreener_com,
2382572334,2020-05-01 12:54:32,"INCY, ","INCYTE, ","dlvr.it/RVqqCR, ",1256265761149997058,False,0,0,0,0,dlvr.it,$INCY #INCYTE - Journalier: analyse https://t.co/2S9Vk5B8EZ,,,2014-03-10 15:25:33,,CentralCharts,https://pbs.twimg.com/profile_images/684473844732661766/iOwwFGTg_normal.png,7824,3019,172,95429,CentralCharts,
2416188264,2020-05-01 10:24:20,"INCY, ","markets, ","thestockobserver.com/?p=2920231, ",1256227961734402050,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Sees Large Growth in Short Interest  https://t.co/wcn6EGHQEh #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1217293817210200064,2020-05-01 09:44:44,,,"liverhealthonline.com/jak-inhibitor-‚Ä¶, ",1256217995921231873,False,0,0,0,0,WordPress.com,JAK inhibitor edge for Incyte and Eli Lilly over Pfizer for¬†Covid-19 https://t.co/uNliDNjUca,,,2020-01-14 22:54:23,"England, United Kingdom",NwokeAgulu,https://pbs.twimg.com/profile_images/1229419489227395074/9pmocdHX_normal.jpg,281,166,3,277755,AguluNwoke,
374729426,2020-05-01 08:47:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1550605, pic.twitter.com/rr3FvsHNLs, ",1256203483893559299,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on March 30, 2020. View odds for this and other indicators: https://t.co/IO4I8EPdLq #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/rr3FvsHNLs",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
68559732,2020-05-01 08:27:48,"INCY, ",,"zpr.io/tdWch, ",1256198635223691264,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Sees Significant Growth in Short Interest https://t.co/0JaWZAKxtI,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
4028839455,2020-04-30 21:24:37,,,"stocktrot.com/company/incyte‚Ä¶, ",1256031738582581251,False,0,0,0,0,StockTrot1,Bullish Brooke Paul A buys 327 of Incyte Corp shares. Largest in 2 months. https://t.co/Glm3OwNyt2,,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
374729426,2020-04-30 09:18:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1546441, pic.twitter.com/VCioFHQfTk, ",1255849096679583745,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average moved above its 50-day Moving Average on April 7, 2020. View odds for this and other indicators: https://t.co/i08kpW66qt #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/VCioFHQfTk",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1889492676,2020-04-30 06:02:54,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1255799780929724416,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/jZjathCYGu,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
2298709746,2020-04-30 05:35:08,"INCY, ",,"zpr.io/tdwwr, ",1255792796973350912,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Buy at BidaskClub https://t.co/wRjpC99y1b,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
61661638,2020-04-29 23:53:40,"INCY, ","stocks, ","americanbankingnews.com/?p=14331418, ",1255706860495257601,False,0,0,0,0,Zapier.com,Incyte $INCY Cut to Equal Weight at Morgan Stanley https://t.co/fF1WuwYgIf #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2344420430,2020-04-29 19:11:17,"INCY, ",,"insideri.com/879169_0001638‚Ä¶, ",1255635798600359937,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

10%+ Owner

BAKER BROS. ADVISORS LP:

https://t.co/oiCDtzIsKn",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
247585711,2020-04-29 11:29:01,,"MSL, medicalaffairs, covid19, cytokinestorm, ","buff.ly/2SkNrS2, pic.twitter.com/VLbpIWloNQ, ",1255519465959313409,False,0,0,0,0,Buffer,"The RUXCOVID study will be sponsored by Incyte in the US and Novartis outside of the US and will enroll approximately 400 patients globally. 
#MSL #medicalaffairs #covid19 #cytokinestorm https://t.co/PRghTliNXC https://t.co/VLbpIWloNQ",,,2011-02-04 22:28:55,"Houston, TX",Dr. Melody Davis,https://pbs.twimg.com/profile_images/977758698163630080/votWl1oP_normal.jpg,1310,4968,211,37021,mrdphd,photo
1069693680066420736,2020-04-29 08:04:49,"INCY, ",,"s.flashalert.me/Giq4I, ",1255468078009331716,False,0,0,0,0,flashalerts,"$INCY: Issued Press Release on April 29, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/44mIHYu9tk",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2020-04-29 08:03:36,,,"dlvr.it/RVglvk, pic.twitter.com/dYMu9jHCvd, ",1255467768180289537,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conference https://t.co/kCVuFX1vrr https://t.co/dYMu9jHCvd,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
2338882843,2020-04-29 08:02:09,"INCY, ",,"dailypolitical.com/?p=3775349, ",1255467406388088833,False,0,0,0,0,Zapier.com,Incyte $INCY Cut to Equal Weight at Morgan Stanley https://t.co/eTnoOjcRsO,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2525892205,2020-04-29 07:59:12,"INCY, ","investingnews, ","modernreaders.com/?p=3190567, ",1255466663396495360,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Lowered by Morgan Stanley  https://t.co/vLmhYOUCYr #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
374729426,2020-04-29 07:48:26,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1542137, pic.twitter.com/RkBeUe8sPY, ",1255463953502740483,False,0,0,1,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on April 2, 2020. View odds for this and other indicators: https://t.co/aVrfyCwtxZ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/RkBeUe8sPY",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
963495628545327104,2020-04-29 07:12:33,"MRSN, VIE, YMAB, MRSN, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1255454923807956993,False,0,0,0,0,STCK.PR0,$MRSN $VIE $YMAB NEW ARTICLE : Morgan Stanley cuts view on Incyte in premarket analyst action https://t.co/VAjziIPyYV Get all the latest $MRSN related news here : https://t.co/uJolJ9fCYa,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
1252420793683849216,2020-04-29 07:11:05,,,"dlvr.it/RVgcpc, ",1255454553413206017,False,0,0,0,0,dlvr.it,Morgan Stanley cuts view on Incyte in premarket analyst action https://t.co/LFkFwY2u4W,,,2020-04-20 22:16:11,,Redivex News,https://pbs.twimg.com/profile_images/1252714229192327174/VfMqCyQv_normal.jpg,90,28,3,22999,RedivexNews,
1637027690,2020-04-29 07:06:36,,,"ift.tt/2SjAZlj, ",1255453427242545154,False,0,0,0,0,IFTTT,Morgan Stanley cuts view on Incyte in premarket analyst action https://t.co/Q4qVCMrJls,,,2013-07-31 23:30:55,Everywhere,Ashish Aggarwal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,557,0,4776,AggarwalTweets,
15296897,2020-04-29 07:06:28,"MRSN, VIE, YMAB, ",,"seekingalpha.com/news/3565899-m‚Ä¶, ",1255453391163199493,False,0,0,0,0,SANewsTwitter,$MRSN $VIE $YMAB - Morgan Stanley cuts view on Incyte in premarket analyst action https://t.co/rv3BeZkzCX,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1252420793683849216,2020-04-29 07:03:35,,,"dlvr.it/RVgbj4, ",1255452666781732868,False,0,0,0,0,dlvr.it,Is Incyte Stock a Buy? https://t.co/IhsGKyva8J,,,2020-04-20 22:16:11,,Redivex News,https://pbs.twimg.com/profile_images/1252714229192327174/VfMqCyQv_normal.jpg,90,28,3,22999,RedivexNews,
963495628545327104,2020-04-29 06:45:09,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/kb3JryOBxu, ",1255448027214594052,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Is Incyte Stock a Buy? https://t.co/u2ekE2zZfz Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/kb3JryOBxu,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
61661638,2020-04-29 04:51:19,"INCY, ","stocks, ","americanbankingnews.com/?p=14322109, ",1255419382228017153,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Rises By 17.6% https://t.co/ewKuIvkIYT #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
121158213,2020-04-28 10:34:02,"INCY, ",,"AlertTrade.us, ",1255143240774238210,False,0,0,0,0,dlvr.it,REVERSALtoDOWN: $INCY Incyte Corporation Common Stock üìâ TradeIdeas via ‚û°  https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
1140762699002871808,2020-04-28 10:16:21,"INCY, ",,"deustrader.com/optimus_mixus4‚Ä¶, ",1255138788461785088,False,0,0,0,0,Deus Ex Trader,"Optimus v4
2020-04-28 10:16 EST. Bought/Opened:
$INCY at $98.43. 
Incyte Corporation - Common Stock
Win Chance: 71%. Avg Win: 4%. Avg Loss: 6.85%. Avg Hold: 5d.
Trade Id: 41780172503063794.
Stats: https://t.co/JZ1yafbugd",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
1140762699002871808,2020-04-28 10:03:16,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1255135496314871810,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-04-28 10:03 EST. Bought/Opened:
$INCY at $99.47. 
Incyte Corporation - Common Stock
Win Chance: 61%. Avg Win: 9%. Avg Loss: 7.83%. Avg Hold: 13d.
Trade Id: 41781669503009053.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
866631347191918593,2020-04-28 09:26:51,,"doctors, hospital, Health, healthcareIT, eHealth, healthcare, digitalhealth, ","twitter.com/CleClinicMD/st‚Ä¶, ",1255126332234752005,False,0,0,0,1,Twitter Web App,Incyte plans Phase III trial of blood cancer drug as potential Covid-19 cytokine storm therapy. #doctors #hospital #Health #healthcareIT #eHealth #healthcare #digitalhealth https://t.co/ysTk3A18f0,,,2017-05-22 08:26:29,"East Brunswick, NJ",Sarah Clark,https://pbs.twimg.com/profile_images/867730855011201028/B6F9x7hC_normal.jpg,446,547,14,9254,SarahClarkBDM,
912094012525486080,2020-04-28 09:12:00,,"Biotech, biotechnology, lifesciences, ","genengnews.com/a-lists/top-25‚Ä¶, ",1255122594518499328,False,0,0,0,0,TweetDeck,"Top 25 #Biotech Companies of 2019 https://t.co/HcUiNfn2rC via @GENbio @Amgen @novonordisk @CSL @GileadSciences @VertexPharma @Incyte @SeattleGenetics
@MylanNews - #biotechnology #lifesciences","GENbio, Amgen, novonordisk, CSL, GileadSciences, VertexPharma, Incyte, SeattleGenetics, MylanNews, ",,2017-09-24 19:18:53,"308 S. Washington Wheaton, IL",info@convergency.cloud,https://pbs.twimg.com/profile_images/912103409209139202/jEMWHICS_normal.jpg,49,483,0,1674,RiskResiliency,
374729426,2020-04-28 07:45:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1537953, pic.twitter.com/IEuoY1L7Q2, ",1255100787144843265,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on March 30, 2020. View odds for this and other indicators: https://t.co/ytNOVGkXMS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/IEuoY1L7Q2",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-04-28 06:54:07,"INCY, ","markets, ","americanbankingnews.com/?p=14310485, ",1255087896601735168,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/Qg3FXrjLcy #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-28 06:54:07,"INCY, ","stocks, ","americanbankingnews.com/?p=14310485, ",1255087894672408581,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/MkZVteqVew #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2266388972,2020-04-28 06:53:48,"INCY, ","stocks, ","dailypolitical.com/?p=3769297, ",1255087814993162241,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/ZZaSlJxl2w #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-28 06:53:47,"INCY, ",,"dailypolitical.com/?p=3769297, ",1255087812862500865,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/CBGWa0jMLz,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
966006214818697218,2020-04-28 06:52:44,"INCY, ",,"theenterpriseleader.com/?p=3047698, ",1255087547014922246,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday  https://t.co/f4Rh5bUQTr,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
68559732,2020-04-28 06:51:03,"INCY, ",,"zpr.io/tdjvA, ",1255087122685603840,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/UbPr6C3fBc,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
750646032258793472,2020-04-28 03:59:32,,"AACR20, ","endpts.com/aacr20-early-d‚Ä¶, ",1255043961221263366,False,0,0,0,1,Twitter Web Client,#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions - https://t.co/oR5pkVLg62,,,2016-07-06 07:02:15,"Paris, France",Mazars,https://pbs.twimg.com/profile_images/1238543616617963521/RBlZCFrU_normal.jpg,114,616,22,8618,CrMazars,
3686628867,2020-04-28 02:59:17,,"Incyte, oncology, dermatology, ","pharmaceuticaldaily.com/incyte-prepare‚Ä¶, pic.twitter.com/pEXUojJk25, ",1255028798929752069,False,1,0,0,0,WordPress.com,"#Incyte has multiple opportunities to launch new products and new indications globally.
#oncology #dermatology https://t.co/qggjZn9VKi https://t.co/pEXUojJk25",,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,photo
1158694129620213761,2020-04-28 01:42:17,,"AACR20, AACR2020, oncology, CancerResearch, lungcancer, ","endpts.com/aacr20-early-d‚Ä¶, ",1255009422755143681,False,0,0,0,0,Twitter for iPhone,#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions - https://t.co/MBNB7tN4lt @Novartis #AACR2020 #oncology #CancerResearch #lungcancer,"Novartis, ",,2019-08-06 06:59:42,,YH,https://pbs.twimg.com/profile_images/1159744697398636544/PinFT1M6_normal.jpg,75,247,4,246,PharmaLeader1,
424089030,2020-04-27 23:50:57,,"AACR20, ","endpts.com/aacr20-early-d‚Ä¶, ",1254981401260240901,False,0,0,0,0,Twitter Web Client,#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions - https://t.co/V8tm5FND5X,,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
3460109487,2020-04-27 21:22:00,,"AACR20, Novartis, ","endpts.com/aacr20-early-d‚Ä¶, ",1254943919072251904,False,4,0,0,3,Buffer,#AACR20: Early data suggest #Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions https://t.co/UR3ZCbxWX9,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
942108737929695235,2020-04-27 19:43:59,,"AACR20, ","endpts.com/aacr20-early-d‚Ä¶, ",1254919253049905157,False,1,0,0,1,Twitter for iPhone,#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions - https://t.co/eTSvSQEjoI,,,2017-12-16 14:06:41,United States,Nidhi Malhotra,https://pbs.twimg.com/profile_images/944725822086184961/_5xrNA4o_normal.jpg,28,121,0,65,MalhotraNidhiK,
2177744681,2020-04-27 19:00:22,,"AACR20, ","ow.ly/CAA030qBdmp, ",1254908274291421192,False,0,0,0,0,Hootsuite Inc.,#AACR20: Early data suggest Novartis‚Äô Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions ‚Äì Endpoints News https://t.co/dGiBxsEaXl,,,2013-11-11 23:56:36,"Atlanta, GA",Lampgen Clinical Research,https://pbs.twimg.com/profile_images/451196302588526592/iSb1JnS6_normal.png,24,45,0,804,Lampgen_CR,
185789961,2020-04-27 16:06:32,,"AACR20, ","dlvr.it/RVZ04K, ",1254864528661032964,False,0,0,0,1,dlvr.it,Fighting stigma ‚Äî  #AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients ...: Data from the mid-stage GEOMETRY mono-1 study showed that 7 of the 13 ... The overall response rate ‚Äî the study's main goal ‚Äî was‚Ä¶ https://t.co/djLzhqhagk,,,2010-09-01 17:06:16,Worldwide,STIGMABASE | EDU,https://pbs.twimg.com/profile_images/983490900927098880/W4EweR5t_normal.jpg,922,694,71,788289,stigmabase,
707270913448919041,2020-04-27 12:02:07,,"MPN, ",,1254803017624322049,False,0,0,0,0,Twitter for Advertisers.,Don‚Äôt skip Incyte‚Äôs #MPN Voices Out Loud! Stream the podcast crafted to support and educate people living with myeloproliferative neoplasms (MPNs) and their support team.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-04-27 12:02:00,,"MPN, ",,1254802988259999745,False,0,0,0,0,Twitter for Advertisers.,Don‚Äôt skip Incyte‚Äôs #MPN Voices Out Loud! Stream the podcast crafted to support and educate people living with myeloproliferative neoplasms (MPNs) and their support team.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-04-27 12:01:53,,"MPN, ",,1254802959025782784,False,3,0,0,2,Twitter for Advertisers.,Don‚Äôt skip Incyte‚Äôs #MPN Voices Out Loud! Stream the podcast crafted to support and educate people living with myeloproliferative neoplasms (MPNs) and their support team.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-04-27 12:01:40,,"MPN, ",,1254802906399858691,False,2,0,0,1,Twitter for Advertisers.,Don‚Äôt skip Incyte‚Äôs #MPN Voices Out Loud! Stream the podcast crafted to support and educate people living with myeloproliferative neoplasms (MPNs) and their support team.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-04-27 12:01:30,,"MPN, ",,1254802861889896449,False,1,0,0,0,Twitter for Advertisers.,Don‚Äôt skip Incyte‚Äôs #MPN Voices Out Loud! Stream the podcast crafted to support and educate people living with myeloproliferative neoplasms (MPNs) and their support team.,,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-04-27 12:01:03,,"MPN, ",,1254802749696479232,False,2,0,0,2,Twitter for Advertisers.,"Listen to #MPN Voices Out Loud‚Äîthe new podcast sponsored by Incyte Corporation, for people affected by myeloproliferative neoplasms, or MPNs.",,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-04-27 12:00:44,,"MPN, ",,1254802669757227009,False,1,0,0,0,Twitter for Advertisers.,"Listen to #MPN Voices Out Loud‚Äîthe new podcast sponsored by Incyte Corporation, for people affected by myeloproliferative neoplasms, or MPNs.",,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-04-27 12:00:35,,"MPN, ",,1254802634801852416,False,1,0,0,0,Twitter for Advertisers.,"Listen to #MPN Voices Out Loud‚Äîthe new podcast sponsored by Incyte Corporation, for people affected by myeloproliferative neoplasms, or MPNs.",,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-04-27 12:00:26,,"MPN, ",,1254802595459325955,False,6,0,1,0,Twitter for Advertisers.,"Listen to #MPN Voices Out Loud‚Äîthe new podcast sponsored by Incyte Corporation, for people affected by myeloproliferative neoplasms, or MPNs.",,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-04-27 12:00:16,,"MPN, ",,1254802551792447490,False,0,0,0,0,Twitter for Advertisers.,"Listen to #MPN Voices Out Loud‚Äîthe new podcast sponsored by Incyte Corporation, for people affected by myeloproliferative neoplasms, or MPNs.",,,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
271475993,2020-04-27 11:35:08,,"Pemazyre, cholangiocarcinoma, pemazyre, fda, fdaapproval, pemigatinib, ","pharmacypracticenews.com/FDA-Approvals/‚Ä¶, ",1254796230275760133,False,1,0,0,0,Hootsuite Inc.,"The @US_FDA granted accelerated approval to @Incyte #Pemazyre the first treatment approved for adults with advanced cholangiocarcinoma.
https://t.co/OkfoYuttmB @GABOUALFA @sloan_kettering @ashp #cholangiocarcinoma #pemazyre #fda #fdaapproval #pemigatinib","US_FDA, Incyte, GABOUALFA, sloan_kettering, ashp, ",,2011-03-24 11:47:42,New York,Pharmacy Practice News,https://pbs.twimg.com/profile_images/1395801938411888646/0XSL96Vq_normal.jpg,5663,1073,105,5741,PharmPracNews,
2212735524,2020-04-27 11:12:42,,"AACR20, ","endpts.com/aacr20-early-d‚Ä¶, ",1254790581357735936,False,6,0,1,0,Twitter for iPhone,"Very interesting #AACR20 
https://t.co/mLwJhG8Hwu",,,2013-11-24 11:30:24,chicago,"chadi nabhan MD, MBA, FACP",https://pbs.twimg.com/profile_images/1121014179673051136/xXe-hf2q_normal.jpg,11897,571,201,29421,chadinabhan,
15974185,2020-04-27 10:50:03,,"AACR20, ","dlvr.it/RVXyn9, ",1254784882426822659,False,1,0,0,1,dlvr.it,#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions https://t.co/FeQEQWibU5,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
133504478,2020-04-27 09:54:09,,"AACR20, strategy, competitiveintelligence, marketing, biotech, productmarketing, pharmaceutical, pharma, healthcare, ","dlvr.it/RVXq30, lqventures.com, pic.twitter.com/K8crKE7GZG, ",1254770815888838659,False,0,0,0,1,dlvr.it,#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions https://t.co/QXATQrx7fM &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #biotech #productmarketing #pharmaceutical #pharma #healthcare https://t.co/K8crKE7GZG,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
2525892205,2020-04-27 09:49:46,"INCY, ","investingnews, ","modernreaders.com/?p=3181753, ",1254769713600593924,False,0,0,0,0,Zapier.com,Oregon Public Employees Retirement Fund Sells 190 Shares of Incyte Co. $INCY  https://t.co/KrDF3N0a1Q #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
374729426,2020-04-27 09:40:10,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1533900, pic.twitter.com/yuRJJzZOIW, ",1254767294074376193,False,0,0,1,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on March 30, 2020. View odds for this and other indicators: https://t.co/xUclXuNFqU #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/yuRJJzZOIW",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
19277975,2020-04-27 09:13:50,,"BakerBrothers, biotech, hedgefund, Kodiak, AmarinNews, Incyte, Alexion, SeattleGenetics, BeiGene, ","onefamilysblog.com/2020/04/tracki‚Ä¶, ",1254760670396104704,False,0,0,0,0,Twitter Web App,Baker Brothers Portfolio - Q4 2019 update @ https://t.co/4mTKVUgH9b #BakerBrothers #biotech #hedgefund #Kodiak #AmarinNews #Incyte #Alexion #SeattleGenetics #BeiGene,,,2009-01-21 00:45:56,"Williamsville, NY, USA",John Vincent,https://pbs.twimg.com/profile_images/72255905/SantaCruzBoardWalk_normal.JPG,364,110,38,1881,OneFamilysBlog,
46297868,2020-04-27 09:13:02,,"AACR20, ","dlvr.it/RVXjgY, ",1254760468985475072,True,0,0,0,0,dlvr.it,#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions https://t.co/fsldDFB3ol,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
3460109487,2020-04-27 09:11:15,,"AACR20, ","endpts.com/aacr20-early-d‚Ä¶, ",1254760018219589632,False,9,0,0,0,Buffer,#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions https://t.co/UR3ZCbxWX9,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
2525892205,2020-04-27 08:32:17,"INCY, ","investingnews, ","modernreaders.com/?p=3180643, ",1254750212985413634,False,0,0,0,0,Zapier.com,"Usca Ria LLC Buys Shares of 5,540 Incyte Co. $INCY  https://t.co/XMHmPr2xB0 #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2181281054,2020-04-26 14:38:37,"INCY, ","markets, ","wkrb13.com/?p=1750737, ",1254480016781565954,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.08 Per Share https://t.co/gj8ivo6lSt #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
2181281054,2020-04-26 14:07:19,"INCY, ","markets, ","wkrb13.com/?p=1750505, ",1254472136682594305,False,0,0,0,0,Zapier.com,$546.49 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/Qh5GQto61r #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1078819131946876929,2020-04-26 13:51:28,,"precisionmedicine, ","twitter.com/Incyte/status/‚Ä¶, ",1254468148637634560,False,4,0,0,1,Twitter for iPhone,Great to see targeted therapy is achieving substantial progress in cholangiocarcinoma! Although the efficacy of Pemigatinib is limited to FGFR fusion/rearrangements this important finding will guide us for future clinical trial development! #precisionmedicine. More to come! https://t.co/nQw53slzLr,,,2018-12-28 20:04:59,"Tampa, FL","Ibrahim Halil SAHIN, MD",https://pbs.twimg.com/profile_images/1315766458161467393/0EMpBNcA_normal.jpg,625,420,7,390,IbrahimSahinMD1,
374729426,2020-04-26 07:12:25,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1529645, pic.twitter.com/MPrlulpgAb, ",1254367725683503104,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on March 30, 2020. View odds for this and other indicators: https://t.co/IKN2lEzZhQ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MPrlulpgAb",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1239315181882224640,2020-04-25 21:19:02,,"coronavirus, SARS_CoV_2, covid19, ","ClinicalTrials.gov, dlvr.it/RVSjDk, ",1254218397128118272,False,0,0,0,0,dlvr.it,https://t.co/k5GfHG63vK:  Ruxolitinib to Combat COVID-19: Condition: ¬† COVID-19 Interventions: ¬† Drug:¬†Ruxolitinib; ¬† Procedure:¬†Peripheral¬†blood¬†draw Sponsors: ¬† Washington¬†University¬†School¬†of¬†Medicine; ¬† Incyte‚Ä¶ https://t.co/fmo6AtGYgF #coronavirus #SARS_CoV_2 #covid19,,,2020-03-15 18:19:25,Ireland,@COVID_Evidence,https://pbs.twimg.com/profile_images/1239513392408408065/yfnDLvXw_normal.jpg,2626,0,46,9121,COVID_Evidence,
415468757,2020-04-25 20:48:42,,,"ashpublications.org/bloodadvances/‚Ä¶, investor.incyte.com/news-releases/‚Ä¶, ",1254210763620790274,False,0,0,0,0,TweetDeck,"Itacitinib in aGVHD steroid naive and ref aGVHD grII-IV. Well tolerated w ORR 75% and 70.6% resp. Important to note that the GRAVITAS 301 Ph 3 trial has failed. Yet another safe BUT in-/not-so effective therapy in aGVHD. 

https://t.co/ezncpKTuTy

https://t.co/9AyAteKRSl",,,2011-11-18 06:23:52,"Kolkata, India",Arijit Nag,https://pbs.twimg.com/profile_images/1197905192122847232/ws1zeL9I_normal.jpg,139,308,1,321,docarijit,
812004702594486272,2020-04-25 11:45:04,,"pemigatinib, ","checkrare.com/fda-approves-p‚Ä¶, ",1254073953053741056,False,1,0,0,0,Hootsuite Inc.,"The U.S. Food and Drug Administration has approved Pemazyre #pemigatinib to treat adults with cholangiocarcinoma. @Incyte @curecc @CCA_Alliance @US_FDA Cholangiocarcinoma Foundation 
Incyte Incyte Cholangiocarcinoma Foundation 
https://t.co/Kas4xZHd1x","Incyte, curecc, CCA_Alliance, US_FDA, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
1134049078424162304,2020-04-25 10:17:32,"INCY, ",,"newsfilter.io/articles/sumit‚Ä¶, ",1254051922413322240,False,0,0,0,0,Newsfilter.io,Sumitomo Mitsui DS Asset Management Company Ltd Sells 263 Shares of Incyte $INCY https://t.co/zK6FmsVyF2,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1239315181882224640,2020-04-25 09:32:02,,"coronavirus, SARS_CoV_2, covid19, ","ClinicalTrials.gov, dlvr.it/RVRKjd, ",1254040474966360064,False,0,0,0,0,dlvr.it,https://t.co/k5GfHG63vK:  Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection: Condition: ¬† COVID-19 Intervention: ¬† Drug:¬†Ruxolitinib Sponsor: ¬† Incyte‚Ä¶ https://t.co/xrLrtESDM5 #coronavirus #SARS_CoV_2 #covid19,,,2020-03-15 18:19:25,Ireland,@COVID_Evidence,https://pbs.twimg.com/profile_images/1239513392408408065/yfnDLvXw_normal.jpg,2626,0,46,9121,COVID_Evidence,
374729426,2020-04-25 07:36:22,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1525460, pic.twitter.com/jaX1F1mpaF, ",1254011367020871680,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on March 30, 2020. View odds for this and other indicators: https://t.co/zbk8ksIYjJ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/jaX1F1mpaF",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1979190776,2020-04-25 05:21:44,"INCY, ",,"tickerreport.com/?p=5458618, ",1253977481578786817,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 1-Year High at $103.22 https://t.co/COJmVENcO1,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2298709746,2020-04-25 05:20:38,"INCY, ",,"zpr.io/tJiPy, ",1253977208588251138,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 1-Year High at $103.22 https://t.co/5BDrzZWIDm,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
930803511918411776,2020-04-25 05:20:36,"INCY, ",,"thelincolnianonline.com/?p=3858197, ",1253977199423770625,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 1-Year High at $103.22 https://t.co/uCZhsCm7QN,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
930803511918411776,2020-04-25 04:41:33,"INCY, ",,"thelincolnianonline.com/?p=3857299, ",1253967372211412992,False,0,0,0,0,Zapier.com,Oppenheimer Boosts Incyte $INCY Price Target to $112.00 https://t.co/16XT09qD7C,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2298709746,2020-04-25 04:40:17,"INCY, ",,"watchlistnews.com/?p=3921781, ",1253967053377212417,False,0,0,0,0,Zapier.com,Oppenheimer Boosts Incyte $INCY Price Target to $112.00 https://t.co/8iUyszWXya,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
852931863547084801,2020-04-25 03:00:15,"INCY, ",,"transcriptdaily.com/?p=3113800, ",1253941876207554562,False,0,0,0,0,Zapier.com,Q1 2020 EPS Estimates for Incyte Co. $INCY Lowered by Oppenheimer https://t.co/AbmnwYLSLJ,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
1979190776,2020-04-25 02:25:55,"INCY, ",,"tickerreport.com/?p=5456050, ",1253933238164369408,False,0,0,0,0,Zapier.com,Q1 2020 EPS Estimates for Incyte Co. $INCY Lowered by Oppenheimer https://t.co/mY7b5VhAGm,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
227778014,2020-04-25 00:00:10,"INCY, BCYC, CHMA, ",,"buff.ly/2KyBu72, ",1253896558199873538,False,0,0,0,0,Buffer,"Management Tracks: Shawver joins Silverback as president and CEO; plus Incyte, Bicycle, Imvax, Chiasma, Regenacy and Noscendo $INCY $BCYC $CHMA https://t.co/Z7QIU8dkSR",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13038,1543,387,33073,BioCentury,
2890915186,2020-04-24 16:45:04,,"Cardiotwitter, ","ow.ly/x8ia50zmTVz, ",1253787060852359168,False,0,0,0,1,Hootsuite Inc.,A phase 3 trial evaluating ruxolitinib (Jakafi; Incyte) for the treatment of coronavirus disease 2019 (COVID-19)-associated cytokine storm is being initiated in patients 12 years of age and older. #Cardiotwitter https://t.co/jh4iQjjkHY,,,2014-11-24 10:31:34,,TheCardiologyAdvisor,https://pbs.twimg.com/profile_images/863033157251149824/4wTe_3Am_normal.jpg,378,50,15,1850,CardioAdvisor,
194586164,2020-04-24 14:10:04,,,"buff.ly/2VOqwiE, pic.twitter.com/n30NT0TcXd, ",1253748053200310274,False,0,0,0,0,Buffer,"Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win. How will this latest data boost Jakafi‚Äôs positioning?
https://t.co/Lf2SnAkf4s https://t.co/n30NT0TcXd",,,2010-09-24 10:12:02,"New York, Paris",Bionest Partners,https://pbs.twimg.com/profile_images/1271043069698326528/K-dF7hlM_normal.jpg,349,512,0,2306,BionestPartners,photo
1171873456276889600,2020-04-24 13:23:50,"INCY, ","INCY, PX14A6G, Incyte, Proxy, ","docoh.com/filing/879169/‚Ä¶, ",1253736418339426310,False,0,0,0,0,Investor Feed,"$INCY  PX14A6G  Incyte   (24 Apr, 1:22pm)

üìÑ Letter to shareholders

https://t.co/79jnkY5LQp

#INCY #PX14A6G #Incyte #Proxy",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
812004702594486272,2020-04-24 11:45:07,,"pemigatinib, ","checkrare.com/fda-approves-p‚Ä¶, ",1253711575338418178,False,12,0,0,8,Hootsuite Inc.,"The U.S. Food and Drug Administration has approved Pemazyre #pemigatinib to treat adults with cholangiocarcinoma. @Incyte @curecc @CCA_Alliance @US_FDA Cholangiocarcinoma Foundation 
Incyte
https://t.co/Kas4xZHd1x","Incyte, curecc, CCA_Alliance, US_FDA, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
38920802,2020-04-24 10:01:44,"INCY, MGNX, ",,"ct.gov, clinicaltrials.gov/ct2/history/NC‚Ä¶, ",1253685561677639682,False,0,0,0,0,Twitter Web App,"$INCY $MGNX MGA012/INCMGA00012 now also known as Retifanlimab. Eight Incyte trials at https://t.co/9XMyPz0CRq updated to reflect such.  Recruitment completed for MGNX B7-H3/PD-1 trial at 145 patients, short of planned 157....  https://t.co/OT3wE1LJlR",,,2009-05-09 16:23:52,,Spontonic,https://pbs.twimg.com/profile_images/1132813877513560065/G7Q68pBw_normal.png,406,197,17,2815,spontonic,
4028839455,2020-04-24 09:24:31,,,"stocktrot.com/company/incyte‚Ä¶, ",1253676195440324609,False,0,0,0,0,StockTrot1,Bullish Dixon Wendy L buys 243 of Incyte Corp shares. Largest in 4 months. https://t.co/Glm3OwNyt2,,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
2931312159,2020-04-24 08:27:27,,"Incyte, Incyte, Montreal, ","STL.News, stl.news/incyte-appoint‚Ä¶, pic.twitter.com/fNhmcsEaGe, ",1253661830846840834,False,0,0,0,0,STL.News,"New post (#Incyte Appoints Christine Lennon as General Manager, #Incyte Biosciences Canada) has been published on https://t.co/gzC9VsBNpz - https://t.co/mEw5pdaJWb
 #Montreal https://t.co/fNhmcsEaGe",,,2014-12-18 21:25:21,"St Louis, MO, US, 63040",STL.News,https://pbs.twimg.com/profile_images/1368239309954965510/GRDvn-8U_normal.jpg,17273,3243,122,100899,stlnewsonline,photo
849417718642159616,2020-04-24 07:41:40,"INCY, ",,"zpr.io/tJ3DB, ",1253650313036398593,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Insider Sells 1,143 Shares of Stock https://t.co/MM7mGzmeIi",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
374729426,2020-04-24 07:40:27,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1521244, pic.twitter.com/sMvvC2kHOz, ",1253650006625488902,False,0,0,0,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: https://t.co/YxamlBePM5 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/sMvvC2kHOz,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2920258887,2020-04-24 07:37:20,"INCY, ",,"dakotafinancialnews.com/?p=1823315, ",1253649220613083137,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Insider Sells $114,300.00 in Stock https://t.co/ukHWY1bZst",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
864573525159325696,2020-04-24 07:34:51,,"trial, Covid_19, Corona, CoronavirusVaccine, clinicaltrials, treatment, ","pharmajournalist.com/incyte-announc‚Ä¶, ",1253648595942686720,False,1,0,0,1,Twitter Web App,"Incyte Announces Initiation Of Phase 3 #trial Of Ruxcovid To Treat #Covid_19 
#Corona #CoronavirusVaccine #clinicaltrials #treatment 
https://t.co/inopBDySPm",,,2017-05-16 16:09:26,"New Delhi, India",Pharma Journalist,https://pbs.twimg.com/profile_images/982208492109938689/FRsIPjLU_normal.jpg,348,521,5,2726,pharmjournalist,
68559732,2020-04-24 07:01:09,"INCY, ",,"zpr.io/tJ3GY, ",1253640112975593475,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Insider Sells $114,300.00 in Stock https://t.co/cDrN7DMXru",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
966006214818697218,2020-04-24 06:04:20,"INCY, ",,"theenterpriseleader.com/?p=3027794, ",1253625816052830208,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúBuy‚Äù by Brokerages  https://t.co/ZG3aPMyLW7,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
732361939490312192,2020-04-24 04:57:13,"INCY, ","markets, ","americanbankingnews.com/?p=14264931, ",1253608926207250433,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúBuy‚Äù by Brokerages https://t.co/0Y98yx0RiK #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-24 04:57:13,"INCY, ","stocks, ","americanbankingnews.com/?p=14264931, ",1253608924189806592,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúBuy‚Äù by Brokerages https://t.co/YgcqmQpbg1 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2020-04-24 04:55:15,"INCY, ",,"tickerreport.com/?p=5452291, ",1253608431598153729,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúBuy‚Äù by Brokerages https://t.co/fQ7mlJJpMI,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1241594733668925440,2020-04-24 04:41:25,,,"fiercepharma.com/pharma/novarti‚Ä¶, ",1253604949444800512,False,0,0,0,0,Twitter Web Client,"Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win https://t.co/w0N9uAeYf5",,,2020-03-22 01:18:09,"305, A Wing, Western Edge 2",TECHIZER TECH SOLUTIONS PRIVATE LIMITED,https://pbs.twimg.com/profile_images/1241595111374327808/ZiGIeiPy_normal.jpg,25,242,0,107,techizer_tech,
849417718642159616,2020-04-24 04:09:11,"INCY, ",,"zpr.io/tJD7K, ",1253596836125868037,False,0,0,0,0,Zapier.com,Oppenheimer Brokers Lower Earnings Estimates for Incyte Co. $INCY https://t.co/psB9YJnFK3,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
68559732,2020-04-24 03:41:26,"INCY, ",,"zpr.io/tJ8Q3, ",1253589854748893187,False,0,0,0,0,Zapier.com,Oppenheimer Brokers Lower Earnings Estimates for Incyte Co. $INCY https://t.co/fDDqioW4L4,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2525892205,2020-04-24 03:41:16,"INCY, ","investingnews, ","modernreaders.com/?p=3163603, ",1253589811501371392,False,0,0,0,0,Zapier.com,Oppenheimer Brokers Lower Earnings Estimates for Incyte Co. $INCY  https://t.co/RA5Ubtd0Yx #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
930803511918411776,2020-04-24 01:52:26,"INCY, ",,"thelincolnianonline.com/?p=3849224, ",1253562423258353669,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY to Post Q1 2020 Earnings of $0.14 Per Share, Oppenheimer Forecasts https://t.co/kXL7eEJTvU",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
3460109487,2020-04-23 16:19:00,,"ruxolitinib, ","endpts.com/pivotal-data-c‚Ä¶, ",1253418115167170561,False,0,0,0,0,Buffer,"Pivotal data cement use of Incyte, Novartis' #ruxolitinib in difficult-to-treat graft-versus-host disease https://t.co/SHAHr1mkUE",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
374729426,2020-04-23 13:57:30,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1517614, pic.twitter.com/Jwk3wCjW67, ",1253382505228460033,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on March 30, 2020. View odds for this and other indicators: https://t.co/3raoBN8x1k #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Jwk3wCjW67",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
760484491555139584,2020-04-23 12:28:05,,,"dlvr.it/RVKPVX, pic.twitter.com/daJnDlT8rG, ",1253360001931853824,False,0,0,0,0,dlvr.it,"Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win https://t.co/Ew7B8WfkCg https://t.co/daJnDlT8rG",,,2016-08-02 10:36:46,,analyst land news,https://pbs.twimg.com/profile_images/1075066740835606534/NpZYEW5E_normal.jpg,10,0,1,5551,analystlandnews,photo
852931863547084801,2020-04-23 12:18:19,"INCY, ",,"zpr.io/tJAx6, ",1253357546351611904,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 1-Year High at $103.22 https://t.co/MTkEEDxtjE,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2920258887,2020-04-23 12:18:19,"INCY, ",,"dakotafinancialnews.com/?p=1820679, ",1253357545554673675,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 1-Year High at $103.22 https://t.co/YMTfje0KBr,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198530,dakotafinancial,
1128239740329705472,2020-04-23 09:21:50,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1253313130114904065,False,0,0,0,0,Twitter for Android,"""The results from the REACH2 study reinforce findings from the pivotal REACH1 trial and demonstrate the potential that ruxolitinib has to effectively and safely improve outcomes for patients with GVHD.""

$INCY 
https://t.co/2gKHGbGcsm",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
1079749795823214594,2020-04-23 08:41:14,"INCY, ","Montana, Incyte, NASDAQ100, SP500, biotech, arthritis, trading, investing, stocks, COVID19, COVID2019, coronavirus, fintech, Pharmaceutical, ","pic.twitter.com/4KuWMlnMX0, ",1253302914514378756,False,2,0,0,0,Twitter Web App,"2nd request from #Montana. #Incyte is in BUY on our system. See chart. Key: above the cloud ""In Buy"" below ""In Sell"" $INCY #NASDAQ100  #SP500 #biotech #arthritis  #trading #investing #stocks #COVID19 #COVID2019 #coronavirus #fintech #Pharmaceutical https://t.co/4KuWMlnMX0",,,2018-12-31 09:43:06,Leeds,The Flying Stocksman,https://pbs.twimg.com/profile_images/1338104605901807616/mj9Jjtta_normal.jpg,3283,178,59,13749,flyingstocksman,photo
732361939490312192,2020-04-23 08:39:50,"INCY, ","markets, ","americanbankingnews.com/?p=14254341, ",1253302562754908160,False,0,0,0,0,Zapier.com,Q1 2020 Earnings Estimate for Incyte Co. Issued By Oppenheimer $INCY https://t.co/tnw2WpFzVQ #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-23 08:39:49,"INCY, ","stocks, ","americanbankingnews.com/?p=14254341, ",1253302558422118400,False,0,0,0,0,Zapier.com,Q1 2020 Earnings Estimate for Incyte Co. Issued By Oppenheimer $INCY https://t.co/xBe0hXIBV2 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
849417718642159616,2020-04-23 08:35:28,"INCY, ",,"zpr.io/tJEUS, ",1253301462597328896,False,0,0,0,0,Zapier.com,Q1 2020 Earnings Estimate for Incyte Co. Issued By Oppenheimer $INCY https://t.co/JnZFpqDrHx,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
32649767,2020-04-23 08:09:23,,,"endpts.com/pivotal-data-c‚Ä¶, ",1253294896682881024,False,0,0,0,0,Twitter Web Client,"Finally, some progress on this diabolical complication of allogeneic BMT...LOLTA - Pivotal data cement use of Incyte, Novartis' ruxolitinib in difficult-to-treat graft-versus-host disease - https://t.co/6KXwDKaRPP",,,2009-04-17 19:12:36,"Boston, MA",Didan Meg,https://pbs.twimg.com/profile_images/3347981111/15dddb3a2259d452c293cac3dd9c91e1_normal.jpeg,77,998,3,11966,Didanmeg,
732361939490312192,2020-04-23 07:18:24,"INCY, ","markets, ","americanbankingnews.com/?p=14253321, ",1253282069276504071,False,0,0,0,0,Zapier.com,Weekly Research Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/e91PDAGOYo #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-23 07:18:24,"INCY, ","stocks, ","americanbankingnews.com/?p=14253321, ",1253282066910846976,False,0,0,0,0,Zapier.com,Weekly Research Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/5Ua3dXfLBu #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
849417718642159616,2020-04-23 07:17:40,"INCY, ",,"zpr.io/tJxHc, ",1253281882437025792,False,0,0,0,0,Zapier.com,Weekly Research Analysts‚Äô Ratings Updates for Incyte $INCY https://t.co/S3grMb8BM1,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
732361939490312192,2020-04-23 07:07:33,"INCY, ","markets, ","americanbankingnews.com/?p=14253161, ",1253279335563304961,False,0,0,0,0,Zapier.com,$537.16 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/UvWUXkJ9Qv #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-23 07:07:32,"INCY, ","stocks, ","americanbankingnews.com/?p=14253161, ",1253279333633929218,False,0,0,0,0,Zapier.com,$537.16 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/8AcvGWFwYM #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2298709746,2020-04-23 07:06:53,"INCY, ",,"zpr.io/tJxUq, ",1253279169104031744,False,0,0,0,0,Zapier.com,$537.16 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/pFG2OmQFym,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
35789155,2020-04-23 06:37:04,"NVS, INCY, ",,"beta.firstwordpharma.com/story/4999221, ",1253271665154416647,False,4,0,0,2,TweetDeck,"Novartis, Incyte's Jakafi more effective than best available therapy in GvHD https://t.co/irAVzFvAWf $NVS $INCY",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
15974185,2020-04-23 06:22:03,,,"dlvr.it/RVJCLY, ",1253267887529185280,False,1,0,0,0,dlvr.it,"Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win https://t.co/JskzYdk1Vf",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
367500725,2020-04-23 06:12:29,,,"fiercepharma.com/marketing/incy‚Ä¶, ",1253265479465988096,False,0,0,0,0,Twitter Web Client,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/bWxtnNxlRD,,,2011-09-03 22:29:08,,vshariharakrishnan,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,9,50,0,6806,drvshkrishnan,
966006214818697218,2020-04-23 06:09:24,"INCY, ",,"theenterpriseleader.com/?p=3021848, ",1253264705063452674,False,0,0,0,0,Zapier.com,"Paul Trower Sells 1,143 Shares of Incyte Co. $INCY Stock  https://t.co/sQYiBH9VUr",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2266388972,2020-04-23 05:06:02,"INCY, ","stocks, ","dailypolitical.com/?p=3743589, ",1253248755308138497,False,0,0,0,0,Zapier.com,"Paul Trower Sells 1,143 Shares of Incyte Co. $INCY Stock https://t.co/COHd2ALr15 #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-23 05:06:01,"INCY, ",,"dailypolitical.com/?p=3743589, ",1253248753206730752,False,0,0,0,0,Zapier.com,"Paul Trower Sells 1,143 Shares of Incyte Co. $INCY Stock https://t.co/nRRuVXmCsU",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
367500725,2020-04-23 05:01:07,,,"finance.yahoo.com/news/incyte-ge‚Ä¶, ",1253247518965559299,False,0,0,0,0,Twitter Web Client,Incyte Gets FDA Nod for Cholangiocarcinoma Drug Pemazyre https://t.co/SVHRJbXmJB via @YahooFinance,"YahooFinance, ",,2011-09-03 22:29:08,,vshariharakrishnan,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,9,50,0,6806,drvshkrishnan,
367500725,2020-04-23 04:59:13,,,"pharmaceutical-business-review.com/news/fda-appro‚Ä¶, ",1253247042979151872,False,0,0,0,0,Twitter Web Client,"FDA approves Incyte‚Äôs Pemazyre as first targeted treatment for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma https://t.co/eYLzuPEVDQ via @Pharmaceutical Business review","Pharmaceutical, ",,2011-09-03 22:29:08,,vshariharakrishnan,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,9,50,0,6806,drvshkrishnan,
852931863547084801,2020-04-23 04:30:59,"INCY, ",,"zpr.io/tJNRM, ",1253239934846107649,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $901,360.00 in Stock https://t.co/N0BaLeSErL",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
68559732,2020-04-23 04:30:57,"INCY, ",,"zpr.io/tJNRx, ",1253239929724964864,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $901,360.00 in Stock https://t.co/wD2WfGIWf0",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
849417718642159616,2020-04-23 04:29:23,"INCY, ",,"zpr.io/tJNHb, ",1253239531698098176,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $901,360.00 in Stock https://t.co/sF7HChvAyw",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2298709746,2020-04-23 02:06:08,"INCY, ",,"zpr.io/tJaUQ, ",1253203482510843905,False,0,0,0,0,Zapier.com,Q2 2020 EPS Estimates for Incyte Co. $INCY Cut by Oppenheimer https://t.co/tfHkNIs8oC,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
966006214818697218,2020-04-23 02:06:06,"INCY, ",,"theenterpriseleader.com/?p=3017792, ",1253203474910720000,False,0,0,0,0,Zapier.com,Q2 2020 EPS Estimates for Incyte Co. $INCY Cut by Oppenheimer  https://t.co/A3duV3B3AW,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
3314135167,2020-04-23 01:03:31,,"jobs, ","goo.gl/fb/tfaPib, ",1253187723969658880,False,0,0,0,0,Google,"#jobs Novartis, Incyte‚Äôs Jakafi boosts its case in graft-versus-host disease with another‚Ä¶ https://t.co/Rrmf1NOXGi",,,2015-08-13 02:43:55,,Career Biotech,https://pbs.twimg.com/profile_images/872856527731793920/HqYH3X_9_normal.jpg,110,59,1,35799,CareerBiotech,
424089030,2020-04-22 22:58:55,,,"fiercepharma.com/pharma/novarti‚Ä¶, ",1253156369378807815,False,0,0,0,0,Twitter Web Client,"Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win https://t.co/T63tD1OGqJ",,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
3911174913,2020-04-22 20:40:34,,"cholangiocarcinoma, ","pic.twitter.com/fWUOBJebac, ",1253121550301179904,False,9,0,0,3,Twitter Web App,"Peter Langmuir, M.D., Group Vice President, Oncology Targeted Therapies, shares what the recent FDA milestone means for adults with previously treated, unresectable locally advanced or metastatic #cholangiocarcinoma. https://t.co/fWUOBJebac",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
3686628867,2020-04-22 20:40:01,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1253121412363141121,False,0,0,0,0,WordPress.com,Incyte Announces Pivotal REACH2 Study Data Published in NEJM Highlight Superior Efficacy of Ruxolitinib (Jakafi¬Æ) versus Best Available Therapy in Patients with Acute Graft-Versus-Host Disease https://t.co/IzmaXInfpg,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1134049078424162304,2020-04-22 20:16:10,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1253115410456739841,False,0,0,0,0,Newsfilter.io,Incyte Announces Pivotal REACH2 Study Data Published in NEJM Highlight Superior Efficacy of Ruxolitinib versus Best Available Therapy in Patients with Acute Graft-Versus-Hos.. $INCY https://t.co/rMpmXxRz9j,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
294877641,2020-04-22 20:15:03,,,"fiercepharma.com/pharma/novarti‚Ä¶, ",1253115132315602945,True,0,0,0,0,Twitter for iPhone,"Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win
https://t.co/uKBct6NG7F",,,2011-05-07 19:22:44,Goiania GO Brazil,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,https://pbs.twimg.com/profile_images/1442830977752092674/XrPCpTqa_normal.jpg,263,542,10,15924,jolivei1967,
72928001,2020-04-22 19:06:18,"INCY, ",,"bit.ly/3bvsxXR, ",1253097826923339776,False,2,0,0,0,BriefingInPlayLimited,$INCY: Incyte announces publication of REACH2 study highlighting ruxolitinib efficacy in acute graft-verus-host... https://t.co/eePr7WjJDF,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
2398845223,2020-04-22 19:05:04,,,"ow.ly/Rjth102edHs, ",1253097517060968448,False,0,0,0,0,Hootsuite Inc.,"Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win https://t.co/73TNeFNz9l",,,2014-03-19 23:11:51,Maryland,Continental Clinical,https://pbs.twimg.com/profile_images/673876383358062593/qyzjJcMn_normal.jpg,669,521,13,5348,Conti_Clinical,
133504478,2020-04-22 19:02:34,,"strategy, competitiveintelligence, marketing, biotech, pharma, productmarketing, healthcare, pharmaceutical, ","dlvr.it/RVGplY, lqventures.com, pic.twitter.com/9xW5wOSlTA, ",1253096890410754048,False,1,0,0,2,dlvr.it,"Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win https://t.co/zjFnlIQr3X &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #biotech #pharma #productmarketing #healthcare #pharmaceutical https://t.co/9xW5wOSlTA",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
140599113,2020-04-22 17:40:28,,,"winway.me/health-remedie‚Ä¶, pic.twitter.com/HvezMkhXsS, ",1253076226551447558,False,0,0,0,0,WordPress.com,"Novartis, Incyte‚Äôs Jakafi boosts its case in graft-versus-host disease with another phase 3¬†win https://t.co/2VlkNhR8gt https://t.co/HvezMkhXsS",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,photo
1089978712685273090,2020-04-22 17:33:04,"INTC, ","Incyte, ","dlvr.it/RVGctw, ",1253074364628516864,False,0,0,0,0,dlvr.it,#Incyte $INTC Announces Pivotal REACH2 Study Data Published in NEJM Highlight Superior Efficacy of Ruxolitinib (Jakafi¬Æ) versus Best Available Therapy in Patients with Acute Graft-Versus-Host Disease https://t.co/jyo4h6Lw6S,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
27645777,2020-04-22 17:32:31,,,"bit.ly/3btm0Nq, pic.twitter.com/Ja4ucqOFUd, ",1253074229521723397,False,5,1,0,2,TweetDeck,"Breaking News in @NEJM - Phase 3 results show Ruxolitinib @Incyte effective, safe for glucocorticoid-refractory acute GVHD https://t.co/VQhuCkUcOP @Uniklinik_Fr / @DukeHMCT @DukeHealth @DukeCancer https://t.co/Ja4ucqOFUd","NEJM, Incyte, Uniklinik_Fr, DukeHMCT, DukeHealth, DukeCancer, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
1006334607946649600,2020-04-22 17:27:08,,,"dlvr.it/RVGc54, ",1253072874019024896,False,0,0,0,0,dlvr.it,Incyte Announces Pivotal REACH2 Study Data Published in NEJM Highlight Superior Efficacy of Ruxolitinib (Jakafi¬Æ) versus Best Available Therapy in Patients with Acute Graft-Versus-Host Disease https://t.co/Baa9xweEb3,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
46297868,2020-04-22 17:11:05,,,"dlvr.it/RVGZ4l, ",1253068833214001152,True,0,0,0,0,dlvr.it,"Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win https://t.co/okflQZpAb3",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
2860693607,2020-04-22 14:01:26,,"Incyte, Novartis, FDA, Cancer, RareBileDuctCancer, BileDuct, ","bit.ly/2RTic07, ",1253021105297727488,False,0,0,0,0,Hootsuite Inc.,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/wQpHnl9dhj #Incyte #Novartis #FDA #Cancer #RareBileDuctCancer #BileDuct,,,2014-11-04 09:01:12,"Brighton, UK",Haybury,https://pbs.twimg.com/profile_images/862943255981436928/jXWuXHim_normal.jpg,1052,1154,161,4283,Hayburysearch,
51066938,2020-04-22 14:01:02,,"BIBrands, FDAapproval, drugnaming, cancer, oncology, cholangiocarcinoma, ","pic.twitter.com/60UgjVc08v, ",1253021005330726912,False,0,0,0,0,Sprout Social,"Congratulations to Incyte on the the FDA approval of PEMAZYRE. #BIBrands

PEMAZYRE is intended to treat adults with bile duct cancer (also known as cholangiocarcinoma) that has spread or cannot be removed by surgery.

#FDAapproval #drugnaming #cancer #oncology #cholangiocarcinoma https://t.co/60UgjVc08v",,,2009-06-26 09:58:17,"Miami, FL","Brand Institute, Inc",https://pbs.twimg.com/profile_images/1136351640229797889/m7bDvGoK_normal.png,1556,360,38,317,BrandInstitute,photo
1118631141102235649,2020-04-22 12:59:43,"INCY, ","IndependentDirector, BoardExAlerts, NASDAQ100, SP500, ",,1253005574763155466,False,0,0,0,0,Sprinklr,"In 2020, Paul A Brooke will leave a role as #IndependentDirector at @incyte. #BoardExAlerts #NASDAQ100 #SP500 $INCY","Incyte, ",,2019-04-17 17:43:41,,BoardEx,https://pbs.twimg.com/profile_images/1410339910360383498/CJczif_7_normal.jpg,281,175,5,2351,BoardEx,
812004702594486272,2020-04-22 11:45:07,,"pemigatinib, ","checkrare.com/fda-approves-p‚Ä¶, ",1252986802845167616,False,4,0,0,4,Hootsuite Inc.,"The U.S. Food and Drug Administration has approved Pemazyre #pemigatinib to treat adults with cholangiocarcinoma. @Incyte @curecc @CCA_Alliance @US_FDA Cholangiocarcinoma Foundation 
Incyte
https://t.co/Kas4xZHd1x","Incyte, curecc, CCA_Alliance, US_FDA, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
2416188264,2020-04-22 08:46:15,"INCY, ","markets, ","thestockobserver.com/?p=2882594, ",1252941787494301699,False,0,0,0,0,Zapier.com,Oppenheimer Comments on Incyte Co.‚Äôs Q2 2020 Earnings $INCY  https://t.co/VkgeWlqFLF #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
732361939490312192,2020-04-22 08:45:56,"INCY, ","markets, ","americanbankingnews.com/?p=14241739, ",1252941710478508035,False,0,0,0,0,Zapier.com,Oppenheimer Comments on Incyte Co.‚Äôs Q2 2020 Earnings $INCY https://t.co/XHI31YGWOw #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-22 08:45:56,"INCY, ","stocks, ","americanbankingnews.com/?p=14241739, ",1252941707664113664,False,0,0,0,0,Zapier.com,Oppenheimer Comments on Incyte Co.‚Äôs Q2 2020 Earnings $INCY https://t.co/8zDUskoxHH #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
852931863547084801,2020-04-22 08:44:30,"INCY, ",,"zpr.io/tJGZr, ",1252941348749131776,False,0,0,0,0,Zapier.com,Oppenheimer Comments on Incyte Co.‚Äôs Q2 2020 Earnings $INCY https://t.co/DiZ0KF7N2p,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
930803511918411776,2020-04-22 06:03:59,"INCY, ",,"thelincolnianonline.com/?p=3841408, ",1252900951675060224,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $110.00 at Piper Sandler https://t.co/Mi9wbe2edT,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-04-22 06:02:44,"INCY, ",,"tickerreport.com/?p=5441857, ",1252900637714636800,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $110.00 at Piper Sandler https://t.co/vLhAbXYcuc,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2266388972,2020-04-22 06:01:36,"INCY, ","stocks, ","dailypolitical.com/?p=3738795, ",1252900352929796096,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúHold‚Äù Rating Reiterated at Mizuho https://t.co/bmSisW4sci #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-22 06:01:35,"INCY, ",,"dailypolitical.com/?p=3738795, ",1252900350362697728,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúHold‚Äù Rating Reiterated at Mizuho https://t.co/yRlIbiF74p,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
966006214818697218,2020-04-22 06:00:30,"INCY, ",,"theenterpriseleader.com/?p=3015746, ",1252900074818097153,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúHold‚Äù Rating Reiterated at Mizuho  https://t.co/PoyCbahr63,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2020-04-22 05:28:13,"INCY, ",,"thelincolnianonline.com/?p=3840454, ",1252891952401584128,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 1,143 Shares of Stock https://t.co/71GWnej27u",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-04-22 05:24:22,"INCY, ",,"tickerreport.com/?p=5440922, ",1252890981583556610,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 1,143 Shares of Stock https://t.co/MHWterQe6i",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
68559732,2020-04-22 04:32:07,"INCY, ",,"zpr.io/tJ6dU, ",1252877831547129861,False,0,0,0,0,Zapier.com,"Maria E. Pasquale Sells 9,488 Shares of Incyte Co. $INCY Stock https://t.co/rE2md9DyY3",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2266388972,2020-04-22 04:32:05,"INCY, ","stocks, ","dailypolitical.com/?p=3738568, ",1252877824324628480,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 9,488 Shares https://t.co/6LaAzmb3Ku #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-22 04:31:59,"INCY, ",,"dailypolitical.com/?p=3738568, ",1252877800219926536,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 9,488 Shares https://t.co/hLhvenSS8A",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1979190776,2020-04-22 04:28:09,"INCY, ",,"tickerreport.com/?p=5439564, ",1252876836016537601,False,0,0,0,0,Zapier.com,"Maria E. Pasquale Sells 9,488 Shares of Incyte Co. $INCY Stock https://t.co/hTf5g883CZ",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
738922748123045888,2020-04-22 03:59:38,,,"instagram.com/p/B_RpA8zD1ZY/‚Ä¶, ",1252869656844529666,False,0,0,0,0,Instagram,"MSL DAILY PHARMA NEWS - FDA approves Incyte‚Äôs Pemazyre as first targeted treatment for metastatic cholangiocarcinoma

‚ÄúPemazyre is the first and only FDA-approved treatment for this indication, which was approved‚Ä¶ https://t.co/DNKqmMxz6S",,,2016-06-03 22:38:06,Austtralia,FSTP,https://pbs.twimg.com/profile_images/1220461989362667520/doBEb2Z7_normal.jpg,178,46,20,2550,PharmaNews,
732361939490312192,2020-04-21 22:55:41,"INCY, ","markets, ","americanbankingnews.com/?p=14237177, ",1252793166450888704,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Sells $114,300.00 in Stock https://t.co/Ll6n9tjgW2 #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-21 22:55:40,"INCY, ","stocks, ","americanbankingnews.com/?p=14237177, ",1252793164588625921,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Sells $114,300.00 in Stock https://t.co/V4INntxzGW #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
14586896,2020-04-21 20:40:06,,,"wdel.com/news/could-a-d‚Ä¶, ",1252759046316318726,False,2,0,0,1,BLOX CMS,"Incyte is based in one of Wilmington's landmark buildings, and they're hoping they can make a breakthrough in the fight against the pandemic, using their top product. https://t.co/yeNPQtKodu",,,2008-04-29 12:27:52,"Wilmington, DE",101.7FM / 1150AM WDEL,https://pbs.twimg.com/profile_images/1166719920442396677/Iq8iWG3__normal.jpg,16412,1230,366,60576,WDEL,
200226529,2020-04-21 19:45:00,,,"bioworld.com/articles/43456‚Ä¶, ",1252745179058057216,False,2,0,0,0,TweetDeck,Incyte wins FDA approval for first targeted cholangiocarcinoma treatment https://t.co/bJqXrhzZZT,,,2010-10-08 15:25:06,"Atlanta, GA",BioWorld MedTech,https://pbs.twimg.com/profile_images/1204781148255215617/GU982b9o_normal.png,31340,1945,665,16693,BioWorldMedTech,
954687664095092736,2020-04-21 18:50:52,,"COVID19, cholangiocarcinoma, ","tinyurl.com/y9dx7n54, ",1252731555534958592,False,0,0,0,2,Twitter Web App,.@FDAOncology have been busy bees despite #COVID19 -- first targeted therapy approved for #cholangiocarcinoma. @cancerhealthmag @Incyte https://t.co/rsUlRgqTY3,"FDAOncology, cancerhealthmag, Incyte, ",,2018-01-20 07:10:51,"San Francisco, CA",Liz Highleyman,https://pbs.twimg.com/profile_images/954690767775150080/WAxdYvZ0_normal.jpg,2002,3239,27,6786,LizCancerHealth,
922461289015906304,2020-04-21 18:14:10,,"DiscoveryStartsHerePHL, ","bit.ly/2XTJasj, ",1252722320327806976,False,3,0,0,0,Twitter Web App,"#DiscoveryStartsHerePHL ‚û°Ô∏è Wilmington-based biotech company, @Incyte, receives FDA approval for therapy to treat a rare cancer found in the bile duct outside the liver. Read more in @PHLBizJournal here: https://t.co/r0rje8AS8o","Incyte, PHLBizJournal, ",,2017-10-23 09:54:44,"Philadelphia, PA",CEO Council,https://pbs.twimg.com/profile_images/922462262140350464/g42_bPOE_normal.jpg,1605,1319,0,2205,CEOCouncilPHL,
2344420430,2020-04-21 17:30:19,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1252711286787506178,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Manager US

BARRY P FLANNELLY:

https://t.co/k3AaRrSZZJ",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2344420430,2020-04-21 16:47:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1252700455140016129,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Principal Accounting Officer

PAUL TROWER:

https://t.co/zsB5B3nY6A",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-04-21 16:43:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1252699469222752257,False,0,0,0,0,InsiderActionMonitor,$INCY Paul Trower Dumps 1.1K Shares of Incyte https://t.co/xaKsK5OJDe,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
1176558075798380544,2020-04-21 16:35:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1252697456300765186,False,0,0,0,0,InsiderActionMonitor,$INCY Barry Flannelly Dumps 6.6K Shares of Incyte https://t.co/BteIRV1tBz,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
94365736,2020-04-21 15:10:11,,"Incyte, ruxolitinib, Covid, ","pharmaceutical-technology.com/news/incyte-ru‚Ä¶, ",1252676018827124737,False,0,0,0,0,Hootsuite Inc.,#Incyte begins Phase III trial of #ruxolitinib to treat #Covid-19 https://t.co/2aHRRCLxes via @PharmaTechFocus @Incyte,"PharmaTechFocus, Incyte, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
32492934,2020-04-21 12:52:00,,,"bioworld.com/articles/43452‚Ä¶, ",1252641244301295616,False,1,0,0,0,TweetDeck,"The FDA has granted accelerated approval to Incyte's Pemazyre (pemigatinib), the first treatment approved for adults with certain types of previously treated, advanced cholangiocarcinoma  https://t.co/GIuPLZLeL4",,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
948362732,2020-04-21 12:44:07,,"Delaware, delawarestrong, choosedelaware, netde, ","delawarepublic.org/post/incyte-ap‚Ä¶, ",1252639262836699139,False,0,0,0,0,Twitter Web App,"#Delaware company @Incyte approved to test Jakafi as COVID-19 treatment  #delawarestrong #choosedelaware #netde
https://t.co/X5xgsZV9gQ","Incyte, ",,2012-11-14 14:39:39,,MidAtLocal,https://pbs.twimg.com/profile_images/1349383823981748224/dH59lLK4_normal.jpg,10,325,0,3881,OrnamentalGlee,
94365736,2020-04-21 11:40:09,,"FDA, Incyte, Pemazyre, bileduct, cancer, ","pmlive.com/pharma_news/fd‚Ä¶, ",1252623164217188355,False,0,0,0,0,Hootsuite Inc.,#FDA approves #Incyte‚Äôs #Pemazyre as first targeted drug for #bileduct #cancer https://t.co/7x09QxqkbL via @PMLiVEcom @Incyte,"PMLiVEcom, Incyte, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
1069693680066420736,2020-04-21 11:17:59,"INCY, ",,"s.flashalert.me/PfDXO, ",1252617586220642305,False,0,0,0,0,flashalerts,"$INCY: Issued Press Release on April 17, 20:53:00: FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma https://t.co/wBVEv1G2F0",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
194586164,2020-04-21 10:08:01,,"bileduct, cancer, ","buff.ly/3eFcZ5V, pic.twitter.com/2zzxGAipRs, ",1252599978159149062,False,0,0,0,0,Buffer,"Incyte beefs up portfolio with FDA nod for rare #bileduct #cancer therapy Pemazyre. With such a low patient pool, how many patients can Incyte expect to capture?
https://t.co/xHLIlE5j3t https://t.co/2zzxGAipRs",,,2010-09-24 10:12:02,"New York, Paris",Bionest Partners,https://pbs.twimg.com/profile_images/1271043069698326528/K-dF7hlM_normal.jpg,349,512,0,2306,BionestPartners,photo
28971730,2020-04-21 09:58:32,,,"fiercepharma.com/marketing/incy‚Ä¶, ",1252597591612829698,False,0,0,0,0,Twitter Web Client,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/6SqK57thcz,,,2009-04-05 07:04:48,Nationwide,Bandish Group,https://pbs.twimg.com/profile_images/654705305570316288/3PUGw-Fk_normal.png,250,342,2,686,Bandishgroup,
1043160843209322496,2020-04-21 09:52:58,,"deadliestcxrs, ","twitter.com/NCIDirector/st‚Ä¶, ",1252596188676792321,False,1,0,0,1,Twitter for iPhone,"First targeted treatment for cholangiocarcinoma - one of the nation‚Äôs #deadliestcxrs. Congratulations to @Incyte and to the cholangiocarcinoma community, including our partner @targetcancer! We still have a long way to go, but this is a great step forward! https://t.co/SlwUHmaXST","Incyte, targetcancer, ",,2018-09-21 11:31:40,"Washington, DC",DeadliestCancersCoalition,https://pbs.twimg.com/profile_images/1126572600765947905/GiXXYVbQ_normal.png,63,98,0,76,DeadliestCxrs,
621060143,2020-04-21 08:39:38,,,"biopharma-asia.com/sections/incyt‚Ä¶, ",1252577734003511300,False,0,0,0,0,Biopharma Website 2017,Incyte‚Äôs Pemazyre‚Ñ¢ is Approved by FDA as First Targeted Treatment for Adults With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma - https://t.co/NkM1EwgI70,,,2012-06-28 11:07:50,,BiopharmaAsia,https://pbs.twimg.com/profile_images/2349565664/ssf38158bnioic4i4wl8_normal.jpeg,1620,1279,24,6684,Biopharma_asia,
621060143,2020-04-21 08:34:53,,,"biopharma-asia.com/sections/incyt‚Ä¶, ",1252576539021099009,False,0,0,0,0,Biopharma Website 2017,Incyte Announces Initiation of Phase 3 RUXCOVID Study Evaluating Ruxolitinib as a Treatment for Patients with COVID-19¬† - https://t.co/UZ2NeHwEVh,,,2012-06-28 11:07:50,,BiopharmaAsia,https://pbs.twimg.com/profile_images/2349565664/ssf38158bnioic4i4wl8_normal.jpeg,1620,1279,24,6684,Biopharma_asia,
732361939490312192,2020-04-21 08:29:04,"INCY, ","markets, ","americanbankingnews.com/?p=14229429, ",1252575076563726342,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $112.00 https://t.co/bmCJXk6uGg #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-21 08:29:04,"INCY, ","stocks, ","americanbankingnews.com/?p=14229429, ",1252575074302951424,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to $112.00 https://t.co/t5ipbWqdYC #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
236854797,2020-04-21 08:15:51,,,"fdanews.com/articles/19673‚Ä¶, ",1252571748765241345,False,0,0,0,0,Twitter for iPhone,FDA Approves Incyte‚Äôs Pemazyre for Rare Cancer  https://t.co/zazV53aJq3,,,2011-01-11 09:36:49,"Charlotte, NC",Pharmacy Now!,https://pbs.twimg.com/profile_images/1212826814/HaroldCohen_normal.jpg,186,106,13,14288,nyrxman,
374729426,2020-04-21 07:40:14,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1513273, pic.twitter.com/1l47nci0BO, ",1252562785105403904,False,0,0,1,0,Tickeron,$INCY's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this and other indicators: https://t.co/d29CE3HcWy #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1l47nci0BO,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
812004702594486272,2020-04-21 07:12:01,,"pemigatinib, ","checkrare.com/fda-approves-p‚Ä¶, ",1252555685868507136,False,4,0,0,5,Hootsuite Inc.,"The U.S. Food and Drug Administration has approved Pemazyre #pemigatinib to treat adults with cholangiocarcinoma. @Incyte @curecc @CCA_Alliance @US_FDA Cholangiocarcinoma Foundation 
Incyte Incyte Cholangiocarcinoma Foundation 
https://t.co/Kas4xZHd1x","Incyte, curecc, CCA_Alliance, US_FDA, ",,2016-12-22 13:39:42,New York,CheckRare,https://pbs.twimg.com/profile_images/980529968634580994/G_FuE2oj_normal.jpg,2433,1304,13,9256,CheckRare,
2525892205,2020-04-21 07:09:41,"INCY, ","investingnews, ","modernreaders.com/?p=3149669, ",1252555098238210048,False,0,0,0,0,Zapier.com,Nisa Investment Advisors LLC Increases Stake in Incyte Co. $INCY  https://t.co/A5V3CqijrK #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2266388972,2020-04-21 06:37:58,"INCY, ","stocks, ","dailypolitical.com/?p=3734023, ",1252547114854383617,False,0,0,0,0,Zapier.com,BidaskClub Upgrades Incyte $INCY to ‚ÄúStrong-Buy‚Äù https://t.co/EEnZKE7f02 #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-21 06:37:53,"INCY, ",,"dailypolitical.com/?p=3734023, ",1252547097590730753,False,0,0,0,0,Zapier.com,BidaskClub Upgrades Incyte $INCY to ‚ÄúStrong-Buy‚Äù https://t.co/90xY799RZR,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1215239622135025665,2020-04-21 06:36:11,,"oncomedic, article, metastatic, cancer, oncology, ","cutt.ly/yyerq7M, ",1252546666105843712,False,4,0,0,3,Twitter Web App,"FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma #oncomedic #article #metastatic #cancer #oncology 

https://t.co/f0eskSk23G",,,2020-01-09 06:51:30,,oncomedic_,https://pbs.twimg.com/profile_images/1215255916045574144/W1soGsSB_normal.jpg,380,498,5,459,oncomedic_,
23059499,2020-04-21 06:12:22,"INCY, ","finance, economy, investing, ","seekingalpha.com/article/433871‚Ä¶, ",1252540675104468994,False,0,0,0,0,SAArticlesTwitter,"$INCY - Incyte's Approval, And Other News: The Good, Bad And Ugly Of Biopharma. https://t.co/sWff3HgBat #finance #economy #investing",,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
852931863547084801,2020-04-21 05:58:21,"INCY, ",,"zpr.io/ticzf, ",1252537148827451392,False,0,0,0,0,Zapier.com,BidaskClub Upgrades Incyte $INCY to ‚ÄúStrong-Buy‚Äù https://t.co/yeKwRCQ5pt,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
19287403,2020-04-21 05:34:07,,"PharmaScrip, ","bit.ly/2XYCNnH, dlvr.it/RV8v1w, pic.twitter.com/6K1lXN0mAL, ",1252531049994706944,False,0,0,0,0,dlvr.it,PharmaScrip:  Incyte Approval In Subset Of Cholangiocarcinoma May Lead To Bigger Opportunities https://t.co/M5fW1HRNLB¬† #PharmaScrip https://t.co/Qc22CjdmCQ https://t.co/6K1lXN0mAL,,,2009-01-21 08:39:09,Nederland,ZorgNL,https://pbs.twimg.com/profile_images/72293628/twitter_health_normal.PNG,15928,442,0,103180,zorgnl,photo
1097819621619630080,2020-04-21 05:29:08,,,"dlvr.it/RV8tBb, pic.twitter.com/kZ3t00isNF, ",1252529794647863296,False,0,0,0,0,dlvr.it,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/8H2QBx5wgg https://t.co/kZ3t00isNF,,,2019-02-19 06:26:09,"London, England",PharmaCrowd,https://pbs.twimg.com/profile_images/1123311799561068545/UnJBMgbE_normal.png,29,22,0,2226,PharmaCrowd,photo
930803511918411776,2020-04-21 04:26:59,"INCY, ",,"thelincolnianonline.com/?p=3832894, ",1252514154721705985,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 9,488 Shares https://t.co/Xpv8o1m16C",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2298709746,2020-04-21 04:25:02,"INCY, ",,"zpr.io/tieyE, ",1252513664411852801,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 9,488 Shares https://t.co/En238OnF3I",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1134049078424162304,2020-04-21 03:24:56,"INCY, ","coronavirus, COVID2019, ","newsfilter.io/articles/incyt‚Ä¶, ",1252498537281134592,False,0,0,0,0,Newsfilter.io,Incyte Announces Initiation of Phase 3 RUXCOVID Study Evaluating Ruxolitinib as a Treatment for Patients with COVID-19 Associated Cytokine Storm $INCY #coronavirus #COVID2019 https://t.co/ZvM2XVsi0B,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
288174027,2020-04-21 03:24:26,,"Pharmanews, Treatment, cholangiocarcinoma, Sciencenews, ","pharmatimes.com/news/us_clears‚Ä¶, ",1252498410453770241,False,0,0,0,0,Hootsuite Inc.,"US regulators have approved Incyte's Pemazyre as the first targeted treatment for cholangiocarcinoma!

https://t.co/dt2x1CK31C

#Pharmanews #Treatment #cholangiocarcinoma #Sciencenews",,,2011-04-26 07:19:09,United Kingdom,Network Scientific Recruitment,https://pbs.twimg.com/profile_images/1018880610545389570/_wf73nOZ_normal.jpg,1852,1732,43,3696,Network_Sci,
966006214818697218,2020-04-21 03:13:38,"INCY, ",,"theenterpriseleader.com/?p=3006421, ",1252495695644438529,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.61 Per Share  https://t.co/mh8ROTrDCc,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
732361939490312192,2020-04-21 03:10:05,"INCY, ","markets, ","americanbankingnews.com/?p=14226434, ",1252494800751910913,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.61 Per Share https://t.co/62W2I4KnzD #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-21 03:10:04,"INCY, ","stocks, ","americanbankingnews.com/?p=14226434, ",1252494798424064000,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.61 Per Share https://t.co/6KMxYN0BY2 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
21079030,2020-04-21 03:01:45,,"PharmaScrip, ","bit.ly/2XYCNnH, ",1252492704031916032,False,0,0,0,0,Sprinklr,"Incyte Approval In Subset Of Cholangiocarcinoma May Lead To Bigger Opportunities
https://t.co/AmrvHXLSRd #PharmaScrip",,,2009-02-17 05:33:29,Global,Scrip,https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg,21541,1629,654,35335,PharmaScrip,
3314135167,2020-04-21 01:30:08,,"jobs, ","goo.gl/fb/jZCMtL, ",1252469649003986944,False,0,0,0,0,Google,#jobs Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/NVvjTa2TeT,,,2015-08-13 02:43:55,,Career Biotech,https://pbs.twimg.com/profile_images/872856527731793920/HqYH3X_9_normal.jpg,110,59,1,35799,CareerBiotech,
424089030,2020-04-20 23:06:45,,,"xconomy.com/national/2020/‚Ä¶, ",1252433564336939014,False,1,0,0,0,Twitter Web Client,"FDA Approves Incyte Drug, First Ever for Rare Bile Duct Cancer https://t.co/zYLPs871wu via @xconomy","Xconomy, ",,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
424089030,2020-04-20 23:04:24,,,"endpts.com/incyte-nabs-2n‚Ä¶, ",1252432971920859150,False,0,0,0,0,Twitter Web Client,Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time - https://t.co/lofi6cbxrK,,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
424089030,2020-04-20 22:59:23,,,"fiercepharma.com/marketing/incy‚Ä¶, ",1252431712593645571,False,0,0,0,0,Twitter Web Client,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/8Hog7SG31u,,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
14845366,2020-04-20 21:25:31,,,"tinyurl.com/y7442pd6, ",1252408087736025088,False,0,0,0,0,Twitter Web Client,Incyte approved to test Jakafi as COVID-19 treatment https://t.co/EVDpjIVYfl,,,2008-05-20 09:56:42,,Gina Fluffpaldi GET VACCINATEDüíâüåà ‚úäüèΩ‚úäüèæ‚úäüèø,https://pbs.twimg.com/profile_images/1381676110103117826/rXqsxzYH_normal.jpg,320,949,16,11580,astralweeks82,
2181281054,2020-04-20 21:18:22,"INCY, ","markets, ","wkrb13.com/?p=1734485, ",1252406290615201792,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $901,360.00 in Stock https://t.co/aQ5wRWOi3q #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
732361939490312192,2020-04-20 21:15:39,"INCY, ","markets, ","americanbankingnews.com/?p=14224077, ",1252405603122548736,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $901,360.00 in Stock https://t.co/ETVgJx8tyI #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-20 21:15:38,"INCY, ","stocks, ","americanbankingnews.com/?p=14224077, ",1252405600798961666,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $901,360.00 in Stock https://t.co/Cc6dNttezV #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
27103620,2020-04-20 20:45:48,,"delaware, COVID19, ","twitter.com/NBCPhiladelphi‚Ä¶, ",1252398095192616960,False,15,1,0,6,Twitter for iPad,A drug @Incyte (#delaware based) already makes could really help people in the toughest stages of #COVID19 fight.  My @NBCPhiladelphia story.... https://t.co/4AKM8Fphkm,"Incyte, NBCPhiladelphia, ",,2009-03-27 17:35:57,Delaware!,Tim Furlong,https://pbs.twimg.com/profile_images/467085647790882817/3KqB_-zn_normal.jpeg,11319,2504,247,24531,tfurlong,
2181281054,2020-04-20 20:36:51,"INCY, ","markets, ","wkrb13.com/?p=1734055, ",1252395839361650688,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúHold‚Äù Rating Reaffirmed at Mizuho https://t.co/YAbk7UmPtH #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
552066959,2020-04-20 20:25:38,,"COVID19, NetDE, ","delawarepublic.org/post/incyte-ap‚Ä¶, ",1252393018696404998,False,0,0,0,0,Twitter Web App,Our @Nick_Ciolino has an update on an @Incyte drug that is being looked at as a possible treatment for serious #COVID19 cases. https://t.co/MzqIUklIM8 #NetDE,"Nick_Ciolino, Incyte, ",,2012-04-12 14:28:59,"Dover, DE",Delaware Public Media,https://pbs.twimg.com/profile_images/1308052313421025280/ETKfCwkX_normal.jpg,8235,742,203,13788,DelawarePublic,
2344420430,2020-04-20 20:16:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1252390663217242112,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/qnOUQCWOfD",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
32492934,2020-04-20 19:50:00,,,"bioworld.com/articles/43452‚Ä¶, ",1252384049475268608,False,2,0,0,0,TweetDeck,Incyte wins FDA approval for first targeted cholangiocarcinoma treatment https://t.co/GIuPM02Q9E,,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
2181281054,2020-04-20 19:14:52,"INCY, ","markets, ","wkrb13.com/?p=1732931, ",1252375208343662595,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by BidaskClub to Strong-Buy https://t.co/8rx8cju6H7 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
3404158181,2020-04-20 18:48:10,,,"fiercepharma.com/marketing/incy‚Ä¶, ",1252368490675105793,False,0,0,0,0,Twitter Web Client,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/gfnA52pfnZ,,,2015-08-05 09:04:05,"Frisco, TX","Sherri Kemp-Putman, CSAM",https://pbs.twimg.com/profile_images/647503146936352768/mINxyh1Y_normal.jpg,140,169,5,4040,Sherri_Kemp,
21268553,2020-04-20 18:19:42,,,"stock-market-newsfeed.blogspot.com/2020/04/incyte‚Ä¶, ",1252361326099193856,False,0,0,0,0,SS Auto Tweet App,"Incyte Gets FDA Nod for Cholangiocarcinoma Drug Pemazyre
 https://t.co/9IPPGUb8fW",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
760134513691242496,2020-04-20 18:03:43,,"thermal, imaging, ","google.com/url?rct=j&sa=t‚Ä¶, ",1252357303568748544,False,0,0,0,0,IFTTT,Incyte Gets FDA Nod for Cholangiocarcinoma Drug Pemazyre https://t.co/GzxLkJLrQM #thermal #imaging,,,2016-08-01 11:26:05,"Dallas, TX",ThermalCameras.Guide,https://pbs.twimg.com/profile_images/828276278054694912/dfln14kJ_normal.jpg,404,810,5,51962,ithermalcameras,
1279763869,2020-04-20 18:00:48,,,"ow.ly/doH530qzj9v, pic.twitter.com/fGeMO1Mp5C, ",1252356570861559812,False,0,0,0,0,Hootsuite Inc.,"FDA Approves Incyte Drug, First Ever for Rare Bile Duct Cancer https://t.co/BRezNrkLvj https://t.co/fGeMO1Mp5C",,,2013-03-19 03:07:32,,Ethical Recruiters,https://pbs.twimg.com/profile_images/3399772862/774dd87f0960517bf14aa33d290e6c24_normal.jpeg,116,458,11,8233,Ethical421,photo
386042607,2020-04-20 17:49:53,,"JAK, COVID, ","hubs.ly/H0pH5s10, pic.twitter.com/X8g1CDrD8k, ",1252353820782280704,False,0,0,0,0,HubSpot,Can #JAK Inhibition Put the Brakes on #COVID-19-Associated Cytokine Storm? @Incyte is starting a Phase 3 trial evaluating the efficacy &amp; safety of ruxolitinib (Jakafi) plus standard-of-care in patients ‚â•12 years with COVID-19-associated cytokine storm.  https://t.co/2svzBF5pGF https://t.co/X8g1CDrD8k,"Incyte, ",,2011-10-06 11:34:39,,Practical Derm,https://pbs.twimg.com/profile_images/1172186203099189249/6ZV9TJxF_normal.jpg,2800,888,49,4503,Practical_Derm,photo
1176558075798380544,2020-04-20 17:24:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1252347399881687043,False,0,0,0,0,InsiderActionMonitor,$INCY Maria Pasquale Dumps 9.5K Shares of Incyte https://t.co/5NRuw2HRmJ,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
4312114277,2020-04-20 17:17:53,"INCY, ",,"fintel.io/sf/us/incy?utm‚Ä¶, ",1252345770088337409,False,0,0,0,0,Fintel.io,$INCY / Incyte files form DEF 14A https://t.co/Oc4NyYPNbm,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,163,418542,fintel_io,
27254739,2020-04-20 17:14:06,,,"bit.ly/34SS8rd, ",1252344819076063235,False,0,0,0,1,Sprout Social,".@US_FDA has approved @Incyte's Pemazyre (pemigatinib), the first targeted treatment for a rare cancer of the bile duct https://t.co/SSJnOQMvEQ","US_FDA, Incyte, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
14442905,2020-04-20 16:32:03,,,"dlvr.it/RV7LgP, pic.twitter.com/eKCuFsid95, ",1252334235324563459,False,1,0,0,0,dlvr.it,FDA Approves Incyte's Pemazyre for Rare Bile Duct Cancer https://t.co/oC0hNxxq5c https://t.co/eKCuFsid95,,,2008-04-19 08:48:59,,Biotechnology,https://pbs.twimg.com/profile_images/1235765602/horizon1202906805-double_helix_500x500_normal.png,57151,3269,1002,53397,Biotechnology,photo
294877641,2020-04-20 16:07:29,,,"fiercepharma.com/marketing/incy‚Ä¶, ",1252328053310722058,True,0,0,0,0,Twitter for iPhone,"Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre
https://t.co/eb5nODAbs5",,,2011-05-07 19:22:44,Goiania GO Brazil,Jorge E. Oliveira üáßüá∑üáµüáπüá∫üá∏üá™üá∏,https://pbs.twimg.com/profile_images/1442830977752092674/XrPCpTqa_normal.jpg,263,542,10,15924,jolivei1967,
2177744681,2020-04-20 15:10:07,,,"ow.ly/tw9x30qzl0K, ",1252313617107648515,False,0,0,0,0,Hootsuite Inc.,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre | FiercePharma https://t.co/LNAsQSJzZE,,,2013-11-11 23:56:36,"Atlanta, GA",Lampgen Clinical Research,https://pbs.twimg.com/profile_images/451196302588526592/iSb1JnS6_normal.png,24,45,0,804,Lampgen_CR,
133504478,2020-04-20 15:02:34,,"strategy, competitiveintelligence, marketing, healthcare, pharma, productmarketing, biotech, pharmaceutical, ","dlvr.it/RV78Y1, lqventures.com, pic.twitter.com/xByM51iJVf, ",1252311715112345600,False,0,0,0,1,dlvr.it,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/UsLeT1RkiY &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #pharma #productmarketing #biotech #pharmaceutical https://t.co/xByM51iJVf,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
29881875,2020-04-20 15:02:00,,,"xconomy.com/national/2020/‚Ä¶, ",1252311572078182402,False,1,1,0,0,TweetDeck,"The FDA has granted speedy approval for an Incyte drug developed to treat cholangiocarcinoma, a rare cancer affecting the bile ducts.
https://t.co/1lqPfhLwu2",,,2009-04-08 21:24:43,United States,Xconomy,https://pbs.twimg.com/profile_images/1218178322347282434/gvnH_9q2_normal.png,26411,2671,1396,23941,Xconomy,
140599113,2020-04-20 14:47:58,,,"winway.me/health-remedie‚Ä¶, pic.twitter.com/A7yCibRkpD, ",1252308039694258181,False,0,0,0,0,WordPress.com,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/kmMMDKTzEu https://t.co/A7yCibRkpD,,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,photo
76385834,2020-04-20 14:47:05,,,"dlvr.it/RV75nD, pic.twitter.com/5QQxBtlgI1, ",1252307818507427840,False,0,0,0,0,dlvr.it,FDA Approves Incyte's Pemazyre for Rare Bile Duct Cancer https://t.co/nSxGPHLpMb https://t.co/5QQxBtlgI1,,,2009-09-22 13:03:55,,Corixis,https://pbs.twimg.com/profile_images/1234473809/favicon_normal.PNG,92,111,17,43317,Corixis,photo
1217293817210200064,2020-04-20 14:06:39,,,"liverhealthonline.com/fda-approves-i‚Ä¶, ",1252297641700085764,False,0,0,0,0,WordPress.com,FDA Approves Incyte‚Äôs Pemazyre for Rare Bile Duct Cancer https://t.co/rKijTy95mM,,,2020-01-14 22:54:23,"England, United Kingdom",NwokeAgulu,https://pbs.twimg.com/profile_images/1229419489227395074/9pmocdHX_normal.jpg,281,166,3,277755,AguluNwoke,
875382419251019776,2020-04-20 13:48:04,,,"bit.ly/2wTce86, pic.twitter.com/H4JDG0NfRy, ",1252292965466116096,False,0,0,0,0,dlvr.it,FDA Approves Incyte's Pemazyre for Rare Bile Duct Cancer https://t.co/AFwxkYzkg7 https://t.co/H4JDG0NfRy,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
732361939490312192,2020-04-20 13:15:20,"INCY, ","markets, ","americanbankingnews.com/?p=14219190, ",1252284730575409154,False,0,0,0,0,Zapier.com,Piper Sandler Raises Incyte $INCY Price Target to $110.00 https://t.co/vYU8JNgMsO #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-20 13:15:20,"INCY, ","stocks, ","americanbankingnews.com/?p=14219190, ",1252284728104947715,False,0,0,0,0,Zapier.com,Piper Sandler Raises Incyte $INCY Price Target to $110.00 https://t.co/L3SB6he2He #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
27103620,2020-04-20 13:07:27,,"pharmaceutical, COVID19, dronephotography, ","pic.twitter.com/qb85luZpxn, ",1252282744941486080,False,40,2,3,8,Twitter for iPad,Delaware #pharmaceutical company @Incyte now testing one of its most popular products as a treatment for #COVID19 - if it works it might just help save lives AND get the country back open a little sooner. The story today at 5 on @NBCPhiladelphia #dronephotography https://t.co/qb85luZpxn,"Incyte, NBCPhiladelphia, ",,2009-03-27 17:35:57,Delaware!,Tim Furlong,https://pbs.twimg.com/profile_images/467085647790882817/3KqB_-zn_normal.jpeg,11319,2504,247,24531,tfurlong,video
15974185,2020-04-20 12:46:03,,,"dlvr.it/RV6ktq, ",1252277359832530947,False,0,0,0,0,dlvr.it,Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time https://t.co/26aOiPpWxv,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
211220879,2020-04-20 12:44:17,"INCY, ","pemigatinib, cholangiocarcinoma, cancer, ","xconomy.com/national/2020/‚Ä¶, ",1252276916104638464,False,2,0,0,0,Twitter Web Client,.@Incyte awarded accelerated FDA approval of #pemigatinib in #cholangiocarcinoma. The FGFR inhibitor is now the first drug approved for the rare bile duct #cancer. Trials are underway to test it in other cancers https://t.co/GxR8L4tYF6 $INCY,"Incyte, ",,2010-11-02 13:20:59,North Carolina,Frank Vinluan,https://pbs.twimg.com/profile_images/1503948370/billy_3_normal.jpg,1579,716,105,5339,frankvinluan,
29881875,2020-04-20 12:36:43,,,"xconomy.com/national/2020/‚Ä¶, ",1252275010171011072,False,0,0,0,1,TweetDeck,"FDA Approves Incyte Drug, First Ever for Rare Bile Duct Cancer
- by @frankvinluan
https://t.co/1lqPfhtVCu","frankvinluan, ",,2009-04-08 21:24:43,United States,Xconomy,https://pbs.twimg.com/profile_images/1218178322347282434/gvnH_9q2_normal.png,26411,2671,1396,23941,Xconomy,
133504478,2020-04-20 12:35:03,,"strategy, competitiveintelligence, marketing, competitivemarketing, pharmaceutical, healthcare, pharma, biotech, ","dlvr.it/RV6jHF, lqventures.com, pic.twitter.com/dBPj1RIwb2, ",1252274590786580485,False,0,0,0,1,dlvr.it,"FDA Approves Incyte Drug, First Ever for Rare Bile Duct Cancer https://t.co/XrDJ9pOVnY &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #competitivemarketing #pharmaceutical #healthcare #pharma #biotech https://t.co/dBPj1RIwb2",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
760484491555139584,2020-04-20 12:23:34,,,"dlvr.it/RV6ggX, ",1252271700206432256,False,0,0,0,0,dlvr.it,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/YjWA84x3Sx,,,2016-08-02 10:36:46,,analyst land news,https://pbs.twimg.com/profile_images/1075066740835606534/NpZYEW5E_normal.jpg,10,0,1,5551,analystlandnews,
133504478,2020-04-20 12:09:07,,"strategy, competitiveintelligence, marketing, productmarketing, pharmaceutical, pharma, biotech, healthcare, ","dlvr.it/RV6dLP, lqventures.com, pic.twitter.com/XAJMjrcuOs, ",1252268063606501376,False,0,0,0,1,dlvr.it,Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time https://t.co/LiD73fhesn &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #pharma #biotech #healthcare https://t.co/XAJMjrcuOs,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
852931863547084801,2020-04-20 11:56:01,"INCY, ",,"zpr.io/tiSk9, ",1252264768049754112,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $110.00 Price Target at Piper Sandler https://t.co/eQoxyZvLKt,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
46297868,2020-04-20 11:55:33,,,"dlvr.it/RV6ZfK, ",1252264652295172099,True,1,0,0,0,dlvr.it,Incyte beefs up portfolio with FDA nod for rare bile duct cancer therapy Pemazyre https://t.co/nTtXUtPRIi,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
849417718642159616,2020-04-20 11:55:07,"INCY, ",,"zpr.io/tiSS8, ",1252264541049819137,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $110.00 Price Target at Piper Sandler https://t.co/K9vRGNAqVA,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
25560065,2020-04-20 10:41:11,,,"bizjournals.com/philadelphia/n‚Ä¶, ",1252245937243684865,False,1,0,0,0,True Anthem,"Wilmington bitoech company Incyte gets its second FDA approval, this one is for a drug to treat a rare type of cancer. https://t.co/rUKNBBCYow",,,2009-03-20 15:31:03,Philadelphia,PHL Business Journal,https://pbs.twimg.com/profile_images/378800000077412316/8b22fbb8c4be97c69f048ff47fe712b6_normal.jpeg,35028,8899,1065,77326,PHLBizJournal,
3911174913,2020-04-20 10:30:00,,"GVHD, ",,1252243122458894337,False,25,0,1,5,Twitter for Advertisers.,"The graft-versus-host disease (#GVHD) community spans from patients to caregivers to physicians. With the Incyte Ingenuity Award, we aim to recognize those in this community who are fostering innovation in this area of need.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
1128239740329705472,2020-04-20 10:17:29,"INCY, ",,"endpts.com/incyte-nabs-2n‚Ä¶, ",1252239973232848896,False,0,0,0,0,Twitter for Android,"""This approval demonstrates that while we continue to focus our efforts on addressing the COVID-19 pandemic, the FDA remains committed to the important work of reviewing treatments for patients with cancer and other serious conditions.""
$INCY 
https://t.co/5suuqrHSdR",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
23779715,2020-04-20 10:08:56,,,,1252237821143851009,False,5,2,0,3,Twitter Web App,FDA has approved 5 new cancer drugs in the last two weeks that are way ahead of schedule. Incyte drug had a May 30 deadline (5 weeks early). Seattle Genetics drug was four months early! OCE is on fire. All had two things: breakthrough therapy designation and priority review.,,,2009-03-11 11:41:28,"Washington, DC",Ramsey Baghdadi,https://pbs.twimg.com/profile_images/1158802742695079936/9_pOIJRq_normal.jpg,1806,128,114,6984,Ramsey_Baghdadi,
2317434732,2020-04-20 10:07:11,,,"bit.ly/2KmdRhD, ",1252237380473454592,False,0,0,0,0,Twitter Web App,"FDA Approves Incyte‚Äôs Pemazyr (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma https://t.co/DOGcjf64K5",,,2014-01-29 11:36:01,"Cranbury, NJ",The Lynx Group,https://pbs.twimg.com/profile_images/1448306767318880257/ga96SZL__normal.jpg,123,108,1,883,TheLynxGroup,
27645777,2020-04-20 09:52:27,,,"bit.ly/3cAATxg, pic.twitter.com/Xr5UCD4esN, ",1252233674000461826,False,0,0,0,1,TweetDeck,.@US_FDA approves pemigatinib (Pemazyre) @Incyte - first targeted therapy for unresectable cholangiocarcinoma https://t.co/J6lK600LJA https://t.co/Xr5UCD4esN,"US_FDA, Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
1193779847727894529,2020-04-20 09:50:33,,,"pic.twitter.com/r24l8yTNyr, ",1252233192225992706,False,2,0,0,0,dlvr.it,Incyte‚Äôs Bile Duct Cancer Drug Wins FDA Approval https://t.co/r24l8yTNyr,,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,photo
1706741204,2020-04-20 09:07:00,,,"bit.ly/2VEfEnA, ",1252222233839316999,False,0,0,0,0,Semrush Social Media Tool,US regulators have approved Incyte's Pemazyre as the first targeted treatment for cholangiocarcinoma. https://t.co/0ls4gfDfEy,,,2013-08-28 04:41:35,UK,Regulatory Jobs,https://pbs.twimg.com/profile_images/378800000580395888/fc53938e01af9ff0efe4b865e981c8fc_normal.jpeg,227,91,0,4810,RegProRecruit,
267943190,2020-04-20 08:50:05,,,"investor.incyte.com/news-releases/‚Ä¶, ",1252217979137396736,False,0,0,0,0,Hootsuite Inc.,"Promising:
https://t.co/do8nrzBqqw",,,2011-03-17 17:19:27,"Bethesda, MD",AA&MDSIF,https://pbs.twimg.com/profile_images/917816894954115072/wZC5tCTh_normal.jpg,3354,2448,56,20690,aamdsif,
374729426,2020-04-20 08:48:10,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1509245, pic.twitter.com/ozeaR3Alpn, ",1252217493227048960,False,0,0,1,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/JdJutbHkIn #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ozeaR3Alpn",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1889492676,2020-04-20 08:38:23,"INCY, ","RUXCOVID, Ruxolitinib, Jakafi, COVID19, CytokineStorm, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1252215031548334082,False,0,0,0,0,Troi URL Plug-in,Incyte Initiates Phase 3 #RUXCOVID Study Evaluating #Ruxolitinib (#Jakafi) as Treatment for #COVID19 Associated #CytokineStorm $INCY https://t.co/CNjgxqAAUG,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
3227303414,2020-04-20 08:30:04,,,"firstwordpharma.com/node/1716640, ",1252212941501464577,False,0,0,0,0,Twitter Web Client,Check out this FWPharma article : FDA approves Incyte's Pemazyre as first targeted treatment in US for cholangiocarcinoma. https://t.co/TYMatrlEk9 via @fwpharma,"fwpharma, ",,2015-05-26 12:02:20,,"Kimberly C. Fields, MBA",https://pbs.twimg.com/profile_images/1248301887465476096/pQtHr7J__normal.jpg,60,527,1,984,Nmybox,
2334614718,2020-04-20 08:01:07,"INCY, ",,"ooc.bz/l/51677, ",1252205655458529280,False,1,0,0,0,Open Outcrier,"$INCY (-1.3% pre) FDA OKs Incyte's pemigatinib for type of bile duct cancer - SA

https://t.co/ulxLBS3t6N",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
301890257,2020-04-20 07:57:59,,,"sco.lt/83Zhrs, pic.twitter.com/Wo59Ix3rWK, ",1252204867264880641,False,1,0,0,1,Scoop.it,"FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma https://t.co/19MmDvigim https://t.co/Wo59Ix3rWK",,,2011-05-20 03:29:21,Geneva and New York,Krishan Maggon,https://pbs.twimg.com/profile_images/1247796373950304256/eskxrohr_normal.jpg,1076,501,40,50478,kkmaggon,photo
725577499,2020-04-20 07:54:37,"INCY, ",,"blog.tipranks.com/incytes-bile-d‚Ä¶, ",1252204020007141376,False,0,0,0,0,Twitter Web App,"Incyte‚Äôs Bile Duct Cancer Drug Wins FDA Approval $INCY 
https://t.co/3P67gRuut6",,,2012-07-30 03:57:38,,TipRanks,https://pbs.twimg.com/profile_images/1445275766195884032/dO0joyh1_normal.jpg,25516,1242,436,23612,TipRanks,
301890257,2020-04-20 07:51:35,,,"HCP.Pemazyre.com, sco.lt/9Appbc, pic.twitter.com/6F1HBfPO6m, ",1252203256987648000,False,0,0,0,0,Scoop.it,Incyte Pemazyre: Now FDA Approved | https://t.co/QBhzOOlpV8 https://t.co/bC4a9zOQ26 https://t.co/6F1HBfPO6m,,,2011-05-20 03:29:21,Geneva and New York,Krishan Maggon,https://pbs.twimg.com/profile_images/1247796373950304256/eskxrohr_normal.jpg,1076,501,40,50478,kkmaggon,photo
3460109487,2020-04-20 07:43:06,,,"endpts.com/incyte-nabs-2n‚Ä¶, ",1252201120484777985,False,1,0,0,1,Buffer,Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time https://t.co/TaK7n0I4pF,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
4312114277,2020-04-20 07:33:04,"INCY, ",,"fintel.io/sfs/us/incy?ut‚Ä¶, ",1252198596050640898,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers https://t.co/xljeWddlXw,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,163,418542,fintel_io,
772471873539977217,2020-04-20 07:32:22,"INCY, ",,"sec.gov/ix?doc=/Archiv‚Ä¶, ",1252198420850323461,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 8-K https://t.co/g3jr5EioE5,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
1171873456276889600,2020-04-20 07:31:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1252198283994451971,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (20 Apr, 7:30am)

üì∞ Departure of Directors or Certain Officers; Election of Directors

https://t.co/qMmkvhHUn9

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
121158213,2020-04-20 07:20:04,,,"dlvr.it/RV5h4k, freetrade.pw, pic.twitter.com/3FwX0gSOsQ, ",1252195323910356994,False,0,0,0,0,dlvr.it,Trading Ideas: Incyte Corporation Resistance target https://t.co/qiqmortYEP üìà FREE trade-of-week via ‚Üí https://t.co/BCEHq7Ce2N https://t.co/3FwX0gSOsQ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,photo
46297868,2020-04-20 07:06:05,,,"dlvr.it/RV5fJW, ",1252191802796371968,True,0,0,0,0,dlvr.it,Incyte nabs 2nd ever approval ahead of schedule as FDA insists it can still review on time https://t.co/9vtvFTpTZ4,,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
1082709654491328512,2020-04-20 07:03:22,,"INCY, ","tradingview.com/chart/INCY/N1T‚Ä¶, ",1252191120991215618,False,0,0,0,0,erased1143779,Incyte Corporation Resistance target  - #INCY chart https://t.co/R2e0UV9bT1,,,2019-01-08 13:44:32,üíØ% Free Subscriptionüîª,#BullishChartsüá∫üá∏,https://pbs.twimg.com/profile_images/1264289711469797376/hKeDDtwW_normal.jpg,11524,2033,46,6751,Bullishcharts01,
72928001,2020-04-20 06:57:46,"INCY, ",,"bit.ly/34NLq5T, ",1252189711692529664,False,1,0,0,1,BriefingInPlayLimited,"$INCY: Incyte receives Orphan Drug, Breakthrough Therapy and Priority Review designations for Pemazyre https://t.co/BrJmhfpYBl",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
58795846,2020-04-20 06:43:43,,,"paper.li/TumorWarrior/1‚Ä¶, ",1252186175739244544,False,0,0,0,0,Paper.li,"FDA approves Incyte‚Äôs Pemazyre as first targeted treatment for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma - Pharmaceutical Business review https://t.co/vMKXpFLkbp",,,2009-07-21 09:35:02,Eastern US,Lou War,https://pbs.twimg.com/profile_images/867392143664533504/cpVTVxMJ_normal.jpg,10295,5657,458,60244,TumorWarrior,
2205909769,2020-04-20 06:32:47,,,"clinicaltrialsarena.com/news/incyte-ru‚Ä¶, ",1252183425269850113,False,0,0,0,0,Twitter for iPhone,Incyte begins Phase III trial of ruxolitinib to treat Covid-19 https://t.co/gR7hbxHATR,,,2013-11-20 19:38:08,"New York, USA",Margaret Anderson,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,10,470,0,5284,AndersmMander43,
3901351277,2020-04-20 06:13:13,,"pharmaceutical, ","bit.ly/3btQGhC, ",1252178499135311872,False,0,0,0,0,IFTTT,"Incyte's Pemazyre becomes FDA's first and only approved unresectable, advanced cholangiocarcinoma treatment : https://t.co/mydcEZFyOR #pharmaceutical",,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
17960461,2020-04-20 06:03:43,,"pharma, ","bit.ly/34QVfQz, pic.twitter.com/QYlkWyXjDA, ",1252176108071653376,False,1,0,0,0,Twitter Web App,"Incyte's Pemazyre becomes FDA's first and only approved unresectable, advanced cholangiocarcinoma treatment
https://t.co/I0JlBtiPMl #pharma https://t.co/QYlkWyXjDA",,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
3356466131,2020-04-20 05:36:02,,,"dlvr.it/RV5Qct, ",1252169143727489025,False,1,0,0,0,dlvr.it,Incyte begins Phase III trial of ruxolitinib to treat Covid-19 https://t.co/PfpizWCC3z,,,2015-07-03 04:44:39,"London, England",ClinicalTrialsArena,https://pbs.twimg.com/profile_images/1029322960442675200/CYjbuNkJ_normal.jpg,3822,1927,81,11352,ArenaClinical,
3356466131,2020-04-20 02:36:04,,,"dlvr.it/RV51hc, pic.twitter.com/gt42Se7Bi8, ",1252123852701761536,False,1,0,0,0,dlvr.it,Incyte begins Phase III trial of ruxolitinib to treat Covid-19 https://t.co/9snMs7COjw https://t.co/gt42Se7Bi8,,,2015-07-03 04:44:39,"London, England",ClinicalTrialsArena,https://pbs.twimg.com/profile_images/1029322960442675200/CYjbuNkJ_normal.jpg,3822,1927,81,11352,ArenaClinical,photo
732361939490312192,2020-04-20 00:29:13,"INCY, ","markets, ","americanbankingnews.com/?p=14213431, ",1252091928478433280,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Hold Rating Reaffirmed at Mizuho https://t.co/kJx6oJ1WxX #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-20 00:29:12,"INCY, ","stocks, ","americanbankingnews.com/?p=14213431, ",1252091925827596289,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Hold Rating Reaffirmed at Mizuho https://t.co/yoDqqbV9xc #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1008902540652494850,2020-04-19 21:11:20,,,"genomeweb.com, ",1252042129557221376,False,0,0,0,0,chatcorenews_app,"Incyte‚Äôs Pemazyre, Foundation Medicine CDx Get FDA Approval for FGFR2-Mutated Bile Duct Cancer
411670 at https://t.co/g4N5Ghzya4",,,2018-06-18 22:41:25,,CHAT Core News,https://pbs.twimg.com/profile_images/1008906806716854273/P7-eqppS_normal.jpg,10,0,0,20635,ChatCoreNews,
21268553,2020-04-19 17:59:37,,,"stock-market-newsfeed.blogspot.com/2020/04/incyte‚Ä¶, ",1251993885410299904,False,0,0,0,0,SS Auto Tweet App,"Incyte, Novartis launch drug study to treat coronavirus complication
 https://t.co/FBTHJrMnhQ",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
374729426,2020-04-19 17:18:00,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1505917, pic.twitter.com/wUdaDudsfv, ",1251983411704520706,False,0,0,0,1,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/U0khKt4VAv #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wUdaDudsfv",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
575910168,2020-04-19 12:22:52,,"YahooFinance, Traffic, Transportation, Shipping, Logistics, Trucking, ","truckingnews.us/incyte-novarti‚Ä¶, ",1251909137086087168,False,0,0,0,0,Trucking News,"Incyte, Novartis Initiate Phase 3 Jakavi Drug Study For Coronavirus Treatment https://t.co/TKk0EmC8Ur
#YahooFinance #Traffic #Transportation #Shipping #Logistics
Follow @AFTvitaliy for #Trucking News","AFTvitaliy, ",,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
707983961897611264,2020-04-19 11:44:32,"INCY, ",,"pro.benzinga.com, ",1251899491327803395,False,2,0,0,0,Twitter Web Client,"FDA Approves Incyte's Pemazyre  as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma $INCY https://t.co/yZhLn9ITia @benzinga","Benzinga, ",,2016-03-10 12:38:25,"Shawnee, OK",TraderZ,https://pbs.twimg.com/profile_images/1446462992934113312/0KCR9vsY_normal.jpg,2602,624,20,15539,MccaslinAndy,
133504478,2020-04-19 11:26:36,,"strategy, competitiveintelligence, marketing, healthcare, pharmaceutical, productmarketing, pharma, biotech, ","dlvr.it/RV3Ngw, lqventures.com, pic.twitter.com/fvb5STbp9e, ",1251894976478248961,False,0,0,0,1,dlvr.it,"Global Cancer Anorexia-Cachexia Syndrome Drug Market Insights 2019-2025 | Acacia Pharma Ltd, Aeterna Zentaris Inc,‚Ä¶ https://t.co/Hb4TJlDTlG &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #productmarketing #pharma #biotech https://t.co/fvb5STbp9e",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
35789155,2020-04-19 10:16:59,,,"firstwordpharma.com/node/1716640?t‚Ä¶, ",1251877458963582984,False,3,0,0,1,Twitter Web App,"FDA approves Incyte's Pemazyre as first targeted treatment for cholangiocarcinoma
https://t.co/N1F0ukRh4G",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
875055104671481857,2020-04-19 09:46:39,,,"delawarebusinessnow.com/2020/04/incyte‚Ä¶, ",1251869826722693121,False,0,0,0,0,Twitter Web Client,Incyte-Novartis get OK for  trial to determine whether  blockbuster drug can treat deadly coronavirus  ‚Äòstorm‚Äô https://t.co/BSAbZKdxK9 via @Delaware Business Now,"Delaware, ",,2017-06-14 14:19:29,NY Metro Area,Gloria Stone,https://pbs.twimg.com/profile_images/1095703708732674048/wpWdnLDf_normal.png,30,325,1,506,GStoneConnect,
906328017986899968,2020-04-19 09:40:46,"INCY, ",,"pic.twitter.com/BaTNB0fZWO, ",1251868344866783232,False,24,0,3,3,Twitter Web App,"$INCY Incyte ...""focuses on the discovery, development, and commercialization of various therapeutics, including a focus on leukemia."" Another Biotech name. Beautiful base on the relative chart, with a BRB setup. New absolute highs coming out of a base as well. https://t.co/BaTNB0fZWO",,,2017-09-08 21:26:53,"Charlotte, NC","Ian McMillan, CMT",https://pbs.twimg.com/profile_images/1407164505247956993/vDCOcrML_normal.jpg,60662,447,1750,38631,the_chart_life,photo
1889492676,2020-04-19 09:24:43,"INCY, ","FDA, Pemazyre, Pemigatinib, Metastatic, Cholangiocarcinoma, ","1stoncology.com/blog/-fda-appr‚Ä¶, ",1251864303851855877,False,1,0,0,4,Troi URL Plug-in,"#FDA Approves Incyte‚Äôs #Pemazyre‚Ñ¢ (#Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or #Metastatic #Cholangiocarcinoma $INCY https://t.co/pH6xs0R6Xx",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
934157084790177792,2020-04-19 08:01:01,,,"feeds.marketwatch.com/~r/marketwatch‚Ä¶, ",1251843242871730182,False,1,0,0,0,RSS Ground,"Incyte, Novartis launch drug study to treat coronavirus complication Incyte Corp. said Friday it and Novartis AG started a late-stage clinical trial to study a drug meant to treat a... - https://t.co/yBuL438uZl",,,2017-11-24 15:29:39,"New York, NY",OTCPicks üé∂üìä,https://pbs.twimg.com/profile_images/1009982925310496768/qMH-49rt_normal.jpg,3301,4183,14,2556,otcpicks1,
15974185,2020-04-19 05:47:33,,,"dlvr.it/RV2qjM, ",1251809653941387265,False,0,0,0,0,dlvr.it,"Incyte, Novartis launch drug study to treat coronavirus complication https://t.co/IGXBjVnrSl",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1008902540652494850,2020-04-19 05:10:38,,,"genomeweb.com, ",1251800363646083072,False,0,0,0,0,chatcorenews_app,"Incyte's Pemazyre Approved for FGFR2 Rearranged Bile Duct Cancer With FoundationOne CDx
411670 at https://t.co/g4N5Ghzya4",,,2018-06-18 22:41:25,,CHAT Core News,https://pbs.twimg.com/profile_images/1008906806716854273/P7-eqppS_normal.jpg,10,0,0,20635,ChatCoreNews,
2920258887,2020-04-19 04:59:27,"INCY, ",,"dakotafinancialnews.com/?p=1799340, ",1251797549024976896,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Increased to Strong-Buy at BidaskClub https://t.co/ZXDmbPdnMJ,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
930803511918411776,2020-04-19 04:59:16,"INCY, ",,"thelincolnianonline.com/?p=3821289, ",1251797503638462464,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Increased to Strong-Buy at BidaskClub https://t.co/yGF0ahHHAG,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
21268553,2020-04-19 03:19:38,,,"stock-market-newsfeed.blogspot.com/2020/04/incyte‚Ä¶, ",1251772429149626371,False,0,0,0,0,SS Auto Tweet App,"Incyte, Novartis launch drug study to treat coronavirus complication
 https://t.co/FBTHJrMnhQ",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
2298709746,2020-04-19 01:35:30,"INCY, ",,"zpr.io/tiXVk, ",1251746224019058688,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 1-Year High at $98.19 https://t.co/OILed3fVPQ,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1979190776,2020-04-19 01:34:25,"INCY, ",,"tickerreport.com/?p=5419339, ",1251745948293832705,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 1-Year High at $98.19 https://t.co/LJpY25meEE,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-04-19 01:34:15,"INCY, ",,"thelincolnianonline.com/?p=3818925, ",1251745909161025538,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 1-Year High at $98.19 https://t.co/9QKMRdimtu,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2020-04-19 01:34:04,"INCY, ",,"theenterpriseleader.com/?p=2993285, ",1251745860834205698,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 1-Year High at $98.19  https://t.co/7S7V9AOJYQ,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
575910168,2020-04-18 22:02:45,,"YahooFinance, Traffic, Transportation, Shipping, Logistics, Trucking, ","truckingnews.us/incyte-scores-‚Ä¶, ",1251692681803128832,False,0,0,0,0,Trucking News,"Incyte Scores New High https://t.co/vWiCkLts7g
#YahooFinance #Traffic #Transportation #Shipping #Logistics
Follow @AFTvitaliy for #Trucking News","AFTvitaliy, ",,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
1193779847727894529,2020-04-18 22:01:32,,,"pic.twitter.com/ehccj8sIrt, ",1251692375165919234,False,0,0,0,0,dlvr.it,Incyte Scores New High https://t.co/ehccj8sIrt,,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,photo
889954942626275329,2020-04-18 18:12:06,,"Covid_19, COVID, ","businesswire.com/news/home/2020‚Ä¶, ",1251634636284985344,False,0,0,0,0,Twitter for iPad,Would like to see more info on eligibility criteria. At least they have a control arm! But surprising that cytokine levels aren‚Äôt being measured as 2ndary endpt esp when the talk is abt cytokine storm. #Covid_19 #COVID https://t.co/AEJhMCNbSq,,,2017-07-25 17:06:07,,Fish4fun,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,8,485,0,223,Fishy_fun7,
55117055,2020-04-18 15:23:47,,"cholangiocarcinoma, rarecancer, ","twitter.com/Incyte/status/‚Ä¶, ",1251592281112576002,False,7,1,0,4,TweetDeck,A truly amazing milestone reached as the first targeted treatment for #cholangiocarcinoma receives FDA approval. We are proud to be a part of this community and grateful to everyone who played a role in making this a reality. #rarecancer https://t.co/HPHuXRWRyV,,,2009-07-08 22:41:39,"Cambridge, MA",TargetCancer Fdn,https://pbs.twimg.com/profile_images/700682483826688000/ESvldBWo_normal.jpg,1080,916,42,1335,targetcancer,
1089824119791726592,2020-04-18 13:57:22,,,"twitter.com/Incyte/status/‚Ä¶, ",1251570531264061441,False,8,0,0,5,Twitter for iPhone,Great news for personalized targeted therapy in patients with Cholangiocarcinoma and FGFR2 fusions/muts. Looking forward to the phase III CT!! üëèüëè https://t.co/T3TwoYHpUY,,,2019-01-28 04:54:52,,ENS-CCA,https://pbs.twimg.com/profile_images/1089827977595105280/M0oswrN9_normal.jpg,496,217,4,1437,CcaEns,
864375020834914304,2020-04-18 13:50:29,,,"bit.ly/2Vk4NQF, pic.twitter.com/ecg8EywH9A, ",1251568801403080704,False,39,1,1,15,Twitter for iPhone,"Pemigatinib @FDAOncology approved for previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a FGFR2 fusion or other rearrangement as detected by an FDA-approved test ‚Äî @_SEOM @OncoAlert @Incyte https://t.co/P2r40ZLMYs https://t.co/ecg8EywH9A","FDAOncology, _SEOM, OncoAlert, Incyte, ",,2017-05-16 03:00:39,"Barcelona, Spain",Aleix Prat #PrecisionOncology,https://pbs.twimg.com/profile_images/1299799809977704451/PqyeWoYW_normal.jpg,5920,427,53,7210,prat_aleix,photo
55654926,2020-04-18 13:47:16,,"cholangiocarcinoma, bileductcancer, curecca, ","cholangiocarcinoma.org/fda-approves-p‚Ä¶, ",1251567990534881280,False,24,1,0,8,Twitter Web App,"https://t.co/wLSCXNXohM

FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma.
#cholangiocarcinoma #bileductcancer #curecca",,,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,
1214880840724795393,2020-04-18 13:14:08,,,"thenewspocket.com/fda-oks-incyte‚Ä¶, ",1251559651067518976,False,0,0,0,0,WordPress.com,FDA OKs Incyte‚Äôs pemigatinib for type of bile duct cancer (NASDAQ:INCY) https://t.co/8RpHaf1lPQ,,,2020-01-08 07:05:48,Worldwide,The News Pocket,https://pbs.twimg.com/profile_images/1387054910802259981/GZbHVLEa_normal.jpg,16,0,0,25627,thenewspocket,
2214324109,2020-04-18 13:09:11,,,"investor.incyte.com/news-releases/‚Ä¶, ",1251558406286016513,False,4,1,1,0,Twitter Web App,"First drug to be FDA approved specifically for cholangiocarcinoma. A watershed event !
https://t.co/QRtf99C4yZ",,,2013-11-25 11:26:32,"Scottsdale, AZ","Mitesh Borad, M.D.",https://pbs.twimg.com/profile_images/378800000789407478/87dbca8b006ad68826aaef8b301da8a0_normal.jpeg,1353,3919,10,732,MiteshBorad,
1637027690,2020-04-18 11:42:24,,,"ift.tt/34NWhMQ, ",1251536565278564353,False,0,0,0,0,IFTTT,FDA OKs Incyte's pemigatinib for type of bile duct cancer https://t.co/fdmXOrwKlC,,,2013-07-31 23:30:55,Everywhere,Ashish Aggarwal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,557,0,4776,AggarwalTweets,
25406480,2020-04-18 11:39:10,,,"awesomecapital.blogspot.com/2020/04/fda-ok‚Ä¶, ",1251535752816721920,False,0,0,0,1,Twitter Web Client,AwesomeCapital: FDA OKs Incyte‚Äôs pemigatinib for type of bile duct... https://t.co/uZWkBwiBb6,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
14453501,2020-04-18 11:35:40,,,"delawarebusinessnow.com/2020/04/incyte‚Ä¶, ",1251534873325600773,True,0,0,0,0,WordPress.com,Incyte-Novartis trial to gauge whether blockbuster drug can treat deadly coronavirus immune system ‚Äòstorm‚Äô https://t.co/2aAi1E8fPZ,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
373902619,2020-04-18 11:25:26,,,"fightcoronavirus.com/incyte-novarti‚Ä¶, ",1251532295028146176,False,0,0,0,0,FS Poster,"Incyte, Novartis launch drug study to treat coronavirus complication - MarketWatch
https://t.co/vQIXAb3UNm",,,2011-09-15 07:14:54,,FightCoronavirus2020,https://pbs.twimg.com/profile_images/1246359104240697344/N_kRp2j2_normal.jpg,24,8,1,16965,FCoronavirus19,
373902619,2020-04-18 11:24:44,,,"fightcoronavirus.com/incyte-novarti‚Ä¶, ",1251532121451069441,False,0,0,0,0,FS Poster,"Incyte, Novartis launch drug study to treat coronavirus complication - MarketWatch
https://t.co/X31vAF9svl",,,2011-09-15 07:14:54,,FightCoronavirus2020,https://pbs.twimg.com/profile_images/1246359104240697344/N_kRp2j2_normal.jpg,24,8,1,16965,FCoronavirus19,
31372539,2020-04-18 10:46:02,,,"dlvr.it/RV0skD, ",1251522382411382790,False,0,0,0,0,dlvr.it,FDA OKs Incyte's pemigatinib for type of bile duct cancer https://t.co/ljnahDC7OR,,,2009-04-15 05:08:17,Amsterdam,Stocks tweets,https://pbs.twimg.com/profile_images/138834360/stocks1-avatar_normal.jpg,4407,3020,91,70157,stocks_tweets,
1134049078424162304,2020-04-18 10:43:37,"INCY, ",,"newsfilter.io/articles/fda-o‚Ä¶, ",1251521773637562369,False,0,0,0,0,Newsfilter.io,FDA OKs Incyte's pemigatinib for type of bile duct cancer $INCY https://t.co/NFu26J7MbS,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
15296897,2020-04-18 10:41:02,"INCY, ",,"seekingalpha.com/news/3561860-f‚Ä¶, ",1251521121964290049,False,0,0,0,1,SANewsTwitter,$INCY - FDA OKs Incyte's pemigatinib for type of bile duct cancer https://t.co/LN41LwOpds,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
2243532322,2020-04-18 10:34:05,,"cholangiocarcinoma, ","twitter.com/Incyte/status/‚Ä¶, ",1251519372910346242,False,4,0,1,1,Twitter for Android,"FDA approves Pemazyre FGFR2i for adults with #cholangiocarcinoma.
FIGHT-202: Pts w FGFR2 fusions or rearrangements (Cohort A), ORR 36% (1ry EP), and mDOR 9.1 m (2ry EP). 
Watch for: eye problems (dryness/ inflammation etc); hyperphosphatemia; teratogenesis
@JohnJanikj @GABOUALFA https://t.co/eOJh91MmXV","JohnJanikj, GABOUALFA, ",,2013-12-25 12:30:49,"Maryland, USA","Houssein A. Sater, MD",https://pbs.twimg.com/profile_images/1331815829042831360/iCrTgRET_normal.jpg,1167,1130,15,1552,HSaterMD,
121158213,2020-04-18 09:58:33,"INCY, ",,"dlvr.it/RV0nqm, freetrade.pw, pic.twitter.com/wUeOJXfAER, ",1251510432419860481,False,1,0,0,0,dlvr.it,Trading Ideas: INCYTE Corp $INCY https://t.co/yhHVNPpTyl üìà FREE trade-of-week via ‚Üí https://t.co/BCEHq7Ce2N https://t.co/wUeOJXfAER,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,photo
1442263512,2020-04-18 09:56:36,,,"clinicaltrials.gov/ct2/show/NCT03‚Ä¶, twitter.com/Incyte/status/‚Ä¶, ",1251509939757027328,False,12,1,1,3,Twitter Web App,"Approval based on encouraging results of a phase II trial. Good news but we should wait the results of the ongoing phase III trial (FIGHT-302) @BCLC_group
https://t.co/VUinDoDFUQ https://t.co/gyKWQ60zkS","BCLC_group, ",,2013-05-19 17:59:42,"Barcelona, Spain",Alejandro Forner,https://pbs.twimg.com/profile_images/608188501658607616/TRr6YGy9_normal.jpg,1254,354,8,1270,Alexfornergon,
106823467,2020-04-18 09:56:09,"INCY, ","Incyte, Cancer, Cholangiocarcinoma, ","crweworld.com/symbol/INCY, ",1251509828540751874,False,0,0,0,0,Twitter Web App,"FDA OKs $INCY 's Pemazyre for Patients with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma   #Incyte     #Cancer        #Cholangiocarcinoma        https://t.co/x9QsKSOMBZ",,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
21268553,2020-04-18 09:49:39,,,"stock-market-newsfeed.blogspot.com/2020/04/incyte‚Ä¶, ",1251508192061919249,False,0,0,0,0,SS Auto Tweet App,"Incyte, Novartis launch drug study to treat coronavirus complication
 https://t.co/FBTHJrMnhQ",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
2525892205,2020-04-18 09:03:15,"INCY, ","investingnews, ","modernreaders.com/?p=3136203, ",1251496515786473473,False,0,0,0,0,Zapier.com,Incyte $INCY Trading 5.2% Higher  https://t.co/PDSakico8U #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
3085571050,2020-04-18 08:46:36,,"cholangiocarcinoma, ","fda.gov/news-events/pr‚Ä¶, ",1251492323206115331,False,38,1,1,7,Twitter for iPhone,Proud to have been involved since day one. I knew this kid would graduate üéì ‚û°Ô∏èFDA Approves 1st Targeted Treatment for Patients w #cholangiocarcinoma @curecc FGFR inhibitor @Incyte https://t.co/hkf2CDdJ2Q,"curecc, Incyte, ",,2015-03-10 23:24:25,"Houston, TX","Vivek Subbiah, MD",https://pbs.twimg.com/profile_images/1097689560442642432/gDbq9r2-_normal.jpg,13448,1925,141,18030,VivekSubbiah,
981444534637821952,2020-04-18 07:48:45,,"Cholangiocarcinoma, cholangiocarcinoma, FGFR2fusions, ","twitter.com/Incyte/status/‚Ä¶, ",1251477765053956096,False,10,1,0,4,Twitter for iPhone,Major news in #Cholangiocarcinoma. Fist approved therapy in unresectable locally advanced or metastatic #cholangiocarcinoma. The drug targets #FGFR2fusions and its developed by @Incyte... next step will be approval in Europe? https://t.co/8wwlGU1E0b,"Incyte, ",,2018-04-04 04:13:06,"Copenhagen, Denmark",AndersenLab,https://pbs.twimg.com/profile_images/981448757865861121/43-tCql2_normal.jpg,434,188,1,340,UCPHAndersenLab,
374729426,2020-04-18 07:18:37,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1501593, pic.twitter.com/A1EVX5MVJE, ",1251470183249506314,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/ShlTfrsOKC #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/A1EVX5MVJE",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3402544414,2020-04-18 04:47:11,,"pemigatinib, CCA, ","twitter.com/Incyte/status/‚Ä¶, ",1251432071588990978,False,15,1,1,1,Twitter for iPhone,"Great news! Now in the US, hopefully in the near future in Europe too! @Incyte #pemigatinib #CCA https://t.co/wrTt256hRZ","Incyte, ",,2015-08-04 05:57:47,"Milan, Italy ",Lorenza Rimassa,https://pbs.twimg.com/profile_images/1140987670417629184/CCejApO8_normal.jpg,955,1163,6,2433,LorenzaRimassa,
2266388972,2020-04-18 04:28:49,"INCY, ","stocks, ","dailypolitical.com/?p=3718965, ",1251427453437980679,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $1,604,430.00 in Stock https://t.co/QeQBIlMvWi #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-18 04:28:49,"INCY, ",,"dailypolitical.com/?p=3718965, ",1251427451508580352,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $1,604,430.00 in Stock https://t.co/BeGYcjrlmc",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1637027690,2020-04-18 03:42:07,,,"ift.tt/2VgrNAc, ",1251415699949522945,False,0,0,0,0,IFTTT,Incyte launches pivotal study of Jakafi for COVID-19 complication https://t.co/JrCWMze6GP,,,2013-07-31 23:30:55,Everywhere,Ashish Aggarwal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,557,0,4776,AggarwalTweets,
700972645530132480,2020-04-18 03:08:49,"INCY, ","Cholangiocarcinoma, ","businesswire.com/news/home/2020‚Ä¶, ",1251407318924898304,False,0,0,0,0,Twitter for iPhone,"$INCY,  FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ - First Targeted Treatment for #Cholangiocarcinoma  https://t.co/PK8cF7XWeU",,,2016-02-20 04:17:56,Israel,Bio Station,https://pbs.twimg.com/profile_images/1247187929950273536/K_xkX_c4_normal.jpg,38,95,1,265,gideonpISR,
730032660,2020-04-18 01:14:54,,,"nonsell.com/us-market-news‚Ä¶, pic.twitter.com/75rAOFmhCs, ",1251378650940706817,False,0,0,0,0,NonSell Twitter,"Incyte, Novartis launch drug study to treat coronavirus complication - [US Market News], Source: MarketWatch News - https://t.co/5YLb9R3ML1 https://t.co/75rAOFmhCs",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,photo
3686628867,2020-04-17 23:56:50,,,"pharmaceuticaldaily.com/fda-approves-i‚Ä¶, ",1251359003042553857,False,0,0,0,0,WordPress.com,"FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma https://t.co/rqICa6KjHO",,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
16558786,2020-04-17 22:55:33,,"FDA, cholangiocracinoma, ","twitter.com/Incyte/status/‚Ä¶, ",1251343583619104772,False,8,0,0,2,Twitter for Android,"#FDA approved Pemazyre for FGFR2 altered #cholangiocracinoma.

Based on data from the FIGHT-202 study, a multi-center, open-label, single-arm study of Pemazyre in patients with FGFR2 fusions or rearrangements.

Pemazyre had overall response rate of 36%, median DOR of 9.1 months. https://t.co/PI2gSivFci",,,2008-10-02 09:11:03,"Stanford, CA",renumathyd,https://pbs.twimg.com/profile_images/1104602167074148352/0wiPRyC0_normal.png,2636,2651,55,5056,renumathyd,
227778014,2020-04-17 22:30:08,"SGEN, INCY, ",,"buff.ly/3estpyt, ",1251337185107812352,False,2,0,0,0,Buffer,"Trio of approvals for Seattle Genetics, Incyte and Everest Medicines on Friday $SGEN $INCY https://t.co/3SDrQrMKoD",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13038,1543,387,33073,BioCentury,
838428908336734208,2020-04-17 22:18:48,,,"twitter.com/Incyte/status/‚Ä¶, ",1251334332414918656,False,2,0,0,1,Twitter for iPhone,Great advance for patients with very few options https://t.co/mAk7UXKcrj,,,2017-03-05 11:40:03,"Boston, MA",Reid Huber,https://pbs.twimg.com/profile_images/1450546865947099140/yJtYSl44_normal.jpg,182,164,3,134,ReidHuber,
850464331603075072,2020-04-17 22:06:14,,,"news.yahoo.com/fda-approves-i‚Ä¶, ",1251331169553186817,False,3,0,0,1,Twitter Web Client,FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previou... https://t.co/M8FBPqPbZS via @YahooNews,"YahooNews, ",,2017-04-07 17:44:32,"Cleveland, OH ",Timothy Chan,https://pbs.twimg.com/profile_images/1019922389919043585/ZhevL7D4_normal.jpg,3855,597,32,4506,GeneCollector,
2862205661,2020-04-17 22:02:29,,,"instagram.com/p/B_Gs9u9gSib/‚Ä¶, ",1251330229022400514,False,12,0,0,1,Instagram,Great news to all our dear patients! sloan_kettering @GABOUALFA honored to have led this global effort with incyte and all great colleagues! https://t.co/ydDTTAWFVs,"GABOUALFA, ",,2014-11-05 05:11:35,"New York, USA",Ghassan Abou-Alfa,https://pbs.twimg.com/profile_images/1186221212839624705/R0UcYe3y_normal.jpg,2954,1260,28,1295,GABOUALFA,
588507814,2020-04-17 21:18:42,"INCY, ",,"twitter.com/Incyte/status/‚Ä¶, ",1251319207733555201,False,6,0,0,3,Twitter for iPhone,Another late Friday approval $INCY https://t.co/Cr4xRi3WWI,,,2012-05-23 15:01:34,"San Diego, CA",Mandy Jackson,https://pbs.twimg.com/profile_images/474210924400635904/wXzB8YN1_normal.jpeg,5177,737,266,17422,ScripMandy,
1006334607946649600,2020-04-17 21:12:03,,,"dlvr.it/RTzcZF, ",1251317536827650048,False,0,0,0,0,dlvr.it,"FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma https://t.co/yyW3dSw9q2",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
472650465,2020-04-17 21:12:03,"INCY, ",,"otcdynamics.com/incy-fda-appro‚Ä¶, ",1251317533996658688,False,0,0,0,0,OTC Dynamics Twitter Login,"$INCY FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated,  https://t.co/UVHKx91S2x",,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
2862205661,2020-04-17 21:06:58,,,"twitter.com/Incyte/status/‚Ä¶, ",1251316257351241728,False,66,4,1,9,Twitter Web App,Great news to all our dear patients! @sloan_kettering @GABOUALFA honored to have led this global effort with @Incyte and all great colleagues! https://t.co/fJjBnCg58g,"sloan_kettering, GABOUALFA, Incyte, ",,2014-11-05 05:11:35,"New York, USA",Ghassan Abou-Alfa,https://pbs.twimg.com/profile_images/1186221212839624705/R0UcYe3y_normal.jpg,2954,1260,28,1295,GABOUALFA,
3318510966,2020-04-17 21:06:31,,,"crweworld.com/article/news-p‚Ä¶, ",1251316141613449216,False,0,0,0,0,CRWE World,&amp;nbsp;FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treat https://t.co/VU5KPo6ad8,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1089978712685273090,2020-04-17 21:04:32,,"Incyte, ","dlvr.it/RTzbrl, ",1251315643313385472,False,0,0,0,0,dlvr.it,"FDA Approves #Incyte $INTC‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma https://t.co/8eHtucZxsS",,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
1022006086872821762,2020-04-17 21:01:47,"INCY, INCY, ",,,1251314953337942019,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was UP ‚¨Ü on Fri Apr 17
Closed at 100.00 USD for a 4.54% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
976297820532518914,2020-04-17 20:57:32,,,"dlvr.it/RTzbH1, pic.twitter.com/Bbel9kSz0w, ",1251313882389311488,False,0,0,0,0,dlvr.it,"FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma https://t.co/Pll1oqR4mw https://t.co/Bbel9kSz0w",,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2020-04-17 20:55:18,"INCY, ",,"s.flashalert.me/vxgOT, ",1251313321678180352,False,0,0,0,0,flashalerts,"$INCY: Issued Press Release on April 17, 20:53:00: FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma https://t.co/fiQOaOGcWS",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1134049078424162304,2020-04-17 20:54:33,"INCY, ",,"newsfilter.io/articles/fda-a‚Ä¶, ",1251313131843977223,False,0,0,0,0,Newsfilter.io,"FDA Approves Incyte‚Äôs Pemazyre‚Ñ¢ as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangioca.. $INCY https://t.co/wk8jcnliVd",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
16341911,2020-04-17 20:43:57,,"cholangiocarcinoma, ","twitter.com/kmody29/status‚Ä¶, ",1251310462223949826,False,24,0,0,8,Twitter for iPhone,Pemigatinib APPROVED! @Incyte @FDAOncology The first targeted therapy specifically approved for #cholangiocarcinoma @curecc https://t.co/K5vwxqxhzH,"Incyte, FDAOncology, curecc, ",,2008-09-17 23:03:59,"Jacksonville, FL",KModyMD,https://pbs.twimg.com/profile_images/1097258932572180480/2d0wP_3Y_normal.jpg,1252,319,31,2491,kmody29,
3686628867,2020-04-17 19:56:10,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1251298437187821568,False,0,0,0,0,WordPress.com,Incyte Announces Initiation of Phase 3 RUXCOVID Study Evaluating Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/odt0berad6,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
32492934,2020-04-17 19:45:53,"INCY, ",,,1251295850535346177,False,6,0,0,1,TweetDeck,"Keeping busy during the pandemic, the @US_FDA has granted accelerated approval to @Incyte's Pemazyre (pemigatinib) for certain 2L advanced cholangiocarcinoma patients. Review remains underway in Europe. In China, Innovent dosed its first patient in a reg. trial in March. $INCY","US_FDA, Incyte, ",,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
1134049078424162304,2020-04-17 19:10:32,"INCY, ","coronavirus, COVID2019, ","newsfilter.io/articles/incyt‚Ä¶, ",1251286954190295041,False,0,0,0,0,Newsfilter.io,Incyte launches pivotal study of Jakafi for COVID-19 complication $INCY #coronavirus #COVID2019 https://t.co/VqclSQAhxY,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
950942636818432006,2020-04-17 19:09:02,"INCY, ",,"twitter.com/TradeHawk/stat‚Ä¶, ",1251286577721962496,False,3,0,0,2,Twitter for iPhone,"$INCY The FDA granted accelerated approval to Incyte‚Äôs Pemazyre (pemigatinib), the first treatment approved for adults with certain types of previously treated, advanced cholangiocarcinoma.

This was ahead of the PDUFA date of 5/30/20. https://t.co/cU5zDtPK5j",,,2018-01-09 23:09:27,"San Francisco, CA",SY Investing,https://pbs.twimg.com/profile_images/1108963782334672900/Bh_0t4CE_normal.png,5814,300,160,3879,syinvesting,
21268553,2020-04-17 18:49:40,,,"stock-market-newsfeed.blogspot.com/2020/04/incyte‚Ä¶, ",1251281703886299138,False,0,0,0,0,SS Auto Tweet App,"Incyte, Novartis launch drug study to treat coronavirus complication
 https://t.co/FBTHJrMnhQ",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
72928001,2020-04-17 17:51:00,"INCY, ",,"bit.ly/2XKSWNq, ",1251266938874937344,False,1,0,0,0,BriefingInPlayLimited,$INCY: Incyte announces initiation of Phase 3 RUXCOVID study of ruxolitinib in patients with COVID-19 associated... https://t.co/l80aeyphwk,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
25406480,2020-04-17 17:41:23,,,"awesomecapital.blogspot.com/2020/04/incyte‚Ä¶, ",1251264518937874433,False,0,0,0,1,Twitter Web Client,"AwesomeCapital: Incyte, Novartis launch drug study to treat corona... https://t.co/9GTqM7bkRm",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
2193224916,2020-04-17 17:29:57,"INCY, ",,"pic.twitter.com/KJ2YGeTCVX, ",1251261642098257921,False,6,0,0,1,Twitter Web App,"Incyte $INCY climbed for the 15th day of 18, settling +4.5% to giant psy' $100.00. RSI 77s... over-stretched. @sansing_david https://t.co/KJ2YGeTCVX",,,2013-11-13 19:45:46,"London, UK",Philip Calrissian,https://pbs.twimg.com/profile_images/1302039310091378690/VTBMid-L_normal.jpg,13378,6,369,72260,Trading_Sunset,photo
2837784071,2020-04-17 17:10:45,"spy, gspc, aapl, nflx, goog, tsla, ",,"zpr.io/tizQa, ",1251256809328869378,False,0,0,0,0,Zapier.com,"$spy $gspc $aapl $nflx $goog $tsla Incyte, Novartis launch drug study to treat coronavirus complication  https://t.co/LPCfvKCE90",,,2014-10-19 21:22:48,"Toronto, Ontario",FaisamTrader,https://pbs.twimg.com/profile_images/856700180950904832/K-8u6osz_normal.jpg,4206,15,57,21629,FaisamTrader,
3316713321,2020-04-17 17:02:36,,,"marketwatch.com/news/story/inc‚Ä¶, ",1251254758419161088,False,0,0,0,0,WordPress.com,"Incyte, Novartis launch drug study to treat coronavirus complication https://t.co/ZCdmN6ZKP2",,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
270492072,2020-04-17 17:00:22,,"news, mktw, wsj, ","feeds.marketwatch.com/~r/marketwatch‚Ä¶, ",1251254195572756480,False,0,0,0,0,Microsoft Power Platform,"Incyte, Novartis launch drug study to treat coronavirus complication https://t.co/YSZwzfSSzI via MarketWatch #news #mktw #wsj",,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
1178379065197318145,2020-04-17 16:58:31,,,"dlvr.it/RTz6dD, ",1251253733645643776,False,0,0,0,0,dlvr.it,"Incyte, Novartis launch drug study to treat coronavirus complication https://t.co/ii6JhTc2Jw",,,2019-09-29 14:41:04,USA,MDLiveüöÄüí∞,https://pbs.twimg.com/profile_images/1244178263766753281/zXiQB_HJ_normal.jpg,659,232,10,9270,MDLive4,
963495628545327104,2020-04-17 16:57:04,"INCY, NVS, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/fzzEuYU5B5, ",1251253368980492289,False,0,0,0,0,STCK.PR0,"$INCY $NVS NEW ARTICLE : Incyte, Novartis launch drug study to treat coronavirus complication https://t.co/a4yFe9CoY8 Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/fzzEuYU5B5",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
3240385912,2020-04-17 16:54:39,,"finance, ","marketwatch.com/news/story/inc‚Ä¶, pic.twitter.com/HZCk8pJPJz, ",1251252758184972288,False,0,0,0,0,Twibble.io,"*BREAKING* Incyte, Novartis launch drug study to treat coronavirus complication https://t.co/wegSWha604 #finance https://t.co/HZCk8pJPJz",,,2015-05-07 08:45:55,New York and London,ASTUTE Investing,https://pbs.twimg.com/profile_images/598134900949004288/nsiDUtJ2_normal.jpg,64233,45205,512,107693,astuteinvesting,photo
1907769716,2020-04-17 16:09:01,,"treatment, COVID19, mpnsm, ","investor.incyte.com/news-releases/‚Ä¶, pic.twitter.com/1J40Bz5CJz, ",1251241273576624128,False,8,0,0,2,Twitter Web App,Incyte Announces Initiation of Phase 3 RUXCOVID Study Evaluating Ruxolitinib (Jakafi¬Æ) as a #treatment for Patients with #COVID19 Associated Cytokine Storm - #mpnsm https://t.co/HdnP9AhJhd https://t.co/1J40Bz5CJz,,,2013-09-26 08:36:43,"Charlotte, NC",PV Reporter,https://pbs.twimg.com/profile_images/1429560791892697094/XgF4tlne_normal.jpg,791,610,19,634,PVReporter,photo
963495628545327104,2020-04-17 15:59:02,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1251238762807545856,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte launches pivotal study of Jakafi for COVID-19 complication https://t.co/SyNQRdyorD Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
976297820532518914,2020-04-17 15:51:02,,,"dlvr.it/RTyznq, pic.twitter.com/w6h4Mqd84T, ",1251236750342492160,False,0,0,0,0,dlvr.it,Incyte Announces Initiation of Phase 3 RUXCOVID Study Evaluating Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/CvrCHmZJLN https://t.co/w6h4Mqd84T,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1134049078424162304,2020-04-17 15:47:31,"INCY, ","coronavirus, COVID2019, ","newsfilter.io/articles/incyt‚Ä¶, ",1251235866086903810,False,0,0,0,0,Newsfilter.io,Incyte Announces Initiation of Phase 3 RUXCOVID Study Evaluating Ruxolitinib as a Treatment for Patients with COVID-19 Associated Cytokine St.. $INCY #coronavirus #COVID2019 https://t.co/ZvM2XVsi0B,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
849093025884237825,2020-04-17 15:00:24,"INCY, ",,,1251224006151204864,False,14,0,2,1,Twitter Web App,"$INCY new 52 week highs

Yea, the same Incyte that bombed the itacitinib trial on the first trading day of the year

Amazing times üò≥",,,2017-04-03 22:55:27,"Calgary, Alberta",Wilson Cheung,https://pbs.twimg.com/profile_images/883155893570990083/cfZewggF_normal.jpg,5704,310,138,15776,Sanctuary_Bio,
1140762699002871808,2020-04-17 13:05:16,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1251195032192929792,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-04-17 13:05 EST. Shorted/Opened:
$INCY at $98.64. 
Incyte Corporation - Common Stock
Win Chance: 64%. Avg Win: 8%. Avg Loss: 11.38%. Avg Hold: 5d.
Trade Id: 40842008303024008.
Stats: https://t.co/I3x2oUW2yf",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
849417718642159616,2020-04-17 12:40:16,"INCY, ",,"zpr.io/tiqCJ, ",1251188739524694019,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 12-Month High at $98.19 https://t.co/FpRLLm7yPH,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2266388972,2020-04-17 12:37:17,"INCY, ","stocks, ","dailypolitical.com/?p=3716253, ",1251187990690516993,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 1-Year High at $98.19 https://t.co/r8G7GWW8Y1 #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-17 12:37:17,"INCY, ",,"dailypolitical.com/?p=3716253, ",1251187988618412032,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 1-Year High at $98.19 https://t.co/oChsYmbYB7,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
538402387,2020-04-17 11:25:05,,,"ow.ly/W9Ur50zaVmD, ",1251169820659331073,False,0,0,0,0,Hootsuite Inc.,"Incyte and NIMBL to help combat coronavirus. 
https://t.co/4ZSI8VS37V",,,2012-03-27 14:58:09,"Newark, Delaware, USA",DESCA,https://pbs.twimg.com/profile_images/1387774824504823812/S66uJ_x0_normal.jpg,278,179,27,1864,DescaDelaware,
374729426,2020-04-17 07:22:21,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1497372, pic.twitter.com/Zl4ozZzRHz, ",1251108735541374976,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/6CHllJnBR8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Zl4ozZzRHz",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-04-17 06:46:04,"INCY, ","investingnews, ","modernreaders.com/?p=3128735, ",1251099604986335233,False,0,0,0,0,Zapier.com,Frontier Capital Management Co. LLC Has $57.88 Million Holdings in Incyte Co. $INCY  https://t.co/15kMTqvTTM #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
892027226937597953,2020-04-17 05:45:26,,"AML, AMLawarenessday, BloodCancer, acuteleukemia, awareness, ","pic.twitter.com/VPA2pYAwr4, ",1251084345877712896,False,7,1,0,3,Twitter Web Client,"Come together and raise awareness of acute myeloid leukemia
(#AML) on 21st April! #AMLawarenessday #BloodCancer #acuteleukemia
#awareness
@KNOW_AML @HarmonynetEU @ERNEuroBloodNet @Novartis @pfizer @Incyte @Servier @Amgen https://t.co/VPA2pYAwr4","KNOW_AML, HarmonynetEU, ERNEuroBloodNet, Novartis, pfizer, Incyte, Servier, Amgen, ",,2017-07-31 10:20:38,Global,Acute Leukemia Advocates Network (ALAN),https://pbs.twimg.com/profile_images/1405089468525203456/6deSkFEw_normal.jpg,1091,490,5,2276,AcuteLeuk,photo
2416188264,2020-04-17 05:20:42,"INCY, ","markets, ","thestockobserver.com/?p=2862051, ",1251078121387950080,False,0,0,0,0,Zapier.com,"Maria E. Pasquale Sells 17,827 Shares of Incyte Co. $INCY Stock  https://t.co/KrYrL4FC9h #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2920258887,2020-04-17 04:35:03,"INCY, ",,"dakotafinancialnews.com/?p=1788948, ",1251066632908275713,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 17,827 Shares of Stock https://t.co/vqo1FrpHUx",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
849417718642159616,2020-04-17 04:34:16,"INCY, ",,"zpr.io/tigNC, ",1251066434744090626,False,0,0,0,0,Zapier.com,"Maria E. Pasquale Sells 17,827 Shares of Incyte Co. $INCY Stock https://t.co/w4uGwllWfr",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
852931863547084801,2020-04-17 04:33:48,"INCY, ",,"zpr.io/tigNf, ",1251066319669276672,False,0,0,0,0,Zapier.com,"Maria E. Pasquale Sells 17,827 Shares of Incyte Co. $INCY Stock https://t.co/TUUrTg7Mlz",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
1479442159,2020-04-17 03:26:12,,,,1251049304967372800,False,0,0,0,1,Twitter Web App,Incyte announced that they are working with the FDA to initiate a phase III clinical trial to assess ruxolitinib (Jakafi) plus standard-of-care in patients with coronavirus disease 2019 (COVID-19) induced cytokine storm.,,,2013-06-03 06:51:07,"Allahabad,U.P.,India",Dr.Virendra Singh,https://pbs.twimg.com/profile_images/3767381202/99d598cfb2c950db95172abfa161ada0_normal.png,3090,3202,7,8005,singhv2003,
1979190776,2020-04-17 02:05:21,"INCY, ",,"tickerreport.com/?p=5407802, ",1251028960613404672,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by BidaskClub to ‚ÄúStrong-Buy‚Äù https://t.co/dWERZm7f2S,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
68559732,2020-04-17 02:03:21,"INCY, ",,"zpr.io/ti67U, ",1251028455015227395,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by BidaskClub to ‚ÄúStrong-Buy‚Äù https://t.co/aLXaC48pOI,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1134049078424162304,2020-04-17 01:42:29,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1251023203440484352,False,0,0,0,0,Newsfilter.io,Incyte to Report First Quarter Financial Results $INCY https://t.co/QPvvEl6c9X,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
14323846,2020-04-16 18:33:02,,,"pic.twitter.com/YNdSxPulqC, ",1250915128398184448,False,36,1,1,8,Sprout Social,"Thank you to our corporate partners for their support, helping us provide immediate assistance &amp; resources to thousands of blood cancer patients.

@Amgen, @Bmsnews, @Burlington, @FoundationATCG, @Genetech, @Incyte, @MorphoSys, @ServierPharma, @subaru_usa, @TakedaOncology, @Wawa https://t.co/YNdSxPulqC","Amgen, bmsnews, Burlington, FoundationATCG, genetech, Incyte, MorphoSys, ServierPharma, subaru_usa, TakedaOncology, Wawa, ",,2008-04-07 11:30:05,U.S. and Canada,The Leukemia & Lymphoma Society,https://pbs.twimg.com/profile_images/1034530339626971136/rFv8UR7x_normal.jpg,38742,1505,763,12038,LLSusa,photo
1193779847727894529,2020-04-16 11:33:10,,,"pic.twitter.com/PMQaCW98mS, ",1250809464971649025,False,0,0,0,0,dlvr.it,Is Incyte Corporation (NASDAQ:INCY) Trading At A 33% Discount? https://t.co/PMQaCW98mS,,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,photo
1100450877792370688,2020-04-16 09:55:15,"INCY, ",,"blueequity.io/r/100300/de-in‚Ä¶, ",1250784826421948416,False,0,0,0,0,Blue Equity,$INCY Incyte to Report First Quarter Financial Results https://t.co/C7YGT9SZ57,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
1379457751,2020-04-16 09:02:03,,"GVHD, ","ow.ly/XbXk50z6lok, ",1250771435641024514,False,1,0,0,0,Hootsuite Inc.,"Applications are due in two weeks for Incyte's Ingenuity Award -- consider applying, or share with anyone who may be interested. The award funds one innovative activity, idea or initiative that addresses a critical unmet need for people impacted by #GVHD. https://t.co/VGb6Mtm0Qr",,,2013-04-25 09:19:48,"Chicago, Illinois",ASTCT,https://pbs.twimg.com/profile_images/1392522586202968065/utbTJTzw_normal.jpg,8353,424,0,3951,ASTCT,
3318510966,2020-04-16 08:07:36,,,"crweworld.com/article/news-p‚Ä¶, ",1250757732480585729,False,0,0,0,0,CRWE World,Incyte to Report First Quarter Financial Results https://t.co/nou353MkYi,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1069693680066420736,2020-04-16 08:05:19,"INCY, ",,"s.flashalert.me/YAlr5Y, ",1250757158817476608,False,0,0,0,0,flashalerts,"$INCY: Issued Press Release on April 16, 08:00:00: Incyte to Report First Quarter Financial Results https://t.co/R6wVOnQgjS",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
374729426,2020-04-16 08:02:03,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1493203, pic.twitter.com/FEuohUcwGM, ",1250756337618677761,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/rFdSdeG4Td #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/FEuohUcwGM",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1979190776,2020-04-16 04:30:36,"INCY, ",,"tickerreport.com/?p=5403471, ",1250703123120902150,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 17,827 Shares https://t.co/XH0XWuRBvO",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2020-04-16 04:29:35,"INCY, ","markets, ","americanbankingnews.com/?p=14169058, ",1250702867478065152,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 17,827 Shares https://t.co/ioKxOfe43L #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-16 04:29:34,"INCY, ","stocks, ","americanbankingnews.com/?p=14169058, ",1250702865712254977,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 17,827 Shares https://t.co/ldUnlcSFYI #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2298709746,2020-04-16 04:29:10,"INCY, ",,"zpr.io/t5cTn, ",1250702763283095552,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $1,604,430.00 in Stock https://t.co/PYGsAuvpWz",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
68559732,2020-04-16 04:27:20,"INCY, ",,"zpr.io/t5cYG, ",1250702301834158082,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 17,827 Shares https://t.co/KPWwsyx9QR",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
930803511918411776,2020-04-16 04:26:23,"INCY, ",,"thelincolnianonline.com/?p=3803086, ",1250702062700158978,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 17,827 Shares https://t.co/qm2H9By9Fo",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
16341911,2020-04-15 18:29:49,,"FGFR2, cholangiocarcinoma, ","thelancet.com/journals/lanon‚Ä¶, ",1250551933103779840,False,17,1,0,5,Twitter for iPhone,"Pemigatinib #FGFR2 inhibition shows impressive results for 2nd line #cholangiocarcinoma 36%RR, 7.5m DOR. @GABOUALFA @Incyte @DocCatenacci @MiteshBorad https://t.co/W4nM8Y6dew","GABOUALFA, Incyte, DocCatenacci, MiteshBorad, ",,2008-09-17 23:03:59,"Jacksonville, FL",KModyMD,https://pbs.twimg.com/profile_images/1097258932572180480/2d0wP_3Y_normal.jpg,1252,319,31,2491,kmody29,
1176558075798380544,2020-04-15 17:29:21,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1250536717481902080,False,0,0,0,0,InsiderActionMonitor,$INCY Maria Pasquale sells $1.6M Worth Of Incyte Stock https://t.co/0lbkHYJtOH,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
2344420430,2020-04-15 17:06:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1250530909884944384,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/9QlVLnRoBm",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2282235630,2020-04-15 16:01:17,,,"ow.ly/uDy350zd46M, ",1250514551918952449,False,2,0,0,1,Hootsuite Inc.,"Pharma eyes a cancer drug to treat acute respiratory distress which is a hallmark of serious COVID-19 cases.  Will this treatment show promise against the deadly cytokine storm?

https://t.co/5TGq1YfOQS",,,2014-01-08 09:43:49,"Chicago, Illinois",InStep Health,https://pbs.twimg.com/profile_images/1267595275377442816/JY8aOxy__normal.png,147,322,9,1647,InStepHealth,
2835062343,2020-04-15 14:21:20,,"covid, coronavirus, corona, virus, coronavirusoutbreak, viruscorona, ","escalatesciences.com/post/incyte-no‚Ä¶, pic.twitter.com/BVD03CRpXT, ",1250489400271699970,False,0,0,0,0,Twitter Web App,"Incyte, Novartis to test repurposed cancer drug in COVID-19
https://t.co/aFkPAEa8J8
#covid #coronavirus #corona #virus #coronavirusoutbreak #viruscorona https://t.co/BVD03CRpXT",,,2014-10-17 10:15:45,Lake Nona 11954  Narcoossee Rd,Escalate Sciences,https://pbs.twimg.com/profile_images/1059166228491747328/c2gRlg7h_normal.jpg,28,137,15,1554,escalatescience,photo
615157718,2020-04-15 11:40:12,,"WomenInBio, COVID19, ","fool.com/investing/2020‚Ä¶, ",1250448847781978115,False,1,0,0,0,Hootsuite Inc.,"Thank you to all of the companies working on COVID-19 vaccines, treatments, and testing!

üîóhttps://t.co/zImVSYOWIy

@BioNTech_Group @CSLBehring @Amgen @TakedaPharma @biomerieux @Co_Diagnostics @Incyte @vandapharma @TranslateBio @Regeneron @Vir_Biotech 

#WomenInBio #COVID19","BioNTech_Group, CSLBehring, Amgen, TakedaPharma, biomerieux, Co_Diagnostics, Incyte, vandapharma, TranslateBio, Regeneron, Vir_Biotech, ",,2012-06-22 09:16:14,,Women In Bio,https://pbs.twimg.com/profile_images/464732614360719361/WlM2fTnw_normal.jpeg,5856,1099,269,9203,WomenInBio,
2525892205,2020-04-15 10:25:32,"INCY, ","investingnews, ","modernreaders.com/?p=3121823, ",1250430059862618118,False,0,0,0,0,Zapier.com,"Tributary Capital Management LLC Sells 3,900 Shares of Incyte Co. $INCY  https://t.co/r4tiHaJXOF #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
374729426,2020-04-15 07:20:32,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1488975, pic.twitter.com/0lRdNbF0UU, ",1250383503641808899,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/iPtIbJtXgA #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0lRdNbF0UU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
263203640,2020-04-15 04:50:39,,"Sage, Palantir, Incyte, Westworld, ","theguardian.com/uk-news/2020/a‚Ä¶, ",1250345781791297536,False,0,0,0,0,Twitter for iPhone,"#Sage, #Palantir, #Incyte, It‚Äôs just like #Westworld only you can‚Äôt switch off if you don‚Äôt like what‚Äôs happening.  https://t.co/0Dc4LZMy8F",,,2011-03-09 11:04:41,Switzerland,MOIRASC,https://pbs.twimg.com/profile_images/873120849875816448/Asj0CiQV_normal.jpg,511,1375,7,13514,MOIRASC,
371483512,2020-04-14 21:58:45,,,"apple.news/AKmxnc0v1TM2EZ‚Ä¶, ",1250242123934380033,False,0,0,0,0,Twitter for iPhone,"Baricitinib, sold as a prescription drug called Olumiant, is an already approved drug developed by Eli Lilly and Incyte for the treatment of rheumatoid arthritis https://t.co/uxaXU0PFsQ",,,2011-09-10 19:19:16,"Austin,Texas USA",KateATX,https://pbs.twimg.com/profile_images/864451107552088064/Y7Myl-ea_normal.jpg,4823,5313,2,317977,minnnyme,
121158213,2020-04-14 21:14:33,,,"dlvr.it/RTnYsn, freetrade.pw, pic.twitter.com/YgONPeooua, ",1250231000530968576,False,0,0,0,1,dlvr.it,Trading Ideas: Incyte https://t.co/pvDpCVqEU3 üìà FREE trade-of-week via ‚Üí https://t.co/BCEHq7Ce2N https://t.co/YgONPeooua,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,photo
701872255,2020-04-14 16:50:38,,,"news.pinhand.com/content/have-p‚Ä¶, ",1250164584117387264,False,0,0,0,0,Twitter for Mac,"Have Potential to become a good Portfolio:: Incyte Corporation, (NASDAQ: INCY) ‚Äì News Smooth https://t.co/diUVD2UtQz",,,2012-07-17 18:13:28,,bismar caba taboada,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1,4,0,325,bismarcabataboa,
178124272,2020-04-14 16:39:26,,,"amazing.indopin.com/content/have-p‚Ä¶, ",1250161766698496001,False,0,0,0,0,Twitter for Mac,"Have Potential to become a good Portfolio:: Incyte Corporation, (NASDAQ: INCY) ‚Äì News Smooth https://t.co/fClL2A2Owr",,,2010-08-13 19:08:19,,Garrett Dorsey,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,0,1,0,941,don38hancock,
701872255,2020-04-14 15:54:37,,,"life.indopin.com/content/have-p‚Ä¶, ",1250150488030564354,False,0,0,0,0,Twitter for Mac,"Have Potential to become a good Portfolio:: Incyte Corporation, (NASDAQ: INCY) ‚Äì News Smooth https://t.co/7aLzrRlgOJ",,,2012-07-17 18:13:28,,bismar caba taboada,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1,4,0,325,bismarcabataboa,
64927259,2020-04-14 14:51:07,,"COVID19Research, ","news.yahoo.com/potential-trea‚Ä¶, ",1250134504984829953,False,0,0,0,0,Twitter Web Client,"Baricitinib, sold as a prescription drug called Olumiant, is an already approved drug developed by Eli Lilly and Incyte for the treatment of rheumatoid arthritis. #COVID19Research

https://t.co/0hm2PZaRyR",,,2009-08-11 23:46:51,"Oregon, USA",John Williams,https://pbs.twimg.com/profile_images/359158470/IMG_1292_John_Kauai_normal.jpg,530,728,38,26650,ashlandJohn,
18367304,2020-04-14 11:13:28,,,"twitter.com/RaquelHirsch/s‚Ä¶, ",1250079733292777472,False,1,0,0,0,Twitter for iPad,"‚ÄúBaricitinib, sold as a prescription drug called Olumiant, is an already approved drug developed by Eli Lilly and Incyte for the treatment of rheumatoid arthritis.‚Äù https://t.co/TBrh5acJtQ",,,2008-12-24 18:58:49,"√úT: 49.234866,-123.194659",Raquel Hirsch,https://pbs.twimg.com/profile_images/1447230006493515780/zQFbytTZ_normal.jpg,2678,986,0,36941,RaquelHirsch,
374729426,2020-04-14 09:54:47,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1484979, pic.twitter.com/xtQD8pjio6, ",1250059933627879426,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/0mOvP8ciyW #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xtQD8pjio6",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
84909657,2020-04-14 03:45:18,,,"pmlive.com/pharma_news/in‚Ä¶, ",1249966947409833984,False,0,0,0,0,Twitter Web Client,Incyte and Novartis join coronavirus efforts with phase 3 study https://t.co/qdNPUwfy3u via @pmlivecom,"PMLiVEcom, ",,2009-10-24 14:31:54,,Kevin Nacho,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,89,794,3,476,kevinarturo,
31484145,2020-04-14 00:27:41,,,,1249917215345971200,False,29,3,3,14,Twitter Web App,"GEN's new A-List ""Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development"" spotlights 18 top-category ""Front Runner"" therapeutics by @BioNTech_Group @pfizer @Fosun_Intl $6185 @chugai_cc @CytoDyn @distributedbio @FujifilmUS @GileadSciences @Incyte and...","BioNTech_Group, pfizer, Fosun_Intl, chugai_cc, CytoDyn, FujifilmUS, GileadSciences, Incyte, ",,2009-04-15 14:57:15,"New Rochelle, NY",Genetic Engineering & Biotechnology News,https://pbs.twimg.com/profile_images/459406650609115136/dQKQwDAv_normal.jpeg,71709,3561,1430,51542,GENbio,
2525892205,2020-04-13 17:05:14,"INCY, ","investingnews, ","modernreaders.com/?p=3111383, ",1249805870013255690,False,0,0,0,0,Zapier.com,Manning &amp; Napier Group LLC Boosts Position in Incyte Co. $INCY  https://t.co/PEvQLReNg6 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
19494255,2020-04-13 15:59:14,,,"biopharmadive.com/news/coronavir‚Ä¶, ",1249789262834393091,False,0,0,0,0,Twitter Web Client,Two small studies in Canada and Mexico testing Jakafi in COVID-19 recently launched https://t.co/FRs5EOxKfg via @BioPharmaDive,"BioPharmaDive, ",,2009-01-25 11:44:22,"BJ, Mexico City",Solar Destiny ‚òÄÔ∏è,https://pbs.twimg.com/profile_images/1451861317917323265/MC1F_8Af_normal.jpg,3144,2717,0,143243,Jans_Arbor,
3309506106,2020-04-13 09:44:27,,"bloodcancer, covid19, cytokine, stormtherapy, socialcn1699news, ","buff.ly/2Xp2SvG, pic.twitter.com/2bfDMV4S1C, ",1249694942643064844,False,0,0,1,0,Buffer,"Incyte plans Phase III trial of blood cancer drug as potential Covid-19 cytokine storm therapy

#bloodcancer #covid19 #cytokine #stormtherapy #socialcn1699news

For more information |üëá
https://t.co/rZ8zAAf49F https://t.co/2bfDMV4S1C",,,2015-08-08 06:30:07,Macau,CN1699,https://pbs.twimg.com/profile_images/1266622410788237312/GFT8hult_normal.jpg,663,1441,0,9806,Cn1699,photo
374729426,2020-04-13 08:19:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1480871, pic.twitter.com/1g5S24JwFl, ",1249673568553598981,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/tzFEAoc3u7 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1g5S24JwFl",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
433847448,2020-04-13 08:12:18,,,"pci.upenn.edu/alliances/, ",1249671754693345285,False,0,0,0,0,Twitter Web App,"CURRENT PENN ALLIANCES
Biogen ‚Äì gene therapy and gene editing
Celgene ‚Äì oncology and epigenetics
Incyte ‚Äì discovery-stage oncology programs
Janssen ‚Äì gene therapy for flu and Alzheimer‚Äôs
Novartis ‚Äì CAR-T for oncology
... More https://t.co/T4qAQP4LHy",,,2011-12-10 22:11:39,philadelphia area,NGT Consulting,https://pbs.twimg.com/profile_images/1788439416/twitter3_normal.png,2076,905,41,5936,NextGeneTherapy,
2920258887,2020-04-13 06:11:51,"INCY, ",,"dakotafinancialnews.com/?p=1770249, ",1249641440080257025,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at William Blair https://t.co/OSgE3Xjwcc,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
2298709746,2020-04-13 06:09:45,"INCY, ",,"zpr.io/t57Ft, ",1249640913980338181,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at William Blair https://t.co/eRqJpL7fli,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1979190776,2020-04-13 06:09:14,"INCY, ",,"tickerreport.com/?p=5386264, ",1249640783755517957,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at William Blair https://t.co/hehlkIwu7D,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-04-13 06:09:04,"INCY, ",,"thelincolnianonline.com/?p=3785788, ",1249640740365438977,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at William Blair https://t.co/59m7y7avnv,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2920258887,2020-04-13 01:24:52,"INCY, ",,"dakotafinancialnews.com/?p=1767191, ",1249569217826959361,False,0,0,0,0,Zapier.com,Zacks Investment Research Downgrades Incyte $INCY to Sell https://t.co/C9WaVxselA,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
1979190776,2020-04-13 01:24:04,"INCY, ",,"tickerreport.com/?p=5383184, ",1249569020048793600,False,0,0,0,0,Zapier.com,Zacks Investment Research Downgrades Incyte $INCY to Sell https://t.co/sA3sup59tG,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-04-13 01:23:29,"INCY, ",,"thelincolnianonline.com/?p=3782687, ",1249568872497381377,False,0,0,0,0,Zapier.com,Zacks Investment Research Downgrades Incyte $INCY to Sell https://t.co/GwKJ86dKXl,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2298709746,2020-04-13 01:21:32,"INCY, ",,"zpr.io/t5GbE, ",1249568379322740737,False,0,0,0,0,Zapier.com,Zacks Investment Research Downgrades Incyte $INCY to Sell https://t.co/GrrAg5zH46,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
16185922,2020-04-12 15:54:25,,"Covid19usa, ","patientpower.info, ",1249425663037067264,False,0,0,0,0,Twitter Web App,Tomorrow at 10 PT/1 ET interviewing MPN experts including Joe Scandura from Weill Cornell on whether an approved JAK inhibitor might lessen cytokine storm of COVID19. See https://t.co/H9kAuXvXlt #Covid19usa  @WeillCornell @Incyte @bmsnews,"WeillCornell, Incyte, bmsnews, ",,2008-09-08 11:31:56,,Andrew Schorr,https://pbs.twimg.com/profile_images/959845055589531649/dZw_1rcp_normal.jpg,2289,2050,109,6161,andrewschorr,
2416188264,2020-04-12 10:41:33,"INCY, ","markets, ","thestockobserver.com/?p=2843167, ",1249346924496461824,False,0,0,0,0,Zapier.com,William Blair Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY  https://t.co/xkQdhqsVaP #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1134049078424162304,2020-04-12 10:37:37,"INCY, ",,"newsfilter.io/articles/willi‚Ä¶, ",1249345935198564353,False,0,0,0,0,Newsfilter.io,William Blair Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/YcXBWUhQ3y,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2266388972,2020-04-12 10:02:23,"INCY, ","stocks, ","dailypolitical.com/?p=3696179, ",1249337068221796357,False,0,0,0,0,Zapier.com,William Blair Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/rqeEehdWc7 #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-12 10:02:22,"INCY, ",,"dailypolitical.com/?p=3696179, ",1249337066212724736,False,0,0,0,0,Zapier.com,William Blair Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/VRwRRS4iQm,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
849417718642159616,2020-04-12 09:33:39,"INCY, ",,"zpr.io/t5tMD, ",1249329840068722690,False,0,0,0,0,Zapier.com,Incyte $INCY Cut to Sell at Zacks Investment Research https://t.co/oAoWKQhdmc,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
966006214818697218,2020-04-12 09:31:08,"INCY, ",,"theenterpriseleader.com/?p=2955308, ",1249329204207984641,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúHold‚Äù Rating from Royal Bank of Canada  https://t.co/JbkOwpC1U7,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
374729426,2020-04-12 07:12:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1476795, pic.twitter.com/GuFmIJsZ4D, ",1249294432253304832,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/gj5K55Oolp #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GuFmIJsZ4D",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
727193444939079680,2020-04-11 17:50:03,,,"ow.ly/q4NR30qv5Tq, ",1249092374954946563,False,0,0,0,0,Hootsuite Inc.,"Pharma Coronavirus Efforts Continue, Amgen &amp; Incyte Join In | Nasdaq https://t.co/jviLqqIy3U",,,2016-05-02 13:50:02,"West Virginia, USA",HempWV,https://pbs.twimg.com/profile_images/727194537118994432/kC-FXj0t_normal.jpg,9848,5224,56,6863,HempWV,
1134049078424162304,2020-04-11 11:46:32,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1249000889827954689,False,0,0,0,0,Newsfilter.io,Incyte Price Target Increased to $90.00 by Analysts at Oppenheimer $INCY https://t.co/e2DD6Nz90D,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2416188264,2020-04-11 11:38:46,"INCY, ","markets, ","thestockobserver.com/?p=2840300, ",1248998938683867136,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Increased to $90.00 by Analysts at Oppenheimer  https://t.co/ClKnipFJ6i #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2266388972,2020-04-11 11:01:50,"INCY, ","stocks, ","dailypolitical.com/?p=3693089, ",1248989643401564166,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Increased to $90.00 by Analysts at Oppenheimer https://t.co/6oAcmypbDB #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-11 11:01:50,"INCY, ",,"dailypolitical.com/?p=3693089, ",1248989641245700100,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Increased to $90.00 by Analysts at Oppenheimer https://t.co/qjXbCYqTlH,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
966006214818697218,2020-04-11 09:38:42,"INCY, ",,"theenterpriseleader.com/?p=2952775, ",1248968722225733633,False,0,0,0,0,Zapier.com,Zacks Investment Research Downgrades Incyte $INCY to Sell  https://t.co/ckdHbyLCa7,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
374729426,2020-04-11 08:56:21,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1472908, pic.twitter.com/BXzAmtB8eP, ",1248958061944832004,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/loER4iWpvE #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BXzAmtB8eP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
68559732,2020-04-11 07:30:07,"INCY, ",,"zpr.io/tLB6g, ",1248936362721579009,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by William Blair https://t.co/HO7ZsQQtz1,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2525892205,2020-04-11 07:29:24,"INCY, ","investingnews, ","modernreaders.com/?p=3099673, ",1248936179950592000,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by William Blair  https://t.co/0KfwDi7XNW #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
852931863547084801,2020-04-11 07:27:15,"INCY, ",,"zpr.io/tLBna, ",1248935639820783622,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by William Blair https://t.co/gk7AsznajK,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
852931863547084801,2020-04-11 05:30:23,"INCY, ",,"zpr.io/tLVnE, ",1248906230166421504,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 1,842 Shares https://t.co/RJoMNT2zom",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
966006214818697218,2020-04-11 05:30:14,"INCY, ",,"theenterpriseleader.com/?p=2948329, ",1248906191465480193,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $156,570.00 in Stock  https://t.co/m5uyceARLE",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2920258887,2020-04-11 04:44:28,"INCY, ",,"dakotafinancialnews.com/?p=1757619, ",1248894673378304000,False,0,0,0,0,Zapier.com,Oppenheimer Research Analysts Lift Earnings Estimates for Incyte Co. $INCY https://t.co/0avUoW2Tk9,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
68559732,2020-04-11 04:44:26,"INCY, ",,"zpr.io/tLv59, ",1248894667908952065,False,0,0,0,0,Zapier.com,Oppenheimer Research Analysts Lift Earnings Estimates for Incyte Co. $INCY https://t.co/dO5clgSPR7,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2525892205,2020-04-11 04:43:46,"INCY, ","investingnews, ","modernreaders.com/?p=3098441, ",1248894499549478914,False,0,0,0,0,Zapier.com,Oppenheimer Research Analysts Lift Earnings Estimates for Incyte Co. $INCY  https://t.co/ddpdeMDTPA #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
402284409,2020-04-11 01:15:25,,,"goo.gl/fb/zm7pmK, ",1248842066634911744,False,0,0,0,0,Google,"Job Delaware:  Senior Biostatistician to Director, Biostatistics - Incyte Corporation‚Ä¶ https://t.co/2qduKk7p1A",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
402284409,2020-04-11 01:15:20,,,"goo.gl/fb/crZhMo, ",1248842045168455681,False,0,0,0,0,Google,"Job Delaware:  Senior Biostatistician to Director, Biostatistics - Incyte Corporation‚Ä¶ https://t.co/8VhO1hZX8g",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
1134049078424162304,2020-04-10 19:11:27,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1248750472451821568,False,0,0,0,0,Newsfilter.io,Incyte Stock Rating Reaffirmed by Royal Bank of Canada $INCY https://t.co/QOShZHsxxW,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
772471873539977217,2020-04-10 16:37:30,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1248711727065202695,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/mOSDKjg8tW,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
2344420430,2020-04-10 16:37:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1248711672983928834,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/UkTvNjZp73",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1134049078424162304,2020-04-10 16:27:27,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1248709197610483717,False,0,0,0,0,Newsfilter.io,"$44,880.77 of shares sold by Pasquale Maria E (EVP &amp; General Counsel), reported in a new form 4 filed with the SEC  $INCY https://t.co/ZkBdVVSghd",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
4028839455,2020-04-10 14:24:20,,,"stocktrot.com/company/incyte‚Ä¶, ",1248678216799113216,False,0,0,0,1,StockTrot1,"Bullish Bienaime Jean Jacques acquires $17,282.28 of Incyte Corp shares. Largest in 16 months. https://t.co/Glm3OwNyt2",,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
2266388972,2020-04-10 09:55:01,"INCY, ","stocks, ","dailypolitical.com/?p=3688654, ",1248610441208586252,False,0,0,0,0,Zapier.com,Nomura Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/295LpqmpYl #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-10 09:55:01,"INCY, ",,"dailypolitical.com/?p=3688654, ",1248610439119818753,False,0,0,0,0,Zapier.com,Nomura Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/SM3R6j1ccf,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
374729426,2020-04-10 09:41:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1468784, pic.twitter.com/eGv5kotUcl, ",1248606950016700417,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/cechPLS8rC #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/eGv5kotUcl",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-04-10 09:20:26,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1248601736098480128,False,0,0,0,0,Newsfilter.io,Incyte Stock Rating Reaffirmed by Nomura $INCY https://t.co/FbbAOOAhfh,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2416188264,2020-04-10 09:13:41,"INCY, ","markets, ","thestockobserver.com/?p=2835077, ",1248600038181347328,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Nomura  https://t.co/VuCqgRXZ1u #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2416188264,2020-04-10 09:13:37,"INCY, ","markets, ","thestockobserver.com/?p=2835083, ",1248600021408403456,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Royal Bank of Canada  https://t.co/m5FlV99Y07 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2266388972,2020-04-10 09:09:32,"INCY, ","stocks, ","dailypolitical.com/?p=3688128, ",1248598992025419779,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Royal Bank of Canada https://t.co/CuCXmHgpBJ #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-10 09:09:31,"INCY, ",,"dailypolitical.com/?p=3688128, ",1248598988636459008,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Royal Bank of Canada https://t.co/6iLZAHWwph,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
852931863547084801,2020-04-10 09:09:13,"INCY, ",,"zpr.io/tLizJ, ",1248598913633914882,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Nomura https://t.co/6cH62EVdgt,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
3309506106,2020-04-10 08:09:32,,"bloodcancer, covid19, cytokine, cn1699news, ","buff.ly/2Xp2SvG, pic.twitter.com/uPZ6Tw9x47, ",1248583893655130112,False,0,0,0,0,Buffer,"Incyte plans Phase III trial of blood cancer drug as potential Covid-19 cytokine storm therapy

#bloodcancer #covid19 #cytokine #cn1699news

For more information |üëá
https://t.co/rZ8zAAf49F

Sign up and Register for FREE and get the latest LIVE NEWS UPDATES DAILY across the globe https://t.co/uPZ6Tw9x47",,,2015-08-08 06:30:07,Macau,CN1699,https://pbs.twimg.com/profile_images/1266622410788237312/GFT8hult_normal.jpg,663,1441,0,9806,Cn1699,photo
1134049078424162304,2020-04-10 05:16:24,"INCY, ",,"newsfilter.io/articles/oppen‚Ä¶, ",1248540322986102784,False,0,0,0,0,Newsfilter.io,Oppenheimer Analysts Raise Earnings Estimates for Incyte $INCY https://t.co/SLgVeBSpIq,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2298709746,2020-04-10 04:46:35,"INCY, ",,"zpr.io/tLkMh, ",1248532820877807618,False,0,0,0,0,Zapier.com,"Maria E. Pasquale Sells 1,842 Shares of Incyte Co. $INCY Stock https://t.co/h92xgxQQ7t",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2298709746,2020-04-10 04:11:51,"INCY, ",,"zpr.io/tLkzx, ",1248524080346738689,False,0,0,0,0,Zapier.com,Oppenheimer Weighs in on Incyte Co.‚Äôs FY2022 Earnings $INCY https://t.co/D8acs9YmVI,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1979190776,2020-04-10 04:09:34,"INCY, ",,"tickerreport.com/?p=5366923, ",1248523505735479297,False,0,0,0,0,Zapier.com,Oppenheimer Weighs in on Incyte Co.‚Äôs FY2022 Earnings $INCY https://t.co/sZszWqhrPa,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-04-10 04:09:03,"INCY, ",,"thelincolnianonline.com/?p=3766452, ",1248523374302760960,False,0,0,0,0,Zapier.com,Oppenheimer Weighs in on Incyte Co.‚Äôs FY2022 Earnings $INCY https://t.co/nt4Z8Pbl6K,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1134049078424162304,2020-04-10 03:46:24,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1248517675191545856,False,0,0,0,0,Newsfilter.io,Incyte Downgraded by Zacks Investment Research $INCY https://t.co/PDzfPiTF2t,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2181281054,2020-04-09 18:34:57,"INCY, ","markets, ","wkrb13.com/?p=1712036, ",1248378898254983168,False,0,0,0,0,Zapier.com,Oppenheimer Increases Incyte $INCY Price Target to $90.00 https://t.co/n1Vvg7T82J #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
732361939490312192,2020-04-09 17:55:52,"INCY, ","markets, ","americanbankingnews.com/?p=14108073, ",1248369059869138947,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at William Blair https://t.co/vf2KlT8c3C #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-09 17:55:51,"INCY, ","stocks, ","americanbankingnews.com/?p=14108073, ",1248369057763639301,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at William Blair https://t.co/pSHn5Si67l #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
243805548,2020-04-09 17:11:00,,"COVID19, ","investor.incyte.com/news-releases/‚Ä¶, ",1248357769268191232,False,0,0,0,0,TweetDeck,"Incyte announces plans to initiate a phase 3 clinical trial of Ruxolitinib (Jakafi¬Æ) as a treatment for patients with #COVID19 Associated Cytokine Storm!

Read more about it, below:
https://t.co/rpjAYr82xs",,,2011-01-27 16:15:51,Delaware,WeWorkForHealth,https://pbs.twimg.com/profile_images/378800000246557599/53a936eb6b2f1196eea42e8abfda803d_normal.jpeg,586,476,42,2854,WWFH_DE,
1140762699002871808,2020-04-09 16:01:13,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1248340209189523456,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-04-09 16:01 EST. *Closed/Covered previously shorted:
$INCY at $86.90 for 1.14 loss (-1.32%). Incyte Corporation - Common Stock
Trade Id: 39973047303053590.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
2416188264,2020-04-09 14:38:16,"INCY, ","markets, ","thestockobserver.com/?p=2833591, ",1248319332989501447,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by Zacks Investment Research  https://t.co/UOpVo6OKVc #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2266388972,2020-04-09 14:37:58,"INCY, ","stocks, ","dailypolitical.com/?p=3686635, ",1248319259438129152,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Sell at Zacks Investment Research https://t.co/45kvYGg1bX #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-09 14:37:58,"INCY, ",,"dailypolitical.com/?p=3686635, ",1248319257353555968,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Sell at Zacks Investment Research https://t.co/QDS396vwdY,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
732361939490312192,2020-04-09 13:22:58,"INCY, ","markets, ","americanbankingnews.com/?p=14105526, ",1248300383560241157,False,0,0,0,0,Zapier.com,Oppenheimer Analysts Raise Earnings Estimates for Incyte Co. $INCY https://t.co/r6TyIyPxmL #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-09 13:22:57,"INCY, ","stocks, ","americanbankingnews.com/?p=14105526, ",1248300381613981701,False,0,0,0,0,Zapier.com,Oppenheimer Analysts Raise Earnings Estimates for Incyte Co. $INCY https://t.co/yNwk9dYDlc #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-04-09 10:28:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1464763, pic.twitter.com/ttjP6TbXPh, ",1248256390944022528,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/7vlvbO2IeG #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ttjP6TbXPh",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2266388972,2020-04-09 09:34:13,"INCY, ","stocks, ","dailypolitical.com/?p=3683898, ",1248242815718449154,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at Piper Sandler https://t.co/HS6dzX5G9x #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-09 09:34:12,"INCY, ",,"dailypolitical.com/?p=3683898, ",1248242813692772352,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at Piper Sandler https://t.co/gPJkWjxWCr,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2416188264,2020-04-09 09:01:12,"INCY, ","markets, ","thestockobserver.com/?p=2830814, ",1248234506714218496,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at Piper Sandler  https://t.co/WiAyd4V4FD #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2384219072,2020-04-09 08:41:00,,"ICYMI, DEBIO, member, Jakafi, covid19, ","loom.ly/aHDS99A, ",1248229424316678145,False,1,0,0,2,Loomly,"#ICYMI in #DEBIO's latest COVID Tracker newsletter #member company @Incyte is working to get #Jakafi approved to treat #covid19 
https://t.co/GvKjI0pw6u","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,
2920258887,2020-04-09 07:12:08,"INCY, ",,"dakotafinancialnews.com/?p=1745962, ",1248207058677256193,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 1,842 Shares of Stock https://t.co/VKKoT2qbdY",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
849417718642159616,2020-04-09 07:11:46,"INCY, ",,"zpr.io/tLbLq, ",1248206969409802240,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 1,842 Shares of Stock https://t.co/NP6SKKLGjT",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
68559732,2020-04-09 07:09:46,"INCY, ",,"zpr.io/tLbr7, ",1248206463115411456,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Maria E. Pasquale Sells 1,842 Shares of Stock https://t.co/J8U6ZDBDcQ",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1134049078424162304,2020-04-09 03:27:20,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1248150486202580992,False,0,0,0,0,Newsfilter.io,"$75,265.52 of shares sold by Dhanak Dashyant (EVP &amp; Chief Scientific Officer), reported in a new form 4 filed with the SEC  $INCY https://t.co/n7FTwNSxT3",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-04-09 03:24:20,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1248149731152461826,False,0,0,0,0,Newsfilter.io,"$156,570.00 of shares sold by Pasquale Maria E (EVP &amp; General Counsel), reported in a new form 4 filed with the SEC  $INCY https://t.co/g3slLr9QPI",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
732361939490312192,2020-04-08 17:56:15,"INCY, ","markets, ","americanbankingnews.com/?p=14096926, ",1248006768086532098,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $156,570.00 in Stock https://t.co/SJPixW43FU #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-08 17:56:14,"INCY, ","stocks, ","americanbankingnews.com/?p=14096926, ",1248006765888696320,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $156,570.00 in Stock https://t.co/uoeBITmIon #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2344420430,2020-04-08 17:47:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1248004512704413696,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; General Counsel

MARIA E PASQUALE:

https://t.co/oVTQZQuxv7",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
2181281054,2020-04-08 17:26:24,"INCY, ","markets, ","wkrb13.com/?p=1708571, ",1247999258101460993,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 1,842 Shares of Stock https://t.co/cW04Zaj52u #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
2344420430,2020-04-08 17:21:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1247997971712462849,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

EVP &amp; Chief Scientific Officer

DASHYANT DHANAK:

https://t.co/bqqsCIs72c",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1176558075798380544,2020-04-08 16:39:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1247987421083557890,False,0,0,0,0,InsiderActionMonitor,$INCY Dashyant Dhanak Dumps 3.8K Shares of Incyte https://t.co/TWV41CzQJt,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
22195223,2020-04-08 15:55:04,,,"cancernetwork.com/news/planned-p‚Ä¶, pic.twitter.com/bM7Zbs4us8, ",1247976274263453696,False,2,0,0,1,Hootsuite Inc.,"Incyte announced that they are working with the @US_FDA to initiate a phase III clinical trial to assess ruxolitinib (Jakafi) plus standard-of-care in patients with coronavirus disease 2019 (COVID-19) induced cytokine storm. | @Incyte 
https://t.co/CB5a2fQAPi https://t.co/bM7Zbs4us8","US_FDA, Incyte, ",,2009-02-27 16:48:14,"Cranbury, NJ","CancerNetwork¬Æ, Home of the Journal ONCOLOGY¬Æ",https://pbs.twimg.com/profile_images/1196832187376685056/BU2C0XFo_normal.jpg,23603,452,498,13559,CancerNetwrk,photo
68559732,2020-04-08 10:51:56,"INCY, ",,"zpr.io/tLERc, ",1247899988484485120,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúHold‚Äù Rating Reaffirmed at Royal Bank of Canada https://t.co/WhK7m0Cnis,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
849417718642159616,2020-04-08 10:51:02,"INCY, ",,"zpr.io/tLEHk, ",1247899761681694720,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Nomura https://t.co/PjtXUGjfqj,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
852931863547084801,2020-04-08 10:18:18,"INCY, ",,"zpr.io/tLx2V, ",1247891522038587407,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúHold‚Äù Rating Reiterated at Royal Bank of Canada https://t.co/DUrMnEJSSR,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2920258887,2020-04-08 10:17:10,"INCY, ",,"dakotafinancialnews.com/?p=1744806, ",1247891237723504642,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúHold‚Äù Rating Reaffirmed at Royal Bank of Canada https://t.co/btzaHLzQgf,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
2920258887,2020-04-08 10:17:08,"INCY, ",,"dakotafinancialnews.com/?p=1744812, ",1247891228860936192,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Nomura https://t.co/fj5ict23xy,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
68559732,2020-04-08 10:16:53,"INCY, ",,"zpr.io/tLxSm, ",1247891166831366146,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Nomura https://t.co/2GOCIktKyi,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2525892205,2020-04-08 10:16:44,"INCY, ","investingnews, ","modernreaders.com/?p=3087333, ",1247891130470903810,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Nomura  https://t.co/ztOxNwaAEu #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
849417718642159616,2020-04-08 10:16:31,"INCY, ",,"zpr.io/tLxCy, ",1247891075047415809,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúHold‚Äù Rating Reaffirmed at Royal Bank of Canada https://t.co/k4lOQIyPhN,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
523455262,2020-04-08 08:49:05,,"netde, ","tinyurl.com/rzumc89, ",1247869072429244416,False,0,0,0,0,Twitter Web Client,Incyte to test if one of its drugs can treat COVID-19 #netde https://t.co/N4woHNJq1R,,,2012-03-13 13:06:35,,Catherine Nessa,https://pbs.twimg.com/profile_images/1290623348486082561/Cpx809bU_normal.jpg,471,491,9,2653,catenessa,
732361939490312192,2020-04-08 08:36:04,"INCY, ","markets, ","americanbankingnews.com/?p=14092204, ",1247865793569841153,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúHold‚Äù Rating at Royal Bank of Canada https://t.co/qRmEihdpwE #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-08 08:36:03,"INCY, ","stocks, ","americanbankingnews.com/?p=14092204, ",1247865791535611904,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúHold‚Äù Rating at Royal Bank of Canada https://t.co/DPeFeN9Klm #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
19052568,2020-04-08 08:30:39,"INCY, ",,,1247864432538947584,False,0,0,0,0,Twitter Web App,"$INCY
Incyte
Reiterated byNomura$86.66$116.00Buy",,,2009-01-15 22:19:58,,cybercash28,https://pbs.twimg.com/profile_images/1078129658384723969/DKaZn_lH_normal.jpg,43172,449,1113,63130,MadMraket,
732361939490312192,2020-04-08 08:00:42,"INCY, ","markets, ","americanbankingnews.com/?p=14091694, ",1247856893936185346,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúBuy‚Äù Rating from Nomura https://t.co/iz9jUw4mXq #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-08 08:00:41,"INCY, ","stocks, ","americanbankingnews.com/?p=14091694, ",1247856890798903296,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúBuy‚Äù Rating from Nomura https://t.co/T7HFtHYtUy #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-04-08 07:16:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1460691, pic.twitter.com/ah21KU0UUE, ",1247845729151795200,False,0,0,0,1,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/6kv8nFvnpU #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ah21KU0UUE",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
852931863547084801,2020-04-08 02:02:52,"INCY, ",,"zpr.io/tLTfd, ",1247766844175306757,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Piper Sandler https://t.co/vuQHHaeSsP,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
14329864,2020-04-07 22:26:10,,,"investor.incyte.com/news-releases/‚Ä¶, ",1247712309570605057,False,1,0,1,0,Twitter Web App,A clinical trial has started to test a treatment for the cytokine storm that can happen in the immune systems of some people with covid-19. The drug was originally developed as a cancer treatment. https://t.co/YYGb54TUap,,,2008-04-08 01:30:45,"Denver, Colorado, USA",Wayne Radinsky,https://pbs.twimg.com/profile_images/1124148844235640832/Vj6fYePr_normal.png,320,223,0,8088,waynerad,
552066959,2020-04-07 20:18:55,,"COVID19, NetDE, ","delawarepublic.org/post/incyte-te‚Ä¶, ",1247680285690527747,False,3,0,1,1,Twitter Web App,A Delaware-based biopharmaceutical company is working to get one of its drugs approved to treat #COVID19. https://t.co/xwWToZreTg #NetDE,,,2012-04-12 14:28:59,"Dover, DE",Delaware Public Media,https://pbs.twimg.com/profile_images/1308052313421025280/ETKfCwkX_normal.jpg,8235,742,203,13788,DelawarePublic,
993282182,2020-04-07 18:44:26,"CIEN, INCY, SPGI, SNPS, PDD, PDD, TAL, ",,,1247656506692112384,False,7,0,2,0,Twitter Web Client,"Relative Strength Names Below
Healthy Markets don't drop like that So be Cautious
$CIEN Ciena Corporation
$INCY Incyte Corporation
$SPGI S&amp;P Global Inc
$SNPS Synopsys Inc
$PDD Pinduoduo (Not Sure How $PDD trades Tomorrow w/ most China Names Down on that $TAL News)",,,2012-12-06 10:27:10,Michigan,Harris Market Trends,https://pbs.twimg.com/profile_images/624048749971542016/HHcTAyTD_normal.jpg,13721,304,464,29235,pharris667,
732361939490312192,2020-04-07 15:59:33,"INCY, ","markets, ","americanbankingnews.com/?p=14085461, ",1247615015626199040,False,0,0,0,0,Zapier.com,Incyte $INCY Given Buy Rating at Piper Sandler https://t.co/EGlMAP2ipK #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-07 15:59:33,"INCY, ","stocks, ","americanbankingnews.com/?p=14085461, ",1247615012992167939,False,0,0,0,0,Zapier.com,Incyte $INCY Given Buy Rating at Piper Sandler https://t.co/IbbhQAhTOo #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
16185922,2020-04-07 14:59:38,,"covid19, coviddrugtrials, cancer, ",,1247599933911228417,False,4,0,0,0,Twitter Web App,Excited to hear from pharma on trials of approved cancer drugs to help people affected more broadly by COV19. Good luck to companies we know like @karyopharm and @Incyte  and others we haven't heard about yet. #covid19 #coviddrugtrials #cancer,"Karyopharm, Incyte, ",,2008-09-08 11:31:56,,Andrew Schorr,https://pbs.twimg.com/profile_images/959845055589531649/dZw_1rcp_normal.jpg,2289,2050,109,6161,andrewschorr,
1217159999304163334,2020-04-07 12:43:03,,"netde, ","delawarebusinesstimes.com/news/incyte-co‚Ä¶, ",1247565564823908354,False,0,0,0,0,Twitter Web App,Wilmington-based @Incyte is studying whether its drug Jakafi could be used to help treatment of COVID-19 patients. #netde https://t.co/4xxfI3yLCU,"Incyte, ",,2020-01-14 14:02:27,"Wilmington, DE",Jake Owens,https://pbs.twimg.com/profile_images/1309584095681425408/vL6Qco1b_normal.jpg,88,117,4,376,DBTjowens,
1140762699002871808,2020-04-07 11:39:28,"INCY, ",,"deustrader.com/optimus_maximu‚Ä¶, ",1247549563197509632,False,0,0,0,0,Deus Ex Trader,"Optimus Maximus v2
2020-04-07 10:55 EST. Shorted/Opened:
$INCY at $85.98. 
Incyte Corporation - Common Stock
Win Chance: 58%. Avg Win: 8%. Avg Loss: 6.02%. Avg Hold: 2d.
Trade Id: 39973047303053590.
Stats: https://t.co/I3x2oUEr9F",,,2019-06-17 19:26:36,,Deus Ex Trader,https://pbs.twimg.com/profile_images/1140763400777060353/FebtOvD2_normal.png,912,3,24,52641,deus_trader,
2525892205,2020-04-07 10:00:23,"INCY, ","investingnews, ","modernreaders.com/?p=3081879, ",1247524626768355334,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Increased to $90.00 by Analysts at Oppenheimer  https://t.co/2XCcOECzBE #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
68559732,2020-04-07 09:58:00,"INCY, ",,"zpr.io/tLz9K, ",1247524028761296899,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $90.00 Price Target at Oppenheimer https://t.co/Uq2kAGCanb,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
849417718642159616,2020-04-07 09:55:51,"INCY, ",,"zpr.io/tLzb9, ",1247523487385714689,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $90.00 Price Target at Oppenheimer https://t.co/enwCnSom2l,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
852931863547084801,2020-04-07 09:55:02,"INCY, ",,"zpr.io/tLzuL, ",1247523280791023618,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $90.00 Price Target at Oppenheimer https://t.co/1nJCEehUI4,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
732361939490312192,2020-04-07 09:11:52,"INCY, ","markets, ","americanbankingnews.com/?p=14082301, ",1247512417585827840,False,0,0,0,0,Zapier.com,Oppenheimer Boosts Incyte $INCY Price Target to $90.00 https://t.co/85y8wNYthn #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-07 09:11:51,"INCY, ","stocks, ","americanbankingnews.com/?p=14082301, ",1247512414532362240,False,0,0,0,0,Zapier.com,Oppenheimer Boosts Incyte $INCY Price Target to $90.00 https://t.co/3LKIEYmoxm #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1379457751,2020-04-07 09:01:51,,"GVHD, GVHD, ","ow.ly/9bdG50z6lGB, ",1247509897266200578,False,3,0,0,0,Hootsuite Inc.,"Apply today for Incyte's Ingenuity Award or share with anyone who may be interested. The award aims to support the U.S. #GVHD by funding one innovative activity, idea or initiative that addresses a critical unmet need for people impacted by #GVHD. https://t.co/g5NbzlrH7Y",,,2013-04-25 09:19:48,"Chicago, Illinois",ASTCT,https://pbs.twimg.com/profile_images/1392522586202968065/utbTJTzw_normal.jpg,8353,424,0,3951,ASTCT,
631661989,2020-04-07 08:00:04,,"Delaware, COVID19, choosedelaware, resilientdelaware, inthistogether, biotech, netde, globalde, ","hubs.ly/H0pcMKl0, ",1247494348452790272,False,3,1,0,0,HubSpot,"Kudos to #Delaware-based @Incyte and @NIIMBL for their work in the battle against #COVID19!
https://t.co/CXTDxuTjR8
#choosedelaware #resilientdelaware #inthistogether #biotech #netde #globalde","Incyte, NIIMBL, ",,2012-07-09 23:54:36,"Wilmington, Delaware",Global Delaware,https://pbs.twimg.com/profile_images/1059868013459992577/IjSZsC14_normal.jpg,5389,1817,222,6107,DelawareGlobal,
374729426,2020-04-07 07:38:37,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1455621, pic.twitter.com/EDywrSmH3K, ",1247488950207275008,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/eiauAfzGUC #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/EDywrSmH3K",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
818081647,2020-04-07 07:25:04,"INCY, ",,"streetinsider.com/r/16717188, ",1247485539613315075,False,0,0,0,0,StreetInsider.com Integration,Incyte $INCY PT Raised to $86 at BofA Securities https://t.co/DQM5B0FSJ1,,,2012-09-11 15:57:26,,SIAnalystWire,https://pbs.twimg.com/profile_images/2600218874/alkkkjlbds18yu6ld9xj_normal.png,4980,1,230,118501,AnalystWire,
818081647,2020-04-07 06:55:10,"INCY, ",,"streetinsider.com/r/16716996, ",1247478016143429633,False,0,0,0,0,StreetInsider.com Integration,Mizuho Securities Reiterates Neutral Rating on Incyte $INCY as Shares Rally https://t.co/08SD8OxlDc,,,2012-09-11 15:57:26,,SIAnalystWire,https://pbs.twimg.com/profile_images/2600218874/alkkkjlbds18yu6ld9xj_normal.png,4980,1,230,118501,AnalystWire,
849417718642159616,2020-04-07 05:55:36,"INCY, ",,"zpr.io/tLq6g, ",1247463025164136449,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Piper Sandler https://t.co/1uVRnNk6rz,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
68559732,2020-04-07 05:53:40,"INCY, ",,"zpr.io/tLqnn, ",1247462539946070016,False,0,0,0,0,Zapier.com,Incyte $INCY Given Buy Rating at Piper Sandler https://t.co/KmWg9FLyOS,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2920258887,2020-04-07 05:51:17,"INCY, ",,"dakotafinancialnews.com/?p=1735592, ",1247461939678240769,False,0,0,0,0,Zapier.com,Incyte $INCY Given Buy Rating at Piper Sandler https://t.co/hF2gBr3fwv,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
1979190776,2020-04-07 04:16:43,"INCY, ",,"tickerreport.com/?p=5348800, ",1247438141004361728,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Price Up 8.3% https://t.co/uQh0R79l5Q,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-04-07 04:15:24,"INCY, ",,"thelincolnianonline.com/?p=3748312, ",1247437807162920960,False,0,0,0,0,Zapier.com,Incyte $INCY Trading Up 8.3% https://t.co/0TwVmpevwJ,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2298709746,2020-04-07 03:05:04,"INCY, ",,"zpr.io/tLfif, ",1247420107682430976,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Piper Sandler https://t.co/Sq85Pr34WS,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1010565802997710848,2020-04-06 23:48:08,,,"ncbi.nlm.nih.gov/pmc/articles/P‚Ä¶, drugtopics.com/latest/incyte-‚Ä¶, clinicaltrials.gov/ct2/show/NCT04‚Ä¶, delawarebusinesstimes.com/news/incyte-co‚Ä¶, ",1247370547920601089,False,0,0,0,0,Twitter Web App,"ruxolitinib ___ blocks the signaling of cytokine in the JAK-STAT __ Plays a Role in Cytokine Storm Blocking
https://t.co/lw12W9VwVW
https://t.co/koncr42mfj
https://t.co/1d4DR8xaQa

https://t.co/Mk1ZImB3oN",,,2018-06-23 12:50:37,Planet Earth,duelittle2,https://pbs.twimg.com/profile_images/1013513488277258240/_N2CymRs_normal.jpg,424,1380,2,940,duelittle2,
209528657,2020-04-06 19:15:03,,,"ow.ly/k0dG50z6nxQ, ",1247301826447376385,False,1,0,0,0,Hootsuite Inc.,"We salute all the Delaware firms that are working to defeat the virus.   Go Incyte!  We hope Jakafi can help. 

https://t.co/eC80FoUCWx",,,2010-10-29 07:05:22,"Wilmington, Delaware","TechSolutions, Inc.",https://pbs.twimg.com/profile_images/1139180764485095424/4GSuLaq8_normal.png,40,5,1,2274,TechSolutionsDE,
1128239740329705472,2020-04-06 15:14:21,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1247241252648529921,False,0,0,0,0,Twitter for Android,"""Data that will be presented today during the Revolutionizing Atopic Dermatitis Virtual Symposium show that ruxolitinib cream significantly reduced both the skin inflammation and itch associated with atopic dermatitis.""
$INCY 
https://t.co/TkG0j6lQ8U",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
409373333,2020-04-06 15:00:21,,"nkf, cre, stayhome, pandemic, washyourhand, flattenthecurve, ","bizjournals.com/philadelphia/n‚Ä¶, pic.twitter.com/bQZ4Pa277s, ",1247237727290040320,False,0,0,0,0,Hootsuite Inc.,"Wilmington-based Incyte Corp. is currently working with the FDA to repurpose its flagship product, Jakafi, to treat patients with COVID19 associated cytokine storm.  

https://t.co/Yr7izszeZj

#nkf #cre #stayhome #pandemic #washyourhand #flattenthecurve https://t.co/bQZ4Pa277s",,,2011-11-10 12:02:59,"Wilmington, Delaware USA",Wills Elliman,https://pbs.twimg.com/profile_images/2767694093/76de5f13c49d237222551033ca563707_normal.jpeg,161,111,13,496,WillsElliman,photo
929068431546224646,2020-04-06 14:22:22,,"coronavirus, ","delawareonline.com/story/news/202‚Ä¶, ",1247228169020719105,False,4,0,0,0,Twitter Web App,"Delaware biotech institutions @Incyte and @NIIMBL plan to fund the development of treatments and vaccines that could combat the #coronavirus pandemic. 

https://t.co/ZjBBxK1UYJ","Incyte, NIIMBL, ",,2017-11-10 14:29:10,"Wilmington, DE",Delaware Innovation Space,https://pbs.twimg.com/profile_images/929070677302407168/rNf669ob_normal.jpg,683,569,0,452,DE_Innovates,
72928001,2020-04-06 14:12:38,"INCY, ",,"bit.ly/3aMKGzP, ",1247225721488936960,False,1,0,0,0,BriefingInPlayLimited,$INCY: Incyte presents Phase 3 data from the TRuE-AD Program of ruxolitinib cream; plans to file NDA before end of... https://t.co/HUN8Rwzbzt,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1376527957,2020-04-06 13:34:17,,"moleculemonday, Incyte, Jakavi, Ruxolitinib, bonemarrow, drug, corona, ","instagr.am/p/B-pc2iADV5y/, pic.twitter.com/gSFvyNN9m4, ",1247216070265581572,False,0,0,0,0,IFTTT,"Happy #moleculemonday  with @ministryofchemistry „Éª„Éª„Éª
@novartis_ch writes that they are starting a joint study with #Incyte for the drug #Jakavi (#Ruxolitinib), which is actually used for #bonemarrow disease. It is planned to use the #drug in #corona ‚Ä¶ https://t.co/TMguPAkIjq https://t.co/gSFvyNN9m4","Novartis_CH, ",,2013-04-24 04:30:03,The Interwebs,moleculestore,https://pbs.twimg.com/profile_images/1257232282445910016/65lXORIM_normal.jpg,184,68,5,1380,moleculestore,photo
185789961,2020-04-06 11:47:03,,,"dlvr.it/RTGwSn, ",1247189081655660545,False,0,0,0,1,dlvr.it,"Fighting stigma ‚Äî  Clinical Catch-Up: March 30 ‚Äì April 3: Although a significant proportion of clinical trial news is related to the ... Novartis announced that, with Incyte, it is launching a Phase III clinical trial to ... presented data from two‚Ä¶ https://t.co/X29JhmclkU",,,2010-09-01 17:06:16,Worldwide,STIGMABASE | EDU,https://pbs.twimg.com/profile_images/983490900927098880/W4EweR5t_normal.jpg,922,694,71,788289,stigmabase,
1004375641171603458,2020-04-06 11:10:57,,"Delaware, COVID19, choosedelaware, resilientdelaware, inthistogether, biotech, netde, ","hubs.ly/H0pcMK90, ",1247179997527396353,False,1,0,0,4,HubSpot,"Kudos to #Delaware-based @Incyte and @NIIMBL for their work in the battle against #COVID19!
https://t.co/Wl3eBBiUNz
#choosedelaware #resilientdelaware #inthistogether #biotech #netde","Incyte, NIIMBL, ",,2018-06-06 10:53:08,,Delaware Prosperity Partnership @choosedelaware,https://pbs.twimg.com/profile_images/1059872509540134913/PX_tVV7O_normal.jpg,4337,1030,21,2792,choosedelaware,
2315971404,2020-04-06 11:07:21,,"Novartis, ","lnkd.in/gXKgiBG, ",1247179092484427776,False,0,0,0,0,LinkedIn,#Novartis and Incyte to Test Cancer Drug Jakavi in COVID-19 https://t.co/idh2gaZ1RV,,,2014-01-28 14:30:38,"Santa Barbara, CA, USA",Shelli Kenlein Papke,https://pbs.twimg.com/profile_images/1442957181578473475/d4z8c4sV_normal.jpg,61,211,2,1561,USDMRECRUITER,
1229709709420064773,2020-04-06 09:01:55,,"Incyte, ","bit.ly/2UKgOib, ",1247147524349026305,False,0,0,0,0,Twitter Web App,#Incyte presents TRuE-AD Ruxolitinib Phase 3 data at RAD conference https://t.co/hlSp2mZqpL first presentation of Phase 3 data for ruxolitinib cream at the RAD (Revolutionizing Atopic Dermatitis) conference.,,,2020-02-18 05:10:26,,cuereport,https://pbs.twimg.com/profile_images/1229709844384382977/Pg3zxzbh_normal.jpg,2,0,0,150,cuereport1,
1194152189142417408,2020-04-06 08:49:09,,,"bizjournals.com/philadelphia/n‚Ä¶, ",1247144313777201154,False,2,0,1,0,Twitter for iPhone,"‚Å¶@RepAdamSchiff‚Å© 

Did you know that a 60 day supply of 5mg of Jakafi is $14,108.00

That‚Äôs a hell of a lot of money to pay for a COVID-19 drug when it has been shown that 

tRUMP has not mentioned Ramdesivir that has been working
 https://t.co/XB8efIOwiK","RepAdamSchiff, ",,2019-11-12 02:17:38,"Atlanta, GA",ÍßÅü¶ãùñ¶ùñæùóàùóãùóÄùóÇùñ∫ùñ°ùóÖùóéùñæüè≥Ô∏è‚ÄçüåàÍßÇ,https://pbs.twimg.com/profile_images/1340350618108628998/r7rwAWrM_normal.jpg,43103,40931,57,57568,ReSisterChic,
2334614718,2020-04-06 08:05:25,"INCY, ",,"ooc.bz/l/51041, ",1247133306476474379,False,0,0,0,0,Open Outcrier,"$INCY (+1.8% pre) Incyte (INCY) Highlights Phase 3 Data from TRuE-AD Program of Ruxolitinib Cream - SI

https://t.co/CSCIqwF2i7",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
374729426,2020-04-06 07:10:06,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1452783, pic.twitter.com/keJYy6SiyF, ",1247119385426137089,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/rjWtf2ga6v #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/keJYy6SiyF",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
72928001,2020-04-06 07:03:35,"INCY, ",,"bit.ly/3aMKGzP, ",1247117744488603648,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte presents Phase 3 data from the TRuE-AD Program of Ruxolitinib Cream; plans to file NDA before end of... https://t.co/HUN8Rwzbzt,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1194152189142417408,2020-04-06 05:59:00,,,"fool.com/investing/2020‚Ä¶, ",1247101493049729031,False,0,0,0,0,Twitter for iPhone,Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19 | The Motley Fool https://t.co/yJdlnRUDbz,,,2019-11-12 02:17:38,"Atlanta, GA",ÍßÅü¶ãùñ¶ùñæùóàùóãùóÄùóÇùñ∫ùñ°ùóÖùóéùñæüè≥Ô∏è‚ÄçüåàÍßÇ,https://pbs.twimg.com/profile_images/1340350618108628998/r7rwAWrM_normal.jpg,43103,40931,57,57568,ReSisterChic,
3246541758,2020-04-06 05:55:15,,"novartis, jakavi, covid, coronavirus, incyte, ","business.medicaldialogues.in/pharma-news/no‚Ä¶, ",1247100548949540865,False,0,0,0,0,Hocalwire Social Share,Novartis collaborates with Incyte with initiation plan of clinical study of Jakavi in COVID-19 patients @Novartis #novartis #jakavi #covid-19 #coronavirus #incyte https://t.co/o1tZKl92KM,"Novartis, ",,2015-06-16 03:34:34,"New Delhi, India",Medical Dialogues,https://pbs.twimg.com/profile_images/616879208770334722/dCBRoHh9_normal.jpg,6761,749,0,44387,medicaldialogs,
1025186618108530689,2020-04-06 05:26:21,,,"voiceofthehwy.news/incyte-to-tria‚Ä¶, ",1247093277146468352,False,0,0,0,0,WordPress.com,Incyte to Trial Cancer Drug for Patients with COVID-19 Associated Cytokine Storm https://t.co/0hJ4OWF0k2,,,2018-08-02 21:08:31,"Atlanta, GA",voiceofthehwy,https://pbs.twimg.com/profile_images/1120031010211676166/SMmR2HKm_normal.png,437,1062,0,406334,voiceofthehwy,
633824212,2020-04-06 04:59:12,,,"ift.tt/3bXlczU, Theflyonthewall.com, ",1247086442339356672,False,0,0,0,0,IFTTT,"Incyte management to virtually meet with JMP Securities https://t.co/W1xq42yW23 See the rest of the story here.

https://t.co/tnMXlCjEqv provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps ind‚Ä¶",,,2012-07-12 11:31:45,NYC,flylemurs,https://pbs.twimg.com/profile_images/2393843079/wc5oiacqodhfzivmyvmh_normal.jpeg,37,32,4,129630,flylemurs,
575910168,2020-04-06 04:52:42,,"YahooFinance, Traffic, Transportation, Shipping, Logistics, Trucking, ","truckingnews.us/incyte-to-tria‚Ä¶, ",1247084806468333569,False,0,0,0,0,Trucking News,"Incyte to Trial Cancer Drug for Patients with COVID-19 Associated Cytokine Storm https://t.co/qEbDVV8mTz
#YahooFinance #Traffic #Transportation #Shipping #Logistics
Follow @AFTvitaliy for #Trucking News","AFTvitaliy, ",,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
1239059242742460418,2020-04-06 04:51:00,,"stockmarket, stockmarketcrash, coronavirus, stocks, covid19, ","zpr.io/tkQCF, ",1247084379635146753,False,0,0,0,0,Zapier.com,Incyte to Trial Cancer Drug for Patients with COVID-19 Associated Cytokine Storm - https://t.co/Zm9W3GfTJk #stockmarket #stockmarketcrash #coronavirus #stocks #covid19,,,2020-03-15 01:22:04,,Mr. Bull,https://pbs.twimg.com/profile_images/1239059631952908289/seqcSG4E_normal.jpg,34,107,0,1442,TraderHype,
1193779847727894529,2020-04-06 04:48:03,,,,1247083637280886785,False,0,0,0,0,dlvr.it,Incyte to Trial Cancer Drug for Patients with COVID-19 Associated Cytokine Storm,,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,
849417718642159616,2020-04-06 03:22:54,"INCY, ",,"zpr.io/tkQUn, ",1247062207638253569,False,0,0,0,0,Zapier.com,Analysts‚Äô Weekly Ratings Changes for Incyte $INCY https://t.co/eKl5TLX8Xc,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2298709746,2020-04-06 03:22:47,"INCY, ",,"zpr.io/tkWQF, ",1247062177485410304,False,0,0,0,0,Zapier.com,Analysts‚Äô Weekly Ratings Changes for Incyte $INCY https://t.co/eF0TBBkypf,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
732361939490312192,2020-04-06 03:20:45,"INCY, ","markets, ","americanbankingnews.com/?p=14068808, ",1247061668628246528,False,0,0,0,0,Zapier.com,Analysts‚Äô Weekly Ratings Changes for Incyte $INCY https://t.co/IgvfGuZkiI #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-06 03:20:45,"INCY, ","stocks, ","americanbankingnews.com/?p=14068808, ",1247061666933719041,False,0,0,0,0,Zapier.com,Analysts‚Äô Weekly Ratings Changes for Incyte $INCY https://t.co/WudnNlfV7a #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
725577499,2020-04-06 02:43:46,"INCY, ",,"blog.tipranks.com/incyte-to-tria‚Ä¶, ",1247052362415570945,False,0,0,0,2,Twitter Web App,Incyte to Trial Cancer Drug for Patients with COVID-19 Associated Cytokine Storm $INCY https://t.co/evmWGVO5Jr,,,2012-07-30 03:57:38,,TipRanks,https://pbs.twimg.com/profile_images/1445275766195884032/dO0joyh1_normal.jpg,25516,1242,436,23612,TipRanks,
965506680,2020-04-05 22:59:23,,"jobs, ","biospace.com/article/novart‚Ä¶, ",1246995894232219649,False,0,1,0,0,Twitter for iPhone,Novartis and Incyte to Test Cancer Drug Jakavi in COVID-19 | BioSpace https://t.co/HXfrv6yM4v #jobs,,,2012-11-23 00:08:13,"Perth, Western Australia",Louise Archer,https://pbs.twimg.com/profile_images/731630806867681281/FkxHwZUb_normal.jpg,117,333,0,819,louoz55,
3377378248,2020-04-05 22:41:45,,,"barrons.com/articles/incyt‚Ä¶, ",1246991453672390660,False,0,0,0,0,Twitter Web App,A Cancer Drug From Incyte and Novartis Is Latest Potential Weapon Against Covid-19 https://t.co/3DDF1Ju8tU via @BarronsOnline,"barronsonline, ",,2015-07-15 09:41:59,"Fayetteville, NC",Augusta Newman#BlueLady #RESISTANCE,https://pbs.twimg.com/profile_images/621315846481293312/iCPkCZzE_normal.jpg,2674,4974,27,148214,AugustaNewman13,
136463849,2020-04-05 22:26:53,,,"barrons.com/articles/incyt‚Ä¶, ",1246987712369958914,False,0,0,0,0,Twitter for iPhone,Incyte and Novartis to Test Cancer Drug as Covid-19 Treatment - Barron's https://t.co/BfR3La9IP3,,,2010-04-23 21:13:51,Where you wanna be ,Deniseüá∫üá∏,https://pbs.twimg.com/profile_images/745977523591323648/qqGmmzNL_normal.jpg,2340,1962,95,90788,carnivalfanatic,
4819091753,2020-04-05 22:25:27,,,"etrade.wallst.com/v1/stocks/news‚Ä¶, ",1246987352230318082,False,1,0,0,0,Twitter for Android,"It's not out of the realm of possibility that they released this virus strictly for the drug companies and billionaires to make more money. Who cares how many die, right? https://t.co/ekDdjmaG0Q",,,2016-01-16 15:13:40,United States,Pegytoo,https://pbs.twimg.com/profile_images/1446522191395360771/hx4rJ0dE_normal.jpg,854,3979,0,50687,Camdens12me,
2172626998,2020-04-05 21:35:19,"INCY, PFE, DERM, ASLN, GLPG, REGN, SNY, XBIT, SNNA, ABBV, SNOA, CARA, LLY, EVLO, NKTR, BHC, ",,"seekingalpha.com/news/3558456?s‚Ä¶, ",1246974735780663296,False,0,0,0,0,Twitter for Android,"Incyte details late-stage data on ruxolitinib cream for atopic dermatitis https://t.co/uRrtlTLHsW $INCY, $PFE, $DERM, $ASLN, $GLPG, $REGN, $SNY, $XBIT, $SNNA, $ABBV, $SNOA, $CARA, $LLY, $EVLO, $NKTR, $BHC Great Dividend Stock BUY PFE!",,,2013-11-07 16:14:09,"Massachusetts, USA",PeterLekousesJr,https://pbs.twimg.com/profile_images/1411669419751788546/cSrWKqVP_normal.jpg,184,285,5,9004,pjl001,
36369883,2020-04-05 20:10:05,,,"bit.ly/34bRfcM, ",1246953286453747712,False,0,0,0,0,dlvr.it,"Oncology Therapeutic Specialist, Allentown, PA for Incyte Corporation (Allentown, PA) https://t.co/ao4MfPNtFO",,,2009-04-29 10:29:35,"Allentown, PA",PA CareerLink¬Æ Lehigh Valley,https://pbs.twimg.com/profile_images/889881502917435393/_5C36l5D_normal.jpg,1270,552,65,53165,PACareerLinkLV,
13557562,2020-04-05 18:46:31,,,"seekingalpha.com/news/3558456-i‚Ä¶, ",1246932255039258626,False,0,0,0,0,Tweetbot for iŒüS,Incyte details late-stage data on ruxolitinib cream for atopic dermatitis (NASDAQ:INCY) | Seeking Alpha https://t.co/0CaT0U5Qqx,,,2008-02-16 11:58:12,"iPhone: 35.121323,-89.830750","Michael Blaiss, MD",https://pbs.twimg.com/profile_images/1397602816345186304/FFET4jcx_normal.jpg,3944,811,177,14618,wheezemd,
2988965944,2020-04-05 18:46:28,,"covid, covid19, coronavirus, mpnsm, ","biospace.com/article/novart‚Ä¶, ",1246932244028993536,False,1,0,0,0,Twitter for iPad,"JAKAVI ! Wow! üòØ (happens to be my drug, too)! 

#covid #covid19 #coronavirus #mpnsm

Novartis and Incyte to Test Cancer Drug Jakavi in COVID-19 Novartis and Incyte to Test Cancer Drug Jakavi in COVID-19  https://t.co/0EVI99ybsO",,,2015-01-21 00:02:43,"Melbourne, Australia",Josie- MPN Advocate,https://pbs.twimg.com/profile_images/1306842724537044992/wxDAFRLr_normal.jpg,383,995,5,730,MPNAdvocate,
1056526368282951682,2020-04-05 17:53:01,,"INCY, IncyteCorporation, ","dlvr.it/RTDXgr, ",1246918793906941952,False,0,0,0,0,dlvr.it,"Incyte details late-stage data on ruxolitinib cream for atopic dermatitis: * Following up on its initial announcements in January and February, Incyte (NASDAQ:INCY) reports detailed results from two successful Phase 3 clinical‚Ä¶ https://t.co/3WtWUv0Xga #INCY #IncyteCorporation",,,2018-10-28 08:41:30,Hong Kong,Trading News,https://pbs.twimg.com/profile_images/1175995389113061378/IIO0_7KI_normal.png,309,23,9,18794,tradingnews101,
435431627,2020-04-05 17:01:38,,"Cancer, Incyte, Novartis, COVID19, ","barrons.com/articles/incyt‚Ä¶, ",1246905860493676545,False,0,0,0,0,Twitter for Android,A #Cancer Drug From #Incyte and #Novartis Is Latest Potential Weapon Against #COVID19 https://t.co/Zzu01fLqAR via @Barronsonline,"barronsonline, ",,2011-12-12 21:00:35,"here,now and FUTURE ",Man VS Cancer,https://pbs.twimg.com/profile_images/1015889943002996736/UnX6iRm4_normal.jpg,431,1272,53,9259,ManVsCancer,
633824212,2020-04-05 14:29:03,,,"ift.tt/39FCekB, Theflyonthewall.com, ",1246867461976272896,False,0,0,0,0,IFTTT,"Incyte to host conference call https://t.co/lNoP7NumnF See the rest of the story here.

https://t.co/tnMXlCjEqv provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, profes‚Ä¶",,,2012-07-12 11:31:45,NYC,flylemurs,https://pbs.twimg.com/profile_images/2393843079/wc5oiacqodhfzivmyvmh_normal.jpeg,37,32,4,129630,flylemurs,
14453501,2020-04-05 14:14:08,,,"delawarebusinessnow.com/2020/04/delawa‚Ä¶, ",1246863710578237440,True,0,0,0,0,WordPress.com,Delaware‚Äôs Incyte partnering with Novartis to determine whether blockbuster drug Jakafi can aid seriously ill COVID-19 patients https://t.co/afDXRTLcxD,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
1134049078424162304,2020-04-05 13:17:04,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1246849349772025858,False,0,0,0,1,Newsfilter.io,Incyte Upgraded by Morgan Stanley to ‚ÄúOverweight‚Äù $INCY https://t.co/OtVdAQ0FAs,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
360220091,2020-04-05 13:01:17,,,"tinyurl.com/wr5hu4b, pic.twitter.com/0crz4ackOM, ",1246845374016311296,False,0,0,0,0,Newsemia,Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium - https://t.co/rnOIXxN9zh https://t.co/0crz4ackOM,,,2011-08-22 17:48:36,United States,Mazen M,https://pbs.twimg.com/profile_images/1447075007385853954/mzq8-HXd_normal.jpg,890,173,11,199622,Dataemia,photo
68559732,2020-04-05 12:35:39,"INCY, ",,"zpr.io/tkvXL, ",1246838925663989766,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by Morgan Stanley to ‚ÄúOverweight‚Äù https://t.co/5BPxKhwsJG,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2416188264,2020-04-05 12:04:51,"INCY, ","markets, ","thestockobserver.com/?p=2815790, ",1246831174040858624,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by Morgan Stanley to ‚ÄúOverweight‚Äù  https://t.co/RIjlniGFKi #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
3686628867,2020-04-05 11:43:18,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1246825748977065987,False,0,0,0,0,WordPress.com,Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium https://t.co/ffEc722ELZ,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
3318510966,2020-04-05 09:33:27,,,"crweworld.com/article/news-p‚Ä¶, ",1246793073922674689,False,0,0,0,0,CRWE World,Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutioni https://t.co/ey024HXYSa,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1002361483169226752,2020-04-05 09:18:07,,"Incyte, FDAApproval, ClinicalTrial, Treatment, COVID19, Cytokine, coronavirus, healthcare, ","trialsitenews.com/incyte-seeks-f‚Ä¶, ",1246789212168314880,False,1,0,0,0,Twitter Web Client,#Incyte Seeks #FDAApproval of Phase III #ClinicalTrial Targeting #Treatment of #COVID19 Associated #Cytokine Storm https://t.co/FMeJAnDmIz #coronavirus #healthcare,,,2018-05-31 21:29:35,"Salt Lake City, Utah",TrialSite News,https://pbs.twimg.com/profile_images/1002368873918689280/0KP3xUVe_normal.jpg,7886,3205,76,11177,TrialsiteN,
1006334607946649600,2020-04-05 09:03:02,,,"dlvr.it/RTCVfK, ",1246785419980599301,False,0,0,0,0,dlvr.it,Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium https://t.co/ZlOBsBD7OM,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1089978712685273090,2020-04-05 08:55:02,"INTC, ","Incyte, ","dlvr.it/RTCTtx, ",1246783402977529856,False,0,0,0,0,dlvr.it,#Incyte $INTC Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium https://t.co/4sRytloWEz,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
472650465,2020-04-05 08:35:49,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1246778570124537856,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the https://t.co/3wt08XW9WH,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
3772910893,2020-04-05 08:20:06,"INCY, OILX, USO, UCO, ","Toonami, ","marketwirenews.com/news-releases/‚Ä¶, ",1246774614103076864,False,0,0,0,0,Market Wire News,"$INCY News Article - Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium https://t.co/wj826sq6RT

#Toonami @LissaRobert7 $OILX $USO $UCO","LissaRobert7, ",,2015-10-03 14:47:09,"San Jose, CA",Market Wire News,https://pbs.twimg.com/profile_images/1156273358729830406/L5xAuaId_normal.jpg,54480,1818,498,41701,MarketWN,
313862119,2020-04-05 08:09:26,,,"businessfortnight.com/incyte-announc‚Ä¶, pic.twitter.com/tkeVv2nUnh, ",1246771930264481793,False,0,0,0,0,WordPress.com,Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium https://t.co/KWRVUC3GC0 https://t.co/tkeVv2nUnh,,,2011-06-09 06:13:12,Bhopal,"Ravindra Soni, editor, businessfortnight.com",https://pbs.twimg.com/profile_images/809424050770448384/e3p1bqh-_normal.jpg,434,690,4,84691,RavindraSoni1,photo
976297820532518914,2020-04-05 08:08:33,,,"dlvr.it/RTCP5c, pic.twitter.com/ZQ7v3LgQtk, ",1246771707940990976,False,0,0,0,0,dlvr.it,Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium https://t.co/ASdMAGZ9aM https://t.co/ZQ7v3LgQtk,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1134049078424162304,2020-04-05 08:01:03,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1246769821464870920,False,0,0,0,0,Newsfilter.io,Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium $INCY https://t.co/PJIfC4Pomo,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
374729426,2020-04-05 06:44:23,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1448790, pic.twitter.com/bm7IxOh4wu, ",1246750526101831681,False,1,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/tmluHJsj3G #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/bm7IxOh4wu",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-04-05 05:36:04,"INCY, ",,"newsfilter.io/articles/insid‚Ä¶, ",1246733333641539584,False,0,0,0,0,Newsfilter.io,"Insider Selling: Incyte EVP Sells $166,383.76 in Stock $INCY https://t.co/Ty8wR521PV",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2920258887,2020-04-05 05:35:46,"INCY, ",,"dakotafinancialnews.com/?p=1725760, ",1246733258169225216,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,329 Shares of Incyte Co. $INCY Stock https://t.co/e3APFvF2JA",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
2416188264,2020-04-05 05:35:02,"INCY, ","markets, ","thestockobserver.com/?p=2814400, ",1246733071170392064,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $166,383.76 in Stock  https://t.co/MGzpDxGrSX #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
21268553,2020-04-04 16:39:53,,,"stock-market-newsfeed.blogspot.com/2020/04/incyte‚Ä¶, ",1246538000206573570,False,0,0,0,0,SS Auto Tweet App,"Incyte to Evaluate Lead Drug Jakafi for COVID-19 Infection
 https://t.co/jmnindTTTm",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
198557406,2020-04-04 13:16:48,,"COVID2019, mpnsm, ","fiercepharma.com/pharma/novarti‚Ä¶, ",1246486892889210889,False,5,0,0,0,Twitter for Android,"We have been in touch with Incyte and Novartis, who are monitoring the supply that people with MPN rely on as they see if jakafi can be effective for #COVID2019 #mpnsm

Novartis, Incyte set to roll JAK inhibitor Jakafi into COVID-19 clinical trial https://t.co/PktzzGJ0uL",,,2010-10-04 12:44:03,"Chicago, IL",MPN Research Foundation,https://pbs.twimg.com/profile_images/1169329089980841990/sZPRBax-_normal.jpg,2084,221,44,1737,MPN_RF,
14442905,2020-04-04 12:59:04,,,"dlvr.it/RT9gZG, pic.twitter.com/KfA0jHzVsk, ",1246482429813993473,False,2,0,0,0,dlvr.it,Novartis and Incyte to Test Cancer Drug Jakavi in COVID-19 https://t.co/pnCvs3OLoR https://t.co/KfA0jHzVsk,,,2008-04-19 08:48:59,,Biotechnology,https://pbs.twimg.com/profile_images/1235765602/horizon1202906805-double_helix_500x500_normal.png,57151,3269,1002,53397,Biotechnology,photo
204748499,2020-04-04 12:12:53,,"COVID19RX, COVID19, ","fiercepharma.com/pharma/novarti‚Ä¶, pic.twitter.com/uuR5BOof8L, ",1246470808509263879,False,39,1,1,13,Twitter for Android,"JAK inhibitors/ Cytokine storm /COVID-19
Novartis&amp;Incyte will¬†initiate¬†a phase 3 clinical trial for Description
Ruxolitinib/fda approved myelofibrosis
Baricitinib/RA:awaiting the results of prospective studies NCT04320277&amp;NCT04321993)
#COVID19RX #COVID19 https://t.co/Nsp0GqJOyF https://t.co/uuR5BOof8L",,,2010-10-19 07:39:07,üåç,Antibiotic Stewa¬ÆÔ∏èxüÜî Bassam Ghanem,https://pbs.twimg.com/profile_images/1274367456610525190/OIDDvaCl_normal.jpg,36194,299,307,33122,ABsteward,photo
2196742020,2020-04-04 09:05:24,,,"medcitynews.com/2020/04/incyte‚Ä¶, ",1246423626368389120,False,0,0,0,0,Twitter Web Client,Incyte plans Phase III trial of blood cancer drug as potential Covid-19 cytokine storm therapy https://t.co/Wtw2ywLrRd,,,2013-11-15 17:52:52,,Ken Checicki,https://pbs.twimg.com/profile_images/649668229535764480/BfSrqULL_normal.jpg,33,24,0,7167,KenChecicki,
799681941939159040,2020-04-04 08:49:42,,,"twitter.com/OncLive/status‚Ä¶, ",1246419674063134720,False,8,0,1,2,Twitter for iPhone,"In a press release, the companies (Nortis and Incyte) reported that they plan to initiate a compassionate use program for patients with COVID-19 to have access to ruxolitinib. @IDstewardship https://t.co/AC71ufYj2k","IDstewardship, ",,2016-11-18 13:33:27,"Miami, FL",Alga S Ramos Morales,https://pbs.twimg.com/profile_images/802367733446963200/uGXt1TfS_normal.jpg,91,288,4,86,Alga_Ramos,
26573545,2020-04-04 08:41:04,,,"twitter.com/sesiegler/stat‚Ä¶, ",1246417503942774786,False,0,0,1,0,Twitter for iPhone,I am still waiting to hear from @Incyte.  I may send them an email if I don‚Äôt hear anything today.  It‚Äôs worth an email. https://t.co/X5XKIYl504,"Incyte, ",,2009-03-25 15:45:46,OH & The Sunbelt ,It‚Äôs Just ‚ÄúSara‚Äù,https://pbs.twimg.com/profile_images/1329827546247155712/-tEey36Q_normal.jpg,4486,5001,205,187671,sesiegler,
374729426,2020-04-04 07:36:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1443524, pic.twitter.com/xxpDsro0wP, ",1246401285118550022,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/OT06SHbfUI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xxpDsro0wP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2894715220,2020-04-04 05:23:34,,"COVID„Éº19, Ruxolitinib, StayAtHome, Coronavirus, ","pmlive.com/pharma_news/in‚Ä¶, pic.twitter.com/giAeoueE7l, ",1246367798105911297,False,3,0,0,0,Twitter for iPhone,"[#COVID„Éº19 : Phase 3 study]
Incyte and Novartis join coronavirus efforts with phase 3 study. #Ruxolitinib helps to inhibit immune cells from attacking the body‚Äôs own immune system.
https://t.co/AsMdSuFEHD 
#StayAtHome #Coronavirus https://t.co/giAeoueE7l",,,2014-11-27 09:40:08,"Zurich, Suisse",JNS Staffing,https://pbs.twimg.com/profile_images/1402525519174934531/AqOdemKd_normal.jpg,1012,5000,48,2388,JNS_Staffing,photo
2298709746,2020-04-04 04:52:06,"INCY, ",,"zpr.io/tkkcq, ",1246359879847116801,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,329 Shares of Incyte Co. $INCY Stock https://t.co/GWSsmv0dGk",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2344420430,2020-04-04 04:51:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1246359673579745281,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

EDMUND HARRIGAN:

https://t.co/nKKkDAfPUl",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
930803511918411776,2020-04-04 04:49:52,"INCY, ",,"thelincolnianonline.com/?p=3731664, ",1246359317273550848,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,329 Shares of Incyte Co. $INCY Stock https://t.co/39mWIYZ2VT",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2904855645,2020-04-04 02:55:32,,,"investor.incyte.com/news-releases/‚Ä¶, ",1246330547376455680,False,11,1,0,3,Twitter for iPhone,"Ruxolitinib, a new hope for the COVID-19 patients that could stop cytokines storm. Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm | Incyte Corporation https://t.co/oG061usHcO",,,2014-12-04 04:52:10,,Valentin Garcia,https://pbs.twimg.com/profile_images/684838077047685121/dHXOajdv_normal.jpg,852,60,14,914,jvalentingg,
21268553,2020-04-04 01:51:54,,,"stock-market-newsfeed.blogspot.com/2020/04/incyte‚Ä¶, ",1246314533641228288,False,0,0,0,0,SS Auto Tweet App,"Incyte to Evaluate Lead Drug Jakafi for COVID-19 Infection
 https://t.co/jmnindTTTm",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
1102623033435422721,2020-04-04 00:06:54,,"stock, watchlist, tmbnews, ","pic.twitter.com/tRlaQILsU0, ",1246288109005934592,False,0,0,0,0,FS Poster,"(FATE), Incyte Corporation (NASDAQ:INCY) - The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&amp;J, Zentalis IPO
-
-

-
-
#stock #watchlist #tmbnews https://t.co/tRlaQILsU0",,,2019-03-04 12:33:11,,The Millennial Bridge Assets,https://pbs.twimg.com/profile_images/1139734380199337984/gyTHehlc_normal.jpg,34,128,0,754,tmbassets,photo
895929863521095680,2020-04-03 22:18:53,"INCY, ","Incyte, stocks, trading, finance, market, ","tinyurl.com/tlx6lc5, pic.twitter.com/hNzsnZe3sA, ",1246260923326705667,False,0,0,0,0,TradeFlags,"TD SELL $INCY at 78.59, Supp 63.18 Resis 78.59 R24  HiLo 47% T1Y 91 buy 2.2 PE 38.3 DIV N/A #Incyte Cor #stocks #trading #finance #market https://t.co/xnv4ovW1PP https://t.co/hNzsnZe3sA",,,2017-08-11 04:48:19,1130,TradeFlags,https://pbs.twimg.com/profile_images/1444247772769792002/Hc_nWhvE_normal.jpg,636,206,11,58994,TradeFlags,photo
4016708417,2020-04-03 22:16:04,,,,1246260215026245635,False,0,0,1,0,Twitter Web App,"Basel, April 2, 2020 ‚Äî Novartis today announced plans to initiate a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi¬Æ (ruxolitinib) for treatment of a type of severe immune overreaction called cytokine storm with COVID-191-3.",,,2015-10-22 08:05:20,Hamburg,Ralph,https://pbs.twimg.com/profile_images/709194924240019460/wXy4heBV_normal.jpg,178,1409,4,5109,ulenrich,
130442628,2020-04-03 18:55:02,,,"bit.ly/2UFyECP, ",1246209624136695808,False,0,0,0,0,Sailing Blogs,"Incyte, Novartis to test repurposed cancer drug in COVID-19 - BioPharma Dive https://t.co/BOSs8vEqg7",,,2010-04-07 05:07:45,,Diving News,https://pbs.twimg.com/profile_images/804026153/diving-and-activities_diving-and-activities_top_265_1_normal.jpg,9921,343,146,74400,diving_news,
3460109487,2020-04-03 18:19:00,,"Jakafi, coronavirus, ","endpts.com/covid-19-round‚Ä¶, ",1246200557808824320,False,2,0,0,1,Buffer,"Covid-19 roundup: Novartis, Incyte pitch #Jakafi PhIII to tackle severe cases; Is #coronavirus spreading like measles? https://t.co/UTOdPhsVJm",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
2344420430,2020-04-03 17:26:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1246187288981315585,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JACQUALYN A FOUSE:

https://t.co/oFJa4fpazP",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
21793154,2020-04-03 17:08:59,,"biospace, lifesciences, biotechnology, pharmaceuticals, ","hubs.ly/H0p9Tmz0, ",1246182934727532544,False,2,0,0,1,HubSpot,"Novartis and Incyte to Test Cancer Drug Jakavi in COVID-19

#biospace #lifesciences #biotechnology #pharmaceuticals

https://t.co/0T0bAqM8Cj",,,2009-02-24 15:27:40,"Des Moines, IA",BioSpace,https://pbs.twimg.com/profile_images/1042117112020389888/8MCBEVkx_normal.jpg,21738,2830,509,25196,biospace,
1564125781,2020-04-03 16:16:13,,,"biopharmadive.com/news/coronavir‚Ä¶, ",1246169655250685954,False,2,0,0,1,Twitter Web App,"The companies will run two Phase 3 trials in the U.S. and Europe, respectively, as well as launch expanded access programs to allow administration of the drug while those studies gather evidence. https://t.co/rhYUcRN9y2",,,2013-07-02 17:00:07,"Washington, D.C.",BioPharma Dive,https://pbs.twimg.com/profile_images/1247897788702052354/8g5XsbZF_normal.jpg,11666,334,333,14463,BioPharmaDive,
918218741867040768,2020-04-03 15:37:04,,,"finance.yahoo.com/news/rpt-novar‚Ä¶, investorshub.advfn.com/boards/read_ms‚Ä¶, ",1246159802948091907,False,0,0,0,0,Investors Hub Post Tweeter,"COVID-19 News:

https://t.co/ORtqdiRJ7F  https://t.co/OsNWDvK9p3",,,2017-10-11 16:56:22,,Ronald L Fraley,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,148,526,0,11948,goodbuddy4863,
1011535484,2020-04-03 14:56:37,,"jobs, ","biospace.com/article/novart‚Ä¶, ",1246149624257302531,False,0,0,0,0,Twitter Web Client,Novartis and Incyte to Test Cancer Drug Jakavi in COVID-19 | BioSpace https://t.co/0k9KL3w0tW #jobs,,,2012-12-14 12:00:24,"Amelia Island, Florida",Frank,https://pbs.twimg.com/profile_images/2976439148/a69c25cd33074fb5c27049a593e9de0e_normal.jpeg,272,879,3,22188,lombardfm,
794634078159040512,2020-04-03 14:56:19,,"News, Affordablehealthcare, ","bit.ly/39HPbuq, pic.twitter.com/UpejXqk4wf, ",1246149550458441728,False,0,0,0,1,Sendible,#News Incyte plans Phase III trial of blood cancer drug as potential Covid-19 cytokine storm therapy https://t.co/gsOFJPluSB #Affordablehealthcare  @Medcitynews https://t.co/UpejXqk4wf,"medcitynews, ",,2016-11-04 16:15:02,"Los Angeles, CA",Minda Wilson,https://pbs.twimg.com/profile_images/902937545117454340/a-4ywkDI_normal.jpg,22045,9923,151,3614,_mindawilson,photo
1128239740329705472,2020-04-03 14:29:49,"INCY, ","COVID19, SARS_CoV_2, ","bizjournals.com/philadelphia/n‚Ä¶, ",1246142880520892418,False,0,0,0,1,Twitter for Android,"Incyte has some big plans for its flagship drug. 

#COVID19 #SARS_CoV_2 
$INCY 
https://t.co/YxEX8gDnDL",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
38920802,2020-04-03 14:04:50,"BCRX, ",,"inflarx.de/Home/Investors‚Ä¶, investor.incyte.com/news-releases/‚Ä¶, ",1246136593825447937,False,0,0,0,0,Twitter Web App,Difficult to imagine what Stonehouse is thinking.  Paralyzed by fear of running out of money to pay his salary?? Phase III trial for Berotralstat? $BCRX  https://t.co/1bQMUBJp0d https://t.co/WhyVpe9pgI,,,2009-05-09 16:23:52,,Spontonic,https://pbs.twimg.com/profile_images/1132813877513560065/G7Q68pBw_normal.png,406,197,17,2815,spontonic,
76385834,2020-04-03 13:40:33,,,"dlvr.it/RT6yTV, pic.twitter.com/OMqhK3YbfT, ",1246130479780089856,False,0,0,0,0,dlvr.it,Novartis and Incyte to Test Cancer Drug Jakavi in COVID-19 https://t.co/JjaGKLzyx0 https://t.co/OMqhK3YbfT,,,2009-09-22 13:03:55,,Corixis,https://pbs.twimg.com/profile_images/1234473809/favicon_normal.PNG,92,111,17,43317,Corixis,photo
240286075,2020-04-03 13:20:00,,,"buff.ly/3aIu5NA, ",1246125312267747332,False,0,0,0,0,Buffer,: Incyte and Novartis join coronavirus efforts with phase 3 study https://t.co/AWDmXRtURz,,,2011-01-19 10:41:34,,ScienceSeeker Feed,https://pbs.twimg.com/profile_images/1220009784/avatar_normal.gif,1066,3,126,480354,SciSeekFeed,
875382419251019776,2020-04-03 13:12:04,,,"bit.ly/2JBafbd, pic.twitter.com/wnPZrnvGYR, ",1246123312058527749,False,0,0,0,0,dlvr.it,Novartis and Incyte to Test Cancer Drug Jakavi in COVID-19 https://t.co/8JhJRXmlXe https://t.co/wnPZrnvGYR,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
365004971,2020-04-03 12:38:51,,,"pmlive.com/pharma_news/in‚Ä¶, ",1246114954924736512,False,0,0,0,0,Twitter for iPhone,"Phase 3 Trial, great üëá

Incyte and Novartis join coronavirus efforts with phase 3 study https://t.co/F9Az08n7MR",,,2011-08-30 14:12:50,"North West, England",Colin Paul,https://pbs.twimg.com/profile_images/1431649857232584704/l71MS3uc_normal.jpg,315,326,11,23274,JjhColin,
1093067346019782661,2020-04-03 12:22:23,,,"biopharmadive.com/news/coronavir‚Ä¶, ",1246110809740267521,False,0,0,0,0,Twitter Web Client,"Incyte, Novartis to test repurposed cancer drug in COVID-19 https://t.co/kbl7EhbYeB via @BioPharmaDive","BioPharmaDive, ",,2019-02-06 03:42:18,,Tina Meyer üò∑üíâüíâ#FightMS + COVID-19 üåèüåçüåé,https://pbs.twimg.com/profile_images/1437386325515243522/YGODNT-a_normal.jpg,95,483,4,2123,TinaMey90814508,
1330055544,2020-04-03 12:22:21,"INCY, NVS, ","covid19, coronavirus, ","biopharmadive.com/news/coronavir‚Ä¶, ",1246110802895147008,False,1,0,0,0,Twitter Web Client,"Incyte, Novartis to test repurposed cancer drug in #covid19 https://t.co/itJgrUQ2cW by @NedPagliarulo #coronavirus $INCY $NVS","NedPagliarulo, ",,2013-04-05 16:58:03,Virginia,Ben Fidler,https://pbs.twimg.com/profile_images/1370960622293225472/D0Zpicim_normal.jpg,6730,425,300,5195,BentheFidler,
21268553,2020-04-03 11:59:55,,,"stock-market-newsfeed.blogspot.com/2020/04/incyte‚Ä¶, ",1246105157743579138,False,0,0,0,0,SS Auto Tweet App,"Incyte to Evaluate Lead Drug Jakafi for COVID-19 Infection
 https://t.co/jmnindTTTm",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
18834912,2020-04-03 11:52:43,"INCY, ","COVID19, CytokineStorm, coronavirus, ","medcitynews.com/2020/04/incyte‚Ä¶, ",1246103345846255617,False,0,0,0,0,Twitter Web App,"Incyte plans Phase III trial of Jakafi to treat #COVID19-related cytokine storm, writes @biotechvisigoth. #CytokineStorm #coronavirus $INCY
https://t.co/pW1SbyMqq2","biotechvisigoth, ",,2009-01-10 09:09:33,"MedCity, USA",MedCity News,https://pbs.twimg.com/profile_images/598875829976834048/MLQosVo1_normal.png,32781,7502,1628,37912,medcitynews,
19790872,2020-04-03 11:50:44,"AMGN, INCY, ",,"zacks.com/stock/news/852‚Ä¶, ",1246102843515383810,False,0,0,0,0,Twitter Web App,"Pharma Coronavirus Efforts Continue, Amgen &amp; Incyte Join In. $AMGN $INCY https://t.co/Gn997urBHH",,,2009-01-30 16:51:20,Chicago IL,Zacks.com,https://pbs.twimg.com/profile_images/3447073135/4d4a6e8270026a6d00c16d3f66466c2b_normal.png,22069,653,643,39323,ZacksResearch,
267943190,2020-04-03 11:50:08,,,"investor.incyte.com/news-releases/‚Ä¶, pic.twitter.com/ZzhjMNycLK, ",1246102692746989571,False,1,0,0,2,Hootsuite Inc.,"This trial is good news, very promising!
https://t.co/88eASGFEmp https://t.co/ZzhjMNycLK",,,2011-03-17 17:19:27,"Bethesda, MD",AA&MDSIF,https://pbs.twimg.com/profile_images/917816894954115072/wZC5tCTh_normal.jpg,3354,2448,56,20690,aamdsif,photo
2344420430,2020-04-03 11:41:18,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1246100470013267969,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

WENDY L DIXON:

https://t.co/TQi6IOy3BX",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
15550043,2020-04-03 11:29:57,,"philly, feedly, ","bizjournals.com/philadelphia/n‚Ä¶, ",1246097614896082945,False,0,0,0,1,Twitter Web Client,Wilmington-based Incyte looking to repurpose flagship drug as COVID-19 treatment https://t.co/lu25d4sgjl #philly #feedly,,,2008-07-22 20:56:36,"New York, USA",Diancie Network,https://pbs.twimg.com/profile_images/1348916695516082177/UeXKUagp_normal.jpg,2355,1290,436,71444,DiancieNetwork,
25560065,2020-04-03 11:07:41,,,"bizjournals.com/philadelphia/n‚Ä¶, ",1246092009623949317,False,0,0,0,0,True Anthem,Wilmington-based Incyte is working with the FDA to study the company's flagship drug as a potential treatment for some COVID-19 patients. https://t.co/EKybymUyUV,,,2009-03-20 15:31:03,Philadelphia,PHL Business Journal,https://pbs.twimg.com/profile_images/378800000077412316/8b22fbb8c4be97c69f048ff47fe712b6_normal.jpeg,35028,8899,1065,77326,PHLBizJournal,
20449296,2020-04-03 10:15:08,,,"on.barrons.com/2R4HZlu, ",1246078788255055872,False,3,0,0,4,SocialFlow,The companies announced plans on Thursday evening for a clinical trial of their drug Jakafi. https://t.co/nOsfpJGano,,,2009-02-09 12:15:01,"New York, NY",Barron's,https://pbs.twimg.com/profile_images/1400867183333412864/LO1NDNpM_normal.jpg,201867,35,4773,60256,barronsonline,
121158213,2020-04-03 10:14:08,"INCY, ",,"AlertTrade.us, ",1246078533467639808,False,0,0,0,0,dlvr.it,SOCIAL ACTIVITY: $INCY - Incyte Corporation - Common Stock üìà TradeIdeas via ‚û° https://t.co/VS8RO1bzXJ,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
140599113,2020-04-03 10:11:32,,,"winway.me/health-care/in‚Ä¶, pic.twitter.com/FGaf4lXCQR, ",1246077880007868417,False,0,0,0,0,WordPress.com,Incyte plans Phase III trial of blood cancer drug as potential Covid-19 cytokine storm therapy https://t.co/lNPFoHi3oh https://t.co/FGaf4lXCQR,,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,photo
407212567,2020-04-03 10:04:04,,"eHealth, ","ift.tt/2UDOJc6, ",1246076001345515520,False,0,0,0,0,IFTTT,Mi seguimiento üì° sobre #eHealth Incyte plans Phase III trial of blood cancer drug as potential Covid-19 cytokine storm therapy: https://t.co/d5eTZotLy0,,,2011-11-07 14:56:05,Espa√±a,Eugenio Ghirardi,https://pbs.twimg.com/profile_images/378800000532943977/0f99af81bf68382f40a90e89c7ca525c_normal.png,341,485,32,19973,GhirardiEugenio,
575910168,2020-04-03 10:02:46,,"YahooFinance, Traffic, Transportation, Shipping, Logistics, Trucking, ","truckingnews.us/novartis-incyt‚Ä¶, ",1246075673006886923,False,0,0,0,0,Trucking News,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/EmvF7P865b
#YahooFinance #Traffic #Transportation #Shipping #Logistics
Follow @AFTvitaliy for #Trucking News","AFTvitaliy, ",,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
3901351277,2020-04-03 10:02:11,,"healthnews, ","bit.ly/3aIk5UH, ",1246075526634188800,False,0,0,0,0,IFTTT,Incyte plans Phase III trial of blood cancer drug as potential Covid-19 cytokine storm therapy : https://t.co/r8VmPSRucU #healthnews,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
437085904,2020-04-03 09:35:34,,,"dlvr.it/RT69cq, pic.twitter.com/COxVhS8Ybj, ",1246068830218022917,False,0,0,0,2,dlvr.it,Incyte plans Phase III trial of blood cancer drug as potential Covid-19 cytokine storm therapy https://t.co/mkx8ibWleK https://t.co/COxVhS8Ybj,,,2011-12-14 19:20:30,"Hudson Valley, New York",Bruce Judson Telemed,https://pbs.twimg.com/profile_images/904040523580661760/7sz5Ry6z_normal.jpg,5677,1562,245,82548,JudsonTelemed,photo
1193779847727894529,2020-04-03 09:21:33,,,"pic.twitter.com/mCHDp97OSj, ",1246065300681850881,False,0,0,0,0,dlvr.it,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/mCHDp97OSj",,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,photo
1239059242742460418,2020-04-03 09:20:02,,"stockmarket, stockmarketcrash, coronavirus, stocks, covid19, ","zpr.io/tk3eY, ",1246064921638567936,False,0,0,0,0,Zapier.com,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 - https://t.co/XxKyGQrrXf #stockmarket #stockmarketcrash #coronavirus #stocks #covid19",,,2020-03-15 01:22:04,,Mr. Bull,https://pbs.twimg.com/profile_images/1239059631952908289/seqcSG4E_normal.jpg,34,107,0,1442,TraderHype,
25406480,2020-04-03 09:08:09,,,"awesomecapital.blogspot.com/2020/04/incyte‚Ä¶, ",1246061928843284480,False,0,0,0,1,Twitter Web Client,AwesomeCapital: Incyte to test Jakafi in COVID-19 patients https://t.co/xoCZR6VLR7,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
1166648730419904512,2020-04-03 09:06:22,,,"cnbc.com/2020/04/03/wha‚Ä¶, ",1246061481940172800,False,0,0,0,0,Twitter Web Client,"""Novartis (NVS) and Incyte Pharmaceuticals (INCY) will test their bone marrow cancer drug Jakavi as a possible treatment for COVID-19..."" https://t.co/fdqzhT1jjg",,,2019-08-28 05:48:38,,Gantsatsral,https://pbs.twimg.com/profile_images/1404713611642257410/94coej5t_normal.jpg,1751,2064,0,298,Gantsatsral0726,
1024776318175596544,2020-04-03 09:00:11,,"business, sales, newjobs, commercialrealestate, telecommunications, informationtechnology, technology, b2b, salesleads, ","bit.ly/2JAnf0E, pic.twitter.com/7IHmtVtUnV, ",1246059924100190208,False,0,0,0,0,Buffer,"Incyte to spend $50,000,000.00 to occupy 200,000 square feet of space in Wilmington Delaware. #business #sales #newjobs #commercialrealestate #telecommunications #informationtechnology #technology #b2b #salesleads https://t.co/tHFgYke17W https://t.co/7IHmtVtUnV",,,2018-08-01 17:58:08,,intelligence360.io,https://pbs.twimg.com/profile_images/1024776423339261954/O7ISlf2m_normal.jpg,2,0,0,2038,intel360io,photo
39339618,2020-04-03 08:55:16,,"COVID19, ",,1246058688038789120,False,1,0,0,0,Twitter Web App,"#COVID19  Incyte (NASDAQ:INCY) is working with the FDA to initiate a Phase 3 clinical trial, RUXCOVID, to evaluate the efficacy and safety of ruxolitinib (Jakafi) plus standard-of-care (SoC), compared to SoC therapy alone, in patients with COVID-19 associated cytokine storm.",,,2009-05-11 16:56:43,Upstate New York,jim Breitfeller,https://pbs.twimg.com/profile_images/393328062/th_DonQuixtoteandthewindmills-3_1__normal.jpg,160,619,0,929,jimmy_br,
15232532,2020-04-03 08:26:32,,,"dlvr.it/RT5xnp, pic.twitter.com/p9I88UOO3I, ",1246051458815905793,False,0,0,0,0,dlvr.it,"Covid-19 roundup: Novartis, Incyte pitch Jakafi PhIII to tackle severe cases; Is coronavirus spreading like measles? https://t.co/PELn18Cuyf https://t.co/p9I88UOO3I",,,2008-06-25 11:32:12,"Cape Cod, MA",DennisPartners,https://pbs.twimg.com/profile_images/777939023461511168/Lqtz-Jal_normal.jpg,415,425,13,7177,DennisPartners,photo
133504478,2020-04-03 08:26:07,,"strategy, competitiveintelligence, marketing, healthcare, productmarketing, biotech, pharma, pharmaceutical, ","dlvr.it/RT5xlX, lqventures.com, pic.twitter.com/y7deEOjHWV, ",1246051351710199809,False,1,0,0,1,dlvr.it,"Covid-19 roundup: Novartis, Incyte pitch Jakafi PhIII to tackle severe cases; Is coronavirus spreading like measles? https://t.co/qYIkfV1nts &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #productmarketing #biotech #pharma #pharmaceutical https://t.co/y7deEOjHWV",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
47433923,2020-04-03 08:17:09,,,"endpts.com/covid-19-round‚Ä¶, ",1246049096651231233,False,2,0,0,1,Twitter for iPhone,"Novartis, Incyte pitch Jakafi PhIII to tackle severe cases of Covid-19 https://t.co/dED4xbp0YT",,,2009-06-15 16:23:45,"Boston, MA",Jeffrey Flier,https://pbs.twimg.com/profile_images/1380522536216236037/wAiZwQUw_normal.jpg,23396,2751,636,25992,jflier,
3460109487,2020-04-03 08:02:54,,,"endpts.com/covid-19-round‚Ä¶, ",1246045507836882947,False,1,0,0,0,Buffer,"Covid-19 roundup: Novartis, Incyte pitch Jakafi PhIII to tackle severe cases; Is coronavirus spreading like measles? https://t.co/UTOdPhsVJm",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
2266388972,2020-04-03 07:56:40,"INCY, ","stocks, ","dailypolitical.com/?p=3658947, ",1246043939515387909,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Paula J. Swain Sells 2,329 Shares https://t.co/mULOqEbaW3 #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-03 07:56:38,"INCY, ",,"dailypolitical.com/?p=3658947, ",1246043933265797121,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Paula J. Swain Sells 2,329 Shares https://t.co/BydzmkOw3S",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
966006214818697218,2020-04-03 07:52:45,"INCY, ",,"theenterpriseleader.com/?p=2905769, ",1246042954235613184,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Paula J. Swain Sells 2,329 Shares  https://t.co/fTPEox6e4z",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
849417718642159616,2020-04-03 07:50:53,"INCY, ",,"zpr.io/tkw8N, ",1246042483571728384,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 2,329 Shares of Stock https://t.co/52F8LOJPNx",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
132589007,2020-04-03 07:50:20,,"CoronaAlert, ","pharmatimes.com/news/novartis,‚Ä¶, ",1246042346099220480,False,0,0,0,1,Twitter Web App,"""Novartis, Incyte to test Jakavi for coronavirus-linked cytokine storm"".
A clinical study to test the potential of Jakavi(ruxolitinib)in patients with COVID-19 may contribute to respiratory compromise in some patients.
@WHOEgypt 
@mohpegypt 
#CoronaAlert 
https://t.co/txzvTdNm3g","WHOEgypt, mohpegypt, ",,2010-04-13 13:05:54,üá™üá¨ Heart ‚ù§ of The World üåé ,Dr. MOHSEN AFOUNA¬Æ,https://pbs.twimg.com/profile_images/1441719386759380996/8j8WOg6U_normal.jpg,1299,737,7,18327,afounamohsen,
20618879,2020-04-03 07:43:55,,,"firstwordpharma.com/node/1712930, ",1246040732399517697,False,0,0,0,0,Twitter Web Client,"Check out this FWPharma article : Incyte, Novartis to evaluate¬†JAK inhibitor ruxolitinib¬†for severe COVID-19 patients. https://t.co/Oh2Vw2vqph via @fwpharma","fwpharma, ",,2009-02-11 14:38:42,"Doylestown, PA",Mark Schmukler,https://pbs.twimg.com/profile_images/710821516183781376/7GoU3AAX_normal.jpg,14159,8541,465,5028,SagefrogMark,
1022473214457348096,2020-04-03 07:42:12,,,"pharmashots.com/30234/novartis‚Ä¶, pic.twitter.com/REULz5wiXg, ",1246040298817380353,False,8,0,0,9,Twitter Web App,"Novartis and Incyte Intend to Initiate the P-III RUXCOVID Study of Jakavi (ruxolitinib) as a Treatment for Patients with COVID-19 Associated Cytokine Storm @Novartis @Incyte 
https://t.co/xUzEWI6Yz9 https://t.co/REULz5wiXg","Novartis, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,photo
46297868,2020-04-03 07:41:33,,,"dlvr.it/RT5p2d, ",1246040136220954625,True,1,0,0,0,dlvr.it,"Covid-19 roundup: Novartis, Incyte pitch Jakafi PhIII to tackle severe cases; Is coronavirus spreading like measles? https://t.co/SHVo9zCGQv",,,2009-06-10 22:57:35,"Tokyo-to, Japan",ÂâçÁî∞ÈùôÂêæÔΩúInsights4 PharmaÁ∑®ÈõÜÈï∑,https://pbs.twimg.com/profile_images/1235372206227505152/GS4mgJ5R_normal.jpg,626,684,19,52844,seigomaeda,
746441781588426752,2020-04-03 07:40:53,,,"endpts.com/covid-19-round‚Ä¶, ",1246039967509274624,False,1,0,0,1,Twitter Web Client,"Today in Covid-19 roundup (to be updated throughout the day):

Novartis, Incyte pitch Jakafi PhIII to tackle severe cases; Is coronavirus spreading like measles? - https://t.co/le3oCiyh6O",,,2016-06-24 16:36:03,Hong Kong,Amber Tong,https://pbs.twimg.com/profile_images/884631339940687872/t2YNNjMA_normal.jpg,2186,733,44,3674,AmberTongPW,
374729426,2020-04-03 07:39:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1440659, pic.twitter.com/stIiGUeHHY, ",1246039611635195904,False,1,0,1,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on April 1, 2020. View odds for this and other indicators: https://t.co/sqx93DsyYQ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/stIiGUeHHY",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
15974185,2020-04-03 06:43:02,,,"dlvr.it/RT5cvN, ",1246025409487126528,False,1,0,0,3,dlvr.it,Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19 https://t.co/e1lxcV3KXJ,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
2344420430,2020-04-03 06:04:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1246015658485260288,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

PAUL J CLANCY:

https://t.co/zkegbzRmnc",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1134049078424162304,2020-04-03 05:57:22,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1246013918285307906,False,0,0,0,0,Newsfilter.io,"$21,017.01 of shares acquired by Clancy Paul J (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/fiQ6Y1iojH",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-04-03 05:56:21,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1246013662306893825,False,0,0,0,0,Newsfilter.io,"$17,794.89 of shares acquired by Dixon Wendy L (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/KrMeaB7th3",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-04-03 05:45:22,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1246010896448655366,False,0,0,0,0,Newsfilter.io,"$19,772.10 of shares acquired by Fouse Jacqualyn A (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/5lU9AvJfCV",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-04-03 05:33:22,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1246007876763648002,False,0,0,0,0,Newsfilter.io,"$16,046.81 of shares sold by Swain Paula J (EVP, Human Resources), reported in a new form 4 filed with the SEC  $INCY https://t.co/pgKtqgbPIX",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1025186618108530689,2020-04-03 05:24:41,,,"voiceofthehwy.news/rpt-novartis-i‚Ä¶, ",1246005691464192003,False,0,0,0,0,WordPress.com,"RPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/OCDt6GLL6E",,,2018-08-02 21:08:31,"Atlanta, GA",voiceofthehwy,https://pbs.twimg.com/profile_images/1120031010211676166/SMmR2HKm_normal.png,437,1062,0,406334,voiceofthehwy,
20715638,2020-04-03 05:15:05,,,"cnbc.com/2020/04/03/nov‚Ä¶, ",1246003274873860096,False,0,0,0,0,Twitter for iPhone,"CNBC - Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 from @CNBC  https://t.co/wVa9qS92b8","CNBC, ",,2009-02-12 15:42:54,"Southern California, U.S.",Phil De Carolis,https://pbs.twimg.com/profile_images/973632641940430853/bXujzpFo_normal.jpg,3467,35,1267,1537505,PhilDeCarolis,
1088379408,2020-04-03 05:05:44,,"jakpostlife, ","bit.ly/2V0wSem, ",1246000924050546695,False,0,0,0,0,Echobox,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 #jakpostlife https://t.co/SUEfF6a2qy",,,2013-01-14 03:22:55,Jakarta Capital Region,Jakpost Life,https://pbs.twimg.com/profile_images/716918449646120964/nWJ_Fb8C_normal.jpg,31153,678,108,46017,JakpostLife,
1134049078424162304,2020-04-03 04:48:21,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1245996548288380933,False,0,0,0,0,Newsfilter.io,"$14,792.46 of shares acquired by Harrigan Edmund (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/rBOAZhOWnE",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
575910168,2020-04-03 04:32:54,,"YahooFinance, Traffic, Transportation, Shipping, Logistics, Trucking, ","truckingnews.us/rpt-novartis-i‚Ä¶, ",1245992659144986624,False,0,0,0,0,Trucking News,"RPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/BkGILeHCsi
#YahooFinance #Traffic #Transportation #Shipping #Logistics
Follow @AFTvitaliy for #Trucking News","AFTvitaliy, ",,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
1205059957638471680,2020-04-03 04:04:05,,,"newsforforex.com/economy/rpt-no‚Ä¶, ",1245985409848561667,False,0,0,0,0,WordPress.com,"RPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/0tKGLLgXod",,,2019-12-12 04:41:17,,NEWS FOR FOREX,https://pbs.twimg.com/profile_images/1206837837108318209/qGxVcfsH_normal.jpg,230,5,2,24948,NEWSFORFOREX1,
1045994888909606912,2020-04-03 04:01:25,,,"india.timesofnews.com/entertainment/‚Ä¶, ",1245984739590275073,False,0,0,0,0,WordPress.com,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/JheRgGJKC0",,,2018-09-29 07:13:09,,Times of Newsüê¶,https://pbs.twimg.com/profile_images/1045997927997464576/D_pqVQLc_normal.jpg,380,115,1,386795,TimesofNewsHUB,
305271088,2020-04-03 03:54:24,,,"reut.rs/2UZRPpU, ",1245982970881740802,False,0,0,0,0,Twitter Web Client,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/cKjVj2CrhT",,,2011-05-25 18:55:22,Zurich,John Miller,https://pbs.twimg.com/profile_images/1333342092525965313/Ih30-Ad6_normal.jpg,670,64,28,2137,JPMillerSwitz,
1596829382,2020-04-03 03:54:03,,,"dlvr.it/RT59Cq, pic.twitter.com/kiUZDKwmEB, ",1245982884994748418,False,0,0,0,0,dlvr.it,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/Tf3VG4VBJQ https://t.co/kiUZDKwmEB",,,2013-07-15 17:45:17,http://www.zyite.com/,Zyite.news,https://pbs.twimg.com/profile_images/1254426764144553985/vbZXp86B_normal.jpg,3028,4807,154,1641732,ZyiteGadgets,photo
68577507,2020-04-03 03:47:49,,"jakpost, ","bit.ly/3dQFFbK, ",1245981315654090752,False,1,1,0,1,Echobox,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 #jakpost https://t.co/KJJqgkJeiT",,,2009-08-24 22:01:05,Jakarta,The Jakarta Post,https://pbs.twimg.com/profile_images/715730311800172544/T4OlLnFq_normal.jpg,952132,9,4077,263564,jakpost,
336075069,2020-04-03 03:47:33,,,"dlvr.it/RT58Hp, pic.twitter.com/V2N6rS1eZo, ",1245981247265890304,False,0,0,0,0,dlvr.it,"RPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/wCrb4iaDpU via @YahooFinance https://t.co/V2N6rS1eZo","YahooFinance, ",,2011-07-15 14:09:54,Arizona,The Frugal Toad,https://pbs.twimg.com/profile_images/1087220181942685697/EcIF7KMt_normal.jpg,20286,22109,546,32740,thefrugaltoad,photo
1239059242742460418,2020-04-03 03:32:40,,"stockmarket, stockmarketcrash, coronavirus, stocks, covid19, ","zpr.io/tk8XT, ",1245977504604708864,False,0,0,0,0,Zapier.com,"RPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 - https://t.co/cMJQvwuvO4 #stockmarket #stockmarketcrash #coronavirus #stocks #covid19",,,2020-03-15 01:22:04,,Mr. Bull,https://pbs.twimg.com/profile_images/1239059631952908289/seqcSG4E_normal.jpg,34,107,0,1442,TraderHype,
1193779847727894529,2020-04-03 03:27:32,,,"pic.twitter.com/Wy0XQBrlq0, ",1245976212482052097,False,0,0,0,0,dlvr.it,"RPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/Wy0XQBrlq0",,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,photo
1150509674828947456,2020-04-03 03:10:09,,,"ift.tt/3bOCnnu, pic.twitter.com/MA3HMitb3O, ",1245971835566637056,False,0,0,0,0,IFTTT,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/hYBVKSuAKY https://t.co/MA3HMitb3O",,,2019-07-14 16:57:36,Hong Kong,Sonia So and Associates,https://pbs.twimg.com/profile_images/1296897368126701568/D6q7FPfU_normal.jpg,30,170,0,159524,SoniaAssociates,photo
1150509674828947456,2020-04-03 03:07:05,,,"ift.tt/3bOCnnu, ",1245971062807986176,False,0,0,0,0,IFTTT,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/hYBVKSuAKY",,,2019-07-14 16:57:36,Hong Kong,Sonia So and Associates,https://pbs.twimg.com/profile_images/1296897368126701568/D6q7FPfU_normal.jpg,30,170,0,159524,SoniaAssociates,
270492072,2020-04-03 02:52:47,,"news, reuters, ","feeds.reuters.com/~r/reuters/com‚Ä¶, ",1245967464539684865,False,0,0,0,0,Microsoft Power Platform,"RPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/iCVJTZoxzW via Reuters #news #reuters",,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
270492072,2020-04-03 02:52:47,,"news, reuters, ","feeds.reuters.com/~r/reuters/com‚Ä¶, ",1245967464254431232,False,0,0,0,0,Microsoft Power Platform,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/oUNIGh5NRL via Reuters #news #reuters",,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
1134049078424162304,2020-04-03 02:46:20,"INCY, GCVRZ, REGN, MYL, TEVA, ","coronavirus, COVID2019, ","newsfilter.io/articles/rpt-n‚Ä¶, ",1245965842245922817,False,0,0,0,0,Newsfilter.io,"RPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 $INCY $GCVRZ $REGN $MYL $TEVA #coronavirus #COVID2019 https://t.co/HlIOltdRfd",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-04-03 02:42:20,"INCY, GCVRZ, REGN, MYL, TEVA, ","coronavirus, COVID2019, ","newsfilter.io/articles/novar‚Ä¶, ",1245964837022294028,False,0,0,0,0,Newsfilter.io,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 $INCY $GCVRZ $REGN $MYL $TEVA #coronavirus #COVID2019 https://t.co/jT1nAyw7Hn",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
937962626222497793,2020-04-03 02:36:49,,,"devdiscourse.com/article/health‚Ä¶, ",1245963446367256576,False,0,0,0,0,Devdiscourse News Desk,"Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 https://t.co/rzSzt1jlvv",,,2017-12-05 03:31:31,National Capital Region,Devdiscourse,https://pbs.twimg.com/profile_images/994485257327046656/8DSy51HP_normal.jpg,110918,605,78,718653,dev_discourse,
2344420430,2020-04-03 02:24:18,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1245960297627750400,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

JEAN JACQUES BIENAIME:

https://t.co/dF6Kb4psgT",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
221386433,2020-04-03 01:07:25,,,"businesswire.com/news/home/2020‚Ä¶, ",1245940951333232640,False,0,0,0,0,Twitter for iPhone,Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm | Business Wire https://t.co/wutZZDSWpp,,,2010-11-30 09:43:12,Êù±‰∫¨ÈÉΩÊ∏ØÂå∫Êñ∞Ê©ã2-16-1 „Éã„É•„ÉºÊñ∞Ê©ã„Éì„É´621,Â±ÖÊÆã„Çä‰ΩêÂπ≥Ê¨°üíâüç•,https://pbs.twimg.com/profile_images/1363292629752930305/40be4xcO_normal.jpg,1248,650,40,204824,inokori_3814,
175170076,2020-04-03 00:45:22,,,"businesswire.com/news/home/2020‚Ä¶, ",1245935401711407104,False,0,0,0,1,Twitter Web App,Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm | Business Wire https://t.co/kJ0P4kwP0y,,,2010-08-05 16:34:34,,Raul Odriosola,https://pbs.twimg.com/profile_images/1442302904937844747/NRnERP8N_normal.jpg,131,219,0,1821,raulodriosola,
16570067,2020-04-02 23:07:22,,,"fool.com/investing/2020‚Ä¶, ",1245910738218242050,True,0,0,0,0,Twitter for iPhone,Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19 https://t.co/XhxVYprl48,,,2008-10-02 20:48:40,UK,LeAnne Tancred,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1032,5001,60,30374,LeAnneTancred,
1003884025,2020-04-02 22:58:32,,,"dlvr.it/RT4c58, ",1245908514364469249,False,0,0,0,0,dlvr.it,Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19 - The Motley Fool https://t.co/GIJH0xuAoN,,,2012-12-11 06:49:56,Newcastle,Cancer Update,https://pbs.twimg.com/profile_images/3183456331/9220163133e67c0da9a0b3f1001bfdc8_normal.jpeg,1946,1440,40,38653,CancerUpdate2,
1006334607946649600,2020-04-02 21:39:06,,,"dlvr.it/RT4TJv, pic.twitter.com/kochdl6tNH, ",1245888525368614913,False,0,0,0,0,dlvr.it,Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19 https://t.co/3zGml3ho7d https://t.co/kochdl6tNH,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
963495628545327104,2020-04-02 20:45:06,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/CV5Rt4CvRC, ",1245874936692068361,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19 https://t.co/Z7npQqvkI6 Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/CV5Rt4CvRC,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
732361939490312192,2020-04-02 20:06:39,"INCY, ","markets, ","americanbankingnews.com/?p=14040236, ",1245865259262304257,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,329 Shares of Incyte Co. $INCY Stock https://t.co/Vj87SZyiF6 #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-02 20:06:38,"INCY, ","stocks, ","americanbankingnews.com/?p=14040236, ",1245865256737333254,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,329 Shares of Incyte Co. $INCY Stock https://t.co/x0M51E4W9M #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1907769716,2020-04-02 19:58:15,,"COVID, coronavirus, mpnsm, jakafi, clinicaltrial, pandemic, ","investor.incyte.com/node/21681/pdf, pic.twitter.com/llUlfaasF8, ",1245863144548757505,False,6,0,0,4,PromoRepublic,"Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with #COVID-19 Associated Cytokine Storm.
 - #coronavirus #mpnsm #jakafi #clinicaltrial #pandemic
https://t.co/J4LWG8pzl2 https://t.co/llUlfaasF8",,,2013-09-26 08:36:43,"Charlotte, NC",PV Reporter,https://pbs.twimg.com/profile_images/1429560791892697094/XgF4tlne_normal.jpg,791,610,19,634,PVReporter,photo
72928001,2020-04-02 19:07:51,"INCY, ",,"bit.ly/2UZrI2f, ",1245850460352696320,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte to initiate a Phase 3 trial of ruxolitinib in patients with COVID-19 associated cytokine storm https://t.co/VrIYvdUtkW,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
2344420430,2020-04-02 18:35:17,"INCY, ",,"insideri.com/879169_0001209‚Ä¶, ",1245842267841036289,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

Director

PAUL A BROOKE:

https://t.co/8W57ZayKcY",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
3686628867,2020-04-02 18:15:52,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1245837379312570368,False,0,0,0,0,WordPress.com,Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/GmBPVdI9iY,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
19240173,2020-04-02 18:13:23,,,"businesswire.com/news/home/2020‚Ä¶, ",1245836755946934273,False,1,0,2,0,Twitter Web Client,"JAK1/JAK2 inhibitor - If this works, would it make sense to combine a drug to target the virus itself and the cytokine storm?

Initiation of Ph3 Clinical Trial of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://t.co/0Hi73tAbKf",,,2009-01-20 10:11:02,,Stephanie is vaxxed and masked,https://pbs.twimg.com/profile_images/1436155382230093826/pZOA9C7e_normal.jpg,2775,1837,136,149436,stephaniekays,
35789155,2020-04-02 17:58:14,,,"firstwordpharma.com/node/1712930?t‚Ä¶, ",1245832940472410113,False,2,0,0,0,Twitter Web App,"Incyte, Novartis to evaluate JAK inhibitor for severe COVID-19 patients https://t.co/7QoNiKYURW",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
47678782,2020-04-02 17:49:57,,"COVID19, ","businesswire.com/news/home/2020‚Ä¶, ",1245830858105331712,False,28,4,6,7,Twitter for iPhone,"Incyte, Novartis to test Jakafi for the severe immune reaction that can happen in #COVID19 known as cytokine storm; notes several ongoing independent studies and anecdotal results, plans to set up expanded access program https://t.co/tCOuz7BPDX",,,2009-06-16 13:11:26,New York,Meg Tirrell,https://pbs.twimg.com/profile_images/791618485621325824/wBeu2-6V_normal.jpg,95832,3624,2347,21036,megtirrell,
993581474,2020-04-02 17:38:29,"INCY, NVS, ",,"businesswire.com/news/home/2020‚Ä¶, ",1245827972319371264,False,2,0,0,0,Twitter Web App,"$INCY and $NVS starting studies of Jakafi treatment for immune reactions related to COVID-19 in the US and Europe, respectively.

https://t.co/7aBfezvS4k

Separate open-label program in the US will allow pts. to receive drug while it's being studied.",,,2012-12-06 13:23:28,"Washington, DC",Ned Pagliarulo,https://pbs.twimg.com/profile_images/953310204300595201/ymnS3Vyx_normal.jpg,3588,629,123,5338,NedPagliarulo,
772471873539977217,2020-04-02 17:37:15,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1245827660841807872,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/R5Wp9FSEZ2,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
415183987,2020-04-02 17:18:03,,,"twitter.com/Incyte/status/‚Ä¶, ",1245822831444680704,False,0,0,0,0,Twitter Web App,And you *sine Brute*! https://t.co/Cr1nltkIIp,,,2011-11-17 19:50:25,,Miljenko Zuanic,https://pbs.twimg.com/profile_images/894617295154102272/apAcVS12_normal.jpg,351,318,17,6699,Miljenkoz,
950942636818432006,2020-04-02 17:17:03,"INCY, ","COVID19, CytokineStorm, ","businesswire.com/news/home/2020‚Ä¶, ",1245822576871362561,False,12,1,1,8,TweetDeck,"#COVID19 $INCY Incyte announced plans to initiate a Phase 3 clinical trial of ruxolitinib (Jakafi) as a treatment for patients with COVID-19 associated #CytokineStorm. 

https://t.co/YfmKG53yZK",,,2018-01-09 23:09:27,"San Francisco, CA",SY Investing,https://pbs.twimg.com/profile_images/1108963782334672900/Bh_0t4CE_normal.png,5814,300,160,3879,syinvesting,
772471873539977217,2020-04-02 17:12:55,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1245821538286342144,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/aZ7GHjsoCr,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
3318510966,2020-04-02 17:08:49,,,"crweworld.com/article/news-p‚Ä¶, ",1245820504331579392,False,0,0,0,0,CRWE World,Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib (Jakafi¬Æ) as a Treatment for Patients wi https://t.co/G6iCs22isi,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1134049078424162304,2020-04-02 17:07:16,"INCY, ","coronavirus, COVID2019, ","newsfilter.io/articles/incyt‚Ä¶, ",1245820115834322946,False,0,0,0,0,Newsfilter.io,Incyte Announces Plans to Initiate a Phase 3 Clinical Trial of Ruxolitinib as a Treatment for Patients with COVID-19 Associated Cytokin.. $INCY #coronavirus #COVID2019 https://t.co/tOqBGUs6YL,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
60224553,2020-04-02 08:36:03,,,"dlvr.it/RT2PJJ, pic.twitter.com/45iP78pnf6, ",1245691465000316937,False,0,0,0,0,dlvr.it,Hedge Funds Started Buying Incyte Corporation (INCY) Too Early - Yahoo Finance https://t.co/keoWG64Rvg https://t.co/45iP78pnf6,,,2009-07-25 23:46:54,"NYC, NY, USA",Peter Went,https://pbs.twimg.com/profile_images/1216976432825540608/1d7laUNR_normal.jpg,9226,81,306,124562,HedgeFundRisk,photo
374729426,2020-04-02 07:47:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1436543, pic.twitter.com/iQZeu5w705, ",1245679288268935168,False,0,0,1,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on March 30, 2020. View odds for this and other indicators: https://t.co/rmjHjIrpXQ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/iQZeu5w705",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-04-02 04:49:04,"INCY, ",,"newsfilter.io/articles/sunbe‚Ä¶, ",1245634340635066372,False,0,0,0,0,Newsfilter.io,"Sunbelt Securities Acquires Shares of 1,110 Incyte $INCY https://t.co/2mcy9gwsnj",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2344420430,2020-04-02 04:32:17,"INCY, ",,"insideri.com/879169_0001638‚Ä¶, ",1245630116782198784,False,0,0,0,0,Insider Alerts,"$INCY:

New Insider Filing on INCYTE CORP's

10%+ Owner

BAKER BROS. ADVISORS LP:

https://t.co/reiVtub2iX",,,2014-02-14 21:29:07,United States,Insider Alerts,https://pbs.twimg.com/profile_images/548481313670299648/XBAwS1Wn_normal.jpeg,5721,0,171,218534,InsiderAlerts4U,
1134049078424162304,2020-04-02 00:28:03,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1245568653589991429,False,0,0,0,0,Newsfilter.io,"$57,412.32 of shares acquired by Baker Bros. Advisors Lp (Director), reported in a new form 4 filed with the SEC  $INCY https://t.co/nXSIWdtkqZ",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
772471873539977217,2020-04-01 19:57:21,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1245500529620307969,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/arbLR12zmx,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
772471873539977217,2020-04-01 19:42:17,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1245496739311779844,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/arbLR0KYuZ,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
374729426,2020-04-01 10:27:15,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1432663, pic.twitter.com/IW3t9Z74AT, ",1245357060268556289,False,0,0,0,0,Tickeron,"$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on March 30, 2020. View odds for this and other indicators: https://t.co/zNSObfsbzH #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/IW3t9Z74AT",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-04-01 08:33:55,"INCY, ","markets, ","americanbankingnews.com/?p=14021564, ",1245328538322042880,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Upgraded by Morgan Stanley https://t.co/oyfJYHpPUa #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-04-01 08:33:54,"INCY, ","stocks, ","americanbankingnews.com/?p=14021564, ",1245328535646081025,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Upgraded by Morgan Stanley https://t.co/qicmYgOOIa #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2384219072,2020-04-01 08:00:59,,"innovation, debio, NetDe, DeBioGala, ","pic.twitter.com/8pMTO2wNsw, ",1245320249471389696,False,0,0,0,0,Loomly,"Thank you to @Incyte for their #innovation sponsorship for the #debio 2020 Gala! Inycte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs.
#NetDe #DeBioGala https://t.co/8pMTO2wNsw","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
1240543618907000832,2020-04-01 07:46:57,,"dermatology, ",,1245316718580252672,False,0,0,0,0,Twitter Web App,"Eli Lilly and Company and Incyte announced that baricitinib met its primary endpoint in the BREEZE-AD4 and BREEZE-AD5 studies in patients with moderate to severe atopic dermatitis, according to two press releases. Keep touch at: dermatitis@peerjournal.org 
#dermatology",,,2020-03-19 03:40:54,,Frontier Dermatitis,https://pbs.twimg.com/profile_images/1240544064996397057/pRFK607F_normal.jpg,62,189,0,633,FDermatitis,
2266388972,2020-04-01 07:36:26,"INCY, ","stocks, ","dailypolitical.com/?p=3648262, ",1245314072188518400,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded at Morgan Stanley https://t.co/MpLf10oFmX #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-04-01 07:36:25,"INCY, ",,"dailypolitical.com/?p=3648262, ",1245314069571219456,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded at Morgan Stanley https://t.co/f2PqqhZ3lV,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
849417718642159616,2020-04-01 07:31:18,"INCY, ",,"zpr.io/tkzEF, ",1245312782519742466,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded at Morgan Stanley https://t.co/37WewM1OY5,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
374729426,2020-03-31 08:24:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1428523, pic.twitter.com/guHcheNmzv, ",1244963785586008065,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on March 30, 2020. View odds for this and other indicators: https://t.co/kJMriUE0Vr #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/guHcheNmzv",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
61661638,2020-03-31 07:42:32,"INCY, ","stocks, ","americanbankingnews.com/?p=14007478, ",1244953222298636288,False,0,0,0,0,Zapier.com,Analysts Expect Incyte Co. $INCY Will Post Quarterly Sales of $557.04 Million https://t.co/YVAOG2mFS7 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2338882843,2020-03-31 07:42:04,"INCY, ",,"dailypolitical.com/?p=3643426, ",1244953103234990083,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $537.16 Million https://t.co/UqM6fdxyse,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
374729426,2020-03-30 07:29:17,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1424500, pic.twitter.com/r1aMZYnGoJ, ",1244587496589029377,False,0,0,0,1,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators: https://t.co/braSWXCVuQ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/r1aMZYnGoJ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2298709746,2020-03-30 05:20:54,"INCY, ",,"zpr.io/t2iVB, ",1244555187760611328,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Consensus Rating of ‚ÄúBuy‚Äù from Brokerages https://t.co/SriMQMuX3F,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
930803511918411776,2020-03-30 04:48:17,"INCY, ",,"thelincolnianonline.com/?p=3700750, ",1244546980933767169,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Average Recommendation of ‚ÄúBuy‚Äù from Analysts https://t.co/uICpTrfNyD,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
61661638,2020-03-30 04:46:08,"INCY, ","stocks, ","americanbankingnews.com/?p=13993849, ",1244546439872724993,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Average Recommendation of ‚ÄúBuy‚Äù from Analysts https://t.co/yjcI1T9nxk #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1664222006,2020-03-29 20:45:52,,"Incyte, IngenuityAwardProgram, GVHD, ","bit.ly/33Ve2JP, pic.twitter.com/NaUAzIxOGp, ",1244425576196108288,False,0,0,0,0,Twitter Web App,"Incyte Ingenuity Award for Graft versus Host Disease
Read more: https://t.co/WQKSfIAe1C
#Incyte #IngenuityAwardProgram #GVHD https://t.co/NaUAzIxOGp",,,2013-08-12 01:20:15,"Brisbane, Queensland",Health Radio Online,https://pbs.twimg.com/profile_images/378800000381754409/ae483ad62930125687b2c1032aa530b9_normal.png,1288,2397,46,6105,HealthProRadio,photo
1118631141102235649,2020-03-29 10:29:44,"INCY, ","Director, SD, BoardExAlerts, NASDAQ100, SP500, ",,1244270520775950343,False,0,0,0,1,Sprinklr,"On March 26, 2020, Doctor Katherine Ann High has started a role as #Director - #SD at @Incyte. #BoardExAlerts #NASDAQ100 #SP500 $INCY","Incyte, ",,2019-04-17 17:43:41,,BoardEx,https://pbs.twimg.com/profile_images/1410339910360383498/CJczif_7_normal.jpg,281,175,5,2351,BoardEx,
2338882843,2020-03-29 08:08:49,"INCY, ",,"dailypolitical.com/?p=3634013, ",1244235059403673600,False,0,0,0,0,Zapier.com,Incyte $INCY Given New Price Target at Oppenheimer https://t.co/yCpmCd4jqa,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
68559732,2020-03-29 08:06:17,"INCY, ",,"zpr.io/t2S3E, ",1244234421965934592,False,0,0,0,0,Zapier.com,Incyte $INCY Given New Price Target at Oppenheimer https://t.co/2ngoc54t2b,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
374729426,2020-03-29 07:29:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1419149, pic.twitter.com/wjCKvuDdlF, ",1244225190101307395,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators: https://t.co/7rQDe8KlhV #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wjCKvuDdlF",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2416188264,2020-03-29 02:23:02,"INCY, ","markets, ","thestockobserver.com/?p=2785959, ",1244148039973048320,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Earn Q1 2020 Earnings of $0.29 Per Share  https://t.co/L3KgltavJC #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1134049078424162304,2020-03-29 02:21:40,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1244147694987329537,False,0,0,0,0,Newsfilter.io,Incyte Expected to Earn Q1 2020 Earnings of $0.29 Per Share $INCY https://t.co/7YIfbjCMh8,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
61661638,2020-03-29 01:46:45,"INCY, ","stocks, ","americanbankingnews.com/?p=13982345, ",1244138908771856384,False,0,0,0,0,Zapier.com,Analysts Expect Incyte Co. $INCY Will Announce Earnings of $0.12 Per Share https://t.co/Tc7iXwv4y9 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
930803511918411776,2020-03-29 01:43:14,"INCY, ",,"thelincolnianonline.com/?p=3692656, ",1244138024436408320,False,0,0,0,0,Zapier.com,Analysts Expect Incyte Co. $INCY Will Announce Earnings of $0.12 Per Share https://t.co/nOZ8l3Rx4v,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1134049078424162304,2020-03-28 11:45:35,"INCY, ",,"newsfilter.io/articles/capit‚Ä¶, ",1243927222563606529,False,0,0,0,0,Newsfilter.io,Capital World Investors Has $62.70 Million Stock Position in Incyte $INCY https://t.co/Q91qrka5ke,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-03-28 10:31:35,"INCY, ",,"newsfilter.io/articles/capit‚Ä¶, ",1243908601082793985,False,0,0,0,0,Newsfilter.io,Capital Bank &amp; Trust Co Decreases Holdings in Incyte $INCY https://t.co/ldF65oA1Vx,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
374729426,2020-03-28 08:17:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1416504, pic.twitter.com/EfOtgcsoHT, ",1243874899384393730,False,0,0,0,1,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators: https://t.co/DKNpyv0OVC #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/EfOtgcsoHT",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-03-28 04:37:45,"INCY, ",,"zpr.io/t29gv, ",1243819555392192514,False,0,0,0,0,Zapier.com,Oppenheimer Trims Incyte $INCY Target Price to https://t.co/HtvQBhWfFt,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2298709746,2020-03-28 04:35:12,"INCY, ",,"zpr.io/t296i, ",1243818913961558018,False,0,0,0,0,Zapier.com,Oppenheimer Trims Incyte $INCY Target Price to https://t.co/LET0P2fOYj,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
966006214818697218,2020-03-28 04:34:53,"INCY, ",,"theenterpriseleader.com/?p=2870701, ",1243818833963515904,False,0,0,0,0,Zapier.com,Oppenheimer Trims Incyte $INCY Target Price to  https://t.co/PMfVyIfl2m,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2020-03-28 01:33:38,"INCY, ",,"thelincolnianonline.com/?p=3686842, ",1243773218852417536,False,0,0,0,0,Zapier.com,Oppenheimer Research Analysts Decrease Earnings Estimates for Incyte Co. $INCY https://t.co/1r1ekr8dyS,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-03-28 01:33:02,"INCY, ",,"tickerreport.com/?p=5287358, ",1243773067895193600,False,0,0,0,0,Zapier.com,Oppenheimer Research Analysts Decrease Earnings Estimates for Incyte Co. $INCY https://t.co/3zUvzjoAZy,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
374729426,2020-03-27 09:30:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1411136, pic.twitter.com/hYykQZOXfo, ",1243530797883129858,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on March 26, 2020. View odds for this and other indicators: https://t.co/nTHEob9WTr #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/hYykQZOXfo",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2266388972,2020-03-27 07:29:26,"INCY, ","stocks, ","dailypolitical.com/?p=3622364, ",1243500372091699200,False,0,0,0,0,Zapier.com,Q1 2020 EPS Estimates for Incyte Co. Cut by Oppenheimer $INCY https://t.co/Er33P6x6cB #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-03-27 07:29:25,"INCY, ",,"dailypolitical.com/?p=3622364, ",1243500369549889539,False,0,0,0,0,Zapier.com,Q1 2020 EPS Estimates for Incyte Co. Cut by Oppenheimer $INCY https://t.co/XjNnMO1ysN,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
966006214818697218,2020-03-27 07:29:24,"INCY, ",,"theenterpriseleader.com/?p=2865868, ",1243500365598863360,False,0,0,0,0,Zapier.com,Q1 2020 EPS Estimates for Incyte Co. Cut by Oppenheimer $INCY  https://t.co/sfI1ESLiMe,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
849417718642159616,2020-03-27 07:27:37,"INCY, ",,"zpr.io/t2EsX, ",1243499914946101255,False,0,0,0,0,Zapier.com,Q1 2020 EPS Estimates for Incyte Co. Cut by Oppenheimer $INCY https://t.co/89BzNGg1UW,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
732361939490312192,2020-03-27 07:25:30,"INCY, ","markets, ","americanbankingnews.com/?p=13960672, ",1243499380403044352,False,0,0,0,0,Zapier.com,Q1 2020 EPS Estimates for Incyte Co. Cut by Oppenheimer $INCY https://t.co/ZwsmJ4S9Oq #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-03-27 07:25:29,"INCY, ","stocks, ","americanbankingnews.com/?p=13960672, ",1243499378431721473,False,0,0,0,0,Zapier.com,Q1 2020 EPS Estimates for Incyte Co. Cut by Oppenheimer $INCY https://t.co/77PuLCwz0p #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1119384794,2020-03-27 06:36:00,"INCY, ","BoardOfDirectors, biopharma, WomenOnBoard, ","talent4boards.com/incyte-adds-dr‚Ä¶, ",1243486924246904834,False,0,0,0,0,TweetDeck,Incyte adds Dr Kathy High to #BoardOfDirectors @Incyte $INCY #biopharma #WomenOnBoard https://t.co/yG9bBHkXFd,"Incyte, ",,2013-01-25 08:58:15,Worldwide,Talent4Boards,https://pbs.twimg.com/profile_images/1430914546785525763/MjhIJKjv_normal.jpg,3389,4961,167,20042,talent4boards,
2525892205,2020-03-27 06:32:37,"INCY, ","investingnews, ","modernreaders.com/?p=3024269, ",1243486072300077057,False,0,0,0,0,Zapier.com,Incyte $INCY Trading 3.7% Higher  https://t.co/Uu8KSefOaK #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2298709746,2020-03-27 06:31:50,"INCY, ",,"zpr.io/t2xK8, ",1243485875562053632,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Price Up 3.7% https://t.co/geV5kNhvZc,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
930803511918411776,2020-03-27 06:31:04,"INCY, ",,"thelincolnianonline.com/?p=3685513, ",1243485682548563968,False,0,0,0,0,Zapier.com,Incyte $INCY Trading 3.7% Higher https://t.co/syIl02dNhR,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-03-27 06:30:09,"INCY, ",,"tickerreport.com/?p=5286029, ",1243485453132718086,False,0,0,0,0,Zapier.com,Incyte $INCY Trading 3.7% Higher https://t.co/j9lzlMFb71,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1134049078424162304,2020-03-26 23:16:03,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1243376207137210368,False,0,0,0,0,Newsfilter.io,Incyte Names New Member to Its Board of Directors $INCY https://t.co/feszBpnYCs,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
4312114277,2020-03-26 16:09:54,"INCY, ",,"fintel.io/s/us/incy?utm_‚Ä¶, ",1243268962311450627,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers https://t.co/hv89PLGlBC,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,163,418542,fintel_io,
1171873456276889600,2020-03-26 16:09:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1243268948919037952,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (26 Mar, 4:08pm)

üì∞ Departure of Directors or Certain Officers; Election of Directors

https://t.co/R9doBh2rfH

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
1286635807,2020-03-26 15:54:24,"INCY, ","corpgov, ","bwnews.pr/2UmU7QI, ",1243265063437426688,False,0,0,0,0,Twitter Web App,"Incyte adds Katherine A. High (Co-Founder/Fmr President, Spark Therapeutics) to Board $INCY #corpgov https://t.co/QLkIA7F7Um",,,2013-03-21 14:20:50,Chicago,JamesDruryPartners,https://pbs.twimg.com/profile_images/948933059935657984/4zARxdMk_normal.jpg,200,34,10,11520,JDruryPartners,
1128239740329705472,2020-03-26 13:15:43,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1243225131314335747,False,1,0,0,0,Twitter for Android,"""This is an exciting time to be joining Incyte ‚Äì with the potential for three new product approvals this year, the Company‚Äôs discovery, development and strategic focus continue to drive the delivery of innovative solutions for patients in need.""

$INCY 
https://t.co/IZHI2W0Ruc",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
280747092,2020-03-26 10:36:12,,,"oaoa.com/news/business/‚Ä¶, ",1243184984413868032,False,0,0,0,0,GetCurata,Incyte Names New Member to Its Board of Directors https://t.co/CI6gEfzPaZ,,,2011-04-11 19:23:47,Boston,BoardProspects,https://pbs.twimg.com/profile_images/508236277636816896/vI0RH0Lw_normal.png,2728,2031,78,20335,BoardProspects,
15550043,2020-03-26 10:31:30,,"Peoplenews, ","businesswire.com/news/home/2020‚Ä¶, ",1243183804388446210,False,0,0,0,0,Twitter Web Client,Incyte Names New Member to Its Board of Directors | Business Wire https://t.co/sjkv6vynVm  #Peoplenews,,,2008-07-22 20:56:36,"New York, USA",Diancie Network,https://pbs.twimg.com/profile_images/1348916695516082177/UeXKUagp_normal.jpg,2355,1290,436,71444,DiancieNetwork,
1100450877792370688,2020-03-26 09:47:27,"INCY, ",,"blueequity.io/r/95730/de-inc‚Ä¶, ",1243172716099694592,False,0,0,0,0,Blue Equity,$INCY Incyte Names New Member to Its Board of Directors https://t.co/LpPWtSzfki,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
348402639,2020-03-26 08:41:02,,,"bioportfol.io/RSbZXr, ",1243156004642013185,False,0,0,0,0,dlvr.it,BriaCell Continues Clinical Operations Amidst COVID19 Pandemic: BriaCell Therapeutics announces that the Phase IIIa clinical study of BriaIMT with Incyte Corporations immune checkpoint inhibitor is ongoing.The post BriaCell Continues Clinical Operations‚Ä¶ https://t.co/pr1z00g75A,,,2011-08-04 07:10:58,"St. Louis, MO, USA",CRO Contract Res.,https://pbs.twimg.com/profile_images/2304899544/r3wt3ky7jgvrd2lqt73x_normal.jpeg,1030,64,85,122993,cro_bio,
472650465,2020-03-26 08:20:31,"INCY, ",,"otcdynamics.com/incy-incyte-na‚Ä¶, ",1243150839625199617,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Names New Member to Its Board of Directors https://t.co/p5NPKpUc8O,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
976297820532518914,2020-03-26 08:08:37,,,"dlvr.it/RSbSj1, pic.twitter.com/JzRwPl7GCh, ",1243147846829793281,False,0,0,0,0,dlvr.it,Incyte Names New Member to Its Board of Directors https://t.co/GoK8Dk0uvq https://t.co/JzRwPl7GCh,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2020-03-26 08:03:06,,,"crweworld.com/article/news-p‚Ä¶, ",1243146456187326464,False,0,0,0,0,CRWE World,Incyte Names New Member to Its Board of Directors https://t.co/ZY5AKrxbS0,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
374729426,2020-03-26 07:54:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1408422, pic.twitter.com/KKnttIwPkt, ",1243144367310663680,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on March 25, 2020. View odds for this and other indicators: https://t.co/6csRIXgjVw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/KKnttIwPkt",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
135209476,2020-03-26 06:02:56,"INCY, ",,"stockflare.com/stock/INCY.O, ",1243116215670910976,False,0,0,0,0,Stockflare Bot (Prod),$INCY: The forecast EPS for Incyte Corporation has decreased to $2.91 from $3.18 in the last week. (https://t.co/sK8NyKCUuN),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
1134049078424162304,2020-03-26 02:00:55,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1243055308542480385,False,0,0,0,0,Newsfilter.io,Incyte Shares Purchased by Stifel Financial Corp $INCY https://t.co/1ZhlTH1Db4,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-03-26 00:48:54,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1243037188243283969,False,0,0,0,0,Newsfilter.io,Incyte Price Target Lowered to at Oppenheimer $INCY https://t.co/lgVO786HjU,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2416188264,2020-03-25 18:45:03,"INCY, ","markets, ","thestockobserver.com/?p=2774557, ",1242945622187147265,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to at Oppenheimer  https://t.co/lANDg8CdYm #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
732361939490312192,2020-03-25 16:46:01,"INCY, ","markets, ","americanbankingnews.com/?p=13938453, ",1242915665461350404,False,0,0,0,0,Zapier.com,Oppenheimer Lowers Incyte $INCY Price Target to https://t.co/PyKFbz319f #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-03-25 16:46:01,"INCY, ","stocks, ","americanbankingnews.com/?p=13938453, ",1242915663141842945,False,0,0,0,0,Zapier.com,Oppenheimer Lowers Incyte $INCY Price Target to https://t.co/Yl8SjGM4GH #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-03-25 07:43:19,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1402974, pic.twitter.com/lntOGSCJay, ",1242779091847147520,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on March 5, 2020. View odds for this and other indicators: https://t.co/RSK0Pf3vTq #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/lntOGSCJay",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-03-25 05:37:14,"INCY, ","investingnews, ","modernreaders.com/?p=3010429, ",1242747358464675846,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Position Increased by Axa  https://t.co/SBoqzzTtxQ #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
950010035396136962,2020-03-24 18:08:34,,"Incyte, ",,1242574051182329856,False,0,0,0,0,Cresus AI,"#Incyte closed at 67.43. Score +306, credit rating ABBA+ üëé",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
732361939490312192,2020-03-24 12:35:40,"INCY, ","markets, ","americanbankingnews.com/?p=13923321, ",1242490272908533760,False,0,0,0,0,Zapier.com,Incyte $INCY Coverage Initiated by Analysts at William Blair https://t.co/wLnPLWVGSb #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-03-24 12:35:38,"INCY, ","stocks, ","americanbankingnews.com/?p=13923321, ",1242490265669111811,False,0,0,0,0,Zapier.com,Incyte $INCY Coverage Initiated by Analysts at William Blair https://t.co/7byTwBTgEE #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
3426014292,2020-03-24 09:33:10,"FGEN, MOR, ",,"twitter.com/syinvesting/st‚Ä¶, ",1242444346240258048,False,22,1,0,4,Twitter for iPhone,"$FGEN $MOR are in strongest cash positions. FGEN‚Äôs cash position should continue to benefit from milestone payments related to anticipated approval for roxadustat, in CKD anemia, later this year. MorphoSys recently secured $1bn cash through the Incyte collaboration deal https://t.co/xiYaLeF4MT",,,2015-09-02 09:10:37,,dough,https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_normal.jpg,32805,529,852,59439,semodough,
1100450877792370688,2020-03-24 09:19:15,"INCY, ",,"blueequity.io/r/95254/de-inc‚Ä¶, ",1242440844616945666,False,0,0,0,0,Blue Equity,$INCY Data from Phase 3 TRuE-AD Trials of Ruxolitinib Cream in Atopic Dermatitis to be Presented at the 2020 Revolutionizing Atopic Dermatitis Virtual Conference https://t.co/XNQ07Y7OVz,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
2298709746,2020-03-24 09:17:54,"INCY, ",,"zpr.io/tredL, ",1242440506229096448,False,0,0,0,0,Zapier.com,Incyte $INCY Research Coverage Started at William Blair https://t.co/VuyH9NtwJV,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
963495628545327104,2020-03-24 07:57:17,"CGEN, INCY, NXTC, CGEN, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1242420218644828160,False,0,0,0,0,STCK.PR0,$CGEN $INCY $NXTC NEW ARTICLE : Blair likes Incyte in premarket analyst action https://t.co/9vv6pwSGZV Get all the latest $CGEN related news here : https://t.co/r7iRKQqxm4,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
1134049078424162304,2020-03-24 07:56:16,"CGEN, INCY, NXTC, PASG, VRCA, ",,"newsfilter.io/articles/blair‚Ä¶, ",1242419962318389249,False,0,0,0,0,Newsfilter.io,Blair likes Incyte in premarket analyst action $CGEN $INCY $NXTC $PASG $VRCA https://t.co/HXRnaxzDPa,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
15296897,2020-03-24 07:54:02,"CGEN, INCY, NXTC, ",,"seekingalpha.com/news/3554598-b‚Ä¶, ",1242419401019678720,False,0,0,0,0,SANewsTwitter,$CGEN $INCY $NXTC - Blair likes Incyte in premarket analyst action https://t.co/QnVxmnKI9Y,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
374729426,2020-03-24 07:47:00,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1400352, pic.twitter.com/5MZQPZCksQ, ",1242417627818938370,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/WkK31crTcM #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5MZQPZCksQ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1199800417821048834,2020-03-24 07:37:33,,"Company_News_, ","dlvr.it/RSST4F, bit.ly/2StKgrZ, pic.twitter.com/lway0AejYQ, ",1242415252362297346,False,0,0,0,0,dlvr.it,Incyte : Data from Phase 3 TRuE-AD Trials of Ruxolitinib Cream in Atopic Dermatitis to be Presented at the 2020 Revolutionizing Atopic Dermatitis Virtual Conference https://t.co/Kd1xcufTaw #Company_News_ https://t.co/U3dJgzsdcR https://t.co/lway0AejYQ,,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,photo
163565297,2020-03-24 06:00:27,,"CSCDE, Incyte, ","cancersupportdelaware.org, pic.twitter.com/Pp2zfk9Ove, ",1242390816871649282,False,1,0,0,1,Hootsuite Inc.,"#CSCDE &amp; our community partner, #Incyte, find it critical &amp; necessary to continue to provide support for our Delaware cancer patients. This fund helps cover costs such as rent, mortgage, co-pays, &amp; utilities. Fore more info or how to apply visit https://t.co/9KPxER8VsF https://t.co/Pp2zfk9Ove",,,2010-07-06 14:57:24,"Delaware, USA",Cancer Support DE,https://pbs.twimg.com/profile_images/667430529340473346/FSfER-Bd_normal.jpg,543,542,30,3173,CancerSupportDE,photo
2181281054,2020-03-23 19:51:29,"INCY, ","markets, ","wkrb13.com/?p=1677078, ",1242237564431536129,False,0,0,0,0,Zapier.com,Incyte $INCY Reaches New 1-Year Low at $63.29 https://t.co/rmjnwf9oH3 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
3911174913,2020-03-23 13:29:27,,"GVHD, ",,1242141420028334089,False,45,2,1,3,Twitter for Advertisers.,We understand the challenges of graft-versus-host disease (#GVHD). The Incyte Ingenuity Award aims to recognize innovators who are addressing the unmet needs of this patient community.,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
374729426,2020-03-23 10:46:52,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1395453, pic.twitter.com/ZJpieL84A9, ",1242100506308177920,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/W8ZxKe20df #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZJpieL84A9",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
24779833,2020-03-23 10:25:33,,,"twitter.com/Incyte/status/‚Ä¶, ",1242095143190245376,False,2,0,0,0,Twitter for iPhone,‚ÄúHead of Inflammation‚Äù possibly the best job title ever. https://t.co/NKCWucvrvW,,,2009-03-16 18:03:14,"New Jersey, sometimes Brooklyn",Claude Brodesser-Akner,https://pbs.twimg.com/profile_images/1380702067287855105/eEqDomSA_normal.jpg,3036,2493,145,12520,ClaudeBrodesser,
3068641671,2020-03-23 05:19:07,"INCY, ","Incyte, equity, stocks, ","dlvr.it/RSNjcg, pic.twitter.com/omz1cinsiP, ",1242018023763922945,False,0,0,0,0,dlvr.it,"$INCY #Incyte Corp. INCY - Embedded Expectations Analysis - 2020 03 23: ÔÄ≠ Incyte Corporation (INCY:USA) currently trades below recent averages relative to UAFRS-based (Uniform) Earnings, with a 12.7x Uniform P/E, implying bearish‚Ä¶ https://t.co/vkSUmCD7mg #equity #stocks https://t.co/omz1cinsiP",,,2015-03-03 17:15:05,"Paris, France",ResearchPool,https://pbs.twimg.com/profile_images/932829644558016512/Godn_LkX_normal.jpg,8971,4234,0,405156,ResearchPool,photo
119291288,2020-03-22 10:22:11,,"stocks, invest, ",,1241731908397961219,False,2,0,0,1,Twitter for iPhone,"15 safe co. #stocks on S&amp;P500 to #invest 
Abiomed
Intuitive Surgical
Monster Beverage 
Nvidia
Intuit 
Vertex Pharmaceuticals
Ansys
Copart
Incyte
Fastenal
Jack Henry &amp; Associates
Skyworks Solutions 
Edwards Lifesciences
IPG Photonics
Texas Instruments",,,2010-03-03 01:10:44,"Bengaluru, India",LoLBoY,https://pbs.twimg.com/profile_images/1399640181683101697/pTiHnNRA_normal.jpg,120,639,0,3572,LolBoyHere,
374729426,2020-03-22 08:52:47,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1392615, pic.twitter.com/7sel3fXpi0, ",1241709409350242305,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/2fKHY9QH5O #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/7sel3fXpi0",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-03-22 08:10:30,"INCY, ","investingnews, ","modernreaders.com/?p=2994645, ",1241698767268610050,False,0,0,0,0,Zapier.com,Envestnet Asset Management Inc. Has $1.33 Million Holdings in Incyte Co. $INCY  https://t.co/VgXwBdpWGm #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2525892205,2020-03-22 07:18:42,"INCY, ","investingnews, ","modernreaders.com/?p=2994337, ",1241685732915322881,False,0,0,0,0,Zapier.com,Asset Management One Co. Ltd. Sells 727 Shares of Incyte Co. $INCY  https://t.co/SES7DsnZco #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2525892205,2020-03-22 04:22:35,"INCY, ","investingnews, ","modernreaders.com/?p=2990561, ",1241641410740305920,False,0,0,0,0,Zapier.com,Advisory Alpha LLC Increases Holdings in Incyte Co. $INCY  https://t.co/2sV01BCqUp #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1134049078424162304,2020-03-21 14:19:24,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1241429217520353282,False,0,0,0,0,Newsfilter.io,Incyte Upgraded at BidaskClub $INCY https://t.co/jL9PMWhgq9,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
374729426,2020-03-21 07:27:27,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1387000, pic.twitter.com/kIZuzOLEQD, ",1241325545427578881,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/MMfXu9rHzi #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kIZuzOLEQD",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3096702665,2020-03-21 04:50:29,,"NASDAQ, Ma, ","jenke.rs/n6R2Ed, pic.twitter.com/3UwYLTZZGZ, ",1241286042222841856,False,0,0,0,0,Jenkers Eng Posting,Incyte Co. (#NASDAQ:INCY) Shares Sold by Amundi Pioneer Asset #Ma'nagement Inc. https://t.co/QuFu6G1rgX https://t.co/3UwYLTZZGZ,,,2015-03-19 08:47:40,San Francisco,Jenkers News (ENG),https://pbs.twimg.com/profile_images/588324718677254145/-y5BbeY4_normal.png,1316,234,1265,990172,jenkers_en,photo
1134049078424162304,2020-03-21 02:15:23,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1241247013083234305,False,0,0,0,0,Newsfilter.io,Incyte Shares Purchased by Jacobs Levy Equity Management $INCY https://t.co/CnTyr5xHWw,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
4035355935,2020-03-20 23:51:41,,,,1241210846321053696,False,0,0,0,0,WPTS Playlist,Incyte - Numbers,,,2015-10-24 21:01:50,"Pittsburgh, PA",WPTS Playlist,https://pbs.twimg.com/profile_images/658129792408023041/8nflCFL-_normal.jpg,478,5,38,638221,WPTSPlaylist,
4745934986,2020-03-20 16:30:25,,,"nortontechnicalsupport.co, pic.twitter.com/dKATlqm3c6, ",1241099801015525381,False,0,0,0,0,Geekmentor,Incyte Doubles Down On Atopic Dermatitis Push With Trial Win For Ruxolitinib Cream - https://t.co/WHEvfAVFj9 https://t.co/dKATlqm3c6,,,2016-01-11 21:01:34,United States,Martha Jones,https://pbs.twimg.com/profile_images/715456172703113217/EdykiMFw_normal.jpg,99,41,18,43665,Articles_Martha,photo
374729426,2020-03-20 08:00:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1384422, pic.twitter.com/DYoO6mNdoh, ",1240971584531075072,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/9zjOzekWaY #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/DYoO6mNdoh",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
950010035396136962,2020-03-19 18:10:31,,"Incyte, ",,1240762604102057984,False,0,0,0,0,Cresus AI,"#Incyte closed at 66.51. Score +303, credit rating ABBA+ üëé",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
968871413082816513,2020-03-19 16:54:24,"ACAD, AMRN, INCY, SGEN, ",,,1240743448967176192,False,3,0,0,1,Twitter Web App,"Top 4 Holdings of Baker Brothers by Share Count

1. Seattle Genetics: 50,057,277
2. Acadia Pharmaceuticals: 41,904,586
3. Amarin: 34,496,685
4. Incyte: 31,976,873

Sources: CNBC, Nasdaq, SEC filing 3/18/20

$ACAD $AMRN $INCY $SGEN",,,2018-02-28 10:32:00,,FTR,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,99,4,0,818,ForTheRecord01,
2384219072,2020-03-19 10:02:05,,"innovation, debio, NetDe, DeBioGala, ","pic.twitter.com/9Q3UhemLeC, ",1240639684793040897,False,2,0,0,0,Loomly,"Thank you to @Incyte for their #innovation sponsorship for the #debio 2020 Gala! Inycte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs.
#NetDe #DeBioGala https://t.co/9Q3UhemLeC","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
4745934986,2020-03-19 08:40:11,,,"nortontechnicalsupport.co, ",1240619075350548481,False,0,0,0,0,Geekmentor,Eli Lilly And Incyte's Olumiant Helps Eczema Patients In A Late-Stage Clinical Trial - https://t.co/WHEvfAVFj9,,,2016-01-11 21:01:34,United States,Martha Jones,https://pbs.twimg.com/profile_images/715456172703113217/EdykiMFw_normal.jpg,99,41,18,43665,Articles_Martha,
374729426,2020-03-19 08:18:21,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1379057, pic.twitter.com/mFQuwvgSVo, ",1240613580950499328,False,0,0,0,2,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/ludtoLW5R6 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/mFQuwvgSVo",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3246541758,2020-03-19 03:27:54,,"eli, incyte, usfda, baricitinib, alopecia, hairloss, BreakthroughTherapy, ","business.medicaldialogues.in/pharma-news/li‚Ä¶, ",1240540484075806720,False,0,0,0,0,Hocalwire Social Share,"Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for Alopecia Areata @LillyPad,@Incyte #eli-lilly #incyte #usfda #baricitinib #alopecia-areata #hairloss #BreakthroughTherapy https://t.co/SGAW7GBf6l","LillyPad, Incyte, ",,2015-06-16 03:34:34,"New Delhi, India",Medical Dialogues,https://pbs.twimg.com/profile_images/616879208770334722/dCBRoHh9_normal.jpg,6761,749,0,44387,medicaldialogs,
515501206,2020-03-18 14:48:26,,,"twitter.com/Incyte/status/‚Ä¶, ",1240349361017626628,False,0,0,0,0,Twitter for iPad,Amazing! https://t.co/pPAGfQRGkp,,,2012-03-05 09:06:22,"Pennsylvania, USA","President Elect B. Money RN, MSN",https://pbs.twimg.com/profile_images/1277648975018016768/YgDVioey_normal.jpg,60,75,0,2959,NeverSurrenderZ,
732361939490312192,2020-03-18 12:35:31,"INCY, ","markets, ","americanbankingnews.com/?p=13843006, ",1240315911241961472,False,0,0,0,0,Zapier.com,Royal Bank of Canada Reaffirms Hold Rating for Incyte $INCY https://t.co/3w25O3KkhL #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-03-18 12:35:31,"INCY, ","stocks, ","americanbankingnews.com/?p=13843006, ",1240315907852951552,False,0,0,0,0,Zapier.com,Royal Bank of Canada Reaffirms Hold Rating for Incyte $INCY https://t.co/dtwSk884mj #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2920258887,2020-03-18 11:10:22,"INCY, ",,"dakotafinancialnews.com/?p=1652322, ",1240294479451557888,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Royal Bank of Canada https://t.co/ybEBX3OEzV,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
852931863547084801,2020-03-18 11:09:06,"INCY, ",,"zpr.io/tSJGw, ",1240294162215456768,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Royal Bank of Canada https://t.co/d6DLcwnMdR,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
68559732,2020-03-18 11:08:19,"INCY, ",,"zpr.io/tSJGG, ",1240293965716430849,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Royal Bank of Canada https://t.co/STfe1FxKbB,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
374729426,2020-03-18 07:51:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1376288, pic.twitter.com/g4HdICYr0i, ",1240244510669639680,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on March 5, 2020. View odds for this and other indicators: https://t.co/3mDorANXyq #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/g4HdICYr0i",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
950010035396136962,2020-03-17 18:08:34,,"Incyte, ",,1240037338534862849,False,0,0,0,0,Cresus AI,"#Incyte closed at 70.37. Score +300, credit rating ABBA+ üëé",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
15974185,2020-03-17 12:00:33,,,"dlvr.it/RS3VYj, ",1239944720433860608,False,0,0,0,1,dlvr.it,"Lilly, Incyte get FDA breakthrough therapy status for baricitinib to treat alopecia areata https://t.co/YRAk6Nehvw",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
847965875483365376,2020-03-17 10:42:49,,"FDA, therapy, BTD, Olumiant, treatment, alopecia, autoimmune, disease, drugdevelopment, biotech, regulatoryaffairs, ","ow.ly/O5Ld50yNTT2, pic.twitter.com/YJk9kwRZ3H, ",1239925158116233217,False,0,0,0,0,Twitter Web App,"Eli Lilly and Company and Incyte receive #FDA breakthrough #therapy designation (#BTD) for #Olumiant for the #treatment of #alopecia areata, an #autoimmune #disease that can cause hair loss.
Read more at https://t.co/TBYv9v33b3
#drugdevelopment #biotech #regulatoryaffairs https://t.co/YJk9kwRZ3H",,,2017-03-31 20:16:33,"Virginia, USA",BioPharma Global,https://pbs.twimg.com/profile_images/1101510551216316417/whtHLFR3_normal.png,523,424,10,1567,biopharmaglobal,photo
279184000,2020-03-17 10:18:01,,,"bit.ly/2QkBxXm, ",1239918919340765185,False,11,0,0,6,Buffer,Eli Lilly and Company  and Incyte Corporation  announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to baricitinib for the treatment of alopecia areata (AA)  https://t.co/FGVe6G10yM,,,2011-04-08 15:16:02,"Dallas, TX",Dr. John Cush,https://pbs.twimg.com/profile_images/1215290012490702848/mq73skc3_normal.jpg,12140,432,178,16241,RheumNow,
374729426,2020-03-17 08:25:42,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1370775, pic.twitter.com/CVavNLABiu, ",1239890653795872770,False,1,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/vwIphhKaXJ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/CVavNLABiu",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1526051053,2020-03-16 14:37:17,,,"bit.ly/2wbSgFi, ",1239621776201613322,False,0,0,0,0,awswebsite,Incyte (INCY) Down 5.4% Since Last Earnings Report: Can It Rebound? https://t.co/MeBx8HJcQX,,,2013-06-17 18:14:50,,Access WallStreet,https://pbs.twimg.com/profile_images/378800000007902869/3acce0e9d2afd339dca7c930dd3d9282_normal.png,40,17,2,30608,AccessWallST,
267859603,2020-03-16 12:49:32,,"EliLilly, ","bioportfol.io/RS09ZZ, ",1239594661288656903,False,0,0,0,1,dlvr.it,Lilly's Olumiant Gets Breakthrough Therapy Designation for Alopecia: The U.S. Food and Drug Administration granted Eli Lilly and Company and Incyte Corporation Breakthrough Therapy designation for baricitinib for alopecia areata. https://t.co/2oRFe2ZWGE #EliLilly,,,2011-03-17 13:42:21,London,BioPortfolio - Eli Lilly - news and research,https://pbs.twimg.com/profile_images/760036217761198080/RcDwixgH_normal.jpg,127,23,11,6839,Lilly_bio,
18026170,2020-03-16 11:58:16,,"FDA, baricitinib, autoimmune, AlopeciaAreata, RheumatoidArthritis, clinicaltrials, HairLoss, immunology, rheumatology, ","incyte.com/what-we-do/pha‚Ä¶, pic.twitter.com/hmAKj9hA3y, ",1239581760389820417,False,1,0,0,0,Twitter Web App,"#FDA grants Breakthrough status to @LillyPad &amp; @Incyte‚Äôs #baricitinib vs #autoimmune disorder #AlopeciaAreata

JAK inhibitor is indicated vs #RheumatoidArthritis; currently in Ph3 #clinicaltrials vs #HairLoss disorder

https://t.co/8FmtTKjKVQ
#immunology #rheumatology https://t.co/hmAKj9hA3y","LillyPad, Incyte, ",,2008-12-10 13:29:19,"Midland, ON",DDNews Online,https://pbs.twimg.com/profile_images/1286709262287278080/SHRMveT5_normal.jpg,3372,439,86,13763,DDNewsOnline,photo
22287259,2020-03-16 10:55:16,,,"lnkd.in/e625Quj, lnkd.in/e5najq5, ",1239565904607875072,False,0,0,0,1,LinkedIn,"""Incyte‚Äôs newest ambassador to help raise awareness for rare blood cancers is a well-known comic book artist‚Äîand a 10-year survivor. J.G. Jones, diagnosed with a myeloproliferative neoplasm (MPN) more than a decade ago, is the engi‚Ä¶https://t.co/9n0lahogTr https://t.co/HjFe6WBkfV",,,2009-02-28 14:33:33,"New Jersey, USA",Trevor Deal,https://pbs.twimg.com/profile_images/1138258601733218305/JT2I6TD0_normal.jpg,563,1353,20,2003,realdeal17,
1022473214457348096,2020-03-16 07:48:07,,,"pharmashots.com/28987/eli-lill‚Ä¶, pic.twitter.com/46th2HAOb7, ",1239518809297285121,False,0,0,0,0,Twitter Web App,"Eli Lilly and Incyte‚Äôs Olumiant (baricitinib) Receives the US FDA‚Äôs Breakthrough Therapy Designation for Alopecia Areata @LillyPad @Incyte 
https://t.co/nKk6Jhxwyf https://t.co/46th2HAOb7","LillyPad, Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,photo
374729426,2020-03-16 07:41:24,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1368257, pic.twitter.com/MUhhXAWt5v, ",1239517116417507328,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/SPhs5uhijg #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MUhhXAWt5v",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-03-15 21:39:03,"INCY, ","markets, ","americanbankingnews.com/?p=13806277, ",1239365532786348037,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/Jbj9BBFqMu #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-03-15 21:39:03,"INCY, ","stocks, ","americanbankingnews.com/?p=13806277, ",1239365530563346435,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/H6ZZKvunkj #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1134049078424162304,2020-03-15 15:40:36,"INCY, ",,"newsfilter.io/articles/raymo‚Ä¶, ",1239275325378494469,False,0,0,0,0,Newsfilter.io,"Raymond James Financial Services Advisors Sells 135,584 Shares of Incyte $INCY https://t.co/PcO6p1sSwJ",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-03-15 15:31:36,"INCY, ",,"newsfilter.io/articles/raymo‚Ä¶, ",1239273060953477120,False,0,0,0,0,Newsfilter.io,"Raymond James Financial Services Advisors Sells 135,584 Shares of Incyte $INCY https://t.co/I6A9LYjgqj",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2920258887,2020-03-15 10:45:00,"INCY, ",,"dakotafinancialnews.com/?p=1639933, ",1239200932245704705,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $81.00 https://t.co/XkBDqIiHmP,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
852931863547084801,2020-03-15 10:41:43,"INCY, ",,"zpr.io/tSf4N, ",1239200106353758210,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $81.00 https://t.co/z2ebQRXHNH,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
374729426,2020-03-15 09:42:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1362891, pic.twitter.com/tksQwPmWcU, ",1239185240582574081,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/jyCaTQJqz8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/tksQwPmWcU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
402284409,2020-03-15 01:24:37,,,"goo.gl/fb/t5U2g3, ",1239059907682406400,False,0,0,0,0,Google,"Job Delaware:  Sr Staff Scientist, Cell Culture Process Science - Incyte Corporation‚Ä¶ https://t.co/5JDhYn9ar5",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
402284409,2020-03-15 01:24:37,,,"goo.gl/fb/ACCxXi, ",1239059906755530760,False,0,0,0,0,Google,"Job Delaware:  Research Investigator, Cell Culture Process Science - Incyte Corporation‚Ä¶ https://t.co/ivVWP2EWnl",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
402284409,2020-03-15 01:24:36,,,"goo.gl/fb/hFqB5x, ",1239059905723666433,False,0,0,0,0,Google,"Job Delaware:  Research Scientist, Purifcation Process Science - Incyte Corporation‚Ä¶ https://t.co/DPvtGyWcfM",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
730032660,2020-03-14 12:48:18,,,"nonsell.com/us-market-news‚Ä¶, ",1238869573450862592,False,0,0,0,0,NonSell Twitter,"Incyte (INCY) Down 5.4% Since Last Earnings Report: Can It Rebound? - https://t.co/OIgquRkfA1
Want to know more on Incyte (INCY) Down 5.4% Since Last Earnings Report: Can It Rebound? c...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
374729426,2020-03-14 09:02:46,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1360210, pic.twitter.com/x9xzA1KcBC, ",1238812817035165696,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/YfyXzvaO1u #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/x9xzA1KcBC",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-03-13 22:59:32,"INCY, ","markets, ","americanbankingnews.com/?p=13779076, ",1238661009088434181,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded at Bank of America https://t.co/sLUemVZRW9 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-03-13 22:59:31,"INCY, ","stocks, ","americanbankingnews.com/?p=13779076, ",1238661006508863488,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded at Bank of America https://t.co/HXlYy2qafK #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2920258887,2020-03-13 08:51:22,"INCY, ",,"dakotafinancialnews.com/?p=1630332, ",1238447559611494400,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by Bank of America to Buy https://t.co/Bmq3dlzoDa,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
849417718642159616,2020-03-13 08:47:18,"INCY, ",,"zpr.io/tC5WE, ",1238446535928614915,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by Bank of America to Buy https://t.co/p4nlvjVGCs,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
852931863547084801,2020-03-13 08:45:37,"INCY, ",,"zpr.io/tC5BR, ",1238446113977511938,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by Bank of America to Buy https://t.co/ITKrXB6NZH,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
374729426,2020-03-13 08:12:35,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1354516, pic.twitter.com/JmAtwsNx47, ",1238437800430592001,False,0,0,0,0,Tickeron,"$INCY enters a Downtrend because Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/NCKTZDrEyv #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/JmAtwsNx47",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3426014292,2020-03-13 06:12:26,"INCY, ",,,1238407564506861568,False,2,0,0,0,Twitter for iPhone,Baml $INCY US: Incyte Corporation: Rating Change - Upgrade to Buy on valuation and atopic dermatitis opportunity - BUY,,,2015-09-02 09:10:37,,dough,https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_normal.jpg,32805,529,852,59439,semodough,
3911174913,2020-03-12 13:40:07,,"GVHD, ",,1238157841195773953,False,0,0,0,1,Twitter for Advertisers.,We are committed to fostering innovation among those dedicated to finding solutions for graft-versus-host disease (#GVHD). Apply today or share with someone who may be a fit for the Incyte Ingenuity Award Program.,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
2860693607,2020-03-12 13:30:20,,"Incyte, Jakavi, InnovationAward, GraftVersusHost, Patients, ","bit.ly/2ICxstd, ",1238155379462242304,False,0,0,0,0,Hootsuite Inc.,Incyte debuts innovation award to crowdsource ideas for graft-versus-host patients https://t.co/ajGWyLfOK0 #Incyte #Jakavi #InnovationAward #GraftVersusHost #Patients,,,2014-11-04 09:01:12,"Brighton, UK",Haybury,https://pbs.twimg.com/profile_images/862943255981436928/jXWuXHim_normal.jpg,1052,1154,161,4283,Hayburysearch,
1359077910,2020-03-12 13:30:15,,,"europharmajobs.com/job_display/17‚Ä¶, ",1238155357236662274,False,0,0,0,0,EPJ Jobs Post,"Director, Development Project Management, Incyte, Geneva, Switzerland

https://t.co/lsq7iGKvd6",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
3911174913,2020-03-12 11:30:00,,"GVHD, ",,1238125094288818178,False,6,0,0,0,Twitter for Advertisers.,We are committed to fostering innovation among those dedicated to finding solutions for #GVHD. Apply today or share with someone who may be a fit for the Incyte Ingenuity Award Program.,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
374729426,2020-03-12 09:40:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1352112, pic.twitter.com/0xFe53iluA, ",1238097635434590208,False,1,0,0,0,Tickeron,"$INCY enters a Downtrend as Momentum Indicator dropped below the 0 level on March 3, 2020. View odds for this and other indicators: https://t.co/eEgnFFhonV #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0xFe53iluA",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
135209476,2020-03-12 08:30:49,"INCY, ",,"stockflare.com/stock/INCY.O, ",1238080001548959744,False,0,0,0,0,Stockflare Bot (Prod),"$INCY: Incyte Corporation's forecast earnings moved 0.0% over the last week, but the price is -10.3%. It's PE ratio is now 23x earnings. (https://t.co/sK8NyKCUuN)",,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
135209476,2020-03-12 08:30:48,"INCY, ",,"stockflare.com/stock/INCY.O, ",1238079996301848580,False,0,0,0,0,Stockflare Bot (Prod),$INCY: Incyte Corporation's price is -10.3% but the forecast earnings moved 0.0% over the last week. (https://t.co/sK8NyKCUuN),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
38920802,2020-03-12 00:13:17,"INCY, MGNX, ",,"clinicaltrials.gov/ct2/history/NC‚Ä¶, ",1237954792929947649,False,0,0,0,1,Twitter Web App,"$INCY $MGNX crazy changes to this crazy long-delayed trial....  Pfizer out, Incyte in (previous edit).  Anti-PD-L1 out, MGA012 in.  https://t.co/A80hehYrSs",,,2009-05-09 16:23:52,,Spontonic,https://pbs.twimg.com/profile_images/1132813877513560065/G7Q68pBw_normal.png,406,197,17,2815,spontonic,
950010035396136962,2020-03-11 18:14:39,,"Incyte, ",,1237864538654912512,False,0,0,0,0,Cresus AI,"#Incyte closed at 71.90. Score +295, credit rating ABBA+ üëé",,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
1199800417821048834,2020-03-11 12:01:13,,"Hedge_Funds, News, Is_INCY_A_Good_Investment_Right_Now_, ","dlvr.it/RRhBt0, bit.ly/2tNWL7k, pic.twitter.com/ZIm2xX1fPQ, ",1237770562899816448,False,0,0,0,0,dlvr.it,#Hedge_Funds #News #Is_INCY_A_Good_Investment_Right_Now_ Hedge Funds Are Buying Incyte Corporation (INCY) https://t.co/JQqkBg8gVr https://t.co/D9hc6egqxq https://t.co/ZIm2xX1fPQ,,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,photo
1526051053,2020-03-11 10:26:55,,,"bit.ly/2W4f3xt, ",1237746830852702208,False,0,0,0,0,awswebsite,Incyte Joins Elite List Of Stocks With 95-Plus Composite Rating https://t.co/DJjDWNV2Ix,,,2013-06-17 18:14:50,,Access WallStreet,https://pbs.twimg.com/profile_images/378800000007902869/3acce0e9d2afd339dca7c930dd3d9282_normal.png,40,17,2,30608,AccessWallST,
929068431546224646,2020-03-11 10:12:54,,,"fiercepharma.com/marketing/incy‚Ä¶, ",1237743302352519170,False,2,0,0,0,Twitter Web App,"Incyte debuts innovation award to crowdsource ideas for graft-versus-host patients. @Incyte 

https://t.co/f7sMrCXnQ0","Incyte, ",,2017-11-10 14:29:10,"Wilmington, DE",Delaware Innovation Space,https://pbs.twimg.com/profile_images/929070677302407168/rNf669ob_normal.jpg,683,569,0,452,DE_Innovates,
732361939490312192,2020-03-11 08:20:47,"INCY, ","markets, ","americanbankingnews.com/?p=13739353, ",1237715087370174464,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $81.00 at Credit Suisse Group https://t.co/b04HUlBZZz #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-03-11 08:20:46,"INCY, ","stocks, ","americanbankingnews.com/?p=13739353, ",1237715083813425153,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $81.00 at Credit Suisse Group https://t.co/ywRiAoilF5 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2298709746,2020-03-11 07:30:27,"INCY, ",,"zpr.io/tCT6a, ",1237702422966886401,False,1,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $81.00 https://t.co/Jf3ZhCp7w7,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
100612147,2020-03-10 20:56:19,,"Crowdsource, Crowdfund, incyte, crowdsource, ","paper.li/Webiversity/13‚Ä¶, ",1237542836188266496,False,0,0,0,0,Paper.li,Open #Crowdsource &amp; #Crowdfund Award https://t.co/xjN1tfGNKE @Catarse @KIVA @AKVO @Goteofunding @Worldbank  @PlexusVentures #incyte #crowdsource,"catarse, Kiva, akvo, goteofunding, WorldBank, PlexusVentures, ",,2009-12-30 17:28:17,London,Webiversity.org,https://pbs.twimg.com/profile_images/654140154/lucogo_normal.jpg,767,287,854,73150,Webiversity,
963495628545327104,2020-03-10 15:49:02,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/lA75JgEFAK, ",1237465507072282624,False,1,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Joins Elite List Of Stocks With 95-Plus Composite Rating https://t.co/vbkgChlzSJ Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/lA75JgEFAK,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
3911174913,2020-03-10 15:21:35,,"GVHD, ",,1237458598617382912,False,23,0,1,0,Twitter for Advertisers.,The Incyte Ingenuity Award Program is accepting applications. Watch to learn more about the award and apply today. #GVHD,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
94365736,2020-03-10 13:10:12,,"Incyte, crowdsource, graftversushost, marketing, GVHD, ","fiercepharma.com/marketing/incy‚Ä¶, ",1237425537091547136,False,0,0,0,0,Hootsuite Inc.,#Incyte debuts innovation award to #crowdsource ideas for #graftversushost patients https://t.co/ZtolXcNoJv @FiercePharma @Incyte #marketing #GVHD,"FiercePharma, Incyte, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
374729426,2020-03-10 09:42:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1343917, pic.twitter.com/ZwQ2FDuNS8, ",1237373307512471552,False,0,0,0,0,Tickeron,$INCY in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/OoTB1pdT4T #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZwQ2FDuNS8,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2384219072,2020-03-09 11:45:01,,"innovation, debio, NetDe, DeBioGala, ","pic.twitter.com/2aObXXZZhr, ",1237041710867324929,False,0,0,0,0,Loomly,"Thank you to @Incyte for their #innovation sponsorship for the #debio 2020 Gala! Inycte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs.
#NetDe #DeBioGala https://t.co/2aObXXZZhr","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
852931863547084801,2020-03-09 10:59:20,"INCY, ",,"zpr.io/tFerz, ",1237030213432852482,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 52-Week Low at $71.20 https://t.co/b1yFiwjYVS,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
2920258887,2020-03-09 10:59:14,"INCY, ",,"dakotafinancialnews.com/?p=1614595, ",1237030186719367169,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 52-Week Low at $71.20 https://t.co/DcG5FYcEdE,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
2416188264,2020-03-09 10:55:23,"INCY, ","markets, ","thestockobserver.com/?p=2722711, ",1237029220787904515,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 52-Week Low at $71.20  https://t.co/VssaJrHpv2 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
74566615,2020-03-09 10:00:03,,,"lnkd.in/dEWmWsM, pic.twitter.com/YHwZ1lKADI, ",1237015294310301701,False,0,1,0,0,Twitter Web App,"ACI cordially invites you to join us at this year‚Äôs Women Leaders in Life Sciences Law Conference in Boston this July. Meet and network with female industry leaders from: Amgen, Bayer, Eisai US, Incyte and many more. 

Learn More ¬ª https://t.co/Hva1Wpk0mO https://t.co/YHwZ1lKADI",,,2009-09-15 17:51:14,New York,ACI Pharma,https://pbs.twimg.com/profile_images/745285849739366402/fosqe9yJ_normal.jpg,1854,1751,86,9684,ACI_Pharma,photo
374729426,2020-03-09 07:44:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1339857, pic.twitter.com/0uM1aGzNEO, ",1236981139740356610,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on March 5, 2020. View odds for this and other indicators: https://t.co/4z8ymqTjRx #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0uM1aGzNEO",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
25560065,2020-03-08 23:00:24,,,"bizjournals.com/philadelphia/n‚Ä¶, ",1236849286916251653,False,0,0,0,0,True Anthem,Wilmington-based Incyte Corp. has received the green light to provide a $750 million upfront payment to German biotech MorphoSys AG as part of a joint collaboration and licensing agreement. https://t.co/n9bRKBpY3i,,,2009-03-20 15:31:03,Philadelphia,PHL Business Journal,https://pbs.twimg.com/profile_images/378800000077412316/8b22fbb8c4be97c69f048ff47fe712b6_normal.jpeg,35028,8899,1065,77326,PHLBizJournal,
849417718642159616,2020-03-08 09:07:47,"INCY, ",,"zpr.io/tF3ZX, ",1236639754243932165,False,0,0,0,0,Zapier.com,$0.63 EPS Expected for Incyte Co. $INCY This Quarter https://t.co/zA3gh5ATyf,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
68559732,2020-03-08 09:06:18,"INCY, ",,"zpr.io/tF3p9, ",1236639378547621893,False,0,0,0,0,Zapier.com,Analysts Expect Incyte Co. $INCY to Announce $0.63 EPS https://t.co/40LBVPSIwb,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
852931863547084801,2020-03-08 09:05:56,"INCY, ",,"zpr.io/tF3p7, ",1236639287376035840,False,0,0,0,0,Zapier.com,$0.63 EPS Expected for Incyte Co. $INCY This Quarter https://t.co/HnJLDMYcmH,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583761,TranscriptDaily,
374729426,2020-03-08 08:18:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1335824, pic.twitter.com/GTaao0gdAs, ",1236627460109688833,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on March 5, 2020. View odds for this and other indicators: https://t.co/ZnCESQoZii #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GTaao0gdAs",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-03-07 11:33:07,"INCY, ",,"newsfilter.io/articles/tower‚Ä¶, ",1236329039750668290,False,0,0,0,0,Newsfilter.io,Tower Research Capital TRC Decreases Stock Position in Incyte $INCY https://t.co/g5rbB9oIvY,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-03-07 08:59:06,"INCY, ",,"newsfilter.io/articles/45000‚Ä¶, ",1236290279885373440,False,0,0,0,0,Newsfilter.io,"45,000 Shares in Incyte Bought by DCF Advisers $INCY https://t.co/Gqu1pejmBI",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
374729426,2020-03-07 08:13:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1331791, pic.twitter.com/oTnA2JMv7d, ",1236278913430482944,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on March 5, 2020. View odds for this and other indicators: https://t.co/qHybgEOism #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/oTnA2JMv7d",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-03-07 01:46:31,"INCY, ","investingnews, ","modernreaders.com/?p=2898703, ",1236181417610088448,False,0,0,0,0,Zapier.com,$557.04 Million in Sales Expected for Incyte Co. $INCY This Quarter  https://t.co/LZESKY4EjH #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2020-03-07 01:46:19,"INCY, ","markets, ","americanbankingnews.com/?p=13685595, ",1236181367509127169,False,0,0,0,0,Zapier.com,$557.04 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/u8q2Ijqyml #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-03-07 01:46:19,"INCY, ","stocks, ","americanbankingnews.com/?p=13685595, ",1236181364833169408,False,0,0,0,0,Zapier.com,$557.04 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/52M03RfgNg #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2020-03-07 01:46:10,"INCY, ",,"tickerreport.com/?p=5160487, ",1236181329911443456,False,0,0,0,0,Zapier.com,$557.04 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/VA3wlMsJ58,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-03-07 01:44:26,"INCY, ",,"thelincolnianonline.com/?p=3560057, ",1236180893888319488,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $557.04 Million https://t.co/LivitfZtdC,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2266388972,2020-03-07 01:44:15,"INCY, ","stocks, ","dailypolitical.com/?p=3512910, ",1236180845716791297,False,0,0,0,0,Zapier.com,$557.04 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/BqVo8A25KI #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-03-07 01:44:14,"INCY, ",,"dailypolitical.com/?p=3512910, ",1236180843024060416,False,0,0,0,0,Zapier.com,$557.04 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/D1W6BiK1WZ,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1134049078424162304,2020-03-06 23:20:06,"INCY, ",,"newsfilter.io/articles/priva‚Ä¶, ",1236144571018620929,False,0,0,0,0,Newsfilter.io,"Private Advisor Group Invests $240,000 in Incyte $INCY https://t.co/M9juKSD8rR",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1022006086872821762,2020-03-06 15:02:15,"INCY, INCY, ",,,1236019281772580864,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY is DOWN ‚¨á on Fri Mar 06
Currently at 74.87 USD for a -4.76% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
877506085376098305,2020-03-06 11:00:37,,"bladdercancer, researrch, BCaMeetingUK20, ","pic.twitter.com/R1Q3wbHhpi, pic.twitter.com/R1Q3wbHhpi, pic.twitter.com/R1Q3wbHhpi, pic.twitter.com/R1Q3wbHhpi, ",1235958473185255431,False,5,0,0,1,Twitter Web App,"Many thanks to our sponsors @Incyte @frontoncology @Novosanis for supporting #bladdercancer #researrch
#BCaMeetingUK20 https://t.co/R1Q3wbHhpi","Incyte, FrontOncology, Novosanis, ",,2017-06-21 08:38:48,,TOUR Team KCL,https://pbs.twimg.com/profile_images/1388551499286933505/sS1kTMGx_normal.png,597,329,8,1653,TOUR_KCL,photo
374729426,2020-03-06 09:43:06,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1327821, pic.twitter.com/dHBHwvISQQ, ",1235938963342249984,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on February 19, 2020. View odds for this and other indicators: https://t.co/M8GD5lBYfL #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/dHBHwvISQQ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
877506085376098305,2020-03-06 04:55:23,,"BCaMeetingUK20, ","pic.twitter.com/tBUJ2f2xbq, ",1235866560167739392,False,12,1,0,0,Twitter Web App,"And it's kick off to the #BCaMeetingUK20 @EdgbastonPark! Dr Rik Bryan introduces the day giving thanks to our sponsors @FrontOncology, Novosanis, @Incyte etc. https://t.co/tBUJ2f2xbq","EdgbastonPark, FrontOncology, Incyte, ",,2017-06-21 08:38:48,,TOUR Team KCL,https://pbs.twimg.com/profile_images/1388551499286933505/sS1kTMGx_normal.png,597,329,8,1653,TOUR_KCL,photo
1128239740329705472,2020-03-05 16:43:59,"INCY, MOR, ",,"bizjournals.com/philadelphia/n‚Ä¶, ",1235682496144199680,False,1,0,0,1,Twitter for Android,"Through this partnership, Incyte and MorphoSys AG will develop and commercialize tafasitamab, a drug candidate that targets cancer. 

$INCY $MOR
https://t.co/Vbz8RLOxzT",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
49053573,2020-03-05 15:34:26,,,"twitter.com/Incyte/status/‚Ä¶, ",1235664993426845696,False,0,0,0,0,Twitter Web App,"We don't hear of these guys until a virus erupts.  Likewise, we don't hear of the ongoing work to combat inflamation and autoimumunity diseases.  But, they're punching the timeclock daily.  Thankful. https://t.co/Vgfru05kdy",,,2009-06-20 12:56:12,,Neil,https://pbs.twimg.com/profile_images/1246088790403416064/9nT7VuDt_normal.png,2912,2016,417,673579,NPSusa,
133504478,2020-03-05 14:41:34,,"strategy, competitiveintelligence, marketing, healthcare, pharmaceutical, pharma, biotech, competitivemarketing, ","dlvr.it/RRKL7P, lqventures.com, ",1235651687378894849,False,0,0,0,1,dlvr.it,Incyte wins OK to provide $750M payment for drug collaboration - Philadelphia Business Journal https://t.co/VJPhyD337o &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #biotech #competitivemarketing,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
732361939490312192,2020-03-05 14:13:45,"INCY, ","markets, ","americanbankingnews.com/?p=13664635, ",1235644686297112581,False,0,0,0,0,Zapier.com,Analysts Anticipate Incyte Co. $INCY Will Post Earnings of $0.63 Per Share https://t.co/2lyUngdNA4 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-03-05 14:13:44,"INCY, ","stocks, ","americanbankingnews.com/?p=13664635, ",1235644683554115585,False,0,0,0,0,Zapier.com,Analysts Anticipate Incyte Co. $INCY Will Post Earnings of $0.63 Per Share https://t.co/O3Zht5oWed #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
335950885,2020-03-05 10:01:21,,,,1235581171788021765,False,0,0,0,0,Sprout Social,"MorphoSys and Incyte finalizes deal for tafasitamab, in late stage development for B-cell lymphomas, triggering a $750 million upfront payment to MorphoSys",,,2011-07-15 10:20:18,,Clarivate for Life Sciences & Healthcare,https://pbs.twimg.com/profile_images/1265663600510803969/bKZ2FhiC_normal.jpg,4271,923,158,17557,ClarivateHealth,
2266388972,2020-03-05 08:21:04,"INCY, ","stocks, ","dailypolitical.com/?p=3502243, ",1235555930911240197,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Brokerages https://t.co/bNS5XN3J7C #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-03-05 08:21:03,"INCY, ",,"dailypolitical.com/?p=3502243, ",1235555928256245760,False,1,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Brokerages https://t.co/sctC4L5dc2,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
930803511918411776,2020-03-05 08:19:59,"INCY, ",,"thelincolnianonline.com/?p=3549316, ",1235555660680646656,False,1,0,0,0,Zapier.com,Incyte Co. $INCY Receives Average Rating of ‚ÄúHold‚Äù from Analysts https://t.co/Y2e4sCLudL,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2525892205,2020-03-05 08:19:04,"INCY, ","investingnews, ","modernreaders.com/?p=2887933, ",1235555429377290241,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Average Rating of ‚ÄúHold‚Äù from Analysts  https://t.co/BlwdyPZFgz #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2020-03-05 08:18:12,"INCY, ","markets, ","americanbankingnews.com/?p=13661403, ",1235555212414369792,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Average Rating of ‚ÄúHold‚Äù from Analysts https://t.co/TMywHUAIDi #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-03-05 08:18:11,"INCY, ","stocks, ","americanbankingnews.com/?p=13661403, ",1235555208920535040,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Average Rating of ‚ÄúHold‚Äù from Analysts https://t.co/c5TZv2C7GD #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2384219072,2020-03-05 08:01:29,,"innovation, debio, NetDe, DeBioGala, ","loom.ly/BV75rLM, pic.twitter.com/HfviC2ABwf, ",1235551005330284544,False,0,0,0,0,Loomly,"Thank you to @Incyte for their #innovation sponsorship for the #debio 2020 Gala! Inycte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs.
#NetDe #DeBioGala 
https://t.co/4Njw4NNtZR https://t.co/HfviC2ABwf","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
208053736,2020-03-05 06:28:07,,,"delawarebusinessnow.com, theglobe.co.com/2020/03/05/inc‚Ä¶, ",1235527507656335361,False,0,0,0,0,theglobe,(Incyte gets go-ahead for $750 million payment for drug collaboration ‚Äì https://t.co/IA4DTdWUGO) has been published on The Globe - https://t.co/lGdfOPk1Yz,,,2010-10-26 10:57:19,Zieglerville PA,Wellcome-home,https://pbs.twimg.com/profile_images/1269342722/Becky_mug__428x640__normal.jpg,127,10,2,348028,Wellcome_Home,
208053736,2020-03-05 06:20:25,,,"delawarebusinessnow.com, goodnews.co.com/2020/03/05/inc‚Ä¶, ",1235525570521223170,False,0,0,0,0,theglobe,(Incyte gets go-ahead for $750 million payment for drug collaboration ‚Äì https://t.co/IA4DTdWUGO) has been published on Good News - https://t.co/viyiFdEdBY,,,2010-10-26 10:57:19,Zieglerville PA,Wellcome-home,https://pbs.twimg.com/profile_images/1269342722/Becky_mug__428x640__normal.jpg,127,10,2,348028,Wellcome_Home,
1889492676,2020-03-05 05:24:55,"MOR, ","MorphoSys, Incyte, ","1stoncology.com/blog/morphosys‚Ä¶, ",1235511602922663937,False,0,0,0,0,Troi URL Plug-in,"#MorphoSys Resolves a Capital Increase to Implement the Purchase of 3,629,764 American Depositary Shares by #Incyte Corporation $MOR https://t.co/xcZSut6seu",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
14453501,2020-03-05 03:51:53,,,"delawarebusinessnow.com/2020/03/incyte‚Ä¶, ",1235488191534096384,True,0,0,0,0,WordPress.com,Incyte gets go-ahead for $750 million payment for drug¬†collaboration https://t.co/iXkCwaVFnm,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
347315451,2020-03-05 03:27:06,,,"morphosys.com/media-investor‚Ä¶, ",1235481952586805249,False,0,0,0,0,Twitter Web App,"MorphoSys Resolves a Capital Increase to Implement the Purchase of 3,629,764 American Depositary Shares by Incyte Corporation
https://t.co/hkSNmvVduN",,,2011-08-02 12:17:10,Berlin,BIO Deutschland,https://pbs.twimg.com/profile_images/801026554834878465/TZRcLWOl_normal.jpg,4612,2717,178,29124,BIODeutschland,
374729426,2020-03-05 02:51:15,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1323645, pic.twitter.com/QIOnhz5OAd, ",1235472932152856576,False,1,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on February 19, 2020. View odds for this and other indicators: https://t.co/tLFyDc0nWr #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/QIOnhz5OAd",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1006334607946649600,2020-03-04 16:54:03,,,"dlvr.it/RRG0Gl, ",1235322642925850630,False,0,0,0,0,dlvr.it,"MorphoSys Resolves a Capital Increase to Implement the Purchase of 3,629,764 American Depositary Shares by Incyte Corporation https://t.co/DbDKTcqIIO",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
31720614,2020-03-04 16:37:56,,"news, pharma, pharmiweb, ","zpr.io/t3cXs, ",1235318586115264517,False,0,0,0,0,Zapier.com,"MorphoSys Resolves a Capital Increase to Implement the Purchase of 3,629,764 American Depositary Shares by Incyte Corporation (news with additional features)
https://t.co/2KUY5aAYSu
#news #pharma #pharmiweb",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,
3318510966,2020-03-04 16:30:07,,,"crweworld.com/article/news-p‚Ä¶, ",1235316616222605314,False,0,0,0,0,CRWE World,"MorphoSys Resolves a Capital Increase to Implement the Purchase of 3,629,764 American Depositary Shares by Incyte Co https://t.co/OrPzU1cPnh",,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
266143766,2020-03-04 16:20:30,"MOR, ",,"accesswire.com/579115/MorphoS‚Ä¶, ",1235314199775059975,False,0,0,0,2,Accesswire,"$MOR MorphoSys Resolves a Capital Increase to Implement the Purchase of 3,629,764 American Depositary Shares by Incyte ... https://t.co/mG2JTsBa8b",,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
1199800417821048834,2020-03-04 16:10:06,,"Company_News_, ","dlvr.it/RRFtxt, bit.ly/2StKgrZ, pic.twitter.com/OUO32UmswY, ",1235311580419678215,False,0,0,0,0,dlvr.it,"#Company_News_ MorphoSys : Resolves a Capital Increase to Implement the Purchase of 3,629,764 American Depositary Shares by Incyte Corporation https://t.co/WNUML4VvWB https://t.co/U3dJgzaClj https://t.co/OUO32UmswY",,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,photo
42410755,2020-03-04 16:02:13,,,"tinyurl.com/qlhqn85, ",1235309598522978307,False,1,0,0,2,DGAP_News_Int,"MorphoSys Resolves a Capital Increase to Implement the Purchase of 3,629,764 American Depositary Sha... https://t.co/SSQxidYcHU",,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
730032660,2020-03-04 11:20:29,,,"nonsell.com/us-market-news‚Ä¶, ",1235238697219567617,False,0,0,0,0,NonSell Twitter,"These 2 Things Will Help Incyte‚Äôs Stock Rebound - https://t.co/RiJV6DFe8M why Incyte could recover from its poor performance in recent weeks.
Want to know more on These 2 Things Will H...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
1171873456276889600,2020-03-04 11:05:50,"MOR, ","MOR, 6K, Morphosys, News, ","docoh.com/filing/1340243‚Ä¶, ",1235235007901425666,False,0,0,0,0,Investor Feed,"$MOR  6-K  Morphosys   (4 Mar, 11:04am)

üì∞ MorphoSys and Incyte Announce Antitrust Clearance of Global

https://t.co/hDONfw5Btn

#MOR #6K #Morphosys #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
963495628545327104,2020-03-04 10:29:37,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/QJeUXpuw3A, ",1235225894664441857,False,1,0,0,0,STCK.PR0,$INCY NEW ARTICLE : These 2 Things Will Help Incyte‚Äôs Stock Rebound https://t.co/WuuYwVdgXb Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/QJeUXpuw3A,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
2334614718,2020-03-04 08:04:10,"MOR, INCY, ",,"ooc.bz/l/49546, ",1235189290667212801,False,1,0,0,0,Open Outcrier,"$MOR (+5.5% pre) Antitrust watchdog OK with MorphoSys - Incyte $INCY tafasitamab partnership -- SA

https://t.co/jkJtYVvwZV",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
1889492676,2020-03-04 06:11:05,"MOR, INCY, ","MorphoSys, Incyte, Tafasitamab, ","1stoncology.com/blog/morphosys‚Ä¶, ",1235160832394182658,False,0,0,0,0,Troi URL Plug-in,#MorphoSys and #Incyte Announce Antitrust Clearance of Global Collaboration and License Agreement for #Tafasitamab $MOR $INCY https://t.co/72TTH63Eg5,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1637027690,2020-03-04 03:16:03,,,"ift.tt/2Tkl9aY, ",1235116784841347072,False,0,0,0,0,IFTTT,Antitrust watchdog OK with MorphoSys - Incyte tafasitamab partnership https://t.co/9eA5uIgu4h,,,2013-07-31 23:30:55,Everywhere,Ashish Aggarwal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,557,0,4776,AggarwalTweets,
133504478,2020-03-03 23:40:34,,"strategy, competitiveintelligence, marketing, pharma, biotech, productmarketing, healthcare, pharmaceutical, ","dlvr.it/RRC2cP, lqventures.com, ",1235062555988488194,False,0,0,0,1,dlvr.it,"Vitiligo Treatment Market to Witness Rapid Growth by 2026 with Key Players like Incyte, Astellas Pharma, Bausch‚Ä¶ https://t.co/yKC9JxrLjX &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #healthcare #pharmaceutical",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
1006334607946649600,2020-03-03 21:41:34,,,"dlvr.it/RRBrDv, pic.twitter.com/eVIwxqw9Kd, ",1235032607886151680,False,0,0,0,0,dlvr.it,"MorphoSys, Incyte Receive Antitrust Clearance For Collaboration On Tafasitamab https://t.co/6TNoyZou0w https://t.co/eVIwxqw9Kd",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
25406480,2020-03-03 17:10:39,,,"awesomecapital.blogspot.com/2020/03/antitr‚Ä¶, ",1234964432016617472,False,0,0,0,1,Twitter Web Client,AwesomeCapital: Antitrust watchdog OK with MorphoSys ‚Äì Incyte tafa... https://t.co/EaLV2P1kIf,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
1006334607946649600,2020-03-03 17:06:04,,,"dlvr.it/RRBHN1, ",1234963276145971200,False,0,0,0,0,dlvr.it,MorphoSys and Incyte Announce Antitrust Clearance of Global Collaboration and License Agreement for Tafasitamab https://t.co/gDdzOs6527,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
15296897,2020-03-03 17:02:57,"MOR, INCY, ",,"seekingalpha.com/news/3548367-a‚Ä¶, ",1234962492175990784,False,0,0,0,0,SANewsTwitter,$MOR $INCY - Antitrust watchdog OK with MorphoSys - Incyte tafasitamab partnership https://t.co/Sf24frWgSN,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3318510966,2020-03-03 17:00:24,,,"crweworld.com/article/news-p‚Ä¶, ",1234961850720124928,False,1,0,0,1,CRWE World,MorphoSys and Incyte Announce Antitrust Clearance of Global Collaboration and License Agreement for Tafasitamab  https://t.co/8eE0LLzCL3,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
823220596687437824,2020-03-03 16:53:00,,,"twitter.com/Incyte/status/‚Ä¶, ",1234959989745254401,False,0,0,0,0,Twitter for iPad,"Darlise is one of the unknown &amp; unsung heroines of modern medicine.  I am alive and recovering nicely because of people like her.

Thank you all.  You give life! https://t.co/aqsdGvEKYe",,,2017-01-22 12:27:39,"Connecticut, USA",Nicholas Borelli,https://pbs.twimg.com/profile_images/823223340513054722/lr-CGqWM_normal.jpg,594,1670,0,24477,BorelliBooks,
126416038,2020-03-03 16:45:26,"MOR, INCY, ",,"morphosys.com/media-investor‚Ä¶, pic.twitter.com/Cz2t2a9B2S, ",1234958086189785093,False,5,0,0,0,Twitter for iPhone,"$MOR $INCY Announce Antitrust Clearance of Global Collaboration and License Agreement for Tafasitamab 
https://t.co/SOiUsA90xd https://t.co/Cz2t2a9B2S",,,2010-03-25 16:17:38,Tel Aviv,Odi Bruckman,https://pbs.twimg.com/profile_images/1182595151899836417/Y4fMBMd5_normal.jpg,14629,185,415,30356,odibro,photo
31720614,2020-03-03 16:32:14,,"news, pharma, pharmiweb, ","zpr.io/t383H, ",1234954762631729153,False,0,0,0,0,Zapier.com,"MorphoSys and Incyte Announce Antitrust Clearance of Global Collaboration and License Agreement for Tafasitamab (news with additional features)
https://t.co/39yPWKySK9
#news #pharma #pharmiweb",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,
266143766,2020-03-03 16:30:41,"MOR, ",,"accesswire.com/578894/MorphoS‚Ä¶, ",1234954373907845129,False,0,0,0,0,Accesswire,$MOR MorphoSys and Incyte Announce Antitrust Clearance of Global Collaboration and License Agreement for Tafasitamab ... https://t.co/UHj75PXI2a,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
949657442241130497,2020-03-03 16:25:23,"Mor, INCY, INCY, MOR, MOR, ",,"morphosys.com/media-investor‚Ä¶, ",1234953037875175426,False,0,0,1,0,Twitter for iPad,"Clearance for $Mor and $INCY deal is there. $INCY will be happy that they get more shares for their $150 million because the $MOR is cheap after the crash. Bad for $MOR

https://t.co/npD2EMGGdS",,,2018-01-06 10:02:32,,Orange Apple,https://pbs.twimg.com/profile_images/1218476621402923009/3BE0SgQ0_normal.jpg,315,99,8,931,ainge_man,
42410755,2020-03-03 16:02:14,,,"tinyurl.com/qsbjwvb, ",1234947211282219009,False,3,1,1,3,DGAP_News_Int,MorphoSys and Incyte Announce Antitrust Clearance of Global Collaboration and License Agreement for ... https://t.co/2TbRhjOaWr,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
3911174913,2020-03-03 14:30:00,,"GVHD, ",,1234924001455169536,False,9,0,0,1,Twitter for Advertisers.,"Our Executive Vice President, General Manager, U.S. Barry Flannelly explains how Incyte Ingenuity Award program intends to foster innovation and address the challenges faced by the #GVHD community.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
374729426,2020-03-03 09:00:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1317957, pic.twitter.com/Bv4wkPWeCr, ",1234841118841270273,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on February 21, 2020. View odds for this and other indicators: https://t.co/gG5QEZ4if1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Bv4wkPWeCr",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
227778014,2020-03-02 21:30:06,"MOR, INCY, PFE, LLY, MRK, ABBV, NVS, ",,"buff.ly/2PE0RqD, ",1234667335790682112,False,0,0,0,0,Buffer,"The latest roundup of company news includes Priority Review for MorphoSys' lymphoma therapy, just months after Incyte pays for co-commercialization rights; plus confirmatory data for Merck and AbbVie drugs, and more $MOR $INCY $PFE $LLY $MRK $ABBV $NVS https://t.co/xqAESiFJ4i",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13038,1543,387,33073,BioCentury,
3096702665,2020-03-02 11:30:02,,"NASDAQ, ","jenke.rs/Ba3d2Y, ",1234516323998347266,False,0,0,0,0,Jenkers Eng Posting,Key Financial Inc Invests $4.59 Million in Incyte Co. (#NASDAQ:INCY) https://t.co/xiwV5HXcnl,,,2015-03-19 08:47:40,San Francisco,Jenkers News (ENG),https://pbs.twimg.com/profile_images/588324718677254145/-y5BbeY4_normal.png,1316,234,1265,990172,jenkers_en,
54689430,2020-03-02 10:42:04,,,"pic.twitter.com/ETVA5UiCHH, ",1234504252590088192,False,0,0,0,2,Twitter Web App,Specialty drugmaker Incyte is expanding from blood disorders into a new field - dermatology. Here's a look. https://t.co/ETVA5UiCHH,,,2009-07-07 17:49:39,Philadelphia area,Linda A. Johnson,https://pbs.twimg.com/profile_images/1877599864/LJ_photo3_normal.JPG,5020,887,261,2418,LindaJ_onPharma,photo
374729426,2020-03-02 08:17:30,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1315384, pic.twitter.com/nmoGVPwWsl, ",1234467872862158848,False,1,0,0,1,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 21, 2020. View odds for this and other indicators: https://t.co/qXPfcq5hGi #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/nmoGVPwWsl",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
374729426,2020-03-01 07:46:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1311238, pic.twitter.com/tuvdA4I45K, ",1234097577076776960,False,1,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 21, 2020. View odds for this and other indicators: https://t.co/ENx2KEcAme #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/tuvdA4I45K",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3911174913,2020-02-29 13:00:00,,"raredisease, MPNs, ","pic.twitter.com/snNC40Z3ot, ",1233814188994244609,False,3,0,0,1,Twitter for Advertisers.,We show support for the #raredisease community through our @VoicesOfMPN program that provides resources &amp; a place to connect for those living with #MPNs. https://t.co/snNC40Z3ot,"VoicesofMPN, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
1134049078424162304,2020-02-29 12:24:01,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1233805132833443841,False,1,0,0,0,Newsfilter.io,Incyte Shares Purchased by Oppenheimer Asset Management $INCY https://t.co/iAHpQBr1g2,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
374729426,2020-02-29 09:17:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1307274, pic.twitter.com/ZGRW80PSUv, ",1233758237863759873,False,1,0,0,2,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 21, 2020. View odds for this and other indicators: https://t.co/8iE7pljBUG #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZGRW80PSUv",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-02-29 07:12:53,"INCY, ","investingnews, ","modernreaders.com/?p=2861531, ",1233726835382476801,False,0,0,0,0,Zapier.com,Fjarde AP Fonden Fourth Swedish National Pension Fund Has $4.29 Million Stake in Incyte Co. $INCY  https://t.co/grUfPW1R72 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2525892205,2020-02-29 04:58:49,"INCY, ","investingnews, ","modernreaders.com/?p=2859133, ",1233693095889428481,False,0,0,0,0,Zapier.com,Bank of Montreal Can Has $28.44 Million Stake in Incyte Co. $INCY  https://t.co/rNnAcmJLSh #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2020-02-28 23:58:09,"INCY, ","markets, ","americanbankingnews.com/?p=13597635, ",1233617431739977730,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Down 12.1% in February https://t.co/VW8y7JqoTG #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-28 23:58:09,"INCY, ","stocks, ","americanbankingnews.com/?p=13597635, ",1233617429030461442,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Down 12.1% in February https://t.co/BYQOPqxQkB #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1204967326543699968,2020-02-28 17:31:11,"INCY, ",,,1233520047349542912,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
32492934,2020-02-28 11:33:00,,,"bioworld.com/articles/43335‚Ä¶, ",1233429906081509377,False,0,0,0,0,TweetDeck,"Kadmon's recent oral late-breaker session on KD-025 in chronic GVHD at the Transplantation &amp; Cellular Therapy meeting and recent data  from studies testing competitor Jakafi signaled potential advantages in the former‚Äôs candidate, already highly regarded. https://t.co/DJB6Y25b0j",,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
374729426,2020-02-28 10:56:35,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1301736, pic.twitter.com/5Fcsm8f5Jx, ",1233420743385341952,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on February 19, 2020. View odds for this and other indicators: https://t.co/P2DQWeYmt1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5Fcsm8f5Jx",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3136805274,2020-02-28 10:29:48,,"Artist, pharma, video, ComicBook, ","businesswire.com/news/home/2020‚Ä¶, ",1233414000844689409,False,0,0,0,0,Twitter Web Client,.@Incyte Partners with #Artist and Patient J.G. Jones to Raise Awareness for Myeloproliferative Neoplasms (MPNs) | #pharma #video #ComicBook | Business Wire https://t.co/3fDcpIoM03,"Incyte, ",,2015-04-03 13:13:23,"Plymouth Meeting, PA",John Osborn,https://pbs.twimg.com/profile_images/1126638023213486081/C8vyImKT_normal.png,499,1090,99,4191,John0sborn,
29802659,2020-02-28 09:51:08,,,"VoicesofMPN.com/RareReflections, pic.twitter.com/ygmq7enZAd, ",1233404270961143809,False,2,0,0,0,Twitter Web App,Tomorrow is ‚ÄúRare Disease Day.‚Äù  I was diagnosed with a rare blood¬†cancer in 2016. I was asked by Incyte to help kick off their ‚ÄúRare Reflections‚Äù campaign.¬† My image that you are looking at was created by renowned illustrator @JG_JONESfanpage  My Journey¬†https://t.co/koTVLoqRFk https://t.co/ygmq7enZAd,"JG_JONESfanpage, ",,2009-04-08 15:51:15,Fancy Gap........,C.David Gelly,https://pbs.twimg.com/profile_images/1193906813462286336/DKdRwq70_normal.jpg,6885,6029,0,12176,FancyGap,photo
585864688,2020-02-28 09:42:58,,,"businesswire.com/news/home/2020‚Ä¶, ",1233402217790570496,False,22,0,0,10,Twitter for iPhone,Incyte Partners with Artist and Patient J.G. Jones to Raise Awareness for Myeloproliferative Neoplasms (MPNs) | Business Wire https://t.co/1lyU2Le4tF,,,2012-05-20 14:03:10,Philadelphia,JG Bones,https://pbs.twimg.com/profile_images/1444676776534364162/y8PGfv32_normal.jpg,3534,1073,56,4086,JG_JONESfanpage,
1100450877792370688,2020-02-27 19:21:28,"INCY, ",,"blueequity.io/r/90275/de-inc‚Ä¶, ",1233185412480286721,False,0,0,0,0,Blue Equity,$INCY Incyte Partners with Artist and Patient J.G. Jones to Raise Awareness for Myeloproliferative Neoplasms (MPNs) https://t.co/WCElIhL9E6,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
32492934,2020-02-27 18:20:00,,,"bioworld.com/articles/43335‚Ä¶, ",1233169942729461760,False,0,0,0,0,TweetDeck,"Kadmon TCT data provide ‚ÄòIncyte,‚Äô GVHD odds looking better https://t.co/DJB6Y25b0j",,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
1204967326543699968,2020-02-27 17:31:24,"INCY, ",,,1233157712734834688,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
1134049078424162304,2020-02-27 14:19:52,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1233109513739362306,False,0,0,0,0,Newsfilter.io,Incyte Partners with Artist and Patient J.G. Jones to Raise Awareness for Myeloproliferative Neoplasms $INCY https://t.co/Rx2BNNJM2X,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
707270913448919041,2020-02-27 14:00:00,,"MPN, ",,1233104512824381441,False,3,0,0,0,Twitter for Advertisers.,A rare cancer diagnosis is nothing short of life changing. Watch as J.G. Jones candidly shares his #MPN diagnosis journey in hopes of raising awareness and encouraging others to share their story via ‚ÄúRare Reflections‚Äù with @Incyte.,"Incyte, ",,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
707270913448919041,2020-02-27 10:28:39,,"MPN, ",,1233051326067740674,False,3,0,0,1,Twitter for Advertisers.,A rare cancer diagnosis is nothing short of life changing. Watch as J.G. Jones candidly shares his #MPN diagnosis journey in hopes of raising awareness and encouraging others to share their story via ‚ÄúRare Reflections‚Äù with @Incyte.,"Incyte, ",,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
1139387949768835072,2020-02-27 09:25:15,"EFX, MU, F, IRM, DUK, ANET, INCY, ","TradeTipsApp, StocksToWatch, StockMarket, ",,1233035371719667712,False,2,0,1,0,Twitter Web App,"Stocks we're watching today:

Equifax Inc. $EFX
Micron Tech. Inc. $MU
Ford Motor Co. $F
Iron Mountain Inc. $IRM
Duke Energy $DUK
Arista Networks Inc $ANET
Incyte Corp $INCY

What are we missing? Let us know!

#TradeTipsApp #StocksToWatch #StockMarket",,,2019-06-14 00:23:50,,TradeTips,https://pbs.twimg.com/profile_images/1232726148553101312/kkd1ffTs_normal.jpg,499,783,13,1641,TradeTipsApp,
472650465,2020-02-27 09:16:35,"INCY, ",,"otcdynamics.com/incy-incyte-pa‚Ä¶, ",1233033187221217281,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Partners with Artist and Patient J.G. Jones to Raise Awareness for Myeloproliferative Neoplasms (MPNs) https://t.co/CtzLFt3LrW,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1069693680066420736,2020-02-27 09:05:34,"INCY, ",,"s.flashalert.me/xAhSL6, ",1233030417097396224,False,0,0,0,0,flashalerts,"$INCY: Issued Press Release on February 27, 09:00:00: Incyte Partners with Artist and Patient J.G. Jones to Raise Awareness for Myeloproliferative Neoplasms (MPNs) https://t.co/RRSFpLgZee",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
707270913448919041,2020-02-27 09:00:00,,"MPN, ",,1233029016254283776,False,2,1,0,0,Twitter for Advertisers.,"We‚Äôre thrilled to unveil ‚ÄúRare Reflections: MPNs Unmasked,‚Äù a campaign with @Incyte that beautifully shines light on J.G. Jones‚Äô journey living with an #MPN.","Incyte, ",,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
374729426,2020-02-27 08:32:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1299166, pic.twitter.com/iozuLCJCCk, ",1233022131178336256,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on February 19, 2020. View odds for this and other indicators: https://t.co/yu4ix0QWPd #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/iozuLCJCCk",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
477131488,2020-02-26 19:06:30,,"immunotherapy, MAP, cancer, antigens, PNAS, ","ous-research.no/lund-johansen, pic.twitter.com/jToSCwr2yR, pic.twitter.com/jToSCwr2yR, pic.twitter.com/jToSCwr2yR, twitter.com/RandiMHernande‚Ä¶, ",1232819258574413825,False,6,0,0,1,Twitter for iPhone,Great insights by Drs @petitprez_f &amp; colleagues into #immunotherapy responders/MY OPINION:Arrays like #MAP by @F_Lund_Johansen https://t.co/rP1Kggr5I1 or @tylerwhulett @cdi_labs tech/will guide monitoring &amp; ID of #cancer #antigens /Read below Tripathi #PNAS 2016 @bmsnews @Incyte https://t.co/jToSCwr2yR https://t.co/cvHXUcFMz8,"petitprez_f, F_Lund_Johansen, tylerwhulett, cdi_labs, bmsnews, Incyte, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
1204967326543699968,2020-02-26 17:31:19,"INCY, ",,,1232795302568087553,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
707270913448919041,2020-02-26 17:29:49,,"MPN, ",,1232794926812946433,False,0,0,0,1,Twitter for Advertisers.,"We‚Äôre thrilled to unveil ‚ÄúRare Reflections: MPNs Unmasked,‚Äù a campaign with @Incyte that beautifully shines light on J.G. Jones‚Äô journey living with an #MPN.","Incyte, ",,2016-03-08 13:25:01,,Voices of MPN,https://pbs.twimg.com/profile_images/867444811216900097/5tkC-AQ6_normal.jpg,502,0,3,358,VoicesofMPN,
296326514,2020-02-26 14:29:51,,"SpokaneValley, HVAC, ","pic.twitter.com/jlOU78Fgu1, pic.twitter.com/jlOU78Fgu1, pic.twitter.com/jlOU78Fgu1, pic.twitter.com/jlOU78Fgu1, ",1232749636277850113,False,2,0,0,0,Twitter Web App,"New crane lift photos of a job @RandRHeating did for Incyte Diagnostics in the #SpokaneValley. The larger item that was installed was a Valent 30-ton ERV unit. For more info on our commercial #HVAC services, give us a call at 509-484-1405 or visit our website. https://t.co/jlOU78Fgu1","randrheating, ",,2011-05-10 11:33:41,"Spokane, WA / Hayden, ID",R&R Heating & AC,https://pbs.twimg.com/profile_images/817098424235347968/U3CVykRZ_normal.jpg,391,22,0,2353,randrheating,photo
296326514,2020-02-26 14:29:18,,"commercialHVAC, ","pic.twitter.com/gHyeQKxjxn, pic.twitter.com/gHyeQKxjxn, pic.twitter.com/gHyeQKxjxn, pic.twitter.com/gHyeQKxjxn, ",1232749497521860609,False,2,0,0,0,Twitter Web App,"New crane lift photos of a job R&amp;R Heating &amp; Air Conditioning did for Incyte Diagnostics in the Spokane Valley. The larger item that was installed was a Valent 30-ton ERV unit. For more info on our #commercialHVAC services, give us a call at 509-484-1405 or visit our website. https://t.co/gHyeQKxjxn",,,2011-05-10 11:33:41,"Spokane, WA / Hayden, ID",R&R Heating & AC,https://pbs.twimg.com/profile_images/817098424235347968/U3CVykRZ_normal.jpg,391,22,0,2353,randrheating,photo
940506141536141312,2020-02-26 10:08:29,,"Myelofibrosis, MF, ","bit.ly/2UVkHS3, pic.twitter.com/EJ9CxYabG5, ",1232683861949079553,False,1,0,0,1,Twitter Web App,"#Myelofibrosis (#MF) Therapeutics Pipeline to Witness Remarkable Growth due to Increased Number of Pipeline Candidates by Drug Developers.

Get the Sample Pages at: https://t.co/6EwVrBcZOJ

Key Company: @Incyte, @ctibiotech, @VisitSuzhou, @Novartis, @abbvie, @nipponshinyaku. https://t.co/EJ9CxYabG5","Incyte, ctibiotech, VisitSuzhou, Novartis, abbvie, nipponshinyaku, ",,2017-12-12 03:58:32,India,PharmProff,https://pbs.twimg.com/profile_images/1090504682491994112/jzTrBOWi_normal.jpg,36,119,1,92,PharmaProff,photo
374729426,2020-02-26 08:31:26,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1295003, pic.twitter.com/qkqme58t1X, ",1232659438437199872,False,0,0,0,0,Tickeron,$INCY in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/vjUgAUCtxN #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/qkqme58t1X,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-02-26 03:36:59,"INCY, ",,"zpr.io/tDcBs, ",1232585338696146945,False,0,0,0,0,Zapier.com,FY2021 EPS Estimates for Incyte Co. $INCY Lifted by Analyst https://t.co/wwIDHmW5iv,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1093993095148986368,2020-02-25 22:32:30,,,,1232508713195327488,False,0,0,0,0,Twitter for iPhone,Why can‚Äôt  government get the drug company‚Äôs to lower drug costs. As of this month a drug I take is  made by  incyte  and my cost went up from $658.00 per month to $2800.00 per month.I cannot  pay this.If I stop taking the drug then I will die. Something has to be done?,,,2019-02-08 17:00:54,,Pete@river,https://pbs.twimg.com/profile_images/1093993931312787457/TMNyekAw_normal.jpg,0,26,0,39,Peteriver3,
1204967326543699968,2020-02-25 17:31:23,"INCY, ",,,1232432932142206976,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
3911174913,2020-02-25 14:30:00,,"GVHD, ",,1232387287192752128,False,1,0,0,1,Twitter for Advertisers.,"The Incyte Ingenuity Award is now open for applications. Our Executive Vice President, General Manager, U.S., Barry Flannelly, sheds light on what opportunities this presents for the #GVHD community.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
4505683408,2020-02-25 12:50:05,,,"buff.ly/2v4XPVm, pic.twitter.com/3Pzya49IIE, ",1232362143393165313,False,0,0,0,0,Buffer,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/GTkW45xlKi https://t.co/3Pzya49IIE,,,2015-12-16 13:35:24,United States,Christopher Walker,https://pbs.twimg.com/profile_images/859480402775429122/f_L6rKud_normal.jpg,2719,2798,67,28050,risk_averse_,photo
765563638048395269,2020-02-25 12:10:11,,,"buff.ly/2v4XPVm, pic.twitter.com/YtBHhMpAip, ",1232352101109575680,False,0,0,0,0,Buffer,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/ITd4Hm3I0b https://t.co/YtBHhMpAip,,,2016-08-16 10:59:29,"Illinois, USA",Financial Carnivores,https://pbs.twimg.com/profile_images/765582076095574016/gWTrUTCM_normal.jpg,1790,1856,113,24792,HowieRegay,photo
3363228003,2020-02-25 11:30:31,,,"buff.ly/2v4XPVm, pic.twitter.com/QOFa1KW6ce, ",1232342118204657666,False,0,0,0,0,Buffer,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/oI5FT7Mc4F https://t.co/QOFa1KW6ce,,,2015-07-06 19:26:37,,Analysts' Analyst,https://pbs.twimg.com/profile_images/658975687223701504/ORzKekze_normal.jpg,767,821,5,10945,AnalystsAnalyst,photo
22709198,2020-02-25 11:01:06,,,"buff.ly/2v4XPVm, pic.twitter.com/WboR1nDJt7, ",1232334717283917828,False,0,0,0,0,Buffer,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/DPfEVY33xw https://t.co/WboR1nDJt7,,,2009-03-03 19:52:54,U.S.,HealthyCarnivores,https://pbs.twimg.com/profile_images/868171389743894529/WidBkAEW_normal.jpg,4585,4591,323,50211,HealthyCarnivor,photo
43921687,2020-02-25 10:30:31,,,"buff.ly/2v4XPVm, pic.twitter.com/ojXrfER2wc, ",1232327018148237312,False,0,0,0,0,Buffer,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/LUUscMgze6 https://t.co/ojXrfER2wc,,,2009-06-01 13:03:56,"Chicago, IL",BioPharmaDevice,https://pbs.twimg.com/profile_images/841433473588068352/Ab4Ggetb_normal.jpg,2076,1537,78,24549,OneMedWorld,photo
3363291113,2020-02-25 10:10:07,,,"buff.ly/2v4XPVm, pic.twitter.com/FHMRFjSNwX, ",1232321883544133632,False,0,0,0,0,Buffer,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/z4UG2gVz8J https://t.co/FHMRFjSNwX,,,2015-07-06 19:40:06,"Chicago, IL",Julie Lakeview,https://pbs.twimg.com/profile_images/926542318190104576/eZp4RhRN_normal.jpg,897,892,10,17512,LakeviewJulie,photo
374729426,2020-02-25 09:01:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1289169, pic.twitter.com/443aUB9dit, ",1232304614654873600,False,1,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on February 21, 2020. View odds for this and other indicators: https://t.co/EwnyqEQTD8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/443aUB9dit",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3389185084,2020-02-25 07:50:04,,,"buff.ly/2v4XPVm, pic.twitter.com/hbVccKuL4u, ",1232286642372849667,False,0,0,0,0,Buffer,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/H0QVD1ixeb https://t.co/hbVccKuL4u,,,2015-07-23 08:41:42,United States,About Medtech,https://pbs.twimg.com/profile_images/836351563434090501/P7_dmG2v_normal.jpg,1382,1386,24,13130,AboutMedtech,photo
732361939490312192,2020-02-25 04:37:45,"INCY, ","markets, ","americanbankingnews.com/?p=13541423, ",1232238243917312000,False,0,0,0,0,Zapier.com,Recent Research Analysts‚Äô Ratings Changes for Incyte $INCY https://t.co/By76Gs9IH0 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-25 04:37:45,"INCY, ","stocks, ","americanbankingnews.com/?p=13541423, ",1232238241526489088,False,0,0,0,0,Zapier.com,Recent Research Analysts‚Äô Ratings Changes for Incyte $INCY https://t.co/4mVs61y2Il #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
966006214818697218,2020-02-25 04:37:08,"INCY, ",,"theenterpriseleader.com/?p=2693776, ",1232238087595610112,False,1,0,0,0,Zapier.com,Recent Research Analysts‚Äô Ratings Changes for Incyte $INCY  https://t.co/5GlgF59icg,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1204967326543699968,2020-02-24 17:31:34,"INCY, ",,,1232070592309977088,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
1087563377889763329,2020-02-24 14:50:10,,"Incyte, endpoint, atopicdermatitis, clinicaltrial, ","ow.ly/qPWq30qjRlt, ",1232029972803588097,False,0,0,0,0,Hootsuite Inc.,#Incyte hits #endpoint in 2nd pivotal #atopicdermatitis #clinicaltrial | FierceBiotech https://t.co/m9CBOmeEtH,,,2019-01-21 23:11:30,"Bradenton, FL","Synergy Healthcare, LLC",https://pbs.twimg.com/profile_images/1255687146624692224/hdDn-7ye_normal.jpg,19,135,1,1173,SynergyHealthCR,
3911174913,2020-02-24 10:00:00,,"GVHD, ",,1231956950201643009,False,6,0,0,3,Twitter for Advertisers.,"The Incyte Ingenuity Award was created to support people living with #GVHD, as well as their caregivers and physicians, by encouraging the development of innovative solutions. Now accepting applications.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
374729426,2020-02-24 07:51:46,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1286648, pic.twitter.com/ULhZPqIqmL, ",1231924679788523520,False,1,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on February 19, 2020. View odds for this and other indicators: https://t.co/5V4xz9cEZD #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ULhZPqIqmL",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1979190776,2020-02-24 05:37:06,"INCY, ",,"tickerreport.com/?p=5090435, ",1231890789120212993,False,1,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $200,000.00 in Stock https://t.co/vdTMZbtmFj",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2525892205,2020-02-24 04:42:32,"INCY, ","investingnews, ","modernreaders.com/?p=2827439, ",1231877059682689025,False,0,0,0,0,Zapier.com,Andra AP fonden Has $5.27 Million Stock Holdings in Incyte Co. $INCY  https://t.co/KWa9hjnqpf #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
2525892205,2020-02-24 03:31:10,"INCY, ","investingnews, ","modernreaders.com/?p=2826539, ",1231859098813190145,False,0,0,0,0,Zapier.com,"Incyte Co. to Post FY2021 Earnings of $3.18 Per Share, Oppenheimer Forecasts $INCY  https://t.co/bS8kE2aTMS #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
966006214818697218,2020-02-24 03:30:20,"INCY, ",,"theenterpriseleader.com/?p=2686378, ",1231858888850509825,False,1,0,0,0,Zapier.com,"Incyte Co. to Post FY2021 Earnings of $3.18 Per Share, Oppenheimer Forecasts $INCY  https://t.co/xLHEZG58qW",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
4419993470,2020-02-24 03:20:21,,"stocks, news, ","ift.tt/39VeyJC, ",1231856378085543936,False,0,0,0,0,IFTTT,Stocks This Week: Sell Short General Dynamics And Incyte And Buy General Electric - Forbes https://t.co/hykLPxIrme #stocks #news,,,2015-12-01 06:37:16,,Signals.me,https://pbs.twimg.com/profile_images/686123587200143360/hr4lhxxx_normal.png,23819,12097,148,174057,SignalsMe,
354537587,2020-02-23 13:09:33,,,"dlvr.it/RQbltJ, pic.twitter.com/ZF9pFEnZnn, ",1231642265220603904,True,0,0,0,0,dlvr.it,Stocks This Week: Sell Short General Dynamics And Incyte And Buy General Electric https://t.co/ip8gnoLSeV https://t.co/ZF9pFEnZnn,,,2011-08-13 18:02:26,,George Mentz JD MBA CWM,https://pbs.twimg.com/profile_images/645305436032229376/OLzZNOQD_normal.png,169213,798,54,280565,GeorgeMentz,photo
777467401629753344,2020-02-23 10:47:24,,,"forbes.com/sites/greatspe‚Ä¶, forbes.com/sites/greatspe‚Ä¶, ",1231606493037965319,False,1,0,0,1,Twitter Web App,"Here are stocks to trade over the short-term and stocks to trade in the month of March...

https://t.co/SQv5entQzB

https://t.co/uqOCwlWwqS",,,2016-09-18 07:20:48,Austria,Bill Sarubbi,https://pbs.twimg.com/profile_images/819997437947420672/QlRk9nHI_normal.jpg,582,27,5,404,cyclesresearch7,
3064967368,2020-02-23 10:39:34,,"clinicaltrial, topical, JAKinhibitor, eczema, QoL, itch, ","jaad.org/article/S0190-‚Ä¶, ",1231604519643025408,False,16,0,3,2,Twitter Web App,"Please see our #clinicaltrial on #topical #JAKinhibitor #eczema #QoL #itch with @Incyte in @JAADjournals 
https://t.co/lJveyAZ0JO","Incyte, JAADjournals, ",,2015-02-28 14:04:33,"St. Louis, MO","Brian S. Kim, MD, MTR",https://pbs.twimg.com/profile_images/1390351360303026176/LaQoWrfp_normal.jpg,2104,371,16,1490,itchdoctor,
374729426,2020-02-23 10:36:14,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1281190, pic.twitter.com/gcuh4cIBHv, ",1231603679913889792,False,1,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on February 19, 2020. View odds for this and other indicators: https://t.co/4OVzxY0Gbw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/gcuh4cIBHv",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2344711740,2020-02-23 10:35:26,,,"realestate.retailconcepts.in/world-market/s‚Ä¶, pic.twitter.com/eLMwrP8qAa, ",1231603480432971778,False,0,0,0,0,WordPress.com,Stocks This Week: Sell Short General Dynamics And Incyte And Buy General¬†Electric https://t.co/3VuVkJxhy5 https://t.co/eLMwrP8qAa,,,2014-02-15 02:20:39,Pune,Retail Concepts,https://pbs.twimg.com/profile_images/434593139429347328/R2VqqB6Y_normal.jpeg,43,8,3,24435,retailconcept,photo
1181964022998011910,2020-02-23 10:31:33,,,"dlvr.it/RQbPN6, pic.twitter.com/D0R9O7cTZP, ",1231602503201869824,False,0,0,0,0,dlvr.it,Stocks This Week: Sell Short General Dynamics And Incyte And Buy General Electric: The current decline is likely to extend into mid-March. https://t.co/hn1CMQGRwU https://t.co/D0R9O7cTZP,,,2019-10-09 12:06:13,"New York, United States",Virtual Data Rooms Reviews for M&A,https://pbs.twimg.com/profile_images/1181964420454457345/7k8uKSDq_normal.jpg,113,7,2,22031,rooms_data,photo
963576775350497281,2020-02-23 10:31:33,,,"dlvr.it/RQbPKz, pic.twitter.com/Ja0zW7dLzw, ",1231602502472097792,False,0,0,0,0,dlvr.it,Stocks This Week: Sell Short General Dynamics And Incyte And Buy General Electric https://t.co/1fPRj7tmsB https://t.co/Ja0zW7dLzw,,,2018-02-13 19:53:00,,DataMangler,https://pbs.twimg.com/profile_images/1373473329701527553/9MjPt81Y_normal.jpg,223,977,0,5663,DataMunger1,photo
852931863547084801,2020-02-23 08:51:54,"INCY, ",,"zpr.io/tDZzf, ",1231577425978499073,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Cowen https://t.co/6lpLtOa44O,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
68559732,2020-02-23 08:02:13,"INCY, ",,"zpr.io/tDpJe, ",1231564920493309952,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to at Nomura https://t.co/VX0bvzHuYA,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
849417718642159616,2020-02-23 08:01:01,"INCY, ",,"zpr.io/tDpJH, ",1231564619585593345,False,0,0,0,0,Zapier.com,Incyte $INCY PT Raised to at Nomura https://t.co/qEA3f25OS6,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
966006214818697218,2020-02-23 06:25:45,"INCY, ",,"theenterpriseleader.com/?p=2683892, ",1231540645631844352,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $200,000.00 in Stock  https://t.co/lqvFqe5r7J",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
849417718642159616,2020-02-23 02:38:02,"INCY, ",,"zpr.io/tDzPT, ",1231483339963498496,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Piper Sandler https://t.co/zEQfaRhGtZ,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2298709746,2020-02-23 02:37:45,"INCY, ",,"zpr.io/tDzP7, ",1231483267494359041,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Piper Sandler https://t.co/RiHIJfijSI,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
374729426,2020-02-22 10:46:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1278631, pic.twitter.com/ZOjKlOWlhW, ",1231243880550371328,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on February 19, 2020. View odds for this and other indicators: https://t.co/uwgFiIM0V2 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZOjKlOWlhW",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-02-22 08:22:46,"INCY, ",,"zpr.io/tDHbn, ",1231207707375476736,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Paula J. Swain Sells 2,500 Shares of Stock https://t.co/10OuZcQyL7",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
852931863547084801,2020-02-22 08:19:18,"INCY, ",,"zpr.io/tDHKw, ",1231206834117234688,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Paula J. Swain Sells 2,500 Shares of Stock https://t.co/7hD37Z5jKG",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
852931863547084801,2020-02-22 08:04:58,"INCY, ",,"zpr.io/tDHEW, ",1231203226835439617,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúBuy‚Äù Rating at Piper Sandler https://t.co/OlrGb8Wg9D,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
852931863547084801,2020-02-22 08:04:57,"INCY, ",,"zpr.io/tDHEB, ",1231203223035424768,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Raised to https://t.co/MUfyAKATFC,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
68559732,2020-02-22 08:03:46,"INCY, ",,"zpr.io/tDHx7, ",1231202926556831744,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúBuy‚Äù Rating from Piper Sandler https://t.co/wCKKqBkwYk,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
68559732,2020-02-22 08:03:46,"INCY, ",,"zpr.io/tDHxq, ",1231202923633414149,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Cowen https://t.co/WEGUUVtfUj,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2266388972,2020-02-22 08:01:35,"INCY, ","stocks, ","dailypolitical.com/?p=3438928, ",1231202375597219843,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúBuy‚Äù Rating from Piper Sandler https://t.co/rRpl1D8NGX #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-02-22 08:01:34,"INCY, ",,"dailypolitical.com/?p=3438928, ",1231202371520344066,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúBuy‚Äù Rating from Piper Sandler https://t.co/X2jVCjktzk,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2266388972,2020-02-22 08:01:33,"INCY, ","stocks, ","dailypolitical.com/?p=3438931, ",1231202367212793856,False,0,0,0,0,Zapier.com,Nomura Increases Incyte $INCY Price Target to https://t.co/3HNYIp5BIQ #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-02-22 08:01:33,"INCY, ",,"dailypolitical.com/?p=3438931, ",1231202364767526913,False,0,0,0,0,Zapier.com,Nomura Increases Incyte $INCY Price Target to https://t.co/Q2PIQHPmJr,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2266388972,2020-02-22 07:44:24,"INCY, ","stocks, ","dailypolitical.com/?p=3438517, ",1231198052523925504,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded to Sell at BidaskClub https://t.co/HLbn7D09sP #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-02-22 07:44:23,"INCY, ",,"dailypolitical.com/?p=3438517, ",1231198048400953345,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded to Sell at BidaskClub https://t.co/2RQqkglYYQ,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
68559732,2020-02-22 07:43:00,"INCY, ",,"zpr.io/tDH7N, ",1231197700248494080,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded to Sell at BidaskClub https://t.co/KfOSdT5YgX,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
823977635768365056,2020-02-22 06:30:20,,,"buff.ly/2v4XPVm, pic.twitter.com/d2Q1Z7xE95, ",1231179412852400128,False,0,0,0,0,Buffer,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/UfnHpRM0t5 https://t.co/d2Q1Z7xE95,,,2017-01-24 14:35:51,United States,InvestmentCupboard,https://pbs.twimg.com/profile_images/1285609482974879744/EdXS07f6_normal.jpg,1039,1061,16,12149,InvstmtCupboard,photo
1259694398,2020-02-22 06:30:03,,,"buff.ly/2v4XPVm, pic.twitter.com/6I6a5ece9X, ",1231179341524013056,False,0,0,0,0,Buffer,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/WaMH3nmRHo https://t.co/6I6a5ece9X,,,2013-03-11 11:12:50,Chicago,CarnivoresHealth,https://pbs.twimg.com/profile_images/820845362705481728/eSMZRJDT_normal.jpg,6197,6134,509,55396,HealthierIT,photo
3363332327,2020-02-22 04:30:10,,,"buff.ly/2v6kVuU, pic.twitter.com/WTD41IIZG0, ",1231149170892967937,False,0,0,0,0,Buffer,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/m3332Sl6K1 https://t.co/WTD41IIZG0,,,2015-07-06 20:15:16,"Stockholm, Sweden",Swedish Biotech,https://pbs.twimg.com/profile_images/825044879411650560/BVzozrPt_normal.jpg,2794,2365,25,25407,BiotechSweden,photo
1134049078424162304,2020-02-22 01:43:09,"INCY, ",,"newsfilter.io/articles/nomur‚Ä¶, ",1231107139684438017,False,0,0,0,0,Newsfilter.io,Nomura Increases Incyte Price Target to $INCY https://t.co/TzyCEdPLJE,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-02-21 20:58:08,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1231035413986447360,False,0,0,0,0,Newsfilter.io,"$38,625.00 of shares sold by Swain Paula J (EVP, Human Resources), reported in a new form 4 filed with the SEC  $INCY https://t.co/zGR1lviaTj",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
895929863521095680,2020-02-21 20:07:16,"INCY, ","DeathCross, Incyte, stocks, trading, finance, market, ","bit.ly/2V83KUt, pic.twitter.com/yGJWYtyBX9, ",1231022610131148802,False,0,0,0,0,TradeFlags,#DeathCross $INCY at 80.89 R7  HiLo 36% T1Y 91 buy 2.4 PE 39.5 DIV N/A #Incyte Cor #stocks #trading #finance #market https://t.co/vzHLTH5zU3 https://t.co/yGJWYtyBX9,,,2017-08-11 04:48:19,1130,TradeFlags,https://pbs.twimg.com/profile_images/1444247772769792002/Hc_nWhvE_normal.jpg,636,206,11,58994,TradeFlags,photo
732361939490312192,2020-02-21 18:00:14,"INCY, ","markets, ","americanbankingnews.com/?p=13502635, ",1230990642483953666,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/PxFwuQWifM #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-21 18:00:13,"INCY, ","stocks, ","americanbankingnews.com/?p=13502635, ",1230990638092603395,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/6J30D1g70B #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2266388972,2020-02-21 17:59:40,"INCY, ","stocks, ","dailypolitical.com/?p=3436674, ",1230990499005304837,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/Yg39PCesAt #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-02-21 17:59:39,"INCY, ",,"dailypolitical.com/?p=3436674, ",1230990496400539648,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/3s5MClg2m1",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
68559732,2020-02-21 17:58:58,"INCY, ",,"zpr.io/tDnt3, ",1230990324060868608,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/dUShzvSsFq",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1204967326543699968,2020-02-21 17:31:20,"INCY, ",,,1230983367715426306,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
1176558075798380544,2020-02-21 16:31:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1230968277880451072,False,0,0,0,0,InsiderActionMonitor,$INCY Paula Swain Dumps 2.5K Shares of Incyte https://t.co/OFCFZRiyW2,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
2564014766,2020-02-21 16:13:29,"INCY, ",,"jivedata.com/filing/0001209‚Ä¶, ",1230963777283117058,False,0,0,0,0,jivedata insider filings,"$INCY: SWAIN PAULA J sold $200,000 in INCYTE CORP https://t.co/oJUpR384dL",,,2014-06-12 16:19:36,"New York, NY",Insider Filings,https://pbs.twimg.com/profile_images/1223746535835308032/1dG0OLg2_normal.png,428,0,30,73984,insider_filings,
3911174913,2020-02-21 15:30:00,,"GVHD, ",,1230952833857421312,False,1,0,1,1,Twitter for Advertisers.,We're continuously searching for new ways to foster innovation among the #GVHD community. The Incyte Ingenuity Award is now open to support innovators making a difference in this area of high unmet need.,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
1002361483169226752,2020-02-21 15:25:59,,"Incyte, PositiveResults, TRuEAD, Ruxolitinib, AtopicDermatitis, cream, healthcare, ","trialsitenews.com/incyte-announc‚Ä¶, ",1230951822396780544,False,1,0,0,0,Twitter Web Client,#Incyte Announces #PositiveResults from Phase 3 #TRuEAD Program of #Ruxolitinib Cream for #AtopicDermatitis https://t.co/H1Mtli3bZ1 #cream #healthcare,,,2018-05-31 21:29:35,"Salt Lake City, Utah",TrialSite News,https://pbs.twimg.com/profile_images/1002368873918689280/0KP3xUVe_normal.jpg,7886,3205,76,11177,TrialsiteN,
1027129900828909568,2020-02-21 09:24:35,,,"lnkd.in/eYh3Rbm, lnkd.in/e_mcx4k, ",1230860873624846336,False,1,0,0,0,LinkedIn,"Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD Community. Up to $100,000 to be awarded for an innovative solution addressing an unmet need in the graft-versus-host disease (GVH‚Ä¶https://t.co/j5tfkzVy5e https://t.co/cbgqkp1K6C",,,2018-08-08 05:50:26,"District of Columbia, USA",Andre Williams,https://pbs.twimg.com/profile_images/1034147603049590785/aRNDno3r_normal.jpg,545,682,2,865,AndreWi54721839,
374729426,2020-02-21 08:32:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1272816, pic.twitter.com/SjR2lrCrFd, ",1230847878131666945,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on February 19, 2020. View odds for this and other indicators: https://t.co/VT8B4RSk2q #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/SjR2lrCrFd",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2416188264,2020-02-21 07:11:06,"INCY, ","markets, ","thestockobserver.com/?p=2657198, ",1230827284665376768,False,0,0,0,0,Zapier.com,Nomura Increases Incyte $INCY Price Target to  https://t.co/W197T3okK6 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
966006214818697218,2020-02-21 02:06:00,"INCY, ",,"theenterpriseleader.com/?p=2667799, ",1230750503375499266,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Piper Sandler  https://t.co/awSRacMFsU,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2525892205,2020-02-21 02:05:10,"INCY, ","investingnews, ","modernreaders.com/?p=2807967, ",1230750292846604289,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Piper Sandler  https://t.co/9xZiGLwSl0 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
3033227178,2020-02-20 22:12:00,,"dermatitis, ","bit.ly/2SLGmKT, ",1230691615204954114,False,0,0,0,1,Sprout Social,Incyte announces positive topline results from Phase III TRuE-AD program evaluating ruxolitinib cream in patients with atopic #dermatitis. https://t.co/irPSgVXTzc,,,2015-02-20 15:50:10,,Dermal Cell News,https://pbs.twimg.com/profile_images/1280900311024988160/C-7sd8cl_normal.jpg,619,246,30,5807,DermalCell,
1204967326543699968,2020-02-20 17:31:17,"INCY, ",,,1230620967413653505,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
3911174913,2020-02-20 14:56:56,,"GVHD, ",,1230582125944098816,False,2,0,0,0,Twitter for Advertisers.,"Last night, we celebrated the launch of the first annual Incyte Ingenuity Award program. We are committed to those affected by #GVHD &amp; encourage those who qualify for the program to apply.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
732361939490312192,2020-02-20 13:02:33,"INCY, ","markets, ","americanbankingnews.com/?p=13484276, ",1230553338091102209,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Piper Sandler https://t.co/m4k0ben4lN #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-20 13:02:31,"INCY, ","stocks, ","americanbankingnews.com/?p=13484276, ",1230553333548470274,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Piper Sandler https://t.co/hK2Gu5lpyR #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
94365736,2020-02-20 12:10:15,,"Incyte, atopicdermatitis, ruxolitinib, ","fiercebiotech.com/biotech/incyte‚Ä¶, ",1230540178441330690,False,0,0,0,0,Hootsuite Inc.,#Incyte hits endpoint in 2nd pivotal #atopicdermatitis trial https://t.co/V3Lbsft26I @FierceBiotech @Incyte #ruxolitinib,"FierceBiotech, Incyte, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
2384219072,2020-02-20 12:01:56,,"innovation, debio, NetDe, DeBioGala, ","pic.twitter.com/8EPoe18c3x, ",1230538084200124417,False,1,0,0,0,Loomly,"Thank you to @Incyte for their #innovation sponsorship for the #debio 2020 Gala! Inycte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs.
#NetDe #DeBioGala https://t.co/8EPoe18c3x","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
1001516954916618241,2020-02-20 11:13:14,,"eczema, dermatitis, dermatology, DERMATOLOGISTS, ClinicalResearch, clinicaltrials, clinicaltrial, healthcare, Doctors, Physicians, medicine, news, USA, Europe, ","biotech-investments.com/incyte-phase-3‚Ä¶, pic.twitter.com/VlCbLnvShP, ",1230525829584740354,False,5,0,1,0,Twitter Web App,"Breakthrough: Non-steroidal Cream for the Treatment of Millions of Patients with Eczema:
https://t.co/1bbmXMU822

#eczema #dermatitis #dermatology #DERMATOLOGISTS #ClinicalResearch #clinicaltrials #clinicaltrial #healthcare #Doctors #Physicians #medicine #news #USA #Europe https://t.co/VlCbLnvShP",,,2018-05-29 13:33:44,Switzerland,Biotech Investments,https://pbs.twimg.com/profile_images/1201182180975661056/y9NlME8P_normal.jpg,6338,124,23,153,BiotechInvsts,photo
495524785,2020-02-20 10:41:51,"INCY, ",,,1230517933547380741,False,0,0,0,0,Twitter Web App,$INCY Incyte has been running up good.  Target to reach $100 in March.,,,2012-02-17 21:11:18,Invest in Energy/Biotechs,Henry Nguyen,https://pbs.twimg.com/profile_images/2281171479/zk3vj1l6hcktsq6941qr_normal.jpeg,258,63,7,11460,hieuvnguyen,
374729426,2020-02-20 08:37:33,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1270288, pic.twitter.com/EKgtQzYAMe, ",1230486652151160832,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator enters overbought zone. View odds for this and other indicators: https://t.co/JaKi7PPeQ3 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/EKgtQzYAMe,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
13557562,2020-02-20 06:23:32,,,"firstwordpharma.com/node/1702077, ",1230452924377116673,False,0,0,0,4,Twitter Web Client,Check out this FWPharma article : Incyte's ruxolitinib cream achieves main goal in second late-stage atopic dermatitis study. https://t.co/STulFe7q4x via @fwpharma,"fwpharma, ",,2008-02-16 11:58:12,"iPhone: 35.121323,-89.830750","Michael Blaiss, MD",https://pbs.twimg.com/profile_images/1397602816345186304/FFET4jcx_normal.jpg,3944,811,177,14618,wheezemd,
1979190776,2020-02-20 06:05:21,"INCY, ",,"tickerreport.com/?p=5069099, ",1230448346168512512,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Upgraded by BidaskClub https://t.co/tGA00T0hYV,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
19287403,2020-02-20 04:31:33,,"PharmaScrip, ","bit.ly/2HDI2Q7, dlvr.it/RQP75r, pic.twitter.com/mWYEp8P4iD, ",1230424744333209601,False,0,0,0,0,dlvr.it,PharmaScrip:  Incyte Ready To Go For Approval Of Topical Ruxolitinib In Atopic Dermatitis https://t.co/CSVK0r99rR¬† #PharmaScrip https://t.co/iwqvA8gcMh https://t.co/mWYEp8P4iD,,,2009-01-21 08:39:09,Nederland,ZorgNL,https://pbs.twimg.com/profile_images/72293628/twitter_health_normal.PNG,15928,442,0,103180,zorgnl,photo
21079030,2020-02-20 04:04:26,,"PharmaScrip, ","bit.ly/2HDI2Q7, ",1230417919064133632,False,0,0,0,0,Sprinklr,"Incyte Ready To Go For Approval Of Topical Ruxolitinib In Atopic Dermatitis
https://t.co/3alzp7Yh6a #PharmaScrip",,,2009-02-17 05:33:29,Global,Scrip,https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg,21541,1629,654,35335,PharmaScrip,
1979190776,2020-02-20 02:51:57,"INCY, ",,"tickerreport.com/?p=5066903, ",1230399675674615809,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by JPMorgan Chase &amp; Co. https://t.co/ce6ereqSrh,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
852931863547084801,2020-02-20 02:51:07,"INCY, ",,"zpr.io/t8x85, ",1230399466236252161,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by JPMorgan Chase &amp; Co. https://t.co/aB9dB1k4uM,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
1134049078424162304,2020-02-20 02:46:57,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1230398419342102529,False,0,0,0,0,Newsfilter.io,Incyte Announces Positive Topline Results From Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients With Atopic Dermatitis $INCY https://t.co/AJaQXXoGgQ,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
3068641671,2020-02-20 02:44:34,"SAN, ","Sanofi, equity, stocks, ","dlvr.it/RQNs0y, pic.twitter.com/XpZd9Ug1Zy, ",1230397818570821633,False,0,0,0,0,dlvr.it,$SAN #Sanofi Sanofi : Read-across from results of clinical trials for Incyte‚Äôs ruxolitinib: &gt;Convincing results in phase III for ruxolitinib - The US biotech Incyte yesterday released top-line results from its two phase III studies‚Ä¶ https://t.co/ehQfSmvpiv #equity #stocks https://t.co/XpZd9Ug1Zy,,,2015-03-03 17:15:05,"Paris, France",ResearchPool,https://pbs.twimg.com/profile_images/932829644558016512/Godn_LkX_normal.jpg,8971,4234,0,405156,ResearchPool,photo
2525892205,2020-02-20 02:39:29,"INCY, ","investingnews, ","modernreaders.com/?p=2805031, ",1230396538532302848,False,0,0,0,0,Zapier.com,Evercore ISI Reiterates Buy Rating for Incyte $INCY  https://t.co/25Tf6bh6Bu #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1979190776,2020-02-20 02:36:37,"INCY, ",,"tickerreport.com/?p=5066821, ",1230395820626804736,False,0,0,0,0,Zapier.com,Piper Sandler Reiterates ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/b2L60vw2c4,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-02-20 02:35:51,"INCY, ",,"thelincolnianonline.com/?p=3465719, ",1230395624840888320,False,0,0,0,0,Zapier.com,Evercore ISI Reiterates Buy Rating for Incyte $INCY https://t.co/BFiSz80Qng,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
29549589,2020-02-20 02:21:27,,"Stockholm, Operations, Research, Jobs, ","g.drctry.biz/r/4c9xI, ",1230392003327860736,False,0,0,0,0,Engineering Daily ,"[Job] Associate Director, Clinical Operations Nordics | Company: Incyte Corporation | Location: Stockholm AB  Sweden | #Stockholm #Operations #Research #Jobs | More info at  https://t.co/mNdURNz2Mn",,,2009-04-07 17:25:22,"Atlanta, GA USA",Engineering Daily,https://pbs.twimg.com/profile_images/445765099626582016/cXn6S9kL_normal.png,16933,1915,385,1338778,EngineersDay,
334585053,2020-02-19 19:00:50,,,"s.einnews.com/q-YHVW-B_r, ",1230281116315258882,False,0,0,0,0,EIN Presswire,Incyte A Buy On 2020 Guidance And Possible Drug Approvals https://t.co/ycvwJNKaM3,,,2011-07-13 06:16:51,"Washington, D.C.",EIN Presswire: Lung Cancer Newswire,https://pbs.twimg.com/profile_images/1288514359396904962/bd9OSmiA_normal.jpg,718,415,28,35060,EINLungCancer,
732361939490312192,2020-02-19 17:51:36,"INCY, ","markets, ","americanbankingnews.com/?p=13474240, ",1230263694841479168,False,0,0,0,0,Zapier.com,Incyte $INCY Given New Price Target at Nomura https://t.co/OAFJXwj71q #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-19 17:51:36,"INCY, ","stocks, ","americanbankingnews.com/?p=13474240, ",1230263692165632000,False,0,0,0,0,Zapier.com,Incyte $INCY Given New Price Target at Nomura https://t.co/8ZIwmOtVtG #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1204967326543699968,2020-02-19 17:32:09,"INCY, ",,,1230258799178637313,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
1100450877792370688,2020-02-19 16:05:22,"INCY, ",,"blueequity.io/r/88186/de-inc‚Ä¶, ",1230236961098489856,False,0,0,0,0,Blue Equity,$INCY Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD Community https://t.co/aG0svc3ghq,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
1199802479694749698,2020-02-19 15:53:13,,"fredyevichdaily, investinthefuture, knowyourworth, ","businesswire.com/news/home/2020‚Ä¶, ",1230233899894214657,False,0,0,0,0,Twitter Web Client,"Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD Community | Business Wire https://t.co/AsnPv7jtTX
 #fredyevichdaily #investinthefuture #knowyourworth",,,2019-11-27 16:29:47,"The ""Concrete Jungle""",Fred Yevich Daily,https://pbs.twimg.com/profile_images/1223006561544605698/Wod_ApPQ_normal.jpg,75,36,0,744,FredYevich,
963495628545327104,2020-02-19 15:51:01,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1230233350075535360,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte A Buy On 2020 Guidance And Possible Drug Approvals https://t.co/V1gMYj9DnO Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
23059499,2020-02-19 15:48:33,"INCY, ","stocks, markets, stockmarket, ","seekingalpha.com/article/432538‚Ä¶, ",1230232725635813376,False,0,0,0,1,SAArticlesTwitter,$INCY - Incyte A Buy On 2020 Guidance And Possible Drug Approvals. https://t.co/FYM9gpa2cj #stocks #markets #stockmarket,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
730032660,2020-02-19 15:33:24,,,"nonsell.com/us-market-news‚Ä¶, ",1230228913340604416,False,0,0,0,0,NonSell Twitter,"Incyte's Ruxolitinib Works in Patients With Eczema - https://t.co/wD8Cwcajoy biotech company just reported data from a pair of successful late-stage clinical trials.
Want to know more ...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
100024370,2020-02-19 15:30:05,"INCY, ",,"cmlviz.com/summary/INCY, ",1230228079815135232,False,1,0,0,0,Twitter for Android,$INCY Incyte shares are trading higher after the company reported primary and secondary endpoints from Phase 3 TRuE-AD study was met. https://t.co/HX4dtxr9ZR,,,2009-12-28 14:13:21,"Los Angeles, CA",Ophir Gottlieb,https://pbs.twimg.com/profile_images/1088833938351509504/1YK9-k09_normal.jpg,145234,249,2799,170405,OphirGottlieb,
18026170,2020-02-19 14:30:00,,"clinicaltrials, ruxolitinib, AtopicDermatitis, EASI75, dermatology, pediatrics, ","clinicaltrials.gov/ct2/show/NCT03‚Ä¶, pic.twitter.com/Q87ynCBtpD, ",1230212960087228416,False,1,0,0,0,TweetDeck,"+ve topline for 2nd Ph3 #clinicaltrials of @Incyte‚Äôs #ruxolitinib vs #AtopicDermatitis in kids 

39% (51.3%) of patients on 0.75% (1.5%) cream saw ‚Üë IGA-TS (7.6% vehicle); 51.5% (61.8%) reached #EASI75 (vs 14.4% vehicle)

https://t.co/Tr5TsgjBG0
#dermatology #pediatrics https://t.co/Q87ynCBtpD","Incyte, ",,2008-12-10 13:29:19,"Midland, ON",DDNews Online,https://pbs.twimg.com/profile_images/1286709262287278080/SHRMveT5_normal.jpg,3372,439,86,13763,DDNewsOnline,photo
730032660,2020-02-19 14:05:00,,,"nonsell.com/us-market-news‚Ä¶, ",1230206670057267200,False,0,0,0,0,NonSell Twitter,"Better Buy: Vertex Pharmaceuticals vs. Incyte - https://t.co/MKVQBXexXN drug developers reinvest revenues from cash-cow products to fuel the pipeline for the future.
Want to know more ...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
1279763869,2020-02-19 14:01:25,,,"ow.ly/wdzF30qj0DD, ",1230205764385615873,False,0,0,0,0,Hootsuite Inc.,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/72C29ijj3j,,,2013-03-19 03:07:32,,Ethical Recruiters,https://pbs.twimg.com/profile_images/3399772862/774dd87f0960517bf14aa33d290e6c24_normal.jpeg,116,458,11,8233,Ethical421,
3088796493,2020-02-19 13:45:39,,"LatestComments, ","latestcommentary.com/incy-stock-pri‚Ä¶, ",1230201796636925952,False,0,0,0,0,Latest Commentary,INCY Stock Price | Incyte Corp. Stock Quote (U.S.: Nasdaq) - https://t.co/GPJj1qgEbg #LatestComments,,,2015-03-12 09:19:49,Washington D.C,Latest Commentary - #LatestComments,https://pbs.twimg.com/profile_images/576760403469828097/D54BkNc8_normal.jpeg,13797,278,140,298044,LatestComments,
963495628545327104,2020-02-19 12:45:19,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/ED438TyKY3, ",1230186614338572288,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's Ruxolitinib Works in Patients With Eczema https://t.co/GebnPTixSC Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/ED438TyKY3,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
270492072,2020-02-19 12:18:20,,"news, ",,1230179825060470784,False,0,0,0,0,Microsoft Power Platform,Incyte stock price target raised to $116 from $111 at Instinet #news,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
15232532,2020-02-19 12:11:05,,,"dlvr.it/RQLtgf, pic.twitter.com/cVbashWmB2, ",1230177999854559232,False,0,0,0,0,dlvr.it,Incyte's opical Jakafi scores again in eczema Phase III; Priority review lines Roche's Tecentriq up for new lung cancer nod https://t.co/1BROKT34JQ https://t.co/cVbashWmB2,,,2008-06-25 11:32:12,"Cape Cod, MA",DennisPartners,https://pbs.twimg.com/profile_images/777939023461511168/Lqtz-Jal_normal.jpg,415,425,13,7177,DennisPartners,photo
3316713321,2020-02-19 12:02:08,,,"marketwatch.com/tools/quotes/q‚Ä¶, ",1230175747030962178,False,0,0,0,0,WordPress.com,Incyte stock price target raised to $116 from $111 at¬†Instinet https://t.co/qaoqUN9V6p,,,2015-06-10 01:01:33,"Toronto, Ontario",ValenzuelaPost,https://pbs.twimg.com/profile_images/608500204925517824/ttQPqS2s_normal.jpg,126,58,5,142783,ValenzuelaPost,
18026170,2020-02-19 12:01:00,,"Award, immunology, transplant, StemCells, GvHD, ","incyteingenuityawards.com, pic.twitter.com/UlzWpGCOt7, ",1230175461822607363,False,1,0,0,0,TweetDeck,".@Incyte launches $100K Ingenuity #Award to support efforts in graft-versus-host disease

Opens call for submission due April 30, 2020; to announce 1st recipient in August

https://t.co/vHAEU7TU90
#immunology #transplant #StemCells #GvHD https://t.co/UlzWpGCOt7","Incyte, ",,2008-12-10 13:29:19,"Midland, ON",DDNews Online,https://pbs.twimg.com/profile_images/1286709262287278080/SHRMveT5_normal.jpg,3372,439,86,13763,DDNewsOnline,photo
963495628545327104,2020-02-19 11:57:06,"INCY, VRTX, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/thPZ2FULom, ",1230174480921776128,False,0,0,0,0,STCK.PR0,$INCY $VRTX NEW ARTICLE : Better Buy: Vertex Pharmaceuticals vs. Incyte https://t.co/7kE4SdHBiH Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/thPZ2FULom,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1134049078424162304,2020-02-19 11:48:53,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1230172411313754112,False,0,0,0,0,Newsfilter.io,Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD Community $INCY https://t.co/boQWBNXiW1,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
732361939490312192,2020-02-19 11:37:41,"INCY, ","markets, ","americanbankingnews.com/?p=13468738, ",1230169593693511685,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Cowen https://t.co/tGxLqBFg8J #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-19 11:37:40,"INCY, ","stocks, ","americanbankingnews.com/?p=13468738, ",1230169589989957633,False,0,0,0,0,Zapier.com,Incyte $INCY Earns Buy Rating from Cowen https://t.co/MiXufSPZA8 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
930803511918411776,2020-02-19 11:36:59,"INCY, ",,"thelincolnianonline.com/?p=3463786, ",1230169419038494720,False,0,0,0,0,Zapier.com,Cowen Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/UY6gW9d1bR,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
133504478,2020-02-19 11:23:09,,"strategy, competitiveintelligence, marketing, healthcare, pharmaceutical, biotech, productmarketing, pharma, ","dlvr.it/RQLkgv, lqventures.com, pic.twitter.com/ae3gRQZCZx, ",1230165938839805952,False,0,0,0,1,dlvr.it,Incyte's opical Jakafi scores again in eczema Phase III; Priority review lines Roche's Tecentriq up for new lung‚Ä¶ https://t.co/xNQykaACvX &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #productmarketing #pharma https://t.co/ae3gRQZCZx,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1100450877792370688,2020-02-19 11:19:12,"INCY, ",,"blueequity.io/r/88145/de-inc‚Ä¶, ",1230164941618835456,False,0,0,0,0,Blue Equity,$INCY Incyte Announces Positive Topline Results From Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients With Atopic Dermatitis https://t.co/4GgWxvfySm,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
15974185,2020-02-19 10:53:02,,,"dlvr.it/RQLchz, ",1230158357354274818,False,0,0,0,0,dlvr.it,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/Q7l4Xz4bON,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
374729426,2020-02-19 10:44:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1264585, pic.twitter.com/RTA0jFQ8z7, ",1230156330289123328,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on February 13, 2020. View odds for this and other indicators: https://t.co/a8CQQoaYxO #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/RTA0jFQ8z7",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
18294197,2020-02-19 10:36:23,,,"fiercebiotech.com/biotech/incyte‚Ä¶, ",1230154167769014274,False,3,0,0,2,Twitter Web Client,"Ruxolitinib is the small molecule JAK1/2 inhibitor found in Jakafi, Incyte‚Äôs myelofibrosis treatment. By reformulating ruxolitinib as a topical cream, Incyte has positioned itself to generate more cash from the molecule https://t.co/jJMi5fwgkR",,,2008-12-21 17:21:58,"Washington, DC",FierceBiotech,https://pbs.twimg.com/profile_images/1270578068701224962/2YHKa3mX_normal.jpg,92204,663,2073,25532,FierceBiotech,
3136805274,2020-02-19 10:29:52,"INCY, ","Award, pharma, video, ","businesswire.com/news/home/2020‚Ä¶, ",1230152528559517698,False,1,0,0,0,Twitter Web Client,.@Incyte Announces Launch of the Incyte Ingenuity #Award Program to Recognize Innovation Within the GVHD Community | #pharma #video $INCY | Business Wire https://t.co/QevBx5Q2Mn,"Incyte, ",,2015-04-03 13:13:23,"Plymouth Meeting, PA",John Osborn,https://pbs.twimg.com/profile_images/1126638023213486081/C8vyImKT_normal.png,499,1090,99,4191,John0sborn,
72928001,2020-02-19 09:47:44,"INCY, ",,"bit.ly/2HEv0BO, ",1230141925874814976,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte announces pivotal Phase 3 study from the TRuE-AD clinical trial program met its primary and secondary... https://t.co/4UFc68SVg1,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
3686628867,2020-02-19 09:37:19,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1230139303340146688,False,0,0,0,0,WordPress.com,Incyte Announces Positive Topline Results From Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients With Atopic¬†Dermatitis https://t.co/VVzvJmyJZm,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
3686628867,2020-02-19 09:28:43,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1230137137724608519,False,0,0,0,0,WordPress.com,Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD¬†Community https://t.co/uRIzWPreb2,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
472650465,2020-02-19 09:17:01,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1230134193335742467,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD https://t.co/Xo04SMMupv,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
3314135167,2020-02-19 09:16:07,,"jobs, fiercepharma, ","goo.gl/fb/8gwDER, ",1230133968248418305,False,0,0,0,0,Google,#jobs Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/OxVGIZFHlz #fiercepharma,,,2015-08-13 02:43:55,,Career Biotech,https://pbs.twimg.com/profile_images/872856527731793920/HqYH3X_9_normal.jpg,110,59,1,35799,CareerBiotech,
976297820532518914,2020-02-19 09:10:05,,,"dlvr.it/RQLGgW, pic.twitter.com/1iuft89UDM, ",1230132448651968512,False,0,0,0,0,dlvr.it,Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD Community https://t.co/H5b9RnkRrl https://t.co/1iuft89UDM,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
875382419251019776,2020-02-19 09:09:07,,,"bit.ly/3285Gh7, pic.twitter.com/09kOgeLMMV, ",1230132206120493057,False,0,0,0,0,dlvr.it,Incyte hits endpoint in 2nd pivotal atopic dermatitis trial https://t.co/lS0Ud83MiQ https://t.co/09kOgeLMMV,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
1069693680066420736,2020-02-19 09:05:39,"INCY, ",,"s.flashalert.me/b4vqN, ",1230131334208724994,False,0,0,0,0,flashalerts,"$INCY: Issued Press Release on February 19, 09:00:00: Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD Community https://t.co/1TjK3hSGda",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
3911174913,2020-02-19 09:05:14,,"Breaking, GVHD, ",,1230131229053399040,False,7,0,0,2,Twitter for Advertisers.,"#Breaking: We've launched the Incyte Ingenuity Award program, which will award up to $100,000 to recognize innovation within the #GVHD community. Get the details on application requirements.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
3318510966,2020-02-19 09:01:30,,,"crweworld.com/article/news-p‚Ä¶, ",1230130290275704832,False,0,0,0,0,CRWE World,Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD Community https://t.co/TWyIHVH0g4,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
730032660,2020-02-19 08:08:49,,,"nonsell.com/us-market-news‚Ä¶, ",1230117033360015360,False,0,0,0,0,NonSell Twitter,Incyte's ruxolitinib successful in second late-stage dermatitis study - https://t.co/Ug4LMqgd3j ruxolitinib successful in second late-stage dermatitis studyIncyte (NASDAQ:INCY) perks up...,,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
963495628545327104,2020-02-19 07:57:17,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1230114128276135941,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's ruxolitinib successful in second late-stage dermatitis study https://t.co/YBJc0HqyOK Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
472650465,2020-02-19 07:53:26,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1230113161401028608,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Positive Topline Results From Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in https://t.co/OF6rE4MK0c,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
3318510966,2020-02-19 07:47:06,,,"crweworld.com/article/news-p‚Ä¶, ",1230111565937958912,False,0,0,0,0,CRWE World,Incyte Announces Positive Topline Results From Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients With https://t.co/8LrU2qKGcq,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
864584576,2020-02-19 07:46:32,"INCY, ",,,1230111425676369920,False,1,0,0,0,Twitter Web App,"$INCY(79.30) up 2 - Incyte announced that
the second randomized, vehicle-controlled, pivotal Phase 3 study from theTRuE-AD clinical trial program has met its primary endpoint....dermatitis",,,2012-10-06 08:06:29,Currently planet Earth.,Palmer,https://pbs.twimg.com/profile_images/943970836431671298/vn0Vf4ma_normal.jpg,7364,93,153,16468,BankTheTrade,
633824212,2020-02-19 07:46:02,,,"dlvr.it/RQL022, ",1230111298869813250,False,0,0,0,0,dlvr.it,Incyte announces results from Phase 3 TRuE-AD program https://t.co/PABjVr8C8R,,,2012-07-12 11:31:45,NYC,flylemurs,https://pbs.twimg.com/profile_images/2393843079/wc5oiacqodhfzivmyvmh_normal.jpeg,37,32,4,129630,flylemurs,
247195508,2020-02-19 07:41:32,,,"bioportfol.io/RQKzFG, ",1230110165472403458,False,0,0,0,1,dlvr.it,Incyte Announces Positive Topline Results From Phase 3 TRuEAD Program Evaluating Ruxolitinib Cream in Patients With Atopic Dermatitis: Primary and secondary endpoints met in both TRuEAD1 and TRuEAD2Incyte NasdaqINCY today announced that the second‚Ä¶ https://t.co/iKdHH41VJH,,,2011-02-04 03:47:02,London,Allergy News,https://pbs.twimg.com/profile_images/2229775486/Twitter-FB_Profile_pic_-crops_1__normal,321,77,8,20790,Allergy_bio,
41458395,2020-02-19 07:31:25,"INCY, ",,,1230107620423458816,False,4,0,0,4,TweetDeck,$INCY Incyte Announces Positive Topline Results From Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients With Atopic Dermatitis,,,2009-05-20 17:45:03,,TexMex,https://pbs.twimg.com/profile_images/1051818539991031808/DBloaH2G_normal.jpg,49004,71,1144,7365,TraderTexMex,
403855355,2020-02-19 07:30:53,"INCY, ",,,1230107483533959169,False,1,0,0,1,Twitter Web App,$INCY: Incyte Announces Positive Topline Results From Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients With Atopic Dermatitis,,,2011-11-02 22:53:29,https://thetradexchange.com,ZoZoTrader,https://pbs.twimg.com/profile_images/1032734699569864704/GbU8IYwT_normal.jpg,17972,580,442,78954,ZoZoStockwatch,
2525892205,2020-02-19 04:43:42,"INCY, ","investingnews, ","modernreaders.com/?p=2802983, ",1230065413083496449,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded to Sell by BidaskClub  https://t.co/omwID8kxJq #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1979190776,2020-02-19 03:25:25,"INCY, ",,"tickerreport.com/?p=5063993, ",1230045711938543618,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at Evercore ISI https://t.co/RPow1nM2As,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-02-19 00:59:14,"INCY, ",,"thelincolnianonline.com/?p=3462672, ",1230008922842505216,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by BidaskClub to Sell https://t.co/o5WceEmE3F,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
895929863521095680,2020-02-18 19:58:41,"INCY, ","Incyte, stocks, trading, finance, market, ","bit.ly/39MxoCO, pic.twitter.com/nS8QBaNwIa, ",1229933286727786496,False,0,0,0,0,TradeFlags,"TD SELL $INCY at 79.30, Supp 72.94 Resis 79.30 R9  HiLo 30% T1Y 91 buy 2.4 PE 38.7 DIV N/A #Incyte Cor #stocks #trading #finance #market https://t.co/dAxHXUAKgb https://t.co/nS8QBaNwIa",,,2017-08-11 04:48:19,1130,TradeFlags,https://pbs.twimg.com/profile_images/1444247772769792002/Hc_nWhvE_normal.jpg,636,206,11,58994,TradeFlags,photo
1204967326543699968,2020-02-18 17:31:20,"INCY, ",,,1229896206811312128,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
374729426,2020-02-18 07:54:32,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1262183, pic.twitter.com/JpSv2zBk88, ",1229751050703228928,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on February 7, 2020. View odds for this and other indicators: https://t.co/qYZCXbLnOi #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/JpSv2zBk88",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
135209476,2020-02-18 05:11:14,"INCY, ",,"stockflare.com/stock/INCY.O, ",1229709954048811008,False,0,0,0,0,Stockflare Bot (Prod),$INCY: The forecast long term gain for Incyte Corporation has decreased substantially in the last week to 40.13% from 45.97%. (https://t.co/sK8NyKCUuN),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
135209476,2020-02-18 05:11:14,"INCY, ",,"stockflare.com/stock/INCY.O, ",1229709952303935488,False,0,0,0,0,Stockflare Bot (Prod),"$INCY: Incyte Corporation's forecast earnings moved 14.3% over the last month, but the price is -2.5%. It's PE ratio is now 25x earnings. (https://t.co/sK8NyKCUuN)",,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
135209476,2020-02-18 05:11:13,"INCY, ",,"stockflare.com/stock/INCY.O, ",1229709949325971456,False,0,0,0,0,Stockflare Bot (Prod),"$INCY: Incyte Corporation's forecast earnings moved 14.7% over the last week, but the price is 3.0%. It's PE ratio is now 25x earnings. (https://t.co/sK8NyKCUuN)",,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
135209476,2020-02-18 05:11:12,"INCY, ",,"stockflare.com/stock/INCY.O, ",1229709947266486273,False,0,0,0,0,Stockflare Bot (Prod),$INCY: The long term growth forecast for Incyte Corporation has decreased substantially in the last week to 43.04% from 50.37%. (https://t.co/sK8NyKlj6d),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
966006214818697218,2020-02-18 02:24:11,"INCY, ",,"theenterpriseleader.com/?p=2658410, ",1229667912945893376,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by JPMorgan Chase &amp; Co.  https://t.co/BHTEe8ElRP,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
966006214818697218,2020-02-18 02:24:06,"INCY, ",,"theenterpriseleader.com/?p=2658440, ",1229667891320107009,False,0,0,0,0,Zapier.com,Evercore ISI Reiterates ‚ÄúBuy‚Äù Rating for Incyte $INCY  https://t.co/RI7w2BIE22,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1117356436437315585,2020-02-18 02:22:11,,,"rssfeeds.cloudsite.builders/2020/02/17/lat‚Ä¶, ",1229667411349078019,False,0,0,0,0,WordPress.com,"Latest Fundamentals:: Incyte Corporation, (NASDAQ:¬†INCY) https://t.co/DSpY3fpRI0",,,2019-04-14 05:18:28,"Dallas, TX",RSSFeedsCloud,https://pbs.twimg.com/profile_images/1117356575029698560/p6gwzwvL_normal.jpg,420,460,7,198956,RSSFeedsCloud,
1204967326543699968,2020-02-17 17:31:15,"INCY, ",,,1229533796606906370,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
24247824,2020-02-17 17:10:33,,,"clinicaltrials.gov, ",1229528589428641792,False,0,0,0,0,TweetDeck,"What could INCB099318 be? Couldn't find it on Incyte's website, but is on an Australian  P1 and on a P1 posting on https://t.co/yLEgOuHJ6v",,,2009-03-13 16:34:08,"Bethesda, MD",C. 'Harris' Floudas,https://pbs.twimg.com/profile_images/1135191147045904384/ixKK4UM5_normal.jpg,630,793,88,9187,chfloudas,
1006734899837980672,2020-02-17 16:38:20,,,"twitter.com/Incyte/status/‚Ä¶, ",1229520480689745920,False,2,0,1,1,Twitter for Android,Your getting there..nature is a morphing displacement of energies seen and unseen..and thy humans bodies are created as same in nature found..unique only will be thy bodies acceptance of interference in thy harmonys thereof..mastery given thy tools to do so will be a one on one.x https://t.co/2amVhRwsxx,,,2018-06-12 23:07:59,"California, USA",Dehanna Mattson,https://pbs.twimg.com/profile_images/1406150698799038466/7kRFMnGe_normal.jpg,2148,5002,9,65600,DehannaMattson,
2181281054,2020-02-17 11:19:10,"INCY, ","markets, ","wkrb13.com/?p=1608174, ",1229440159483121666,False,0,0,0,0,Zapier.com,Incyte $INCY Given Buy Rating at JPMorgan Chase &amp; Co. https://t.co/wQpCayx7HY #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
2181281054,2020-02-17 11:09:27,"INCY, ","markets, ","wkrb13.com/?p=1608151, ",1229437714895974400,False,0,0,0,0,Zapier.com,Evercore ISI Reiterates ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/i4M8TTdXqx #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
374729426,2020-02-17 08:03:10,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1256489, pic.twitter.com/BSlld2i8hH, ",1229390834031742976,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on February 7, 2020. View odds for this and other indicators: https://t.co/mZHYDvDRT4 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BSlld2i8hH",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1099898965682618368,2020-02-16 21:37:50,,,"cannabis-investment-group.com/2020/02/16/bio‚Ä¶, ",1229233465180217345,False,0,0,0,0,WordPress.com,[Biotech&amp;Pharma] Incyte Stock Pummeled As Late-Stage Failure Casts Doubt On¬†Pipeline https://t.co/avZmVKW1uW,,,2019-02-25 00:08:43,,CANDLR,https://pbs.twimg.com/profile_images/1255911209267679234/u241thNh_normal.jpg,1253,2254,3,25050,CannabisGroup19,
1099898965682618368,2020-02-16 15:37:28,,,"cannabis-investment-group.com/2020/02/16/bio‚Ä¶, ",1229142775704236036,False,0,0,0,0,WordPress.com,"[Biotech&amp;Pharma] Stock Market Rally Continues Into 2020; Tesla, Lockheed Soar, Incyte Plunges: Weekly¬†Review https://t.co/psvnI05K9v",,,2019-02-25 00:08:43,,CANDLR,https://pbs.twimg.com/profile_images/1255911209267679234/u241thNh_normal.jpg,1253,2254,3,25050,CannabisGroup19,
1134049078424162304,2020-02-16 10:38:34,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1229067555358347268,False,0,0,0,0,Newsfilter.io,Incyte Shares Sold by Swiss National Bank $INCY https://t.co/v2TFTOJeI0,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1181966655347417088,2020-02-16 10:06:41,,"Incy, ","seekingalpha.com/instablog/5101‚Ä¶, ",1229059529029160961,False,1,0,0,1,Twitter Web App,"#Incy Posed For A Short Term Rally?
By Philipp Markopulos
https://t.co/GfYvN4RMNT",,,2019-10-09 12:16:40,,"Philipp Markopulos, CFTe",https://pbs.twimg.com/profile_images/1374787742769500168/ZbFbv_jb_normal.png,24,97,0,58,Profitopulos,
930803511918411776,2020-02-16 09:29:45,"INCY, ",,"thelincolnianonline.com/?p=3455575, ",1229050234107498497,False,0,0,0,0,Zapier.com,"Incyte $INCY Issues Earnings Results, Beats Expectations By $0.08 EPS https://t.co/VlnCypmsBw",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
849417718642159616,2020-02-16 08:54:57,"INCY, ",,"zpr.io/t9KhP, ",1229041476463681536,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúHold‚Äù Rating at Mizuho https://t.co/X3pK9KvkFD,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2920258887,2020-02-16 08:53:32,"INCY, ",,"dakotafinancialnews.com/?p=1531011, ",1229041122879643649,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúHold‚Äù Rating from Mizuho https://t.co/vefpmJhy0u,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
732361939490312192,2020-02-16 08:29:25,"INCY, ","markets, ","americanbankingnews.com/?p=13428703, ",1229035052983558150,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at JPMorgan Chase &amp; Co. https://t.co/guteife1Tv #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-16 08:29:24,"INCY, ","stocks, ","americanbankingnews.com/?p=13428703, ",1229035048738881536,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at JPMorgan Chase &amp; Co. https://t.co/RS3O3FpS8P #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2266388972,2020-02-16 08:19:10,"INCY, ","stocks, ","dailypolitical.com/?p=3418602, ",1229032472018550785,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by JPMorgan Chase &amp; Co. https://t.co/vqFrWEhzJ5 #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-02-16 08:19:09,"INCY, ",,"dailypolitical.com/?p=3418602, ",1229032469145538560,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by JPMorgan Chase &amp; Co. https://t.co/JvcLdleLJt,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
374729426,2020-02-16 08:05:48,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1253957, pic.twitter.com/ewG5yNGSEj, ",1229029108618678274,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on February 7, 2020. View odds for this and other indicators: https://t.co/LLev8ZilSO #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ewG5yNGSEj",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-02-16 07:47:11,"INCY, ","markets, ","americanbankingnews.com/?p=13428034, ",1229024424382386176,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúBuy‚Äù Rating from Evercore ISI https://t.co/roENNm1rVp #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-16 07:47:11,"INCY, ","stocks, ","americanbankingnews.com/?p=13428034, ",1229024422125821952,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúBuy‚Äù Rating from Evercore ISI https://t.co/emxdDLCLS3 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
794963070057639936,2020-02-15 17:34:23,,"cannabis, ","bit.ly/36twKJ2, ",1228809808104632322,False,0,0,0,0,TweetGoogleAlerts,Analyzing Auxly Cannabis Group (OTCMKTS:CBWTF) and Incyte (OTCMKTS:INCY) - Riverton Roll https://t.co/iy61zJZafP #cannabis,,,2016-11-05 14:02:20,United States,Cannabis Biz News,https://pbs.twimg.com/profile_images/807996532343480320/Cv_vX0MF_normal.jpg,28375,7659,285,299535,CannabisBizNews,
865494108,2020-02-15 16:50:23,,,"twitter.com/Incyte/status/‚Ä¶, ",1228798735783645184,False,0,0,0,0,Twitter Web App,Good news! https://t.co/38BD7qyG8w,,,2012-10-06 20:08:25,,Constance,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,180,281,1,50042,howardoyama,
2298709746,2020-02-15 09:41:39,"INCY, ",,"zpr.io/t9xPY, ",1228690841562161152,False,0,0,0,0,Zapier.com,Mizuho Reaffirms ‚ÄúHold‚Äù Rating for Incyte $INCY https://t.co/gHw09kUcT6,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
68559732,2020-02-15 09:41:14,"INCY, ",,"zpr.io/t9xUF, ",1228690739569332225,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Mizuho https://t.co/xQ5jVzGpxC,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
374729426,2020-02-15 09:40:33,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1248203, pic.twitter.com/tnUT1IEC9c, ",1228690566151409664,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on February 7, 2020. View odds for this and other indicators: https://t.co/zWKJCSw4rk #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/tnUT1IEC9c",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
966006214818697218,2020-02-15 03:52:09,"INCY, ",,"theenterpriseleader.com/?p=2650043, ",1228602889045762048,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update  https://t.co/ABybeH3uJ0,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
2525892205,2020-02-15 03:51:05,"INCY, ","investingnews, ","modernreaders.com/?p=2790159, ",1228602620811542530,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update  https://t.co/zaUtxeBhwK #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1979190776,2020-02-15 01:31:14,"INCY, ",,"tickerreport.com/?p=5050874, ",1228567424603213824,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Gap Up on Better-Than-Expected Earnings https://t.co/HCmMoNmRVh,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1218533402296668160,2020-02-14 23:02:30,,,"piobird.com/current-techni‚Ä¶, pic.twitter.com/tTjpNjvCV3, ",1228529996064591872,False,0,0,0,0,WordPress.com,"Current Technicals:: Incyte Corporation, (NASDAQ:¬†INCY) https://t.co/hLFWlR8GUp https://t.co/tTjpNjvCV3",,,2020-01-18 08:59:55,,Pio Bird News,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,9,1,0,3781,BirdPio,photo
68559732,2020-02-14 22:25:47,"INCY, ",,"zpr.io/t9YxS, ",1228520756704878592,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/pjP3Favo3M,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2266388972,2020-02-14 21:34:55,"INCY, ","stocks, ","dailypolitical.com/?p=3414340, ",1228507953688432640,False,0,0,0,0,Zapier.com,Incyte $INCY Receives Hold Rating from Mizuho https://t.co/EBiHcJaXBU #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-02-14 21:34:54,"INCY, ",,"dailypolitical.com/?p=3414340, ",1228507951125626880,False,0,0,0,0,Zapier.com,Incyte $INCY Receives Hold Rating from Mizuho https://t.co/4P4TP1QE24,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1204967326543699968,2020-02-14 17:31:17,"INCY, ",,,1228446642355003393,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
895693223368081408,2020-02-14 15:27:41,,,"twitter.com/Incyte/status/‚Ä¶, ",1228415537358819328,False,0,0,0,0,Twitter Web App,I can so that with one herb. Just hoping it can do a little with the Lab Made Corona virus https://t.co/TYstBbOM9W,,,2017-08-10 13:08:00,"Downtown Jacksonville, FL",Melissa BakerLhermit,https://pbs.twimg.com/profile_images/895708212783087618/R8vvDXnq_normal.jpg,1206,3388,17,104920,melissabak3,
18026170,2020-02-14 13:30:00,,"immunotherapy, immunooncology, tafasitamab, lymphoma, leukemia, ","ddn-news.com/index.php?news‚Ä¶, pic.twitter.com/Ca8n46kOch, ",1228385920522555393,False,1,0,0,0,TweetDeck,"What‚Äôs behind @Incyte‚Äôs decision to invest ~$1B into an anti-CD19 #immunotherapy?

Dig deeper w/ ‚ÄúMorphoSys &amp; Incyte sign collaboration &amp; license deal‚Äù in Feb DDNews

https://t.co/sgtb8hnQGl
#immunooncology #tafasitamab #lymphoma #leukemia @MorphoSys https://t.co/Ca8n46kOch","Incyte, MorphoSys, ",,2008-12-10 13:29:19,"Midland, ON",DDNews Online,https://pbs.twimg.com/profile_images/1286709262287278080/SHRMveT5_normal.jpg,3372,439,86,13763,DDNewsOnline,photo
68559732,2020-02-14 11:13:55,"INCY, ",,"zpr.io/t973c, ",1228351676328882176,False,0,0,0,0,Zapier.com,"Incyte $INCY Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS https://t.co/VGwBYoVpg3",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2266388972,2020-02-14 11:12:23,"INCY, ","stocks, ","dailypolitical.com/?p=3412004, ",1228351286439030784,False,0,0,0,0,Zapier.com,"Incyte $INCY Announces Quarterly Earnings Results, Beats Expectations By $0.08 EPS https://t.co/CH5dRMJ2K9 #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-02-14 11:12:22,"INCY, ",,"dailypolitical.com/?p=3412004, ",1228351283825958912,False,0,0,0,0,Zapier.com,"Incyte $INCY Announces Quarterly Earnings Results, Beats Expectations By $0.08 EPS https://t.co/0nbfx2StcN",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
23184067,2020-02-14 09:00:03,,,"buff.ly/2UREr8M, pic.twitter.com/WPhFleXeJZ, ",1228317986223722502,False,1,0,0,5,Buffer,"‚ÄúRuxolitinib cream met its primary endpoint in the TRuE-AD2 study in adolescent and adult patients with atopic dermatitis, according to a press release from Incyte‚Äù https://t.co/KZZkVhxcLl https://t.co/WPhFleXeJZ",,,2009-03-07 05:56:51,Buenos Aires,Juan C Ivancevich MD,https://pbs.twimg.com/profile_images/1427600321505857539/-m2-zdWi_normal.jpg,6820,603,249,84875,Aller_MD,photo
374729426,2020-02-14 08:35:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1245745, pic.twitter.com/4TLWwd8zGy, ",1228311830985994241,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on February 7, 2020. View odds for this and other indicators: https://t.co/hCiRqxUZF1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/4TLWwd8zGy",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1097819621619630080,2020-02-14 08:09:35,,,"dlvr.it/RQ26sF, pic.twitter.com/9wDqqWoUAH, ",1228305286277947392,False,0,0,0,0,dlvr.it,Can Jakafi hit $3B? Incyte thinks so‚Äîand it's got other launches on the way https://t.co/OaEV7MOJ9c https://t.co/9wDqqWoUAH,,,2019-02-19 06:26:09,"London, England",PharmaCrowd,https://pbs.twimg.com/profile_images/1123311799561068545/UnJBMgbE_normal.png,29,22,0,2226,PharmaCrowd,photo
94365736,2020-02-14 08:05:13,"LLY, INCY, ","EliLilly, Incyte, ClinicalTrial, Olumiant, Eczema, stocks, ","fool.com/investing/2020‚Ä¶, ",1228304186971955205,False,1,0,0,0,Hootsuite Inc.,#EliLilly and #Incyte Record Another Positive #ClinicalTrial for #Olumiant Works in #Eczema @themotleyfool @Incyte @LillyPad #stocks $LLY $INCY https://t.co/8Z6eRzFyyk,"themotleyfool, Incyte, LillyPad, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
15974185,2020-02-14 06:22:32,,,"dlvr.it/RQ1nCW, ",1228278343641923590,False,0,0,0,1,dlvr.it,Can Jakafi hit $3B? Incyte thinks so‚Äîand it's got other launches on the way https://t.co/JXWDbE7fHK,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1134049078424162304,2020-02-14 05:25:21,"REGN, INCY, LLY, NVS, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1228263955304452096,False,0,0,0,0,Newsfilter.io,Incyte Q4 Earnings Top Estimates on Solid Jakafi Sales $REGN $INCY $LLY $NVS https://t.co/dcmbo8XIQ6,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
2525892205,2020-02-14 04:30:16,"INCY, ","investingnews, ","modernreaders.com/?p=2787477, ",1228250094564147201,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.58 Per Share  https://t.co/MByiOl4hUE #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
966006214818697218,2020-02-14 04:29:02,"INCY, ",,"theenterpriseleader.com/?p=2647405, ",1228249780696080385,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.58 Per Share  https://t.co/nHHtCso9Tt,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
135209476,2020-02-14 04:09:40,"INCY, ",,"stockflare.com/stock/INCY.O, ",1228244909750132736,False,0,0,0,0,Stockflare Bot (Prod),$INCY: The forecast EPS for Incyte Corporation has increased to $3.08 from $2.78 in the last week. (https://t.co/sK8NyKCUuN),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
424089030,2020-02-14 03:19:19,,,"fiercepharma.com/pharma/amid-pr‚Ä¶, ",1228232237709049856,False,0,0,0,0,Twitter Web Client,Can Jakafi hit $3B? Incyte thinks so‚Äîand it's got other launches on the way https://t.co/kc1gpi0ad8,,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
1134049078424162304,2020-02-14 02:47:20,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1228224190190239745,False,0,0,0,0,Newsfilter.io,Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates on Key Clinical Programs $INCY https://t.co/B83EQFrO90,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-02-14 02:27:20,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1228219157059031040,False,0,0,0,0,Newsfilter.io,"Incyte EPS beats by $0.07, beats on revenue $INCY https://t.co/ATNODbwr6y",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1134049078424162304,2020-02-14 00:49:21,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1228194497378443265,False,0,0,0,0,Newsfilter.io,Incyte +2% premarket on Q4 beat $INCY https://t.co/0clY4rT1lH,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
849417718642159616,2020-02-13 21:30:13,"INCY, ",,"zpr.io/t9grw, ",1228144383880462338,False,0,0,0,0,Zapier.com,"Incyte $INCY Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS https://t.co/RUeDDXlEQ6",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2920258887,2020-02-13 21:27:29,"INCY, ",,"dakotafinancialnews.com/?p=1522657, ",1228143695087665152,False,0,0,0,0,Zapier.com,"Incyte $INCY Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS https://t.co/LJhZMj9Byp",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
2416188264,2020-02-13 21:12:34,"INCY, ","markets, ","thestockobserver.com/?p=2635246, ",1228139942909546497,False,0,0,0,0,Zapier.com,Incyte $INCY Posts Quarterly Earnings Results  https://t.co/rOXCiSw1l4 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2020-02-13 21:12:25,"INCY, ",,"zpr.io/t9g3h, ",1228139903478910976,False,0,0,0,0,Zapier.com,"Incyte $INCY Releases Quarterly Earnings Results, Beats Estimates By $0.11 EPS https://t.co/zTBKi0kigw",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
732361939490312192,2020-02-13 21:10:07,"INCY, ","markets, ","americanbankingnews.com/?p=13395882, ",1228139326808248321,False,0,0,0,0,Zapier.com,Incyte $INCY Posts Quarterly Earnings Results https://t.co/MYoqY9RzFd #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-13 21:10:07,"INCY, ","stocks, ","americanbankingnews.com/?p=13395882, ",1228139324639731712,False,0,0,0,0,Zapier.com,Incyte $INCY Posts Quarterly Earnings Results https://t.co/0YjqmAKoeE #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1204967326543699968,2020-02-13 17:31:18,"INCY, ",,,1228084258914349059,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +2.85% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
773578537764851712,2020-02-13 17:25:03,"INCY, ",,"sitefocus.com/cif/ei/cd_incy‚Ä¶, ",1228082686071148544,False,0,0,0,0,CIF-QBA,"$INCY Earnings Intelligence Analysis of recent earnings identified Incyte Corp.  (NASDAQ: INCY ) business focus on (commercial,rux), (rux,topical), (rux,safety)
, (rux,ruxolitinib), (performance,rux)
https://t.co/QdJYI8UTDx",,,2016-09-07 13:47:50,"Cupertino, CA",SiteFocus,https://pbs.twimg.com/profile_images/908465036598820864/6ZQsC4KD_normal.jpg,195,35,8,57439,SiteFocusHQ,
772471873539977217,2020-02-13 17:24:38,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1228082582262251525,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/LpCkkM5bVb,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
18294275,2020-02-13 16:25:00,,,"fiercepharma.com/pharma/amid-pr‚Ä¶, ",1228067572190343168,False,3,1,0,3,TweetDeck,Can Jakafi hit $3B? Incyte thinks so‚Äîand it's got other launches on the way https://t.co/3boztqQZBp,,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
1188117778567454720,2020-02-13 16:19:32,"INCY, ",,"jodie.ai/company/INCY, ",1228066197457035267,False,0,0,1,0,erased17009697,"$INCY INCYTE CORP posted their annual return.  Reporting an EPS of $2.08 with revenue of $2B.

New Risks:

100% of Risk content changed

https://t.co/q9dumdaYzF",,,2019-10-26 11:38:58,London,Jodie Insights,https://pbs.twimg.com/profile_images/1310896987466760198/cVg3gmLj_normal.jpg,624,1781,16,28832,jodietheai,
23059499,2020-02-13 14:27:08,"INCY, ","investing, stockmarket, economy, ","seekingalpha.com/article/432399‚Ä¶, ",1228037910932287488,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation (INCY) CEO Herv√© Hoppenot on Q4 2019 Results - Earnings Call Transcript. https://t.co/EtK7akTYJp #investing #stockmarket #economy,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
730032660,2020-02-13 14:16:39,,,"nonsell.com/us-market-news‚Ä¶, ",1228035274199879682,False,0,0,0,0,NonSell Twitter,"How Incyte Beat Wall Street Estimates in Q4 - https://t.co/8WlFwzphwP biotech posted strong sales growth for all three of its approved drugs.
Want to know more on How Incyte Beat Wall ...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
509015879,2020-02-13 14:04:10,,"ClinicalTrial, ","nasdaq.com/articles/eli-l‚Ä¶, ",1228032131252867072,False,1,0,0,0,Twitter Web Client,Eli Lilly and Incyte Record Another Positive #ClinicalTrial for Olumiant Works in Eczema https://t.co/mds2kv5bVl,,,2012-02-29 11:44:04,"Boston, MA",AG Mednet,https://pbs.twimg.com/profile_images/632197324274597888/D50KBMAE_normal.png,620,943,29,3655,AGMednet,
730032660,2020-02-13 13:06:24,,,"nonsell.com/us-market-news‚Ä¶, ",1228017594713534464,False,0,0,0,0,NonSell Twitter,"Incyte's Fourth-Quarter Report Signals Better Times Ahead - https://t.co/9VQShhF2Ri the pharmaceutical company reported a big clinical trial failure last month, there are other reasons ...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
17960461,2020-02-13 13:00:00,,,"bit.ly/2wfKfPl, pic.twitter.com/cd0F1b2hSb, ",1228015982372892672,False,0,0,0,0,TweetDeck,Lilly and Incyte's atopic dermatitis drug shows promise at Phase 3. https://t.co/8vOSvJIGV4 https://t.co/cd0F1b2hSb,,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
3300865039,2020-02-13 12:47:51,"INCY, NVS, LLY, ","Jakafi, biotech, earnings, stocks, investingnews, ","investors.com/news/technolog‚Ä¶, ",1228012923789946881,False,1,1,0,0,Hootsuite Inc.,"Sales of $INCY's blockbuster drug, #Jakafi, came in better than expected in the fourth quarter, leading to a beat. #biotech #earnings #stocks #investingnews $NVS $LLY https://t.co/ushnC6LBTm",,,2015-07-29 15:22:19,"California, USA",Allison Gatlin,https://pbs.twimg.com/profile_images/1379079645480378371/V22zIHh9_normal.jpg,6295,1000,201,6646,IBD_AGatlin,
15974185,2020-02-13 12:17:03,,,"dlvr.it/RPzG19, ",1228005175203258368,False,0,0,0,0,dlvr.it,"Incyte Earnings, Revenue Beat in Q4 https://t.co/LZgcDPAtWi",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
963495628545327104,2020-02-13 12:09:21,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/whuJuEKYJd, ",1228003238550687746,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : How Incyte Beat Wall Street Estimates in Q4 https://t.co/ET0DGvDWnW Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/whuJuEKYJd,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1006334607946649600,2020-02-13 11:59:10,,,"dlvr.it/RPzC2s, pic.twitter.com/RasbMkV2NC, ",1228000674836701185,False,0,0,0,0,dlvr.it,Incyte‚Äôs Fourth-Quarter Report Signals Better Times Ahead https://t.co/SValAt5o1v https://t.co/RasbMkV2NC,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
133504478,2020-02-13 11:54:34,,"strategy, competitiveintelligence, marketing, biotech, healthcare, pharmaceutical, pharma, productmarketing, ","dlvr.it/RPzBN2, lqventures.com, pic.twitter.com/Z7DDPfJN5i, ",1227999517783379968,False,0,0,0,1,dlvr.it,Can Jakafi hit $3B? Incyte thinks so‚Äîand it's got other launches on the way https://t.co/j4rlg8Bn0d &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #biotech #healthcare #pharmaceutical #pharma #productmarketing https://t.co/Z7DDPfJN5i,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
68931280,2020-02-13 11:32:03,,,"dlvr.it/RPz6LK, pic.twitter.com/Krd9ZbB79D, ",1227993848900550656,False,0,0,0,0,dlvr.it,Lilly and Incyte‚Äôs atopic dermatitis drug shows promise at Phase 3 https://t.co/XBXnt0Wfs6 https://t.co/Krd9ZbB79D,,,2009-08-26 04:22:38,Uitgave van Medix Publishers,Pharmamarketeer,https://pbs.twimg.com/profile_images/1052198378640150528/33zQPOSL_normal.jpg,1026,494,59,9635,Pharmamarketeer,photo
963495628545327104,2020-02-13 11:25:11,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/dike3WpXSW, ",1227992121464033280,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's Fourth-Quarter Report Signals Better Times Ahead https://t.co/a2WgrM7Qh6 Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/dike3WpXSW,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
140599113,2020-02-13 11:16:58,,,"winway.me/health-remedie‚Ä¶, pic.twitter.com/EnIOalQL9W, ",1227990054007721990,False,0,0,0,0,WordPress.com,Can Jakafi hit $3B? Incyte thinks so‚Äîand it‚Äôs got other launches on the¬†way https://t.co/w9EiDDtMVT https://t.co/EnIOalQL9W,,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,photo
17960461,2020-02-13 10:55:00,,,"bit.ly/2wfKfPl, pic.twitter.com/YQcxRUZ9OL, ",1227984524845383680,False,0,0,0,0,TweetDeck,Lilly and Incyte's atopic dermatitis drug shows promise at Phase 3 https://t.co/8vOSvJIGV4 https://t.co/YQcxRUZ9OL,,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
1100450877792370688,2020-02-13 10:29:23,"INCY, ",,"blueequity.io/r/87109/de-inc‚Ä¶, ",1227978080381067265,False,0,0,0,0,Blue Equity,$INCY Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates on Key Clinical Programs https://t.co/BDt627I8Al,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
495524785,2020-02-13 10:27:24,"INCY, ",,,1227977582014062592,False,0,0,0,0,Twitter Web App,$INCY Time for Incyte Stock to get back the $150 level.  Good earning and guidance.  Opportunity for buyout.  long on it now.,,,2012-02-17 21:11:18,Invest in Energy/Biotechs,Henry Nguyen,https://pbs.twimg.com/profile_images/2281171479/zk3vj1l6hcktsq6941qr_normal.jpeg,258,63,7,11460,hieuvnguyen,
4028839455,2020-02-13 10:23:35,,,"stocktrot.com/company/incyte‚Ä¶, ",1227976621002412032,False,1,0,0,0,StockTrot1,Incyte Corp had 8 active insiders last month. Most active insiders in 3 months. https://t.co/Glm3OwNyt2,,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
68931280,2020-02-13 10:11:29,,,"pharmamarketeer.nl/lilly-and-incy‚Ä¶, ",1227973575921033217,False,0,0,0,0,Pharmamarketeertweets,Lilly and Incyte's atopic dermatitis drug shows promise at Phase 3 - https://t.co/c6Uh27f2e9,,,2009-08-26 04:22:38,Uitgave van Medix Publishers,Pharmamarketeer,https://pbs.twimg.com/profile_images/1052198378640150528/33zQPOSL_normal.jpg,1026,494,59,9635,Pharmamarketeer,
374729426,2020-02-13 09:54:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1240177, pic.twitter.com/CuOPoimR4I, ",1227969324461068289,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on February 7, 2020. View odds for this and other indicators: https://t.co/fMBJKKa8mB #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/CuOPoimR4I",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
953788131601502208,2020-02-13 09:07:17,,,"marketwatch.com/articles/incyt‚Ä¶, pic.twitter.com/LTuXJcvvBI, ",1227957419294195713,False,0,0,0,0,Wall St Solver Auto-Tweeter,"Incyte Climbs After Reporting a 'Solid Quarter and Guidance'

üì∞ ¬ª https://t.co/6DrY0BmlGH https://t.co/LTuXJcvvBI",,,2018-01-17 19:36:25,,Wall St Solver,https://pbs.twimg.com/profile_images/1029252349716512769/HAdlBHZA_normal.jpg,472,39,12,58222,wallstsolver,photo
72928001,2020-02-13 09:07:06,"INCY, ",,"bit.ly/39viUqB, ",1227957372322107393,False,0,0,0,0,BriefingInPlayLimited,"$INCY: Incyte beats by $0.09, beats on revs https://t.co/mk2EJbA8rs",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
20449296,2020-02-13 09:05:38,,,"on.barrons.com/2Spd5p9, ",1227957000899874818,False,0,0,0,0,SocialFlow,Incyte Climbs After Reporting a ‚ÄòSolid Quarter and Guidance‚Äô https://t.co/vyFfsAc3iF,,,2009-02-09 12:15:01,"New York, NY",Barron's,https://pbs.twimg.com/profile_images/1400867183333412864/LO1NDNpM_normal.jpg,201867,35,4773,60256,barronsonline,
25406480,2020-02-13 09:03:38,,,"awesomecapital.blogspot.com/2020/02/incyte‚Ä¶, ",1227956498149629952,False,0,0,0,1,Twitter Web Client,AwesomeCapital: Incyte +2% premarket on Q4 beat https://t.co/E5fz0iyQPu,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
2334614718,2020-02-13 08:46:56,"INCY, ",,"ooc.bz/l/48487, ",1227952298627825667,False,0,0,0,0,Open Outcrier,"$INCY (+1.8% pre) Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates on Key Clinical Programs - BW

https://t.co/xrYZbZJ10s",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
732361939490312192,2020-02-13 08:44:29,"INCY, ","markets, ","americanbankingnews.com/?p=13385719, ",1227951680555298821,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Mizuho https://t.co/nAP3LtThti #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-13 08:44:28,"INCY, ","stocks, ","americanbankingnews.com/?p=13385719, ",1227951677682180103,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Mizuho https://t.co/FPQOusvwt1 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
963495628545327104,2020-02-13 08:29:26,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1227947891412623361,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte +2% premarket on Q4 beat https://t.co/oevX4aVled Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
1637027690,2020-02-13 08:13:09,,,"ift.tt/37oC53O, ",1227943795205058561,False,0,0,0,0,IFTTT,Incyte +2% premarket on Q4 beat https://t.co/AACKs0V1dH,,,2013-07-31 23:30:55,Everywhere,Ashish Aggarwal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,557,0,4776,AggarwalTweets,
121158213,2020-02-13 08:06:03,,,"dlvr.it/RPyQ0h, freetrade.pw, pic.twitter.com/s0zWWKV6TW, ",1227942006405484544,False,0,0,0,0,dlvr.it,Trading Ideas: Incyte Corp on reversal watchlist https://t.co/NqX5oR58Uk üìà FREE trade-of-week via ‚Üí https://t.co/BCEHq7Ce2N https://t.co/s0zWWKV6TW,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,photo
1082709654491328512,2020-02-13 08:01:20,,"INCY, ","tradingview.com/chart/INCY/WDd‚Ä¶, ",1227940821502058497,False,2,0,0,0,erased1143779,Incyte Corp on reversal watchlist  - #INCY chart https://t.co/f0LLoEnYcF,,,2019-01-08 13:44:32,üíØ% Free Subscriptionüîª,#BullishChartsüá∫üá∏,https://pbs.twimg.com/profile_images/1264289711469797376/hKeDDtwW_normal.jpg,11524,2033,46,6751,Bullishcharts01,
3318510966,2020-02-13 07:59:33,,,"crweworld.com/article/news-p‚Ä¶, ",1227940374053707777,False,0,0,0,0,CRWE World,Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates o https://t.co/NVoX866XI4,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
23059499,2020-02-13 07:52:47,"INCY, ","trading, finance, stocks, ","seekingalpha.com/article/432380‚Ä¶, ",1227938669438177281,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation 2019 Q4 - Results - Earnings Call Presentation. https://t.co/t5yS8WtJOg #trading #finance #stocks,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
15296897,2020-02-13 07:50:14,"INCY, ",,"seekingalpha.com/news/3541664-i‚Ä¶, ",1227938028221452291,False,0,0,0,0,SANewsTwitter,$INCY - Incyte +2% premarket on Q4 beat https://t.co/jDOQX1xuHx,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3901351277,2020-02-13 07:38:08,,"pharmaceutical, ","bit.ly/2HjFxlN, ",1227934984188694528,False,0,0,0,0,IFTTT,Lilly and Incyte's atopic dermatitis drug shows promise at Phase 3 : https://t.co/pBFtY7bmiP #pharmaceutical,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
3314135167,2020-02-13 07:34:58,,"jobs, pharmafile, ","goo.gl/fb/jX5QD4, ",1227934185907769345,False,0,0,0,0,Google,#jobs Lilly and Incyte‚Äôs atopic dermatitis drug shows promise at Phase 3 https://t.co/cuMhkpEPvV #pharmafile,,,2015-08-13 02:43:55,,Career Biotech,https://pbs.twimg.com/profile_images/872856527731793920/HqYH3X_9_normal.jpg,110,59,1,35799,CareerBiotech,
772471873539977217,2020-02-13 07:26:35,"INCY, ",,"sec.gov/ix?doc=/Archiv‚Ä¶, ",1227932077762531328,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 8-K https://t.co/yJAGK4Bd5s,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
472650465,2020-02-13 07:22:20,"INCY, ",,"otcdynamics.com/incy-incyte-re‚Ä¶, ",1227931008273715207,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and https://t.co/lBRghQuC3O,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
4312114277,2020-02-13 07:18:29,"INCY, ",,"fintel.io/s/us/incy?utm_‚Ä¶, ",1227930037757923329,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 8-K - Results of Operations and Financial Condition https://t.co/hv89PLGlBC,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,163,418542,fintel_io,
1171873456276889600,2020-02-13 07:16:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1227929621053804546,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (13 Feb, 7:14am)

üì∞ Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates on Key Clinical Programs

https://t.co/JVzKiohm8e

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
730032660,2020-02-13 07:12:53,,,"nonsell.com/au-market-news‚Ä¶, ",1227928629645987841,False,0,0,0,0,NonSell Twitter,"Incyte Earnings, Revenue beat in Q4 - https://t.co/ZjOqv1ux3G
Want to know more on Incyte Earnings, Revenue beat in Q4 click here go to market news source.
Market news summary from In...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
730032660,2020-02-13 07:12:46,,,"nonsell.com/au-market-news‚Ä¶, ",1227928599283421185,False,0,0,0,0,NonSell Twitter,"Incyte Earnings, Revenue beat in Q4 - https://t.co/OAOoBaJSQQ
Want to know more on Incyte Earnings, Revenue beat in Q4 click here go to market news source.
Market news summary from In...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
3426014292,2020-02-13 07:10:31,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1227928033232871430,False,1,1,0,1,Twitter for iPhone,$INCY Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates on Key Clinical Programs | Incyte Corporation https://t.co/JfE9B4ryXr,,,2015-09-02 09:10:37,,dough,https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_normal.jpg,32805,529,852,59439,semodough,
427877977,2020-02-13 07:07:18,"INCY, ",,"twitter.com/Incyte/status/‚Ä¶, ",1227927222712963072,False,1,0,0,0,Twitter Web Client,$INCY. https://t.co/TawbhMTVsg,,,2011-12-03 21:43:03,D√ºsseldorf,Volker Schulz,https://pbs.twimg.com/profile_images/1421288833862311941/Xw3abFlt_normal.jpg,4103,3000,238,132534,portefeuillefun,
3911174913,2020-02-13 07:06:22,,,,1227926987152465922,False,4,1,0,2,Twitter for Advertisers.,Incyte reports 2019 Q4 financial results &amp; provides updates on key clinical programs. Read our press release.,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
976297820532518914,2020-02-13 07:05:35,,,"dlvr.it/RPyCb4, pic.twitter.com/QxKiseqfYJ, ",1227926790552686592,False,0,0,0,0,dlvr.it,Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates on Key Clinical Programs https://t.co/wo6rYGK5Bi https://t.co/QxKiseqfYJ,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
963495628545327104,2020-02-13 07:03:05,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1227926163747753984,False,0,0,0,0,STCK.PR0,"$INCY NEW ARTICLE : Incyte EPS beats by $0.07, beats on revenue https://t.co/P9S47sGeKh Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
2812632288,2020-02-13 07:03:04,,,"invst.ly/pum6x, ",1227926157351321601,False,0,0,0,0,ForexPros News & Analysis,"Incyte Earnings, Revenue Beat in Q4 - https://t.co/PjHlRucLTQ",,,2014-09-16 03:56:03,Worldwide,Investing.com Stocks,https://pbs.twimg.com/profile_images/1108338732019695616/CAvg-ixc_normal.png,20430,38,256,339289,InvestingStockz,
185663478,2020-02-13 07:02:48,"INCY, ",,"seekingalpha.com/news/3541596, ",1227926091614113792,False,0,0,0,0,Twitter for iPhone,"$INCY Q4 Non-GAAP EPS of $0.65 beats by $0.07; GAAP EPS of $0.51 beats by $0.21.
‚Ä¢ Revenue of $579.39M (+35.2% Y/Y) beats by $4.5M. https://t.co/1yaDwSYy9q",,,2010-09-01 10:52:28,"Chicago, IL",CHItraders,https://pbs.twimg.com/profile_images/623935252357058560/AaeCRlHB_normal.jpg,1253,501,63,45319,CHItraders,
15296897,2020-02-13 07:01:48,"INCY, ",,"seekingalpha.com/news/3541596-i‚Ä¶, ",1227925839385227264,False,0,0,0,0,SANewsTwitter,"$INCY - Incyte EPS beats by $0.07, beats on revenue https://t.co/CURDKYKQc3",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
15974185,2020-02-13 06:07:32,,,"dlvr.it/RPy28z, ",1227912184136519681,False,0,0,0,1,dlvr.it,Eli Lilly and Incyte Record Another Positive Clinical Trial for Olumiant Works in Eczema https://t.co/UarS3fsvm2,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
374729426,2020-02-13 04:41:39,"INCY, ","Incyte, stockmarket, stock, earnings, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1239314, ",1227890567381577729,False,0,0,0,0,Tickeron,"Incyte Corp. to report earnings on February 13, 2020. Earnings per share (EPS) estimate: $0.35 $INCY #Incyte #stockmarket #stock #earnings #money #trading #investing #daytrading #news #today https://t.co/5ypQhack2Z",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,
1979190776,2020-02-13 04:35:42,"INCY, ",,"tickerreport.com/?p=5046355, ",1227889073232195584,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Sees Significant Increase in Short Interest https://t.co/RgGYNukJ46,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
61661638,2020-02-13 04:32:33,"INCY, ","stocks, ","americanbankingnews.com/?p=13382671, ",1227888279552479232,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Sees Significant Increase in Short Interest https://t.co/wXLDNN8RcI #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2525892205,2020-02-13 02:34:20,"INCY, ","investingnews, ","modernreaders.com/?p=2783559, ",1227858528091693057,False,0,0,0,0,Zapier.com,Zacks: Brokerages Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $570.07 Million  https://t.co/Iq4neffjuP #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2020-02-13 02:33:27,"INCY, ","markets, ","americanbankingnews.com/?p=13382001, ",1227858308855476224,False,0,0,0,0,Zapier.com,Zacks: Brokerages Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $570.07 Million https://t.co/NIMwpvu2f7 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-13 02:33:27,"INCY, ","stocks, ","americanbankingnews.com/?p=13382001, ",1227858306435342336,False,0,0,0,0,Zapier.com,Zacks: Brokerages Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $570.07 Million https://t.co/BvN9Ko8s3c #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
963495628545327104,2020-02-12 18:57:03,"INCY, LLY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/OEv5A6IIXp, ",1227743448138240005,False,0,0,0,0,STCK.PR0,$INCY $LLY NEW ARTICLE : Eli Lilly and Incyte Record Another Positive Clinical Trial for Olumiant Works in Eczema https://t.co/3xg5oxDviL Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/OEv5A6IIXp,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
953788131601502208,2020-02-12 18:52:17,,,"fool.com/investing/2020‚Ä¶, pic.twitter.com/NpEs089OGp, ",1227742249393573888,False,0,0,0,0,Wall St Solver Auto-Tweeter,"Eli Lilly and Incyte Record Another Positive Clinical Trial for Olumiant Works in Eczema

üì∞ ¬ª https://t.co/DGg0RReYND https://t.co/NpEs089OGp",,,2018-01-17 19:36:25,,Wall St Solver,https://pbs.twimg.com/profile_images/1029252349716512769/HAdlBHZA_normal.jpg,472,39,12,58222,wallstsolver,photo
1134049078424162304,2020-02-12 17:42:03,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1227724575942770688,False,0,0,0,0,Newsfilter.io,Incyte Q4 2019 Earnings Preview $INCY https://t.co/RlhaPvPpIp,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
15296897,2020-02-12 17:30:43,"INCY, ",,"seekingalpha.com/news/3541186-i‚Ä¶, ",1227721724172455939,False,0,0,0,0,SANewsTwitter,$INCY - Incyte Q4 2019 Earnings Preview https://t.co/jnZxqAFtCn,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
2266388972,2020-02-12 15:10:40,"INCY, ","stocks, ","dailypolitical.com/?p=3405845, ",1227686480061050882,False,0,0,0,0,Zapier.com,Analysts Set Incyte Co. $INCY Target Price at $91.42 https://t.co/Xkk7bYoK5O #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-02-12 15:10:40,"INCY, ",,"dailypolitical.com/?p=3405845, ",1227686477812969484,False,0,0,0,0,Zapier.com,Analysts Set Incyte Co. $INCY Target Price at $91.42 https://t.co/vo4vwUgWFb,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
68559732,2020-02-12 15:06:58,"INCY, ",,"zpr.io/tbL5s, ",1227685548371869704,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $91.42 Average PT from Analysts https://t.co/EHrg00sgaJ,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
374729426,2020-02-12 08:39:35,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1237466, pic.twitter.com/wqRu14QNgO, ",1227588059840909315,False,0,0,1,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on February 7, 2020. View odds for this and other indicators: https://t.co/UJIuBQrVx2 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wqRu14QNgO",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
260959063,2020-02-12 08:00:30,"INCY, INCY, ","INCY, IncyteCorporation, tradeupdate, Stockmarket, stocktwits, Stocksearning, ","stocksearning.com/stocks/INCY/ea‚Ä¶, pic.twitter.com/pwY6SCILK1, ",1227578224835809281,False,1,0,0,0,StockTwits Web,"$INCY releasing Earnings on 2/13 Before Open (Confirmed). $INCY INCYTE for a quick $5 turnaround on a $72 stock? What you say buying/selling in Earnings?  
https://t.co/vLhjnEGgrb 
 
#INCY #IncyteCorporation #tradeupdate #Stockmarket #stocktwits #Stocksearning https://t.co/pwY6SCILK1",,,2011-03-04 18:40:27,"New York, NY",Hiral Ghelani,https://pbs.twimg.com/profile_images/981655724475461635/Oa8TTeB9_normal.jpg,128,32,0,38289,hg5096,photo
360777012,2020-02-12 07:51:29,,"cholangiocarcinoma, ","twitter.com/Incyte/status/‚Ä¶, ",1227575956543614976,False,0,0,0,0,Twitter for iPad,My mother passed away from #cholangiocarcinoma https://t.co/dBrFJBi9uB,,,2011-08-23 15:03:12,"Wilmington, NC",Ernestine Kuhr,https://pbs.twimg.com/profile_images/768392125251719168/9BfIYFvG_normal.jpg,144,177,11,3648,tmkuhr,
1889492676,2020-02-12 06:54:15,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1227561552200339456,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/bBlSJLDbOu,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2020-02-12 06:50:27,"INCY, ","Incyte, PriorityReview, NDA, Capmatinib, NonSmallCellLungCancer, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1227560596364619777,False,0,0,0,0,Troi URL Plug-in,#Incyte Announces Acceptance and #PriorityReview of #NDA for #Capmatinib for Advanced #NonSmallCellLungCancer $INCY https://t.co/HOEJHdeRfl,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
176371365,2020-02-12 06:42:43,,"review, reviews, ","bit.ly/3btmAuN, pic.twitter.com/Bs0WKlReLS, ",1227558647791865856,False,0,0,0,1,Twitter Web App,What lab products have been key to your research success? Share your opinion like Sean Schuette from Incyte Research Institute and help other scientists find their dream equipment! https://t.co/w7W44O2u4g @analytikjenaAI @Incyte #review #reviews https://t.co/Bs0WKlReLS,"Incyte, ",,2010-08-09 06:35:42,Global,SelectScience,https://pbs.twimg.com/profile_images/1437699365364195329/Ri5eccCy_normal.jpg,10421,2899,128,9634,SelectScience,photo
712927915,2020-02-12 06:40:08,,,"businesswire.com/news/home/2020‚Ä¶, ",1227557998823866368,False,0,0,0,0,Crowdfire App,Incyte Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced Non-Small Cell Lung Cancer https://t.co/mxYfBXuyB0,,,2012-07-23 15:00:02,"Brooklyn, NY, US, 11204",Laptop Repair Data,https://pbs.twimg.com/profile_images/1452615561549172746/cO9T9Q7__normal.jpg,814,4885,66,36506,LaptopRepairDat,
1134049078424162304,2020-02-12 04:34:56,"AZN, MRK, INCY, NVS, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1227526491312971776,False,0,0,0,0,Newsfilter.io,Incyte's Capmatinib NDA Gets Priority Review From FDA $AZN $MRK $INCY $NVS https://t.co/9emBTAN09t,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
849417718642159616,2020-02-12 03:01:14,"INCY, ",,"zpr.io/tbbVi, ",1227502912315592704,False,0,0,0,0,Zapier.com,Incyte $INCY Scheduled to Post Quarterly Earnings on Thursday https://t.co/h0QSkrGyqj,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1134049078424162304,2020-02-12 00:51:55,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1227470369155616770,False,0,0,0,0,Newsfilter.io,Incyte to Present at Upcoming Investor Conference $INCY https://t.co/GhV6dE1mGZ,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
3460109487,2020-02-11 22:52:00,"NVS, INCY, ","NSCLC, ","endpts.com/novartis-nabs-‚Ä¶, ",1227440190702202882,False,4,0,0,1,Buffer,Novartis nabs priority review for a blockbuster-to-be aimed at #NSCLC niche ‚Äî delighting Incyte execs https://t.co/QiEnA3WvAR $NVS $INCY,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
2266388972,2020-02-11 22:15:00,"INCY, ","stocks, ","dailypolitical.com/?p=3403743, ",1227430879586287622,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Post Earnings of $0.58 Per Share https://t.co/uOZIg5AW8g #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-02-11 22:15:00,"INCY, ",,"dailypolitical.com/?p=3403743, ",1227430877182996480,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Post Earnings of $0.58 Per Share https://t.co/Io8LpxScoG,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
732361939490312192,2020-02-11 22:12:42,"INCY, ","markets, ","americanbankingnews.com/?p=13366184, ",1227430300617265152,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Post Earnings of $0.58 Per Share https://t.co/1Xemua8jRL #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-11 22:12:42,"INCY, ","stocks, ","americanbankingnews.com/?p=13366184, ",1227430297102364677,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Post Earnings of $0.58 Per Share https://t.co/2rkywnlvEN #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
68559732,2020-02-11 22:12:24,"INCY, ",,"zpr.io/tbK4L, ",1227430224960327680,False,0,0,0,0,Zapier.com,Zacks: Analysts Anticipate Incyte Co. $INCY Will Post Earnings of $0.58 Per Share https://t.co/iI3YtK9v2M,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
424089030,2020-02-11 21:31:26,,,"endpts.com/novartis-nabs-‚Ä¶, ",1227419912219561984,False,0,0,0,0,Twitter Web Client,Novartis nabs priority review for a blockbuster-to-be aimed at NSCLC niche ‚Äî delighting Incyte execs - https://t.co/WtXxZax8fn,,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
227778014,2020-02-11 21:30:01,"NTRA, INCY, LOGC, ","COVID19, ","buff.ly/2tQBxGv, ",1227419555389222914,False,2,0,0,1,Buffer,"BioCentury's latest roundup of company newsincludes: J&amp;J getting BARDA funding for #COVID19 vaccine; plus Novartis-Incyte, LogicBio and Elicio-Natera $NTRA $INCY $LOGC https://t.co/xUlRkIXjYS",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13038,1543,387,33073,BioCentury,
247195508,2020-02-11 18:35:02,,,"bioportfol.io/RPrq55, ",1227375521991815170,False,0,0,0,1,dlvr.it,Lilly and Incyte Announce Positive TopLine Results from the North American Phase 3 Study BREEZEAD5 of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis: Study met the primary endpoint of at least 75‚Ä¶ https://t.co/EBcmcPpuBt,,,2011-02-04 03:47:02,London,Allergy News,https://pbs.twimg.com/profile_images/2229775486/Twitter-FB_Profile_pic_-crops_1__normal,321,77,8,20790,Allergy_bio,
21306486,2020-02-11 18:31:53,,,"stockguru.com/2020/02/11/lil‚Ä¶, ",1227374727762718721,False,0,0,0,0,StockGuru,Lilly and Incyte Announce Positive Top-Line Results from the North American Phase 3 Study (BREEZE-AD5) of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate- to Severe Atopic Dermatitis  https://t.co/Mv7gL81obR,,,2009-02-19 10:17:36,United States,StockGuru,https://pbs.twimg.com/profile_images/1257700696952053764/vwiLdNMC_normal.jpg,8114,5424,158,260898,StockGuruDotCom,
126416038,2020-02-11 18:31:48,"LLY, INCY, ",,"globenewswire.com/news-release/2‚Ä¶, ",1227374705889464328,False,3,1,2,3,Twitter for iPhone,$LLY $INCY Positive Top-Line Results from the North American Phase 3 Study (BREEZE-AD5) of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate- to Severe Atopic Dermatitis https://t.co/LKspkYgDF2,,,2010-03-25 16:17:38,Tel Aviv,Odi Bruckman,https://pbs.twimg.com/profile_images/1182595151899836417/Y4fMBMd5_normal.jpg,14629,185,415,30356,odibro,
730032660,2020-02-11 12:21:44,,,"nonsell.com/us-market-news‚Ä¶, ",1227281578209894400,False,0,0,0,0,NonSell Twitter,"Potential Lung Cancer Drug from Incyte and Novartis to Get a Priority Review from FDA - https://t.co/Ezh5ylTDWG Food and Drug Administration will expedite its review of capmatinib.
Wan...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
730032660,2020-02-11 12:21:09,,,"nonsell.com/us-market-news‚Ä¶, ",1227281429848940544,False,0,0,0,0,NonSell Twitter,"Potential Lung Cancer Drug from Incyte and Novartis to Get a Priority Review from FDA - https://t.co/OjsaTxfPMo Food and Drug Administration will expedite its review of capmatinib.
Wan...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
730032660,2020-02-11 12:21:09,,,"nonsell.com/us-market-news‚Ä¶, ",1227281428573904897,False,0,0,0,0,NonSell Twitter,"Potential Lung Cancer Drug from Incyte and Novartis to Get a Priority Review from FDA - https://t.co/oEXloLAq1l Food and Drug Administration will expedite its review of capmatinib.
Wan...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
598251794,2020-02-11 12:06:11,,"WorldCCADay, ","twitter.com/Incyte/status/‚Ä¶, ",1227277665570258946,False,3,0,0,1,Twitter for iPhone,Raising the awareness of cholangiocarcinoma on #WorldCCADay https://t.co/ciaoFtr3Qy,,,2012-06-03 07:16:54,,Dr. Luis F√©liz,https://pbs.twimg.com/profile_images/1135315461468512256/VsiKnHW-_normal.jpg,84,342,1,359,lrfeliz,
133504478,2020-02-11 12:00:38,,"strategy, competitiveintelligence, marketing, pharmaceutical, healthcare, pharma, productmarketing, biotech, ","dlvr.it/RPql05, lqventures.com, pic.twitter.com/JM87ssDP1z, ",1227276268502052864,False,0,0,0,1,dlvr.it,Novartis nabs priority review for a blockbuster-to-be aimed at NSCLC niche ‚Äî delighting Incyte execs https://t.co/jmUblYlVqt &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #pharma #productmarketing #biotech https://t.co/JM87ssDP1z,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
72928001,2020-02-11 10:57:42,"INCY, ",,"bit.ly/38hOnwn, ",1227260428675235842,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte receives Priority Review of NDA for capmatinib https://t.co/i41y0BfewY,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
963495628545327104,2020-02-11 10:53:14,"INCY, NVS, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/IBcGX5VOtm, ",1227259307063943170,False,0,0,0,0,STCK.PR0,$INCY $NVS NEW ARTICLE : Potential Lung Cancer Drug from Incyte and Novartis to Get a Priority Review from FDA https://t.co/4vxlxQwf2E Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/IBcGX5VOtm,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1006334607946649600,2020-02-11 10:49:03,,,"dlvr.it/RPqV5w, ",1227258251474915329,False,0,0,0,0,dlvr.it,Incyte‚Äôs (INCY) Capmatinib NDA Gets Priority Review From FDA https://t.co/5ZaP3jAAka,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1100450877792370688,2020-02-11 10:36:14,"INCY, ",,"blueequity.io/r/86506/de-inc‚Ä¶, ",1227255026030010368,False,0,0,0,0,Blue Equity,$INCY Incyte to Present at Upcoming Investor Conference https://t.co/LzckVeFXGV,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
15974185,2020-02-11 10:33:03,,,"dlvr.it/RPqR4C, ",1227254227258339330,False,2,0,0,1,dlvr.it,Novartis nabs priority review for a blockbuster-to-be aimed at NSCLC niche ‚Äî delighting Incyte execs https://t.co/s0ZX79FWrN,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
3911174913,2020-02-11 10:30:00,,"cholangiocarcinoma, WorldCCADay, ",,1227253458681524225,False,39,2,1,6,Twitter for Advertisers.,"Luis R. F√©liz Vi√±as, Medical Director Oncology at Incyte, explains what #cholangiocarcinoma is &amp; how personalized molecular profiling can help identify different treatment approaches. #WorldCCADay",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
3318510966,2020-02-11 10:19:52,,,"crweworld.com/article/news-p‚Ä¶, ",1227250907265372160,False,0,0,0,0,CRWE World,Incyte to Present at Upcoming Investor Conference https://t.co/j7UiipyFq9,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
746441781588426752,2020-02-11 10:07:59,,,"endpts.com/novartis-nabs-‚Ä¶, ",1227247916726857730,False,0,0,0,0,Twitter Web Client,Novartis nabs priority review for a blockbuster-to-be aimed at NSCLC niche ‚Äî delighting Incyte execs - https://t.co/1zMKKxx4nV,,,2016-06-24 16:36:03,Hong Kong,Amber Tong,https://pbs.twimg.com/profile_images/884631339940687872/t2YNNjMA_normal.jpg,2186,733,44,3674,AmberTongPW,
3460109487,2020-02-11 10:06:43,,,"endpts.com/novartis-nabs-‚Ä¶, ",1227247601382297600,False,0,0,0,0,Buffer,Novartis nabs priority review for a blockbuster-to-be aimed at NSCLC niche ‚Äî delighting Incyte execs https://t.co/QiEnA3WvAR,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
334585053,2020-02-11 09:00:34,,,"s.einnews.com/1W4L_ycRaG, ",1227230950976868352,False,0,0,0,0,EIN Presswire,Incyte receives FDA priority review for Capmatinib NDA to treat advanced non-small cell lung cancer https://t.co/Rwg7Tkc9Q8,,,2011-07-13 06:16:51,"Washington, D.C.",EIN Presswire: Lung Cancer Newswire,https://pbs.twimg.com/profile_images/1288514359396904962/bd9OSmiA_normal.jpg,718,415,28,35060,EINLungCancer,
374729426,2020-02-11 08:48:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1231652, pic.twitter.com/sSN1jnQ59u, ",1227227908629917696,False,0,0,1,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on February 7, 2020. View odds for this and other indicators: https://t.co/AME8COsWNe #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/sSN1jnQ59u",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1069693680066420736,2020-02-11 08:05:25,"INCY, ",,"s.flashalert.me/855SA, ",1227217071672565761,False,0,0,0,0,flashalerts,"$INCY: Issued Press Release on February 11, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/UGDowhSJDh",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2020-02-11 08:01:35,,,"dlvr.it/RPpwVK, pic.twitter.com/E4nUltj6Oa, ",1227216109725552640,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conference https://t.co/PPRwe55kqr https://t.co/E4nUltj6Oa,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
72928001,2020-02-11 06:51:40,"INCY, ",,"bit.ly/38hOnwn, ",1227198512107900929,False,0,0,0,1,BriefingInPlayLimited,$INCY: Incyte receives Priority Review of NDA for Capmatinib https://t.co/i41y0BfewY,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
707983961897611264,2020-02-11 06:03:10,"INCY, ",,"ca.finance.yahoo.com/news/incyte-an‚Ä¶, ",1227186309824942080,False,0,0,0,0,Twitter for iPhone,Incyte Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced Non-Small Cell Lung Cancer $INCY https://t.co/ht3bVsqvk5,,,2016-03-10 12:38:25,"Shawnee, OK",TraderZ,https://pbs.twimg.com/profile_images/1446462992934113312/0KCR9vsY_normal.jpg,2602,624,20,15539,MccaslinAndy,
112872946,2020-02-11 05:58:39,"INCY, NVS, ",,"ca.finance.yahoo.com/news/incyte-an‚Ä¶, ",1227185171667079168,False,4,0,0,2,Twitter Web Client,"$INCY Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced NSCLC. 
https://t.co/7n5WH5gEJV $NVS",,,2010-02-09 19:09:48,Toronto,Bio Stocks‚Ñ¢,https://pbs.twimg.com/profile_images/1345176821185306624/4OaDT_lb_normal.jpg,58832,77,1249,48782,BioStocks,
966006214818697218,2020-02-11 03:41:50,"INCY, ",,"theenterpriseleader.com/?p=2637437, ",1227150738377388032,False,0,0,0,0,Zapier.com,Incyte $INCY Set to Announce Quarterly Earnings on Thursday  https://t.co/rTnZVn2Iyd,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
3772910893,2020-02-11 03:40:06,"INCY, TQQQ, SCO, PLT, ","ElCacas, ","marketwirenews.com/news-releases/‚Ä¶, ",1227150302064914432,False,0,0,0,0,Market Wire News,"$INCY News Article - Incyte Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced Non-Small Cell Lung Cancer https://t.co/NBFOBJZee9

#ElCacas @otcdynamics @TraderKarthik $TQQQ $SCO $PLT","otcdynamics, TraderKarthik, ",,2015-10-03 14:47:09,"San Jose, CA",Market Wire News,https://pbs.twimg.com/profile_images/1156273358729830406/L5xAuaId_normal.jpg,54480,1818,498,41701,MarketWN,
3142088601,2020-02-11 03:33:03,"INCY, NVS, ",,"businesswire.com/news/home/2020‚Ä¶, ",1227148530923507712,False,3,0,1,0,Twitter Web Client,"$INCY $NVS Announce Acceptance and Priority Review of NDA for Capmatinib in Advanced METex14 NSCLC
https://t.co/cSNfJusrgN",,,2015-04-06 18:27:23,"Lyon, France",Bertrand Delsuc,https://pbs.twimg.com/profile_images/1118239110018273280/DDy8QJv8_normal.png,8047,263,283,59416,BertrandBio,
3318510966,2020-02-11 03:14:06,,,"crweworld.com/article/news-p‚Ä¶, ",1227143762033274883,False,0,0,0,0,CRWE World,Incyte Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced Non-Small Cell Lung Cancer https://t.co/k7PnsoAokU,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1006334607946649600,2020-02-11 02:04:03,,,"dlvr.it/RPnwrq, pic.twitter.com/hWIDtQbw5L, ",1227126133306454016,False,0,0,0,0,dlvr.it,Incyte Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced Non-Small Cell Lung Cancer https://t.co/VQ8EWxZVyz https://t.co/hWIDtQbw5L,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
472650465,2020-02-11 02:03:14,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1227125925843787783,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced Non-Small Cell Lung Cancer https://t.co/awImhCsOdL,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1089978712685273090,2020-02-11 01:44:32,"INTC, ","Incyte, ","dlvr.it/RPntqP, pic.twitter.com/Lz8NwBFIXa, ",1227121222074286080,False,1,0,0,0,dlvr.it,#Incyte $INTC Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced Non-Small Cell Lung Cancer https://t.co/KNMltVLx22 https://t.co/Lz8NwBFIXa,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,photo
472650465,2020-02-11 01:37:17,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1227119396730085377,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced Non-Small Cell Lung Cancer https://t.co/rRf59Pit0F,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
976297820532518914,2020-02-11 01:23:33,,,"dlvr.it/RPnrbm, pic.twitter.com/LZoERqKaUB, ",1227115938362773510,False,0,0,0,0,dlvr.it,Incyte Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced Non-Small Cell Lung Cancer https://t.co/7c3PmqtGmr https://t.co/LZoERqKaUB,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
247395947,2020-02-11 01:19:31,,,"bioportfol.io/RPnr9b, ",1227114926897950720,False,0,0,0,1,dlvr.it,Incyte Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced NonSmall Cell Lung Cancer: The U.S. Food and Drug Administration FDA Priority Review for capmatinib is based on Phase 2 data in firstline and previously treated patients‚Ä¶ https://t.co/pOsSbJPeEu,,,2011-02-04 13:18:05,London,Cancer News,https://pbs.twimg.com/profile_images/2231517370/FB_Profile_pic_cells_3__normal,1308,101,91,134522,Cancer_bio,
1134049078424162304,2020-02-11 01:18:46,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1227114736866775041,False,0,0,0,0,Newsfilter.io,Incyte Announces Acceptance and Priority Review of NDA for Capmatinib for Advanced Non-Small Cell Lung Cancer $INCY https://t.co/bW27sW1rAS,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
3911174913,2020-02-10 15:05:56,,"Cholangiocarcinoma, raredisease, WorldCCADay, ","pic.twitter.com/NXo1nGGWcw, ",1226960512019292161,False,139,3,2,42,Twitter for Advertisers.,"#Cholangiocarcinoma is often overlooked due to non-specific symptoms, which can lead to a late diagnosis. Hear from Incyte Chief Medical Officer, Steven Stein, about the importance of advancing research for this #raredisease. #WorldCCADay https://t.co/NXo1nGGWcw",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
56160822,2020-02-10 13:23:08,,,"nasdaq.com/articles/incyt‚Ä¶, ",1226934642504130566,False,0,0,0,0,Crowdfire App,Incyte (INCY) to Report Q4 Earnings: What's in the Cards? https://t.co/TmJK5kcUd9,,,2009-07-12 14:51:28,Norway,B2B Info,https://pbs.twimg.com/profile_images/958662147671719936/XMLe09ry_normal.jpg,12800,11907,314,43402,B2Binfo,
3911174913,2020-02-10 10:00:00,,"cholangiocarcinoma, WorldCCADay, ","pic.twitter.com/MioyBFmKvl, ",1226883522327126016,False,34,0,1,13,Twitter for Advertisers.,Learn more about what FGFR2 fusions or rearrangements mean for people with #cholangiocarcinoma. #WorldCCADay @WorldCCADay https://t.co/MioyBFmKvl,"WorldCCADay, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
374729426,2020-02-10 08:17:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1229171, pic.twitter.com/SnQmCLn7WB, ",1226857731505524736,False,1,0,0,1,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on January 30, 2020. View odds for this and other indicators: https://t.co/N6eynf1Knl #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/SnQmCLn7WB",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
249758623,2020-02-09 11:14:11,,"worldCCADay, CancerAwareness, ","twitter.com/Incyte/status/‚Ä¶, ",1226539803208015875,False,1,0,0,0,Twitter Web App,Bile Duct Cancer. #worldCCADay Not just another cancer day for me. Screening helped identify a structural anomaly that may make me more susceptible. Not much data to rely on yet so screening is my action. Raise the profile Know the symptoms Support the research. #CancerAwareness https://t.co/COo6F0IToR,,,2011-02-09 13:29:23,,Jocelyn,https://pbs.twimg.com/profile_images/1364196691285434368/IFcpFaIf_normal.jpg,48,1264,1,316,Joestte,
374729426,2020-02-09 09:36:27,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1223440, pic.twitter.com/zG5vvFcqaf, ",1226515208547360768,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on January 30, 2020. View odds for this and other indicators: https://t.co/XmSx2i94py #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/zG5vvFcqaf",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
477131488,2020-02-09 07:15:14,,"cancer, FoxLab, TNBC, ","twitter.com/JoeYeong/statu‚Ä¶, ",1226479669438042113,False,5,0,1,1,Twitter for iPhone,Nice work @JoeYeong &amp; colleagues! Increasing data humoral immunity may play critical role in improving outcomes of patients with #cancer/More reason to follow @F_Lund_Johansen efforts &amp; those of #FoxLab @cdi_labs @tylerwhulett @BMS_ImmunOnc_US @Incyte @Immunopole @ubivac #TNBC https://t.co/MY7dDepY7n,"JoeYeong, F_Lund_Johansen, cdi_labs, tylerwhulett, BMS_ImmunOnc_US, Incyte, Immunopole, UbiVac, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,
1979190776,2020-02-09 04:45:43,"INCY, ",,"tickerreport.com/?p=5034400, ",1226442043020451840,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Brokerages https://t.co/hB4lpVBKaZ,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2020-02-09 04:45:03,"INCY, ","markets, ","americanbankingnews.com/?p=13333044, ",1226441874879238144,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Analysts https://t.co/tSCNMyAE4w #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-09 04:45:01,"INCY, ","stocks, ","americanbankingnews.com/?p=13333044, ",1226441865882480640,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúHold‚Äù by Analysts https://t.co/ODtztz5RQi #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2920258887,2020-02-08 11:43:51,"INCY, ",,"dakotafinancialnews.com/?p=1506347, ",1226184879173443585,False,1,0,0,0,Zapier.com,Bank of America Reaffirms ‚ÄúNeutral‚Äù Rating for Incyte $INCY https://t.co/WN9yIk6Uyw,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
930803511918411776,2020-02-08 11:41:10,"INCY, ",,"thelincolnianonline.com/?p=3432572, ",1226184206767751171,False,1,0,0,0,Zapier.com,Bank of America Reaffirms ‚ÄúNeutral‚Äù Rating for Incyte $INCY https://t.co/jR8o6RWfOe,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
374729426,2020-02-08 09:20:49,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1220995, pic.twitter.com/pXtSTSH1Le, ",1226148886722437120,False,1,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on January 30, 2020. View odds for this and other indicators: https://t.co/54DaMJWldf #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/pXtSTSH1Le",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-02-08 04:12:04,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1226071183344488449,False,0,0,0,0,Newsfilter.io,"$1,011,296.30 of shares sold by Wenqing Yao (EVP, Head of Discovery Chem), reported in a new form 4 filed with the SEC  $INCY https://t.co/fZliDxoA6O",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
985228784042377216,2020-02-08 03:47:31,,,"pic.twitter.com/V2ryqpod4J, ",1226065008171331584,False,18,0,0,7,Twitter for iPhone,Promissing results of FGFR2 inh for patients with tumor  fusions and rearrangements!! Phase II CT. Looking forward to see the results of phase III on first line compared to GemCis @Incyte @EASLedu https://t.co/V2ryqpod4J,"Incyte, EASLedu, ",,2018-04-14 14:50:21,"Artajona, Espa√±a",Jesus Ba√±ales,https://pbs.twimg.com/profile_images/985272301833916418/rXKfXd-X_normal.jpg,938,465,6,2516,JesusMBanales,photo
829114715053883393,2020-02-07 22:45:40,,,"Siomni.com, siomni.com/heres-why-incy‚Ä¶, ",1225989045060329472,False,0,0,0,0,siomnipost,https://t.co/NfYqxxVjwD -   Here's Why Incyte Stock Tumbled 16.3% in January  https://t.co/mVEBoZHOJU,,,2017-02-07 18:48:47,Global,Siomni‚Ñ¢,https://pbs.twimg.com/profile_images/1218205028038725634/B1a--epI_normal.jpg,1369,1860,5,127090,SiomniMedia,
2181281054,2020-02-07 21:19:51,"INCY, ","markets, ","wkrb13.com/?p=1578582, ",1225967449167876096,False,0,0,0,0,Zapier.com,Incyte $INCY Given Neutral Rating at Bank of America https://t.co/K7bT4FMZTM #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
18435372,2020-02-07 20:36:27,,,"twitter.com/Incyte/status/‚Ä¶, ",1225956525035802624,False,0,0,0,0,Twitter Web App,This is what killed PaTek. https://t.co/7p3YkdygnU,,,2008-12-28 17:13:18,"Seattle, WA",MedTek,https://pbs.twimg.com/profile_images/1432537534714703879/mSVAKUMq_normal.jpg,2212,2186,138,96587,medtek,
730032660,2020-02-07 19:54:30,,,"nonsell.com/us-market-news‚Ä¶, ",1225945970451439617,False,0,0,0,0,NonSell Twitter,"Here's Why Incyte Stock Tumbled 16.3% in January - https://t.co/ERb7oGfNhE failed study disappointed investors, but the company's pipeline should withstand the blow.
Want to know more ...",,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
1134049078424162304,2020-02-07 18:16:02,"LLY, NVS, INCY, IMMU, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1225921187802382341,False,0,0,0,0,Newsfilter.io,Incyte to Report Q4 Earnings: What's in the Cards? $LLY $NVS $INCY $IMMU https://t.co/oTq9dnOgus,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1176558075798380544,2020-02-07 17:05:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1225903402691047429,False,0,0,0,0,InsiderActionMonitor,$INCY Yao Wenqing sells $1.3M Worth Of Incyte Stock https://t.co/X0xXV0jmvc,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
3911174913,2020-02-07 17:00:00,,"WorldCCADay, cholangiocarcinoma, ",,1225902055094652928,False,46,2,0,14,Twitter for Advertisers.,"For Incyte, #WorldCCADay means recognizing the global efforts made to address the serious unmet need for people with #cholangiocarcinoma.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
47679200,2020-02-07 12:14:40,,,"twitter.com/society_sir/st‚Ä¶, ",1225830249298112512,False,2,1,0,1,Twitter Web App,"This is a serious problem.  @CancerSupportDE refers to this as ""financial toxicity"" and has a program with @Incyte to provide emergency financial assistance to people with cancer who reside in Delaware. https://t.co/TWa6Hi8pZG","CancerSupportDE, Incyte, ",,2009-06-16 13:12:45,Delaware,Jaimie Pickles,https://pbs.twimg.com/profile_images/1034533271948939264/U01QY5jK_normal.jpg,169,85,17,544,jaimiepickles,
178441882,2020-02-07 10:49:30,,,"noahsrss.wordpress.com/2020/02/07/apr‚Ä¶, ",1225808814362046464,False,0,0,0,0,WordPress.com,April 17th Options Now Available For Incyte¬†(INCY) https://t.co/RQ6WPCRCBO,,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
374729426,2020-02-07 09:57:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1215327, pic.twitter.com/k2puBDNME9, ",1225795763025764357,False,1,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on January 30, 2020. View odds for this and other indicators: https://t.co/uHfu62oI1i #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/k2puBDNME9",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-02-06 18:01:44,"INCY, ",,"zpr.io/tuu2a, ",1225555199865081864,False,1,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Bank of America https://t.co/PhSfobkATn,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2416188264,2020-02-06 18:01:16,"INCY, ","markets, ","thestockobserver.com/?p=2613016, ",1225555085368926208,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Bank of America  https://t.co/Sx2fAENqr5 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1193779847727894529,2020-02-06 10:14:06,,,"pic.twitter.com/EQquQP4lXO, ",1225437517459021825,False,0,0,0,0,dlvr.it,Incyte (NASDAQ:INCY) Has A Rock Solid Balance Sheet https://t.co/EQquQP4lXO,,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,photo
374729426,2020-02-06 09:44:02,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1212702, pic.twitter.com/96pNBtYlze, ",1225429952318722053,False,1,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on January 30, 2020. View odds for this and other indicators: https://t.co/weH2pd0daY #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/96pNBtYlze",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-02-06 02:11:54,"INCY, ","markets, ","americanbankingnews.com/?p=13297112, ",1225316169709649923,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Earnings on Thursday https://t.co/KrIV1VmDgu #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-06 02:11:54,"INCY, ","stocks, ","americanbankingnews.com/?p=13297112, ",1225316166996054016,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Earnings on Thursday https://t.co/I4MQsRPjEW #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2020-02-06 02:10:42,"INCY, ",,"tickerreport.com/?p=5023863, ",1225315868235698176,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Earnings on Thursday https://t.co/0kACxN1dG7,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2920258887,2020-02-05 20:47:42,"INCY, ",,"dakotafinancialnews.com/?p=1497427, ",1225234579830824961,False,0,0,0,0,Zapier.com,Research Analysts‚Äô Weekly Ratings Changes for Incyte $INCY https://t.co/2ofLltLfj0,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
732361939490312192,2020-02-05 20:45:45,"INCY, ","markets, ","americanbankingnews.com/?p=13295074, ",1225234090485526529,False,0,0,0,0,Zapier.com,Research Analysts‚Äô Weekly Ratings Changes for Incyte $INCY https://t.co/IUrZOi4kyd #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-05 20:45:44,"INCY, ","stocks, ","americanbankingnews.com/?p=13295074, ",1225234087352373249,False,0,0,0,0,Zapier.com,Research Analysts‚Äô Weekly Ratings Changes for Incyte $INCY https://t.co/W3AHmw8iaf #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
849417718642159616,2020-02-05 20:43:44,"INCY, ",,"zpr.io/tuaPR, ",1225233580709810176,False,0,0,0,0,Zapier.com,Research Analysts‚Äô Weekly Ratings Changes for Incyte $INCY https://t.co/Itizd2gQMO,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
852931863547084801,2020-02-05 18:07:55,"INCY, ",,"zpr.io/tuYi8, ",1225194369193533442,False,0,0,0,0,Zapier.com,Incyte $INCY Receives Neutral Rating from Bank of America https://t.co/lWEWUftPOm,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
2842742151,2020-02-05 15:16:55,,,"medschool.vanderbilt.edu/career-develop‚Ä¶, ",1225151337110786048,False,1,0,0,1,Twitter Web App,Incyte Research Scholars Program at Vanderbilt University Medical Center https://t.co/1vXlVCtpDZ,,,2014-10-24 15:43:59,"Nashville, TN",VU BRET ASPIRE PhD Job Feed,https://pbs.twimg.com/profile_images/1146522809562271746/SvMlReG3_normal.png,716,22,20,4046,VUBRETPhDJobs,
23184067,2020-02-05 14:00:09,,,"buff.ly/3b135JZ, ",1225132019329486848,False,2,0,0,4,Buffer,"‚ÄúEli Lilly and Company and Incyte announced that baricitinib met its primary endpoint in the BREEZE-AD4 and BREEZE-AD5 studies in patients with moderate to severe atopic dermatitis, according to two press releases.‚Äù https://t.co/z7HIkYA1JU",,,2009-03-07 05:56:51,Buenos Aires,Juan C Ivancevich MD,https://pbs.twimg.com/profile_images/1427600321505857539/-m2-zdWi_normal.jpg,6820,603,249,84875,Aller_MD,
374729426,2020-02-05 13:14:32,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1207429, pic.twitter.com/oE4Zdv5w7h, ",1225120537728339968,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on January 30, 2020. View odds for this and other indicators: https://t.co/3O5DqUfiap #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/oE4Zdv5w7h",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1370906497,2020-02-04 17:55:05,"INCY, BAC, ",,,1224828752389181445,False,0,0,0,0,Twitter Web App,"$INCY BofA Securities $BAC  Initiates Coverage on Incyte With Neutral Rating, $82 Price Target",,,2013-04-21 20:38:27,U.S.A,MAISA,https://pbs.twimg.com/profile_images/3557296223/a73cb8bb8effbfd1f90590ab48523b10_normal.jpeg,2858,7,76,70211,MaisaCorp,
732361939490312192,2020-02-04 10:03:10,"INCY, ","markets, ","americanbankingnews.com/?p=13276183, ",1224709991145377792,False,0,0,0,0,Zapier.com,Bank of America Reaffirms ‚ÄúNeutral‚Äù Rating for Incyte $INCY https://t.co/RUsUUmaP3X #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-02-04 10:03:09,"INCY, ","stocks, ","americanbankingnews.com/?p=13276183, ",1224709988662247426,False,0,0,0,0,Zapier.com,Bank of America Reaffirms ‚ÄúNeutral‚Äù Rating for Incyte $INCY https://t.co/7rYesyjojW #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-02-04 09:22:17,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1204619, pic.twitter.com/farK75MErn, ",1224699701133377536,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on January 30, 2020. View odds for this and other indicators: https://t.co/mGk9wpz7pY #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/farK75MErn",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3426014292,2020-02-04 06:08:17,"INCY, ",,,1224650879527268352,False,2,0,0,0,Twitter for iPhone,Baml $INCY US: Incyte Corporation: Reinstatement of Coverage - Ruxolitinib could be a JAK of all trades; Reinstate at Neutral - NEUTRAL,,,2015-09-02 09:10:37,,dough,https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_normal.jpg,32805,529,852,59439,semodough,
477131488,2020-02-03 23:43:11,,"CANCER, WorldCancerDay, FoxLab, FinishCancer, ","pic.twitter.com/3kfjFCs0NG, twitter.com/UN/status/1224‚Ä¶, ",1224553968556052481,False,22,1,2,3,Twitter for iPhone,WANT TO REDUCE #CANCER RISK on #WorldCancerDay¬†? THANKS @UN for @WHO tips / My colleagues in #FoxLab @ChilesResearch @ProvHealth @psjh &amp; @UbiVac + @bmsnews @Incyte @AstraZeneca @Boehringer @AkoyaBio @Ultivue @HalioDx @InnatePharma are working to #FinishCancer @sitcancer https://t.co/3kfjFCs0NG https://t.co/ET1w87oUc0,"UN, WHO, ChilesResearch, ProvHealth, UbiVac, bmsnews, Incyte, AstraZeneca, Boehringer, AkoyaBio, Ultivue, HalioDx, InnatePharma, sitcancer, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
2298709746,2020-02-03 19:11:36,"INCY, ",,"zpr.io/tKi2j, ",1224485618950057985,False,1,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Royal Bank of Canada https://t.co/GxuaLTS7H3,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
852931863547084801,2020-02-03 19:09:30,"INCY, ",,"zpr.io/tKirz, ",1224485090287398912,False,1,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Royal Bank of Canada https://t.co/oQO01le6bf,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
950010035396136962,2020-02-03 17:01:27,,"Incyte, ",,1224452866582052868,False,0,0,0,0,Cresus AI,#Incyte closed at 72.94. Anguish and fear index +269. Ploutos says: TR A EBITDA C Net C Debt B üëé Use at your own risk,,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
374729426,2020-02-03 08:55:09,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1199202, pic.twitter.com/MCSu28v62M, ",1224330487616827392,False,1,0,0,0,Tickeron,$INCY in Downtrend: RSI indicator stops in oversold zone for 2 days. View odds for this and other indicators: https://t.co/1Y4xkl8yX1 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MCSu28v62M,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2020-02-02 11:25:42,"INCY, ",,"zpr.io/tKyYk, ",1224005984458354688,False,1,0,0,0,Zapier.com,Incyte $INCY Given Hold Rating at Royal Bank of Canada https://t.co/VXuH8h3a1A,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2920258887,2020-02-02 11:23:24,"INCY, ",,"dakotafinancialnews.com/?p=1488127, ",1224005406936248320,False,1,0,0,0,Zapier.com,Incyte $INCY Earns Hold Rating from Royal Bank of Canada https://t.co/BtI641BrcQ,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
374729426,2020-02-02 08:03:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1196429, pic.twitter.com/Ufxm7M6oMW, ",1223955056594018304,False,1,0,0,0,Tickeron,$INCY in Downtrend: RSI indicator stops in oversold zone for 2 days. View odds for this and other indicators: https://t.co/TF7AjU2XyH #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Ufxm7M6oMW,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1002361483169226752,2020-02-01 11:39:48,,"Incyte, Baricitinib, Ruxolitinib, Endpoints, AtopicDermatitis, clinicaltrials, healthcare, ","trialsitenews.com/incytes-barici‚Ä¶, ",1223647144487182336,False,0,0,0,0,Twitter Web Client,#Incyte‚Äôs #Baricitinib and #Ruxolitinib Hit #Endpoints in Phase 3 Trials for #AtopicDermatitis https://t.co/jdYBfLqG2W #clinicaltrials #healthcare,,,2018-05-31 21:29:35,"Salt Lake City, Utah",TrialSite News,https://pbs.twimg.com/profile_images/1002368873918689280/0KP3xUVe_normal.jpg,7886,3205,76,11177,TrialsiteN,
374729426,2020-02-01 08:19:01,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1190607, pic.twitter.com/qQGehhbWxj, ",1223596616533213184,False,1,0,0,0,Tickeron,$INCY in Downtrend: RSI indicator stops in oversold zone for 2 days. View odds for this and other indicators: https://t.co/4DnPXybZRt #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/qQGehhbWxj,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1072907304767512581,2020-02-01 00:30:10,,"Medicine, ","plow.io/post/incytes-s‚Ä¶, ",1223478625527189505,False,0,0,0,0,MedicinePlow,"Incyte's skin disease drug meets main goal in late-stage study
https://t.co/P94BRmE4pZ
+1 VigorBot #Medicine",,,2018-12-12 12:33:29,internet,Medicine Briefly,https://pbs.twimg.com/profile_images/1263257882319106048/v1sr7xnk_normal.jpg,1869,4829,6,5763,MedicineNews_b,
2288833020,2020-01-31 23:27:22,,"collaboration, ","prn.to/2RGwrFJ, ",1223462824804016130,False,0,0,0,0,Twitter Web App,A #collaboration producing exciting positive top-line results. Read more: https://t.co/LnZDibDHM5,,,2014-01-12 18:59:53,US & China,WuXi AppTec,https://pbs.twimg.com/profile_images/524834082262245376/J4kjV77Z_normal.png,4740,2153,71,1796,WuXi_AppTec,
895929863521095680,2020-01-31 20:30:37,"INCY, ","Incyte, stocks, trading, finance, market, ","bit.ly/3aZL4vn, pic.twitter.com/BliFyD3JtC, ",1223418343341940737,False,0,0,0,0,TradeFlags,"TD BUY $INCY at 73.07, Supp 73.07 Resis 81.47 R11  HiLo 5% T1Y 91 buy 2.4 PE 39.1 DIV N/A #Incyte Cor #stocks #trading #finance #market https://t.co/VsLF1Z2MeD https://t.co/BliFyD3JtC",,,2017-08-11 04:48:19,1130,TradeFlags,https://pbs.twimg.com/profile_images/1444247772769792002/Hc_nWhvE_normal.jpg,636,206,11,58994,TradeFlags,photo
36193867,2020-01-31 12:17:39,,"WiredPhilly, Philly, ","bit.ly/31cLz0I, ",1223294283404496896,False,1,1,0,2,Hootsuite Inc.,"The list of employers coming to #WiredPhilly on Feb. 11 at @TheFranklin, just keeps growing! Connect w/ employers like @amicusrx1 @Vanguard_Group @o3world @Lutron @comcastcareers @Incyte @elastic @theGREENprogram &amp; more. View full list &amp; sign up: https://t.co/fWFUlbY1PA #Philly","TheFranklin, amicusrx1, Vanguard_Group, o3world, Lutron, comcastcareers, Incyte, elastic, theGREENprogram, ",,2009-04-28 17:45:04,"Philadelphia, PA",Campus Philly,https://pbs.twimg.com/profile_images/1292876383014854657/p-RZxjld_normal.jpg,10353,2434,289,17420,campusphilly,
357659949,2020-01-31 12:04:22,,"biotechjobcafe, ","tinyurl.com/s59xopj, pic.twitter.com/bD4jqnGiI8, ",1223290941185974274,False,0,0,0,0,Paiger,Incyte Stock Rises After Biotech Company's Eczema Treatment Succeeds In Test - Investor's Business Daily #biotechjobcafe https://t.co/UshmHXCxhD https://t.co/bD4jqnGiI8,,,2011-08-18 14:22:17,United States,BioTechJobCafe,https://pbs.twimg.com/profile_images/1115735412637618176/GwY54Jdc_normal.png,15,67,0,147,biotechjobcafe,photo
1039636207645417473,2020-01-31 10:57:33,,,"pic.twitter.com/zjEwb4Q6eH, ",1223274125017276416,False,2,0,0,0,Twitter Web App,"Congratulations to Lucila Sackmann Sala, OU Biological Sciences &amp; MCB Ph.D. (2011) on receiving the 2020 Medical Science Liaison award from Incyte europe. https://t.co/zjEwb4Q6eH",,,2018-09-11 18:06:02,"Athens, OH",OU Biological Sciences,https://pbs.twimg.com/profile_images/1108790064065249281/1a3YGb1g_normal.png,517,570,0,769,OhioBioSciences,photo
32492934,2020-01-31 10:24:00,,,"bioworld.com/articles/43274‚Ä¶, ",1223265681300389891,False,1,0,0,0,TweetDeck,"Eli Lilly ($LLY) and Incyte ($INCY) are working on atopic dermatitis from several angles and finding success, most recently with positive top-line results from a collaborative phase III trial of baricitinib https://t.co/LkEuKDnRoM",,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
374729426,2020-01-31 09:16:15,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1188336, pic.twitter.com/yuQwcsU1e6, ",1223248630863106050,False,0,0,0,1,Tickeron,"$INCY's price moved below its 50-day Moving Average on December 31, 2019. View odds for this and other indicators: https://t.co/5DMkysys8T #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/yuQwcsU1e6",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
75639425,2020-01-31 08:30:21,,,"buff.ly/2S5ghES, pic.twitter.com/7vaNnILUYK, ",1223237082174435328,False,0,0,0,0,Buffer,Incyte's Big Dermatitis Week: Ruxolitinib and Baricitinib Hit Primary Endpoints https://t.co/gKBQJtCQzL https://t.co/7vaNnILUYK,,,2009-09-19 16:50:15,Chicago Region,Chelli Miller,https://pbs.twimg.com/profile_images/459756204206469120/EfGbLSm5_normal.jpeg,6871,6956,482,134749,cmiller1225,photo
68559732,2020-01-31 00:44:16,"INCY, ",,"zpr.io/tKfmw, ",1223119786147639296,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Gap Up to $76.07 https://t.co/pyjagckb14,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1001221394435313665,2020-01-31 00:37:05,,,"hcpfeed.com/2020/01/27/inc‚Ä¶, ",1223117980646559746,False,0,0,0,0,feed to posr,"Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis,,https://t.co/gmdbe72Ph8,",,,2018-05-28 17:59:17,,HCP Feed,https://pbs.twimg.com/profile_images/1001233343076171776/1AQQgkoM_normal.jpg,26,0,1,15366,FeedHcp,
964867368911626240,2020-01-30 23:50:15,,,"fdadaily.com/2020/01/28/inc‚Ä¶, ",1223106193284988929,False,0,0,0,0,FDA Daily Blog,"Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis, ,https://t.co/tnkKj0LNjG",,,2018-02-17 09:21:21,,FDA Daily,https://pbs.twimg.com/profile_images/972543348740370432/deQuPIOn_normal.jpg,105,155,1,4934,fdadaily,
2288833020,2020-01-30 21:26:39,,"collaboration, ","prn.to/2RGwrFJ, ",1223070054675308544,False,0,0,0,0,Twitter Web App,A  #collaboration producing exciting positive top-line results. Read more: https://t.co/LnZDibDHM5,,,2014-01-12 18:59:53,US & China,WuXi AppTec,https://pbs.twimg.com/profile_images/524834082262245376/J4kjV77Z_normal.png,4740,2153,71,1796,WuXi_AppTec,
32492934,2020-01-30 19:15:00,,,"bioworld.com/articles/43274‚Ä¶, ",1223036923784126464,False,0,0,0,0,TweetDeck,Skin deep: Lilly and Incyte find success in treating atopic dermatitis https://t.co/LkEuKDnRoM,,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
2288833020,2020-01-30 17:42:14,,"atopicdermatitis, ","bit.ly/313SVnh, twitter.com/Incyte/status/‚Ä¶, ",1223013580875935747,False,0,0,0,0,Twitter Web App,Primary endpoint achieved! #atopicdermatitis https://t.co/1iV5N39YeV https://t.co/rYKU74Cb36,,,2014-01-12 18:59:53,US & China,WuXi AppTec,https://pbs.twimg.com/profile_images/524834082262245376/J4kjV77Z_normal.png,4740,2153,71,1796,WuXi_AppTec,
27645777,2020-01-30 16:23:48,,"Jakafi, ","bit.ly/318SlEC, pic.twitter.com/9f6usyuOSH, ",1222993842359689216,False,1,0,0,1,TweetDeck,"Read a new commentary by Jonathan M. Gerber, MD @UMassMedical @umassmemorial on recent @ASCO_pubs study on ruxolitinib's efficacy for certain patients with chronic neutrophilic leukemia &amp; atypical chronic myeloid leukemia https://t.co/psKn0jCn0K #Jakafi @Incyte https://t.co/9f6usyuOSH","umassmemorial, ASCO_pubs, Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,photo
3873763761,2020-01-30 15:23:55,,,"lilly.mediaroom.com/2020-01-30-Lil‚Ä¶, pic.twitter.com/1Jfjh1f6i6, ",1222978771692728321,False,0,0,0,0,Twitter Web App,"Congratulations Eli Lilly and thank you Sudbury for helping make this possible!
https://t.co/EJauybpXyW https://t.co/1Jfjh1f6i6",,,2015-10-05 15:32:57,Greater Sudbury / Grand Sudbury,Medicor Research Inc,https://pbs.twimg.com/profile_images/1059479912397053952/RXtEHmxA_normal.jpg,70,248,2,315,MedicorResearch,photo
732361939490312192,2020-01-30 12:38:15,"INCY, ","markets, ","americanbankingnews.com/?p=13220945, ",1222937079115669506,False,0,0,0,0,Zapier.com,Royal Bank of Canada Reaffirms Hold Rating for Incyte $INCY https://t.co/69Jonw3uCK #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-30 12:38:14,"INCY, ","stocks, ","americanbankingnews.com/?p=13220945, ",1222937075823128576,False,0,0,0,0,Zapier.com,Royal Bank of Canada Reaffirms Hold Rating for Incyte $INCY https://t.co/mS9Lm1u8X2 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
57313817,2020-01-30 10:04:55,,,,1222898490570752000,False,0,0,0,0,Twitter Web App,"Incyte gets Indian patent for BDBM98027 
6998/DELNP/2012, family to US8487096",,,2009-07-16 07:53:04,"Mumbai, India",Sandeep K. Rathod,https://pbs.twimg.com/profile_images/1106160154167427073/lIHJIt2h_normal.jpg,895,109,5,24175,GenericIPguy,
94365736,2020-01-30 09:15:17,,"Incyte, skindisease, ","finance.yahoo.com/news/incytes-s‚Ä¶, ",1222886003301634055,False,0,0,0,1,Hootsuite Inc.,#Incyte's #skindisease drug meets main goal in late-stage study https://t.co/pMulVS3HNu via @YahooFinance @Incyte,"YahooFinance, Incyte, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
2554107798,2020-01-30 08:58:55,"INCY, ",,,1222881880481173504,False,1,0,0,0,Twitter Web App,$INCY Incyte and Eli Lilly Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis. Study met the primary endpoint of at least 75% improvement..,,,2014-06-08 03:25:44,,NASDAQ,https://pbs.twimg.com/profile_images/1141287270487662593/Uc-g_z1D_normal.png,523,0,58,396038,NASDAQODUK,
1053347494862688256,2020-01-30 08:57:18,"INCY, ",,,1222881474279591936,False,2,0,0,0,Twitter Web App,$INCY Incyte and Eli Lilly Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis,,,2018-10-19 14:09:47,,ClinicalTrialsData,https://pbs.twimg.com/profile_images/1053357678624419840/Nl8xFmks_normal.jpg,1147,22,15,5804,DataTrials,
1087563377889763329,2020-01-30 08:55:15,,"Incyte, PhIII, ruxolitinib, atopicdermatitis, drugdevelopment, dermatology, clinicalresearch, ","ow.ly/AtyR30qd3AM, ",1222880960091475968,False,0,0,0,0,Hootsuite Inc.,#Incyte scores much needed #PhIII success ‚Äî and of course it‚Äôs delivered by #ruxolitinib ‚Äì Endpoints News https://t.co/mELmArVl3m #atopicdermatitis #drugdevelopment #dermatology #clinicalresearch,,,2019-01-21 23:11:30,"Bradenton, FL","Synergy Healthcare, LLC",https://pbs.twimg.com/profile_images/1255687146624692224/hdDn-7ye_normal.jpg,19,135,1,1173,SynergyHealthCR,
72928001,2020-01-30 08:21:30,"LLY, ",,"bit.ly/2Gx5JZZ, ",1222872466546020354,False,0,0,0,0,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) announced that baricitinib met the primary endpoint in BREEZE-AD5 https://t.co/pt7Ivoav1w,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
374729426,2020-01-30 08:17:21,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1182871, pic.twitter.com/T6vr5UHjZO, ",1222871423602970624,False,1,0,0,2,Tickeron,$INCY in Downtrend: RSI indicator enters oversold zone. View odds for this and other indicators: https://t.co/nmCjC4KQZu #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/T6vr5UHjZO,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
178441882,2020-01-30 06:56:25,,,"noahsrss.wordpress.com/2020/01/30/lil‚Ä¶, ",1222851054276173825,False,0,0,0,0,WordPress.com,Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic¬†Dermatitis https://t.co/b5390WlGZP,,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
178441882,2020-01-30 06:43:49,,,"noahsrss.wordpress.com/2020/01/30/lil‚Ä¶, ",1222847885257117696,False,0,0,0,0,WordPress.com,Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic¬†Dermatitis https://t.co/FL9cXTt0ds,,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
1089978712685273090,2020-01-30 06:41:02,"INTC, ","Incyte, ","dlvr.it/RP2jsW, ",1222847183461867521,False,0,0,0,0,dlvr.it,Lilly and #Incyte $INTC Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis https://t.co/YUxs6tFchU,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
472650465,2020-01-30 06:30:44,"INCY, ",,"otcdynamics.com/incy-lilly-and‚Ä¶, ",1222844590782324736,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of https://t.co/4V1YYZUWZi,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1069693680066420736,2020-01-30 06:26:13,"LLY, ",,"s.flashalert.me/4A7O32, ",1222843454243442690,False,0,0,0,0,flashalerts,"$LLY: Issued Press Release on January 30, 06:15:00: Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis https://t.co/mv5qJulAFb",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
126416038,2020-01-30 06:25:06,"LLY, INCY, ",,"prnewswire.com/news-releases/‚Ä¶, ",1222843174252613632,False,2,0,0,0,Twitter for iPhone,$LLY $INCY Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis https://t.co/BQEsAPo5s8,,,2010-03-25 16:17:38,Tel Aviv,Odi Bruckman,https://pbs.twimg.com/profile_images/1182595151899836417/Y4fMBMd5_normal.jpg,14629,185,415,30356,odibro,
3318510966,2020-01-30 06:25:06,,,"crweworld.com/article/news-p‚Ä¶, ",1222843173510057985,False,0,0,0,0,CRWE World,Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selec https://t.co/9NGFpin0UN,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
112872946,2020-01-30 06:19:44,"LLY, INCY, ",,"prnewswire.com/news-releases/‚Ä¶, ",1222841822197813248,False,3,0,0,2,TweetDeck,"$LLY $INCY Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with Moderate to Severe Atopic Dermatitis
https://t.co/v0Tw5grC54",,,2010-02-09 19:09:48,Toronto,Bio Stocks‚Ñ¢,https://pbs.twimg.com/profile_images/1345176821185306624/4OaDT_lb_normal.jpg,58832,77,1249,48782,BioStocks,
849401209568059392,2020-01-29 19:26:01,,"bringontheDIN, ","twitter.com/synbiocan/stat‚Ä¶, ",1222677310589079555,False,0,0,1,0,Twitter Web App,"The science. Their patents, The wording of their last news release;which is why they were able to defer paying Talent shareholders. Fantastic phase 2 clinical results. Their GvHD drug = unmet medical need. Incyte failed phase 3.Cannaccord loading shares today. #bringontheDIN https://t.co/Hh2TSm0HZ1",,,2017-04-04 19:20:04,,Stephen Conohan,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,102,396,1,9550,stephen_conohan,
845236116,2020-01-29 16:23:11,,,"pharmaphorum.com/?p=63639, ",1222631299988512769,False,0,0,0,0,Twitter for Android,Incyte gets much-needed boost as eczema cream trial hits target https://t.co/uSN9Vki2uw via @pharmaphorum,"pharmaphorum, ",,2012-09-25 06:11:06,,EczemaVoice üíô,https://pbs.twimg.com/profile_images/3391713299/c91fe779ea2591597f0c6a68d6d2bd32_normal.jpeg,2169,603,38,3950,EczemaVoice,
738922748123045888,2020-01-29 15:17:26,,,"instagram.com/p/B76qrTEJgS0/‚Ä¶, ",1222614750879801347,False,0,0,0,0,Instagram,"MSL DAILY CLINICAL TRIAL NEWS - ATOPIC DERMATITIS
‚ÄúIncyte announced positive topline results from its randomized, vehicle-controlled, pivotal Phase 3 TRuE-AD2 study evaluating the safety and efficacy of ruxolitinib‚Ä¶ https://t.co/Mv0eREdKMu",,,2016-06-03 22:38:06,Austtralia,FSTP,https://pbs.twimg.com/profile_images/1220461989362667520/doBEb2Z7_normal.jpg,178,46,20,2550,PharmaNews,
194586164,2020-01-29 12:59:02,,"atopicdermatitis, ","buff.ly/38NoLHr, pic.twitter.com/dcXdPm9oki, ",1222579920490110976,False,0,0,0,0,Buffer,"Incyte doubles down on atopic dermatitis push with trial win for JAK med Jakafi. How will Incyte position both their JAK inhibitors, Olumiant and Jakafi, in #atopicdermatitis? https://t.co/5PHip3QFDo https://t.co/dcXdPm9oki",,,2010-09-24 10:12:02,"New York, Paris",Bionest Partners,https://pbs.twimg.com/profile_images/1271043069698326528/K-dF7hlM_normal.jpg,349,512,0,2306,BionestPartners,photo
18294275,2020-01-29 11:20:00,,,"fiercepharma.com/pharma/incyte-‚Ä¶, ",1222554998950645760,False,0,0,0,0,TweetDeck,Incyte doubles down on atopic dermatitis push with trial win for ruxolitinib cream https://t.co/r7d02pkXiV,,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
21268553,2020-01-29 11:10:06,,,"stock-market-newsfeed.blogspot.com/2020/01/incyte‚Ä¶, ",1222552507995557889,False,0,0,0,0,SS Auto Tweet App,"Incyte's Phase III Atopic Dermatitis Study Meets Primary Goal
 https://t.co/ZZ5dhghuJm",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
21268553,2020-01-29 11:00:08,,,"stock-market-newsfeed.blogspot.com/2020/01/incyte‚Ä¶, ",1222549998862135296,False,0,0,0,0,SS Auto Tweet App,"Incyte's Phase III Atopic Dermatitis Study Meets Primary Goal
 https://t.co/ZZ5dhgz5AU",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
178108186,2020-01-29 09:59:55,,"Incyte, ","lnkd.in/eKyWq-5, globaldata.com/incytes-topica‚Ä¶, ",1222534844930019333,False,1,0,0,0,LinkedIn,"Check out the latest investigative reporting from GlobalData Healthcare journalist, Reynald Casta√±eda, as he follows up on #Incyte's announcement about‚Ä¶https://t.co/6wXbJkrvfp https://t.co/RZgdgoq2JX",,,2010-08-13 18:15:00,Boston Massachusetts,Bornadata Bain,https://pbs.twimg.com/profile_images/843920134125314049/3muc2M3z_normal.jpg,212,234,10,2802,bornadata,
178108186,2020-01-29 09:28:41,,"Incyte, ","lnkd.in/e3jj-PH, lnkd.in/eAdr_aC, ",1222526984607215616,False,0,0,0,0,LinkedIn,"Check out the latest investigative reporting from GlobalData Healthcare journalist, Reynald Casta√±eda, as he follows up on #Incyte's announcement about positive topline Phase III results for topical Jakafi (#ruxolitini#ruxolitini#r‚Ä¶https://t.co/498kTsUDKU https://t.co/RAtF2GWkNF",,,2010-08-13 18:15:00,Boston Massachusetts,Bornadata Bain,https://pbs.twimg.com/profile_images/843920134125314049/3muc2M3z_normal.jpg,212,234,10,2802,bornadata,
113373418,2020-01-29 08:55:32,,"Incyte, Jakafi, dermatitis, Pharmaceutical, ","globaldata.com/incytes-topica‚Ä¶, ",1222518642044284930,False,2,0,0,2,TweetDeck,"#Incyte‚Äôs topical #Jakafi draws long-term side-effect caution, says GlobalData's Reynald Castaneda

#dermatitis #Pharmaceutical

https://t.co/sgynUmxvg0",,,2010-02-11 10:09:21,Worldwide,GlobalData Pharma,https://pbs.twimg.com/profile_images/826032229780451328/ax8xozhi_normal.jpg,2553,897,92,5394,Pharma_GD,
404283686,2020-01-29 08:50:11,,,"firstwordpharma.com/node/1696288, ",1222517296264028164,False,0,0,0,0,Twitter Web Client,"Eli Lilly, Incyte's JAK inhibitor Olumiant meets skin inflammation improvement goal in Phase III atopic dermatitis study. https://t.co/bFsaTjPuv9",,,2011-11-03 14:07:30,,Tina Witte,https://pbs.twimg.com/profile_images/461513057420599296/oCT2AfYo_normal.jpeg,213,732,12,4444,TinaWitte,
2263595708,2020-01-29 08:43:50,,,"pharmafile.com/news/539717/li‚Ä¶, ",1222515700780146691,False,1,0,0,0,Twitter Web Client,Lilly &amp; Incyte's Olumiant hits main goal in atopic dermatitis | Pharmafile https://t.co/MYMuDWg5oQ,,,2013-12-26 20:44:07,"Lake Worth, FL",HCRFFNGO #COP26 #INSAS #UNGMP #Homeless #GPML,https://pbs.twimg.com/profile_images/1420697941732433921/HEMA5d6x_normal.jpg,1785,3972,25,52207,hcrffngo,
404283686,2020-01-29 08:33:13,,,"firstwordpharma.com/node/1696555, ",1222513028396126211,False,0,0,0,0,Twitter Web Client,Incyte's cream formulation of ruxolitinib hits main goal of late-stage atopic dermatitis study. https://t.co/ahDxcyzbtW,,,2011-11-03 14:07:30,,Tina Witte,https://pbs.twimg.com/profile_images/461513057420599296/oCT2AfYo_normal.jpeg,213,732,12,4444,TinaWitte,
374729426,2020-01-29 08:25:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1180088, pic.twitter.com/eh4wT5wpeH, ",1222510979197464577,False,1,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on December 31, 2019. View odds for this and other indicators: https://t.co/jEy0SinAR9 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/eh4wT5wpeH",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
14442889,2020-01-29 08:25:03,,,"dlvr.it/RNzFq4, pic.twitter.com/lGIM2PXp59, ",1222510969915445248,False,1,0,0,0,dlvr.it,Incyte's Big Dermatitis Week: Ruxolitinib and Baricitinib Hit Primary Endpoints https://t.co/JfaeBZjIkb https://t.co/lGIM2PXp59,,,2008-04-19 08:47:12,,Pharmaceutical,https://pbs.twimg.com/profile_images/1249577991/Pill_with_transparent_background_normal.png,26095,1507,434,54180,Pharmaceutical,photo
14442905,2020-01-29 07:04:02,,,"dlvr.it/RNz0XJ, pic.twitter.com/voeIfqQRyU, ",1222490581810573312,False,1,0,0,0,dlvr.it,Incyte's Big Dermatitis Week: Ruxolitinib and Baricitinib Hit Primary Endpoints https://t.co/v6czduqBDW https://t.co/voeIfqQRyU,,,2008-04-19 08:48:59,,Biotechnology,https://pbs.twimg.com/profile_images/1235765602/horizon1202906805-double_helix_500x500_normal.png,57151,3269,1002,53397,Biotechnology,photo
247195508,2020-01-29 06:42:04,,,"bioportfol.io/RNyxLq, ",1222485054611288064,False,0,0,0,1,dlvr.it,Incyte's Big Dermatitis Week Ruxolitinib and Baricitinib Hit Primary Endpoints: Results from both latestage trials were announced this week. https://t.co/WM2dSuN8vy,,,2011-02-04 03:47:02,London,Allergy News,https://pbs.twimg.com/profile_images/2229775486/Twitter-FB_Profile_pic_-crops_1__normal,321,77,8,20790,Allergy_bio,
875382419251019776,2020-01-29 05:59:34,,,"bit.ly/2RyLmBV, pic.twitter.com/EdI4BNGOOq, ",1222474359245168640,False,0,0,0,0,dlvr.it,Incyte's Big Dermatitis Week: Ruxolitinib and Baricitinib Hit Primary Endpoints https://t.co/rpU6gHYb3d https://t.co/EdI4BNGOOq,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
3314135167,2020-01-29 05:05:02,,"jobs, ","goo.gl/fb/DK2msj, ",1222460635910418432,False,0,0,0,0,Google,#jobs Incyte announces that TRuE-AD2 trial of ruxolitinib cream met its primary endpoint in‚Ä¶ https://t.co/UH44iGBbuk,,,2015-08-13 02:43:55,,Career Biotech,https://pbs.twimg.com/profile_images/872856527731793920/HqYH3X_9_normal.jpg,110,59,1,35799,CareerBiotech,
930803511918411776,2020-01-29 04:21:51,"INCY, ",,"thelincolnianonline.com/?p=3402329, ",1222449766493229057,False,1,0,0,0,Zapier.com,Evercore ISI Reiterates Buy Rating for Incyte $INCY https://t.co/7SaeKa8jnr,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2525892205,2020-01-29 04:21:21,"INCY, ","investingnews, ","modernreaders.com/?p=2738789, ",1222449643377844224,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at Evercore ISI  https://t.co/DwrH4e3I22 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1001516954916618241,2020-01-29 01:26:10,,"eczema, dermatitis, dermatology, DERMATOLOGISTS, ClinicalResearch, clinicaltrials, clinicaltrial, healthcare, ","biotech-investments.com/incyte-positiv‚Ä¶, pic.twitter.com/2EmBsHCCSI, ",1222405557920780289,False,2,0,0,1,Twitter Web App,"Incyte's Eczema Drug Paves the Way Towards Regulatory Approval
https://t.co/sMmLkviPmb
#eczema #dermatitis #dermatology #DERMATOLOGISTS #ClinicalResearch #clinicaltrials #clinicaltrial #healthcare https://t.co/2EmBsHCCSI",,,2018-05-29 13:33:44,Switzerland,Biotech Investments,https://pbs.twimg.com/profile_images/1201182180975661056/y9NlME8P_normal.jpg,6338,124,23,153,BiotechInvsts,photo
2298709746,2020-01-29 01:18:41,"INCY, ",,"zpr.io/tyr5b, ",1222403673940267009,False,1,0,0,0,Zapier.com,Incyte $INCY Cut to Strong Sell at BidaskClub https://t.co/UIbfykFQYb,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
68559732,2020-01-29 01:15:52,"INCY, ",,"zpr.io/tyrLM, ",1222402963307683841,False,0,0,0,0,Zapier.com,Incyte $INCY Cut to Strong Sell at BidaskClub https://t.co/PpXcW44CpA,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
3460109487,2020-01-28 23:49:00,"INCY, ","ruxolitinib, ","endpts.com/incyte-scores-‚Ä¶, ",1222381104881192960,False,5,0,0,3,Buffer,Incyte scores much needed PhIII success ‚Äî and of course it‚Äôs delivered by #ruxolitinib https://t.co/rtp7T9czaH $INCY,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
3460109487,2020-01-28 22:52:00,"ALKS, INCY, ","Dupixent, ","endpts.com/sanofi-regener‚Ä¶, ",1222366759690416129,False,1,0,0,0,Buffer,Sanofi/Regeneron #Dupixent; Alkermes' antipsychotic get dates with the FDA; Concert wins reprieve in Incyte patent fight https://t.co/iXmHUPWt8E $ALKS $INCY,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
424089030,2020-01-28 21:11:50,,,"endpts.com/incyte-scores-‚Ä¶, ",1222341552468525056,False,0,0,0,0,Twitter Web Client,UPDATED: Incyte scores much needed PhIII success ‚Äî and of course it‚Äôs delivered by ruxolitinib - https://t.co/ssNd8wkfHT,,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
424089030,2020-01-28 21:05:26,,,"fiercepharma.com/pharma/incyte-‚Ä¶, ",1222339941314826240,False,0,0,0,0,Twitter Web Client,Incyte doubles down on atopic dermatitis push with trial win for JAK med Jakafi https://t.co/Bm45102qKO,,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
1120631024306802688,2020-01-28 20:25:02,"INCY, ","STOCKS, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, markets.dataswarm.tech, ",1222329771733987328,False,0,0,0,1,DataSwarm Markets,"$INCY We have detected a noticeable change in the Zeitgeist for Incyte Corporation at  https://t.co/OxItqO0RgL
Visit https://t.co/ApK6iYCrer for more information
#STOCKS #NASDAQ
DataSwarm ref: 87278",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
732361939490312192,2020-01-28 20:20:42,"INCY, ","markets, ","americanbankingnews.com/?p=13201565, ",1222328681995145216,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Down 14.5% in January https://t.co/5LQJsaaubo #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-28 20:20:41,"INCY, ","stocks, ","americanbankingnews.com/?p=13201565, ",1222328678484496384,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Down 14.5% in January https://t.co/uTxU3WDpOg #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2416188264,2020-01-28 20:16:06,"INCY, ","markets, ","thestockobserver.com/?p=2585622, ",1222327526145581056,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Down 14.5% in January  https://t.co/2dhisTBORw #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
849417718642159616,2020-01-28 20:15:13,"INCY, ",,"zpr.io/tyStp, ",1222327304313024512,False,1,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Down 14.5% in January https://t.co/o82BG9shCj,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
227778014,2020-01-28 20:00:01,"REGN, SNY, INCY, NH, SRNE, GILD, ",,"buff.ly/2vw5YSL, ",1222323477463621632,False,0,0,0,1,Buffer,"BioCentury's latest roundup of company news includes therapies under review for Alkermes, Regeneron-Sanofi, and Kite, plus news from Incyte, NantHealth-NantOmics, Sorrento, MicroCures and Paion $REGN $SNY $INCY $NH $SRNE $GILD https://t.co/eT4lvVbZxW",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13038,1543,387,33073,BioCentury,
896877581940781056,2020-01-28 19:10:12,,,"nasdaq.com/articles/incyt‚Ä¶, ",1222310941854879746,True,0,0,0,0,boutlineprod,"https://t.co/c88GGLbxQC 
 Results of a phase 3 clinical trial dubbed TRuE-AD2 showed that Incyte's ruxolitinib cream helped patients with atopic dermatitis, an autoimmune disease commonly",,,2017-08-13 19:34:13,"Austin, TX",Eager Beaver,https://pbs.twimg.com/profile_images/896879927286530049/06qmSNcs_normal.jpg,121,0,6,205300,eagerbeavertech,
27254739,2020-01-28 19:03:47,,"eczema, ","bit.ly/30Zs0ZQ, ",1222309327337402368,False,0,0,0,0,Sprout Social,"US biotech @Incyte has announced positive topline results from a phase 3 trial of its ruxolitinib #eczema cream in adults and adolescents aged 12 or above, sending its shares ticking up https://t.co/KIk9TIMNWS","Incyte, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
4493706195,2020-01-28 17:20:03,,,"ow.ly/qDAX30qd4FM, ",1222283219678175243,False,0,0,0,0,Hootsuite Inc.,Incyte‚Äôs skin disease drug meets main goal in late-stage study - Reuters https://t.co/wHekz9Zxse,,,2015-12-15 11:28:14,"Ontario, Canada",Mr. Brian Uberig,https://pbs.twimg.com/profile_images/1047073926990450690/NXLPvzrD_normal.jpg,476,905,20,54169,Brian_Uberig,
963495628545327104,2020-01-28 15:05:07,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/54GprnMnsR, ",1222249264761528328,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's Eczema Drug Ruxolitinib Works in a Late-Stage Clinical Trial https://t.co/RGTkfL8bix Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/54GprnMnsR,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
18294275,2020-01-28 14:40:00,,,"fiercepharma.com/pharma/incyte-‚Ä¶, ",1222242942271676416,False,4,0,0,0,TweetDeck,Incyte doubles down on atopic dermatitis push with trial win for JAK med Jakafi https://t.co/r7d02pkXiV,,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
140599113,2020-01-28 14:10:54,,,"winway.me/health-remedie‚Ä¶, pic.twitter.com/AUsGmhcfPG, ",1222235620212453376,False,0,0,0,0,WordPress.com,Incyte doubles down on atopic dermatitis push with trial win for JAK med¬†Jakafi https://t.co/mO3U6dULR3 https://t.co/AUsGmhcfPG,,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,photo
247195508,2020-01-28 13:20:02,"INCY, ",,"bioportfol.io/RNwWy9, ",1222222820416970754,False,0,0,0,1,dlvr.it,Incyte's cream formulation of ruxolitinib hits main goal of latestage atopic dermatitis study httpswww.firstwordpharma.comnode1696555√Ç $INCY: Incyte's cream formulation of ruxolitinib hits main goal of latestage atopic dermatitis study‚Ä¶ https://t.co/zhk9VMEy29,,,2011-02-04 03:47:02,London,Allergy News,https://pbs.twimg.com/profile_images/2229775486/Twitter-FB_Profile_pic_-crops_1__normal,321,77,8,20790,Allergy_bio,
3258569603,2020-01-28 13:00:04,,,"tinyurl.com/sahzvbr, pic.twitter.com/zviUBISb1k, ",1222217793904480263,False,0,0,0,0,24sante,Incyte's skin disease drug meets main goal in late-stage study https://t.co/uKiROpxWbg https://t.co/zviUBISb1k,,,2015-05-15 19:41:58,,24H Sante,https://pbs.twimg.com/profile_images/605093629997236224/Kw2mvgaH_normal.png,721,665,46,280400,24sante_fr,photo
17960461,2020-01-28 13:00:00,,,"bit.ly/2t9D9La, pic.twitter.com/uQbr0oC78C, ",1222217777169281024,False,1,0,0,0,TweetDeck,Lilly &amp; Incyte's Olumiant hits main goal in atopic dermatitis https://t.co/rOttGFWrfl https://t.co/uQbr0oC78C,,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
15974185,2020-01-28 12:27:03,,,"dlvr.it/RNwMWy, ",1222209484505767936,False,0,0,0,0,dlvr.it,Incyte's skin disease drug meets main goal in late-stage study https://t.co/etgE30ThFW,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
133504478,2020-01-28 12:19:08,,"strategy, competitiveintelligence, marketing, healthcare, pharma, biotech, productmarketing, pharmaceutical, ","dlvr.it/RNwLGN, lqventures.com, pic.twitter.com/su0vCfOZuk, ",1222207493482221568,False,0,0,0,2,dlvr.it,Incyte doubles down on atopic dermatitis push with trial win for JAK med Jakafi https://t.co/uoClAPExt2 &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #pharma #biotech #productmarketing #pharmaceutical https://t.co/su0vCfOZuk,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
950942636818432006,2020-01-28 12:00:00,"LLY, INCY, REGN, SNY, INCY, ARQT, ","AtopicDermatitis, IPO, Dermatology, ","prnewswire.com/news-releases/‚Ä¶, prnewswire.com/news-releases/‚Ä¶, businesswire.com/news/home/2020‚Ä¶, ",1222202679134474241,False,3,0,0,0,TweetDeck,"Notable #AtopicDermatitis newsflow this week

$LLY $INCY Ph 3 baricitinib data: https://t.co/0fPVVWyADz

$REGN $SNY Dupixent FDA Priority Review in children: https://t.co/h7YCFG6Nee

$INCY Ph 3 ruxolitinib data: https://t.co/bxA18udu80

$ARQT #IPO is also this week. #Dermatology",,,2018-01-09 23:09:27,"San Francisco, CA",SY Investing,https://pbs.twimg.com/profile_images/1108963782334672900/Bh_0t4CE_normal.png,5814,300,160,3879,syinvesting,
818081647,2020-01-28 11:51:08,"INCY, ",,"streetinsider.com/r/16381305, ",1222200448628772864,False,0,0,0,0,StreetInsider.com Integration,"Incyte $INCY PT Raised to $86 at SVB Leerink, Following TRuE-AD2 Pivotal Trial of Ruxolitinib ... https://t.co/5pPMp8VJvC",,,2012-09-11 15:57:26,,SIAnalystWire,https://pbs.twimg.com/profile_images/2600218874/alkkkjlbds18yu6ld9xj_normal.png,4980,1,230,118501,AnalystWire,
133504478,2020-01-28 11:50:11,,"strategy, competitiveintelligence, marketing, biotech, pharmaceutical, pharma, healthcare, productmarketing, ","dlvr.it/RNwF8j, lqventures.com, pic.twitter.com/xZg9dFbK4h, ",1222200205707182081,False,0,0,0,2,dlvr.it,Incyte scores much needed PhIII success ‚Äî and of course it‚Äôs delivered by ruxolitinib https://t.co/82SqxSjpuI &gt;&gt;&gt; https://t.co/HTA6IsGiV5 #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #healthcare #productmarketing https://t.co/xZg9dFbK4h,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
133504478,2020-01-28 11:50:09,,"strategy, competitiveintelligence, marketing, pharmaceutical, biotech, pharma, healthcare, productmarketing, ","dlvr.it/RNwF8K, lqventures.com, pic.twitter.com/I3BDFCnVd1, ",1222200199956746240,False,0,0,0,2,dlvr.it,Sanofi/Regeneron Dupixent; Alkermes' antipsychotic get dates with the FDA; Concert wins reprieve in Incyte patent fight https://t.co/Oe442UVuyL &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #healthcare #productmarketing https://t.co/I3BDFCnVd1,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
35789155,2020-01-28 11:33:01,"INCY, ",,"firstwordpharma.com/node/1696555, ",1222195886413008897,False,1,0,0,0,TweetDeck,Incyte's cream formulation of ruxolitinib hits main goal of late-stage atopic dermatitis study https://t.co/SbVzGIQF6Y $INCY,,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
852931863547084801,2020-01-28 11:24:18,"INCY, ",,"zpr.io/ty8aM, ",1222193692729126916,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reaffirmed at Evercore ISI https://t.co/GuYXLGyGkM,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
2844414692,2020-01-28 11:22:35,,,"zpr.io/ty8sr, ",1222193260736716800,False,0,0,0,0,Zapier.com,"Incyte doubles down on atopic dermatitis push with trial win for JAK med Jakafi
https://t.co/AswxNizd4u",,,2014-10-07 15:21:46,"Montr√©al, Qu√©bec",Labofine,https://pbs.twimg.com/profile_images/1222261856359809024/QSpRZp1o_normal.jpg,158,622,7,7643,tw_labofine,
3300865039,2020-01-28 11:05:44,"INCY, ","eczema, biotech, stocks, investingnews, ","investors.com/news/technolog‚Ä¶, ",1222189020303806464,False,0,0,0,0,Hootsuite Inc.,Can an #eczema treatment pull $INCY stock out of its downtrend? #biotech #stocks #investingnews https://t.co/cZJ4PvrglB,,,2015-07-29 15:22:19,"California, USA",Allison Gatlin,https://pbs.twimg.com/profile_images/1379079645480378371/V22zIHh9_normal.jpg,6295,1000,201,6646,IBD_AGatlin,
746441781588426752,2020-01-28 11:00:28,,,"endpts.com/incyte-scores-‚Ä¶, ",1222187696921219072,False,0,0,0,0,Twitter Web Client,Incyte scores much needed PhIII success ‚Äî and of course it‚Äôs delivered by ruxolitinib - https://t.co/GKi5dwNiYv,,,2016-06-24 16:36:03,Hong Kong,Amber Tong,https://pbs.twimg.com/profile_images/884631339940687872/t2YNNjMA_normal.jpg,2186,733,44,3674,AmberTongPW,
374729426,2020-01-28 10:55:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1174409, pic.twitter.com/PvTh7xIjkY, ",1222186487321522176,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on December 31, 2019. View odds for this and other indicators: https://t.co/2pDyHQZ3gy #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/PvTh7xIjkY",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3460109487,2020-01-28 10:52:59,,,"endpts.com/incyte-scores-‚Ä¶, ",1222185813599031302,False,3,0,0,1,Buffer,Incyte scores much needed PhIII success ‚Äî and of course it‚Äôs delivered by ruxolitinib https://t.co/rtp7T9czaH,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
3460109487,2020-01-28 10:48:31,,,"endpts.com/sanofi-regener‚Ä¶, ",1222184687323504640,False,0,0,0,0,Buffer,Sanofi/Regeneron Dupixent; Alkermes' antipsychotic get dates with the FDA; Concert wins reprieve in Incyte patent fight https://t.co/iXmHUPWt8E,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
1100450877792370688,2020-01-28 10:43:17,"INCY, ",,"blueequity.io/r/83670/de-inc‚Ä¶, ",1222183370727149569,False,0,0,0,0,Blue Equity,$INCY Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis https://t.co/PRz0noDA1h,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
3686628867,2020-01-28 10:18:02,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1222177015106809863,False,0,0,0,0,WordPress.com,Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic¬†Dermatitis https://t.co/uMOqj7u4k1,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
963495628545327104,2020-01-28 10:17:22,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/6BOTVe7tbW, ",1222176848739696641,False,0,0,0,1,STCK.PR0,$INCY NEW ARTICLE : Could An Eczema Treatment Pull Incyte Stock Out Of Its Downtrend? https://t.co/MZEAo8rX4n Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/6BOTVe7tbW,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
194586164,2020-01-28 10:08:01,"LLY, ","dermatitis, ","buff.ly/315zZVk, pic.twitter.com/hC9m27I1V0, ",1222174497140289537,False,0,0,0,0,Buffer,"Eli Lilly, Incyte's Olumiant notches another atopic dermatitis win. How will Olumiant stand up to Sanofi and Regeneron‚Äôs powerhouse Dupixent ‚Äì who has an early lead in atopic #dermatitis? https://t.co/qfiN2iCaYH $LLY https://t.co/hC9m27I1V0",,,2010-09-24 10:12:02,"New York, Paris",Bionest Partners,https://pbs.twimg.com/profile_images/1271043069698326528/K-dF7hlM_normal.jpg,349,512,0,2306,BionestPartners,photo
72928001,2020-01-28 09:38:05,"INCY, ",,"bit.ly/2U2avGF, ",1222166965483032576,False,0,0,0,0,BriefingInPlayLimited,"$INCY: Incyte announces ""positive"" top-line results from Phase 3 TRuE-AD2 study of ruxolitinib cream https://t.co/0spGt8ejDU",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
402719725,2020-01-28 09:22:29,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1222163038121463808,False,0,0,1,1,Twitter Web App,$INCY TRuE-AD2 (1st of 2x P3) trial of ruxolotinib cream reads out +ve in atopic dermatitis. https://t.co/By6zs6ipRV. P3 results of same drug in vitiligo (TRuE-V 1&amp;2) due in 2021.,,,2011-11-01 09:43:53,Horam,Robin Davison,https://pbs.twimg.com/profile_images/651413991504265216/hJkBhxzD_normal.jpg,796,1767,22,2767,RobinDavison2,
204959977,2020-01-28 09:21:10,,,"articletrunk.com/incytes-skin-d‚Ä¶, ",1222162707635494914,False,0,0,0,0,WordPress.com,Incyte‚Äôs skin disease drug meets main goal in late-stage¬†study https://t.co/kpSpKF2qEE,,,2010-10-19 17:16:00,"New York, New York",TheArticleTrunk,https://pbs.twimg.com/profile_images/1670533112/logo_normal.jpg,927,1706,26,431500,TheArticleTrunk,
99539910,2020-01-28 09:00:44,,,"DennisBenson.net, feeds.reuters.com/~r/reuters/UKH‚Ä¶, pic.twitter.com/ZNuAhTsNn6, ",1222157564680527872,False,0,0,0,0,erased13300255,Incyte's skin disease drug meets main goal in late-stage study: https://t.co/iIQ6idaiGW - https://t.co/Fe6yWW931s https://t.co/ZNuAhTsNn6,,,2009-12-26 12:15:45,,chorley chicken,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,276,890,82,268355,chorleychicken,photo
1099892798931812352,2020-01-28 08:56:34,"INCY, ",,,1222156514426793985,False,0,0,0,0,StockTwits Web,$INCY Incyte Says Study of Eczema Treatment Meets Primary Endpoint,,,2019-02-24 23:44:13,,ùîΩùï£ùïíùïüùïú ùï•ùïôùïñ ùïãùï†ùï†ùï•ùïô,https://pbs.twimg.com/profile_images/1393147494486454276/HnL7sCTK_normal.jpg,245,140,9,9222,ToothFrank,
963495628545327104,2020-01-28 08:50:10,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1222154905533779969,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's ruxolitinib cream successful in dermatitis study; shares up 6% premarket https://t.co/cWAuqQe1ln Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
1120631024306802688,2020-01-28 08:50:01,"INCY, ","STOCKS, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, markets.dataswarm.tech, ",1222154869026492418,False,0,0,0,1,DataSwarm Markets,"$INCY We have detected a noticeable change in the Zeitgeist for Incyte Corporation at  https://t.co/OxItqO0RgL
Visit https://t.co/ApK6iYCrer for more information
#STOCKS #NASDAQ
DataSwarm ref: 87195",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
1134049078424162304,2020-01-28 08:49:24,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1222154710993514497,False,0,0,0,0,Newsfilter.io,Incyte's ruxolitinib cream successful in dermatitis study; shares up 6% premarket $INCY https://t.co/FZzubfiJyL,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
15296897,2020-01-28 08:47:57,"INCY, ",,"seekingalpha.com/news/3535104-i‚Ä¶, ",1222154345480769539,False,1,0,0,1,SANewsTwitter,$INCY - Incyte's ruxolitinib cream successful in dermatitis study; shares up 6% premarket https://t.co/KvlvljVr01,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
204959977,2020-01-28 08:47:42,,,"articletrunk.com/incytes-skin-d‚Ä¶, ",1222154283656908801,False,0,0,0,0,WordPress.com,Incyte‚Äôs skin disease drug meets main goal in late-stage¬†study https://t.co/K9tg5hTF9k,,,2010-10-19 17:16:00,"New York, New York",TheArticleTrunk,https://pbs.twimg.com/profile_images/1670533112/logo_normal.jpg,927,1706,26,431500,TheArticleTrunk,
204959977,2020-01-28 08:43:08,,,"articletrunk.com/update-1-incyt‚Ä¶, ",1222153133113081863,False,0,0,0,0,WordPress.com,UPDATE 1-Incyte‚Äôs skin disease drug meets main goal in late-stage¬†study https://t.co/VRUoKHImA8,,,2010-10-19 17:16:00,"New York, New York",TheArticleTrunk,https://pbs.twimg.com/profile_images/1670533112/logo_normal.jpg,927,1706,26,431500,TheArticleTrunk,
798878888399085568,2020-01-28 08:28:12,,,"uk.reuters.com/article/us-inc‚Ä¶, pic.twitter.com/WJuC5iNMSX, ",1222149376862228480,False,0,0,0,0,Twibble.io,Incyte's skin disease drug meets main goal in late-stage study https://t.co/aQ3T3PQOH5 https://t.co/WJuC5iNMSX,,,2016-11-16 08:22:24,"Nottingham, England",Sai Legal Services,https://pbs.twimg.com/profile_images/836584423768350721/lV7-TXr7_normal.jpg,43,56,1,36541,SLS_Legal,photo
2334614718,2020-01-28 08:25:56,"INCY, ",,"ooc.bz/l/47392, ",1222148804868222976,False,1,0,0,1,Open Outcrier,"$INCY (+4.5% pre) Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis - SI

https://t.co/OjvyLIxUMy",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
472650465,2020-01-28 08:11:43,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1222145229068865536,False,1,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients https://t.co/1PR32IHbzs,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
3901351277,2020-01-28 07:57:20,,"pharmaceutical, ","bit.ly/36ByK10, ",1222141607677440000,False,0,0,0,0,IFTTT,Lilly &amp; Incyte's Olumiant hits main goal in atopic dermatitis : https://t.co/4P1PmBBVHY #pharmaceutical,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
3318510966,2020-01-28 07:48:29,,,"crweworld.com/article/news-p‚Ä¶, ",1222139382754205696,False,0,0,0,0,CRWE World,Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atop https://t.co/qL6oymeHzD,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3314135167,2020-01-28 07:44:54,,"jobs, pharmafile, ","goo.gl/fb/DQZrLN, ",1222138481075539968,False,0,0,0,0,Google,#jobs Lilly &amp; Incyte‚Äôs Olumiant hits main goal in atopic dermatitis https://t.co/fxJ2r0NLkO #pharmafile,,,2015-08-13 02:43:55,,Career Biotech,https://pbs.twimg.com/profile_images/872856527731793920/HqYH3X_9_normal.jpg,110,59,1,35799,CareerBiotech,
17960461,2020-01-28 07:36:56,,"pharma, ","bit.ly/2t9D9La, pic.twitter.com/RcFLVxlsHy, ",1222136476642807808,False,0,0,0,0,Twitter Web App,Lilly &amp; Incyte's Olumiant hits main goal in atopic dermatitis https://t.co/rOttGFWrfl #pharma https://t.co/RcFLVxlsHy,,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
976297820532518914,2020-01-28 07:34:04,,,"dlvr.it/RNvMhH, pic.twitter.com/tAGMKz4DvY, ",1222135754005942274,False,0,0,0,0,dlvr.it,Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis https://t.co/UjazzI3XE0 https://t.co/tAGMKz4DvY,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
112872946,2020-01-28 07:33:48,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1222135686708461568,False,8,0,0,4,Twitter Web Client,"$INCY Announces Pivotal Phase 3 TRuE-AD2 Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis
https://t.co/adckOyBWsf",,,2010-02-09 19:09:48,Toronto,Bio Stocks‚Ñ¢,https://pbs.twimg.com/profile_images/1345176821185306624/4OaDT_lb_normal.jpg,58832,77,1249,48782,BioStocks,
1022006086872821762,2020-01-28 05:02:32,"INCY, INCY, ",,,1222097619482267648,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Mon Jan 27
Closed at 76.07 USD for a -0.87% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
1979190776,2020-01-28 04:25:59,"INCY, ",,"tickerreport.com/?p=4997489, ",1222088420182413312,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub https://t.co/UEZcSsqNec,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
424089030,2020-01-27 23:43:53,,,"fiercepharma.com/pharma/eli-lil‚Ä¶, ",1222017429582307328,False,0,0,0,0,Twitter Web Client,"Eli Lilly, Incyte's Olumiant notches another atopic dermatitis win. But can it fight Dupixent? https://t.co/pz2NyraY7Q",,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
872379820973457414,2020-01-27 23:00:12,"INCY, ","Incyte, ","bidaskclub.com/news/company-n‚Ä¶, ",1222006433555927041,False,0,0,0,0,BidaskClubAllScoreChangesBot,#Incyte $INCY BidaskScore is Lowered to StronglySold https://t.co/mW12OexGQZ,,,2017-06-07 05:08:52,Luxembourg,BACAllScoreChanges,https://pbs.twimg.com/profile_images/872380691010510848/9DEqosBk_normal.jpg,198,1338,5,58331,BACScoreChanges,
1131353832,2020-01-27 20:29:49,,,"finance.yahoo.com/news/lilly-inc‚Ä¶, ",1221968591064461312,False,1,0,1,0,Twitter for Android,Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK ... https://t.co/oj7Ao1d3B1 via @YahooFinance,"YahooFinance, ",,2013-01-29 10:36:34,San Diego,Rana H,https://pbs.twimg.com/profile_images/753441229967204352/79N21hc7_normal.jpg,804,1836,25,1570,Zalhee,
963495628545327104,2020-01-27 18:17:06,"INCY, LLY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/xwu4XPIoL7, ",1221935190613856258,False,0,0,0,0,STCK.PR0,$INCY $LLY NEW ARTICLE : Eli Lilly and Incyte's Olumiant Helps Eczema Patients in a Late-Stage Clinical Trial https://t.co/NhmLcW6ByV Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/xwu4XPIoL7,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
247195508,2020-01-27 16:27:34,,,"bioportfol.io/RNsPCS, ",1221907624997707776,False,0,0,0,0,dlvr.it,Eli Lilly Incyte's JAK inhibitor Olumiant improves skin inflammation in Phase III atopic dermatitis study httpswww.firstwordpharma.comnode1696288tsid28&amp;regionid6√Ç: Eli Lilly Incyte's JAK inhibitor Olumiant improves skin inflammation in Phase III atopic‚Ä¶ https://t.co/g1i9UDUKfC,,,2011-02-04 03:47:02,London,Allergy News,https://pbs.twimg.com/profile_images/2229775486/Twitter-FB_Profile_pic_-crops_1__normal,321,77,8,20790,Allergy_bio,
267859603,2020-01-27 16:27:33,,"EliLilly, ","bioportfol.io/RNsPBD, ",1221907619939401730,False,0,0,0,1,dlvr.it,Eli Lilly Incyte's JAK inhibitor Olumiant improves skin inflammation in Phase III atopic dermatitis study httpswww.firstwordpharma.comnode1696288tsid28&amp;regionid6√Ç: Eli Lilly Incyte's JAK inhibitor Olumiant improves skin inflammation in Phase‚Ä¶ https://t.co/KSuwzu5umo #EliLilly,,,2011-03-17 13:42:21,London,BioPortfolio - Eli Lilly - news and research,https://pbs.twimg.com/profile_images/760036217761198080/RcDwixgH_normal.jpg,127,23,11,6839,Lilly_bio,
635572478,2020-01-27 16:08:15,,,"fiercepharma.com/pharma/eli-lil‚Ä¶, ",1221902765527650304,False,0,0,0,0,Twitter for iPhone,"Eli Lilly, Incyte's Olumiant notches another atopic dermatitis win. But can it fight Dupixent?
https://t.co/OAvtYlsDvq",,,2012-07-14 14:45:14,,Dr Maanane Fouad,https://pbs.twimg.com/profile_images/2397625820/image_normal.jpg,193,259,10,22771,FouadMaanane,
35789155,2020-01-27 16:02:14,,,"firstwordpharma.com/node/1696288?t‚Ä¶, ",1221901251123843072,False,1,0,0,0,Twitter Web App,"Eli Lilly, Incyte's JAK inhibitor Olumiant improves skin inflammation in Phase III atopic dermatitis study https://t.co/p16k2vwDEE",,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
1134049078424162304,2020-01-27 15:20:21,"LLY, INCY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1221890707742515252,False,0,0,0,0,Newsfilter.io,Lilly and Incyte Announce Top-Line Results from Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in.. $LLY $INCY https://t.co/k5ZUX6qwvk,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880678,newsfilterio,
1001516954916618241,2020-01-27 14:48:37,,"dermatology, clinicaltrials, pipeline, drugdiscovery, research, pipeline, biotech, Biotechnology, stockmarketnews, ","biotech-investments.com/eli-lilly-incy‚Ä¶, ",1221882723481964545,False,2,0,0,1,Twitter Web App,"New Hope for Millions of Patients With Atopic Dermatitis? Eli Lilly and Incyte Announce  Olumiant's Phase 3 Clinical Trial Results
https://t.co/YBkOc6ZsFN
#dermatology #clinicaltrials #pipeline #drugdiscovery #research #pipeline #biotech #Biotechnology #stockmarketnews",,,2018-05-29 13:33:44,Switzerland,Biotech Investments,https://pbs.twimg.com/profile_images/1201182180975661056/y9NlME8P_normal.jpg,6338,124,23,153,BiotechInvsts,
772471873539977217,2020-01-27 14:45:51,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1221882026544062464,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form SC 13G/A https://t.co/qlbLnk8GYR,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
1087563377889763329,2020-01-27 14:20:07,,"EliLilly, Incyte, atopicdermatitis, dermatology, drugdevelopment, PhIII, clinicaltrials, ","ow.ly/C2SB30qcJ8X, ",1221875549854937093,False,0,0,0,0,Hootsuite Inc.,"#EliLilly, #Incyte‚Äôs Olumiant notches another 
#atopicdermatitis win. But can it fight Dupixent? | FiercePharma https://t.co/jiN8qxoEHk #dermatology #drugdevelopment #PhIII #clinicaltrials",,,2019-01-21 23:11:30,"Bradenton, FL","Synergy Healthcare, LLC",https://pbs.twimg.com/profile_images/1255687146624692224/hdDn-7ye_normal.jpg,19,135,1,1173,SynergyHealthCR,
1128239740329705472,2020-01-27 13:17:48,"LLY, INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1221859869826797568,False,0,0,0,0,Twitter for Android,"""As we look to progress our treatment portfolio for chronic skin conditions, the continued insights from the development program in AD further the potential of baricitinib to pursue this indication and to reach patients.""

$LLY $INCY 
https://t.co/eCoDZ0JSiV",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
18294275,2020-01-27 12:48:00,,,"fiercepharma.com/pharma/eli-lil‚Ä¶, ",1221852368758853632,False,3,0,0,2,TweetDeck,"Eli Lilly, Incyte's Olumiant notches another atopic dermatitis win. But can it fight Dupixent? https://t.co/CRrcXGiXNa",,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
2844414692,2020-01-27 11:38:45,,,"zpr.io/tyaZb, ",1221834941664780289,False,0,0,0,0,Zapier.com,"Eli Lilly, Incyte's Olumiant notches another atopic dermatitis win. But can it fight Dupixent?
https://t.co/bWw3DG3GZV",,,2014-10-07 15:21:46,"Montr√©al, Qu√©bec",Labofine,https://pbs.twimg.com/profile_images/1222261856359809024/QSpRZp1o_normal.jpg,158,622,7,7643,tw_labofine,
140599113,2020-01-27 11:35:23,,,"winway.me/health-remedie‚Ä¶, pic.twitter.com/BeKs5ESDFW, ",1221834093329027073,False,0,0,0,0,WordPress.com,"Eli Lilly, Incyte‚Äôs Olumiant notches another atopic dermatitis win. But can it fight¬†Dupixent? https://t.co/OF1V5qT7LZ https://t.co/BeKs5ESDFW",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,photo
415183987,2020-01-27 09:58:34,"REGN, ",,"investor.regeneron.com/news-releases/‚Ä¶, seekingalpha.com/pr/17759380-li‚Ä¶, ",1221809728839241730,False,6,0,1,0,Twitter Web App,"2mg Baricitinib little bit better than placebo. Not even close to Dupi. $REGN
https://t.co/rt6SRuOoNx
https://t.co/U9lLE4GHg1",,,2011-11-17 19:50:25,,Miljenko Zuanic,https://pbs.twimg.com/profile_images/894617295154102272/apAcVS12_normal.jpg,351,318,17,6699,Miljenkoz,
374729426,2020-01-27 09:35:40,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1172135, pic.twitter.com/FN9KAvGoJn, ",1221803966956109825,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on December 31, 2019. View odds for this and other indicators: https://t.co/qiuR2i6XTX #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/FN9KAvGoJn",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
72928001,2020-01-27 08:49:52,"LLY, ",,"bit.ly/2TZd1NZ, ",1221792442254364678,False,0,0,0,0,BriefingInPlayLimited,$LLY: Eli Lilly and Incyte (INCY) announce top-line results from phase 3 study of oral selective JAK inhibitor... https://t.co/WqhOc6b60z,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
730032660,2020-01-27 08:07:06,,,"nonsell.com/us-market-news‚Ä¶, ",1221781678533693448,False,0,0,0,0,NonSell Twitter,Lilly and Incyte's Olumiant shows mixed results in late-stage dermatitis study - https://t.co/WBd6gbrSbB and Incyte's Olumiant shows mixed results in late-stage dermatitis studyIncyte (...,,,2012-08-01 01:16:53,,NonSell.com,https://pbs.twimg.com/profile_images/1221028599962038272/qbMBnpKa_normal.jpg,555,595,6,259269,nonsellcom,
25406480,2020-01-27 08:04:15,,,"awesomecapital.blogspot.com/2020/01/lilly-‚Ä¶, ",1221780963614740480,False,0,0,0,1,Twitter Web Client,AwesomeCapital: Lilly and Incyte‚Äôs Olumiant shows mixed results in... https://t.co/f31NIMPuOc,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
1134049078424162304,2020-01-27 07:52:18,"INCY, LLY, ",,"newsfilter.io/articles/lilly‚Ä¶, ",1221777954088288256,False,0,0,0,0,Newsfilter.io,Lilly and Incyte's Olumiant shows mixed results in late-stage dermatitis study $INCY $LLY https://t.co/uZLO7YAGnd,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
963495628545327104,2020-01-27 07:51:03,"INCY, LLY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1221777638957703175,False,0,0,0,0,STCK.PR0,$INCY $LLY NEW ARTICLE : Lilly and Incyte's Olumiant shows mixed results in late-stage dermatitis study https://t.co/cF1w143DRZ Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
15296897,2020-01-27 07:49:02,"INCY, LLY, ",,"seekingalpha.com/news/3534611-l‚Ä¶, ",1221777130469543936,False,0,0,0,0,SANewsTwitter,$INCY $LLY - Lilly and Incyte's Olumiant shows mixed results in late-stage dermatitis study https://t.co/63QzDAhyHK,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
472650465,2020-01-27 07:20:53,"INCY, ",,"otcdynamics.com/incy-lilly-and‚Ä¶, ",1221770046076280832,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor https://t.co/TQ7Kp9dhsk,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
178441882,2020-01-27 07:17:50,,,"noahsrss.wordpress.com/2020/01/27/lil‚Ä¶, ",1221769282205503491,False,0,0,0,0,WordPress.com,Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis Not Controlled with¬†Cyclosporine https://t.co/oL4ZbTi34D,,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
178441882,2020-01-27 07:09:20,,,"noahsrss.wordpress.com/2020/01/27/lil‚Ä¶, ",1221767140509917184,False,0,0,0,0,WordPress.com,Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis Not Controlled with¬†Cyclosporine https://t.co/tqZXUeC0hA,,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
4196782272,2020-01-27 07:03:35,,"gaming, ","twib.in/l/q9gakg64q4ey, pic.twitter.com/HLRIxazyQJ, ",1221765696079659010,False,0,0,0,0,Twibble.io,Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis Not Controlled with Cyclosp... https://t.co/GL8pS4IPRL #gaming https://t.co/HLRIxazyQJ,,,2015-11-10 21:52:49,,This Online,https://pbs.twimg.com/profile_images/664484277661265920/XI8gqZW9_normal.png,517,0,179,126043,ThisOnline_Co,photo
3318510966,2020-01-27 07:01:08,,,"crweworld.com/article/news-p‚Ä¶, ",1221765076362772481,False,0,0,0,0,CRWE World,Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor Baricitin https://t.co/hIcDCL7YKc,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
718440932652109824,2020-01-27 07:00:31,,,"marketcheetah.com/2020/01/27/lil‚Ä¶, ",1221764922796912640,False,0,0,0,0,marketcheetah,Lilly and Incyte Announce Top-Line Results from Phase 3 Study (BREEZE-AD4) of Oral Selective JAK Inhibitor https://t.co/rat6yy9WTK,,,2016-04-08 10:10:41,,Market Cheetah,https://pbs.twimg.com/profile_images/725265074802155520/rffG8aKq_normal.jpg,1976,2168,115,283931,marketcheetah,
732361939490312192,2020-01-27 06:52:34,"INCY, ","markets, ","americanbankingnews.com/?p=13179925, ",1221762923049242627,False,0,0,0,0,Zapier.com,Evercore ISI Reaffirms Buy Rating for Incyte $INCY https://t.co/QUxliOPwAU #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-27 06:52:32,"INCY, ","stocks, ","americanbankingnews.com/?p=13179925, ",1221762914094329856,False,0,0,0,0,Zapier.com,Evercore ISI Reaffirms Buy Rating for Incyte $INCY https://t.co/Gxigk9pgp7 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
112872946,2020-01-27 06:49:02,"LLY, INCY, ",,"prnewswire.com/news-releases/‚Ä¶, ",1221762034158784513,False,7,5,0,6,Twitter Web Client,"$LLY $INCY Announce Top-Line Results from Phase 3 Study of JAK Inhibitor Baricitinib in Combination with Topical Corticosteroids in Patients with Moderate to Severe Atopic Dermatitis 
https://t.co/q7cxpepK1H",,,2010-02-09 19:09:48,Toronto,Bio Stocks‚Ñ¢,https://pbs.twimg.com/profile_images/1345176821185306624/4OaDT_lb_normal.jpg,58832,77,1249,48782,BioStocks,
1979190776,2020-01-27 05:25:07,"INCY, ",,"tickerreport.com/?p=4995209, ",1221740912981807107,False,0,0,0,0,Zapier.com,Evercore ISI Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/ghDCkm4Pjm,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
374729426,2020-01-26 13:31:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1166738, pic.twitter.com/kFLcEN2EHq, ",1221500830739660800,False,0,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on December 31, 2019. View odds for this and other indicators: https://t.co/ZqRUBjxeyX #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kFLcEN2EHq",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1006334607946649600,2020-01-26 07:33:34,,,"dlvr.it/RNmvFk, pic.twitter.com/o3JSl1SkI9, ",1221410852676329473,False,0,0,0,0,dlvr.it,Incyte to Report Fourth Quarter and Year-End Financial Results https://t.co/273mWCZuxz https://t.co/o3JSl1SkI9,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,photo
1022006086872821762,2020-01-26 05:00:34,"INCY, INCY, ",,,1221372348961607680,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Fri Jan 24
Closed at 76.74 USD for a -1.92% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
2181281054,2020-01-25 20:23:53,"INCY, ","markets, ","wkrb13.com/?p=1539545, ",1221242320126910464,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $569.75 Million https://t.co/T2wPlxQX15 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1134049078424162304,2020-01-25 10:00:52,"INCY, ",,"newsfilter.io/articles/hunti‚Ä¶, ",1221085531523686401,False,1,0,0,0,Newsfilter.io,Huntington National Bank Buys Shares of 325 Incyte $INCY https://t.co/5AODueF0On,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
374729426,2020-01-25 09:00:14,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1164387, pic.twitter.com/KMPSVCE2XV, ",1221070275128619010,False,1,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on December 31, 2019. View odds for this and other indicators: https://t.co/w9cvbKMiYK #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/KMPSVCE2XV",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
966006214818697218,2020-01-25 03:12:42,"INCY, ",,"theenterpriseleader.com/?p=2585788, ",1220982816869179394,False,1,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub  https://t.co/Kx10iCon2r,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1134049078424162304,2020-01-25 00:40:50,"INCY, ",,"newsfilter.io/articles/patto‚Ä¶, ",1220944597951688704,False,1,0,0,0,Newsfilter.io,Patton Fund Management Takes Position in Incyte $INCY https://t.co/wz6jeIn4tM,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
1134049078424162304,2020-01-24 19:06:46,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1220860525225050112,False,1,0,0,0,Newsfilter.io,Incyte to Report Fourth Quarter and Year-End Financial Results $INCY https://t.co/T9L9vxmMGo,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
145670106,2020-01-24 17:07:20,,,"instagram.com/p/B7t_R9Tlg8V/‚Ä¶, ",1220830467915755521,False,0,0,0,0,Instagram,"HLJ is happy to announce our latest project in Wilmington, DE  - Incyte Pharmaceuticals. This is our second project working for Whiting-Turner Construction on the Incyte HQ Campus. Two years ago our team completed a‚Ä¶ https://t.co/goBvharA8R",,,2010-05-19 11:24:40,"Wilmington, Delaware",Healy Long & Jevin,https://pbs.twimg.com/profile_images/1994823372/Picture2_normal.jpg,547,610,9,1023,HealyLongJevin,
374729426,2020-01-24 12:55:24,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1159008, pic.twitter.com/ukS52Me6iv, ",1220767070175940613,False,1,0,0,0,Tickeron,"$INCY's price moved below its 50-day Moving Average on December 31, 2019. View odds for this and other indicators: https://t.co/1hH0Us5Qzr #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ukS52Me6iv",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
23059499,2020-01-24 11:43:51,"INCY, ","trading, markets, stockmarket, ","seekingalpha.com/article/431891‚Ä¶, ",1220749062053318656,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte (INCY) Presents At JP Morgan Healthcare Conference - Slideshow. https://t.co/UFl435npPf #trading #markets #stockmarket,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
27645777,2020-01-24 11:39:53,,,"bit.ly/3aBWTb4, ",1220748063930712065,False,1,0,0,1,TweetDeck,"JAK inhibitor Ruxolitinib @Incyte shows efficacy for certain patients with chronic neutrophilic leukemia and atypical CML, according to study from @JCO_ASCO led by Kim-Hien T. Dao, Ph D, DO of @OHSUNews https://t.co/pFOtxXQ2o1","Incyte, JCO_ASCO, OHSUNews, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,
943184736003993601,2020-01-24 04:11:47,,,"pic.twitter.com/BHhBRx8I8N, ",1220635295089156102,False,8,0,1,2,Twitter for iPhone,"Willemijn presents data on RMS responding to Ponatinib @Incyte @Takeda  we need new drugs in childhood Sarcoma , we need to cooperate to design cooperative clinicsl trials. @FORTRESSMEETING https://t.co/BHhBRx8I8N","Incyte, takeda, FORTRESSMEETING, ",,2017-12-19 13:22:19,,Cooperative Ewing Sarcoma Study Group,https://pbs.twimg.com/profile_images/967820268981940224/dZZ7oCCt_normal.jpg,328,175,0,1105,EwingStudy,photo
786038665625554944,2020-01-24 00:13:24,"INCY, ","Wallstreet, ",,1220575305984806912,False,1,0,0,0,SFE Robot1,I bet all the other humans are jealous of your superior trading skills. Show off by just pick up some Incyte $INCY #Wallstreet,,,2016-10-11 22:59:56,The Markets,Stock Advicebot 2000,https://pbs.twimg.com/profile_images/786041984376983553/Zkm6Ab6h_normal.jpg,1797,69,38,43757,StockTipRobot,
1083163368821743616,2020-01-23 14:47:06,,"DESOTS, ","twitter.com/delbiz/status/‚Ä¶, ",1220432792066105344,False,4,0,0,0,Twitter Web App,"EDGE awards to great companies such as MCET Technologies, Veramorph Materials, Extrave Biosciences, and Lignolix !!!  #DESOTS   The next DuPont, the next Gore, and the next Incyte will be built from programs like this.  Keep up the great support for small business @JohnCarneyDE . https://t.co/iLP5WUWdvO","JohnCarneyDE, ",,2019-01-09 19:47:26,"Greenville, DE",Bill Provine,https://pbs.twimg.com/profile_images/1155547703419580416/li7smpsl_normal.jpg,183,561,6,502,BillProvine,
1100450877792370688,2020-01-23 12:14:28,"INCY, ",,"blueequity.io/r/82790/de-inc‚Ä¶, ",1220394380139216897,False,0,0,0,0,Blue Equity,$INCY Incyte to Report Fourth Quarter and Year-End Financial Results https://t.co/1B8yBDOKvv,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
2266388972,2020-01-23 12:06:56,"INCY, ","stocks, ","dailypolitical.com/?p=3345779, ",1220392482741145602,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY Will Post Earnings of $0.58 Per Share https://t.co/8SUJCz6Nyg #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-01-23 12:06:55,"INCY, ",,"dailypolitical.com/?p=3345779, ",1220392480081838082,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY Will Post Earnings of $0.58 Per Share https://t.co/u3Pw2YRFXj,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2181281054,2020-01-23 12:06:28,"INCY, ","markets, ","wkrb13.com/?p=1531885, ",1220392366231760896,False,0,0,0,0,Zapier.com,Analysts Expect Incyte Co. $INCY to Announce $0.58 EPS https://t.co/AqAFsJHyRZ #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
3318510966,2020-01-23 09:53:42,,,"crweworld.com/article/news-p‚Ä¶, ",1220358954124922882,False,0,0,0,0,CRWE World,Incyte to Report Fourth Quarter and Year-End Financial Results https://t.co/XEGFT309nl,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
374729426,2020-01-23 09:16:26,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1156457, pic.twitter.com/AGi8TwRGkD, ",1220349575883419649,False,1,0,0,1,Tickeron,"$INCY's price moved below its 50-day Moving Average on December 31, 2019. View odds for this and other indicators: https://t.co/0QMuKrmAX3 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/AGi8TwRGkD",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
976297820532518914,2020-01-23 08:06:03,,,"dlvr.it/RNbjL4, pic.twitter.com/jKqoWVvo2N, ",1220331864889516032,False,0,0,0,0,dlvr.it,Incyte to Report Fourth Quarter and Year-End Financial Results https://t.co/YZXP3C9t9y https://t.co/jKqoWVvo2N,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1069693680066420736,2020-01-23 08:04:54,"INCY, ",,"s.flashalert.me/0iuNX, ",1220331572760580098,False,0,0,0,0,flashalerts,"$INCY: Issued Press Release on January 23, 08:00:00: Incyte to Report Fourth Quarter and Year-End Financial Results https://t.co/TES0xGwxiL",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
68559732,2020-01-23 07:54:20,"INCY, ",,"zpr.io/tA9rJ, ",1220328916361129985,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Cantor Fitzgerald https://t.co/TJZ3Y1nUwa,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2266388972,2020-01-23 07:53:39,"INCY, ","stocks, ","dailypolitical.com/?p=3344987, ",1220328742733647873,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Cantor Fitzgerald https://t.co/C6Bod7XEY3 #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-01-23 07:53:38,"INCY, ",,"dailypolitical.com/?p=3344987, ",1220328739743117312,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Cantor Fitzgerald https://t.co/LsM3bpSIhs,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
732361939490312192,2020-01-23 07:45:15,"INCY, ","markets, ","americanbankingnews.com/?p=13139993, ",1220326627453886465,False,0,0,0,0,Zapier.com,Incyte $INCY Given Neutral Rating at Cantor Fitzgerald https://t.co/gvn2CF7KIM #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-23 07:45:14,"INCY, ","stocks, ","americanbankingnews.com/?p=13139993, ",1220326624509550592,False,0,0,0,0,Zapier.com,Incyte $INCY Given Neutral Rating at Cantor Fitzgerald https://t.co/7hUoe4sQNH #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
772471873539977217,2020-01-22 16:15:24,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1220092622783549444,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/Vq2UeKqLIe,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
75337774,2020-01-22 15:31:29,,,"medcitynews.com/2020/01/incyte‚Ä¶, ",1220081572709380097,False,0,0,0,0,Twitter Web Client,Incyte pays MorphoSys $750M upfront in lymphoma drug partnership https://t.co/cVv29LWtXs,,,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
2911141774,2020-01-22 10:24:02,,,"svmpharma.com/largest-uk-rwe‚Ä¶, pic.twitter.com/9CwQ4PTBEZ, ",1220004197837524994,False,0,0,0,0,Twitter Web App,"SVMPharma and Incyte recently presented the results from the largest real-world UK study on TKI sequencing in chronic myeloid leukemia at ASH 2019. To find out more, follow this link: https://t.co/EZBhM4QPPO https://t.co/9CwQ4PTBEZ",,,2014-12-08 10:46:49,"Hampshire, United Kingdom",SVM Real World,https://pbs.twimg.com/profile_images/746011592467283968/d_oXj_1e_normal.jpg,96,207,9,736,SVMPharma,photo
374729426,2020-01-22 10:08:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1150662, pic.twitter.com/Jpzd6bm39I, ",1220000329833410561,False,1,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/0mK71U3AL9 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Jpzd6bm39I,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-01-22 02:34:54,"INCY, ","markets, ","americanbankingnews.com/?p=13125753, ",1219886137566732288,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/e83uBod8cf #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-22 02:34:53,"INCY, ","stocks, ","americanbankingnews.com/?p=13125753, ",1219886133385093120,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/1Fw9XoOlUZ #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2020-01-21 08:30:19,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1148386, pic.twitter.com/ZDVbOzUXq2, ",1219613196064935939,False,2,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators: https://t.co/GcnOetqpcz #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZDVbOzUXq2,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
975337043944407040,2020-01-20 16:35:17,"INCY, ","Incyte, INCY, ","finscreener.com/title/financia‚Ä¶, ",1219372851624652800,False,0,0,0,0,Twitter Web App,"Financials of #Incyte #INCY $INCY 
https://t.co/Exsy3FikDe",,,2018-03-18 07:44:06,,Finscreener,https://pbs.twimg.com/profile_images/976083323347984384/71mUunXo_normal.jpg,652,202,12,15317,Finscreener_com,
1134049078424162304,2020-01-20 11:43:59,"MOR, INCY, ",,"newsfilter.io/articles/morph‚Ä¶, ",1219299543373746179,False,1,0,0,0,Newsfilter.io,MorphoSys and Incyte team up to advance tafasitamab in $2B deal $MOR $INCY https://t.co/MFtsHWwxcs,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
732361939490312192,2020-01-20 08:25:08,"INCY, ","markets, ","americanbankingnews.com/?p=13109431, ",1219249503745855488,False,0,0,0,0,Zapier.com,$0.58 EPS Expected for Incyte Co. $INCY This Quarter https://t.co/qhHJQ2jVIk #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-20 08:25:08,"INCY, ","stocks, ","americanbankingnews.com/?p=13109431, ",1219249500679802882,False,0,0,0,0,Zapier.com,$0.58 EPS Expected for Incyte Co. $INCY This Quarter https://t.co/Ui9c2tbd7a #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
178441882,2020-01-20 08:24:49,,,"noahsrss.wordpress.com/2020/01/20/per‚Ä¶, ",1219249421738827776,False,0,0,0,0,WordPress.com,"Perrigo, McKesson Are Best-Performing Healthcare Stocks So Far in 2020. Incyte and Biogen Are the¬†Worst. https://t.co/wxfCx69Lv8",,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
374729426,2020-01-20 08:19:37,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1142683, pic.twitter.com/MW64hMoIFx, ",1219248114869002240,False,1,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators: https://t.co/lryDd2QZZI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/MW64hMoIFx,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
178441882,2020-01-20 08:13:47,,,"noahsrss.wordpress.com/2020/01/20/per‚Ä¶, ",1219246645801558017,False,0,0,0,0,WordPress.com,"Perrigo, McKesson Are Best-Performing Healthcare Stocks So Far in 2020. Incyte and Biogen Are the¬†Worst. https://t.co/zXLY2cMRwd",,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
953788131601502208,2020-01-20 08:07:17,,,"marketwatch.com/articles/perri‚Ä¶, pic.twitter.com/4SaR8XccNE, ",1219245010874441734,False,0,0,0,0,Wall St Solver Auto-Tweeter,"Perrigo, McKesson Are Best-Performing Healthcare Stocks So Far in 2020. Incyte and Biogen Are the Worst.

üì∞ ¬ª https://t.co/27Mm8YpdMZ https://t.co/4SaR8XccNE",,,2018-01-17 19:36:25,,Wall St Solver,https://pbs.twimg.com/profile_images/1029252349716512769/HAdlBHZA_normal.jpg,472,39,12,58222,wallstsolver,photo
20449296,2020-01-20 07:31:11,,,"on.barrons.com/2NG8f48, ",1219235926137810945,False,1,0,0,0,SocialFlow,"Perrigo, McKesson Are Best-Performing Healthcare Stocks So Far in 2020. Incyte and Biogen Are the Worst. https://t.co/U833wizQTG",,,2009-02-09 12:15:01,"New York, NY",Barron's,https://pbs.twimg.com/profile_images/1400867183333412864/LO1NDNpM_normal.jpg,201867,35,4773,60256,barronsonline,
1979190776,2020-01-20 04:59:48,"INCY, ",,"tickerreport.com/?p=4973502, ",1219197826216927232,False,1,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $202,800.00 in Stock https://t.co/3QQ3c7o8gd",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2525892205,2020-01-20 03:36:20,"INCY, ","investingnews, ","modernreaders.com/?p=2710835, ",1219176823482916865,False,0,0,0,0,Zapier.com,Analysts‚Äô Recent Ratings Changes for Incyte $INCY  https://t.co/pFZM33uWmg #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2020-01-20 03:35:44,"INCY, ","markets, ","americanbankingnews.com/?p=13107646, ",1219176672374808576,False,0,0,0,0,Zapier.com,Analysts‚Äô Recent Ratings Changes for Incyte $INCY https://t.co/IBLxRREj8N #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-20 03:35:43,"INCY, ","stocks, ","americanbankingnews.com/?p=13107646, ",1219176667765186560,False,0,0,0,0,Zapier.com,Analysts‚Äô Recent Ratings Changes for Incyte $INCY https://t.co/SL6UCjWJIU #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
809413388820480000,2020-01-20 02:01:12,,,"morphosys.com/media-investor‚Ä¶, ",1219152883859496960,False,0,0,0,0,Crowdfire App,MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab https://t.co/O8qpeG79hX,,,2016-12-15 10:02:44,"G√∂ttingen, Deutschland",myriamed,https://pbs.twimg.com/profile_images/809423402423480320/U8cg8IuB_normal.jpg,1853,4989,26,17839,myriamed_de,
374729426,2020-01-19 08:12:46,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1140467, pic.twitter.com/6T9CnhXQh9, ",1218884003425443841,False,1,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators: https://t.co/dfaBvrlFbA #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/6T9CnhXQh9,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2020-01-19 05:33:24,"INCY, ","investingnews, ","modernreaders.com/?p=2708485, ",1218843897255944192,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 2,500 Shares of Stock  https://t.co/wMOVFKNOnm #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
4035355935,2020-01-18 22:28:13,,,,1218736896269942784,False,0,0,0,0,WPTS Playlist,Incyte - The Slide,,,2015-10-24 21:01:50,"Pittsburgh, PA",WPTS Playlist,https://pbs.twimg.com/profile_images/658129792408023041/8nflCFL-_normal.jpg,478,5,38,638221,WPTSPlaylist,
1134049078424162304,2020-01-18 18:49:57,"INCY, ",,"newsfilter.io/articles/seven‚Ä¶, ",1218681964942721024,False,0,0,0,0,Newsfilter.io,SevenBridge Financial Group Purchases New Shares in Incyte $INCY https://t.co/5oWQp9f7ES,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
977877883803889664,2020-01-18 18:14:37,,,"twitter.com/Incyte/status/‚Ä¶, ",1218673075685859333,False,0,0,0,0,Twitter Web App,"Immune system can fight cancer.  Look up Israel's discovery, too. https://t.co/5Xzr54WCp6",,,2018-03-25 08:00:30,In the beginning God created..,Rae Hart Anderson,https://pbs.twimg.com/profile_images/1302320694655700994/Pb2C6bLi_normal.jpg,914,3324,0,15272,GodisHere2day4U,
2866848993,2020-01-18 15:38:15,,,"youtu.be/i95hK54OABY, ",1218633723719159813,False,0,0,0,0,Twitter Web Client,BriaCell Therapeutics CEO talks through Incyte collaboration and future ... https://t.co/rYqH9Mj7H5 via @YouTube,"YouTube, ",,2014-11-08 00:07:09,united states,Penny Stock Plays,https://pbs.twimg.com/profile_images/532028511704190976/_ORQ_jxG_normal.jpeg,827,1464,43,50265,bigstockplays,
38197752,2020-01-18 14:28:32,,,"dlvr.it/RNJHGT, pic.twitter.com/rQknc4K2F5, ",1218616180870508544,False,0,0,0,0,dlvr.it,Incyte pays MorphoSys $750M upfront in lymphoma drug partnership https://t.co/feE09A0FbS https://t.co/rQknc4K2F5,,,2009-05-06 11:14:22,"Dubai, United Arab Emirates",Dr. Osama Ahmed,https://pbs.twimg.com/profile_images/1351682680111423493/wUfRGAIf_normal.jpg,1854,3669,106,9628,DrOsamaAhmed,photo
1134049078424162304,2020-01-18 14:17:55,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1218613508394319872,False,0,0,0,0,Newsfilter.io,Incyte Receives ‚ÄúOutperform‚Äù Rating from JMP Securities $INCY https://t.co/VqthchJNHg,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
2266388972,2020-01-18 12:14:45,"INCY, ","stocks, ","dailypolitical.com/?p=3336650, ",1218582510491328513,False,0,0,0,0,Zapier.com,Brokerages Set Incyte Co. $INCY Target Price at $92.10 https://t.co/vFO9NXYj4R #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-01-18 12:14:44,"INCY, ",,"dailypolitical.com/?p=3336650, ",1218582507773407233,False,0,0,0,0,Zapier.com,Brokerages Set Incyte Co. $INCY Target Price at $92.10 https://t.co/oeFpaKppNe,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2181281054,2020-01-18 12:14:05,"INCY, ","markets, ","wkrb13.com/?p=1522745, ",1218582343486713856,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $92.10 Average Price Target from Brokerages https://t.co/b1L6PdQ80A #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
2181281054,2020-01-18 11:17:07,"INCY, ","markets, ","wkrb13.com/?p=1522434, ",1218568008198688770,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at JPMorgan Chase &amp; Co. https://t.co/SUU0f4Ppqy #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
852931863547084801,2020-01-18 11:07:20,"INCY, ",,"zpr.io/thwxA, ",1218565547266277376,False,0,0,0,0,Zapier.com,Incyte $INCY Receives ‚ÄúOutperform‚Äù Rating from JMP Securities https://t.co/43oMMIWris,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
2416188264,2020-01-18 11:07:15,"INCY, ","markets, ","thestockobserver.com/?p=2561089, ",1218565525648891911,False,0,0,0,0,Zapier.com,Incyte $INCY Receives ‚ÄúOutperform‚Äù Rating from JMP Securities  https://t.co/sEveabiJzt #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
374729426,2020-01-18 09:01:14,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1134808, pic.twitter.com/qpC95cMoJY, ",1218533811534696448,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators: https://t.co/6tU6J4jlJw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/qpC95cMoJY,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2298709746,2020-01-18 08:00:19,"INCY, ",,"zpr.io/th8VV, ",1218518482750525440,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $202,800.00 in Stock https://t.co/z6gGDh89bv",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
68559732,2020-01-18 07:58:09,"INCY, ",,"zpr.io/th8vQ, ",1218517936685625344,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Paula J. Swain Sells 2,500 Shares https://t.co/dupggitxlM",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
708160201,2020-01-18 05:16:20,,,"fiercepharma.com/pharma/jpm-kic‚Ä¶, ",1218477213378654208,True,0,0,0,0,Facebook,"JPM Day 1: Merck's assurances, Teva's shutdown tally, Biogen's launch prep and one CEO's word on another https://t.co/ORoAKeBgWY",,,2012-07-20 21:55:42,Âè∞ÁÅ£,Tammy,https://pbs.twimg.com/profile_images/648842678566715392/D0Tx0DtZ_normal.jpg,9,126,0,3109,tammylovelife,
2298709746,2020-01-17 19:49:57,"INCY, ",,"zpr.io/thuBf, ",1218334680262430721,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reaffirmed at JPMorgan Chase &amp; Co. https://t.co/O0FqEOf166,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
68559732,2020-01-17 19:47:16,"INCY, ",,"zpr.io/thuVb, ",1218334002534322176,False,0,0,0,0,Zapier.com,JPMorgan Chase &amp; Co. Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/lielwFAbuS,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
732361939490312192,2020-01-17 18:02:00,"INCY, ","markets, ","americanbankingnews.com/?p=13088495, ",1218307512199524352,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/46UE4zJhLu #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-17 18:01:55,"INCY, ","stocks, ","americanbankingnews.com/?p=13088495, ",1218307491290845186,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/Kz6Vgt0tB4 #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1176558075798380544,2020-01-17 16:45:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1218288224851972103,False,0,0,0,0,InsiderActionMonitor,$INCY Paula Swain Dumps 2.5K Shares of Incyte https://t.co/l7uiY6tqlM,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
772471873539977217,2020-01-17 16:24:30,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1218282976108318720,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/fnvK81yOTY,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
73423519,2020-01-17 14:45:13,,"intellusWW, mrx, rxmrx, marketresearch, marketingresearch, insights, iammrx, intellusYP, ","fiercepharma.com/pharma/jpm-kic‚Ä¶, ",1218257991289405440,False,0,0,0,0,Hootsuite Inc.,J.P. Morgan Healthcare Conference - what you need to know https://t.co/rvkMpnbet7 #intellusWW #mrx #rxmrx #marketresearch #marketingresearch #insights #iammrx #intellusYP,,,2009-09-11 12:33:45,United States of America,Intellus,https://pbs.twimg.com/profile_images/946776122766667776/0j9Z8N4M_normal.jpg,1296,868,39,3809,IntellusWW,
374729426,2020-01-17 09:15:26,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1132310, pic.twitter.com/BsO2YPKU7n, ",1218174996238913538,False,0,0,0,1,Tickeron,$INCY in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators: https://t.co/9rJm9NsCpS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BsO2YPKU7n,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
31484145,2020-01-17 08:55:04,,"JPM20, ","ow.ly/FNXr50xXKjO, pic.twitter.com/PahBxqmQBN, ",1218169872745738241,False,2,0,0,0,Hootsuite Inc.,#JPM20 -- Jakafi Success Helps @Incyte Land Blockbuster @MorphoSys Partnership: https://t.co/URitdJFVmV https://t.co/PahBxqmQBN,"Incyte, MorphoSys, ",,2009-04-15 14:57:15,"New Rochelle, NY",Genetic Engineering & Biotechnology News,https://pbs.twimg.com/profile_images/459406650609115136/dQKQwDAv_normal.jpeg,71709,3561,1430,51542,GENbio,photo
976297820532518914,2020-01-17 08:40:05,,,"ResearchAndMarkets.com, dlvr.it/RNDKDQ, pic.twitter.com/s0C4AlAoah, ",1218166099469991938,False,0,0,0,0,dlvr.it,"Serine Threonine Protein Kinase Pim 3, Pipeline Review, H2 2019 - Incyte Corp, Jasco Pharmaceuticals, Novartic AG &amp; Yakult Honsha Co. Ltd. - https://t.co/guyiBzPH8C https://t.co/IN89vGzmnj https://t.co/s0C4AlAoah",,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
864573525159325696,2020-01-17 08:33:31,,,"pharmajournalist.com/morphosys-and-‚Ä¶, ",1218164446905815041,False,0,0,0,0,Twitter Web App,MorphoSys And Incyte Sign Global Collaboration And License Agreement For Tafasitamab https://t.co/qKdnNkvOtt,,,2017-05-16 16:09:26,"New Delhi, India",Pharma Journalist,https://pbs.twimg.com/profile_images/982208492109938689/FRsIPjLU_normal.jpg,348,521,5,2726,pharmjournalist,
1637027690,2020-01-17 03:40:13,,,"ift.tt/2R4cOY6, ",1218090638857687040,False,0,0,0,0,IFTTT,MorphoSys and Incyte team up to advance tafasitamab in $2B deal https://t.co/nBFijzu1bq,,,2013-07-31 23:30:55,Everywhere,Ashish Aggarwal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,557,0,4776,AggarwalTweets,
70020543,2020-01-16 23:54:53,,,"ow.ly/FNXr50xXKjO, ",1218033931662045189,False,2,0,0,1,Twitter Web App,"17January: How did its success with Jakafi help @Incyte land an up-to-$2B partnership? @MorphoSys CEO Jean-Paul Kress, MD, breaks down the blockbuster deal in my latest for @GENbio:  https://t.co/daPpeo6MtU","Incyte, MorphoSys, GENbio, ",,2009-08-29 21:59:34,"White Plains, NY, USA",Alex Philippidis,https://pbs.twimg.com/profile_images/1324432898905223170/EhBGUBEp_normal.jpg,5214,5056,128,12339,AlexWestchester,
1134049078424162304,2020-01-16 20:37:39,"MOR, INCY, ",,"newsfilter.io/articles/morph‚Ä¶, ",1217984295823990784,False,0,0,0,0,Newsfilter.io,MorphoSys and Incyte team up to advance tafasitamab in $2B deal $MOR $INCY https://t.co/MFtsHWwxcs,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
25406480,2020-01-16 18:53:45,,,"awesomecapital.blogspot.com/2020/01/morpho‚Ä¶, ",1217958147467501568,False,0,0,0,1,Twitter Web Client,AwesomeCapital: MorphoSys and Incyte team up to advance tafasitama... https://t.co/KyfPKfivGb,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
15296897,2020-01-16 16:50:05,"MOR, INCY, ",,"seekingalpha.com/news/3532568-m‚Ä¶, ",1217927023902937088,False,0,0,0,1,SANewsTwitter,$MOR $INCY - MorphoSys and Incyte team up to advance tafasitamab in $2B deal https://t.co/fcBnVyVQHk,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1171873456276889600,2020-01-16 16:11:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1217917399942541312,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (16 Jan, 4:09pm)

üì∞ MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab

https://t.co/pdvMAoNCjU

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
4312114277,2020-01-16 16:11:11,"INCY, ",,"fintel.io/s/us/incy?utm_‚Ä¶, ",1217917235169239042,False,0,0,0,0,Fintel.io,"$INCY / Incyte files form 8-K - Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits https://t.co/hv89PLGlBC",,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,163,418543,fintel_io,
374729426,2020-01-16 09:16:01,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1126504, pic.twitter.com/xkiXl1ikzJ, ",1217812757237526529,False,0,0,0,1,Tickeron,$INCY in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators: https://t.co/gRz9Pe4IjB #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/xkiXl1ikzJ,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
966006214818697218,2020-01-16 08:07:55,"INCY, ",,"theenterpriseleader.com/?p=2560501, ",1217795619156373504,False,0,0,0,0,Zapier.com,Cowen Reaffirms Buy Rating for Incyte $INCY  https://t.co/HiqDd2KGDm,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2020-01-16 08:06:09,"INCY, ",,"thelincolnianonline.com/?p=3364195, ",1217795172198703110,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Cowen https://t.co/KM1Ef284HB,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2998580214,2020-01-16 05:05:26,,"Immune, CheckpointInhibitors, ","bit.ly/2u1VVnG, bit.ly/2QY28tR, pic.twitter.com/04vga5LHJ2, ",1217749695058984960,False,0,0,0,0,Twitter Web App,"Present status and the future prospects of the Global #Immune #CheckpointInhibitors Market for 2015-2025.
Read report- https://t.co/fOr27x3aWD

Get report sample- https://t.co/fIe1YDJ5mE

@GSK @InnatePharma @Immutep @MacroGenics @SeattleGenetics @NLNKGenetics @Incyte @bmsnews https://t.co/04vga5LHJ2","GSK, InnatePharma, Immutep, MacroGenics, SeattleGenetics, NLNKGenetics, Incyte, bmsnews, ",,2015-01-27 12:53:11,"Dallas, TX",OrbisResearch,https://pbs.twimg.com/profile_images/1007535829294768128/G5f5ck4O_normal.jpg,1303,1230,30,17072,Orbisresearch,photo
17988404,2020-01-16 02:05:00,,"pharma, ","buff.ly/2QUliAG, ",1217704287649828874,False,0,0,0,0,Buffer,MorphoSys gets $750m from Incyte for anti-CD19 cancer drug - https://t.co/mUOcZsX7cA #pharma,,,2008-12-09 04:51:27,UK,Dominic Tyer,https://pbs.twimg.com/profile_images/976500059251625985/2sEavKx-_normal.jpg,9062,4712,516,17455,Dominic_Tyer,
133504478,2020-01-15 21:16:34,,"strategy, competitiveintelligence, marketing, pharma, healthcare, biotech, pharmaceutical, productmarketing, ","dlvr.it/RN79nQ, lqventures.com, ",1217631698818457601,False,0,0,0,2,dlvr.it,"Vitiligo Treatment Market 2020 Brief Analysis by Top Companies- Incyte, Astellas Pharma, Bausch Health, Baxter,‚Ä¶ https://t.co/izJ89h1F6V &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #pharmaceutical #productmarketing",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
2177744681,2020-01-15 18:00:29,,"Incyte, MorphoSys, lymphoma, drug, oncology, drugdevelopment, cancer, clinicalresearch, ","ow.ly/KTcn30q9Fcn, ",1217582353838678017,False,0,0,0,0,Hootsuite Inc.,#Incyte pays #MorphoSys $750M upfront in #lymphoma #drug partnership - MedCity News https://t.co/Q7vYfSPXMO #oncology #drugdevelopment #cancer #clinicalresearch,,,2013-11-11 23:56:36,"Atlanta, GA",Lampgen Clinical Research,https://pbs.twimg.com/profile_images/451196302588526592/iSb1JnS6_normal.png,24,45,0,804,Lampgen_CR,
2920258887,2020-01-15 16:51:27,"INCY, ",,"dakotafinancialnews.com/?p=1438853, ",1217564980855394305,False,1,0,0,0,Zapier.com,JMP Securities Reaffirms ‚ÄúOutperform‚Äù Rating for Incyte $INCY https://t.co/ZBSV4T7BNG,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
75337774,2020-01-15 11:44:17,,,"medcitynews.com/2020/01/incyte‚Ä¶, ",1217487679836839941,False,0,0,0,0,Twitter Web Client,Incyte pays MorphoSys $750M upfront in lymphoma drug partnership https://t.co/cVv29LWtXs,,,2009-09-18 13:37:21,"Eaubonne, 95, France",Teresa MASIA PERALES,https://pbs.twimg.com/profile_images/854434970269609985/QH3-9K9u_normal.jpg,710,903,78,392279,Spanishcountry,
1525137691,2020-01-15 11:12:02,,,"bioportfol.io/RN5bwB, ",1217479563061522432,False,0,0,0,1,dlvr.it,Jakafi Success Helps Incyte Land Blockbuster MorphoSys Partnership: Incytes success with Jakafi√Ç ruxolitinihb helped persuade MorphoSys that its tafasitamab MOR208 could also be successfully commercialized by the Wilmington DE biopharma which is‚Ä¶ https://t.co/t5DeSJzIyl,,,2013-06-17 11:21:24,,Renal Cell Carcinoma,https://pbs.twimg.com/profile_images/656427745304530945/qbgWaiHn_normal.png,341,12,5,45347,Renal_Bio,
963495628545327104,2020-01-15 09:09:14,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/mKq3nAbkxl, ",1217448660885286912,False,1,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Stock Is Down: Buy the Dip? https://t.co/rFOmH6WiZC Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/mKq3nAbkxl,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
25560065,2020-01-15 07:00:42,,,"bizjournals.com/philadelphia/n‚Ä¶, ",1217416314685399040,False,0,0,0,0,True Anthem,Wilmington-based Incyte signs a licensing deal with a German drug developer that could end up being valued at as much as $2 billion. https://t.co/4zYToY3g6p,,,2009-03-20 15:31:03,Philadelphia,PHL Business Journal,https://pbs.twimg.com/profile_images/378800000077412316/8b22fbb8c4be97c69f048ff47fe712b6_normal.jpeg,35028,8899,1065,77326,PHLBizJournal,
27254739,2020-01-15 06:12:31,"INCY, MOR, ","tafasitamab, lymphoma, ","bit.ly/35TtzJx, ",1217404187031588867,False,0,0,0,0,Sprout Social,"Stung by a late-stage pipeline failure, @Incyte $INCY bolsters its pipeline via a $750m upfront deal with @MorphoSys $MOR for CD19 antibody #tafasitamab, in trials for non-Hodgkin‚Äôs #lymphoma https://t.co/k1QTLjA3Hd","Incyte, MorphoSys, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
930803511918411776,2020-01-15 04:33:29,"INCY, ",,"thelincolnianonline.com/?p=3359798, ",1217379267782365184,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Analysts https://t.co/f3zfeafEBx,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-01-15 04:32:03,"INCY, ",,"tickerreport.com/?p=4958179, ",1217378904715026433,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Rating of ‚ÄúHold‚Äù by Brokerages https://t.co/XCHYCWY2QG,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2020-01-15 04:30:30,"INCY, ","markets, ","americanbankingnews.com/?p=13055118, ",1217378515273863168,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Analysts https://t.co/e6jMCBY4XG #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-15 04:30:29,"INCY, ","stocks, ","americanbankingnews.com/?p=13055118, ",1217378511578636288,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúHold‚Äù by Analysts https://t.co/nRsCSK1f5v #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1022006086872821762,2020-01-15 03:01:47,"INCY, INCY, ",,,1217356187156598784,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was UP ‚¨Ü on Tue Jan 14
Closed at 81.47 USD for a 5.67% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
2891146588,2020-01-15 02:44:09,,,"youtube.com/embed/i95hK54O‚Ä¶, ",1217351752590098432,False,2,0,0,1,Twitter Web App,"Christine Corrado of Proactive interviews Dr. Bill Williams at the at Biotech Showcase‚Ñ¢ 2020 in San Francisco
*Alert* ""BriaCell Therapeutics CEO talks through Incyte collaboration and future plans in 2020"" 
https://t.co/x8Yr4mvI6A",,,2014-11-24 13:16:48,"New York, NY",BriaCell,https://pbs.twimg.com/profile_images/1433876026656952323/yM_H4sLw_normal.jpg,1215,551,9,477,BriaCell,
3338829779,2020-01-15 01:00:10,,"jpmorgan, JPM2020, medtech, digitalmed, DigMedShow, ","ow.ly/GFAM50xVGLb, pic.twitter.com/dXIHx8mdjv, ",1217325582523957248,False,0,0,0,1,Hootsuite Inc.,"#jpmorgan #JPM2020 Day 1: Merck's assurances, Teva's shutdown tally, Biogen's launch prep and one CEO's word on another https://t.co/cGpJKGFThT #medtech #digitalmed #DigMedShow https://t.co/dXIHx8mdjv",,,2015-06-21 07:50:23,"Long Island, NY",MedGizmo,https://pbs.twimg.com/profile_images/710333701901516800/mgOLMo1x_normal.jpg,2981,3387,1588,48076,MedGizmo,photo
68559732,2020-01-14 23:09:00,"INCY, ",,"zpr.io/tm4q2, ",1217297608789647361,False,0,0,0,0,Zapier.com,Incyte $INCY Trading Up 5.7% https://t.co/obdv69XgDG,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1204967326543699968,2020-01-14 17:31:12,"INCY, ",,,1217212597587664899,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is shooting through the roof with a +5.67% increase today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
4493706195,2020-01-14 16:54:46,,,"ow.ly/Ps0c30q9uNG, ",1217203426645499906,False,0,0,0,0,Hootsuite Inc.,Incyte turns to German Morphosys to refresh cancer pipeline | BioPharma Dive https://t.co/QqT8kBQ5x8,,,2015-12-15 11:28:14,"Ontario, Canada",Mr. Brian Uberig,https://pbs.twimg.com/profile_images/1047073926990450690/NXLPvzrD_normal.jpg,476,905,20,54169,Brian_Uberig,
372879078,2020-01-14 16:11:33,,,"dlvr.it/RN2rQx, pic.twitter.com/OsPxuqoh1c, ",1217192553709092864,False,0,0,0,0,dlvr.it,Incyte pays MorphoSys $750M upfront in lymphoma drug partnership https://t.co/ZCha7Jpm42 - @MedCityNews https://t.co/OsPxuqoh1c,"medcitynews, ",,2011-09-13 11:51:51,"Montgomery County, MD",AE Eckert,https://pbs.twimg.com/profile_images/1381608105021165568/io8VhV9J_normal.jpg,558,355,50,50180,AndrewEEckert,photo
984003259278020608,2020-01-14 16:06:03,"BCT, ","BCT, brighterir, stevedarling, ","tinyurl.com/t3ylwuq, ",1217191169341476866,False,0,0,0,0,proactive_ca,$BCT BriaCell Therapeutics CEO talks through Incyte collaboration and future plans in 2020 https://t.co/Das2NXpl8P via @proactive_ca @BriaCell #BCT #brighterir #stevedarling,"proactive_ca, BriaCell, ",,2018-04-11 05:40:33,"Vancouver, British Columbia",Proactive Canada,https://pbs.twimg.com/profile_images/1156931373602693121/cFhVxnP8_normal.jpg,2140,418,17,12534,proactive_ca,
3901351277,2020-01-14 15:57:13,,"healthnews, ","bit.ly/38cUiT7, ",1217188945236197377,False,0,0,0,0,IFTTT,Incyte pays MorphoSys $750M upfront in lymphoma drug partnership : https://t.co/kwkrzjNiux #healthnews,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
834728958721683456,2020-01-14 15:55:22,,,"fiercepharma.com/pharma/jpm-kic‚Ä¶, ",1217188480633188353,False,0,0,0,0,Twitter Web Client,"JPM Day 1: Merck's assurances, Teva's shutdown tally, Biogen's launch prep and one CEO's word on another https://t.co/kYp53xdXHl",,,2017-02-23 06:37:47,"Overland Park, KS USA",Oncology Strategies,https://pbs.twimg.com/profile_images/835186170392780800/yf187ZUP_normal.jpg,227,1463,2,693,OncologyStrate1,
407212567,2020-01-14 15:55:12,,"eHealth, ","ift.tt/36PfUo9, ",1217188437025050625,False,0,0,0,0,IFTTT,Mi seguimiento üì° sobre #eHealth Incyte pays MorphoSys $750M upfront in lymphoma drug partnership: https://t.co/wiN9AMx5ZS,,,2011-11-07 14:56:05,Espa√±a,Eugenio Ghirardi,https://pbs.twimg.com/profile_images/378800000532943977/0f99af81bf68382f40a90e89c7ca525c_normal.png,341,485,32,19973,GhirardiEugenio,
140599113,2020-01-14 15:54:31,,,"winway.me/health-care/in‚Ä¶, pic.twitter.com/TI7KQJYJUy, ",1217188264865685504,False,0,0,0,0,WordPress.com,Incyte pays MorphoSys $750M upfront in lymphoma drug¬†partnership https://t.co/ranHYBu7SS https://t.co/TI7KQJYJUy,,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,photo
27683381,2020-01-14 15:52:36,,,"conta.cc/2uJQie8, pic.twitter.com/24aifeoIrL, ",1217187783892185089,False,0,0,0,0,Constant Contact,Incyte Turns to Morphosys to Refresh Cancer Pipeline https://t.co/scSdJjmXfa https://t.co/24aifeoIrL,,,2009-03-30 13:16:27,"Park City, Utah",Larry West,https://pbs.twimg.com/profile_images/1102595619582029824/oyAu3YHn_normal.png,40,27,2,3241,lwestab1,photo
437085904,2020-01-14 15:37:33,,,"dlvr.it/RN2ldn, pic.twitter.com/VtrDeKEEJ3, ",1217183995705745408,False,0,0,0,1,dlvr.it,Incyte pays MorphoSys $750M upfront in lymphoma drug partnership https://t.co/kClUIi0NUL https://t.co/VtrDeKEEJ3,,,2011-12-14 19:20:30,"Hudson Valley, New York",Bruce Judson Telemed,https://pbs.twimg.com/profile_images/904040523580661760/7sz5Ry6z_normal.jpg,5677,1562,245,82548,JudsonTelemed,photo
194586164,2020-01-14 14:10:06,,"cancer, DLBCL, pharma, oncology, ","buff.ly/2tY5BQ2, pic.twitter.com/hX7lgoPOiQ, ",1217161989136494592,False,0,0,0,0,Buffer,Incyte pays $750M upfront for rights to MorphoSys #cancer drug. Will the CAR-T-like efficacy of the anti-CD19 antibody translate to significant market share in #DLBCL if approved? https://t.co/1XlgvYJsjf #pharma #oncology https://t.co/hX7lgoPOiQ,,,2010-09-24 10:12:02,"New York, Paris",Bionest Partners,https://pbs.twimg.com/profile_images/1271043069698326528/K-dF7hlM_normal.jpg,349,512,0,2306,BionestPartners,photo
45543166,2020-01-14 14:01:14,,,"pmlive.com/pharma_news/in‚Ä¶, ",1217159757825478656,False,0,0,0,1,SocialPilot.co,Incyte signs lymphoma deal worth up to $1.1bn with MorphoSys - PMLiVE https://t.co/uxPI1xmzKv,,,2009-06-08 07:07:45,"Surrey, UK",Pharmaceutical Market Europe,https://pbs.twimg.com/profile_images/378800000806601474/9cf87bf47a70fe715664e76280625c82_normal.jpeg,14407,3838,368,16661,PMLiVEcom,
1279763869,2020-01-14 14:01:12,,,"ow.ly/GI5O30q9oga, ",1217159748472143872,False,0,0,0,0,Hootsuite Inc.,"JPM kickoff: Gilead's deal mojo, Novartis' image-polishing, Vertex's new chief and one CEO's word on another https://t.co/gqYdCp3O59",,,2013-03-19 03:07:32,,Ethical Recruiters,https://pbs.twimg.com/profile_images/3399772862/774dd87f0960517bf14aa33d290e6c24_normal.jpeg,116,458,11,8233,Ethical421,
635572478,2020-01-14 13:58:38,,,"fiercepharma.com/pharma/jpm-kic‚Ä¶, ",1217159104025780225,False,0,0,0,0,Twitter for iPhone,"JPM Day 1: Merck's assurances, Teva's shutdown tally, Biogen's launch prep and one CEO's word on another
https://t.co/rCnkaLQh5i",,,2012-07-14 14:45:14,,Dr Maanane Fouad,https://pbs.twimg.com/profile_images/2397625820/image_normal.jpg,193,259,10,22771,FouadMaanane,
146496334,2020-01-14 13:07:57,,,"fiercepharma.com/pharma/jpm-kic‚Ä¶, ",1217146347192754182,True,0,0,0,0,Twitter Web Client,"JPM Day 1: Merck's assurances, Teva's shutdown tally, Biogen's launch prep and one CEO's word on another https://t.co/662D0xbqMo",,,2010-05-21 11:40:44,Brazil,Christiano,https://pbs.twimg.com/profile_images/1383408250108801027/JvAmAMEj_normal.jpg,199,325,44,9882,Chris_P_Silva,
44381112,2020-01-14 12:30:33,,,"buff.ly/2uFZT5F, pic.twitter.com/tgaW9CsCK7, ",1217136937825423365,False,0,0,0,0,Buffer,"Incyte is set to pay MorphoSys $750M upfront for rights to anti-CD19 antibody tafasitamab.
https://t.co/qPRvc9GBGb https://t.co/tgaW9CsCK7",,,2009-06-03 11:28:24,"Philadelphia, PA",Ashton Tweed,https://pbs.twimg.com/profile_images/463035692965064705/MTuVtkEq_normal.jpeg,433,566,20,5133,AshtonTweedLtd,photo
121158213,2020-01-14 10:02:02,"INCY, ",,"AlertTrade.us, ",1217099560364867587,False,0,0,0,0,dlvr.it,TREND REVERSAL UP ALERT: $INCY Incyte Corporation Common Stock üìà TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
2236425032,2020-01-14 09:45:20,,,"fiercebiotech.com/biotech/incyte‚Ä¶, ",1217095358385356801,False,0,0,0,0,Twitter for iPhone,Incyte pays $750M upfront for rights to MorphoSys cancer drug | FierceBiotech https://t.co/iRgP4O3wPd,,,2013-12-08 13:35:25,Delaware,MB Devine,https://pbs.twimg.com/profile_images/1080973438460674048/-uzWh-F2_normal.jpg,144,987,29,25721,devine_mb,
240286075,2020-01-14 08:40:03,,,"buff.ly/36WQLrG, ",1217078928449376256,False,0,0,0,0,Buffer,: Incyte signs lymphoma deal worth up to $1.1bn with MorphoSys https://t.co/ZokPoLYGVk,,,2011-01-19 10:41:34,,ScienceSeeker Feed,https://pbs.twimg.com/profile_images/1220009784/avatar_normal.gif,1066,3,126,480354,SciSeekFeed,
75639425,2020-01-14 08:30:03,,,"buff.ly/2QTCYeS, pic.twitter.com/ibKldJ4VD7, ",1217076413326598144,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/diXHuRdYWC https://t.co/ibKldJ4VD7,,,2009-09-19 16:50:15,Chicago Region,Chelli Miller,https://pbs.twimg.com/profile_images/459756204206469120/EfGbLSm5_normal.jpeg,6871,6956,482,134749,cmiller1225,photo
732361939490312192,2020-01-14 08:20:13,"INCY, ","markets, ","americanbankingnews.com/?p=13045230, ",1217073936359444481,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $121.00 Price Target at JMP Securities https://t.co/FF68gIZ3nE #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-14 08:20:12,"INCY, ","stocks, ","americanbankingnews.com/?p=13045230, ",1217073932869799936,False,1,0,0,0,Zapier.com,Incyte $INCY Given New $121.00 Price Target at JMP Securities https://t.co/adnn1MtWTN #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2020-01-14 07:43:12,"INCY, ",,"tickerreport.com/?p=4956568, ",1217064620126605313,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at JPMorgan Chase &amp; Co. https://t.co/VxTmIqCBaj,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2020-01-14 07:35:48,"INCY, ","markets, ","americanbankingnews.com/?p=13044849, ",1217062758757359618,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúBuy‚Äù Rating at JPMorgan Chase &amp; Co. https://t.co/5LLgKP1eKK #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-14 07:35:47,"INCY, ","stocks, ","americanbankingnews.com/?p=13044849, ",1217062755112554496,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúBuy‚Äù Rating at JPMorgan Chase &amp; Co. https://t.co/ugSt3r8G0F #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
15974185,2020-01-14 07:34:04,,,"dlvr.it/RN1DS9, ",1217062322306314241,False,0,0,0,0,dlvr.it,"JPM kickoff: Gilead's deal ideal, Novartis' image-polishing, Teva's shutdown tally and one CEO's word on another https://t.co/TNNuohCsTO",,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
1979190776,2020-01-14 07:33:36,"INCY, ",,"tickerreport.com/?p=4956534, ",1217062207386783744,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Increased to $121.00 by Analysts at JMP Securities https://t.co/khy06gvJwk,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
930803511918411776,2020-01-14 07:32:26,"INCY, ",,"thelincolnianonline.com/?p=3358156, ",1217061912757854208,False,0,0,0,0,Zapier.com,JMP Securities Raises Incyte $INCY Price Target to $121.00 https://t.co/hXAUGX3bpJ,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
15974185,2020-01-14 07:17:02,,,"dlvr.it/RN19t8, ",1217058038231621633,False,0,0,0,0,dlvr.it,Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug https://t.co/Hd8S8rbqdy,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
3901351277,2020-01-14 06:58:19,,"pharmaceutical, ","bit.ly/37Za3N8, ",1217053325478199300,False,0,0,0,0,IFTTT,MorphoSys and Incyte forge potential $1.1bn partnership to develop B cell malignancy drug candidate : https://t.co/gME0wPLJQw #pharmaceutical,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
17960461,2020-01-14 06:37:32,,"pharma, ","bit.ly/2Nqvqix, pic.twitter.com/voQT1rN9I8, ",1217048097374773249,False,0,0,0,0,Twitter Web App,MorphoSys and Incyte forge potential $1.1bn partnership to develop B cell malignancy drug candidate https://t.co/3bCxhvHmUv #pharma https://t.co/voQT1rN9I8,,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
252546993,2020-01-14 06:06:38,,"pharmadeals, Bcellcancers, developingoncologydrugs, druglicensingdeals, ","bit.ly/2tfK19L, ",1217040321021870080,False,0,0,0,0,Twitter Web App,"MorphoSys and Incyte sign $900m deal for B-cell malignancies drug

@MorphoSys @Incyte #pharmadeals #Bcellcancers #developingoncologydrugs #druglicensingdeals 

https://t.co/8QbPR7e2hC","MorphoSys, Incyte, ",,2011-02-15 07:21:36,,Pharma Tech Focus,https://pbs.twimg.com/profile_images/1263845495425896448/HWH1Fkn6_normal.jpg,4160,2099,95,5874,PharmaTechFocus,
25560065,2020-01-14 06:00:36,,,"bizjournals.com/philadelphia/n‚Ä¶, ",1217038802860105729,False,0,0,0,0,True Anthem,Wilmington-based Incyte signs a licensing deal with a German drug developer that could end up being valued at as much as $2 billion. https://t.co/XhEGq0gZUk,,,2009-03-20 15:31:03,Philadelphia,PHL Business Journal,https://pbs.twimg.com/profile_images/378800000077412316/8b22fbb8c4be97c69f048ff47fe712b6_normal.jpeg,35028,8899,1065,77326,PHLBizJournal,
1889492676,2020-01-14 05:57:35,"MOR, ","MorphoSys, Tafasitamab, ","1stoncology.com/blog/morphosys‚Ä¶, ",1217038042428395520,False,0,0,0,0,Troi URL Plug-in,"#MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for #Tafasitamab $MOR https://t.co/BJ3L41R92h",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1889492676,2020-01-14 05:40:10,"MOR, INCY, ","MorphoSys, Incyte, Tafasitamab, ","1stoncology.com/blog/morphosys‚Ä¶, ",1217033658747408385,False,0,0,0,0,Troi URL Plug-in,#MorphoSys and #Incyte Sign Global Collaboration and License Agreement for #Tafasitamab $MOR $INCY https://t.co/qDCzsobeYM,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
3068641671,2020-01-14 04:40:05,"MOR, ","MorphoSys, equity, stocks, ","dlvr.it/RN0kM3, pic.twitter.com/Y1hkQIrHbv, ",1217018540445724673,False,0,0,0,0,dlvr.it,"$MOR #MorphoSys AG MORPHOSYS: Incyte‚Äôs deal ticks the right boxes, but disappoints the most bullish investors | BUY | EUR140 vs. UR (+13%): MORPHOSYS - BUY | EUR140 vs. UR (+13%) Incyte‚Äôs deal ticks the right boxes, but disappoints the‚Ä¶ https://t.co/7sj3AXqunp #equity #stocks https://t.co/Y1hkQIrHbv",,,2015-03-03 17:15:05,"Paris, France",ResearchPool,https://pbs.twimg.com/profile_images/932829644558016512/Godn_LkX_normal.jpg,8971,4234,0,405156,ResearchPool,photo
301890257,2020-01-14 04:12:26,,,"sco.lt/8PvGhk, pic.twitter.com/gqiTiwqMve, ",1217011581567094784,False,0,0,0,0,Scoop.it,"Incyte pays $750 million upfront for commercial rights¬† tafasitamab (MOR208, MorphoSys AG) https://t.co/FDjqP2PLmH https://t.co/gqiTiwqMve",,,2011-05-20 03:29:21,Geneva and New York,Krishan Maggon,https://pbs.twimg.com/profile_images/1247796373950304256/eskxrohr_normal.jpg,1076,501,40,50478,kkmaggon,photo
301890257,2020-01-14 03:38:44,,,"sco.lt/9Kp18a, pic.twitter.com/q1scdyRPd8, ",1217003101196079104,False,0,0,0,0,Scoop.it,"Incyte pays $750 million upfront for commercial rights¬† tafasitamab (MOR208, MorphoSys AG) https://t.co/evZa57E2yG https://t.co/q1scdyRPd8",,,2011-05-20 03:29:21,Geneva and New York,Krishan Maggon,https://pbs.twimg.com/profile_images/1247796373950304256/eskxrohr_normal.jpg,1076,501,40,50478,kkmaggon,photo
77899506,2020-01-14 03:35:44,,"Incyte, Morphosys, Antibody, DLBCL, FL, AntiCD19, Oncology, Milliondollars, Pact, ","fiercebiotech.com/biotech/incyte‚Ä¶, ",1217002344312795137,False,0,0,0,0,Twitter for iPhone,"Incyte deals with MorphoSys in the Anti-CD19 Drug Development. #Incyte #Morphosys #Antibody #DLBCL #FL #AntiCD19 #Oncology #Milliondollars #Pact .
https://t.co/he6exP3KrI",,,2009-09-27 22:20:34,San Francisco bay area,"Neil Sankar M.D.,MPH",https://pbs.twimg.com/profile_images/1426297340038500353/vDAGfLTb_normal.jpg,448,82,30,2500,neilsankar,
91522535,2020-01-14 03:08:12,,,"fiercepharma.com/pharma/jpm-kic‚Ä¶, ",1216995417751113729,False,1,0,0,2,Twitter for iPhone,The upcoming JPM and the progress report that all pharma has to offer. Interesting article that summarises the trends with all major pharma cos. today. https://t.co/pYpNitxP9o,,,2009-11-21 02:04:15,India,Mahesh Sundar,https://pbs.twimg.com/profile_images/420760811825397761/nZAEiWek_normal.jpeg,47,23,2,775,mahesh_sundar,
1158694129620213761,2020-01-13 19:54:44,,"cancer, oncology, dealmaking, ","fiercebiotech.com/biotech/incyte‚Ä¶, ",1216886330493480960,False,2,0,0,1,Twitter Web Client,Incyte pays $750M upfront for rights to MorphoSys cancer drug https://t.co/eQqQI2VkiO #cancer #oncology #dealmaking,,,2019-08-06 06:59:42,,YH,https://pbs.twimg.com/profile_images/1159744697398636544/PinFT1M6_normal.jpg,75,247,4,246,PharmaLeader1,
32492934,2020-01-13 19:46:28,,,"bioworld.com/articles/43235‚Ä¶, ",1216884248109637633,False,1,0,0,1,TweetDeck,Morphosys banks $750M up front plus $150M in stock sale as Incyte swoops in on tafasitamab https://t.co/vV8Pa6Wwmi,,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
732361939490312192,2020-01-13 19:17:09,"INCY, ","markets, ","americanbankingnews.com/?p=13040612, ",1216876872291758080,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Drops By 14.5% https://t.co/ByCO5m8mUp #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-13 19:17:08,"INCY, ","stocks, ","americanbankingnews.com/?p=13040612, ",1216876868726673408,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Drops By 14.5% https://t.co/PH4g5HhvX7 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
21793154,2020-01-13 19:04:59,,"Immuno, biospace, lifesciences, biotech, pharma, ","hubs.ly/H0myR3f0, ",1216873809648738305,False,2,0,0,0,HubSpot,"Incyte and MorphoSys Ink $1.1 Billion #Immuno-Oncology Pact

#biospace #lifesciences #biotech #pharma

https://t.co/db3YVmY9r5",,,2009-02-24 15:27:40,"Des Moines, IA",BioSpace,https://pbs.twimg.com/profile_images/1042117112020389888/8MCBEVkx_normal.jpg,21738,2830,509,25196,biospace,
3460109487,2020-01-13 17:44:01,"INCY, ","tafasitamab, ","endpts.com/with-sparse-rd‚Ä¶, ",1216853432587427842,False,0,0,0,0,Buffer,"With sparse R&amp;D prospects, Incyte bets on MorphoSys' CAR-T rival #tafasitamab https://t.co/pb5VEobbrD $INCY",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
19287403,2020-01-13 17:28:32,,"PharmaScrip, ","bit.ly/2RqDQrF, dlvr.it/RMzSHw, pic.twitter.com/IXHRdz47RX, ",1216849540092792833,False,0,0,0,0,dlvr.it,PharmaScrip:  MorphoSys Chooses Incyte As Its Global Tafasitamab Partner https://t.co/qlFa1slHIh¬† #PharmaScrip https://t.co/tXTc94doC3 https://t.co/IXHRdz47RX,,,2009-01-21 08:39:09,Nederland,ZorgNL,https://pbs.twimg.com/profile_images/72293628/twitter_health_normal.PNG,15928,442,0,103180,zorgnl,photo
25560065,2020-01-13 17:06:23,,,"bizjournals.com/philadelphia/n‚Ä¶, ",1216843964470394881,False,0,0,0,0,True Anthem,Wilmington-based Incyte signs a licensing deal with a German drug developer that could end up being valued at as much as $2 billion. https://t.co/b1Bxbw3BNH,,,2009-03-20 15:31:03,Philadelphia,PHL Business Journal,https://pbs.twimg.com/profile_images/378800000077412316/8b22fbb8c4be97c69f048ff47fe712b6_normal.jpeg,35028,8899,1065,77326,PHLBizJournal,
732361939490312192,2020-01-13 16:57:07,"INCY, ","markets, ","americanbankingnews.com/?p=13039334, ",1216841633850953728,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reaffirmed at Cowen https://t.co/mDvpiSeHNE #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-13 16:57:07,"INCY, ","stocks, ","americanbankingnews.com/?p=13039334, ",1216841631132987399,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reaffirmed at Cowen https://t.co/2aaXBeyx0t #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2181281054,2020-01-13 16:54:08,"INCY, ","markets, ","wkrb13.com/?p=1507748, ",1216840881199812614,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reaffirmed at Cowen https://t.co/8TEnOs3mq1 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1564125781,2020-01-13 16:49:00,"MOR, INCY, ",,"biopharmadive.com/news/incyte-mo‚Ä¶, ",1216839588246949888,False,2,0,0,1,TweetDeck,"A licensing deal for $MOR's near-to-market lymphoma drug will pad a pipeline that was recently weakened by a surprising study setback for $INCY

https://t.co/OcDgap0jCt",,,2013-07-02 17:00:07,"Washington, D.C.",BioPharma Dive,https://pbs.twimg.com/profile_images/1247897788702052354/8g5XsbZF_normal.jpg,11666,334,333,14463,BioPharmaDive,
211220879,2020-01-13 16:44:07,"INCY, MOR, ","lymphoma, ","xconomy.com/national/2020/‚Ä¶, ",1216838358875373568,False,5,0,0,2,Twitter Web Client,Incyte nabs rights to a MorphoSys #lymphoma drug already submitted to FDA for review. $INCY is paying $750M cash up front and buying $150M of $MOR stock. Incyte will split US rights to the antibody drug and gains global rights to develop and sell it... https://t.co/ZLzMCOuNyX,,,2010-11-02 13:20:59,North Carolina,Frank Vinluan,https://pbs.twimg.com/profile_images/1503948370/billy_3_normal.jpg,1579,716,105,5339,frankvinluan,
18294275,2020-01-13 16:24:42,,"JPM20, ","fiercepharma.com/pharma/jpm-kic‚Ä¶, ",1216833473068986370,False,1,0,0,0,TweetDeck,"Updated: #JPM20 kickoff: Novartis' image-polishing, Teva's shutdown tally and one CEO's word on another https://t.co/trgmVqDqN1",,,2008-12-21 17:25:49,"West End, District of Columbia",FiercePharma,https://pbs.twimg.com/profile_images/1270578385429975041/LVifagc-_normal.jpg,88402,469,1941,30180,FiercePharma,
29881875,2020-01-13 15:47:38,"INCY, MOR, ",,"xconomy.com/national/2020/‚Ä¶, ",1216824145260044289,False,0,0,0,0,TweetDeck,".@Incyte Commits $900M to @MorphoSys for Rights to Lymphoma Drug
- by @frankvinluan
https://t.co/EuCrUfqPqb $INCY $MOR","Incyte, MorphoSys, frankvinluan, ",,2009-04-08 21:24:43,United States,Xconomy,https://pbs.twimg.com/profile_images/1218178322347282434/gvnH_9q2_normal.png,26411,2671,1396,23941,Xconomy,
96033840,2020-01-13 15:29:35,,"bendamustine, Biotech, CART, Chemotherapy, ","dlvr.it/RMz9zj, pic.twitter.com/YPRNunn54e, ",1216819603319357440,False,0,0,0,0,dlvr.it,"#bendamustine #Biotech #CART #Chemotherapy Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug: Two weeks after MorphoSys filed for FDA review of its experimental treatment for a form of lymphoma, the company has struck a deal with Incyte to‚Ä¶ https://t.co/iXLUq5MbeE https://t.co/YPRNunn54e",,,2009-12-10 20:58:22,"Halifax, Nova Scotia, Canada",ùòæùôñùôßùô° ùôçùôûùô§ùô™ùô≠,https://pbs.twimg.com/profile_images/1169378263157878784/4TS9WqLx_normal.jpg,1093,1028,520,46883,CarlRioux,photo
111425542,2020-01-13 15:21:15,,"Regulatory, ","ift.tt/2Rc1QOR, ",1216817507329282050,False,0,0,0,0,IFTTT,Recon: Startup EQRx Raises $200M in Effort to Bring Cheaper Drugs to Market; Incyte Buys Rights to MorphoSys CAR-T Rival | #Regulatory Focus https://t.co/VWjU62MQtJ,,,2010-02-04 16:58:23,"Rockville, MD, USA",Regulatory Affairs Professionals Society,https://pbs.twimg.com/profile_images/1425166554640048128/m_WzjmkG_normal.png,10712,1296,292,28682,RAPSorg,
133504478,2020-01-13 15:14:35,,"strategy, competitiveintelligence, marketing, healthcare, competitivemarketing, pharma, pharmaceutical, biotech, ","dlvr.it/RMz7vc, lqventures.com, pic.twitter.com/InfJTKsGom, ",1216815827208433664,False,0,0,0,2,dlvr.it,Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug https://t.co/1I9UaXLG4B &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #competitivemarketing #pharma #pharmaceutical #biotech https://t.co/InfJTKsGom,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1136762823030104064,2020-01-13 15:04:02,,,"bit.ly/387fppx, ",1216813172381929473,False,0,0,0,1,Sprout Social,Recon: Startup EQRx Raises $200M in Effort to Bring Cheaper Drugs to Market; Incyte Buys Rights to MorphoSys CAR-... https://t.co/A8anhvu3jt,,,2019-06-06 18:32:31,"San Francisco, CA",RAC Medical Consulting,https://pbs.twimg.com/profile_images/1137472123973226496/9km6CQps_normal.jpg,80,398,0,4496,RAC_Medical,
21079030,2020-01-13 15:02:27,,"PharmaScrip, ","bit.ly/2RqDQrF, ",1216812775751802881,False,2,0,0,0,Sprinklr,"MorphoSys Chooses Incyte As Its Global Tafasitamab Partner
https://t.co/7tmvb3aDBJ #PharmaScrip",,,2009-02-17 05:33:29,Global,Scrip,https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg,21541,1629,654,35335,PharmaScrip,
834728958721683456,2020-01-13 14:51:43,,,"fiercepharma.com/pharma/jpm-kic‚Ä¶, ",1216810074640998402,False,0,0,0,0,Twitter Web Client,"JPM kickoff: BMS cuts costs, Incyte deals and the case of the missing mattresses https://t.co/kYp53xdXHl",,,2017-02-23 06:37:47,"Overland Park, KS USA",Oncology Strategies,https://pbs.twimg.com/profile_images/835186170392780800/yf187ZUP_normal.jpg,227,1463,2,693,OncologyStrate1,
133504478,2020-01-13 14:33:35,,"strategy, competitiveintelligence, marketing, healthcare, pharmaceutical, biotech, pharma, productmarketing, ","dlvr.it/RMz2LZ, lqventures.com, pic.twitter.com/v5N3retPXX, ",1216805511057702912,False,0,0,0,2,dlvr.it,"JPM kickoff: BMS cuts costs, Incyte deals and the case of the missing mattresses https://t.co/FAHh7hmgh3 &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #pharma #productmarketing https://t.co/v5N3retPXX",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
204949973,2020-01-13 14:31:26,,"biotech, stocks, investing, ","bit.ly/innd_biobria, pic.twitter.com/N8wJqPYlui, ",1216804967798931457,False,0,0,0,0,Sprout Social,"BriaCell is pleased to provide an update on the top responder in the combination study of Bria-IMT‚Ñ¢, with Incyte‚Äôs INCMGA00012, a PD-1 inhibitor. https://t.co/WNrL3XRc7G @BriaCell #biotech #stocks #investing https://t.co/N8wJqPYlui","BriaCell, ",,2010-10-19 16:46:35,Vancouver BC,InvestingNewsNetwork,https://pbs.twimg.com/profile_images/1212114377010221067/3U37GHA8_normal.jpg,5413,1591,146,14815,DigMedia,photo
898405933,2020-01-13 14:31:07,,"biotech, stocks, investing, ","bit.ly/innd_biobria, pic.twitter.com/D98CGTYZH7, ",1216804887717142528,False,0,0,0,0,Sprout Social,"BriaCell is pleased to provide an update on the top responder in the combination study of Bria-IMT‚Ñ¢, with Incyte‚Äôs INCMGA00012, a PD-1 inhibitor. https://t.co/SrTgHkUsJ6 @BriaCell #biotech #stocks #investing https://t.co/D98CGTYZH7","BriaCell, ",,2012-10-22 16:55:41,,INN Life Science,https://pbs.twimg.com/profile_images/1212856731342114817/lIjBwLju_normal.jpg,5076,3476,92,7478,INN_LifeScience,photo
227778014,2020-01-13 14:28:52,"INCY, ","JPM20, tafasitamab, ","buff.ly/35SnVHw, ",1216804325403627520,False,3,0,0,1,Buffer,The biggest deal so far at #JPM20 is @MorphoSys and @Incyte deal for #tafasitamab for $900M up front; but investors are questioning the choice of partner as $INCY has no existing commercial footprint outside the U.S. and Europe https://t.co/XmfwsOU0uL,"MorphoSys, Incyte, ",,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13038,1543,387,33073,BioCentury,
2848493747,2020-01-13 14:26:07,"MOR, INCY, ",,"biocentury.com/bc-extra/compa‚Ä¶, ",1216803630721818624,False,4,0,0,2,Twitter Web App,$MOR deal underwhelms investors who appear to question choice of $INCY as partner but $900M upfront is 2nd largest in past year for an EU biotech. via @BioCentury's @StephenPHansen https://t.co/CQTN0BIcZm,"BioCentury, StephenPHansen, ",,2014-10-28 13:19:58,"San Carlos, Calif.",Jeff Cranmer,https://pbs.twimg.com/profile_images/1009677183877447680/76chZHUe_normal.jpg,1807,1102,57,3932,jeff_cranmer,
1379301222,2020-01-13 14:24:32,,"JPM20, ","fiercepharma.com/topic/jpm-2020, fiercepharma.com/pharma/jpm-kic‚Ä¶, ",1216803232233578496,False,4,0,0,2,TweetDeck,"Handy link to all of the @FiercePharma #JPM20 coverage: https://t.co/ss3objWuss and to our Monday roundup, which we'll be updating continuously throughout the day: https://t.co/gIRLB8jalB","FiercePharma, ",,2013-04-25 08:09:35,"Portland, OR",Carly Helfand,https://pbs.twimg.com/profile_images/3636071471/0cc6c528c0205318f207d97bb01e6d2f_normal.jpeg,3220,249,173,4995,CarlyHFierce,
2334365461,2020-01-13 13:59:31,,"privacy, privacyjobs, security, ","dlvr.it/RMyx2t, ",1216796935715057665,False,0,0,0,1,dlvr.it,"Now Hiring: Sr. Manager, Privacy at Incyte (Wilmington, DE) https://t.co/SgkeJRayZf #privacy #privacyjobs #security",,,2014-02-08 20:52:23,,DataPrivacyCareers,https://pbs.twimg.com/profile_images/438024813563506688/NTjUSRHM_normal.png,5238,3624,156,48469,dataprivacyfeed,
140599113,2020-01-13 13:40:32,,,"winway.me/health-remedie‚Ä¶, pic.twitter.com/GQmf5dMlrv, ",1216792160072278016,False,0,0,0,0,WordPress.com,"JPM kickoff: BMS cuts costs, Incyte deals and the case of the missing¬†mattresses https://t.co/q0cGMDdGTz https://t.co/GQmf5dMlrv",,,2010-05-05 19:05:00,"East Brunswick, NJ",NewExpressNews,https://pbs.twimg.com/profile_images/938197843373887490/F-Hy_zUC_normal.jpg,1924,4480,7,107059,NewExpressNews,photo
3069964341,2020-01-13 13:33:29,,"cancer, oncology, lymphoma, ","fiercebiotech.com/biotech/incyte‚Ä¶, ",1216790385336471553,False,0,0,0,0,Twitter Web App,Incyte pays $750M upfront for rights to MorphoSys cancer drug https://t.co/hadnQLCbKB #cancer #oncology #lymphoma,,,2015-03-04 09:15:33,"Research Triangle (RTP), NC","Nathan Letts, PhD",https://pbs.twimg.com/profile_images/723476303920267264/DauOohp-_normal.jpg,1537,2995,73,16290,Sciguy999,
25406480,2020-01-13 13:18:03,,,"awesomecapital.blogspot.com/2020/01/incyte‚Ä¶, ",1216786501859790848,False,0,0,0,1,Twitter Web Client,AwesomeCapital: Incyte and MorphoSys Ink $1.1 Billion Immuno-Oncol... https://t.co/BdMtyzguPE,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
4493706195,2020-01-13 13:02:32,,,"ow.ly/HidW30q97FE, ",1216782595255676928,False,0,0,0,0,Hootsuite Inc.,Incyte turns to German Morphosys to refresh cancer pipeline | BioPharma Dive https://t.co/bhejLhRJKc,,,2015-12-15 11:28:14,"Ontario, Canada",Mr. Brian Uberig,https://pbs.twimg.com/profile_images/1047073926990450690/NXLPvzrD_normal.jpg,476,905,20,54169,Brian_Uberig,
2844414692,2020-01-13 12:46:58,,,"zpr.io/tm9uh, ",1216778677553373187,False,0,0,0,0,Zapier.com,"JPM kickoff: BMS cuts, Incyte pickup and the case of the missing mattresses
https://t.co/YKLQ9SOzf5",,,2014-10-07 15:21:46,"Montr√©al, Qu√©bec",Labofine,https://pbs.twimg.com/profile_images/1222261856359809024/QSpRZp1o_normal.jpg,158,622,7,7643,tw_labofine,
130442628,2020-01-13 12:35:06,,,"bit.ly/2FNLCGl, ",1216775691192143872,False,0,0,0,0,Sailing Blogs,Incyte turns to German Morphosys to refresh cancer pipeline - BioPharma Dive https://t.co/2eaODbfGxh,,,2010-04-07 05:07:45,,Diving News,https://pbs.twimg.com/profile_images/804026153/diving-and-activities_diving-and-activities_top_265_1_normal.jpg,9921,343,146,74400,diving_news,
71542880,2020-01-13 12:32:52,,"biotech, ","thepharmaletter.com/article/major-‚Ä¶, ",1216775131567140864,False,0,0,0,0,TweetDeck,Major collaboration agreed for novel B cell candidate https://t.co/gmQ3jJ1VE7 #biotech @Incyte,"Incyte, ",,2009-09-04 10:07:54,London,The Pharma Letter,https://pbs.twimg.com/profile_images/1286243845659856897/vbFCz4-e_normal.jpg,21836,1954,530,18020,ThePharmaLetter,
875382419251019776,2020-01-13 12:31:03,,,"bit.ly/35KgIcA, pic.twitter.com/ARBchKrMqz, ",1216774675314774016,False,0,0,0,0,dlvr.it,Incyte and MorphoSys Ink $1.1 Billion Immuno-Oncology Pact https://t.co/Sy9b0h9CYK https://t.co/ARBchKrMqz,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
431940711,2020-01-13 11:04:03,,,"fiercebiotech.com/biotech/incyte‚Ä¶, ",1216752780846592001,False,0,0,0,0,Twitter Web Client,Incyte pays $750M upfront for rights to MorphoSys cancer drug https://t.co/wJZ9Q2rA3Z,,,2011-12-08 16:21:34,USA,buzz lightyear,https://pbs.twimg.com/profile_images/2406022783/d5v6aqxpuhev5ksyubd0_normal.jpeg,136,526,8,18392,buzzlightyear58,
2236261122,2020-01-13 10:45:50,"MOR, XNCR, ","tafasitamab, ",,1216748193439940608,False,1,0,0,0,Twitter Web App,"The deal between $MOR and $ ICY is good for $XNCR in that #tafasitamab is now to be launched in several indications (-&gt; high regulatory milestones).  On the negative side, Morphosys and Incyte have little distribution power.",,,2013-12-08 11:23:17,Germany,German Biotech,https://pbs.twimg.com/profile_images/1184938278224646145/CdvTZ-M6_normal.jpg,1199,78,32,1941,GermanBiotech,
746441781588426752,2020-01-13 09:04:30,,,"twitter.com/endpts/status/‚Ä¶, ",1216722694080811011,False,3,0,0,0,Twitter Web App,"Germany's MorphoSys has found a US partner in Incyte ‚Äî $750M cash upfront, $150M equity investment 
@NatalieGrover https://t.co/fzKTefHgEb","NatalieGrover, ",,2016-06-24 16:36:03,Hong Kong,Amber Tong,https://pbs.twimg.com/profile_images/884631339940687872/t2YNNjMA_normal.jpg,2186,733,44,3674,AmberTongPW,
18294197,2020-01-13 09:01:00,,,"fiercebiotech.com/biotech/incyte‚Ä¶, ",1216721811297226755,False,3,0,0,2,Twitter Web Client,"Incyte is handing over $750 million and making a $150 million equity investment in MorphoSys at a premium price to get the deal underway. Down the line, Incyte is on the hook for up to $1.1 billion in milestones. https://t.co/nq4SGzOH2X",,,2008-12-21 17:21:58,"Washington, DC",FierceBiotech,https://pbs.twimg.com/profile_images/1270578068701224962/2YHKa3mX_normal.jpg,92204,663,2073,25532,FierceBiotech,
2334614718,2020-01-13 08:49:10,"MOR, INCY, ",,"ooc.bz/l/46719, ",1216718835493023744,False,1,0,0,0,Open Outcrier,"$MOR (-4.5% pre) MorphoSys AG: Ad hoc: MorphoSys and Incyte $INCY Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for Tafasitamab

https://t.co/f1exPXiYgV",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
133504478,2020-01-13 08:47:08,,"strategy, competitiveintelligence, marketing, healthcare, pharma, competitivemarketing, biotech, pharmaceutical, ","dlvr.it/RMxxX7, lqventures.com, pic.twitter.com/enzrU7dbct, ",1216718324702142467,False,0,0,0,2,dlvr.it,Incyte pays $750M upfront for rights to MorphoSys cancer drug https://t.co/jpaqbe0IUc &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #pharma #competitivemarketing #biotech #pharmaceutical https://t.co/enzrU7dbct,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
26759915,2020-01-13 08:35:08,,,"dlvr.it/RMxvcH, pic.twitter.com/GklFA3PNwZ, ",1216715301791731713,False,1,0,0,0,dlvr.it,Incyte pays $750M upfront for rights to MorphoSys cancer drug https://t.co/dwjlYb6XUb https://t.co/GklFA3PNwZ,,,2009-03-26 10:26:33,United States,Biotech World,https://pbs.twimg.com/profile_images/114801338/BiotechWorldv5_normal.jpg,38033,0,596,34960,BiotechWorld,photo
875382419251019776,2020-01-13 08:28:34,,,"bit.ly/30hZnXo, pic.twitter.com/woWeLAEd5Y, ",1216713649827401728,False,0,0,0,0,dlvr.it,Incyte pays $750M upfront for rights to MorphoSys cancer drug https://t.co/7xUtpyKlmi https://t.co/woWeLAEd5Y,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
374729426,2020-01-13 08:24:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1119729, pic.twitter.com/z0hGMLlpty, ",1216712523623301121,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on January 10, 2020. View odds for this and other indicators: https://t.co/xuBXiw62UD #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/z0hGMLlpty",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
133504478,2020-01-13 08:13:34,,"strategy, competitiveintelligence, marketing, healthcare, biotech, pharmaceutical, pharma, productmarketing, ","dlvr.it/RMxqzz, lqventures.com, pic.twitter.com/UXsNXz0HP3, ",1216709874223968256,False,0,0,0,2,dlvr.it,"With sparse R&amp;D prospects, Incyte bets on MorphoSys' CAR-T rival tafasitamab https://t.co/eRpOKZKtpr &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #biotech #pharmaceutical #pharma #productmarketing https://t.co/UXsNXz0HP3",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
1142831555850592256,2020-01-13 08:04:45,,"BayArea, Biotech, ","tinyurl.com/une33bq, ",1216707655781289986,False,0,0,0,0,FeedBlitz,"SFBN Feed: With sparse R&amp;D prospects, Incyte bets on MorphoSys' CAR-T rival tafasitamab: Having suffered a string of pipeline setbacks in recent years, Incyte is reinvigorating its R&amp;D ... #BayArea #Biotech https://t.co/BOsM7O96qf",,,2019-06-23 12:27:30,"San Francisco, CA",San Francisco Biotechnology Network,https://pbs.twimg.com/profile_images/1430570245622693888/y8PFDscc_normal.jpg,1095,3775,7,7847,sfbionetwork,
834728958721683456,2020-01-13 07:31:58,,,"nasdaq.com/articles/morph‚Ä¶, ",1216699405727936512,False,0,0,0,0,Twitter for iPhone,"MorphoSys, Incyte Agree To Co-commercialize Tafasitamab In The U.S.  | NASDAQ https://t.co/oaZYxQLLg2",,,2017-02-23 06:37:47,"Overland Park, KS USA",Oncology Strategies,https://pbs.twimg.com/profile_images/835186170392780800/yf187ZUP_normal.jpg,227,1463,2,693,OncologyStrate1,
3460109487,2020-01-13 07:06:16,,,"endpts.com/with-sparse-rd‚Ä¶, ",1216692937834270721,False,1,1,0,1,Buffer,"With sparse R&amp;D prospects, Incyte bets on MorphoSys' CAR-T rival tafasitamab https://t.co/pb5VEobbrD",,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
993581474,2020-01-13 07:02:45,"INCY, MOR, MOR, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1216692055122087937,False,2,0,0,0,TweetDeck,"$INCY licenses $MOR's tafasitimab, paying $750m upfront plus $150m equity investment.

$MOR recently submitted tafasitimab to FDA for approval in lymphoma. A decision is expected by mid 2020

https://t.co/PBuDyBwmoe",,,2012-12-06 13:23:28,"Washington, DC",Ned Pagliarulo,https://pbs.twimg.com/profile_images/953310204300595201/ymnS3Vyx_normal.jpg,3588,629,123,5338,NedPagliarulo,
347315451,2020-01-13 07:00:05,,,"morphosys.com/media-investor‚Ä¶, ",1216691382489886721,False,0,0,0,0,Twitter Web App,"MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab
https://t.co/W3SPEw7LIb",,,2011-08-02 12:17:10,Berlin,BIO Deutschland,https://pbs.twimg.com/profile_images/801026554834878465/TZRcLWOl_normal.jpg,4612,2717,178,29124,BIODeutschland,
1481745314,2020-01-13 06:39:19,,"pharmashots, incyte, morphoSys, ","lnkd.in/fC8VfWT, ",1216686155313373185,False,0,0,0,0,LinkedIn,Incyte Signs a Worldwide License Agreement with MorphoSys for Tafasitamab | #pharmashots #incyte #morphoSys https://t.co/6cOM8vhwln,,,2013-06-04 04:42:08,"New Delhi, India",Adi Singh,https://pbs.twimg.com/profile_images/1047542247204446208/zYzlZzdK_normal.jpg,600,2106,12,1659,adisingh_,
1022473214457348096,2020-01-13 06:34:09,,,"pharmashots.com/25982/incyte-s‚Ä¶, ",1216684857801101317,False,1,0,0,0,Twitter Web Client,"Incyte Signs a Worldwide License Agreement with MorphoSys for Tafasitamab @Incyte @MorphoSys
https://t.co/GdJMdBWibj","Incyte, MorphoSys, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
3068641671,2020-01-13 05:05:35,"MOR, ","MorphoSys, equity, stocks, ","dlvr.it/RMxJ3V, pic.twitter.com/1PJ8oxUMeT, ",1216662570582581248,False,0,0,0,0,dlvr.it,$MOR #MorphoSys AG MORPHOSYS: Highly anticipated MOR208 deal finally signed with ‚Ä¶ Incyte | BUY | Under Review vs. EUR140: MORPHOSYS - BUY | Under Review vs. EUR140 Highly anticipated MOR208 deal finally signed with ‚Ä¶ Incyte The perfect‚Ä¶ https://t.co/GKkM6nROet #equity #stocks https://t.co/1PJ8oxUMeT,,,2015-03-03 17:15:05,"Paris, France",ResearchPool,https://pbs.twimg.com/profile_images/932829644558016512/Godn_LkX_normal.jpg,8971,4234,0,405156,ResearchPool,photo
35789155,2020-01-13 04:54:35,"MOR, INCY, ",,"firstwordpharma.com/node/1693241, ",1216659801209524225,False,1,0,0,0,TweetDeck,Incyte to pay $750 million upfront under deal with MorphoSys to develop anti-CD19 antibody tafasitamab https://t.co/J4IryN1beH $MOR $INCY,,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
243228907,2020-01-13 03:34:52,,"biotech, tafasitamab, ",,1216639737043259392,False,2,1,0,6,Twitter Web App,"German #biotech @MorphoSys bags $750M upfront, plus $150M in equity &amp; potential $1.1bn milestones from @Incyte as firms sign collaboration &amp; license deal for #tafasitamab; companies will co-commercialize tafasitamab in US &amp; Incyte has exclusive commercialization rights outside US","MorphoSys, Incyte, ",,2011-01-26 10:58:16,"London, UK",Mike Ward,https://pbs.twimg.com/profile_images/378800000308429980/0288ff3098daceff8672357bac3209fd_normal.jpeg,5908,1076,265,13657,BioPharmaMike,
1525137691,2020-01-13 03:08:04,,,"bioportfol.io/RMx1bt, ",1216632994481373184,False,0,0,0,1,dlvr.it,MorphoSys AG Ad hoc MorphoSys and Incyte Sign Global Collaboration and License Agreement including U.S. CoCommercialization and ExU.S. Commercialization Rights for Tafasitamab: PLANEGGMUNICH GERMANY ACCESSWIRE January 13 2020 MorphoSys AG FSE MOR; Prime‚Ä¶ https://t.co/VJHVY0RN3v,,,2013-06-17 11:21:24,,Renal Cell Carcinoma,https://pbs.twimg.com/profile_images/656427745304530945/qbgWaiHn_normal.png,341,12,5,45347,Renal_Bio,
1525137691,2020-01-13 03:08:03,,,"bioportfol.io/RMx1Zl, ",1216632992178659329,False,0,0,0,1,dlvr.it,MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab: MorphoSys and Incyte to cocommercialize tafasitamab in the U.S. Incyte has exclusive commercialization rights outside of the U.S. MorphoSys and Incyte to host joint‚Ä¶ https://t.co/sAYc2MFXWn,,,2013-06-17 11:21:24,,Renal Cell Carcinoma,https://pbs.twimg.com/profile_images/656427745304530945/qbgWaiHn_normal.png,341,12,5,45347,Renal_Bio,
1525137691,2020-01-13 02:57:05,,,"bioportfol.io/RMx0Cj, ",1216630229197713408,False,0,0,0,1,dlvr.it,MorphoSys AG Ad hoc MorphoSys and Incyte Sign Global Collaboration and License Agreement including U.S. CoCommercialization and ExU.S. Commercialization Rights for Tafasitamab: MorphoSys AG Key words AllianceMorphoSys AG Ad hoc MorphoSys and Incyte Sign‚Ä¶ https://t.co/svzqj6aKf6,,,2013-06-17 11:21:24,,Renal Cell Carcinoma,https://pbs.twimg.com/profile_images/656427745304530945/qbgWaiHn_normal.png,341,12,5,45347,Renal_Bio,
1006334607946649600,2020-01-13 02:43:02,,,"dlvr.it/RMwyfp, ",1216626695437840384,False,0,0,0,0,dlvr.it,"MorphoSys AG: Ad hoc: MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for Tafasitamab https://t.co/ve5vtY2aKk",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1089978712685273090,2020-01-13 02:42:07,"INTC, ","stocktwits, stockmarketnews, ","dlvr.it/RMwyb4, ",1216626463794855937,False,0,0,0,1,dlvr.it,"MorphoSys AG: Ad hoc: MorphoSys and Incyte $INTC Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for Tafasitamab https://t.co/L6bqDEpRbM #stocktwits #stockmarketnews",,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
3314135167,2020-01-13 02:35:02,,"jobs, ","goo.gl/fb/gaQ7Ry, ",1216624682838974464,False,0,0,0,0,Google,#jobs Incyte licenses Morphosys‚Äô tafasitamab in US$2bn deal ‚Äì European Biotechnology https://t.co/TX8gweBCTx,,,2015-08-13 02:43:55,,Career Biotech,https://pbs.twimg.com/profile_images/872856527731793920/HqYH3X_9_normal.jpg,110,59,1,35799,CareerBiotech,
981822752716935169,2020-01-13 02:33:44,,,"dgap.de/dgap/News/corp‚Ä¶, ",1216624354794057729,False,1,0,0,0,Twitter Web App,Stark @MorphoSys https://t.co/KRPQjIuOZo,"MorphoSys, ",,2018-04-05 05:16:00,,Volker Glaser,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,305,85,4,6840,VolkerGlaser1,
3318510966,2020-01-13 02:30:08,,,"crweworld.com/article/news-p‚Ä¶, ",1216623448174153728,False,0,0,0,0,CRWE World,"MorphoSys AG: Ad hoc: MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commer https://t.co/r1fET357uQ",,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
261473143,2020-01-13 02:29:58,,,"morphosys.com/media-investor‚Ä¶, life-sciences-usa.com/news/transatla‚Ä¶, pic.twitter.com/FMMUnwAgHR, ",1216623406994673665,False,0,0,0,0,Twitter Web App,MorphoSys &amp; Incyte Sign Global Collaboration and License Agreement for Tafasitamab https://t.co/LsINCGhiCm @MorphoSys @Incyte More Transatlantic Life Science Business News at [LSUS] at https://t.co/CirThZ34rn https://t.co/FMMUnwAgHR,"MorphoSys, Incyte, ",,2011-03-05 20:26:19,"Bremen, Germany",[iito] Life Science,https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_normal.jpeg,2596,238,89,29254,iitoLifeScience,photo
950942636818432006,2020-01-13 02:27:22,"MOR, INCY, MOR, ",,"morphosys.com/media-investor‚Ä¶, ",1216622753748381697,False,12,0,0,10,Twitter for iPhone,"$MOR &amp; $INCY entered into a collab and license agreement to further develop and commercialize MorphoSys' proprietary anti-CD19 antibody tafasitamab (MOR208) globally.

$MOR will receive $750M upfront + $150M equity investment + up to $1.1B milestones.

https://t.co/pXMkJBCLF3",,,2018-01-09 23:09:27,"San Francisco, CA",SY Investing,https://pbs.twimg.com/profile_images/1108963782334672900/Bh_0t4CE_normal.png,5814,300,160,3879,syinvesting,
266143766,2020-01-13 02:25:55,"MOR, ",,"accesswire.com/572835/MorphoS‚Ä¶, ",1216622386176495616,False,0,0,0,0,Accesswire,"$MOR MorphoSys AG: Ad hoc: MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization ... https://t.co/U7HvhZo4Ur",,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
126416038,2020-01-13 02:22:53,"MOR, INCY, MOR, INCY, MOR, ","JPM20, ","morphosys.com/media-investor‚Ä¶, ",1216621625816375298,False,15,0,1,6,Twitter for iPhone,$MOR $INCY Sign Global Collab and License Agreement for Tafasitamab. $MOR will receive  an upfront payment of $750M. $INCY will make $150M equity investment into $MOR + up to $1.1B in milestone payments #JPM20 https://t.co/YTiXBrWziO,,,2010-03-25 16:17:38,Tel Aviv,Odi Bruckman,https://pbs.twimg.com/profile_images/1182595151899836417/Y4fMBMd5_normal.jpg,14629,185,415,30356,odibro,
1089978712685273090,2020-01-13 02:11:33,"INTC, ","stocktwits, stockmarketnews, ","dlvr.it/RMwvJ1, ",1216618772900933637,False,0,0,0,1,dlvr.it,MorphoSys and Incyte $INTC Sign Global Collaboration and License Agreement for Tafasitamab https://t.co/9VjP7sVqOV #stocktwits #stockmarketnews,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
1006334607946649600,2020-01-13 02:11:32,,,"dlvr.it/RMwvH1, ",1216618767389609984,False,0,0,0,0,dlvr.it,MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab https://t.co/jIDou842ds,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
31720614,2020-01-13 02:04:44,,"news, pharma, pharmiweb, ","zpr.io/tmhHS, ",1216617057460027392,False,1,0,0,0,Zapier.com,"MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab (news with additional features)
https://t.co/v7sqgRHnb9
#news #pharma #pharmiweb",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,
31720614,2020-01-13 02:04:43,,"news, pharma, pharmiweb, ","zpr.io/tmhHF, ",1216617052728975360,False,2,0,0,0,Zapier.com,"MorphoSys AG: Ad hoc: MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for Tafasitamab
https://t.co/9VtuohtwFN
#news #pharma #pharmiweb",,,2009-04-16 06:47:23,UK,Pharma & Life Science News,https://pbs.twimg.com/profile_images/595963235054067712/M05vNOCM_normal.png,54624,309,704,135885,pharminews,
3318510966,2020-01-13 02:00:14,,,"crweworld.com/article/news-p‚Ä¶, ",1216615922963664897,False,0,0,0,0,CRWE World,MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab https://t.co/10dTdmYirw,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1199800417821048834,2020-01-13 01:59:32,,"Company_News_, ","dlvr.it/RMwshD, bit.ly/2StKgrZ, pic.twitter.com/HdCU8O3y02, ",1216615748514140162,False,0,0,0,0,dlvr.it,"#Company_News_ MorphoSys AG: Ad hoc: MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for Tafasitamab https://t.co/RFu16PTlb4 https://t.co/U3dJgzsdcR https://t.co/HdCU8O3y02",,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,photo
3911174913,2020-01-13 01:59:04,,"Breaking, ","bit.ly/2Tp9M1Q, pic.twitter.com/ll6dJw82Bj, ",1216615628401807360,False,9,0,0,1,Twitter Web App,"#Breaking: Incyte &amp; @MorphoSys announce a global collaboration &amp; license agreement, including U.S. co-commercialization and Ex-U.S. commercialization rights for tafasitamab https://t.co/40J6lGkBmN https://t.co/ll6dJw82Bj","MorphoSys, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
266143766,2020-01-13 01:51:06,"MOR, ",,"accesswire.com/572834/MorphoS‚Ä¶, ",1216613626469146624,False,1,0,0,0,Accesswire,$MOR MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab https://t.co/nMnQKcfgM5,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
3312065387,2020-01-13 01:44:32,,,"morphosys.com/media-investor‚Ä¶, ",1216611973208530944,False,0,0,0,1,Twitter for iPhone,MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab | MorphoSys AG https://t.co/YxOsbsxRwW,,,2015-06-07 12:24:38,,üëæ,https://pbs.twimg.com/profile_images/608539455243210753/CXfYz7i6_normal.png,373,1840,22,20997,BioGraphica1,
42410755,2020-01-13 01:35:17,,,"tinyurl.com/smculef, ",1216609643952267264,False,0,0,0,0,DGAP_News_Int,MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab (news with addi... https://t.co/STcZqxKxCM,,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
47519668,2020-01-13 01:34:43,"MOR.DE, INCY, ",,"tradethenews.com/?twtId=11598, ",1216609503145275392,False,0,0,0,2,Updates Poster,"$MOR.DE Signs global license pact with Incyte for Tafasitamab; to receive upfront of $750M from Incyte $INCY (Morphosys AG)
(More at https://t.co/OwwKmhDz0L)",,,2009-06-15 22:37:04,Global,TradeTheNews.com,https://pbs.twimg.com/profile_images/916119563191889920/ylR4h5y0_normal.jpg,21141,1222,761,53590,Trade_The_News,
42410755,2020-01-13 01:33:15,,,"tinyurl.com/ropojcb, ",1216609133102862336,False,0,0,0,0,DGAP_News_Int,"MorphoSys AG: Ad hoc: MorphoSys and Incyte Sign Global Collaboration and License Agreement, includin... https://t.co/DnsN2TvA6r",,,2009-05-25 10:07:47,"Munich, Germany",DGAP-News-Int,https://pbs.twimg.com/profile_images/2645179638/22b9a130088114615fe36332e67951db_normal.png,612,75,42,365535,DGAP_News_Int,
374729426,2020-01-12 09:09:56,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1114550, pic.twitter.com/P2KzRwsrgq, ",1216361675458150400,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on January 10, 2020. View odds for this and other indicators: https://t.co/SZbXbq6q6u #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/P2KzRwsrgq",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1002361483169226752,2020-01-11 19:45:39,,"Incyte, Itacitinib, Patients, Na√ØveAcuteGraft, HostDisease, Fails, Endpoint, Healthcare, ","trialsitenews.com/incyte-announc‚Ä¶, ",1216159269319372801,False,0,0,0,0,Twitter Web Client,#Incyte Announces Phase 3 Study of #Itacitinib in #Patients with Treatment-#Na√ØveAcuteGraft-Versus-#HostDisease #Fails to Meet #Endpoint https://t.co/56CuoOwOcl #Healthcare,,,2018-05-31 21:29:35,"Salt Lake City, Utah",TrialSite News,https://pbs.twimg.com/profile_images/1002368873918689280/0KP3xUVe_normal.jpg,7886,3205,76,11177,TrialsiteN,
374729426,2020-01-11 12:23:45,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1112433, pic.twitter.com/Sb14EMq9Y9, ",1216048060905582592,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on January 10, 2020. View odds for this and other indicators: https://t.co/0NS8vRfWDR #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Sb14EMq9Y9",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
19478114,2020-01-11 12:19:54,,,"youtu.be/SbnA94sJmow, ",1216047091828453376,False,1,0,0,0,Twitter Web App,"Vantagepoint Hot Stocks Outlook for January 10, 2020üî•
üë®‚Äçüè´Sometimes you need to limit losses to win! 
üëéShopify trending on the upside. (SHOP)
üëéIncyte may be one you avoid for the short-term (INCY)
https://t.co/iwXLPWUIjR",,,2009-01-24 23:46:07,"Tampa, FL",Lane Mendelsohn,https://pbs.twimg.com/profile_images/991751404321681410/YqFDrg75_normal.jpg,13133,88,105,4823,lanemen,
20187378,2020-01-11 12:18:43,,,"youtu.be/SbnA94sJmow, ",1216046792745242624,False,2,1,0,2,Twitter Web App,"Vantagepoint Hot Stocks Outlook for January 10, 2020üî•
üë®‚Äçüè´Sometimes you need to limit losses to win! 
üëéShopify trending on the upside. (SHOP)
üëéIncyte may be one you avoid for the short-term (INCY)
https://t.co/NYkULf97z0",,,2009-02-05 15:59:25,Get a FREE demo ‚¨áÔ∏è‚¨áÔ∏è,Vantagepoint AI,https://pbs.twimg.com/profile_images/1050027620904181763/sZVyl3HU_normal.jpg,3027,1721,82,48699,vantagepoint,
1022006086872821762,2020-01-11 10:01:36,"INCY, INCY, ",,,1216012288311922688,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Fri Jan 10
Closed at 76.47 USD for a -1.90% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
849417718642159616,2020-01-11 07:23:14,"INCY, ",,"zpr.io/tm7TP, ",1215972432101638144,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub to ‚ÄúSell‚Äù https://t.co/fzg5QVYG8e,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2266388972,2020-01-10 10:48:43,"INCY, ","stocks, ","dailypolitical.com/?p=3315357, ",1215661758196613121,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúNeutral‚Äù Rating Reaffirmed at Royal Bank of Canada https://t.co/pHljAnEcbE #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-01-10 10:48:43,"INCY, ",,"dailypolitical.com/?p=3315357, ",1215661755239669763,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúNeutral‚Äù Rating Reaffirmed at Royal Bank of Canada https://t.co/uM3X0n543q,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
68559732,2020-01-10 10:32:43,"INCY, ",,"zpr.io/tm6HE, ",1215657729030668290,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $83.00 https://t.co/uSaFexfgY8,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
3064967368,2020-01-10 09:46:56,,"clinicaltrial, ruxolitinib, eczema, ","aaaai.org/global/latest-‚Ä¶, ",1215646208401776645,False,6,0,0,1,Twitter Web App,"Thanks to @AAAAI_org @jacionline for highlighting our @Incyte #clinicaltrial on #ruxolitinib for #eczema - promising to be the first truly potent nonsteroidal agent
https://t.co/OPeqSSVOa2","AAAAI_org, jacionline, Incyte, ",,2015-02-28 14:04:33,"St. Louis, MO","Brian S. Kim, MD, MTR",https://pbs.twimg.com/profile_images/1390351360303026176/LaQoWrfp_normal.jpg,2104,371,16,1490,itchdoctor,
374729426,2020-01-10 09:46:42,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1107388, pic.twitter.com/czBgqeTjxs, ",1215646150302109698,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on January 2, 2020. View odds for this and other indicators: https://t.co/uyKzMYNO9u #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/czBgqeTjxs",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2020-01-10 01:26:57,"INCY, ",,"newsfilter.io/articles/morga‚Ä¶, ",1215520383157383168,False,0,0,0,0,Newsfilter.io,Morgan Stanley Trims Incyte Target Price to $83.00 $INCY https://t.co/BLE1VQK9Nr,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
852931863547084801,2020-01-09 11:55:10,"INCY, ",,"zpr.io/tMJw7, ",1215316093486673920,False,0,0,0,0,Zapier.com,Royal Bank of Canada Reaffirms Neutral Rating for Incyte $INCY https://t.co/52QFosB29X,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
2416188264,2020-01-09 11:23:29,"INCY, ","markets, ","thestockobserver.com/?p=2537603, ",1215308120362299394,False,0,0,0,0,Zapier.com,Morgan Stanley Trims Incyte $INCY Target Price to $83.00  https://t.co/C3HqwXvEBP #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1099898965682618368,2020-01-09 11:18:49,,,"cannabis-investment-group.com/2020/01/09/bio‚Ä¶, ",1215306942970769411,False,0,0,0,0,WordPress.com,[Biotech&amp;Pharma] Incyte Stock Pummeled As Late-Stage Failure Casts Doubt On¬†Pipeline https://t.co/JiwDfkoUAV,,,2019-02-25 00:08:43,,CANDLR,https://pbs.twimg.com/profile_images/1255911209267679234/u241thNh_normal.jpg,1253,2254,3,25050,CannabisGroup19,
374729426,2020-01-09 09:51:52,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1104644, pic.twitter.com/LBsl6oKSyE, ",1215285061060161536,False,1,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on January 2, 2020. View odds for this and other indicators: https://t.co/gfjGLqT2wn #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/LBsl6oKSyE",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1099898965682618368,2020-01-09 09:18:09,,,"cannabis-investment-group.com/2020/01/09/bio‚Ä¶, ",1215276577321357313,False,0,0,0,0,WordPress.com,"[Biotech&amp;Pharma] Stock Market Rally Continues Into 2020; Tesla, Lockheed Soar, Incyte Plunges: Weekly¬†Review https://t.co/Yd3dTjjetx",,,2019-02-25 00:08:43,,CANDLR,https://pbs.twimg.com/profile_images/1255911209267679234/u241thNh_normal.jpg,1253,2254,3,25050,CannabisGroup19,
1203009669016571904,2020-01-09 08:47:31,,,"tutierra.net/social/inphi-a‚Ä¶, pic.twitter.com/pAR128Svji, ",1215268868291211268,False,0,0,0,0,SocialTT3,Inphi And Vertex Flatten Out; Incyte Gets Support  https://t.co/v7tRSrKqbs https://t.co/pAR128Svji,,,2019-12-06 12:54:10,,SocialTT,https://pbs.twimg.com/profile_images/1203014880724496384/WcLMoS2S_normal.jpg,18,0,0,5752,SocialTT3,photo
3389185084,2020-01-09 01:50:00,,,"buff.ly/2tzptZO, ",1215163796723064832,False,0,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/VIQTv0Bes0,,,2015-07-23 08:41:42,United States,About Medtech,https://pbs.twimg.com/profile_images/836351563434090501/P7_dmG2v_normal.jpg,1382,1386,24,13130,AboutMedtech,
1134049078424162304,2020-01-08 23:39:36,"AGIO, EBS, INCY, ALXN, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1215130980828241920,False,0,0,0,0,Newsfilter.io,Incyte's Application for Pemigatinib Gets EMA's Validation $AGIO $EBS $INCY $ALXN https://t.co/F8ED2mILYy,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
772471873539977217,2020-01-08 19:45:06,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1215071967876931584,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/B0CfZJ2qNF,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
1905174829,2020-01-08 18:01:35,,,"miamiroofing162.wordpress.com/2020/01/08/two‚Ä¶, ",1215045915272261635,False,0,0,0,0,WordPress.com,"Two Stocks To Tuck Away: Incyte Corporation (NASDAQ:INCY), Beacon Roofing Supply Inc¬†‚Ä¶ https://t.co/T8oVEadlHb",,,2013-09-25 15:14:33,,Simona J. Johnson,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,43,0,0,122983,Roofing162,
3363291113,2020-01-08 15:30:15,,,"buff.ly/2tzptZO, ",1215007832006889473,False,0,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/1ux2yJNkWp,,,2015-07-06 19:40:06,"Chicago, IL",Julie Lakeview,https://pbs.twimg.com/profile_images/926542318190104576/eZp4RhRN_normal.jpg,897,892,10,17512,LakeviewJulie,
43921687,2020-01-08 15:10:00,,,"buff.ly/2tzptZO, ",1215002737550798848,False,0,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/KbB4cd6prX,,,2009-06-01 13:03:56,"Chicago, IL",BioPharmaDevice,https://pbs.twimg.com/profile_images/841433473588068352/Ab4Ggetb_normal.jpg,2076,1537,78,24549,OneMedWorld,
43921687,2020-01-08 14:30:03,,,"buff.ly/2QTCYeS, pic.twitter.com/y76hTlfEYZ, ",1214992683137196035,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/NPQNOwBrSg https://t.co/y76hTlfEYZ,,,2009-06-01 13:03:56,"Chicago, IL",BioPharmaDevice,https://pbs.twimg.com/profile_images/841433473588068352/Ab4Ggetb_normal.jpg,2076,1537,78,24549,OneMedWorld,photo
3363291113,2020-01-08 13:50:04,,,"buff.ly/2QTCYeS, pic.twitter.com/i6pv2Or8XX, ",1214982620423081984,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/FFWNd4gzXl https://t.co/i6pv2Or8XX,,,2015-07-06 19:40:06,"Chicago, IL",Julie Lakeview,https://pbs.twimg.com/profile_images/926542318190104576/eZp4RhRN_normal.jpg,897,892,10,17512,LakeviewJulie,photo
4505683408,2020-01-08 13:10:02,,,"buff.ly/2QTCYeS, pic.twitter.com/Vu0P7CBNHQ, ",1214972544442421249,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/bNNl8Q1oaa https://t.co/Vu0P7CBNHQ,,,2015-12-16 13:35:24,United States,Christopher Walker,https://pbs.twimg.com/profile_images/859480402775429122/f_L6rKud_normal.jpg,2719,2798,67,28050,risk_averse_,photo
4505683408,2020-01-08 13:10:02,,,"buff.ly/2tzptZO, ",1214972543427325952,False,0,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/7Vy4ZTZmM3,,,2015-12-16 13:35:24,United States,Christopher Walker,https://pbs.twimg.com/profile_images/859480402775429122/f_L6rKud_normal.jpg,2719,2798,67,28050,risk_averse_,
21268553,2020-01-08 13:00:06,,,"stock-market-newsfeed.blogspot.com/2020/01/incyte‚Ä¶, ",1214970046629502979,False,0,0,0,0,SS Auto Tweet App,"Incyte's Application for Pemigatinib Gets EMA's Validation
 https://t.co/g6WD3Kg7VC",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
765563638048395269,2020-01-08 12:50:02,,,"buff.ly/2tzptZO, ",1214967510879129600,False,0,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/gZA1gX8oDA,,,2016-08-16 10:59:29,"Illinois, USA",Financial Carnivores,https://pbs.twimg.com/profile_images/765582076095574016/gWTrUTCM_normal.jpg,1790,1856,113,24792,HowieRegay,
22709198,2020-01-08 12:30:17,,,"buff.ly/2QTCYeS, pic.twitter.com/HXWWrpQinG, ",1214962540708532225,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/OWzXiYUUdi https://t.co/HXWWrpQinG,,,2009-03-03 19:52:54,U.S.,HealthyCarnivores,https://pbs.twimg.com/profile_images/868171389743894529/WidBkAEW_normal.jpg,4585,4591,323,50211,HealthyCarnivor,photo
765563638048395269,2020-01-08 12:10:06,,,"buff.ly/2QTCYeS, pic.twitter.com/RPFPO9Q7y7, ",1214957460353667072,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/c7hh6VzpDF https://t.co/RPFPO9Q7y7,,,2016-08-16 10:59:29,"Illinois, USA",Financial Carnivores,https://pbs.twimg.com/profile_images/765582076095574016/gWTrUTCM_normal.jpg,1790,1856,113,24792,HowieRegay,photo
22709198,2020-01-08 12:00:29,,,"buff.ly/2tzptZO, ",1214955041527865345,False,0,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/vd6V1JwPwo,,,2009-03-03 19:52:54,U.S.,HealthyCarnivores,https://pbs.twimg.com/profile_images/868171389743894529/WidBkAEW_normal.jpg,4585,4591,323,50211,HealthyCarnivor,
3363228003,2020-01-08 11:50:07,,,"buff.ly/2QTCYeS, pic.twitter.com/PqJUUd3LX3, ",1214952434956668929,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/wiJ6zIqkt6 https://t.co/PqJUUd3LX3,,,2015-07-06 19:26:37,,Analysts' Analyst,https://pbs.twimg.com/profile_images/658975687223701504/ORzKekze_normal.jpg,767,821,5,10945,AnalystsAnalyst,photo
3389185084,2020-01-08 11:50:05,,,"buff.ly/2QTCYeS, pic.twitter.com/KvBEbrUeyJ, ",1214952422919098368,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/EdiWa3wpU1 https://t.co/KvBEbrUeyJ,,,2015-07-23 08:41:42,United States,About Medtech,https://pbs.twimg.com/profile_images/836351563434090501/P7_dmG2v_normal.jpg,1382,1386,24,13130,AboutMedtech,photo
3363228003,2020-01-08 11:50:04,,,"buff.ly/2tzptZO, ",1214952420373123072,False,0,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/QywSama73n,,,2015-07-06 19:26:37,,Analysts' Analyst,https://pbs.twimg.com/profile_images/658975687223701504/ORzKekze_normal.jpg,767,821,5,10945,AnalystsAnalyst,
374729426,2020-01-08 08:52:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1099225, pic.twitter.com/bThqMjnlBP, ",1214907731091415040,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on January 2, 2020. View odds for this and other indicators: https://t.co/zGGTuL0q2X #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/bThqMjnlBP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3314135167,2020-01-08 07:24:51,,"jobs, ","goo.gl/fb/NvWiKm, ",1214885678447841285,False,0,0,0,0,Google,#jobs Incyte announces validation by EMA of its MAA for pemigatinib in patients with‚Ä¶ https://t.co/9SHE1GRZkG,,,2015-08-13 02:43:55,,Career Biotech,https://pbs.twimg.com/profile_images/872856527731793920/HqYH3X_9_normal.jpg,110,59,1,35799,CareerBiotech,
2525892205,2020-01-08 06:36:30,"INCY, ","investingnews, ","modernreaders.com/?p=2675777, ",1214873508158885889,False,0,0,0,0,Zapier.com,Morgan Stanley Trims Incyte $INCY Target Price to $83.00  https://t.co/jxRX53uHoi #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1979190776,2020-01-08 06:33:26,"INCY, ",,"tickerreport.com/?p=4937699, ",1214872739271589890,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Neutral Rating Reaffirmed at Royal Bank of Canada https://t.co/cwkS0NycsI,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1889492676,2020-01-08 05:19:03,"INCY, ","Incyte, EuropeanMedicinesAgency, MarketingAuthorizationApplication, Pemigatinib, Cholangiocarcinoma, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1214854018729566209,False,0,0,0,1,Troi URL Plug-in,#Incyte Announces the Validation by the #EuropeanMedicinesAgency of its #MarketingAuthorizationApplication for #Pemigatinib in Patients with #Cholangiocarcinoma $INCY https://t.co/hyJd3G2WG1,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
930803511918411776,2020-01-08 01:36:28,"INCY, ",,"thelincolnianonline.com/?p=3337379, ",1214798001748754432,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Earn FY2024 Earnings of $8.68 Per Share https://t.co/U79hNkPAKC,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2020-01-08 01:06:11,"INCY, ",,"theenterpriseleader.com/?p=2533318, ",1214790383366017025,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Gap Down Following Analyst Downgrade  https://t.co/LCuFv6Modc,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2020-01-08 01:01:35,"INCY, ",,"thelincolnianonline.com/?p=3337110, ",1214789225738113025,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Gap Down After Analyst Downgrade https://t.co/LH4dbCeW1i,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2181281054,2020-01-07 21:44:35,"INCY, ","markets, ","wkrb13.com/?p=1496727, ",1214739649278681090,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Neutral Rating Reaffirmed at Royal Bank of Canada https://t.co/BvfAZX8QJS #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
55654926,2020-01-07 19:11:57,,"cholangiocarcinoma, bileductcancer, curecca, ","investor.incyte.com/news-releases/‚Ä¶, ",1214701235380506625,False,5,0,0,5,Twitter Web App,"Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Pemigatinib in Patients with Cholangiocarcinoma.
https://t.co/0BMkl965Bm
#cholangiocarcinoma #bileductcancer #curecca",,,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,
2266388972,2020-01-07 17:00:27,"INCY, ","stocks, ","dailypolitical.com/?p=3310013, ",1214668143739768841,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $107.00 at Goldman Sachs Group https://t.co/ADeQJa6TqI #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-01-07 17:00:26,"INCY, ",,"dailypolitical.com/?p=3310013, ",1214668141135048705,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $107.00 at Goldman Sachs Group https://t.co/PwMLHHTvII,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2181281054,2020-01-07 17:00:11,"INCY, ","markets, ","wkrb13.com/?p=1496133, ",1214668075620024320,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $107.00 at Goldman Sachs Group https://t.co/cksXRGvBx3 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
68559732,2020-01-07 17:00:03,"INCY, ",,"zpr.io/tMT88, ",1214668043667816450,False,0,0,0,0,Zapier.com,Credit Suisse Group Cuts Incyte $INCY Price Target to $86.00 https://t.co/5IHyCAHNUC,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2920258887,2020-01-07 16:57:16,"INCY, ",,"dakotafinancialnews.com/?p=1421639, ",1214667342132723712,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $99.00 at JMP Securities https://t.co/jJmvRs2MVn,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
849417718642159616,2020-01-07 16:52:53,"INCY, ",,"zpr.io/tMTuV, ",1214666240578465794,False,0,0,0,0,Zapier.com,Cantor Fitzgerald Lowers Incyte $INCY Price Target to $65.00 https://t.co/1QDn4PCj82,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
72928001,2020-01-07 12:22:57,"INCY, ",,"bit.ly/2ZWOQkh, ",1214598308028661760,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte announces the validation by the European Medicines Agency of its marketing authorization application... https://t.co/eX70Q0EiSm,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
1100450877792370688,2020-01-07 10:08:57,"INCY, ",,"blueequity.io/r/79538/de-inc‚Ä¶, ",1214564588101914629,False,0,0,0,0,Blue Equity,$INCY Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Pemigatinib in Patients with Cholangiocarcinoma https://t.co/DxmazCpw4S,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
963495628545327104,2020-01-07 09:57:11,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/BeT40XSVIz, ",1214561624469561348,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Better Buy: Geron vs. Incyte https://t.co/CtPwZOfEne Get all the latest $INCY related news here : https://t.co/Y7ZKRzZCpd https://t.co/BeT40XSVIz,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
374729426,2020-01-07 09:56:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1096899, pic.twitter.com/VyjeaO5G0v, ",1214561537202909188,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on January 2, 2020. View odds for this and other indicators: https://t.co/uIhkwQsGNF #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/VyjeaO5G0v",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3686628867,2020-01-07 09:52:30,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1214560446612533248,False,0,0,0,0,WordPress.com,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Pemigatinib in Patients with Cholangiocarcinoma https://t.co/wlxqAtVSiP,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
1979190776,2020-01-07 09:39:23,"INCY, ",,"tickerreport.com/?p=4934129, ",1214557145661923328,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $80.00 by Analysts at Royal Bank of Canada https://t.co/xmomXjX87m,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
966006214818697218,2020-01-07 09:37:36,"INCY, ",,"theenterpriseleader.com/?p=2531974, ",1214556697571651584,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $80.00 by Analysts at Royal Bank of Canada  https://t.co/wnLRni2Wtz,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
135209476,2020-01-07 08:31:42,"INCY, ",,"stockflare.com/stock/INCY.O, ",1214540112559853568,False,0,0,0,0,Stockflare Bot (Prod),$INCY: The target price for Incyte Corporation has fallen to $88.6 from $95.0 in the last week. (https://t.co/sK8NyKCUuN),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
72928001,2020-01-07 08:01:54,"INCY, ",,"bit.ly/2ZWOQkh, ",1214532614880518144,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte announces the validation by the European Medicines Agency of its marketing authorization application... https://t.co/eX70Q0VTJU,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
472650465,2020-01-07 06:43:50,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1214512965577330689,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application https://t.co/qZW1fHkgwd,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
3318510966,2020-01-07 06:17:41,,,"crweworld.com/article/news-p‚Ä¶, ",1214506385586585601,False,0,0,0,0,CRWE World,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Pemi https://t.co/vqCc55n8rD,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
126416038,2020-01-07 06:04:36,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1214503094903545862,False,0,0,0,1,Twitter for iPhone,$INCY Announces the Validation by the EMA of its MAA for Pemigatinib in Patients with Cholangiocarcinoma  https://t.co/e9lZnI3i6N,,,2010-03-25 16:17:38,Tel Aviv,Odi Bruckman,https://pbs.twimg.com/profile_images/1182595151899836417/Y4fMBMd5_normal.jpg,14629,185,415,30356,odibro,
1525137691,2020-01-07 06:03:33,,,"bioportfol.io/RMZbQl, ",1214502830779691011,False,0,0,0,1,dlvr.it,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Pemigatinib in Patients with Cholangiocarcinoma: Incyte NasdaqINCY today announced the validation of the Companys Marketing Authorization‚Ä¶ https://t.co/ejNslII8XQ,,,2013-06-17 11:21:24,,Renal Cell Carcinoma,https://pbs.twimg.com/profile_images/656427745304530945/qbgWaiHn_normal.png,341,12,5,45347,Renal_Bio,
976297820532518914,2020-01-07 06:02:11,,,"dlvr.it/RMZb9d, pic.twitter.com/L0MPzVwQPG, ",1214502484728631296,False,0,0,0,0,dlvr.it,Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Pemigatinib in Patients with Cholangiocarcinoma https://t.co/OPxnfjSXe2 https://t.co/L0MPzVwQPG,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1134049078424162304,2020-01-07 05:19:16,"INCY, ",,"newsfilter.io/articles/jmp-s‚Ä¶, ",1214491682944831488,False,0,0,0,0,Newsfilter.io,JMP Securities Cuts Incyte Price Target to $99.00 $INCY https://t.co/h0NBayPbc1,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
1134049078424162304,2020-01-07 04:50:15,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1214484382213459968,False,0,0,0,0,Newsfilter.io,Incyte PT Lowered to $86.00 at Credit Suisse Group $INCY https://t.co/OBxHX6MVw4,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
1979190776,2020-01-07 04:05:50,"INCY, ",,"tickerreport.com/?p=4932880, ",1214473206435893248,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Sell at BidaskClub https://t.co/byuGXNSb0N,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2298709746,2020-01-07 04:02:04,"INCY, ",,"zpr.io/tMGcQ, ",1214472256958676992,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Sell at BidaskClub https://t.co/VQWaXr5TmK,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1134049078424162304,2020-01-07 02:10:07,"INCY, ",,"newsfilter.io/articles/analy‚Ä¶, ",1214444083160211456,False,0,0,0,0,Newsfilter.io,Analysts Anticipate Incyte Will Post Quarterly Sales of $569.75 Million $INCY https://t.co/Ln2vPve8PT,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
918188324426194944,2020-01-07 02:06:43,,,"rviv.ly/A7eZpn, ",1214443227962658816,False,0,0,0,0,Revive Social App,"Better Buy: Inovio Pharmaceuticals, Inc. vs. Incyte Corporation Inovio Pharmaceuticals, Inc. (NASDAQ: INO) and https://t.co/gz7fqyRlf0",,,2017-10-11 14:55:30,"El Dorado Hills, CA",Free America Network,https://pbs.twimg.com/profile_images/918257391199588352/MRMPkfSa_normal.jpg,95,136,3,121507,stand_4_america,
1979190776,2020-01-07 01:31:04,"INCY, ",,"tickerreport.com/?p=4932564, ",1214434255968845826,False,0,0,0,0,Zapier.com,"Incyte Co. to Post FY2024 Earnings of $8.68 Per Share, Oppenheimer Forecasts $INCY https://t.co/a5SONr7Oqy",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1979190776,2020-01-07 01:26:23,"INCY, ",,"tickerreport.com/?p=4932529, ",1214433078061535232,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Gap Down After Analyst Downgrade https://t.co/lD2wXlBAId,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2416188264,2020-01-07 00:06:41,"INCY, ","markets, ","thestockobserver.com/?p=2534407, ",1214413022804037633,False,0,0,0,0,Zapier.com,Analysts Anticipate Incyte Co. $INCY Will Post Quarterly Sales of $569.75 Million  https://t.co/jlUh2wF4Uv #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2020-01-07 00:05:08,"INCY, ",,"zpr.io/tMfbk, ",1214412631118888960,False,0,0,0,0,Zapier.com,$569.75 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/iMjV17QIIN,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
75639425,2020-01-06 17:10:00,,,"buff.ly/2tzptZO, ",1214308160527360003,False,0,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/OOaBgo6PiQ,,,2009-09-19 16:50:15,Chicago Region,Chelli Miller,https://pbs.twimg.com/profile_images/459756204206469120/EfGbLSm5_normal.jpeg,6871,6956,482,134749,cmiller1225,
950010035396136962,2020-01-06 17:01:11,,"Incyte, ",,1214305939576250368,False,0,0,0,0,Cresus AI,#Incyte closed at 77.34. Anguish and fear index +57. Ploutos says: TR A EBITDA C Net C Debt B üëé Use at your own risk,,,2018-01-07 09:23:37,,Cresus AI,https://pbs.twimg.com/profile_images/1350195034738589697/MyfBCkTb_normal.jpg,28,12,1,9022,cresus_ai,
1120631024306802688,2020-01-06 13:50:02,"INCY, ","STOCKS, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, markets.dataswarm.tech, ",1214257833941880832,False,0,0,0,0,DataSwarm Markets,"$INCY We have detected a noticeable change in the Zeitgeist for Incyte Corporation at  https://t.co/OxItqO0RgL
Visit https://t.co/ApK6iYCrer for more information
#STOCKS #NASDAQ
DataSwarm ref: 83916",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
2525892205,2020-01-06 13:44:16,"INCY, ","investingnews, ","modernreaders.com/?p=2669961, ",1214256385837453312,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Gap Down After Analyst Downgrade  https://t.co/MYE8dhZD8Z #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2020-01-06 13:35:38,"INCY, ","markets, ","americanbankingnews.com/?p=12979115, ",1214254210847522823,False,0,0,0,0,Zapier.com,Royal Bank of Canada Reiterates Neutral Rating for Incyte $INCY https://t.co/fX7AhY0O2W #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-06 13:35:37,"INCY, ","stocks, ","americanbankingnews.com/?p=12979115, ",1214254208045780993,False,0,0,0,0,Zapier.com,Royal Bank of Canada Reiterates Neutral Rating for Incyte $INCY https://t.co/qLvW35XWbk #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
524772210,2020-01-06 12:32:23,,,"ow.ly/UR1A1025C2d, pic.twitter.com/MfOBkplU1j, ",1214238295800057856,False,0,0,0,0,Hootsuite Inc.,Incyte JAK1 inhibitor misses the mark in GVHD trial https://t.co/cBXLBGyXhb https://t.co/MfOBkplU1j,,,2012-03-14 18:00:41,"Washington, DC",Saleh Stevens,https://pbs.twimg.com/profile_images/756531629997363202/qImEbsOr_normal.jpg,11393,354,5,3084,SalehStevens,photo
1017610177141526528,2020-01-06 11:53:50,,,"bit.ly/2NaOZxi, ",1214228594211348481,False,0,0,0,0,AutoPostingFromHealthCare,Trial failure keeps Incyte searching for its next act... https://t.co/sIo4TsgZQ5,,,2018-07-12 23:22:27,"New York, NY",HEALTHCARE REPORT,https://pbs.twimg.com/profile_images/1042889061478932480/WFoyrJtF_normal.jpg,67,34,0,12613,HCREPORT2022,
52354784,2020-01-06 11:31:12,,"lifesciences, pharma, ","pharmatimes.com/news/incyte_ja‚Ä¶, ",1214222898585636865,False,0,0,0,0,SocialPilot.co,Incyte JAK1 inhibitor misses the mark in GVHD trial https://t.co/TPUsKKA7Xq #lifesciences #pharma,,,2009-06-30 05:46:48,"Surrey, UK",PharmaTimes,https://pbs.twimg.com/profile_images/533273520885616640/vb4_MuJ1_normal.png,53067,1318,1008,19444,PharmaTimes,
59310742,2020-01-06 11:06:32,,,"dlvr.it/RMX6PY, pic.twitter.com/zQ8O9xUpDO, ",1214216688884862977,False,0,0,0,0,dlvr.it,Incyte JAK1 inhibitor misses the mark in GVHD trial https://t.co/a24AZYzuLd https://t.co/zQ8O9xUpDO,,,2009-07-22 20:57:49,ANZ,David Ledger,https://pbs.twimg.com/profile_images/621209163566182400/AWY0hAql_normal.jpg,826,1827,26,25935,Vedere_Group,photo
402176451,2020-01-06 10:29:31,,,"pharmaphorum.com/?p=62843, ",1214207373444710402,False,0,0,0,0,Twitter Web Client,Incyte‚Äôs JAK inhibitor for GVHD fails phase 3 trial https://t.co/T2ZAcxjQYa via @pharmaphorum,"pharmaphorum, ",,2011-10-31 13:26:07,UNITED STATES/E.U,DR.ARUN ACHUTHAN,https://pbs.twimg.com/profile_images/3610646307/5744f501931ec8d64d0f833db704150f_normal.jpeg,721,4322,5,21211,DOCTORHELLOW8YM,
985090779965255681,2020-01-06 10:03:39,"INCY, ","stocks, StockTrading, SwingTrading, PositionTrading, StockCharts, TradeIdeas, Aktien, B√∂rse, ChartBargain, ","pic.twitter.com/8buxRRtqc3, ",1214200866112245767,False,0,0,0,0,Twitter Web Client,"Chart-Bargain-Trade: Incyte 
#stocks #StockTrading #SwingTrading #PositionTrading
#StockCharts #TradeIdeas #Aktien #B√∂rse #ChartBargain $INCY https://t.co/8buxRRtqc3",,,2018-04-14 05:41:58,,Stock-ETF-CFD and Crypto-Trader,https://pbs.twimg.com/profile_images/1180123345708355586/8-73rSGH_normal.jpg,2972,4914,0,24012,AktienTrader1,photo
76913784,2020-01-06 09:48:00,,"trial, pharma, ","bit.ly/2QR7NRi, ",1214196924313735168,False,0,0,0,0,Semrush Social Media Tool,Incyte‚Äôs JAK inhibitor for GVHD fails phase 3 #trial https://t.co/iVDRntHMda #pharma,,,2009-09-24 07:10:21,UK,Cpl Life Sciences,https://pbs.twimg.com/profile_images/1321422353969090561/TxMp7fL7_normal.jpg,1611,417,129,10431,CPLLifeSciences,
732361939490312192,2020-01-06 09:35:47,"INCY, ","markets, ","americanbankingnews.com/?p=12977685, ",1214193852581580801,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $83.00 https://t.co/eTzKaCksCR #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-06 09:35:35,"INCY, ","stocks, ","americanbankingnews.com/?p=12977685, ",1214193801679519744,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $83.00 https://t.co/PVIXRZHaLR #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
930803511918411776,2020-01-06 09:32:28,"INCY, ",,"thelincolnianonline.com/?p=3332641, ",1214193016254152705,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $83.00 at Morgan Stanley https://t.co/s3zFGD2G7r,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2298709746,2020-01-06 09:29:58,"INCY, ",,"zpr.io/tEQQv, ",1214192388110999552,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $83.00 at Morgan Stanley https://t.co/XyceOofqPg,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
374729426,2020-01-06 09:20:43,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1091569, pic.twitter.com/jTHHlpyphV, ",1214190061459136513,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on January 2, 2020. View odds for this and other indicators: https://t.co/PwupcWevjI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/jTHHlpyphV",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2298709746,2020-01-06 08:52:55,"INCY, ",,"zpr.io/tEQFf, ",1214183064319987712,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $80.00 Price Target at Royal Bank of Canada https://t.co/lyVEKbPb3A,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
16505200,2020-01-06 08:47:04,,"economy, ","seekingalpha.com/article/431531‚Ä¶, ",1214181590697467904,False,0,0,0,0,Paper.li,"Incyte: Looking More Appealing, Yet Pipeline Conversion Is Required https://t.co/W3Yc9996GV #economy",,,2008-09-28 20:43:30,"Fort Worth, TX",Frank Gustafson,https://pbs.twimg.com/profile_images/1443357533436055557/j4zOX8RC_normal.jpg,5912,5500,249,26573,SandlerFtW,
852931863547084801,2020-01-06 08:36:03,"INCY, ",,"zpr.io/tEQAm, ",1214178817989890048,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $86.00 Price Target at Credit Suisse Group https://t.co/MM2UBrl51K,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
2266388972,2020-01-06 08:35:44,"INCY, ","stocks, ","dailypolitical.com/?p=3308864, ",1214178738428108800,False,0,0,0,0,Zapier.com,Oppenheimer Cuts Incyte $INCY Price Target to $96.00 https://t.co/TabCC6sDqG #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-01-06 08:35:43,"INCY, ",,"dailypolitical.com/?p=3308864, ",1214178734955204609,False,0,0,0,0,Zapier.com,Oppenheimer Cuts Incyte $INCY Price Target to $96.00 https://t.co/IpvPpJerll,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2416188264,2020-01-06 08:35:25,"INCY, ","markets, ","thestockobserver.com/?p=2533606, ",1214178658560233474,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $86.00 at Credit Suisse Group  https://t.co/HXIKUTBEwP #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2416188264,2020-01-06 08:00:55,"INCY, ","markets, ","thestockobserver.com/?p=2533579, ",1214169976325758977,False,0,0,0,0,Zapier.com,JMP Securities Cuts Incyte $INCY Price Target to $99.00  https://t.co/an441UVQuR #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2181281054,2020-01-06 08:00:54,"INCY, ","markets, ","wkrb13.com/?p=1494950, ",1214169974824198145,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $74.00 https://t.co/nv57eJp4UK #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
852931863547084801,2020-01-06 07:59:36,"INCY, ",,"zpr.io/tEQtk, ",1214169647584600066,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $99.00 at JMP Securities https://t.co/Vyx0fCelrI,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
2266388972,2020-01-06 07:59:34,"INCY, ","stocks, ","dailypolitical.com/?p=3308838, ",1214169637157511168,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $65.00 https://t.co/KgeU2Ye1Tt #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-01-06 07:59:33,"INCY, ",,"dailypolitical.com/?p=3308838, ",1214169633294618624,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $65.00 https://t.co/gM1GCzHXFZ,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2920258887,2020-01-06 07:58:52,"INCY, ",,"dakotafinancialnews.com/?p=1420466, ",1214169463727230976,False,0,0,0,0,Zapier.com,Citigroup Reaffirms Outperform Rating for Incyte $INCY https://t.co/ZzjyCLLWeZ,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
849417718642159616,2020-01-06 07:56:56,"INCY, ",,"zpr.io/tEQ6J, ",1214168976760201216,False,0,0,0,0,Zapier.com,Citigroup Reaffirms Outperform Rating for Incyte $INCY https://t.co/EvrPKYHwdF,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
27254739,2020-01-06 06:52:06,,"pharmanews, ","bit.ly/2twqKk8, ",1214152661030838272,False,0,0,0,0,Sprout Social,".@Incyte's JAK1 inhibitor itacitinib has failed a key trial in graft-versus-host disease (GVHD), marking another setback for a company in need of more drug successes https://t.co/VPi97bceyP #pharmanews","Incyte, ",,2009-03-28 12:12:42,"London, England",pharmaphorum,https://pbs.twimg.com/profile_images/893437018683969536/KNCE8GMU_normal.jpg,22040,3344,956,61673,pharmaphorum,
17960461,2020-01-06 04:51:35,,"pharma, ","bit.ly/2SVR0it, pic.twitter.com/A2toJZbZYR, ",1214122330567462912,False,0,0,0,0,Twitter Web App,Incyte's drug stumbles at Phase 3 in treatment-naive acute graft-versus-host disease https://t.co/ieMV0IiMnN #pharma https://t.co/A2toJZbZYR,,,2008-12-08 05:47:08,"London, UK",Pharmafocus,https://pbs.twimg.com/profile_images/810864550056775680/ENXFWwlP_normal.jpg,46724,1866,1027,26383,Pharmafocus,photo
3901351277,2020-01-06 04:50:30,,"pharmaceutical, ","bit.ly/39Ew1qB, ",1214122057333714944,False,0,0,0,0,IFTTT,Incyte's drug stumbles at Phase 3 in treatment-naive acute graft-versus-host disease : https://t.co/H1BBCffjSm #pharmaceutical,,,2015-10-08 13:19:34,,Jon Angelo,https://pbs.twimg.com/profile_images/652186977761161216/l7fkWqhO_normal.jpg,157,67,66,29158,healthcarejon,
2298709746,2020-01-06 04:18:14,"INCY, ",,"zpr.io/tEVvf, ",1214113935554678785,False,0,0,0,0,Zapier.com,ValuEngine Upgrades Incyte $INCY to ‚ÄúHold‚Äù https://t.co/k1mTsMd9NF,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1979190776,2020-01-06 04:16:58,"INCY, ",,"tickerreport.com/?p=4929918, ",1214113620516315137,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded at ValuEngine https://t.co/OQk3ALRCF2,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
849417718642159616,2020-01-06 03:47:23,"INCY, ",,"zpr.io/tEVC6, ",1214106173068197888,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded to ‚ÄúNeutral‚Äù at Mizuho https://t.co/A9IMzJ4BkY,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2266388972,2020-01-06 03:46:55,"INCY, ","stocks, ","dailypolitical.com/?p=3308689, ",1214106057645187072,False,0,0,0,0,Zapier.com,Piper Jaffray Companies Reiterates Buy Rating for Incyte $INCY https://t.co/DkqsfkIYLo #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-01-06 03:46:55,"INCY, ",,"dailypolitical.com/?p=3308689, ",1214106055409573888,False,0,0,0,0,Zapier.com,Piper Jaffray Companies Reiterates Buy Rating for Incyte $INCY https://t.co/Hqr6DSx6rF,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
68559732,2020-01-06 03:46:40,"INCY, ",,"zpr.io/tEVFb, ",1214105995410051072,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reaffirmed at Cowen https://t.co/HeA4k5xBMt,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1134049078424162304,2020-01-06 03:46:38,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1214105985142468610,False,0,0,0,0,Newsfilter.io,Incyte Downgraded to ‚ÄúNeutral‚Äù at Mizuho $INCY https://t.co/5lhPhrt1s6,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
2416188264,2020-01-06 03:45:30,"INCY, ","markets, ","thestockobserver.com/?p=2533436, ",1214105698247827456,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded to ‚ÄúNeutral‚Äù at Mizuho  https://t.co/tyrYfObKOd #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2181281054,2020-01-06 03:43:28,"INCY, ","markets, ","wkrb13.com/?p=1494812, ",1214105187780059137,False,0,0,0,0,Zapier.com,Piper Jaffray Companies Reiterates Buy Rating for Incyte $INCY https://t.co/MAhPUxQum7 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
849417718642159616,2020-01-06 02:26:12,"INCY, ",,"zpr.io/tEVtV, ",1214085745155198977,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by Guggenheim https://t.co/TGHos1W5k5,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1134049078424162304,2020-01-06 02:25:38,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1214085601240199168,False,0,0,0,0,Newsfilter.io,Incyte Downgraded by Guggenheim $INCY https://t.co/0srjUQ0d8N,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
2416188264,2020-01-06 02:25:02,"INCY, ","markets, ","thestockobserver.com/?p=2533377, ",1214085448487882752,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by Guggenheim  https://t.co/6phbbhBDO3 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
750646032258793472,2020-01-06 02:24:30,,,"endpts.com/incyte-takes-a‚Ä¶, ",1214085314031079424,False,0,0,0,0,Twitter Web Client,Incyte takes a beating as a key PhIII study flops in their latest painful setback ‚Äî blockbuster hopes crushed - https://t.co/HX4o65OCVa,,,2016-07-06 07:02:15,"Paris, France",Mazars,https://pbs.twimg.com/profile_images/1238543616617963521/RBlZCFrU_normal.jpg,114,616,22,8618,CrMazars,
732361939490312192,2020-01-06 01:35:29,"INCY, ","markets, ","americanbankingnews.com/?p=12975990, ",1214072980239736832,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY to Post FY2024 Earnings of $8.68 Per Share, Oppenheimer Forecasts https://t.co/m9fwDORW6s #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-06 01:35:28,"INCY, ","stocks, ","americanbankingnews.com/?p=12975990, ",1214072976779468800,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY to Post FY2024 Earnings of $8.68 Per Share, Oppenheimer Forecasts https://t.co/ssjrsIcbUu #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
966006214818697218,2020-01-06 01:32:38,"INCY, ",,"theenterpriseleader.com/?p=2527375, ",1214072262363623424,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY to Post FY2024 Earnings of $8.68 Per Share, Oppenheimer Forecasts  https://t.co/47aTxMYpdB",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
354537587,2020-01-06 01:02:08,,,"dlvr.it/RMVcDL, ",1214064587693182976,True,0,0,0,1,dlvr.it,"Incyte: Looking More Appealing, Yet Pipeline Conversion Is Required https://t.co/MoDXUNAeRA",,,2011-08-13 18:02:26,,George Mentz JD MBA CWM,https://pbs.twimg.com/profile_images/645305436032229376/OLzZNOQD_normal.png,169213,798,54,280565,GeorgeMentz,
3735644601,2020-01-06 00:16:01,,,"easytradingsignals.com/incyte-looking‚Ä¶, pic.twitter.com/tlz9hd9oOR, ",1214052981735395329,False,0,0,0,0,WordPress.com,"Incyte: Looking More Appealing, Yet Pipeline Conversion Is Required ‚Äì Incyte Corporation¬†(NASDAQ:INCY) https://t.co/S2H3J2N9p0 https://t.co/tlz9hd9oOR",,,2015-09-22 01:32:31,"California, USA",Sam Schout,https://pbs.twimg.com/profile_images/646196186924236800/hvey9RYD_normal.png,733,392,5,9744,easytradingsign,photo
1134049078424162304,2020-01-06 00:15:37,"LLY, NVS, INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1214052881789313025,False,0,0,0,1,Newsfilter.io,"Incyte: Looking More Appealing, Yet Pipeline Conversion Is Required $LLY $NVS $INCY https://t.co/0ceh8QE2Ws",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
963495628545327104,2020-01-06 00:12:02,"LLY, NVS, INCY, LLY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1214051979925823488,False,0,0,0,1,STCK.PR0,"$LLY $NVS $INCY NEW ARTICLE : Incyte: Looking More Appealing, Yet Pipeline Conversion Is Required https://t.co/W4YBgMsF3O Get all the latest $LLY related news here : https://t.co/qIevRwib66",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
23059499,2020-01-06 00:09:54,"INCY, ","economy, finance, business, ","seekingalpha.com/article/431531‚Ä¶, ",1214051444124340229,False,0,0,0,0,SAArticlesTwitter,"$INCY - Incyte: Looking More Appealing, Yet Pipeline Conversion Is Required. Read more: https://t.co/2tATINvLH0 #economy #finance #business",,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
57168970,2020-01-05 20:30:03,"DO, OXY, INCY, AAL, ","DO, OXY, INCY, AAL, ","pic.twitter.com/4qVUAqQNCx, ",1213996115755974656,False,0,0,0,1,Buffer,"For week ending Jan. 3, industrials (defense &amp; aero) gained the most while real estate lost the most. 
Top performers in S&amp;P 500 were: 
Diamond Off. +12%
Occidental Pet. +9%
Bottom performers in S&amp;P 500 were: 
Incyte  -12%
Amer. Air. -7%
$DO $OXY $INCY $AAL #DO #OXY #INCY #AAL https://t.co/4qVUAqQNCx",,,2009-07-15 19:13:18,"Sugar Land, TX","Sam Subramanian PhD, MBA",https://pbs.twimg.com/profile_images/315719088/sambio110110_normal.jpg,139,250,5,1558,SamSubramanian,photo
1204967326543699968,2020-01-05 17:31:17,"INCY, ",,,1213951127013724160,False,0,0,0,1,stocksoftheday,$INCY Incyte Corp is falling fast! It's down -9.39% today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
823977635768365056,2020-01-05 17:10:00,,,"buff.ly/2tzptZO, ",1213945772850458630,False,0,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/9z6tTpWvla,,,2017-01-24 14:35:51,United States,InvestmentCupboard,https://pbs.twimg.com/profile_images/1285609482974879744/EdXS07f6_normal.jpg,1039,1061,16,12149,InvstmtCupboard,
823977635768365056,2020-01-05 14:50:02,,,"buff.ly/2QTCYeS, pic.twitter.com/tsjbLqMay5, ",1213910547512668160,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/x4ix7EP0uh https://t.co/tsjbLqMay5,,,2017-01-24 14:35:51,United States,InvestmentCupboard,https://pbs.twimg.com/profile_images/1285609482974879744/EdXS07f6_normal.jpg,1039,1061,16,12149,InvstmtCupboard,photo
3363332327,2020-01-05 13:50:01,,,"buff.ly/2tzptZO, ",1213895442972512256,False,0,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/5739h6cKuz,,,2015-07-06 20:15:16,"Stockholm, Sweden",Swedish Biotech,https://pbs.twimg.com/profile_images/825044879411650560/BVzozrPt_normal.jpg,2794,2365,25,25407,BiotechSweden,
1259694398,2020-01-05 11:50:02,,,"buff.ly/2tzptZO, ",1213865247993475072,False,1,0,0,0,Buffer,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/haFMvtvN2g,,,2013-03-11 11:12:50,Chicago,CarnivoresHealth,https://pbs.twimg.com/profile_images/820845362705481728/eSMZRJDT_normal.jpg,6197,6134,509,55396,HealthierIT,
374729426,2020-01-05 11:09:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1089499, pic.twitter.com/chs5jOH02K, ",1213855052059697152,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on January 2, 2020. View odds for this and other indicators: https://t.co/0KV5BbUWze #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/chs5jOH02K",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
14453501,2020-01-05 10:39:33,,,"delawarebusinessnow.com/2020/01/incyte‚Ä¶, ",1213847511145885701,True,0,0,0,0,WordPress.com,Incyte reports disappointing results in late stage drug¬†trial https://t.co/itQtrHDg2S,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
1259694398,2020-01-05 10:10:01,,,"buff.ly/2QTCYeS, pic.twitter.com/tH18G9mOE5, ",1213840080265240577,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/NontMUEk7V https://t.co/tH18G9mOE5,,,2013-03-11 11:12:50,Chicago,CarnivoresHealth,https://pbs.twimg.com/profile_images/820845362705481728/eSMZRJDT_normal.jpg,6197,6134,509,55396,HealthierIT,photo
2298709746,2020-01-05 10:07:40,"INCY, ",,"zpr.io/tEdwE, ",1213839488423727106,False,0,0,0,0,Zapier.com,JMP Securities Lowers Incyte $INCY Price Target to $99.00 https://t.co/SAolZakOUn,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2525892205,2020-01-05 10:05:46,"INCY, ","investingnews, ","modernreaders.com/?p=2666419, ",1213839008045948928,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $65.00  https://t.co/QpIjsjpV0G #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1979190776,2020-01-05 10:04:11,"INCY, ",,"tickerreport.com/?p=4928275, ",1213838610803363841,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $99.00 https://t.co/0GPvEDmJfP,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1979190776,2020-01-05 10:04:10,"INCY, ",,"tickerreport.com/?p=4928276, ",1213838606558732288,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $107.00 Price Target at Goldman Sachs Group https://t.co/qWyFgYMxYs,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
966006214818697218,2020-01-05 10:03:01,"INCY, ",,"theenterpriseleader.com/?p=2526185, ",1213838315557998592,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Citigroup  https://t.co/Tsr1U4r9hi,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
3363332327,2020-01-05 09:50:02,,,"buff.ly/2QTCYeS, pic.twitter.com/yqp7cSv34Y, ",1213835047863824387,False,0,0,0,0,Buffer,Trial failure keeps Incyte searching for its next act https://t.co/GfYcjSCrBu https://t.co/yqp7cSv34Y,,,2015-07-06 20:15:16,"Stockholm, Sweden",Swedish Biotech,https://pbs.twimg.com/profile_images/825044879411650560/BVzozrPt_normal.jpg,2794,2365,25,25407,BiotechSweden,photo
930803511918411776,2020-01-05 09:20:04,"INCY, ",,"thelincolnianonline.com/?p=3329640, ",1213827508405182464,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $80.00 https://t.co/JYKN5HjBeQ,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
3549429319,2020-01-05 08:34:51,,"news, ","latesttoday.news/2020/01/03/bus‚Ä¶, ",1213816131040841730,False,0,0,0,0,Revive Social App,Incyte Stock Collapses After Graft Vs. Host Disease Treatment Fails ‚Äì Investor's Business Daily https://t.co/clwDhNnMyz #news,,,2015-09-13 09:07:51,America,Today's news summary,https://pbs.twimg.com/profile_images/1303326591678775296/uX9wI_0D_normal.jpg,280,1140,1,257461,k29664911,
2920258887,2020-01-05 06:35:53,"INCY, ",,"dakotafinancialnews.com/?p=1419705, ",1213786189704110081,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at Cowen https://t.co/AcmbObaify,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
849417718642159616,2020-01-05 06:35:34,"INCY, ",,"zpr.io/tEJ85, ",1213786110066868224,False,0,0,0,0,Zapier.com,Cowen Reiterates Buy Rating for Incyte $INCY https://t.co/6j8SW7oC4G,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
917639060,2020-01-05 02:58:49,,,"fiercebiotech.com/biotech/incyte‚Ä¶, ",1213731564745625601,False,1,0,0,0,Twitter for iPad,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/L3t4u7Rggr,,,2012-10-31 16:48:41,,FarmaOnco,https://pbs.twimg.com/profile_images/2930931336/c5ed1efcf9ddf36d4803c1ab88604f4f_normal.jpeg,2531,1142,102,21767,FarmaOnco,
1120631024306802688,2020-01-05 01:25:02,"INCY, ","STOCKS, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, markets.dataswarm.tech, ",1213707962532990976,False,0,0,0,0,DataSwarm Markets,"$INCY We have detected a noticeable change in the Zeitgeist for Incyte Corporation at  https://t.co/OxItqO0RgL
Visit https://t.co/ApK6iYCrer for more information
#STOCKS #NASDAQ
DataSwarm ref: 83703",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
1979190776,2020-01-05 01:20:29,"INCY, ",,"tickerreport.com/?p=4926433, ",1213706818008100864,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Price Down 9.4% on Analyst Downgrade https://t.co/XW85FNtiTe,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2525892205,2020-01-05 01:17:02,"INCY, ","investingnews, ","modernreaders.com/?p=2664559, ",1213705947803246592,False,0,0,0,0,Zapier.com,Incyte $INCY Shares Down 9.4% Following Analyst Downgrade  https://t.co/y13BpXvm14 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
3113963440,2020-01-04 18:05:33,,,"dlvr.it/RMRdWj, pic.twitter.com/JHUgDkBf9n, ",1213597361697460224,False,0,0,0,0,dlvr.it,Incyte takes a beating as a key PhIII study flops in their latest painful setback ‚Äî blockbuster hopes crushed https://t.co/mOLcMBbHkl https://t.co/JHUgDkBf9n,,,2015-03-25 04:40:13,,Thomas S√©n√©chal,https://pbs.twimg.com/profile_images/654316411158982656/T0ScIvOH_normal.jpg,19,137,0,529,Toto_Chal,photo
1204967326543699968,2020-01-04 17:31:15,"INCY, ",,,1213588729128013824,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is falling fast! It's down -9.39% today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
374729426,2020-01-04 11:54:43,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1085660, pic.twitter.com/3QeHPQ5G5Z, ",1213504040098623488,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on January 2, 2020. View odds for this and other indicators: https://t.co/qceeNGy4jY #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/3QeHPQ5G5Z",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2920258887,2020-01-04 11:20:53,"INCY, ",,"dakotafinancialnews.com/?p=1418741, ",1213495524583727105,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $80.00 Price Target at Royal Bank of Canada https://t.co/icsOlKlC8f,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
849417718642159616,2020-01-04 11:17:22,"INCY, ",,"zpr.io/tE299, ",1213494639153598464,False,0,0,0,0,Zapier.com,Royal Bank of Canada Lowers Incyte $INCY Price Target to $80.00 https://t.co/3iWpYkD9Sw,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
966006214818697218,2020-01-04 10:55:24,"INCY, ",,"theenterpriseleader.com/?p=2524157, ",1213489113896292354,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $74.00 Price Target at BMO Capital Markets  https://t.co/noE4zNgBwL,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
966006214818697218,2020-01-04 10:55:24,"INCY, ",,"theenterpriseleader.com/?p=2524160, ",1213489112352722944,False,0,0,0,0,Zapier.com,Goldman Sachs Group Lowers Incyte $INCY Price Target to $107.00  https://t.co/52Gq1hrr75,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2020-01-04 10:54:30,"INCY, ",,"thelincolnianonline.com/?p=3327882, ",1213488886292369409,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $65.00 at Cantor Fitzgerald https://t.co/LRQayQfvdq,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
930803511918411776,2020-01-04 10:54:28,"INCY, ",,"thelincolnianonline.com/?p=3327890, ",1213488878805487616,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $74.00 Price Target at BMO Capital Markets https://t.co/LKQaLpbhv1,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-01-04 10:53:09,"INCY, ",,"tickerreport.com/?p=4926248, ",1213488547392565254,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Outperform Rating Reaffirmed at Citigroup https://t.co/8jkP8mAl8M,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1979190776,2020-01-04 10:53:07,"INCY, ",,"tickerreport.com/?p=4926256, ",1213488539352088576,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $86.00 at Credit Suisse Group https://t.co/B4cpCvz5G4,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
913537855846256640,2020-01-04 10:52:32,,,"dlvr.it/RMQnn6, ",1213488389044883457,False,0,0,0,0,dlvr.it,"Stock Market Rally Continues Into 2020; Tesla, Lockheed martin Soar, Incyte Plunges - Investor's Business Daily: Stock Market Rally Continues Into 2020; Tesla, Lockheed martin Soar, Incyte Plunges¬†¬†Investor's Business Daily https://t.co/BvZtyGMeK6",,,2017-09-28 18:56:12,"Toronto, Ontario",Elly Shobeiriüá®üá¶,https://pbs.twimg.com/profile_images/1162783518147207168/rD0VnU7a_normal.jpg,530,1006,4,56471,EllyShobeiri,
2298709746,2020-01-04 10:52:19,"INCY, ",,"zpr.io/tE2Ee, ",1213488335202791425,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Outperform Rating Reaffirmed at Citigroup https://t.co/5cNfXQ9eGt,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
985090779965255681,2020-01-04 08:46:23,"INCY, ",,"pic.twitter.com/0tb9P0c9m6, ",1213456642794250241,False,0,0,0,1,Twitter Web Client,Incyte: Nice Gap Down. My next Buy. $INCY https://t.co/0tb9P0c9m6,,,2018-04-14 05:41:58,,Stock-ETF-CFD and Crypto-Trader,https://pbs.twimg.com/profile_images/1180123345708355586/8-73rSGH_normal.jpg,2972,4914,0,24012,AktienTrader1,photo
135209476,2020-01-04 07:25:12,"INCY, ",,"stockflare.com/stock/INCY.O, ",1213436212817616902,False,0,0,0,0,Stockflare Bot (Prod),"$INCY: Incyte Corporation's forecast earnings moved 0.0% over the last week, but the price is -11.9%. It's PE ratio is now 28x earnings. (https://t.co/sK8NyKCUuN)",,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
135209476,2020-01-04 07:25:11,"INCY, ",,"stockflare.com/stock/INCY.O, ",1213436211014127616,False,0,0,0,0,Stockflare Bot (Prod),"$INCY: Incyte Corporation's forecast earnings moved -0.4% over the last month, but the price is -18.0%. It's PE ratio is now 28x earnings. (https://t.co/sK8NyKCUuN)",,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
135209476,2020-01-04 07:25:11,"INCY, ",,"stockflare.com/stock/INCY.O, ",1213436209101463554,False,0,0,0,0,Stockflare Bot (Prod),$INCY: Incyte Corporation's price is -11.9% but the forecast earnings moved 0.0% over the last week. (https://t.co/sK8NyKCUuN),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
135209476,2020-01-04 07:25:10,"INCY, ",,"stockflare.com/stock/INCY.O, ",1213436206937231360,False,0,0,0,0,Stockflare Bot (Prod),$INCY: Incyte Corporation's price is -18.0% but the forecast earnings moved 0.0% over the last month. (https://t.co/sK8NyKCUuN),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
1979190776,2020-01-04 06:19:39,"INCY, ",,"tickerreport.com/?p=4924758, ",1213419718180319233,False,0,0,0,0,Zapier.com,Incyte $INCY Cut to Neutral at Guggenheim https://t.co/1BGZhquwnl,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2525892205,2020-01-04 06:16:36,"INCY, ","investingnews, ","modernreaders.com/?p=2662871, ",1213418948345159680,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Neutral at Guggenheim  https://t.co/TalcAwjUD6 #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
15974185,2020-01-04 06:05:32,,,"dlvr.it/RMQCMB, ",1213416164124028928,False,1,0,0,0,dlvr.it,Here's Why Incyte Fell as Researchers Identify Epigenetic Inhibiting Drugs to Kill Resistant Malaria Parasites by as Much as 12.6% Today https://t.co/3jiVDrSdin,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
374729426,2020-01-04 05:13:05,"INCY, ","Incyte, stockmarket, stock, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1083548, pic.twitter.com/WGKc48KSfs, ",1213402965936988160,False,0,0,0,2,Tickeron,"$INCY Incyte's (INCY, $85.97) clinical trial disappoints. #Incyte #stockmarket #stock #money #trading #investing #daytrading #news #today Read more: https://t.co/eRClslrLWO https://t.co/WGKc48KSfs",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2149170848,2020-01-04 04:10:02,,"Biotech, Shareholdervalue, PrecisionMedicine, investing, pharma, drugdevelopment, ","bit.ly/37vviWI, pic.twitter.com/S8MbUOE2Rc, ",1213387099191357440,False,0,0,0,0,Buffer,Leading #Biotech Stock Crashes After Promising Drug Fails Late-Stage Test  #Shareholdervalue and a #PrecisionMedicine strategy seem to be intertwined? More failures to be anticipated if this fact is being denied #investing #pharma   #drugdevelopment https://t.co/oBGZ90GmbU https://t.co/S8MbUOE2Rc,,,2013-10-22 10:46:04,"M√ºnchen, Bayern",Dr. Thomas Wilckens,https://pbs.twimg.com/profile_images/1197085548021796866/iLUQjrHs_normal.jpg,4998,3493,442,59192,Thomas_Wilckens,photo
2298709746,2020-01-04 04:08:16,"INCY, ",,"zpr.io/tESMr, ",1213386653504548867,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Reiterated by Cowen https://t.co/6JxqymR3wt,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1637027690,2020-01-04 03:35:04,,,"ift.tt/2rRMhTS, ",1213378299608666113,False,0,0,0,0,IFTTT,"Incyte's pain is Equillium's gain, up 12% https://t.co/y42ES8k6R5",,,2013-07-31 23:30:55,Everywhere,Ashish Aggarwal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,557,0,4776,AggarwalTweets,
930803511918411776,2020-01-04 02:51:27,"INCY, ",,"thelincolnianonline.com/?p=3325431, ",1213367323295399936,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded by ValuEngine to ‚ÄúHold‚Äù https://t.co/xUNSZ91CtZ,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2020-01-04 02:48:57,"INCY, ",,"theenterpriseleader.com/?p=2521700, ",1213366692769910784,False,1,0,0,2,Zapier.com,Incyte $INCY Upgraded by ValuEngine to ‚ÄúHold‚Äù  https://t.co/jzSqJkdoq9,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
966006214818697218,2020-01-04 01:12:58,"INCY, ",,"theenterpriseleader.com/?p=2521292, ",1213342538058412032,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Price Down 9.4% After Analyst Downgrade  https://t.co/EOdUJq40uA,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
533475851,2020-01-04 00:12:08,"INCY, ",,"businesswire.com/news/home/2020‚Ä¶, ",1213327230010626049,False,0,0,0,0,Twitter for iPad,Incyte $INCY Announces Results of Phase 3 Study of Itacitinib in Patients with Treatment-Na√Øve Acute Graft-Versus-Host Disease | Business Wire https://t.co/qbcwXaZ4og,,,2012-03-22 16:35:56,"Canada, Dalhousie Medicine, NB",Dr. Keith R. Brunt,https://pbs.twimg.com/profile_images/605745356857483265/2IQmAMIE_normal.jpg,2098,1115,96,27119,prof_brunt,
1046038742971158530,2020-01-03 22:21:29,,"stockmarket, stocks, investing, investor, stocktrading, stockexchange, stockwatch, dividends, ","nytimes.com/aponline/2020/‚Ä¶, pic.twitter.com/PiSZSLFarW, ",1213299383397040128,False,0,0,0,0,TweetDeck,"Tesla, Hess Rise; Incyte, Landec Fall
NEW YORK ‚Äî Stocks that moved substantially or traded heavily on Friday:

Tesla Inc., up $12.75 to $443.01.

https://t.co/qBqPiOHUx9

#stockmarket #stocks #investing #investor #stocktrading #stockexchange #stockwatch #dividends https://t.co/PiSZSLFarW",,,2018-09-29 10:07:25,,What.pe,https://pbs.twimg.com/profile_images/1198604876277788673/DK3ZaYcH_normal.jpg,316,1948,1,702,what_pe,photo
3279944630,2020-01-03 21:40:32,,,"dlvr.it/RMPR3R, ",1213289076909998085,False,0,0,0,0,dlvr.it,"Stock Market Rally Continues Into 2020; Tesla, Lockheed Soar, Incyte Plunges: Weekly Review https://t.co/jgULCehqOl",,,2015-07-14 16:55:33,"Surrey, UK",SAS Ltd,https://pbs.twimg.com/profile_images/621062470216642560/PxqEFmQc_normal.jpg,140,210,25,32363,SinclairASLtd,
821875574796734464,2020-01-03 20:18:11,,,"carinformation.ml/tesla-hess-ris‚Ä¶, ",1213268352669347841,False,0,0,0,0,carinformation2,"New post (Tesla, Hess rise; Incyte, Landec fall - Minneapolis Star Tribune) has been published on CAR INFORMATION - https://t.co/NNLI7ZMWcX",,,2017-01-18 19:23:01,,carinformation,https://pbs.twimg.com/profile_images/824359398357098496/XFHUuMAQ_normal.jpg,83,28,2,30755,carinformation5,
39975891,2020-01-03 19:36:03,,,"investors.com/news/stock-mar‚Ä¶, ",1213257751167557632,False,0,0,0,0,dlvr.it,"Stock Market Rally Continues Into 2020; Tesla, Lockheed martin Soar, Incyte Plunges - Investor's Business Daily https://t.co/kH4U9XZKID",,,2009-05-14 07:39:17,Global,Saeed Valadbaygi,https://pbs.twimg.com/profile_images/1224252964547723265/uJ0173SQ_normal.jpg,14062,1111,566,324914,SaeedBaygi,
1134049078424162304,2020-01-03 19:16:50,"INCY, ",,"newsfilter.io/articles/4-for‚Ä¶, ",1213252914732584960,False,0,0,0,0,Newsfilter.io,"$2,436,819.65 of shares sold by Hoppenot Herve (Chairman / CEO), form 4 filed with the SEC  $INCY https://t.co/DGdARFr5UF",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
2266388972,2020-01-03 18:45:50,"INCY, ","stocks, ","dailypolitical.com/?p=3306440, ",1213245112014327808,False,0,0,0,0,Zapier.com,Incyte $INCY Trading Down 9.4% Following Analyst Downgrade https://t.co/uSgQh65JBX #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2020-01-03 18:45:49,"INCY, ",,"dailypolitical.com/?p=3306440, ",1213245109233434625,False,0,0,0,0,Zapier.com,Incyte $INCY Trading Down 9.4% Following Analyst Downgrade https://t.co/ItBtd8Oqlj,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
25406480,2020-01-03 18:41:08,,,"awesomecapital.blogspot.com/2020/01/incyte‚Ä¶, ",1213243928868048898,False,0,0,0,1,Twitter Web Client,"AwesomeCapital: Incyte‚Äôs pain is Equillium‚Äôs gain, up 12% https://t.co/DrZYoiqZqU",,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
32492934,2020-01-03 17:35:00,,,"bioworld.com/articles/43218‚Ä¶, ",1213227285714739200,False,1,0,0,1,TweetDeck,Incyte's itacitinib fails phase III test against acute GVHD https://t.co/Q5ZzQsPMhv,,,2009-04-17 13:38:52,USA,BioWorld,https://pbs.twimg.com/profile_images/1204780931489374208/UcGKBM4D_normal.png,36672,9885,805,33840,BioWorld,
1204967326543699968,2020-01-03 17:31:14,"INCY, ",,,1213226340863938560,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is falling fast! It's down -9.39% today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
821875574796734464,2020-01-03 17:03:41,,,"carinformation.ml/tesla-hess-ris‚Ä¶, ",1213219405502414848,False,0,0,0,0,carinformation2,"New post (Tesla, Hess rise; Incyte, Landec fall - Washington Post) has been published on CAR INFORMATION - https://t.co/maDt5JB8cL",,,2017-01-18 19:23:01,,carinformation,https://pbs.twimg.com/profile_images/824359398357098496/XFHUuMAQ_normal.jpg,83,28,2,30755,carinformation5,
178441882,2020-01-03 16:39:13,,,"noahsrss.wordpress.com/2020/01/03/sto‚Ä¶, ",1213213249656754177,False,0,0,0,0,WordPress.com,"Stock Market Trims Losses After U.S. Airstrike Sends Stocks Tumbling; Apple, Incyte, Tesla Key¬†Movers https://t.co/ZpoQj9a2r4",,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
1120631024306802688,2020-01-03 16:20:02,"INCY, ","STOCKS, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, markets.dataswarm.tech, ",1213208420867878913,False,0,0,0,0,DataSwarm Markets,"$INCY We have detected a noticeable change in the Zeitgeist for Incyte Corporation at  https://t.co/OxItqO0RgL
Visit https://t.co/ApK6iYCrer for more information
#STOCKS #NASDAQ
DataSwarm ref: 83550",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
772471873539977217,2020-01-03 16:15:21,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1213207243212103683,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/XsrF8VcUMK,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
963495628545327104,2020-01-03 15:53:11,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/2ZAlU7jwVh, ",1213201664045395974,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte News: INCY Stock Tumbles 10% on Experimental Drug Study Failure https://t.co/dpZT6jTJqZ Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/2ZAlU7jwVh,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1670317082,2020-01-03 15:47:33,"INCY, ",,"investorplace.com/2020/01/incyte‚Ä¶, ",1213200245502423046,False,0,0,0,0,Twitter Web App,$INCY is down today after reporting poor results from a drug trial. https://t.co/VLiXiqiJeS,,,2013-08-14 07:52:49,Tennessee,William White,https://pbs.twimg.com/profile_images/1043246984218337280/kPK4PN97_normal.jpg,516,320,15,13322,WilliamWhiteIP,
963495628545327104,2020-01-03 15:30:03,"EQ, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, ",1213195842263437314,False,0,0,0,0,STCK.PR0,"$EQ $INCY NEW ARTICLE : Incyte's pain is Equillium's gain, up 12% https://t.co/Jm6Y1QPq8v",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
166597717,2020-01-03 15:30:00,"EQ, INCY, ",,"bit.ly/2QjwmHk, ",1213195829202128897,False,0,0,0,1,TweetDeck,Stifel says Incyte setback means Equillium may have most advanced aGVHD product $EQ $INCY https://t.co/7A8FoqF9Vx,,,2010-07-14 11:10:34,Greater New York City Area,The Fly,https://pbs.twimg.com/profile_images/885896700472287233/NunLvfQW_normal.jpg,27381,167,0,106350,theflynews,
1134049078424162304,2020-01-03 15:29:49,"EQ, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1213195781940887552,False,0,0,0,0,Newsfilter.io,"Incyte's pain is Equillium's gain, up 12% $EQ https://t.co/wTOI2Yo5vN",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
15296897,2020-01-03 15:28:10,"EQ, INCY, ",,"seekingalpha.com/news/3529605-i‚Ä¶, ",1213195368306864128,False,1,0,0,0,SANewsTwitter,"$EQ $INCY - Incyte's pain is Equillium's gain, up 12% https://t.co/LNwHCXwdPr",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
21793154,2020-01-03 14:11:59,,"Endpoint, shares, dropped, biospace, lifesciences, biotech, pharma, ","hubs.ly/H0mrM_b0, ",1213176194671271943,False,2,0,0,1,HubSpot,"Incyte's Graft-Versus-Host Trial Fails to Meet Primary #Endpoint

Company #shares #dropped almost 10% at the news.

#biospace #lifesciences #biotech #pharma

https://t.co/RUlThehmej",,,2009-02-24 15:27:40,"Des Moines, IA",BioSpace,https://pbs.twimg.com/profile_images/1042117112020389888/8MCBEVkx_normal.jpg,21738,2830,509,25196,biospace,
178441882,2020-01-03 13:53:38,,,"noahsrss.wordpress.com/2020/01/03/sto‚Ä¶, ",1213171580068610048,False,0,0,0,0,WordPress.com,"Stock Market Rally Continues Into 2020; Tesla, Lockheed Soar, Incyte Plunges: Weekly¬†Review https://t.co/TZx8Shya8n",,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
732361939490312192,2020-01-03 13:47:35,"INCY, ","markets, ","americanbankingnews.com/?p=12961699, ",1213170056374427650,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $80.00 at Royal Bank of Canada https://t.co/LM0eKwUNqn #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-03 13:47:32,"INCY, ","stocks, ","americanbankingnews.com/?p=12961699, ",1213170041564385286,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $80.00 at Royal Bank of Canada https://t.co/9YQE9evXnZ #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
178441882,2020-01-03 13:40:46,,,"noahsrss.wordpress.com/2020/01/03/sto‚Ä¶, ",1213168339859705866,False,0,0,0,0,WordPress.com,"Stock Market Rally Continues Into 2020; Tesla, Lockheed Soar, Incyte Plunges: Weekly¬†Review https://t.co/jEwlR6rH6Z",,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
1128239740329705472,2020-01-03 13:30:08,"INCY, ",,"biopharmadive.com/news/incyte-tr‚Ä¶, ",1213165662975201292,False,0,0,0,0,Hootsuite Inc.,"""We believe the failure of GRAVITAS-301, which follows three prior high-profile pipeline disappointments in four years ... may lead some investors to question the company's ability to consistently generate value from R&amp;D investment.""

$INCY
https://t.co/MYf02JkMg0",,,2019-05-14 06:04:50,"Philadelphia, PA",Big4Bio:Philly,https://pbs.twimg.com/profile_images/1137782553140744192/jDtcwvSX_normal.png,474,669,5,2769,Big4BioPhilly,
3549429319,2020-01-03 13:00:10,,,"latesttoday.news/2020/01/03/bus‚Ä¶, ",1213158121289506816,False,0,0,0,0,WordPress.com,Incyte Stock Collapses After Graft Vs. Host Disease Treatment Fails ‚Äì Investor's Business¬†Daily https://t.co/clwDhNFnX9,,,2015-09-13 09:07:51,America,Today's news summary,https://pbs.twimg.com/profile_images/1303326591678775296/uX9wI_0D_normal.jpg,280,1140,1,257461,k29664911,
606571099,2020-01-03 12:43:53,,,"trib.al/foNafHa, ",1213154026394664960,False,0,0,0,1,SocialFlow,Incyte shares tumbled after a study failure https://t.co/VS2TI6HDzT,,,2012-06-12 15:22:45,Sydney,Bloomberg Australia,https://pbs.twimg.com/profile_images/768354336103600128/AktQ5A17_normal.jpg,14977,234,475,156078,BloombergAU,
821875574796734464,2020-01-03 12:30:39,,,"carinformation.ml/stocks-tesla-b‚Ä¶, ",1213150693780905984,False,0,0,0,0,carinformation2,"New post (Stocks - Tesla, BAT, Newmont Rise in Premarket; Incyte Falls - Yahoo Finance) has been published on  - https://t.co/ed8MZOAYeG",,,2017-01-18 19:23:01,,carinformation,https://pbs.twimg.com/profile_images/824359398357098496/XFHUuMAQ_normal.jpg,83,28,2,30755,carinformation5,
130442628,2020-01-03 12:30:05,,,"bit.ly/2MSVL8V, ",1213150552785375232,False,0,0,0,0,Sailing Blogs,Trial failure keeps Incyte searching for its next act - BioPharma Dive https://t.co/eBGgyd47Wz,,,2010-04-07 05:07:45,,Diving News,https://pbs.twimg.com/profile_images/804026153/diving-and-activities_diving-and-activities_top_265_1_normal.jpg,9921,343,146,74400,diving_news,
72928001,2020-01-03 12:25:47,"INCY, ",,"bit.ly/39xJdgV, ",1213149470109528065,False,1,0,0,1,UpgradesDowngrades,"Incyte falls on disappointing Phase 3 results for its promising drug candidate 
https://t.co/Y9OvvCf632 $INCY",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
963495628545327104,2020-01-03 12:17:02,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/SHPv8hIqsl, ",1213147268125274113,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Here's Why Incyte Fell as Much as 12.6% Today https://t.co/2rumo8xAhj Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/SHPv8hIqsl,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
1564125781,2020-01-03 11:53:21,"INCY, ",,"bit.ly/2MQwhZA, ",1213141306190548992,False,0,0,0,0,TweetDeck,A setback for $INCY's experimental drug itacitinib adds to a list of pipeline disappointments for the Delaware biotech https://t.co/Por3JJ7xQi,,,2013-07-02 17:00:07,"Washington, D.C.",BioPharma Dive,https://pbs.twimg.com/profile_images/1247897788702052354/8g5XsbZF_normal.jpg,11666,334,333,14463,BioPharmaDive,
953788131601502208,2020-01-03 11:52:17,,,"fool.com/investing/2020‚Ä¶, pic.twitter.com/7PN5uNUzSX, ",1213141038715604992,False,0,0,0,0,Wall St Solver Auto-Tweeter,"Here's Why Incyte Fell as Much as 12.6% Today

üì∞ ¬ª https://t.co/5VZdCa91TF https://t.co/7PN5uNUzSX",,,2018-01-17 19:36:25,,Wall St Solver,https://pbs.twimg.com/profile_images/1029252349716512769/HAdlBHZA_normal.jpg,472,39,12,58222,wallstsolver,photo
3300865039,2020-01-03 11:41:08,"INCY, ","biotech, stocks, investingnews, ","investors.com/news/technolog‚Ä¶, ",1213138231409233922,False,1,0,0,1,Hootsuite Inc.,$INCY stock pummeled as late-stage failure casts doubt on pipeline #biotech #stocks #investingnews https://t.co/1DQulehTTm,,,2015-07-29 15:22:19,"California, USA",Allison Gatlin,https://pbs.twimg.com/profile_images/1379079645480378371/V22zIHh9_normal.jpg,6295,1000,201,6646,IBD_AGatlin,
963495628545327104,2020-01-03 11:33:02,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/cwdOvvfz8n, ",1213136196093788161,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte Stock Pummeled As Late-Stage Failure Casts Doubt On Pipeline https://t.co/lPiEW5alf3 Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/cwdOvvfz8n,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
913537855846256640,2020-01-03 11:31:32,,,"dlvr.it/RMN70Z, ",1213135818962792449,False,0,0,0,0,dlvr.it,Incyte Stock Collapses After Graft Vs. Host Disease Treatment Fails - Investor's Business Daily: Incyte Stock Collapses After Graft Vs. Host Disease Treatment Fails¬†¬†Investor's Business Daily https://t.co/6D1AkD6qph,,,2017-09-28 18:56:12,"Toronto, Ontario",Elly Shobeiriüá®üá¶,https://pbs.twimg.com/profile_images/1162783518147207168/rD0VnU7a_normal.jpg,530,1006,4,56471,EllyShobeiri,
1134049078424162304,2020-01-03 11:24:49,"MRK, NVS, INCY, ALXN, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1213134125806305280,False,1,0,0,0,Newsfilter.io,Incyte's Itacitinib Fails in Late-Stage GVHD Study $MRK $NVS $INCY $ALXN https://t.co/cHnGxKQ0ui,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
1878462302,2020-01-03 11:08:32,,,"dlvr.it/RMN34q, ",1213130028868747264,False,0,0,0,0,dlvr.it,"Incyte Falls on Study Failure, Dermatology Pipeline Sparks Hope https://t.co/Gc1Z7ImB2A",,,2013-09-18 03:23:17,Africa,African Peace,https://pbs.twimg.com/profile_images/863838212275490817/V2U6Nc63_normal.jpg,201,591,2,107750,AfricanPeacemag,
15935963,2020-01-03 11:08:32,,,"dlvr.it/RMN340, ",1213130028071837696,False,0,0,0,1,dlvr.it,"Incyte Falls on Study Failure, Dermatology Pipeline Sparks Hope https://t.co/tsq5HXB8KF",,,2008-08-21 15:53:01,"Texas, USA",BradHolt,https://pbs.twimg.com/profile_images/888829664336138240/LbeoL7HA_normal.jpg,190,23,20,49253,BradHolt,
715009219934691328,2020-01-03 11:08:32,,,"dlvr.it/RMN33z, ",1213130027463634944,False,0,0,0,0,dlvr.it,"Incyte Falls on Study Failure, Dermatology Pipeline Sparks Hope https://t.co/dNgCz6mupX",,,2016-03-29 22:54:17,"1 Gabalaya St., Zamalek, Cairo",OSTOUL Securities,https://pbs.twimg.com/profile_images/1194545093996417025/rAVWCqKA_normal.jpg,192,82,3,95463,OstoulSB,
40721566,2020-01-03 11:08:31,,,"dlvr.it/RMN329, ",1213130026847047680,False,0,0,0,0,dlvr.it,"Incyte Falls on Study Failure, Dermatology Pipeline Sparks Hope https://t.co/k9P0JDfBeE",,,2009-05-17 15:40:14,Canada,Ron,https://pbs.twimg.com/profile_images/1396716069373480960/TQqANv_h_normal.jpg,18837,20726,176,323935,ronmc1,
1181964022998011910,2020-01-03 11:08:31,,,"dlvr.it/RMN2zN, ",1213130026297593856,False,0,0,0,0,dlvr.it,"Incyte Falls on Study Failure, Dermatology Pipeline Sparks Hope https://t.co/gB0PnMCFJn",,,2019-10-09 12:06:13,"New York, United States",Virtual Data Rooms Reviews for M&A,https://pbs.twimg.com/profile_images/1181964420454457345/7k8uKSDq_normal.jpg,113,7,2,22031,rooms_data,
270492072,2020-01-03 11:08:17,,"news, ",,1213129964951764993,False,0,0,0,0,Microsoft Power Platform,Incyte stock price target cut to $74 from $85 at BMO Research #news,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
875382419251019776,2020-01-03 11:04:33,,,"bit.ly/2sL3Q8v, pic.twitter.com/usGnP4z1kK, ",1213129025477959681,False,0,0,0,0,dlvr.it,Incyte's Graft-Versus-Host Trial Fails to Meet Primary Endpoint https://t.co/ljMVMdZKtC https://t.co/usGnP4z1kK,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
1134049078424162304,2020-01-03 10:52:38,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1213126029545525248,False,0,0,0,1,Newsfilter.io,"Incyte Falls on Study Failure, Dermatology Pipeline Sparks Hope $INCY https://t.co/24TQTZ8WMT",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
4876582225,2020-01-03 10:33:53,"INCY, ",,"ideas.quantcha.com/2020/01/03/big‚Ä¶, pic.twitter.com/maRzXLYjiu, ",1213121309011533824,False,0,0,0,0,WordPress.com,Big Loser Alert: Trading today‚Äôs -10.1% move in INCYTE¬†$INCY https://t.co/dsBs5KJWl4 https://t.co/maRzXLYjiu,,,2016-02-07 21:25:37,,Quantcha Trade Ideas,https://pbs.twimg.com/profile_images/696520568175112193/UyDAatYN_normal.png,1603,2,51,89372,QuantchaIdeas,photo
732361939490312192,2020-01-03 10:33:41,"INCY, ","markets, ","americanbankingnews.com/?p=12960719, ",1213121260697325569,False,0,0,0,0,Zapier.com,Goldman Sachs Group Cuts Incyte $INCY Price Target to $107.00 https://t.co/aY9sFrQG7E #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-03 10:33:41,"INCY, ","stocks, ","americanbankingnews.com/?p=12960719, ",1213121256997998593,False,1,0,0,0,Zapier.com,Goldman Sachs Group Cuts Incyte $INCY Price Target to $107.00 https://t.co/wXMqCgE0G1 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
17622474,2020-01-03 10:30:10,,,"ow.ly/3EMl50xMoL4, pic.twitter.com/baevwuLNqP, ",1213120374776434690,False,0,0,0,0,Hootsuite Inc.,Friday's Top Analyst Upgrades and Downgrades Part 2: https://t.co/ABtKQYBrlj https://t.co/baevwuLNqP,,,2008-11-25 11:01:58,"New York, NY",24/7 Wall St.,https://pbs.twimg.com/profile_images/378800000058745584/d9c62169620bdd66022ca24da0a26f5e_normal.jpeg,181730,212,2748,56837,247WallSt,photo
930803511918411776,2020-01-03 10:30:05,"INCY, ",,"thelincolnianonline.com/?p=3324624, ",1213120352177590273,False,0,0,0,0,Zapier.com,Goldman Sachs Group Trims Incyte $INCY Target Price to $107.00 https://t.co/LsyQycpbwd,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
788899165220671488,2020-01-03 10:29:03,"MESO, MESO, INCY, ",,"finance.yahoo.com/news/mesoblast‚Ä¶, finance.yahoo.com/news/incyte-an‚Ä¶, ",1213120094370447361,False,1,0,0,0,Twitter Web App,"$MESO has the solution for aGvHD.  This will help a lot of people!

$MESO https://t.co/Rqx9nNW5ZS

$INCY https://t.co/BnsjJPkgSV",,,2016-10-19 20:26:32,,techfan20,https://pbs.twimg.com/profile_images/909328678458462208/UfTQDFVg_normal.jpg,263,33,5,1969,biotechfan20,
3363291113,2020-01-03 10:10:03,,"biotechshowcase, ","buff.ly/2Pe1acc, pic.twitter.com/H3onXyb6fZ, ",1213115310728978432,False,0,0,0,0,Buffer,"BriaCell Therapeutics Corp. https://t.co/XxrdzCWd9M It is conducting a Phase I/IIa clinical trial of Bria-IMT‚Ñ¢ in combination with Incyte drugs, INCMGA00012 and epacadostat, in advanced breast cancer.  #biotechshowcase https://t.co/H3onXyb6fZ",,,2015-07-06 19:40:06,"Chicago, IL",Julie Lakeview,https://pbs.twimg.com/profile_images/926542318190104576/eZp4RhRN_normal.jpg,897,892,10,17512,LakeviewJulie,photo
15281391,2020-01-03 09:56:04,"INCY, ",,"buff.ly/2ZLAjaW, ",1213111793318551552,False,1,0,0,0,Buffer,"The average price target on Wall Street for Incyte $INCY is $92.65, according to Bloomberg.  https://t.co/7zTbwuvZI4",,,2008-06-30 15:12:38,"New York, NY",TheStreet,https://pbs.twimg.com/profile_images/1438558308164644866/JLxN88qJ_normal.jpg,804750,1161,7179,215649,TheStreet,
100024370,2020-01-03 09:51:54,"INCY, ",,"cmlviz.com/article/INCY/b‚Ä¶, ",1213110744406884352,False,1,0,0,0,Twitter for Android,$INCY Incyte Stock Is Tanking After a Disappointing Study. Analysts Are Mixed on How Bad the News Really Is. https://t.co/DW7QpQMYof,,,2009-12-28 14:13:21,"Los Angeles, CA",Ophir Gottlieb,https://pbs.twimg.com/profile_images/1088833938351509504/1YK9-k09_normal.jpg,145234,249,2799,170405,OphirGottlieb,
59485976,2020-01-03 09:51:00,"INCY, ",,,1213110516899622913,False,0,0,1,0,Twitter Web Client,"Goldman Sachs Maintains Buy on Incyte, Lowers Price Target to $107; Keeps On Americas Conviction List $INCY",,,2009-07-23 10:54:46,"Houston, TX",PSK2329 - JHC,https://pbs.twimg.com/profile_images/791065727780458497/9YsXethd_normal.jpg,17706,478,504,42918,psk2329,
989878361924268032,2020-01-03 09:50:32,,"Investing, StockMarket, StockMarketNews, StockstoWatch, NYSE, Trading, Stocks, Iran, ","moneyandmarkets.com/stocks-to-watc‚Ä¶, ",1213110399576498177,False,0,0,1,0,Hootsuite Inc.,Here‚Äôs a look at our Opening Bell analysis of financial markets today. #Investing #StockMarket #StockMarketNews #StockstoWatch #NYSE #Trading #Stocks #Iran https://t.co/sJAMgQRmQS,,,2018-04-27 10:46:07,"Florida, USA",Money & Markets,https://pbs.twimg.com/profile_images/1237356085780140033/c065xTfT_normal.jpg,1129,252,11,2618,TheMoneyMarkets,
930803511918411776,2020-01-03 09:45:08,"INCY, ",,"thelincolnianonline.com/?p=3324560, ",1213109042266222592,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúBuy‚Äù Rating from Cowen https://t.co/8VEgK94ZdC,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2020-01-03 09:43:41,"INCY, ",,"theenterpriseleader.com/?p=2520827, ",1213108675767939072,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúBuy‚Äù Rating at Cowen  https://t.co/83vZZa5udU,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
20449296,2020-01-03 09:37:22,,,"on.barrons.com/2QlStgw, ",1213107086697078784,False,0,0,0,0,SocialFlow,Incyte Stock Is Tanking After a Disappointing Study. Analysts Are Mixed on How Bad the News Really Is. https://t.co/Ewhb3WV4vq,,,2009-02-09 12:15:01,"New York, NY",Barron's,https://pbs.twimg.com/profile_images/1400867183333412864/LO1NDNpM_normal.jpg,201867,35,4773,60256,barronsonline,
17622474,2020-01-03 09:30:09,,,"ow.ly/to2Y50xMoHC, pic.twitter.com/NqIjLk0rLp, ",1213105269611335680,False,0,0,0,1,Hootsuite Inc.,Friday's Top Analyst Upgrades and Downgrades Part 1: https://t.co/CHjqFPHnYd https://t.co/NqIjLk0rLp,,,2008-11-25 11:01:58,"New York, NY",24/7 Wall St.,https://pbs.twimg.com/profile_images/378800000058745584/d9c62169620bdd66022ca24da0a26f5e_normal.jpeg,181730,212,2748,56837,247WallSt,photo
1120631024306802688,2020-01-03 09:25:02,"INCY, ","STOCKS, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, markets.dataswarm.tech, ",1213103983486816257,False,0,0,0,0,DataSwarm Markets,"$INCY We have detected a noticeable change in the Zeitgeist for Incyte Corporation at  https://t.co/OxItqO0RgL
Visit https://t.co/ApK6iYCrer for more information
#STOCKS #NASDAQ
DataSwarm ref: 83496",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
732361939490312192,2020-01-03 09:21:52,"INCY, ","markets, ","americanbankingnews.com/?p=12960435, ",1213103187332345857,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $86.00 at Credit Suisse Group https://t.co/JjJhQ432w6 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
732361939490312192,2020-01-03 09:21:52,"INCY, ","markets, ","americanbankingnews.com/?p=12960436, ",1213103185327464452,False,0,0,0,0,Zapier.com,Oppenheimer Lowers Incyte $INCY Price Target to $96.00 https://t.co/qwMjOBXl1w #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-03 09:21:52,"INCY, ","stocks, ","americanbankingnews.com/?p=12960435, ",1213103184480210944,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Lowered to $86.00 at Credit Suisse Group https://t.co/Ok9NXwYpvD #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
61661638,2020-01-03 09:21:51,"INCY, ","stocks, ","americanbankingnews.com/?p=12960436, ",1213103180571172865,False,0,0,0,0,Zapier.com,Oppenheimer Lowers Incyte $INCY Price Target to $96.00 https://t.co/10BgKjbynX #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
21268553,2020-01-03 09:20:05,,,"stock-market-newsfeed.blogspot.com/2020/01/incyte‚Ä¶, ",1213102736989966336,False,0,0,0,0,SS Auto Tweet App,"Incyte's (INCY) Itacitinib Fails in Late-Stage GVHD Study
 https://t.co/9y5OylWWjG",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
374729426,2020-01-03 09:19:26,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1080226, pic.twitter.com/wx5CsXTlbz, ",1213102573307084800,False,0,0,0,0,Tickeron,$INCY in Downtrend: RSI indicator enters oversold zone. View odds for this and other indicators: https://t.co/RRF0IhGjVJ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wx5CsXTlbz,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
17945997,2020-01-03 09:15:09,"ADI, AAPL, BAC, CMG, CCOI, ENDP, HUM, INCY, LB, MD, NEE, NOC, PZZA, SYNA, WING, ","Stockmarket, daytrading, ","247wallst.com/investing/2020‚Ä¶, ",1213101495140454400,False,1,0,0,0,Twitter Web App,"#Stockmarket #daytrading Friday's Top Analyst Upgrades and Downgrades included $ADI $AAPL $BAC $CMG $CCOI $ENDP $HUM $INCY $LB $MD $NEE $NOC $PZZA $SYNA $WING and many more.

https://t.co/1A0Qxca6mr",,,2008-12-07 14:16:01,Texas Hill Country,Jon Ogg,https://pbs.twimg.com/profile_images/1301884149565923329/Y0NaLlGw_normal.jpg,1268,111,102,11103,jonogg,
237960956,2020-01-03 09:13:35,,,"moneyandmarkets.com/stocks-to-watc‚Ä¶, ",1213101100745793536,False,0,0,0,0,Twitter Web Client,Wall Street Wake-Up: US Airstrike in Iraq Sends Equities Down and Stocks to Watch https://t.co/jTMgPlYaLM,,,2011-01-13 20:36:04,"Delray Beach, Florida",Matthew Clark,https://pbs.twimg.com/profile_images/1404437360281100295/Z2xVUAz0_normal.jpg,892,4986,30,22291,InvestWithMattC,
930803511918411776,2020-01-03 09:10:52,"INCY, ",,"thelincolnianonline.com/?p=3324362, ",1213100416893935616,False,0,0,0,0,Zapier.com,Oppenheimer Lowers Incyte $INCY Price Target to $96.00 https://t.co/83QVxd5UlY,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2020-01-03 09:07:54,"INCY, ",,"theenterpriseleader.com/?p=2520628, ",1213099671188578307,False,0,0,0,0,Zapier.com,Oppenheimer Lowers Incyte $INCY Price Target to $96.00  https://t.co/th8CSA4eXr,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
35550239,2020-01-03 09:05:52,"AAPL, LB, MNI, ILMN, AXE, WCC, INCY, TSLA, BG, ACOR, HUM, ENDP, ","Stocks, ","cnbc.com/2020/01/03/sto‚Ä¶, ",1213099159823228929,False,0,0,0,0,Twitter Web App,"#Stocks making the biggest moves premarket: @Apple, @L_Brands, @McClatchy &amp; more https://t.co/nUYimtG73Y $AAPL $LB $MNI @Illumina $ILMN @Anixter $AXE @WESCOcorp $WCC @Incyte $INCY @Tesla $TSLA @Bunge $BG @AcordaNews $ACOR @Humana $HUM $ENDP","Apple, mcclatchy, illumina, Anixter, WESCOcorp, Incyte, Tesla, Bunge, AcordaNews, Humana, ",,2009-04-26 16:05:09,"Atlanta, GA",DeSota Wilson,https://pbs.twimg.com/profile_images/1350995246684004356/Z_XBENrl_normal.jpg,8445,7376,0,38139,desota,
849635211302318080,2020-01-03 09:02:54,,,,1213098414273126400,False,0,0,0,0,Twitter Web Client,"Pharmaceutical company Incyte Corp's new drug trial failed, with shares plummeting 12%. Iran does not have the ability to confront the United States in an all-round way.",,,2017-04-05 10:49:54,Beijing China,Yuncai Li,https://pbs.twimg.com/profile_images/1249123782897401856/aVj451RR_normal.jpg,10,99,0,465,RealTrade2017,
108617488,2020-01-03 09:00:07,,"Stocks, ","invst.ly/pd352, ",1213097713291681792,False,0,0,0,0,FP News Publisher - COM,"#Stocks -  Tesla, BAT, Newmont Rise in Premarket; Incyte Falls - https://t.co/QDZqVIZMCO",,,2010-01-26 09:23:07,Global,Investing.com News,https://pbs.twimg.com/profile_images/1108338556504862720/m5mXMHAV_normal.png,133612,1545,1526,291367,newsinvesting,
2298709746,2020-01-03 08:59:05,"INCY, ",,"zpr.io/tE9Ke, ",1213097453290962945,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Neutral at Mizuho https://t.co/kG8in0v1yB,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
930803511918411776,2020-01-03 08:56:24,"INCY, ",,"thelincolnianonline.com/?p=3324302, ",1213096778163277825,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Neutral at Mizuho https://t.co/mqnXXgnHTB,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2812632288,2020-01-03 08:52:18,,,"invst.ly/pd352, ",1213095744267333637,False,0,0,0,0,ForexPros News & Analysis,"Stocks -  Tesla, BAT, Newmont Rise in Premarket; Incyte Falls - https://t.co/c7vR6dEh7D",,,2014-09-16 03:56:03,Worldwide,Investing.com Stocks,https://pbs.twimg.com/profile_images/1108338732019695616/CAvg-ixc_normal.png,20430,38,256,339289,InvestingStockz,
732361939490312192,2020-01-03 08:47:16,"INCY, ","markets, ","americanbankingnews.com/?p=12960253, ",1213094479969816577,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $74.00 at BMO Capital Markets https://t.co/nmCAzc0XIK #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-03 08:47:16,"INCY, ","stocks, ","americanbankingnews.com/?p=12960253, ",1213094477352636417,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $74.00 at BMO Capital Markets https://t.co/9ajqj0PSt2 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2334614718,2020-01-03 08:42:39,"INCY, ",,"ooc.bz/l/46362, ",1213093315593330690,False,0,0,0,0,Open Outcrier,"$INCY (-10.3% pre) Incyte stock slammed after study fails to hit goal - MW

https://t.co/5nfqv7puKN",,,2014-02-09 00:53:38,"Chicago, IL & Austin, Tx",Open Outcrier,https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_normal.jpg,75758,766,2330,174934,OpenOutcrier,
2298709746,2020-01-03 08:37:59,"INCY, ",,"zpr.io/tE9xt, ",1213092143956471808,False,0,0,0,0,Zapier.com,BMO Capital Markets Cuts Incyte $INCY Price Target to $74.00 https://t.co/P7FjauOSKq,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
1979190776,2020-01-03 08:35:04,"INCY, ",,"tickerreport.com/?p=4922512, ",1213091409655455744,False,0,0,0,0,Zapier.com,Incyte $INCY Price Target Cut to $74.00 by Analysts at BMO Capital Markets https://t.co/ujiSsVO5IY,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
345524677,2020-01-03 08:35:04,"INCY, ","investinbiotech, incytenews, ","pic.twitter.com/Y7RAsdLHGb, ",1213091408376213504,False,1,0,0,0,Hootsuite Inc.,Shares of Incyte $INCY fell 11.38% to $76.19 in premarket trading Friday after a Phase 3 trial of the biotech company's treatment for graft vs. host disease didn't meet its primary endpoint. #investinbiotech #incytenews https://t.co/Y7RAsdLHGb,,,2011-07-30 14:57:54,Global,SprinkleBit,https://pbs.twimg.com/profile_images/1134038676118351873/8aLU-lJ8_normal.png,2570,2452,102,12516,SprinkleBit,photo
727519600787750913,2020-01-03 08:30:27,"INCY, ","Incyte, ","marketchameleon.com/Overview/INCY/‚Ä¶, pic.twitter.com/EBOKexrGV4, ",1213090247308926979,False,0,1,0,0,MarketChameleon.com,$INCY #Incyte declines in premarket trading. See the latest news. https://t.co/pPNN525lke https://t.co/EBOKexrGV4,,,2016-05-03 11:26:04,"Philadelphia, PA",Chameleon ü¶é,https://pbs.twimg.com/profile_images/1141429857613680640/UQDYIDcD_normal.png,10088,29,265,124066,MarketChmln,photo
930803511918411776,2020-01-03 08:21:34,"INCY, ",,"thelincolnianonline.com/?p=3324077, ",1213088012814487555,False,0,0,0,0,Zapier.com,JMP Securities Cuts Incyte $INCY Price Target to $99.00 https://t.co/JWp85xkfvs,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2525892205,2020-01-03 08:20:05,"INCY, ","investingnews, ","modernreaders.com/?p=2660565, ",1213087638577659904,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Outperform Rating Reiterated at Citigroup  https://t.co/d2WWHKKqOU #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
954423021825126401,2020-01-03 08:20:02,"INCY, ","sentiment, trading, stocks, ","socialmarketanalytics.com, ",1213087626758107140,False,0,0,0,0,Sma Stock Alerts,"$INCY (Incyte Corporation) Extreme Negative investor sentiment Jan 3, 8:19 AM ET, see chart at https://t.co/GoRWi8oWFd #sentiment #trading #stocks",,,2018-01-19 13:39:15,,Social Market Analytics Alerts,https://pbs.twimg.com/profile_images/955458800693207041/Tz3TXdZR_normal.jpg,37,1,0,2531,SMA_alerts,
966006214818697218,2020-01-03 08:19:51,"INCY, ",,"theenterpriseleader.com/?p=2520338, ",1213087577705795584,False,0,0,0,0,Zapier.com,JMP Securities Cuts Incyte $INCY Price Target to $99.00  https://t.co/OdsFVqLo0I,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1979190776,2020-01-03 08:19:02,"INCY, ",,"tickerreport.com/?p=4922443, ",1213087373598371840,False,0,0,0,0,Zapier.com,Cantor Fitzgerald Trims Incyte $INCY Target Price to $65.00 https://t.co/ZheTqvWOwa,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2020-01-03 08:18:43,"INCY, ","markets, ","americanbankingnews.com/?p=12959874, ",1213087294233690112,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $99.00 https://t.co/P8Goa8OZ8H #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-03 08:18:42,"INCY, ","stocks, ","americanbankingnews.com/?p=12959874, ",1213087291121524736,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $99.00 https://t.co/iaOOE0zkqt #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-01-03 08:18:41,"INCY, ","markets, ","americanbankingnews.com/?p=12959876, ",1213087286688206848,False,0,0,0,0,Zapier.com,Citigroup Reiterates Outperform Rating for Incyte $INCY https://t.co/fcLDCFxpXb #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-03 08:18:41,"INCY, ","stocks, ","americanbankingnews.com/?p=12959876, ",1213087283135598595,False,0,0,0,0,Zapier.com,Citigroup Reiterates Outperform Rating for Incyte $INCY https://t.co/DGHFPMfjGo #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-01-03 08:18:40,"INCY, ","markets, ","americanbankingnews.com/?p=12959877, ",1213087280874840070,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $65.00 at Cantor Fitzgerald https://t.co/VVArgXyBWk #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-03 08:18:39,"INCY, ","stocks, ","americanbankingnews.com/?p=12959877, ",1213087278295334914,False,0,0,0,0,Zapier.com,Incyte $INCY PT Lowered to $65.00 at Cantor Fitzgerald https://t.co/SklVARhjlx #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
875382419251019776,2020-01-03 08:18:03,,,"bit.ly/2Qkv5Qt, pic.twitter.com/hgPft6kjv8, ",1213087124351676416,False,0,0,0,0,dlvr.it,Incyte sinks as itacitinib fails pivotal test in acute GVHD https://t.co/dLephCJwlZ https://t.co/hgPft6kjv8,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
18294197,2020-01-03 08:11:23,,,"fiercebiotech.com/biotech/incyte‚Ä¶, ",1213085446466686977,False,3,0,1,4,Twitter Web Client,"Incyte won FDA approval for Jakafi, an inhibitor of JAK1 and JAK2, in steroid-refractory acute GVHD last year, fueling optimism that the more selective itacitinib could succeed in related indications https://t.co/DQQ2paDNKI",,,2008-12-21 17:21:58,"Washington, DC",FierceBiotech,https://pbs.twimg.com/profile_images/1270578068701224962/2YHKa3mX_normal.jpg,92204,663,2073,25532,FierceBiotech,
3074191785,2020-01-03 08:09:19,,,"ift.tt/2u5JLtV, ",1213084928818200576,False,0,0,0,0,IFTTT,Incyte Stock Crashes After Biotech Company's Graft Vs. Host Drug Fails - Investor's Business Daily https://t.co/BcLVA18g5J,,,2015-03-06 01:21:41,,Rebus Legalis,https://pbs.twimg.com/profile_images/573730565880311811/cPNGBOzE_normal.jpeg,49,0,4,40813,RebusLegalis,
59485976,2020-01-03 08:08:10,"INCY, ",,,1213084639205691399,False,0,0,0,1,Twitter Web Client,Incyte Announces Itacitinib Did Not Statistically Improve Overall Response Rate Or Non-Relapse Mortality Compared To Placebo In Phase 3 Study $INCY,,,2009-07-23 10:54:46,"Houston, TX",PSK2329 - JHC,https://pbs.twimg.com/profile_images/791065727780458497/9YsXethd_normal.jpg,17706,478,504,42918,psk2329,
25755825,2020-01-03 08:04:35,"KDMN, ",,,1213083734821486594,False,0,0,0,0,TweetDeck,"$KDMN Incyte setback supports GVHD opportunity for Kadmon, says Cantor Fitzgerald , $10 target",,,2009-03-21 20:50:28,global,Profit Hunter,https://pbs.twimg.com/profile_images/1210525206474895360/NKnr9Zr5_normal.jpg,125,228,1,647,Dariogz,
1022473214457348096,2020-01-03 07:33:01,,,"pharmashots.com/25550/incyte-r‚Ä¶, ",1213075792436969474,False,1,0,0,0,Twitter Web Client,Incyte Reports Results of Itacitinib in GRAVITAS-301 P-III Study for Patients with Treatment-Naive Acute Graft-Versus-Host Disease @Incyte https://t.co/By3kVrFTMm,"Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
71542880,2020-01-03 07:14:31,,"biotech, ","thepharmaletter.com/article/incyte‚Ä¶, ",1213071135811747843,False,0,0,0,0,TweetDeck,. @Incyte takes double-digit hit after Phase III setback https://t.co/T4h8Y4Pmhl #biotech,"Incyte, ",,2009-09-04 10:07:54,London,The Pharma Letter,https://pbs.twimg.com/profile_images/1286243845659856897/vbFCz4-e_normal.jpg,21836,1954,530,18020,ThePharmaLetter,
35789155,2020-01-03 07:04:50,"INCY, ",,"firstwordpharma.com/node/1691036, ",1213068698396831745,False,1,0,0,1,TweetDeck,Incyte's JAK1 inhibitor itacitinib misses main goal of late-stage study for acute GVHD https://t.co/dlS93zmTez $INCY,,,2009-04-27 12:44:14,,FirstWord Pharma,https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_normal.jpg,52083,640,990,32708,fwpharma,
1672120591,2020-01-03 07:01:46,"INCY, ",,"bit.ly/35geykB, ",1213067929882943488,False,0,0,0,1,StockTwits Web,Leading Biotech Stock Crashes After Promising Drug Fails Late-Stage Test $INCY @investors https://t.co/h18FTDlzP1,"investors, ",,2013-08-14 23:20:37,The Daily Planet in Metropolis,Clark Joseph Kent,https://pbs.twimg.com/profile_images/459575613754310656/qtxdENZ4_normal.jpeg,4323,890,146,56714,JorelLaraKalel,
15281391,2020-01-03 06:59:23,"INCY, ",,"buff.ly/2ZLAjaW, ",1213067327111127042,False,0,0,0,0,Buffer,Incyte $INCY is cut to neutral from buy at Mizuho Securities USA after a Phase 3 trial of the biotech company's treatment for graft vs. host disease didn't meet its primary endpoint.  https://t.co/7zTbwuvZI4,,,2008-06-30 15:12:38,"New York, NY",TheStreet,https://pbs.twimg.com/profile_images/1438558308164644866/JLxN88qJ_normal.jpg,804750,1161,7179,215649,TheStreet,
261473143,2020-01-03 06:47:44,,,"investor.incyte.com/news-releases/‚Ä¶, life-sciences-usa.com/news/transatla‚Ä¶, pic.twitter.com/gr6mswtdFJ, ",1213064398002102272,False,0,0,0,0,Twitter Web App,Incyte: Phase 3 of Itacitinib in Treatment-Na√Øve Acute Graft-Versus-Host Disease Misses Endpoint https://t.co/p7EL4Z11Uf @Incyte More U.S. Life Science Business News at [LSUS] at https://t.co/DTBNC3i9Lk https://t.co/gr6mswtdFJ,"Incyte, ",,2011-03-05 20:26:19,"Bremen, Germany",[iito] Life Science,https://pbs.twimg.com/profile_images/555518370523525120/54L7-_yi_normal.jpeg,2596,238,89,29254,iitoLifeScience,photo
102754598,2020-01-03 06:43:49,"INCY, ",,"endpts.com/incyte-takes-a‚Ä¶, ",1213063409924747264,False,1,0,0,1,TweetDeck,"From the PM bureau:
Incyte takes a beating as a key PhIII study flops in their latest painful setback ‚Äî blockbuster hopes crushed
$INCY
https://t.co/IEeWDuFNOd",,,2010-01-07 13:33:18,VT and TX (yes),John Carroll,https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_normal.jpeg,61485,280,1456,48410,JohnCendpts,
818081647,2020-01-03 06:42:44,"INCY, ",,"streetinsider.com/r/16293975, ",1213063138540736513,False,0,0,0,0,StreetInsider.com Integration,Incyte $INCY PT Lowered to $65 at Cantor Fitzgerald https://t.co/Al4Qg9oTni,,,2012-09-11 15:57:26,,SIAnalystWire,https://pbs.twimg.com/profile_images/2600218874/alkkkjlbds18yu6ld9xj_normal.png,4980,1,230,118501,AnalystWire,
835077285199794176,2020-01-03 06:31:55,"INCY, MESO, MSB, ",,"investors.com/news/technolog‚Ä¶, ",1213060418178039808,False,2,0,0,0,Twitter Web Client,"$INCY $MESO $MSB

Incyte's loss is Mesoblast's gain. 

Leading Biotech Stock Crashes After Promising Drug Fails Late-Stage Test https://t.co/u8fUhSkMD7 via @IBDinvestors","IBDinvestors, ",,2017-02-24 05:41:54,,Silver Fox,https://pbs.twimg.com/profile_images/1254445545734705153/je6gpGhz_normal.png,1365,582,10,5383,Kaizen__8,
732361939490312192,2020-01-03 06:29:54,"INCY, ","markets, ","americanbankingnews.com/?p=12959408, ",1213059907005681667,False,0,0,0,0,Zapier.com,Mizuho Downgrades Incyte $INCY to Hold https://t.co/rEpsHkimyM #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-03 06:29:52,"INCY, ","stocks, ","americanbankingnews.com/?p=12959408, ",1213059899787284482,False,0,0,0,0,Zapier.com,Mizuho Downgrades Incyte $INCY to Hold https://t.co/UFQo7NKjMs #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-01-03 06:29:50,"INCY, ","markets, ","americanbankingnews.com/?p=12959410, ",1213059892958892037,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Piper Jaffray Companies https://t.co/iqjAuMDqlM #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-03 06:29:50,"INCY, ","stocks, ","americanbankingnews.com/?p=12959410, ",1213059890413002752,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Piper Jaffray Companies https://t.co/TSRo5Q0C0K #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2020-01-03 06:29:48,"INCY, ","markets, ","americanbankingnews.com/?p=12959412, ",1213059885346234369,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Cowen https://t.co/t8DBiXxDXB #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-03 06:29:48,"INCY, ","stocks, ","americanbankingnews.com/?p=12959412, ",1213059882900955137,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Cowen https://t.co/VAhwRnWurY #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
15974185,2020-01-03 06:22:33,,,"dlvr.it/RMMFTb, ",1213058059586564096,False,0,0,0,0,dlvr.it,Incyte stock slammed after study fails to hit goal https://t.co/Km4cOVO4HB,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
633824212,2020-01-03 06:15:32,,,"dlvr.it/RMMDc7, ",1213056292568190978,False,0,0,0,0,dlvr.it,Incyte downgraded to Neutral from Buy at Mizuho https://t.co/qi5yyRh59N,,,2012-07-12 11:31:45,NYC,flylemurs,https://pbs.twimg.com/profile_images/2393843079/wc5oiacqodhfzivmyvmh_normal.jpeg,37,32,4,129630,flylemurs,
21268553,2020-01-03 06:00:03,,,"stock-market-newsfeed.blogspot.com/2020/01/incyte‚Ä¶, ",1213052395573387264,False,0,0,0,0,SS Auto Tweet App,"Incyte stock slammed after study fails to hit goal
 https://t.co/WLX3vGz6DO",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
1637027690,2020-01-03 03:35:33,,,"ift.tt/2FirCLL, ",1213016030467022848,False,0,0,0,0,IFTTT,Incyte's itacitinib flunks GvHD study; shares down 10% after hours https://t.co/qNbG9mvpV1,,,2013-07-31 23:30:55,Everywhere,Ashish Aggarwal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,557,0,4776,AggarwalTweets,
2525892205,2020-01-03 03:01:59,"INCY, ","investingnews, ","modernreaders.com/?p=2659061, ",1213007585906974721,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reaffirmed at Cowen  https://t.co/QYMnegM8Pb #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
930803511918411776,2020-01-03 03:00:56,"INCY, ",,"thelincolnianonline.com/?p=3322549, ",1213007320642392064,False,0,0,0,0,Zapier.com,Piper Jaffray Companies Reaffirms Buy Rating for Incyte $INCY https://t.co/HFD0P32hg8,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1979190776,2020-01-03 02:59:52,"INCY, ",,"tickerreport.com/?p=4920919, ",1213007052756410369,False,0,0,0,0,Zapier.com,Incyte $INCY Cut to Hold at Mizuho https://t.co/mKV2x9kjAG,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1979190776,2020-01-03 02:59:48,"INCY, ",,"tickerreport.com/?p=4920928, ",1213007036679696384,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reaffirmed at Cowen https://t.co/4bNvgENwDC,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1100450877792370688,2020-01-02 22:44:27,"INCY, ",,"blueequity.io/r/78990/DE-INC‚Ä¶, ",1212942776205070336,False,0,0,0,0,Blue Equity,$INCY Incyte Announces Results of Phase 3 Study of Itacitinib in Patients with Treatment-Na√Øve Acute Graft-Versus-Host Disease https://t.co/emNlThQn1i,,,2019-02-26 12:41:49,Los Angeles,Corporate News,https://pbs.twimg.com/profile_images/1199804753686851584/zILMjO7N_normal.jpg,210,0,8,37064,equity_newswire,
227778014,2020-01-02 20:30:14,"INCY, ",,"buff.ly/35jFBf0, ",1212908996144828417,False,0,0,0,1,Buffer,"JAK-1 inhibitor itacitinib fails in Phase III graft-versus-host disease trial, but Incyte pressing on in other GvHD settings, plus cytokine release syndrome, myleofibrosis $INCY https://t.co/4yimEEyz1P",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13038,1543,387,33073,BioCentury,
1424156964,2020-01-02 20:24:22,,"bmtsm, gvhd, ","investor.incyte.com/news-releases/‚Ä¶, ",1212907523323228160,False,17,1,0,5,Twitter Web App,"Itacitanib plus steroids not better than SOC in front line treatment of aGVHD. Disappointing but not surprising. I have been concerned about its toxicity signal in upfront and ref aGVHD setting #bmtsm #gvhd 
https://t.co/Q2qvYemvD4",,,2013-05-12 18:40:18,"Milwaukee, WI",Mehdi Hamadani,https://pbs.twimg.com/profile_images/1413576435185356807/QxpaISuY_normal.jpg,6422,2258,78,6228,MediHumdani,
2851552811,2020-01-02 20:01:27,,"GVHD, ","investor.incyte.com/news-releases/‚Ä¶, ",1212901752833531905,False,14,1,2,7,Twitter for Android,Well that's too bad. Itacitinib in front line for Acute #GVHD fails in a RCT. https://t.co/WPy9CVH5kA,,,2014-10-30 11:39:14,"Boston, MA",Corey Cutler,https://pbs.twimg.com/profile_images/1351947730352893952/U4D7Y6Ke_normal.jpg,1971,213,44,763,DrCCutler,
1006334607946649600,2020-01-02 19:15:32,,,"dlvr.it/RML4vq, ",1212890200860266496,False,0,0,0,0,dlvr.it,Incyte Announces Results of Phase 3 Study of Itacitinib in Patients with Treatment-Na√Øve Acute Graft-Versus-Host Disease https://t.co/pGCh6bDmO1,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
56121651,2020-01-02 18:43:44,"NOVN, INCY, DRRX, PULM, TRIL, IPHA, BNTX, GMDA, MESO, SLGL, ",,"biopharmcatalyst.com/news/2020/nova‚Ä¶, ",1212882196484120576,False,13,0,1,15,TweetDeck,"Biotech updates 01/02:

$NOVN Ph3 fail -71% AH
$INCY Phase 3 fail -10% AH
$DRRX Phase 2a fail-31%
$PULM +88%; $TRIL +45%; $IPHA +14%

Pipeline updates $BNTX $GMDA $MESO $SLGL
 https://t.co/epg8U09SHN",,,2009-07-12 11:59:54,,BioPharmCatalyst,https://pbs.twimg.com/profile_images/1425820382091636746/Xx33Y7hR_normal.jpg,25993,182,548,6628,BPharmCatalyst,
916787510822436864,2020-01-02 18:37:02,"INCY, ",,"thestreet.com/investing/incy‚Ä¶, ",1212880508276944896,False,0,0,0,0,StockTwits Web,"$INCY Incyte Shares Fall in After-Hours Trading on Drug Trial Disappointment

https://t.co/s2ARLRXwWF",,,2017-10-07 18:09:10,"New York, USA",Top Stock Alerts,https://pbs.twimg.com/profile_images/917029562432872449/VJbFmEQ0_normal.jpg,93095,0,955,158453,TopStockAlerts1,
72928001,2020-01-02 18:34:57,"INCY, ",,"bit.ly/2QAXZuw, ",1212879986467565568,False,1,0,0,0,BriefingInPlayLimited,"$INCY: Incyte falls 6.5% after hours on GRAVITAS-301 results, see 16:31 comment https://t.co/XMseSsLEac",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
72928001,2020-01-02 18:31:57,"INCY, ",,"bit.ly/2sF77pS, ",1212879231367041024,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte: GRAVITAS-301 results show that treatment with itacitinib in combination with corticosteroids did not... https://t.co/4eb0pkgG9T,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
913537855846256640,2020-01-02 18:18:02,,,"dlvr.it/RMKzXM, ",1212875727944552448,False,1,0,0,0,dlvr.it,Incyte Stock Crashes After Biotech Company's Graft Vs. Host Drug Fails - Investor's Business Daily: Incyte Stock Crashes After Biotech Company's Graft Vs. Host Drug Fails¬†¬†Investor's Business Daily https://t.co/cfwY2maTO1,,,2017-09-28 18:56:12,"Toronto, Ontario",Elly Shobeiriüá®üá¶,https://pbs.twimg.com/profile_images/1162783518147207168/rD0VnU7a_normal.jpg,530,1006,4,56471,EllyShobeiri,
624413,2020-01-02 17:58:17,,,"on.mktw.net/2sImDkP, ",1212870759275810819,False,4,1,0,1,SocialFlow,Incyte stock slammed after study fails to hit goal https://t.co/4NOakL05qU,,,2007-01-11 00:15:48,"New York, NY",MarketWatch,https://pbs.twimg.com/profile_images/705601245596090368/Z6xUOnRg_normal.jpg,4125163,200,28863,354060,MarketWatch,
993581474,2020-01-02 17:51:57,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1212869164991430656,False,4,0,2,1,TweetDeck,"$INCY's Phase 3 study of itacitinib in graft-vs-host disease failed

https://t.co/XSdRyjojUx

Itacitinib is an important drug in Incyte's plans to build on Jakafi, so this setback should sting. 

Shares down 10% post-market",,,2012-12-06 13:23:28,"Washington, DC",Ned Pagliarulo,https://pbs.twimg.com/profile_images/953310204300595201/ymnS3Vyx_normal.jpg,3588,629,123,5338,NedPagliarulo,
3300865039,2020-01-02 17:42:16,"INCY, ","biotech, stocks, investingnews, ","investors.com/news/technolog‚Ä¶, ",1212866727874351104,False,3,0,1,0,Hootsuite Inc.,Leading #biotech stock crashes after promising drug fails late-stage test $INCY #stocks #investingnews https://t.co/GTJlSWjZKz,,,2015-07-29 15:22:19,"California, USA",Allison Gatlin,https://pbs.twimg.com/profile_images/1379079645480378371/V22zIHh9_normal.jpg,6295,1000,201,6646,IBD_AGatlin,
21268553,2020-01-02 17:30:02,,,"stock-market-newsfeed.blogspot.com/2020/01/incyte‚Ä¶, ",1212863649888514049,False,0,0,0,0,SS Auto Tweet App,"Incyte stock slammed after study fails to hit goal
 https://t.co/WLX3vGz6DO",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
270492072,2020-01-02 17:10:23,,"news, mktw, wsj, ","feeds.marketwatch.com/~r/marketwatch‚Ä¶, ",1212858705298898944,False,0,0,0,0,Microsoft Power Platform,Incyte stock slammed after study fails to hit goal https://t.co/Y70iAbBeA0 via MarketWatch #news #mktw #wsj,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
727519600787750913,2020-01-02 17:06:19,"INCY, ","Incyte, ","marketchameleon.com/Overview/INCY/‚Ä¶, pic.twitter.com/wxCBOPhLT9, ",1212857678625681409,False,0,0,0,0,MarketChameleon.com,$INCY #Incyte declines in after hours trading. See the latest news. https://t.co/aUIgycq6YI https://t.co/wxCBOPhLT9,,,2016-05-03 11:26:04,"Philadelphia, PA",Chameleon ü¶é,https://pbs.twimg.com/profile_images/1141429857613680640/UQDYIDcD_normal.png,10088,29,265,124066,MarketChmln,photo
3318510966,2020-01-02 17:03:17,,,"crweworld.com/article/news-p‚Ä¶, ",1212856916612763650,False,0,0,0,0,CRWE World,Incyte Announces Results of Phase 3 Study of Itacitinib in Patients with Treatment-Na√Øve Acute Graft-Versus-Host Di https://t.co/I9QW81VYuz,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
3460109487,2020-01-02 17:01:31,,,"endpts.com/incyte-takes-a‚Ä¶, ",1212856474508177413,False,2,0,1,0,Buffer,Incyte takes a beating as a key PhIII study flops in their latest painful setback ‚Äî blockbuster hopes crushed https://t.co/2U3QSonpXT,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
1134049078424162304,2020-01-02 17:00:34,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1212856233201414145,False,0,0,0,0,Newsfilter.io,Incyte's itacitinib flunks GvHD study; shares down 10% after hours $INCY https://t.co/t8p2kh4Zms,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
102754598,2020-01-02 16:58:36,"INCY, ",,"endpts.com/incyte-takes-a‚Ä¶, ",1212855736520323073,False,0,0,0,1,TweetDeck,"Catalyst --
Incyte takes a beating as a key PhIII study flops in their latest painful setback ‚Äî blockbuster hopes crushed
$INCY -10%
https://t.co/IEeWDuFNOd",,,2010-01-07 13:33:18,VT and TX (yes),John Carroll,https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_normal.jpeg,61485,280,1456,48410,JohnCendpts,
25406480,2020-01-02 16:57:04,,,"awesomecapital.blogspot.com/2020/01/incyte‚Ä¶, ",1212855352015884288,False,0,0,0,1,Twitter Web Client,AwesomeCapital: Incyte‚Äôs itacitinib flunks GvHD study https://t.co/y9C59muvhe,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
963495628545327104,2020-01-02 16:49:06,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/S1GPU7I7iP, ",1212853349659402241,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte stock slammed after study fails to hit goal https://t.co/tGXz3Mhyhg Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/S1GPU7I7iP,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
322033635,2020-01-02 16:48:46,"INCY, ",,"seekingalpha.com/news/3529324-i‚Ä¶, ",1212853263558696961,False,1,0,0,0,Twitter for iPhone,$INCY Now I know why the breakout failed. Incyte's itacitinib flunks GvHD study; shares down 10% after hours | Seeking Alpha https://t.co/xo4V4jejj8,,,2011-06-22 10:50:09,,Michael Finkelstein,https://pbs.twimg.com/profile_images/1055907977922863105/ufeRHhyq_normal.jpg,234,374,3,1234,MichaelFinkels1,
963495628545327104,2020-01-02 16:46:05,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1212852588850249728,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Incyte's itacitinib flunks GvHD study; shares down 10% after hours https://t.co/2T0awgT9kS Get all the latest $INCY related news here : https://t.co/Y7ZKRzZCpd,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
15296897,2020-01-02 16:44:45,"INCY, ",,"seekingalpha.com/news/3529324-i‚Ä¶, ",1212852254799056896,False,1,0,0,0,SANewsTwitter,$INCY - Incyte's itacitinib flunks GvHD study; shares down 10% after hours https://t.co/mhr7PLEJYK,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
2837784071,2020-01-02 16:44:42,"spy, gspc, aapl, nflx, goog, tsla, ",,"zpr.io/tEhbW, ",1212852240131772416,False,0,0,0,0,Zapier.com,$spy $gspc $aapl $nflx $goog $tsla Incyte stock slammed after study fails to hit goal  https://t.co/cqNUZ9AG2e,,,2014-10-19 21:22:48,"Toronto, Ontario",FaisamTrader,https://pbs.twimg.com/profile_images/856700180950904832/K-8u6osz_normal.jpg,4206,15,57,21629,FaisamTrader,
472650465,2020-01-02 16:39:31,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1212850937305415686,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Results of Phase 3 Study of Itacitinib in Patients with Treatment-Na√Øve Acute  https://t.co/VOPcY2yjGI,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
103011458,2020-01-02 16:35:18,"INCY, ",,"investor.incyte.com/news-releases/‚Ä¶, ",1212849873999011862,False,7,2,2,8,Twitter for iPad,"$INCY Phase 3 GRAVITAS-301 itacitinib in combination with corticosteroids in patients with treatment-na√Øve acute GVHD did not meet primary endpoint of ORR at Day 28 compared to placebo plus corticosteroids (74.0% vs. 66.4%, p=0.08) https://t.co/R74hRbEwaK",,,2010-01-08 10:32:14,"Boston, MA",JQ,https://pbs.twimg.com/profile_images/1296832284415463424/BCbaYWR9_normal.jpg,7853,229,258,13663,jq1234t,
950942636818432006,2020-01-02 16:34:49,"INCY, ","GVHD, Fail, ","businesswire.com/news/home/2020‚Ä¶, ",1212849752326336512,False,3,2,0,1,TweetDeck,"$INCY announced that pivotal Ph 3 GRAVITAS-301 trial evaluating itacitinib in combination with corticosteroids in #GVHD did not meet the primary ORR endpoint. #Fail

Itacitinib ORR at Day 28 vs placebo was 74.0% vs. 66.4% (p=0.08).

https://t.co/6OAboztYzf",,,2018-01-09 23:09:27,"San Francisco, CA",SY Investing,https://pbs.twimg.com/profile_images/1108963782334672900/Bh_0t4CE_normal.png,5814,300,160,3879,syinvesting,
1134049078424162304,2020-01-02 16:32:24,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1212849143779123200,False,0,0,0,0,Newsfilter.io,Incyte Announces Results of Phase 3 Study of Itacitinib in Patients with Treatment-Na√Øve Acute Graft-Versus-Host Disease $INCY https://t.co/GTtjvs2ePu,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
41458395,2020-01-02 16:30:30,"INCY, ","fail, ",,1212848666156900364,False,6,0,1,2,TweetDeck,"$INCY Incyte Announces Results of Phase 3 Study of Itacitinib in Patients with Treatment-Na√Øve Acute Graft-Versus-Host Disease 

#fail",,,2009-05-20 17:45:03,,TexMex,https://pbs.twimg.com/profile_images/1051818539991031808/DBloaH2G_normal.jpg,49004,71,1144,7365,TraderTexMex,
2181281054,2020-01-02 16:07:29,"INCY, ","markets, ","wkrb13.com/?p=1491137, ",1212842876696170496,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $569.75 Million https://t.co/XDIbNmfNXw #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
374729426,2020-01-02 07:50:47,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1077961, pic.twitter.com/8nvmiUEnml, ",1212717874327851008,False,0,0,1,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/kOFUE8lkrH #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/8nvmiUEnml",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2020-01-02 07:38:24,"INCY, ","markets, ","americanbankingnews.com/?p=12953213, ",1212714761210781700,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by Guggenheim to ‚ÄúNeutral‚Äù https://t.co/qm8xFJkFii #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2020-01-02 07:38:20,"INCY, ","stocks, ","americanbankingnews.com/?p=12953213, ",1212714742760067073,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by Guggenheim to ‚ÄúNeutral‚Äù https://t.co/0rBR8QCnis #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
930803511918411776,2020-01-02 07:27:02,"INCY, ",,"thelincolnianonline.com/?p=3320574, ",1212711900108271616,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Neutral at Guggenheim https://t.co/yqrBXaJbo8,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1204967326543699968,2020-01-01 17:31:19,"INCY, ",,,1212501583679893504,False,0,0,0,1,stocksoftheday,$INCY Incyte Corp is falling fast! It's down -0.83% today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
1193779847727894529,2020-01-01 15:02:33,,,"pic.twitter.com/lOCPgXFztm, ",1212464144479211521,False,0,0,0,0,dlvr.it,"How Good Is Incyte Corporation (NASDAQ:INCY), When It Comes To ROE? https://t.co/lOCPgXFztm",,,2019-11-11 01:39:37,,Investingport,https://pbs.twimg.com/profile_images/1222337139662295048/ApBaEbnL_normal.jpg,566,101,13,54939,investingport,photo
3363228003,2020-01-01 10:30:11,,"biotechshowcase, ","buff.ly/2Pe1acc, pic.twitter.com/h2yHgWviCM, ",1212395603214381056,False,0,1,0,0,Buffer,"BriaCell Therapeutics Corp. https://t.co/EhgDxWkZZ9 It is conducting a Phase I/IIa clinical trial of Bria-IMT‚Ñ¢ in combination with Incyte drugs, INCMGA00012 and epacadostat, in advanced breast cancer.  #biotechshowcase https://t.co/h2yHgWviCM",,,2015-07-06 19:26:37,,Analysts' Analyst,https://pbs.twimg.com/profile_images/658975687223701504/ORzKekze_normal.jpg,767,821,5,10945,AnalystsAnalyst,photo
3911174913,2020-01-01 10:30:00,,,,1212395555365642241,False,19,0,0,1,Twitter for Advertisers.,"We're committed to finding solutions that don't yet exist for patients who are top of mind in all that we do. At Incyte, we Solve On.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
374729426,2020-01-01 09:31:00,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1072730, pic.twitter.com/kpL3viZuws, ",1212380708355768320,False,0,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/v0sbx3VQq7 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kpL3viZuws",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3389185084,2020-01-01 03:10:04,,"biotechshowcase, ","buff.ly/2Pe1acc, pic.twitter.com/RU3CppSlLV, ",1212284841913462785,False,0,0,0,0,Buffer,"BriaCell Therapeutics Corp. https://t.co/N4ej6vB6jV It is conducting a Phase I/IIa clinical trial of Bria-IMT‚Ñ¢ in combination with Incyte drugs, INCMGA00012 and epacadostat, in advanced breast cancer.  #biotechshowcase https://t.co/RU3CppSlLV",,,2015-07-23 08:41:42,United States,About Medtech,https://pbs.twimg.com/profile_images/836351563434090501/P7_dmG2v_normal.jpg,1382,1386,24,13130,AboutMedtech,photo
43921687,2019-12-31 21:30:03,,"biotechshowcase, ","buff.ly/2Pe1acc, pic.twitter.com/vu6NDd2Cbx, ",1212199275326779393,False,0,0,0,0,Buffer,"BriaCell Therapeutics Corp. https://t.co/dQxL119jQr It is conducting a Phase I/IIa clinical trial of Bria-IMT‚Ñ¢ in combination with Incyte drugs, INCMGA00012 and epacadostat, in advanced breast cancer.  #biotechshowcase https://t.co/vu6NDd2Cbx",,,2009-06-01 13:03:56,"Chicago, IL",BioPharmaDevice,https://pbs.twimg.com/profile_images/841433473588068352/Ab4Ggetb_normal.jpg,2076,1537,78,24549,OneMedWorld,photo
22709198,2019-12-31 20:30:05,,"biotechshowcase, ","buff.ly/2Pe1acc, pic.twitter.com/ykJcHJBVhv, ",1212184182706917376,False,0,0,0,0,Buffer,"BriaCell Therapeutics Corp. https://t.co/P2Ok8TmeWb It is conducting a Phase I/IIa clinical trial of Bria-IMT‚Ñ¢ in combination with Incyte drugs, INCMGA00012 and epacadostat, in advanced breast cancer.  #biotechshowcase https://t.co/ykJcHJBVhv",,,2009-03-03 19:52:54,U.S.,HealthyCarnivores,https://pbs.twimg.com/profile_images/868171389743894529/WidBkAEW_normal.jpg,4585,4591,323,50211,HealthyCarnivor,photo
4505683408,2019-12-31 20:10:02,,"biotechshowcase, ","buff.ly/2Pe1acc, pic.twitter.com/oMCGNz2xB8, ",1212179139492503552,False,0,0,0,0,Buffer,"BriaCell Therapeutics Corp. https://t.co/wErtqNDQHE It is conducting a Phase I/IIa clinical trial of Bria-IMT‚Ñ¢ in combination with Incyte drugs, INCMGA00012 and epacadostat, in advanced breast cancer.  #biotechshowcase https://t.co/oMCGNz2xB8",,,2015-12-16 13:35:24,United States,Christopher Walker,https://pbs.twimg.com/profile_images/859480402775429122/f_L6rKud_normal.jpg,2719,2798,67,28050,risk_averse_,photo
765563638048395269,2019-12-31 19:50:03,,"biotechshowcase, ","buff.ly/2Pe1acc, pic.twitter.com/dh5ai4zTXx, ",1212174108156448768,False,0,0,0,0,Buffer,"BriaCell Therapeutics Corp. https://t.co/jHf5I8wD7J It is conducting a Phase I/IIa clinical trial of Bria-IMT‚Ñ¢ in combination with Incyte drugs, INCMGA00012 and epacadostat, in advanced breast cancer.  #biotechshowcase https://t.co/dh5ai4zTXx",,,2016-08-16 10:59:29,"Illinois, USA",Financial Carnivores,https://pbs.twimg.com/profile_images/765582076095574016/gWTrUTCM_normal.jpg,1790,1856,113,24792,HowieRegay,photo
374729426,2019-12-31 18:34:25,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1071109, pic.twitter.com/mKRiaTctN1, ",1212155076300509184,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator is remaining in oversold zone for 6 days. View odds for this and other indicators: https://t.co/BolYAyOMVK #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/mKRiaTctN1,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1204967326543699968,2019-12-31 17:31:17,"INCY, ",,,1212139185844445185,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is falling fast! It's down -0.83% today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
3911174913,2019-12-31 15:30:00,,"HappyNewYear, ","pic.twitter.com/u5S2WomXhD, ",1212108665706221568,False,6,0,0,1,Twitter for Advertisers.,"Discovery, development &amp; delivery drove us in 2019. Now, we're ready to continue and Solve On in 2020. #HappyNewYear https://t.co/u5S2WomXhD",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1069693680066420736,2019-12-31 08:01:08,"MRUS, ",,"s.flashalert.me/V5ngS, ",1211995706690588672,False,0,0,0,0,flashalerts,"$MRUS filed SEC form 3: 10% Owner INCYTE CORP: 
 https://t.co/UTucdvyumu",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
1069693680066420736,2019-12-31 08:01:08,"MRUS, ",,"s.flashalert.me/2FvILb, ",1211995706581508096,False,0,0,0,0,flashalerts,"$MRUS filed SEC form 3: 10% Owner INCYTE CORP: 
 https://t.co/TM7JpQtzNI",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
38361270,2019-12-30 21:57:25,,,"youtu.be/dkmqKuB6uUk, ",1211843776445968384,False,0,0,0,0,Twitter Web Client,Inphi And Vertex Flatten Out; Incyte Gets Support https://t.co/tNm8NM7uNb via @YouTube,"YouTube, ",,2009-05-06 23:47:07,,Gino Chimienti,https://pbs.twimg.com/profile_images/1425555060/0729100816a_normal.jpg,528,2504,25,55376,ginochimienti,
963495628545327104,2019-12-30 16:49:06,"INCY, IPHI, VRTX, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/o0dyR7khPS, ",1211766184149950464,False,0,0,0,0,STCK.PR0,$INCY $IPHI $VRTX NEW ARTICLE : Inphi And Vertex Flatten Out; Incyte Gets Support https://t.co/hvkuL6Qjpc Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/o0dyR7khPS,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
40640343,2019-12-30 14:08:51,,"vitiligo, results, incyte, ","umassmed.edu/vitiligo/blog/‚Ä¶, ",1211725856411914241,False,2,0,0,0,Twitter for iPhone,Thanks for sharing @HarrisVitiligo  https://t.co/nzmeto3Pv4 #vitiligo #results #incyte,"HarrisVitiligo, ",,2009-05-17 06:35:45,Netherlands,George Veerman,https://pbs.twimg.com/profile_images/795228537770934272/d_q8WcCc_normal.jpg,230,429,5,3909,gveerman79,
959113172824313856,2019-12-30 13:54:36,,"vitiligo, ","bit.ly/2rClnPI, ",1211722268356890624,False,27,2,1,7,Twitter Web App,Continuous improvement and 1 year results of placebo-controlled clinical trial to test topical ruxolitinib cream as a treatment for #vitiligo https://t.co/dlML4yPSdo,,,2018-02-01 12:16:14,"Worcester, MA",Vitiligo Clinic & Research Center,https://pbs.twimg.com/profile_images/1139558103714861056/YCBEQcTO_normal.png,935,92,6,157,UMassVitiligo,
3911174913,2019-12-30 09:30:00,,"cancer, ",,1211655680777539584,False,26,0,1,4,Twitter for Advertisers.,"At Incyte, we aim to develop &amp; deliver innovative therapies for patients affected by #cancer &amp; immune-mediated diseases.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
374729426,2019-12-30 07:56:45,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1065818, pic.twitter.com/Gb9rpEK0IT, ",1211632215584456705,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator is staying in oversold zone for 5 days. View odds for this and other indicators: https://t.co/mArYRmwcWI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Gb9rpEK0IT,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2019-12-30 03:25:51,"INCY, ","markets, ","americanbankingnews.com/?p=12933530, ",1211564040943755264,False,0,0,0,0,Zapier.com,Analysts Expect Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/FihrQs8EJJ #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-30 03:25:51,"INCY, ","stocks, ","americanbankingnews.com/?p=12933530, ",1211564037915447296,False,0,0,0,0,Zapier.com,Analysts Expect Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/gJYKVqvZMR #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2019-12-30 03:24:20,"INCY, ",,"tickerreport.com/?p=4908867, ",1211563657383104512,False,0,0,0,0,Zapier.com,Analysts Expect Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/spQGH6beOr,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1170829002690293761,2019-12-30 02:10:52,"INCY, ",,,1211545167968296961,False,2,0,0,0,StockTwits Web,"Incyte Corporation, $INCY is attractive as potential M&amp;A target with its blockbuster commercial product in Jakafi.",,,2019-09-08 18:39:30,"Honolulu, Hawaii",Nikola,https://pbs.twimg.com/profile_images/1170849735600570369/o1u9t6TN_normal.jpg,104,131,3,1554,ItsMeKola,
374729426,2019-12-29 12:33:22,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1063930, pic.twitter.com/1pEtBDiSSw, ",1211339440494268418,False,0,0,0,1,Tickeron,$INCY in Downtrend: Stochastic indicator remains in oversold zone for 5 days. View odds for this and other indicators: https://t.co/L9GscYGhSk #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/1pEtBDiSSw,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1080419261544349696,2019-12-29 10:39:10,,,"pic.twitter.com/WkkdlXqO7e, ",1211310699789590528,False,0,0,0,0,IFTTT,"Incyte Corporation: Wait And Watch

Investment Thesis

Incyte (INCY) provides the potential for very high returns, based on analysts‚Äô EPS estimates and a high P/E multiple. There are also significant downside risks if EPS growth estimates are not met and P/E multiple contrac‚Ä¶ https://t.co/WkkdlXqO7e",,,2019-01-02 06:03:19,"Maryland, USA",dolcify,https://pbs.twimg.com/profile_images/1176800851291267072/tK1Zgt0K_normal.jpg,13,1,1,6038,OfficialDolcify,photo
23059499,2019-12-29 07:45:15,"INCY, ","markets, investing, business, ","seekingalpha.com/article/431440‚Ä¶, ",1211266932789239809,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation: Wait And Watch. Keep reading: https://t.co/sLpOTBFtZ5 #markets #investing #business,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
2181281054,2019-12-29 00:48:15,"INCY, ","markets, ","wkrb13.com/?p=1487160, ",1211161988925145093,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $93.47 Consensus Price Target from Analysts https://t.co/ZaQoGwzZJV #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1022006086872821762,2019-12-28 18:02:06,"INCY, INCY, ",,,1211059780560850945,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Fri Dec 27
Closed at 88.39 USD for a -0.45% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
1569573878,2019-12-28 11:50:43,,,"pic.twitter.com/9UMT7uC8my, pic.twitter.com/9UMT7uC8my, ",1210966316213047296,False,1,0,0,1,Twitter for Android,"See Frozen again for free today at 2:00, at the Lyceum Theatre. Thanks to Incyte Environmental and Gull Lake Car Wash! Come early! https://t.co/9UMT7uC8my",,,2013-07-04 22:53:42,"Gull Lake, Saskatchewan",Town of Gull Lake,https://pbs.twimg.com/profile_images/770344591996309504/sjdekdYQ_normal.jpg,616,313,13,4349,TownofGullLake,photo
374729426,2019-12-28 08:38:00,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1058522, pic.twitter.com/ZBNllh3x2V, ",1210917818578817025,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator is sitting in oversold zone for 5 days. View odds for this and other indicators: https://t.co/iJ5J4tW3gV #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZBNllh3x2V,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2019-12-28 08:30:44,"INCY, ","markets, ","americanbankingnews.com/?p=12920466, ",1210915989610741761,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.58 Per Share https://t.co/LlUyW6adC3 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-28 08:30:42,"INCY, ","stocks, ","americanbankingnews.com/?p=12920466, ",1210915983369613313,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.58 Per Share https://t.co/QRSoDOx1BA #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
930803511918411776,2019-12-28 08:28:10,"INCY, ",,"thelincolnianonline.com/?p=3305816, ",1210915344640094208,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY to Announce $0.58 EPS https://t.co/9XIs6C0Rj8,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
38361270,2019-12-27 22:20:45,,,"youtu.be/EeD1FvAQRg0, ",1210762482488209419,False,0,0,0,0,Twitter Web Client,Inphi And Vertex Flatten Out; Incyte Gets Support https://t.co/ZtMcaGJmDp via @YouTube,"YouTube, ",,2009-05-06 23:47:07,,Gino Chimienti,https://pbs.twimg.com/profile_images/1425555060/0729100816a_normal.jpg,528,2504,25,55376,ginochimienti,
1370906497,2019-12-27 17:58:43,"MAISA, ALXN, AMRN, BMRN, BLUE, CLVS, INCY, NBIX, SGEN, SRPT, SAGE, VRTX, ","biotech, 2020_Buyout, ",,1210696540794314757,False,19,0,0,6,Twitter Web App,"$MAISA #biotech candidates for #2020_Buyout

* $ALXN Alexion 
* $AMRN Amarin
$BMRN BioMarin
$BLUE bluebird bio
* $CLVS Clovis 
* $INCY Incyte
* $NBIX Neurocrine Biosciences
* $SGEN Seattle Genetics
* $SRPT Sarepta Therapeutics
$SAGE Sage Therapeutics
* $VRTX Vertex

*owned",,,2013-04-21 20:38:27,U.S.A,MAISA,https://pbs.twimg.com/profile_images/3557296223/a73cb8bb8effbfd1f90590ab48523b10_normal.jpeg,2858,7,76,70211,MaisaCorp,
963495628545327104,2019-12-27 16:57:10,"INCY, IPHI, VRTX, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/n5lOYPnK3b, ",1210681051875545089,False,1,0,0,0,STCK.PR0,$INCY $IPHI $VRTX NEW ARTICLE : Inphi And Vertex Flatten Out; Incyte Gets Support https://t.co/x2HJKCsxDX Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/n5lOYPnK3b,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
500198689,2019-12-27 11:58:07,,,"pic.twitter.com/dkbvFlVizR, pic.twitter.com/dkbvFlVizR, pic.twitter.com/dkbvFlVizR, ",1210605790266048518,False,3,0,1,2,Twitter Web App,"We are counting down our top highlights of the year!
This year's Tell Awards were presented by Ambassador B√∂rlin, Consul General
The Tell Awards recognize American companies that have invested and prospered in Switzerland. Congratulations to Fourth-IR, Incyte, and Xylem Inc.! https://t.co/dkbvFlVizR",,,2012-02-22 17:12:05,New York City,Swiss Consulate NY,https://pbs.twimg.com/profile_images/1395407717901156352/9HT9urpZ_normal.png,5891,1834,0,13027,SwissCGNY,photo
374729426,2019-12-27 08:55:46,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1056119, pic.twitter.com/mFmIHVh9Ak, ",1210559901568663553,False,1,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on December 17, 2019. View odds for this and other indicators: https://t.co/Iej49L99J8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/mFmIHVh9Ak",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1204967326543699968,2019-12-26 17:31:20,"INCY, ",,,1210327261213339650,False,0,0,0,0,stocksoftheday,$INCY Incyte Corp is falling fast! It's down -2.89% today!,,,2019-12-11 22:33:17,,stocksoftheday,https://pbs.twimg.com/profile_images/1204967716114849792/KMkMr2Vj_normal.jpg,142,0,3,9676,stocksoftheday1,
2416188264,2019-12-26 16:58:10,"INCY, ","markets, ","thestockobserver.com/?p=2522807, ",1210318912782553089,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $93.47 Average Price Target from Analysts  https://t.co/7PlENEaqLj #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2019-12-26 16:56:25,"INCY, ",,"zpr.io/tx9eg, ",1210318472623861760,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $93.47 Consensus Target Price from Analysts https://t.co/NkrtlK5lde,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
1134049078424162304,2019-12-26 16:55:47,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1210318312917422081,False,0,0,0,0,Newsfilter.io,Incyte Receives $93.47 Average Price Target from Analysts $INCY https://t.co/iMquseozfs,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
1199800417821048834,2019-12-26 10:49:12,,"Hedge_Funds, News, Is_INCY_A_Good_Investment_Right_Now_, ","dlvr.it/RLySCJ, bit.ly/2CMEYi0, ",1210226059544649734,False,0,0,0,0,dlvr.it,#Hedge_Funds #News #Is_INCY_A_Good_Investment_Right_Now_ How Did Incyte Corporation (INCY) Compare Against Top Hedge Fund Stocks in 2019? https://t.co/zKTxcycE3E https://t.co/py0IHBtDku,,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,
1134049078424162304,2019-12-26 08:20:46,"LLY, NVS, ALXN, INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1210188707883606016,False,1,0,0,0,Newsfilter.io,Incyte Surges 44% YTD on Jakafi's Strong Performance $LLY $NVS $ALXN $INCY https://t.co/XLs106cYwG,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
374729426,2019-12-26 07:57:14,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1050587, pic.twitter.com/RnEkmWzIVe, ",1210182784838336512,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on December 17, 2019. View odds for this and other indicators: https://t.co/YOtLRKZd4u #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/RnEkmWzIVe",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1134049078424162304,2019-12-25 14:52:11,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1209924821116547072,False,0,0,0,1,Newsfilter.io,Incyte‚Äôs ‚ÄúBuy‚Äù Rating Reaffirmed at Mizuho $INCY https://t.co/tfNxsJ54jG,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
1134049078424162304,2019-12-25 14:34:09,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1209920283211001856,False,0,0,0,1,Newsfilter.io,Incyte Downgraded by BidaskClub $INCY https://t.co/6iKpcLAnZL,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
374729426,2019-12-25 13:00:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1048869, pic.twitter.com/nRrriBP8HK, ",1209896742730137600,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on December 17, 2019. View odds for this and other indicators: https://t.co/SLiJPFBZKc #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/nRrriBP8HK",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2752355256,2019-12-25 03:20:01,,"biotech, ","bit.ly/399hWBg, ",1209750630362943488,False,0,0,0,1,MeetEdgar,"Looking for a #biotech career? These companies are hiring! @sanofi @novonordisk @Incyte 
https://t.co/VSx22d3cTD","sanofi, novonordisk, Incyte, ",,2014-08-21 11:35:19,"Berlin, Germany",Labiotech.eu,https://pbs.twimg.com/profile_images/923844013412769792/UYCJUiSN_normal.jpg,31061,1043,630,26328,Labiotech_eu,
930803511918411776,2019-12-24 14:14:50,"INCY, ",,"thelincolnianonline.com/?p=3295036, ",1209553034155634688,False,0,0,0,0,Zapier.com,Analysts Set Incyte Co. $INCY Price Target at $93.47 https://t.co/ecWCpKQWkO,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
374729426,2019-12-24 13:27:21,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1043475, pic.twitter.com/XKbuyPBg4B, ",1209541083710906368,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on December 17, 2019. View odds for this and other indicators: https://t.co/BNUCpY2MBU #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/XKbuyPBg4B",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3911174913,2019-12-24 13:00:00,,,"pic.twitter.com/K9w2I1pSUK, ",1209534202217058304,False,5,0,0,1,Twitter for Advertisers.,"Wishing everyone - from the patient &amp; local communities we aim to serve, to our employees &amp; industry partners - a joyful holiday season and prosperous New Year. https://t.co/K9w2I1pSUK",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
801116888,2019-12-24 10:43:04,"INCY, ",,"pic.twitter.com/84GQpTm7Nh, ",1209499740766900224,False,3,0,0,1,Twitter Web App,"$INCY Incyte Corporation

pull back into Dec value area support https://t.co/84GQpTm7Nh",,,2012-09-03 16:04:20,"New York, NY",Christian Fromhertz,https://pbs.twimg.com/profile_images/1088570898012090374/s1LnJoO-_normal.jpg,51418,1226,1638,51498,cfromhertz,photo
47513933,2019-12-23 17:06:57,,,"delawareonline.com/story/news/201‚Ä¶, ",1209233961957888002,False,0,0,0,0,Twitter Web Client,Incyte Corp. says $50M for 20 acres of Wilmington Friends School worth it for expansion https://t.co/9hUnOOHb7W via @delawareonline,"delawareonline, ",,2009-06-15 22:11:48,"Newark, Delaware",Nancy Willing,https://pbs.twimg.com/profile_images/276978662/powmiaLOGOsm_normal.gif,871,1115,82,96415,nannyfat,
1022006086872821762,2019-12-23 15:01:10,"INCY, INCY, ",,,1209202305494585345,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY is DOWN ‚¨á on Mon Dec 23
Currently at 89.89 USD for a -0.24% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
14307764,2019-12-23 15:00:29,,,"rssfeeds.delawareonline.com/~/613689010/0/‚Ä¶, ",1209202136078331904,False,2,1,0,2,SocialNewsDesk,"The land of the Wilmington Friends' Lower School is directly behind Incyte's headquarters, so it was willing to shell out a striking amount for it. https://t.co/zCaEqMuSrl",,,2008-04-04 21:46:58,"Wilmington, Delaware",Delaware Online,https://pbs.twimg.com/profile_images/988846473625272320/jrStiVpj_normal.jpg,120412,361,782,102172,delawareonline,
1084105465976553472,2019-12-23 13:57:34,"INCY, ",,"delawareonline.com/story/news/201‚Ä¶, ",1209186302958211072,False,0,0,0,1,Twitter for Android,"$INCY
https://t.co/XavFzQA4SJ",,,2019-01-12 10:10:59,Anywhere,TraderThink4Self,https://pbs.twimg.com/profile_images/1213715649953964034/CGOz-h5l_normal.jpg,253,172,11,5730,SelfThink4,
374729426,2019-12-23 08:21:02,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1041176, pic.twitter.com/u2nz4U1Js8, ",1209101610959294466,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on December 17, 2019. View odds for this and other indicators: https://t.co/4zCmjdbCRv #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/u2nz4U1Js8",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
563084750,2019-12-22 20:28:02,"SPX, FDX, EXPE, PCAR, HSIC, INCY, ","NQ_F, FedEx, Expedia, ","traderscommunity.com/index.php/mark‚Ä¶, pic.twitter.com/hA0JSs6B60, ",1208922175694086146,False,2,0,0,1,Twitter Web App,"In a Week of Manic All Time Highs..The Losers ...
Biggest $SPX #NQ_F Stock Losers Last Week*
#FedEx $FDX
#Expedia $EXPE
Paccar  $PCAR
Henry Schein $HSIC
Incyte $INCY
https://t.co/CHYH8dMe9c https://t.co/hA0JSs6B60",,,2012-04-25 14:17:17,,Traders Community,https://pbs.twimg.com/profile_images/1359537033971183617/bnLftW2a_normal.jpg,18045,5625,918,94381,TradersCom,photo
374729426,2019-12-22 09:09:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1035976, pic.twitter.com/5dux7OZZ0m, ",1208751533648564225,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may ascend as a result of having broken its lower Bollinger Band on December 17, 2019. View odds for this and other indicators: https://t.co/NiGMgtExif #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5dux7OZZ0m",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
930803511918411776,2019-12-22 08:15:44,"INCY, ",,"thelincolnianonline.com/?p=3288438, ",1208737889116405761,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at Mizuho https://t.co/CAMQy05h49,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2019-12-22 08:12:53,"INCY, ",,"theenterpriseleader.com/?p=2484676, ",1208737170296586240,False,0,0,0,0,Zapier.com,Mizuho Reiterates Buy Rating for Incyte $INCY  https://t.co/CvKuD48JyS,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1979190776,2019-12-22 04:48:47,"INCY, ",,"tickerreport.com/?p=4885565, ",1208685808942813184,False,0,0,0,0,Zapier.com,Incyte $INCY Lowered to Hold at BidaskClub https://t.co/jJrU14KMtC,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2416188264,2019-12-21 11:08:23,"INCY, ","markets, ","thestockobserver.com/?p=2517329, ",1208418950591197185,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reaffirmed at Mizuho  https://t.co/e0eWOpUr8c #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
1134049078424162304,2019-12-21 11:07:56,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1208418836388597760,False,0,0,0,0,Newsfilter.io,Incyte‚Äôs ‚ÄúBuy‚Äù Rating Reaffirmed at Mizuho $INCY https://t.co/tfNxsJ54jG,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
2416188264,2019-12-21 10:54:04,"INCY, ","markets, ","thestockobserver.com/?p=2517273, ",1208415346530631681,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub  https://t.co/oD8mFbRdQ0 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2920258887,2019-12-21 10:51:57,"INCY, ",,"dakotafinancialnews.com/?p=1404170, ",1208414815485616133,False,0,0,0,0,Zapier.com,BidaskClub Lowers Incyte $INCY to Hold https://t.co/KfQkKqu8c5,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
1134049078424162304,2019-12-21 10:49:58,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1208414314064830466,False,0,0,0,0,Newsfilter.io,Incyte Downgraded by BidaskClub $INCY https://t.co/6iKpcLAnZL,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
135209476,2019-12-21 09:47:33,"INCY, ",,"stockflare.com/stock/INCY.O, ",1208398604899106816,False,0,0,0,0,Stockflare Bot (Prod),"$INCY: Incyte Corporation has gained a star, now a 3 star stock. (https://t.co/sK8NyKCUuN)",,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
374729426,2019-12-21 09:46:49,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1033609, pic.twitter.com/0rUhUXnbkU, ",1208398424137256967,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on December 17, 2019. View odds for this and other indicators: https://t.co/AAQZFQTHbS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0rUhUXnbkU",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1979190776,2019-12-21 05:50:20,"INCY, ",,"tickerreport.com/?p=4883499, ",1208338910897737728,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives Consensus Rating of ‚ÄúBuy‚Äù from Analysts https://t.co/tkVfgN99es,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2019-12-21 05:50:12,"INCY, ","markets, ","americanbankingnews.com/?p=12875743, ",1208338876412116992,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Recommendation of ‚ÄúBuy‚Äù by Brokerages https://t.co/BBGPoQ7ee4 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-21 05:50:11,"INCY, ","stocks, ","americanbankingnews.com/?p=12875743, ",1208338869822902272,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Recommendation of ‚ÄúBuy‚Äù by Brokerages https://t.co/RrTncYdp6A #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1205059957638471680,2019-12-20 23:08:06,,,"newsforforex.com/incyte-incy-st‚Ä¶, ",1208237685309091840,False,0,0,0,0,WordPress.com,Incyte (INCY) Stock Sinks As Market Gains: What You Should¬†Know https://t.co/kQ1WU5IGx0,,,2019-12-12 04:41:17,,NEWS FOR FOREX,https://pbs.twimg.com/profile_images/1206837837108318209/qGxVcfsH_normal.jpg,230,5,2,24948,NEWSFORFOREX1,
340864775,2019-12-20 17:19:25,,"MarshallES, inspirational, GirlsInSTEM, Science, ","pic.twitter.com/OWZFwUCVUt, pic.twitter.com/OWZFwUCVUt, pic.twitter.com/OWZFwUCVUt, ",1208149936820371461,False,6,0,0,0,Twitter for iPhone,Today #MarshallES AAP students learned about being a chemist &amp; how medicine in capsules is made @Incyte #inspirational #GirlsInSTEM #Science @ChristinaK12 https://t.co/OWZFwUCVUt,"Incyte, ChristinaK12, ",,2011-07-23 08:03:35,"Newark,DE",Dr. Nancy Ventresca,https://pbs.twimg.com/profile_images/1289871064147939328/-xamlrZi_normal.jpg,562,1628,5,1937,DrVentresca,photo
1286635807,2019-12-20 16:17:23,"INCY, ","corpgov, ","bwnews.pr/2SjVBuN, ",1208134322638733318,False,0,0,0,0,Twitter Web App,"Incyte Corporation adds Edmund P. Harrigan (Fmr SVP-Worldwide Safety and Regulatory, Pfizer) to Board $INCY #corpgov https://t.co/1IJnU7R53U",,,2013-03-21 14:20:50,Chicago,JamesDruryPartners,https://pbs.twimg.com/profile_images/948933059935657984/4zARxdMk_normal.jpg,200,34,10,11520,JDruryPartners,
133504478,2019-12-20 14:33:37,,"strategy, competitiveintelligence, marketing, pharma, healthcare, biotech, productmarketing, pharmaceutical, ","dlvr.it/RLg8Jf, lqventures.com, ",1208108211296845824,False,0,0,0,2,dlvr.it,"Janus Kinase (JAK) Inhibitors Market Forecast to 2025 covering Strategies, Application, Growth Estimation and Key‚Ä¶ https://t.co/24NnJTdiSc &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #productmarketing #pharmaceutical",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
2920258887,2019-12-20 11:33:06,"INCY, ",,"dakotafinancialnews.com/?p=1402621, ",1208062780349337600,False,0,0,0,0,Zapier.com,Mizuho Reaffirms Buy Rating for Incyte $INCY https://t.co/8elt25Twmw,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
374729426,2019-12-20 09:35:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1028161, pic.twitter.com/NFLWggG7tG, ",1208033089458339840,False,0,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/EkMmLrlL9i #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/NFLWggG7tG",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
930803511918411776,2019-12-20 06:30:13,"INCY, ",,"thelincolnianonline.com/?p=3282150, ",1207986558122508289,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Lowered to Hold at BidaskClub https://t.co/VZa50GBIer,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1119384794,2019-12-20 06:21:00,"INCY, ","BoardOfDirectors, ","talent4boards.com/incyte-welcome‚Ä¶, ",1207984237992804359,False,0,0,0,1,TweetDeck,Incyte welcomes Dr Ed Harrigan to #BoardOfDirectors @Incyte $INCY https://t.co/ylWUKgSm2p,"Incyte, ",,2013-01-25 08:58:15,Worldwide,Talent4Boards,https://pbs.twimg.com/profile_images/1430914546785525763/MjhIJKjv_normal.jpg,3389,4961,167,20042,talent4boards,
930803511918411776,2019-12-20 05:59:49,"INCY, ",,"thelincolnianonline.com/?p=3282090, ",1207978907590430726,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/ZxTQMJ8kJL",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
966006214818697218,2019-12-20 05:57:25,"INCY, ",,"theenterpriseleader.com/?p=2478329, ",1207978305649074176,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock  https://t.co/176AxxDtG0",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
15782620,2019-12-20 03:39:54,,"biotechM, boltOn, inLicensing, ",,1207943695259095040,False,0,0,0,0,Twitter Web App,"2020 will be such an interesting Biotech M&amp;A year. 
Watching these companies. Alexion, Amarin, Biomarin, Bluebird Bio, Clovis Oncology, Incyte, Neurocrine Biosciences, Sage Therapeutics, Sarepta Therapeutics, Seattle Genetics #biotechM&amp;A  #boltOn #inLicensing",,,2008-08-08 16:28:54,Cambridge MA / Lund Sweden,Mitch de Leon,https://pbs.twimg.com/profile_images/668504896547745792/5bNpo4-2_normal.jpg,1128,1957,150,14700,M1tchdeLeon,
68559732,2019-12-19 19:15:41,"CBWTF, INCY, ",,"zpr.io/tXwHk, ",1207816807412895744,False,0,0,0,0,Zapier.com,Contrasting Auxly Cannabis Group $CBWTF &amp; Incyte $INCY https://t.co/BnQ3aytXUK,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
849417718642159616,2019-12-19 15:17:05,"INCY, ",,"zpr.io/tX8fX, ",1207756761626791939,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub https://t.co/jwBDLwHrBI,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
374729426,2019-12-19 12:49:23,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1026061, pic.twitter.com/Gvfu7PZCxk, ",1207719590270124032,False,1,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/f2VphiPZge #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Gvfu7PZCxk",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2019-12-19 12:06:19,"INCY, ",,"zpr.io/tXbh3, ",1207708754285940736,False,0,0,0,0,Zapier.com,Mizuho Reiterates ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/2mG3VWcJ07,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
280747092,2019-12-19 10:39:49,,,"finance.yahoo.com/news/incyte-na‚Ä¶, ",1207686984250150914,False,0,0,0,0,GetCurata,Incyte Names New Member to Its Board of Directors https://t.co/gICcMX7CNk,,,2011-04-11 19:23:47,Boston,BoardProspects,https://pbs.twimg.com/profile_images/508236277636816896/vI0RH0Lw_normal.png,2728,2031,78,20335,BoardProspects,
3686628867,2019-12-19 09:47:27,,,"pharmaceuticaldaily.com/incyte-names-n‚Ä¶, ",1207673804832546816,False,0,0,0,0,WordPress.com,Incyte Names New Member to Its Board of¬†Directors https://t.co/oxEhNO1Ib7,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
2298709746,2019-12-19 09:25:47,"INCY, ",,"zpr.io/tXyQP, ",1207668351469850624,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Paula J. Swain Sells 2,500 Shares of Stock https://t.co/x4vpU3Vbky",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
324914276,2019-12-19 09:00:34,,,"s.einnews.com/rYFclDIenR, ",1207662006150582273,False,0,0,0,0,EIN Presswire,Incyte Names New Member to Its Board of Directors https://t.co/X15izSUZLC,,,2011-06-27 08:37:38,"Washington, D.C.",EIN Presswire: Pfizer Newswire,https://pbs.twimg.com/profile_images/1288519420021813249/q6tQsLDM_normal.jpg,1035,787,40,32658,EINPfizerNews,
67066114,2019-12-19 08:56:57,"BLCM, ",,"streetinsider.com/Corporate+News‚Ä¶, ",1207661099073638400,False,0,0,1,0,Twitter Web Client,"$BLCM director moving on to Incyte (INCY) Announces Edmund P. Harrigan, M.D. to Board https://t.co/JggbvPA36k via @Street_Insider","Street_Insider, ",,2009-08-19 13:45:22,Birgte,"`((,(Dieter 'Hovekamp)))",https://pbs.twimg.com/profile_images/417268395/dh_tw_2009_normal.png,3858,1845,237,71668,dhovekamp42,
772471873539977217,2019-12-19 08:22:36,"INCY, ",,"sec.gov/ix?doc=/Archiv‚Ä¶, ",1207652452503367680,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 8-K https://t.co/MqqjA0McVU,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
4312114277,2019-12-19 08:04:30,"INCY, ",,"fintel.io/s/us/incy?utm_‚Ä¶, ",1207647899754147846,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers https://t.co/hv89PLGlBC,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,163,418543,fintel_io,
1171873456276889600,2019-12-19 08:01:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1207647226564161537,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (19 Dec, 7:59am)

üì∞ Departure of Directors or Certain Officers; Election of Directors

https://t.co/AKMlVcxg96

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
3318510966,2019-12-19 07:51:56,,,"crweworld.com/article/news-p‚Ä¶, ",1207644736804147201,False,0,0,0,0,CRWE World,Incyte Names New Member to Its Board of Directors https://t.co/xGypVJKMcE,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
976297820532518914,2019-12-19 07:38:11,,,"dlvr.it/RLZPLJ, pic.twitter.com/U2H5XjmbZ9, ",1207641275740016642,False,0,0,0,0,dlvr.it,Incyte Names New Member to Its Board of Directors https://t.co/H9nuNJFOd1 https://t.co/U2H5XjmbZ9,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1134049078424162304,2019-12-19 07:38:01,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1207641233792757760,False,0,0,0,0,Newsfilter.io,Incyte Names New Member to Its Board of Directors $INCY https://t.co/LP4lVx5ITh,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
4035355935,2019-12-18 23:29:07,,,,1207518196523159553,False,0,0,0,0,WPTS Playlist,Incyte - Numbers,,,2015-10-24 21:01:50,"Pittsburgh, PA",WPTS Playlist,https://pbs.twimg.com/profile_images/658129792408023041/8nflCFL-_normal.jpg,478,5,38,638221,WPTSPlaylist,
1176558075798380544,2019-12-18 18:30:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1207443012894240768,False,0,0,0,0,InsiderActionMonitor,$INCY Paula Swain Dumps 2.5K Shares of Incyte https://t.co/wJaXiI6kGS,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
732361939490312192,2019-12-18 18:28:50,"INCY, ","markets, ","americanbankingnews.com/?p=12858604, ",1207442627190296576,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/cDXbVWmhHk #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-18 18:28:49,"INCY, ","stocks, ","americanbankingnews.com/?p=12858604, ",1207442624761802752,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/MLboZ1KkVX #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2920258887,2019-12-18 18:28:13,"INCY, ",,"dakotafinancialnews.com/?p=1399850, ",1207442474379218945,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/U3irs8HXP4",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
575910168,2019-12-18 15:38:38,,"YahooFinance, Traffic, Transportation, Shipping, Logistics, Trucking, ","truckingnews.us/incyte-gets-pr‚Ä¶, ",1207399795729395712,False,0,0,0,0,Trucking News,"Incyte Gets Priority Review for Cancer Treatment https://t.co/3Y2Dt5D7nP
#YahooFinance #Traffic #Transportation #Shipping #Logistics
Follow @AFTvitaliy for #Trucking News","AFTvitaliy, ",,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
17026971,2019-12-18 14:31:59,,"Drugs, DrugDevelopment, Biotech, ClinicalTrials, Cancer, Oncology, MoneyShows, InvestSmarter, ","hubs.ly/H0mjHSh0, ",1207383023899074561,False,1,0,0,0,HubSpot,"Incyte (INCY) recently announced that the FDA has accepted for Priority Review the company‚Äôs new drug application (NDA) for pemigatinib
https://t.co/Ctou3LhfyN
#Drugs #DrugDevelopment #Biotech #ClinicalTrials #Cancer #Oncology #MoneyShows #InvestSmarter",,,2008-10-28 15:34:16,"Sarasota, FL",MoneyShow,https://pbs.twimg.com/profile_images/1364338620832886784/_zPYsotA_normal.jpg,18664,10475,354,20332,MoneyShow,
1022006086872821762,2019-12-18 14:02:16,"INCY, INCY, ",,,1207375542879686656,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY is UP ‚¨Ü on Wed Dec 18
Currently at 91.55 USD for a 0.26% gain from previous close
üìà üìà üìà

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
213769181,2019-12-18 12:49:29,,,"instagram.com/p/Bt5eNhwAHlW, ",1207357227918475264,False,0,0,0,0,Twitter for iPhone,"Most innovative companies, 2018 |
@spectatorindex 
_______

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)

Longer list:
https://t.co/VjWXoqiFKa
_______","spectatorindex, ",,2010-11-09 14:11:29,Cuajimalpa de M - Cd de M√©xico,Carlos C√°rdenas G.,https://pbs.twimg.com/profile_images/1151477412971995141/7Daov6_x_normal.jpg,996,642,17,15283,CPCCCardenasG,
2266388972,2019-12-18 12:41:28,"INCY, ","stocks, ","dailypolitical.com/?p=3287663, ",1207355209334362119,False,0,0,0,0,Zapier.com,Mizuho Reaffirms Buy Rating for Incyte $INCY https://t.co/uCXQCqt6Bu #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-12-18 12:41:27,"INCY, ",,"dailypolitical.com/?p=3287663, ",1207355204921937921,False,0,0,0,0,Zapier.com,Mizuho Reaffirms Buy Rating for Incyte $INCY https://t.co/ykZSo0WR5l,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2829461701,2019-12-18 12:32:53,,,"genphys.com/science-news/w‚Ä¶, ",1207353051356360704,False,0,0,0,0,General Physics Laboratory,"When Will The Slump End?: Incyte Corporation, (NASDAQ: INCY) - Keep Reading - +GENERAL PHYSICS LABORATORY (GPL)

When Will The Slump End?: Incyte Corporation, (NASDAQ: INCY)¬†¬†Keep Reading

https://t.co/lNKAX7ljzI",,,2014-09-24 03:20:22,Los Angeles,General Physics Lab,https://pbs.twimg.com/profile_images/833549629614546944/LkoCEFz5_normal.jpg,676,72,27,356236,genphys,
732361939490312192,2019-12-18 12:15:42,"INCY, ","markets, ","americanbankingnews.com/?p=12856569, ",1207348727679275009,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at Mizuho https://t.co/2JZvVe3J4e #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-18 12:15:41,"INCY, ","stocks, ","americanbankingnews.com/?p=12856569, ",1207348723212308480,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reiterated at Mizuho https://t.co/Fa8XsQcTn5 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
374729426,2019-12-18 09:27:11,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1020653, pic.twitter.com/ACRFqBDg3e, ",1207306316714135553,False,0,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average moved above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/CEAp4R0JeS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ACRFqBDg3e",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
945846032281112577,2019-12-18 07:55:00,,"cancer, IndustryUpdates, ","xeraya.com/#!/firstline-r‚Ä¶, pic.twitter.com/U1AwmKyQyu, ",1207283118173908992,False,0,0,0,0,Twitter Web App,"Polycythemia Vera (PV) is a slow-growing blood #cancer where your bone marrow makes too many red blood cells. Ruxolitinib is now being studied for 1st-line use in the treatment of newly diagnosed patients with PV. #IndustryUpdates @Incyte @Novartis 
https://t.co/0AYqWTvb6U https://t.co/U1AwmKyQyu","Incyte, Novartis, ",,2017-12-26 21:37:21,Kuala Lumpur Federal Territory,Xeraya Capital,https://pbs.twimg.com/profile_images/945854370024890369/eHF6OWyO_normal.jpg,118,242,1,910,xerayacapital,photo
966006214818697218,2019-12-18 04:13:43,"INCY, ",,"theenterpriseleader.com/?p=2471401, ",1207227432299892736,False,0,0,0,0,Zapier.com,Incyte $INCY Downgraded by BidaskClub  https://t.co/DWx5Gg33VN,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
563084750,2019-12-17 21:18:26,"SPX, DJIA, NDX, FB, INCY, LULU, BA, ","Facebook, Lululemon, MercadoLibre, Boeing, ","traderscommunity.com/index.php/mark‚Ä¶, pic.twitter.com/emu3Lwmp9K, ",1207122922147602435,False,4,0,0,3,Twitter Web App,"Biggest $SPX $DJIA $NDX Stock Losers Last Week*
#Facebook $FB
Incyte $INCY
#Lululemon $LULU
#MercadoLibre
#Boeing $BA
https://t.co/0oce0FRRhK https://t.co/emu3Lwmp9K",,,2012-04-25 14:17:17,,Traders Community,https://pbs.twimg.com/profile_images/1359537033971183617/bnLftW2a_normal.jpg,18045,5625,918,94381,TradersCom,photo
1143596939549663233,2019-12-17 19:20:00,,"daytrading, ","finance.yahoo.com/news/heres-why‚Ä¶, pic.twitter.com/IuVZBiwfOk, ",1207093115955351552,False,2,0,0,0,Cloohawk,Does Incyte (INCY) have what it takes to be a top stock pick for momentum investors? Let's find out. #daytrading https://t.co/nx0Z6Rxw1M https://t.co/IuVZBiwfOk,,,2019-06-25 15:08:52,"Denver, CO",Jessica Crypto,https://pbs.twimg.com/profile_images/1181989483966631936/WcNyJaqI_normal.jpg,667,413,10,12863,JessicaCryptoML,photo
374729426,2019-12-17 11:54:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1018425, pic.twitter.com/0ZvdMIhRk6, ",1206981107469545472,False,1,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average moved above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/PIgEyCwqxw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0ZvdMIhRk6",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1000152196061782016,2019-12-16 17:25:52,,,"twitter.com/Incyte/status/‚Ä¶, ",1206702006968180738,False,0,0,0,0,Twitter Web App,"But seemingly not interested in being a good neighbor to the residential communities you back up to: light pollution 24/7, traffic through quiet neighborhoods.  It isn't enough to boast about your products, it is important to respect those you impact geographically. https://t.co/RhALva5wOa",,,2018-05-25 19:10:40,Joe's Home Town,Truth is Reality,https://pbs.twimg.com/profile_images/1271043438314762240/kM0LZkSm_normal.jpg,2728,4864,3,38544,TruthisReality1,
1079749795823214594,2019-12-16 12:23:42,"INCY, ","Incyte, NASDAQ, nasdaq100, WallSt, NYSE, fintech, fintwit, StockMarket, Stock, trading, investments, ","pic.twitter.com/95YzsN2Pgy, ",1206625963662086145,False,0,0,0,0,Twitter Web App,"$INCY #Incyte Corp gave a buy on our system in Oct 2019 &amp; is up 11% since. See chart. Key: above the cloud ""In Buy"" below ""In Sell"". #NASDAQ #nasdaq100 #WallSt #NYSE #fintech #fintwit #StockMarket #Stock #trading #investments https://t.co/95YzsN2Pgy",,,2018-12-31 09:43:06,Leeds,The Flying Stocksman,https://pbs.twimg.com/profile_images/1338104605901807616/mj9Jjtta_normal.jpg,3283,178,59,13749,flyingstocksman,photo
276404828,2019-12-16 12:08:19,,"FF, ","instagram.com/p/Bt5eNhwAHlW, ",1206622094051676160,False,0,0,0,0,IFTTT,"Most innovative companies, 2018

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)

Longer list: https://t.co/wNqOC9M70N [¬© spectatorindex] #FF",,,2011-04-03 04:46:29,Naija,Afroo~Media‚úäüèæ,https://pbs.twimg.com/profile_images/1148159896006737920/y3GHd15k_normal.jpg,562,493,1,37195,afrooomedia,
1979190776,2019-12-16 09:33:10,"INCY, ",,"tickerreport.com/?p=4868956, ",1206583046624948225,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/85E9VuLBjc,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2298709746,2019-12-16 09:32:41,"INCY, ",,"zpr.io/tNeb5, ",1206582926764388353,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/4DvnLYrRLZ,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
374729426,2019-12-16 08:21:05,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1013071, pic.twitter.com/DPx6wnoHGJ, ",1206564909263118338,False,0,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average moved above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/1AJbl3MFHG #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/DPx6wnoHGJ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1067285520206696448,2019-12-16 03:21:53,,"companies, Workday, Tesla, Facebook, ","pic.twitter.com/NcbN2VsycL, ",1206489613117734912,False,0,0,0,0,Twitter Web App,"Most innovative #companies, 2018

1. ServiceNow
2. #Workday
3. Salesforce
4. #Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. #Facebook

(Forbes) https://t.co/NcbN2VsycL",,,2018-11-27 00:14:32,UAE,Dev Technosys Dubai,https://pbs.twimg.com/profile_images/1073453783022231552/8zE92jVw_normal.jpg,1018,2715,6,946,Devtechno_Dubai,photo
1024214886849626113,2019-12-16 03:12:09,,"News, Economy, Politics, ","instagram.com/p/Bt5eNhwAHlW, ",1206487161555628032,False,0,0,0,0,IFTTT,"Most innovative companies, 2018

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)

Longer list: https://t.co/KRd3F8DCkn #News #Economy #Politics",,,2018-07-31 04:47:12,"London, England",The Economian,https://pbs.twimg.com/profile_images/1024220453727027200/xqaENOLE_normal.jpg,294,0,5,19215,TheEconomian,
732361939490312192,2019-12-15 18:48:04,"INCY, ","markets, ","americanbankingnews.com/?p=12837937, ",1206360306311675905,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Increases By 5.5% https://t.co/39iEdjjnMs #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-15 18:48:03,"INCY, ","stocks, ","americanbankingnews.com/?p=12837937, ",1206360299697254405,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Increases By 5.5% https://t.co/bqG9KdmwsW #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
329906361,2019-12-15 17:51:18,,,"instagram.com/p/Bt5eNhwAHlW, twitter.com/spectatorindex‚Ä¶, ",1206346020696793088,True,0,0,0,0,IFTTT,"Most innovative companies, 2018 1. ServiceNow 2. Workday 3. Salesforce 4. Tesla 5. Amazon 6. Netflix 7. Incyte 8. Unilever India 9. Naver 10. Facebook (Forbes) Longer list: https://t.co/eL6qHGyFDF¬†

spectatorindex The Spectator Index https://t.co/LJ7TbB2esQ",,,2011-07-05 16:08:26,#Slovenija ,Blog Slovenijaüá∏üáÆ,https://pbs.twimg.com/profile_images/713726293263691777/_UQufbal_normal.jpg,1963,571,0,166225,BlogSlovenija,
135209476,2019-12-15 09:18:09,"INCY, ",,"stockflare.com/stock/INCY.O, ",1206216881520156673,False,0,0,0,0,Stockflare Bot (Prod),$INCY: The target price for Incyte Corporation of $95.0 is now above that latest price of $91.51. (https://t.co/sK8NyKCUuN),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
374729426,2019-12-15 08:34:30,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1010877, pic.twitter.com/acM3iygcYN, ",1206205896608452611,False,0,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/TkH3GevsId #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/acM3iygcYN",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
374729426,2019-12-14 10:06:08,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1005344, pic.twitter.com/QIh5hzeyFG, ",1205866569286291458,False,0,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/mv0QwX9yHe #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/QIh5hzeyFG",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1979190776,2019-12-14 03:00:48,"INCY, CBWTF, ",,"tickerreport.com/?p=4861483, ",1205759530275135489,False,0,0,0,0,Zapier.com,Critical Survey: Incyte $INCY &amp; Auxly Cannabis Group $CBWTF https://t.co/QilFWAd884,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2266388972,2019-12-14 02:58:10,"CBWTF, INCY, ","stocks, ","dailypolitical.com/?p=3282420, ",1205758865209466881,False,0,0,0,0,Zapier.com,Comparing Auxly Cannabis Group $CBWTF &amp; Incyte $INCY https://t.co/vvO7u0Xq7R #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-12-14 02:58:09,"CBWTF, INCY, ",,"dailypolitical.com/?p=3282420, ",1205758861900165120,False,0,0,0,0,Zapier.com,Comparing Auxly Cannabis Group $CBWTF &amp; Incyte $INCY https://t.co/tvLHR3OpiQ,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
724136801602928640,2019-12-14 02:56:10,,,"statsflash.com/global-tyrosin‚Ä¶, ",1205758362022903808,False,1,0,0,0,Twitter Web Client,"Global Tyrosine Kinase JAK Inhibitors Market Strategic Insights 2019 ‚Äì Pfizer, Incyte, Novartis, Eli Lilly, Gilead https://t.co/zbFKkAXSnV",,,2016-04-24 03:24:02,,Dr. Sameer Agarwal,https://pbs.twimg.com/profile_images/845891413212643328/l9mdqdma_normal.jpg,74,14,0,1362,AgarwalDrSameer,
102728705,2019-12-13 11:54:14,"INCY, ","Incyte, Biotech, Aktien, Equities, ","pic.twitter.com/cJ8CBpE3kZ, twitter.com/weygand_gmt/st‚Ä¶, ",1205531385068478465,False,1,0,0,0,Twitter Web App,"#Incyte

Next: Bounce, again target 96,44 USD

$INCY #Biotech #Aktien #Equities https://t.co/cJ8CBpE3kZ https://t.co/tJpqDX6lwm",,,2010-01-07 11:48:13,Germany,Harald Weygand,https://pbs.twimg.com/profile_images/1260715770608324609/w3v2STvc_normal.jpg,6172,3709,184,15696,weygand_gmt,photo
33258536,2019-12-13 11:00:50,,,"acneblognetwork.com/?p=16863, ",1205517946933497857,False,0,0,0,0,Acne Blog Network App,"Global Acne Vulgaris Treatment Market Insights 2019 AbbVie Inc, Aop Orphan Pharmaceuticals AG, F. Hoffmann-La Roche Ltd, Galena Biopharma Inc, Incyte Corp - Health 365 News https://t.co/x6zWA7Pl6n",,,2009-04-19 13:40:24,"Phoenix, AZ",Eddie Edison,https://pbs.twimg.com/profile_images/378800000008569904/967f34ac8511a77330775a29922e1c7c_normal.jpeg,1059,752,5,60520,edison44,
374729426,2019-12-13 09:45:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/1003181, pic.twitter.com/GzpMSDdNu4, ",1205499106749288453,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds for this and other indicators: https://t.co/j5s39XIYUj #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GzpMSDdNu4,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
420644141,2019-12-13 09:40:00,,"oncology, ash19, ","pic.twitter.com/JXHFwaSawL, ",1205497603095293952,False,0,0,0,0,Twitter Web App,"#oncology segment of #ash19:
@AmgenOncology @Amgen @FinnPartners @TomCalvinJones @Jess_Lise @YaleMed @YNHH @SmilowCancer @ASCO @theNYCprgirl @Incyte @DVLSeigenthaler @NashMedNews @EIUPerspectives @escardio @DrAnneKatz @NIEHS @Areejmd @StoryCorps @abhishekchilku1 @JonMarronMD https://t.co/JXHFwaSawL","AmgenOncology, Amgen, FINNPartners, TomCalvinJones, Jess_Lise, YaleMed, YNHH, SmilowCancer, ASCO, theNYCprgirl, Incyte, DVLSeigenthaler, NashMedNews, escardio, DrAnneKatz, NIEHS, Areejmd, StoryCorps, JonMarronMD, ",,2011-11-24 17:18:48,Istanbul,Yasin Murat Yiƒüit,https://pbs.twimg.com/profile_images/1288450964500951041/LM3D8fT8_normal.jpg,325,10,5,826,yigit_ym,photo
33258536,2019-12-13 06:18:37,,,"acneblognetwork.com/?p=16802, ",1205446925677412352,False,0,0,0,0,Acne Blog Network App,"Global Acne Vulgaris Treatment Market Insights 2019 AbbVie Inc, Aop Orphan Pharmaceuticals AG, F. Hoffmann-La Roche Ltd, Galena Biopharma Inc, Incyte Corp - Health 365 News https://t.co/M2SHU3LKlg",,,2009-04-19 13:40:24,"Phoenix, AZ",Eddie Edison,https://pbs.twimg.com/profile_images/378800000008569904/967f34ac8511a77330775a29922e1c7c_normal.jpeg,1059,752,5,60520,edison44,
852931863547084801,2019-12-12 23:50:26,"INCY, ",,"zpr.io/tNai5, ",1205349233055936513,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.58 Per Share https://t.co/CIDE5M8ibC,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
966006214818697218,2019-12-12 23:49:22,"INCY, ",,"theenterpriseleader.com/?p=2456776, ",1205348967996960768,False,0,0,0,0,Zapier.com,Brokerages Expect Incyte Co. $INCY Will Post Quarterly Sales of $569.75 Million  https://t.co/8JUEYsw72f,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1188117778567454720,2019-12-12 16:40:08,"INCY, ",,"jodie.ai/shareholder/17‚Ä¶, ",1205240947300327424,False,0,0,0,0,erased17009697,"Dashyant Dhanak, EVP &amp; Chief Scientific Officer of INCYTE CORP - $INCY decreased their shareholding by 3% to now own a total of 13106 shares

https://t.co/2cqmOEsa1L",,,2019-10-26 11:38:58,London,Jodie Insights,https://pbs.twimg.com/profile_images/1310896987466760198/cVg3gmLj_normal.jpg,624,1781,16,28832,jodietheai,
121158213,2019-12-12 11:28:32,"INCY, ",,"AlertTrade.us, ",1205162530223489025,False,0,0,0,0,dlvr.it,TREND REVERSAL DOWN ALERT: $INCY Incyte Corporation Common Stock üìâ TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
374729426,2019-12-12 08:44:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/997683, pic.twitter.com/GFY2gQyt3C, ",1205121284020916234,False,0,0,0,0,Tickeron,$INCY's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and other indicators: https://t.co/uoh4Y9OfX5 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/GFY2gQyt3C,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
861087439,2019-12-12 07:21:34,"INCY, ","Incyte, stocks, trading, ","pic.twitter.com/juaDbLEmOI, ",1205100378074886144,False,1,0,0,0,Twitter for iPhone,$INCY 94.93$ can see 116/124 $ *** risky below 80 $ #Incyte #stocks #trading for 2020 ! https://t.co/juaDbLEmOI,,,2012-10-04 04:45:51,,Raf trading,https://pbs.twimg.com/profile_images/1309142917165076482/6f8foLOK_normal.jpg,20322,2998,232,33330,RafKadian,photo
1979190776,2019-12-12 01:58:46,"INCY, ",,"tickerreport.com/?p=4857056, ",1205019141083729920,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 12-Month High at $96.41 https://t.co/81m9k7ACda,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2266388972,2019-12-12 01:57:28,"INCY, ","stocks, ","dailypolitical.com/?p=3277988, ",1205018817103093762,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 12-Month High at $96.41 https://t.co/9kwrBe6rSa #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-12-12 01:57:28,"INCY, ",,"dailypolitical.com/?p=3277988, ",1205018814108307457,False,0,0,0,0,Zapier.com,Incyte $INCY Hits New 12-Month High at $96.41 https://t.co/2qifCzHMmL,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
930803511918411776,2019-12-12 01:33:20,"CBWTF, INCY, ",,"thelincolnianonline.com/?p=3258537, ",1205012742182227971,False,0,0,0,0,Zapier.com,Critical Survey: Auxly Cannabis Group $CBWTF &amp; Incyte $INCY https://t.co/omHntTnllo,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
374729426,2019-12-11 09:06:46,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/995376, pic.twitter.com/QBDgoRiSNH, ",1204764462915280897,False,0,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average moved above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/JrCGNWuQCq #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/QBDgoRiSNH",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
374729426,2019-12-10 10:42:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/991598, pic.twitter.com/KAv0B5S3de, ",1204426159779221505,False,0,0,0,0,Tickeron,"$INCY in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on December 3, 2019. View odds for this and other indicators: https://t.co/k2C8UUVe4o #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/KAv0B5S3de",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
998517334473048064,2019-12-09 20:29:00,"INCY, ",,"seekingalpha.com/article/431047‚Ä¶, ",1204211377386201090,False,1,0,0,0,Twitter Web App,"$INCY Biotech Analysis Central ""Incyte's NDA For Pemigatinib Drug Accepted, But It Is Not A One Hit Wonder"" https://t.co/uLRoK7PwqT",,,2018-05-21 06:54:18,,Terry Chrisomalis,https://pbs.twimg.com/profile_images/998522553831374848/XJJTjFHv_normal.jpg,711,2150,6,505,BioAnalysisCent,
3911174913,2019-12-09 16:30:00,,"ASH19, GVHD, CML, ","pic.twitter.com/f1jZBXQ8Ig, ",1204151232081739776,False,2,0,0,0,Twitter for Advertisers.,This evening's #ASH19 poster sessions will include data surrounding our discoveries in acute/chronic #GVHD and #CML that may drive treatment advances. Join us at 6:00 p.m. in Hall B. https://t.co/f1jZBXQ8Ig,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
732361939490312192,2019-12-09 13:20:14,"INCY, CBWTF, ","markets, ","americanbankingnews.com/?p=12791432, ",1204103475656843265,False,0,0,0,0,Zapier.com,Head to Head Contrast: Incyte $INCY &amp; Auxly Cannabis Group $CBWTF https://t.co/Fv9X2RlYzw #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-09 13:20:13,"INCY, CBWTF, ","stocks, ","americanbankingnews.com/?p=12791432, ",1204103472989310976,False,0,0,0,0,Zapier.com,Head to Head Contrast: Incyte $INCY &amp; Auxly Cannabis Group $CBWTF https://t.co/GUMKoawIO9 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2920258887,2019-12-09 13:16:26,"INCY, CBWTF, ",,"dakotafinancialnews.com/?p=1385304, ",1204102519879847938,False,1,0,0,0,Zapier.com,Contrasting Incyte $INCY &amp; Auxly Cannabis Group $CBWTF https://t.co/1bNEm8iaO0,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
3911174913,2019-12-09 12:00:00,,"MPN, ASH19, mpnsn, ","pic.twitter.com/Me6BzanC22, ",1204083283727831040,False,2,0,0,0,Twitter for Advertisers.,We're sharing insights from our latest global outcomes research evaluating #MPN treatment. Join us this evening at #ASH19. #mpnsn https://t.co/Me6BzanC22,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
284270364,2019-12-09 10:53:13,,,"ash.confex.com/ash/2019/webpr‚Ä¶, pic.twitter.com/mt0IwPiuhu, ",1204066478959538176,False,0,0,0,0,TweetDeck,"We are thrilled to have worked in conjunction with @Incyte by conducting operational work with sites, collecting and organizing the clinical data, and project management!

To view the full abstract, visit https://t.co/ZBbjTS7yWt https://t.co/mt0IwPiuhu","Incyte, ",,2011-04-18 20:02:25,"Cincinnati, Ohio",CTI Clinical Trials,https://pbs.twimg.com/profile_images/1237389081874759680/ukMlpupu_normal.jpg,4524,3143,65,1859,CTIClinical,photo
1889492676,2019-12-09 04:00:50,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1203962700331536384,False,1,0,0,1,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/CNi7to8QQR,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
1134049078424162304,2019-12-08 18:34:27,,,"newsfilter.io/articles/innov‚Ä¶, ",1203820161943228418,False,0,0,0,0,Newsfilter.io,"Innovent Biologics autoimmune, metabolic and other major diseases, announced that the new drug application submitted by Incyte to the U.S. F.. https://t.co/oCTnYLCEXu",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
3911174913,2019-12-08 17:30:00,,"CML, GVHD, ASH19, ","pic.twitter.com/iWFWkGKal1, ",1203803943630884864,False,1,0,0,0,Twitter for Advertisers.,We're sharing additional study findings surrounding treatment of #CML and acute/chronic #GVHD in 30 minutes at #ASH19. https://t.co/iWFWkGKal1,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
3911174913,2019-12-08 14:00:00,,"ASH19, mpnsm, ","pic.twitter.com/V5yRoNx50T, ",1203751095232860167,False,0,0,0,0,Twitter for Advertisers.,"We're sharing new data focused on the advancement of JAK inhibition from our RESPONSE, REALISE and COMFORT-I studies at #ASH19. Join us at 6:00 p.m. #mpnsm https://t.co/V5yRoNx50T",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
53395744,2019-12-08 13:29:28,,"GVHD, ASH19, ","twitter.com/jpgalvin/statu‚Ä¶, ",1203743411699933191,False,4,0,0,2,Twitter for iPhone,"Real üåç data on steroid refractory #GVHD. Even in modern era, *70% mortality in 4 months* with intensified immune suppression paradigm.  Begs the enduring question, what is the right üéØ for these patients? üôè for collaboration, @YuJingboAE, @Incyte and @jpgalvin!! @UMNews #ASH19 https://t.co/BGNhKHBmKm","YuJingboAE, Incyte, jpgalvin, UMNews, ",,2009-07-03 10:17:31,location:  in my head,Shernan Holtan MD,https://pbs.twimg.com/profile_images/1405983097879941124/4RzHTFei_normal.jpg,1784,1846,20,3128,sghmd,
18224660,2019-12-08 11:40:30,,"ASHP19, gvhd, ","pic.twitter.com/Ag9kT55M2L, ",1203715989470416898,False,1,1,0,1,Twitter for iPhone,Important work describing real-world clinical outcomes of steroid refractory aGVHD presented by Dr. Jingbo Yu @YuJingboAE at #ASHP19 @ASH_hematology @UICHemOnc @Incyte @UICancerCenter @UICGVHD #gvhd @aGVHD https://t.co/Ag9kT55M2L,"YuJingboAE, ASH_hematology, UICHemOnc, Incyte, UICancerCenter, UICGVHD, aGVHD, ",,2008-12-18 15:43:52,"Chicago, IL",jpgalvin,https://pbs.twimg.com/profile_images/1069441749708206080/08Trk_aY_normal.jpg,151,1076,1,70,jpgalvin,photo
374729426,2019-12-08 08:00:22,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/984030, pic.twitter.com/4hwD2yQRAL, ",1203660592768176128,False,1,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on November 25, 2019. View odds for this and other indicators: https://t.co/QqhEjioT3G #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/4hwD2yQRAL",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2181281054,2019-12-08 05:01:20,"INCY, ","markets, ","wkrb13.com/?p=1457804, ",1203615537605029894,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY to Announce $0.58 EPS https://t.co/A08BU7eD8Z #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1134049078424162304,2019-12-07 21:14:08,"MRK, SGEN, CARA, BIIB, AXSM, ",,"newsfilter.io/articles/biote‚Ä¶, ",1203497962761928706,False,0,0,0,1,Newsfilter.io,It has been a pretty uneventful week for the biotech sector with updates from a few companies. While Incyte got.. $MRK $SGEN $CARA $BIIB $AXSM https://t.co/CcekJtgrsv,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
2313740317,2019-12-07 19:16:18,"SRRA, ",,,1203468305757065216,False,1,0,0,0,StockTwits Web,"$SRRA this trial suggests that there will be a new standard of care in myelofibrosis.
Incyte marke cap $20 billion
While this is $34 million.
Guess what price will be within the next year?",,,2014-01-27 09:21:31,,Ezekiel saw the wheel.,https://pbs.twimg.com/profile_images/606827551919439874/rs1ZKZV__normal.jpg,96,63,1,6555,Ezehtim,
3911174913,2019-12-07 15:00:00,,"ASH19, MPN, mpnsm, ","pic.twitter.com/hvKCMNim2y, ",1203403807088140290,False,0,0,0,0,Twitter for Advertisers.,#ASH19 presentation info: Join us for this evening's poster presentations to learn more about our recent advancements in treating myelofibrosis that may impact #MPN patient communities. #mpnsm https://t.co/hvKCMNim2y,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
374729426,2019-12-07 10:14:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/980299, pic.twitter.com/ke4nYmBYaS, ",1203332081041854466,False,0,0,0,1,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on November 25, 2019. View odds for this and other indicators: https://t.co/UZjKwRd6D5 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ke4nYmBYaS",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
69603938,2019-12-07 07:12:45,,"netde, ","twitter.com/WillsElliman/s‚Ä¶, ",1203286220509462528,False,20,1,0,4,Twitter for iPhone,"Great news. @Incyte = some of the smartest Scientists in the world, making progress solving one of the most difficult problems - cancer.  Investors think is worth $20B.  Expanding &amp; hiring in Wilmington Delaware.  Awesome. @choosedelaware #netde https://t.co/VvqoB9Ho0h","Incyte, choosedelaware, ",,2009-08-28 10:41:28,Delaware,Ben duPont,https://pbs.twimg.com/profile_images/1363527332011589633/EjuDPUEJ_normal.jpg,9486,6249,142,5442,BenjaminduPont,
2266388972,2019-12-07 02:03:06,"INCY, ","stocks, ","dailypolitical.com/?p=3269381, ",1203208293751103488,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/b3DamF4hq7 #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-12-07 02:03:05,"INCY, ",,"dailypolitical.com/?p=3269381, ",1203208290055983104,False,0,0,0,0,Zapier.com,Zacks: Brokerages Expect Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/k4D0wfiI1D,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1979190776,2019-12-07 02:02:59,"INCY, ",,"tickerreport.com/?p=4848458, ",1203208265783480320,False,0,0,0,0,Zapier.com,Brokerages Anticipate Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/1i192FVFtf,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2019-12-07 02:02:56,"INCY, ","markets, ","americanbankingnews.com/?p=12773703, ",1203208251556401153,False,0,0,0,0,Zapier.com,Brokerages Anticipate Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/DuMIYzTyTB #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-07 02:02:55,"INCY, ","stocks, ","americanbankingnews.com/?p=12773703, ",1203208248209399808,False,0,0,0,0,Zapier.com,Brokerages Anticipate Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million https://t.co/mnPY3HNEot #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
3911174913,2019-12-06 20:09:42,,"MPN, MPNsm, ","pic.twitter.com/63EkoniTZq, ",1203119359604019200,False,2,0,0,0,Twitter Web App,"Thank you to @cure_magazine for hosting the 2019 MPN Heroes at this year‚Äôs Recognition Ceremony. Always such an honor to be surrounded by so many who support, empower and acknowledge the #MPN community. #MPNsm https://t.co/63EkoniTZq","cure_magazine, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
374729426,2019-12-06 11:04:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/976438, pic.twitter.com/uPCzHhJ5NF, ",1202982112640425986,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on November 25, 2019. View odds for this and other indicators: https://t.co/khuvlbZp4V #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/uPCzHhJ5NF",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
849417718642159616,2019-12-06 09:13:00,"INCY, ",,"zpr.io/taHy7, ",1202954093993574400,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $300,675.00 in Stock https://t.co/ja3WxVS0xU",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2416188264,2019-12-06 09:12:57,"INCY, ","markets, ","thestockobserver.com/?p=2492725, ",1202954081943408641,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 3,165 Shares of Stock  https://t.co/VGLIxJS80w #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
409373333,2019-12-06 07:00:21,,"WillsInWilm, InWilm, netde, delawareofficespace, ","lnkd.in/eWP-NQ5, lnkd.in/e8vZrYv, ",1202920713629425664,False,7,1,0,0,Hootsuite Inc.,"Hurray ‚Äì Incyte is able to keep growing in Wilmington &amp; has agreed to pay $50M to buy 20 acres to Wilmington Friends School .

https://t.co/vaUrx8FFRq

Here is an interview with Paula Swain from Incyte - https://t.co/16XXV59L49

#WillsInWilm #InWilm #netde #delawareofficespace",,,2011-11-10 12:02:59,"Wilmington, Delaware USA",Wills Elliman,https://pbs.twimg.com/profile_images/2767694093/76de5f13c49d237222551033ca563707_normal.jpeg,161,111,13,496,WillsElliman,
2266388972,2019-12-06 04:50:15,"INCY, ","stocks, ","dailypolitical.com/?p=3267640, ",1202887972699410432,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells 16,835 Shares of Stock https://t.co/o9LA2gnDX8 #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-12-06 04:50:15,"INCY, ",,"dailypolitical.com/?p=3267640, ",1202887969700487168,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells 16,835 Shares of Stock https://t.co/HGz78H2sXu",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1979190776,2019-12-06 04:47:55,"INCY, ",,"tickerreport.com/?p=4846720, ",1202887382250459136,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $1,599,325.00 in Stock https://t.co/rtyfXCaFwd",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
732361939490312192,2019-12-05 21:56:36,"INCY, ","markets, ","americanbankingnews.com/?p=12764657, ",1202783872368427008,False,0,0,0,0,Zapier.com,$0.58 Earnings Per Share Expected for Incyte Co. $INCY This Quarter https://t.co/AVhX8LOp7I #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-05 21:56:35,"INCY, ","stocks, ","americanbankingnews.com/?p=12764657, ",1202783868786487297,False,0,0,0,0,Zapier.com,$0.58 Earnings Per Share Expected for Incyte Co. $INCY This Quarter https://t.co/PEqqTj4sn4 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1134049078424162304,2019-12-05 14:57:58,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1202678521350344705,False,0,0,0,0,Newsfilter.io,Incyte to Present at Upcoming Investor Conference $INCY https://t.co/al53GETAVA,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
274569466,2019-12-05 12:31:11,,"netde, ","goo.gl/fb/u4mmmZ, ",1202641580189978626,False,0,0,0,0,Google,Incyte to Pay $50 Million for Friends School Property https://t.co/k9H4CbspMq #netde,,,2011-03-30 11:09:40,The Fabulous First State,Town Square Delaware,https://pbs.twimg.com/profile_images/1324437027291615236/PeIY6Mtk_normal.jpg,4566,1093,93,6394,TownSquareDE,
135209476,2019-12-05 11:21:05,"INCY, ",,"stockflare.com/stock/INCY.O, ",1202623939308077056,False,0,0,0,0,Stockflare Bot (Prod),$INCY: Incyte Corporation current price of $95.0 is now higher than the target price of $94.69. (https://t.co/sK8NyKCUuN),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
374729426,2019-12-05 10:15:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/972503, pic.twitter.com/Pd4BlBdHKn, ",1202607520407113736,False,0,0,0,1,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on November 25, 2019. View odds for this and other indicators: https://t.co/rO0fwb1riw #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Pd4BlBdHKn",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1069693680066420736,2019-12-05 08:05:13,"INCY, ",,"s.flashalert.me/w8fS2v, ",1202574650020114434,False,0,0,0,0,flashalerts,"$INCY: Issued Press Release on December 05, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/T8uxmzU4wg",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
14453501,2019-12-05 06:21:41,,,"delawarebusinessnow.com/2019/12/incyte‚Ä¶, ",1202548591157493762,True,0,0,0,1,WordPress.com,Incyte agrees to pay $50 million for portion of Friends School¬†property https://t.co/GApaDwFj3T,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
2181281054,2019-12-05 04:44:18,"INCY, ","markets, ","wkrb13.com/?p=1451594, ",1202524085416288263,False,0,0,0,0,Zapier.com,"Yao Wenqing Sells 16,835 Shares of Incyte Co. $INCY Stock https://t.co/VQ5LDOvpNX #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1134049078424162304,2019-12-04 22:11:55,"MRK, SGEN, CARA, BIIB, AXSM, ",,"newsfilter.io/articles/biote‚Ä¶, ",1202425338753507328,False,1,0,0,0,Newsfilter.io,It has been a pretty uneventful week for the biotech sector with updates from a few companies. While Incyte got.. $MRK $SGEN $CARA $BIIB $AXSM https://t.co/CcekJtgrsv,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
3113963440,2019-12-04 18:05:33,,,"dlvr.it/RKh3m0, pic.twitter.com/J1wZZQtucs, ",1202363340023951360,False,0,0,0,0,dlvr.it,Incyte nabs priority review for bile duct cancer drug; Temasek shows interest in another Woodford darling ‚Äî report https://t.co/vQjNmgjD8Q https://t.co/J1wZZQtucs,,,2015-03-25 04:40:13,,Thomas S√©n√©chal,https://pbs.twimg.com/profile_images/654316411158982656/T0ScIvOH_normal.jpg,19,137,2,529,Toto_Chal,photo
374729426,2019-12-04 14:30:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/969390, pic.twitter.com/BzMNiThTnK, ",1202309331418435584,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on November 25, 2019. View odds for this and other indicators: https://t.co/3b6LtUdQTJ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/BzMNiThTnK",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
963495628545327104,2019-12-04 11:17:10,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/aAYsTKfurm, ",1202260566426955776,False,0,0,0,0,STCK.PR0,"$INCY NEW ARTICLE : Incyte's NDA For Pemigatinib Drug Accepted, But It Is Not A One Hit Wonder https://t.co/MFB6Rlv76T Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/aAYsTKfurm",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
23059499,2019-12-04 11:12:59,"INCY, ","investing, stocks, stockmarket, ","seekingalpha.com/article/431047‚Ä¶, ",1202259512406626304,False,0,0,0,0,SAArticlesTwitter,"$INCY - Incyte's NDA For Pemigatinib Drug Accepted, But It Is Not A One Hit Wonder. Follow this and any other stock on Seeking Alpha! https://t.co/h9i9Zr8m6y #investing #stocks #stockmarket",,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
3911174913,2019-12-04 10:17:51,,,"pic.twitter.com/upDV0MXA4e, ",1202245638634790912,False,13,0,0,1,Twitter Web App,"We are proud to share that our CEO, Herv√© Hoppenot, has been recognized by the @PHLBizJournal as one of the Most Admired CEOs in 2019. His leadership guides our mission to support patients and the communities we serve. https://t.co/upDV0MXA4e","PHLBizJournal, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
963495628545327104,2019-12-04 10:05:07,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/6c6xrE2xpU, ",1202242432169136129,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : Why Incyte Stock Climbed 12.2% in November https://t.co/0ba9d6gTa1 Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/6c6xrE2xpU,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
477131488,2019-12-04 09:34:56,,"ovariancancer, immunotherapy, OVCA, LAG3, PD1, Bridge2019, ","pic.twitter.com/GcnD8ZXYGL, pic.twitter.com/GcnD8ZXYGL, pic.twitter.com/GcnD8ZXYGL, pic.twitter.com/GcnD8ZXYGL, ",1202234838339792896,False,8,1,1,4,Twitter for iPhone,Prof @KunleOdunsiMD #ovariancancer #immunotherapy ROCKSTAR @RoswellPark @TheBuffaloNews asks why aren‚Äôt response rates better for #OVCA /#LAG3 &amp; #PD1 &amp; compensatory mechanisms inhibit anticancer immunity #Bridge2019 @FondMelanoma @BMS_ImmunOnc_US @Incyte @Merck @Novartis @WNYOCP https://t.co/GcnD8ZXYGL,"KunleOdunsiMD, RoswellPark, TheBuffaloNews, FondMelanoma, BMS_ImmunOnc_US, Incyte, Merck, Novartis, WNYOCP, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
930803511918411776,2019-12-04 07:19:47,"INCY, ",,"thelincolnianonline.com/?p=3244282, ",1202200828171431937,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 3,165 Shares https://t.co/n8dii7EU5E",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
68559732,2019-12-04 07:02:39,"INCY, ",,"zpr.io/tTwQu, ",1202196516280176640,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 16,835 Shares https://t.co/LSwQz9xXF9",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
895929863521095680,2019-12-03 21:11:16,"INCY, ","GoldenCross, Incyte, stocks, trading, finance, market, ","bit.ly/2LgQIOA, pic.twitter.com/Yl41cfHM9Y, ",1202047688394625024,False,0,0,0,1,TradeFlags,#GoldenCross $INCY at 94.10 R8  HiLo 97% T1Y 95 buy PE 50.3 DIV N/A #Incyte Cor #stocks #trading #finance #market https://t.co/lvtqjQeHiT https://t.co/Yl41cfHM9Y,,,2017-08-11 04:48:19,1130,TradeFlags,https://pbs.twimg.com/profile_images/1444247772769792002/Hc_nWhvE_normal.jpg,636,206,11,58994,TradeFlags,photo
930803511918411776,2019-12-03 17:54:14,"INCY, ",,"thelincolnianonline.com/?p=3243093, ",1201998101780803584,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 16,835 Shares https://t.co/stvYDShcv2",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2525892205,2019-12-03 17:52:06,"INCY, ","investingnews, ","modernreaders.com/?p=2579721, ",1201997566717677569,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 3,165 Shares  https://t.co/ggZBtQ588S #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
732361939490312192,2019-12-03 17:50:15,"INCY, ","markets, ","americanbankingnews.com/?p=12745410, ",1201997102483738626,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 3,165 Shares https://t.co/vVB0RZIhaf #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-03 17:50:14,"INCY, ","stocks, ","americanbankingnews.com/?p=12745410, ",1201997098557870080,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 3,165 Shares https://t.co/ynB6ZGf4Sx #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2019-12-03 17:49:56,"INCY, ","markets, ","americanbankingnews.com/?p=12745451, ",1201997021101658112,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 16,835 Shares https://t.co/FXbAO0GclH #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-12-03 17:49:55,"INCY, ","stocks, ","americanbankingnews.com/?p=12745451, ",1201997018014597121,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 16,835 Shares https://t.co/3Aigj5vF5d #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2920258887,2019-12-03 17:48:59,"INCY, ",,"dakotafinancialnews.com/?p=1374115, ",1201996783544606728,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 3,165 Shares of Stock https://t.co/Npm9w39h9O",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
1176558075798380544,2019-12-03 16:38:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1201979009866829827,False,0,0,0,0,InsiderActionMonitor,$INCY Barry Flannelly Dumps 6.6K Shares of Incyte https://t.co/VrZjwC5nv2,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
772471873539977217,2019-12-03 16:36:51,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1201978629401513985,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/bwmuM80zZc,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
3911174913,2019-12-03 11:00:00,,,,1201893859229360129,False,7,0,0,2,Twitter for Advertisers.,"Since its creation in 2016, our Incyte Involved program has played an important role in our company's DNA. We're committed to making a difference in our communities.",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
60224553,2019-12-03 10:40:37,,,"dlvr.it/RKbHcq, pic.twitter.com/jnbc0f51Xq, ",1201888979412348929,False,0,0,0,0,dlvr.it,Did Hedge Funds Drop The Ball On Incyte Corporation (INCY) ? - Yahoo Finance https://t.co/ykeqAjs06H https://t.co/jnbc0f51Xq,,,2009-07-25 23:46:54,"NYC, NY, USA",Peter Went,https://pbs.twimg.com/profile_images/1216976432825540608/1d7laUNR_normal.jpg,9226,81,306,124562,HedgeFundRisk,photo
1199800417821048834,2019-12-03 10:20:46,,"Hedge_Funds, News, Is_INCY_A_Good_Investment_Right_Now_, ","dlvr.it/RKbDCj, bit.ly/2CMEYi0, pic.twitter.com/wsZqEHEVwK, ",1201883985711788032,False,0,0,0,0,dlvr.it,#Hedge_Funds #News #Is_INCY_A_Good_Investment_Right_Now_ Did Hedge Funds Drop The Ball On Incyte Corporation (INCY) ? https://t.co/MY6CLcci2m https://t.co/py0IHBtDku https://t.co/wsZqEHEVwK,,,2019-11-27 16:21:43,Trading Strategies,ETF Screener & Stock Picker,https://pbs.twimg.com/profile_images/1199802807215411200/BLXM-mnZ_normal.jpg,249,158,3,130885,ETFsStockPicker,photo
15974185,2019-12-03 09:56:32,,,"dlvr.it/RKb7v7, ",1201877886623453185,False,1,0,0,0,dlvr.it,Is IBD 50 Drugmaker Incyte Stock On The Cusp Of Innovation-Fueled Growth Spurt? https://t.co/iNSQTbxyDC,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
773870221237026816,2019-12-03 03:01:49,,"pharma, regulatory, ","ift.tt/33JDtMK, ",1201773519060787201,False,0,0,0,0,IFTTT,Incyte nabs priority review for bile duct cancer drug; Temasek shows interest in another Woodford darling ‚Äî report: https://t.co/SMjI1Nh7YD #pharma #regulatory,,,2016-09-08 09:06:53,"Vienna, Austria",Pharma Regulatory,https://pbs.twimg.com/profile_images/1203329690779504647/URvpJyls_normal.jpg,1054,1657,7,14716,EURegulatory,
3460109487,2019-12-03 03:00:01,"INCY, ","Temasek, ","endpts.com/incyte-nabs-pr‚Ä¶, ",1201773064758988801,False,1,0,0,1,Buffer,Incyte nabs priority review for bile duct cancer drug; #Temasek shows interest in another Woodford darling ‚Äî report https://t.co/CmSWVwAcNy $INCY,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
1134713973612392448,2019-12-03 00:35:05,,,"investor.incyte.com/news-releases/‚Ä¶, ",1201736594522300416,False,1,0,0,0,Twitter Web App,"CHOLANGIOCARCINOMA: the FDA have granted priority approval review of pemigatinib for patients harbouring FGFR2 fusions, based on interim data from the phase II FIGHT-202 study showing ORR 36%.
https://t.co/fNmcywygwt",,,2019-06-01 02:51:08,,Cancer_Evolve,https://pbs.twimg.com/profile_images/1378246153456775168/6A58Bh4H_normal.jpg,192,0,2,893,cancer_evolve,
1134049078424162304,2019-12-02 22:47:41,,,"newsfilter.io/articles/innov‚Ä¶, ",1201709565697347584,False,0,0,0,0,Newsfilter.io,"Innovent Biologics autoimmune, metabolic and other major diseases, announced that the new drug application submitted by Incyte to the U.S. F.. https://t.co/oCTnYLCEXu",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
39928970,2019-12-02 18:56:46,,"cholangiocarcinoma, Incyte, pemigatinib, InnoventBiologics, FDA, ","pharmanewsdaily.com/incyte-secures‚Ä¶, pic.twitter.com/wI3BJHtHqV, ",1201651453724676097,False,0,0,0,0,WordPress.com,Incyte secures FDA priority review for pemigatinib in #cholangiocarcinoma #Incyte #pemigatinib #InnoventBiologics #FDA https://t.co/yd3wAw1DPb https://t.co/wI3BJHtHqV,,,2009-05-14 00:40:33,Hyderabad,OyeCricket.com,https://pbs.twimg.com/profile_images/590370768514486272/bZssEsY4_normal.png,1299,78,25,51757,cricket_fundas,photo
916787510822436864,2019-12-02 17:48:23,"INCY, ",,"investors.com/research/incyt‚Ä¶, ",1201634244323422208,False,1,0,0,0,StockTwits Web,"$INCY Is IBD 50 Drugmaker Incyte Stock On The Cusp Of Innovation-Fueled Growth Spurt?

https://t.co/t30a2TjCgB",,,2017-10-07 18:09:10,"New York, USA",Top Stock Alerts,https://pbs.twimg.com/profile_images/917029562432872449/VJbFmEQ0_normal.jpg,93095,0,955,158453,TopStockAlerts1,
17393998,2019-12-02 16:23:57,,"WomenOnBoards, ","ow.ly/l1Zf30pYqhn, ",1201612995094368258,False,0,0,0,0,Hootsuite Inc.,"#WomenOnBoards in DE = 27.6%; leaders include Navient, Artesian Resources Corp., Incyte Corp., Interdigital Inc., SLM Corp., The Chemours Corp. &amp; WSFS Financial Corp.  https://t.co/vXUllG12j7",,,2008-11-14 14:48:33,"Cincinnati, OH",GenderEQA,https://pbs.twimg.com/profile_images/461198030952071168/mD4pblBq_normal.png,5727,1753,231,7095,GenderEQA,
14453501,2019-12-02 14:26:02,,,"delawarebusinessnow.com/2019/12/incyte‚Ä¶, ",1201583321966424064,True,0,0,0,0,WordPress.com,Incyte gets fast-track review for drug aimed at treating rare type of bile duct¬†cancer https://t.co/AFn3Gkt8Sx,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
3101763273,2019-12-02 13:04:37,,,"bit.ly/2RtrOfb, pic.twitter.com/vSpT2eJQ92, ",1201562829599494144,False,0,0,0,1,Twitter Web App,"NASP is pleased to feature @Incyte as the December 2019 Corporate Member of the Month. The spotlight program is designed to promote awareness, appreciation &amp; connectivity amongst NASP members. Visit https://t.co/rlUXbEIpkC for more info. https://t.co/vSpT2eJQ92","Incyte, ",,2015-03-21 09:16:17,"Washington, DC",NASP,https://pbs.twimg.com/profile_images/579272203662831616/1vJDKo11_normal.png,1134,281,14,797,Rx_Specialty,photo
2891146588,2019-12-02 12:09:05,,"breastcancer, ","briacell.com/investor-relat‚Ä¶, pic.twitter.com/C0KFwsCrOM, ",1201548855935983618,False,0,0,0,0,Sprout Social,"BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT‚Ñ¢ in combination with Incyte compounds, INCMGA00012 and epacadostat, in advanced #breastcancer.

For more information on BriaCell &amp; its clinical study, please visit: https://t.co/36OH6JuPOm https://t.co/C0KFwsCrOM",,,2014-11-24 13:16:48,"New York, NY",BriaCell,https://pbs.twimg.com/profile_images/1433876026656952323/yM_H4sLw_normal.jpg,1215,551,9,477,BriaCell,photo
133504478,2019-12-02 11:53:15,,"strategy, competitiveintelligence, marketing, pharmaceutical, healthcare, biotech, productmarketing, pharma, ","dlvr.it/RKX0gt, lqventures.com, pic.twitter.com/ewUIpTSQXG, ",1201544870894039040,False,0,0,0,2,dlvr.it,Incyte nabs priority review for bile duct cancer drug; Temasek shows interest in another Woodford darling ‚Äî report https://t.co/6wcg2Qjkrs &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #biotech #productmarketing #pharma https://t.co/ewUIpTSQXG,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
3460109487,2019-12-02 11:49:19,,,"endpts.com/incyte-nabs-pr‚Ä¶, ",1201543879599808518,False,0,0,0,0,Buffer,Incyte nabs priority review for bile duct cancer drug; Temasek shows interest in another Woodford darling ‚Äî report https://t.co/CmSWVwAcNy,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
4489344085,2019-12-02 11:27:54,,,"pic.twitter.com/IeIvR6ImNg, pic.twitter.com/IeIvR6ImNg, pic.twitter.com/IeIvR6ImNg, ",1201538489738833921,False,0,0,0,0,Twitter for Android,"What pains me is seeing healthcare sector not sustaining the good course it was promising for this Q4, not looking like they'll end this year on an uplifting note. Except Bristol Myers Squibb, they got a chance (and Incyte if it gets back on track)
Also a promising stick may join https://t.co/IeIvR6ImNg",,,2015-12-07 15:00:46,,Undead Flint,https://pbs.twimg.com/profile_images/1453237282073452545/DODvThAN_normal.jpg,522,333,41,202013,literallly_who,photo
1979190776,2019-12-02 11:01:40,"INCY, ",,"tickerreport.com/?p=4839462, ",1201531890756472833,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 52-Week High at $95.52 https://t.co/2xG9G4ihdQ,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2266388972,2019-12-02 10:59:56,"INCY, ","stocks, ","dailypolitical.com/?p=3260373, ",1201531451382149133,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 12-Month High at $95.52 https://t.co/hiD5CR2kZ0 #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-12-02 10:59:55,"INCY, ",,"dailypolitical.com/?p=3260373, ",1201531447674314754,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 12-Month High at $95.52 https://t.co/YIwpggMBM5,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1126479667442126848,2019-12-02 09:43:12,"INCY, ","Stocks, UnusualActivity, ",,1201512141393666048,False,0,0,0,0,TweetDeck,"Incyte Corporation $INCY up by 0.94% at $95.04

UNUSUAL ACTIVITY VOLUME 1453.31% STRENGTH 505.8% 

#Stocks #UnusualActivity",,,2019-05-09 09:30:56,London,BREAKING STOCK NEWS,https://pbs.twimg.com/profile_images/1436383970774720513/ttpG7KuY_normal.jpg,2727,7,52,8959,UnusuallyActive,
2298709746,2019-12-02 02:29:53,"INCY, ",,"zpr.io/tTtgS, ",1201403097005928448,False,0,0,0,0,Zapier.com,Incyte $INCY Lifted to Buy at BidaskClub https://t.co/4XQoOSg6Y9,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
68559732,2019-12-02 02:29:46,"INCY, ",,"zpr.io/tTtgD, ",1201403063803826176,False,0,0,0,0,Zapier.com,Incyte $INCY Lifted to Buy at BidaskClub https://t.co/mFd7wrvna8,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
852931863547084801,2019-12-01 16:55:03,"INCY, ",,"zpr.io/tTnyr, ",1201258434311663616,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $93.32 Consensus Price Target from Analysts https://t.co/wVNnjUZMUl,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
966006214818697218,2019-12-01 16:52:51,"INCY, ",,"theenterpriseleader.com/?p=2435965, ",1201257878675476481,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $93.32 Consensus Price Target from Brokerages  https://t.co/xSI3NYMRc7,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
374729426,2019-12-01 13:16:36,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/963886, pic.twitter.com/PQiHH0XGPx, ",1201203457786445825,False,0,0,0,1,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on November 25, 2019. View odds for this and other indicators: https://t.co/qQOvt0lVMI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/PQiHH0XGPx",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1979190776,2019-12-01 07:41:02,"INCY, ",,"tickerreport.com/?p=4837222, ",1201119010915528704,False,0,0,0,0,Zapier.com,Incyte $INCY Lifted to Buy at BidaskClub https://t.co/BR5ekjXEdW,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
852931863547084801,2019-12-01 01:57:31,"INCY, ",,"zpr.io/tYBeV, ",1201032561809641473,False,0,0,0,0,Zapier.com,Incyte $INCY Given Buy Rating at Mizuho https://t.co/7uhUFuMMFB,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
127591460,2019-11-30 23:07:10,,,,1200989693111885824,False,0,0,0,0,Twitter Web App,"We'll buy Pure Cycle Corp($PCYO), The Ensign Group, Inc ($ENSG), Incyte Corp($INCY) and sell Jacobs Engineering Group Inc ($JEC), New Jersey Resources Corp($NJR), World Wrestling Entertainment, Inc ($WWE) at market open on 12/2/2019. (Year to date return 35.2%. see website)",,,2010-03-29 13:53:46,,A+ Stocks,https://pbs.twimg.com/profile_images/378800000089008202/1a7f0d7594b0ee97b2de1d86144215de_normal.png,4008,3529,31,692,aplusstocks,
374729426,2019-11-30 14:37:49,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/961603, pic.twitter.com/tGdqEUX1kl, ",1200861511326945280,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on November 25, 2019. View odds for this and other indicators: https://t.co/1dRiEKVs79 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/tGdqEUX1kl",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2288833020,2019-11-30 09:22:10,,,"bwnews.pr/35GbQ8E, twitter.com/Incyte/status/‚Ä¶, ",1200782075772710912,False,0,0,0,0,Twitter Web App,"‚ÄúThere is a significant need for new therapies for patients with cholangiocarcinoma, who have limited treatment options beyond first-line chemotherapy and often face a poor prognosis‚Äù Read more about @Incyte‚Äôs breaking news: https://t.co/BbJwvR6BcT https://t.co/CT52vEAXyX","Incyte, ",,2014-01-12 18:59:53,US & China,WuXi AppTec,https://pbs.twimg.com/profile_images/524834082262245376/J4kjV77Z_normal.png,4740,2153,71,1796,WuXi_AppTec,
849417718642159616,2019-11-30 05:26:27,"INCY, ",,"zpr.io/tYdip, ",1200722753474695169,False,0,0,0,0,Zapier.com,Incyte $INCY Raised to Buy at BidaskClub https://t.co/0mbJhFPNs8,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1134049078424162304,2019-11-29 21:59:26,"AGIO, INCY, VRTX, ANIK, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1200610258185416704,False,0,0,0,1,Newsfilter.io,Incyte announced that the FDA has accepted its new drug application for its investigational FGFR inhibitor pemigatin.. $AGIO $INCY $VRTX $ANIK https://t.co/hCsreb4yNt,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
2920258887,2019-11-29 12:58:42,"INCY, ",,"dakotafinancialnews.com/?p=1365079, ",1200474176492113921,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $93.32 Consensus Target Price from Brokerages https://t.co/v0F66GLSsh,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
68559732,2019-11-29 11:34:55,"INCY, ",,"zpr.io/tY2iG, ",1200453093273591815,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Mizuho https://t.co/ec9ngCoA58,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
1943734777,2019-11-29 11:28:02,,,"dlvr.it/RKMvtj, ",1200451361801830400,False,0,0,0,0,dlvr.it,Priority Review for Incyte‚Äôs pemigatinib https://t.co/Xc2iSG7URG,,,2013-10-07 06:37:25,Grimsby,Pharma Business Int,https://pbs.twimg.com/profile_images/1184014435368742913/DxTdM0oY_normal.jpg,290,42,9,4775,PBIForum,
391492257,2019-11-29 09:00:12,"INCY, ",,"businesswire.com/news/home/2019‚Ä¶, fdatracker.com/fda-calendar/, ",1200414157633400833,False,0,0,0,0,FDA Tracker,$INCY New PDUFA Date 2020-05-30 INCYTE Link:https://t.co/9Irr5GfTjj Calendar:https://t.co/sCt1qK7blT,,,2011-10-15 13:01:13,San Francisco,FDA Tracker,https://pbs.twimg.com/profile_images/1667207308/square_logo_normal.png,4992,14,113,4060,fda_tracker,
930803511918411776,2019-11-29 08:17:56,"INCY, ",,"thelincolnianonline.com/?p=3233249, ",1200403521612460032,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $192,780.00 in Stock https://t.co/RO3killgrp",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
773870221237026816,2019-11-29 03:08:25,,"pharma, regulatory, ","ift.tt/34tdXg5, ",1200325630128279553,False,0,0,0,0,IFTTT,Incyte claims FDA priority review for bile duct cancer drug: https://t.co/EQOWdiOn8L #pharma #regulatory,,,2016-09-08 09:06:53,"Vienna, Austria",Pharma Regulatory,https://pbs.twimg.com/profile_images/1203329690779504647/URvpJyls_normal.jpg,1054,1657,7,14716,EURegulatory,
45543166,2019-11-28 18:01:08,,,"pmlive.com/pharma_news/in‚Ä¶, ",1200187900824104968,False,0,0,0,1,SocialPilot.co,Incyte claims FDA priority review for bile duct cancer drug - PMLiVE https://t.co/7zkN2OLGF4,,,2009-06-08 07:07:45,"Surrey, UK",Pharmaceutical Market Europe,https://pbs.twimg.com/profile_images/378800000806601474/9cf87bf47a70fe715664e76280625c82_normal.jpeg,14407,3838,368,16661,PMLiVEcom,
240286075,2019-11-28 11:40:00,,,"buff.ly/2Or1Quj, ",1200091985182412801,False,0,0,0,0,Buffer,: Incyte claims FDA priority review for bile duct cancer drug https://t.co/Ba0EWLiAkr,,,2011-01-19 10:41:34,,ScienceSeeker Feed,https://pbs.twimg.com/profile_images/1220009784/avatar_normal.gif,1066,3,126,480354,SciSeekFeed,
1979190776,2019-11-28 10:27:16,"INCY, ",,"tickerreport.com/?p=4828235, ",1200073681839513601,False,0,0,0,0,Zapier.com,Incyte $INCY Receives Buy Rating from Mizuho https://t.co/zjDQAf0FOw,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2266388972,2019-11-28 10:23:36,"INCY, ","stocks, ","dailypolitical.com/?p=3249153, ",1200072757352030209,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at Mizuho https://t.co/fxzunVqhdx #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-11-28 10:23:35,"INCY, ",,"dailypolitical.com/?p=3249153, ",1200072754256633857,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY Buy Rating Reiterated at Mizuho https://t.co/i3XiEszf4Z,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
984134429777031173,2019-11-28 09:24:29,,,"twitter.com/Incyte/status/‚Ä¶, ",1200057882043199490,False,0,0,0,0,Twitter for iPhone,Keep working on it! Thanks! DrG https://t.co/6UfUgsjfyJ,,,2018-04-11 14:21:47,"Philadelphia, PA",Geneva Harris PhD,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,2463,5008,2,47262,HartisPhd,
1889492676,2019-11-28 08:45:58,"INCY, ","Incyte, NDA, Pemigatinib, Cholangiocarcinoma, ","1stoncology.com/blog/incyte-an‚Ä¶, ",1200048186833793024,False,0,0,0,1,Troi URL Plug-in,#Incyte Announces Acceptance and Priority Review of #NDA for #Pemigatinib as a Treatment for Patients with #Cholangiocarcinoma $INCY https://t.co/ATl19is7ns,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
374729426,2019-11-28 07:54:14,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/955621, pic.twitter.com/K54S1HCc0m, ",1200035167550636032,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on November 25, 2019. View odds for this and other indicators: https://t.co/MvBZaRSmL9 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/K54S1HCc0m",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2525892205,2019-11-28 07:26:59,"INCY, ","investingnews, ","modernreaders.com/?p=2566151, ",1200028310111023105,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $192,780.00 in Stock  https://t.co/hQlEflAHlz #investingnews",,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
821413810116395009,2019-11-28 05:08:25,,,"is.gd/2h7EP8, pic.twitter.com/qxEDyHhBTJ, ",1199993440211292160,False,0,0,0,0,GMP news,FDA Accepted Incyte‚Äôs NDA for Priority Review of Pemigatinib - https://t.co/OAq0b5c0Kq https://t.co/qxEDyHhBTJ,,,2017-01-17 12:48:08,,GMPnews.Net,https://pbs.twimg.com/profile_images/821775776269946881/LnUS5mq3_normal.jpg,277,272,0,7581,GMPnewsNet,photo
2181281054,2019-11-28 04:59:18,"INCY, ","markets, ","wkrb13.com/?p=1434483, ",1199991143682981888,False,0,0,0,0,Zapier.com,"Paul Trower Sells 15,000 Shares of Incyte Co. $INCY Stock https://t.co/nEbdqAfDwS #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
72272550,2019-11-28 04:54:19,,"award, Employer, ","sciencemag.org/features/2019/‚Ä¶, pic.twitter.com/lVs2KDhYGK, pic.twitter.com/lVs2KDhYGK, pic.twitter.com/lVs2KDhYGK, pic.twitter.com/lVs2KDhYGK, ",1199989889724551169,False,5,0,0,0,Twitter for iPhone,"Finally the #award is at @merckgroup‚Äòs headquarters in @Stadt_Darmstadt: @sciencemagazine‚Äòs Top #Employer recognition. As @aaas‚Äò publication states it: ‚ÄûTop5 innovators with breakthroughs in products and pricing‚Äú. 
@Alnylam @Regeneron @Incyte @spark_tx 
https://t.co/bB4ZOSqTrV https://t.co/lVs2KDhYGK","merckgroup, Stadt_Darmstadt, ScienceMagazine, aaas, Alnylam, Regeneron, Incyte, spark_tx, ",,2009-09-07 08:43:56,"Hessen, Germay",Gangolf Schrimpf,https://pbs.twimg.com/profile_images/1316330601176236032/svjCzqp2_normal.jpg,983,3102,25,4533,GangolfSchrimpf,photo
3314135167,2019-11-28 04:15:31,,"jobs, ","goo.gl/fb/Q5AExx, ",1199980127855292416,False,0,0,0,0,Google,#jobs FDA accepts Incyte‚Äôs NDA for priority review of pemigatinib to treat‚Ä¶ https://t.co/nkTwjPCkbR,,,2015-08-13 02:43:55,,Career Biotech,https://pbs.twimg.com/profile_images/872856527731793920/HqYH3X_9_normal.jpg,110,59,1,35799,CareerBiotech,
1096085580868407297,2019-11-28 04:09:50,,"PMEA2019, ","pic.twitter.com/r3IVmSzfzy, pic.twitter.com/r3IVmSzfzy, pic.twitter.com/r3IVmSzfzy, ",1199978698121842688,False,7,0,0,3,Twitter for iPhone,"The team had a fantastic time at the #PMEA2019 last night &amp; were hugely proud to be finalists in the Excellence in Patient Education &amp; Support category, for their work on Incyte Biosciences‚Äô CML Life patient support platform. Well done to all the deserving winners! @PMLiVEcom https://t.co/r3IVmSzfzy","PMLiVEcom, ",,2019-02-14 11:35:41,"London, Marlow",OPEN Health Patient & Brand Communications,https://pbs.twimg.com/profile_images/1278218433398820865/3nKM9HAK_normal.jpg,147,257,0,241,OPENHealthPBC,photo
930803511918411776,2019-11-28 02:53:41,"INCY, ",,"thelincolnianonline.com/?p=3228570, ",1199959532690165760,False,0,0,0,0,Zapier.com,Incyte $INCY Upgraded to ‚ÄúBuy‚Äù by BidaskClub https://t.co/cKYz1zy3pp,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2525892205,2019-11-28 00:51:37,"INCY, ","investingnews, ","modernreaders.com/?p=2565317, ",1199928813351780352,False,0,0,0,0,Zapier.com,Incyte $INCY Trading 5.9% Higher  https://t.co/jg0HxLg6fa #investingnews,,,2014-05-26 17:20:18,Florida,InterCooler,https://pbs.twimg.com/profile_images/471038514675474432/wc-6YgXp_normal.jpeg,854,11,102,1269522,intercooleronli,
1006334607946649600,2019-11-28 00:32:32,,,"dlvr.it/RKGhVv, ",1199924013444694022,False,0,0,0,0,dlvr.it,Incyte Announces Acceptance and Priority Review of NDA for Pemigatinib as a Treatment for Patients with Cholangiocarcinoma https://t.co/AqZN7vn5YY,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
56121651,2019-11-27 18:00:07,"VRCA, INCY, ZSAN, ARAV, ASLN, HEPA, OBSV, SEEL, ",,"biopharmcatalyst.com/news/2019/pduf‚Ä¶, ",1199825256757620736,False,10,0,2,5,TweetDeck,"Biotech updates 11/27:

$VRCA PDUFA July 13
$INCY PDUFA May 30
$ZSAN offering +22%
$ARAV -12% (Tue offering)
$ASLN +81%; $HEPA +36%; $OBSV +14%
Pipeline update $SEEL
https://t.co/imNxWPR0vG",,,2009-07-12 11:59:54,,BioPharmCatalyst,https://pbs.twimg.com/profile_images/1425820382091636746/Xx33Y7hR_normal.jpg,25993,182,548,6628,BPharmCatalyst,
1134049078424162304,2019-11-27 17:52:09,"INCY, ",,"newsfilter.io/articles/picte‚Ä¶, ",1199823250928201728,False,0,0,0,0,Newsfilter.io,Pictet Asset Management Ltd. Raises Stake in Incyte Co. (NASDAQ:INCY) $INCY https://t.co/K2uxSUXzKj,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
732361939490312192,2019-11-27 17:17:02,"INCY, ","markets, ","americanbankingnews.com/?p=12675535, ",1199814413273968640,False,0,0,0,0,Zapier.com,Incyte‚Äôs $INCY ‚ÄúBuy‚Äù Rating Reaffirmed at Mizuho https://t.co/I1OtrUzJl1 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
227778014,2019-11-27 15:30:28,"INCY, ","ESMO, ","buff.ly/34sVdwW, ",1199787593854062595,False,1,0,0,0,Buffer,"Incyte wins Priority Review and May PDUFA date for bile duct cancer candidate pemigatinib, just two months after reporting positive Phase II data at #ESMO $INCY https://t.co/31dTVDXquF",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13038,1543,387,33073,BioCentury,
55654926,2019-11-27 12:54:38,,"cholangiocarcinoma, bileductcancer, curecca, ","investor.incyte.com/news-releases/‚Ä¶, ",1199748379225444353,False,8,0,0,4,Twitter Web App,"Incyte Announces Acceptance and Priority Review of NDA for Pemigatinib as a Treatment for Patients with Cholangiocarcinoma. #cholangiocarcinoma #bileductcancer #curecca 
https://t.co/ZKXrW8Cssg",,,2009-07-10 16:24:54,Biliary Tract,Cholangiocarcinoma Foundation,https://pbs.twimg.com/profile_images/1351686110737416192/oCrz5Mf__normal.jpg,2810,1322,52,6758,curecc,
1096085580868407297,2019-11-27 11:45:33,,"PMEA2019, ","pic.twitter.com/Rj0GIp4Tue, ",1199730995055988736,False,5,0,0,0,Twitter Web App,We‚Äôre delighted to be attending the @PMLiVEcom Pharmaceutical Market Excellence Awards! We have been shortlisted in the Excellence in Patient Education &amp; Support category for supporting Incyte Biosciences‚Äô CML Life patient support platform. Fingers crossed! #PMEA2019 @OPENHealth https://t.co/Rj0GIp4Tue,"PMLiVEcom, OPENHealth, ",,2019-02-14 11:35:41,"London, Marlow",OPEN Health Patient & Brand Communications,https://pbs.twimg.com/profile_images/1278218433398820865/3nKM9HAK_normal.jpg,147,257,0,241,OPENHealthPBC,photo
135209476,2019-11-27 11:41:31,"INCY, ",,"stockflare.com/stock/INCY.O, ",1199729978935521282,False,0,0,0,0,Stockflare Bot (Prod),"$INCY: Incyte Corporation has lost a star, now a 2 star stock. (https://t.co/sK8NyKCUuN)",,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
27645777,2019-11-27 11:12:19,,,"healio.com/hematology-onc‚Ä¶, ",1199722632423317505,False,0,0,0,1,Healio Twitter,.@US_FDA grants priority review to pemigatinib @Incyte for the treatment of cholangiocarcinoma https://t.co/y2cRWpNymw,"US_FDA, Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,
3686628867,2019-11-27 09:52:20,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1199702503450955778,False,0,0,0,0,WordPress.com,Incyte Announces Acceptance and Priority Review of NDA for Pemigatinib as a Treatment for Patients with Cholangiocarcinoma https://t.co/1OpnqPz7Q8,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
72928001,2019-11-27 09:31:47,"INCY, ",,"bit.ly/33o1xVn, ",1199697331731320833,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte: FDA has accepted for Priority Review its NDA for pemigatinib as a treatment for patients with... https://t.co/gp8CggC1St,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
374729426,2019-11-27 08:54:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/952643, pic.twitter.com/ZJOrRnalaN, ",1199688044971823109,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average broke above its 50-day Moving Average on October 29, 2019. View odds for this and other indicators: https://t.co/J2jInQqufQ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ZJOrRnalaN",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1022473214457348096,2019-11-27 08:31:44,,,"pharmashots.com/23900/incyte-r‚Ä¶, ",1199682217741406208,False,1,0,0,0,Twitter Web Client,"Incyte Reports Acceptance and Priority Review of NDA for Pemigatinib to Treat Patients with Cholangiocarcinoma @Incyte
https://t.co/PB3U0ImnwI","Incyte, ",,2018-07-26 09:26:25,"New Delhi, India",PharmaShots - Incisive news in 3 shots,https://pbs.twimg.com/profile_images/1022476723458166790/7EOrIWF5_normal.jpg,2095,4873,10,5737,Pharmashot,
472650465,2019-11-27 08:02:44,"INCY, ",,"otcdynamics.com/incy-incyte-an‚Ä¶, ",1199674921938493440,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte Announces Acceptance and Priority Review of NDA for Pemigatinib as a Treatment for Patients with https://t.co/Xw5j2RLYPn,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
963495628545327104,2019-11-27 07:54:02,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, ",1199672730506928129,False,0,0,0,0,STCK.PR0,$INCY NEW ARTICLE : FDA accepts Incyte's NDA for pemigatinib https://t.co/siJ1bRkLTk Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF,,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
25406480,2019-11-27 07:42:29,,,"awesomecapital.blogspot.com/2019/11/fda-ac‚Ä¶, ",1199669823489413120,False,0,0,0,1,Twitter Web Client,AwesomeCapital: FDA accepts Incyte‚Äôs NDA for pemigatinib https://t.co/qly3K41hBm,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
3911174913,2019-11-27 07:40:47,,"Breaking, ",,1199669395624222720,False,15,1,1,4,Twitter for Advertisers.,"#Breaking: Incyte announces that the @US_FDA has accepted for priority review a new drug application to potentially advance treatment in patients with previously treated, locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements.","US_FDA, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
15296897,2019-11-27 07:36:42,"INCY, ",,"seekingalpha.com/news/3522343-f‚Ä¶, ",1199668370464894977,False,0,0,0,1,SANewsTwitter,$INCY - FDA accepts Incyte's NDA for pemigatinib https://t.co/nvGx7TSqsG,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
976297820532518914,2019-11-27 07:36:05,,,"dlvr.it/RKCjMY, pic.twitter.com/sD1ygQQWB6, ",1199668213182676992,False,0,0,0,0,dlvr.it,Incyte Announces Acceptance and Priority Review of NDA for Pemigatinib as a Treatment for Patients with Cholangiocarcinoma https://t.co/oZ9zYIQhRK https://t.co/sD1ygQQWB6,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2019-11-27 07:34:10,,,"crweworld.com/article/news-p‚Ä¶, ",1199667730846081024,False,0,0,0,0,CRWE World,Incyte Announces Acceptance and Priority Review of NDA for Pemigatinib as a Treatment for Patients with Cholangiocar https://t.co/g56MRd5RMm,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
930803511918411776,2019-11-27 06:51:02,"INCY, ",,"thelincolnianonline.com/?p=3225058, ",1199656877648429057,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 15,000 Shares https://t.co/4aOmGrv2An",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
1134049078424162304,2019-11-27 06:44:05,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1199655126140514304,False,0,0,0,0,Newsfilter.io,"Incyte Co. (NASDAQ:INCY) EVP Barry P. Flannelly Sells 2,142 Shares $INCY https://t.co/QJr5v0sXqW",,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
849417718642159616,2019-11-27 06:42:11,"INCY, ",,"zpr.io/tYzY8, ",1199654647943880704,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Barry P. Flannelly Sells 2,142 Shares https://t.co/sfSFr3xKAP",,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2416188264,2019-11-27 06:41:35,"INCY, ","markets, ","thestockobserver.com/?p=2469171, ",1199654500061122561,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Barry P. Flannelly Sells 2,142 Shares  https://t.co/2Mc1XPoYQK #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
68559732,2019-11-27 03:02:11,"INCY, ",,"ift.tt/2L0QWJI, ",1199599285890879488,False,0,0,0,0,IFTTT,"Incyte Insider Paul Trower Sells $1,406,400.00 in $INCY https://t.co/t3bOrVl0Fc",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
732361939490312192,2019-11-26 21:36:44,"INCY, ","markets, ","americanbankingnews.com/?p=12663298, ",1199517381405622272,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Sells $1,406,400.00 in Stock https://t.co/JLqrhjz0Rc #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-26 21:36:43,"INCY, ","stocks, ","americanbankingnews.com/?p=12663298, ",1199517378243186691,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Sells $1,406,400.00 in Stock https://t.co/1QpHA68QVy #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2920258887,2019-11-26 21:34:47,"INCY, ",,"dakotafinancialnews.com/?p=1355273, ",1199516889287987202,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Sells $1,406,400.00 in Stock https://t.co/xNh8lB2rv8",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
732361939490312192,2019-11-26 17:51:29,"INCY, ","markets, ","americanbankingnews.com/?p=12661127, ",1199460694283968513,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Barry P. Flannelly Sells 2,142 Shares https://t.co/9AFRSHdQdY #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-26 17:51:28,"INCY, ","stocks, ","americanbankingnews.com/?p=12661127, ",1199460691478024193,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Barry P. Flannelly Sells 2,142 Shares https://t.co/quvXrXDNUu #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1176558075798380544,2019-11-26 17:26:22,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1199454375099453440,False,0,0,0,0,InsiderActionMonitor,$INCY Paul Trower sells $1.4M Worth Of Incyte Stock https://t.co/TXHyOgr2YP,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
772471873539977217,2019-11-26 16:40:43,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1199442885864767489,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/MheigbZrm7,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
751440653599567872,2019-11-26 14:00:42,,,"stockinvest.us/l/OQYgqXJGJS, ",1199402615458713608,False,0,0,0,0,Hootsuite Inc.,"https://t.co/bmDDdm983D
Our scoring system ranks Incyte Corporation (INCY) as a buy.",,,2016-07-08 11:39:47,,StockInvest.us,https://pbs.twimg.com/profile_images/1446067851132084227/tv0U0wG0_normal.jpg,2272,0,19,11762,StockInvestUS,
374729426,2019-11-26 13:58:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/950030, pic.twitter.com/CoLq68rOBP, ",1199402097034219520,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed above its 50-day Moving Average on October 29, 2019. View odds for this and other indicators: https://t.co/ALbEDm7hbk #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/CoLq68rOBP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1889492676,2019-11-26 09:25:43,"INCY, ","Incyte, Oncology, ASH19, ","1stoncology.com/blog/data-from‚Ä¶, ",1199333417332006912,False,0,0,0,0,Troi URL Plug-in,Data from #Incyte‚Äôs #Oncology Portfolio Accepted for Presentation at #ASH19 $INCY https://t.co/XTa8xgSQvc,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
956484027384582144,2019-11-26 07:02:06,"INCY, ","stocks, stockmarket, ","danversrecord.com/2018/03/12/sha‚Ä¶, ",1199297274272264192,False,0,0,0,0,stockspredictor,Shares in the Spotlight: Incyte Corporation (NASDAQ:INCY) https://t.co/F7HCN1NhP1 $INCY #stocks #stockmarket,,,2018-01-25 06:08:57,,StocksPredictor,https://pbs.twimg.com/profile_images/956485778384850944/S5_3tIPa_normal.jpg,1445,1604,8,20822,StocksPredictr,
732361939490312192,2019-11-26 05:54:25,"INCY, ","markets, ","americanbankingnews.com/?p=12657288, ",1199280240947847168,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Rating of ‚ÄúBuy‚Äù by Brokerages https://t.co/76BvD9Mx9L #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-26 05:54:25,"INCY, ","stocks, ","americanbankingnews.com/?p=12657288, ",1199280238481608705,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Rating of ‚ÄúBuy‚Äù by Brokerages https://t.co/Ehad2Y7Tjt #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2298709746,2019-11-26 05:53:47,"INCY, ",,"zpr.io/tsBPx, ",1199280080603811840,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúBuy‚Äù by Brokerages https://t.co/kcpkwsC9c1,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
68559732,2019-11-26 05:51:15,"INCY, ",,"zpr.io/tsBUA, ",1199279442654367744,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Rating of ‚ÄúBuy‚Äù by Brokerages https://t.co/lpZ8LbFlWh,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
4419993470,2019-11-26 03:11:29,,"stocks, news, ","ift.tt/2OkKXl6, ",1199239236655992837,False,0,0,0,0,IFTTT,Dow Jones Gain Sharply Lags This Index; Incyte And These Growth Stocks Add To Breakouts - Investor's Business Daily https://t.co/8UjHl3r2Wr #stocks #news,,,2015-12-01 06:37:16,,Signals.me,https://pbs.twimg.com/profile_images/686123587200143360/hr4lhxxx_normal.png,23819,12097,148,174057,SignalsMe,
849417718642159616,2019-11-25 23:38:49,"INCY, ",,"zpr.io/ts4ny, ",1199185718461059072,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Price Up 5.9% https://t.co/irnwiolBGD,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1120631024306802688,2019-11-25 22:55:02,"INCY, ","STOCKS, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, markets.dataswarm.tech, ",1199174700955512832,False,0,0,0,0,DataSwarm Markets,"$INCY New market information for Incyte Corporation at  https://t.co/OxItqO0RgL #STOCKS #NASDAQ
Visit https://t.co/ApK6iYCrer to sign up for personalised alerts direct to your inbox
DataSwarm ref: 78473",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
38361270,2019-11-25 22:20:16,,,"youtu.be/nInjoqw_mlE, ",1199165949997273088,False,0,0,0,0,Twitter Web Client,"Nasdaq Soars To New High; Alibaba, Splunk, Incyte Break Out https://t.co/7rWIbJyRxG via @YouTube","YouTube, ",,2009-05-06 23:47:07,,Gino Chimienti,https://pbs.twimg.com/profile_images/1425555060/0729100816a_normal.jpg,528,2504,25,55376,ginochimienti,
21328656,2019-11-25 16:00:05,"BABA, SPLK, INCY, ",,"pscp.tv/w/cKw4VTFkclFl‚Ä¶, ",1199070273506463744,False,12,0,1,5,Periscope,"Nasdaq, S&amp;P 500 soar to new highs; Alibaba, Splunk, Incyte break out $BABA $SPLK $INCY Sponsored by Interactive Brokers. @IBKR https://t.co/xAU4azKdl4","IBKR, ",,2009-02-19 14:11:46,"Los Angeles, CA",Investors.com,https://pbs.twimg.com/profile_images/929121870107918336/gO-6qGSu_normal.jpg,263233,600,5629,85009,IBDinvestors,
272125054,2019-11-25 13:52:02,,,"dlvr.it/RK4Tqc, pic.twitter.com/OBUJACL5Ws, ",1199038047964164096,False,0,0,0,0,dlvr.it,"Stock Market Rally Hits Fresh Highs; Alibaba, Incyte, StoneCo In Or Near Buy Zones https://t.co/PLl4y1NEfV https://t.co/OBUJACL5Ws",,,2011-03-25 17:57:29,"Los Angeles, CA",MarketSmith,https://pbs.twimg.com/profile_images/804395620526002177/rgTWlQT2_normal.jpg,47273,503,870,19033,MarketSmith,photo
3686628867,2019-11-25 13:11:20,,,"pharmaceuticaldaily.com/data-from-incy‚Ä¶, ",1199027805335498752,False,0,0,0,0,WordPress.com,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 61st Annual ASH¬†Meeting https://t.co/ieHV00bdyz,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
39975891,2019-11-25 12:50:10,,"Data, ","twib.in/l/Kx4KEG7L6Xo7, pic.twitter.com/CweJ6h44rC, ",1199022481249624067,False,0,0,0,0,Twibble.io,#Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 61st Annual ASH Meeting¬†¬†Yahoo Finance https://t.co/MbHO6uU6h3 https://t.co/CweJ6h44rC,,,2009-05-14 07:39:17,Global,Saeed Valadbaygi,https://pbs.twimg.com/profile_images/1224252964547723265/uJ0173SQ_normal.jpg,14062,1111,566,324914,SaeedBaygi,photo
1544270486,2019-11-25 11:01:58,"SPLK, BABA, INCY, ","IBDLive, ","twitter.com/IBDinvestors/s‚Ä¶, ",1198995248460058624,False,6,0,1,0,Hootsuite Inc.,"Splunk, Alibaba, Incyte were notable breakouts discussed on #IBDLive today. $SPLK $BABA $INCY
https://t.co/Yf5D5cdMJP",,,2013-06-24 18:42:18,,Ed Carson,https://pbs.twimg.com/profile_images/1197680405756801024/DP7-EekI_normal.jpg,14449,459,363,27808,IBD_ECarson,
1544227476,2019-11-25 11:00:15,"INCY, ","IBDLive, trading, IBDStockOfTheDay, ","investors.com/research/ibd-s‚Ä¶, ",1198994818149601281,False,11,0,2,2,Hootsuite Inc.,"#IBDLive I: Big thanks to all who made our show on a holiday-shortened #trading week. $INCY was one of our heavily discussed names, now moving out of the 5% buy zone from an 89.40 buy point. It recently got featured in #IBDStockOfTheDay too https://t.co/qrZU3yXjtR @SaitoChung","SaitoChung, ",,2013-06-24 18:31:17,,David Chung,https://pbs.twimg.com/profile_images/843864690698543104/YIkat7xF_normal.jpg,9871,1244,261,6512,IBD_DChung,
1126479667442126848,2019-11-25 10:56:49,"INCY, ","Stocks, UnusualActivity, ",,1198993952533307392,False,0,0,0,1,TweetDeck,"Incyte Corporation $INCY up by 6.38% at $94.39

UNUSUAL ACTIVITY VOLUME 1963.93% STRENGTH 1000.35% 

#Stocks #UnusualActivity",,,2019-05-09 09:30:56,London,BREAKING STOCK NEWS,https://pbs.twimg.com/profile_images/1436383970774720513/ttpG7KuY_normal.jpg,2727,7,52,8959,UnusuallyActive,
819883602,2019-11-25 09:15:07,,"techtransfer, openinnovation, ","in-part.com, pic.twitter.com/2HGr5YlizJ, ",1198968359536222208,False,0,0,0,0,Buffer,"A warm welcome to R&amp;D professionals from @VarexImaging, @Sunovion, @Incyte, and many others who joined IN-PART‚Äôs matchmaking platform last week! https://t.co/YJpiWqN8Rm | #techtransfer #openinnovation https://t.co/2HGr5YlizJ","VarexImaging, Sunovion, Incyte, ",,2012-09-12 12:28:33,"UK-based, global community",IN-PART,https://pbs.twimg.com/profile_images/989162187737518080/8HN-0uHX_normal.jpg,1689,2228,114,4665,IN_PART,photo
976297820532518914,2019-11-25 08:10:07,,,"dlvr.it/RK3HLz, pic.twitter.com/EYF3fb6ETL, ",1198952004233465857,False,0,0,0,0,dlvr.it,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 61st Annual ASH Meeting https://t.co/2BLHnoK3lL https://t.co/EYF3fb6ETL,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
3318510966,2019-11-25 08:05:56,,,"crweworld.com/article/news-p‚Ä¶, ",1198950951521898496,False,0,0,0,0,CRWE World,Data from Incyte‚Äôs Oncology Portfolio Accepted for Presentation at the 61st Annual ASH Meeting https://t.co/1uT0AlPQyo,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
374729426,2019-11-25 07:27:46,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/947048, pic.twitter.com/tdurmFMbEw, ",1198941343738818560,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on October 29, 2019. View odds for this and other indicators: https://t.co/zAJ7pPv1vH #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/tdurmFMbEw",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
374729426,2019-11-24 08:13:20,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/944186, pic.twitter.com/C1ElTLlhw2, ",1198590425868619777,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on October 29, 2019. View odds for this and other indicators: https://t.co/v3dhJbpjDq #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/C1ElTLlhw2",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
38361270,2019-11-23 22:37:09,,,"investors.com/stock-lists/st‚Ä¶, ",1198445424715022336,False,0,0,0,0,Twitter Web Client,Top Biotech Aims For Breakout As Strong Cancer Drug Sales Boost Stock https://t.co/7mIG8huHWa via @IBDinvestors,"IBDinvestors, ",,2009-05-06 23:47:07,,Gino Chimienti,https://pbs.twimg.com/profile_images/1425555060/0729100816a_normal.jpg,528,2504,25,55376,ginochimienti,
1120631024306802688,2019-11-23 12:10:02,"INCY, ","STOCKS, NASDAQ, ","markets.dataswarm.tech/t/9/INCY, markets.dataswarm.tech, ",1198287601834303488,False,0,0,0,0,DataSwarm Markets,"$INCY New market information for Incyte Corporation at  https://t.co/OxItqO0RgL #STOCKS #NASDAQ
Visit https://t.co/ApK6iYCrer to sign up for personalised alerts direct to your inbox
DataSwarm ref: 78192",,,2019-04-23 06:10:31,"London, England",DataSwarm Markets,https://pbs.twimg.com/profile_images/1120666809152282624/aRBc852e_normal.png,390,82,10,117117,DataswarmM,
102625296,2019-11-23 03:02:13,,,"instagram.com/p/Bt5eNhwAHlW, ",1198149743060361216,False,0,0,0,0,IFTTT,"Most innovative companies, 2018

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)

Longer list: https://t.co/n7454pA0xc",,,2010-01-07 04:10:27,Mumbai,Rizwan Shaikh,https://pbs.twimg.com/profile_images/487901688607416320/vxDk5lHi_normal.jpeg,202,1422,7,26351,rizwan236,
295832987,2019-11-23 02:48:09,,"stemcelltransplant, ","pic.twitter.com/87XkR1x8tw, ",1198146202874892288,False,3,0,0,0,Twitter Web App,Brilliant @Leic_hospital Stem Cell Transplant Education day @TheLeicsVenue Many thanks to @AnthonyNolan @BSBMTCT @AlexionPharma @sanofi @Incyte @MNK #stemcelltransplant https://t.co/87XkR1x8tw,"Leic_hospital, TheLeicsVenue, AnthonyNolan, BSBMTCT, AlexionPharma, sanofi, Incyte, MNK, ",,2011-05-09 14:52:50,,sputrik,https://pbs.twimg.com/profile_images/849731685788864512/8rOxp8VT_normal.jpg,75,210,1,269,1966sputrik,photo
1024214886849626113,2019-11-22 17:32:25,,"News, Economy, Politics, ","instagram.com/p/Bt5eNhwAHlW, ",1198006344743366657,False,0,0,0,0,IFTTT,"Most innovative companies, 2018

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)

Longer list: https://t.co/KRd3F8DCkn #News #Economy #Politics",,,2018-07-31 04:47:12,"London, England",The Economian,https://pbs.twimg.com/profile_images/1024220453727027200/xqaENOLE_normal.jpg,294,0,5,19215,TheEconomian,
272125054,2019-11-22 15:08:02,,,"dlvr.it/RJtPHF, ",1197970010414579712,False,3,0,0,2,dlvr.it,Top Biotech Aims For Breakout As Healthy Cancer Drug Sales Boost Stock https://t.co/urtqrlzUF2,,,2011-03-25 17:57:29,"Los Angeles, CA",MarketSmith,https://pbs.twimg.com/profile_images/804395620526002177/rgTWlQT2_normal.jpg,47273,503,870,19033,MarketSmith,
133504478,2019-11-22 11:18:09,,"strategy, competitiveintelligence, marketing, pharmaceutical, pharma, biotech, healthcare, productmarketing, ","dlvr.it/RJscLr, lqventures.com, ",1197912158002020355,False,0,0,0,2,dlvr.it,"Jakinibs market to witness high demand during 2020-2024 with top key players are Astellas Pharma, Inc., Novartis AG,‚Ä¶ https://t.co/rqJNY7Xi05 &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #biotech #healthcare #productmarketing",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
133504478,2019-11-22 11:18:08,,"strategy, competitiveintelligence, marketing, healthcare, pharma, biotech, pharmaceutical, productmarketing, ","dlvr.it/RJscLm, lqventures.com, ",1197912156794048512,False,0,0,0,2,dlvr.it,"Janus Kinase (JAK) Inhibitors market to boom in near future by 2024 industry key players Astellas Pharma, Inc.,‚Ä¶ https://t.co/aALZQ1JHtL &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #healthcare #pharma #biotech #pharmaceutical #productmarketing",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
111648072,2019-11-22 11:00:03,,,"buff.ly/2JvCUh7, pic.twitter.com/0fbUgsVrvX, ",1197907603021582338,False,0,0,0,0,Buffer,"CHECK OUT THE POSTINGS on the ISMPP JOBS BOARD! Opportunities available at AbbVie, Bayer, Bristol-Myers Squibb, Incyte Corp., Nucleus Global, and Takeda. Find out more: https://t.co/vJPj6bIXLM https://t.co/0fbUgsVrvX",,,2010-02-05 12:32:26,,ISMPP,https://pbs.twimg.com/profile_images/785842416754520065/sh0T72mi_normal.jpg,2584,680,44,4227,ISMPP,photo
374729426,2019-11-22 08:56:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/940001, pic.twitter.com/RFi7kUFzyb, ",1197876414332096512,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator is sitting in overbought zone for 16 days. View odds for this and other indicators: https://t.co/yvjDOe2gYi #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/RFi7kUFzyb,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
852931863547084801,2019-11-22 08:10:10,"INCY, ",,"zpr.io/tspaL, ",1197864850900295681,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $216,150.00 in Stock https://t.co/6aKDSNOUNL",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
966006214818697218,2019-11-22 08:06:44,"INCY, ",,"theenterpriseleader.com/?p=2412980, ",1197863987947474944,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock  https://t.co/Th1Vbporf5",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2019-11-22 01:18:17,"INCY, ",,"thelincolnianonline.com/?p=3216018, ",1197761198529404928,False,0,0,0,0,Zapier.com,Incyte Target of Unusually Large Options Trading $INCY https://t.co/tZcJIimM4y,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
3911174913,2019-11-21 15:28:24,,"MPN, raredisease, KWFF, ","pic.twitter.com/WLfAIcLWHF, ",1197612747426586624,False,8,0,0,1,Twitter Web App,"We're at the @KeyWestFilmFest where our short film ""Beyond Blue"" shows a glimpse inside Barbara's life living with an #MPN. We're proud to have created a film that supports the #raredisease community &amp; raises awareness of MPNs. #KWFF https://t.co/WLfAIcLWHF","KeyWestFilmFest, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
4028839455,2019-11-21 13:22:28,,"insidertrading, stocktrot, ","stocktrot.com/company/incyte‚Ä¶, ",1197581056347492352,False,0,0,0,0,StockTrot1,9 Incyte Corp insiders active last month. Most in 3 months. https://t.co/Glm3OwNyt2 #insidertrading #stocktrot,,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
2384219072,2019-11-21 13:05:09,,"DEBIO, BioBreakfast, member, ","pic.twitter.com/O8ySFUxiDb, ",1197576699132760065,False,5,0,0,0,Loomly,Thank you to everyone that joined #DEBIO today for the November #BioBreakfast!  Thank you to #member host sponsor  @Incyte  and event sponsors Delaware Biotechnology Institute and @VWR! https://t.co/O8ySFUxiDb,"Incyte, VWR, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,video
3911174913,2019-11-21 10:45:00,,"dermatology, ","pic.twitter.com/F9LLY8IIFM, ",1197541427892412421,False,3,0,0,1,Twitter for Advertisers.,"On the agenda at the Dermatology Drug Development Summit: Incyte Senior Director of Translational Research, Michael D. Howell, PhD, to present the integration of personalized medicine for #dermatology patients. https://t.co/F9LLY8IIFM",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
2216628696,2019-11-21 09:24:48,,"BioBreakfast, ","pic.twitter.com/Zu4T6bbH3X, pic.twitter.com/Zu4T6bbH3X, ",1197521245178400768,False,8,0,0,1,Twitter for iPhone,Great morning @Incyte for the @Delaware_Bio #BioBreakfast! https://t.co/Zu4T6bbH3X,"Incyte, Delaware_Bio, ",,2013-11-26 17:23:39,"Wilmington, DE",Potter Anderson,https://pbs.twimg.com/profile_images/378800000794967703/6ac9a3aa5ee08b4f1b8c707471250d6a_normal.jpeg,206,202,8,677,PotterAnderson,photo
107505455,2019-11-21 09:06:24,,"innovation, collaboration, debio, ",,1197516613400092673,False,1,1,0,0,Twitter for Android,"One of @Delaware_Bio goals is to build bridges between academic and industry, because we need more #innovation and #collaboration. Thank you @Incyte and @CLGrimesLab for sharing insights on innovation, collaboration, problem-solving. #debio","Delaware_Bio, Incyte, CLGrimesLab, ",,2010-01-22 14:58:04,"Hockessin, Delaware",GILLESPIEHALL,https://pbs.twimg.com/profile_images/1072881742011355137/wTU1eeXB_normal.jpg,1704,815,69,4290,GILLESPIEHALL,
852931863547084801,2019-11-21 08:55:00,"INCY, ",,"zpr.io/tsUGM, ",1197513745041436672,False,0,0,0,0,Zapier.com,Investors Purchase Large Volume of Incyte Put Options $INCY https://t.co/6iJ0KkbcVX,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
2416188264,2019-11-21 08:54:09,"INCY, ","markets, ","thestockobserver.com/?p=2459025, ",1197513531022819329,False,0,0,0,0,Zapier.com,Investors Purchase Large Volume of Incyte Put Options $INCY  https://t.co/TAFzHiOFwp #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
107505455,2019-11-21 08:37:17,,"debio, ",,1197509289201586176,False,0,0,0,0,Twitter for Android,"Q: @Incyte culture is not like big pharma. You work on impacting 400 people here, 400 people there... Big pharma has been criticized for focusing on 'moneymakers.' A: ""You have to stay close to the edge because that's how you innovate, make a difference."" Herve Hoppenot #debio","Incyte, ",,2010-01-22 14:58:04,"Hockessin, Delaware",GILLESPIEHALL,https://pbs.twimg.com/profile_images/1072881742011355137/wTU1eeXB_normal.jpg,1704,815,69,4290,GILLESPIEHALL,
374729426,2019-11-21 08:36:04,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/936924, pic.twitter.com/pZuSsUDyvy, ",1197508980458672129,False,0,0,0,0,Tickeron,"$INCY's price moved above its 50-day Moving Average on October 28, 2019. View odds for this and other indicators: https://t.co/hRVUdqMAlS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/pZuSsUDyvy",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
107505455,2019-11-21 08:34:23,,"debio, ",,1197508558981664769,False,0,0,0,0,Twitter for Android,"""From a scientific perspective, how do we create a culture where everybody is comfortable with the uncertainty of innovating.... And the concrete is also important."" This means taking care of the people (HR) and also strategic corporate expansion! - Herve Hoppenot @Incyte #debio","Incyte, ",,2010-01-22 14:58:04,"Hockessin, Delaware",GILLESPIEHALL,https://pbs.twimg.com/profile_images/1072881742011355137/wTU1eeXB_normal.jpg,1704,815,69,4290,GILLESPIEHALL,
107505455,2019-11-21 08:28:30,,"innovation, debio, ",,1197507075707981824,False,0,0,0,0,Twitter for Android,"""How does #innovation happen? Sometimes it is serendipity, but what is exciting is that this changes the lives of patients."" Herve Hoppenot @Incyte #debio","Incyte, ",,2010-01-22 14:58:04,"Hockessin, Delaware",GILLESPIEHALL,https://pbs.twimg.com/profile_images/1072881742011355137/wTU1eeXB_normal.jpg,1704,815,69,4290,GILLESPIEHALL,
107505455,2019-11-21 08:24:53,,"debio, ",,1197506168907796480,False,0,0,0,0,Twitter for Android,"""There are groups of patients who have a disease and physicians don't know what it is or how to treat it."" @Incyte takes pride in having found a drug that not only improved life expectancy for myelofibrosis patients but changed their quality of life. - Herve Hoppenot #debio","Incyte, ",,2010-01-22 14:58:04,"Hockessin, Delaware",GILLESPIEHALL,https://pbs.twimg.com/profile_images/1072881742011355137/wTU1eeXB_normal.jpg,1704,815,69,4290,GILLESPIEHALL,
107505455,2019-11-21 08:16:24,,"innovation, debio, ",,1197504033851944960,False,1,1,0,0,Twitter for Android,"Herve Hoppenot @Incyte asks: What makes #innovation possible? Being willing to live with a certain level of confusion &amp; anxiety, being uncomfortable, and working through it. We are used to this cycle.(Referencing Richard Phillips Feynman) #debio","Incyte, ",,2010-01-22 14:58:04,"Hockessin, Delaware",GILLESPIEHALL,https://pbs.twimg.com/profile_images/1072881742011355137/wTU1eeXB_normal.jpg,1704,815,69,4290,GILLESPIEHALL,
107505455,2019-11-21 08:11:32,,"debio, ","pic.twitter.com/urmV5vUqEm, ",1197502807991083011,False,0,0,0,0,Twitter for Android,"""It's good to be surrounded by this group of innovative bioscientists. Being part of a community like this is very positive."" Herve Hoppenot @Incyte #debio https://t.co/urmV5vUqEm","Incyte, ",,2010-01-22 14:58:04,"Hockessin, Delaware",GILLESPIEHALL,https://pbs.twimg.com/profile_images/1072881742011355137/wTU1eeXB_normal.jpg,1704,815,69,4290,GILLESPIEHALL,photo
732361939490312192,2019-11-21 07:19:18,"INCY, ","markets, ","americanbankingnews.com/?p=12624558, ",1197489661758889984,False,0,0,0,0,Zapier.com,Incyte Sees Unusually High Options Volume $INCY https://t.co/pJpW7hjiP3 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-21 07:19:17,"INCY, ","stocks, ","americanbankingnews.com/?p=12624558, ",1197489659103850496,False,0,0,0,0,Zapier.com,Incyte Sees Unusually High Options Volume $INCY https://t.co/veEDOgoiws #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
966006214818697218,2019-11-21 06:59:24,"INCY, ",,"theenterpriseleader.com/?p=2411027, ",1197484656247087104,False,0,0,0,0,Zapier.com,Incyte Sees Unusually High Options Volume $INCY  https://t.co/4wxL09cr0K,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
826179494767640576,2019-11-20 19:42:02,,,"investors.com/stock-lists/in‚Ä¶, ",1197314191322963968,False,0,0,0,0,Twitter Web Client,Sector Leaders: Incyte Makes IBD's Most Stringent Watchlist https://t.co/t5XqAvlOyd via @IBDinvestors,"IBDinvestors, ",,2017-01-30 16:25:16,,TJ,https://pbs.twimg.com/profile_images/1144783262793043968/ni_rGG0T_normal.png,83,155,2,916,Buschtjj,
374729426,2019-11-20 17:07:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/934634, pic.twitter.com/4QJ6bCq7qB, ",1197275418765561857,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average broke above its 50-day Moving Average on October 29, 2019. View odds for this and other indicators: https://t.co/KWc89VjToR #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/4QJ6bCq7qB",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
21328656,2019-11-20 16:00:28,"TGT, INCY, NOW, ",,"pscp.tv/w/cKWg7DFkclFl‚Ä¶, ",1197258429703655424,False,10,0,2,3,Periscope,Trade headlines steal the show as Target gaps up on earnings while Incyte and ServiceNow clear resistance  $TGT $INCY $NOW Sponsored by Interactive Brokers. @IBKR https://t.co/PpI64lfl47,"IBKR, ",,2009-02-19 14:11:46,"Los Angeles, CA",Investors.com,https://pbs.twimg.com/profile_images/929121870107918336/gO-6qGSu_normal.jpg,263233,600,5629,85009,IBDinvestors,
3300865039,2019-11-20 15:35:59,"INCY, NVS, CELG, BMY, ",,"investors.com/research/ibd-s‚Ä¶, ",1197252267595980801,False,4,0,0,1,Hootsuite Inc.,IBD Stock of the Day flirts with a buy point at Street looks ahead to 2020 $INCY $NVS $CELG $BMY https://t.co/FAGVTu5DFH,,,2015-07-29 15:22:19,"California, USA",Allison Gatlin,https://pbs.twimg.com/profile_images/1379079645480378371/V22zIHh9_normal.jpg,6295,1000,201,6646,IBD_AGatlin,
122436733,2019-11-20 13:58:08,"INCY, ","incyte, incytestock, biotechstock, investing, Ibd, ","ow.ly/qpjt50xgixd, ",1197227644359720960,False,0,0,0,0,Hootsuite Inc.,"Incyte $INCY, the IBD Stock Of The Day, flirts with buy point as street looks ahead to 2020......  https://t.co/4HA3jdl8Ie...... #incyte #incytestock #biotechstock #investing #Ibd",,,2010-03-12 13:10:57,Los Angeles,Russ Britt,https://pbs.twimg.com/profile_images/1126175766784294912/HyB_x1dT_normal.png,2108,855,97,3624,rbrittbiznews,
3300833041,2019-11-20 13:57:58,"INCY, ","incyte, incytestock, biotechstock, investing, Ibd, ","investors.com/research/ibd-s‚Ä¶, ",1197227601623994373,False,0,0,0,0,Hootsuite Inc.,"Incyte $INCY, the IBD Stock Of The Day, flirts with buy point as street looks ahead to 2020......  https://t.co/cq3nWbblbJ...... #incyte #incytestock #biotechstock #investing #Ibd",,,2015-07-29 14:31:39,"Los Angeles, CA",Russ Britt,https://pbs.twimg.com/profile_images/651784933837398016/W1FRJCW0_normal.jpg,1321,661,39,2099,IBD_RBritt,
2416188264,2019-11-20 12:04:35,"INCY, ","markets, ","thestockobserver.com/?p=2457356, ",1197199067119525895,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 12-Month High at $89.95  https://t.co/3rxcxVRfg7 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2019-11-20 12:02:16,"INCY, ",,"zpr.io/tjiLj, ",1197198484631379968,False,0,0,0,0,Zapier.com,Incyte $INCY Sets New 12-Month High at $89.95 https://t.co/xb1B9PFWm1,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
1126479667442126848,2019-11-20 09:43:41,"INCY, ","Stocks, UnusualActivity, ",,1197163611094945792,False,0,0,0,0,TweetDeck,"Incyte Corporation $INCY up by 0.56% at $88.4308

UNUSUAL ACTIVITY VOLUME 1160.97% STRENGTH 679.57% 

#Stocks #UnusualActivity",,,2019-05-09 09:30:56,London,BREAKING STOCK NEWS,https://pbs.twimg.com/profile_images/1436383970774720513/ttpG7KuY_normal.jpg,2727,7,52,8959,UnusuallyActive,
2891146588,2019-11-20 08:59:02,"BCT, ","Health, Investment, ","briacell.com/investor-relat‚Ä¶, pic.twitter.com/flCqxhaMIV, ",1197152373749231617,False,2,0,0,1,Sprout Social,"BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT‚Ñ¢ in combination with Incyte compounds, INCMGA00012 and epacadostat, in advanced breast cancer 

For more information on BriaCell &amp; its clinical study, please visit: https://t.co/36OH6JuPOm

#Health #Investment $BCT https://t.co/flCqxhaMIV",,,2014-11-24 13:16:48,"New York, NY",BriaCell,https://pbs.twimg.com/profile_images/1433876026656952323/yM_H4sLw_normal.jpg,1215,551,9,477,BriaCell,photo
1176558075798380544,2019-11-20 02:40:13,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1197057042328039424,False,0,0,0,0,InsiderActionMonitor,$INCY Paula Swain Dumps 2.5K Shares of Incyte https://t.co/B1C67hlxUQ,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
732361939490312192,2019-11-19 19:21:57,"INCY, ","markets, ","americanbankingnews.com/?p=12614877, ",1196946747739783168,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 2,500 Shares of Stock https://t.co/5MJ5OlVwzc #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-19 19:21:56,"INCY, ","stocks, ","americanbankingnews.com/?p=12614877, ",1196946743952367617,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 2,500 Shares of Stock https://t.co/cGbwrhZ3RD #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2181281054,2019-11-19 19:17:55,"INCY, ","markets, ","wkrb13.com/?p=1417349, ",1196945730625265665,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 2,500 Shares of Stock https://t.co/MqxCNAo8eW #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
705671484,2019-11-19 15:00:29,,"GreaterHere, ","bit.ly/335BbIg, pic.twitter.com/thwhStF562, ",1196880949071536128,False,0,0,0,0,Buffer,"Delaware pharmaceutical company, @Incyte, will build additional 200,000-square-feet of office and lab space: https://t.co/NJgdtVf7Z7 #GreaterHere https://t.co/thwhStF562","Incyte, ",,2012-07-19 15:49:25,Greater Philadelphia,Select Greater PHL,https://pbs.twimg.com/profile_images/1145781100272336896/55HkoapA_normal.png,2100,1072,54,4267,SelectPHL,photo
985090779965255681,2019-11-19 14:52:24,"INCY, ",,"pic.twitter.com/DGYThjKDrU, ",1196878914183938049,False,0,0,0,0,Twitter Web Client,Take Profit on Incyte: $INCY https://t.co/DGYThjKDrU,,,2018-04-14 05:41:58,,Stock-ETF-CFD and Crypto-Trader,https://pbs.twimg.com/profile_images/1180123345708355586/8-73rSGH_normal.jpg,2972,4914,0,24012,AktienTrader1,photo
3911174913,2019-11-19 09:00:01,,"LifeAtIncyte, ","pic.twitter.com/gIOD5ek7Gr, ",1196790232768753664,False,13,0,2,3,Twitter for Advertisers.,"Hear from our colleague &amp; Research Fellow, Discovery Chemistry, Eddy Yue, on why he decided to pursue a career as a chemist. #LifeAtIncyte https://t.co/gIOD5ek7Gr",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
374729426,2019-11-19 08:51:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/931509, pic.twitter.com/Hm08OGPEgV, ",1196788194735353857,False,0,0,0,0,Tickeron,"$INCY's 10-day Moving Average crossed above its 50-day Moving Average on October 29, 2019. View odds for this and other indicators: https://t.co/71b3Oas3b8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Hm08OGPEgV",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
36959871,2019-11-19 08:06:21,,,"a.co/eOGqwAj, ",1196776725474168832,False,0,0,0,0,Kindle,"Here is a link to changes in @IBDInvestors Stock Lists ""A Dozen New Stocks For Your Watchlist, Including Incyte, ... https://t.co/RBDZTcou1L","IBDinvestors, ",,2009-05-01 10:59:56,"St. Louis, MO",Ric Ratkowski,https://pbs.twimg.com/profile_images/1406639759/ric_ratkowski_normal.jpg,11581,10908,332,5184,rratkowski,
34324846,2019-11-18 15:55:17,,,"jobs.sciencecareers.org/job/507381/inc‚Ä¶, ",1196532351880323073,False,2,0,0,3,Madgex Twitter Tweeter,"Incyte Research Scholars Program at Vanderbilt University Medical Center -Vanderbilt University Medical Center, Nas https://t.co/23rw14C5dH",,,2009-04-22 12:51:07,"Washington, DC",Science Careers,https://pbs.twimg.com/profile_images/1298289631188922368/ta9Sb-p3_normal.jpg,47975,243,591,72316,ScienceCareers,
2842742151,2019-11-18 13:42:12,,,"nature.com/naturecareers/‚Ä¶, ",1196498859213479942,False,0,0,0,0,Twitter Web App,Incyte Research Scholars Program at Vanderbilt University Medical Center https://t.co/GDg969pDIu,,,2014-10-24 15:43:59,"Nashville, TN",VU BRET ASPIRE PhD Job Feed,https://pbs.twimg.com/profile_images/1146522809562271746/SvMlReG3_normal.png,716,22,20,4046,VUBRETPhDJobs,
118052129,2019-11-18 11:49:40,,,"instagram.com/p/Bt5eNhwAHlW, facebook.com/10000770634751‚Ä¶, ",1196470540355227649,False,0,0,0,0,Facebook,"2018 Most Innovative Companies.

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)

Longer list: https://t.co/gmaansoUuo https://t.co/qZNJ04aRZq",,,2010-02-27 07:56:14,NIGERIA,Naija Channels,https://pbs.twimg.com/profile_images/577774300121415681/CgmFiWQT_normal.jpeg,190,439,6,12168,NAIJACHANNELS,
1004375641171603458,2019-11-18 11:29:02,,"Biopharma, ChooseDelaware, ","pic.twitter.com/6jvHKXPZN1, ",1196465348008194048,False,5,1,0,1,Sprout Social,"Congratulations to Paula Swain of Wilmington, Del.-based @Incyte. She recently made The Health Care Technology‚Äôs Report‚Äôs list of ""2019 Top 25 Women Leaders in Biotech.""  #Biopharma #ChooseDelaware https://t.co/6jvHKXPZN1","Incyte, ",,2018-06-06 10:53:08,,Delaware Prosperity Partnership @choosedelaware,https://pbs.twimg.com/profile_images/1059872509540134913/PX_tVV7O_normal.jpg,4337,1030,21,2792,choosedelaware,photo
374729426,2019-11-18 07:36:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/928532, pic.twitter.com/CjKgrIdCd3, ",1196406943427915776,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator is staying in overbought zone for 12 days. View odds for this and other indicators: https://t.co/wB3zgEBdhS #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/CjKgrIdCd3,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2920258887,2019-11-17 22:41:09,"INCY, ",,"dakotafinancialnews.com/?p=1339385, ",1196272104150306816,False,0,0,0,0,Zapier.com,$569.75 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/0VnLtQhsAH,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
849417718642159616,2019-11-17 22:40:50,"INCY, ",,"zpr.io/tjHtJ, ",1196272022818570241,False,0,0,0,0,Zapier.com,Zacks: Brokerages Anticipate Incyte Co. $INCY to Announce $0.58 EPS https://t.co/TKGYWn3bFc,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2416188264,2019-11-17 22:38:57,"INCY, ","markets, ","thestockobserver.com/?p=2452467, ",1196271546840563712,False,0,0,0,0,Zapier.com,Brokerages Expect Incyte Co. $INCY Will Announce Earnings of $0.58 Per Share  https://t.co/eRRa7IcQUp #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
2298709746,2019-11-17 19:52:50,"INCY, ",,"zpr.io/tjg49, ",1196229746008481792,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Declines By 15.7% https://t.co/sKw5pDubQt,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
732361939490312192,2019-11-17 19:48:58,"INCY, ","markets, ","americanbankingnews.com/?p=12600520, ",1196228770715389953,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Declines By 15.7% https://t.co/PsOJid0Mst #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-17 19:48:57,"INCY, ","stocks, ","americanbankingnews.com/?p=12600520, ",1196228767749947392,False,0,0,0,0,Zapier.com,Short Interest in Incyte Co. $INCY Declines By 15.7% https://t.co/jwauo71myo #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
752353070089142272,2019-11-17 12:40:43,,,"instagram.com/p/Bt5eNhwAHlW, ",1196120998677864450,False,0,0,0,0,Twitter for Android,"Most innovative companies, 2018

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)

Longer list: https://t.co/xNcma2Fqeo",,,2016-07-11 00:05:24,"Here There & Everywhere, üáÆüá≥",Rambraksh Yadav üáÆüá≥,https://pbs.twimg.com/profile_images/1432287974222225411/UyoMHDJv_normal.jpg,394,296,2,18071,RambrakshYadav,
102625296,2019-11-17 12:17:48,,,"instagram.com/p/Bt5eNhwAHlW, ",1196115229979086849,False,0,0,0,0,IFTTT,"Most innovative companies, 2018

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)

Longer list: https://t.co/n7454pA0xc",,,2010-01-07 04:10:27,Mumbai,Rizwan Shaikh,https://pbs.twimg.com/profile_images/487901688607416320/vxDk5lHi_normal.jpeg,202,1422,7,26351,rizwan236,
319735357,2019-11-17 12:17:18,,,"instagram.com/p/Bt5eNhwAHlW, facebook.com/story.php?stor‚Ä¶, ",1196115103738990592,False,0,0,0,0,Facebook,"Most innovative companies, 2018

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)

Longer list: https://t.co/GomrSJxaMx https://t.co/XuqSqRw91W",,,2011-06-18 12:58:49,Cotonou,Parfait DAHISSIHO,https://pbs.twimg.com/profile_images/503838380472680448/Z_cnCKik_normal.jpeg,607,1431,4,2199,pdahissiho,
1101095849852047360,2019-11-17 12:08:52,,,,1196112984126283776,False,0,0,0,0,Twitter for Android,"Most innovative companies, 2018

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)",,,2019-02-28 07:24:42,Kingdom Of Nepal,ùêÄùê´ùêÆùêß ùêíùê°ùêöùê°‚Ñ¢,https://pbs.twimg.com/profile_images/1414194372225105925/pTrkC3MN_normal.jpg,3475,2773,0,39819,arunshah240,
1024214886849626113,2019-11-17 12:01:31,,"News, Economy, Politics, ","instagram.com/p/Bt5eNhwAHlW, ",1196111131280125953,False,0,0,0,0,IFTTT,"Most innovative companies, 2018

1. ServiceNow
2. Workday
3. Salesforce
4. Tesla
5. Amazon
6. Netflix
7. Incyte
8. Unilever India
9. Naver
10. Facebook

(Forbes)

Longer list: https://t.co/KRd3F8DCkn #News #Economy #Politics",,,2018-07-31 04:47:12,"London, England",The Economian,https://pbs.twimg.com/profile_images/1024220453727027200/xqaENOLE_normal.jpg,294,0,5,19215,TheEconomian,
374729426,2019-11-17 07:14:13,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/925560, pic.twitter.com/oq0mdXKfJf, ",1196038832430280707,False,0,0,0,1,Tickeron,$INCY in Uptrend: Stochastic indicator stays in overbought zone for 12 days. View odds for this and other indicators: https://t.co/MDQwNdEV6h #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/oq0mdXKfJf,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
374729426,2019-11-16 08:00:19,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/922530, pic.twitter.com/pt7wkogWoT, ",1195688043841064965,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator stays in overbought zone for 12 days. View odds for this and other indicators: https://t.co/gY1N4liXmK #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/pt7wkogWoT,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
845021745203630080,2019-11-15 10:46:04,,,"dlvr.it/RJLyty, pic.twitter.com/LghDugEIU1, ",1195367369150881793,False,0,0,0,0,dlvr.it,"Incyte: A Buy On Revenue, EPS Growth And Strong Pipeline https://t.co/MqeG2UEgCo https://t.co/LghDugEIU1",,,2017-03-23 17:17:38,Dividend ,Early Retirement,https://pbs.twimg.com/profile_images/849030380522840064/9QP1jEDv_normal.jpg,278,369,0,13641,InfoDividend,photo
963495628545327104,2019-11-15 10:29:10,"INCY, INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, dashboard.stck.pro/news.php?ticke‚Ä¶, pic.twitter.com/tlTVgPGjfL, ",1195363118668566528,False,0,0,0,0,STCK.PR0,"$INCY NEW ARTICLE : Incyte: A Buy On Revenue, EPS Growth And Strong Pipeline https://t.co/9ogtUijX1H Get all the latest $INCY related news here : https://t.co/Y7ZKRzI1xF https://t.co/tlTVgPGjfL",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,photo
23059499,2019-11-15 10:20:33,"INCY, ","economy, trading, stocks, ","seekingalpha.com/article/430699‚Ä¶, ",1195360950263500801,False,0,0,0,0,SAArticlesTwitter,"$INCY - Incyte: A Buy On Revenue, EPS Growth And Strong Pipeline. Read more and get updates on any stock! https://t.co/4jQrjDehmG #economy #trading #stocks",,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
374729426,2019-11-15 08:41:41,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/919508, pic.twitter.com/4evfP2jM79, ",1195336069702508544,False,1,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator sits in overbought zone for 11 days. View odds for this and other indicators: https://t.co/4C4XBrBtNT #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/4evfP2jM79,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
852931863547084801,2019-11-15 07:44:00,"INCY, ",,"zpr.io/tZw4J, ",1195321550565789696,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Earnings of $0.58 Per Share https://t.co/rJMXqTzAg8,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
1889492676,2019-11-15 06:36:27,"INCY, ","Incyte, InvestorConference, ","1stoncology.com/blog/incyte-to‚Ä¶, ",1195304550028103681,False,0,0,0,0,Troi URL Plug-in,#Incyte to Present at Upcoming #InvestorConference $INCY https://t.co/bLmhvewbgC,,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
59133374,2019-11-14 18:00:00,,"ACSMNMade, ","pic.twitter.com/NSvlv0VPWs, ",1195114185501356039,False,10,0,0,2,TweetDeck,"Huge thank you to all our sponsors who made tonight possible! #ACSMNMade 

@KSTP @Vital_Images @WellsFargo @AllianzLife @northmemorial @MHealthFairview @InsightEnt @Incyte https://t.co/NSvlv0VPWs","KSTP, WellsFargo, AllianzLife, northmemorial, MHealthFairview, InsightEnt, Incyte, ",,2009-07-22 10:04:02,"Minnesota, USA",ACS Minnesota,https://pbs.twimg.com/profile_images/1166099322070544385/0bqXhWJd_normal.jpg,2893,2010,55,4389,ACS_Minnesota,photo
875701843,2019-11-14 13:22:03,,,"pic.twitter.com/mNe9vYv8Y6, pic.twitter.com/mNe9vYv8Y6, ",1195044237907255296,False,7,0,0,1,Twitter Web App,"We had a fantastic day attending and presenting at the AXIS Incyte event in San Francisco. In particular Sadie Creese had a fantastic presentation on her research into Cyber Value at risk.  Also, congratulations to John Donald on his book launch - ""35 views of Cyber Risk"". https://t.co/mNe9vYv8Y6",,,2012-10-12 10:03:32,"Birmingham, AL",SecurIT360,https://pbs.twimg.com/profile_images/707953888469639168/qnwxVrgR_normal.jpg,54,154,2,136,SecurIT360,photo
133504478,2019-11-14 12:54:37,,"strategy, competitiveintelligence, marketing, biotech, productmarketing, healthcare, pharmaceutical, pharma, ","dlvr.it/RJHbz1, lqventures.com, ",1195037334300839936,False,0,0,0,2,dlvr.it,"Janus Kinase (JAK) Inhibitors Market 2019 ‚Äì Insights On Scope 2024 | Top Players: Astellas Pharma, Inc., Novartis AG,‚Ä¶ https://t.co/mhDaEEHOHq &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharmaceutical #pharma",,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,
1126479667442126848,2019-11-14 10:21:41,"INCY, ","Stocks, UnusualActivity, ",,1194998844737671168,False,0,0,0,0,TweetDeck,"Incyte Corporation $INCY down by -0.77% at $86.76

UNUSUAL ACTIVITY VOLUME 1056.87% STRENGTH 511.82% 

#Stocks #UnusualActivity",,,2019-05-09 09:30:56,London,BREAKING STOCK NEWS,https://pbs.twimg.com/profile_images/1436383970774720513/ttpG7KuY_normal.jpg,2727,7,52,8959,UnusuallyActive,
374729426,2019-11-14 08:24:44,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/916421, pic.twitter.com/jhIR4yqyhg, ",1194969415227305985,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator stops in overbought zone for 1 day. View odds for this and other indicators: https://t.co/3UTjFRSwL2 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/jhIR4yqyhg,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
472650465,2019-11-14 08:22:58,"INCY, ",,"bit.ly/2XdVbGw, ",1194968970744516608,False,0,0,0,0,OTC Dynamics Twitter Login,$INCY Incyte to Present at Upcoming Investor Conference https://t.co/yl1Hh1o8Ap,,,2012-01-24 00:00:23,"Winnipeg, Manitoba","OTC Dynamics, Inc.",https://pbs.twimg.com/profile_images/1344416590096338945/2BZynvIz_normal.jpg,7018,11,187,400150,otcdynamics,
1069693680066420736,2019-11-14 08:05:49,"INCY, ",,"s.flashalert.me/w1fAK2, ",1194964653278945281,False,0,0,0,0,flashalerts,"$INCY: Press Release published article on November 14, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/4TKpfXOqmU",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2019-11-14 08:05:06,,,"dlvr.it/RJGbFx, pic.twitter.com/pjUQaBkPYQ, ",1194964472726556673,False,0,0,0,0,dlvr.it,Incyte to Present at Upcoming Investor Conference https://t.co/KuOvTxpkPc https://t.co/pjUQaBkPYQ,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
826179494767640576,2019-11-14 06:09:08,,,"investors.com/stock-lists/se‚Ä¶, ",1194935289162194944,False,0,0,0,0,Twitter Web Client,Top Stocks In Biotech; Why Incyte Is Closing In On Buy Point After Post-Earnings Surge https://t.co/RlDsYXxknl via @IBDinvestors,"IBDinvestors, ",,2017-01-30 16:25:16,,TJ,https://pbs.twimg.com/profile_images/1144783262793043968/ni_rGG0T_normal.png,83,155,2,916,Buschtjj,
849417718642159616,2019-11-14 03:21:47,"INCY, ",,"zpr.io/tZYJF, ",1194893175082639360,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $569.75 Million https://t.co/QtbieAaT01,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2416188264,2019-11-14 03:20:46,"INCY, ","markets, ","thestockobserver.com/?p=2443402, ",1194892919938912256,False,0,0,0,0,Zapier.com,Brokerages Anticipate Incyte Co. $INCY Will Announce Quarterly Sales of $569.75 Million  https://t.co/n4EtsAFrnU #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
732361939490312192,2019-11-14 03:18:29,"INCY, ","markets, ","americanbankingnews.com/?p=12566872, ",1194892344073576448,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $569.75 Million https://t.co/0a36meeTfB #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-14 03:18:28,"INCY, ","stocks, ","americanbankingnews.com/?p=12566872, ",1194892340462272514,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $569.75 Million https://t.co/PJwEpguKAS #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
234905402,2019-11-13 13:29:44,,"FinalTrades, ","pic.twitter.com/VC1FZXX2aJ, ",1194683783347351554,False,11,0,2,4,Wildmoka,"#FinalTrades on CVS, Boston Scientific, Incyte, and U.S. Bancorp https://t.co/VC1FZXX2aJ",,,2011-01-06 16:33:58,,CNBC Halftime Report,https://pbs.twimg.com/profile_images/590580807753986049/fhYEXRiC_normal.png,78531,628,1158,7597,HalftimeReport,video
2193224916,2019-11-13 13:02:32,"USB, INCY, CSCO, ",,"marketrebellion.com, pic.twitter.com/o0xHE0vkE6, ",1194676936775208961,False,5,0,0,1,Twitter Web App,"Final trade from Pete Najarian of https://t.co/wQyU2sojtK - U. S. Bancorp $USB   
--
*Dr J had Incyte $INCY
@petenajarian @jonnajarian ps'  yours... awaiting $CSCO https://t.co/o0xHE0vkE6","petenajarian, jonnajarian, ",,2013-11-13 19:45:46,"London, UK",Philip Calrissian,https://pbs.twimg.com/profile_images/1302039310091378690/VTBMid-L_normal.jpg,13378,6,369,72260,Trading_Sunset,photo
455006011,2019-11-13 08:44:19,,"ACSCANTriStateForum, ","pic.twitter.com/YDzfis09Zy, ",1194611955761393665,False,4,0,0,1,Twitter Web App,Thank you to our sponsors for supporting the #ACSCANTriStateForum on Survivorship and the Future of Cancer Care! @IBX @pfizer @Incyte @Celgene @TakedaPharma @genentech @AstraZeneca @PennMedicine @Amgen @AstellasUS @bmsnews @NCCN @Merck @Novartis @TJUHospital @PAWWFH https://t.co/YDzfis09Zy,"IBX, pfizer, Incyte, celgene, TakedaPharma, genentech, AstraZeneca, PennMedicine, Amgen, AstellasUS, bmsnews, NCCN, Merck, Novartis, TJUHospital, PAWWFH, ",,2012-01-04 11:46:01,Pennsylvania,ACS CAN Pennsylvania,https://pbs.twimg.com/profile_images/1734394132/ACS_CAN_normal.jpg,548,609,10,2587,ACSCANPA,photo
705671484,2019-11-13 08:30:35,,"GreaterHere, ","bit.ly/2CIwJU9, pic.twitter.com/tc6tz0Bjgj, ",1194608500615393281,False,2,0,0,0,Buffer,"Wilmington, DE-based pharmaceutical company @Incyte was ranked on @GENbio Top 25 Biotech Companies of 2019: https://t.co/eXkhkpLvxI #GreaterHere https://t.co/tc6tz0Bjgj","Incyte, GENbio, ",,2012-07-19 15:49:25,Greater Philadelphia,Select Greater PHL,https://pbs.twimg.com/profile_images/1145781100272336896/55HkoapA_normal.png,2100,1072,54,4267,SelectPHL,photo
374729426,2019-11-13 07:54:18,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/913278, pic.twitter.com/mktM4crfOD, ",1194599367841214464,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator enters overbought zone. View odds for this and other indicators: https://t.co/EMd0zu0O6I #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/mktM4crfOD,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2019-11-12 20:04:52,"INCY, ","markets, ","americanbankingnews.com/?p=12551931, ",1194420833982337027,False,0,0,0,0,Zapier.com,Brokerages Anticipate Incyte Co. $INCY Will Announce Earnings of $0.58 Per Share https://t.co/v9ihwXoXJN #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-12 20:04:51,"INCY, ","stocks, ","americanbankingnews.com/?p=12551931, ",1194420830702321666,False,0,0,0,0,Zapier.com,Brokerages Anticipate Incyte Co. $INCY Will Announce Earnings of $0.58 Per Share https://t.co/Wic3RLOaf7 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2181281054,2019-11-12 19:56:27,"INCY, ","markets, ","wkrb13.com/?p=1401595, ",1194418715690967045,False,0,0,0,0,Zapier.com,Analysts Expect Incyte Co. $INCY to Announce $0.58 Earnings Per Share https://t.co/2omMjUkqdm #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1126479667442126848,2019-11-12 10:42:21,"INCY, ","Stocks, UnusualActivity, ",,1194279270497034240,False,0,0,0,0,TweetDeck,"Incyte Corporation $INCY up by 1.11% at $85.8

UNUSUAL ACTIVITY VOLUME 652.04% STRENGTH 800% 

#Stocks #UnusualActivity",,,2019-05-09 09:30:56,London,BREAKING STOCK NEWS,https://pbs.twimg.com/profile_images/1436383970774720513/ttpG7KuY_normal.jpg,2727,7,52,8959,UnusuallyActive,
178441882,2019-11-12 09:01:39,,,"noahsrss.wordpress.com/2019/11/12/the‚Ä¶, ",1194253927639928832,False,0,0,0,0,WordPress.com,"The Zacks Analyst Blog Highlights: Coherus, Incyte, ACADIA and¬†Celgene https://t.co/FueqyIYV8h",,,2010-08-14 15:40:41,United States,$TIDAL,https://pbs.twimg.com/profile_images/1429348015970525184/KeopaqH6_normal.jpg,1848,4291,22,85089,AltcoinHolder,
374729426,2019-11-12 07:50:00,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/910180, pic.twitter.com/LwAYRlQTpa, ",1194235898751094786,False,0,0,1,0,Tickeron,$INCY in Uptrend: Stochastic indicator is remaining in overbought zone for 8 days. View odds for this and other indicators: https://t.co/X34Y1rTEnu #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/LwAYRlQTpa,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
334944709,2019-11-11 07:40:00,,,"reut.rs/2Q6VAZI, pic.twitter.com/xpF0i3HSsc, ",1193870992101146630,False,0,0,0,1,TweetDeck,Incyte unlawfully marketed cancer drug Jakafi says whistleblower lawsuit https://t.co/CZsjOOYf0O @nateraymond ($) https://t.co/xpF0i3HSsc,"nateraymond, ",,2011-07-13 18:28:32,New York,Reuters Legal,https://pbs.twimg.com/profile_images/877491866706395139/QnLtTu2w_normal.jpg,79679,556,1877,89501,ReutersLegal,photo
374729426,2019-11-11 07:31:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/907222, pic.twitter.com/ItfYBRsYMM, ",1193868889769168896,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator enters overbought zone. View odds for this and other indicators: https://t.co/yanEsDY3AN #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ItfYBRsYMM,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2266388972,2019-11-11 04:38:10,"INCY, ","stocks, ","dailypolitical.com/?p=3211111, ",1193825232362098688,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Director Sells 10,576 Shares of Stock https://t.co/d8dnQd5os9 #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-11-11 04:38:09,"INCY, ",,"dailypolitical.com/?p=3211111, ",1193825228029407233,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Director Sells 10,576 Shares of Stock https://t.co/p4WXzNamyw",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1979190776,2019-11-11 04:34:28,"INCY, ",,"tickerreport.com/?p=4790634, ",1193824302497456129,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Director Sells $890,076.16 in Stock https://t.co/aGXNZ4KwIO",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
102728705,2019-11-10 16:27:35,"INCY, ","Incyte, Biotech, Aktien, Equities, ","pic.twitter.com/JDafjsfyU9, ",1193641376296124421,False,2,1,1,1,Twitter Web App,"#Incyte

Targets: 88,83 and 96,44 USD

$INCY #Biotech #Aktien #Equities https://t.co/JDafjsfyU9",,,2010-01-07 11:48:13,Germany,Harald Weygand,https://pbs.twimg.com/profile_images/1260715770608324609/w3v2STvc_normal.jpg,6172,3709,184,15696,weygand_gmt,photo
786038665625554944,2019-11-10 08:13:24,"INCY, ","money, ",,1193517012787564544,False,0,0,0,0,SFE Robot1,"Buy! Sell! No buy! On second thought, sell! Actually just stop buying Incyte $INCY #money",,,2016-10-11 22:59:56,The Markets,Stock Advicebot 2000,https://pbs.twimg.com/profile_images/786041984376983553/Zkm6Ab6h_normal.jpg,1797,69,38,43757,StockTipRobot,
374729426,2019-11-10 08:04:14,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/904330, pic.twitter.com/WyJzaLOJyE, ",1193514703885983744,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator enters overbought zone. View odds for this and other indicators: https://t.co/Sn6Nx0vYlI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/WyJzaLOJyE,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2298709746,2019-11-10 06:41:57,"INCY, ",,"zpr.io/tpXDN, ",1193493996846407681,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Director Wendy L. Dixon Sells 10,576 Shares https://t.co/4Fb0xYXj8U",,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
852931863547084801,2019-11-10 05:53:36,"INCY, ",,"zpr.io/tpXjr, ",1193481828646227968,False,0,0,0,0,Zapier.com,"Wendy L. Dixon Sells 41,218 Shares of Incyte Co. $INCY Stock https://t.co/2n0CeLrqKV",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
966006214818697218,2019-11-10 05:52:30,"INCY, ",,"theenterpriseleader.com/?p=2385415, ",1193481552451252224,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Director Wendy L. Dixon Sells 41,218 Shares  https://t.co/qKYq6H43Ad",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
107762262,2019-11-10 02:38:46,"NKTR, INCY, ",,"fiercebiotech.com/biotech/incyte‚Ä¶, ",1193432797404418048,False,2,0,0,2,Tweetings for Android,"$NKTR $INCY
https://t.co/oidSO66afi
""Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combination""",,,2010-01-23 12:01:33,"Brooklyn, NY",Edward Taussig,https://pbs.twimg.com/profile_images/2862264586/09e5ec5855f8fd04106be367c34fa579_normal.jpeg,282,409,26,38493,edtaussig,
107762262,2019-11-10 02:37:03,,,"fiercebiotech.com/biotech/incyte‚Ä¶, twitter.com/AndyBiotech/st‚Ä¶, ",1193432365726609409,False,0,0,0,0,Tweetings for Android,"""Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combination""
https://t.co/oidSO66afi https://t.co/FQOaAu6m0b",,,2010-01-23 12:01:33,"Brooklyn, NY",Edward Taussig,https://pbs.twimg.com/profile_images/2862264586/09e5ec5855f8fd04106be367c34fa579_normal.jpeg,282,409,26,38493,edtaussig,
335950885,2019-11-09 14:27:39,,"SITC2019, ",,1193248804432228353,False,0,0,0,0,Sprout Social,"Preliminary interim data from a phase II study of NCMGA00012 (Incyte) in platinum-refractory patients with advanced/metastatic anal canal squamous carcinoma (POD1UM-202) showed antitumoral activity, including independently confirmed RECIST responses #SITC2019",,,2011-07-15 10:20:18,,Clarivate for Life Sciences & Healthcare,https://pbs.twimg.com/profile_images/1265663600510803969/bKZ2FhiC_normal.jpg,4271,923,158,17557,ClarivateHealth,
374729426,2019-11-09 09:50:59,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/901405, pic.twitter.com/CB6yFxp7v0, ",1193179181296701442,False,0,0,0,0,Tickeron,$INCY in Uptrend: RSI indicator enters overbought zone. View odds for this and other indicators: https://t.co/IimdbDqZB8 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/CB6yFxp7v0,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
47513933,2019-11-09 09:31:11,,,"townsquaredelaware.com/2019/11/06/ala‚Ä¶, ",1193174196773380097,False,0,0,0,0,Twitter Web Client,Alapocas Opposition to Friends Lower School Sale to Incyte Could Scuttle Deal https://t.co/vwq3LbVXCd,,,2009-06-15 22:11:48,"Newark, Delaware",Nancy Willing,https://pbs.twimg.com/profile_images/276978662/powmiaLOGOsm_normal.gif,871,1115,82,96415,nannyfat,
2266388972,2019-11-09 08:41:13,"INCY, ","stocks, ","dailypolitical.com/?p=3206031, ",1193161623101493248,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Director Wendy L. Dixon Sells 41,218 Shares of Stock https://t.co/YtVEJ8CYs4 #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-11-09 08:41:12,"INCY, ",,"dailypolitical.com/?p=3206031, ",1193161619557236737,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Director Wendy L. Dixon Sells 41,218 Shares of Stock https://t.co/YkJ5I5sjGS",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1176558075798380544,2019-11-08 22:15:13,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1193004086523760641,False,0,0,0,0,InsiderActionMonitor,$INCY Wendy Dixon sells $3.5M Worth Of Incyte Stock https://t.co/tRadk7lSjv,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
732361939490312192,2019-11-08 19:02:18,"INCY, ","markets, ","americanbankingnews.com/?p=12504233, ",1192955536259633152,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Director Sells 10,576 Shares of Stock https://t.co/erDYnfK7Ww #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-08 19:02:17,"INCY, ","stocks, ","americanbankingnews.com/?p=12504233, ",1192955532182740993,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Director Sells 10,576 Shares of Stock https://t.co/jg1EeSsNZt #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2019-11-08 19:01:55,"INCY, ","markets, ","americanbankingnews.com/?p=12504281, ",1192955437773185030,False,0,0,0,0,Zapier.com,"Wendy L. Dixon Sells 41,218 Shares of Incyte Co. $INCY Stock https://t.co/qUAhvyETZ2 #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-08 19:01:54,"INCY, ","stocks, ","americanbankingnews.com/?p=12504281, ",1192955435025911809,False,0,0,0,0,Zapier.com,"Wendy L. Dixon Sells 41,218 Shares of Incyte Co. $INCY Stock https://t.co/6YkpkRmeji #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
68559732,2019-11-08 19:00:49,"INCY, ",,"zpr.io/tp7GU, ",1192955161804779522,False,0,0,0,0,Zapier.com,"Wendy L. Dixon Sells 41,218 Shares of Incyte Co. $INCY Stock https://t.co/lB6PsNHp4v",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
334944709,2019-11-08 18:25:00,,,"reut.rs/2Q6VAZI, pic.twitter.com/lUtfCFITUS, ",1192946148056502272,False,0,0,0,0,TweetDeck,Incyte unlawfully marketed cancer drug Jakafi says whistleblower lawsuit https://t.co/CZsjOOYf0O @nateraymond ($) https://t.co/lUtfCFITUS,"nateraymond, ",,2011-07-13 18:28:32,New York,Reuters Legal,https://pbs.twimg.com/profile_images/877491866706395139/QnLtTu2w_normal.jpg,79679,556,1877,89501,ReutersLegal,photo
39318996,2019-11-08 13:14:44,,,"reut.rs/2PZLEBy, ",1192868067367370753,False,0,0,0,0,Twitter Web Client,"U.S. company directors compensated more than ever [especially biotech/ pharma like Incyte, Regeneron, Vertex] https://t.co/lwg6VpKFsg",,,2009-05-11 15:21:06,,Roy Poses et al.,https://pbs.twimg.com/profile_images/942161700719034369/udaz4mHl_normal.jpg,1869,449,81,37911,HealthCareRenew,
374729426,2019-11-08 12:50:49,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/898591, pic.twitter.com/kI7CW8Sdb2, ",1192862049216237568,False,0,0,0,0,Tickeron,$INCY in Uptrend: Stochastic indicator stays in overbought zone for 6 days. View odds for this and other indicators: https://t.co/fXyLGb1nad #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kI7CW8Sdb2,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
532343672,2019-11-08 08:23:12,,,"townsquaredelaware.com/2019/11/06/ala‚Ä¶, ",1192794700639547392,False,0,0,0,0,Facebook,Alapocas Opposition to Friends Lower School Sale to Incyte Could Scuttle Deal https://t.co/qjEacFzTtP,,,2012-03-21 12:09:06,delaware puerto rico,kevin g a melloy,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,26,55,0,5188,kevingamelloy,
2787240286,2019-11-08 07:13:28,,,"townsquaredelaware.com/2019/11/06/ala‚Ä¶, ",1192777153689075712,False,0,0,0,0,Facebook,Alapocas Opposition to Friends Lower School Sale to Incyte Could Scuttle Deal https://t.co/tou7Bh4p8g,,,2014-09-27 10:49:59,"Arden, Delaware",Tom Wheeler,https://pbs.twimg.com/profile_images/517702789401542656/Mo8mOal6_normal.jpeg,14,2,0,417,Wheelhousesteam,
14586896,2019-11-08 05:00:06,,,"wdel.com/news/incyte-fo‚Ä¶, ",1192743589299806208,False,2,0,0,0,BLOX CMS,Wilmington Friends School and Incyte Corporation have entered into a sales agreement for the Friends Lower School property in Alapocas which sits behind the biopharmaceutical research company's headquarters off Augustine Cut-Off. https://t.co/CjjN0Ll3Pw,,,2008-04-29 12:27:52,"Wilmington, DE",101.7FM / 1150AM WDEL,https://pbs.twimg.com/profile_images/1166719920442396677/Iq8iWG3__normal.jpg,16412,1230,366,60576,WDEL,
121158213,2019-11-07 13:40:03,"INCY, ",,"AlertTrade.us, ",1192512050888445953,False,0,0,0,0,dlvr.it,TREND REVERSAL DOWN ALERT: $INCY Incyte Corporation Common Stock üìâ TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
1921812811,2019-11-07 13:24:40,,,"townsquaredelaware.com/2019/11/06/ala‚Ä¶, ",1192508177939607552,False,0,0,0,0,Facebook,Alapocas Opposition to Friends Lower School Sale to Incyte Could Scuttle Deal https://t.co/2dSihmaBrX,,,2013-09-30 20:57:32,"Wilmington, DE",Fancy Greenberg,https://pbs.twimg.com/profile_images/1385035231749709826/irdW2Hw__normal.jpg,64,34,2,1902,FancyFells,
772471873539977217,2019-11-07 13:09:47,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1192504434770825216,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form CT ORDER https://t.co/yNNicH45cR,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
374729426,2019-11-07 08:13:52,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/895423, pic.twitter.com/HLuvEdbbtH, ",1192429962596212742,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/wisF4GqHSq #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/HLuvEdbbtH",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
930803511918411776,2019-11-07 05:05:30,"INCY, ",,"thelincolnianonline.com/?p=3180339, ",1192382559424012288,False,0,0,0,0,Zapier.com,"Yao Wenqing Sells 7,960 Shares of Incyte Co. $INCY Stock https://t.co/IwaF753yu2",,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2416188264,2019-11-06 22:59:16,"INCY, ","markets, ","thestockobserver.com/?p=2423625, ",1192290396942094337,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúBuy‚Äù by Brokerages  https://t.co/DgcyuOyGQa #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2019-11-06 22:58:58,"INCY, ",,"zpr.io/tzrVf, ",1192290317610958849,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Average Recommendation of ‚ÄúBuy‚Äù by Brokerages https://t.co/BmoilwTHjt,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
849417718642159616,2019-11-06 22:58:09,"INCY, ",,"zpr.io/tzrvk, ",1192290114157895680,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúBuy‚Äù by Brokerages https://t.co/Jd4bJha1jt,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
274569466,2019-11-06 18:14:59,,"netde, ","goo.gl/fb/9NkeX8, ",1192218854581293056,False,1,0,0,0,Google,Alapocas Opposition to Friends Lower School Sale to Incyte Could Scuttle Deal https://t.co/jRhUX8kyN7 #netde,,,2011-03-30 11:09:40,The Fabulous First State,Town Square Delaware,https://pbs.twimg.com/profile_images/1324437027291615236/PeIY6Mtk_normal.jpg,4566,1093,93,6394,TownSquareDE,
116545390,2019-11-06 17:08:44,,"biotech, WhySwitzerland, ","bit.ly/2JTnjcM, ",1192202180859748353,False,0,0,0,0,Twitter Web App,"Euro Crisis? Surprisingly positive signs are seen by @ESM_Press, the crisis resolution mechanism for euro area countries. American #biotech @Incyte is an example as it builds a larger HQ and new production facility in üá®üá≠, says @NZZ üëâhttps://t.co/YN57Ic8f6N #WhySwitzerland","ESM_Press, Incyte, NZZ, ",,2010-02-22 16:18:41,New York,Swiss Business Hub,https://pbs.twimg.com/profile_images/1222562837580611584/xj43v5PC_normal.png,4013,445,108,3037,SBH_USA,
111648072,2019-11-06 12:00:03,,,"buff.ly/2JvCUh7, pic.twitter.com/WmZ0c5NoHZ, ",1192124498046332928,False,0,0,0,0,Buffer,"CHECK OUT THE NEW JOB POSTINGS! View the posted jobs on the ISMPP Jobs Board! Opportunities available at AbbVie, Bayer, Bristol-Myers Squibb, Incyte Corp., Nucleus Global, and Takeda. Find out more: https://t.co/vJPj6bIXLM https://t.co/WmZ0c5NoHZ",,,2010-02-05 12:32:26,,ISMPP,https://pbs.twimg.com/profile_images/785842416754520065/sh0T72mi_normal.jpg,2584,680,44,4227,ISMPP,photo
104745251,2019-11-06 10:10:00,,"CPhIWW, ","pic.twitter.com/HPpB3umcGN, ",1192096801547046912,False,0,0,0,0,TweetDeck,"Hamilton Bonaduz presents the long-awaited Incyte Arc Sensor for measuring fresh cell density at the #CPhIWW. Of course we are on site and could already get a first impression. Take a look at the sensor, the booth number is 120C35. @HamiltonCompany @CPhIWW https://t.co/HPpB3umcGN","HamiltonCompany, CPhIWW, ",,2010-01-14 02:42:26,"Weinheim, Germany",CHEManager International,https://pbs.twimg.com/profile_images/1083027722992005120/XAwkzjPO_normal.jpg,3768,1195,107,26815,CHEManager_EU,photo
374729426,2019-11-06 08:10:33,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/892325, pic.twitter.com/EmY77J9A8E, ",1192066743717384192,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average moved below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/WHYV88Gz6T #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/EmY77J9A8E",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
852931863547084801,2019-11-06 06:28:26,"INCY, ",,"zpr.io/tzuNt, ",1192041042427752450,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 8,500 Shares https://t.co/A9wHp2XRku",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
966006214818697218,2019-11-06 06:22:05,"INCY, ",,"theenterpriseleader.com/?p=2373565, ",1192039444972548097,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 8,500 Shares  https://t.co/e5xBjyljWW",,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
911268285425094662,2019-11-06 03:57:07,,,"ift.tt/2qr4tme, ",1192002962350055424,False,0,0,0,0,IFTTT,Reviewing Incyte Corporation (INCY)'s and Revance Therapeutics Inc. (NASDAQ:RVNC)'s results https://t.co/EuF9XZ8W8q,,,2017-09-22 12:37:44,"Wrexham, Wales",bobrob1@btinternet.com,https://pbs.twimg.com/profile_images/1150276654897487878/Ca8H54cI_normal.png,248,1092,1,3362,bobrobaitch,
3201961533,2019-11-06 03:07:11,,,"ift.tt/2CjNfKo, ",1191990397498736640,False,0,0,0,0,IFTTT,"The Zacks Analyst Blog Highlights: Sony, Allstate and Incyte https://t.co/ig2A7I7zHT",,,2015-04-24 14:45:24,"Geneva, Switzerland",Africa Mining News,https://pbs.twimg.com/profile_images/594609682595094528/2ShH503b_normal.png,790,0,49,257832,africaminenews,
1176558075798380544,2019-11-05 23:50:13,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1191940830942105606,False,0,0,0,1,InsiderActionMonitor,$INCY Paul Trower Dumps 8.5K Shares of Incyte https://t.co/tRadk7lSjv,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
732361939490312192,2019-11-05 17:48:02,"INCY, ","markets, ","americanbankingnews.com/?p=12462512, ",1191849683238432771,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $676,600.00 in Stock https://t.co/1izfCEiVso #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-05 17:48:01,"INCY, ","stocks, ","americanbankingnews.com/?p=12462512, ",1191849680092708865,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $676,600.00 in Stock https://t.co/wIbP2jXl4e #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2019-11-05 17:47:58,"INCY, ","markets, ","americanbankingnews.com/?p=12462536, ",1191849665886662657,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 8,500 Shares https://t.co/dukzims8bE #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-05 17:47:57,"INCY, ","stocks, ","americanbankingnews.com/?p=12462536, ",1191849663051259904,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 8,500 Shares https://t.co/Ui2Qndfm16 #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
68559732,2019-11-05 17:46:07,"INCY, ",,"zpr.io/tzE2f, ",1191849201677803521,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY Insider Paul Trower Sells 8,500 Shares https://t.co/mt2hWSWNL1",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
772471873539977217,2019-11-05 16:37:48,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1191832005853487110,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/jbrSgJDsYq,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
922461289015906304,2019-11-05 12:08:42,,"DiscoveryStartsHerePHL, ","genengnews.com/a-lists/top-25‚Ä¶, ",1191764284675629056,False,5,0,0,5,Twitter Web App,"THIS JUST IN! Companies with Greater Philadelphia regional ties including @Incyte, @WuXiApp, and @CSL ranked among top 25 biotech companies of 2019, per @genengnews.  https://t.co/qjgVT1rfB7 
#DiscoveryStartsHerePHL","Incyte, wuxiapp, CSL, genengnews, ",,2017-10-23 09:54:44,"Philadelphia, PA",CEO Council,https://pbs.twimg.com/profile_images/922462262140350464/g42_bPOE_normal.jpg,1605,1319,0,2205,CEOCouncilPHL,
3911174913,2019-11-05 09:00:01,,"SCTopEmployer, LifeAtIncyte, ","pic.twitter.com/pDijMMCuuE, ",1191716801148641280,False,21,0,0,2,Twitter Ads,"We‚Äôre proud to have been named a #SCTopEmployer again this year. Hear from our Head of HR, Paula Swain, on why we believe in work-life balance for all of our employees. #LifeAtIncyte https://t.co/pDijMMCuuE",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
17844220,2019-11-05 08:50:53,,"DEHRawards, DelawareHR, ","twitter.com/DelawareSHRM/s‚Ä¶, ",1191714506415714305,False,2,0,0,0,Twitter for iPhone,Congratulations to all the winners! Including @paulaswain4 of @Incyte #DEHRawards #DelawareHR https://t.co/8QPsEUIuua,"paulaswain4, Incyte, ",,2008-12-03 13:40:46,19702,Kevin M. Cameron,https://pbs.twimg.com/profile_images/1384884854639276036/_UBPZbHE_normal.jpg,833,2329,14,1954,KevinCameronDE,
374729426,2019-11-05 08:12:25,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/889292, pic.twitter.com/bvN6UrmBvW, ",1191704821922820096,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/pje0oKNvMA #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/bvN6UrmBvW",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
72297554,2019-11-05 07:25:04,"INCY, ",,"ow.ly/42kz30pPXHs, ",1191692909176934401,False,0,0,0,0,Hootsuite Inc.,"Incyte $INCY, is getting closer to a buy point after the highly rated biotech's big quarterly beat. https://t.co/8ShtBSVaWP",,,2009-09-07 10:49:46,"Maryland, USA",myrollingstocks,https://pbs.twimg.com/profile_images/1182244872/HappyDayTrader_normal.jpg,74,118,4,63569,channelingstock,
72284492,2019-11-05 07:25:04,"INCY, ",,"ow.ly/B07630pPXDL, ",1191692908950360064,False,0,0,0,0,Hootsuite Inc.,"Incyte $INCY, is getting closer to a buy point after the highly rated biotech's big quarterly beat. https://t.co/PqCThNuNa5",,,2009-09-07 09:49:42,USA - Maryland,Myrollingstocks,https://pbs.twimg.com/profile_images/430713133/Finance_3_normal.jpg,109354,122110,483,135217,myrollingstocks,
873399943,2019-11-05 04:53:52,"INCY, AGIO, ",,"bit.ly/2WK4wFL, twitter.com/bio_clouseau/s‚Ä¶, ",1191654856706134016,False,2,0,1,2,TweetDeck,Advantage $INCY ? https://t.co/ypbpOPA4am $AGIO https://t.co/2YYBPmm7HQ,,,2012-10-11 06:45:00,"London, UK",Jacob Plieth,https://pbs.twimg.com/profile_images/453547761401462784/a2Lp0d3m_normal.jpeg,17752,328,0,20982,JacobPlieth,
374729426,2019-11-05 03:51:33,"INCY, ","Incyte, stockmarket, stock, money, trading, investing, daytrading, news, today, ","tickeron.com/go/888026, ",1191639175482597376,False,0,0,0,0,Tickeron,"3 Insiders at Incyte sold 19,470 shares last week for $1.6M $INCY #Incyte #stockmarket #stock #money #trading #investing #daytrading #news #today https://t.co/aJZmTOE7L9",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,
335246117,2019-11-05 03:02:28,,"liquidbiopsy, genomics, ","ift.tt/2Niu89I, ",1191626822859014144,False,0,0,0,0,IFTTT,#liquidbiopsy #genomics Virtusa (VRTU) Holder Monarch Partners Asset Management Boosted Its Stake; As Incyte (INCY ... https://t.co/RwuCdR3805,,,2011-07-14 07:33:48,,SeqComplete,https://pbs.twimg.com/profile_images/432012289185546240/nESezhJN_normal.jpeg,4083,3056,329,259526,SeqComplete,
940506141536141312,2019-11-05 00:22:42,,"Janus, Kinase, Inhibitors, ","bit.ly/31UUEKs, pic.twitter.com/xeMH6Yc8fV, ",1191586616684363776,False,0,0,0,0,Twitter Web App,"#Janus #Kinase (JAK) #Inhibitors - Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments.

Request to Get the Sample: https://t.co/yU917jfTta

Key company : @pfizer , @EliLillyItalia , @Incyte , @abbvie @italfarmacoes https://t.co/xeMH6Yc8fV","pfizer, EliLillyItalia, Incyte, abbvie, italfarmacoes, ",,2017-12-12 03:58:32,India,PharmProff,https://pbs.twimg.com/profile_images/1090504682491994112/jzTrBOWi_normal.jpg,36,119,1,92,PharmaProff,photo
940506141536141312,2019-11-05 00:11:02,,"Myelofibrosis, MF, Therapeutics, ","bit.ly/2MFki1l, pic.twitter.com/0jXe8uaOMQ, ",1191583678142414848,False,0,0,0,0,Twitter Web App,"#Myelofibrosis (#MF) #Therapeutics ‚Äì Pipeline Analysis 2019, Clinical Trials and Results, Patents, Designations, Collaborations, and Other Developments.

Request to Get the Sample Pages at: https://t.co/kexqcNqh16

@Incyte @VisitSuzhou @Novartis @abbvie https://t.co/0jXe8uaOMQ","Incyte, VisitSuzhou, Novartis, abbvie, ",,2017-12-12 03:58:32,India,PharmProff,https://pbs.twimg.com/profile_images/1090504682491994112/jzTrBOWi_normal.jpg,36,119,1,92,PharmaProff,photo
301129964,2019-11-04 23:15:02,,,"dlvr.it/RHdMV5, ",1191569586774130688,False,0,0,0,0,dlvr.it,Incyte: An Undervalued Biotech With Catalysts https://t.co/Yb21tRGra5,,,2011-05-18 18:59:56,"London, England",IPO Sniffer,https://pbs.twimg.com/profile_images/378800000772192949/ca0b3ba33d894cdecb38345b34431cdd_normal.jpeg,1578,59,101,317601,IPOSniffer,
3911174913,2019-11-04 20:20:28,,"WomanInScience, DEHRAwards, ","pic.twitter.com/1vdjIuGWaN, ",1191525655642542080,False,111,0,7,20,Twitter Web App,"We're proud to announce that our Head of Human Resources, Paula Swain, has won the @DeBusinessTimes 2019 HR Executive of the Year Award. Congratulations to her &amp; all other nominees for their outstanding leadership. #WomanInScience #DEHRAwards https://t.co/1vdjIuGWaN","DeBusinessTimes, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
1979190776,2019-11-04 16:05:18,"INCY, ",,"tickerreport.com/?p=4770791, ",1191461440286347266,False,0,0,0,0,Zapier.com,Analysts Set Incyte Co. $INCY PT at $93.32 https://t.co/DEZ8Fv9hX8,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
34324846,2019-11-04 10:35:04,,"biotech, pharma, SCTopEmployer, ","fcld.ly/51axcjr, pic.twitter.com/FScY1rSs2z, ",1191378335043072001,False,2,0,0,2,erased6981162,"Want to get to know some of the Top Employers in #biotech #pharma? 

Explore 2019 Top Employer Profiles for @Alnylam, @pfizer, @GSK, @Roche, @LillyPad, and @Incyte at: https://t.co/h0P8cWE4hg

#SCTopEmployer https://t.co/FScY1rSs2z","Alnylam, pfizer, GSK, Roche, LillyPad, Incyte, ",,2009-04-22 12:51:07,"Washington, DC",Science Careers,https://pbs.twimg.com/profile_images/1298289631188922368/ta9Sb-p3_normal.jpg,47975,243,591,72316,ScienceCareers,photo
1126479667442126848,2019-11-04 09:42:44,"INCY, ","Stocks, UnusualActivity, ",,1191365165167628291,False,0,0,0,0,TweetDeck,"Incyte Corporation $INCY up by 0.44% at $83.95

UNUSUAL ACTIVITY VOLUME 954.58% STRENGTH 505.2% 

#Stocks #UnusualActivity",,,2019-05-09 09:30:56,London,BREAKING STOCK NEWS,https://pbs.twimg.com/profile_images/1436383970774720513/ttpG7KuY_normal.jpg,2727,7,52,8959,UnusuallyActive,
72284492,2019-11-04 08:25:03,,,"ow.ly/CP1930pPwMh, ",1191345615567032320,False,0,0,0,0,Hootsuite Inc.,"Incyte boosted its guidance for full-year Jakafi sales to a range of $1.65 billion to $1.68 billion, from $1.61 billion to $1.65 billion. https://t.co/NLaLF4csky",,,2009-09-07 09:49:42,USA - Maryland,Myrollingstocks,https://pbs.twimg.com/profile_images/430713133/Finance_3_normal.jpg,109354,122110,483,135217,myrollingstocks,
72297554,2019-11-04 08:25:03,,,"ow.ly/xkwi30pPwRT, ",1191345615143362562,False,0,0,0,0,Hootsuite Inc.,"Incyte boosted its guidance for full-year Jakafi sales to a range of $1.65 billion to $1.68 billion, from $1.61 billion to $1.65 billion. https://t.co/m2GDQXTKY8",,,2009-09-07 10:49:46,"Maryland, USA",myrollingstocks,https://pbs.twimg.com/profile_images/1182244872/HappyDayTrader_normal.jpg,74,118,4,63569,channelingstock,
374729426,2019-11-04 07:26:16,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/886305, pic.twitter.com/7voOxfpB1G, ",1191330823758172160,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/zQahfsGsEc #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/7voOxfpB1G",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
72297554,2019-11-04 07:25:03,"INCY, ",,"ow.ly/dZrg30pPwRI, ",1191330514260692992,False,0,0,0,0,Hootsuite Inc.,"Incyte $INCY, is getting closer to a buy point after the highly rated biotech's big quarterly beat. https://t.co/6gmCaQ256i",,,2009-09-07 10:49:46,"Maryland, USA",myrollingstocks,https://pbs.twimg.com/profile_images/1182244872/HappyDayTrader_normal.jpg,74,118,4,63569,channelingstock,
72284492,2019-11-04 07:25:02,"INCY, ",,"ow.ly/jUr030pPwMc, ",1191330513623142400,False,0,0,0,0,Hootsuite Inc.,"Incyte $INCY, is getting closer to a buy point after the highly rated biotech's big quarterly beat. https://t.co/qer6LnrlgM",,,2009-09-07 09:49:42,USA - Maryland,Myrollingstocks,https://pbs.twimg.com/profile_images/430713133/Finance_3_normal.jpg,109354,122110,483,135217,myrollingstocks,
1163748588419203075,2019-11-04 06:54:19,,,"ift.tt/2C7fpbg, ",1191322780194742272,False,0,0,0,0,IFTTT,Incyte: An Undervalued Biotech With Catalysts https://t.co/ayxhl6Gt6A,,,2019-08-20 05:46:38,,Sol Wisdom,https://pbs.twimg.com/profile_images/1163749715890102272/F46ad2Yu_normal.jpg,73,473,0,20117,sol_wisdom,
23059499,2019-11-04 06:21:45,"INCY, ","investing, markets, trading, ","seekingalpha.com/article/430210‚Ä¶, ",1191314586374303744,False,1,0,0,0,SAArticlesTwitter,$INCY - Incyte: An Undervalued Biotech With Catalysts. Read more and sign up for updates: https://t.co/XYcTVHNZC0 #investing #markets #trading,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
956484027384582144,2019-11-04 00:40:06,"INCY, ","stocks, stockmarket, ","tradingnewsnow.com/2018/03/12/var‚Ä¶, ",1191228607135399936,False,0,0,0,0,stockspredictor,"VARIED ANALYST COMMENTS ON: Incyte Corporation, (NASDAQ: INCY), Cabot Oil ... https://t.co/FMxQWBeyCj $INCY #stocks #stockmarket",,,2018-01-25 06:08:57,,StocksPredictor,https://pbs.twimg.com/profile_images/956485778384850944/S5_3tIPa_normal.jpg,1445,1604,8,20822,StocksPredictr,
1979190776,2019-11-03 08:53:06,"INCY, ",,"tickerreport.com/?p=4766941, ",1190990287230971904,False,1,0,0,0,Zapier.com,Oppenheimer Comments on Incyte Co.‚Äôs FY2020 Earnings $INCY https://t.co/uOvUzqm9rM,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2298709746,2019-11-03 08:49:15,"INCY, ",,"zpr.io/t7JKD, ",1190989317335846912,False,1,0,0,0,Zapier.com,Oppenheimer Comments on Incyte Co.‚Äôs FY2020 Earnings $INCY https://t.co/Uor3xnR5xQ,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
374729426,2019-11-03 07:07:39,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/883329, pic.twitter.com/F8Vup6RHPo, ",1190963747243741184,False,1,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/SxcdQkDZgX #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/F8Vup6RHPo",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2266388972,2019-11-03 05:50:55,"INCY, ","stocks, ","dailypolitical.com/?p=3187046, ",1190944438597685248,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $173,400.00 in Stock https://t.co/VKIZV1FvHt #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-11-03 05:50:54,"INCY, ",,"dailypolitical.com/?p=3187046, ",1190944436139757568,False,1,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells $173,400.00 in Stock https://t.co/wnpJ0KAv8a",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2416188264,2019-11-03 04:58:27,"INCY, ","markets, ","thestockobserver.com/?p=2411831, ",1190931236430262272,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Insider Sells $1,327,425.00 in Stock  https://t.co/gA8CAEMyFX #markets",,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2019-11-03 04:57:59,"INCY, ",,"zpr.io/t7isp, ",1190931116032741378,False,1,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY Insider Sells 16,500 Shares of Stock https://t.co/KVJ02Axux0",,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
4419993470,2019-11-03 02:55:10,,"stocks, news, ","ift.tt/2BWFQjI, ",1190900207933960192,False,0,0,0,0,IFTTT,Stocks To Watch: Top Biotech Stock Near Buy Point After Blowout Earnings - Investor's Business Daily https://t.co/ySPnJ59JKY #stocks #news,,,2015-12-01 06:37:16,,Signals.me,https://pbs.twimg.com/profile_images/686123587200143360/hr4lhxxx_normal.png,23819,12097,148,174057,SignalsMe,
930803511918411776,2019-11-02 14:42:20,"INCY, ",,"thelincolnianonline.com/?p=3166251, ",1190700686230671365,False,1,0,0,0,Zapier.com,Mizuho Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/j8Ka50haNM,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
68559732,2019-11-02 14:39:47,"INCY, ",,"zpr.io/t728C, ",1190700044661526528,False,0,0,0,0,Zapier.com,Mizuho Reaffirms Buy Rating for Incyte $INCY https://t.co/Chx0nItUoC,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
68559732,2019-11-02 14:39:44,"INCY, ",,"zpr.io/t728w, ",1190700030639800321,False,0,0,0,0,Zapier.com,Mizuho Reaffirms ‚ÄúBuy‚Äù Rating for Incyte $INCY https://t.co/ImFzxVa3BB,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
374729426,2019-11-02 12:33:52,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/880646, pic.twitter.com/XfcjvhrBQB, ",1190668355767635968,False,1,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/2YljExqnoe #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/XfcjvhrBQB",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2920258887,2019-11-02 05:33:14,"INCY, ",,"dakotafinancialnews.com/?p=1296067, ",1190562500854603777,False,1,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 2,040 Shares https://t.co/vxpLuovIst",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
4419993470,2019-11-02 03:04:17,,"stocks, news, ","ift.tt/2BWFQjI, ",1190525017735548928,False,0,0,0,0,IFTTT,Stocks To Watch: Top Biotech Stock Near Buy Point After Blowout Earnings - Investor's Business Daily https://t.co/ySPnJ59JKY #stocks #news,,,2015-12-01 06:37:16,,Signals.me,https://pbs.twimg.com/profile_images/686123587200143360/hr4lhxxx_normal.png,23819,12097,148,174057,SignalsMe,
68559732,2019-11-01 22:38:18,"INCY, ",,"zpr.io/t7wuf, ",1190458078728196096,False,0,0,0,0,Zapier.com,"Incyte Co. to Post FY2020 Earnings of $2.33 Per Share, Oppenheimer Forecasts $INCY https://t.co/oaGypi8y4M",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
732361939490312192,2019-11-01 22:37:43,"INCY, ","markets, ","americanbankingnews.com/?p=12415376, ",1190457933160763392,False,0,0,0,0,Zapier.com,"Incyte Co. to Post FY2020 Earnings of $2.33 Per Share, Oppenheimer Forecasts $INCY https://t.co/v1IsaMDSvy #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-01 22:37:42,"INCY, ","stocks, ","americanbankingnews.com/?p=12415376, ",1190457930304425984,False,0,0,0,0,Zapier.com,"Incyte Co. to Post FY2020 Earnings of $2.33 Per Share, Oppenheimer Forecasts $INCY https://t.co/8Ag9SL41D5 #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1015383484439957510,2019-11-01 15:30:01,,,,1190350300332384256,False,0,1,0,0,Twitter Web App,"Congrats! Nicole Figueroa Cetin appointed as Director, Corporate Counsel - Development at Incyte",,,2018-07-06 19:54:22,,clo,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,21,0,0,22596,clo31741753,
21793154,2019-11-01 15:07:24,,,"hubs.ly/H0lBgBS0, ",1190344608099786758,False,1,0,0,0,HubSpot,"Biopharma Q3: @pfizer, @Merck,  @Amgen,  @Incyte, @JNJCares

As the third quarter of 2019 comes to an end, most biopharma companies are reporting their earnings as they head into the final lap for the year. Here‚Äôs a look:

https://t.co/kUmMXDuS0j","pfizer, Merck, Amgen, Incyte, JNJCares, ",,2009-02-24 15:27:40,"Des Moines, IA",BioSpace,https://pbs.twimg.com/profile_images/1042117112020389888/8MCBEVkx_normal.jpg,21738,2830,509,25196,biospace,
1979190776,2019-11-01 12:33:01,"INCY, ",,"tickerreport.com/?p=4761670, ",1190305755406180354,False,0,0,0,0,Zapier.com,"Incyte $INCY Posts Quarterly Earnings Results, Beats Expectations By $0.27 EPS https://t.co/1Z4Iuuckl7",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
68559732,2019-11-01 12:31:44,"INCY, ",,"zpr.io/t7KHT, ",1190305433858322433,False,0,0,0,0,Zapier.com,"Incyte $INCY Announces Quarterly Earnings Results, Beats Expectations By $0.27 EPS https://t.co/7se9qk4l3y",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
3911174913,2019-11-01 10:00:00,,"LifeAtIncyte, ","pic.twitter.com/Xq11QxiMSL, ",1190267247614259200,False,17,0,0,4,Twitter Ads,"Our Head of HR, Paula Swain, weighs in on our patient-focused mission and how we integrate this belief into our everyday work at Incyte. Watch to learn more. #LifeAtIncyte https://t.co/Xq11QxiMSL",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
374729426,2019-11-01 08:36:27,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/877505, pic.twitter.com/itxonavNYV, ",1190246220490403840,False,0,0,0,0,Tickeron,"$INCY in Downtrend: its price may drop because broke its higher Bollinger Band on October 29, 2019. View odds for this and other indicators: https://t.co/SddvUqjogy #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/itxonavNYV",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
72297554,2019-11-01 08:25:04,,,"ow.ly/WHue30pOGMT, ",1190243354732322817,False,0,0,0,0,Hootsuite Inc.,"Incyte boosted its guidance for full-year Jakafi sales to a range of $1.65 billion to $1.68 billion, from $1.61 billion to $1.65 billion. https://t.co/ijnyAgTf4F",,,2009-09-07 10:49:46,"Maryland, USA",myrollingstocks,https://pbs.twimg.com/profile_images/1182244872/HappyDayTrader_normal.jpg,74,118,4,63569,channelingstock,
72284492,2019-11-01 08:25:03,,,"ow.ly/dEAB30pOGL2, ",1190243354291974145,False,0,0,0,0,Hootsuite Inc.,"Incyte boosted its guidance for full-year Jakafi sales to a range of $1.65 billion to $1.68 billion, from $1.61 billion to $1.65 billion. https://t.co/veJIRk0WG7",,,2009-09-07 09:49:42,USA - Maryland,Myrollingstocks,https://pbs.twimg.com/profile_images/430713133/Finance_3_normal.jpg,109354,122110,483,135217,myrollingstocks,
732361939490312192,2019-11-01 07:46:19,"INCY, ","markets, ","americanbankingnews.com/?p=12405900, ",1190233603038466048,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúBuy‚Äù by Analysts https://t.co/02vS4T9hzi #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-11-01 07:46:18,"INCY, ","stocks, ","americanbankingnews.com/?p=12405900, ",1190233600756797442,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Given Consensus Rating of ‚ÄúBuy‚Äù by Analysts https://t.co/uYEQxyt7fe #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
72297554,2019-11-01 07:25:03,"INCY, ",,"ow.ly/i9Mk30pOGML, ",1190228251714740224,False,0,0,0,0,Hootsuite Inc.,"Incyte $INCY, is getting closer to a buy point after the highly rated biotech's big quarterly beat. https://t.co/MROQvdtqAu",,,2009-09-07 10:49:46,"Maryland, USA",myrollingstocks,https://pbs.twimg.com/profile_images/1182244872/HappyDayTrader_normal.jpg,74,118,4,63569,channelingstock,
72284492,2019-11-01 07:25:03,"INCY, ",,"ow.ly/DTb530pOGKP, ",1190228250825576449,False,0,0,0,0,Hootsuite Inc.,"Incyte $INCY, is getting closer to a buy point after the highly rated biotech's big quarterly beat. https://t.co/yK2ueeQ32J",,,2009-09-07 09:49:42,USA - Maryland,Myrollingstocks,https://pbs.twimg.com/profile_images/430713133/Finance_3_normal.jpg,109354,122110,483,135217,myrollingstocks,
4419993470,2019-11-01 03:04:31,,"stocks, news, ","ift.tt/2BWFQjI, ",1190162689110282243,False,0,0,0,1,IFTTT,Stocks To Watch: Top Biotech Stock Near Buy Point After Blowout Earnings - Investor's Business Daily https://t.co/ySPnJ59JKY #stocks #news,,,2015-12-01 06:37:16,,Signals.me,https://pbs.twimg.com/profile_images/686123587200143360/hr4lhxxx_normal.png,23819,12097,148,174057,SignalsMe,
732361939490312192,2019-10-31 16:48:26,"INCY, ","markets, ","americanbankingnews.com/?p=12398715, ",1190007646713200654,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 2,040 Shares https://t.co/VuNKKuehKX #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-31 16:48:26,"INCY, ","stocks, ","americanbankingnews.com/?p=12398715, ",1190007644515385353,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Yao Wenqing Sells 2,040 Shares https://t.co/N1DSKaQVwl #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
732361939490312192,2019-10-31 16:48:17,"INCY, ","markets, ","americanbankingnews.com/?p=12398740, ",1190007605739106309,False,0,0,0,0,Zapier.com,"Paul Trower Sells 16,500 Shares of Incyte Co. $INCY Stock https://t.co/LgYr75Mlw1 #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-31 16:48:16,"INCY, ","stocks, ","americanbankingnews.com/?p=12398740, ",1190007602513625088,False,0,0,0,0,Zapier.com,"Paul Trower Sells 16,500 Shares of Incyte Co. $INCY Stock https://t.co/q4o3bxUnPR #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2181281054,2019-10-31 16:35:13,"INCY, ","markets, ","wkrb13.com/?p=1365936, ",1190004317266296846,False,0,0,0,0,Zapier.com,"Insider Selling: Incyte Co. $INCY EVP Sells 2,040 Shares of Stock https://t.co/n7g74BvyxD #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1176558075798380544,2019-10-31 16:05:13,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1189996769775685633,False,0,0,0,0,InsiderActionMonitor,$INCY  Incyte https://t.co/tRadk7lSjv,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
772471873539977217,2019-10-31 16:04:35,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1189996609075138563,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/btl8QMzsRT,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
374729426,2019-10-31 13:46:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/874902, pic.twitter.com/zm7mGMQ5rL, ",1189961956196618240,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/XUYVU2bzsI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/zm7mGMQ5rL",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
616043992,2019-10-31 13:02:18,,,,1189950737532489730,False,1,0,0,0,Twitter for iPhone,"The World's Most Innovative Companies of 2018:

1.üá∫üá∏ ServiceNow
2.üá∫üá∏ Workday
3.üá∫üá∏ Salesforce
4.üá∫üá∏ Tesla
5.üá∫üá∏ Amazon
6.üá∫üá∏ Netflix
7.üá∫üá∏ Incyte
8.üáÆüá≥ Hindustan Unilever
9.üá∞üá∑ Naver
10.üá∫üá∏ Facebook

(Forbes)",,,2012-06-23 07:42:32,,BUSINESS STORIES,https://pbs.twimg.com/profile_images/1182961238856343552/T2wFm9Sp_normal.jpg,45,44,0,265,Businessst1,
3911174913,2019-10-31 12:00:00,,,"bit.ly/2MvSOZd, pic.twitter.com/UuB1scVb5Y, ",1189935057168809984,False,1,0,0,0,Twitter for Advertisers.,Our targeted therapy discovery strategy enables us to leverage cross-program knowledge in our R&amp;D efforts. https://t.co/vTz0En6t7O https://t.co/UuB1scVb5Y,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
261855764,2019-10-31 09:19:32,,,"dlvr.it/RHLFs5, ",1189894677241028608,False,0,0,0,0,dlvr.it,Global Cancer Anorexia-Cachexia Syndrome Drug Market Research Report 2026 Observational ... https://t.co/32bCw0QCzu,,,2011-03-06 16:06:50,"New York, USA",Tina Richardson,https://pbs.twimg.com/profile_images/1264374625/62218_1172772fdb_normal.jpg,1012,658,31,6943,tinarichardson1,
2181281054,2019-10-31 06:39:22,"INCY, ","markets, ","wkrb13.com/?p=1364772, ",1189854366775304197,False,0,0,0,0,Zapier.com,Incyte $INCY Receives Buy Rating from Mizuho https://t.co/5RkJxijxFY #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
4419993470,2019-10-31 03:04:23,,"stocks, news, ","ift.tt/2BWFQjI, ",1189800265341382662,False,0,0,0,0,IFTTT,Stocks To Watch: Top Biotech Stock Near Buy Point After Blowout Earnings - Investor's Business Daily https://t.co/ySPnJ59JKY #stocks #news,,,2015-12-01 06:37:16,,Signals.me,https://pbs.twimg.com/profile_images/686123587200143360/hr4lhxxx_normal.png,23819,12097,148,174057,SignalsMe,
940506141536141312,2019-10-31 01:39:46,,"Janus, Kinase, Inhibitors, ","bit.ly/31UUEKs, pic.twitter.com/wcNNcg7ppF, ",1189778972000714752,False,0,0,0,0,Twitter Web App,"Janus Kinase (JAK) Inhibitors Pipeline to Witness Significant Growth due to Positive Clinical Results in the Coming Years.

Request to Get the Sample Pages at: https://t.co/yU917jfTta

@pfizer , @EliLillyItalia , @Incyte , @abbvie , @portola_pharma  #Janus #Kinase #Inhibitors https://t.co/wcNNcg7ppF","pfizer, EliLillyItalia, Incyte, abbvie, ",,2017-12-12 03:58:32,India,PharmProff,https://pbs.twimg.com/profile_images/1090504682491994112/jzTrBOWi_normal.jpg,36,119,1,92,PharmaProff,photo
1979190776,2019-10-30 20:39:06,"INCY, ",,"tickerreport.com/?p=4756626, ",1189703306769252358,False,0,0,0,0,Zapier.com,Incyte $INCY Given Buy Rating at Mizuho https://t.co/UUBO2glv7S,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2298709746,2019-10-30 20:38:57,"INCY, ",,"zpr.io/t77QV, ",1189703270069084160,False,0,0,0,0,Zapier.com,Incyte $INCY Given Buy Rating at Mizuho https://t.co/fEIjRvYSGg,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
2181281054,2019-10-30 16:42:47,"INCY, ","markets, ","wkrb13.com/?p=1362896, ",1189643833400872960,False,0,0,0,0,Zapier.com,Incyte $INCY Posts Earnings Results https://t.co/uTNMAB4sc9 #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
732361939490312192,2019-10-30 15:35:36,"INCY, ","markets, ","americanbankingnews.com/?p=12386088, ",1189626927432241163,False,0,0,0,0,Zapier.com,"Incyte $INCY Posts Quarterly Earnings Results, Beats Estimates By $0.27 EPS https://t.co/BBFz02nxiG #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-30 15:35:35,"INCY, ","stocks, ","americanbankingnews.com/?p=12386088, ",1189626923590266882,False,0,0,0,0,Zapier.com,"Incyte $INCY Posts Quarterly Earnings Results, Beats Estimates By $0.27 EPS https://t.co/jWcC8XeqKW #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
3911174913,2019-10-30 15:00:00,,"SCTopEmployer, LifeAtIncyte, ","pic.twitter.com/009rb84Ffr, ",1189617967782383618,False,3,0,0,1,Twitter Ads,"We recognize that with growth often comes change. While reflecting on our recent #SCTopEmployer recognition, our Head of HR, Paula Swain, shares how we strive to maintain the strong culture behind #LifeAtIncyte. https://t.co/009rb84Ffr",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
1544392183,2019-10-30 14:59:17,"INCY, ","IBD50, ","ow.ly/SFE650wXCCv, pic.twitter.com/1vsyYGkHzx, ",1189617790493351937,False,0,0,0,0,Hootsuite Inc.,This leading biotech and #IBD50 stock is closing in on a potential buy point after blowout earnings: https://t.co/BmP7DHsK9Z $INCY https://t.co/1vsyYGkHzx,,,2013-06-24 19:58:27,,Nancy Gondo,https://pbs.twimg.com/profile_images/378800000296825981/c22c6ab53d80f3880b7ef54f74568b20_normal.jpeg,3200,156,99,2484,IBD_NGondo,photo
34324846,2019-10-30 10:00:13,,"biotech, pharma, SCTopEmployer, ","fcld.ly/51axcjr, pic.twitter.com/JZjwflvChF, ",1189542524907593733,False,4,0,0,2,erased6981162,"Want to get to know some of the Top Employers in #biotech #pharma? 

Explore 2019 Top Employer Profiles for @Alnylam, @pfizer, @GSK, @Roche, @LillyPad, and @Incyte at: https://t.co/h0P8cWE4hg

#SCTopEmployer https://t.co/JZjwflvChF","Alnylam, pfizer, GSK, Roche, LillyPad, Incyte, ",,2009-04-22 12:51:07,"Washington, DC",Science Careers,https://pbs.twimg.com/profile_images/1298289631188922368/ta9Sb-p3_normal.jpg,47975,243,591,72316,ScienceCareers,photo
135209476,2019-10-30 09:11:43,"INCY, ",,"stockflare.com/stock/INCY.O, ",1189530320707751937,False,0,0,0,0,Stockflare Bot (Prod),$INCY: The forecast EPS for Incyte Corporation has increased to $2.73 from $2.58 in the last week. (https://t.co/sK8NyKCUuN),,,2010-04-20 12:59:29,Stock & ETF data for consumers,Stockflare US Page,https://pbs.twimg.com/profile_images/571343422351347712/7dSW3e_r_normal.png,414,23,18,318863,StockflareUS,
374729426,2019-10-30 08:25:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/871744, pic.twitter.com/KUL2uDcV6E, ",1189518803568218112,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average moved below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/DMq8z4rXP6 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/KUL2uDcV6E",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
818081647,2019-10-30 08:05:48,"INCY, ",,"streetinsider.com/r/16063031, ",1189513733938339846,False,0,0,0,1,StreetInsider.com Integration,Incyte $INCY PT Raised to $89 at Morgan Stanley https://t.co/4XuW4xtXha,,,2012-09-11 15:57:26,,SIAnalystWire,https://pbs.twimg.com/profile_images/2600218874/alkkkjlbds18yu6ld9xj_normal.png,4980,1,230,118501,AnalystWire,
14453501,2019-10-30 07:07:35,,,"delawarebusinessnow.com/2019/10/incyte‚Ä¶, ",1189499082739372037,True,0,0,0,0,WordPress.com,"Incyte net income soars in third quarter, nine months of¬†2019 https://t.co/Qkf3X2X18u",,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
2384219072,2019-10-30 07:00:40,,"BioBreakfast, ","loom.ly/LinPD8E, pic.twitter.com/xOUkIov0gP, ",1189497342044626944,False,1,0,0,1,Loomly,"Have you registered for the November #BioBreakfast on Thurs, Nov 21st from 7:30 - 9:30 AM? You will not want to miss @Incyte CEO Herve Hoppenot!  REGISTER today!! https://t.co/7N03V8O7Vl https://t.co/xOUkIov0gP","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
4312114277,2019-10-30 06:21:35,"INCY, ",,"fintel.io/filings/us/inc‚Ä¶, ",1189487506691182592,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 10-Q https://t.co/bA1g6WNJPU,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,163,418543,fintel_io,
4104899715,2019-10-30 06:18:59,,,"ainews.spxbot.com/2019/10/29/inc‚Ä¶, ",1189486852560117760,False,0,0,0,0,spxbot auto tweet,"AI+ NEWS * Incyte Stock, Merck, Trade Desk Appear On IBD Stock Watchlists ‚Äì Investor's Business Daily https://t.co/PWmK5grYso",,,2015-11-03 08:57:26,https://spxbot.com,r.Virgeel/spxbot,https://pbs.twimg.com/profile_images/1238606819066621963/ZBbxrZZP_normal.jpg,75,89,3,31316,spxbot,
227778014,2019-10-29 20:30:00,"INCY, ICPT, PFE, AMAG, REGN, SNY, ",,"buff.ly/2WqCFue, ",1189338628973088768,False,0,0,0,0,Buffer,"Oct. 29 company quick takes include a stock bump for Incyte after it posted a beat for Jakafi; plus Sumitomo returns rights to Ocaliva to Intercept, and more $INCY $ICPT $PFE $AMAG $REGN $SNY https://t.co/pVmYWPUyAf",,,2010-12-17 14:51:49,"Redwood City, Calif.",BioCentury,https://pbs.twimg.com/profile_images/1445077593632477193/brcY-VTq_normal.png,13038,1543,387,33073,BioCentury,
334585053,2019-10-29 16:00:40,,,"s.einnews.com/GuHxyhnaMy, ",1189270847204319232,False,0,0,0,0,EIN Presswire,Incyte Corporation's (INCY) CEO Herv√© Hoppenot on Q3 2019 Results - Earnings Call Transcript https://t.co/njSzFc1ziK,,,2011-07-13 06:16:51,"Washington, D.C.",EIN Presswire: Lung Cancer Newswire,https://pbs.twimg.com/profile_images/1288514359396904962/bd9OSmiA_normal.jpg,718,415,28,35060,EINLungCancer,
773578537764851712,2019-10-29 15:10:03,"INCY, ",,"sitefocus.com/cif/cifqbainq?‚Ä¶, ",1189258109140819969,False,0,0,0,0,CIF-QBA,"$INCY Earnings Intelligence Analysis of recent earnings identified Incyte Corp.  (NASDAQ: INCY ) business focus on (growth,jakafi,year-over-year), (growth,jakafi,vera), (growth,jakafi,polycythemia)

https://t.co/i6sspiZqtH",,,2016-09-07 13:47:50,"Cupertino, CA",SiteFocus,https://pbs.twimg.com/profile_images/908465036598820864/6ZQsC4KD_normal.jpg,195,35,8,57439,SiteFocusHQ,
23059499,2019-10-29 14:48:09,"INCY, ","stockmarket, economy, investing, ","seekingalpha.com/article/430001‚Ä¶, ",1189252598177636352,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation's (INCY) CEO Herv√© Hoppenot on Q3 2019 Results - Earnings Call Transcript. Follow this and any other stock on Seeking Alpha! https://t.co/h4QVypje2w #stockmarket #economy #investing,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
122436733,2019-10-29 13:45:09,"INCY, ","incyte, earnings, ibd, ","ow.ly/LE7s50wWz8R, ",1189236745012953089,False,1,0,0,1,Hootsuite Inc.,"Incyte $INCY jumps on a ""solid"" third quarter driven by cancer drug Jakafi, leading the biotech company to raise its 2019 outlook. .... IBD's Allison Gatlin @IBD_AGatlin reports. .... https://t.co/OUGvzS4llv .... #incyte #earnings #ibd","IBD_AGatlin, ",,2010-03-12 13:10:57,Los Angeles,Russ Britt,https://pbs.twimg.com/profile_images/1126175766784294912/HyB_x1dT_normal.png,2108,855,97,3624,rbrittbiznews,
3300833041,2019-10-29 13:45:09,"INCY, ","incyte, earnings, ibd, ","ow.ly/Wnxd50wWz6c, ",1189236744903938049,False,0,0,0,0,Hootsuite Inc.,"Incyte $INCY jumps on a ""solid"" third quarter driven by cancer drug Jakafi, leading the biotech company to raise its 2019 outlook. .... IBD's Allison Gatlin @IBD_AGatlin reports. .... https://t.co/4aGHUK7lNY .... #incyte #earnings #ibd","IBD_AGatlin, ",,2015-07-29 14:31:39,"Los Angeles, CA",Russ Britt,https://pbs.twimg.com/profile_images/651784933837398016/W1FRJCW0_normal.jpg,1321,661,39,2099,IBD_RBritt,
3300865039,2019-10-29 12:33:03,"INCY, LLY, NVS, ","biotech, stocks, investingnews, earnings, ","investors.com/news/technolog‚Ä¶, ",1189218601838010371,False,3,0,0,0,Hootsuite Inc.,Will this #biotech's solid quarter be enough to help it break out? $INCY $LLY $NVS #stocks #investingnews #earnings https://t.co/igz3dMfjSi,,,2015-07-29 15:22:19,"California, USA",Allison Gatlin,https://pbs.twimg.com/profile_images/1379079645480378371/V22zIHh9_normal.jpg,6295,1000,201,6646,IBD_AGatlin,
3911174913,2019-10-29 12:00:01,,"innovation, LifeAtIncyte, ","pic.twitter.com/EQpUk2Dr1v, ",1189210285464309760,False,1,0,0,0,Twitter Ads,"To our Chief Scientific Officer, Dash Dhanak, #innovation means making a difference for patients. Watch to hear more. #LifeAtIncyte https://t.co/EQpUk2Dr1v",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
3686628867,2019-10-29 11:02:24,,,"pharmaceuticaldaily.com/incyte-reports‚Ä¶, ",1189195787286265856,False,0,0,0,0,WordPress.com,Incyte Reports 2019 Third Quarter Financial Results and Provides Updates on Key Clinical¬†Programs https://t.co/esC3NOXftu,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
374729426,2019-10-29 10:09:38,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/868808, pic.twitter.com/hztKHNk01T, ",1189182507347918849,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average moved below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/65kSNyxOj6 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/hztKHNk01T",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
121158213,2019-10-29 10:06:02,"INCY, ",,"AlertTrade.us, ",1189181603571830784,False,0,0,0,0,dlvr.it,UP WITH EARNINGS TODAY ALERT: $INCY Incyte Corporation Common Stock üìà TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,
23059499,2019-10-29 09:33:48,"INCY, ","trading, business, stockmarket, ","seekingalpha.com/article/429986‚Ä¶, ",1189173491674648578,False,0,0,0,0,SAArticlesTwitter,$INCY - Incyte Corporation 2019 Q3 - Results - Earnings Call Presentation. Continue reading: https://t.co/IkNXyqi5Fi #trading #business #stockmarket,,,2009-03-06 07:52:56,"New York, NY",Seeking Alpha,https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_normal.png,187388,75,4792,839121,SeekingAlpha,
72928001,2019-10-29 09:05:40,"INCY, ",,"bit.ly/31W7qs6, ",1189166410963943425,False,0,0,0,1,BriefingInPlayLimited,"$INCY: Incyte beats by $0.18, beats on revs; raises Jakafi revenue guidance https://t.co/zx2QkupPjz",,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
732361939490312192,2019-10-29 08:45:53,"INCY, ","markets, ","americanbankingnews.com/?p=12369733, ",1189161431775793163,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúBuy‚Äù Rating from Mizuho https://t.co/LfkLGq2FCl #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-29 08:45:52,"INCY, ","stocks, ","americanbankingnews.com/?p=12369733, ",1189161427770265601,False,0,0,0,0,Zapier.com,Incyte $INCY Earns ‚ÄúBuy‚Äù Rating from Mizuho https://t.co/wVqHNokNkt #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
966006214818697218,2019-10-29 08:38:25,"INCY, ",,"theenterpriseleader.com/?p=2349418, ",1189159552962482176,False,0,0,0,0,Zapier.com,Incyte $INCY Receives ‚ÄúBuy‚Äù Rating from Mizuho  https://t.co/SNRz9BrdMr,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
25406480,2019-10-29 08:17:29,,,"awesomecapital.blogspot.com/2019/10/incyte‚Ä¶, ",1189154282966265859,False,0,0,0,1,Twitter Web Client,AwesomeCapital: Incyte up 5% premarket on Q3 beat https://t.co/78m7NLuEaQ,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
15296897,2019-10-29 08:03:31,"INCY, ",,"seekingalpha.com/news/3510643-i‚Ä¶, ",1189150768193867777,False,0,0,0,0,SANewsTwitter,$INCY - Incyte up 5% premarket on Q3 beat https://t.co/PKqYY3IK1J,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
4104899715,2019-10-29 07:38:13,,,"ainews.spxbot.com/2019/10/29/inc‚Ä¶, ",1189144401802600449,False,0,0,0,0,spxbot auto tweet,AI+ NEWS * Incyte Earnings Top; Incyte Stock Pops ‚Äì Investor's Business Daily https://t.co/ypn8mCOmKG,,,2015-11-03 08:57:26,https://spxbot.com,r.Virgeel/spxbot,https://pbs.twimg.com/profile_images/1238606819066621963/ZBbxrZZP_normal.jpg,75,89,3,31316,spxbot,
772471873539977217,2019-10-29 07:35:37,"INCY, ",,"sec.gov/ix?doc=/Archiv‚Ä¶, ",1189143746547474432,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 8-K https://t.co/gtMsN2iP9c,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
963495628545327104,2019-10-29 07:33:10,"INCY, ",,"dashboard.stck.pro/news.php?ticke‚Ä¶, ",1189143133831008256,False,0,0,0,0,Twitter Web App,"$INCY NEW ARTICLE : Incyte Earnings Top, Stock Pops https://t.co/8URuVfnZ4s",,,2018-02-13 14:30:33,,STCK.PRO,https://pbs.twimg.com/profile_images/1207114648836853760/dGgKpI0u_normal.png,3893,2,66,404942,StckPro,
864584576,2019-10-29 07:23:45,"INCY, ",,,1189140762182770691,False,1,0,0,0,Twitter Web App,"$INCY(79.86) up 3 
Incyte beats by $0.18, beats on revs; raises Jakafi revenue guidance",,,2012-10-06 08:06:29,Currently planet Earth.,Palmer,https://pbs.twimg.com/profile_images/943970836431671298/vn0Vf4ma_normal.jpg,7364,93,153,16468,BankTheTrade,
4312114277,2019-10-29 07:19:15,"INCY, ",,"fintel.io/s/us/incy?utm_‚Ä¶, ",1189139630886735872,False,0,0,0,0,Fintel.io,$INCY / Incyte files form 8-K - Results of Operations and Financial Condition https://t.co/hv89PLGlBC,,,2015-11-28 18:40:12,,Fintel,https://pbs.twimg.com/profile_images/1044647076770963456/ynYAFLm9_normal.jpg,8920,192,163,418543,fintel_io,
1637027690,2019-10-29 07:14:24,,,"ift.tt/32ZrlaM, ",1189138410071412736,False,0,0,0,0,IFTTT,"Incyte EPS beats by $0.18, beats on revenue https://t.co/Z0kod40ymI",,,2013-07-31 23:30:55,Everywhere,Ashish Aggarwal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,17,557,0,4776,AggarwalTweets,
3911174913,2019-10-29 07:14:10,,,,1189138349644234752,False,4,0,0,2,Twitter for Advertisers.,Incyte reports 2019 Q3 financial results &amp; provides updates on key clinical programs. Read our press release.,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
1171873456276889600,2019-10-29 07:11:50,"INCY, ","INCY, 8K, Incyte, News, ","docoh.com/filing/879169/‚Ä¶, ",1189137761485369344,False,0,0,0,0,Investor Feed,"$INCY  8-K  Incyte   (29 Oct, 7:09am)

üì∞ Incyte Reports 2019 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

https://t.co/nljaUEPRrM

#INCY #8K #Incyte #News",,,2019-09-11 15:50:02,"Toronto, Canada",Docoh Feed,https://pbs.twimg.com/profile_images/1240312690037460992/AJNPTR7U_normal.jpg,113,7,7,243550,investor_feed,
3318510966,2019-10-29 07:04:12,,,"crweworld.com/article/news-p‚Ä¶, ",1189135840888274944,False,0,0,0,0,CRWE World,Incyte Reports 2019 Third Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/GzV0xm7W3e,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
976297820532518914,2019-10-29 07:04:10,,,"dlvr.it/RHB141, pic.twitter.com/mCqmA9hw3B, ",1189135835444072448,False,0,0,0,0,dlvr.it,Incyte Reports 2019 Third Quarter Financial Results and Provides Updates on Key Clinical Programs https://t.co/oDjqwlBAmf https://t.co/mCqmA9hw3B,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
15296897,2019-10-29 07:03:20,"INCY, ",,"seekingalpha.com/news/3510579-i‚Ä¶, ",1189135622264348672,False,0,0,0,0,SANewsTwitter,"$INCY - Incyte EPS beats by $0.18, beats on revenue https://t.co/VpCNsFv3xq",,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3318510966,2019-10-29 06:30:05,,,"crweworld.com/article/news-p‚Ä¶, ",1189127256620224512,False,0,0,0,0,CRWE World,Incyte Corp. to Host Earnings Call https://t.co/zUXRoXcinh,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
266143766,2019-10-29 06:00:21,"ICY, ",,"accesswire.com/564465/Incyte-‚Ä¶, ",1189119774065864704,False,0,0,0,0,Accesswire,$ICY Incyte Corp. to Host Earnings Call https://t.co/RBZhCo5TDE,,,2011-03-14 14:55:49,"Morrisville, NC",AccesswireNews,https://pbs.twimg.com/profile_images/1055091851324243971/MpK_d4ww_normal.jpg,2191,543,39,81734,AccesswireNews,
1134049078424162304,2019-10-29 03:27:54,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1189081408469270528,False,0,0,0,0,Newsfilter.io,Incyte Q3 2019 Earnings Preview $INCY https://t.co/vLg7W84ydd,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
916787510822436864,2019-10-28 21:34:39,"VRTX, IBB, INCY, XBI, ",,"fool.com/investing/2019‚Ä¶, ",1188992509403451393,False,0,0,0,0,StockTwits Web,"Better Buy: Vertex Pharmaceuticals vs. Incyte

$VRTX $IBB $INCY $XBI  

https://t.co/htNLPTdKTo",,,2017-10-07 18:09:10,"New York, USA",Top Stock Alerts,https://pbs.twimg.com/profile_images/917029562432872449/VJbFmEQ0_normal.jpg,93095,0,955,158453,TopStockAlerts1,
727519600787750913,2019-10-28 20:39:13,"INCY, ","Incyte, ","marketchameleon.com/Overview/INCY/‚Ä¶, pic.twitter.com/vo5uODfhX1, ",1188978558976348162,False,0,0,1,0,MarketChameleon.com,$INCY #Incyte gains in after hours trading. See vwap price action. https://t.co/a8SP9aDPgW https://t.co/vo5uODfhX1,,,2016-05-03 11:26:04,"Philadelphia, PA",Chameleon ü¶é,https://pbs.twimg.com/profile_images/1141429857613680640/UQDYIDcD_normal.png,10088,29,265,124066,MarketChmln,photo
1110889087186206720,2019-10-28 18:52:05,"INCY, snap, fit, msft, lyft, cmg, tsla, roku, nflx, bac, amd, cgc, tdoc, nvda, tgt, fb, amzn, twtr, baba, tiff, uber, sbux, cost, pcg, t, spot, wba, btc, uber, googl, mrtx, grub, bynd, ba, ","NASDAQ, NYSE, DAYTRADING, WALLST, ","bit.ly/31TTuyP, ",1188951600016056320,False,2,0,0,0,Twitter Web App,"Bullish action pre earnings in $INCY

https://t.co/M621iIJVDo

$snap $fit $msft $lyft  $cmg $tsla $roku $nflx $bac $amd $cgc $tdoc $nvda $tgt $fb $amzn $twtr $baba $tiff $uber $sbux $cost $pcg $t $spot $wba $btc $uber $googl $mrtx $grub $bynd $ba #NASDAQ #NYSE #DAYTRADING #WALLST",,,2019-03-27 08:59:32,"Manhattan, NY",#TopMarketGainers,https://pbs.twimg.com/profile_images/1137492350194855936/hDuBDbJZ_normal.png,2520,2137,15,2863,TMGStockTips,
121158213,2019-10-28 18:27:03,"INCY, ",,"dlvr.it/RH8Ns3, freetrade.pw, pic.twitter.com/SpuY1AnF8f, ",1188945298615197696,False,0,0,0,0,dlvr.it,Trading Ideas: $INCY Bullish action pre earnings in Incyte https://t.co/bo8DBDOuEf üìà FREE trade-of-week via ‚Üí https://t.co/BCEHq7Ce2N https://t.co/SpuY1AnF8f,,,2010-03-08 11:14:34,,"Trade Alerts, Trade Ideas and Crypto üá∫üá∏",https://pbs.twimg.com/profile_images/909427952001146880/UoMAp4JA_normal.jpg,161357,152442,2585,2462625,AlertTrade,photo
99782750,2019-10-28 18:19:31,"INCY, ","INCY, ","tradingview.com/chart/INCY/RCe‚Ä¶, ",1188943402861125632,False,0,0,0,0,erased1143779,$INCY Bullish action pre earnings in Incyte  - #INCY chart https://t.co/c1YOTgOmlS,,,2009-12-27 16:04:43,USA üá∫üá∏,#StockRockAndRoll,https://pbs.twimg.com/profile_images/1265784823924342784/WHY7Aedy_normal.jpg,31553,36970,85,10882,StockRockNRoll,
47513933,2019-10-28 17:44:55,,,"townsquaredelaware.com/2019/10/24/inc‚Ä¶, ",1188934694223728645,False,0,0,0,0,Twitter Web Client,Incyte to Acquire Wilmington Friends Lower School Property https://t.co/KM16cwaqer,,,2009-06-15 22:11:48,"Newark, Delaware",Nancy Willing,https://pbs.twimg.com/profile_images/276978662/powmiaLOGOsm_normal.gif,871,1115,82,96415,nannyfat,
15296897,2019-10-28 17:30:45,"INCY, ",,"seekingalpha.com/news/3510157-i‚Ä¶, ",1188931128918364160,False,0,0,0,0,SANewsTwitter,$INCY - Incyte Q3 2019 Earnings Preview https://t.co/j7KHB6P1pP,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
204949973,2019-10-28 12:04:01,,"biotech, breastcancer, clinicaltrials, investing, ","bit.ly/inn_ceobwill, pic.twitter.com/qolt6OHapz, ",1188848907499069440,False,0,0,0,0,Sprout Social,"CEO Interview - Dr. Bill Williams, CEO BriaCell: Incyte Collaboration Enabling New Clinical Trials for Breast Cancer Treatments https://t.co/zffqt6AIR8 @BriaCell #biotech #breastcancer #clinicaltrials #investing https://t.co/qolt6OHapz","BriaCell, ",,2010-10-19 16:46:35,Vancouver BC,InvestingNewsNetwork,https://pbs.twimg.com/profile_images/1212114377010221067/3U37GHA8_normal.jpg,5413,1591,146,14815,DigMedia,photo
1583359764,2019-10-28 12:00:00,,"Investing, OnlineTradingBroker, ","bit.ly/36c3RkU, pic.twitter.com/k7YGIIwzVn, ",1188847894192779264,False,0,0,1,0,Twitter for Advertisers.,Choosing between Vertex Pharmaceuticals ($VRTX) and Incyte ($INCY) #Investing #OnlineTradingBroker: https://t.co/7inC0kMWys https://t.co/k7YGIIwzVn,,,2013-07-10 11:33:49,"Nassau, Bahamas",TradeZero,https://pbs.twimg.com/profile_images/1192537875377774592/Up_NVNeo_normal.jpg,28859,243,226,7364,TradeZer0,photo
3911174913,2019-10-28 12:00:00,,"SCTopEmployer, LifeAtIncyte, ","pic.twitter.com/HWXZmqcnbi, ",1188847893580525568,False,3,0,0,0,Twitter Ads,"ICYMI: We‚Äôve been recognized as a #SCTopEmployer by @ScienceCareers. Hear from our Head of HR, Paula Swain, on the top qualities that Incyte looks for when growing teams. #LifeAtIncyte https://t.co/HWXZmqcnbi","ScienceCareers, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
3305562093,2019-10-28 10:44:41,,"LifeAtIncyte, ","bit.ly/2W91HOr, ",1188828938866483200,False,0,0,0,0,Twitter for iPhone,"Proud to work for @Incyte, who was just named a Top Five Biopharma Employer by @ScienceCareers for the second year in a row! Thrilled to be part of an inspiring team that makes #LifeAtIncyte special.

¬∑       Link: https://t.co/kxvGv4rQJU","Incyte, ScienceCareers, ",,2015-06-01 09:56:58,,Mark Tanner,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,5,15,0,6,MarkTan29540712,
898405933,2019-10-28 09:06:01,,"biotech, breastcancer, clinicaltrials, investing, ","bit.ly/inn_ceobwill, pic.twitter.com/xj5wUAluKL, ",1188804112089042945,False,0,0,0,0,Sprout Social,"CEO Interview - Dr. Bill Williams, CEO BriaCell: Incyte Collaboration Enabling New Clinical Trials for Breast Cancer Treatments https://t.co/WhJrAkzMQ3 @BriaCell #biotech #breastcancer #clinicaltrials #investing https://t.co/xj5wUAluKL","BriaCell, ",,2012-10-22 16:55:41,,INN Life Science,https://pbs.twimg.com/profile_images/1212856731342114817/lIjBwLju_normal.jpg,5076,3476,92,7478,INN_LifeScience,photo
374729426,2019-10-28 08:57:16,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/865882, pic.twitter.com/PuNTGYsJ1U, ",1188801907910774785,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/cJBi0YIs4s #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/PuNTGYsJ1U",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2384219072,2019-10-28 08:00:39,,"BioBreakfast, DEBIO, BB, ","loom.ly/LinPD8E, pic.twitter.com/eZTqcitDID, ",1188787661269557249,False,0,0,0,1,Loomly,"Register for the November #BioBreakfast on Thurs, Nov 21st from 7:30 - 9:30 AM!! It will be @ #DEBIO member company @Incyte and is the last #BB of 2019!  
REGISTER today!! https://t.co/7N03V8O7Vl https://t.co/eZTqcitDID","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
1672120591,2019-10-28 07:41:21,"INCY, VRTX, XBI, IBB, ",,"bit.ly/2WgSfsm, ",1188782802394894337,False,0,0,0,0,StockTwits Web,Better Buy: Vertex Pharmaceuticals vs. Incyte $INCY $VRTX $XBI $IBB https://t.co/xcainBzWd7,,,2013-08-14 23:20:37,The Daily Planet in Metropolis,Clark Joseph Kent,https://pbs.twimg.com/profile_images/459575613754310656/qtxdENZ4_normal.jpeg,4323,890,146,56714,JorelLaraKalel,
492168041,2019-10-28 05:09:27,,,"fool.com/investing/2019‚Ä¶, ",1188744578507116544,False,1,0,0,0,Twitter for iPhone,Better Buy: Vertex Pharmaceuticals vs. Incyte | The Motley Fool https://t.co/Z7LxKYE59G,,,2012-02-14 07:28:25,,cf/Aware,https://pbs.twimg.com/profile_images/1346022964282744835/sRxExWUM_normal.jpg,13009,9786,146,81393,CFAware,
972364208108163074,2019-10-27 09:16:03,"INCY, VRTX, LLY, NVS, ","stocks, ","fool.com/investing/2019‚Ä¶, ",1188444247306973189,False,1,0,0,1,Twitter Web Client,Better Buy: Vertex Pharmaceuticals vs. Incyte @themotleyfool #stocks $INCY $VRTX $LLY $NVS https://t.co/E7zsKAd30y,"themotleyfool, ",,2018-03-10 01:51:07,South Africa & Europe,thegreenisback,https://pbs.twimg.com/profile_images/972367018946191361/ywzowTW8_normal.jpg,141,5,6,22777,thegreenisback,
374729426,2019-10-27 07:36:24,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/862886, pic.twitter.com/aNncrNF90V, ",1188419170767003648,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/70g7YmgWuM #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/aNncrNF90V",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1979190776,2019-10-27 05:18:58,"INCY, ",,"tickerreport.com/?p=4746224, ",1188384582816751616,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/2yy64mu1wu",,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
2298709746,2019-10-27 04:41:17,"INCY, ",,"zpr.io/tqEGV, ",1188375099008782337,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/vMfT5CZE6U,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
3392222362,2019-10-26 10:46:20,,,"pic.twitter.com/t7AgV7Wc8h, pic.twitter.com/t7AgV7Wc8h, pic.twitter.com/t7AgV7Wc8h, ",1188104578966966273,False,121,3,1,6,Twitter for iPhone,Congratulations to the latest graduate from the group. Good luck at Incyte Dr. McAtee https://t.co/t7AgV7Wc8h,,,2015-07-28 11:05:30,"Ann Arbor, MI",Corey Stephenson,https://pbs.twimg.com/profile_images/892972127929769984/8jy5Unux_normal.jpg,5616,680,27,1004,crjsteph,photo
374729426,2019-10-26 08:04:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/859828, pic.twitter.com/Z3pEgkHz0U, ",1188063971741298688,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/YO5ijblxiP #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Z3pEgkHz0U",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2920258887,2019-10-26 04:42:20,"INCY, ",,"dakotafinancialnews.com/?p=1275806, ",1188012976839770112,False,0,0,0,0,Zapier.com,"Paula J. Swain Sells 2,500 Shares of Incyte Co. $INCY Stock https://t.co/g5rCjEfqis",,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
4035355935,2019-10-25 23:11:49,,,,1187929800163221505,False,0,0,0,0,WPTS Playlist,Incyte - The Slide,,,2015-10-24 21:01:50,"Pittsburgh, PA",WPTS Playlist,https://pbs.twimg.com/profile_images/658129792408023041/8nflCFL-_normal.jpg,478,5,38,638221,WPTSPlaylist,
2207248104,2019-10-25 16:26:13,,"Wilmington, ","sciencemag.org/features/2019/‚Ä¶, ",1187827725001773057,False,2,0,0,0,Twitter Web App,"Kudos to our #Wilmington neighbors @Incyte #3 on @aaas 
top employers list https://t.co/vTP9eTguA2","Incyte, aaas, ",,2013-11-21 09:15:19,Wilmington DE,Paul Drees,https://pbs.twimg.com/profile_images/378800000770214010/3437418215be109cd952bfbf9d716cbe_normal.jpeg,301,288,44,1746,MarketEdgePD,
2384219072,2019-10-25 15:45:04,,"BioBreakfast, DEBIO, Incyte, DELifeScience, netDE, innovation, ","loom.ly/LinPD8E, pic.twitter.com/ZoQ1zfgHML, ",1187817371119083522,False,3,0,0,1,Loomly,"Register for the November #BioBreakfast on Thurs, Nov 21st from 7:30 - 9:30 AM @ #DEBIO member company @Incyte! Don't miss your chance to hear from #Incyte CEO Herve Hoppenot!
REGISTER: https://t.co/7N03V8O7Vl 
#DELifeScience #netDE #innovation https://t.co/ZoQ1zfgHML","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
774031407794487296,2019-10-25 09:23:45,,,"pic.twitter.com/BCrYUdzw5A, pic.twitter.com/BCrYUdzw5A, pic.twitter.com/BCrYUdzw5A, ",1187721410078072832,False,6,0,0,0,Twitter for Android,"Thank you, Dr. Nick Carruthers, for another great POCC talk! Had a great time learning about Janssen's CNS orphan GPCR program. Thank you as well to Incyte for sponsoring last night's event! https://t.co/BCrYUdzw5A",,,2016-09-08 19:47:23,"Philadelphia, PA",POCC,https://pbs.twimg.com/profile_images/1222210364806270979/8OTVwbSL_normal.jpg,270,97,1,68,POCC_Chem,photo
3911174913,2019-10-25 09:00:00,,"SCTopEmployer, LifeAtIncyte, ","pic.twitter.com/l7MiZgmrrR, ",1187715432704286723,False,16,0,0,2,Twitter Ads,"Our Chief Scientific Officer, Dash Dhanak, shares his perspective on what it means for Incyte to be recognized as a #SCTopEmployer by @ScienceCareers. #LifeAtIncyte https://t.co/l7MiZgmrrR","ScienceCareers, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
14453501,2019-10-25 08:44:30,,,"delawarebusinessnow.com/2019/10/incyte‚Ä¶, ",1187711534044254208,True,0,0,0,0,WordPress.com,Incyte agrees to buy portion of Friends School¬†property https://t.co/RtAo27Pmn9,,,2008-04-20 13:55:40,Delaware,Doug Rainey,https://pbs.twimg.com/profile_images/671033475219120129/RTGAi8LI_normal.png,1023,790,68,16825,DelBizNow,
374729426,2019-10-25 08:17:53,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/856746, pic.twitter.com/6dsv2kyo7q, ",1187704832011853826,False,0,0,0,1,Tickeron,"$INCY in Downtrend: 50-day Moving Average moved below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/Uf5SHCE9cg #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/6dsv2kyo7q",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2266388972,2019-10-25 06:56:52,"INCY, ","stocks, ","dailypolitical.com/?p=3160809, ",1187684445802958848,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Paula J. Swain Sells 2,500 Shares https://t.co/XQKTNOnu1z #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-10-25 06:56:50,"INCY, ",,"dailypolitical.com/?p=3160809, ",1187684435048710144,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Paula J. Swain Sells 2,500 Shares https://t.co/c2k2nvMIqF",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
3007790661,2019-10-25 05:25:36,,,"pic.twitter.com/Xb8Pqm0Yq5, ",1187661475525120002,False,15,1,0,1,Twitter for iPhone,"Congratulations to MD Shady Awad, PhD student at HRUH @helsinkiuni for winning Nordic grant for hematology @Incyte https://t.co/Xb8Pqm0Yq5","helsinkiuni, Incyte, ",,2015-01-31 10:05:02,"Helsinki, Finland",HRUH hematology,https://pbs.twimg.com/profile_images/561553705687060480/imorq8Bd_normal.jpeg,508,93,5,280,hruh_research,photo
598251794,2019-10-25 05:00:50,,"LifeAtIncyte, ","sciencemag.org/features/2019/‚Ä¶, ",1187655242936147969,False,0,0,0,0,Twitter for iPhone,"Proud to work for @Incyte, who was just named a Top Five Biopharma Employer by @ScienceCareers for the second year in a row! Thrilled to be part of an inspiring team that makes #LifeAtIncyte special. Top employers: Breakthroughs, impact, and purpose https://t.co/whdZNzy39W","Incyte, ScienceCareers, ",,2012-06-03 07:16:54,,Dr. Luis F√©liz,https://pbs.twimg.com/profile_images/1135315461468512256/VsiKnHW-_normal.jpg,84,342,1,359,lrfeliz,
68559732,2019-10-25 03:02:18,"INCY, ",,"ift.tt/31EfsWs, ",1187625413729755137,False,0,0,0,0,IFTTT,"Incyte EVP Paula Swain Sells $200,000.00 in $INCY https://t.co/IteAT2slDs",,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
14770715,2019-10-24 22:31:32,,,"dlvr.it/RGvxYt, ",1187557274165731329,False,0,0,0,0,dlvr.it,"Fourth-IR, Incyte, and Xylem Receive ""Tell Awards"" for FDI in Switzerland - Yahoo Finance https://t.co/zGOt69drlh",,,2008-05-14 04:12:16,Zurich,swissbusiness,https://pbs.twimg.com/profile_images/54168182/index.html_normal.jpg,88340,97059,1539,654162,swissbusiness,
14770715,2019-10-24 21:01:32,,,"dlvr.it/RGvnMG, ",1187534626157289473,False,0,0,0,0,dlvr.it,"Fourth-IR, Incyte, and Xylem Receive ""Tell Awards"" for FDI in Switzerland - BioSpace https://t.co/R7bYLwCSB1",,,2008-05-14 04:12:16,Zurich,swissbusiness,https://pbs.twimg.com/profile_images/54168182/index.html_normal.jpg,88340,97059,1539,654162,swissbusiness,
2920258887,2019-10-24 20:53:09,"INCY, ",,"dakotafinancialnews.com/?p=1271679, ",1187532512983162883,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Earnings of $0.65 Per Share https://t.co/vARt2NRsQt,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
1176558075798380544,2019-10-24 20:00:13,"INCY, ",,"chartexe.com/article/latest‚Ä¶, ",1187519194729996288,False,0,0,0,0,InsiderActionMonitor,$INCY Paula Swain Dumps 2.5K Shares of Incyte https://t.co/tRadk7lSjv,,,2019-09-24 14:04:58,,InsiderActionMonitor,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,577,10,7,42226,MonitorAction,
2181281054,2019-10-24 19:56:17,"INCY, ","markets, ","wkrb13.com/?p=1346199, ",1187518205251784705,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $200,000.00 in Stock https://t.co/2JCeVKTEsO #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
732361939490312192,2019-10-24 19:55:37,"INCY, ","markets, ","americanbankingnews.com/?p=12316954, ",1187518037433442305,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $200,000.00 in Stock https://t.co/BD4xvVSEPT #markets",,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-24 19:54:31,"INCY, ","stocks, ","americanbankingnews.com/?p=12316954, ",1187517759070101506,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY EVP Sells $200,000.00 in Stock https://t.co/1gbCY2POjl #stocks",,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
772471873539977217,2019-10-24 19:00:08,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1187504072208900096,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/1uBF5b21Au,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
3911174913,2019-10-24 18:00:00,,"LifeAtIncyte, SCTopEmployer, ","pic.twitter.com/LEozjKKfbE, ",1187488942230294529,False,12,1,0,2,Twitter Ads,"To Barry Flannelly, Executive Vice President, General Manager, U.S., #LifeAtIncyte offers the opportunity to discover, develop and deliver for patients. Hear more on what it means to be recognized as a #SCTopEmployer by @ScienceCareers. https://t.co/LEozjKKfbE","ScienceCareers, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
274569466,2019-10-24 17:54:33,,"netde, ","goo.gl/fb/YrRmMQ, ",1187487568843161605,False,0,0,0,0,Google,Incyte to Acquire Wilmington Friends Lower School Property https://t.co/XlOiM7oTqh #netde,,,2011-03-30 11:09:40,The Fabulous First State,Town Square Delaware,https://pbs.twimg.com/profile_images/1324437027291615236/PeIY6Mtk_normal.jpg,4566,1093,93,6394,TownSquareDE,
3911174913,2019-10-24 15:00:00,,"LifeAtIncyte, SCTopEmployer, ","pic.twitter.com/leq2xsITOL, ",1187443643612712961,False,13,0,1,0,Twitter Ads,"For our Head of HR, Paula Swain, our 2019 Top Employer recognition by @ScienceCareers truly reflects how Incyte employees feel about the company. Thank you to all who contribute to #LifeAtIncyte! #SCTopEmployer https://t.co/leq2xsITOL","ScienceCareers, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
948505266,2019-10-24 12:19:09,,"MaximizeLife, ","pic.twitter.com/KO9so8gIWe, ",1187403164086964224,False,6,0,0,3,Twitter Web App,We're still buzzing with excitement from our 2019 #MaximizeLife Gala. Big shout out to all of our sponsors that made this night possible: @TannerPharma @Amgen @bmsnews @Incyte @Novartis @pfizer @TakedaPharma https://t.co/KO9so8gIWe,"TannerPharma, Amgen, bmsnews, Incyte, Novartis, pfizer, TakedaPharma, ",,2012-11-14 16:15:20,"Seattle, WA",The Max Foundation,https://pbs.twimg.com/profile_images/937832721392349184/Srf07Z67_normal.jpg,1447,497,36,2108,stompoutcancer,photo
374729426,2019-10-24 08:49:33,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/853691, pic.twitter.com/HmG5CsIRcZ, ",1187350414384975873,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/JqQkMfk0ve #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/HmG5CsIRcZ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2384219072,2019-10-24 08:00:35,,"BioBreakfast, DEBIO, ","loom.ly/LinPD8E, pic.twitter.com/qW0s2lGXlM, ",1187338092690247680,False,2,0,0,0,Loomly,"Register for the November #BioBreakfast on Thurs, Nov 21st from 7:30 - 9:30 AM! It will be @ #DEBIO member company @Incyte!  
REGISTER today!! https://t.co/7N03V8O7Vl https://t.co/qW0s2lGXlM","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
221961207,2019-10-24 03:08:23,,,,1187264556235706374,False,0,0,0,0,IFTTT,"Fourth-IR, Incyte, and Xylem Receive ""Tell Awards"" for FDI in Switzerland - Yahoo Finance",,,2010-12-01 21:38:35,Switzerland,LGT Capital,https://pbs.twimg.com/profile_images/433244425427226624/Q5tCy83y_normal.jpeg,403,450,23,55072,lgtcaptial,
3243551873,2019-10-23 18:42:58,,"deeplearning, intoAInews, ","into.ai/blog/news-stor‚Ä¶, ",1187137364214341633,False,0,0,0,0,into.AI,"Fourth-IR, Incyte, and Xylem Receive ‚ÄúTell Awards‚Äù for FDI in Switzerland - ... for its https://t.co/6malooiOcq #deeplearning #intoAInews",,,2015-05-09 11:19:08,Podcast & Live Show,THE AI FUTURE SHOW Podcast #intoAI #AI,https://pbs.twimg.com/profile_images/1413145237040418816/beG_h64a_normal.jpg,18896,1699,3125,532807,into_AI,
221961207,2019-10-23 11:53:48,,,,1187034396311871489,False,0,0,0,0,IFTTT,"Fourth-IR, Incyte, and Xylem Receive ""Tell Awards"" for FDI in Switzerland - Yahoo Finance",,,2010-12-01 21:38:35,Switzerland,LGT Capital,https://pbs.twimg.com/profile_images/433244425427226624/Q5tCy83y_normal.jpeg,403,450,23,55072,lgtcaptial,
14770715,2019-10-23 11:27:02,,,"dlvr.it/RGp7Yv, ",1187027661052248066,False,0,0,0,0,dlvr.it,"Fourth-IR, Incyte, and Xylem Receive ""Tell Awards"" for FDI in Switzerland - PRNewswire https://t.co/moWZZDdAff",,,2008-05-14 04:12:16,Zurich,swissbusiness,https://pbs.twimg.com/profile_images/54168182/index.html_normal.jpg,88340,97059,1539,654162,swissbusiness,
374729426,2019-10-23 10:34:23,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/849772, pic.twitter.com/PjY1pePciB, ",1187014407991123968,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/2cfOragFdI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/PjY1pePciB",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
21268553,2019-10-23 09:30:07,,,"stock-market-newsfeed.blogspot.com/2019/10/will-s‚Ä¶, ",1186998234989903872,False,0,0,0,1,SS Auto Tweet App,"Will Strong Jakafi Sales Drive Incyte's (INCY) Q3 Earnings?
 https://t.co/bq19C2IBwJ",,,2009-02-18 21:35:59,"Toronto, Ontario",Stanley Suen,https://pbs.twimg.com/profile_images/1396812231019536385/-FLNyd3l_normal.jpg,20606,13,2292,518173,stanleysuen,
956484027384582144,2019-10-23 07:44:06,"INCY, ","stocks, stockmarket, ","postanalyst.com/2018/03/12/ana‚Ä¶, ",1186971556142092290,False,0,0,0,0,stockspredictor,Analysts Layout Best- And Worst-Case Scenarios: Archer-Daniels-Midland Company ... https://t.co/vXqQxDEXIk $INCY #stocks #stockmarket,,,2018-01-25 06:08:57,,StocksPredictor,https://pbs.twimg.com/profile_images/956485778384850944/S5_3tIPa_normal.jpg,1445,1604,8,20822,StocksPredictr,
966006214818697218,2019-10-23 04:47:37,"INCY, ",,"theenterpriseleader.com/?p=2331490, ",1186927144070504448,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Quarterly Sales of $538.95 Million  https://t.co/fLdrHTCE0d,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
732361939490312192,2019-10-23 04:45:34,"INCY, ","markets, ","americanbankingnews.com/?p=12293346, ",1186926626350731264,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Quarterly Sales of $538.95 Million https://t.co/7GFkDP0Rez #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-23 04:45:33,"INCY, ","stocks, ","americanbankingnews.com/?p=12293346, ",1186926623830003714,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Post Quarterly Sales of $538.95 Million https://t.co/0Ev549qLNb #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
964867368911626240,2019-10-22 20:49:49,,,"fdadaily.com/2019/10/21/inn‚Ä¶, ",1186806899133562881,False,0,0,0,0,FDA Daily Blog,"Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma, ,https://t.co/QXV46lHTkd",,,2018-02-17 09:21:21,,FDA Daily,https://pbs.twimg.com/profile_images/972543348740370432/deQuPIOn_normal.jpg,105,155,1,4934,fdadaily,
1001221394435313665,2019-10-22 20:35:16,,,"hcpfeed.com/2019/10/21/inn‚Ä¶, ",1186803239666225152,False,0,0,0,0,feed to posr,"Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma,,https://t.co/23jIBi6Udr,",,,2018-05-28 17:59:17,,HCP Feed,https://pbs.twimg.com/profile_images/1001233343076171776/1AQQgkoM_normal.jpg,26,0,1,15366,FeedHcp,
742132906127183872,2019-10-22 17:41:26,,"DIAwards, CML, Leukaemia, Patient, Cancer, leusm, ","cml-life.com, pic.twitter.com/3SbnOFmwXo, ",1186759490152079362,False,21,1,1,9,Twitter for iPhone,"A well deserved award for CML Life for the use of digital in the healthcare sector at #DIAwards from @Incyte @OPENHealth @OPENHealthPBC @SamanthaNier #CML #Leukaemia #Patient #Cancer #leusm  

You can check it out here: https://t.co/7ul7DE6MgA https://t.co/3SbnOFmwXo","Incyte, OPENHealth, OPENHealthPBC, SamanthaNier, ",,2016-06-12 19:14:07,United Kingdom,Zack Pemberton-Whiteley (he/him),https://pbs.twimg.com/profile_images/1433083092160352264/Fr1Re2Wt_normal.jpg,1358,1134,14,6235,ZPWLC,photo
1133717236340936705,2019-10-22 17:40:39,,,"twitter.com/MarkTan2954071‚Ä¶, ",1186759296501071883,False,2,0,0,0,Twitter for iPhone,Great being part of an award winning team! @Incyte @OPENHealth @SproutBehaviour https://t.co/WxpMb5att7,"Incyte, OPENHealth, ",,2019-05-29 08:50:27,"London, England",Dr Lina Eliasson,https://pbs.twimg.com/profile_images/1133719186893619200/GTvMYYoN_normal.jpg,46,36,1,68,SproutLina,
972364208108163074,2019-10-22 13:39:16,"INCY, JNJ, NVS, ","stocks, ","fool.com/investing/2019‚Ä¶, ",1186698548311662592,False,0,0,0,0,Twitter Web Client,Is Incyte a Buy? @themotleyfool #stocks $INCY $JNJ $NVS https://t.co/bvaqGRnDxi,"themotleyfool, ",,2018-03-10 01:51:07,South Africa & Europe,thegreenisback,https://pbs.twimg.com/profile_images/972367018946191361/ywzowTW8_normal.jpg,141,5,6,22777,thegreenisback,
1359077910,2019-10-22 12:30:14,,,"europharmajobs.com/job_display/17‚Ä¶, ",1186681174837596161,False,0,0,0,0,EPJ Jobs Post,"Associate Director, Clinical Operations, Incyte, Milan, Italy

https://t.co/9Pm0gb0142",,,2013-04-17 06:27:20,,EuroPharmaJobs,https://pbs.twimg.com/profile_images/1224280411058122752/XfmuExCY_normal.jpg,471,4,11,4969,EuroPharmaJobs,
2384219072,2019-10-22 11:45:06,,"BioBreakfast, DEBIO, ","loom.ly/LinPD8E, pic.twitter.com/N0qQjp0tKa, ",1186669817123737606,False,1,0,0,0,Loomly,"Register for the November #BioBreakfast on Thurs, Nov 21st from 7:30 - 9:30 AM! It will be @ #DEBIO member company @Incyte and Professor Catherine Grimes from @UDelaware will be speaking!  
REGISTER today!! https://t.co/7N03V8O7Vl https://t.co/N0qQjp0tKa","Incyte, UDelaware, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
2931312159,2019-10-22 10:29:59,,,"STL.News, stl.news/incyte-to-pres‚Ä¶, pic.twitter.com/qiiEFvHZbj, ",1186650914612039680,False,0,0,0,0,OnlyWire App,Incyte to Present at Upcoming Investor Conference ‚Äì (https://t.co/gzC9VsBNpz) ‚Äì¬†Incyte Corporation (Nasdaq:INCY) announced today that it will present at the Credit Suisse 28th Annual Healthcare Conference on ... https://t.co/AElPuWhp7W https://t.co/qiiEFvHZbj,,,2014-12-18 21:25:21,"St Louis, MO, US, 63040",STL.News,https://pbs.twimg.com/profile_images/1368239309954965510/GRDvn-8U_normal.jpg,17273,3243,122,100899,stlnewsonline,photo
374729426,2019-10-22 08:42:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/846625, pic.twitter.com/wlAdIfGOdZ, ",1186623978586005504,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/0gu1fRtUoe #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wlAdIfGOdZ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3318510966,2019-10-22 08:25:03,,,"crweworld.com/article/news-p‚Ä¶, ",1186619474843037699,False,0,0,0,0,CRWE World,Incyte to Present at Upcoming Investor Conference https://t.co/1SJ7zQC4Oa,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1069693680066420736,2019-10-22 08:04:41,"INCY, ",,"s.flashalert.me/Bp0lC3, ",1186614349152112648,False,0,0,0,0,flashalerts,"$INCY: Press Release published article on October 22, 08:00:00: Incyte to Present at Upcoming Investor Conference https://t.co/CQ2JzOoQnr",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
732361939490312192,2019-10-22 05:54:14,"INCY, ","markets, ","americanbankingnews.com/?p=12281954, ",1186581519281934337,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/UMCRIpv6Hb #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-22 05:54:01,"INCY, ","stocks, ","americanbankingnews.com/?p=12281954, ",1186581466861461506,False,0,0,0,0,Zapier.com,Incyte $INCY to Release Quarterly Earnings on Tuesday https://t.co/LrCPRQmGpr #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1161933859409317888,2019-10-22 02:52:02,,,"dlvr.it/RGhZzH, ",1186535669247557632,False,0,0,0,0,dlvr.it,Adobe Systems (ADBE) Shareholder Bank Of Hawaii Cut Its Stake; Cibc World Markets Stake in ... https://t.co/BHPUSPeBPI MagentoNews,,,2019-08-15 05:33:14,,MagentoNews,https://pbs.twimg.com/profile_images/1161934167782895616/3_JVOwJZ_normal.jpg,31,34,0,2160,news_magento,
500198689,2019-10-21 14:31:04,,"Switzerland, ","pic.twitter.com/vbT0nWDxLz, pic.twitter.com/vbT0nWDxLz, pic.twitter.com/vbT0nWDxLz, ",1186349195164299267,False,12,0,1,6,Twitter Web App,"Each year, the Tell Awards recognize American companies that have made significant investments, and have prospered by placing substantial operations in Switzerland. Congratulations to Fourth-IR, @Incyte, and @XylemInc! We are excited to have them in #Switzerland. https://t.co/vbT0nWDxLz","Incyte, XylemInc, ",,2012-02-22 17:12:05,New York City,Swiss Consulate NY,https://pbs.twimg.com/profile_images/1395407717901156352/9HT9urpZ_normal.png,5891,1834,0,13027,SwissCGNY,photo
1889492676,2019-10-21 10:04:41,,"InnoventBiologics, Incyte, Pemigatinib, Cholangiocarcinoma, ","1stoncology.com/blog/innovent-‚Ä¶, ",1186282157800443904,False,0,0,0,0,Troi URL Plug-in,"#InnoventBiologics Announces Positive Updated Result from the #Incyte-sponsored Phase II Trial of #Pemigatinib in Patients with Previously Treated, Advanced #Cholangiocarcinoma https://t.co/UYGNCDqt7Z",,,2013-09-21 05:10:17,"Stockholm, Sweden",1stOncology,https://pbs.twimg.com/profile_images/1198975064793911297/A0Mbdawk_normal.jpg,1694,1505,59,27486,1stOncology,
374729426,2019-10-21 08:17:58,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/843650, pic.twitter.com/Q8oOXYqghW, ",1186255303727149057,False,0,0,0,1,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/s6l4TnE8v6 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Q8oOXYqghW",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2384219072,2019-10-21 08:00:41,,"BioBreakfast, DEBIO, BB, ","loom.ly/LinPD8E, pic.twitter.com/Z4tSnS1RJv, ",1186250951759482880,False,1,0,0,0,Loomly,"Register for the November #BioBreakfast on Thurs, Nov 21st from 7:30 - 9:30 AM! It will be @ #DEBIO member company @Incyte and is the last #BB of 2019!  
REGISTER today!! https://t.co/7N03V8O7Vl https://t.co/Z4tSnS1RJv","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
247395947,2019-10-21 04:02:03,,,"bioportfol.io/RGd0np, ",1186190898964484096,False,0,0,0,1,dlvr.it,Innovent Biologics Announces Positive Updated Result from the Incytesponsored Phase II Trial of Pemigatinib in Patients with Previously Treated Advanced Cholangiocarcinoma: SUZHOU China Oct. 21 2019 PRNewswire Innovent Biologics Inc. &amp;quot;Innovent&amp;quot;‚Ä¶ https://t.co/NHGUigjw2J,,,2011-02-04 13:18:05,London,Cancer News,https://pbs.twimg.com/profile_images/2231517370/FB_Profile_pic_cells_3__normal,1308,101,91,134522,Cancer_bio,
873399943,2019-10-21 03:43:01,"RHHBY, ","ESMO19, ","bit.ly/2o2Xz5P, ",1186186111535779841,False,3,0,0,2,TweetDeck,My earlier take on $RHHBY Imbrave-150. As I was saying at #ESMO19 GO30140 made this a readout you could handicap https://t.co/ogIoQvh29D,,,2012-10-11 06:45:00,"London, UK",Jacob Plieth,https://pbs.twimg.com/profile_images/453547761401462784/a2Lp0d3m_normal.jpeg,17752,328,0,20982,JacobPlieth,
930803511918411776,2019-10-21 03:22:57,"INCY, ",,"thelincolnianonline.com/?p=3129846, ",1186181058758361088,False,0,0,0,0,Zapier.com,Zacks: Analysts Expect Incyte Co. $INCY Will Post Earnings of $0.65 Per Share https://t.co/6lCVcYpL6t,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
718440932652109824,2019-10-20 21:00:16,,,"marketcheetah.com/2019/10/21/inn‚Ä¶, ",1186084754870943745,False,0,0,0,0,marketcheetah,Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in https://t.co/h9K7WwdHKq,,,2016-04-08 10:10:41,,Market Cheetah,https://pbs.twimg.com/profile_images/725265074802155520/rffG8aKq_normal.jpg,1976,2168,115,283931,marketcheetah,
1006334607946649600,2019-10-20 20:48:02,,,"dlvr.it/RGcBNW, ",1186081675714781186,False,0,0,0,0,dlvr.it,"Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma https://t.co/PDLfVnA68o",,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1089978712685273090,2019-10-20 20:34:02,"INTC, ","stocktwits, stockmarketnews, ","dlvr.it/RGc9Tq, ",1186078152956596224,False,0,0,0,0,dlvr.it,"Innovent Biologics Announces Positive Updated Result from the $INTC-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma https://t.co/HMvdiBGsfr #stocktwits #stockmarketnews",,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
3318510966,2019-10-20 20:24:17,,,"crweworld.com/article/news-p‚Ä¶, ",1186075698076606464,False,0,0,0,0,CRWE World,Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Pati https://t.co/u0Mw8hQWUt,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
4196782272,2019-10-20 20:05:44,,"gaming, ","twib.in/l/EBKe67noeMy5, ",1186071029006979072,False,0,0,0,0,Twibble.io,"Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma https://t.co/Yds9ofuehu #gaming",,,2015-11-10 21:52:49,,This Online,https://pbs.twimg.com/profile_images/664484277661265920/XI8gqZW9_normal.png,517,0,179,126043,ThisOnline_Co,
374729426,2019-10-20 08:09:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/840710, pic.twitter.com/iXtVmQZwVQ, ",1185890778519724032,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/2QNcXTw4kg #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/iXtVmQZwVQ",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
18179696,2019-10-20 06:14:03,,,"bioportfol.io/RGZKL8, ",1185861732167667712,False,0,0,0,0,dlvr.it,"Incyte Corp INCY Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250: Summary Incyte Corp Incyte is a biopharmaceutical company that discovers, develops, and commercializes proprietary cancer‚Ä¶ https://t.co/x73jW0mCWL",,,2008-12-16 21:17:40,"St. Louis, MO",DrugGenius,https://pbs.twimg.com/profile_images/1247277670649540608/3OBNsimw_normal.jpg,6103,1384,352,351136,BioPortfolio,
2181281054,2019-10-20 01:33:01,"INCY, ","markets, ","wkrb13.com/?p=1332921, ",1185791005506883584,False,0,0,0,0,Zapier.com,"Incyte Co. $INCY to Post Q3 2019 Earnings of $0.42 Per Share, Oppenheimer Forecasts https://t.co/y3TFM5uzCr #markets",,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
1148669077520408576,2019-10-19 17:17:36,,,"healthsonar.com/novartis-and-i‚Ä¶, ",1185666332630667264,False,0,0,0,0,FS Poster,"Novartis and Incyte's JAK Inhibitor Jakavi Profitable In opposition to Graft-Versus-Host Illness
https://t.co/pVuk2WqEEq",,,2019-07-09 15:03:44,,Unidrugscom,https://pbs.twimg.com/profile_images/1262430609655443458/mKRz1mme_normal.jpg,15,1,0,11124,unidrugscom,
15974185,2019-10-19 13:42:32,,,"dlvr.it/RGXdNF, ",1185612207800799233,False,0,0,0,0,dlvr.it,Why the Earnings Surprise Streak Could Continue for Incyte (INCY) https://t.co/WzDynSzn8e,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
374729426,2019-10-19 11:08:29,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/837886, pic.twitter.com/5Xht06YqKa, ",1185573437638500352,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/mTK60Tb4X7 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/5Xht06YqKa",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1105181977249005568,2019-10-19 08:15:15,,,"total-pharma-news.com/news/global-ty‚Ä¶, ",1185529844458774540,False,0,0,0,0,Facebook,"Global Tyrosine Kinase JAK Inhibitors Market Insights 2019 : Pfizer, Incyte, Novartis, Eli Lilly, Gilead, Sanofi, Galapagos, AbbVie - News Agree https://t.co/Ll9lKr2GfC",,,2019-03-11 15:01:31,,Total Pharma News,https://pbs.twimg.com/profile_images/1105182027266052102/c-nuqw9s_normal.jpg,151,14,3,13828,total_pharma,
2266388972,2019-10-19 01:37:06,"INCY, ","stocks, ","dailypolitical.com/?p=3143496, ",1185429647254851584,False,0,0,0,0,Zapier.com,"Incyte Co. to Post Q3 2019 Earnings of $0.42 Per Share, Oppenheimer Forecasts $INCY https://t.co/c1eJWy0sxZ #stocks",,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-10-19 01:37:04,"INCY, ",,"dailypolitical.com/?p=3143496, ",1185429638673326081,False,0,0,0,0,Zapier.com,"Incyte Co. to Post Q3 2019 Earnings of $0.42 Per Share, Oppenheimer Forecasts $INCY https://t.co/2uJfIpUHqs",,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
1267928143,2019-10-18 21:56:00,,,"investor.incyte.com/news-releases/‚Ä¶, ",1185374003579510785,False,14,1,0,3,Twitter for iPhone,Incyte Announces that the REACH2 Pivotal Trial of Ruxolitinib (Jakafi¬Æ) Meets Primary Endpoint in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease | Incyte Corporation https://t.co/mhys38cohs,,,2013-03-14 16:27:04,"New York, USA",Marcel van den Brink,https://pbs.twimg.com/profile_images/3380100954/70e6d478a7eb705e9921bf5d039e88c5_normal.jpeg,6835,42,105,3062,DrMvandenBrink,
3064967368,2019-10-18 16:48:52,,"ruxolitinib, eczema, basicscience, clinicaltrial, translationalscience, atopicdermatitis, itch, neuroimmune, partnership, ","jacionline.org/article/S0091-‚Ä¶, ",1185296713180803072,False,13,0,0,2,Twitter for iPhone,Our phase 2 Clin trial for JAKi #ruxolitinib cream for #eczema with @incyte is online @jacionline #basicscience to #clinicaltrial via #translationalscience making a difference for #atopicdermatitis patients! #itch #neuroimmune #partnership @nationaleczema https://t.co/OuACvdCPAJ,"Incyte, jacionline, nationaleczema, ",,2015-02-28 14:04:33,"St. Louis, MO","Brian S. Kim, MD, MTR",https://pbs.twimg.com/profile_images/1390351360303026176/LaQoWrfp_normal.jpg,2104,371,16,1490,itchdoctor,
111120412,2019-10-18 15:02:16,,"BehindTheMystery, NORDSummit, ",,1185269886760767488,False,2,0,0,0,HeyOrca,"We are the creators of @AccessHealthTV &amp; @AccessHealthTV Our popular segment, #BehindTheMystery is devoted to rare diseases. We hope to see you next week at #NORDSummit! 

@EVERSANAcompany @HorizonNews @HorizonNews @Incyte @Incyte @Sarepta @SangamoTx @avrobio @achc","AccessHealthTV, AccessHealthTV, EVERSANAcompany, HorizonNews, HorizonNews, Incyte, Incyte, Sarepta, SangamoTx, avrobio, achc, ",,2010-02-03 16:47:17,Florida,BrandStar,https://pbs.twimg.com/profile_images/654751034665889792/VpoyqGoc_normal.png,8687,204,152,3318,BrandStarAgency,
116545390,2019-10-18 14:48:47,,"TellAwards, ","pic.twitter.com/rqflcbrR13, pic.twitter.com/rqflcbrR13, ",1185266493698793473,False,3,0,0,0,Twitter Web App,"The winner of last night‚Äôs #TellAwards are Fourth-IR, @Incyte and @XylemInc, congratulations to all three companies, we are excited to have them in Switzerland üá®üá≠! https://t.co/rqflcbrR13","Incyte, XylemInc, ",,2010-02-22 16:18:41,New York,Swiss Business Hub,https://pbs.twimg.com/profile_images/1222562837580611584/xj43v5PC_normal.png,4013,445,108,3037,SBH_USA,photo
374729426,2019-10-18 14:08:13,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/835089, pic.twitter.com/vY9ffW6nge, ",1185256282732675072,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/tUr3ixJrOR #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/vY9ffW6nge",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
732361939490312192,2019-10-18 06:42:46,"INCY, ","markets, ","americanbankingnews.com/?p=12235417, ",1185144179925622785,False,0,0,0,0,Zapier.com,Incyte Co. Forecasted to Earn Q3 2019 Earnings of $0.42 Per Share $INCY https://t.co/qFa2zirezo #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-18 06:42:45,"INCY, ","stocks, ","americanbankingnews.com/?p=12235417, ",1185144177316814848,False,0,0,0,0,Zapier.com,Incyte Co. Forecasted to Earn Q3 2019 Earnings of $0.42 Per Share $INCY https://t.co/L2a2iTNeb8 #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
966006214818697218,2019-10-18 06:42:08,"INCY, ",,"theenterpriseleader.com/?p=2318246, ",1185144020437221376,False,0,0,0,0,Zapier.com,Incyte Co. Forecasted to Earn Q3 2019 Earnings of $0.42 Per Share $INCY  https://t.co/lx0dqUiwn4,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
1156133747852374016,2019-10-18 04:11:14,,"Incyte, Ruxolitinib, GvHD, marketresearch, ","delveinsight.com/blog/incyte-su‚Ä¶, ",1185106045674442753,False,0,0,0,0,Twitter Web App,"#Incyte Corporation submits positive results of trials for its drug #Ruxolitinib in #GvHD
#marketresearch 
Click to know more:
https://t.co/FKxH3fufua",,,2019-07-30 05:25:40,New Delhi,DelveInsight,https://pbs.twimg.com/profile_images/1222806973487255552/pWZKXuZ9_normal.jpg,122,1363,1,2930,delve_insight,
2549856254,2019-10-18 04:07:20,,"Incyte, Novartis, REACH2, Ruxolitinib, Jakafi, ","delveinsight.com/blog/incyte-su‚Ä¶, ",1185105063825563651,False,0,0,0,0,Facebook,#Incyte Corporation has recently announced the results of #Novartis-sponsored Phase III clinical trials #REACH2 evaluating its candidate #Ruxolitinib (#Jakafi) in patients... https://t.co/Wxk1oHbRQN,,,2014-06-06 07:55:31,,Birendra Agrawal,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,2,0,0,138,BirendraAgrawa1,
948963785166921729,2019-10-18 01:24:36,,,"trialsitenews.com/incytes-ruxoli‚Ä¶, ",1185064110846812160,False,0,0,0,0,Twitter Web App,Incyte‚Äôs Ruxolitinib Cream Meets Primary Endpoint in Phase 2 Trial for Vitiligo; Phase 3 Trials Planned https://t.co/m6XzZy0tk2,,,2018-01-04 12:06:12,"Dhaka, Bangladesh",Sharif Ullah Manik,https://pbs.twimg.com/profile_images/987511646926000128/18ht6Ki__normal.jpg,1,4,0,6,manik_sheeriff,
94365736,2019-10-17 14:20:10,,"Incyte, Jakafi, GVHD, ","endpts.com/incytes-cash-c‚Ä¶, ",1184896902074114053,False,0,0,0,0,Hootsuite Inc.,#Incyte's cash cow #Jakafi chugs along with positive frontline results for #GVHD - https://t.co/7rXSuhlCHa @endpts @Incyte,"endpts, Incyte, ",,2009-12-03 11:47:30,267-337-7038,Plexus Ventures,https://pbs.twimg.com/profile_images/1214254577958162432/2u9mNY5z_normal.jpg,579,255,134,12688,PlexusVentures,
1105181977249005568,2019-10-17 10:22:26,,,"total-pharma-news.com/news/thalassem‚Ä¶, ",1184837073162899458,False,0,0,0,0,Facebook,"Thalassemia Treatment Market 2019 ‚Äì Key Players are Acceleron Pharma, Bluebird Bio, GlaxoSmithKline, Incyte Corporation, IONIS Pharmaceuticals and Others - The Ukiah Post https://t.co/BekKcFDDAq",,,2019-03-11 15:01:31,,Total Pharma News,https://pbs.twimg.com/profile_images/1105182027266052102/c-nuqw9s_normal.jpg,151,14,3,13828,total_pharma,
374729426,2019-10-17 10:04:14,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/831983, pic.twitter.com/kg2RKh8tqP, ",1184832492722778112,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/16yhnOkhbh #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kg2RKh8tqP",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2384219072,2019-10-17 08:00:41,,"DEBio, BB, membercompany, ","loom.ly/LinPD8E, pic.twitter.com/Z9PvXjK9Q7, ",1184801401752424448,False,2,0,0,0,Loomly,"Come to the #DEBio November #BB on the 21st to hear CEO Herve Hoppenot from #membercompany @Incyte speak!  
REGISTER today!! https://t.co/7N03V8O7Vl https://t.co/Z9PvXjK9Q7","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
3460109487,2019-10-17 03:00:10,"INCY, ","Jakafi, GVHD, ","endpts.com/incytes-cash-c‚Ä¶, ",1184725773950865408,False,2,0,0,0,Buffer,Incyte's cash cow #Jakafi chugs along with positive frontline results for #GVHD https://t.co/FNMM3akkms $INCY,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
21793154,2019-10-16 19:09:59,,,"hubs.ly/H0lj0jv0, ",1184607450932142080,False,1,0,0,2,HubSpot,"Novartis and Incyte's JAK Inhibitor Jakavi Successful Against Graft-Versus-Host Disease
https://t.co/3DcGPqD7gF",,,2009-02-24 15:27:40,"Des Moines, IA",BioSpace,https://pbs.twimg.com/profile_images/1042117112020389888/8MCBEVkx_normal.jpg,21738,2830,509,25196,biospace,
15232532,2019-10-16 17:42:32,,,"dlvr.it/RGLPP9, pic.twitter.com/YBHsIHFZon, ",1184585443662274560,False,0,0,0,0,dlvr.it,Incyte's cash cow Jakafi chugs along with positive frontline results for GVHD https://t.co/sK4dq2r011 https://t.co/YBHsIHFZon,,,2008-06-25 11:32:12,"Cape Cod, MA",DennisPartners,https://pbs.twimg.com/profile_images/777939023461511168/Lqtz-Jal_normal.jpg,415,425,13,7177,DennisPartners,photo
14442889,2019-10-16 17:35:03,,,"dlvr.it/RGLNJk, pic.twitter.com/jKs1zbI86D, ",1184583557836091398,False,1,0,0,0,dlvr.it,Novartis and Incyte's JAK Inhibitor Jakavi Successful Against Graft-Versus-Host Disease https://t.co/d7IrEQCwZz https://t.co/jKs1zbI86D,,,2008-04-19 08:47:12,,Pharmaceutical,https://pbs.twimg.com/profile_images/1249577991/Pill_with_transparent_background_normal.png,26095,1507,434,54180,Pharmaceutical,photo
27645777,2019-10-16 16:42:28,,"Jakafi, ","bit.ly/2puOtyZ, ",1184570325083791360,False,1,0,0,1,TweetDeck,Ruxolitinib significantly improves response rate in steroid-refractory acute graft-versus-host disease  Read more: https://t.co/xCpPDHYPYO  #Jakafi @Incyte,"Incyte, ",,2009-03-30 10:27:06,"Thorofare, NJ",HemOnc Today,https://pbs.twimg.com/profile_images/1137001146940362754/lpVRkuZX_normal.jpg,11328,1019,393,19226,HemOncToday,
875382419251019776,2019-10-16 15:00:33,,,"bit.ly/2VOUwdP, pic.twitter.com/rDHZTYXyHK, ",1184544675706748930,False,0,0,0,0,dlvr.it,Novartis and Incyte's JAK Inhibitor Jakavi Successful Against Graft-Versus-Host Disease https://t.co/GRjQZjgbgG https://t.co/rDHZTYXyHK,,,2017-06-15 12:00:07,"California, USA",BioCalifornia,https://pbs.twimg.com/profile_images/875384394759913472/QVXSpYZr_normal.jpg,251,129,14,27676,BioCalifornia,photo
59299156,2019-10-16 14:40:47,,,"bit.ly/32lXM33, ",1184539702008975372,False,0,0,0,0,FiWEH Life,Incyte reports positive results in late-stage trial of treatment for GVHD - FiWEH Life - https://t.co/1fjL3PZ4SL,,,2009-07-22 20:09:15,Worldwide,FiWEH Life,https://pbs.twimg.com/profile_images/1099133148783292416/Fv7BPGnM_normal.png,1050,357,30,886192,fiweh,
15974185,2019-10-16 13:08:32,,,"dlvr.it/RGKZ5h, ",1184516488708780033,False,1,0,0,0,dlvr.it,Incyte's cash cow Jakafi chugs along with positive frontline results for GVHD https://t.co/sUd5FNMPa9,,,2008-08-24 19:25:38,Atlanta,cafepharma,https://pbs.twimg.com/profile_images/1863292810/cp_square_normal.jpg,17747,299,511,69244,cafepharma,
977984050697850882,2019-10-16 12:49:57,,"Incyte, Novartis, Jakafi, steroid, refractory, acute, graft, versus, host, disease, GVHD, ","lnkd.in/f5kfret, lnkd.in/fXwtq8A, ",1184511809694375936,False,0,0,0,0,LinkedIn,#Incyte Corporation announced positive results from the #Novartis-sponsored pivotal Phase 3 REACH2 study evaluating ruxolitinib ( #Jakafi¬Æ) in patients with #steroid- #refractory #acute #graft- #versus- #host #disease (#GVHD). The‚Ä¶https://t.co/0uoM97RuTD https://t.co/MqCBPYPXqu,,,2018-03-25 15:02:22,"San Francisco, CA",Sciinov Insights,https://pbs.twimg.com/profile_images/1240509936188059648/E7hwKcIx_normal.jpg,57,99,0,166,bridge_insights,
133504478,2019-10-16 12:13:07,,"strategy, competitiveintelligence, marketing, pharma, productmarketing, pharmaceutical, biotech, healthcare, ","dlvr.it/RGKNTD, lqventures.com, pic.twitter.com/KBEW9W2o4w, ",1184502542404702209,False,0,0,0,2,dlvr.it,Incyte's cash cow Jakafi chugs along with positive frontline results for GVHD https://t.co/nLtXvWUMl7 &gt;&gt;&gt; https://t.co/HTA6IsoHwv #strategy #competitiveintelligence #marketing #pharma #productmarketing #pharmaceutical #biotech #healthcare https://t.co/KBEW9W2o4w,,,2010-04-15 20:01:32,Global,Dr Timos Papagatsias,https://pbs.twimg.com/profile_images/1136214111317045248/vLXrfBc8_normal.jpg,3231,3862,111,178120,_timos_,photo
3460109487,2019-10-16 11:14:03,,,"endpts.com/incytes-cash-c‚Ä¶, ",1184487678621954049,False,0,0,0,0,Buffer,Incyte's cash cow Jakafi chugs along with positive frontline results for GVHD https://t.co/FNMM3akkms,,,2015-08-27 14:08:04,Global,Endpoints News,https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_normal.png,19612,34,466,39883,endpts,
374729426,2019-10-16 10:06:42,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/828066, pic.twitter.com/YwHAL30Fvw, ",1184470727740645377,False,1,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average moved below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/OQIqNOlPp5 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/YwHAL30Fvw",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
72928001,2019-10-16 09:02:30,"INCY, ",,"bit.ly/2Biw1wp, ",1184454570866397185,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte announces 'positive' results from the Novartis-sponsored pivotal Phase 3 REACH2 study evaluating... https://t.co/yDOs2qlCl8,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
270492072,2019-10-16 08:30:10,,"news, mktw, wsj, ","feeds.marketwatch.com/~r/marketwatch‚Ä¶, ",1184446432519979013,False,0,0,0,0,Microsoft Power Platform,Incyte reports positive results in late-stage trial of treatment for GVHD   https://t.co/f5rmlAnTxq via MarketWatch #news #mktw #wsj,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
1105181977249005568,2019-10-16 08:27:23,,,"total-pharma-news.com/news/incyte-an‚Ä¶, ",1184445733883305986,False,0,0,0,0,Facebook,Incyte Announces that the REACH2 Pivotal Trial of Ruxolitinib (Jakafi¬Æ) Meets Primary Endpoint in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease https://t.co/86xAi2m4Ij,,,2019-03-11 15:01:31,,Total Pharma News,https://pbs.twimg.com/profile_images/1105182027266052102/c-nuqw9s_normal.jpg,151,14,3,13828,total_pharma,
2837784071,2019-10-16 08:13:07,"spy, gspc, aapl, nflx, goog, tsla, ",,"faisamtrader.com/incyte-reports‚Ä¶, ",1184442141805809669,False,0,0,0,0,Zapier.com,$spy $gspc $aapl $nflx $goog $tsla Incyte reports positive results in late-stage trial of treatment for GVHD  https://t.co/9We4KUDPIu,,,2014-10-19 21:22:48,"Toronto, Ontario",FaisamTrader,https://pbs.twimg.com/profile_images/856700180950904832/K-8u6osz_normal.jpg,4206,15,57,21629,FaisamTrader,
25406480,2019-10-16 08:04:59,,,"awesomecapital.blogspot.com/2019/10/incyte‚Ä¶, ",1184440096432578561,False,0,0,0,1,Twitter Web Client,AwesomeCapital: Incyte‚Äôs Jakafi successful in late-stage Graft v H... https://t.co/77GtwOzdBW,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
15296897,2019-10-16 07:50:23,"INCY, NVS, ",,"seekingalpha.com/news/3506061-i‚Ä¶, ",1184436422503124992,False,0,0,0,0,SANewsTwitter,$INCY $NVS - Incyte's Jakafi successful in late-stage GvHD study https://t.co/jezPg7n4oT,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
3686628867,2019-10-16 07:34:16,,,"pharmaceuticaldaily.com/incyte-announc‚Ä¶, ",1184432367848579075,False,0,0,0,0,WordPress.com,Incyte Announces that the REACH2 Pivotal Trial of Ruxolitinib (Jakafi¬Æ) Meets Primary Endpoint in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease https://t.co/kImNc5zaka,,,2015-09-17 10:50:25,,Pharmacutical Daily,https://pbs.twimg.com/profile_images/644524811880923136/FhDNvz-5_normal.jpg,1534,216,61,43857,PharmacDaily,
270492072,2019-10-16 07:30:09,,"news, mktw, wsj, ","feeds.marketwatch.com/~r/marketwatch‚Ä¶, ",1184431331947581441,False,0,0,0,0,Microsoft Power Platform,Incyte rerpots positive results in late-stage trial of treatment for GVHD   https://t.co/CYZFgNXX3g via MarketWatch #news #mktw #wsj,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
270492072,2019-10-16 07:28:12,,"news, ",,1184430839360147456,False,0,0,0,0,Microsoft Power Platform,Incyte shares up 1.2% premarket #news,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
270492072,2019-10-16 07:28:12,,"news, ",,1184430839079194624,False,0,0,0,0,Microsoft Power Platform,Incyte rerpots positive results in trial of treatment for GVHD  #news,,,2011-03-22 14:29:17,,BlackCentaur,https://pbs.twimg.com/profile_images/1281546314187247620/bKoicbOg_normal.jpg,1227,1939,122,1303965,JacekWierzbicki,
2837784071,2019-10-16 07:23:59,"spy, gspc, aapl, nflx, goog, tsla, ",,"faisamtrader.com/incyte-rerpots‚Ä¶, ",1184429777211531265,False,0,0,0,0,Zapier.com,$spy $gspc $aapl $nflx $goog $tsla Incyte rerpots positive results in late-stage trial of treatment for GVHD  https://t.co/jckvqNuaDS,,,2014-10-19 21:22:48,"Toronto, Ontario",FaisamTrader,https://pbs.twimg.com/profile_images/856700180950904832/K-8u6osz_normal.jpg,4206,15,57,21629,FaisamTrader,
1006334607946649600,2019-10-16 07:21:32,,,"dlvr.it/RGJMNW, ",1184429162380976128,False,0,0,0,0,dlvr.it,Incyte Announces that the REACH2 Pivotal Trial of Ruxolitinib (Jakafi¬Æ) Meets Primary Endpoint in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease https://t.co/NJp18AzKvh,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1089978712685273090,2019-10-16 07:19:38,"INTC, ","stocktwits, stockmarketnews, ","dlvr.it/RGJM5c, ",1184428684939120640,False,0,0,0,0,dlvr.it,$INTC Announces that the REACH2 Pivotal Trial of Ruxolitinib (Jakafi¬Æ) Meets Primary Endpoint in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease https://t.co/v4DLV3Nuiu #stocktwits #stockmarketnews,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
260676166,2019-10-16 07:12:04,,,"bioportfol.io/RGJKH2, ",1184426778405683200,False,0,0,0,1,dlvr.it,Incyte Announces that the REACH2 Pivotal Trial of Ruxolitinib Jakafi√Ç Meets Primary Endpoint in Patients with SteroidRefractory Acute GraftVersusHost Disease: Results of randomized Phase 3 REACH2 trial show that ruxolitinib significantly improves overall‚Ä¶ https://t.co/7vMUutJNto,,,2011-03-04 05:46:09,London,Public Health,https://pbs.twimg.com/profile_images/2228723638/Twitter-FB_Profile_pic_-_plant_1__normal,857,32,42,82095,PublicHealthBio,
950942636818432006,2019-10-16 07:08:24,"INCY, NVS, ",,"businesswire.com/news/home/2019‚Ä¶, ",1184425855440818176,False,4,0,0,2,Twitter for iPhone,"$INCY $NVS announced pivotal Phase 3 REACH2 study evaluating Jakafi in patients with steroid-refractory acute GVHD met its primary endpoint of improving ORR at Day 28 with treatment compared to best available therapy.

https://t.co/5BakBRCYI4",,,2018-01-09 23:09:27,"San Francisco, CA",SY Investing,https://pbs.twimg.com/profile_images/1108963782334672900/Bh_0t4CE_normal.png,5814,300,160,3879,syinvesting,
976297820532518914,2019-10-16 07:06:32,,,"dlvr.it/RGJJLz, pic.twitter.com/fkuxVnm0c5, ",1184425388807614464,False,0,0,0,0,dlvr.it,Incyte Announces that the REACH2 Pivotal Trial of Ruxolitinib (Jakafi¬Æ) Meets Primary Endpoint in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease https://t.co/eIErNZIMCM https://t.co/fkuxVnm0c5,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
427877977,2019-10-16 07:05:03,"INCY, ","Incyte, Ruxolitinib, Jakafi, GvHD, ","businesswire.com/news/home/2019‚Ä¶, ",1184425015334359047,False,0,0,0,0,Twitter Web Client,$INCY. #Incyte Announces that the REACH2 Pivotal Trial of #Ruxolitinib (#Jakafi) Meets Primary Endpoint in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease https://t.co/2bBCk8CAM1. #GvHD,,,2011-12-03 21:43:03,D√ºsseldorf,Volker Schulz,https://pbs.twimg.com/profile_images/1421288833862311941/Xw3abFlt_normal.jpg,4103,3000,238,132534,portefeuillefun,
3318510966,2019-10-16 07:04:44,,,"crweworld.com/article/news-p‚Ä¶, ",1184424933750792193,False,0,0,0,0,CRWE World,Incyte Announces that the REACH2 Pivotal Trial of Ruxolitinib (Jakafi¬Æ) Meets Primary Endpoint in Patients with Ste https://t.co/L9IJUb0xsh,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
2920258887,2019-10-16 01:45:18,"INCY, ",,"dakotafinancialnews.com/?p=1246032, ",1184344546756513794,False,1,0,0,0,Zapier.com,Q3 2019 EPS Estimates for Incyte Co. Cut by Oppenheimer $INCY https://t.co/rSuR3vYDT0,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
1029104777223958528,2019-10-16 01:21:32,,,"dlvr.it/RGHP3C, ",1184338563883618305,False,0,0,0,0,dlvr.it,BidaskScore Ups Prudential Financial (PRU); Maltese Capital Management Decreased By $3.80 ...: Some Historical PJC News: 31/05/2018 ‚Äì Incyte Coverage Assumed by PiperJaffray at Overweight; 27/03/2018 ‚Äì Fungus Kills Bed Bugs ‚Äì First Used¬†... https://t.co/kkvRTkm2Cr,,,2018-08-13 16:37:53,"New Jersey, USA",NJ Bed Bug Lawyer,https://pbs.twimg.com/profile_images/1029105494441451520/g1xIY11k_normal.jpg,4,0,0,3298,njbedbuglawyer,
1105181977249005568,2019-10-15 21:13:28,,,"total-pharma-news.com/news/global-ca‚Ä¶, ",1184276137993744384,False,0,0,0,0,Facebook,"Global Castleman Disease Drug Market Future Outlook and by Top key players Analysis Bristol-Myers Squibb Company, Incyte Corporation, Jazz Pharmaceuticals, Inc ‚Äì Online News Guru https://t.co/g4CW39arUs",,,2019-03-11 15:01:31,,Total Pharma News,https://pbs.twimg.com/profile_images/1105182027266052102/c-nuqw9s_normal.jpg,151,14,3,13828,total_pharma,
575910168,2019-10-15 17:08:34,,,"truckingnews.us/were-hedge-fun‚Ä¶, ",1184214504814661633,False,0,0,0,0,WordPress.com,Were Hedge Funds Right About Dumping Incyte Corporation¬†(INCY)? https://t.co/nhRQQ6QeGA,,,2012-05-09 21:30:36,"Salt Lake City, Utah",AFT Dispatch & A2C Logistics,https://pbs.twimg.com/profile_images/1385776493385576448/L9CsB7Kk_normal.jpg,2805,157,71,146407,AFTvitaliy,
60224553,2019-10-15 17:03:34,,,"dlvr.it/RGGLRX, pic.twitter.com/rWFd5xDTPQ, ",1184213247966072832,False,0,0,0,0,dlvr.it,Were Hedge Funds Right About Dumping Incyte Corporation (INCY)? - Yahoo Finance https://t.co/kyC5WddF02 https://t.co/rWFd5xDTPQ,,,2009-07-25 23:46:54,"NYC, NY, USA",Peter Went,https://pbs.twimg.com/profile_images/1216976432825540608/1d7laUNR_normal.jpg,9226,81,306,124562,HedgeFundRisk,photo
2384219072,2019-10-15 15:45:04,,"BioBreakfast, DEBIO, BB, ","loom.ly/LinPD8E, pic.twitter.com/jr6VxS5FhE, ",1184193491213127681,False,0,0,0,0,Loomly,"Register for the November #BioBreakfast on Thurs, Nov 21st from 7:30 - 9:30 AM!! It will be @ #DEBIO member company @Incyte and is the last #BB of 2019!  REGISTER today!! https://t.co/7N03V8O7Vl https://t.co/jr6VxS5FhE","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
4028839455,2019-10-15 15:21:59,,,"stocktrot.com/company/incyte‚Ä¶, ",1184187682563379200,False,0,0,0,0,StockTrot1,"$193,575.61: largest disposition of Incyte Corp shares for Flannelly Barry P in over two years. https://t.co/Glm3OwNyt2",,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
19277975,2019-10-15 15:06:14,,"JulianBaker, FelixBaker, BakerBrothers, biotech, investing, seattlegenetics, incyte, BeiGene, ","onefamilysblog.com/2019/10/tracki‚Ä¶, ",1184183720145833985,False,0,0,0,0,Twitter Web App,Baker Brothers Portfolio Q2 2019 13F Report Quarter-over-Quarter Comparison at https://t.co/jphhxZlzW0 #JulianBaker #FelixBaker #BakerBrothers #biotech #investing #seattlegenetics #incyte #BeiGene,,,2009-01-21 00:45:56,"Williamsville, NY, USA",John Vincent,https://pbs.twimg.com/profile_images/72255905/SantaCruzBoardWalk_normal.JPG,364,110,38,1881,OneFamilysBlog,
898405933,2019-10-15 13:52:02,,"biotech, breastcancer, clinicaltrials, investing, ","bit.ly/inn_ceobwill, pic.twitter.com/5IrBpzwNsC, ",1184165046840156160,False,1,0,0,1,Sprout Social,"CEO Interview - Dr. Bill Williams, CEO BriaCell: Incyte Collaboration Enabling New Clinical Trials for Breast Cancer Treatments https://t.co/WhJrAkzMQ3 @BriaCell #biotech #breastcancer #clinicaltrials #investing https://t.co/5IrBpzwNsC","BriaCell, ",,2012-10-22 16:55:41,,INN Life Science,https://pbs.twimg.com/profile_images/1212856731342114817/lIjBwLju_normal.jpg,5076,3476,92,7478,INN_LifeScience,photo
2811966313,2019-10-15 11:45:04,"INCY, ","INCYTE, ","dlvr.it/RGFJvZ, ",1184133093222780928,False,0,0,0,0,dlvr.it,"$INCY #INCYTE - Daily: @Incyte The basic trend is bearish on INCYTE CORP. and in the short term, the price is trying to rebound. For the time being, this is only a technical rebound and the basic trend is not threatened. To have the rebound confirmed, it‚Ä¶ https://t.co/PdwmpW3CNz","Incyte, ",,2014-09-15 16:55:15,,CentralCharts EN,https://pbs.twimg.com/profile_images/511620866958848001/D0S5gp2s_normal.png,1590,412,42,24499,CentralChartsEN,
1096035827505905664,2019-10-15 11:39:40,"INCY, ","INCYTE, ","centralcharts.com/en/3008-incyte‚Ä¶, ",1184131733828096001,False,0,0,0,0,CentralCharts,"$INCY #INCYTE - Daily: The basic trend is bearish on INCYTE CORP. and in the short term, the price is trying to rebound. For the time being, this is only a technical rebound... https://t.co/s3z5luEWKS",,,2019-02-14 08:17:59,,Londinia IA,https://pbs.twimg.com/profile_images/1140533491534352384/3Gu8u6Wr_normal.png,717,217,10,21617,Londinia_IA,
374729426,2019-10-15 09:12:55,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/825087, pic.twitter.com/4dqkznrfdz, ",1184094805413941248,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/2WiL2Argz0 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/4dqkznrfdz",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
966006214818697218,2019-10-14 21:38:26,"INCY, ",,"theenterpriseleader.com/?p=2307898, ",1183920033715482624,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Increased to Hold at BidaskClub  https://t.co/jb1GtdtKGU,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
930803511918411776,2019-10-14 21:37:26,"INCY, ",,"thelincolnianonline.com/?p=3111940, ",1183919781033975809,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Increased to Hold at BidaskClub https://t.co/AAMUhr4OmY,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
2416188264,2019-10-14 20:50:06,"INCY, ","markets, ","thestockobserver.com/?p=2355885, ",1183907866664755202,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $92.35 Consensus Target Price from Brokerages  https://t.co/sDgL91ESQA #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
849417718642159616,2019-10-14 20:49:02,"INCY, ",,"themarketsdaily.com/?p=2646962, ",1183907599923732480,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Receives $92.35 Consensus Target Price from Analysts https://t.co/U5DCEv1vJS,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
1105181977249005568,2019-10-14 16:13:40,,,"total-pharma-news.com/news/global-ta‚Ä¶, ",1183838300311818241,False,0,0,0,0,Facebook,"Global Targeted Cancer Drugs Market 2019 Future Statistics ‚Äì Pfizer, Incyte, Novartis, Eli Lilly, Gilead, Sanofi, Galapagos, AbbVie, Vertex, Teva ‚Äì News Carve https://t.co/ohGNzhDijl",,,2019-03-11 15:01:31,,Total Pharma News,https://pbs.twimg.com/profile_images/1105182027266052102/c-nuqw9s_normal.jpg,151,14,3,13828,total_pharma,
374729426,2019-10-14 08:44:21,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/822124, pic.twitter.com/vCfY19IQn0, ",1183725227685007362,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/h7VuefxiLE #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/vCfY19IQn0",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2432028553,2019-10-14 08:21:25,,,"service9.rumbletalk.net/xT_sgrKR/, ",1183719456616390657,False,0,0,0,0,Twitter Web Client,"ncyte data enchances confidence in $500M opportunity, says Piper Jaffray Incyte over the weekend... https://t.co/vhfEObzvnQ via @HotStocks_NYC","HotStocks_NYC, ",,2014-04-07 09:08:56,"Boynton Beach, FL",Hot Stocks NYC,https://pbs.twimg.com/profile_images/1130845412888260610/96sTWPTi_normal.png,7925,1215,90,39280,HotStocks_NYC,
72928001,2019-10-14 08:16:05,"INCY, ",,"bit.ly/35AZIqf, ",1183718113755316225,False,0,0,0,0,BriefingInPlayLimited,$INCY: Incyte announces positive 52-week results from Phase 2 study evaluating ruxolitinib cream in adult patients... https://t.co/5AbWlxVMJc,,,2009-09-09 15:23:53,Chicago,Briefing.com,https://pbs.twimg.com/profile_images/461180942367739904/_atv5vcZ_normal.jpeg,31218,3686,1344,465291,Briefingcom,
2432028553,2019-10-14 07:56:35,,,"lnkd.in/ebMqfjW, ",1183713205283180545,False,0,0,0,0,LinkedIn,"ncyte data enchances confidence in $500M opportunity, says Piper Jaffray Incyte over the weekend reported 52-week follow-up data for the Phase II topical ruxolitinib study in vitiligo patients. Previously, Incyte reported positive 24-week data, which incl‚Ä¶https://t.co/b3tsY87YTk",,,2014-04-07 09:08:56,"Boynton Beach, FL",Hot Stocks NYC,https://pbs.twimg.com/profile_images/1130845412888260610/96sTWPTi_normal.png,7925,1215,90,39280,HotStocks_NYC,
87784777,2019-10-14 07:56:32,,,,1183713195065659392,False,0,0,0,0,Twitter Web Client,"ncyte data enchances confidence in $500M opportunity, says Piper Jaffray Incyte over the weekend reported 52-week follow-up data for the Phase II topical ruxolitinib study in vitiligo patients. Previously, Incyte reported positive 24-week data, which included",,,2009-11-05 16:14:54,"Boynton Beach, FL",Hotstocks.nyc,https://pbs.twimg.com/profile_images/710434600795959296/cUfH5J4u_normal.jpg,208,657,9,7199,IcemanStocks,
1152084487502622720,2019-10-14 07:50:35,,"Pharmaceutical, Medical, USA, ","news.marketsizeforecasters.com/incyte-unveils‚Ä¶, ",1183711695362875392,False,5,0,0,4,Twitter Web App,"Incyte Corporation- a U.S. based pharmaceutical co. announces positive results from Phase 2 clinical trial of ruxolitinib cream in the treatment of vitiligo. 

READ: https://t.co/gAUh6FvfoC

#Pharmaceutical #Medical #USA",,,2019-07-19 01:15:21,,Shreshtha Dhatrak,https://pbs.twimg.com/profile_images/1262966744404103169/BqhW9a11_normal.jpg,123,107,0,586,ShreshthaRD,
15296897,2019-10-14 07:28:23,"INCY, ",,"seekingalpha.com/news/3505428-i‚Ä¶, ",1183706109246234626,False,1,0,0,0,SANewsTwitter,$INCY - Incyte's ruxolitinib cream shows sustained benefit in mid-stage vitiligo study https://t.co/dMKNuhiMNJ,,,2008-07-02 06:38:58,New York,Breaking News,https://pbs.twimg.com/profile_images/562235643225309184/BbO5bjbH_normal.png,76105,1,2331,895985,MarketCurrents,
1099892798931812352,2019-10-14 06:53:09,"INCY, ",,,1183697243439845376,False,0,0,0,0,StockTwits Web,Incyte ( $INCY ) said Saturday that 52-week results from a phase 2 trial of ruxolitinib cream in adult patients with vitiligo showed continued improvement in repigmentation compared to patients treated with a non-medicated cream.,,,2019-02-24 23:44:13,,ùîΩùï£ùïíùïüùïú ùï•ùïôùïñ ùïãùï†ùï†ùï•ùïô,https://pbs.twimg.com/profile_images/1393147494486454276/HnL7sCTK_normal.jpg,245,140,9,9222,ToothFrank,
633824212,2019-10-14 05:23:08,,,"ift.tt/2MeqnBz, Theflyonthewall.com, ",1183674590565982209,False,0,0,0,0,IFTTT,"Incyte data enchances confidence in $500M opportunity, says Piper Jaffray https://t.co/IJ19LqJdWP See the rest of the story here.

https://t.co/tnMXlCjEqv provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming n‚Ä¶",,,2012-07-12 11:31:45,NYC,flylemurs,https://pbs.twimg.com/profile_images/2393843079/wc5oiacqodhfzivmyvmh_normal.jpeg,37,32,4,129630,flylemurs,
175782459,2019-10-13 19:48:21,,,"lnkd.in/ePsuEMd, ",1183529939171250179,False,3,0,0,0,LinkedIn,Very productive weekend of facilitating strategic growth with the wonderful team of Incyte Diagnostics. These exceptional pathologists and laboratory leaders are fearless at addressing the tough issues affecting their industry! https://t.co/iAicUHQxXr,,,2010-08-07 12:06:37,"Denver, CO","Karim Sirgi MD, MBA, FCAP",https://pbs.twimg.com/profile_images/864258362094919680/FjuwY4Ck_normal.jpg,1584,1412,44,3474,ksirgimd,
175782459,2019-10-13 19:47:04,,,"pic.twitter.com/aJV3BTVleh, ",1183529619040768001,False,4,0,1,0,Twitter for iPhone,Very productive weekend of facilitating strategic growth with the wonderful team of Incyte Diagnostics. These exceptional pathologists and laboratory leaders are fearless at addressing the tough issues affecting their industry! https://t.co/aJV3BTVleh,,,2010-08-07 12:06:37,"Denver, CO","Karim Sirgi MD, MBA, FCAP",https://pbs.twimg.com/profile_images/864258362094919680/FjuwY4Ck_normal.jpg,1584,1412,44,3474,ksirgimd,photo
374729426,2019-10-13 18:10:22,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/819985, pic.twitter.com/kzjXHN8ftz, ",1183505281583476736,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/LQfWmD9iTK #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/kzjXHN8ftz",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
633824212,2019-10-13 15:28:17,,,"ift.tt/32et8Zc, Theflyonthewall.com, ",1183464494636384256,False,0,0,0,0,IFTTT,"Incyte announces 52-week results from Phase 2 study of Ruxolitinib cream https://t.co/QXBj2AK80b See the rest of the story here.

https://t.co/tnMXlCjEqv provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming ne‚Ä¶",,,2012-07-12 11:31:45,NYC,flylemurs,https://pbs.twimg.com/profile_images/2393843079/wc5oiacqodhfzivmyvmh_normal.jpeg,37,32,4,129630,flylemurs,
106823467,2019-10-13 14:36:00,"INCY, ","Incyte, vitiligo, ","crweworld.com/symbol/INCY, ",1183451334378262530,False,0,0,0,0,Twitter Web App,$INCY Reveals findings from mid-stage study evaluating ruxolitinib cream in adult patients with vitiligo     #Incyte     #vitiligo       https://t.co/x9QsKSOMBZ,,,2010-01-20 15:20:39,"Las Vegas, NV",Hottest Stocks Now,https://pbs.twimg.com/profile_images/1053492745094889472/OpoAa1Xa_normal.jpg,2283,1733,73,58525,HottestStockNow,
1015383484439957510,2019-10-13 13:54:23,,,,1183440864208736257,False,0,0,0,0,Twitter Web App,"Congrats! Nicole Figueroa Cetin appointed as Director, Corporate Counsel - Development at Incyte",,,2018-07-06 19:54:22,,clo,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,21,0,0,22596,clo31741753,
415183987,2019-10-13 13:05:32,,,"finance.yahoo.com/news/incyte-an‚Ä¶, ",1183428569898205184,False,0,0,0,0,Twitter Web Client,Incyte Announces Positive 52-Week Results From a Randomized Phase 2 Study of Ruxolitinib Cream in... https://t.co/8ru0isxWRr via @YahooFinance,"YahooFinance, ",,2011-11-17 19:50:25,,Miljenko Zuanic,https://pbs.twimg.com/profile_images/894617295154102272/apAcVS12_normal.jpg,351,318,17,6699,Miljenkoz,
402284409,2019-10-13 01:42:20,,,"goo.gl/fb/p3qu8v, ",1183256635143180289,False,0,0,0,0,Google,"Job Delaware:  Medical Operations Manager - Incyte Corporation - Wilmington, DE: Enable‚Ä¶ https://t.co/9VWh2MFurX",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
402284409,2019-10-13 01:42:19,,,"goo.gl/fb/f7YwhU, ",1183256633746415626,False,0,0,0,0,Google,"Job Delaware:  Associate Director to Director, Global Publications - Incyte Corporation‚Ä¶ https://t.co/0XyskPbkeu",,,2011-10-31 16:45:12,,myincome,https://pbs.twimg.com/profile_images/469591345330286594/tc-5jOR8_normal.jpeg,397,251,39,153588,My_Income,
732361939490312192,2019-10-12 20:13:44,"INCY, ","markets, ","americanbankingnews.com/?p=12177404, ",1183173940396646400,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/9tjlBYrVHo #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-12 20:13:43,"INCY, ","stocks, ","americanbankingnews.com/?p=12177404, ",1183173938089791489,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/9tyKRSD9Qr #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
2920258887,2019-10-12 19:48:58,"INCY, ",,"dakotafinancialnews.com/?p=1239119, ",1183167708394905601,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Short Interest Update https://t.co/1OveLssmqA,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
2370871404,2019-10-12 17:08:23,,,"ispot.tv/ad/o6XK/incyte‚Ä¶, ",1183127294073655296,False,0,0,0,0,Facebook,Hah!!! Finally a commercial for my blood disorder! https://t.co/JwTSHZiEDE,,,2014-03-03 14:54:52,,Robin Hershey,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,4,2,0,1488,hersheyrobin,
68559732,2019-10-12 14:20:51,"INCY, ",,"thecerbatgem.com/?p=3260614, ",1183085136008622080,False,0,0,0,0,Zapier.com,Analysts Set Incyte Co. $INCY Target Price at $92.35 https://t.co/XOPlgq36I5,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
374729426,2019-10-12 13:46:08,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/817000, pic.twitter.com/QxfEvifX6F, ",1183076398350524417,False,1,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/6Pp023yOPh #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/QxfEvifX6F",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1006334607946649600,2019-10-12 11:46:04,,,"dlvr.it/RG3QrD, ",1183046183570165761,False,0,0,0,0,dlvr.it,Incyte to Report Third Quarter Financial Results https://t.co/Q6ARCX9htY,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
1089978712685273090,2019-10-12 11:43:34,"INTC, ","stocktwits, stockmarketnews, ","dlvr.it/RG3QXY, ",1183045552692318210,False,0,0,0,0,dlvr.it,$INTC to Report Third Quarter Financial Results https://t.co/aYJ328Sq70 #stocktwits #stockmarketnews,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
3318510966,2019-10-12 10:12:48,,,"crweworld.com/article/news-p‚Ä¶, ",1183022712223961089,False,0,0,0,0,CRWE World,Incyte Announces Positive 52-Week Results From a Randomized Phase 2 Study of Ruxolitinib Cream in Patients With Viti https://t.co/LHIrO5Ghuw,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
69543843,2019-10-12 06:41:52,,,,1182969628001091585,False,2,0,0,0,Twitter for iPhone,"The World's Most Innovative Companies of 2018:

1.üá∫üá∏ ServiceNow
2.üá∫üá∏ Workday
3.üá∫üá∏ Salesforce
4.üá∫üá∏ Tesla
5.üá∫üá∏ Amazon
6.üá∫üá∏ Netflix
7.üá∫üá∏ Incyte
8.üáÆüá≥ Hindustan Unilever
9.üá∞üá∑ Naver
10.üá∫üá∏ Facebook",,,2009-08-28 04:57:13,"New Delhi, India",Kapil Dhama üáÆüá≥,https://pbs.twimg.com/profile_images/1453441512130301954/JlUZ7YYx_normal.png,36101,225,129,24906,kapildhama,
25406480,2019-10-12 06:38:04,,,"awesomecapital.blogspot.com/2019/10/incyte‚Ä¶, ",1182968670563307521,False,0,0,0,1,Twitter Web Client,AwesomeCapital: Incyte Positive 52-Week Results of Phase 2 Study o... https://t.co/XzW4gzXUfD,,,2009-03-19 19:14:07,,****,https://pbs.twimg.com/profile_images/352453738/CAZ-L_normal.jpg,1430,2177,21,150385,cmencke,
3911174913,2019-10-12 05:30:00,,"EADV2019, vitiligo, ","pic.twitter.com/IzjNkXH0y5, ",1182951540937637889,False,6,0,0,1,Twitter for Advertisers.,Happening now at #EADV2019: We're presenting results of our Phase 2 data on a potential treatment for patients living with #vitiligo. https://t.co/IzjNkXH0y5,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
55561590,2019-10-12 04:26:51,"INCY, ",,"businesswire.com/news/home/2019‚Ä¶, ",1182935650607210497,False,2,0,0,1,Twitter for iPhone,$INCY Incyte Announces Positive 52-Week Results From a Randomized Phase 2 Study of Ruxolitinib Cream in Patients With Vitiligo | Business Wire https://t.co/qeI7jJyfO9,,,2009-07-10 09:33:23,,Antonio Costa,https://pbs.twimg.com/profile_images/1436665283062771713/wp5K6dCf_normal.jpg,167110,334,3121,140863,ACInvestorBlog,
1089978712685273090,2019-10-12 03:21:02,"INTC, ","stocktwits, stockmarketnews, ","dlvr.it/RG2KSy, ",1182919088198184961,False,0,0,0,0,dlvr.it,$INTC Announces Positive 52-Week Results From a Randomized Phase 2 Study of Ruxolitinib Cream in Patients With Vitiligo https://t.co/wQy2fSUOT3 #stocktwits #stockmarketnews,,,2019-01-28 15:09:10,,Stock Market News,https://pbs.twimg.com/profile_images/1089979474823790598/SBXMPXJt_normal.jpg,26934,55,177,163753,Stock_Market_Pr,
3911174913,2019-10-12 03:12:19,,"Breaking, EADV2019, vitiligo, ","bit.ly/2IG8Foj, pic.twitter.com/8jCkYrBsEJ, ",1182916891607625728,False,6,0,1,1,Twitter for iPhone,#Breaking at #EADV2019: We've announced results from our Phase 2 study evaluating a potential treatment for patients living with #vitiligo. https://t.co/87NuxOnQZy https://t.co/8jCkYrBsEJ,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
1006334607946649600,2019-10-12 02:53:02,,,"dlvr.it/RG2GZb, ",1182912039288594433,False,0,0,0,0,dlvr.it,Incyte Announces Positive 52-Week Results From a Randomized Phase 2 Study of Ruxolitinib Cream in Patients With Vitiligo https://t.co/PDsRtGw5X7,,,2018-06-11 20:37:22,"Florida, USA",Stocks News Feed,https://pbs.twimg.com/profile_images/1006335249226268672/R33dqHcO_normal.jpg,3407,104,38,472232,feed_stocks,
976297820532518914,2019-10-12 02:40:03,,,"dlvr.it/RG2DjP, pic.twitter.com/L1kpZcZnA9, ",1182908774907969536,False,0,0,0,0,dlvr.it,Incyte Announces Positive 52-Week Results From a Randomized Phase 2 Study of Ruxolitinib Cream in Patients With Vitiligo https://t.co/ZZeTDhr6tF https://t.co/L1kpZcZnA9,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
1134049078424162304,2019-10-12 02:38:17,"INCY, ",,"newsfilter.io/articles/incyt‚Ä¶, ",1182908329619644422,False,0,0,0,0,Newsfilter.io,Incyte Announces Positive 52-Week Results From a Randomized Phase 2 Study of Ruxolitinib Cream in Patients With Vitiligo $INCY https://t.co/arHsUNR87k,,,2019-05-30 06:49:04,"New York, NY",Investor News,https://pbs.twimg.com/profile_images/1166658906610786306/Z397yIAD_normal.jpg,19118,181,346,880679,newsfilterio,
1015268417195184128,2019-10-11 17:13:27,,,,1182766184678219778,False,0,0,0,0,Twitter Web App,Congrats! Nari Narayanan appointed as Senior Director - Cybersecurity (CISO) at Incyte,,,2018-07-06 12:17:08,,Ciso_Ciso,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,32,0,1,7677,CisoCiso5,
68559732,2019-10-11 16:54:02,"INCY, ",,"thecerbatgem.com/?p=3258550, ",1182761297336852480,False,0,0,0,0,Zapier.com,Incyte $INCY Rating Increased to Hold at BidaskClub https://t.co/Svj3otlROL,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
772471873539977217,2019-10-11 16:53:00,"INCY, ",,"sec.gov/Archives/edgar‚Ä¶, ",1182761038799949826,False,0,0,0,0,StockTexts,$INCY Incyte Corporation SEC Filing: Form 4 https://t.co/a00decYMrM,,,2016-09-04 12:30:21,,StockTexts,https://pbs.twimg.com/profile_images/894058885715120128/gnTzTFBx_normal.jpg,1865,1,45,509949,StockTexts,
1171476150415241216,2019-10-11 16:00:00,"INCY, ","Oncology, oncologyjobs, oncologyhiring, sciencejobs, medicaldirector, ","bit.ly/2M4Ge5N, ",1182747699214458887,False,0,0,0,0,TweetDeck,"Director to Executive Medical Director, Targeted Therapeutics Development (MD required, Board certified or eligible in #Oncology preferred)- @Incyte - Wilmington, DE https://t.co/lXKWkKfg9r $INCY #oncologyjobs #oncologyhiring #sciencejobs #medicaldirector","Incyte, ",,2019-09-10 13:32:40,North America and Europe,OncologyJobs,https://pbs.twimg.com/profile_images/1174265286721200135/cEXgoilS_normal.jpg,233,450,3,237,OncologyHiring,
1171476150415241216,2019-10-11 13:30:00,"INCY, ","immunoOncology, oncology, biotechnology, pharmaceutical, oncologyhiring, oncologyjobs, sciencejobs, ","bit.ly/33h1paq, ",1182709951258513409,False,0,0,0,0,TweetDeck,"Director to Sr. Director, #immunoOncology (M.D.)- @Incyte - Wilmington, DE- Req'd: MD or DO w/ min 3-5 years of experience in #oncology drug development in a #biotechnology or #pharmaceutical company https://t.co/Dzp2n2lO7R $INCY #oncologyhiring #oncologyjobs #sciencejobs","Incyte, ",,2019-09-10 13:32:40,North America and Europe,OncologyJobs,https://pbs.twimg.com/profile_images/1174265286721200135/cEXgoilS_normal.jpg,233,450,3,237,OncologyHiring,
2384219072,2019-10-11 12:45:06,,"BioBreakfast, DEBIO, ","loom.ly/LinPD8E, pic.twitter.com/uV4yeuE7Ko, ",1182698649513529344,False,0,0,0,0,Loomly,"Registration is OPEN for the November #BioBreakfast on Thurs, Nov 21st from 7:30 - 9:30 AM! It will be @ #DEBIO member company @Incyte  and professor Catherine Grimes from @UDelaware will be guest speaking! 
REGISTER: https://t.co/7N03V8O7Vl https://t.co/uV4yeuE7Ko","Incyte, UDelaware, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
1171476150415241216,2019-10-11 12:30:00,"INCY, ","oncology, drug, development, incyte, oncologyjobs, oncologyhiring, medicaljobs, ","bit.ly/2OEWmg6, ",1182694850732232705,False,0,0,0,0,TweetDeck,"Executive Medical Director- @Incyte - Geneva, Switzerland- Req'd: MD degree, 7-10 years industry experience in #oncology #drug #development https://t.co/Sn2wVbvNne #incyte #oncologyjobs #oncologyhiring $INCY #medicaljobs","Incyte, ",,2019-09-10 13:32:40,North America and Europe,OncologyJobs,https://pbs.twimg.com/profile_images/1174265286721200135/cEXgoilS_normal.jpg,233,450,3,237,OncologyHiring,
960765194,2019-10-11 11:06:33,,,"evaluate.com/vantage/articl‚Ä¶, ",1182673849822928896,False,0,1,0,1,Twitter Web App,Upcoming catalysts: Data from Roche‚Äôs Imbrave-150 in 1L liver cancer (Tecentriq plus Avastin vs Nexavar) via @JacobPlieth while I had a look at Incyte's itacitinib in 1L GVHD (Gravitas-301) https://t.co/f0LLDBar7X,"JacobPlieth, ",,2012-11-20 11:30:36,"London, UK",Joanne Fagg,https://pbs.twimg.com/profile_images/3437749768/2bff7a67ad4c1c8396a87ee49acc17a7_normal.jpeg,1149,1141,52,2456,ByJoFagg,
374729426,2019-10-10 10:34:46,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/814009, pic.twitter.com/mQHPsEcuRk, ",1182303464245694465,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/j7n1HZn6Sk #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/mQHPsEcuRk",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3911174913,2019-10-10 09:00:00,,"vitiligo, EADV2019, ","pic.twitter.com/32qbf70pTm, ",1182279613461876736,False,94,0,1,25,Twitter for Advertisers.,"Jim Lee, Group VP &amp; Head of Inflammation &amp; Autoimmunity, explains how we're utilizing our expertise of the JAK pathway as we seek to address unmet needs for people with #vitiligo. #EADV2019 https://t.co/32qbf70pTm",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
3318510966,2019-10-10 08:08:17,,,"crweworld.com/article/news-p‚Ä¶, ",1182266598234550277,False,0,0,0,0,CRWE World,Incyte to Report Third Quarter Financial Results https://t.co/ife2H6lxz2,,,2015-08-18 06:21:05,"Las Vegas, NV",Crwe World,https://pbs.twimg.com/profile_images/633584665601814528/AF-Nh26Y_normal.jpg,932,2063,38,1221838,CrweWorld,
1069693680066420736,2019-10-10 08:07:38,"INCY, ",,"s.flashalert.me/IZJM6A, ",1182266437181808640,False,0,0,0,0,flashalerts,"$INCY: Press Release published article on October 10, 08:00:00: Incyte to Report Third Quarter Financial Results https://t.co/tDmwPsiQ9x",,,2018-12-03 15:43:42,"New York, USA",Flash Alert,https://pbs.twimg.com/profile_images/1097981011131068417/ilJIYvHC_normal.png,3154,0,95,842261,FlashAlert_me,
976297820532518914,2019-10-10 08:06:10,,,"dlvr.it/RFvMCs, pic.twitter.com/sAs4nSCnUQ, ",1182266066371665920,False,0,0,0,0,dlvr.it,Incyte to Report Third Quarter Financial Results https://t.co/0WyEY1Aw7M https://t.co/sAs4nSCnUQ,,,2018-03-20 23:21:53,,Latest News from Business Wire,https://pbs.twimg.com/profile_images/1232441740960751618/uibDWsPi_normal.jpg,2084,23,31,283662,NewsFromBW,photo
973396999646208000,2019-10-09 23:31:18,,"ispottv, ","ispot.tv/ad/o6XK/incyte‚Ä¶, ",1182136498663182342,False,0,0,0,1,Twitter for Android,"I have this and it's torture! 

Incyte TV Commercial, 'Living With PV' - https://t.co/jLA6Oqn20O #ispottv",,,2018-03-12 23:15:04,"South Charleston, WV",John David Smith,https://pbs.twimg.com/profile_images/1359489953248509954/Sxy0FIW7_normal.jpg,10542,10804,0,57440,notbuyingit365,
3911174913,2019-10-09 18:00:00,,"vitiligo, ","pic.twitter.com/bXgIPxZ1Cp, ",1182053122614743040,False,120,0,4,27,Twitter for Advertisers.,"Our Chief Medical Officer, Steven Stein, explains how our inflammation &amp; autoimmunity group uncovered the potential to address unmet needs in #vitiligo. Watch to learn more. https://t.co/bXgIPxZ1Cp",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,video
631661989,2019-10-09 12:12:05,,"ChooseDelaware, growth, NetDE, ","pic.twitter.com/oRg9x5h2tf, ",1181965565159718912,False,1,0,0,0,Sprout Social,"Congrats to @thebancorp, @DuPont_News, @Incyte, Chesapeake Utilities Corp and @WSFS for making the ""Soaring 76: Fastest Growing Companies"" list compiled by @PHLBizJournal. #ChooseDelaware #growth #NetDE https://t.co/oRg9x5h2tf","thebancorp, DuPont_News, Incyte, WSFS, PHLBizJournal, ",,2012-07-09 23:54:36,"Wilmington, Delaware",Global Delaware,https://pbs.twimg.com/profile_images/1059868013459992577/IjSZsC14_normal.jpg,5389,1817,222,6107,DelawareGlobal,photo
175782459,2019-10-09 11:20:42,,,"lnkd.in/ebCB9pW, ",1181952637077458945,False,4,0,1,0,LinkedIn,"Honored to facilitate, this year again, Incyte Diagnostics annual retreat. Incyte is a superb group of 40+ pathologists providing multi-specialty anatomic and clinical pathology services throughout the Pacific Northwest https://t.co/e0wgz0argB",,,2010-08-07 12:06:37,"Denver, CO","Karim Sirgi MD, MBA, FCAP",https://pbs.twimg.com/profile_images/864258362094919680/FjuwY4Ck_normal.jpg,1584,1412,44,3474,ksirgimd,
1105181977249005568,2019-10-09 11:05:13,,,"total-pharma-news.com/news/splenomeg‚Ä¶, ",1181948739348582400,False,0,0,0,0,Facebook,"Splenomegaly Therapeutics Market Growth Prospects, Demand, Future Scenario and Key Vendors: GlaxoSmithKline plc, Incyte Corporation, Novartis AG, Sanofi, Merck &amp; Co., Inc - techtiding https://t.co/dmiC1024Pt",,,2019-03-11 15:01:31,,Total Pharma News,https://pbs.twimg.com/profile_images/1105182027266052102/c-nuqw9s_normal.jpg,151,14,3,13828,total_pharma,
135474465,2019-10-09 10:20:44,,"Pharma, ","statnews.com/2019/10/09/ice‚Ä¶, ",1181937543773712384,False,9,0,1,5,Twitter for Android,.One disclosure that @statnews might've included about this op-ed on @icer_review is that @CancerCare receives significant financial support from #Pharma. Top donors of $1m or more in 2018 include @abbvie @genentech @Incyte @JanssenUS etc. https://t.co/Zi0tZUWUlY @VPrasadMDMPH,"statnews, icer_review, CancerCare, abbvie, genentech, Incyte, JanssenUS, VPrasadMDMPH, ",,2010-04-21 08:03:43,"New Haven, CT, United States",Reshma Ramachandran,https://pbs.twimg.com/profile_images/378800000297352887/e399ff83745d32b58f17cd71ea5d6583_normal.jpeg,1974,2073,0,4921,reshmagar,
3911174913,2019-10-09 10:11:10,,"EADV2019, ","pic.twitter.com/5J2Y3Ko18V, ",1181935135484207105,False,3,0,0,1,Twitter Web App,We're live at #EADV2019. Follow along to learn more about our latest R&amp;D efforts in inflammation &amp; autoimmunity. https://t.co/5J2Y3Ko18V,,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
374729426,2019-10-09 10:03:11,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/809952, pic.twitter.com/sUBqHoC5Cs, ",1181933129264582656,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average moved below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/Gjr4zpvV8D #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/sUBqHoC5Cs",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
2384219072,2019-10-09 08:00:43,,"BioBreakfast, DEBIO, BB, ","loom.ly/LinPD8E, pic.twitter.com/zTjD8fMRIN, ",1181902306733891584,False,2,0,0,0,Loomly,"Haven't registered for the November #BioBreakfast on Thurs, Nov 21st from 7:30 - 9:30 AM?? It will be @ #DEBIO member company @Incyte and is the last #BB of 2019!  
REGISTER today!! https://t.co/7N03V8O7Vl https://t.co/zTjD8fMRIN","Incyte, ",,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
732361939490312192,2019-10-09 04:55:24,"INCY, ","markets, ","americanbankingnews.com/?p=12143860, ",1181855669584109578,False,0,0,0,0,Zapier.com,Incyte $INCY ‚Äì Investment Analysts‚Äô Recent Ratings Updates https://t.co/UTFbWRRuZ6 #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-09 04:55:23,"INCY, ","stocks, ","americanbankingnews.com/?p=12143860, ",1181855667247882240,False,0,0,0,0,Zapier.com,Incyte $INCY ‚Äì Investment Analysts‚Äô Recent Ratings Updates https://t.co/7I8rfVNlOr #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
1979190776,2019-10-09 03:14:55,"INCY, ",,"tickerreport.com/?p=4697220, ",1181830385312960512,False,0,0,0,0,Zapier.com,ValuEngine Lowers Incyte $INCY to Strong Sell https://t.co/GYDH1TcPpX,,,2013-10-21 11:58:27,Virginia,Ticker Report,https://pbs.twimg.com/profile_images/378800000629011324/02a58ce4852fa2c0b053a8853393c35c_normal.png,3948,41,196,2033676,TickerReport,
1696513088,2019-10-08 15:17:35,,,"ajmc.com/newsroom/phase‚Ä¶, ",1181649862808481797,False,0,0,0,0,TweetDeck,"Findings from a phase 2 study assessing pemigatinib in patients with previously treated, advanced cholangiocarcinoma are supporting Incyte‚Äôs planned submission for a NDA for the selective fibroblast growth factor receptor inhibitor by the end of the year
https://t.co/BJeCa9s0mI",,,2013-08-24 09:37:21,"Cranbury, NJ",AJMC-Oncology,https://pbs.twimg.com/profile_images/842440624171298817/92BNA7F__normal.jpg,2196,968,114,7540,EBOncology,
631661989,2019-10-08 12:46:01,,"ChooseDelaware, innovation, biopharma, ","bit.ly/2ohAGex, ",1181611718834827271,False,3,0,0,1,Sprout Social,"Innovative biopharmaceutical research company @Incyte to expand in Delaware, bringing all of their employees to its Augustine Cut-Off headquarters. https://t.co/KoYaig8J5n #ChooseDelaware #innovation #biopharma","Incyte, ",,2012-07-09 23:54:36,"Wilmington, Delaware",Global Delaware,https://pbs.twimg.com/profile_images/1059868013459992577/IjSZsC14_normal.jpg,5389,1817,222,6107,DelawareGlobal,
114898847,2019-10-08 11:11:39,,,,1181587968299024384,False,4,0,0,0,Facebook,"The World's Most Innovative Companies of 2018:

1.üá∫üá∏ ServiceNow
2.üá∫üá∏ Workday
3.üá∫üá∏ Salesforce
4.üá∫üá∏ Tesla
5.üá∫üá∏ Amazon
6.üá∫üá∏ Netflix
7.üá∫üá∏ Incyte
8.üáÆüá≥ Hindustan Unilever
9.üá∞üá∑ Naver
10.üá∫üá∏ Facebook
11.üáπüá≥ SFBT 
(Forbes)",,,2010-02-16 18:54:00,La La Land ,Gino Martinez,https://pbs.twimg.com/profile_images/1153356853088280576/4FHoWtPZ_normal.jpg,1564,4481,8,49142,pulpficction,
374729426,2019-10-08 09:09:57,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/806814, pic.twitter.com/Wtw4Y2jtIM, ",1181557343261057024,False,0,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/O9d5405hSj #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Wtw4Y2jtIM",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
752353070089142272,2019-10-08 05:10:53,,,,1181497179065569281,False,1,0,0,0,Twitter for Android,"The World's Most Innovative Companies of 2018:

1.üá∫üá∏ ServiceNow
2.üá∫üá∏ Workday
3.üá∫üá∏ Salesforce
4.üá∫üá∏ Tesla
5.üá∫üá∏ Amazon
6.üá∫üá∏ Netflix
7.üá∫üá∏ Incyte
8.üáÆüá≥ Hindustan Unilever
9.üá∞üá∑ Naver
10.üá∫üá∏ Facebook

(Forbes)",,,2016-07-11 00:05:24,"Here There & Everywhere, üáÆüá≥",Rambraksh Yadav üáÆüá≥,https://pbs.twimg.com/profile_images/1432287974222225411/UyoMHDJv_normal.jpg,394,296,2,18071,RambrakshYadav,
31855062,2019-10-07 23:56:27,,,,1181418049385254913,False,0,0,0,1,IFTTT,"Carlos Penna Charolet | TResearch The World's Most Innovative Companies of 2018:

1.üá∫üá∏ ServiceNow
2.üá∫üá∏ Workday
3.üá∫üá∏ Salesforce
4.üá∫üá∏ Tesla
5.üá∫üá∏ Amazon
6.üá∫üá∏ Netflix
7.üá∫üá∏ Incyte
8.üáÆüá≥ Hindustan Unilever
9.üá∞üá∑ Naver
10.üá∫üá∏ Facebook

(Forbes)",,,2009-04-16 10:48:23,Global,Carlos Penna Charolet,https://pbs.twimg.com/profile_images/1262421099062669320/8MPllFAA_normal.jpg,5709,1934,84,11496,CarlosPennaC,
103915897,2019-10-07 23:56:02,,,,1181417945743925249,False,1,1,0,1,Twitter for Android,"The World's Most Innovative Companies of 2018:

1.üá∫üá∏ ServiceNow
2.üá∫üá∏ Workday
3.üá∫üá∏ Salesforce
4.üá∫üá∏ Tesla
5.üá∫üá∏ Amazon
6.üá∫üá∏ Netflix
7.üá∫üá∏ Incyte
8.üáÆüá≥ Hindustan Unilever
9.üá∞üá∑ Naver
10.üá∫üá∏ Facebook

(Forbes)",,,2010-01-11 12:29:50,Latinoam√©rica,üÑ≥üÑ∞üÖÖüÑ∏üÑ≥ üÖâüÑ∞üÑªüÑ≥üÖÑüÑºüÑ±üÑ∏üÑ≥üÑ¥ üí°,https://pbs.twimg.com/profile_images/1417716992572805125/UWL5ZSJf_normal.jpg,3633,4957,106,18341,davidavidu,
938419883745869824,2019-10-07 23:52:04,,,,1181416948569186304,False,691,9,21,172,Twitter Web App,"The World's Most Innovative Companies of 2018:

1.üá∫üá∏ ServiceNow
2.üá∫üá∏ Workday
3.üá∫üá∏ Salesforce
4.üá∫üá∏ Tesla
5.üá∫üá∏ Amazon
6.üá∫üá∏ Netflix
7.üá∫üá∏ Incyte
8.üáÆüá≥ Hindustan Unilever
9.üá∞üá∑ Naver
10.üá∫üá∏ Facebook

(Forbes)",,,2017-12-06 09:48:30,Global,World Index,https://pbs.twimg.com/profile_images/966631777220603904/bSPrJFRy_normal.jpg,267929,0,756,6163,theworldindex,
1852162861,2019-10-07 18:33:50,,"CompanySpotlight, ","twitter.com/BriaCell/statu‚Ä¶, ",1181336859445608449,False,1,0,0,0,Twitter Web App,#CompanySpotlight: The initiation of the Bria-IMT‚Ñ¢ clinical study marks the launch of @BriaCell's first clinical collaboration with Incyte. The goal is to remove cancer-induced suppression of the immune system thereby awakening the immune response. https://t.co/rXMF4in4eT,"BriaCell, ",,2013-09-10 14:03:34,"Vancouver, BC",Market One,https://pbs.twimg.com/profile_images/1194296670671912962/UPL9ZQ27_normal.jpg,6154,3825,104,6264,MarketOneMedia,
898405933,2019-10-07 15:23:02,,"biotech, breastcancer, clinicaltrials, investing, ","bit.ly/inn_ceobwill, pic.twitter.com/rH9FUb2AdH, ",1181288843938426880,False,0,0,0,0,Sprout Social,"CEO Interview - Dr. Bill Williams, CEO BriaCell: Incyte Collaboration Enabling New Clinical Trials for Breast Cancer Treatments https://t.co/WhJrAkRnHB @BriaCell #biotech #breastcancer #clinicaltrials #investing https://t.co/rH9FUb2AdH","BriaCell, ",,2012-10-22 16:55:41,,INN Life Science,https://pbs.twimg.com/profile_images/1212856731342114817/lIjBwLju_normal.jpg,5076,3476,92,7478,INN_LifeScience,photo
2891146588,2019-10-07 14:18:01,,"breastcancer, ","bit.ly/2VmMqc8, ",1181272481254035459,False,0,0,0,0,Sprout Social,"With 12% of women in the US expected to develop a form of #breastcancer at some point in their life, there is an urgent need for solutions.

See Dr.Williams' interview about how we are working on fighting this disease &amp; the technology we're using.

https://t.co/IEn1894Frz",,,2014-11-24 13:16:48,"New York, NY",BriaCell,https://pbs.twimg.com/profile_images/1433876026656952323/yM_H4sLw_normal.jpg,1215,551,9,477,BriaCell,
204949973,2019-10-07 13:11:02,,"biotech, breastcancer, clinicaltrials, investing, ","bit.ly/inn_ceobwill, pic.twitter.com/AynGvP3x52, ",1181255626984439808,False,0,0,0,0,Sprout Social,"CEO Interview - Dr. Bill Williams, CEO BriaCell: Incyte Collaboration Enabling New Clinical Trials for Breast Cancer Treatments https://t.co/zffqt6AIR8 @BriaCell #biotech #breastcancer #clinicaltrials #investing https://t.co/AynGvP3x52","BriaCell, ",,2010-10-19 16:46:35,Vancouver BC,InvestingNewsNetwork,https://pbs.twimg.com/profile_images/1212114377010221067/3U37GHA8_normal.jpg,5413,1591,146,14815,DigMedia,photo
190337035,2019-10-07 12:29:39,,"hpbcsm, PrecisionMedicine, NCT02924376, ESMO19, LBA40, ","ow.ly/TK1f30pE6cD, ",1181245212389253120,False,0,0,0,0,Twitter Web App,"Incyte Announces Positive Updated Results from FIGHT-202 Phase 2 Trial of Pemigatinib FGFR inhibitor in Previously Treated, Advanced Cholangiocarcinoma [Sep 27, 2019] @Incyte https://t.co/AQzsihNgmn #hpbcsm #PrecisionMedicine #NCT02924376 #ESMO19 Abstract #LBA40 HT @agrothey","Incyte, agrothey, ",,2010-09-13 14:03:36,"Milwaukee, WI","Mike Thompson, MD, PhD, FASCO",https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_normal.jpg,22209,3726,814,131006,mtmdphd,
1171886451723624448,2019-10-07 10:18:01,,"medicalsciences, ","lnkd.in/dcwEFwE, lnkd.in/dNMeqdg, ",1181212085763608576,False,0,0,0,0,LinkedIn,"Check out the latest breast cancer treatment news out from BriaCell. They are working together with Incyte Corporation on an innovative immunotherapy and look forward to connecting with the FDA in the near future. 
#medicalsciences‚Ä¶https://t.co/tvKBIwLnte https://t.co/je9k1PhyZG",,,2019-09-11 16:41:28,"Vancouver, BC Canada",Allie_INN,https://pbs.twimg.com/profile_images/1171886551489318912/sITl1Wr1_normal.jpg,46,207,1,318,AllieInn,
374729426,2019-10-07 08:04:28,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/803875, pic.twitter.com/Jgrz9ezWX2, ",1181178475723386881,False,1,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/rtJl54lyI7 #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/Jgrz9ezWX2",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
1148669077520408576,2019-10-07 07:51:34,,,"BioPortfolio.com, healthsonar.com/incyte-collabo‚Ä¶, ",1181175230707982337,False,0,0,0,0,FS Poster,"Incyte Collaboration Enabling New Scientific Trials for Breast Most cancers Remedies ‚Äî https://t.co/DmlB9Q5oCz
https://t.co/bLaf1kQHvi",,,2019-07-09 15:03:44,,Unidrugscom,https://pbs.twimg.com/profile_images/1262430609655443458/mKRz1mme_normal.jpg,15,1,0,11124,unidrugscom,
1525137691,2019-10-07 07:14:01,,,"bioportfol.io/RFgTqj, ",1181165779900719105,False,0,0,0,1,dlvr.it,BriaCell CEO Incyte Collaboration Enabling New Clinical Trials for Breast Cancer Treatments: Incyte Collaboration Enabling New Clinical Trials for Breast Cancer TreatmentsThe post BriaCell CEO Incyte Collaboration Enabling New Clinical Trials for Breast‚Ä¶ https://t.co/ZW72auy2Ep,,,2013-06-17 11:21:24,,Renal Cell Carcinoma,https://pbs.twimg.com/profile_images/656427745304530945/qbgWaiHn_normal.png,341,12,5,45347,Renal_Bio,
2266388972,2019-10-07 01:15:39,"INCY, ","stocks, ","dailypolitical.com/?p=3116683, ",1181075594991341568,False,0,0,0,0,Zapier.com,$0.65 Earnings Per Share Expected for Incyte Co. $INCY This Quarter https://t.co/C8rY4IA7zF #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-10-07 01:15:38,"INCY, ",,"dailypolitical.com/?p=3116683, ",1181075589261926400,False,1,0,0,0,Zapier.com,$0.65 Earnings Per Share Expected for Incyte Co. $INCY This Quarter https://t.co/uzHeZgdmgf,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
849417718642159616,2019-10-06 22:49:23,"INCY, ",,"themarketsdaily.com/?p=2634272, ",1181038783384444928,False,1,0,0,0,Zapier.com,Incyte $INCY Downgraded by ValuEngine to ‚ÄúStrong Sell‚Äù https://t.co/v0nmJfKkve,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2181281054,2019-10-06 19:58:10,"INCY, ","markets, ","wkrb13.com/?p=1302698, ",1180995694271877121,False,0,0,0,0,Zapier.com,Incyte Co. $INCY Expected to Announce Quarterly Sales of $540.90 Million https://t.co/0oRt0FgXzg #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
374729426,2019-10-06 07:54:03,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/800924, pic.twitter.com/wkZZPjI1oq, ",1180813467214737408,False,1,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/pQL1fZqfJM #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wkZZPjI1oq",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
856240505826496513,2019-10-06 06:58:01,,"regulatoryreporting, regulation, ","Businesswire.com, dlvr.it/RFcMbZ, ",1180799367147483137,False,0,0,0,0,dlvr.it,British Columbia Investment Management Stake in Incyte (INCY) Has Cut by $1.89 Million ...: ... https://t.co/1epLjifSlC published: ‚ÄúNorthern Trust and Confluence Partnership Enhances Financial and Regulatory Reporting for‚Ä¶ https://t.co/YxwDh13Iof #regulatoryreporting #regulation,,,2017-04-23 16:16:59,"London, UK",Suriya Subramanian,https://pbs.twimg.com/profile_images/874697519179198465/phy05IkZ_normal.jpg,5273,3038,111,365013,SuriyaSubraman,
374729426,2019-10-05 12:10:31,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/798219, pic.twitter.com/9HGlZHuwCO, ",1180515618698588162,False,1,0,0,0,Tickeron,"$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this and other indicators: https://t.co/wIKAuToKAm #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/9HGlZHuwCO",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
956484027384582144,2019-10-05 05:52:05,"INCY, ","stocks, stockmarket, ","danversrecord.com/2018/03/12/are‚Ä¶, ",1180420385185107970,False,2,0,0,0,stockspredictor,"Are CBS Corporation (NYSE:CBS), Incyte Corporation (NasdaqGS:INCY) Producing ... https://t.co/uAcoGKDxgp $INCY #stocks #stockmarket",,,2018-01-25 06:08:57,,StocksPredictor,https://pbs.twimg.com/profile_images/956485778384850944/S5_3tIPa_normal.jpg,1445,1604,8,20822,StocksPredictr,
2181281054,2019-10-05 02:17:19,"INCY, ","markets, ","wkrb13.com/?p=1299824, ",1180366336175886336,False,0,0,0,0,Zapier.com,Incyte $INCY Now Covered by Mizuho https://t.co/tWqlNunbnE #markets,,,2013-11-07 21:17:02,,WKRB News,https://pbs.twimg.com/profile_images/378800000709495912/4d5b1653db87aeb8c4685ea3febc9ab0_normal.png,1210,9,0,1704200,WKRBNews,
2920258887,2019-10-05 02:15:31,"INCY, ",,"dakotafinancialnews.com/?p=1227941, ",1180365885728591872,False,1,0,0,0,Zapier.com,Incyte $INCY Now Covered by Mizuho https://t.co/M2VR05roKe,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
2298709746,2019-10-05 01:08:12,"INCY, ",,"watchlistnews.com/?p=3214417, ",1180348941969362944,False,1,0,0,0,Zapier.com,Incyte $INCY Coverage Initiated by Analysts at Mizuho https://t.co/1T9wNvrCN5,,,2014-01-18 19:22:08,,Watchlist News,https://pbs.twimg.com/profile_images/424704502822760448/Kbvk9XzQ_normal.jpeg,3097,11,160,1339574,WatchlistN,
895929863521095680,2019-10-04 21:26:27,"INCY, ","DeathCross, Incyte, stocks, trading, finance, market, ","bit.ly/2VeyQaK, pic.twitter.com/kfXqUItXqh, ",1180293137459228672,False,0,0,1,0,TradeFlags,#DeathCross $INCY at 74.87 R8  HiLo 55% T1Y 94 buy 2.2 PE 52.7 DIV N/A #Incyte Cor #stocks #trading #finance #market https://t.co/d8StqFoHud https://t.co/kfXqUItXqh,,,2017-08-11 04:48:19,1130,TradeFlags,https://pbs.twimg.com/profile_images/1444247772769792002/Hc_nWhvE_normal.jpg,636,206,11,58994,TradeFlags,photo
2920258887,2019-10-04 20:54:59,"INCY, ",,"dakotafinancialnews.com/?p=1227261, ",1180285219934494721,False,0,0,0,0,Zapier.com,$0.65 EPS Expected for Incyte Co. $INCY This Quarter https://t.co/2En0pYW0Ln,,,2014-12-13 15:48:14,,Dakota Financial,https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png,1553,40,76,1198531,dakotafinancial,
852931863547084801,2019-10-04 13:19:33,"INCY, ",,"transcriptdaily.com/?p=2523387, ",1180170605481607168,False,0,0,0,0,Zapier.com,JMP Securities Increases Incyte $INCY Price Target to $110.00 https://t.co/MojbpFIEqg,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
2416188264,2019-10-04 13:19:31,"INCY, ","markets, ","thestockobserver.com/?p=2339212, ",1180170596413509634,False,0,0,0,0,Zapier.com,JMP Securities Increases Incyte $INCY Price Target to $110.00  https://t.co/uKojNOvx20 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
477131488,2019-10-04 11:30:59,,"immunotherapy, cancer, vaccines, ThinkTank2019, ","pic.twitter.com/SJwrT6m0tK, pic.twitter.com/SJwrT6m0tK, pic.twitter.com/SJwrT6m0tK, ",1180143284884267009,False,6,0,0,0,Twitter for iPhone,Prof @SamirNKhleif #immunotherapy Rockstar @Georgetown talks strategies 2 improve outcomes 4 patients with #cancer/#vaccines alone don‚Äôt work/can be improved with anti#PD1/but also made worse/depends on schedule/ #ThinkTank2019 @NIBITSIENA @BMS_ImmunOnc_US @Incyte @AstraZeneca https://t.co/SJwrT6m0tK,"SamirNKhleif, Georgetown, NIBITSIENA, BMS_ImmunOnc_US, Incyte, AstraZeneca, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
374729426,2019-10-04 10:35:26,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/795099, pic.twitter.com/4sZwtOg6Yt, ",1180129302903324674,False,0,0,0,0,Tickeron,"$INCY's Aroon indicator reaches into Uptrend on October 3, 2019. View odds for this and other indicators: https://t.co/GSlOPL63pI #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/4sZwtOg6Yt",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
87784777,2019-10-04 08:39:29,,,,1180100124191547392,False,0,0,0,0,Twitter Web Client,"However, they are postively biased on the group and have confidence in FY19 guidance and estimates, the analysts said. They see Alexion (ALXN), Biogen (BIIB), Genmab (GMAB), GW Pharmaceuticals (GWPH), Incyte (INCY), Neurocrine (NBIX), Regeneron (REGN) and",,,2009-11-05 16:14:54,"Boynton Beach, FL",Hotstocks.nyc,https://pbs.twimg.com/profile_images/710434600795959296/cUfH5J4u_normal.jpg,208,657,9,7199,IcemanStocks,
409373333,2019-10-04 08:01:53,,"WillsInWilm, InWilm, wilmington, netde, delaware, officespace, delawareofficespace, ItsTimeWilmDE, ","lnkd.in/eCfcwav, ",1180090662647152642,False,0,0,0,0,Hootsuite Inc.,"INCYTE is moving forward with Incyte is moving forward, even though it had other options in the region. Way to go Wilmington. 

https://t.co/pff9LcXb5S

#WillsInWilm  #InWilm #wilmington
#netde  #delaware  #officespace 
#delawareofficespace  #ItsTimeWilmDE",,,2011-11-10 12:02:59,"Wilmington, Delaware USA",Wills Elliman,https://pbs.twimg.com/profile_images/2767694093/76de5f13c49d237222551033ca563707_normal.jpeg,161,111,13,496,WillsElliman,
477131488,2019-10-04 07:48:55,,"immunotherapy, ICOS, GSK3359609, ESMO2019, ThinkTank2019, ","pic.twitter.com/Tg6ABftZci, pic.twitter.com/Tg6ABftZci, pic.twitter.com/Tg6ABftZci, pic.twitter.com/Tg6ABftZci, ",1180087399554207744,False,11,0,1,4,Twitter for iPhone,Dr Marc S. Ballas #immunotherapy lead of #ICOS Program @GSK talks clinical development of #GSK3359609 critical role of @NIBITSIENA &amp; @unisiena &amp; early results of INDUCE-1 alone or + anti-PD1 / reviewed #ESMO2019 data  @Merck #ThinkTank2019 @NIBITSIENA @Incyte @BMS_ImmunOnc_US https://t.co/Tg6ABftZci,"GSK, NIBITSIENA, unisiena, Merck, NIBITSIENA, Incyte, BMS_ImmunOnc_US, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
111648072,2019-10-04 07:00:04,,,"buff.ly/2ogxzDO, pic.twitter.com/57TvGsa5xz, ",1180075104849551362,False,0,0,0,0,Buffer,"CHECK OUT THE JOB POSTINGS! View the recently posted jobs on the ISMPP Jobs Board! Opportunities available at AbbVie, Bristol-Myers Squibb, Incyte Corp., Innovative Strategic Communications, Johnson &amp; Johnson, Optellum, Takeda, and Vaniam. Find out more: https://t.co/esgTobgN7A https://t.co/57TvGsa5xz",,,2010-02-05 12:32:26,,ISMPP,https://pbs.twimg.com/profile_images/785842416754520065/sh0T72mi_normal.jpg,2584,680,44,4227,ISMPP,photo
477131488,2019-10-04 03:26:27,,"HDAC, Immunotherapy, ThinkTank2019, melanoma, FinishCancer, ","pic.twitter.com/ZDkujqxiso, pic.twitter.com/ZDkujqxiso, pic.twitter.com/ZDkujqxiso, pic.twitter.com/ZDkujqxiso, ",1180021345733763073,False,18,1,0,7,Twitter for iPhone,"Prof Michele Maio #HDAC #Immunotherapy Guru @NIBITSIENA @unisiena opens today‚Äôs #ThinkTank2019 /Reviews 20yrs data on how DNA Methylation loss promotes immune evasion/T, NK/@parkerici @WICouncil @AIRC_it #melanoma #FinishCancer @Incyte @bmsnews @jsoriamd @gulleyj1 @GeneCollector https://t.co/ZDkujqxiso","NIBITSIENA, unisiena, parkerici, WICouncil, AIRC_it, Incyte, bmsnews, jsoriamd, gulleyj1, GeneCollector, ",,2012-01-28 16:37:48,"Portland, Oregon, USA",Bernard A Fox,https://pbs.twimg.com/profile_images/1106988648983986177/sO0btOnd_normal.jpg,5282,5714,89,11609,BernardAFox,photo
2266388972,2019-10-04 03:05:30,"INCY, ","stocks, ","dailypolitical.com/?p=3110586, ",1180016073233616897,False,0,0,0,0,Zapier.com,JMP Securities Increases Incyte $INCY Price Target to $110.00 https://t.co/hiFbcDRJZt #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-10-04 03:05:28,"INCY, ",,"dailypolitical.com/?p=3110586, ",1180016067357347840,False,0,0,0,0,Zapier.com,JMP Securities Increases Incyte $INCY Price Target to $110.00 https://t.co/PEVY9ASvHW,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
849417718642159616,2019-10-03 22:04:23,"INCY, ",,"themarketsdaily.com/?p=2629168, ",1179940297440186374,False,0,0,0,0,Zapier.com,$540.90 Million in Sales Expected for Incyte Co. $INCY This Quarter https://t.co/DPTGghqIvx,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
4028839455,2019-10-03 21:21:49,,,"stocktrot.com/company/incyte‚Ä¶, ",1179929585116274690,False,0,0,0,0,StockTrot1,728 shares: largest acquisition of Incyte Corp shares for Baker Bros Advisors Llc in 3 months. https://t.co/Glm3OwNyt2,,,2015-10-23 23:48:18,,StockTrot,https://pbs.twimg.com/profile_images/698515854661521408/zyTTWXN7_normal.png,1776,3138,15,29913,stocktrot,
21079030,2019-10-03 14:00:18,,"PharmaScrip, ","bit.ly/2oc6S3w, ",1179818473570131970,False,0,0,0,0,Sprinklr,"Bile Duct Cancer Enters Targeted Therapy Era As Agios And Incyte Prepare Filings
https://t.co/vc1D0d3hmy #PharmaScrip",,,2009-02-17 05:33:29,Global,Scrip,https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg,21541,1629,654,35335,PharmaScrip,
314598153,2019-10-03 10:14:32,,,,1179761658077618176,False,0,0,0,0,Twitter Web App,November 21st...see you all at DelawareBio. It is going to be a great event at Incyte,,,2011-06-10 10:25:30,,Pam,https://pbs.twimg.com/profile_images/920109189690810368/swt8BFp-_normal.jpg,49,243,0,143,High5995,
1004375641171603458,2019-10-03 09:31:01,,"ChooseDelaware, Growth, NetDE, ","pic.twitter.com/UvyEMfPMFZ, ",1179750706519183362,False,4,0,0,3,Sprout Social,"Congrats to @thebancorp, @DuPont_News, @Incyte, Chesapeake Utilities Corp and @WSFS for making the ""Soaring 76: Fastest Growing Companies"" list compiled by @PHLBizJournal. #ChooseDelaware #Growth #NetDE https://t.co/UvyEMfPMFZ","thebancorp, DuPont_News, Incyte, WSFS, PHLBizJournal, ",,2018-06-06 10:53:08,,Delaware Prosperity Partnership @choosedelaware,https://pbs.twimg.com/profile_images/1059872509540134913/PX_tVV7O_normal.jpg,4337,1030,21,2792,choosedelaware,photo
374729426,2019-10-03 09:06:07,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/791977, pic.twitter.com/wzu3Di247a, ",1179744437657731072,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price may jump up because it broke its lower Bollinger Band on September 26, 2019. View odds for this and other indicators: https://t.co/C7FmZWd2yF #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/wzu3Di247a",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3183637130,2019-10-03 07:25:12,,"NavyCapital, barronsonline, ","on.barrons.com/2oNPAJO, ",1179719043886047232,False,0,0,0,0,IFTTT,#NavyCapital #barronsonline: European Conference Highlights Cancer-Drug Developments https://t.co/ypnvQUMaMi,,,2015-05-02 23:52:00,,NAVY CAPITAL,https://pbs.twimg.com/profile_images/1267078817908174848/RiUFXVXM_normal.jpg,690,58,25,106030,navycapital,
20449296,2019-10-03 07:02:27,,,"on.barrons.com/2oNPAJO, ",1179713319214690305,False,2,0,0,0,SocialFlow,European Conference Highlights Cancer-Drug Developments https://t.co/dPv1SBA7jY,,,2009-02-09 12:15:01,"New York, NY",Barron's,https://pbs.twimg.com/profile_images/1400867183333412864/LO1NDNpM_normal.jpg,201867,35,4773,60256,barronsonline,
1022006086872821762,2019-10-03 07:02:20,"INCY, INCY, ",,,1179713288428498944,False,0,0,0,0,Communist stocks,"Incyte - $INCY

üí∞ QUOTE
$INCY was DOWN ‚¨á on Wed Oct 02
Closed at 73.04 USD for a -1.24% loss from previous close
üìâ üìâ üìâ

üìä ANALYSIS
Incyte should be nationalized
‚ò≠ ‚ò≠ ‚ò≠",,,2018-07-25 02:30:13,,Communist Stock Analysis,https://pbs.twimg.com/profile_images/1022740990388404224/kZtCpJx4_normal.jpg,123,1,2,25631,communiststocks,
732361939490312192,2019-10-02 22:58:24,"INCY, ","markets, ","americanbankingnews.com/?p=12080240, ",1179591502579867648,False,0,0,0,0,Zapier.com,Incyte $INCY Now Covered by Analysts at Mizuho https://t.co/sVIMmCqxhW #markets,,,2016-05-16 20:07:47,"Sioux Falls, SD",Community Financial,https://pbs.twimg.com/profile_images/732362091781312513/l5uerSUM_normal.jpg,392,164,44,1393764,CFinancialNews,
61661638,2019-10-02 22:58:24,"INCY, ","stocks, ","americanbankingnews.com/?p=12080240, ",1179591500285562880,False,0,0,0,0,Zapier.com,Incyte $INCY Now Covered by Analysts at Mizuho https://t.co/mWnRyVBh3V #stocks,,,2009-07-30 21:58:33,"Sioux Falls, SD",US Banking News,https://pbs.twimg.com/profile_images/541252987/Image5_normal.jpg,8471,2035,723,2853562,AmericanBanking,
966006214818697218,2019-10-02 18:32:10,"INCY, ",,"theenterpriseleader.com/?p=2287013, ",1179524503401123840,False,0,0,0,0,Zapier.com,Incyte $INCY Research Coverage Started at Mizuho  https://t.co/wvKg0HSVzf,,,2018-02-20 12:46:43,United States,Enterprise Leader,https://pbs.twimg.com/profile_images/966007162500562945/JE8dLxj__normal.jpg,686,4,21,616944,EnterpriseLeade,
852931863547084801,2019-10-02 18:31:05,"INCY, ",,"transcriptdaily.com/?p=2519209, ",1179524231387893762,False,0,0,0,0,Zapier.com,Incyte $INCY Research Coverage Started at Mizuho https://t.co/qP4O5rYfSY,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
2384219072,2019-10-02 14:00:50,,"BioBreakfast, DEBIO, Incyte, DELifeScience, netDE, innovation, ","loom.ly/LinPD8E, pic.twitter.com/SVgwoz4TTp, ",1179456221071527937,False,0,0,0,0,Loomly,"Registration is OPEN for the November #BioBreakfast on Thurs, Nov 21st from 7:30 - 9:30 AM @ #DEBIO member company Incyte! Don't miss your chance to hear from #Incyte CEO Herve Hoppenot!
REGISTER: https://t.co/7N03V8O7Vl 
#DELifeScience #netDE #innovation https://t.co/SVgwoz4TTp",,,2014-03-11 17:25:29,"Wilmington, DE",Delaware Bio,https://pbs.twimg.com/profile_images/1348667372891238404/-I2pULPs_normal.png,1137,445,55,2894,Delaware_Bio,photo
1004375641171603458,2019-10-02 13:54:02,,"ChooseDelaware, innovation, biopharma, ","bit.ly/2ohAGex, ",1179454506347716609,False,3,0,0,1,Sprout Social,"Innovative biopharmaceutical research company @Incyte to expand in Delaware, bringing all of their employees to its Augustine Cut-Off headquarters. https://t.co/S2ga53SGLC #ChooseDelaware #innovation #biopharma","Incyte, ",,2018-06-06 10:53:08,,Delaware Prosperity Partnership @choosedelaware,https://pbs.twimg.com/profile_images/1059872509540134913/PX_tVV7O_normal.jpg,4337,1030,21,2792,choosedelaware,
2426346337,2019-10-02 12:22:37,,,"pic.twitter.com/qMuhBLkxvs, pic.twitter.com/qMuhBLkxvs, pic.twitter.com/qMuhBLkxvs, ",1179431504008683521,False,3,0,1,0,Twitter Web App,"How cool are these?! Dr. Isaac Grindeland, Pathologist at PRH &amp; InCyte Diagnostics, finds art in his everyday pathology work. A skin biopsy that looks like a whale, thyroid tissue with the pattern of a giraffe, small intestinal biopsy with the stripes of a zebra, &amp; more. https://t.co/qMuhBLkxvs",,,2014-04-03 19:42:27,"Pullman, Washington",Pullman Regional Hospital,https://pbs.twimg.com/profile_images/1411021643481112578/Q3cGCMIa_normal.jpg,1453,569,28,1547,PullmanRegional,photo
374729426,2019-10-02 09:40:51,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/787953, pic.twitter.com/ysGX9SeCKj, ",1179390792244383744,False,0,0,0,0,Tickeron,"$INCY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on September 26, 2019. View odds for this and other indicators: https://t.co/1eg3Z1iyAH #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/ysGX9SeCKj",,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
3911174913,2019-10-01 15:00:00,,"rarecancer, RareCancerDay, ",,1179108720350920704,False,3,0,0,2,Twitter for Advertisers.,"Our Chief Medical Officer, Steven Stein, shares his perspective on Incyte's commitment to continued research for the #rarecancer community. #RareCancerDay",,,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,
930803511918411776,2019-10-01 12:50:32,"INCY, ",,"thelincolnianonline.com/?p=3086070, ",1179076141027598339,False,0,0,0,0,Zapier.com,Incyte $INCY Given New $110.00 Price Target at JMP Securities https://t.co/ryHcHl2kAb,,,2017-11-15 09:23:45,United States,The Lincolnian,https://pbs.twimg.com/profile_images/930807052535865344/LxG61pp2_normal.jpg,737,34,23,662741,ThisLincolnian,
190337035,2019-10-01 12:38:21,,"hpbcsm, PrecisionMedicine, NCT02924376, ESMO19, LBA40, ","ow.ly/TK1f30pE6cD, pic.twitter.com/ii304mY0s3, pic.twitter.com/ii304mY0s3, ",1179073072588103681,False,1,0,0,0,Hootsuite Inc.,"Incyte Announces Positive Updated Results from FIGHT-202 Phase 2 Trial of Pemigatinib FGFR inhibitor in Previously Treated, Advanced Cholangiocarcinoma [Sep 27, 2019] @Incyte https://t.co/AQzsihNgmn #hpbcsm #PrecisionMedicine #NCT02924376 #ESMO19 Abstract #LBA40 HT @agrothey https://t.co/ii304mY0s3","Incyte, agrothey, ",,2010-09-13 14:03:36,"Milwaukee, WI","Mike Thompson, MD, PhD, FASCO",https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_normal.jpg,22209,3726,814,131006,mtmdphd,photo
374729426,2019-10-01 09:05:50,"INCY, ","Incyte, stockmarket, stock, technicalanalysis, money, trading, investing, daytrading, news, today, ","tickeron.com/go/784999, pic.twitter.com/2IfiDybI16, ",1179019590916960256,False,0,0,0,0,Tickeron,$INCY in Downtrend: Stochastic indicator remains in oversold zone for 5 days. View odds for this and other indicators: https://t.co/WQYy3qmcLQ #Incyte #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/2IfiDybI16,,,2011-09-16 16:46:39,"Sunnyvale, CA",Tickeron,https://pbs.twimg.com/profile_images/881978009279881216/7fnZZ_Pl_normal.jpg,11622,755,233,1390859,Tickeron,photo
928816302017404928,2019-10-01 04:41:29,,"esmo19, ","paper.li/DNASurgery/152‚Ä¶, ",1178953065128431616,False,0,0,0,0,Paper.li,Esmo 2019 ‚Äì Targeted bile duct treatment pits Incyte against Agios https://t.co/OnNVFGCnLq by @VantageAnalysis #esmo19,"vantageanalysis, ",,2017-11-09 21:47:17,"Boston, MA",DNA Surgery,https://pbs.twimg.com/profile_images/977851453258829824/40V5_a23_normal.jpg,7,17,0,1523,DNASurgery,
424089030,2019-09-30 22:38:03,,,"evaluate.com/vantage/articl‚Ä¶, ",1178861605242716160,False,0,0,0,0,Twitter Web Client,Esmo 2019 ‚Äì Targeted bile duct treatment pits Incyte against Agios https://t.co/ci2hzCNfd8,,,2011-11-29 04:27:50,"Paris, France",EIPG,https://pbs.twimg.com/profile_images/815655457696137216/Nlslb4Bq_normal.jpg,789,155,0,19758,EIPGeu,
68559732,2019-09-30 22:30:12,"INCY, ",,"thecerbatgem.com/?p=3238255, ",1178859630518263808,False,0,0,0,0,Zapier.com,Incyte $INCY Stock Rating Reaffirmed by Cowen https://t.co/AFO12LYCsE,,,2009-08-24 20:39:44,"Sioux Falls, SD",MarketBeat,https://pbs.twimg.com/profile_images/1310570343245938689/tj6NI-25_normal.png,9220,2544,765,1751232,MarketBeatCom,
2266388972,2019-09-30 22:04:28,"INCY, ","stocks, ","dailypolitical.com/?p=3104318, ",1178853151497170945,False,0,0,0,0,Zapier.com,Incyte $INCY Given a $101.00 Price Target by Guggenheim Analysts https://t.co/73pljeOW5l #stocks,,,2013-12-28 15:16:47,Florida,MidEast Times,https://pbs.twimg.com/profile_images/417030592358662144/QDAne7E5_normal.png,686,46,88,1096162,midetimes,
2338882843,2019-09-30 22:04:26,"INCY, ",,"dailypolitical.com/?p=3104318, ",1178853146778583041,False,0,0,0,0,Zapier.com,Incyte $INCY Given a $101.00 Price Target by Guggenheim Analysts https://t.co/9lRdzqNXLP,,,2014-02-11 14:38:04,,Daily Political,https://pbs.twimg.com/profile_images/433324818658623488/hxhCoePy_normal.jpeg,1411,10,84,1257973,dailypoliticaln,
2416188264,2019-09-30 21:45:52,"INCY, ","markets, ","thestockobserver.com/?p=2332301, ",1178848474797953025,False,0,0,0,0,Zapier.com,Incyte $INCY Given ‚ÄúBuy‚Äù Rating at Cowen  https://t.co/PnZWWQ4Y08 #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
852931863547084801,2019-09-30 20:24:54,"INCY, ",,"transcriptdaily.com/?p=2516231, ",1178828095039721472,False,0,0,0,0,Zapier.com,Incyte $INCY Given a $101.00 Price Target at Guggenheim https://t.co/rDlsS27JWY,,,2017-04-14 13:09:37,,Transcript Daily,https://pbs.twimg.com/profile_images/852935198387732480/RZ-jnMw__normal.jpg,713,9,27,583762,TranscriptDaily,
849417718642159616,2019-09-30 20:11:05,"INCY, ",,"themarketsdaily.com/?p=2623436, ",1178824620352425984,False,0,0,0,0,Zapier.com,Incyte $INCY Given a $101.00 Price Target at Guggenheim https://t.co/s4r3UQFxya,,,2017-04-04 20:25:40,,The Markets Daily,https://pbs.twimg.com/profile_images/849428984488185857/i3dIvJVS_normal.jpg,1948,11,67,797399,TheMarketsDaily,
2416188264,2019-09-30 20:08:36,"INCY, ","markets, ","thestockobserver.com/?p=2332154, ",1178823992964210688,False,0,0,0,0,Zapier.com,Incyte $INCY Given a $101.00 Price Target at Guggenheim  https://t.co/k1n0Cr2gjy #markets,,,2014-03-28 13:00:55,,Storm Investor,https://pbs.twimg.com/profile_images/449593713677713408/LDoyR03v_normal.jpeg,652,9,19,984293,storminvestor,
3911174913,2019-09-30 20:00:00,,"rarecancer, RareCancerDay, ","pic.twitter.com/OKmwboLCGl, ",1178821831987351552,False,40,0,0,11,Twitter for Advertisers.,We're honored to partner with advocacy organizations like @curecc to help raise awareness &amp; offer support for the #rarecancer community. #RareCancerDay https://t.co/OKmwboLCGl,"curecc, ",,2015-10-09 14:27:47,"Wilmington, DE",Incyte,https://pbs.twimg.com/profile_images/1203326443910057984/tqnuzniF_normal.jpg,5958,145,75,1578,Incyte,photo
